Citrus Sinensis ID: 014559

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420--
Protein Sequence
MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccEEccEEEccccccEEEEEEEccccccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccHHccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccHHHHEEcccEcccccccEEEEEEEccccccccEEEEEEHcHHHcccHHHHHHHHHHHHHHHHHcccccEEEEEcccccHHHEEEEEEEccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccccccEEEEccccEEEccccEEccccccHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccHHHccHHHHHHHHHHccccHHHcccHHHHcccHHHHHHHHHHHHHc
Coil and Loop (DISEMBL)
mgqcygktipttendattsaTTTTMVVSanqnqtplppstpgngsmpvkntpgrsshpspwpspyphgvsasplpagvspsparastprrffrrpfpppspakhIKASLAkrlgggkpkestipeergtepeqsldksfgynknfgakyelgkevgrghfghtcsargkkgelkDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHlqgvvhrdlkpenflftsgrddadmRLIDfglsdfirpderlndIVGSAYyvapevlhrsysleadIWSIGVISYILLcgsrpfwarteSGIFRAvlrsdpnfddlpwpsvspeAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Flexible Loop (DISEMBL)
mgqcygktipttendattsATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFrrpfpppspakhikaslakrlgggkpkestipeergtepeqsldksfgyNKNFGAKYELGKEVGRGHFGHtcsargkkgelkdQQVAVKIIskakmttaisiedvRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGvvhrdlkpenflftsgrddadMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRsdpnfddlpwpsvspeaKDFVKRLLNKDYRKRMTAvqalsklvvpilsfkivcry
Low Complexity Region (SEG)
MGQCYGKTIPttendattsattttMVVSANQNQTPLPPSTPGNGSMPVKNTpgrsshpspwpspypHGVSASPLPAGVSPSparastprrffrrpfpppspaKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Disordered region (IsUnstruct)
*******************************************************************************************************************************************GYNKNFGAKYELGKEVGRGHFGHTCSAR*****LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVC**
Disordered Region (DISOPRED)
*******************************************************************************************************************************************GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCR*
Disordered Region (DISEMBL)
MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPV**************SPYPHGVSA***************TPRRFFRRPFPPPSPAKHIKASLAKR**********************LDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Disordered Region (DISPRO)
*****************************************************************************************************************************************SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	422	2.2.26 [Sep-21-2011]
Q9ZUZ2	595	CDPK-related kinase 3 OS=	yes	no	0.983	0.697	0.784	1e-177
Q9SCS2	601	CDPK-related kinase 5 OS=	no	no	0.879	0.617	0.684	1e-148
P53681	602	CDPK-related protein kina	N/A	no	0.976	0.684	0.621	1e-148
Q10KY3	600	Calcium/calmodulin-depend	no	no	0.827	0.581	0.694	1e-144
O80673	576	CDPK-related kinase 1 OS=	no	no	0.900	0.659	0.633	1e-144
Q9LET1	577	CDPK-related kinase 7 OS=	no	no	0.902	0.660	0.628	1e-143
Q9FIM9	594	CDPK-related kinase 4 OS=	no	no	0.926	0.658	0.640	1e-140
Q9LJL9	599	CDPK-related kinase 2 OS=	no	no	0.917	0.646	0.620	1e-137
Q9FX86	606	CDPK-related kinase 8 OS=	no	no	0.869	0.605	0.625	1e-137
Q9SG12	594	CDPK-related kinase 6 OS=	no	no	0.933	0.663	0.644	1e-134

>sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1

 Score =  622 bits (1605), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 339/432 (78%), Positives = 373/432 (86%), Gaps = 17/432 (3%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQT-PLPPSTPGNGSMPVKNTPGRSSHPS 59
           MGQCYGK   + +N     A TTT VVS + NQ  PL P   G      KNTP RSS+PS
Sbjct: 1   MGQCYGKVNQSKQN-GEEEANTTTYVVSGDGNQIQPLTPVNYGRA----KNTPARSSNPS 55

Query: 60  PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK 119
           PWPSP+PHG SASPLP+GVSPSPAR STPRRFFRRPFPPPSPAKHIKASL KRLG  KPK
Sbjct: 56  PWPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPK 113

Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVA 179
           E  IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD  +A
Sbjct: 114 EGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIA 173

Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
           VKIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELL
Sbjct: 174 VKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELL 233

Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
           DRILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDF
Sbjct: 234 DRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDF 293

Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
           GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTES
Sbjct: 294 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTES 353

Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS-------KLVVP 412
           GIFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQAL+         V+P
Sbjct: 354 GIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIP 413

Query: 413 --ILSFKIVCRY 422
             IL +K+V  Y
Sbjct: 414 LDILIYKLVKAY 425

May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  526 bits (1356), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 265/387 (68%), Positives = 310/387 (80%), Gaps = 16/387 (4%)

Query: 50  NTPGRSSHPSPWPSPYP-HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKAS 108
           N  G+ S   P+ SP P H   +   PA    + +  STP+RFF+RPFPPPSPAKHI+A 
Sbjct: 47  NNEGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAV 106

Query: 109 LAKRLGGGKPKESTIPEERGTEPEQS---LDKSFGYNKNFGAKYELGKEVGRGHFGHTCS 165
           LA+R G  KP  S IPE  G+E E     LDKSFG++K+F +KYELG EVGRGHFG+TC+
Sbjct: 107 LARRHGSVKPNSSAIPE--GSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCA 164

Query: 166 ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225
           A+ KKG+ K QQVAVK+I KAKMTTAI+IEDVRREVKIL+ALSGH +L  F DA ED +N
Sbjct: 165 AKFKKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDN 224

Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
           VYIVMELCEGGELLDRIL+RGG+YTEEDAK +++QIL+VVAFCHLQGVVHRDLKPENFLF
Sbjct: 225 VYIVMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLF 284

Query: 286 TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYI 345
           TS  D + ++ IDFGLSD++RPDERLNDIVGSAYYVAPEVLHRSYS EADIWS+GVI YI
Sbjct: 285 TSKEDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYI 344

Query: 346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
           LLCGSRPFWARTESGIFRAVL++DP+FDD PWP +S EA+DFVKRLLNKD RKR+TA QA
Sbjct: 345 LLCGSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQA 404

Query: 406 LS----------KLVVPILSFKIVCRY 422
           LS          K+ + IL FK++  Y
Sbjct: 405 LSHPWIKDSNDAKVPMDILVFKLMRAY 431

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1

 Score =  525 bits (1353), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 274/441 (62%), Positives = 331/441 (75%), Gaps = 29/441 (6%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPST----PGNGSMPVKNT---PG 53
           MG C  K  P+ E D     T+  +      N T LPP      P + ++P ++    PG
Sbjct: 1   MGICVSK--PSPEPDLHNHHTSIPV------NDTSLPPQDNSIPPKDIAIPAQDNNKPPG 52

Query: 54  RSSHPSPWPSPYP-HGVSASPLPAGVSPSPARA-STPRRFFRRPFPPPSPAKHIKASLAK 111
           + S   P+ SP P H + +   PA  SP+   + STP+R F  PFPPPSPAKHIKA+ A+
Sbjct: 53  KKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPAKHIKAAWAR 110

Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
           R G  KP E+ IPE    +    LDKSFG++K FG+K+E+G+EVGRGHFG+TC A+ KKG
Sbjct: 111 RHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKG 170

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
           E K Q VAVK+I KAKMTTAI+IEDVRREVKIL+AL+GH +LV+F DA ED  NVY+VME
Sbjct: 171 EFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVME 230

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
           LCEGGELLDRIL+RGG+YTE+DAKA+++QIL+VVAFCHLQGVVHRDLKPENFLF S  +D
Sbjct: 231 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDED 290

Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
           + ++ IDFGLSD+++PDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGSR
Sbjct: 291 SQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSR 350

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS---- 407
           PFWARTESGIFRAVL+++ +FD+ PWPSVS EAKDFVKRLLNKD RKRMTA QAL     
Sbjct: 351 PFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWI 410

Query: 408 ------KLVVPILSFKIVCRY 422
                 K  + IL FK++  Y
Sbjct: 411 KNSNDIKFPLDILVFKLMKVY 431

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1

 Score =  513 bits (1321), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 248/357 (69%), Positives = 295/357 (82%), Gaps = 8/357 (2%)

Query: 51  TPGRSSHPSPWPSPYP-HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASL 109
           TP +   P   PSP P      SP  + V+ +PAR       F+RPFPPPSPAKHI+A L
Sbjct: 55  TPKQHKFPFYLPSPLPASSYKGSPANSSVASTPARGG-----FKRPFPPPSPAKHIRALL 109

Query: 110 AKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGK 169
           A+R G  KP E++IPE    EP  +LDK FG++++F AKYELG+EVGRGHFG+TC+A  K
Sbjct: 110 ARRHGSVKPNEASIPE--SGEPGVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCK 167

Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           KGELK   VAVK+I KAKMTTAI+IEDVRREV+IL +L+GH +LV+F DA ED  NVYIV
Sbjct: 168 KGELKGDDVAVKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIV 227

Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           MELC+GGELLDRILARGG+Y+EEDAK ++ QILSV +FCHLQGVVHRDLKPENFLF+S  
Sbjct: 228 MELCKGGELLDRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKD 287

Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCG 349
           +++ M++IDFGLSDF++PDERLNDIVGSAYYVAPEVLHRSY  EAD+WSIGVI YILLCG
Sbjct: 288 ENSAMKVIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCG 347

Query: 350 SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           SRPFWARTESGIFRAVL++DP+F++ PWP++S EAKDFV+RLLNKDYRKRMTA QAL
Sbjct: 348 SRPFWARTESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQAL 404

Possesses kinase activity in vitro.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 257/406 (63%), Positives = 313/406 (77%), Gaps = 26/406 (6%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
           MG C+GK +            + ++ VS   N+ P       N   P K+    S  P  
Sbjct: 1   MGICHGKPV---------EQQSKSLPVSGETNEAP------TNSQPPAKS----SGFPFY 41

Query: 61  WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
            PSP P     S   +  S S + +STP R F+RPFPPPSPAKHI+A LA+R G  KP E
Sbjct: 42  SPSPVP-----SLFKSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNE 96

Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
            +IPE  G E E  LDKSFG++K F + YE+  EVGRGHFG+TCSA+GKKG LK Q+VAV
Sbjct: 97  VSIPE--GKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAV 154

Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
           K+I K+KMTTAI+IEDV REVK+L+AL+GHK+LV+F DA ED  NVYIVMELC+GGELLD
Sbjct: 155 KVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLD 214

Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
           +IL RGG+Y+E+DAK ++VQILSVVA+CHLQGVVHRDLKPENFLF++  + + ++ IDFG
Sbjct: 215 KILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFG 274

Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
           LSD+++PDERLNDIVGSAYYVAPEVLHR+Y  EAD+WSIGVI+YILLCGSRPFWARTESG
Sbjct: 275 LSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESG 334

Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           IFRAVL+++PNF++ PWPS+SPEA DFVKRLLNKDYRKR+TA QAL
Sbjct: 335 IFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQAL 380

May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1

 Score =  507 bits (1306), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 255/406 (62%), Positives = 309/406 (76%), Gaps = 25/406 (6%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
           MG C+GK I     +   S                    TP N S   K++      PSP
Sbjct: 1   MGLCHGKPIEQQSKNLPISNEIE---------------ETPKNSSQKAKSSGFPFYSPSP 45

Query: 61  WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
            PS +    + S        S + +STP R F+RPFPPPSPAKHI+A LA+R G  KP E
Sbjct: 46  LPSLFKTSPAVS--------SSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNE 97

Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
           ++IPE  G+E E  LDK FG++K F + YE+  EVGRGHFG+TCSA+GKKG LK Q VAV
Sbjct: 98  ASIPE--GSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAV 155

Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
           K+I K+KMTTAI+IEDVRREVKIL+AL+GHK+LV+F DA ED  NVYIVMELC+GGELLD
Sbjct: 156 KVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLD 215

Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
           +IL RGG+Y+E DAK +++QILSVVA+CHLQGVVHRDLKPENFLFT+  + + ++ IDFG
Sbjct: 216 KILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFG 275

Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
           LSD++RPDERLNDIVGSAYYVAPEVLHR+Y  EAD+WSIGVI+YILLCGSRPFWAR+ESG
Sbjct: 276 LSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESG 335

Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           IFRAVL+++PNF++ PWPS+SP+A DFVKRLLNKDYRKR+TA QAL
Sbjct: 336 IFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQAL 381

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1

 Score =  498 bits (1281), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 267/417 (64%), Positives = 315/417 (75%), Gaps = 26/417 (6%)

Query: 1   MGQCYGKTIPTTENDAT-TSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPS 59
           MG CY + I   E+D   T     +   S N     +P S   +G+  V      S + S
Sbjct: 1   MGHCYSRNISAVEDDEIPTGNGEVSNQPSQNHRHASIPQSPVASGTPEVN-----SYNIS 55

Query: 60  PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KP 118
           P+          SPLPAGV+PSPAR  TP R F+ PFPPPSPAK I A+L +R G   +P
Sbjct: 56  PF---------QSPLPAGVAPSPAR--TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQP 104

Query: 119 KESTIPEERGTEPE--------QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK 170
           ++  IPE+     +        + LDK+FG+ KNF  KYELGKEVGRGHFGHTC A+ KK
Sbjct: 105 RDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKK 164

Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
           G++K+Q VAVKIISKAKMT+ +SIEDVRREVK+LKALSGH+H+VKF D  ED +NV++VM
Sbjct: 165 GKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVM 224

Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
           ELCEGGELLDRILARGGRY E DAK I+VQILS  AF HLQGVVHRDLKPENFLFTS  +
Sbjct: 225 ELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNE 284

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGS 350
           DA +++IDFGLSDFIR D+RLND+VGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGS
Sbjct: 285 DAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGS 344

Query: 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           RPF+ RTES IFR VLR++PNF+D+PWPS+SP AKDFVKRLLNKD+RKRMTA QAL+
Sbjct: 345 RPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALA 401

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1

 Score =  488 bits (1256), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 257/414 (62%), Positives = 315/414 (76%), Gaps = 27/414 (6%)

Query: 27  VSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPS-PW--PSPYPHGVSASPLPAGVSPSPA 83
           V  N + TP  P     G  PV+++P   + P  P+  PSP  H  + S    G   S +
Sbjct: 23  VLQNDDSTPAHP-----GKSPVRSSPAVKASPFFPFYTPSPARHRRNKSR-DGGGGESKS 76

Query: 84  RASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQS-----LDKS 138
             STP R   R F PPSPA+HI+  L +R    + KE+ +P  R  + E+      LDK 
Sbjct: 77  VTSTPLRQLARAFHPPSPARHIRDVLRRR---KEKKEAALPAARQQKEEEEREEVGLDKR 133

Query: 139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
           FG++K   ++ ELG+E+GRGHFG+TCSA+ KKGELKDQ+VAVK+I K+KMT+AISIEDVR
Sbjct: 134 FGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVR 193

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REVKIL+ALSGH++LV+F DA ED  NVYIVMELC GGELLDRILARGG+Y+E+DAKA++
Sbjct: 194 REVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVL 253

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
           +QIL+VVAFCHLQGVVHRDLKPENFL+TS  +++ +++IDFGLSDF+RPDERLNDIVGSA
Sbjct: 254 IQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSA 313

Query: 319 YYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           YYVAPEVLHRSY+ EAD+WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWP
Sbjct: 314 YYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWP 373

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQAL--------SKLVVP--ILSFKIVCRY 422
           S+S EAKDFVKRLL KD RKRMTA QAL         K+ +P  IL FK +  Y
Sbjct: 374 SLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAY 427

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1

 Score =  487 bits (1254), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 246/393 (62%), Positives = 294/393 (74%), Gaps = 26/393 (6%)

Query: 38  PSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPAR------------- 84
           P  PGN    + +      HP   P P P    ASP     +PSPAR             
Sbjct: 17  PFAPGNDYPQIDDFA--PDHPGKSPIPTPSAAKASPFFPFYTPSPARHRRNKSRDVGGGG 74

Query: 85  -----ASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQ------ 133
                 STP R  RR F PPSPAKHI+A+L +R G  +   S + +     P++      
Sbjct: 75  ESKSLTSTPLRQLRRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEV 134

Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
            LDK FG++K F ++ ELG+E+GRGHFG+TCSA+ KKGELK Q VAVKII K+KMTTAI+
Sbjct: 135 GLDKRFGFSKEFHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIA 194

Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
           IEDVRREVKIL+ALSGHK+LV+F DA ED  NVYI MELCEGGELLDRILARGG+Y+E D
Sbjct: 195 IEDVRREVKILQALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSEND 254

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
           AK +++QIL+VVAFCH QGVVHRDLKPENFL+TS  +++ ++ IDFGLSDF+RPDERLND
Sbjct: 255 AKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLND 314

Query: 314 IVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           IVGSAYYVAPEVLHRSY+ EAD+WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD
Sbjct: 315 IVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 374

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           + PWP +S +AKDFVKRLL KD R+RM+A QAL
Sbjct: 375 EPPWPFLSSDAKDFVKRLLFKDPRRRMSASQAL 407

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  480 bits (1235), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 266/413 (64%), Positives = 314/413 (76%), Gaps = 19/413 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
           MG CY + I T ++D    + T  +   ++QN       T  + S+P   +P  S     
Sbjct: 1   MGHCYSRNISTVDDDDEIPSATAQLPHRSHQNHH----QTSSSSSIP--QSPATSE---- 50

Query: 61  WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KPK 119
             +PY      SPLPAGV+PSPAR  TP R F+ PFPPPSPAK I A+L +R G    P+
Sbjct: 51  -VNPYNISPFQSPLPAGVAPSPAR--TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPR 107

Query: 120 ESTIPEE-----RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           +  IPE+      G    + LDK+FG+ KNF  KYELG+EVGRGHFGHTC A+ KKG++K
Sbjct: 108 DGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIK 167

Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
            Q VAVKIISK+KMT+A+SIEDVRREVK+LKALSGH H+VKF D  ED +NV++VMELCE
Sbjct: 168 GQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCE 227

Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
           GGELLD ILARGGRY E +AK I+VQILS  AF HLQGVVHRDLKPENFLFTS  +DA +
Sbjct: 228 GGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVL 287

Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 354
           ++IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYS EADIWSIGVISYILLCGSRPF+
Sbjct: 288 KVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFY 347

Query: 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            RTES IFR VLR++PNFDDLPWPS+SP AKDFVKRLLNKD+RKRMTA QAL+
Sbjct: 348 GRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALA 400

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	422
255578190	602	calcium-dependent protein kinase, putati	0.952	0.667	0.888	0.0
224130636	608	predicted protein [Populus trichocarpa]	0.992	0.689	0.807	0.0
224068086	604	cpk-related protein kinase 3 [Populus tr	0.990	0.692	0.796	0.0
449445491	609	PREDICTED: CDPK-related protein kinase-l	1.0	0.692	0.784	0.0
449519762	609	PREDICTED: LOW QUALITY PROTEIN: CDPK-rel	1.0	0.692	0.781	0.0
225453579	591	PREDICTED: CDPK-related protein kinase [	0.976	0.697	0.786	0.0
357512599	596	Calcium dependent protein kinase-like pr	0.978	0.692	0.770	1e-178
222636222	639	hypothetical protein OsJ_22648 [Oryza sa	0.976	0.644	0.709	1e-177
53792933	623	putative calcium/calmodulin-dependent pr	0.976	0.661	0.709	1e-177
194700508	608	unknown [Zea mays] gi|194707624|gb|ACF87	0.992	0.689	0.730	1e-177

>gi|255578190|ref|XP_002529963.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530525|gb|EEF32406.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  697 bits (1798), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/413 (88%), Positives = 377/413 (91%), Gaps = 11/413 (2%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRS-SHPS 59
           MGQCYGKT PT END TT+  TT     A+ NQTPL PSTP NG   VKNTP RS +HPS
Sbjct: 1   MGQCYGKTNPTNENDTTTTIVTT-----ADPNQTPLRPSTPRNGVPSVKNTPARSFNHPS 55

Query: 60  PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KP 118
           PWPSPYPHGVSASPLP GVSPSPARASTPRRFFRRPFPPPSPAKHI ASLAKRLGGG KP
Sbjct: 56  PWPSPYPHGVSASPLPGGVSPSPARASTPRRFFRRPFPPPSPAKHIAASLAKRLGGGAKP 115

Query: 119 KESTIPEERGTEP----EQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           KE  IPE  G EP    +QSLDKSFGY+KNFGAKYELGKEVGRGHFGHTCSAR KKGELK
Sbjct: 116 KEGPIPEHGGAEPDQQQQQSLDKSFGYSKNFGAKYELGKEVGRGHFGHTCSARVKKGELK 175

Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
           DQ VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF DACED NNVYIVMELCE
Sbjct: 176 DQPVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFYDACEDANNVYIVMELCE 235

Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
           GGELLDRILARGGRYTEEDAKAIVVQILSVV+FCHLQGVVHRDLKPENFLFTSG +DADM
Sbjct: 236 GGELLDRILARGGRYTEEDAKAIVVQILSVVSFCHLQGVVHRDLKPENFLFTSGGEDADM 295

Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 354
           RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW
Sbjct: 296 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 355

Query: 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           ARTESGIFR+VLRSDPNFDDLPWPSV+PE KDFVKRLLNKDYRKRMTAVQAL+
Sbjct: 356 ARTESGIFRSVLRSDPNFDDLPWPSVTPEGKDFVKRLLNKDYRKRMTAVQALT 408

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224130636|ref|XP_002320890.1| predicted protein [Populus trichocarpa] gi|222861663|gb|EEE99205.1| predicted protein [Populus trichocarpa]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/441 (80%), Positives = 376/441 (85%), Gaps = 22/441 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQ-TPLPPSTPGNGSMPVKNTPGRSS--H 57
           MGQCYGKT P  ENDATT    T +  S + NQ T LP ST  NG + VKNTP RSS  H
Sbjct: 1   MGQCYGKTSPANENDATT---VTIVASSTDHNQPTSLPSSTSRNGVLSVKNTPARSSSTH 57

Query: 58  PSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGK 117
           PSPWPS YPHGV+ASPLP GVSPSPARASTPRRFFRRPFPPPSPAKHI ASL KRLGGG 
Sbjct: 58  PSPWPSTYPHGVAASPLPGGVSPSPARASTPRRFFRRPFPPPSPAKHIAASLVKRLGGGG 117

Query: 118 PKEST-IPEERGTEPEQ------SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK 170
             +   IPE  G E EQ      SLDKSFGY+KNFGAKYELGKE+GRGHFGHTCSA  KK
Sbjct: 118 KPKEGPIPEHGGVEAEQQQQQQQSLDKSFGYSKNFGAKYELGKEIGRGHFGHTCSATVKK 177

Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
           GELKDQ VAVKIISKAKMTTAISIEDVRREVKILK LSGH+HLVKF DACED NNVYIVM
Sbjct: 178 GELKDQTVAVKIISKAKMTTAISIEDVRREVKILKGLSGHRHLVKFYDACEDANNVYIVM 237

Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
           ELCEGGELLDRILARGGRYTEEDAKAI+VQIL VVAFCHLQGVVHRDLKPENFLFTSG +
Sbjct: 238 ELCEGGELLDRILARGGRYTEEDAKAIIVQILCVVAFCHLQGVVHRDLKPENFLFTSGSE 297

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGS 350
           DADM+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YIL+CGS
Sbjct: 298 DADMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILICGS 357

Query: 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK-- 408
           RPFWARTESGIFRAVLRSDPNF+DLPWPSV+PEAKDFVKRLLNKDYRKRMTAVQAL+   
Sbjct: 358 RPFWARTESGIFRAVLRSDPNFEDLPWPSVTPEAKDFVKRLLNKDYRKRMTAVQALTHPW 417

Query: 409 -------LVVPILSFKIVCRY 422
                  + + IL +K+V  Y
Sbjct: 418 LRDDSRPINLDILIYKLVKAY 438

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068086|ref|XP_002302662.1| cpk-related protein kinase 3 [Populus trichocarpa] gi|222844388|gb|EEE81935.1| cpk-related protein kinase 3 [Populus trichocarpa]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/438 (79%), Positives = 375/438 (85%), Gaps = 20/438 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQ-TPLPPSTPGNGSMPVK-NTPGRSSHP 58
           MGQCYGKT  T  NDATT    T +  S +QNQ TPLP STP NG   +K +    S+HP
Sbjct: 1   MGQCYGKTNSTNINDATT---VTIVASSTDQNQQTPLPSSTPRNGVRSLKYSASSSSTHP 57

Query: 59  SPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGG-GK 117
           SPWPSPYP GV+ASPL  GVSPSPAR+STPRRFF+RPFPPPSPA+HI ASL KRLGG GK
Sbjct: 58  SPWPSPYPQGVAASPL-QGVSPSPARSSTPRRFFKRPFPPPSPARHIAASLVKRLGGRGK 116

Query: 118 PKESTIPE----ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGEL 173
           PKE  IPE    E   + EQSLDKSFGY+KNFGAKYELGKE+GRGHFGHTCSAR KKGEL
Sbjct: 117 PKEGPIPEHGSVEAEQQQEQSLDKSFGYSKNFGAKYELGKEIGRGHFGHTCSARVKKGEL 176

Query: 174 KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233
           KD+ VAVKIISKAKMT+ ISIEDVRREVKILKALSGH+HLVKF DA ED NNVYIVMELC
Sbjct: 177 KDEAVAVKIISKAKMTSTISIEDVRREVKILKALSGHRHLVKFYDAFEDANNVYIVMELC 236

Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
           EGGELLDRILARGGRYTEEDAKAI+VQIL VVAFCHLQGVVHRDLKPENFLFTSG +DAD
Sbjct: 237 EGGELLDRILARGGRYTEEDAKAIIVQILCVVAFCHLQGVVHRDLKPENFLFTSGSEDAD 296

Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPF 353
           M+LIDFGLSDF RPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIG+I+YILLCGSRPF
Sbjct: 297 MKLIDFGLSDFFRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGIITYILLCGSRPF 356

Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK----- 408
           WARTESGIFRAVLRSDPNF+DLPWPSV+PEAKDFVKRLLNKDYRKRMTAVQAL+      
Sbjct: 357 WARTESGIFRAVLRSDPNFEDLPWPSVTPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 416

Query: 409 ----LVVPILSFKIVCRY 422
               + V IL +K+V  Y
Sbjct: 417 DSRPIHVDILIYKLVKVY 434

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445491|ref|XP_004140506.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus]

 Score =  664 bits (1714), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/440 (78%), Positives = 371/440 (84%), Gaps = 18/440 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTP-----GNGSMPVKNTPGRS 55
           MGQCYGKTIPTT+ND T +  TTT+   +       P   P     GNG + +K T   +
Sbjct: 1   MGQCYGKTIPTTDNDVTPTTITTTVSPPSTTGYGVDPSHFPSGSGAGNGVVNLKTTTATT 60

Query: 56  SHPSPWPS----PYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAK 111
              + +PS    PYPHGV ASPLP GVSPSPARASTP RFF+R F PPSPAKHIKASLAK
Sbjct: 61  PARTSYPSPWPSPYPHGVGASPLPVGVSPSPARASTPGRFFKRRFAPPSPAKHIKASLAK 120

Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
           R G  KPKE  IPEERG EPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSA+GKKG
Sbjct: 121 RFGYTKPKEGPIPEERGAEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKG 180

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
           EL+DQ VAVKIISKAKMTTAISIEDVRREVKILK+LSGHKHLVKF DACED NNVYIVME
Sbjct: 181 ELRDQPVAVKIISKAKMTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVME 240

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
           LCEGGELLDRIL+RGGRYTEEDAK IVVQILSVVAFCHLQGVVHRDLKPENFLFTS  +D
Sbjct: 241 LCEGGELLDRILSRGGRYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSED 300

Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
           ADM+LIDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+LEADIWSIGVI+YILLCGSR
Sbjct: 301 ADMKLIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSR 360

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS---- 407
           PFWARTESGIFRAVLR+DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL+    
Sbjct: 361 PFWARTESGIFRAVLRADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 420

Query: 408 -----KLVVPILSFKIVCRY 422
                ++ + IL +K+V  Y
Sbjct: 421 QDDSRRIPLDILIYKLVKSY 440

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449519762|ref|XP_004166903.1| PREDICTED: LOW QUALITY PROTEIN: CDPK-related protein kinase-like [Cucumis sativus]

 Score =  661 bits (1706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/440 (78%), Positives = 370/440 (84%), Gaps = 18/440 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTP-----GNGSMPVKNTPGRS 55
           MGQCYGKTIPTT+ND T +  TTT+   +       P   P     GNG + +K T   +
Sbjct: 1   MGQCYGKTIPTTDNDVTPTTITTTVSPPSTTGYGVDPSHFPSGSGAGNGVVNLKTTTATT 60

Query: 56  SHPSPWPS----PYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAK 111
              + +PS    PYPHGV ASPLP GVSPSPARASTP R F+R F PPSPAKHIKASLAK
Sbjct: 61  PARTSYPSPWPSPYPHGVGASPLPVGVSPSPARASTPGRXFKRRFAPPSPAKHIKASLAK 120

Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
           R G  KPKE  IPEERG EPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSA+GKKG
Sbjct: 121 RFGYTKPKEGPIPEERGAEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKG 180

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
           EL+DQ VAVKIISKAKMTTAISIEDVRREVKILK+LSGHKHLVKF DACED NNVYIVME
Sbjct: 181 ELRDQPVAVKIISKAKMTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVME 240

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
           LCEGGELLDRIL+RGGRYTEEDAK IVVQILSVVAFCHLQGVVHRDLKPENFLFTS  +D
Sbjct: 241 LCEGGELLDRILSRGGRYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSED 300

Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
           ADM+LIDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+LEADIWSIGVI+YILLCGSR
Sbjct: 301 ADMKLIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSR 360

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS---- 407
           PFWARTESGIFRAVLR+DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL+    
Sbjct: 361 PFWARTESGIFRAVLRADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 420

Query: 408 -----KLVVPILSFKIVCRY 422
                ++ + IL +K+V  Y
Sbjct: 421 QDDSRRIPLDILIYKLVKSY 440

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453579|ref|XP_002266654.1| PREDICTED: CDPK-related protein kinase [Vitis vinifera] gi|296088985|emb|CBI38688.3| unnamed protein product [Vitis vinifera]

 Score =  649 bits (1675), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/431 (78%), Positives = 363/431 (84%), Gaps = 19/431 (4%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
           MGQCYGK +                 V     Q+PLP    G  S+    TP RSS  SP
Sbjct: 1   MGQCYGKPVVNGNGKGG---------VVEEYPQSPLPSVGNGAASVQSVKTPARSSSTSP 51

Query: 61  WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
           W SP+PHG ++SPLPAGV+PSPAR+STPRRFFRRPFPPPSPAKHIKASLAKRLG  KPKE
Sbjct: 52  WRSPFPHGSASSPLPAGVAPSPARSSTPRRFFRRPFPPPSPAKHIKASLAKRLGPAKPKE 111

Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
             IPEE GTEPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSARGKKGEL+DQ +AV
Sbjct: 112 GPIPEE-GTEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSARGKKGELRDQPLAV 170

Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
           KIISKAKMTTAI+IEDVRREVKILKALSGH HLVKF DACED NNVYI+MELCEGGELLD
Sbjct: 171 KIISKAKMTTAIAIEDVRREVKILKALSGHAHLVKFYDACEDANNVYIIMELCEGGELLD 230

Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
           RIL+RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  +DADM+LIDFG
Sbjct: 231 RILSRGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSEDADMKLIDFG 290

Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
           LSDFIRPDERLNDIVGSAYYVAPEVLHRSY LEADIWS+GVI+YILLCGSRPFWARTESG
Sbjct: 291 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYYLEADIWSVGVITYILLCGSRPFWARTESG 350

Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK---------LVV 411
           IFRAVLR+DPNFDDLPWP+VS EAKDFVKRLLNKDYRKRMTAVQAL+          + +
Sbjct: 351 IFRAVLRADPNFDDLPWPTVSAEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDGSHPIPL 410

Query: 412 PILSFKIVCRY 422
            IL +K+V  Y
Sbjct: 411 DILIYKLVKSY 421

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357512599|ref|XP_003626588.1| Calcium dependent protein kinase-like protein [Medicago truncatula] gi|355501603|gb|AES82806.1| Calcium dependent protein kinase-like protein [Medicago truncatula]

 Score =  632 bits (1630), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 335/435 (77%), Positives = 366/435 (84%), Gaps = 22/435 (5%)

Query: 1   MGQCYGKTIPTTENDATTSATTT--TMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSS-H 57
           MGQCYGKT+P   +    + TT   T     + ++TPLP  +  NG   VKNTP RSS H
Sbjct: 1   MGQCYGKTVPGAGSHRQQNTTTIIDTSAGDGDGSRTPLP--SFANGIPSVKNTPARSSSH 58

Query: 58  PSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGK 117
            SPWPSPYPHGV+ SP       SPARASTP+RFFRRPFPPPSPAKHI+ SLAKRLG  K
Sbjct: 59  ASPWPSPYPHGVNPSP-------SPARASTPKRFFRRPFPPPSPAKHIRESLAKRLGKAK 111

Query: 118 PKESTIPEERGTEPE-QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
           PKE  IPEE G E + QSLDKSFGY+KNFGAKYELGKEVGRGHFGHTCSAR KKG+LKDQ
Sbjct: 112 PKEGPIPEEHGVETDSQSLDKSFGYSKNFGAKYELGKEVGRGHFGHTCSARAKKGDLKDQ 171

Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
            VAVKIISK+KMT+AI+IEDVRREVK+LKALSGHKHL+KF DACED NNVYIVMELCEGG
Sbjct: 172 PVAVKIISKSKMTSAIAIEDVRREVKLLKALSGHKHLIKFHDACEDANNVYIVMELCEGG 231

Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           ELLDRIL+RGGRYTEEDAKAIV+QILSV AFCHLQGVVHRDLKPENFLFTS  +DADM+L
Sbjct: 232 ELLDRILSRGGRYTEEDAKAIVLQILSVAAFCHLQGVVHRDLKPENFLFTSRSEDADMKL 291

Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           IDFGLSDFIRP+ERLNDIVGSAYYVAPEVLHRSYS+EADIWSIGVI+YILLCGSRPFWAR
Sbjct: 292 IDFGLSDFIRPEERLNDIVGSAYYVAPEVLHRSYSVEADIWSIGVITYILLCGSRPFWAR 351

Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK-------- 408
           TESGIFR VLR+DPNFDDLPWPSVSPE KDFVKRLLNKDYRKRMTA QAL+         
Sbjct: 352 TESGIFRTVLRADPNFDDLPWPSVSPEGKDFVKRLLNKDYRKRMTAAQALTHPWLRDESR 411

Query: 409 -LVVPILSFKIVCRY 422
            + + IL +K+V  Y
Sbjct: 412 PIPLDILIYKLVKSY 426

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222636222|gb|EEE66354.1| hypothetical protein OsJ_22648 [Oryza sativa Japonica Group]

 Score =  627 bits (1616), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 329/464 (70%), Positives = 359/464 (77%), Gaps = 52/464 (11%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLP----PSTP--------------- 41
           MGQCYGK       D      T        ++Q+P P    PSTP               
Sbjct: 1   MGQCYGKGASGRTADDEGGVVT--------EHQSPPPANGLPSTPPRQQAQAQAQQVGTP 52

Query: 42  -GNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPS 100
              GS     TPG  +    WPSPYP G  ASPLPAGVSPSPAR STPRRFF+RPFPPPS
Sbjct: 53  RRRGSKSGSTTPGHQTPGVAWPSPYPSG-GASPLPAGVSPSPAR-STPRRFFKRPFPPPS 110

Query: 101 PAKHIKASLAKRLGGGKPKESTIPEERGT-------------EPEQSLDKSFGYNKNFGA 147
           PAKHIKA+LAKRLGGGKPKE TIPEE G              E E+ LDK+FG++KNFGA
Sbjct: 111 PAKHIKATLAKRLGGGKPKEGTIPEEGGVGAGGGGGGAADGAETERPLDKTFGFSKNFGA 170

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYELGKEVGRGHFGHTCSA  KKGE K Q VAVKII+KAKMTTAISIEDVRREVKIL+AL
Sbjct: 171 KYELGKEVGRGHFGHTCSAVVKKGEYKGQTVAVKIIAKAKMTTAISIEDVRREVKILRAL 230

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           SGH +LVKF DACED  NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF
Sbjct: 231 SGHNNLVKFYDACEDGLNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 290

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
           CHLQGVVHRDLKPENFLFT+  ++A M+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH
Sbjct: 291 CHLQGVVHRDLKPENFLFTTRDENAPMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 350

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           RSYS+EADIWSIGVI+YILLCGSRPFWARTESGIFR+VLR+DPNFDD PWP+VS EAKDF
Sbjct: 351 RSYSMEADIWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFDDSPWPTVSAEAKDF 410

Query: 388 VKRLLNKDYRKRMTAVQALS---------KLVVPILSFKIVCRY 422
           VKR LNKDYRKRMTAVQAL+         ++ + IL F+++ +Y
Sbjct: 411 VKRFLNKDYRKRMTAVQALTHPWLRDEQRQIPLDILIFRLIKQY 454

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|53792933|dbj|BAD54109.1| putative calcium/calmodulin-dependent protein kinase [Oryza sativa Japonica Group] gi|218198881|gb|EEC81308.1| hypothetical protein OsI_24450 [Oryza sativa Indica Group]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 329/464 (70%), Positives = 359/464 (77%), Gaps = 52/464 (11%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLP----PSTP--------------- 41
           MGQCYGK       D      T        ++Q+P P    PSTP               
Sbjct: 1   MGQCYGKGASGRTADDEGGVVT--------EHQSPPPANGLPSTPPRQQAQAQAQQVGTP 52

Query: 42  -GNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPS 100
              GS     TPG  +    WPSPYP G  ASPLPAGVSPSPAR STPRRFF+RPFPPPS
Sbjct: 53  RRRGSKSGSTTPGHQTPGVAWPSPYPSG-GASPLPAGVSPSPAR-STPRRFFKRPFPPPS 110

Query: 101 PAKHIKASLAKRLGGGKPKESTIPEERGT-------------EPEQSLDKSFGYNKNFGA 147
           PAKHIKA+LAKRLGGGKPKE TIPEE G              E E+ LDK+FG++KNFGA
Sbjct: 111 PAKHIKATLAKRLGGGKPKEGTIPEEGGVGAGGGGGGAADGAETERPLDKTFGFSKNFGA 170

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYELGKEVGRGHFGHTCSA  KKGE K Q VAVKII+KAKMTTAISIEDVRREVKIL+AL
Sbjct: 171 KYELGKEVGRGHFGHTCSAVVKKGEYKGQTVAVKIIAKAKMTTAISIEDVRREVKILRAL 230

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           SGH +LVKF DACED  NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF
Sbjct: 231 SGHNNLVKFYDACEDGLNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 290

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
           CHLQGVVHRDLKPENFLFT+  ++A M+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH
Sbjct: 291 CHLQGVVHRDLKPENFLFTTRDENAPMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 350

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           RSYS+EADIWSIGVI+YILLCGSRPFWARTESGIFR+VLR+DPNFDD PWP+VS EAKDF
Sbjct: 351 RSYSMEADIWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFDDSPWPTVSAEAKDF 410

Query: 388 VKRLLNKDYRKRMTAVQALS---------KLVVPILSFKIVCRY 422
           VKR LNKDYRKRMTAVQAL+         ++ + IL F+++ +Y
Sbjct: 411 VKRFLNKDYRKRMTAVQALTHPWLRDEQRQIPLDILIFRLIKQY 454

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|194700508|gb|ACF84338.1| unknown [Zea mays] gi|194707624|gb|ACF87896.1| unknown [Zea mays] gi|413943138|gb|AFW75787.1| putative protein kinase superfamily protein [Zea mays]

 Score =  626 bits (1614), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 323/442 (73%), Positives = 352/442 (79%), Gaps = 23/442 (5%)

Query: 1   MGQCYGKTIPTT----ENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSS 56
           MGQCYGK    +    ++D    A      + AN    P  P+TPG             +
Sbjct: 1   MGQCYGKAGGASSRRADHDDHAHAVAPPSPLPAN-GAPPPQPATPGRRKSGSATPVHHQA 59

Query: 57  HPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG 116
             + WPSPYP G  ASPLPAGVSPSPAR STPRRFF+RPFPPPSPAKHIKA+LAKRLGGG
Sbjct: 60  ATTAWPSPYPAG-GASPLPAGVSPSPAR-STPRRFFKRPFPPPSPAKHIKATLAKRLGGG 117

Query: 117 KPKESTIPEERGT-------EPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGK 169
           KPKE TIPEE G        E E+ LDK+FG+  NFGAKY+LGKEVGRGHFGHTCSA  K
Sbjct: 118 KPKEGTIPEEGGAGVAADSAEAERPLDKTFGFANNFGAKYDLGKEVGRGHFGHTCSALVK 177

Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           KGE K   VAVKIISKAKMTTAISIEDVRREVKILKALSGH +LVKF DACED  NVYIV
Sbjct: 178 KGEYKGHAVAVKIISKAKMTTAISIEDVRREVKILKALSGHNNLVKFYDACEDALNVYIV 237

Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV+FCHLQGVVHRDLKPENFLF +  
Sbjct: 238 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVSFCHLQGVVHRDLKPENFLFATRD 297

Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCG 349
           + A M+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYS+EADIWSIGVI+YILLCG
Sbjct: 298 ESAPMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSMEADIWSIGVITYILLCG 357

Query: 350 SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS-- 407
           SRPFWARTESGIFR+VLR+DPNFDD PWPSVS EAKDFVKR LNKDYRKRMTAVQAL+  
Sbjct: 358 SRPFWARTESGIFRSVLRADPNFDDSPWPSVSAEAKDFVKRFLNKDYRKRMTAVQALTHP 417

Query: 408 -------KLVVPILSFKIVCRY 422
                  ++ + IL F++V +Y
Sbjct: 418 WLRDEQRQIPLDILVFRLVKQY 439

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	422
TAIR|locus:2062764	595	CRK3 "AT2G46700" [Arabidopsis	0.985	0.699	0.700	3.2e-152
TAIR|locus:2103655	577	AT3G56760 [Arabidopsis thalian	0.715	0.523	0.730	4.6e-121
TAIR|locus:2063197	576	CRK1 "AT2G41140" [Arabidopsis	0.715	0.524	0.730	1.2e-120
TAIR|locus:2152876	594	AT5G24430 [Arabidopsis thalian	0.791	0.562	0.684	4.1e-120
TAIR|locus:2082931	594	AT3G49370 [Arabidopsis thalian	0.791	0.562	0.684	2.6e-118
TAIR|locus:2094053	599	AT3G19100 [Arabidopsis thalian	0.713	0.502	0.715	2.7e-116
TAIR|locus:2012232	606	AT1G49580 [Arabidopsis thalian	0.720	0.501	0.709	9.1e-116
TAIR|locus:2827826	571	CPK16 "AT2G17890" [Arabidopsis	0.630	0.465	0.618	3.8e-85
TAIR|locus:2156947	523	CPK28 "calcium-dependent prote	0.630	0.508	0.592	1.4e-80
TAIR|locus:2061290	582	CPK24 "AT2G31500" [Arabidopsis	0.599	0.434	0.528	5.3e-71

TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)]

 Score = 1485 (527.8 bits), Expect = 3.2e-152, P = 3.2e-152
 Identities = 302/431 (70%), Positives = 334/431 (77%)

Query:     1 MGQCYGKTIPXXXXXXXXXXXXXXMVVSANQNQTPLPPSTPGNGSMPVKNTXXXXXXXXX 60
             MGQCYGK +                VVS + NQ  + P TP N     KNT         
Sbjct:     1 MGQCYGK-VNQSKQNGEEEANTTTYVVSGDGNQ--IQPLTPVNYGR-AKNTPARSSNPSP 56

Query:    61 XXXXXXHGVSASPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGGKPKE 120
                   HG SASPLP+GVSPS                     KHIKASL KRLG  KPKE
Sbjct:    57 WPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPKE 114

Query:   121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
               IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD  +AV
Sbjct:   115 GPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIAV 174

Query:   181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
             KIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELLD
Sbjct:   175 KIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLD 234

Query:   241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             RILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDFG
Sbjct:   235 RILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFG 294

Query:   301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
             LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTESG
Sbjct:   295 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESG 354

Query:   361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS-------KLVVP- 412
             IFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQAL+         V+P 
Sbjct:   355 IFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIPL 414

Query:   413 -ILSFKIVCRY 422
              IL +K+V  Y
Sbjct:   415 DILIYKLVKAY 425

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010150 "leaf senescence" evidence=IEP

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)]

 Score = 1191 (424.3 bits), Expect = 4.6e-121, P = 4.6e-121
 Identities = 222/304 (73%), Positives = 267/304 (87%)

Query:   103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGH 162
             KHI+A LA+R G  KP E++IPE  G+E E  LDK FG++K F + YE+  EVGRGHFG+
Sbjct:    80 KHIRALLARRHGSVKPNEASIPE--GSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGY 137

Query:   163 TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222
             TCSA+GKKG LK Q VAVK+I K+KMTTAI+IEDVRREVKIL+AL+GHK+LV+F DA ED
Sbjct:   138 TCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFED 197

Query:   223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
               NVYIVMELC+GGELLD+IL RGG+Y+E DAK +++QILSVVA+CHLQGVVHRDLKPEN
Sbjct:   198 DENVYIVMELCQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPEN 257

Query:   283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 342
             FLFT+  + + ++ IDFGLSD++RPDERLNDIVGSAYYVAPEVLHR+Y  EAD+WSIGVI
Sbjct:   258 FLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVI 317

Query:   343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
             +YILLCGSRPFWAR+ESGIFRAVL+++PNF++ PWPS+SP+A DFVKRLLNKDYRKR+TA
Sbjct:   318 AYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTA 377

Query:   403 VQAL 406
              QAL
Sbjct:   378 AQAL 381

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)]

 Score = 1187 (422.9 bits), Expect = 1.2e-120, P = 1.2e-120
 Identities = 222/304 (73%), Positives = 267/304 (87%)

Query:   103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGH 162
             KHI+A LA+R G  KP E +IPE  G E E  LDKSFG++K F + YE+  EVGRGHFG+
Sbjct:    79 KHIRAFLARRYGSVKPNEVSIPE--GKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGY 136

Query:   163 TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222
             TCSA+GKKG LK Q+VAVK+I K+KMTTAI+IEDV REVK+L+AL+GHK+LV+F DA ED
Sbjct:   137 TCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFED 196

Query:   223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
               NVYIVMELC+GGELLD+IL RGG+Y+E+DAK ++VQILSVVA+CHLQGVVHRDLKPEN
Sbjct:   197 DENVYIVMELCKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPEN 256

Query:   283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 342
             FLF++  + + ++ IDFGLSD+++PDERLNDIVGSAYYVAPEVLHR+Y  EAD+WSIGVI
Sbjct:   257 FLFSTKDETSPLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVI 316

Query:   343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
             +YILLCGSRPFWARTESGIFRAVL+++PNF++ PWPS+SPEA DFVKRLLNKDYRKR+TA
Sbjct:   317 AYILLCGSRPFWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTA 376

Query:   403 VQAL 406
              QAL
Sbjct:   377 AQAL 380

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010286 "heat acclimation" evidence=IMP

TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)]

 Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
 Identities = 236/345 (68%), Positives = 275/345 (79%)

Query:    72 SPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGG-KPKESTIPEE---- 126
             SPLPAGV+PS                     K I A+L +R G   +P++  IPE+    
Sbjct:    59 SPLPAGVAPSPARTPGRKFKWPFPPPSPA--KPIMAALRRRRGAPPQPRDEPIPEDSEDV 116

Query:   127 --RGTEPE--QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
                G +    + LDK+FG+ KNF  KYELGKEVGRGHFGHTC A+ KKG++K+Q VAVKI
Sbjct:   117 VDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKI 176

Query:   183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI 242
             ISKAKMT+ +SIEDVRREVK+LKALSGH+H+VKF D  ED +NV++VMELCEGGELLDRI
Sbjct:   177 ISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRI 236

Query:   243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
             LARGGRY E DAK I+VQILS  AF HLQGVVHRDLKPENFLFTS  +DA +++IDFGLS
Sbjct:   237 LARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLS 296

Query:   303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIF 362
             DFIR D+RLND+VGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGSRPF+ RTES IF
Sbjct:   297 DFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIF 356

Query:   363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             R VLR++PNF+D+PWPS+SP AKDFVKRLLNKD+RKRMTA QAL+
Sbjct:   357 RCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALA 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006865 "amino acid transport" evidence=RCA

TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)]

 Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
 Identities = 234/342 (68%), Positives = 270/342 (78%)

Query:    72 SPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGGK-PKESTIPEER--- 127
             SPLPAGV+PS                     K I A+L +R G    P++  IPE+    
Sbjct:    61 SPLPAGVAPSPARTPGRKFKWPFPPPSPA--KPIMAALRRRRGTAPHPRDGPIPEDSEAG 118

Query:   128 --GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
               G    + LDK+FG+ KNF  KYELG+EVGRGHFGHTC A+ KKG++K Q VAVKIISK
Sbjct:   119 GSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKIISK 178

Query:   186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
             +KMT+A+SIEDVRREVK+LKALSGH H+VKF D  ED +NV++VMELCEGGELLD ILAR
Sbjct:   179 SKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSILAR 238

Query:   246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
             GGRY E +AK I+VQILS  AF HLQGVVHRDLKPENFLFTS  +DA +++IDFGLSD+ 
Sbjct:   239 GGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSDYA 298

Query:   306 RPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365
             R D+RLND+VGSAYYVAPEVLHRSYS EADIWSIGVISYILLCGSRPF+ RTES IFR V
Sbjct:   299 RFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFRCV 358

Query:   366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             LR++PNFDDLPWPS+SP AKDFVKRLLNKD+RKRMTA QAL+
Sbjct:   359 LRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALA 400

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 221/309 (71%), Positives = 268/309 (86%)

Query:   103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQS-----LDKSFGYNKNFGAKYELGKEVGR 157
             +HI+  L +R    + KE+ +P  R  + E+      LDK FG++K   ++ ELG+E+GR
Sbjct:    96 RHIRDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGR 152

Query:   158 GHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFC 217
             GHFG+TCSA+ KKGELKDQ+VAVK+I K+KMT+AISIEDVRREVKIL+ALSGH++LV+F 
Sbjct:   153 GHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFY 212

Query:   218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
             DA ED  NVYIVMELC GGELLDRILARGG+Y+E+DAKA+++QIL+VVAFCHLQGVVHRD
Sbjct:   213 DAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRD 272

Query:   278 LKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIW 337
             LKPENFL+TS  +++ +++IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+ EAD+W
Sbjct:   273 LKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVW 332

Query:   338 SIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
             SIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWPS+S EAKDFVKRLL KD R
Sbjct:   333 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPR 392

Query:   398 KRMTAVQAL 406
             KRMTA QAL
Sbjct:   393 KRMTASQAL 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
 Identities = 220/310 (70%), Positives = 263/310 (84%)

Query:   103 KHIKASLAKRLG------GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
             KHI+A+L +R G       G  + +T   +R  E E  LDK FG++K F ++ ELG+E+G
Sbjct:    98 KHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIG 157

Query:   157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF 216
             RGHFG+TCSA+ KKGELK Q VAVKII K+KMTTAI+IEDVRREVKIL+ALSGHK+LV+F
Sbjct:   158 RGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQF 217

Query:   217 CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHR 276
              DA ED  NVYI MELCEGGELLDRILARGG+Y+E DAK +++QIL+VVAFCH QGVVHR
Sbjct:   218 YDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHR 277

Query:   277 DLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADI 336
             DLKPENFL+TS  +++ ++ IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+ EAD+
Sbjct:   278 DLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 337

Query:   337 WSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY 396
             WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWP +S +AKDFVKRLL KD 
Sbjct:   338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDP 397

Query:   397 RKRMTAVQAL 406
             R+RM+A QAL
Sbjct:   398 RRRMSASQAL 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)]

 Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
 Identities = 167/270 (61%), Positives = 209/270 (77%)

Query:   139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
             FGY K+F  +Y +GK +G G FG+T  A  KK      +VAVK I KAKMT  I++EDV+
Sbjct:    98 FGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIAVEDVK 154

Query:   199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAI 257
             REVKIL+AL+GH+++V+F +A ED N+VYIVMELCEGGELLDRILAR   RY+E DA  +
Sbjct:   155 REVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVV 214

Query:   258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
             V Q+L V A CHL+G+VHRD+KPENFLF S  +D+ ++  DFGLSDFI+P ++ +DIVGS
Sbjct:   215 VRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGS 274

Query:   318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
             AYYVAPEVL R    E+D+WSIGVISYILLCG RPFW +TE GIF+ VL++ P+F   PW
Sbjct:   275 AYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPW 334

Query:   378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             P++S  AKDFVK+LL KD R R+TA QALS
Sbjct:   335 PTISNSAKDFVKKLLVKDPRARLTAAQALS 364

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0005886 "plasma membrane" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)]

 Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
 Identities = 160/270 (59%), Positives = 204/270 (75%)

Query:   139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
             FGY+K+F   Y +GK +G G FG+T  A  +       +VAVK + K+KM   I++EDV+
Sbjct:    52 FGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDKSKMVLPIAVEDVK 108

Query:   199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAI 257
             REV+IL ALSGH+++V+F +A ED + VYIVMELCEGGELLDRIL++ G RY+E+DA  +
Sbjct:   109 REVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAVV 168

Query:   258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
             V Q+L V   CHL G+VHRD+KPENFLF S + D+ ++  DFGLSDFI+P +R +DIVGS
Sbjct:   169 VRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVGS 228

Query:   318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
             AYYVAPEVL R    E+D+WSIGVI+YILLCG RPFW RTE GIF+ VLR+ P+F   PW
Sbjct:   229 AYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKPW 288

Query:   378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              ++S  AKDFVK+LL KD R R+TA QALS
Sbjct:   289 ATISDSAKDFVKKLLVKDPRARLTAAQALS 318

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)]

 Score = 700 (251.5 bits), Expect = 5.3e-71, Sum P(2) = 5.3e-71
 Identities = 138/261 (52%), Positives = 181/261 (69%)

Query:   148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
             KY+LGKE+GRG FG  H C     +     ++ A K ISK K+ T I +EDVRREV+I++
Sbjct:    65 KYDLGKELGRGEFGVTHECIEISTR-----ERFACKRISKEKLRTEIDVEDVRREVEIMR 119

Query:   206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
              L  H ++V F +A ED + VY+VME+CEGGEL DRI++RG  YTE  A ++   IL VV
Sbjct:   120 CLPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRG-HYTERAAASVAKTILEVV 178

Query:   266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
               CH  GV+HRDLKPENFLF++G + A ++ IDFGLS F +P +R N+IVGS YY+APEV
Sbjct:   179 KVCHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEV 238

Query:   326 LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             L R+Y  E D+WS GVI YILLCG  PFWA TE GI  A++R + +F+  PWP VS EAK
Sbjct:   239 LRRNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAK 298

Query:   386 DFVKRLLNKDYRKRMTAVQAL 406
             + VK +L+ +   R+T  + L
Sbjct:   299 ELVKNMLDANPYSRLTVQEVL 319

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9ZUZ2	CAMK3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7847	0.9834	0.6974	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	422
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-97
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-79
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-61
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-58
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-57
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-51
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-49
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-48
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-47
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-40
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-40
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-36
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-35
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-35
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-35
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-35
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-34
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-33
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-33
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-33
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-33
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-32
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-31
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-30
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-29
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-29
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-29
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-29
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-28
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-28
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-28
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-27
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-27
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-26
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-26
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-26
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-26
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-25
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-25
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-25
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-25
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-25
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-24
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-24
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-24
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-24
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-24
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-24
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-23
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-22
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-22
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-22
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-22
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-22
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-22
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-22
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-21
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-20
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-20
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-20
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-19
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-19
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-19
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-06
pfam06293	206	pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa	2e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-06
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	3e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	4e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-04
PHA03132	580	PHA03132, PHA03132, thymidine kinase; Provisional	7e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  290 bits (744), Expect = 7e-97
 Identities = 111/260 (42%), Positives = 158/260 (60%), Gaps = 13/260 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+ +++G G FG    AR KK     + VA+K+I K K+      E + RE+KILK L 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKK--DRERILREIKILKKL- 54

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V+  D  ED + +Y+VME CEGG+L D +  RG R +E++A+  + QILS + + 
Sbjct: 55  KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H +G+VHRDLKPEN L      D  ++L DFGL+  + P E+L   VG+  Y+APEVL  
Sbjct: 114 HSKGIVHRDLKPENILLDE---DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y    DIWS+GVI Y LL G  PF    +   +F+ + +  P F   P   +SPEAKD
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKD 229

Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +++LL KD  KR+TA +AL
Sbjct: 230 LIRKLLVKDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  244 bits (624), Expect = 8e-79
 Identities = 107/264 (40%), Positives = 153/264 (57%), Gaps = 15/264 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YEL +++G G FG    A+ K      + VAVKI+ K    +       RRE++IL+ LS
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTG---KIVAVKILKKRSEKSKKDQTA-RREIRILRRLS 56

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V+  DA ED +++Y+VME CEGG+L D  L+RGG  +E++AK I +QIL  + + 
Sbjct: 57  -HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H  G++HRDLKPEN L      +  +++ DFGL+   ++    L   VG+ +Y+APEVL 
Sbjct: 115 HSNGIIHRDLKPENILLDE---NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNFDDLPWPSVSP 382
               Y  + D+WS+GVI Y LL G  PF          + R +L     FD+  W S S 
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 383 EAKDFVKRLLNKDYRKRMTAVQAL 406
           EAKD +K+ LNKD  KR TA + L
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  197 bits (504), Expect = 2e-61
 Identities = 96/258 (37%), Positives = 140/258 (54%), Gaps = 46/258 (17%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G FG    AR KK     ++VA+KII K   ++   +E++ RE++ILK L+ H ++V
Sbjct: 1   LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIV 54

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           K     ED N++Y+VME CEGG L D +    G+ +E++   I++QIL  + + H  G++
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH--RSYS 331
           HRDLKPEN L  S  D+  ++L DFGLS  +  D+  L  IVG+  Y+APEVL     YS
Sbjct: 115 HRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
            ++DIWS+GVI Y L                                   PE KD ++++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197

Query: 392 LNKDYRKRMTAVQALSKL 409
           L KD  KR +A + L  L
Sbjct: 198 LQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  190 bits (485), Expect = 4e-58
 Identities = 83/254 (32%), Positives = 129/254 (50%), Gaps = 16/254 (6%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G FG     R K       ++ A+K++ K K+     +E    E  IL  ++ H  +
Sbjct: 1   LGKGSFGKVLLVRKKD----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFI 55

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           VK   A +    +Y+V+E   GGEL   +   G R++EE A+    +I+  + + H  G+
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGI 114

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHRS-YS 331
           ++RDLKPEN L      D  ++L DFGL+ +      R N   G+  Y+APEVL    Y 
Sbjct: 115 IYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
              D WS+GV+ Y +L G  PF+A     I+  +L+    F +     +SPEA+D +  L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGL 227

Query: 392 LNKDYRKRMTAVQA 405
           L KD  KR+ +  A
Sbjct: 228 LQKDPTKRLGSGGA 241

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  188 bits (480), Expect = 2e-57
 Identities = 82/266 (30%), Positives = 139/266 (52%), Gaps = 18/266 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE+ K++G+G FG     R K      +   +K I  + M+     ED   EVKILK L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSV 264
           + H +++K+ ++ E+   + IVME  +GG+L  +I  +   G  + EE      VQ+   
Sbjct: 57  N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 265 VAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVA 322
           + + H + ++HRD+KP+N FL ++G     ++L DFG+S  +     L   +VG+ YY++
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PE+  ++ Y+ ++DIWS+G + Y L     PF       +   +L+    +  +P    S
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIP-SQYS 228

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
            E ++ V  LL KD  +R +  Q L 
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (450), Expect = 1e-51
 Identities = 92/292 (31%), Positives = 147/292 (50%), Gaps = 30/292 (10%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y + +++G G FG    AR +K       VA+K+++K   + +  +E   RE++IL +L
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVV 265
           +   ++VK  D  +D  ++Y+VME  +GG L D +   G  G  +E +A  I+ QILS +
Sbjct: 55  NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-------PDERLNDIVGSA 318
            + H +G++HRD+KPEN L     D   ++LIDFGL+  +             +  VG+ 
Sbjct: 115 EYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 319 YYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPF----WARTESGIFRAVLRSDP 370
            Y+APEVL        S  +DIWS+G+  Y LL G  PF     +   S   + +L    
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 371 NFDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
                P        +S  A D +K+LL KD + R+++   LS  ++  L  K
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  171 bits (436), Expect = 2e-50
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 37/278 (13%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++ GK +G G F     A+ K+    +++ A+KI+ K ++     ++ V+ E ++L  L+
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
           GH  ++K     +D  N+Y V+E    GELL  I   G    E+  +    +IL  + + 
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-DEKCTRFYAAEILLALEYL 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDE----------------- 309
           H +G++HRDLKPEN L      D DM   + DFG +  + P+                  
Sbjct: 119 HSKGIIHRDLKPENILL-----DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 310 ----RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
               R    VG+A YV+PE+L  +     +D+W++G I Y +L G  PF    E   F+ 
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233

Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
           +L+ + +F     P+  P+AKD +++LL  D + R+  
Sbjct: 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGV 267

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  168 bits (428), Expect = 1e-49
 Identities = 88/265 (33%), Positives = 144/265 (54%), Gaps = 20/265 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E+ +++G+G FG    AR K+     ++VA+K+I   K+ +    E +  E++ILK  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVI---KLESKEKKEKIINEIQILKKC 54

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK+  +    + ++IVME C GG L D + +     TE     +  ++L  + +
Sbjct: 55  K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
            H  G++HRD+K  N L TS   D +++LIDFGLS  +   +  N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170

Query: 328 R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSDPNFDDLPWPS-VSP 382
              Y  +ADIWS+G+ +  L  G  P+   +E    +A   +  + P    L  P   S 
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPG--LRNPEKWSD 225

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALS 407
           E KDF+K+ L K+  KR TA Q L 
Sbjct: 226 EFKDFLKKCLQKNPEKRPTAEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  166 bits (423), Expect = 9e-49
 Identities = 80/244 (32%), Positives = 119/244 (48%), Gaps = 18/244 (7%)

Query: 169 KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228
           KK    D   A+K+I KA M     ++ V  E  IL       ++VK   + +   N+Y+
Sbjct: 13  KKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYL 70

Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           VME   GG+L   +L   G   E+ A+  + +I+  + + H  G++HRDLKP+N L  S 
Sbjct: 71  VMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS- 128

Query: 289 RDDADMRLIDFGLSDF---------IRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWS 338
             +  ++L DFGLS              ++    IVG+  Y+APEV L + +S   D WS
Sbjct: 129 --NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186

Query: 339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK 398
           +G I Y  L G  PF   T   IF+ +L     + +     VS EA D + +LL  D  K
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEK 244

Query: 399 RMTA 402
           R+ A
Sbjct: 245 RLGA 248

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 8e-48
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 22/266 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y+LG  +GRG FG        +       VA+K IS  K+    +++ + +E+ +LK L
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK+  + E  +++YI++E  E G L  +I+ + G + E      V Q+L  +A+
Sbjct: 57  K-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
            H QGV+HRD+K  N L T    D  ++L DFG++       +    +VG+ Y++APEV+
Sbjct: 115 LHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171

Query: 327 HRS-YSLEADIWSIG--VISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPS-VS 381
             S  S  +DIWS+G  VI   LL G+ P++     + +FR V    P     P P  +S
Sbjct: 172 EMSGASTASDIWSLGCTVIE--LLTGNPPYYDLNPMAALFRIVQDDHP-----PLPEGIS 224

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           PE KDF+ +   KD   R TA Q L 
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  161 bits (410), Expect = 5e-47
 Identities = 78/259 (30%), Positives = 137/259 (52%), Gaps = 22/259 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +EL + +G+G FG  C  + +  +   +  A+K ++K K     S+ +V  E +IL+ L+
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTK---KMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAF 267
            H  LV    + +D  N+Y+V++L  GG+L  R  L++  +++EE  K  + +I+  + +
Sbjct: 59  -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
            H +G++HRD+KP+N L      D    + + DF ++  + PD       G+  Y+APEV
Sbjct: 116 LHSKGIIHRDIKPDNILL-----DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVS 381
           L  + YS+  D WS+GV +Y  L G RP+   +      I      +D  +      + S
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWS 226

Query: 382 PEAKDFVKRLLNKDYRKRM 400
            EA D + +LL +D +KR+
Sbjct: 227 TEAIDAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  161 bits (411), Expect = 1e-46
 Identities = 85/253 (33%), Positives = 131/253 (51%), Gaps = 17/253 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E  K +G G FG     R K      +  A+KI+SKAK+     +E V  E +IL+++ 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSG---KYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV    + +D +N+Y+VME   GGEL    L + GR+ E  A+    Q++  + + 
Sbjct: 60  -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LH 327
           H   +V+RDLKPEN L  S   D  +++ DFG +  +    R   + G+  Y+APE+ L 
Sbjct: 118 HSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILS 172

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKD 386
           + Y    D W++G++ Y +L G  PF+      I+  +L     F     PS  SP+AKD
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-----PSFFSPDAKD 227

Query: 387 FVKRLLNKDYRKR 399
            ++ LL  D  KR
Sbjct: 228 LIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  155 bits (394), Expect = 1e-44
 Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 26/270 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
           ++  G+ +GRG FG +          KD  + +AVK +  +  +    +E + RE++IL 
Sbjct: 1   EWTRGELLGRGSFG-SVYL----ALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILS 54

Query: 206 ALSGHKHLVKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           +L  H ++V++   +  E+ N + I +E   GG L   +L + G+  E   +    QIL 
Sbjct: 55  SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112

Query: 264 VVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAY 319
            +A+ H  G+VHRD+K  N  + + G     ++L DFG +     I   E    + G+ Y
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGV----VKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 320 YVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESG--IFRAVLRSDPNFDDLP 376
           ++APEV+    Y   ADIWS+G     +  G  P+         +++     +P   ++P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--PEIP 226

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              +S EAKDF+++ L +D +KR TA + L
Sbjct: 227 -EHLSEEAKDFLRKCLRRDPKKRPTADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 1e-40
 Identities = 87/289 (30%), Positives = 133/289 (46%), Gaps = 43/289 (14%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE  +++G G +G    AR KK     + VA+K I        I    +R E+ +LK L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALR-EISLLKELK 56

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H ++VK  D       +Y+V E C+    + LD+   R G  +    K+I+ Q+L  +A
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLA 112

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEV 325
           +CH   ++HRDLKP+N L      D  ++L DFGL+     P       V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVL-----RSDPNFDD 374
           L   + YS   DIWS+G I   ++ G   F   +E      IF+ +L      S P    
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTK 228

Query: 375 LPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           LP                  P + PE  D + ++L  +  KR++A +AL
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  144 bits (366), Expect = 2e-40
 Identities = 75/253 (29%), Positives = 132/253 (52%), Gaps = 21/253 (8%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQV--AVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +G G FG     R +  ++K +    A+K + K  +      E +  E +IL+  + H  
Sbjct: 1   LGVGGFG-----RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPF 54

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +VK     +D   +Y++ME C GGEL   IL   G + E  A+  +  ++    + H +G
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113

Query: 273 VVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSY 330
           +++RDLKPEN L  ++G     ++L+DFG +  ++  ++     G+  YVAPE+ L++ Y
Sbjct: 114 IIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY 169

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS-VSPEAKDF 387
               D WS+G++ Y LL G  PF    E    I+  +L+ +     L +P+ +   AKD 
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDL 226

Query: 388 VKRLLNKDYRKRM 400
           +K+LL ++  +R+
Sbjct: 227 IKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 6e-40
 Identities = 101/296 (34%), Positives = 142/296 (47%), Gaps = 56/296 (18%)

Query: 149 YELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAI-SIEDVR--REVKIL 204
           Y++ K++G G FG    AR K  GEL    VA+K     KM     S E+    REVK L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGEL----VAIK-----KMKKKFYSWEECMNLREVKSL 51

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILS 263
           + L+ H ++VK  +   + + +Y V E  EG  L   +  R G+  +E   ++I+ QIL 
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
            +A  H  G  HRDLKPEN L +       +++ DFGL+  IR      D V + +Y AP
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167

Query: 324 EVL--HRSYSLEADIWSIGVIS---YILLCGSRP-FWARTESG-IFR--AVLRSDPNFDD 374
           E+L    SYS   DIW++G I    Y L    RP F   +E   +++  +VL + P   D
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLGT-PTKQD 222

Query: 375 LP------------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            P                         P+ SPEA D +K +L  D +KR TA QAL
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 2e-38
 Identities = 90/288 (31%), Positives = 136/288 (47%), Gaps = 42/288 (14%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E+ K +GRG FG     R K       QV A+K++ K+ M     I  VR E  IL A 
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKD----TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-AD 57

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    +VK   + +D  ++Y+VME   GG+L+  +L R   + EE A+  + +++  +  
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDS 116

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL--------------- 311
            H  G +HRD+KP+N L  +   D  ++L DFGL     +  +R                
Sbjct: 117 VHKLGFIHRDIKPDNILIDA---DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 312 --------------NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR 356
                         N  VG+  Y+APEVL    Y LE D WS+GVI Y +L G  PF++ 
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233

Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
           T    +  ++    +    P P VSPEA D + RLL  D   R+ + +
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE 280

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  138 bits (350), Expect = 2e-37
 Identities = 97/304 (31%), Positives = 148/304 (48%), Gaps = 60/304 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDV----R--REV 201
           +YEL K +G G +G  CSA  K+     ++VA+K IS          +D+    R  RE+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNV-------FDDLIDAKRILREI 50

Query: 202 KILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           K+L+ L  H++++   D     + ED N+VYIV EL E    L +++      T++  + 
Sbjct: 51  KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LN 312
            + QIL  + + H   V+HRDLKP N L  S   + D+++ DFGL+  + PDE     L 
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVI--------------SYI----LLC---G 349
           + V + +Y APE+L     Y+   DIWS+G I               YI    L+    G
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224

Query: 350 SRP--FWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAV 403
           +          S   R  L+S P     P     P  SPEA D ++++L  D +KR+TA 
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284

Query: 404 QALS 407
           +AL+
Sbjct: 285 EALA 288

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 3e-36
 Identities = 90/288 (31%), Positives = 133/288 (46%), Gaps = 40/288 (13%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+   ++G G +G    AR K   L  + VA+K I     +  I    +R E+K+LK L+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN 56

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H +++K  D      ++Y+V E  +  +L   I  R     E   K+ + Q+L  +AFC
Sbjct: 57  -HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH 327
           H  G++HRDLKPEN L  +   +  ++L DFGL+       R     V + +Y APE+L 
Sbjct: 115 HSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 328 RS--YSLEADIWSIGVISYILLCGSRPFWARTE-----SGIF------------------ 362
               YS   DIWS+G I   LL   RP +           IF                  
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 363 RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           R    S P    +P     P+ SP+A D + ++L+ D  KR+TA QAL
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 2e-35
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 49/292 (16%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
            +    +EL + +G G +G    AR KK     Q VA+KI+           E+++ E  
Sbjct: 2   PDPTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYN 54

Query: 203 ILKALSGHKHLVKFCDA--------CEDVNNVYIVMELCEGG---ELLDRILARGGRYTE 251
           IL+  S H ++  F  A         +D   +++VMELC GG   +L+  +  +G R  E
Sbjct: 55  ILRKYSNHPNIATFYGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112

Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDER 310
           E    I+ + L  +A+ H   V+HRD+K +N L T    +A+++L+DFG+S        R
Sbjct: 113 EWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGR 169

Query: 311 LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
            N  +G+ Y++APEV+        SY   +D+WS+G+ +  L  G  P     +    RA
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRA 226

Query: 365 ---VLRSDPNFDDLPWPSVSPEAK------DFVKRLLNKDYRKRMTAVQALS 407
              + R+ P       P++           DF+   L K+Y +R    + L 
Sbjct: 227 LFKIPRNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  131 bits (331), Expect = 2e-35
 Identities = 94/275 (34%), Positives = 139/275 (50%), Gaps = 31/275 (11%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAV-KIISKAKMTTAISIEDVRREVKILKA 206
            YE+ + +G+G FG     R K     D ++ V K I    MT     + V  EV IL+ 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKS----DGKILVWKEIDYGNMTEKEKQQLVS-EVNILRE 55

Query: 207 LSGHKHLVKFCDACEDVNN--VYIVMELCEGGEL--LDRILARGGRYTEEDAK-AIVVQI 261
           L  H ++V++ D   D +N  +YIVME CEGG+L  L +   +  +Y EE+    I+ Q+
Sbjct: 56  LK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 262 LSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIV 315
           L  +  CH +      V+HRDLKP N +F    ++   +L DFGL+  +  D       V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPAN-IFLDANNNV--KLGDFGLAKILGHDSSFAKTYV 171

Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS---DPN 371
           G+ YY++PE L H SY  ++DIWS+G + Y L   S PF AR +       L S   +  
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKIKEGK 226

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           F  +P    S E  + +K +LN D  KR +  + L
Sbjct: 227 FRRIP-YRYSSELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  131 bits (331), Expect = 2e-35
 Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 24/267 (8%)

Query: 150 ELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           E  K +G+G  G     R K  G++     A+K I           + + RE+K L++  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKI----YALKKI-HVDGDEEF-RKQLLRELKTLRS-C 56

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              ++VK   A      + IV+E  +GG L   +L + G+  E     I  QIL  + + 
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115

Query: 269 HLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL 326
           H +  ++HRD+KP N L  S     ++++ DFG+S  +    ++ N  VG+  Y++PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINS---KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172

Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF---RAVLRSDPNFDDLPWPS--V 380
              SYS  ADIWS+G+       G  PF    +   F   +A+    P       P+   
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLPAEEF 228

Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALS 407
           SPE +DF+   L KD +KR +A + L 
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 3e-35
 Identities = 82/247 (33%), Positives = 123/247 (49%), Gaps = 19/247 (7%)

Query: 154 EVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +VG+G +G    A+ K  GE+    VA+K + K+ +     +  V  E  IL   +  + 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEI----VALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEW 62

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   A +D   +Y+ ME   GG+    +L   G  +E+ A+  + ++   V   H  G
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYS 331
            +HRDLKPENFL  +      ++L DFGLS  I      N +VGS  Y+APEVL  + Y 
Sbjct: 122 YIHRDLKPENFLIDA---SGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYD 176

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----SDPNFDDLPWPSVSPEAKD 386
              D WS+G + Y  LCG  PF   T +  +  +         P +DD P  ++S EA D
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFNLSDEAWD 235

Query: 387 FVKRLLN 393
            + +L+N
Sbjct: 236 LITKLIN 242

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 6e-35
 Identities = 74/251 (29%), Positives = 118/251 (47%), Gaps = 11/251 (4%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K + +G FG    A+ +         A+K++ K+ M     + +V+ E  I+       +
Sbjct: 2   KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K   + +  + +Y+VME   GG+    I   GG   E+ AK  + +++  V   H +G
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSL 332
           ++HRD+KPEN L         ++L DFGLS   R        VG+  Y+APE +      
Sbjct: 118 IIHRDIKPENLLID---QTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDD 171

Query: 333 EA-DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
           +  D WS+G + +  L G  PF A T   +F  +L    N+ +      SPEA D + RL
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231

Query: 392 LNKDYRKRMTA 402
           L  D  KR+ A
Sbjct: 232 LCMDPAKRLGA 242

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  128 bits (323), Expect = 2e-34
 Identities = 86/275 (31%), Positives = 132/275 (48%), Gaps = 32/275 (11%)

Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +++ G ++G G FG  +T       GEL    +AVK I          I+++  E+K+L+
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNL-DTGEL----MAVKEIRIQDNDPKT-IKEIADEMKVLE 54

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSV 264
            L  H +LVK+         VYI ME C GG L +  L   GR  +E   +   +Q+L  
Sbjct: 55  LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEG 111

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-----RPDERLNDIVGSAY 319
           +A+ H  G+VHRD+KP N        +  ++L DFG +  +        E +  + G+  
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168

Query: 320 YVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNF 372
           Y+APEV+       +   ADIWS+G +   +  G RP W+  ++    +F       P  
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPI 227

Query: 373 -DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            D L    +SPE KDF+ R L  D +KR TA + L
Sbjct: 228 PDSL---QLSPEGKDFLDRCLESDPKKRPTASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 3e-34
 Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 53/298 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVR----REVK 202
           KYE+   VG G +G     R K  GE+    VA+K     K   +   EDV+    REVK
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEI----VAIK-----KFKESEDDEDVKKTALREVK 52

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           +L+ L  H+++V   +A      +Y+V E  E   LL+ + A  G    +  ++ + Q+L
Sbjct: 53  VLRQLR-HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL 110

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDERLNDIVGSAYY 320
             +A+CH   ++HRD+KPEN L +       ++L DFG +  +  RP   L D V + +Y
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSE---SGVLKLCDFGFARALRARPASPLTDYVATRWY 167

Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-----GIFRA--------- 364
            APE+L    +Y    D+W+IG I   LL G  P +           I +          
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226

Query: 365 -VLRSDPNFDDLPWPSVSPE--------------AKDFVKRLLNKDYRKRMTAVQALS 407
            +  S+P F  + +P  S                A DF+K  L  D ++R+T  + L 
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  128 bits (323), Expect = 4e-34
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 36/273 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK--IISKAKMTTAISIEDVRREVKILK 205
            Y+  +++G G  G    A  +      ++VA+K   + K      I       E+ I+K
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILIMK 70

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
               H ++V + D+    + +++VME  +GG L D I     R  E     +  ++L  +
Sbjct: 71  DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPE 324
            + H Q V+HRD+K +N L +    D  ++L DFG +  + +   + N +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSK---DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDD 374
           V+ R  Y  + DIWS+G++   +  G  P+         +  T  GI        P   +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--------PPLKN 238

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                 SPE KDF+ + L KD  KR +A + L 
Sbjct: 239 P--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  127 bits (320), Expect = 1e-33
 Identities = 83/266 (31%), Positives = 139/266 (52%), Gaps = 22/266 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKAL 207
           +EL + +G G +G     R   G    +  A+K++ KA +   A + E  R E ++L+A+
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
                LV    A +    ++++++   GGEL   +  R   +TE + +  + +I  V+A 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLAL 118

Query: 268 CHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAP 323
            HL   G+++RD+K EN L  S   +  + L DFGLS     +E  R     G+  Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 324 EVLHR---SYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNFDDLP 376
           EV+      +    D WS+GV+++ LL G+ PF       ++S I R +L+S P F    
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--- 232

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTA 402
             ++S EA+DF+++LL KD +KR+ A
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGA 257

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  126 bits (317), Expect = 1e-33
 Identities = 72/262 (27%), Positives = 130/262 (49%), Gaps = 16/262 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E+  ++G+G FG       K     D++V A+K I  +KM      E +  E ++L  L
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKA----DKRVYAMKQIDLSKMNRREREEAID-EARVLAKL 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVA 266
               +++++ ++  D   + IVME  E G+L   +   RG    E+      +QIL  +A
Sbjct: 57  D-SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAPEV 325
             H + ++HRD+K  N LF    D  ++++ D G++  +  +    N IVG+ YY++PE+
Sbjct: 116 HLHSKKILHRDIKSLN-LFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
              + Y+ ++D+W++GV+ Y    G  PF A  +  +   ++R    F  +     S + 
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQL 229

Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
              + + L KDYR+R    Q L
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  127 bits (320), Expect = 2e-33
 Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 43/281 (15%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G  G     R K         A+K++ K +M     ++ V  E +IL A   H  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKL---FALKVLDKKEMIKRNKVKRVLTEQEIL-ATLDHPF 62

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHL 270
           L     + +    + +VM+ C GGEL  R+L R  G   +EE A+    ++L  + + HL
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---------------------------- 302
            G+V+RDLKPEN L     +   + L DF LS                            
Sbjct: 122 LGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 303 DFIR--PDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES 359
           +     P  R N  VG+  Y+APEV+    +    D W++G++ Y +L G+ PF      
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238

Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM 400
             F  +L+ +  F     P VS  A+D +++LL KD  KR+
Sbjct: 239 ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (314), Expect = 4e-33
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            LGK++G G FG     +   KG  K  +VAVK + +      I  E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK    C +   +YIVME  EGG+LL  +     + +  D  +  +QI   + + 
Sbjct: 60  -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  +HRDL   N L         +++ DFGLS  +  D+         YY        
Sbjct: 119 ESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYRKRGGKLP 166

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFW 354
               APE L    ++ ++D+WS GV+ + I   G +P+ 
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  125 bits (316), Expect = 5e-33
 Identities = 88/299 (29%), Positives = 137/299 (45%), Gaps = 57/299 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--------TAISIEDVRR 199
           +YE GK++G G +     AR K+     + VA+K I   +          TA+      R
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG-ELL--DRILARGGRYTEEDAKA 256
           E+K+L+ L  H +++   D     +N+ +V E  E   E +  D+ +      T  D K+
Sbjct: 52  EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI----VLTPADIKS 106

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
            ++  L  + + H   ++HRDLKP N L  S   D  ++L DFGL+  F  P+ ++   V
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQV 163

Query: 316 GSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRA---- 364
            + +Y APE+L   R Y +  D+WS+G I   LL    PF            IF A    
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTP 222

Query: 365 ------VLRSDPN---FDDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                  + S P+   F   P       +P+ S +A D ++RLL  +  KR+TA QAL 
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  125 bits (315), Expect = 6e-33
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 39/290 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y++   +G G  G    A+ ++     + VA+K ++  ++   I      RE+K L+A 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK  D     +   +VME     +L + +        E   K+ +  +L  VA+
Sbjct: 57  Q-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL--NDIVGSAYYVAPEV 325
            H  G++HRDLKP N L      D  +++ DFGL+     +E    +  V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Query: 326 LH--RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV----LRSDPNFDDL 375
           L+  R Y    D+W++G I   LL GS  F    +    + +FR +      + P    L
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231

Query: 376 P------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           P                  +P  SPEA D +K LL  D  KR++A +AL 
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 81/269 (30%), Positives = 136/269 (50%), Gaps = 31/269 (11%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            + L + +G+G FG    A  K+    +Q VA+K+I   +      IED+++E++ L   
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQC 56

Query: 208 -SGH--KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            S +  K+   F         ++I+ME C GG  LD  L + G+  E     I+ ++L  
Sbjct: 57  RSPYITKYYGSFLKGS----KLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLG 110

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAP 323
           + + H +G +HRD+K  N L +    + D++L DFG+S  +     + N  VG+ +++AP
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167

Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGI--FRAVL---RSDPNFDDLPW 377
           EV+ +S Y  +ADIWS+G+ +  L  G  P      S +   R +    +++P    L  
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNP--PSLEG 220

Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              S   KDFV   LNKD ++R +A + L
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 1e-32
 Identities = 85/294 (28%), Positives = 128/294 (43%), Gaps = 48/294 (16%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           YE   ++G G +G    AR KK GEL    VA+K I          I  +R E+K+L+ L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGEL----VALKKIRMENEKEGFPITAIR-EIKLLQKL 55

Query: 208 SGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSV 264
             H ++V+  +    +   ++Y+V E  +    L  +L     ++TE   K  + Q+L  
Sbjct: 56  R-HPNIVRLKEIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEG 112

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDERLNDIVGSAYYVA 322
           + + H  G++HRD+K  N L     +D  ++L DFGL+     R      + V + +Y  
Sbjct: 113 LQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169

Query: 323 PEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSD-----PN 371
           PE+L     Y  E D+WS+G I   L  G   F   TE      IF  +  S      P 
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE-LCGSPTDENWPG 228

Query: 372 FDDLPW----------PSV---------SPEAKDFVKRLLNKDYRKRMTAVQAL 406
              LPW                       P A D + +LL  D +KR++A QAL
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  124 bits (314), Expect = 1e-32
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 15/254 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A  K     D+  AVK++ K  +     +E    E ++L     H  
Sbjct: 1   KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           L +     +  + ++ VME   GG+L+  I  R GR+ E  A+    +I+  + F H +G
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
           +++RDLK +N L  S   +  +++ DFG+  + I      +   G+  Y+APE+L ++ Y
Sbjct: 117 IIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVK 389
               D W++GV+ Y +L G  PF    E  +F+++L  +  +     P  +S EAK  +K
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILK 228

Query: 390 RLLNKDYRKRMTAV 403
             L K+  KR+  +
Sbjct: 229 SFLTKNPEKRLGCL 242

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  123 bits (310), Expect = 1e-32
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 18/265 (6%)

Query: 148 KYELGKEVGRGHFGHTCSA-RGKKGELKDQQVAVKIISKAK--MTTAISIEDVRREVKIL 204
           ++  G+ +G G FG          G+      AVK +S A    T   +++ + +E+ +L
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIALL 56

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             L  H ++V++     + +N+YI +EL  GG L  ++L + G + E   +    QIL  
Sbjct: 57  SKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLG 114

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H +  VHRD+K  N L  +   +  ++L DFG++  +          GS Y++APE
Sbjct: 115 LEYLHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171

Query: 325 VLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVS 381
           V+ +   Y L ADIWS+G  + + +   +P W++ E     AV +   + +  P P  +S
Sbjct: 172 VIAQQGGYGLAADIWSLGC-TVLEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHLS 228

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
            EAKDF+ + L +D   R TA + L
Sbjct: 229 DEAKDFILKCLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 2e-32
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            LGK++G G FG       K KG+ K+ +VAVK + +      I  E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
            H ++VK    C +   + IVME   GG+LLD +     +  +  D  +  +QI   + +
Sbjct: 60  -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
              +  +HRDL   N L         +++ DFGLS  +  D+         YY       
Sbjct: 119 LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYKVKGGKL 166

Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFW 354
                APE L    ++ ++D+WS GV+ + I   G  P+ 
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 5e-32
 Identities = 71/256 (27%), Positives = 124/256 (48%), Gaps = 17/256 (6%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
              E  K VG G FG     R +  E      A+K+++  ++      + V  E ++LK 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           +S H  +++      D   +Y++ME   GGEL   +   G R++         +I+  + 
Sbjct: 58  VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALE 115

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           + H + +V+RDLKPEN L      +  ++L DFG +  +R  +R   + G+  Y+APEV+
Sbjct: 116 YLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVI 170

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEA 384
               ++   D W++G++ Y +L G  PF+     GI+  +L        L +P  +   A
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----KLEFPRHLDLYA 225

Query: 385 KDFVKRLLNKDYRKRM 400
           KD +K+LL  D  +R+
Sbjct: 226 KDLIKKLLVVDRTRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (305), Expect = 8e-32
 Identities = 77/272 (28%), Positives = 136/272 (50%), Gaps = 37/272 (13%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ +++G G +G    A  K+     Q VA+K++    +     ++++ +E+ ILK   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEE--DLQEIIKEISILKQ-C 55

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              ++VK+  +     +++IVME C  G + D +       TEE+  AI+ Q L  + + 
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-------IVGSAYYV 321
           H    +HRD+K  N L     ++   +L DFG+S       +L D       ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILLN---EEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166

Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL----RSDPNFDDLP 376
           APEV+    Y+ +ADIWS+G I+ I +   +P ++       RA+     +  P   D  
Sbjct: 167 APEVIQEIGYNNKADIWSLG-ITAIEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSD-- 221

Query: 377 WPS-VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            P   SPE  DFVK+ L KD  +R +A+Q L 
Sbjct: 222 -PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  120 bits (303), Expect = 2e-31
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 40/279 (14%)

Query: 149 YELGKEVGRGH----FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           YEL + +G G     +   C    +K       VA+K I   K  T  S++++R+EV+ +
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEK-------VAIKRIDLEKCQT--SVDELRKEVQAM 53

Query: 205 KALSGHKHLVK-FCDACEDVNNVYIVMELCEGGELLD---RILARGGRYTEEDAKAIVV- 259
            +   H ++VK +       + +++VM    GG LLD       RGG   +E   A V+ 
Sbjct: 54  -SQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLK 109

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-----RPDERLNDI 314
           ++L  + + H  G +HRD+K  N L     +D  +++ DFG+S  +     R  +     
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 315 VGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-- 370
           VG+  ++APEV+     Y  +ADIWS G+ +  L  G+ P+       +    L++DP  
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226

Query: 371 ---NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                D   +   S   +  +   L KD  KR TA + L
Sbjct: 227 LETGADYKKY---SKSFRKMISLCLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 3e-31
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 32/274 (11%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            YEL + +G G +G    AR    GEL    VA+K+I   K+      E +++E+ +LK 
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGEL----VAIKVI---KLEPGDDFEIIQQEISMLKE 56

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV-VQILSVV 265
              H ++V +  +    + ++IVME C GG L D I         E   A V  + L  +
Sbjct: 57  CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL 114

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPE 324
           A+ H  G +HRD+K  N L T   +D D++L DFG+S  +     +    +G+ Y++APE
Sbjct: 115 AYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171

Query: 325 VL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP---- 376
           V        Y  + DIW++G I+ I L   +P     +    RA+     +    P    
Sbjct: 172 VAAVERKGGYDGKCDIWALG-ITAIELAELQP--PMFDLHPMRALFLISKSNFPPPKLKD 228

Query: 377 ---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              W   SP   DF+K+ L KD +KR TA + L 
Sbjct: 229 KEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  119 bits (301), Expect = 4e-31
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 29/206 (14%)

Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ELGK++G G FG       K  GE  + +VAVK + +    +    E+   E  I+K LS
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLS 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V+    C     +YIV E   GG+LLD +   G + T +D   + +QI   + + 
Sbjct: 60  -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  VHRDL   N L T       +++ DFGLS  I  D+         YY        
Sbjct: 119 ESKNFVHRDLAARNCLVTENL---VVKISDFGLSRDIYEDD---------YYRKRGGGKL 166

Query: 322 -----APEVL-HRSYSLEADIWSIGV 341
                APE L    ++ ++D+WS GV
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGV 192

Length = 258

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  118 bits (297), Expect = 1e-30
 Identities = 87/280 (31%), Positives = 135/280 (48%), Gaps = 26/280 (9%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS---IEDVRREVKILK 205
           +E+  E+G G FG    A+ K+           +++ AK+    S   +ED   E+ IL 
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDIL- 56

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           A   H ++VK  DA    NN++I++E C GG +   +L      TE   + +  Q L  +
Sbjct: 57  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPE 324
            + H   ++HRDLK  N LFT    D D++L DFG+S    R  +R +  +G+ Y++APE
Sbjct: 117 NYLHENKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173

Query: 325 VL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           V+       R Y  +AD+WS+G+    +     P        +   + +S+P    L  P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PTLAQP 231

Query: 379 SV-SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
           S  S E KDF+K+ L K+   R T  Q L    V + S K
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  117 bits (294), Expect = 5e-30
 Identities = 79/263 (30%), Positives = 136/263 (51%), Gaps = 20/263 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKAL 207
           +EL K +G G +G     R   G    +  A+K++ KA +   A + E  R E ++L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
                LV    A +    ++++++   GGEL   +  R  R+ E++ +    +I+  +  
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPD-ERLNDIVGSAYYVAPEV 325
            H  G+++RD+K EN L  S   +  + L DFGLS +F   + ER     G+  Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 326 LH---RSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNFDDLPWP 378
           +      +    D WS+GV+ Y LL G+ PF       +++ I R +L+S+P     P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232

Query: 379 S-VSPEAKDFVKRLLNKDYRKRM 400
             +S  AKD ++RLL KD +KR+
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 82/298 (27%), Positives = 143/298 (47%), Gaps = 52/298 (17%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            +Y+    VG G +G  CSA   K   K   VA+K +S+    +AI  +   RE+++LK 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRK---VAIKKLSRP-FQSAIHAKRTYRELRLLKH 70

Query: 207 LSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           +  H++++   D        ED  +VY+V  L   G  L+ I+ +  + +++  + +V Q
Sbjct: 71  MD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQFLVYQ 126

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAY 319
           IL  + + H  G++HRDLKP N       +D +++++DFGL+   R  D+ +   V + +
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLA---RHTDDEMTGYVATRW 180

Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCG-----------------------SRPFW 354
           Y APE++     Y+   DIWS+G I   LL G                            
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 355 ARTESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +  S   R  ++S P     +F ++ +   +P A D ++++L  D  KR+TA +AL+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA 297

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  116 bits (293), Expect = 2e-29
 Identities = 86/298 (28%), Positives = 144/298 (48%), Gaps = 47/298 (15%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YEL KE+G+G +G  CSAR      +++ VA+K I+    +  I  +   RE+K+L+   
Sbjct: 2   YELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFR 59

Query: 209 GHKHLVKFCDA----CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           GHK++    D       + N +Y+  EL E    L +I+  G   T+   ++ + QIL  
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-----DFIRPDERLNDIVGSAY 319
           + + H   V+HRDLKP N L  +   D ++++ DFGL+     +       + + V + +
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW----------------------- 354
           Y APE++   +SY+   D+WS+G I   LL G +P +                       
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 355 -ARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +R  S   +  +RS PN    P+ S+    +P A D +++LL  D  KR++  +AL 
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  116 bits (291), Expect = 3e-29
 Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 45/286 (15%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           + VG G FG  CSAR    +L  Q VA+K I K   T  ++ +   RE+K+LK L  H++
Sbjct: 16  QPVGMGAFGLVCSARD---QLTGQNVAIKKIMKPFSTPVLA-KRTYRELKLLKHLR-HEN 70

Query: 213 LVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++   D     + ++Y V EL   G  L R+L       ++  +  + QIL  + + H  
Sbjct: 71  IISLSDIFISPLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL--HR 328
           GVVHRDLKP N L     ++ D+++ DFGL+   R  D ++   V + YY APE++   +
Sbjct: 128 GVVHRDLKPSNILIN---ENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQ 181

Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---------------------- 366
            Y +E DIWS G I   +L G   F  +     F  +                       
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 367 -RSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +S P  + +P    + +  P A D ++++L  D +KR++A +AL+
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  116 bits (292), Expect = 3e-29
 Identities = 85/301 (28%), Positives = 136/301 (45%), Gaps = 50/301 (16%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
            G++Y+  + +G G +G  CSA   +     ++VA+K I  A        +   RE+KIL
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHA-FDVPTLAKRTLRELKIL 58

Query: 205 KALSGHKHLVKFCD----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           +    H +++   D       D  +VY+VM+L E    L  I+      TEE  +  + Q
Sbjct: 59  RHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQ 115

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDER---LNDIV 315
           +L  + + H   V+HRDLKP N L      D ++R+ DFG++  +   P E    + + V
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 316 GSAYYVAPE---VLHRSYSLEADIWSIGVI--------------SY-------ILLCGSR 351
            + +Y APE    L   Y+   D+WS+G I              +Y       + + GS 
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231

Query: 352 P--FWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                 R  S   R  +++ P    +PW    P  SPEA D + ++L  D  +R+T  QA
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291

Query: 406 L 406
           L
Sbjct: 292 L 292

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 4e-29
 Identities = 85/285 (29%), Positives = 147/285 (51%), Gaps = 36/285 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + EL   +GRG +G     RGK      + VA+KII+    T    + D++REV +L  L
Sbjct: 5   RLEL---IGRGAYGAV--YRGKHVPTG-RVVALKIINLD--TPDDDVSDIQREVALLSQL 56

Query: 208 --SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
             S   ++ K+  +      ++I+ME  EGG +  R L + G   E+    I+ ++L  +
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVAL 114

Query: 266 AFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
            + H  GV+HRD+K  N L T +G     ++L DFG++    +   + +  VG+ Y++AP
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGN----VKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Query: 324 EVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPWP 378
           EV+   + Y  +ADIWS+G+  Y +  G+ P+   ++   FRA++   +S P    L   
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKP--PRLEDN 225

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTA--------VQALSKLVVPILS 415
             S   ++FV   L+++ ++R++A        ++A SK  V IL 
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILK 270

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  114 bits (286), Expect = 7e-29
 Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 15/256 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
            ++G G  G  C A  K      +QVAVK   K  +      E +  EV I++    H +
Sbjct: 25  VKIGEGSTGIVCIATDKS---TGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HPN 77

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+   +    + +++VME  EGG L D +     R  EE    + + +L  ++F H QG
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG 135

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-Y 330
           V+HRD+K ++ L TS   D  ++L DFG    +  +  R   +VG+ Y++APEV+ R  Y
Sbjct: 136 VIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
             E DIWS+G++   ++ G  P++        + +  + P         VSP  + F+ R
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDR 251

Query: 391 LLNKDYRKRMTAVQAL 406
           +L +D  +R TA + L
Sbjct: 252 MLVRDPAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 9e-29
 Identities = 86/270 (31%), Positives = 129/270 (47%), Gaps = 28/270 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+  E+G G FG    A+ K+        A KII   ++ +   +ED   E+ IL    
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDILSECK 60

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V   +A    N ++I++E C+GG L   +L      TE   + +  Q+L  + F 
Sbjct: 61  -HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H   V+HRDLK  N L T    D D++L DFG+S       ++ +  +G+ Y++APEV+ 
Sbjct: 120 HSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176

Query: 327 -----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSDPNFDDLP-- 376
                   Y  +ADIWS+G I+ I L    P     E    R    +L+S+P   D P  
Sbjct: 177 CETFKDNPYDYKADIWSLG-ITLIELAQMEP--PHHELNPMRVLLKILKSEPPTLDQPSK 233

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           W   S    DF+K  L KD   R TA + L
Sbjct: 234 W---SSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  111 bits (280), Expect = 2e-28
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 28/274 (10%)

Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR----EV 201
           KYE  + VGRG FG  H C     + +   + V +K I   +MT     +D R     E 
Sbjct: 1   KYEKIRVVGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNEC 50

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQ 260
           ++LK LS H +++++ +   +   + IVME   GG L + I  R     +ED      VQ
Sbjct: 51  QVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           IL  +   H + ++HRDLK +N L    +    +++ DFG+S  +    +   +VG+  Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 321 VAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNFDDLPW 377
           ++PE+   + Y+ ++DIW++G + Y L    R F A     +   ++     P  D    
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---- 223

Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV 411
              SP+ +  +  +LN D  KR    Q +++ + 
Sbjct: 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  111 bits (280), Expect = 2e-28
 Identities = 74/264 (28%), Positives = 137/264 (51%), Gaps = 14/264 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   K++G G FG     + K+     +Q  +K I+ +KM+     E+ R+EV +L  +
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVA 266
             H ++V++ ++ E+  N+YIVM+ CEGG+L  +I A RG  + E+      VQI   + 
Sbjct: 57  K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAPEV 325
             H + ++HRD+K +N   T    D  ++L DFG++  +     L    +G+ YY++PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTK---DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
             +R Y+ ++DIW++G + Y +      F A     +   ++R   ++  +     S + 
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229

Query: 385 KDFVKRLLNKDYRKRMTAVQALSK 408
           ++ V +L  ++ R R +    L K
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  113 bits (283), Expect = 3e-28
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 15/249 (6%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG    AR K+     +  AVK++ K  +     +E    E +IL     H  L 
Sbjct: 3   LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           +     +  + ++ VME   GG+L+  I  +  R+ E  A+    +I S + F H +G++
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-YSL 332
           +RDLK +N L      +   +L DFG+  + I   +  +   G+  Y+APE+L    Y  
Sbjct: 119 YRDLKLDNVLLDH---EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKRL 391
             D W++GV+ Y +LCG  PF A  E  +F A+L      D++ +P+ +S +A D +K  
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230

Query: 392 LNKDYRKRM 400
           + K+   R+
Sbjct: 231 MTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  110 bits (278), Expect = 5e-28
 Identities = 74/265 (27%), Positives = 131/265 (49%), Gaps = 14/265 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y   + +G+G FG     R  +    D  V  K ++  +++      D   E+ IL  L 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQ 57

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAF 267
            H +++ + +   D N + I ME   GG L D+I+ + G+ + EE     + QI+S V++
Sbjct: 58  -HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-IVGSAYYVAPEVL 326
            H  G++HRD+K  N   T  +    ++L DFG+S  +  +  + + +VG+ YY++PE+ 
Sbjct: 117 IHKAGILHRDIKTLNIFLT--KAGL-IKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173

Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
               Y+ ++DIW++G + Y LL   R F A     +   +++   N+  +     S E  
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTPVVSV-YSSELI 230

Query: 386 DFVKRLLNKDYRKRMTAVQALSKLV 410
             V  LL +D  KR TA + L + +
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  112 bits (281), Expect = 5e-28
 Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 15/254 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A   KG   D+  A+K++ K  +     ++    E +IL   + H  
Sbjct: 1   KVLGKGSFGKVMLAE-LKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           L       +  + ++ VME   GG+L+ +I  R  ++ E  ++    ++   + F H  G
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHR-SY 330
           V++RDLK +N L  +   +   +L DFG+  + I          G+  Y+APE+L    Y
Sbjct: 117 VIYRDLKLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVK 389
               D W++GV+ Y ++ G  PF A  E  +F ++L      DD+ +P  +S EA   +K
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILK 228

Query: 390 RLLNKDYRKRMTAV 403
             + K+  KR+  V
Sbjct: 229 AFMTKNPNKRLGCV 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  110 bits (275), Expect = 1e-27
 Identities = 84/265 (31%), Positives = 135/265 (50%), Gaps = 17/265 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y + + VG G FG    A   +    DQ+ A+K I   K ++A+  ED R+E  +L  +
Sbjct: 1   QYNVLRVVGEGSFGR---ALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKM 55

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVA 266
             H ++V F ++ E   ++YIVME C+GG+L+ +I L RG  + E+      VQ+   V 
Sbjct: 56  K-HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEV 325
             H + V+HRD+K +N   T    +  ++L DFG +  +  P       VG+ YYV PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPE 383
                Y+ ++DIWS+G I Y L     PF A +   +   V +        P PS  S E
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYE 227

Query: 384 AKDFVKRLLNKDYRKRMTAVQALSK 408
            +  +K++  ++ R R +A   LS+
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTILSR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  111 bits (280), Expect = 1e-27
 Identities = 74/259 (28%), Positives = 130/259 (50%), Gaps = 15/259 (5%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           + +E+G+ +G G FG    A+ K      +  A+K + K ++     ++ V +E  IL  
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           LS H  +V    + +D N VY ++E   GGEL    L + GR+  + AK    +++    
Sbjct: 75  LS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFE 132

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           + H + +++RDLKPEN L  +      +++ DFG +  +   +R   + G+  Y+APEV+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDN---KGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI 187

Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             + +    D W++GV+ Y  + G  PF+  T   I+  +L     F +  W      A+
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRAR 243

Query: 386 DFVKRLLNKDYRKRMTAVQ 404
           D VK LL  D+ KR+  ++
Sbjct: 244 DLVKGLLQTDHTKRLGTLK 262

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  111 bits (279), Expect = 1e-27
 Identities = 78/253 (30%), Positives = 126/253 (49%), Gaps = 12/253 (4%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHK 211
           K +G+G +G     R   G    +  A+K++ KA +          + E  IL+A+  H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    A +    +Y+++E   GGEL    L R G + E+ A   + +I   +   H Q
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS- 329
           G+++RDLKPEN L  +      ++L DFGL  + I      +   G+  Y+APE+L RS 
Sbjct: 120 GIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
           +    D WS+G + Y +L G+ PF A         +L+   N   LP P ++PEA+D +K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN---LP-PYLTPEARDLLK 232

Query: 390 RLLNKDYRKRMTA 402
           +LL ++   R+ A
Sbjct: 233 KLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 41/237 (17%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K++G G FG     + K  + K  +VAVK + +    +    +D  +E +++K L GH +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC---- 268
           +V+    C +   +Y+V+E  EGG+LLD +      +   +   + ++ L  ++F     
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL--LSFAIQIA 115

Query: 269 ----HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV- 321
               +L  +  VHRDL   N L         +++ DFGLS  +  D+         YY  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDL---VVKISDFGLSRDVYDDD---------YYRK 163

Query: 322 -----------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                      APE L    ++ ++D+WS GV+ + I   G+ P+   +   +   +
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (272), Expect = 4e-27
 Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 20/269 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ K++G+G F     A      L  + VA+K +   +M  A + +D  +E+ +LK L 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI--LARGGRYTEEDAKAI---VVQILS 263
            H +++K+  +  + N + IV+EL + G+L   I    +  R   E  + I    VQ+ S
Sbjct: 61  -HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE--RTIWKYFVQLCS 117

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVA 322
            +   H + ++HRD+KP N   T+      ++L D GL  F        + +VG+ YY++
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS 379
           PE +H + Y+ ++DIWS+G + Y +     PF+    +   + + + + D  +  LP   
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADH 232

Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALSK 408
            S E +D V R +N D  KR      L  
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 8e-27
 Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 15/260 (5%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL--KALSGHKH 212
           +G+G FG     R K      +  A+K++SK ++     +     E  IL    L     
Sbjct: 1   IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V    + +  +++Y+V +   GGEL    L + GR++E+ AK  + +++  +   H   
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVL--HRS 329
           +V+RDLKPEN L  +      + L DFGLS   +  ++  N   G+  Y+APEVL   + 
Sbjct: 117 IVYRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
           Y+   D WS+GV+ + + CG  PF+A     ++R +      F   P   +S E + FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230

Query: 390 RLLNKDYRKRMTAVQALSKL 409
            LLN++ + R+ A +   +L
Sbjct: 231 GLLNRNPQHRLGAHRDAVEL 250

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 25/257 (9%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
            E+G G+ G       +       ++ AVK I + ++  AI  + + RE+ IL       
Sbjct: 7   GELGAGNSGVVSKVLHRP----TGKIMAVKTI-RLEINEAI-QKQILRELDILHK-CNSP 59

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHL 270
           ++V F  A  +  ++ I ME  +GG  LD+IL    GR  E     I V +L  + + H 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGS-LDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 271 Q-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-R 328
           +  ++HRD+KP N L  S      ++L DFG+S  +  +      VG++ Y+APE +   
Sbjct: 119 KHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGN 174

Query: 329 SYSLEADIWSIGVISYILLCGSR---PFWARTESGIF---RAVLRSDPNFDDLPWPSVSP 382
            YS+++DIWS+G +S I L   R   P       GIF   + ++   P    LP    SP
Sbjct: 175 DYSVKSDIWSLG-LSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSP 231

Query: 383 EAKDFVKRLLNKDYRKR 399
           + +DFV   L KD R+R
Sbjct: 232 DFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  107 bits (269), Expect = 2e-26
 Identities = 85/271 (31%), Positives = 133/271 (49%), Gaps = 30/271 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E+  E+G G FG    A+ K+ G L     A K+I   +  +   +ED   E++IL A 
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGAL----AAAKVI---ETKSEEELEDYMVEIEIL-AT 65

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK   A      ++I++E C GG +   +L      TE   + I  Q+L  + +
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
            H   ++HRDLK  N L T    D D++L DFG+S   ++  +R +  +G+ Y++APEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTL---DGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182

Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLP- 376
                    Y  +ADIWS+G I+ I +    P     E    R +L   +S+P     P 
Sbjct: 183 MCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHELNPMRVLLKIAKSEPPTLSQPS 239

Query: 377 -WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            W   S E +DF+K  L+K    R +A Q L
Sbjct: 240 KW---SMEFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (269), Expect = 2e-26
 Identities = 76/255 (29%), Positives = 132/255 (51%), Gaps = 15/255 (5%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G G  G  C AR K      +QVAVK++   K       E +  EV I++    H+++
Sbjct: 28  KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           V+   +      ++++ME  +GG L D  +    R  EE    +   +L  + + H QGV
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTD--IVSQTRLNEEQIATVCESVLQALCYLHSQGV 138

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YS 331
           +HRD+K ++ L T    D  ++L DFG    I  D  +   +VG+ Y++APEV+ R+ Y 
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
            E DIWS+G++   ++ G  P+++ +     +  LR  P         +SP  +DF++R+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERM 254

Query: 392 LNKDYRKRMTAVQAL 406
           L ++ ++R TA + L
Sbjct: 255 LTREPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 62/302 (20%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIED------VRREV 201
           YE   E+G G +G    AR    +L   + VA+K +        + + +        RE+
Sbjct: 1   YEELAEIGEGAYGTVYKAR----DLNTGRFVALKKVR-------VPLSEEGIPLSTLREI 49

Query: 202 KILKAL--SGHKHLVKFCDACEDVNN-----VYIVMELCEG--GELLDRILARGGRYTEE 252
            +LK L    H ++V+  D C          + +V E  +      L +    G     E
Sbjct: 50  ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPE 107

Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
             K ++ Q+L  V F H   +VHRDLKP+N L TS   D  +++ DFGL+     +  L 
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALT 164

Query: 313 DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVL 366
            +V + +Y APEVL +S Y+   D+WS+G I   L    RP F   +E+     IF  + 
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIG 223

Query: 367 RSDPNFDD------LPW---------------PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
              P+ ++      LP                P +  E  D +K++L  +  KR++A +A
Sbjct: 224 L--PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281

Query: 406 LS 407
           L 
Sbjct: 282 LQ 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  108 bits (271), Expect = 2e-26
 Identities = 77/263 (29%), Positives = 135/263 (51%), Gaps = 17/263 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKAL 207
           +EL K +G G +G     R   G    +  A+K++ KA +   A ++E  R E  +L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
                LV    A +    ++++++   GGE+   +  R   ++E++ +    +I+  +  
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPD-ERLNDIVGSAYYVAPEV 325
            H  G+V+RD+K EN L  S   +  + L DFGLS +F+  + ER     G+  Y+APE+
Sbjct: 121 LHKLGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 326 LH--RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLRSDPNFDDLPWPS 379
           +     +    D WS+G++ + LL G+ PF       T+S + R +L+ DP F       
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233

Query: 380 VSPEAKDFVKRLLNKDYRKRMTA 402
           + PEA+D + +LL KD +KR+ A
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGA 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  106 bits (267), Expect = 2e-26
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 13/217 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKG-----ELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           Y + + +G G FG     R K        LK+  V      K K     SI D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEG---GELLDRILARGGRYTEEDAKAIVVQ 260
           +K    H ++V++     + + +YIVM+L EG   GE  + +  +  R+TEE    I VQ
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 261 ILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           ++  + + H +  +VHRDL P N +     +D  + + DFGL+   +P+ +L  +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWA 355
           Y  PE++ +  Y  +AD+W+ G I Y +     PF++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  107 bits (268), Expect = 4e-26
 Identities = 76/252 (30%), Positives = 128/252 (50%), Gaps = 26/252 (10%)

Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           VGRGHFG     R K  G++     A+K++ K+ +    ++     E  IL ++S    +
Sbjct: 9   VGRGHFGEVQVVREKATGDI----YAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWI 63

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
            +   A +D +N+Y+VME   GG+LL  +     ++ E+ A+  + +++  +   H  G 
Sbjct: 64  PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--VGSAYYVAPEVLHR--- 328
           VHRD+KPEN L         ++L DFG +  +  ++ +N    VG+  Y+APEVL     
Sbjct: 124 VHRDIKPENVLIDR---TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 329 ----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWPS---V 380
               +Y +E D WS+GVI+Y ++ G  PF   T +  +  ++    NF   L +P    V
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM----NFQRFLKFPEDPKV 236

Query: 381 SPEAKDFVKRLL 392
           S +  D ++ LL
Sbjct: 237 SSDFLDLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  106 bits (265), Expect = 1e-25
 Identities = 78/258 (30%), Positives = 131/258 (50%), Gaps = 24/258 (9%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSG 209
           K +G+G FG     R   G    Q  A+K++ KA     + + D  R   E  IL A   
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA----TLKVRDRVRTKMERDIL-AEVN 56

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + ++   +   H
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR 328
             G+++RDLKPEN L     ++  ++L DFGLS + I  +++     G+  Y+APEV++R
Sbjct: 116 SLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 329 -SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSVSPEA 384
             ++  AD WS GV+ + +L GS PF  +        +L++    P F       +SPEA
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEA 225

Query: 385 KDFVKRLLNKDYRKRMTA 402
           +  ++ L  ++   R+ A
Sbjct: 226 QSLLRALFKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 25/272 (9%)

Query: 152 GKEVGRGHFGHTCSA-RGKKGEL---KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           G+ +G+G +G    A     GE+   K  ++   I  +        ++ +R E++ LK L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 208 SGHKHLVKFCDACEDVNNVY-IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
             H ++V+     E       I +E   GG +    L   GR+ E+  +    Q+L  +A
Sbjct: 66  D-HLNIVQ-YLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGL---SDFIRPDERLNDIVGSAYYV 321
           + H +G++HRDLK +N L      DAD   ++ DFG+   SD I  +++   + GS +++
Sbjct: 123 YLHSKGILHRDLKADNLLV-----DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 322 APEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFR-AVLRSDPNFDDL 375
           APEV+H   + YS + DIWS+G +   +  G RP W+  E+   +F+    RS P     
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPD 236

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              ++SP A DF+      +   R TA + L 
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  103 bits (259), Expect = 3e-25
 Identities = 86/279 (30%), Positives = 133/279 (47%), Gaps = 38/279 (13%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ + +G+G +G       KK      + AVKI+           E++  E  ILKALS
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID----EEIEAEYNILKALS 72

Query: 209 GHKHLVKFCDAC--EDVNN---VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQ 260
            H ++VKF      +DV N   +++V+ELC GG + D +   L RG R  E     I+ +
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAY 319
            L  +   H+   +HRD+K  N L T+      ++L+DFG+S        R N  VG+ +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 320 YVAPEV------LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           ++APEV      L  +Y    D+WS+G+ +  L  G  P     +    RA+ +   N  
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRN-- 244

Query: 374 DLPWPSV------SPEAKDFVKRLLNKDYRKRMTAVQAL 406
             P P++      S E  DF+++ L KDY KR T    L
Sbjct: 245 --PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 84/274 (30%), Positives = 134/274 (48%), Gaps = 35/274 (12%)

Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +  GK +G+G FG  + C       EL  +QV     S     T   +  +  E+++LK 
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP---ETKKEVNALECEIQLLKN 60

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           L  H+ +V++     D   + I ME   GG + D++ A G   TE   +    QIL  V 
Sbjct: 61  LQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVE 118

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERLNDI----------V 315
           + H   +VHRD+K  N L    RD A +++L DFG S      +RL  I           
Sbjct: 119 YLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGAS------KRLQTICSSGTGMKSVT 168

Query: 316 GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNF 372
           G+ Y+++PEV+    Y  +AD+WS+G     +L   +P WA  E  + IF+  + + P  
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQPTN 225

Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             LP   VSP+A++F++R   ++ +KR +A + L
Sbjct: 226 PQLP-SHVSPDARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 4e-25
 Identities = 77/254 (30%), Positives = 122/254 (48%), Gaps = 18/254 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K      Q  A+KI++K +M         R E  +L    
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL-VNG 58

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
             + +     A +D NN+Y+VM+   GG+LL  +     R  E+ A+  + +++  +   
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
           H  G VHRD+KP+N L      +  +RL DFG    +  D   + N  VG+  Y++PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDK---NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 327 HR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW--P 378
                    Y  E D WS+GV  Y +L G  PF+A +    +  ++    +F   P    
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF-QFPPDVT 234

Query: 379 SVSPEAKDFVKRLL 392
            VS EAKD ++RL+
Sbjct: 235 DVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  104 bits (260), Expect = 5e-25
 Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 16/251 (6%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  + H  
Sbjct: 1   KLLGKGTFGKVILVREKATG---KYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF 56

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + + H   
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
           VV+RDLK EN +      D  +++ DFGL  + I     +    G+  Y+APEVL  + Y
Sbjct: 116 VVYRDLKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVK 389
               D W +GV+ Y ++CG  PF+ +    +F  +L  +  F     P  +SPEAK  + 
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-----PRTLSPEAKSLLA 227

Query: 390 RLLNKDYRKRM 400
            LL KD ++R+
Sbjct: 228 GLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  103 bits (259), Expect = 6e-25
 Identities = 75/252 (29%), Positives = 120/252 (47%), Gaps = 13/252 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    AR K  E   +  AVK++ K  +      + +  E  +L     H  
Sbjct: 1   KVIGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV    + +  + +Y V++   GGEL    L R   + E  A+    +I S + + H   
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLN 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
           +V+RDLKPEN L  S      + L DFGL  + I  +   +   G+  Y+APEVLH+  Y
Sbjct: 117 IVYRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +G + Y +L G  PF++R  + ++  +L           P+++  A+  ++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEG 229

Query: 391 LLNKDYRKRMTA 402
           LL KD  KR+ A
Sbjct: 230 LLQKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  103 bits (259), Expect = 6e-25
 Identities = 75/250 (30%), Positives = 122/250 (48%), Gaps = 14/250 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  + H  
Sbjct: 1   KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPF 56

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + H + 
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSY 330
           VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL    Y
Sbjct: 116 VVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK  +  
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228

Query: 391 LLNKDYRKRM 400
           LL KD ++R+
Sbjct: 229 LLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 9e-25
 Identities = 84/305 (27%), Positives = 140/305 (45%), Gaps = 56/305 (18%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR--REV 201
           + G +Y+    +G G +G  CSA  K       +VA+K IS  +  T       R  RE+
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFC----QRTLREI 54

Query: 202 KILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           KIL+    H++++   D     + E  N+VYIV EL E    L +++ +    + +  + 
Sbjct: 55  KILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQY 110

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LN 312
            + QIL  + + H   V+HRDLKP N L  +   + D+++ DFGL+    P+      L 
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLT 167

Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW---------------- 354
           + V + +Y APE++   + Y+   DIWS+G I   +L   RP +                
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYLHQLNLILGVL 226

Query: 355 --------ARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTA 402
                       S   R  ++S P    +PW    P+  P+A D + ++L  +  KR+T 
Sbjct: 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV 286

Query: 403 VQALS 407
            +AL+
Sbjct: 287 EEALA 291

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  101 bits (254), Expect = 1e-24
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 22/215 (10%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+ K++G G FG    A+ K      +   +K I   KM      E  ++EV IL A 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVA 266
             H ++V F  + ++   ++IVME C+GG+L+ RI   RG  ++E+   +  VQI   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-------IVGSAY 319
             H + ++HRD+K +N   +     A  +L DFG++       +LND        VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVA--KLGDFGIA------RQLNDSMELAYTCVGTPY 167

Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
           Y++PE+  +R Y+ + DIWS+G + Y L     PF
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (254), Expect = 1e-24
 Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 31/273 (11%)

Query: 152 GKEVGRGHFGHT-CSARGKKGELKD-QQVAVKIIS-KAKMTTAISIEDVRREVKILKALS 208
           G  +G G FG          GEL   +QV +  +S  +K      ++ + RE+ +LK L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H+++V++  +  D +++ I +E   GG +   +L   G + E   +  V QIL  + + 
Sbjct: 65  -HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYL 122

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------------RPDERLNDIVG 316
           H +G++HRD+K  N L     +   +++ DFG+S  +            RP      + G
Sbjct: 123 HNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQG 174

Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDD 374
           S +++APEV+ + SY+ +ADIWS+G +   +L G  PF   T+   IF+    + P    
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               ++S EA DF+++    D+ KR TA + L 
Sbjct: 235 ----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (254), Expect = 1e-24
 Identities = 82/273 (30%), Positives = 130/273 (47%), Gaps = 35/273 (12%)

Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKII---SKAKMTTAISIEDVRREVKILKALS 208
           G+ +G+G +G        +G+L    +AVK +   +   +      E ++ EV +LK+L 
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V++   C D N + I ME   GG +   IL R G   E        QIL  VA+ 
Sbjct: 61  -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-------RPDERLNDIVGSAYYV 321
           H   VVHRD+K  N +      +  ++LIDFG +  +            L  + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIF-----RAVLRSDPNFD 373
           APEV++ S Y  ++DIWSIG   + +  G +P  A  +  + +F     R ++   P   
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           D    S S  A DFV   L +D  +R +A+Q L
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  102 bits (256), Expect = 2e-24
 Identities = 74/251 (29%), Positives = 124/251 (49%), Gaps = 15/251 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A  K     ++  A+K + K  +     +E    E ++L     H  
Sbjct: 1   KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57

Query: 213 LVK-FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           L   FC   +   +++ VME   GG+L+  I    GR+ E  A+    +I+  + F H +
Sbjct: 58  LTHLFC-TFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVLH-RS 329
           G+++RDLK +N L      D  +++ DFG+    +  + + +   G+  Y+APE+L  + 
Sbjct: 116 GIIYRDLKLDNVLLDK---DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
           Y+   D WS GV+ Y +L G  PF    E  +F ++L   P+F    W  +S EAKD + 
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLS 228

Query: 390 RLLNKDYRKRM 400
           +L  +D  KR+
Sbjct: 229 KLFERDPTKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 56/288 (19%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E  K +GRG FG     + K  G +     A+K + K++M     +  VR E  IL A 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHI----YAMKKLRKSEMLEKEQVAHVRAERDIL-AE 57

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + +  +VK   + +D N +Y++ME   GG+++  +L +   +TEE+ +  + + +  +  
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDS 116

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL---------SDFIR------PDERLN 312
            H  G +HRD+KP+N L  +      ++L DFGL         ++F R      P   L+
Sbjct: 117 IHKLGYIHRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173

Query: 313 DI------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
            I                        VG+  Y+APEV  ++ Y+ E D WS+GVI Y +L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233

Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPS---VSPEAKDFVKRLL 392
            G  PF +      +R ++        L +P    +SPEAKD +KRL 
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKET---LQFPDEVPLSPEAKDLIKRLC 278

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 72/252 (28%), Positives = 118/252 (46%), Gaps = 13/252 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A+ K      +  AVK++ K  +      + +  E  +L     H  
Sbjct: 1   KVIGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV    + +  + +Y V++   GGEL    L R   + E  A+    +I S + + H   
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLN 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
           +++RDLKPEN L  S      + L DFGL  + I   +  +   G+  Y+APEVL +  Y
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +G + Y +L G  PF++R  + ++  +L           P++S  A+  ++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEG 229

Query: 391 LLNKDYRKRMTA 402
           LL KD  KR+ A
Sbjct: 230 LLQKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  101 bits (253), Expect = 6e-24
 Identities = 76/265 (28%), Positives = 122/265 (46%), Gaps = 23/265 (8%)

Query: 142 NKNFGAKYE---LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
            +    KYE     + +G G FG    A  K  +     VA+K   K+K+     ++ V 
Sbjct: 22  KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVF 79

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
            E KIL  ++ H   V    + +D + +Y+V+E   GGE     L R  R+  +      
Sbjct: 80  SERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYA 137

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            QI+ +  +     +V+RDLKPEN L      D  +++ DFG +  +  D R   + G+ 
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDK---DGFIKMTDFGFAKVV--DTRTYTLCGTP 192

Query: 319 YYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDD 374
            Y+APE+L +  +   AD W++G+  Y +L G  PF+A     I++ +L      P F D
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKR 399
                     K  +K+LL+ D  KR
Sbjct: 253 -------NNCKHLMKKLLSHDLTKR 270

Length = 340

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 6e-24
 Identities = 81/296 (27%), Positives = 143/296 (48%), Gaps = 50/296 (16%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+    VG G +G  C+A   K  L+   VAVK +S+    + I  +   RE+++LK +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRP-FQSIIHAKRTYRELRLLKHM 73

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
             H++++   D      + E+ N+VY+V  L   G  L+ I+ +  + T++  + ++ QI
Sbjct: 74  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQI 129

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  + + H   ++HRDLKP N       +D +++++DFGL+     D+ +   V + +Y 
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR--HTDDEMTGYVATRWYR 184

Query: 322 APEVLHR--SYSLEADIWSIGVISYILLCGSRPF-----------------------WAR 356
           APE++     Y+   DIWS+G I   LL G   F                         +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244

Query: 357 TESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S   R  ++S       NF ++ +   +P A D ++++L  D  KR+TA QAL+
Sbjct: 245 ISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 299

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 68/231 (29%), Positives = 113/231 (48%), Gaps = 35/231 (15%)

Query: 199 REVKILKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGEL---LDRILARGGRYTEED 253
           RE++I K+     ++VK+  A   E  +++ I ME CEGG L     ++  RGGR  E+ 
Sbjct: 48  RELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
              I   +L  +++ H + ++HRD+KP N L T       ++L DFG+S      E +N 
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR---KGQVKLCDFGVS-----GELVNS 158

Query: 314 I----VGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTE---------- 358
           +     G+++Y+APE +  + YS+ +D+WS+G+    +     PF    E          
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218

Query: 359 --SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               +    L+ +P  + + W   S E KDF+K+ L KD  +R T    L 
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  101 bits (253), Expect = 7e-24
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 69/308 (22%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILK 205
           KYE+ +++G+G +G    A  ++     + VA+K I  A    T A   +   RE+  L+
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDA---QRTFREIMFLQ 61

Query: 206 ALSGHKHLVKFCDACEDVNN--VYIVMELCEG-------GELLDRILARGGRYTEEDAKA 256
            L  H ++VK  +  +  N+  +Y+V E  E          +L+ +  R   Y       
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR---Y------- 111

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER------ 310
           I+ Q+L  + + H   V+HRDLKP N L  S   D  ++L DFGL+  +   E       
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENPV 168

Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWART----------- 357
           L D V + +Y APE+L     Y+   D+WS+G I   +L G +P +  T           
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIE 227

Query: 358 -------------ESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
                        +S     +L S P       D+L  P  S +A D +K+LL  +  KR
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKR 286

Query: 400 MTAVQALS 407
           +TA +AL 
Sbjct: 287 LTAEEALE 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 75/249 (30%), Positives = 118/249 (47%), Gaps = 37/249 (14%)

Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
           Q+ A+K I+K  +     I+ V  E  IL   + +  +V    + E   ++ +VME  EG
Sbjct: 27  QRFAMKKINKQNLILRNQIQQVFVERDIL-TFAENPFVVSMFCSFETKRHLCMVMEYVEG 85

Query: 236 GE---LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
           G+   LL  I    G    + A+    + +  + + H  G+VHRDLKP+N L TS     
Sbjct: 86  GDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM---G 138

Query: 293 DMRLIDFGLSD-------------FIRPDERL---NDIVGSAYYVAPEV-LHRSYSLEAD 335
            ++L DFGLS               I  D R      + G+  Y+APEV L + Y    D
Sbjct: 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVD 198

Query: 336 IWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP----SVSPEAKDFVKRL 391
            W++G+I Y  L G  PF+  T   +F  V+      DD+ WP    ++  +A+D + RL
Sbjct: 199 WWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLISRL 253

Query: 392 LNKDYRKRM 400
           L ++  +R+
Sbjct: 254 LRQNPLERL 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 24/263 (9%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K  E   +  A+KI++K +M         R E  +L  ++
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57

Query: 209 GH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           G  + +     A +D N +Y+VM+   GG+LL  +     R  E+ A+  + +++  +  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
            H    VHRD+KP+N L      +  +RL DFG    +  D  +     VG+  Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDM---NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           L         Y  E D WS+GV  Y +L G  PF+A +    +  ++  +  F    +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 231

Query: 380 ----VSPEAKDFVKRLLNKDYRK 398
               VS EAKD ++RL+    R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 99.4 bits (247), Expect = 3e-23
 Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 25/274 (9%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K     D+  A+KI++K +M         R E  +L  ++
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVL--VN 57

Query: 209 G-HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           G ++ +     A +D NN+Y+VM+   GG+LL  +     R  E+ A+  + +++  +  
Sbjct: 58  GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
            H    VHRD+KP+N L      +  +RL DFG    +  D  +     VG+  Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           L         Y  E D WS+GV  Y +L G  PF+A +    +  ++     F    +P+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPA 231

Query: 380 ----VSPEAKDFVKRLL-NKDYRKRMTAVQALSK 408
               VS +AKD ++RL+ ++++R     ++   +
Sbjct: 232 QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 71/263 (26%), Positives = 130/263 (49%), Gaps = 18/263 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
           +++ K++G+G +G     +     L D Q  A+K +    M+     ED   E++IL ++
Sbjct: 2   FKVLKKLGKGSYGSVYKVK----RLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASV 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSV 264
           + H +++ + +A  D N + IVME    G+L   I  R        E++   I +Q+L  
Sbjct: 57  N-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +   H Q ++HRDLK  N L  +      +++ D G+S  ++        +G+ +Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVAN---DLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPE 171

Query: 325 VLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           V   R YS ++DIWS+G + Y +   + PF AR+   +   V R    +  +P P  S +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIP-PIYSQD 228

Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
            ++F++ +L    + R    + L
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.8 bits (243), Expect = 3e-23
 Identities = 72/264 (27%), Positives = 133/264 (50%), Gaps = 24/264 (9%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           A +++ K++GRG F     A      L  + VA+K +   +M  A + +D  +E+ +LK 
Sbjct: 2   ANFQIEKKIGRGQFSEVYRA---TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ 58

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI--------V 258
           L+ H +++K+ D+  + N + IV+EL + G+L   I     +Y ++  + I         
Sbjct: 59  LN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYF 112

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGS 317
           VQ+ S V   H + V+HRD+KP N   T+      ++L D GL  F        + +VG+
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDL 375
            YY++PE +H + Y+ ++DIWS+G + Y +     PF+   +  +F    + +  ++  L
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPL 228

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKR 399
           P    S + ++ V   +  D  +R
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 73/251 (29%), Positives = 123/251 (49%), Gaps = 15/251 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  S H  
Sbjct: 1   KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 56

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ- 271
           L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + + H + 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RS 329
            VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEVL    
Sbjct: 116 NVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
           Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK  + 
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS 228

Query: 390 RLLNKDYRKRM 400
            LL KD ++R+
Sbjct: 229 GLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 99.1 bits (247), Expect = 5e-23
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 53/284 (18%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG  C  R  K +      A+K + KA +        V+ E  IL A + ++ 
Sbjct: 7   KTIGIGAFGEVCLVR--KVDTN-ALYAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEW 62

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +VK   + +D +N+Y VM+   GG+++  +L R G + E+ A+  + ++   +   H  G
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMG 121

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL--------------------SDFIRPDERLN 312
            +HRD+KP+N L      D  ++L DFGL                     D + P E  +
Sbjct: 122 FIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 313 DI------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
           +I                        VG+  Y+APEVL R+ Y+   D WS+GVI Y +L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
            G  PF A T +     V+  +          +S EA D + RL
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 20/253 (7%)

Query: 156 GRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-- 212
           GRGHFG    A  KK GEL     A+K + K  +     +E +  E +I +  +  +H  
Sbjct: 8   GRGHFGKVLLAEYKKTGEL----YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV      +  ++V  VME   GG+L+  I      ++E  A      ++  + + H   
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
           +V+RDLK +N L  +   +  +++ DFGL  + +   +R +   G+  ++APEVL   SY
Sbjct: 122 IVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVK 389
           +   D W +GV+ Y +L G  PF    E  +F +++      D++ +P  +S EA   ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMR 233

Query: 390 RLLNKDYRKRMTA 402
           RLL ++  +R+ +
Sbjct: 234 RLLRRNPERRLGS 246

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  100 bits (250), Expect = 1e-22
 Identities = 88/298 (29%), Positives = 144/298 (48%), Gaps = 47/298 (15%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS----KAKMTTAISIE-DVRREVK 202
           +YE+ K++G G FG     + K+ +   +    K IS    K +  + + IE +V RE+K
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 203 ILKALSGHKHLVKFCDACEDVNN--VYIVMELCEGGEL---LDRILARGGRYTEEDAKAI 257
                  HK++V++ D   +  N  +YI+ME C+ G+L   + +     G+  E     I
Sbjct: 71  -------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 258 VVQILSVVAFCHL-------QGVVHRDLKPENFLFTSG----------RDDADMRLI--- 297
             Q+L  +A+CH        + V+HRDLKP+N   ++G           ++ + R I   
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 298 -DFGLSDFIRPDERLNDIVGSAYYVAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
            DFGLS  I  +   +  VG+ YY +PE+L    +SY  ++D+W++G I Y L  G  PF
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV 411
                     + L+  P   DLP    S E    +K LLN   ++R +A+Q L   ++
Sbjct: 244 HKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298

Length = 1021

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 61/300 (20%)

Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVK---------IISKAKMTTAISIEDV 197
           KYE L K +G G +G     R ++     Q VA+K         +I K  +         
Sbjct: 2   KYEKLSK-IGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIAL--------- 48

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            RE+++LK L  H +LV   +       +++V E C+   +L+ +        E   K I
Sbjct: 49  -REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKI 105

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVG 316
           + Q L  V FCH    +HRD+KPEN L T       ++L DFG +  +  P +   D V 
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILITK---QGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWA------------RT----- 357
           + +Y APE+L     Y    D+W+IG +   LL G +P W             +T     
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLI 221

Query: 358 --------ESGIFRAVLRSDP-NFDDLP--WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                    +  F+ +   +P   + L   +P++S  A  F+K  L  D  +R++  + L
Sbjct: 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-L 213
           +G+G FG    A  +KG   D+  A+KI+ K  +     +E    E ++L AL G    L
Sbjct: 8   LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKPPFL 63

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
            +     + ++ +Y VME   GG+L+  I  + G++ E  A     +I   + F H +G+
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           ++RDLK +N +  +   +  +++ DFG+  + I   +      G+  Y+APE + ++ Y 
Sbjct: 123 IYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
              D W+ GV+ Y +L G  PF    E  +F++++  + ++      S+S EA    K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235

Query: 392 LNKDYRKRM 400
           L K   KR+
Sbjct: 236 LTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 79/295 (26%), Positives = 141/295 (47%), Gaps = 48/295 (16%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+    VG G +G  CSA   +     Q+VAVK +S+    + I      RE+++LK +
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRP-FQSLIHARRTYRELRLLKHM 71

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
             H++++   D      + E+ N VY+V  L   G  L+ I+ +  + ++E  + ++ Q+
Sbjct: 72  K-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQL 127

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  + + H  G++HRDLKP N       +D ++R++DFGL+   + D+ +   V + +Y 
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDEMTGYVATRWYR 182

Query: 322 APEVLHR--SYSLEADIWSIGVISYILLCG-----------------------SRPFWAR 356
           APE++     Y+   DIWS+G I   LL G                       S     +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242

Query: 357 TESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S   R  ++S P+        +    +P A D ++++L  D  KR++A +AL+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 67/257 (26%), Positives = 124/257 (48%), Gaps = 22/257 (8%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG +      R KK    ++  A+K++ K  +     I+ V+ E  + +  S H  LV
Sbjct: 3   IGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                 +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + + H +G++
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
           +RDLK +N L  S   +  ++L D+G+  + +RP +  +   G+  Y+APE+L    Y  
Sbjct: 119 YRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 333 EADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
             D W++GV+ + ++ G  PF            TE  +F+ +L            S+S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231

Query: 384 AKDFVKRLLNKDYRKRM 400
           A   +K  LNKD ++R+
Sbjct: 232 AASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 67/255 (26%), Positives = 123/255 (48%), Gaps = 20/255 (7%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG +      R KK    DQ  A+K++ K  +     I+ V+ E  + +  S +  LV
Sbjct: 3   IGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                 +  + +++V+E   GG+L+   + R  +  EE A+    +I   + F H +G++
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
           +RDLK +N L  +   D  ++L D+G+  + + P +  +   G+  Y+APE+L    Y  
Sbjct: 119 YRDLKLDNVLLDA---DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 333 EADIWSIGVISYILLCGSRPF-------WARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             D W++GV+ + ++ G  PF          TE  +F+ +L             +S +A 
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231

Query: 386 DFVKRLLNKDYRKRM 400
             +K  LNKD ++R+
Sbjct: 232 HVLKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 50/289 (17%)

Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKAL 207
           +++G G +      R +  GE+    VA+K I     +   +TAI      RE+ ++K L
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEI----VALKEIHLDAEEGTPSTAI------REISLMKEL 55

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE--DAKAIVVQILSVV 265
             H+++V+  D     N + +V E  +  +L   +   G R   +    K+   Q+L  +
Sbjct: 56  K-HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPE 324
           AFCH   V+HRDLKP+N L        +++L DFGL+  F  P    ++ V + +Y AP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170

Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS- 381
           VL   R+YS   DIWS+G I   ++ G   F           + R      +  WP +S 
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230

Query: 382 -PEAK-----------------------DFVKRLLNKDYRKRMTAVQAL 406
            PE K                       D + RLL  +   R++A  AL
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 80/261 (30%), Positives = 131/261 (50%), Gaps = 27/261 (10%)

Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  K  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 78

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 137 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-----WPSVSPEAK 385
             E DIWS+G++   ++ G  P++        + +       D+LP        VSP  K
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------DNLPPKLKNLHKVSPSLK 247

Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
            F+ RLL +D  +R TA + L
Sbjct: 248 GFLDRLLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 71/248 (28%), Positives = 118/248 (47%), Gaps = 14/248 (5%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG     R K+   +    A+K I KA + +   +     E  +L A      +V
Sbjct: 1   IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               + +    +Y+V+    GGEL    L R GR+    A+    ++L  +   H   V+
Sbjct: 57  PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
           +RDLKPEN L         + L DFGL    ++ D++ N   G+  Y+APE+L    Y+ 
Sbjct: 116 YRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
             D W++GV+ Y +L G  PF+    + ++R +L+    F D        +AKD +  LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228

Query: 393 NKDYRKRM 400
           ++D  +R+
Sbjct: 229 SRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 74/252 (29%), Positives = 117/252 (46%), Gaps = 13/252 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A+ K         AVK++ K  +        +  E  +L     H  
Sbjct: 1   KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV    + +    +Y V++   GGEL    L R   + E  A+    ++ S + + H   
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
           +++RDLKPEN L  S      + L DFGL  + + P+E  +   G+  Y+APEVL +  Y
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +G + Y +L G  PF++R  S ++  +L        LP    +  A D +  
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ---LP-GGKTVAACDLLVG 229

Query: 391 LLNKDYRKRMTA 402
           LL+KD R+R+ A
Sbjct: 230 LLHKDQRRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 71/257 (27%), Positives = 120/257 (46%), Gaps = 27/257 (10%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A  K     +Q  A+K + K  +     +E    E ++L     H  
Sbjct: 1   KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRI-------LARGGRYTEEDAKAIVVQILSVV 265
           L       +   N++ VME   GG+L+  I       L R   Y  E        I+  +
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGL 109

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPE 324
            F H +G+V+RDLK +N L  +   D  +++ DFG+  + +  D +     G+  Y+APE
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166

Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  + Y+   D WS GV+ Y +L G  PF    E  +F+++   +P +    W  ++ E
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTRE 222

Query: 384 AKDFVKRLLNKDYRKRM 400
           AKD + +L  ++  +R+
Sbjct: 223 AKDILVKLFVREPERRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 72/250 (28%), Positives = 118/250 (47%), Gaps = 14/250 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG     R K      +  A+KI+ K  +     +     E ++LK  + H  
Sbjct: 1   KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPF 56

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           L     + +  + +  VME   GGEL    L+R   ++E+  +    +I+S + + H   
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSY 330
           +V+RDLK EN +      D  +++ DFGL  + I     +    G+  Y+APEVL    Y
Sbjct: 116 IVYRDLKLENLMLDK---DGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +GV+ Y ++CG  PF+ +    +F  +L  D  F      ++S +AK  +  
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSG 228

Query: 391 LLNKDYRKRM 400
           LL KD  KR+
Sbjct: 229 LLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 83/299 (27%), Positives = 139/299 (46%), Gaps = 53/299 (17%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            KY   K +GRG +G  CSA   K    +++VA+K I+ A     I  +   RE+K+L+ 
Sbjct: 5   TKYVPIKPIGRGAYGIVCSA---KNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRH 60

Query: 207 LSGHKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           L  H++++   D       E  N+VYIV EL +    L +I+      +++  +  + Q+
Sbjct: 61  LD-HENVIAIKDIMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQYFLYQL 117

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP----DERLNDIVGS 317
           L  + + H   V+HRDLKP N L  +   + D+++ DFGL+   R      + + + V +
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLA---RTTSEKGDFMTEYVVT 171

Query: 318 AYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE----------------- 358
            +Y APE+L     Y+   D+WS+G I   LL G +P +   +                 
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELLGSPSE 230

Query: 359 -------SGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                  +   R  +RS P          +P  +P A D ++++L  D  KR+T  +AL
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 30/274 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +EL + VG G +G     R  K     Q  A+K++      T    E+++ E+ +LK  S
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLKKYS 70

Query: 209 GHKHL-------VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA-IVVQ 260
            H+++       +K      D + +++VME C  G + D +    G   +ED  A I  +
Sbjct: 71  HHRNIATYYGAFIKKSPPGHD-DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAY 319
           IL  +A  H   V+HRD+K +N L T   ++A+++L+DFG+S    R   R N  +G+ Y
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 320 YVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNF 372
           ++APEV+        +Y   +DIWS+G+ +  +  G+ P         +F       P  
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246

Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
               W   S +  DF++  L K+Y  R +  Q L
Sbjct: 247 KSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 94.4 bits (234), Expect = 7e-22
 Identities = 74/273 (27%), Positives = 131/273 (47%), Gaps = 28/273 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +EL + VG G +G     R  K     Q  A+K++      T    E++++E+ +LK  S
Sbjct: 8   FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 60

Query: 209 GHKHLVKFCDACEDVN------NVYIVMELCEGGELLDRIL-ARGGRYTEEDAKAIVVQI 261
            H+++  +  A    N       +++VME C  G + D I   +G    EE    I  +I
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
           L  ++  H   V+HRD+K +N L T   ++A+++L+DFG+S    R   R N  +G+ Y+
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177

Query: 321 VAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFD 373
           +APEV+        +Y  ++D+WS+G+ +  +  G+ P         +F       P   
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              W   S + + F++  L K++ +R T  Q +
Sbjct: 238 SKKW---SKKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 96.2 bits (239), Expect = 7e-22
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 57/288 (19%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG  C AR           A+K + K  +     +  V+ E  IL A + ++ 
Sbjct: 7   KTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEW 62

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+   + +D +N+Y VM+   GG+++  +L R G + E+ A+  + ++   V   H  G
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMG 121

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL------------------------------- 301
            +HRD+KP+N L      D  ++L DFGL                               
Sbjct: 122 FIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 302 -------SDFIRPDER----------LNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVIS 343
                   D ++P ER           + +VG+  Y+APEVL R+ Y+   D WS+GVI 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 344 YILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
           Y +L G  PF A+T       V+    +    P   +SPEA D + +L
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 94.1 bits (234), Expect = 9e-22
 Identities = 85/291 (29%), Positives = 135/291 (46%), Gaps = 52/291 (17%)

Query: 153 KEVGRGHFGHTCSARGKK-GELKDQQVAVKII-----SKAKMTTAISIEDVRREVKILKA 206
           +++G G +G    AR K  GE+    VA+K I     ++   +TAI      RE+ +LK 
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEV----VALKKIRLDTETEGVPSTAI------REISLLKE 55

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL--ARGGRYTEEDAKAIVVQILSV 264
           L+ H ++VK  D     N +Y+V E     + L + +  +          K+ + Q+L  
Sbjct: 56  LN-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAP 323
           +AFCH   V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y AP
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169

Query: 324 EVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSD----PNFD 373
           E+L   + YS   DIWS+G I   ++     F   +E      IFR +   D    P   
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229

Query: 374 DLP--------W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            LP        W         P +  + +D + ++L+ D  KR++A  AL+
Sbjct: 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
             KE+G G FG         G+ + +  VA+K+I +  M    S +D   E K++  LS 
Sbjct: 8   FLKELGSGQFG-----VVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS- 57

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +LV+    C     ++IV E    G LL+ +  R G+   E    +   +   + +  
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVL 326
             G +HRDL   N L      D  +++ DFGL+ ++  D+  +   G+ + V    PEV 
Sbjct: 118 SNGFIHRDLAARNCLVGE---DNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173

Query: 327 HRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
             S +S ++D+WS GV+ + +   G  P+   + S +  +V  
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 81/297 (27%), Positives = 140/297 (47%), Gaps = 53/297 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y   K+VG G +G  CSA  K+     ++VA+K +S+    + I  +   RE+ +LK +
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHM 71

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
             H++++   D      + ++  + Y+VM   +     D     G   +E+  + +V Q+
Sbjct: 72  Q-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQM 126

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  + + H  G++HRDLKP N       +D +++++DFGL+     D  +   V + +Y 
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--HADAEMTGYVVTRWYR 181

Query: 322 APEV----LHRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNF- 372
           APEV    +H  Y+   DIWS+G I   +L G   F  +      + I +      P F 
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 373 ---DD---------LP----------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              +D         LP          +P  SP+A D ++++L  D  KR+TA +AL 
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 19/253 (7%)

Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G FG  C+ + K  G++     A K + K ++      +    E KIL+ +S  + +
Sbjct: 1   LGKGGFGEVCACQVKATGKM----YACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFI 55

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQG 272
           V    A E  +++ +VM L  GG+L   I   G   + E  A     QI+  +   H + 
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YS 331
           +V+RDLKPEN L     D  ++R+ D GL+  ++  +++    G+  Y+APEVL    Y 
Sbjct: 116 IVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 332 LEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
              D +++G   Y ++ G  PF  R E      + R  L     + D      SPEAKD 
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD----KFSPEAKDL 228

Query: 388 VKRLLNKDYRKRM 400
            + LL KD  KR+
Sbjct: 229 CEALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 94.2 bits (234), Expect = 1e-21
 Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 15/254 (5%)

Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G+G FG    A  K KGE      AVK + K  +     +E    E ++L     + 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEY----FAVKALKKDVVLIDDDVECTMVEKRVLALAWENP 56

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            L       +   +++ VME   GG+L+  I  +G R+    A     +I+  + F H +
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK 115

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RS 329
           G+++RDLK +N +      D  +++ DFG+  + +  D R +   G+  Y+APE+L    
Sbjct: 116 GIIYRDLKLDNVMLDR---DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
           Y+   D WS GV+ Y +L G  PF    E  +F ++    P++    W  ++ E+KD ++
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILE 228

Query: 390 RLLNKDYRKRMTAV 403
           +L  +D  +R+  V
Sbjct: 229 KLFERDPTRRLGVV 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 74/256 (28%), Positives = 127/256 (49%), Gaps = 17/256 (6%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G G  G  C A  K      +QVAVK   K  +      E +  EV I++    H+++
Sbjct: 29  KIGEGSTGIVCIATEKH---TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HENV 81

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           V   ++    + +++VME  EGG L D  +    R  EE    + + +L  +++ H QGV
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLHNQGV 139

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SYS 331
           +HRD+K ++ L TS   D  ++L DFG    +  +  +   +VG+ Y++APEV+ R  Y 
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVKR 390
            E DIWS+G++   ++ G  P++        R +  +  P   D     VS   + F+  
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254

Query: 391 LLNKDYRKRMTAVQAL 406
           +L ++  +R TA + L
Sbjct: 255 MLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 22/257 (8%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG +        KK     +  A+K+I K  +     I+ V+ E  + +  S H  LV
Sbjct: 3   IGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                 +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + F H +G++
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
           +RDLK +N L  +   +  ++L D+G+  + IRP +  +   G+  Y+APE+L    Y  
Sbjct: 119 YRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 333 EADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
             D W++GV+ + ++ G  PF            TE  +F+ +L        +P  S+S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IP-RSLSVK 231

Query: 384 AKDFVKRLLNKDYRKRM 400
           A   +K  LNKD ++R+
Sbjct: 232 ASSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 19/240 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + L +++G G+FG       K       +VA+KI+    +      +D ++EV+ LK L 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDLLKQ---QDFQKEVQALKRLR 60

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAF 267
            HKHL+     C     VYI+ EL E G LL  + +  G+         +  Q+   +A+
Sbjct: 61  -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-YVAPEVL 326
              Q  +HRDL   N L     +D   ++ DFGL+  I+ D  L+      Y + APE  
Sbjct: 120 LEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176

Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
            H ++S ++D+WS G++ Y +   G  P+       ++  +      +  +P P+  P+ 
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA---GY-RMPCPAKCPQE 232

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 87/312 (27%), Positives = 128/312 (41%), Gaps = 70/312 (22%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE   ++G+G FG    AR KK     Q VA+K +          I  +R E+KIL+ L
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQLL 68

Query: 208 SGHKHLVKFCDACED----VNN----VYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
             H+++V   + C       N      Y+V E CE     LL     +   +T  + K +
Sbjct: 69  K-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKV 124

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDE----RLN 312
           +  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+  F         R  
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITK---DGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVI-------SYIL--------------LCG 349
           + V + +Y  PE+L   R Y    D+W  G I       S I+              LCG
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241

Query: 350 S-----------RPFWARTE--SGIFRAVLRSDPNFDDLPWPSVS-PEAKDFVKRLLNKD 395
           S              + + E   G  R V       + L  P V  P A D + +LL  D
Sbjct: 242 SITPEVWPGVDKLELFKKMELPQGQKRKVK------ERL-KPYVKDPHALDLIDKLLVLD 294

Query: 396 YRKRMTAVQALS 407
             KR+ A  AL+
Sbjct: 295 PAKRIDADTALN 306

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 72/254 (28%), Positives = 120/254 (47%), Gaps = 22/254 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
           +++ K +GRG FG     R K      +QV A+K++SK +M           E  I+ A 
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKS----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-AH 99

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +  + +V+   A +D   +Y+VME   GG+L++  L       E+ A+    +++  +  
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLALDA 157

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAP 323
            H  G +HRD+KP+N L         ++L DFG    ++ D     R +  VG+  Y++P
Sbjct: 158 IHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212

Query: 324 EVL-----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           EVL        Y  E D WS+GV  Y +L G  PF+A +  G +  ++    +       
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272

Query: 379 SVSPEAKDFVKRLL 392
            +S +AKD +   L
Sbjct: 273 EISKQAKDLICAFL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 13/252 (5%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G+G FG    A+ K   L  +  AVK++ K  +      + +  E  +L     H  
Sbjct: 1   KVIGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV    + +    +Y V++   GGEL    L R   + E  A+    +I S + + H   
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSIN 116

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
           +V+RDLKPEN L  S      + L DFGL  + I   +      G+  Y+APEV+ +  Y
Sbjct: 117 IVYRDLKPENILLDS---QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
               D W +G + Y +L G  PF+ R  + ++  +L           P  S  A   ++ 
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEE 229

Query: 391 LLNKDYRKRMTA 402
           LL KD ++R+ A
Sbjct: 230 LLEKDRQRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA---KMTTAISIEDVRREVKIL 204
           KYE    VG G +G     + K+     Q VA+K   ++   KM   I++    RE+++L
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRML 54

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H++LV   +       +Y+V E  +   +LD +        E   +  + QIL  
Sbjct: 55  KQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRG 112

Query: 265 VAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
           + FCH   ++HRD+KPEN L + SG     ++L DFG +  +  P E   D V + +Y A
Sbjct: 113 IEFCHSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVYTDYVATRWYRA 168

Query: 323 PEVL--HRSYSLEADIWSIGVISYILLCG 349
           PE+L     Y    DIW++G +   +L G
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 91.6 bits (227), Expect = 6e-21
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 32/274 (11%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG     +G     K + VA+KII   +      IED+++E+ +L       ++ 
Sbjct: 12  IGKGSFGEV--YKGIDNRTK-EVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PYIT 65

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           ++  +      ++I+ME   GG  LD  L + G   E     I+ +IL  + + H +  +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
           HRD+K  N L +   +  D++L DFG++  +   + + N  VG+ +++APEV+ +S Y  
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFV 388
           +ADIWS+G+ +  L  G  P        +   + ++ P       P++    S   K+FV
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQYSKPFKEFV 233

Query: 389 KRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY 422
           +  LNKD R R TA +        +L  K + RY
Sbjct: 234 EACLNKDPRFRPTAKE--------LLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 83/303 (27%), Positives = 125/303 (41%), Gaps = 59/303 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIED------VRRE 200
            YE  +++G G +G    AR K  G+L    VA+K        T + +++        RE
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKL----VALK-------KTRLEMDEEGIPPTALRE 50

Query: 201 VKILKALSGHKHLVKFCDACEDVNN-----VYIVMELCEGGELLDRILARGGRYTEEDAK 255
           + +L+ LS   ++V+  D            +Y+V E  +            G      AK
Sbjct: 51  ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK 110

Query: 256 AI---VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL 311
            I   + Q+L  VA CH  GV+HRDLKP+N L    +    +++ D GL   F  P +  
Sbjct: 111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSY 168

Query: 312 NDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAV 365
              + + +Y APEVL     YS   DIWS+G I   +      F   +E      IF+  
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK-- 226

Query: 366 LRSDPNFDDLP-------W---------------PSVSPEAKDFVKRLLNKDYRKRMTAV 403
           L   P     P       W               P +SPE  D ++++L  D  KR++A 
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286

Query: 404 QAL 406
            AL
Sbjct: 287 AAL 289

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.7 bits (227), Expect = 9e-21
 Identities = 80/276 (28%), Positives = 137/276 (49%), Gaps = 21/276 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA+K I+  K       E +  E+ ++K L
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQPKK---ELIINEILVMKEL 73

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             + ++V F D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 74  K-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEF 130

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +SP  
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSPIF 245

Query: 385 KDFVKRLLNKDYRKRMTAVQALS----KLVVPILSF 416
           +DF+ R L  D  KR +A + L     KL  P+ S 
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 73/248 (29%), Positives = 118/248 (47%), Gaps = 9/248 (3%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG  C+ + +      +  A K + K ++           E +IL+ ++  + +V
Sbjct: 8   LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVV 63

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGV 273
               A E  + + +V+ +  GG+L   I   G   + EE A     +IL  +   H +  
Sbjct: 64  NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
           V+RDLKPEN L     D   +R+ D GL+  I   E +   VG+  Y+APEVL ++ Y+L
Sbjct: 124 VYRDLKPENILLD---DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
             D W +G + Y ++ G  PF  R E      V R     +++     S EAK   K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240

Query: 393 NKDYRKRM 400
            KD ++R+
Sbjct: 241 TKDPKQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 72/250 (28%), Positives = 128/250 (51%), Gaps = 17/250 (6%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG    A  +KG   D+  A+KI+ K  +     +E    E ++L ALSG    +
Sbjct: 8   LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63

Query: 215 KFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
               +C + ++ +Y VME   GG+L+ +I  + GR+ E  A     +I   + F H +G+
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSYS 331
           ++RDLK +N +  S   +  +++ DFG+  + +          G+  Y+APE++ ++ Y 
Sbjct: 123 IYRDLKLDNVMLDS---EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVKR 390
              D W+ GV+ Y +L G  PF    E  +F++++       ++ +P S+S EA    K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----NVAYPKSMSKEAVAICKG 234

Query: 391 LLNKDYRKRM 400
           L+ K   KR+
Sbjct: 235 LMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 55/288 (19%)

Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED------------ 222
           D++VAVK I    +T   S++   RE+KI++ L  H ++VK  +                
Sbjct: 30  DKRVAVKKIV---LTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85

Query: 223 --VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP 280
             +N+VYIV E  E    L  +L +G   +EE A+  + Q+L  + + H   V+HRDLKP
Sbjct: 86  TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142

Query: 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAPEVL--HRSYSLEA 334
            N    +  +D  +++ DFGL+  + P       L++ + + +Y +P +L    +Y+   
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200

Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD---------LPW-------- 377
           D+W+ G I   +L G   F    E    + +L S P   +         +P         
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260

Query: 378 ---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF 416
                    P V+PEA DF++++L  +   R+TA +AL    +   S 
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 45/279 (16%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E  K +GRG FG     + K         A+KI+ KA M     +  +R E  IL    
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
           G   +VK   + +D  N+Y++ME   GG+++  +L +    +EE  +  + + +  +   
Sbjct: 60  G-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN---------------- 312
           H  G +HRD+KP+N L  +      ++L DFGL   ++   R                  
Sbjct: 118 HQLGFIHRDIKPDNLLLDA---KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 313 --------------------DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSR 351
                                 VG+  Y+APEV  ++ Y+   D WS+GVI Y +L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
           PF + T    +R V+         P   +S +AKD + R
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 69/265 (26%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y L + +G+G FG     + KK   +++   +K I   ++    +++   +E ++L  L
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSV 264
             H  +VKF  +  + +   I+ E CEG +L  ++      G   +E       +Q+L  
Sbjct: 60  D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAP 323
           V + H + ++HRDLK +N    +      +++ DFG+S  +     L     G+ YY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 324 EVL-HRSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSVS 381
           E L H+ Y  ++DIWS+G I Y + C +  F  +   S + R V    P+  +    + S
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE----TYS 230

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
            +    ++ +LNKD   R +A + L
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 74/271 (27%), Positives = 133/271 (49%), Gaps = 18/271 (6%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           A + + K++GRG F     A      L    VA+K +    +  A +  D  +E+ +LK 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 58

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGEL--LDRILARGGRYT-EEDAKAIVVQILS 263
           L+ H +++K+  +  + N + IV+EL + G+L  + +   +  R   E+      VQ+ S
Sbjct: 59  LN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVA 322
            +   H + V+HRD+KP N   T+      ++L D GL  F        + +VG+ YY++
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS 379
           PE +H + Y+ ++DIWS+G + Y +     PF+    +   + + + + D  +  LP   
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDH 232

Query: 380 VSPEAKDFVKRLLNKDYRKR--MTAVQALSK 408
            S E +  V   +N D  KR  +T V  ++K
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 25/256 (9%)

Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           + LGK +G+G FG  + C       EL  +QV     S     T+  +  +  E+++LK 
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE---TSKEVNALECEIQLLKN 60

Query: 207 LSGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           L  H+ +V++     D     + I ME   GG + D++ + G   TE   +    QIL  
Sbjct: 61  LL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEG 118

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAY 319
           V++ H   +VHRD+K  N L    RD   +++L DFG S  ++        +  + G+ Y
Sbjct: 119 VSYLHSNMIVHRDIKGANIL----RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 320 YVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLP 376
           +++PEV+    Y  +ADIWS+G  + + +   +P WA  E  + IF+  + + P    LP
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVLP 231

Query: 377 WPSVSPEAKDFVKRLL 392
            P VS   +DF+KR+ 
Sbjct: 232 -PHVSDHCRDFLKRIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 68/242 (28%), Positives = 113/242 (46%), Gaps = 40/242 (16%)

Query: 199 REVKILKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           RE+ IL  L  H ++V   +     +++ +Y+VME  E  +L   +      + + + K 
Sbjct: 53  REINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLS-DFIRPDERLNDI 314
           +++Q+LS VA  H   ++HRDLK  N L    G     +++ DFGL+ ++  P +    +
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI----LKICDFGLAREYGSPLKPYTQL 166

Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV--- 365
           V + +Y APE+L   + YS   D+WS+G I   LL     F  ++E    + IF+ +   
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226

Query: 366 -LRSDPNFDDLPW--------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
             +  P F +LP                      S+S    D + RLL  D  KR++A  
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286

Query: 405 AL 406
           AL
Sbjct: 287 AL 288

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 31/280 (11%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +N    YEL + VG G +G    AR    GEL     AVKII   K+        +++E+
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGEL----AAVKII---KLEPGDDFSLIQQEI 57

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            ++K    H ++V +  +      ++I ME C GG L D I    G  +E     +  + 
Sbjct: 58  FMVKECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRET 115

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYY 320
           L  +A+ H +G +HRD+K  N L T   D+ D++L DFG++  I     +    +G+ Y+
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 321 VAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV-LRSDPNF--- 372
           +APEV     +  Y+   DIW++G+ +  L     P +   +    RA+ L S  NF   
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMSKSNFQPP 229

Query: 373 ---DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
              D   W   S    +FVK  L K+ +KR TA + L+ L
Sbjct: 230 KLKDKTKW---SSTFHNFVKISLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 45/280 (16%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E  K +GRG FG     + K         A+KI+ KA M     +  +R E  IL   +
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEA 58

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +VK   + +D  N+Y++ME   GG+++  +L +    TEE+ +  + + +  +   
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER------LN---------- 312
           H  G +HRD+KP+N L  S      ++L DFGL   ++   R      LN          
Sbjct: 118 HQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 313 --------------------DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSR 351
                                 VG+  Y+APEV +   Y+   D WS+GVI Y +L G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
           PF + T    ++ V+         P   +S +AKD + R 
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 66/270 (24%), Positives = 124/270 (45%), Gaps = 27/270 (10%)

Query: 152 GKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAIS---IEDVRREVKILKAL 207
           G+++G G F     AR  K G L    +AVK ++  + T++     +E +R+E++++  L
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H H+++   A  + ++  + +E   GG +   +L++ G + E        Q+L  +++
Sbjct: 61  N-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 268 CHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGL-----SDFIRPDERLNDIVGSAYYV 321
            H   ++HRD+K  N L  S G+    +R+ DFG      +      E    ++G+  ++
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 322 APEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDLP 376
           APEVL    Y    D+WS+G +   +     P+ A   S     IF+    +      +P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIP 233

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              +SP  +D   R L      R  + + L
Sbjct: 234 -EHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 25/262 (9%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG    AR  +     + VA+K +S +   +    +D+ +EV+ L+ L  H +
Sbjct: 21  REIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPN 76

Query: 213 LVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++       +  ++VME C G   ++L+ +  +  +  E +  AI    L  +A+ H 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKPLQ--EVEIAAICHGALQGLAYLHS 133

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL---- 326
              +HRD+K  N L T   +   ++L DFG +  + P    N  VG+ Y++APEV+    
Sbjct: 134 HERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMD 187

Query: 327 HRSYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
              Y  + D+WS+G I+ I L   +P  F     S ++       P      W   S   
Sbjct: 188 EGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYF 243

Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           ++FV   L K  + R ++ + L
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.6 bits (219), Expect = 7e-20
 Identities = 75/258 (29%), Positives = 129/258 (50%), Gaps = 24/258 (9%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG        + +   Q VA+KII   +      IED+++E+ +L       ++ 
Sbjct: 12  IGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PYVT 65

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           K+  +      ++I+ME   GG  LD  L R G + E     ++ +IL  + + H +  +
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
           HRD+K  N L +   +  D++L DFG++  +   + + N  VG+ +++APEV+ +S Y  
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE----AKDFV 388
           +ADIWS+G+ +  L  G  P    ++    R VL   P       P+++ E     K+F+
Sbjct: 181 KADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFKEFI 233

Query: 389 KRLLNKDYRKRMTAVQAL 406
              LNKD   R TA + L
Sbjct: 234 DACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 88.6 bits (220), Expect = 7e-20
 Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 40/289 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           KYE  +++G G +G    A+ ++  E+    VA+K +        +    +R E+ +LK 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRVRLDDDDEGVPSSALR-EICLLKE 55

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           L  HK++V+  D       + +V E C+  +L     +  G    E  K+ + Q+L  +A
Sbjct: 56  LK-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
           FCH   V+HRDLKP+N L      + +++L DFGL+  F  P    +  V + +Y  P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAV----------LRS 368
           L   + YS   D+WS G I   L    RP +   +       IFR +          +  
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230

Query: 369 DPNFDDLP-------W----PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            P++   P            P ++   +D ++ LL  +  +R++A +AL
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.8 bits (220), Expect = 8e-20
 Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 27/279 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS---KAKMTTAISIEDVRREVKIL 204
           KY   +++G+G  G   +A         Q+VA+K ++   + K    I+   V RE K  
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQPKKELIINEILVMRENK-- 74

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
                H ++V + D+    + +++VME   GG L D +        E    A+  + L  
Sbjct: 75  -----HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQA 127

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAP 323
           + F H   V+HRD+K +N L      D  ++L DFG    I P++   + +VG+ Y++AP
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVS 381
           EV+ R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLS 242

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS----KLVVPILSF 416
              +DF+ R L  D  KR +A + L     K+  P+ S 
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 40/280 (14%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ + +G+G +G       KK        AVKI+           E++  E  IL++L 
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD----EEIEAEYNILQSLP 76

Query: 209 GHKHLVKF------CDACEDVNNVYIVMELCEGG---ELLDRILARGGRYTEEDAKAIVV 259
            H ++VKF       D       +++V+ELC GG   EL+  +L  G R  E     I+ 
Sbjct: 77  NHPNVVKFYGMFYKADKLVG-GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSA 318
             L  +   H   ++HRD+K  N L T+   +  ++L+DFG+S  +     R N  VG+ 
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192

Query: 319 YYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
           +++APEV+        SY    D+WS+G+ +  L  G  P +          + R+ P  
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-- 250

Query: 373 DDLPWPSV-SPEA-----KDFVKRLLNKDYRKRMTAVQAL 406
                P++  PE        F+ + L KD+  R +    L
Sbjct: 251 -----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 72/250 (28%), Positives = 118/250 (47%), Gaps = 22/250 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+ K +GRG FG     R K      +  A+K++SK +M           E  I+ A +
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 100

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ A+    +++  +   
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAI 158

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
           H  G +HRD+KP+N L         ++L DFG    +  +   R +  VG+  Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 327 HRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378
                   Y  E D WS+GV  Y +L G  PF+A +  G +  ++      + L +P   
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDN 272

Query: 379 SVSPEAKDFV 388
            +S EAK+ +
Sbjct: 273 DISKEAKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 23/253 (9%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG    A  K     D+  A+KI+ K  +     +E    E ++L        L 
Sbjct: 8   LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           +     + V+ +Y VME   GG+L+  I  + G++ E  A     +I   + F H +G++
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123

Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPEVL-H 327
           +RDLK +N +  S   +  +++ DFG+       E + D V      G+  Y+APE++ +
Sbjct: 124 YRDLKLDNVMLDS---EGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + Y    D W+ GV+ Y +L G  PF    E  +F++++  + ++      S+S EA   
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231

Query: 388 VKRLLNKDYRKRM 400
            K L+ K   KR+
Sbjct: 232 CKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 73/296 (24%), Positives = 143/296 (48%), Gaps = 48/296 (16%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            +Y   K+VG G +G  CSA  ++   K   VA+K + +    + +  +   RE+++LK 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAK---VAIKKLYRP-FQSELFAKRAYRELRLLKH 70

Query: 207 LSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           +  H++++   D      + +  ++ Y+VM     G  L +++ +  + +E+  + +V Q
Sbjct: 71  MK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQ 126

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           +L  + + H  G++HRDLKP N       +D +++++DFGL+   + D  +   V + +Y
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSEMTGYVVTRWY 181

Query: 321 VAPEVLHR--SYSLEADIWSIGVISYILLCG-----------------------SRPFWA 355
            APEV+     Y+   DIWS+G I   +L G                       S+ F  
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241

Query: 356 RTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + +S   +  ++  P F    +    P+ +P A + ++++L  D   R+TA +AL+
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 24/271 (8%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           K    KY + + +G G  G    A+        +  AVK++    M+ A      + EV 
Sbjct: 28  KEQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEA-DKNRAQAEVC 83

Query: 203 IL------KALSGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRI--LARGGR-YTEE 252
            L        +  H+   K      E+V  + +V++    G+L   I   A+  R + E 
Sbjct: 84  CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143

Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR---PDE 309
           +A  + +Q+L  V   H + ++HRD+K  N L  S   +  ++L DFG S        D+
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDD 200

Query: 310 RLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS 368
                 G+ YYVAPE+  R  YS +AD++S+GV+ Y LL   RPF       +    L  
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260

Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
              +D LP PS+SPE ++ V  LL+ D ++R
Sbjct: 261 --RYDPLP-PSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 20/227 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +GRG FG     R K  +   +  A+K++SK +M           E  I+ A +
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 100

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ AK    +++  +   
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAI 158

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAPE 324
           H  G++HRD+KP+N L         ++L DFG    ++ DE    R +  VG+  Y++PE
Sbjct: 159 HSMGLIHRDVKPDNMLLDK---HGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPE 213

Query: 325 VLHRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL 366
           VL        Y  E D WS+GV  + +L G  PF+A +  G +  ++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 87/299 (29%), Positives = 137/299 (45%), Gaps = 59/299 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVK 202
           +YE  +++G G +G    AR +   + ++ +A+K I      +   +TAI      RE+ 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REIS 53

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KA 256
           +LK +  H ++V+  D       +Y+V E       LD  L +    + + A      K 
Sbjct: 54  LLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKT 106

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIV 315
            + QIL  +A+CH   V+HRDLKP+N L    R    ++L DFGL+  F  P       V
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEV 164

Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTE----SGIFRAV--- 365
            + +Y APE+L   R YS   DIWS+G I +  +   +P F   +E      IFR +   
Sbjct: 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTP 223

Query: 366 -------LRSDPNFDD-LP-W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                  + S P++    P W         P++ P   D + ++L  D  KR+TA  AL
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 59/289 (20%)

Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG  C A       L     A+K + K  +     +  V+ E  IL A + ++
Sbjct: 7   KTLGIGAFGEVCLACKVDTHAL----YAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNE 61

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +VK   + +D +N+Y VM+   GG+++  +L R   + E  A+  + ++   +   H  
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKM 120

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL--------------------SDFIRPDERL 311
           G +HRD+KP+N L      D  ++L DFGL                     D + P +  
Sbjct: 121 GFIHRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 312 NDI----------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVI 342
           +D+                            VG+  Y+APEVL R  Y+   D WS+GVI
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
            + +L G  PF A T +     V+  +      P   +SPEA D + +L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)

Query: 153 KEVGRGHFGHTCSAR-----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           K++G GHFG     R        GE    QVAVK ++           D  RE++IL+ L
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGE----QVAVKSLNH--SGEEQHRSDFEREIEILRTL 63

Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQIL 262
             H+++VK+   CE     ++ ++ME    G L  R   +  R  + + K ++    QI 
Sbjct: 64  D-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHR-DQINLKRLLLFSSQIC 119

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGS-A 318
             + +   Q  +HRDL   N L  S   +  +++ DFGL+  +  D+    + +   S  
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPF 353
           ++ APE L    +S  +D+WS GV  Y L     P 
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 44/233 (18%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L +E+G G FG          E ++    VAVK + +    +  + +D  RE ++L    
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKDFEREAELLTNF- 65

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-------------GRYTEEDAK 255
            H+++VKF   C + +   +V E  E G+L   + + G             G  T     
Sbjct: 66  QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            I VQI S + +   Q  VHRDL   N L      D  +++ DFG+S          D+ 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---------RDVY 173

Query: 316 GSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
            + YY            + PE +++R ++ E+D+WS GV+ + I   G +P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 44/293 (15%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            ++E    +G G +G    AR        + VA+K +        I I  +R E+ +L  
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62

Query: 207 LSGHKHLVKFCD--ACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQIL 262
           L  H ++V+  +    + ++++++VME CE     LLD +      ++E   K +++Q+L
Sbjct: 63  LR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLL 118

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYV 321
             + + H   ++HRDLK  N L T   D   +++ DFGL+  +  P + +   V + +Y 
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175

Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----SD---PN 371
           APE+L    +Y+   D+W++G I   LL        ++E      +++     ++   P 
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235

Query: 372 FDDLP------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           F DLP                  +P +S      +  LL  D +KR TA +AL
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 60/299 (20%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVKI 203
           Y+  +++G G +G    AR K      + VA+K I      +   +TAI      RE+ +
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVPSTAI------REISL 51

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KAI 257
           LK L+ H ++V+  D     N +Y+V E       LD  L +    +          K+ 
Sbjct: 52  LKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSY 104

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVG 316
           + Q+L  +A+CH   V+HRDLKP+N L      +  ++L DFGL+  F  P       V 
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVV 161

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVLRSD 369
           + +Y APE+L   R YS   DIWSIG I +  +   RP F   +E      IFR +   D
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220

Query: 370 ----PNFDDLP--------W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               P    LP        W         P++  +  D + ++L  D  KR++A  AL 
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 16/217 (7%)

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR---YTEEDA 254
           R E+  L A   H  +VK  D  +  + + ++ME   GG+L  +I  R      + E + 
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLN- 312
             +  QI+  +   H + ++HRDLK  N FL  +G     ++L DFG S        L+ 
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI----IKLGDFGFSKQYSDSVSLDV 227

Query: 313 --DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
                G+ YY+APE+  R  YS +AD+WS+GVI Y LL   RPF   ++  I + VL   
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG- 286

Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             +D  P P VS   K  +  LL+K+   R T  Q L
Sbjct: 287 -KYDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 91/301 (30%), Positives = 138/301 (45%), Gaps = 61/301 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVK 202
            Y   +++G G +G     R KK     Q VA+K I      +   +TAI      RE+ 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAI------REIS 51

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMEL--CEGGELLDRILARGGRYTE-EDAKAIVV 259
           +LK L  H ++V   D     + +Y++ E    +  + LD +    G+Y + E  K+ + 
Sbjct: 52  LLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLY 108

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           QIL  + FCH + V+HRDLKP+N L  +      ++L DFGL+  F  P       V + 
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDN---KGVIKLADFGLARAFGIPVRVYTHEVVTL 165

Query: 319 YYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVLRSDPN 371
           +Y APEVL  S  YS   DIWSIG I +  +   +P F   +E      IFR +    P 
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRIL--GTPT 222

Query: 372 FDDLPWPSVS--PEAK-----------------------DFVKRLLNKDYRKRMTAVQAL 406
            D   WP V+  P+ K                       D ++++L  D  KR++A +AL
Sbjct: 223 EDV--WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280

Query: 407 S 407
           +
Sbjct: 281 N 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.4 bits (208), Expect = 2e-18
 Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 26/268 (9%)

Query: 152 GKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           GK +G+G FG  + C       EL  +QV     S     T+  +  +  E+++LK L  
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQ- 62

Query: 210 HKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           H+ +V++     D     + I ME   GG + D++ A G   TE   +    QIL  +++
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAYYVA 322
            H   +VHRD+K  N L    RD A +++L DFG S  ++        +  + G+ Y+++
Sbjct: 122 LHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 323 PEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS 379
           PEV+    Y  +AD+WS+G  + + +   +P WA  E  + IF+  + + P    LP   
Sbjct: 178 PEVISGEGYGRKADVWSLGC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTNPQLP-SH 233

Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           +S  A+DF+  +   + R R +A + L 
Sbjct: 234 ISEHARDFLGCIF-VEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 24/260 (9%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G FG        + +   + VA+KII   +      IED+++E+ +L       +
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PY 63

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K+  +      ++I+ME   GG  LD  L   G   E     I+ +IL  + + H + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
            +HRD+K  N L +   +  +++L DFG++  +   + + N  VG+ +++APEV+ +S Y
Sbjct: 122 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
             +ADIWS+G+ +  L  G  P        +   + +++P       P++    S   K+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 231

Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           FV+  LNK+   R TA + L
Sbjct: 232 FVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 44/243 (18%)

Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
            Q++ V+ I KAK   AI       E  + + +  + + +K   +   +    ++M+  +
Sbjct: 40  TQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92

Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
            G+L D +L + G+ +E + K I+ Q++  +   H   ++H D+K EN L+   +D   +
Sbjct: 93  DGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--I 149

Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRPF 353
            L D+GL   I       D  G+  Y +PE +   +Y +  D W++GV++Y LL G  PF
Sbjct: 150 YLCDYGLCK-IIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Query: 354 WARTESGIFRAVLRSDPNFD--------------DLPWPS-VSPEAKDFVKRLLNKDYRK 398
                            + D               LP+   VS  A DFV+ +L  +   
Sbjct: 207 ---------------KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251

Query: 399 RMT 401
           R+T
Sbjct: 252 RLT 254

Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.0 bits (207), Expect = 4e-18
 Identities = 72/276 (26%), Positives = 136/276 (49%), Gaps = 21/276 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 73

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 385 KDFVKRLLNKDYRKRMTAVQALS----KLVVPILSF 416
           +DF+ R L+ D  KR +A + L     K+  P+ S 
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSL 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 77/262 (29%), Positives = 131/262 (50%), Gaps = 25/262 (9%)

Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           + LGK +GRG FG  + C       EL  +QV     S+    T+  +  +  E+++LK 
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE---TSKEVNALECEIQLLKN 60

Query: 207 LSGHKHLVKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           L  H  +V++  C    +   + I +E   GG + D++ A G   TE   +    QIL  
Sbjct: 61  LR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQG 118

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAY 319
           V++ H   +VHRD+K  N L    RD A +++L DFG S  I+        +  + G+ Y
Sbjct: 119 VSYLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 320 YVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLP 376
           +++PEV+    Y  +AD+WS+   + + +   +P WA  E  + IF+  + + P    LP
Sbjct: 175 WMSPEVISGEGYGRKADVWSVAC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTKPMLP 231

Query: 377 WPSVSPEAKDFVKRLLNKDYRK 398
              VS   +DF+K++  ++ R+
Sbjct: 232 -DGVSDACRDFLKQIFVEEKRR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR          VA+K +        + +  VR EV +LK L
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56

Query: 208 SG--HKHLVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
               H ++V+  D C          V +V E  +      LD++   G     E  K ++
Sbjct: 57  EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q L  + F H   +VHRDLKPEN L TSG     ++L DFGL+        L  +V + 
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVVTL 171

Query: 319 YYVAPEVLHRS-YSLEADIWSIGVI 342
           +Y APEVL +S Y+   D+WS+G I
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCI 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.4 bits (214), Expect = 6e-18
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 16/242 (6%)

Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA--CEDVNNVYIVMELC 233
            +VA+K++              RRE  +   L  H ++V   D+        ++ V E  
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
            G  L +  LA  G     +   +++Q+L  +A  H QG+VHRDLKP+N + +       
Sbjct: 62  PGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 294 MRLIDFG----LSDFIRPDE----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISY 344
            +++DFG    L      D     R  +++G+  Y APE L     +  +D+++ G+I  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
             L G R     + + I    L         PW +  P     +++ LNKD R+R  +  
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIAGHPLG-QVLRKALNKDPRQRAASAP 238

Query: 405 AL 406
           AL
Sbjct: 239 AL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 82/316 (25%), Positives = 135/316 (42%), Gaps = 62/316 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKA 206
           KYE+   +GRG +G    A+ K G+   ++ A+K     K   T IS    R E+ +L+ 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDG-KEYAIKKFKGDKEQYTGISQSACR-EIALLRE 58

Query: 207 LSGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI----LARGGRYTEEDAKAIVVQ 260
           L  H+++V   +   +  +  VY++ +  E  +L   I     A+         K+++ Q
Sbjct: 59  LK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDF----IRPDERLNDIV 315
           IL+ V + H   V+HRDLKP N L    G +   +++ D GL+      ++P   L+ +V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTES------------- 359
            + +Y APE+L   R Y+   DIW+IG I +  L    P F  R                
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 360 GIFRAV----------LRSDPNFDDLP-------------------WPSVSPEAKDFVKR 390
            IF  +          ++  P +D L                          +  D +++
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295

Query: 391 LLNKDYRKRMTAVQAL 406
           LL  D  KR+TA +AL
Sbjct: 296 LLEYDPTKRITAEEAL 311

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 74/252 (29%), Positives = 117/252 (46%), Gaps = 17/252 (6%)

Query: 155 VGRGHFGHTCS----ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+G FG  C+    A GK    K  ++  K I K K   A+++     E +IL+ ++  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRK-GEAMALN----EKQILEKVNS- 59

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCH 269
           + +V    A E  + + +V+ L  GG+L   I   G   + EE A     +I   +   H
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HR 328
            + +V+RDLKPEN L     D   +R+ D GL+  I   E +   VG+  Y+APEV+ + 
Sbjct: 120 RERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
            Y+   D W +G + Y ++ G  PF  R E      V R      +      S  A+   
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236

Query: 389 KRLLNKDYRKRM 400
           ++LL KD   R+
Sbjct: 237 RQLLTKDPGFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 96/364 (26%), Positives = 150/364 (41%), Gaps = 69/364 (18%)

Query: 71  ASPLPAGVSPSPARASTPRRFFRRP---FPPPSPAKHIKASLAKRLGGGKPKESTIPEER 127
             P P    PS AR +T  R  RRP    P P     +   L           S+     
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63

Query: 128 GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFG------HTCSARGKKGELKDQQVAVK 181
           G+ P  +   S         + E    +G G  G      H  + R           A+K
Sbjct: 64  GSAPSAAKSLS---------ELERVNRIGSGAGGTVYKVIHRPTGR---------LYALK 105

Query: 182 IISKAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
           +I           + VR    RE++IL+ ++ H ++VK  D  +    + +++E  +GG 
Sbjct: 106 VIYGNHE------DTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGS 158

Query: 238 LLDRILARGGRYTEEDAKAIVV-QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           L       G    +E   A V  QILS +A+ H + +VHRD+KP N L  S +   ++++
Sbjct: 159 L------EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKI 209

Query: 297 IDFGLSDFI-RPDERLNDIVGSAYYVAPEVL-----HRSYSLEA-DIWSIGVISYILLCG 349
            DFG+S  + +  +  N  VG+  Y++PE +     H +Y   A DIWS+GV       G
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Query: 350 SRPF-------WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
             PF       WA     +  A+  S P        + S E + F+   L ++  KR +A
Sbjct: 270 RFPFGVGRQGDWA----SLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 403 VQAL 406
           +Q L
Sbjct: 323 MQLL 326

Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG         G+ + Q +VA+K I++  M    S ED   E K++  LS H 
Sbjct: 10  KELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HP 59

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     +YIV E  E G LL+ +  R G+ +++   ++   +   + +    
Sbjct: 60  KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVLHR 328
             +HRDL   N L +       +++ DFG++ ++  DE  +   G+ + V    PEV + 
Sbjct: 120 SFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNF 175

Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSD 369
           S YS ++D+WS GV+ + +   G  PF  ++   +   + R  
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M    S ++   E K++  LS H+
Sbjct: 10  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HE 59

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     +YIV E    G LL+ +   G R+       +   +   +A+   +
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS + V    PEVL  
Sbjct: 120 QFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175

Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++D+W+ GV+ + +   G  P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 80/323 (24%), Positives = 133/323 (41%), Gaps = 91/323 (28%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVK--IISKAK---MTTAISIEDVRREVK 202
           YE+  ++G G FG    AR    ++K    VA+K  ++   K     TA+      RE+K
Sbjct: 10  YEILGKLGEGTFGEVYKAR----QIKTGRVVALKKILMHNEKDGFPITAL------REIK 59

Query: 203 ILKALSGHKHLVKFCD--------ACEDVNNVYIVM-----ELCEGGELLD--RILARGG 247
           ILK L  H ++V   D        +     +VY+V      +L     LL+   +     
Sbjct: 60  ILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV----- 110

Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
           + TE   K  ++Q+L  + + H   ++HRD+K  N L     +   +++ DFGL+   RP
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLA---RP 164

Query: 308 ---------------DERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGS 350
                            +  ++V + +Y  PE+L   R Y+   DIW IG +   +    
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223

Query: 351 RP-FWARTE----SGIFRAV----LRSDPNFDDLP------------------WPSVSPE 383
           RP    +++      IF+        + P +  LP                  +  + PE
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283

Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
             D + +LL+ D  KR+TA  AL
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDAL 306

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 9/248 (3%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG  C+ + +      +  A K + K ++           E +IL+ ++  + +V
Sbjct: 8   LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVV 63

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGV 273
               A E  + + +V+ L  GG+L   I   G   + E  A     +I   +   H + +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
           V+RDLKPEN L     D   +R+ D GL+  +   + +   VG+  Y+APEV+ +  Y+ 
Sbjct: 124 VYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
             D W++G + Y ++ G  PF  R +      V R      +      SP+A+   K LL
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 393 NKDYRKRM 400
            KD ++R+
Sbjct: 241 CKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 80/312 (25%), Positives = 135/312 (43%), Gaps = 72/312 (23%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA-KMTTAISIEDVRREVKILKA 206
           +Y+  K +G G  G  C+A      +  Q VA+K +S+  +  T    +   RE+ ++K 
Sbjct: 17  RYQNLKPIGSGAQGIVCAA---YDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKL 71

Query: 207 LSGHKHLVKFCDA------CEDVNNVYIVME-----LCEGGEL-LDRILARGGRYTEEDA 254
           ++ HK+++   +        E+  +VY+VME     LC+  ++ LD           E  
Sbjct: 72  VN-HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----------HERM 120

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
             ++ Q+L  +   H  G++HRDLKP N +    + D  ++++DFGL+        +   
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY 177

Query: 315 VGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR------TES 359
           V + YY APEV L   Y    DIWS+G I   ++ G+  F        W +      T S
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237

Query: 360 GIF--------RAVLRSDPN---------FDDLPWPSVSPE--------AKDFVKRLLNK 394
             F        R  + + P          F D+ +P  S          A+D + ++L  
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297

Query: 395 DYRKRMTAVQAL 406
           D  KR++   AL
Sbjct: 298 DPEKRISVDDAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 60/186 (32%), Positives = 91/186 (48%), Gaps = 20/186 (10%)

Query: 225 NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHL---QGVVHRDLKP 280
           +V+I MEL      LD++L R  G   E+    + V I+   A  +L    GV+HRD+KP
Sbjct: 88  DVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVK--ALHYLKEKHGVIHRDVKP 143

Query: 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-----HRSYSLEAD 335
            N L        +++L DFG+S  +   +      G A Y+APE +     +  Y + AD
Sbjct: 144 SNILLD---ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRAD 200

Query: 336 IWSIGVISYILLCGSRPF-WARTESGIFRAVLRSDPNFDDLPW-PSVSPEAKDFVKRLLN 393
           +WS+G+    L  G  P+   +TE  +   +L+ +P    LP     SP+   FV   L 
Sbjct: 201 VWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--PSLPPNEGFSPDFCSFVDLCLT 258

Query: 394 KDYRKR 399
           KD+RKR
Sbjct: 259 KDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 73/276 (26%), Positives = 135/276 (48%), Gaps = 21/276 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA+K   +  +      E +  E+ +++  
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIA---TGQEVAIK---QMNLQQQPKKELIINEILVMRE- 72

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDF 130

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPERLSAVF 245

Query: 385 KDFVKRLLNKDYRKRMTAVQALS----KLVVPILSF 416
           +DF+ R L  D  +R +A + L     KL  P+ S 
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 29/271 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKA 206
           Y   + VG+G +G     R +      Q V    I K  +  A   E     +E ++L  
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRT--DGKQYV----IKKLNLRNASRRERKAAEQEAQLLSQ 55

Query: 207 LSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSV 264
           L  H ++V + ++ E  +  +YIVM  CEGG+L  ++  + G+   E       VQI   
Sbjct: 56  LK-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYY 320
           + + H + ++HRDLK +N   T       +++ D G++   R  E   D    ++G+ YY
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTN---IIKVGDLGIA---RVLENQCDMASTLIGTPYY 168

Query: 321 VAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWP 378
           ++PE+  ++ Y+ ++D+W++G   Y +      F A+   S ++R +    P     P P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMP 223

Query: 379 S-VSPEAKDFVKRLLNKDYRKRMTAVQALSK 408
              SPE  + +  +L+K   KR +    L +
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 21/216 (9%)

Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRREVKILKA 206
             GK +G G FG     +A G        +VAVK++   A  +     E +  E+KI+  
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKIMSH 94

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSV 264
           L  H+++V    AC     + ++ E C  G+LL+  L R      T ED  +   Q+   
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSAY---- 319
           +AF   +  +HRDL   N L T G+    +++ DFGL+  I  D   N +V G+A     
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDS--NYVVKGNARLPVK 208

Query: 320 YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           ++APE + +  Y+ E+D+WS G++ + I   GS P+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 20/215 (9%)

Query: 151 LGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           L +E+G G FG         G  L+ ++VA+K I +  M    S ED   E +++  LS 
Sbjct: 8   LVQEIGSGQFGLV-----WLGYWLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS- 57

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H  LV+    C + + + +V E  E G L D + A+ G++++E    + + +   +A+  
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVL 326
              V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ + V   +PEV 
Sbjct: 118 SSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVF 173

Query: 327 HRS-YSLEADIWSIGVISYILLC-GSRPFWARTES 359
             S YS ++D+WS GV+ + +   G  P+  R+ S
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 21/265 (7%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG    AR  +    ++ VA+K +S +   +    +D+ +EVK L+ +  H +
Sbjct: 31  REIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPN 86

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
            +++       +  ++VME C G    D +        E +  AI    L  +A+ H   
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
           ++HRD+K  N L T   +   ++L DFG +    P    N  VG+ Y++APEV+      
Sbjct: 146 MIHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEG 199

Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            Y  + D+WS+G I+ I L   +P  F     S ++       P      W   S   ++
Sbjct: 200 QYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRN 255

Query: 387 FVKRLLNKDYRKRMTAVQALSKLVV 411
           FV   L K  + R T+ + L  + V
Sbjct: 256 FVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 38/269 (14%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G +G   +AR    ++   ++A+K I +        ++ +  E+ +   L  H+++V
Sbjct: 16  LGKGTYGIVYAARDLSTQV---RIAIKEIPERDSR---YVQPLHEEIALHSYLK-HRNIV 68

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVVAFCHLQG 272
           ++  +  +     I ME   GG L   + ++ G   + +   I    QIL  + + H   
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 273 VVHRDLKPENFLFT--SGRDDADMRLIDFGLSDFIRPDERLNDI-------VGSAYYVAP 323
           +VHRD+K +N L    SG     +++ DFG S      +RL  I        G+  Y+AP
Sbjct: 129 IVHRDIKGDNVLVNTYSGV----VKISDFGTS------KRLAGINPCTETFTGTLQYMAP 178

Query: 324 EVLH---RSYSLEADIWSIGVISYILLCGSRPFW--ARTESGIFR-AVLRSDPNFDDLPW 377
           EV+    R Y   ADIWS+G     +  G  PF      ++ +F+  + +  P   +   
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--- 235

Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            S+S EAK+F+ R    D  KR +A   L
Sbjct: 236 -SLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 9/248 (3%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG  C+ + +      +  A K + K ++           E +IL+ ++  + +V
Sbjct: 8   LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGV 273
               A E  + + +V+ +  GG+L   I   G   + E+ A     ++   +     + +
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
           V+RDLKPEN L     D   +R+ D GL+  I   E +   VG+  Y+APEV+ +  Y+ 
Sbjct: 124 VYRDLKPENILLD---DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
             D W +G + Y ++ G  PF  R E      V R      +      S +AK   + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240

Query: 393 NKDYRKRM 400
            K+ ++R+
Sbjct: 241 TKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 41/282 (14%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +N    +EL + +G G +G    AR    GEL     A+K+I   K+        V++E+
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL----AAIKVI---KLEPGEDFAVVQQEI 57

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            ++K    H ++V +  +    + ++I ME C GG L D I    G  +E     +  + 
Sbjct: 58  IMMKDCK-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRET 115

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYY 320
           L  + + H +G +HRD+K  N L T   D+  ++L DFG+S  I     +    +G+ Y+
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172

Query: 321 VAPEV--LHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIF-----RAV-LRSDP 370
           +APEV  + R   Y+   DIW++G+ +  L        A  +  +F     RA+ L +  
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIEL--------AELQPPMFDLHPMRALFLMTKS 224

Query: 371 NF------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF      D + W   S     FVK  L K+ +KR TA + L
Sbjct: 225 NFQPPKLKDKMKW---SNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 23/198 (11%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +LG  +G+G FG         G+ + Q+VAVK + K   T A +      E  ++  L  
Sbjct: 9   KLGATIGKGEFGDV-----MLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +LV+        N +YIV E    G L+D + +R GR     A+ +   +       +
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEY 117

Query: 270 LQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAPEV 325
           L+    VHRDL   N L +   +D   ++ DFGL+     +       G     + APE 
Sbjct: 118 LEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEA 170

Query: 326 L-HRSYSLEADIWSIGVI 342
           L  + +S ++D+WS G++
Sbjct: 171 LREKKFSTKSDVWSFGIL 188

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 21/256 (8%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG    AR  +     + VA+K +S +   +    +D+ +EV+ L+ L  H +
Sbjct: 21  REIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 76

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
            +++       +  ++VME C G    D +        E +  A+    L  +A+ H   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
           ++HRD+K  N L +   +   ++L DFG +  + P    N  VG+ Y++APEV+      
Sbjct: 136 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEG 189

Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            Y  + D+WS+G+   I L   +P  F     S ++       P      W   S   ++
Sbjct: 190 QYDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRN 245

Query: 387 FVKRLLNKDYRKRMTA 402
           FV   L K  + R T+
Sbjct: 246 FVDSCLQKIPQDRPTS 261

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 65/310 (20%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-----------VRR 199
            G  +G G +G    A      L  + VA+K +   +++  ++ +              R
Sbjct: 13  KGAHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           E+KI+  +  H++++   D   + + + +VM++      L +++ R  R TE   K I++
Sbjct: 70  ELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILL 126

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---------------DF 304
           QIL+ +   H    +HRDL P N            ++ DFGL+               + 
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 305 IRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE---- 358
           ++  E +   V + +Y APE+L  +  Y    D+WS+G I   LL G   F    E    
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 359 SGIFRAVLRSDPNFDDLP----------------------WPSVSPEAKDFVKRLLNKDY 396
             IF   L   PN D+ P                      +P+ S +A D ++ LL  + 
Sbjct: 244 GRIFE--LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301

Query: 397 RKRMTAVQAL 406
            +R++A +AL
Sbjct: 302 LERISAKEAL 311

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 80/302 (26%), Positives = 134/302 (44%), Gaps = 55/302 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILK 205
           +Y++ + +G+G +G  CSA         ++VA+K I+     ++ A  I    RE+K+L+
Sbjct: 1   RYKIQEVIGKGSYGVVCSA---IDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLR 54

Query: 206 ALSGHKHLVK-----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
            L  H  +V+        +  +  ++Y+V EL E    L +++      T E  +  + Q
Sbjct: 55  LLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQ 111

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVG 316
           +L  + + H   V HRDLKP+N L  +   D  +++ DFGL+     D        D V 
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 317 SAYYVAPEV---LHRSYSLEADIWSIGVISYILLCGSRPFW------------------- 354
           + +Y APE+       Y+   DIWSIG I   +L G +P +                   
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTP 227

Query: 355 -----ARTESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                +R  +   R  L S      +P    +P+  P A   ++RLL  D + R TA +A
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287

Query: 406 LS 407
           L+
Sbjct: 288 LA 289

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 68/291 (23%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           K++G G FG       ++GE          VAVK +   K++  +   D  +E  I+ +L
Sbjct: 1   KKLGDGSFGVV-----RRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL 53

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--------- 258
             H++L++        + + +V EL   G LLDR+         +DA             
Sbjct: 54  D-HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRL--------RKDALGHFLISTLCDYA 103

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
           VQI + + +   +  +HRDL   N L  S      +++ DFGL         L       
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLM------RALPQ--NED 152

Query: 319 YYV------------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESG 360
           +YV            APE L  R++S  +D+W  GV      +Y    G  P+   + S 
Sbjct: 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY----GEEPWAGLSGSQ 208

Query: 361 IFRAVLRSDPNFDDLPWPSVSPE-AKDFVKRLLNKDYRKRMTAVQALSKLV 410
           I + +   D   + L  P   P+   + + +    +   R T       L 
Sbjct: 209 ILKKI---DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 77/314 (24%), Positives = 127/314 (40%), Gaps = 79/314 (25%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           K+++  ++G G +G    AR K      + VA+K +          I  +R E+KIL+ L
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL 63

Query: 208 SGHKHLVKFCDAC----------EDVNNVYIVME--------LCEGGELLDRILARGGRY 249
           + H+++V   +            +D    Y+V E        L E G L+         +
Sbjct: 64  N-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVH--------F 113

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           +E+  K+ + Q+L  + +CH +  +HRD+K  N L     +   ++L DFGL+     +E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEE 170

Query: 310 R--LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL------------------- 346
                + V + +Y  PE+L     Y    D+WS G I   L                   
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230

Query: 347 --LCGSR-----------PFWARTE-SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
             LCGS            P++   +    +R  LR +  F  +P       A D +  +L
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIP-----TPALDLLDHML 283

Query: 393 NKDYRKRMTAVQAL 406
             D  KR TA +AL
Sbjct: 284 TLDPSKRCTAEEAL 297

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 66/299 (22%)

Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G+G FG     + K  G++     A+K + K++M     +  V+ E  +L A S   
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKI----YAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSP 61

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    + +D   +Y++ME   GG+L+  +L +   ++E+  +  + + +  +   H  
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSD----------FIRP----------DERL 311
           G +HRD+KP+N L         ++L DFGLS           + +           D R 
Sbjct: 121 GFIHRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 312 NDIVGS---------------------AY-------YVAPEV-LHRSYSLEADIWSIGVI 342
           +  V S                     AY       Y+APE+ L + Y  E D WS+G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 343 SYILLCGSRPFWARTESGIFRAVL--RSDPNF-DDLPWPSVSPEAKDFVKRLL-NKDYR 397
            +  L G  PF +      +R ++  R    F DD+    +S EA+D ++RL+ N + R
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI---HLSVEAEDLIRRLITNAENR 293

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 21/259 (8%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           E+G G FG    A        ++ VAVK +S +   T    +D+ +EVK L+ L  H + 
Sbjct: 28  EIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           +++       +  ++VME C G    D +        E +  AI    L  +A+ H   +
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HRS 329
           +HRD+K  N L T   +   ++L DFG +    P    N  VG+ Y++APEV+       
Sbjct: 143 IHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQ 196

Query: 330 YSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           Y  + D+WS+G I+ I L   +P  F     S ++       P      W   +   + F
Sbjct: 197 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGF 252

Query: 388 VKRLLNKDYRKRMTAVQAL 406
           V   L K  ++R  + + L
Sbjct: 253 VDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 16/253 (6%)

Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G FG   + + +  G+L     A K ++K ++      E    E +IL  +   + +
Sbjct: 1   LGKGGFGEVSACQMRATGKL----YACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFI 55

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
           V    A +   ++ +VM +  GG+L   I         + E  A     QI+S +   H 
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-R 328
           + +++RDLKPEN L     +D ++R+ D GL+ +      +     G+  ++APE+L   
Sbjct: 116 RRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDF 387
            Y    D +++GV  Y ++    PF AR E    + + +   N D + +P   SP +K F
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSF 231

Query: 388 VKRLLNKDYRKRM 400
            + LL KD  KR+
Sbjct: 232 CEALLAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 44/275 (16%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKIL-KALSGHK 211
           E+G+G++G       +   +      +++ + ++K    I       E+ IL KA+S   
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDILHKAVS--P 59

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++V F  A      VY+ ME  + G L D++ A GG  TE     I   +L  + +  ++
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA-GGVATE----GIPEDVLRRITYAVVK 113

Query: 272 G---------VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYV 321
           G         ++HRD+KP N L      +  ++L DFG+S + +    + N  +G   Y+
Sbjct: 114 GLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVASLAKTN--IGCQSYM 168

Query: 322 APEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWARTESGIF---RAVLRSDPN 371
           APE +         +Y++++D+WS+G+    +  G  P+   T + IF    A++  DP 
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP- 227

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              LP    S +A+DFV + LNK   +R T  Q L
Sbjct: 228 -PTLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           RE++I+       ++V F  A  + NN+ + ME  + G L DRI  +GG    E    I 
Sbjct: 52  RELQIMHECRS-PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIA 109

Query: 259 VQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
           V ++  + + + +  ++HRD+KP N L  S      ++L DFG+S      E +N I   
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVS-----GELINSIADT 161

Query: 315 -VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
            VG++ Y++PE +    Y++++D+WS+G+    L  G  PF              GI   
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221

Query: 363 --RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
             + V    P    LP      + +DFV   L KD  +R T  Q
Sbjct: 222 LQQIVQEPPPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 63/303 (20%)

Query: 150 ELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTA----ISIEDVRREV 201
           E  + +G G FG   S      GK+  LK            KM       +S + V RE+
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALK------------KMPNVFQNLVSCKRVFREL 50

Query: 202 KILKALSGHKHLVKFCDACEDVN-----NVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           K+L     H +++   D  +  +      +Y+V EL +    L +I+      + +  K 
Sbjct: 51  KMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKV 107

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI-- 314
            + QIL  + + H  G++HRD+KP N L  S   +  +++ DFGL+    PDE  +    
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQE 164

Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE-------------- 358
           V + YY APE+L   R Y+   DIWS+G I   LL     F A++               
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224

Query: 359 ---------SGIFRAVLRSDPNFDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                     G    +LR       LP         + EA   + R+L  D  KR++A  
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284

Query: 405 ALS 407
           AL+
Sbjct: 285 ALA 287

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 77/282 (27%), Positives = 119/282 (42%), Gaps = 52/282 (18%)

Query: 168 GKKGE-----------LKDQQ-VAVKIISKAKMTTAISIEDVR--REVKILKALSGHKHL 213
           GK GE            K  +  A+K + K       S+E V   RE++ L+ LS H ++
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 214 VKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++  +   D     + +V EL +   L + I  R     E+  K+ + Q+L  +   H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-- 329
           G+ HRD+KPEN L      D  ++L DFG    I       + + + +Y APE L     
Sbjct: 120 GIFHRDIKPENILI----KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY 175

Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTE----SGI--------------FRAVLRSDPN 371
           Y  + DIW++G + + +L     F    E    + I              FR     + N
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 372 FDD-----LPW--PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           F       L    P+ S E  D +K+LL  D  +R+TA QAL
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 19/223 (8%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG               +VAVK +    M    S E   +E +I+K L  H
Sbjct: 10  LERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-H 60

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFCH 269
             LV+    C +   +YIV E    G LLD + +  G+         +  QI   +A+  
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-V 325
            +  +HRDL   N L          ++ DFGL+  I  DE      G+ +   + APE  
Sbjct: 121 SRNYIHRDLAARNILVGENL---VCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176

Query: 326 LHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
            +  +++++D+WS G++   I+  G  P+   T   +   V R
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 57/294 (19%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKALSG 209
           ++G G +      R K   L D  VA+K I     +    TAI      REV +LK L  
Sbjct: 13  KLGEGTYATVYKGRSK---LTDNLVALKEIRLEHEEGAPCTAI------REVSLLKDLK- 62

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSV 264
           H ++V   D      ++ +V E       LD+ L +     G      + K  + Q+L  
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAP 323
           + +CH + V+HRDLKP+N L     +  +++L DFGL+     P +  ++ V + +Y  P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 324 EVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAV----------LR 367
           ++L  S  YS + D+W +G I Y +  G   F   T       IFR +          + 
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233

Query: 368 SDPNFDDLPWPSVSPEA------------KDFVKRLLNKDYRKRMTAVQALSKL 409
           S+  F    +P    +              + + +LL  + RKR++A +A+   
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 66/251 (26%)

Query: 199 REVKILKALSGHK----HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA 254
           RE+K+L     H+    ++V F  A      + I ME  +GG L D++L + GR  E   
Sbjct: 48  RELKVL-----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPE--- 98

Query: 255 KAIVVQILSVVAFCHLQG---------VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
                 IL  ++   L+G         ++HRD+KP N L  S     +++L DFG+S  +
Sbjct: 99  -----NILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL 150

Query: 306 RPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGI--- 361
             D   N  VG+  Y++PE L  + Y++++DIWS+G+    +  G  P        +   
Sbjct: 151 I-DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Query: 362 ----------FRAVLRSDPNFDD---------------------LPWPSVSPEAKDFVKR 390
                       +      +  D                     LP  + S E +DFV +
Sbjct: 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK 269

Query: 391 LLNKDYRKRMT 401
            L K+ ++R  
Sbjct: 270 CLKKNPKERAD 280

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 18/205 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR  K     + VA+K +        + +  +R EV +L+ L
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 58

Query: 208 SG--HKHLVKFCDAC-----EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
               H ++V+  D C     +    + +V E  +      LD++   G     E  K ++
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 116

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q+L  + F H   VVHRDLKP+N L TS      ++L DFGL+        L  +V + 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y APEV L  SY+   D+WS+G I
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCI 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 14/203 (6%)

Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           +++G GHFG     R   +G+   +QVAVK  S    +    I D+++E++IL+ L  H+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLY-HE 66

Query: 212 HLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           ++VK+   C +   N + ++ME    G L + +     +   +      VQI   + +  
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAYYVAPEV 325
            +  VHRDL   N L  S   +  +++ DFGL+  I  D+      +D+    ++ APE 
Sbjct: 127 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 326 L-HRSYSLEADIWSIGVISYILL 347
           L    + + +D+WS GV  Y LL
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 16/252 (6%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG  C+ + K      +  A K + K ++      +    E +IL+ ++    +V
Sbjct: 1   LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIV 56

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGV 273
               A E   ++ +VM L  GG+L   I   G R  E E       QI   +   H   +
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
           V+RD+KPEN L     D  + RL D GL+  ++  + +    G+  Y+APE+L    YS 
Sbjct: 117 VYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 333 EADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
             D +++G   Y ++ G  PF    E      + R  L  +  F+     + + E+KD  
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH---QNFTEESKDIC 230

Query: 389 KRLLNKDYRKRM 400
           +  L K    R+
Sbjct: 231 RLFLAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 33/204 (16%)

Query: 153 KEVGRGHFGHTCSA--RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           KE+G G+FG         K G  K+ +VAVK + +  +      ++  RE  ++  L  H
Sbjct: 1   KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-H 55

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
             +V+    C+    + +VMEL   G LL  +  R       D K +  Q+   +A+   
Sbjct: 56  PCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES 113

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY---------- 320
           +  VHRDL   N L  + R  A  ++ DFG+S  +          GS YY          
Sbjct: 114 KHFVHRDLAARNVLLVN-RHQA--KISDFGMSRALGA--------GSDYYRATTAGRWPL 162

Query: 321 --VAPEVLH-RSYSLEADIWSIGV 341
              APE ++   +S ++D+WS GV
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGV 186

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 82/304 (26%), Positives = 135/304 (44%), Gaps = 57/304 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      +    VAVK +S+         +   RE+ +LK +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDT---VLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV 77

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 78  N-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLYQM 132

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+     +  +   V + YY 
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYR 189

Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR------TESGIFRAVL 366
           APEV L   Y    DIWS+G I   L+ GS  F        W +      T S  F   L
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 367 R--------SDPN---------FDDLPWPSVS-------PEAKDFVKRLLNKDYRKRMTA 402
           +        + P          F D  +PS S        +A+D + ++L  D  KR++ 
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309

Query: 403 VQAL 406
            +AL
Sbjct: 310 DEAL 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192

Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           APEV L   Y    DIWS+G I   ++ G   F   
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 54/178 (30%), Positives = 93/178 (52%), Gaps = 16/178 (8%)

Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           +++L  GG+L    L++ G ++E + +    +I+  +   H + VV+RDLKP N L    
Sbjct: 75  ILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-- 131

Query: 289 RDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYI 345
            +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  +Y   AD +S+G + + 
Sbjct: 132 -EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188

Query: 346 LLCGSRPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM 400
           LL G  PF     + +  I R  L       D    S SPE +  ++ LL +D  +R+
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 75/304 (24%), Positives = 132/304 (43%), Gaps = 57/304 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73

Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 74  N-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 128

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185

Query: 322 APEV-LHRSYSLEADIWSIGVI------SYILLCGSR----------------PFWARTE 358
           APEV L   Y    DIWS+G I        IL  G                  P + +  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 359 SGIFRAVLRSDPNFDDLPWPSVSP----------------EAKDFVKRLLNKDYRKRMTA 402
               R  + + P +  L +P + P                +A+D + ++L  D  KR++ 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 403 VQAL 406
            +AL
Sbjct: 306 DEAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 30/253 (11%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           K+E+   VG G +G     R K+     + VA+K    ++    +  E   RE+K+L+ L
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL 57

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
              +++V+  +A      +Y+V E  E    ELL+  +  G     E  ++ + Q++  +
Sbjct: 58  K-QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGV--PPEKVRSYIYQLIKAI 113

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP--DERLNDIVGSAYYVAP 323
            +CH   +VHRD+KPEN L +    +  ++L DFG +  +    +    + V + +Y +P
Sbjct: 114 HWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR--------------S 368
           E+L  + Y    D+WS+G I   L  G   F   +E      + +              S
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230

Query: 369 DPNFDDLPWPSVS 381
           +P F  L +P+V+
Sbjct: 231 NPRFHGLRFPAVN 243

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 31/241 (12%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKALS 208
           +++G G +      R K   L +  VA+K I     +    TAI      REV +LK L 
Sbjct: 12  EKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAI------REVSLLKDLK 62

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILS 263
            H ++V   D      ++ +V E       LD+ L +     G   +  + K  + QIL 
Sbjct: 63  -HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
            +A+CH + V+HRDLKP+N L     +  +++L DFGL+     P +  ++ V + +Y  
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172

Query: 323 PEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           P+VL  S  YS + D+W +G I + +  G   F   T       + R      +  WP +
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232

Query: 381 S 381
           S
Sbjct: 233 S 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 53/277 (19%)

Query: 170 KGELKDQQVAVKIIS----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225
           + +L  Q VA+K I     +    TAI      RE  +LK L  H ++V   D       
Sbjct: 25  RSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLKDLK-HANIVTLHDIIHTKKT 77

Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
           + +V E  +  +L   +   GG  +  + +  + Q+L  +A+CH + V+HRDLKP+N L 
Sbjct: 78  LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136

Query: 286 TSGRDDADMRLIDFGLSDFIR----PDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSI 339
           +   +  +++L DFGL+   R    P +  ++ V + +Y  P+VL  S  YS   D+W +
Sbjct: 137 S---ERGELKLADFGLA---RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190

Query: 340 GVISYILLCGSRPFWARTESG-----IFRAV----------LRSDPNFDDLP-------- 376
           G I Y +  G   F   T+       IFR +          + S+P F            
Sbjct: 191 GCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250

Query: 377 ----WPSVS--PEAKDFVKRLLNKDYRKRMTAVQALS 407
                P +   P  ++   + L  + +KR++A +A+ 
Sbjct: 251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 23/241 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L +++G G FG                VAVK +    M      +D   E +I+K L  
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNN----TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR- 59

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFC 268
           H  L++    C     +YIV EL + G LL+ +    GR  +      +  Q+ S +A+ 
Sbjct: 60  HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE- 324
             Q  +HRDL   N L     ++   ++ DFGL+  I+ D       G+ +   + APE 
Sbjct: 120 EAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEA 175

Query: 325 VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
            L+  +S+++D+WS G++   I+  G  P+   T + + + V   D  +  +P P   P+
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQGY-RMPCPPGCPK 231

Query: 384 A 384
            
Sbjct: 232 E 232

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHKH 212
           +GRG FG     R        +  A+K + K   KM    ++    R +  L +      
Sbjct: 2   IGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V    A    + +  +++L  GG+L    L++ G ++E++ +    +I+  +   H + 
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR--S 329
           VV+RDLKP N L     +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  +
Sbjct: 118 VVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTA 172

Query: 330 YSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           Y   AD +S+G + + LL G  PF     + +  I R  L  +    D    S SPE K 
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKS 228

Query: 387 FVKRLLNKDYRKRM 400
            ++ LL +D  KR+
Sbjct: 229 LLEGLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 73.8 bits (181), Expect = 5e-14
 Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 11/173 (6%)

Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K + RG FG     R     +L     AVK++ KA M     +  V+ E   L ALS   
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKL----YAVKVVKKADMINKNMVHQVQAERDAL-ALSKSP 64

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    + +  NNVY+VME   GG++   +L   G + EE A   + ++   + + H  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAP 323
           G++HRDLKP+N L ++   +  ++L DFGLS   +  +  + DI+ +     P
Sbjct: 124 GIIHRDLKPDNMLISN---EGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 38/255 (14%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRR----EVKILKAL 207
           +++G+G+FG        KG LK   +VAVK     + T      D++R    E +ILK  
Sbjct: 1   EKIGKGNFGDV-----YKGVLKGNTEVAVK---TCRSTL---PPDLKRKFLQEAEILKQY 49

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK    C     +YIVMEL  GG LL  +  +  R T +    + +   + + +
Sbjct: 50  D-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YV 321
              +  +HRDL   N L     ++  +++ DFG+S   R +E     V          + 
Sbjct: 109 LESKNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWT 162

Query: 322 APEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           APE L+   Y+ E+D+WS G++ +     G  P+   +     +   R +  +  +P P 
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGY-RMPAPQ 218

Query: 380 VSPEAKDFVKRLLNK 394
           + PE    + RL+ +
Sbjct: 219 LCPEE---IYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 34/245 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILK 205
           +L K +G G +      R K   L +  VA+K I     +    TAI      REV +LK
Sbjct: 9   KLDK-LGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAI------REVSLLK 58

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILS 263
            L  H ++V   D       + +V E  +    + LD     G   +  + K  + Q+L 
Sbjct: 59  NLK-HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLR 114

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
            +++CH + ++HRDLKP+N L     +  +++L DFGL+     P +  ++ V + +Y  
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171

Query: 323 PEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDLP 376
           P+VL  S  YS   D+W +G I Y +  G   F   T       IFR  L   P  +   
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPTEET-- 227

Query: 377 WPSVS 381
           WP ++
Sbjct: 228 WPGIT 232

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            LG+ +G G FG          E +   VAVK   K   + ++  E   +E  I++    
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVR-EKFLQEAYIMRQFD- 65

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+VK      + N V+IVMEL   GEL   +                 Q+ + +A+  
Sbjct: 66  HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAPEVLH 327
            +  VHRD+   N L +S      ++L DFGLS ++  +       G     ++APE ++
Sbjct: 125 SKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 328 -RSYSLEADIWSIGVISY-ILLCGSRPF 353
            R ++  +D+W  GV  + IL+ G +PF
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 25/228 (10%)

Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           K  LGK +G G FG    A   G   +   + V V +       T   + D+  E++++K
Sbjct: 16  KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            T
Sbjct: 76  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  +   + 
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDY 192

Query: 311 LNDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 30/230 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR-----REVK 202
           +YE G +VGRG +GH   A+ K G+  D+  A+K I      T IS+   R     RE+K
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEG----TGISMSACREIALLRELK 56

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-------K 255
               +S  K  +   D       V+++ +  E          R  +  ++         K
Sbjct: 57  HPNVISLQKVFLSHAD-----RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDF----IRPDER 310
           +++ QIL  + + H   V+HRDLKP N L    G +   +++ D G +      ++P   
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
           L+ +V + +Y APE+L   R Y+   DIW+IG I   LL     F  R E
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG  C  R K    K+  VA+K + KA  +    + D   E  I+     H +
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRL-DFLTEASIMGQFD-HPN 66

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +++          V I+ E  E G  LD+ L       E D K  V Q++ +     L+G
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGS-LDKFL------RENDGKFTVGQLVGM-----LRG 114

Query: 273 V------------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG---S 317
           +            VHRDL   N L  S   +   ++ DFGLS  +   E      G    
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
             + APE + +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 67/237 (28%), Positives = 101/237 (42%), Gaps = 55/237 (23%)

Query: 155 VGRGHFGHTCSARGKKGELKD--------QQVAVKIISKAKMTTAISIEDVR--REVKIL 204
           +G G FG        +G   D         +VAVK + K     A   E     +E  ++
Sbjct: 3   LGSGAFGEV-----YEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLM 53

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI----VVQ 260
              + H ++VK    C      YI+MEL EGG+LL  +  R  R        +    ++ 
Sbjct: 54  SNFN-HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLD 110

Query: 261 I-LSVVAFCH-LQGV--VHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDI 314
           I L V   C  L+ +  +HRDL   N L +    DAD  +++ DFGL+          DI
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDI 161

Query: 315 VGSAYY------------VAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
             S YY            +APE L    ++ ++D+WS GV+ + IL  G +P+ A  
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 41/235 (17%)

Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +  LGK +G G FG      A G     +   VAVK++        +S  D+  E++++K
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSEMEMMK 70

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS-- 263
            +  HK+++     C     +Y+V+E    G L D + AR  R   E A     +     
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR--RPPGEYASPDDPRPPEET 128

Query: 264 -----VVAFCHL----------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
                +V+F +           +  +HRDL   N L T   +D  M++ DFGL+      
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185

Query: 303 DFIRP--DERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D+ R   + RL        ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 68.6 bits (167), Expect = 8e-13
 Identities = 83/321 (25%), Positives = 139/321 (43%), Gaps = 73/321 (22%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR-----REVK 202
           +YE G +VGRG +GH   A+ K G+  +++ A+K I      T IS+   R     RE+K
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEG----TGISMSACREIALLRELK 56

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED-------AK 255
               ++  K  +   D       V+++ +  E          R  +  ++         K
Sbjct: 57  HPNVIALQKVFLSHSD-----RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDF----IRPDER 310
           +++ QIL  + + H   V+HRDLKP N L    G +   +++ D G +      ++P   
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE---------- 358
           L+ +V + +Y APE+L   R Y+   DIW+IG I   LL     F  R E          
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231

Query: 359 ---SGIFRAV-LRSDPNFDDL----PWPS-----------------------VSPEAKDF 387
                IF  +   +D +++D+     +P+                       V P++K F
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF 291

Query: 388 --VKRLLNKDYRKRMTAVQAL 406
             +++LL  D  KR+T+ QAL
Sbjct: 292 LLLQKLLTMDPTKRITSEQAL 312

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 45/217 (20%)

Query: 153 KEVGRGHFGHTCSAR-----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +++G+G+FG     R        GE+    VAVK   K + +TA  + D  RE++ILK+L
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEV----VAVK---KLQHSTAEHLRDFEREIEILKSL 62

Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV---QIL 262
             H ++VK+   C      N+ +VME    G L D +     R    D + +++   QI 
Sbjct: 63  Q-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQIC 118

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV- 321
             + +   +  VHRDL   N L  S   +  +++ DFGL+  +  D+         YY  
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKE--------YYKV 167

Query: 322 -----------APEVLHRS-YSLEADIWSIGVISYIL 346
                      APE L  S +S+ +D+WS GV+ Y L
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 24/225 (10%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG  CS R K    ++  VA+K + KA  T      D   E  I+     H +
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEK-QRRDFLSEASIMGQFD-HPN 66

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           ++           V IV E  E G L   +    G++T      ++  I S + +    G
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY----------YVA 322
            VHRDL   N L  S   +   ++ DFGLS  +  D        +AY          + A
Sbjct: 127 YVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWTA 177

Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           PE + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 39/263 (14%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKALSGHK 211
           + +GRG+FG   S R +     +  VAVK     + T    ++    +E +ILK  S H 
Sbjct: 1   ERIGRGNFGEVFSGRLRA---DNTPVAVK---SCRETLPPDLKAKFLQEARILKQYS-HP 53

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++V+    C     +YIVMEL +GG+ L  +   G R   ++   +V    + + +   +
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---------YVA 322
             +HRDL   N L T   +   +++ DFG+S   R +E   D V ++          + A
Sbjct: 114 HCIHRDLAARNCLVT---EKNVLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTA 164

Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           PE L +  YS E+D+WS G++ +     G+ P+   +      A+ +       LP P +
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPEL 220

Query: 381 SPEAKDFVKRLLNK----DYRKR 399
            P+A   V RL+ +    D  +R
Sbjct: 221 CPDA---VYRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)

Query: 147 AKYELGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
            +  LGK +G G FG    A      K    K   VAVK++      T   + D+  E++
Sbjct: 12  TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEME 69

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 70  MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129

Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   +D  M++ DFGL+  +  
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186

Query: 308 DERLNDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 19/194 (9%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G+FG        KG LKD+  VAVK   K  +   + I+ +  E +ILK    H ++
Sbjct: 3   LGKGNFGEV-----FKGTLKDKTPVAVKT-CKEDLPQELKIKFLS-EARILKQYD-HPNI 54

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           VK    C     +YIVMEL  GG+ L  +  +      +      +   + +A+   +  
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLS----DFIRPDERLNDIVGSAYYVAPEVL-HR 328
           +HRDL   N L   G ++  +++ DFG+S    D I     L  I     + APE L + 
Sbjct: 115 IHRDLAARNCLV--GENNV-LKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYG 169

Query: 329 SYSLEADIWSIGVI 342
            YS E+D+WS G++
Sbjct: 170 RYSSESDVWSYGIL 183

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 153 KEVGRGHFGHTCSARGKKGELK----DQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            E+G G+FG       KKG  K    ++ VAVKI+       A+  +++ RE  +++ L 
Sbjct: 1   GELGSGNFGTV-----KKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQLD 54

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            + ++V+    CE   +  +VMEL E G L ++ L +    TE++   +V Q+   + + 
Sbjct: 55  -NPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYL 111

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPE 324
                VHRDL   N L  +       ++ DFGLS  +  DE              + APE
Sbjct: 112 EETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168

Query: 325 VL-HRSYSLEADIWSIGVI-----SYILLCGSRPF 353
            + +  +S ++D+WS GV+     SY    G +P+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSY----GQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 16/192 (8%)

Query: 225 NVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPE 281
           +V+I ME+ +    +   ++  +G    E+    I V I+  + + H +  V+HRD+KP 
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-----HRSYSLEADI 336
           N L      +  ++L DFG+S ++          G   Y+APE +      + Y +++D+
Sbjct: 134 NVLINR---NGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190

Query: 337 WSIGVISYILLCGSRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK 394
           WS+G+    L  G  P+  W      + + V    P    LP    SPE +DFV + L K
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ---LPAEKFSPEFQDFVNKCLKK 247

Query: 395 DYRKRMTAVQAL 406
           +Y++R    + L
Sbjct: 248 NYKERPNYPELL 259

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 19/224 (8%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG               +VAVK +    M    S++    E  ++K L  
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNN----STKVAVKTLKPGTM----SVQAFLEEANLMKTLQ- 59

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LV+          +YI+ E    G LLD + +  GG+           QI   +A+ 
Sbjct: 60  HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   +    ++ DFGL+  I  +E      G+ +   + APE 
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175

Query: 326 LHR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
           ++  S+++++D+WS G++ Y I+  G  P+   + S +  A+ R
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 47/246 (19%)

Query: 151 LGKEVGRGHFGHTCSARGKK-GELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L +E+G G FG    A        KD+  VAVK +    +      +D +RE ++L  L 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQ 65

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---------------GRYTEED 253
            H+H+VKF   C D + + +V E  + G+L   + A G               G      
Sbjct: 66  -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
              I  QI S + +   Q  VHRDL   N L  +      +++ DFG+S          D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS---------RD 172

Query: 314 IVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTES 359
           +  + YY            + PE +++R ++ E+D+WS GVI + I   G +P++  + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 360 GIFRAV 365
            +   +
Sbjct: 233 EVIECI 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
              +L K++G G FG    A   K      +VAVK +    M    S+E    E  ++K 
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKT 57

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVV 265
           L  H  LVK   A      +YI+ E    G LLD + +  G +           QI   +
Sbjct: 58  LQ-HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 115

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
           AF   +  +HRDL+  N L ++       ++ DFGL+  I  +E      G+ +   + A
Sbjct: 116 AFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTA 171

Query: 323 PEVL-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           PE +   S+++++D+WS G+ +  I+  G  P+   +   + RA+ R
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 29/227 (12%)

Query: 151 LGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           LGK +G G FG    A      K+   +  +VAVK++      T   + D+  E++++K 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------TE 251
           +  HK+++    AC     +Y+++E    G L + + AR   G  Y            + 
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
           +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   +  
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196

Query: 312 NDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
                      ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 8/156 (5%)

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           RE+++L   +   ++V F  A      + I ME  +GG L D++L    R  EE    + 
Sbjct: 52  RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109

Query: 259 VQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + +L  +A+   +  ++HRD+KP N L  S     +++L DFG+S  +  D   N  VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGT 165

Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP 352
             Y++PE L  + YS+++DIWS+G+    L  G  P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 11/183 (6%)

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    + 
Sbjct: 52  RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109

Query: 259 VQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + ++  + +   +  ++HRD+KP N L  S     +++L DFG+S  +  D   N  VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGT 165

Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFD 373
             Y++PE L  + YS+++DIWS+G+    +  G  P     A+    +F   +  DP   
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225

Query: 374 DLP 376
           +  
Sbjct: 226 ETS 228

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQ---VAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           E+G G FG    A      L +Q    VAVK + +A  +     +D +RE ++L  L  H
Sbjct: 12  ELGEGAFGKVFLAECHN-LLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQ-H 66

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLD---------RILARG-----GRYTEEDAKA 256
           +H+V+F   C +   + +V E    G+L           +ILA G     G+ T     A
Sbjct: 67  QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           I  QI S + +      VHRDL   N L         +++ DFG+S          DI  
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174

Query: 317 SAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
           + YY            + PE +L+R ++ E+DIWS GV+ + I   G +P++
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 48/235 (20%)

Query: 148 KYELGKEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR---REV 201
           K  L +E+G+G FG      +    KGE  + +VA+K +++       S+ +      E 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGE-PETRVAIKTVNENA-----SMRERIEFLNEA 60

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---------GGRYTEE 252
            ++K  + H H+V+            +VMEL   G+L   + +R          G  T +
Sbjct: 61  SVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
               +  +I   +A+   +  VHRDL   N +      D  +++ DFG++          
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE---DLTVKIGDFGMT---------R 167

Query: 313 DIVGSAYY------------VAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPF 353
           DI  + YY            +APE L    ++ ++D+WS GV+ + +     +P+
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 17/215 (7%)

Query: 147 AKYELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            + E  K +G G FG         +GE     VA+K++ +   T+  + +++  E  ++ 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMA 64

Query: 206 ALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           ++  H H+V+    C    V  +  +M L   G LLD +         +      VQI  
Sbjct: 65  SV-DHPHVVRLLGICLSSQVQLITQLMPL---GCLLDYVRNHKDNIGSQYLLNWCVQIAK 120

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---Y 320
            +++   + +VHRDL   N L  +      +++ DFGL+  +  DE+     G      +
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 321 VAPE-VLHRSYSLEADIWSIGV-ISYILLCGSRPF 353
           +A E +LHR Y+ ++D+WS GV +  ++  G++P+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 35/230 (15%)

Query: 151 LGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           LGK +G G FG    A   G      DQ V V +       T   + D+  E++++K + 
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR----------GGRYTEE-----D 253
            HK+++     C     +Y+++E    G L + + AR            +  EE     D
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIR- 306
             +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+      D+ + 
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192

Query: 307 -PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
             + RL        ++APE L  R Y+ ++D+WS G++ + I   G  P+
Sbjct: 193 TSNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           K  LG+ +G G FG        +GE   Q+VAVK I K  +T    +E+     K+    
Sbjct: 7   KLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             HK+LV+        N +YIVMEL   G L++ +  R GR      + +   +      
Sbjct: 57  -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGM 113

Query: 268 CHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
            +L+   +VHRDL   N L +   +D   ++ DFGL+        +++      + APE 
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKWTAPEA 168

Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           L H+ +S ++D+WS GV+ + +   G  P+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 40/238 (16%)

Query: 148 KYELGKEVGRGHFGHTCSARGK--KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
              LGK +G G FG    A     KG      VAVK++ +    ++  + D+  E  +LK
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLK 58

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-------------- 251
            ++ H H++K   AC     + +++E  + G L  R   R  R                 
Sbjct: 59  QVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSL--RSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 252 ---EDAKAIVVQILSVVAFCHLQG--------VVHRDLKPENFLFTSGRDDADMRLIDFG 300
               D +A+ +  L   A+   +G        +VHRDL   N L   GR    M++ DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFG 172

Query: 301 LS-DFIRPDERLNDIVGS--AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           LS D    D  +    G     ++A E L    Y+ ++D+WS GV+ + I+  G  P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 44/243 (18%)

Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L +E+G G FG    A       E     VAVK +  A        +D  RE ++L  L 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG------------GRYTEEDAKA 256
            H+H+VKF   C + + + +V E  + G+L   + A G               T+     
Sbjct: 66  -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           I  QI + + +   Q  VHRDL   N L     ++  +++ DFG+S          D+  
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYS 172

Query: 317 SAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
           + YY            + PE +++R ++ E+D+WS+GV+ + I   G +P++  + + + 
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232

Query: 363 RAV 365
             +
Sbjct: 233 ECI 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 51/269 (18%)

Query: 176 QQVAVKIIS----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
           Q VA+K+IS    +    TAI      RE  +LK L  H ++V   D       +  V E
Sbjct: 31  QLVALKVISMKTEEGVPFTAI------REASLLKGLK-HANIVLLHDIIHTKETLTFVFE 83

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
                +L   ++   G     + +  + Q+L  +A+ H Q ++HRDLKP+N L +     
Sbjct: 84  YMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY---L 139

Query: 292 ADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLC 348
            +++L DFGL+     P +  +  V + +Y  P+VL  +  YS   DIW  G I +I + 
Sbjct: 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEML 198

Query: 349 GSRPFWARTESGIFRAVLR-----------SDPNFDDLP--------WP----------- 378
             +P +    S +F  + +           + P    LP                     
Sbjct: 199 QGQPAFPGV-SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257

Query: 379 -SVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            S  P+A+D   ++L    + R++A  AL
Sbjct: 258 LSRPPKAEDLASQMLMMFPKDRISAQDAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)

Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G G +G       KK       VAVK + +  M     +E+  +E  ++K +  H +L
Sbjct: 13  KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64

Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAFCHL 270
           V+    C      YI+ E    G LLD  L    R  E +A  ++    QI S + +   
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR-QEVNAVVLLYMATQISSAMEYLEK 122

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVL- 326
           +  +HRDL   N L     ++  +++ DFGLS  +   +      G+ +   + APE L 
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178

Query: 327 HRSYSLEADIWSIGVI 342
           +  +S+++D+W+ GV+
Sbjct: 179 YNKFSIKSDVWAFGVL 194

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 54/297 (18%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKIL 204
           YE  +++G G +      + K   +  + VA+K+I     +    TAI      RE  +L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI------REASLL 57

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H ++V   D       + +V E     +L   +    G    E+ K  + Q+L  
Sbjct: 58  KGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG 115

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAP 323
           +++ H + ++HRDLKP+N L +   D  +++L DFGL+     P    ++ V + +Y  P
Sbjct: 116 LSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172

Query: 324 EVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAVLRSDPNFDDLP 376
           +VL  S  YS   D+W +G I   ++ G   F    +       IF  ++   PN D  P
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPNEDTWP 230

Query: 377 ----WPSVSPE----------------------AKDFVKRLLNKDYRKRMTAVQALS 407
                P   PE                      A+D   +LL    + R++A  ALS
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 22/223 (9%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---HK 211
           +G G FG  C  R K    ++  VA+K + K+  T     E  RR+     ++ G   H 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFDHP 65

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           +++           V I+ E  E G L   +    G++T      ++  I + + +    
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-------YVAPE 324
             VHRDL   N L  S   +   ++ DFGLS F+  D+  +    S+        + APE
Sbjct: 126 NYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 325 -VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            + +R ++  +D+WS G++ + ++  G RP+W  +   +  A+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 41/214 (19%)

Query: 153 KEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
             +GRG FG      A+G + E  +  V VK + K K     S  + RRE+ + + LS H
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-H 67

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH- 269
           K++V+    C +    Y+++E  + G+L   + A   +  +E  K   +     VA C  
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQ 125

Query: 270 -LQGV--------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
              G+        VHRDL   N L +S R   ++++    LS          D+  S YY
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQR---EVKVSLLSLS---------KDVYNSEYY 173

Query: 321 -----------VAPE-VLHRSYSLEADIWSIGVI 342
                      +APE V    +S ++D+WS GV+
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 53/277 (19%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----DVRREVKILK 205
           +LG E+GRG FG       K        +AVK I       +   E     +  ++ ++ 
Sbjct: 8   DLG-EIGRGAFGTVNKMLHKP---SGTIMAVKRIR------STVDEKEQKRLLMDLDVVM 57

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA-IVVQILSV 264
             S   ++VKF  A     + +I MEL      +D  L +  +Y  E  K+ I  +IL  
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGK 111

Query: 265 VAFC------HLQ---GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
           +A        +L+    ++HRD+KP N L        +++L DFG+S  +     ++ I 
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQL-----VDSIA 163

Query: 315 ----VGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESGIF---R 363
                G   Y+APE +  S    Y + +D+WS+G+  Y +  G  P+     + +F    
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLT 221

Query: 364 AVLRSD-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
            V++ D P   +      SP   +F+   L KD  KR
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)

Query: 153 KEVGRGHFGHTC-----SARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + +G GHFG         A    GE+    VAVK + +       +    ++E+ ILK L
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRE--CGQQNTSGWKKEINILKTL 63

Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILS 263
             H+++VK+   C +     + ++ME    G L D +     ++    A+ ++   QI  
Sbjct: 64  Y-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICE 118

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAY 319
            +A+ H Q  +HRDL   N L     +D  +++ DFGL+  +           D     +
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175

Query: 320 YVAPEVLHR-SYSLEADIWSIGVISYILL 347
           + A E L    +S  +D+WS GV  Y LL
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 54/297 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y++ + +G+G  G    A       +   VA+K I +      +  +   RE KI   L
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRR---VALKKIREDLSENPLLKKRFLREAKIAADL 59

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK------------ 255
             H  +V     C D + VY  M   EG   L  +L +     E  +K            
Sbjct: 60  I-HPGIVPVYSICSDGDPVYYTMPYIEG-YTLKSLL-KSVWQKESLSKELAEKTSVGAFL 116

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFL---FTSGRDDADMRLIDFGLSDFIRPDE--- 309
           +I  +I + + + H +GV+HRDLKP+N L   F       ++ ++D+G + F + +E   
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLF------GEVVILDWGAAIFKKLEEEDL 170

Query: 310 ----------------RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRP 352
                               IVG+  Y+APE +L    S   DI+++GVI Y +L  S P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Query: 353 FWARTESG---IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           +  R + G    +R V+   P  +  P+  + P       + L  D  +R ++VQ L
Sbjct: 231 Y--RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 24/241 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG               +VA+K + +  M    S E    E  ++K L  
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ- 59

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAFC 268
           H  LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 60  HPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   +    ++ DFGL+  I  +E      G+ +   + APE 
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA 174

Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R       +P P   PE
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----YRMPRPDNCPE 230

Query: 384 A 384
            
Sbjct: 231 E 231

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 38/232 (16%)

Query: 150 ELGKEVGRGHFGHTCSA--RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            L + +G G FG       RG+ G+  + QVAVK  +  +  +     D   E  I+   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVK--TLPESCSEQDESDFLMEALIMSKF 66

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H+++V+      +    +I++EL  GG+L      R  R   E   ++ ++ L   A 
Sbjct: 67  N-HQNIVRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCAR 123

Query: 268 -----CHL---QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
                C        +HRD+   N L T        ++ DFG++          DI  ++Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASY 174

Query: 320 Y------------VAPEV-LHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
           Y            + PE  L   ++ + D+WS GV+ + I   G  P+  RT
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 69/320 (21%), Positives = 140/320 (43%), Gaps = 62/320 (19%)

Query: 130 EPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT 189
           + E+ +D     N++    Y+LG  +G G FG    A         ++VA+K +      
Sbjct: 51  DEEKMIDNDI--NRSPNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKV------ 99

Query: 190 TAISIEDVR---REVKILKALSGHKHLVKFCD----ACEDVNNVYIVMELCEGGELLDRI 242
               ++D +   RE+ I+K L+ H +++   D     C   N   I + +    E + + 
Sbjct: 100 ----LQDPQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVM--EFIPQT 152

Query: 243 LARGGRYTEEDAKAIVV--------QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
           + +  ++   +  A+ +        Q+   +A+ H + + HRDLKP+N L     +   +
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTL 210

Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP 352
           +L DFG +  +   +R    + S +Y APE++    +Y+   D+WS+G I   ++ G   
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270

Query: 353 FWARTESGIFRAVLR------------SDPNFDDLPWPSVSP-------------EAKDF 387
           F  ++       +++             +PN+ D+ +P V P             +A +F
Sbjct: 271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINF 330

Query: 388 VKRLLNKDYRKRMTAVQALS 407
           + + L  +  KR+  ++AL+
Sbjct: 331 ISQFLKYEPLKRLNPIEALA 350

Length = 440

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 29/223 (13%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G+FG    A  KK  LK    A+K++ +    +     D   E+++L  L  H +++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNII 66

Query: 215 KFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKA----------IVV 259
               ACE+   +YI +E    G LLD     R+L     + +E   A             
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGS- 317
            + + + +   +  +HRDL   N L     ++   ++ DFGLS   R +E  +   +G  
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS---RGEEVYVKKTMGRL 180

Query: 318 -AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
              ++A E L+ S Y+ ++D+WS GV+ + I+  G  P+   T
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 34/216 (15%)

Query: 154 EVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKALSGHK 211
           E+G G+FG  C  +G  K   K   VA+K++   K     S+ D + RE +I+  L  + 
Sbjct: 2   ELGSGNFG--CVKKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD-NP 55

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++V+    CE    + +VME+  GG L   +  +    T  +   ++ Q+   + +   +
Sbjct: 56  YIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----------- 320
             VHRDL   N L     +    ++ DFGLS  +  D+        +YY           
Sbjct: 115 NFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADD--------SYYKARSAGKWPLK 163

Query: 321 -VAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPF 353
             APE ++ R +S  +D+WS G+  +     G +P+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 29/223 (13%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G+FG    AR KK  L+    A+K + +    +     D   E+++L  L  H +++
Sbjct: 3   IGEGNFGQVLKARIKKDGLR-MDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 215 KFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVV---QILSVVA 266
               ACE    +Y+ +E    G LLD     R+L     +   ++ A  +   Q+L   A
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 267 -------FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGS- 317
                  +   +  +HRDL   N L   G +    ++ DFGLS   R  E  +   +G  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV--GENYVA-KIADFGLS---RGQEVYVKKTMGRL 173

Query: 318 -AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
              ++A E L+ S Y+  +D+WS GV+ + I+  G  P+   T
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 9/149 (6%)

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H ++V+    C   + + +V +L   G LLD +         +      VQI   + +  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVL 326
              +VHR+L   N L  S   D+ +++ DFG++D + PD++    ++      ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 327 H-RSYSLEADIWSIGVISYILLC-GSRPF 353
               Y+ ++D+WS GV  + ++  G+ P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 20/214 (9%)

Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
           +VA+K +    M    S E   +E +++K L  H+ LV+      +   +YIV E    G
Sbjct: 32  RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG 85

Query: 237 ELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            LLD +    G+Y        +  QI S +A+      VHRDL+  N L     ++   +
Sbjct: 86  SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCK 142

Query: 296 LIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHRSYSLEADIWSIGVISYILLCGSR 351
           + DFGL+  I  D       G+ +   + APE  L+  +++++D+WS G++   L    R
Sbjct: 143 VADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Query: 352 -PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
            P+       +   V R       +P P   PE+
Sbjct: 202 VPYPGMVNREVLDQVERG----YRMPCPPECPES 231

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 39/228 (17%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHK 211
           +G G+FG    AR KK  L+    A+K     +M    S +D R    E+++L  L  H 
Sbjct: 15  IGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 68

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED-AKAIVVQILSVVAFCHL 270
           +++    ACE    +Y+ +E    G LLD    R  R  E D A AI     S ++   L
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 271 ----------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313
                           +  +HRDL   N L     ++   ++ DFGLS   R  E  +  
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKK 180

Query: 314 IVGS--AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
            +G     ++A E L+ S Y+  +D+WS GV+ + I+  G  P+   T
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 19/198 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG             + +VAVK +    M    S E    E +I+K L  
Sbjct: 9   QLIKKLGNGQFGEVWMGTWNG----NTKVAVKTLKPGTM----SPESFLEEAQIMKKLR- 59

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFC 268
           H  LV+   A      +YIV E    G LLD +    GR  +  +   +  Q+ + +A+ 
Sbjct: 60  HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE- 324
                +HRDL+  N L   G      ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 119 ERMNYIHRDLRSANILVGDG---LVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEA 174

Query: 325 VLHRSYSLEADIWSIGVI 342
            L+  +++++D+WS G++
Sbjct: 175 ALYGRFTIKSDVWSFGIL 192

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 16/238 (6%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG       K    K+  VA+K +      T    +D   E  I+   S H +
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHN 67

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +++            I+ E  E G L   +    G ++      ++  I + + +     
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL-H 327
            VHRDL   N L  S   + + ++ DFGLS  +  D E      G      + APE + +
Sbjct: 128 YVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 328 RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           R ++  +D+WS G++ + ++  G RP+W  +   + +A+   +  F  LP P   P A
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGF-RLPAPMDCPSA 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 23/228 (10%)

Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
           +VA+K +    M      E   +E +I+K L   K +  +    E+   +YIV E    G
Sbjct: 32  KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSEE--PIYIVTEFMGKG 85

Query: 237 ELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            LLD +    G+Y +      +  QI   +A+      +HRDL+  N L     D+   +
Sbjct: 86  SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCK 142

Query: 296 LIDFGLSDFIRPDERLNDIVGSAY---YVAPEV-LHRSYSLEADIWSIGVISYILLCGSR 351
           + DFGL+  I  D       G+ +   + APE  L+  +++++D+WS G++   L+   R
Sbjct: 143 IADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Query: 352 -PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK 398
            P+       +   V R       +P P   PE+   +  L+   ++K
Sbjct: 202 VPYPGMVNREVLEQVERG----YRMPCPQGCPES---LHELMKLCWKK 242

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 6/105 (5%)

Query: 245 RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI-DFGLSD 303
           R      + A  I  QIL  + + H Q ++HRD+K EN       +D D   I D G + 
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAAQ 205

Query: 304 FIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
           F         + G+    APEVL R  Y+ +ADIWS G++ + +L
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 29/210 (13%)

Query: 169 KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228
           K G+ + ++V VK ++  K           RE+ ILK +S H+ ++    A    + V +
Sbjct: 113 KHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYRWKSTVCM 163

Query: 229 VMEL--CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286
           VM    C+    +DR     G    E A  I  ++L  +A+ H +G++HRD+K EN +F 
Sbjct: 164 VMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFL 218

Query: 287 SGRDDADMRLIDFGLSDFIRPDERLND-----IVGSAYYVAPEVLH-RSYSLEADIWSIG 340
              ++A   L DFG +   + D   +        G+    +PE+L    Y  + DIWS G
Sbjct: 219 DEPENA--VLGDFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG 274

Query: 341 VISYILLCGSRPFWAR---TESGIFRAVLR 367
           ++ + +   +   + +   + S   R+++R
Sbjct: 275 LVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304

Length = 392

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)

Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 69

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 70  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLH 327
            +VHRDL   N L    +    +++ DFGL+  +  DE+     G      ++A E +LH
Sbjct: 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 41/226 (18%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSG 209
           KE+G G FG         G     QV VK     ++  + S+++  +   E +  ++L  
Sbjct: 1   KEIGNGWFGKVILGEVNSG-YTPAQVVVK-----ELRVSASVQEQMKFLEEAQPYRSLQ- 53

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KAIVVQILS 263
           H +L++    C +V    +VME C  G+ L   L R  R  E         + +  +I  
Sbjct: 54  HSNLLQCLGQCTEVTPYLLVMEFCPLGD-LKGYL-RSCRKAELMTPDPTTLQRMACEIAL 111

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-------FIRPDERLNDIVG 316
            +   H    +H DL   N L T+   D  +++ D+GLS        ++ PD+    +  
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL-- 166

Query: 317 SAYYVAPEVLHRSY--------SLEADIWSIGVISYILL-CGSRPF 353
              ++APE++   +        + E+++WS+GV  + L   GS+P+
Sbjct: 167 --RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 19/196 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I       A   E       ++  L  
Sbjct: 9   KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAFLAE-----ASVMTQLR- 57

Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK-AIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      D      + +   + +
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
                 VHRDL   N L +   +D   ++ DFGL+      +    +     + APE L 
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172

Query: 327 HRSYSLEADIWSIGVI 342
            + +S ++D+WS G++
Sbjct: 173 EKKFSTKSDVWSFGIL 188

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 20/148 (13%)

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           +++ F  A    N + I  E  +GG L         +  E     I V ++  + +    
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 272 GVVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPE-V 325
            ++HRD+KP N L  T G+    ++L DFG+S      + +N I    VG+  Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQ----VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERI 165

Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPF 353
               Y + +D+WS+G+    L  G  P+
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283
           + V +V +L   G LLD +     R   +D     VQI   +++     +VHRDL   N 
Sbjct: 81  STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140

Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS----AYYVAPEVLHRSYSLEADIWSI 339
           L  S      +++ DFGL+  +  DE      G      +     +LHR ++ ++D+WS 
Sbjct: 141 LVKS---PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197

Query: 340 GVISYILLC-GSRPF 353
           GV  + L+  G++P+
Sbjct: 198 GVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 51.4 bits (124), Expect = 1e-07
 Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
           D  N  IVME  EG  L D ++   G    E ++ I       V   H  G++H DL   
Sbjct: 70  DPENFIIVMEYIEGEPLKD-LINSNGMEELELSREIGRL----VGKLHSAGIIHGDLTTS 124

Query: 282 NFLFTSGRDDADMRLIDFGLSDF 304
           N + + G+    + LIDFGL++F
Sbjct: 125 NMILSGGK----IYLIDFGLAEF 143

Length = 211

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)

Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+KI+++   TT         +  ++ A   H 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE---TTGPKANVEFMDEALIMASMDHP 69

Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           HLV+    C     + +V +L   G LLD +         +      VQI   + +   +
Sbjct: 70  HLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLH- 327
            +VHRDL   N L  S      +++ DFGL+  +  DE+  +  G      ++A E +H 
Sbjct: 129 RLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R ++ ++D+WS GV  + L+  G +P+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 40/236 (16%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQ---VAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G+G FG    AR   G L  +    VAVK++ +    +A    D +RE  ++     
Sbjct: 11  RDIGQGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD- 66

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK-------------- 255
           H ++VK    C     + ++ E    G+L + +  R  R     +               
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 256 -------AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
                   I  Q+ + +A+   +  VHRDL   N L     ++  +++ DFGLS      
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSA 183

Query: 303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
           D+ +  E  ND +   +     + +  Y+ E+D+W+ GV+ + I   G +P++   
Sbjct: 184 DYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 29/137 (21%)

Query: 241 RILARGGRYTEEDAKAIVV-----------------QILSVVAFCHLQGVVHRDLKPENF 283
           R   R G Y ++D  + ++                 Q+   ++F   +  +HRDL   N 
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245

Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSAY----YVAPE-VLHRSYSLEADIW 337
           L T GR     ++ DFGL+  IR D   N +V G+A     ++APE + +  Y+ E+D+W
Sbjct: 246 LLTHGR---ITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300

Query: 338 SIGVISY-ILLCGSRPF 353
           S G++ + I   GS P+
Sbjct: 301 SYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 25/185 (13%)

Query: 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283
           ++V++V++  EGG+L   I        EE  K    +++  +   H +G+V RDL P N 
Sbjct: 58  DSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEA-DIWSIGVI 342
           L     D   ++L  F     +       + V    Y APEV   S   EA D WS+G I
Sbjct: 117 LLD---DRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAI 171

Query: 343 SYILLCG-----SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
            + LL G       P      SGI      + P +       VS EA+  +++LL  +  
Sbjct: 172 LFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPT 218

Query: 398 KRMTA 402
           +R+ A
Sbjct: 219 ERLGA 223

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 52/256 (20%), Positives = 107/256 (41%), Gaps = 33/256 (12%)

Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK----FCDACEDVNN 225
           KG   +++V ++   K      + I+    E+K L+ +  + +++K      D  +D+  
Sbjct: 38  KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPR 96

Query: 226 VYIVMELCEGGELLDRILARGGRYTEED------AKAIVVQILSVVAFCHLQGVVHRDLK 279
           + +++E C  G L      R     E+D          +     +          +++L 
Sbjct: 97  LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150

Query: 280 PENFLFTSGRDDADMRLIDFGLSDFIR--PDERLNDIVGSAYYVAPEVLH---RSYSLEA 334
             +FL T   ++  +++I  GL   +   P + +N +V    Y + ++L+     Y+++ 
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203

Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP-EAKDFVKRLLN 393
           DI+S+GV+ + +  G  PF   T   I+  ++      + L  P   P E K  V+   +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN---KNNSLKLPLDCPLEIKCIVEACTS 260

Query: 394 KDYRKRMTAVQALSKL 409
            D  KR    + L  L
Sbjct: 261 HDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 46/236 (19%)

Query: 150 ELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
              +E+G G FG        G    L    VA+K + K      +  ++ R+E +++  L
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQ-QEFRQEAELMSDL 65

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR------GGRYTEEDAKA----- 256
             H ++V     C       ++ E    G+L + ++        G    +E  K+     
Sbjct: 66  Q-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124

Query: 257 ----IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
               I +QI + + +      VHRDL   N L   G     +++ DFGLS          
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS---------R 172

Query: 313 DIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
           DI  + YY            + PE +L+  ++ E+DIWS GV+ + I   G +P++
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 20/135 (14%)

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV-KFCDACEDVNNVYIVM 230
             KD+   +KI       +     D  REV IL+ L+     V K   + E     Y++M
Sbjct: 18  GTKDEDYVLKIN-----PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72

Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH---LQGVVHRDLKPENFLFTS 287
           E  EG  L           +EE+ + I  Q+  ++A  H   L  + H DL P N L   
Sbjct: 73  EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124

Query: 288 GRDDADMRLIDFGLS 302
           G+      +ID+  +
Sbjct: 125 GKILG---IIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 45/231 (19%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           LGK +G G FG     +  + +    +VAVK + K  + T   IE+   E   +K    H
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-H 60

Query: 211 KHLVKFCDAC---EDVNNV---YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            +++K    C     +  +    +++   + G+L   +L           + + +Q L  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTLLK 117

Query: 265 VAFCHLQGV--------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
                  G+        +HRDL   N +    R+D  + + DFGLS           I  
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKIYS 165

Query: 317 SAYY------------VAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
             YY            +A E L  R Y+ ++D+W+ GV  + I   G  P+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 23/72 (31%), Positives = 34/72 (47%)

Query: 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287
           ++ E  EG + L   LA+     EE  +A+   +  ++A  H  GV H DL   N L  +
Sbjct: 94  LLTERLEGAQDLVTWLAQWADPAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDT 153

Query: 288 GRDDADMRLIDF 299
           G     + LIDF
Sbjct: 154 GEGGFKVWLIDF 165

These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 56/239 (23%), Positives = 103/239 (43%), Gaps = 30/239 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ---QVAVKIISK-AKMTTAISIEDVRREVKI 203
           K  + +E+G+G FG       K G +KD+   +VA+K +++ A M   I   +   E  +
Sbjct: 7   KITMSRELGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLN---EASV 62

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV---- 259
           +K  + H H+V+            ++MEL   G+L   +  R  R   E+          
Sbjct: 63  MKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLK 119

Query: 260 -------QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL 311
                  +I   +A+ +    VHRDL   N +     +D  +++ DFG++ D    D   
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 176

Query: 312 NDIVG--SAYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVL 366
               G     +++PE L    ++  +D+WS GV+ + I     +P+   +   + R V+
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 41/152 (26%), Positives = 59/152 (38%), Gaps = 24/152 (15%)

Query: 166 ARGKKGELKDQQVAVKI-ISKA----KMTTAISIEDVRREVKIL---KALSGHKHLVKFC 217
           A     +       VK  I K     ++   +  E  RRE +IL   +       +V   
Sbjct: 10  AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV 69

Query: 218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
           D     +N  IVME  EG  L D          EE    ++ ++  +V   H  G+VH D
Sbjct: 70  D----PDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGD 117

Query: 278 LKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           L   N + + GR    +  IDFGL +F    E
Sbjct: 118 LTTSNIILSGGR----IYFIDFGLGEFSDEVE 145

Length = 204

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 7/91 (7%)

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN--- 312
           A+  Q+LS + + H +G++HRD+K EN L        D+ L DFG + F R         
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DICLGDFGAACFARGSWSTPFHY 320

Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVI 342
            I G+    APEVL    Y+   DIWS G++
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351

Length = 461

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 51/238 (21%)

Query: 153 KEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISI----------EDVRRE 200
           +++G G FG  H C A G + +  D+  ++ +     +  A+ +           D  +E
Sbjct: 11  EKLGEGQFGEVHLCEAEGME-KFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL---LDRILARGGRYTEE----- 252
           +KI+  L    ++++    C   + + ++ E  E G+L   L R   +      +     
Sbjct: 70  IKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 253 --DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DF 304
                 +  QI S + +      VHRDL   N L   G++   +++ DFG+S      D+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--GKNYT-IKIADFGMSRNLYSGDY 185

Query: 305 IRPDERLNDIVGSAYYVAP-------EVLHRSYSLEADIWSIGVISY--ILLCGSRPF 353
            R       I G A  V P        +L   ++  +D+W+ GV  +  + LC  +P+
Sbjct: 186 YR-------IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 36/203 (17%)

Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
           VAVKI+       A +  D  +EVKIL  L    ++++    C D + + ++ E  E G+
Sbjct: 49  VAVKILRPDANKNARN--DFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 238 L--------LDRILARGGRYTEEDAKAIVV----------QILSVVAFCHLQGVVHRDLK 279
           L        LD     G            +          QI S + +      VHRDL 
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165

Query: 280 PENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSAYYVAPE-VLHRSYSL 332
             N L         +++ DFG+S      D+ R   R    V    ++A E +L   ++ 
Sbjct: 166 TRNCLVGENL---TIKIADFGMSRNLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTT 219

Query: 333 EADIWSIGVISY--ILLCGSRPF 353
            +D+W+ GV  +  ++LC  +P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG-LSDFIRPDE-RLN 312
           +AI+ Q+L  V + H + ++HRD+K EN +F +   D  + L DFG    F +  E    
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNC--DGKIVLGDFGTAMPFEKEREAFDY 326

Query: 313 DIVGSAYYVAPEVLHR-SYSLEADIWSIGVI 342
             VG+    +PE+L    Y    DIWS G+I
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLI 357

Length = 501

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 36/224 (16%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRR---EVKIL 204
             +GK        H   A+ K    L    VAVK I+    +     ED++    E+   
Sbjct: 4   TLIGKCFEDLMIVHL--AKHKPTNTL----VAVKKINLDSCSK----EDLKLLQQEIITS 53

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGG---ELLDRILARGGRYTEEDAKAIVVQ- 260
           + L  H +++ +  +    + +Y+V  L   G   +LL      G     E A A +++ 
Sbjct: 54  RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKD 109

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA- 318
           +L+ + + H +G +HR +K  + L +    D  + L     S   I+  +R   +     
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSG---DGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 319 ------YYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPF 353
                  +++PEVL ++   Y+ ++DI+S+G+ +  L  G  PF
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 12/108 (11%)

Query: 192 ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE 251
           +S     RE + L+ L      V         N   +VME  EG EL         R   
Sbjct: 151 VSRLAAEREFEALQRLYPEGVKVP---KPIAWNRHAVVMEYIEGVEL------YRLRLDV 201

Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
           E+   I+ +IL  V   + +G+VH DL   N L T   +D D+ +ID+
Sbjct: 202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDGDIVVIDW 246

Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 25/232 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + LG+ +G+G FG    A+ K  +   Q+VAVK++ KA + ++  IE+  RE   +K   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 209 GHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA------ 256
            H +++K         A   +    +++   + G+L   +L    R  EE          
Sbjct: 60  -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFTLPLQTLV 116

Query: 257 -IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
             ++ I S + +   +  +HRDL   N +     ++  + + DFGLS  I   +      
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 316 GSAY---YVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
            S     ++A E L  + Y+  +D+W+ GV  + I+  G  P+     S I+
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 4/92 (4%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKALS 208
           LG+ +G G FG    A      L   Q  +K+  K   +TA S E   +  E+KI+  L 
Sbjct: 41  LGRTLGSGAFGRVVEATAHG--LSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG 98

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
            H ++V    AC     +YI+ E C  G+L+D
Sbjct: 99  PHLNIVNLLGACTKGGPIYIITEYCRYGDLVD 130

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 50/238 (21%), Positives = 102/238 (42%), Gaps = 37/238 (15%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR--REVKILKALSGH 210
            E+G G FG         GE        +++ K    +A   E +   +EV+  + L+ H
Sbjct: 1   DEIGNGWFGKVL-----LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-H 54

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQ-----ILSV 264
            ++++    C +     +V+E C  G+L + +  R  R    + A+  V+Q     + S 
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSA 318
           + + H    +H DL   N   T+   D  +++ D+GL+      D+    +         
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCH---AVPL 166

Query: 319 YYVAPEV--------LHRSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLR 367
            ++APE+        L +  + +++IWS+GV  + L     +P+   ++  + + V+R
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.7 bits (104), Expect = 4e-05
 Identities = 27/88 (30%), Positives = 34/88 (38%), Gaps = 12/88 (13%)

Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
           D +N  IVME  EG  L D I         E  +         V   H  G+VH DL   
Sbjct: 68  DPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRL--------VGKLHKAGIVHGDLTTS 119

Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           N +    +    + LIDFGL  +    E
Sbjct: 120 NIIVRDDK----LYLIDFGLGKYSDEIE 143

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 57/244 (23%)

Query: 150 ELGKEVGRGHFG--HTCSARG---------KKGELKDQ--QVAVKIISKAKMTTAISIED 196
              +++G G FG  H C A G          + +  D    VAVK++       A   ED
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR--ED 65

Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE----LLDRILARGGRYTEE 252
             +EVKIL  LS   ++ +    C     + ++ME  E G+    L   +    G     
Sbjct: 66  FLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG--LAC 122

Query: 253 DAKAI--------VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
           ++K++          QI S + +      VHRDL   N L         +++ DFG+S  
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFGMS-- 177

Query: 305 IRPDERLNDIVGSAYY------VAP-------EVLHRSYSLEADIWSIGVISY-IL-LCG 349
                   ++  S YY        P        VL   ++ ++D+W+ GV  + IL LC 
Sbjct: 178 -------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230

Query: 350 SRPF 353
            +P+
Sbjct: 231 EQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 18/114 (15%)

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
           T ED      Q+   + F   +  +HRDL   N L +   ++  +++ DFGL+       
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 233

Query: 303 DFIRP-DERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D++R  D RL        ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 234 DYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 48/233 (20%), Positives = 93/233 (39%), Gaps = 30/233 (12%)

Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
              ++ + +G G FG  C    K    ++  VA+  +            D +R   + +A
Sbjct: 5   KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-------GCSDKQRRGFLAEA 57

Query: 207 LS----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQI 261
           L+     H ++V+        N + IV E    G  LD  L +  G+        ++  +
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGL 116

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGS--- 317
            S + +    G VH+ L     L  S         +   +S F R  +++   I  +   
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSD--------LVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 318 ---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                + APE + +  +S  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 10/91 (10%)

Query: 314 IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
           I+G+  Y+APE+L  + +    D W++GV  +  L G  PF   T   +F+ +L      
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR---- 595

Query: 373 DDLPWP----SVSPEAKDFVKRLLNKDYRKR 399
            D+PWP     +S  A++ ++ LL  D  KR
Sbjct: 596 -DIPWPEGEEKLSVNAQNAIEILLTMDPTKR 625

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 12/88 (13%)

Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
           L +G     +  + I+ QIL  +   H  G+VHRD+KP+N +F+ G      ++ID G +
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG--SGSFKIIDLGAA 303

Query: 303 DFIR------PDERLNDIVGSAYYVAPE 324
             +R      P E L D      Y APE
Sbjct: 304 ADLRVGINYIPKEFLLD----PRYAAPE 327

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 26/210 (12%)

Query: 155 VGRGHFGHTCSARGKKGELKD------QQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +G+G F      +G + E+ D       +V +K++ K+    +   E       ++  LS
Sbjct: 3   LGQGTFTKI--FKGIRREVGDYGELHKTEVLLKVLDKSHRNYS---ESFFEAASMMSQLS 57

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            HKHLV     C   +   +V E  + G L D  L +         K  V + L+  A  
Sbjct: 58  -HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAW-ALH 114

Query: 269 HLQ--GVVHRDLKPENFLFTSGRDDAD-----MRLIDFGLSDFIRPDERLNDIVGSAYYV 321
            L+  G+ H ++  +N L     D        ++L D G+S  + P E L + +    +V
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP---WV 171

Query: 322 APEVLH--RSYSLEADIWSIGVISYILLCG 349
            PE +   ++ SL AD WS G   + +  G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 4/95 (4%)

Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
             + GK +G G FG     +A G   E    +VAVK++  +  T     E +  E+KIL 
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILS 96

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
            L  HK++V    AC     V ++ E C  G+LL+
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 36/235 (15%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKA 206
           LGK +G G FG        +G+L       +VAVK + K  + T   +ED   E   +K 
Sbjct: 3   LGKTLGEGEFGSV-----MEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKE 56

Query: 207 LSGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRIL-ARGGRYTEEDAKAIVV 259
              H ++++    C      E   +  +++   + G+L   +L +R G   +     ++V
Sbjct: 57  FD-HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115

Query: 260 QILSVVA----FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDE 309
           + ++ +A    +   +  +HRDL   N +     ++ ++ + DFGLS      D+ R   
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYR-QG 171

Query: 310 RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
           R+  +     ++A E L  R Y+ ++D+WS GV  + I   G  P+     S I+
Sbjct: 172 RIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 77/294 (26%)

Query: 150 ELGKE----VGRGH-FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           ELG++    V +GH FG         GE + Q VA+K + K K    +  E+ + E  ++
Sbjct: 12  ELGEDRFGKVYKGHLFGTA------PGE-QTQAVAIKTL-KDKAEGPLR-EEFKHEA-MM 61

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY----TEEDAKA---- 256
           ++   H ++V           + ++   C   +L + ++ R        T++D       
Sbjct: 62  RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 257 -------IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
                  IV QI + + F     VVH+DL   N L     D  ++++ D GL        
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGL-------- 170

Query: 310 RLNDIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWA 355
              ++  + YY            ++PE +++  +S+++DIWS GV+ + +   G +P+  
Sbjct: 171 -FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229

Query: 356 RTESGIF-----RAVLRSDPNFDDLP-------------WPSVSPEAKDFVKRL 391
            +   +      R VL   P  DD P             +PS  P  KD   RL
Sbjct: 230 YSNQDVIEMIRNRQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 20/46 (43%), Positives = 30/46 (65%), Gaps = 3/46 (6%)

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
           K ++ Q+L+ +   H  G+VHRD+KPEN L T    D  +++IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354

Length = 507

>gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional

 Score = 41.7 bits (98), Expect = 7e-04
 Identities = 39/181 (21%), Positives = 49/181 (27%), Gaps = 16/181 (8%)

Query: 17  TTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPA 76
            T   +T+   S + +    P  T   G +    T    + P P   P         LPA
Sbjct: 37  LTPLGSTSEATSEDDDDLYPPRETGSGGGVA---TSTIYTVPRPPRGPEQTLDKPDSLPA 93

Query: 77  GVSPSPARASTPRRFFRRPFPPPSPAKHI----------KASLAKRLGGGKPKESTIPEE 126
                P     P   FR    P   A                LA         E    EE
Sbjct: 94  SRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEE 153

Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
             + P  S        KN G  Y  G    + H     S   KK   K +   V   S+ 
Sbjct: 154 EHSRPPPS---ESLKVKNGGKVYPKGFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQL 210

Query: 187 K 187
           K
Sbjct: 211 K 211

Length = 580

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 12/101 (11%)

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           Q+ + + F   +  VHRDL   N L   G+    +++ DFGL+ D +R    ++   GS 
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISK--GST 301

Query: 319 Y----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           +    ++APE + +  Y+  +D+WS G++ + I   G  P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 12/101 (11%)

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSA 318
           Q+   + F   +  +HRD+   N L T GR     ++ DFGL+  I  D   N +V G+A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDS--NYVVKGNA 274

Query: 319 Y----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
                ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 22/129 (17%)

Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDAD--- 293
           LLD I+ + G ++      I+ Q    + + H +  ++H DLKPEN L  +     D   
Sbjct: 218 LLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276

Query: 294 ----------MRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV-LHRSYSLEADIWSIG 340
                     +R+ D G       DER +   IV + +Y +PEV L   +    D+WS+G
Sbjct: 277 NRALPPDPCRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332

Query: 341 VISYILLCG 349
            I Y L  G
Sbjct: 333 CIIYELYTG 341

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 18/113 (15%)

Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           D  AI   +L  + + H   ++HRD+K EN          D+ L DFG + F        
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINH---PGDVCLGDFGAACFPV------ 233

Query: 313 DIVGSAYY--------VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           DI  + YY         APE+L R  Y    DIWS G++ + +       + +
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286

Length = 391

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 14/112 (12%)

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T ED      Q+   + F   +  +HRDL   N L +   ++  +++ DFGL+  I  D 
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 228

Query: 310 RLNDIV--GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              D V  GSA     ++APE +  + Y+ ++D+WS GV+ + I   G+ P+
Sbjct: 229 ---DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 18/114 (15%)

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
           T ED  +   Q+   + F   +  +HRDL   N L +   ++  +++ DFGL+       
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 227

Query: 303 DFIRP-DERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D++R  D RL        ++APE +  + Y+ ++D+WS GV+ + I   G+ P+
Sbjct: 228 DYVRKGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 56/261 (21%), Positives = 101/261 (38%), Gaps = 60/261 (22%)

Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
           Q VA+K +    +       + ++E  ++  L  H ++V           V ++ E    
Sbjct: 35  QLVAIKTLKD--INNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQ 91

Query: 236 GELLDRILARG-----GRYTEEDAKA-----------IVVQILSVVAFCHLQGVVHRDLK 279
           G+L + ++ R      G  ++ED              I +QI + + +      VH+DL 
Sbjct: 92  GDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLA 151

Query: 280 PENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY------------VAPE-VL 326
             N L     +   +++ D GLS          +I  + YY            + PE ++
Sbjct: 152 ARNILIG---EQLHVKISDLGLS---------REIYSADYYRVQPKSLLPIRWMPPEAIM 199

Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSD--PNFDDLP------- 376
           +  +S ++DIWS GV+ + I   G +P++  +   +   V +    P  +D P       
Sbjct: 200 YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLM 259

Query: 377 ---W---PSVSPEAKDFVKRL 391
              W   PS  P  KD   RL
Sbjct: 260 TECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 35/182 (19%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI------SIEDVR 198
            G ++++ K +G G FG     +       + Q   KI +    T  +      +I D+ 
Sbjct: 10  TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDID 69

Query: 199 REVKILKALSGHKHL----------VKFCDACEDVNNVYIVME-LCEG-GELLDRILARG 246
           + + + K +    HL           K C     +   +I++E L E   E+  RI    
Sbjct: 70  K-IALWKNIHNIDHLGIPKYYGCGSFKRCR----MYYRFILLEKLVENTKEIFKRIKC-- 122

Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGL-SD 303
               ++  K I+  +L+ + + H  G+ H D+KPEN +      D + R  +ID+G+ S 
Sbjct: 123 --KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV-----DGNNRGYIIDYGIASH 175

Query: 304 FI 305
           FI
Sbjct: 176 FI 177

Length = 294

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKALS 208
           LG+ +G G FG      G    L   Q  +K+  K    TA S E   +  E+KI+  L 
Sbjct: 41  LGRILGSGAFGKV--VEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG 98

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
            H ++V    AC     +YI+ E C  G+L++
Sbjct: 99  PHLNIVNLLGACTKSGPIYIITEYCFYGDLVN 130

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 28/211 (13%)

Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           + RG  G +   +  K  +   Q  VK I+      +  I D+ +    L+    H ++V
Sbjct: 698 ISRGKKGASYKGKSIKNGM---QFVVKEINDVNSIPSSEIADMGK----LQ----HPNIV 746

Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--- 271
           K    C      Y++ E  EG   L  +L R   +  E  + I + I   + F H +   
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKN-LSEVL-RNLSW--ERRRKIAIGIAKALRFLHCRCSP 802

Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
            VV  +L PE  +   G+D+  +RL    L   +  D        S+ YVAPE    +  
Sbjct: 803 AVVVGNLSPEKIII-DGKDEPHLRL---SLPGLLCTD---TKCFISSAYVAPETRETKDI 855

Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGI 361
           + ++DI+  G+I   LL G  P  A  E G+
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP--ADAEFGV 884

Length = 968

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.1 bits (92), Expect = 0.004
 Identities = 27/81 (33%), Positives = 36/81 (44%), Gaps = 13/81 (16%)

Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
           D     IVME   G +L D +         E    +V ++  +VA  H  G+VH DL   
Sbjct: 407 DPEEKTIVMEYIGGKDLKDVL---------EGNPELVRKVGEIVAKLHKAGIVHGDLTTS 457

Query: 282 NFLFTSGRDDADMRLIDFGLS 302
           NF+      D  + LIDFGL 
Sbjct: 458 NFI----VRDDRLYLIDFGLG 474

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	422
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10345	210	hypothetical protein; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.53
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.43
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.2
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.99
PRK09902	216	hypothetical protein; Provisional	98.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.71
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.68
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.49
PLN02876	822	acyl-CoA dehydrogenase	98.45
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.4
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.15
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.03
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.0
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.98
KOG2270	520	consensus Serine/threonine protein kinase involved	97.86
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.76
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.69
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.66
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.66
PRK05231	319	homoserine kinase; Provisional	97.63
PLN02236	344	choline kinase	97.41
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.37
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.33
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.31
PRK10593	297	hypothetical protein; Provisional	97.21
PLN02756	418	S-methyl-5-thioribose kinase	97.13
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.09
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.87
KOG1924	1102	consensus RhoA GTPase effector DIA/Diaphanous [Sig	96.85
PRK11768	325	serine/threonine protein kinase; Provisional	96.7
PRK12396	409	5-methylribose kinase; Reviewed	96.64
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.57
PTZ00384	383	choline kinase; Provisional	96.51
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.33
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.25
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.92
PTZ00296	442	choline kinase; Provisional	95.61
COG2334	331	Putative homoserine kinase type II (protein kinase	95.55

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-62  Score=453.43  Aligned_cols=271  Identities=35%  Similarity=0.568  Sum_probs=245.3

Q ss_pred             CcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchh----cHHHHHHHHHHHHHhcCCCCeeE
Q 014559          140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI----SIEDVRREVKILKALSGHKHLVK  215 (422)
Q Consensus       140 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~  215 (422)
                      .+.+.+.+.|.+.+.||+|+||.|-+|..++   +|+.||||++.+.+.....    ....+++|+++|++|+ |||||+
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~  240 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVR  240 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEE
Confidence            4456678889999999999999999999998   9999999999886654422    3345789999999998 999999


Q ss_pred             EEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          216 FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       216 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      ++++|+..+..||||||++||+|.+.+... +.+.+...+.+++||+.||.|||++||+||||||+|||+..++++..+|
T Consensus       241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             EeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence            999999999999999999999999988654 5789999999999999999999999999999999999998866788999


Q ss_pred             EeecCcccccCCCCCccccccCCcccCccccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcCCC
Q 014559          296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDP  370 (422)
Q Consensus       296 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~  370 (422)
                      |+|||+|++......+.+.|||+.|.|||++..    .+..++|+||||||||-+++|.+||.+..... ..++|..+..
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            999999999988888999999999999999863    35669999999999999999999998766555 8899999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .+....|..+++++.+||.+||..||++|+++.|+|+|+||+...
T Consensus       400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999899999999999999999999999999999999999999543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-59  Score=449.81  Aligned_cols=253  Identities=33%  Similarity=0.592  Sum_probs=238.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|+.++.||+|||+.||.+++..   +|+.||+|++.+.........+++.+||+|.++|+ |||||+|+++|++.+++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV   93 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV   93 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence            579999999999999999999976   89999999999988888888899999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||+|+|+.++|.++++ +.+.++|.+++.+++||+.||.|||+++|||||||..|+||+   ++.+|||+|||||..+.
T Consensus        94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeec
Confidence            99999999999988765 667899999999999999999999999999999999999994   68899999999999887


Q ss_pred             C-CCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 P-DERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      . +++..+.|||+.|.|||++.+ .++..+||||+|||||-||.|++||...+-.+++..|...+..++.    .++.++
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A  245 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA  245 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence            4 478889999999999999874 7999999999999999999999999999999999999999988877    799999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++||.+||+.||.+|||+.++|.|.||
T Consensus       246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  246 KDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            999999999999999999999999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=416.69  Aligned_cols=263  Identities=28%  Similarity=0.579  Sum_probs=240.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+++.+.   +++.||+|++++.........+...+|..||.+++ ||+||+++..|.+.+.+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeE
Confidence            479999999999999999999886   99999999999988888778889999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc-c
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-I  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~-~  305 (422)
                      |||+||+.||.|..++ ++.+.|++..++.++.+|+.||.|||++|||||||||+||||   |++|+++|+|||+++. .
T Consensus       101 ylVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcc
Confidence            9999999999999877 445789999999999999999999999999999999999999   5799999999999984 4


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ..+....++|||+.|||||++. ..|+..+|+|||||++|||++|..||.+.+...+++.|...+.....   ..++.++
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~a  253 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEA  253 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHH
Confidence            4456677789999999999976 58999999999999999999999999999999999999998833332   1489999


Q ss_pred             HHHHHHhchhccccCC----CHHHHHhccCccchhhhhhh
Q 014559          385 KDFVKRLLNKDYRKRM----TAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rp----s~~elL~~l~~~~l~~k~~~  420 (422)
                      +++|+++|..||++|.    ++.++-+|+||..+.|+.+.
T Consensus       254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL  293 (357)
T ss_pred             HHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence            9999999999999995    79999999999999998764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-57  Score=412.37  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=224.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-e
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-N  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~  225 (422)
                      .+.+.++.||+|+.|+||+++++.   +++.+|+|++...  .+.....++.+|+++++.+. |||||++||.|..++ .
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCce
Confidence            456788999999999999999998   8999999999433  23345578999999999995 999999999999999 5


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ++|+||||++|+|.+.+.. .++++|..+.+++.++++||.|||+ ++||||||||+|||++.   .|.|||||||.++.
T Consensus       153 isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs---kGeVKicDFGVS~~  228 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS---KGEVKICDFGVSGI  228 (364)
T ss_pred             EEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc---CCCEEeccccccHH
Confidence            9999999999999887654 4789999999999999999999996 89999999999999964   99999999999987


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHcCCCC-CCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR-----TESGIFRAVLRSDPN-FDDLPW  377 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~-~~~~~~  377 (422)
                      +... ..++++||..|||||.+.+ .|+.++||||||++++|+++|+.||...     ...+++..|+...+. ++.   
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~---  304 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE---  304 (364)
T ss_pred             hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc---
Confidence            7644 6688999999999999986 7999999999999999999999999774     445677777775443 333   


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ..+|++|++||..||++||.+|+++.|+|+|+|+.....
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            259999999999999999999999999999999986544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=413.06  Aligned_cols=260  Identities=34%  Similarity=0.618  Sum_probs=233.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+.++||+|+||+||+|++++   ++..||||.+.+... .....+.+..||.+|+.|+ |+|||.|++++.+.+.+
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence            469999999999999999999998   789999999988764 4446678899999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC---CCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD---ADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~---~~vkl~DfG~a~  303 (422)
                      |||||||+||+|.+++..+ +.+++..++.++.||+.||++||+++||||||||+||||+....+   -.+||+|||+|+
T Consensus        85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999998766 479999999999999999999999999999999999999874233   579999999999


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .+..+....+.||++.|||||+++ +.|+.|+|+||+|+|||+|++|+.||...+..+++..+.++....+... ..++.
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~  242 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSN  242 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccC
Confidence            999888889999999999999985 7899999999999999999999999999999999887777665544332 25677


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ...+++...|..++.+|.+..+.+.+.+++.
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence            7889999999999999999999999877653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-56  Score=424.42  Aligned_cols=263  Identities=31%  Similarity=0.578  Sum_probs=242.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+++.||+|+|++|++|+++.   +++.||||++.+.-...+....-+.+|-.+|.+|.+||.|++||-.|.|...+
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             hhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            369999999999999999999998   89999999998877666666777889999999998899999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+|+||+++|+|+++|.+. +.|++...+.++.||+.||+|||++|||||||||+||||   |+++++||+|||.|+.+.
T Consensus       150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence            9999999999999998665 789999999999999999999999999999999999999   579999999999998765


Q ss_pred             CCCC--------------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          307 PDER--------------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       307 ~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      +...              ..+++||..|.+||+|.. ..+..+|||+||||||+|+.|.+||.+.++..++++|+..+..
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            3321              245899999999999974 6789999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhhh
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~~  420 (422)
                      |++    +.+++++|||+++|..||.+|+++.|+-+|+||..+.|+.+.
T Consensus       306 fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  306 FPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             CCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence            887    789999999999999999999999999999999999998753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3e-56  Score=395.85  Aligned_cols=263  Identities=28%  Similarity=0.467  Sum_probs=230.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|+.+.++|+|+||.||+++++.   +|+.||||++..+. .+....+-..|||++|++|+ |+|+|.|+++|.....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence            368899999999999999999998   99999999986543 33334455789999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||+|||+. ++++.+......++.+.+..++.|++.|+.|||++++|||||||+||||+.   ++.+||||||+|+.+.
T Consensus        77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~---~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ---NGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec---CCcEEeccchhhHhhc
Confidence            999999987 777777777677999999999999999999999999999999999999974   8999999999999887


Q ss_pred             -CCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----------
Q 014559          307 -PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----------  373 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------  373 (422)
                       ++...+.++.|.||+|||.+-+  .|+..+||||+||++.||++|.+.|.+..+.+++..|...-..+.          
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             6777888999999999998865  699999999999999999999999999988888776654322211          


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          374 -----------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       374 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                                       +..++.++.-+.||+++||..||.+|++.+|+|.|.+|+.+..|.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~  294 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERE  294 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHH
Confidence                             112456788899999999999999999999999999998877763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-55  Score=385.91  Aligned_cols=259  Identities=30%  Similarity=0.570  Sum_probs=241.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||.|+||+|.+++.+.   +|..||+|++++.+.......+...+|..+|+.+. ||+++++++.|.+.+++
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeE
Confidence            469999999999999999999998   78999999999988888888899999999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||+.||.|..++.+ .++|++..++.++.||+.||+|||+++|++|||||+||||   |.+|.+||+|||+|+...
T Consensus       120 ymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEec
Confidence            999999999999998754 4689999999999999999999999999999999999999   569999999999998875


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .  ++.+.|||+.|+|||++. +.|+.++|+|||||++|||+.|..||...+...++++|+.++..++.    .++.+++
T Consensus       196 ~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~k  269 (355)
T KOG0616|consen  196 G--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAK  269 (355)
T ss_pred             C--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHH
Confidence            3  377899999999999876 68999999999999999999999999999999999999999999987    6899999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      +||+++|+.|-.+|.     ...++..|+||+.+.|.-+
T Consensus       270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             HHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            999999999999993     5678999999999988654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-54  Score=412.07  Aligned_cols=267  Identities=30%  Similarity=0.482  Sum_probs=239.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      -.++|++++.||+|+||.||+|+-+.   +|+.||+|+++++.+.....++.++.|-.+|... ++++||+||-.|.+..
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKE  214 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCC
Confidence            44679999999999999999999887   9999999999999998888899999999999996 5999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ++||||||++||++..+|.. .+.|+++.++.++.+++.|++.||+.|+|||||||+|+||   |..|++||+||||+.-
T Consensus       215 ~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTG  290 (550)
T ss_pred             eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccch
Confidence            99999999999999887654 5789999999999999999999999999999999999999   5799999999999842


Q ss_pred             cCC----------------------C--C-----C-------------------ccccccCCcccCccccCc-cCCCchh
Q 014559          305 IRP----------------------D--E-----R-------------------LNDIVGSAYYVAPEVLHR-SYSLEAD  335 (422)
Q Consensus       305 ~~~----------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~~-~~~~~~D  335 (422)
                      +..                      .  .     .                   ....+||+.|+|||++.+ .|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            210                      0  0     0                   012579999999999874 7999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHHhccCcc
Q 014559          336 IWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVP  412 (422)
Q Consensus       336 vwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~  412 (422)
                      +|||||||||||.|.+||.+.+..+++++|.+....+.......++++++|||.+||+ ||++|..   ++|+-+|+||.
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK  449 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence            9999999999999999999999999999999988666555555789999999999999 9999995   99999999999


Q ss_pred             chhhhhhh
Q 014559          413 ILSFKIVC  420 (422)
Q Consensus       413 ~l~~k~~~  420 (422)
                      .+.|..++
T Consensus       450 ~v~W~~l~  457 (550)
T KOG0605|consen  450 GVDWDHLR  457 (550)
T ss_pred             cCCcchhh
Confidence            99998775

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=409.38  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=230.8

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .....+.|+.+++||+|+||.||+|++..   +|+.||+|+++.+..... ...-..+||.||++|. ||||++|.+...
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~-HpNIikL~eivt  186 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKEG-FPITAIREIKILRRLD-HPNIIKLEEIVT  186 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcC-CCcccceeeEEE
Confidence            34455679999999999999999999987   999999999987654443 2345678999999997 999999999988


Q ss_pred             eC--CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          222 DV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       222 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                      +.  +.+|||+|||++ +|.-++....-.|++.+|+.|++||+.||+|||.+||+|||||.+||||   |.+|.+||+||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDF  262 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADF  262 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccc
Confidence            77  789999999988 8888877767789999999999999999999999999999999999999   56999999999


Q ss_pred             CcccccCCCC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          300 GLSDFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       300 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      |||+++....  ..+..+.|+||+|||+|.+  .|+.++|+||.||||.||++|++.|.+.++.+++..|.+......+.
T Consensus       263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence            9999776554  4677899999999999875  69999999999999999999999999999999999998866655554


Q ss_pred             CCC-------------------------CCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          376 PWP-------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       376 ~~~-------------------------~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .|+                         .++....+|+..||+.||.+|.||.++|.+.||
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            443                         235788999999999999999999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-55  Score=412.19  Aligned_cols=261  Identities=31%  Similarity=0.446  Sum_probs=230.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +.++|.++++||.|+||.||+|+.+.   +|+.||||.+++.-...+  .-.-.||+..|++|+.|||||+|.+++.+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            44689999999999999999999887   889999999976433321  1223589999999977999999999999988


Q ss_pred             -eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 -NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                       .+|+|||||+. +|++++..++..|++..|+.|+.||+.||+|+|.+|+.|||+||+|||+..   ...|||+|||+|+
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAR  158 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccc
Confidence             99999999986 999999999889999999999999999999999999999999999999953   7789999999999


Q ss_pred             ccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC-----
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-----  376 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  376 (422)
                      .+......+.++.|.||+|||++.  +.|+.++||||+|||++|+++-++.|.+..+.+++.+|+.--.......     
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            998888899999999999999875  5799999999999999999999999999999998888875333222211     


Q ss_pred             ---------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          377 ---------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       377 ---------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                           .+..+.++.++|.+||.|||.+||||.|+|+|+||+.-
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence                                 23467999999999999999999999999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-53  Score=408.80  Aligned_cols=257  Identities=37%  Similarity=0.698  Sum_probs=233.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch--hcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ...|++++.||+|+||.|++|++..   +++.||+|++.+......  ...+.+.+|+.+++.++.||||+++++++...
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4579999999999999999999887   789999998876532211  34567789999999997799999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC-CCEEEeecCcc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD-ADMRLIDFGLS  302 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~-~~vkl~DfG~a  302 (422)
                      ..+|+|||||.||+|++++.. .+++.+.+++.+++||+.|++|||++||+||||||+|||++   .+ +++||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEeccccc
Confidence            999999999999999999988 68899999999999999999999999999999999999995   45 99999999999


Q ss_pred             ccc-CCCCCccccccCCcccCccccCc-c-C-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          303 DFI-RPDERLNDIVGSAYYVAPEVLHR-S-Y-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       303 ~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ... .......+.|||+.|+|||++.+ . | +.++||||+||+||.|++|+.||...+...++..|..+...++.    
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----  244 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----  244 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----
Confidence            987 56677899999999999999975 3 5 58899999999999999999999998889999999998888887    


Q ss_pred             CC-CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          379 SV-SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       379 ~~-s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .+ +.++++||++||..||.+|+++.+++.|+||+.
T Consensus       245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            35 999999999999999999999999999999986

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-55  Score=380.56  Aligned_cols=265  Identities=35%  Similarity=0.666  Sum_probs=246.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .|.++|++.+.||+|.|+.|+++.+..   +|+.+|+|++...++... ..+++.+|++|-+.|+ |||||+|.+.+.+.
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEE   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence            466789999999999999999998776   899999999987766554 6688999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +..|||+|+++|++|..-|..+ ..+++..+-.+++||+++|.|+|.+||||||+||+|+|+.+.+...-+||+|||++.
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999999999998777666 458999999999999999999999999999999999999987777889999999999


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .+..+.....++||+.|||||++.+ .|+..+|||+-|||||-|+.|.+||++.+...+++.|..+...++...|+.+++
T Consensus       162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence            8887777888999999999999975 799999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++++||++||..||.+|.|+.|+|.|+|...-
T Consensus       242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            99999999999999999999999999998753

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-53  Score=406.05  Aligned_cols=269  Identities=53%  Similarity=0.892  Sum_probs=251.6

Q ss_pred             cCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       141 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      ....+...|++.+.||+|.||.||+++.+.   +|+.+|+|++.+.........+.+.+|+.+|++|.+|||||.++++|
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345667789999999999999999999987   79999999999887776666789999999999998899999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC-CCCEEEeec
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDF  299 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~-~~~vkl~Df  299 (422)
                      ++...+++|||+|.||.|.+.+...  .+++..+..++.|++.++.|||+.||+||||||+|+|+...++ ++.+|++||
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999999999999887  3999999999999999999999999999999999999987443 458999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      |++.+...+......+||+.|+|||++. ..|+..+||||+||++|.|++|..||++.++......|..++..+....|.
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence            9999888877888999999999999998 689999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++..+++||++||..||.+|+++.++|+|+|+...
T Consensus       264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999999999999998754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.6e-54  Score=373.80  Aligned_cols=258  Identities=28%  Similarity=0.489  Sum_probs=230.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|...++||+|.||.||+|++.+   +|+.||||+++..+..+... ....|||+.|+.++ |+||+.++++|...+.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence            368889999999999999999988   99999999998876554433 45678999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      .||+||++. +|...+..+...++..+++.|+.++++||+|||++.|+||||||+|+|++   .+|.+||+|||+++.+.
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccC
Confidence            999999976 99999988888899999999999999999999999999999999999996   49999999999999876


Q ss_pred             CCCC-ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC---
Q 014559          307 PDER-LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV---  380 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---  380 (422)
                      .... ....+.|.||+|||.+.+  .|+..+||||.|||+.||+.|.+-|.+.++-+++..|...-....+..|+++   
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            5444 344588999999999864  6999999999999999999999999999999999999886666555555443   


Q ss_pred             ---------------------CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 ---------------------SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 ---------------------s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                           ++++.||+.+||..||.+|+++.|+|+|.||..
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                                 478899999999999999999999999999874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-53  Score=416.17  Aligned_cols=261  Identities=26%  Similarity=0.483  Sum_probs=242.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|.+++.||+|+||.|++|..+.   +++.||||+++++.......++.+..|.+|+....+||.++.++..|.+..++
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            479999999999999999999988   88999999999999888888999999999999998899999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+.||++..+  .+.+.|++..++.|+.+|+.||.|||++||||||||.+||||   |.+|.+||+||||++...
T Consensus       445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence            999999999995443  344689999999999999999999999999999999999999   569999999999998654


Q ss_pred             -CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 -PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                       .+....++|||+.|||||++.+ .|+..+|+|||||+|||||.|..||.++++++++..|+..++.++.    .++.|+
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea  595 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEA  595 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHH
Confidence             6677889999999999999975 7999999999999999999999999999999999999999999887    699999


Q ss_pred             HHHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      .++++++|.+||++|..     +.++.+|+||.-+.|.-+
T Consensus       596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence            99999999999999995     589999999999988754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-55  Score=383.54  Aligned_cols=254  Identities=28%  Similarity=0.514  Sum_probs=220.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEe-EEEeC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD-ACEDV  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~~  223 (422)
                      ...+|+++++||+|+||.||++.+..   +|..||.|.+.-+. -+....+.+..|+.+|++|+ |||||++++ .|.++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~   91 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIED   91 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhcc
Confidence            34579999999999999999999987   89999999997433 44556678999999999997 999999998 55555


Q ss_pred             Ce-EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCcEEEeeCCCCCCEE
Q 014559          224 NN-VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHL--QG--VVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       224 ~~-~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~--~~--iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      +. ++||||||++|+|.+.+..   ....+++..+|+++.|++.||..||.  ..  |+||||||.||+|+   .+|.||
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvK  168 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVK  168 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCcee
Confidence            54 9999999999999887753   44679999999999999999999999  44  99999999999995   599999


Q ss_pred             EeecCcccccCCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          296 LIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       296 l~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      |+|||+++++..... ..+.+||+.||+||+++ ..|++++||||+||++|||+.-..||.+.+-.++..+|.+++..  
T Consensus       169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--  246 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--  246 (375)
T ss_pred             eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--
Confidence            999999998876544 45689999999999987 58999999999999999999999999999888999999888543  


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+-..+|.++..+|..|++.|+++||+...++.+
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            22223689999999999999999999997655554

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=371.63  Aligned_cols=257  Identities=29%  Similarity=0.570  Sum_probs=238.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|.||.||+|+.++   ++..||+|++.+++.........+.+|++|...|+ ||||+++|++|.+...+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRI   97 (281)
T ss_pred             hhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecccee
Confidence            579999999999999999999998   78899999999988888778889999999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ||++||...|+|+..+.. +..++++...+.++.|++.||.|||.++||||||||+|+|++.   .+.+||+|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~---~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC---CCCeeccCCCceeec
Confidence            999999999999998864 4467999999999999999999999999999999999999964   889999999999544


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                       +..+..+.|||..|++||+..+ .++..+|+|++|++.||++.|..||......+.+++|.+.+..++.    .++.++
T Consensus       175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a  249 (281)
T KOG0580|consen  175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGA  249 (281)
T ss_pred             -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhH
Confidence             4677788999999999999875 7999999999999999999999999999999999999999988885    799999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      +|+|.+||.++|.+|....|++.|+|.....
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~  280 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMDHPWIVANG  280 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence            9999999999999999999999999986543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=401.30  Aligned_cols=258  Identities=31%  Similarity=0.532  Sum_probs=225.1

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+-...|....+||+|..|.||.|+...   +++.||||.+...+...   .+-+.+|+.+|+.++ |+|||++++.|..
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~-H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPK---KELLLNEILVMRDLH-HPNIVNFLDSYLV  341 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCCc---hhhhHHHHHHHHhcc-chHHHHHHHHhcc
Confidence            4445678899999999999999999887   88899999997765443   367899999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+|+||||++||+|.|.+...  .++|.+|..|+++++.||+|||.+||||||||.+|||++   .+|.+||+|||++
T Consensus       342 ~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFc  416 (550)
T KOG0578|consen  342 GDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFC  416 (550)
T ss_pred             cceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeee
Confidence            99999999999999999987543  599999999999999999999999999999999999995   5888999999999


Q ss_pred             cccCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH-cCCCCCCCCCCCC
Q 014559          303 DFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL-RSDPNFDDLPWPS  379 (422)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  379 (422)
                      ..+.... ...+.+||++|||||++. +.|++|+||||||++++||+.|.+||...+...-+..|. ++.+.+..  +..
T Consensus       417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~--~~k  494 (550)
T KOG0578|consen  417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN--PEK  494 (550)
T ss_pred             eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC--ccc
Confidence            8776554 567789999999999987 579999999999999999999999998765544444444 34444433  237


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +|.+|++|+.+||+.|+++|++|.|||+|+||+..
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999999999653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-53  Score=407.74  Aligned_cols=255  Identities=31%  Similarity=0.556  Sum_probs=236.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .-|++++-||.|+-|.|-+|++..   +|+.+|||++.+...........+++||-||+.|. ||||+++|++|+++.++
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceE
Confidence            359999999999999999999887   99999999998875555555678999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+|+||++||.|.+++..+ +.+.+.++.++++||+.|+.|||..+|+||||||+|+||   |.++++||+|||+|..-.
T Consensus        88 ylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeeccc
Confidence            9999999999999998766 579999999999999999999999999999999999999   457779999999998877


Q ss_pred             CCCCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ++.-..+.||++.|.+||++++ . .+.++||||.|||||.||+|++||.+++...++.++..+....+.    .++.++
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~ea  239 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEA  239 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHH
Confidence            7888899999999999999986 3 589999999999999999999999999999999999999988875    799999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||++||..||.+|.|.+|+++|+|+..
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhhCchhhc
Confidence            99999999999999999999999999864

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-53  Score=372.08  Aligned_cols=264  Identities=34%  Similarity=0.599  Sum_probs=240.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-----chhcHHHHHHHHHHHHHhcCCCCeeEEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFC  217 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~  217 (422)
                      +.|-..|.-.+.||+|..+.|-++..+.   +|..+|+|++......     .....+.-.+|+.||+++.+||+|+++.
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            3455678888999999999998888877   8889999999753221     1223455678999999999999999999


Q ss_pred             eEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      ++++.+..+++|+|.|+.|.|.|++... -.+++...++|++||++|++|||.++|+||||||+|||+   |++.++||+
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~is  165 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKIS  165 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEe
Confidence            9999999999999999999999998664 569999999999999999999999999999999999999   579999999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |||+++.+.++++....|||++|+|||.+.       ..|+..+|+|++|||||-|+.|..|||.....-+++.|..++.
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999873       3699999999999999999999999999988899999999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .|....|.+++.+.+|||.+||..||.+|.|++|+|+|+||+-
T Consensus       246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            9999999999999999999999999999999999999999954

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-52  Score=375.33  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=225.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--C
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  224 (422)
                      ++|+.++.|++|+||.||+|++++   +++.||+|+++.++......+. ..+||.+|.+++ |||||.+-.+....  +
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~-H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPIT-SLREINILLKAR-HPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcch-hHHHHHHHHhcC-CCCeeeeEEEEeccccc
Confidence            469999999999999999999998   8999999999877644443333 457999999997 99999998887654  5


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||+. +|...+.....+|...+++.+..|+++||+|||.+.|+|||||++|+|++   ..|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhh
Confidence            79999999987 88888887778899999999999999999999999999999999999996   599999999999997


Q ss_pred             cCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC--
Q 014559          305 IRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS--  379 (422)
Q Consensus       305 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--  379 (422)
                      +... ...+..+.|+||+|||++.+  .|+..+|+||+|||+.||+++++.|.+..+.+++..|........+..|++  
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            7544 45677899999999999864  699999999999999999999999999999999998876544433333322  


Q ss_pred             --------------------------CCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          380 --------------------------VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       380 --------------------------~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                                +++...+|+..+|..||.+|.||.|.|+|.||.-
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence                                      3478899999999999999999999999999865

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-52  Score=399.19  Aligned_cols=253  Identities=30%  Similarity=0.572  Sum_probs=228.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+.+.||+|+||+||+|+.+.   +.+.||+|.+.+... .......+.+|++|++.|+ |||||.++++|+...++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence            368899999999999999999887   899999999988654 3445678999999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+|+|||.| +|..++ ..++.++++.++.++.+++.||.|||+++|+|||+||.|||+   +..+.+|+||||+|+.+.
T Consensus        77 ~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             EEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence            999999987 888765 556789999999999999999999999999999999999999   469999999999999876


Q ss_pred             CCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .+.. .+.+-||+.|||||++. +.|+..+|+||||||+||+++|++||.......+.+.|+..+...+.    .++.++
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f  227 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF  227 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence            5543 45567999999999987 47999999999999999999999999988888888889887776654    799999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||+.+|.+||.+|.+..+++.|+|.+.
T Consensus       228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999998764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-51  Score=380.86  Aligned_cols=266  Identities=29%  Similarity=0.495  Sum_probs=241.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.|++++.||+|.-|+||+|+.+.   ++..+|+|++.+..........+++.|-+||+.+. ||.++.||..|+.+...
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYS  152 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeecccee
Confidence            468999999999999999999987   77899999999988888778888999999999995 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |+|||||.||+|....+++ ++.|++..++.++.+++.||+|||..|||+|||||+||||   .++|+|.|+||.|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccC
Confidence            9999999999999877765 4669999999999999999999999999999999999999   56999999999986321


Q ss_pred             C----------------------------------C-C----------------------CCccccccCCcccCccccCc
Q 014559          306 R----------------------------------P-D----------------------ERLNDIVGSAYYVAPEVLHR  328 (422)
Q Consensus       306 ~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~  328 (422)
                      .                                  . .                      .+.+.++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            0                                  0 0                      11234689999999999986


Q ss_pred             -cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC----HH
Q 014559          329 -SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT----AV  403 (422)
Q Consensus       329 -~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~  403 (422)
                       ..+.++|+|+|||+||||+.|..||.+.+..+.+..|+.....+++.+  .++..++|||+++|.+||.+|..    |.
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchH
Confidence             699999999999999999999999999999999999999999998865  78999999999999999999999    99


Q ss_pred             HHHhccCccchhhhhhhc
Q 014559          404 QALSKLVVPILSFKIVCR  421 (422)
Q Consensus       404 elL~~l~~~~l~~k~~~~  421 (422)
                      |+-+|+||+.+.|-+++.
T Consensus       388 eIK~HpFF~gVnWaLir~  405 (459)
T KOG0610|consen  388 EIKRHPFFEGVNWALIRC  405 (459)
T ss_pred             HhhcCccccCCChhheec
Confidence            999999999999987764

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=388.27  Aligned_cols=258  Identities=32%  Similarity=0.582  Sum_probs=224.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-----------hcHHHHHHHHHHHHHhcCCCCe
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----------ISIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      .-.+|++++.||+|.||.|-+|++..   +++.||||++.+.+....           ...+++.+||.+|++|. |+||
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nV  170 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNV  170 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCe
Confidence            34579999999999999999999987   899999999987543221           23468999999999997 9999


Q ss_pred             eEEEeEEEeC--CeEEEEEEccCCCChHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          214 VKFCDACEDV--NNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       214 v~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      |+|+.+..+.  +.+|||+|||..|.+...  ..... +++.++++|+++++.||+|||.+|||||||||+|+||+   +
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~  245 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---S  245 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---C
Confidence            9999998874  679999999999887542  23334 89999999999999999999999999999999999995   4


Q ss_pred             CCCEEEeecCcccccCCC------CCccccccCCcccCccccCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 014559          291 DADMRLIDFGLSDFIRPD------ERLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTES  359 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~  359 (422)
                      +|.|||+|||.+.....+      ......+||+.|+|||.+.+     ..+.+.||||+||+||.|+.|+.||.+..+.
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            799999999998766322      22445789999999998754     2478899999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       360 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++.+|.+....|+..+  .+.++++|||.+||++||++|.+..++-.|+|...
T Consensus       326 ~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            99999999998888753  68999999999999999999999999999999754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=383.69  Aligned_cols=258  Identities=32%  Similarity=0.521  Sum_probs=213.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  224 (422)
                      .+|..++.||+|+||.||++.+++   +|...|||.+.....   ...+.+.+|+.+|++|+ |||||+++|......  
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDS---PTSESLEREIRILSRLN-HPNIVQYYGSSSSREND   89 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC---CCcceeeeeeecccc---hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCe
Confidence            458889999999999999999987   688999999876521   12577999999999998 999999999855444  


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++|.|||+.+|+|.+.+...++.+++..++.+.+||++||.|||++||||||||++||||+.  .++.+||+|||+++.
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~--~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP--SNGDVKLADFGLAKK  167 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC--CCCeEEeccCccccc
Confidence            699999999999999998876668999999999999999999999999999999999999952  168999999999986


Q ss_pred             cCC----CCCccccccCCcccCccccCcc--CCCchhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHcCCCCCCCCCC
Q 014559          305 IRP----DERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       305 ~~~----~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ...    ........||+.|||||++...  ...++|||||||+++||+||+.||... .....+..+.... ..+.. .
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~i-p  245 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEI-P  245 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCC-C
Confidence            653    1223457899999999998843  234999999999999999999999763 3333333444333 11211 1


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ..++.++++||.+||.+||++||||.++|.|+|+....
T Consensus       246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            26999999999999999999999999999999986643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-51  Score=378.83  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=228.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++...||.|..++||+|+...   +++.||||++..++....  .+.+++|+..|+.++ ||||++++..|..+..+
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEeccee
Confidence            469999999999999999999987   889999999998876654  688999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |+||.||.+|++++.+... ...++|..|..|++++++||.|||.+|.||||||+.||||   +.+|.|||+|||.+-.+
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASL  176 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeee
Confidence            9999999999999988764 2459999999999999999999999999999999999999   56999999999986544


Q ss_pred             CCC-CC----ccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----
Q 014559          306 RPD-ER----LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----  373 (422)
Q Consensus       306 ~~~-~~----~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  373 (422)
                      ... .+    +++++||++|||||+++   ..|+.|+|||||||+..||++|..||.....-.++-.-+++.+...    
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            322 22    25679999999999965   3699999999999999999999999998888777777777666422    


Q ss_pred             --CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          374 --DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       374 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                        ......++..|+.+|..||.+||.+||||.++|+|.||+....+
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence              22233567889999999999999999999999999999876543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-52  Score=380.39  Aligned_cols=258  Identities=33%  Similarity=0.593  Sum_probs=239.1

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+..-+|++.+.||+|.||.|-+|+...   .|+.||||.|++++..+.+..-.+++||+||..|+ ||||+.+|.+|+.
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN  124 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN  124 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence            3455679999999999999999999877   89999999999999999988899999999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+.|||||..+|.|+|++..+ +.+++.+++.+++||+.|+.|||.++++|||||.+|||+   |.++++||+|||++
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS  200 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS  200 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence            99999999999999999998665 579999999999999999999999999999999999999   56999999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ..+.......++||++.|.+||++++ .| ++.+|-|||||+||-|+.|..||.+.+...++++|..+...-+     .-
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~  275 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ET  275 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CC
Confidence            99988888999999999999999986 34 7899999999999999999999999999999999987765444     35


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +.++.-||++||..||++|.|++++..|-|+++
T Consensus       276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             CchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            678999999999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=381.46  Aligned_cols=249  Identities=27%  Similarity=0.438  Sum_probs=213.3

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCce-EEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-eE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-NV  226 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~  226 (422)
                      ..+.+.||+|+||+||++.++     |+. ||||++......... .+.+.+|+.+|.+|+ |||||+|+|++.+.. .+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCce
Confidence            455667999999999999875     445 999999876555444 678999999999997 999999999999987 79


Q ss_pred             EEEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEEeeCCCCC-CEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDA-DMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~-iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~  303 (422)
                      +|||||+++|+|.+++.. +...++...+..++.||++||+|||+++ |||||||++||||+   .++ ++||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccce
Confidence            999999999999999987 4788999999999999999999999999 99999999999995   565 99999999998


Q ss_pred             ccCCC-CCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPD-ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ..... .......||..|||||++.+   .|+.|+|||||||+||||+||+.||...........+..........  ..
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~  270 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KE  270 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--cc
Confidence            76654 34444789999999999984   49999999999999999999999999888766555555433322211  14


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++.+..+|.+||..||.+||+..+++..+
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l  300 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRL  300 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence            899999999999999999999999998753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-49  Score=373.87  Aligned_cols=265  Identities=25%  Similarity=0.405  Sum_probs=221.3

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||+|+||.||+|.+..   +++.||||++.+...........+.+|+.+++.+. |+||+++++++.+.+.+++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~l   77 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEE
Confidence            7888999999999999999887   78999999997655444334456789999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+.+|+|.+.+... ...+++..+..++.|++.||.|||++||+||||||+|||++   +++.+||+|||++.....
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCC
Confidence            99999999998877653 34689999999999999999999999999999999999994   578999999999987654


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      ........|+..|+|||++. ..++.++|||||||++|||++|+.||...........+..............++.++.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (285)
T cd05631         155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS  234 (285)
T ss_pred             CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence            44455668999999999986 47999999999999999999999999876543222222211111111112368999999


Q ss_pred             HHHHhchhccccCCC-----HHHHHhccCccchhhhhhh
Q 014559          387 FVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       387 li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~~  420 (422)
                      ||++||..||.+|++     ++++++|+||+.+.++.+.
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE  273 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence            999999999999997     9999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-49  Score=364.40  Aligned_cols=263  Identities=30%  Similarity=0.461  Sum_probs=226.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEeCC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVN-  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~-  224 (422)
                      ..|..+++||+|+||+||+|+++.   +|+.||+|+++....... .-....+|+.+|+.|+ |+| ||.+++++.+.+ 
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG-~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLS-HANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccC-CCchhhHHHHHHHHhC-CCcceEEEEeeeeeccc
Confidence            358888899999999999999998   889999999987644211 2345679999999998 999 999999999877 


Q ss_pred             -----eEEEEEEccCCCChHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 -----NVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 -----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                           .+++||||++. +|.+++....   ..++...++.++.||+.||+|||+++|+||||||+||||+   ++|.+||
T Consensus        86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKl  161 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKL  161 (323)
T ss_pred             ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEee
Confidence                 89999999976 9999887755   3588899999999999999999999999999999999995   5999999


Q ss_pred             eecCcccccC-CCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          297 IDFGLSDFIR-PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       297 ~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      +|||+|+... +.......++|.+|+|||++.+  .|+...||||+|||++||++++..|.+..+.+++..|...-....
T Consensus       162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            9999998665 4455677889999999999865  599999999999999999999999999999999988877554444


Q ss_pred             CCCCCCC--------------------------CHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          374 DLPWPSV--------------------------SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       374 ~~~~~~~--------------------------s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      +..|+++                          +.+..+++.+||+.+|.+|.|++.+|.|.+|..+..+.
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            4444332                          25899999999999999999999999999998875543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-49  Score=375.77  Aligned_cols=258  Identities=27%  Similarity=0.498  Sum_probs=226.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++...........+.+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   77 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLY   77 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEE
Confidence            68999999999999999999886   78899999997654433344567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          78 MLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhccC
Confidence            999999999999987654 5799999999999999999999999999999999999994   588999999999976543


Q ss_pred             CCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      .  ....+|++.|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......++.    .++.++++
T Consensus       154 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~  227 (291)
T cd05612         154 R--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKD  227 (291)
T ss_pred             C--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHH
Confidence            2  334679999999998864 6899999999999999999999999988888888888877665554    57899999


Q ss_pred             HHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          387 FVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       387 li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      ||++||..||.+|++     +.++++|+||..+.|...
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  265 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV  265 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence            999999999999995     999999999988776543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=366.45  Aligned_cols=261  Identities=32%  Similarity=0.548  Sum_probs=221.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  222 (422)
                      ....|...+.||+|+||.|+.|.++.   +|+.||||++.. .+......++..+|+++|+.++ |+||+.+++.+..  
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPS   94 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccc
Confidence            44567778999999999999999998   889999999863 2445556688899999999998 9999999999865  


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                         -+.+|+|+|+|+. +|...+ +.+..++++.+..++.||++||+|+|+.+|+||||||.|+|++   .+..+|||||
T Consensus        95 ~~~f~DvYiV~elMet-DL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DF  169 (359)
T KOG0660|consen   95 RDKFNDVYLVFELMET-DLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDF  169 (359)
T ss_pred             ccccceeEEehhHHhh-HHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccc
Confidence               3579999999953 777655 4445699999999999999999999999999999999999995   4888999999


Q ss_pred             CcccccCC---CCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC-
Q 014559          300 GLSDFIRP---DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-  373 (422)
Q Consensus       300 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-  373 (422)
                      |+|+....   ...++..+.|.||+|||++.  ..|+.++||||+||||.||++|+..|.+....+++..|+..-+... 
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998764   44567788999999999864  4799999999999999999999999988887777776654333222 


Q ss_pred             ----------------------CCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 ----------------------DLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 ----------------------~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                            ..+    +++.++++.||+.+||..||.+|+|++|+|+|+++....
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence                                  111    457889999999999999999999999999999987543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-49  Score=380.18  Aligned_cols=255  Identities=28%  Similarity=0.516  Sum_probs=222.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +|+.||||++.+...........+.+|+.++++++ |+||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence            469999999999999887   78999999998654444444567788999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +.+++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++... .....
T Consensus        77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~  152 (323)
T cd05571          77 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCCcc
Confidence            999999888754 45799999999999999999999999999999999999994   58899999999987532 23334


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+......++.    .++.++.+||++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~  228 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAG  228 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            5568999999999986 46899999999999999999999999888877777777776665554    689999999999


Q ss_pred             hchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          391 LLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       391 ~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ||+.||++|+     ++.++++|.||..+.|...
T Consensus       229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         229 LLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             HccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            9999999999     8999999999988766544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-49  Score=380.50  Aligned_cols=258  Identities=28%  Similarity=0.519  Sum_probs=227.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|+++.   +++.||||++...........+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRV   93 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEE
Confidence            579999999999999999999887   78899999997655444445577899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        94 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcC
Confidence            999999999999998765 45789999999999999999999999999999999999994   58899999999997654


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      ..  ....+|++.|+|||++. ..++.++|||||||++|||++|+.||.+......+..+......++.    .++.+++
T Consensus       170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  243 (329)
T PTZ00263        170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRAR  243 (329)
T ss_pred             CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHH
Confidence            32  33467999999999986 46899999999999999999999999888877888888777655543    4889999


Q ss_pred             HHHHHhchhccccCCC-----HHHHHhccCccchhhhh
Q 014559          386 DFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKI  418 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~  418 (422)
                      +||++||..||.+|++     +++++.|+||....|+.
T Consensus       244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~  281 (329)
T PTZ00263        244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK  281 (329)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence            9999999999999997     79999999998766654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-50  Score=377.63  Aligned_cols=263  Identities=33%  Similarity=0.600  Sum_probs=241.9

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ...+..-|.+.+-||+|.|..|-+|++-   ++|+.||||++++.++.... ...+.+|++.|+.+. |||||+||++..
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQ-HpNiVRLYEViD   87 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQ-HPNIVRLYEVID   87 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhh---cccceeEEEEecccccchhh-hhHHHHHHHHHHHhc-CcCeeeeeehhc
Confidence            3455667999999999999999999876   49999999999998776543 356888999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      ....+|||+|+-++|+|+|+|.+....++++..++|+.||+.|+.|||+..||||||||+||.+.  ..-|.|||.|||+
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGF  165 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGF  165 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccc
Confidence            99999999999999999999999888899999999999999999999999999999999999987  4689999999999


Q ss_pred             ccccCCCCCccccccCCcccCccccCc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      +..+.++...++.||++.|-|||++.+ .| .+++||||||||||.|++|+.||...++.+.+-.|+..+...+.    .
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----h  241 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----H  241 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----h
Confidence            999999999999999999999999876 45 57899999999999999999999999999999999998887776    7


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++.+.++||..||..||++|.+.+|+..+.|++...
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            999999999999999999999999999999998653

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.7e-49  Score=383.05  Aligned_cols=264  Identities=27%  Similarity=0.457  Sum_probs=223.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++.+...........+.+|+.++..+. |+||+++++.+.+.+.+|
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~   77 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLY   77 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEE
Confidence            68999999999999999999876   78899999998755444445567889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||||++|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus        78 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          78 LIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCcccccc
Confidence            99999999999998765 45799999999999999999999999999999999999994   588999999999875432


Q ss_pred             CC------------------------------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCC
Q 014559          308 DE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS  350 (422)
Q Consensus       308 ~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~  350 (422)
                      ..                                    .....+||+.|+|||++. ..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            11                                    012457999999999986 47999999999999999999999


Q ss_pred             CCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhcccc---CCCHHHHHhccCccchhhhhhh
Q 014559          351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK---RMTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       351 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~---Rps~~elL~~l~~~~l~~k~~~  420 (422)
                      .||.+....+.+..+..............++++++++|.+|++ ++.+   ||+++|+++|+||+...|..++
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~  305 (363)
T cd05628         234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIR  305 (363)
T ss_pred             CCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHH
Confidence            9999888888888887654333322333589999999999876 4544   5899999999999988877653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.7e-48  Score=373.94  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=205.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|+++++||+|+||.||+|++..   +++.||||++....  .......+.+|+++++.++ |+||+++++++.+.+.+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeE
Confidence            357888999999999999999876   78899999986532  2233467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+.     ....+..+..++.||+.||.|||++||+||||||+|||++   +++.+||+|||++....
T Consensus       148 ~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecc
Confidence            999999999987642     2467888999999999999999999999999999999994   58899999999998654


Q ss_pred             CCC-CccccccCCcccCccccCc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ... ......|+..|+|||++..      .++.++|||||||++|||++|+.||......+....+..............
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT  299 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence            332 2345679999999998742      245789999999999999999999974333222221111111111111236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++.++++||.+||..||++||++.|+|+|+|+..-
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            88999999999999999999999999999998764

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-49  Score=385.82  Aligned_cols=262  Identities=29%  Similarity=0.411  Sum_probs=221.2

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-----CCeeEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-----KHLVKF  216 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~l  216 (422)
                      ++.+..+|++.+.||+|+||.|.+|.+.+   +++.||||+++.....    ..+...|+.+|..|+.|     -|||++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm  253 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRM  253 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence            45666789999999999999999999998   8999999999765433    35567899999999833     489999


Q ss_pred             EeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          217 CDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       217 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      +++|...+++|||+|+++. +|+++++... ..++...++.++.||+.||.+||+.||||+||||+||||.. .....||
T Consensus       254 ~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~-~~r~~vK  331 (586)
T KOG0667|consen  254 LDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD-PKRSRIK  331 (586)
T ss_pred             eeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc-CCcCcee
Confidence            9999999999999999965 9999987643 55999999999999999999999999999999999999986 3345899


Q ss_pred             EeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       296 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      |+|||++++....-  -+.+-+..|+|||++.+ .|+.+.||||||||++||++|.+.|.+..+.+++..|.+.....+.
T Consensus       332 VIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  332 VIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             EEecccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            99999998765333  37788999999999765 8999999999999999999999999999998888877543221110


Q ss_pred             C---------------C--------------------------------CC------------CCCHHHHHHHHHhchhc
Q 014559          375 L---------------P--------------------------------WP------------SVSPEAKDFVKRLLNKD  395 (422)
Q Consensus       375 ~---------------~--------------------------------~~------------~~s~~~~~li~~~L~~d  395 (422)
                      .               .                                .+            .-...|.|||++||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence            0               0                                00            01256899999999999


Q ss_pred             cccCCCHHHHHhccCccch
Q 014559          396 YRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       396 P~~Rps~~elL~~l~~~~l  414 (422)
                      |.+|+|+.|+|+|+|+...
T Consensus       490 P~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  490 PAERITPAQALNHPFLTGT  508 (586)
T ss_pred             chhcCCHHHHhcCcccccc
Confidence            9999999999999999844

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=380.86  Aligned_cols=262  Identities=29%  Similarity=0.504  Sum_probs=224.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||+|+||.||+|++..   +++.||||++.............+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~   77 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLY   77 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEE
Confidence            68999999999999999999987   78899999998654444444567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||||.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+..
T Consensus        78 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             EEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceeccc
Confidence            999999999999987654 5799999999999999999999999999999999999994   588999999999865422


Q ss_pred             CC---------------------------------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHH
Q 014559          308 DE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILL  347 (422)
Q Consensus       308 ~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell  347 (422)
                      ..                                       .....+||+.|+|||++. ..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11                                       011346999999999876 47899999999999999999


Q ss_pred             hCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHHhccCccchhhhh
Q 014559          348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVPILSFKI  418 (422)
Q Consensus       348 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~~l~~k~  418 (422)
                      +|..||........+..+......+.......+++++++||++||. +|.+|++   +.|+|.|+||+...|..
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            9999998888777777777655443333333689999999999997 9999998   99999999998877654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-48  Score=374.10  Aligned_cols=261  Identities=29%  Similarity=0.476  Sum_probs=224.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++.+...........+.+|+.++..++ |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~   77 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLY   77 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEE
Confidence            69999999999999999999886   78899999998754444444567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      |||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          78 LAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCccccc
Confidence            99999999999998754 45799999999999999999999999999999999999994   588999999999976543


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC----CCCCH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSP  382 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~  382 (422)
                        .....+|+..|+|||++. ..++.++|||||||++|||++|..||......+.+..+......+....+    ..++.
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~  231 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD  231 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence              345567999999999986 47899999999999999999999999888777777666654332222111    25789


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      ++.+||.+||..+|.+|+++.++++|+||..+.+..
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence            999999999999999999999999999998775543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-48  Score=381.78  Aligned_cols=262  Identities=24%  Similarity=0.434  Sum_probs=220.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+++++.+. |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~   77 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLY   77 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeE
Confidence            68999999999999999999887   88999999997655444445577889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      |||||+++|+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++   .++.+||+|||+++.+..
T Consensus        78 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          78 LIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccc
Confidence            99999999999998764 45799999999999999999999999999999999999994   588999999999863211


Q ss_pred             CCC------------------------------------------------ccccccCCcccCccccC-ccCCCchhHHH
Q 014559          308 DER------------------------------------------------LNDIVGSAYYVAPEVLH-RSYSLEADIWS  338 (422)
Q Consensus       308 ~~~------------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DvwS  338 (422)
                      ...                                                ....+||+.|+|||++. ..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000                                                01246999999999976 47999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccC---CCHHHHHhccCccchh
Q 014559          339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALSKLVVPILS  415 (422)
Q Consensus       339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~elL~~l~~~~l~  415 (422)
                      |||++|||++|..||......+.+..+......+.......++.++++||.+||. +|.+|   +++.|++.|+||....
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999998887777777776543333222233589999999999998 77776   5999999999998765


Q ss_pred             hhh
Q 014559          416 FKI  418 (422)
Q Consensus       416 ~k~  418 (422)
                      +..
T Consensus       313 ~~~  315 (377)
T cd05629         313 WDT  315 (377)
T ss_pred             HHH
Confidence            543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-48  Score=374.75  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=226.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||+|.++..  .+..||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY  105 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence            34799999999999999999987642  34689999997655444445567889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeec
Confidence            9999999999999988754 45799999999999999999999999999999999999994   5889999999999765


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ..  .....+||+.|+|||++.+ .++.++|||||||++|||++|..||........+..+......++.    .+++++
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  255 (340)
T PTZ00426        182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNC  255 (340)
T ss_pred             CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHH
Confidence            43  2345689999999999864 6899999999999999999999999988887788888876655544    588999


Q ss_pred             HHHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          385 KDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      .++|++||..||.+|+     +++++++|+||..+.|..
T Consensus       256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~  294 (340)
T PTZ00426        256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS  294 (340)
T ss_pred             HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            9999999999999996     899999999998776543

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-48  Score=371.43  Aligned_cols=254  Identities=29%  Similarity=0.518  Sum_probs=220.2

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||++++..   +|+.||+|++.............+.+|+.+++.++ ||||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence            469999999999999876   78999999998654444444567788999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .....
T Consensus        77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~  152 (323)
T cd05595          77 ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCCcc
Confidence            999999887654 45799999999999999999999999999999999999994   58899999999987532 22333


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ....|+..|+|||++. +.++.++|||||||++|||++|+.||...........+......++.    .+++++.+||.+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~  228 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG  228 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence            4567999999999986 57899999999999999999999999888877777777766655543    689999999999


Q ss_pred             hchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          391 LLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       391 ~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      ||..||++|+     ++.++++|.||....|..
T Consensus       229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             HccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            9999999998     999999999998776654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-49  Score=349.60  Aligned_cols=256  Identities=36%  Similarity=0.621  Sum_probs=230.8

Q ss_pred             cceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          147 AKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       147 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      ++|.+. ++||-|-.|.|..+..+.   +++.+|+|++...        .+.++|+++.-..++|+|||.++++|+.   
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            456664 578999999999999988   9999999998533        5568899998888899999999998865   


Q ss_pred             -CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          223 -VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       223 -~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                       ...+.+|||.++||.|+..+..++ ..|++.++..|++||+.|+.|||+.+|.||||||+|+|.+....+..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             356899999999999999998765 469999999999999999999999999999999999999887778899999999


Q ss_pred             cccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCCCCCCCC
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  375 (422)
                      +|+.........+.|-|++|.|||++. .+|+..+|+||+||++|-|++|.+||.....    .++-.+|..+...|+..
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999877777788899999999999997 5799999999999999999999999976543    46778899999999999


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .|..+|++++|+|+.+|..+|.+|.|+++++.|+|..-
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence            99999999999999999999999999999999999863

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-48  Score=372.51  Aligned_cols=253  Identities=28%  Similarity=0.502  Sum_probs=219.7

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||++++..   +++.||||++.+...........+.+|+.+++.++ |+||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence            469999999999999877   78999999998654444445567889999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~  311 (422)
                      +++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... ....
T Consensus        77 ~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~  152 (328)
T cd05593          77 VNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATM  152 (328)
T ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccc
Confidence            999999887654 45799999999999999999999999999999999999994   588999999999875332 2333


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++.    .++.++.+||++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~  228 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSG  228 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHH
Confidence            4567999999999986 47899999999999999999999999888777777777666655543    689999999999


Q ss_pred             hchhccccCC-----CHHHHHhccCccchhhh
Q 014559          391 LLNKDYRKRM-----TAVQALSKLVVPILSFK  417 (422)
Q Consensus       391 ~L~~dP~~Rp-----s~~elL~~l~~~~l~~k  417 (422)
                      ||.+||++|+     ++.|+++|+||....|.
T Consensus       229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999997     89999999999876554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-48  Score=369.76  Aligned_cols=252  Identities=28%  Similarity=0.522  Sum_probs=219.8

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|+||.||+|++..   +++.||+|++.............+.+|+.++++++ |+||+++++++.+.+.+|+||||++
T Consensus         1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence            7999999999999876   78899999997654444445567889999999996 9999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCccc
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLND  313 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  313 (422)
                      +|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... ......
T Consensus        77 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          77 GGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCcccc
Confidence            9999998755 45799999999999999999999999999999999999994   588999999999975432 233445


Q ss_pred             cccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 014559          314 IVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL  392 (422)
Q Consensus       314 ~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  392 (422)
                      .+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++.    .++.++++||.+||
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L  228 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL  228 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHc
Confidence            679999999999864 6899999999999999999999999988888888888776665554    68999999999999


Q ss_pred             hhccccCC---CHHHHHhccCccchhhhh
Q 014559          393 NKDYRKRM---TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       393 ~~dP~~Rp---s~~elL~~l~~~~l~~k~  418 (422)
                      ..||.+|+   ++.|+|.|+||....++.
T Consensus       229 ~~dp~~R~~~~~~~e~l~hp~~~~~~~~~  257 (312)
T cd05585         229 SRDPTRRLGYNGAQEIKNHPFFSQLSWKK  257 (312)
T ss_pred             CCCHHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence            99999997   589999999999876543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.4e-48  Score=379.48  Aligned_cols=262  Identities=28%  Similarity=0.454  Sum_probs=219.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++++.||+|+||.||+|++..   +++.||||++.+.........+.+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence            58999999999999999999887   78999999998765545555677899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          78 FVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccc
Confidence            99999999999998755 35699999999999999999999999999999999999994   588999999999753210


Q ss_pred             CC------------------------------------------------CccccccCCcccCccccC-ccCCCchhHHH
Q 014559          308 DE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWS  338 (422)
Q Consensus       308 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwS  338 (422)
                      ..                                                .....+||..|+|||++. ..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            00                                                012357999999999976 46899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchh--ccccCCCHHHHHhccCccchhh
Q 014559          339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK--DYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      |||++|||++|+.||...........+......+....+..+++++++||.+||+.  ++..|+++.|++.|+||..+.+
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            99999999999999988777666666665433333333346899999999996654  4555999999999999987665


Q ss_pred             h
Q 014559          417 K  417 (422)
Q Consensus       417 k  417 (422)
                      .
T Consensus       314 ~  314 (381)
T cd05626         314 S  314 (381)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.6e-48  Score=371.12  Aligned_cols=255  Identities=28%  Similarity=0.499  Sum_probs=221.2

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +++.||||++.+.........+.+..|+.++..+.+|+||+++++++.+.+.+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence            469999999999999876   78899999997654433344566778999998876799999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .....
T Consensus        78 ~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          78 VNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcc
Confidence            999999887754 45799999999999999999999999999999999999994   58899999999987533 22334


Q ss_pred             cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||+.|+|||++.+ .++.++|||||||++|||++|+.||.......++..+......++.    .++.++++||++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~  229 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKA  229 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence            45679999999999864 6899999999999999999999999998888888888876665543    589999999999


Q ss_pred             hchhccccCCCH------HHHHhccCccchhhhh
Q 014559          391 LLNKDYRKRMTA------VQALSKLVVPILSFKI  418 (422)
Q Consensus       391 ~L~~dP~~Rps~------~elL~~l~~~~l~~k~  418 (422)
                      ||+.||.+|+++      ++++.|+||..+.|..
T Consensus       230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~  263 (320)
T cd05590         230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK  263 (320)
T ss_pred             HcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            999999999998      9999999999877644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-47  Score=363.26  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|+++.   +++.||+|+++.....  .....+.+|+.+++.++ |+||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccC--CcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeE
Confidence            369999999999999999999876   7889999998754322  12356778999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeecc
Confidence            999999975 89988877666789999999999999999999999999999999999994   58899999999987543


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----------  373 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------  373 (422)
                      .. .......++..|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+........          
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            22 22344578999999998753  589999999999999999999999988776665554433211100          


Q ss_pred             ---------CC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          374 ---------DL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       374 ---------~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                               ..       ..+.++.++++||++||.+||.+|+|++|+|+|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                     00       013568899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-48  Score=376.96  Aligned_cols=262  Identities=33%  Similarity=0.568  Sum_probs=226.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++.+...........+.+|+.++..++ |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   77 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLY   77 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEE
Confidence            69999999999999999999887   78999999998765444445577889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCcc
Confidence            999999999999988665 6799999999999999999999999999999999999994   588999999999976543


Q ss_pred             CC------------------------------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014559          308 DE------------------------------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       308 ~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                      ..                              ......||..|+|||++.+ .++.++|||||||+||||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                              2334579999999999864 6899999999999999999999999888


Q ss_pred             ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-HHHHHhccCccchhhhh
Q 014559          357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT-AVQALSKLVVPILSFKI  418 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~elL~~l~~~~l~~k~  418 (422)
                      ........+......+.......+++++.+||.+||. ||.+|++ +.++|+|+||....+..
T Consensus       234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence            8777777777633333222233589999999999997 9999999 99999999998776543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.8e-48  Score=377.02  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=224.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++.+.........+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~  117 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKY  117 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCE
Confidence            3579999999999999999999887   78899999997654444444456788999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+|||||++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~  192 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeec
Confidence            9999999999999987754  3689999999999999999999999999999999999994   5899999999999765


Q ss_pred             CCCC--CccccccCCcccCccccCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ....  .....+||+.|+|||++..     .++.++|||||||++|||++|+.||........+..+......+......
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            4332  2345679999999998753     37899999999999999999999999888888888887655443333334


Q ss_pred             CCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSF  416 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~  416 (422)
                      .++.++++||++||..+|.+  |+++.|++.|+||....|
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            68999999999999999988  999999999999986544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-49  Score=359.99  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=220.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..-.|.-.+.+|.|+||.||.|....   +++.||||.+-.+....       .+|+.+|+.+. |||||+|.-+|....
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~k-------nrEl~im~~l~-HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRYK-------NRELQIMRKLD-HPNIVRLLYFFSSST   90 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCcC-------cHHHHHHHhcC-CcCeeeEEEEEEecC
Confidence            33468999999999999999999987   68899999986554322       47999999986 999999998886532


Q ss_pred             -----eEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 -----NVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 -----~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                           .+.+||||++. +|.+.+..   .+.+++.-.++-+..||++||.|||+.||+||||||+|||++.  +.|.+||
T Consensus        91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKi  167 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKI  167 (364)
T ss_pred             CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEe
Confidence                 46789999976 99888764   3567999999999999999999999999999999999999973  6799999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC---
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN---  371 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---  371 (422)
                      ||||.|+.+..++...+...|..|+|||.+.+  .|+.+.||||.|||+.||+.|++.|.+....+++..|.+.-..   
T Consensus       168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            99999999998988888999999999998865  6999999999999999999999999998888877766542211   


Q ss_pred             -----------------CCCCCC-----CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          372 -----------------FDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       372 -----------------~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                       +....|     ..+++++.+|+.++|..+|.+|.++.|+|.|.||+-+..
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                             111122     246899999999999999999999999999999998764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-49  Score=374.94  Aligned_cols=255  Identities=32%  Similarity=0.510  Sum_probs=230.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN-  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  225 (422)
                      ++|..++.||+|+||.+++++++.   .++.|++|.+........ ..+...+|+.+++++. |||||.+.+.|++++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCce
Confidence            579999999999999999999887   778999999988765544 3457889999999997 9999999999999988 


Q ss_pred             EEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ++|||+||+||++.+.+.+.. ..|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.   ++.|||+|||+|+.
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk---~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK---DKKVKLGDFGLAKI  155 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc---cCceeecchhhhhh
Confidence            999999999999999998765 66999999999999999999999999999999999999974   77789999999999


Q ss_pred             cCCCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      +.... ...+.+||+.|+.||++.+ .|+.|+|||||||++|||++-+.+|...+...++..|.+.......   ..++.
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~  232 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSS  232 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccH
Confidence            88776 6778899999999999985 7999999999999999999999999999999999999887733222   26899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +++.+|+.||..+|..||++.++|.++.+.
T Consensus       233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  233 ELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            999999999999999999999999996554

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-47  Score=368.20  Aligned_cols=260  Identities=25%  Similarity=0.454  Sum_probs=224.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++.+.........+.+..|++++..+..|++|+++++++.+.+.+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   77 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence            48899999999999999999876   788999999987544444455678889999999974567999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-  306 (422)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... 
T Consensus        78 lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          78 FVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCC
Confidence            99999999999988754 35689999999999999999999999999999999999994   58899999999986432 


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      ........+||..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+......++.    .++.++.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~  229 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAV  229 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHH
Confidence            2233445679999999999864 6899999999999999999999999988888888888876665544    6899999


Q ss_pred             HHHHHhchhccccCCCH-----HHHHhccCccchhhhh
Q 014559          386 DFVKRLLNKDYRKRMTA-----VQALSKLVVPILSFKI  418 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~-----~elL~~l~~~~l~~k~  418 (422)
                      ++|++||..||.+|++.     .++++|+||....|..
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~  267 (324)
T cd05587         230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK  267 (324)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            99999999999999976     8999999998776643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.7e-48  Score=379.36  Aligned_cols=263  Identities=29%  Similarity=0.476  Sum_probs=222.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||+|+||.||+|++..   +++.||||++.+...........+.+|+.+++.+. |+||+++++.+.+++.+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~   77 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY   77 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEE
Confidence            69999999999999999999887   78999999997654433444567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+..
T Consensus        78 lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccc
Confidence            999999999999987554 5689999999999999999999999999999999999994   588999999999743210


Q ss_pred             C--------------------------------------------CCccccccCCcccCccccCc-cCCCchhHHHHHHH
Q 014559          308 D--------------------------------------------ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVI  342 (422)
Q Consensus       308 ~--------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~i  342 (422)
                      .                                            ......+||+.|+|||++.+ .++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                            00123579999999999864 68999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHHhccCccchhhhhh
Q 014559          343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       343 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~elL~~l~~~~l~~k~~  419 (422)
                      +|||++|+.||......+....+...........+..++.++.++|.+|+ .+|.+|+   ++.|++.|+||..+.+...
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence            99999999999888777776666655444433334568999999999976 5999999   9999999999988766543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.3e-48  Score=378.77  Aligned_cols=261  Identities=29%  Similarity=0.499  Sum_probs=221.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++++.||+|+||.||+|++..   +++.||||++.+...........+.+|+.+++.+. |+||+++++.+.+.+.+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEE
Confidence            58999999999999999999887   78899999997654444445577889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+..
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccc
Confidence            999999999999987554 5789999999999999999999999999999999999994   588999999999753210


Q ss_pred             C------------------------------------------------CCccccccCCcccCccccC-ccCCCchhHHH
Q 014559          308 D------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWS  338 (422)
Q Consensus       308 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwS  338 (422)
                      .                                                ......+||+.|+|||++. ..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            0                                                0012357999999999876 47999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHHhccCccchh
Q 014559          339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVPILS  415 (422)
Q Consensus       339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~~l~  415 (422)
                      |||+||||++|+.||......+....+..............+++++.++|.+|+ .||.+|++   +.+++.|+||....
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            999999999999999888777777777665444443344578999999999976 59999997   99999999998765


Q ss_pred             hh
Q 014559          416 FK  417 (422)
Q Consensus       416 ~k  417 (422)
                      +.
T Consensus       313 ~~  314 (382)
T cd05625         313 FS  314 (382)
T ss_pred             hH
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-47  Score=364.76  Aligned_cols=262  Identities=25%  Similarity=0.384  Sum_probs=212.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|+++.   +++.||||++.......  ....+.+|+.+++.+. |+||+++++++.+....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   78 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEG--TPFTAIREASLLKGLK-HANIVLLHDIIHTKETL   78 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccc--cchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeE
Confidence            579999999999999999999886   78899999987543221  2345678999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+. ++|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKS  154 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceecc
Confidence            99999996 588888877667799999999999999999999999999999999999994   58899999999987543


Q ss_pred             C-CCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcCCCC-----------
Q 014559          307 P-DERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPN-----------  371 (422)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~-----------  371 (422)
                      . ........|+..|+|||++.+  .++.++|||||||++|||++|..||.+... ...+..+......           
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            2 223344678999999998753  589999999999999999999999976433 2223222211000           


Q ss_pred             ---CCCC--------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          372 ---FDDL--------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       372 ---~~~~--------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                         +...              ....+++++.+||++||+.||++|+|+.|+|+|+||..+..++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~~  298 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRL  298 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChhh
Confidence               0000              0012457899999999999999999999999999999887654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-47  Score=368.20  Aligned_cols=261  Identities=25%  Similarity=0.456  Sum_probs=226.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++.+.........+.+..|..++..+..|++|+++++++.+.+.+|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY   77 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence            48899999999999999999876   788999999987554444445567788888888866899999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++|+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus        78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          78 FVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCC
Confidence            999999999999887543 5699999999999999999999999999999999999994   588999999999875432


Q ss_pred             -CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 -DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                       .......+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......++.    .++.++.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  229 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV  229 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHH
Confidence             23344567999999999986 46999999999999999999999999988888888888876665554    6899999


Q ss_pred             HHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      ++|.+||+.||.+|++     ..++++|.||..+.|...
T Consensus       230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~  268 (323)
T cd05616         230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  268 (323)
T ss_pred             HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999999999999998     489999999988776543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4e-48  Score=373.19  Aligned_cols=264  Identities=27%  Similarity=0.464  Sum_probs=226.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++.............+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~   77 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLY   77 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEE
Confidence            58999999999999999999887   78899999998765444445567889999999986 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      |||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTA  154 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCC
Confidence            99999999999998877667899999999999999999999999999999999999994   588999999999986654


Q ss_pred             CCC--ccccccCCcccCccccC-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          308 DER--LNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       308 ~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ...  .....||..|+|||++.       ..++.++|||||||++|||++|+.||........+..+............+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP  234 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence            332  22347899999999874       357899999999999999999999998887777777776654332222234


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~  419 (422)
                      .++.++.+||++||. ||.+|+++.+++.|+||..+.+..+
T Consensus       235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence            689999999999998 9999999999999999988766554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-47  Score=368.41  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=221.0

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHH---HhcCCCCeeEEEeEEEeCCe
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK---ALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~  225 (422)
                      |++.+.||+|+||.||+|++..   +++.||||++.+.........+.+.+|++++.   .++ |+||+++++++.+.+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDH   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCE
Confidence            6789999999999999999876   78899999998654444444566777877664   454 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+++++|...+.  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        77 ~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEG  151 (324)
T ss_pred             EEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccC
Confidence            999999999999987764  34799999999999999999999999999999999999994   5889999999998753


Q ss_pred             CC-CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RP-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .. .......+|+..|+|||++. ..++.++|||||||++|||++|+.||.+......+..+......++.    .++.+
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~  227 (324)
T cd05589         152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSRE  227 (324)
T ss_pred             CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            32 23345578999999999886 46899999999999999999999999988888888888776665543    68999


Q ss_pred             HHHHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          384 AKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +.+||.+||..||.+||     ++.++++|+||..+.+..
T Consensus       228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~  267 (324)
T cd05589         228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD  267 (324)
T ss_pred             HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence            99999999999999999     799999999998876543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-50  Score=372.75  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=220.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|...+.||+|+||.||+|.+..   +++.||+|++..+....  .++++++|+.+|.+++ ++||.++|+.+..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~-~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeecc---ccceEEEEEechhhcch--hhHHHHHHHHHHHhcC-cchHHhhhhheeecccH
Confidence            357888999999999999999988   89999999998775443  5688999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |++||||.||++.+.+. .+..+.+..+..++++++.||.|||.++.+|||||+.|||+..   +|.+||+|||.+..+.
T Consensus        87 wiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~---~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE---SGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEec---cCcEEEEecceeeeee
Confidence            99999999999999764 4455699999999999999999999999999999999999974   6999999999998765


Q ss_pred             CCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ... +..+++||+.|||||++.+ .|+.|+||||||++.+||++|.+|+........+..|-+..+....   ..+++.+
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~  239 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPF  239 (467)
T ss_pred             chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHH
Confidence            443 3478999999999999986 7999999999999999999999999776664444444443332222   2689999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||..||.+||+.||+|.++|+|.|.+-
T Consensus       240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  240 KEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            99999999999999999999999988765

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-47  Score=369.25  Aligned_cols=262  Identities=29%  Similarity=0.519  Sum_probs=219.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +|++++.||+|+||.||++++..+..+++.||+|++.+.... .....+.+.+|+.+++.+++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999998665557899999999764322 2233466788999999997799999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++|+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCcccc
Confidence            9999999999999987654 5699999999999999999999999999999999999995   57899999999997653


Q ss_pred             CCC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHcCCCCCCCCCCC
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ...  .....+||..|+|||++.+  .++.++|||||||++|||++|+.||....    .......+......++.    
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  232 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS----  232 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC----
Confidence            322  2334679999999999864  47899999999999999999999996432    23344455554444433    


Q ss_pred             CCCHHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFK  417 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k  417 (422)
                      .++.++.+||.+||..||++|+     ++.++++|+||....+.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            6899999999999999999999     89999999999876553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-47  Score=368.17  Aligned_cols=256  Identities=25%  Similarity=0.454  Sum_probs=222.1

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +++.||||++.+.........+.+..|++++..+.+|+||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence            469999999999999876   78899999998754444444566778999998876799999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +++++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .....
T Consensus        78 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          78 VNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccc
Confidence            999999887754 45799999999999999999999999999999999999994   58899999999987543 22334


Q ss_pred             cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+|+..|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++.    .++.++.++|.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~  229 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA  229 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            45679999999999864 7899999999999999999999999998888888888877665543    478999999999


Q ss_pred             hchhccccCC-------CHHHHHhccCccchhhhhh
Q 014559          391 LLNKDYRKRM-------TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       391 ~L~~dP~~Rp-------s~~elL~~l~~~~l~~k~~  419 (422)
                      ||..||++|+       ++.++++|+||....|...
T Consensus       230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            9999999999       9999999999988776643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=354.89  Aligned_cols=262  Identities=28%  Similarity=0.533  Sum_probs=240.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .-.+|..++.||+|.||.|.+++.+.   +++.||+|+++++.......+..-..|-++|+..+ ||.+..|--.|..++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQD  241 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCc
Confidence            34579999999999999999999887   99999999999887777767777888999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ++|+||||..||.|.-++. +...+++...+.+..+|+.||.|||+++||+||||.+|.|+   |.+|++||+|||+++.
T Consensus       242 rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKE  317 (516)
T ss_pred             eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchh
Confidence            9999999999999987764 45679999999999999999999999999999999999999   6799999999999974


Q ss_pred             -cCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 -IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 -~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                       +..+....++|||+.|+|||++. ..|+..+|+|.+||+||||++|++||.......++..|+-.+..|+.    .+++
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~  393 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSP  393 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCH
Confidence             44566778999999999999997 58999999999999999999999999999999999999999998887    7999


Q ss_pred             HHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +++.|+..+|.+||.+|.     .+.|+.+|.||..+.|-.
T Consensus       394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            999999999999999998     589999999998887753

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.9e-48  Score=370.00  Aligned_cols=254  Identities=28%  Similarity=0.508  Sum_probs=219.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||+|++.+...........+.+|+++++.++ |+||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence            469999999999999876   78999999998755444444567788999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCC
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER  310 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~  310 (422)
                      +++|+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||+++... ....
T Consensus        77 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          77 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcc
Confidence            999999887644 4579999999999999999999997 7999999999999994   58899999999987533 2333


Q ss_pred             ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+||..|+|||++. ..++.++|||||||++|||++|+.||...........+......++.    .+++++.+||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  228 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS  228 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence            44567999999999986 47899999999999999999999999888877777777766655554    68999999999


Q ss_pred             HhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          390 RLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       390 ~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +||+.||++|+     ++.++++|+||....|..
T Consensus       229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~  262 (325)
T cd05594         229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD  262 (325)
T ss_pred             HHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            99999999997     999999999998766553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-47  Score=365.15  Aligned_cols=256  Identities=26%  Similarity=0.477  Sum_probs=218.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +++.||||++++.........+.+..|+.++..+.+|+||+++++++.+.+.+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence            469999999999999887   78899999997654333334456778888888765699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~  311 (422)
                      +.+|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++.... ....
T Consensus        78 ~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          78 LNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCce
Confidence            999999988755 45799999999999999999999999999999999999994   578999999999874322 2334


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||..|+|||++. ..++.++|||||||++|||++|+.||...........+....+.++.    .++.++++||++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~  229 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK  229 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence            5567999999999986 47899999999999999999999999988888887777766655544    488999999999


Q ss_pred             hchhccccCCCH-HHHHhccCccchhhhhh
Q 014559          391 LLNKDYRKRMTA-VQALSKLVVPILSFKIV  419 (422)
Q Consensus       391 ~L~~dP~~Rps~-~elL~~l~~~~l~~k~~  419 (422)
                      ||+.||++|+++ .+++.|+||+...+...
T Consensus       230 ~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~  259 (316)
T cd05620         230 LFERDPTRRLGVVGNIRGHPFFKTINWTAL  259 (316)
T ss_pred             HccCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence            999999999998 58888999998877643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-47  Score=359.03  Aligned_cols=266  Identities=27%  Similarity=0.406  Sum_probs=220.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++.+.||+|+||.||++.+..   +++.||||++.............+.+|+.+++.++ |+||+++++.+.+.+.+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence            38899999999999999999876   78899999997654433333456778999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++   +++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecC
Confidence            9999999999988776543 4699999999999999999999999999999999999994   57899999999998765


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      ........+|+..|+|||++. ..++.++|||||||++|||++|+.||.+.........+..............++..+.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd05605         154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR  233 (285)
T ss_pred             CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence            444445568999999999976 4689999999999999999999999987655433322221111111111235889999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~~  420 (422)
                      +||.+||..||.+|+     ++++++.|+||....++...
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  273 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE  273 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence            999999999999999     99999999999988777544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-47  Score=364.92  Aligned_cols=255  Identities=28%  Similarity=0.498  Sum_probs=217.5

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||||+++..........+.+..|..++..+.+|+||+++++++...+.+|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            369999999999999876   78899999998654433334455667888887665699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~  311 (422)
                      +++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ....
T Consensus        78 ~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          78 LNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCCcc
Confidence            999999887754 45799999999999999999999999999999999999994   588999999999975432 2334


Q ss_pred             cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....+.++.    .++.++.+||.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ll~~  229 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSK  229 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            45689999999999864 6899999999999999999999999988888888877766555443    588999999999


Q ss_pred             hchhccccCCCH-HHHHhccCccchhhhh
Q 014559          391 LLNKDYRKRMTA-VQALSKLVVPILSFKI  418 (422)
Q Consensus       391 ~L~~dP~~Rps~-~elL~~l~~~~l~~k~  418 (422)
                      ||+.||.+|+++ .+++.|+||..+.|..
T Consensus       230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05592         230 LFERDPTKRLGVDGDIRQHPFFRGIDWER  258 (316)
T ss_pred             HccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence            999999999986 5888999998876654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-47  Score=373.54  Aligned_cols=263  Identities=28%  Similarity=0.480  Sum_probs=223.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++.............+.+|+.++..+. |+||+++++.+.+.+.+|
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~   77 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLY   77 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence            58999999999999999999887   78899999997654444445577889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||||++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccc
Confidence            999999999999987553 5699999999999999999999999999999999999994   588999999999864421


Q ss_pred             CC------------------------------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCC
Q 014559          308 DE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS  350 (422)
Q Consensus       308 ~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~  350 (422)
                      ..                                    .....+||+.|+|||++. ..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            10                                    012357999999999986 47999999999999999999999


Q ss_pred             CCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHHhccCccchhhhhh
Q 014559          351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       351 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~elL~~l~~~~l~~k~~  419 (422)
                      .||........+..+......+.......++.++++||.+|+ .||.+|+   ++.|+++|+||+...|..+
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         234 PPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             CCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence            999988888887777764433322222358899999999977 5999998   4899999999998877654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-47  Score=367.00  Aligned_cols=254  Identities=26%  Similarity=0.483  Sum_probs=214.9

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||||++++...........+.+|+.+++.+.+|+||+++++++.+.+.+||||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence            469999999999999887   78899999998755444445567889999999996799999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc-CCCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~-~~~~~~  311 (422)
                      |++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.. ......
T Consensus        78 ~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          78 VSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCCcc
Confidence            999999887654 46799999999999999999999999999999999999994   5889999999998743 233344


Q ss_pred             cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          312 NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...+||..|+|||++.+ .++.++|||||||++|+|++|+.||...         ........+......++.    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~  229 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCC
Confidence            56789999999999864 6899999999999999999999999531         112234455555444443    588


Q ss_pred             HHHHHHHHHhchhccccCCC------HHHHHhccCccchhhh
Q 014559          382 PEAKDFVKRLLNKDYRKRMT------AVQALSKLVVPILSFK  417 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps------~~elL~~l~~~~l~~k  417 (422)
                      .++.++|++||..||.+|++      +.++++|+||..+.|.
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            99999999999999999987      7999999999877664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-47  Score=365.12  Aligned_cols=256  Identities=28%  Similarity=0.496  Sum_probs=219.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.||+|+||.||++++..+..+++.||||++...... .......+.+|+.+++.++ |+||+++++++.+++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            6799999999999998655557899999999764432 2223456788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCC
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DER  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~  310 (422)
                      |+.+++|.+.+.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... ...
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCCCc
Confidence            9999999988754 45789999999999999999999999999999999999994   588999999999875432 233


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+|++.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++.    .+++++.+||+
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~  232 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLK  232 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            345679999999999864 6899999999999999999999999988887878888776655443    58899999999


Q ss_pred             HhchhccccCC-----CHHHHHhccCccchhhh
Q 014559          390 RLLNKDYRKRM-----TAVQALSKLVVPILSFK  417 (422)
Q Consensus       390 ~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k  417 (422)
                      +||..||++|+     ++.+++.|+||....+.
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~  265 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD  265 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999999     89999999999765543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-47  Score=373.04  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=222.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|+++.   +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~  117 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKY  117 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCE
Confidence            4579999999999999999999887   78899999997654444434466889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+|||||++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~  192 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceec
Confidence            9999999999999998754  3689999999999999999999999999999999999994   5889999999999866


Q ss_pred             CCCC--CccccccCCcccCccccCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ....  .....+||+.|+|||++.+     .++.++|||||||+||||++|+.||........+..+......+......
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            4332  2345679999999999753     37899999999999999999999999888878888887655433332334


Q ss_pred             CCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSF  416 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~  416 (422)
                      .++..++++|.+||..++.+  |+++.|+++|+||+...+
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            68999999999999865544  899999999999986443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.2e-47  Score=364.17  Aligned_cols=254  Identities=27%  Similarity=0.492  Sum_probs=220.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +++.||||++.+...........+.+|+.++..+.+|+||+++++++.+.+.+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            469999999999999876   78899999998765444444567788999999886799999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +.+++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .....
T Consensus        78 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          78 VNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCCcc
Confidence            999999887754 45799999999999999999999999999999999999994   58899999999986532 22333


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+......++.    .++.++.+||++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~  229 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKS  229 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHH
Confidence            4567999999999986 47899999999999999999999999888888887777776655543    589999999999


Q ss_pred             hchhccccCCCH-----HHHHhccCccchhhh
Q 014559          391 LLNKDYRKRMTA-----VQALSKLVVPILSFK  417 (422)
Q Consensus       391 ~L~~dP~~Rps~-----~elL~~l~~~~l~~k  417 (422)
                      ||..||.+|+++     .+++.|+|+....|.
T Consensus       230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             HccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            999999999999     999999999887664

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-46  Score=363.33  Aligned_cols=265  Identities=29%  Similarity=0.474  Sum_probs=222.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||+|+||.||++++..   +++.||||++.+.........+.+.+|+.++..++ |+||+++++++.+++.+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   77 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLY   77 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEE
Confidence            69999999999999999999887   78899999997644444444566889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCC
Confidence            99999999999998876667799999999999999999999999999999999999994   588999999999876543


Q ss_pred             CCC--ccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC-CCCC
Q 014559          308 DER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWP  378 (422)
Q Consensus       308 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~  378 (422)
                      ...  ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||......+.+..+......+.. ....
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  234 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT  234 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence            332  22356999999999975      34788999999999999999999999887777777777654432221 1223


Q ss_pred             CCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~k~~  419 (422)
                      .++.++++||++||+.++++  |+++.+++.|+||..+.|..+
T Consensus       235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence            58999999999999765544  789999999999987766543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=347.50  Aligned_cols=263  Identities=35%  Similarity=0.575  Sum_probs=229.7

Q ss_pred             cccceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          145 FGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       145 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      |.+-|++. +.||+|+|+.|-.+....   +|..||||++.+.   ....+.++.+|++++.++.+|+||++|+++|+++
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            44456654 678999999999998877   8999999999765   3445688999999999999999999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ..+|||||.|.||.|+.+|.++ ..|++.++.++.++|+.||.|||.+||.||||||+|||....+.-.-||||||.+..
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence            9999999999999999999776 469999999999999999999999999999999999999764555679999999865


Q ss_pred             ccCCC--------CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-----------
Q 014559          304 FIRPD--------ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTE-----------  358 (422)
Q Consensus       304 ~~~~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-----------  358 (422)
                      ...-.        ....+.+|+..|||||+..      ..|+.++|+||||||||-||.|.+||.+...           
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            43221        2245578999999999863      2599999999999999999999999965432           


Q ss_pred             ----hHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          359 ----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       359 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                          ..++..|..+...|++..|..+|.+++|+|+.+|..|+.+|.++.+++.|+|++..
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence                45788999999999999999999999999999999999999999999999999754

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-46  Score=361.86  Aligned_cols=261  Identities=25%  Similarity=0.461  Sum_probs=225.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY   77 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence            37888999999999999999887   788999999986544444445667889999988876788999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++|+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          78 FVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCC
Confidence            99999999999887754 45799999999999999999999999999999999999994   588999999999875432


Q ss_pred             C-CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 D-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      . ......+||..|+|||++. +.++.++|||||||++|||++|+.||........+..+......++.    .++.++.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  229 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAV  229 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHH
Confidence            2 2334567999999999986 46899999999999999999999999988888888888876665543    6889999


Q ss_pred             HHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      ++|.+||..||.+|++     ..++++|.||..+.|+..
T Consensus       230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~  268 (323)
T cd05615         230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL  268 (323)
T ss_pred             HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHH
Confidence            9999999999999997     589999999998877654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.7e-47  Score=356.14  Aligned_cols=255  Identities=25%  Similarity=0.426  Sum_probs=209.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||||++...... ....+.+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEE
Confidence            69999999999999999999886   7889999999764322 233467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||++++.+ +.+......+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        77 lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          77 LVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccc
Confidence            99999988654 44555556799999999999999999999999999999999999994   588999999999986543


Q ss_pred             CC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC--------------
Q 014559          308 DE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP--------------  370 (422)
Q Consensus       308 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------  370 (422)
                      ..  ......|+..|+|||++. ..++.++|||||||++|||++|+.||......+....+.....              
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            22  233457899999999876 4689999999999999999999999987665444333322111              


Q ss_pred             CC-----CCC---------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          371 NF-----DDL---------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       371 ~~-----~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .+     +..         .+..++.++.+||++||++||++|+|++|+|+|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00     000         012368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.3e-47  Score=363.41  Aligned_cols=255  Identities=25%  Similarity=0.482  Sum_probs=214.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||+|++.+...........+.+|+.++.++.+|+||+++++++.+.+.+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence            469999999999999887   78899999998765444445567888999998886699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .....
T Consensus        78 ~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          78 VNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcc
Confidence            999999887644 45799999999999999999999999999999999999994   58899999999987532 23334


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...+||..|+|||++. ..++.++|||||||++|||++|+.||...         ........+......++.    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~  229 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCC
Confidence            5568999999999986 46899999999999999999999999521         122344455555554443    688


Q ss_pred             HHHHHHHHHhchhccccCCC------HHHHHhccCccchhhhh
Q 014559          382 PEAKDFVKRLLNKDYRKRMT------AVQALSKLVVPILSFKI  418 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps------~~elL~~l~~~~l~~k~  418 (422)
                      .++.+||++||..||++|++      +.+++.|+||....|..
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~  272 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL  272 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence            99999999999999999998      58999999998876654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-46  Score=360.33  Aligned_cols=256  Identities=26%  Similarity=0.460  Sum_probs=217.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||||++...........+....|..++..+.+||||+++++++.+.+.+|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence            469999999999999886   78899999997654332333456677888888765699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~  311 (422)
                      +++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..... ....
T Consensus        78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          78 LNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCCce
Confidence            999999988754 35689999999999999999999999999999999999995   578999999999875322 2234


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+||..|+|||++. ..++.++|||||||++|||++|+.||........+..+......++.    .++.++++||.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~  229 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVK  229 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence            4567999999999986 46899999999999999999999999888877777777665544443    488999999999


Q ss_pred             hchhccccCCCHH-HHHhccCccchhhhhh
Q 014559          391 LLNKDYRKRMTAV-QALSKLVVPILSFKIV  419 (422)
Q Consensus       391 ~L~~dP~~Rps~~-elL~~l~~~~l~~k~~  419 (422)
                      ||+.||++|+++. +++.|+||..+.|...
T Consensus       230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         230 LFVREPERRLGVKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             HhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence            9999999999996 8999999998877643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=366.92  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=215.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+..++..||+|.||+||+|++..      .||||++........ ..+.|++|+.++++-+ |.||+-|.|+|..... 
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-  462 (678)
T ss_pred             HHhhccceeccccccceeeccccc------ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-
Confidence            456788999999999999999876      599999988665544 6789999999999997 9999999999998877 


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc--
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF--  304 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~--  304 (422)
                      .||+.||+|.+|+.+++....+|.......|++||+.|+.|||.++|||||||..||||   ++++.|||+|||++..  
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeee
Confidence            99999999999999998877889999999999999999999999999999999999999   4579999999999853  


Q ss_pred             -cCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC-CCC
Q 014559          305 -IRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-PWP  378 (422)
Q Consensus       305 -~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~  378 (422)
                       ...........|...|||||+++    ..|++.+||||||||+|||++|.+||.....+.++..+-.+....... ...
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence             23334455567899999999985    369999999999999999999999998666666655554443222211 123


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .+++++++|+..||..++++||...++|..+..
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~  652 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE  652 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence            577899999999999999999999999986443

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-46  Score=354.68  Aligned_cols=257  Identities=28%  Similarity=0.401  Sum_probs=209.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEe---
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACED---  222 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  222 (422)
                      +|++.+.||+|+||.||+|++...  .++.||||++........ ....+.+|+.+++.+.  +||||+++++++..   
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            699999999999999999998541  467899999875433222 2245567888887764  49999999998852   


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 --VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                        ...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Df  154 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF  154 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEccc
Confidence              456999999996 5888887653 34589999999999999999999999999999999999995   5789999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC---
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL---  375 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  375 (422)
                      |+++............|+..|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..+..........   
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            9998765554455667999999999875 578999999999999999999999999888777776665432111000   


Q ss_pred             --------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          376 --------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       376 --------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                          ..+.++..+++||.+||+.||++||++.|+|+|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                013577889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-46  Score=368.04  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=222.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|+++.   +++.||+|++.+...........+.+|+.+++.++ |+||+++++.+.+.+.
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~  117 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRY  117 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence            3579999999999999999999887   78899999997644444444466788999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+|||||++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEc
Confidence            9999999999999988754  3589999999999999999999999999999999999995   5889999999999866


Q ss_pred             CCCC--CccccccCCcccCccccCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ....  .....+||+.|+|||++..     .++.++|||||||++|||++|+.||........+..+......+......
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN  272 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence            4332  2345679999999999753     37899999999999999999999999888888888887655443333344


Q ss_pred             CCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSF  416 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~  416 (422)
                      .++.+++++|.+||..++.+  |+++.|+++|+||+...+
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            78999999999999844433  789999999999977543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-45  Score=371.54  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=201.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-----CCCCeeEEEeEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-----GHKHLVKFCDAC  220 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~  220 (422)
                      ..+|+++++||+|+||.||+|++..   +++.||||+++....    ....+..|+.+++.++     +|.+|++++++|
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            4689999999999999999999876   788999999964321    2244567888888775     234589999988


Q ss_pred             EeC-CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCC---------
Q 014559          221 EDV-NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGR---------  289 (422)
Q Consensus       221 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~---------  289 (422)
                      ... +.+|||||++ +++|.+++.+. +.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++         
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            765 5799999998 67898887654 579999999999999999999998 5999999999999996421         


Q ss_pred             ----CCCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 014559          290 ----DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ----~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  364 (422)
                          +...+||+|||++....  ......+||..|+|||++.+ .|+.++|||||||+||||++|+.||......+.+..
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                11259999999886432  23345789999999999864 799999999999999999999999987766555444


Q ss_pred             HHcCCCCCCCC------------------------------------CC--CCCCHHHHHHHHHhchhccccCCCHHHHH
Q 014559          365 VLRSDPNFDDL------------------------------------PW--PSVSPEAKDFVKRLLNKDYRKRMTAVQAL  406 (422)
Q Consensus       365 i~~~~~~~~~~------------------------------------~~--~~~s~~~~~li~~~L~~dP~~Rps~~elL  406 (422)
                      +......++..                                    .+  ...++.+.|||.+||++||++|+|++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            33221111100                                    00  01145688999999999999999999999


Q ss_pred             hccCccc
Q 014559          407 SKLVVPI  413 (422)
Q Consensus       407 ~~l~~~~  413 (422)
                      +|+||..
T Consensus       437 ~Hp~~~~  443 (467)
T PTZ00284        437 THPYVLK  443 (467)
T ss_pred             cCccccc
Confidence            9999975

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.9e-46  Score=351.97  Aligned_cols=254  Identities=26%  Similarity=0.463  Sum_probs=211.9

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|+||.||++.++.   +++.||||++...........+.+..|+++++.++ |+||+++++++.+.+.+|+||||++
T Consensus         1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence            7999999999999887   78899999997655444444566788999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC-C
Q 014559          235 GGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-R  310 (422)
Q Consensus       235 ~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~  310 (422)
                      +|+|.+.+..   ....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....... .
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCcc
Confidence            9999877643   345699999999999999999999999999999999999994   58899999999997654332 2


Q ss_pred             ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .....|+..|+|||++. ..++.++|||||||++|||++|+.||......    .....+......++    ..++.++.
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  229 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP----DKFSPASK  229 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc----ccCCHHHH
Confidence            34467899999999986 47899999999999999999999999765432    22233333222222    25899999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++|.+||+.||++|+     +++++++|+||+.+.|...
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            999999999999999     8899999999998877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-46  Score=361.01  Aligned_cols=266  Identities=27%  Similarity=0.451  Sum_probs=223.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+++++.   +++.||+|++.+...........+.+|+.++..+. |+||+++++.+.+.+.+|
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   77 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLY   77 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEE
Confidence            68999999999999999999876   77899999997644333334456788999999986 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheeccc
Confidence            99999999999999877667899999999999999999999999999999999999994   588999999999875533


Q ss_pred             CCC--ccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC-CCC
Q 014559          308 DER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-PWP  378 (422)
Q Consensus       308 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~  378 (422)
                      ...  ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||........+..+......+... ...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  234 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT  234 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence            322  23457999999999874      358899999999999999999999998888777777777654333211 123


Q ss_pred             CCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~k~~~  420 (422)
                      .++.++++||++||+.++++  |+++.|+++|+||..+.|..++
T Consensus       235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~  278 (332)
T cd05623         235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR  278 (332)
T ss_pred             cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence            68999999999999765544  6899999999999987765543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-46  Score=361.65  Aligned_cols=266  Identities=27%  Similarity=0.456  Sum_probs=223.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+++++.   +++.||||++.+...........+.+|+.++..+. |+||+++++++.+.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~   76 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYL   76 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence            369999999999999999999876   78899999997644333334456788999999986 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||+.||+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMN  153 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeecc
Confidence            999999999999999877667899999999999999999999999999999999999994   58899999999997654


Q ss_pred             CCCCc--cccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC-CCC
Q 014559          307 PDERL--NDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPW  377 (422)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~  377 (422)
                      .....  ...+|++.|+|||++.      +.++.++|||||||+||||++|+.||......+.+..+......+.. ...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI  233 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence            33322  3357999999999875      35789999999999999999999999887777777777664433321 112


Q ss_pred             CCCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhhhhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~k~~  419 (422)
                      ..++.+++++|.+||+.++++  |++++++++|+||+...|...
T Consensus       234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            357899999999999976654  569999999999988776544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=363.19  Aligned_cols=246  Identities=28%  Similarity=0.432  Sum_probs=212.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .+++++.||+|.||.||++++..    ...||+|.++.....    .+.+.+|+++|++|+ |+|||+|+++|...+.+|
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMS----PEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccC----hhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceE
Confidence            46778899999999999999863    347999999765443    367889999999998 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||..|+|++++.. ....+...+...++.|||+|++||+++++|||||-..||||+   ++..+||+|||||+...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccC
Confidence            99999999999999987 457799999999999999999999999999999999999994   68899999999999554


Q ss_pred             CCCCcccc--ccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLNDI--VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~~~--~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ++......  --...|.|||.++ +.++.|+|||||||+||||+| |+.||.+....+.++.+.++..-...   ..+++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~  431 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPD  431 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCH
Confidence            43332221  2245699999986 689999999999999999998 99999999999999888876643322   37999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ++.+++..||..+|++|||.+.+...
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~~L~~~  457 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFETLREV  457 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHHHH
Confidence            99999999999999999999866543

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-46  Score=360.44  Aligned_cols=253  Identities=27%  Similarity=0.519  Sum_probs=214.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHH-HHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.||+|+||.||+|+++.   +++.||||++.+...........+.+|.. +++.++ |+||+++++.+.+.+.+|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence            469999999999999887   78999999997654433333445556655 456776 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCC
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DER  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~  310 (422)
                      |+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ...
T Consensus        77 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~  152 (323)
T cd05575          77 YVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKT  152 (323)
T ss_pred             CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCCc
Confidence            9999999887754 45799999999999999999999999999999999999994   588999999999875322 233


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+||..|+|||++.+ .++.++|||||||++|||++|..||........+..+......+.    +.++.++.++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE  228 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            445679999999998864 689999999999999999999999998888888888877655443    368999999999


Q ss_pred             HhchhccccCCCH----HHHHhccCccchhhh
Q 014559          390 RLLNKDYRKRMTA----VQALSKLVVPILSFK  417 (422)
Q Consensus       390 ~~L~~dP~~Rps~----~elL~~l~~~~l~~k  417 (422)
                      +||+.||.+|+++    .+++.|+||....|.
T Consensus       229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             HHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999988    699999999876653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.8e-46  Score=373.07  Aligned_cols=257  Identities=24%  Similarity=0.368  Sum_probs=209.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      ..+|++++.||+|+||.||+|.+..   +++.||||++....       ....+|+.+++.++ |+|||++++++...  
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF  133 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence            4579999999999999999999876   78899999885432       23457999999997 99999999887532  


Q ss_pred             ------CeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          224 ------NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       224 ------~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                            ..+++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCce
Confidence                  247899999975 77766643   3467999999999999999999999999999999999999952  34579


Q ss_pred             EEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC--
Q 014559          295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP--  370 (422)
Q Consensus       295 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--  370 (422)
                      ||+|||+++............||+.|+|||++.+  .|+.++|||||||+||||++|..||.+....+.+..+.....  
T Consensus       211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999999987765555566788999999998753  689999999999999999999999988776655555443111  


Q ss_pred             ---------------CCCCCC--------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          371 ---------------NFDDLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       371 ---------------~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                     .++...        ....+.++++||.+||.+||.+|+|+.|+|+|+||..+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                           111100        0136789999999999999999999999999999976643

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.8e-47  Score=362.35  Aligned_cols=255  Identities=27%  Similarity=0.500  Sum_probs=219.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||++++..+..+|+.||+|++.+..... .....+.+|++++++++ |+||+++++++.+++.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            57999999999999876544578999999997644322 23355778999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC-CCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~  311 (422)
                      +++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... ...
T Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCCce
Confidence            999999988754 45699999999999999999999999999999999999994   5889999999998765433 233


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...+|+..|+|||++. ..++.++|||||||++|||++|+.||........+..+......++.    .++.++.+||++
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~  231 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRA  231 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            4567999999999986 46899999999999999999999999988887888877776655543    589999999999


Q ss_pred             hchhccccCCC-----HHHHHhccCccchhhh
Q 014559          391 LLNKDYRKRMT-----AVQALSKLVVPILSFK  417 (422)
Q Consensus       391 ~L~~dP~~Rps-----~~elL~~l~~~~l~~k  417 (422)
                      ||+.||++|++     +.+++.|+||....|.
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            99999999999     7889999999876654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-46  Score=359.07  Aligned_cols=256  Identities=26%  Similarity=0.486  Sum_probs=215.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|++..   +++.||||++.+.........+.+.+|+.++.++.+|+||+++++++.+.+.+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence            469999999999999887   78899999998765444445567889999999997799999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~  311 (422)
                      +++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .....
T Consensus        78 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          78 VNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCce
Confidence            999999887654 35799999999999999999999999999999999999995   58899999999987532 23334


Q ss_pred             cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-------ChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR-------TESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...+||..|+|||++. ..++.++|||||||++|||++|+.||...       ........+......++.    .++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~  229 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVK  229 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC----CCCHH
Confidence            5578999999999976 47899999999999999999999999532       122344444444444433    58899


Q ss_pred             HHHHHHHhchhccccCCC------HHHHHhccCccchhhhhh
Q 014559          384 AKDFVKRLLNKDYRKRMT------AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps------~~elL~~l~~~~l~~k~~  419 (422)
                      +.++|++||..||.+|++      ..+++.|+||..+.|...
T Consensus       230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence            999999999999999998      579999999998877654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.8e-46  Score=350.31  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=217.8

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||+|+||.||++.+..   +++.||||.+.............+.+|+.++++++ |+||+.+++.+.+.+.+|+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~l   77 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEE
Confidence            7788999999999999999987   78999999987654444333456778999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++   .++.++|+|||++.....
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCC
Confidence            999999999988875433 4589999999999999999999999999999999999994   578899999999976554


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ........|+..|+|||++. ..++.++|||||||++|+|++|+.||......   .....+....   .......++.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (285)
T cd05630         155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPD  231 (285)
T ss_pred             CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHH
Confidence            44444567999999999986 46899999999999999999999999765432   1222222111   11122368899


Q ss_pred             HHHHHHHhchhccccCCC-----HHHHHhccCccchhhhhhh
Q 014559          384 AKDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~~  420 (422)
                      +.+||++||+.||.+|++     ++|+++|+||+-+.++.+.
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLE  273 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHh
Confidence            999999999999999999     9999999999987776554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=362.79  Aligned_cols=254  Identities=29%  Similarity=0.523  Sum_probs=215.4

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ||+|+||.||+|+++.   +++.||||++.+..............|..++..+.  +|+||+++++++.+.+.+|+||||
T Consensus         1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence            7999999999999876   78899999997654433333445566777776654  699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC-CCCc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~  311 (422)
                      +.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ....
T Consensus        78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          78 MSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCCCc
Confidence            999999887754 46799999999999999999999999999999999999994   588999999999875432 2334


Q ss_pred             cccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          312 NDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ...+||..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+......++.   ..+++++++||+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~  230 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK  230 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence            55789999999998753  4899999999999999999999999888877777777766655443   257899999999


Q ss_pred             HhchhccccCC----CHHHHHhccCccchhhhh
Q 014559          390 RLLNKDYRKRM----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       390 ~~L~~dP~~Rp----s~~elL~~l~~~~l~~k~  418 (422)
                      +||..||.+|+    ++.++++|+||....+..
T Consensus       231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         231 GLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             HHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence            99999999998    799999999998766544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.5e-46  Score=355.01  Aligned_cols=262  Identities=26%  Similarity=0.432  Sum_probs=215.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+.+.||+|+||.||+|+++.   +++.||||+++......  ....+.+|+.++++++ |+||+++++++.+++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCC--cchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeE
Confidence            469999999999999999999876   78899999987543222  2345778999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecC
Confidence            999999975 88888877666789999999999999999999999999999999999994   58899999999987543


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC------------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------  371 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------  371 (422)
                      .. .......++..|+|||++.+  .++.++|||||||++|+|++|+.||......+.+..+......            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            22 22334568999999998753  5899999999999999999999999877665554444321110            


Q ss_pred             -------CCC-------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          372 -------FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       372 -------~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                             ++.       ...+.++.++++||.+||..||.+|+|+.|+|+|+||..+..++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence                   000       01135788999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-45  Score=355.75  Aligned_cols=258  Identities=25%  Similarity=0.365  Sum_probs=212.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||++++..   ++..||+|++....  .....+.+.+|+++++.++ |+||+++++++.+++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence            3579999999999999999999887   78899999987542  2233467899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++   .++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~  153 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccc
Confidence            9999999999999988754 35689999999999999999999986 699999999999995   578999999999876


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--------------
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------------  369 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------  369 (422)
                      ... .......|+..|+|||++.+ .++.++|||||||++|||++|+.||......+....+....              
T Consensus       154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence            543 23345679999999999864 68999999999999999999999997655433322111000              


Q ss_pred             ------------------------------CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          370 ------------------------------PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       370 ------------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                                    ...+......++.++++||.+||.+||++||++.|+|+|+|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                          000111122478899999999999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-45  Score=348.47  Aligned_cols=265  Identities=28%  Similarity=0.432  Sum_probs=221.4

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |+..+.||+|+||.||+|.+..   +++.||+|++.............+.+|+++++.++ |+||+.+++.+.+++.+|+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~l   77 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCL   77 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEE
Confidence            7788999999999999999887   78899999997654444434456788999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCC
Confidence            99999999998877654 34699999999999999999999999999999999999994   578899999999976554


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      ........|+..|+|||++. ..++.++|+|||||++|+|++|..||...........+..............++.++.+
T Consensus       155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05632         155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS  234 (285)
T ss_pred             CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence            44445567999999999875 57899999999999999999999999876554433333322222222223468899999


Q ss_pred             HHHHhchhccccCCC-----HHHHHhccCccchhhhhhh
Q 014559          387 FVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       387 li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~~  420 (422)
                      ||.+||..||++|++     +.+++.|.||....++.+.
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  273 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLE  273 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHh
Confidence            999999999999999     8999999999988777544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-46  Score=358.38  Aligned_cols=253  Identities=28%  Similarity=0.513  Sum_probs=212.9

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHH-HHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.||+|+||.||+|++..   +++.||||++.+...........+.+|+. +++.++ |+||+++++++.+.+.+|+|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence            469999999999999876   78899999997654433333445556655 567776 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCC
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~  310 (422)
                      |+++++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... ....
T Consensus        77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~  152 (321)
T cd05603          77 YVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEET  152 (321)
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCCc
Confidence            9999999887654 45799999999999999999999999999999999999994   58899999999987532 2233


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+|+..|+|||++.+ .++.++|||||||++|||++|..||...........+......++.    ..+.++.++|.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  228 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG----GKTVAACDLLV  228 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence            445679999999999864 6899999999999999999999999988877777777766544443    57899999999


Q ss_pred             HhchhccccCCCH----HHHHhccCccchhhh
Q 014559          390 RLLNKDYRKRMTA----VQALSKLVVPILSFK  417 (422)
Q Consensus       390 ~~L~~dP~~Rps~----~elL~~l~~~~l~~k  417 (422)
                      +||+.||.+|+++    .++++|+||..+.+.
T Consensus       229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         229 GLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             HHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            9999999999976    599999999866554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=367.28  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=223.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|.-++.||.|+||.||.|++..   +.+.||||.+..........+.++..|+++|++|+ |||+|.+-|+|..+...
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence            457778999999999999999988   88899999998777666667889999999999998 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||-| +-.|.+.-...++-+.+|..|+.+.+.||.|||+.+.||||||..|||++   +.|.|||+|||.|....
T Consensus       102 WLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcC
Confidence            999999965 77777766667899999999999999999999999999999999999996   59999999999997654


Q ss_pred             CCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                         ..++++||++|||||++.    +.|+-++|||||||++.||...++|+...+.-.-+..|...+...  +..+.+++
T Consensus       178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~  252 (948)
T KOG0577|consen  178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSD  252 (948)
T ss_pred             ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHH
Confidence               346789999999999873    679999999999999999999999988877766666666655432  33457899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      .|++||..||.+-|.+|||++++|.|.|+.
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            999999999999999999999999998863

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.7e-46  Score=358.00  Aligned_cols=253  Identities=28%  Similarity=0.526  Sum_probs=212.1

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHH-HHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.||+|+||.||+|++..   +++.||+|++.+...........+..|.. +++.+. |+||+++++++.+.+.+|+|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence            469999999999999886   77899999997654333323344455554 466775 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCC
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~  310 (422)
                      |+.+++|.+.+.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... ....
T Consensus        77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~~  152 (325)
T cd05602          77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT  152 (325)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCCC
Confidence            9999999887754 45689999999999999999999999999999999999994   58899999999987542 2333


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+||+.|+|||++.+ .++.++|||||||++|||++|..||......+.+..+......+.    +.++.++.++|.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLE  228 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHH
Confidence            455689999999998864 689999999999999999999999998888888777776544433    368999999999


Q ss_pred             HhchhccccCCCHH----HHHhccCccchhhh
Q 014559          390 RLLNKDYRKRMTAV----QALSKLVVPILSFK  417 (422)
Q Consensus       390 ~~L~~dP~~Rps~~----elL~~l~~~~l~~k  417 (422)
                      +||+.||.+|+++.    ++++|+|+....|.
T Consensus       229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             HHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence            99999999999876    89999998776553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.6e-46  Score=358.70  Aligned_cols=259  Identities=30%  Similarity=0.465  Sum_probs=207.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC----
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  223 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++..... .......+.+|+++++.++ |+||+++++++...    
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence            58999999999999999999887   788999999864322 2223356889999999997 99999999988643    


Q ss_pred             -CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       224 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                       ..+|+|||||. ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        76 ~~~~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~  150 (338)
T cd07859          76 FKDIYVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLA  150 (338)
T ss_pred             CceEEEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccc
Confidence             35899999995 588887654 45699999999999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCC----CccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc--------
Q 014559          303 DFIRPDE----RLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR--------  367 (422)
Q Consensus       303 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------  367 (422)
                      +......    .....+|+..|+|||++.   ..++.++|||||||++|||++|+.||.+......+..+..        
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            7543221    123457999999999875   4689999999999999999999999977654333222111        


Q ss_pred             -------------------CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          368 -------------------SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       368 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                         .........++.++.++.++|.+||+.||++||++.|+|+|+||+.+..
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                               0111111123467889999999999999999999999999999976544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.5e-46  Score=358.88  Aligned_cols=253  Identities=28%  Similarity=0.492  Sum_probs=213.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHH-HHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI-LKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.||+|+||.||+|+++.   +|+.||||++.+...........+.+|..+ ++.++ |+||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence            469999999999999876   789999999976543333334555666654 56675 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-CCCC
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~  310 (422)
                      |+.+|+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... ....
T Consensus        77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          77 FVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCCC
Confidence            9999999887654 46799999999999999999999999999999999999994   58899999999987532 2233


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      ....+|+..|+|||++.+ .++.++|||||||++|||++|..||........+..+......+.    +.++.++.++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~  228 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILE  228 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHH
Confidence            455679999999999864 689999999999999999999999998888788787776554333    368899999999


Q ss_pred             HhchhccccCCCH----HHHHhccCccchhhh
Q 014559          390 RLLNKDYRKRMTA----VQALSKLVVPILSFK  417 (422)
Q Consensus       390 ~~L~~dP~~Rps~----~elL~~l~~~~l~~k  417 (422)
                      +||..||.+|+++    .+++.|+||....|.
T Consensus       229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             HHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999999977    599999999876654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-45  Score=347.81  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEe---
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACED---  222 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  222 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||+|++....... .....+.+|+.+++.+.  +|+||+++++++.+   
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence            48999999999999999999987   78999999987543222 12234567888887764  49999999998865   


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 --VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                        ...+++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~df  152 (288)
T cd07863          77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADF  152 (288)
T ss_pred             CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcc
Confidence              2468999999975 8888776543 4589999999999999999999999999999999999995   5889999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC-----
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-----  373 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  373 (422)
                      |++.............|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+........     
T Consensus       153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            9998765444445567899999999875 4789999999999999999999999987776665555543111000     


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          374 ------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       374 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                        ....+.++.++.+||.+||+.||++||++.|+|.|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                              00123578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=368.85  Aligned_cols=257  Identities=31%  Similarity=0.486  Sum_probs=224.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+.|+|+..||-|+||.||+|.++.   ++-..|-|+|.   ......++++.-||+||..+. ||+||+|++.|...+.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIe---tkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIE---TKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhc---ccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCc
Confidence            3569999999999999999999886   77778888884   344556788999999999996 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc-
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~-  304 (422)
                      +||..|||.||-+...+..-+..+++.+|..+++|++.||.|||+++|||||||..|||++.   +|.++|+|||.+.. 
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl---dGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL---DGDIRLADFGVSAKN  180 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe---cCcEeeecccccccc
Confidence            99999999999999988888889999999999999999999999999999999999999985   89999999998643 


Q ss_pred             cCCCCCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ........+++||++|||||+.+      ..|+.++|||||||+|.||..+.+|-...+...++-.|.+..+... +...
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS  259 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPS  259 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcc
Confidence            33344567789999999999863      3699999999999999999999999877777666666766555432 2234


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .++..|.||+++||.+||..||++.++|+|+|+..
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            68999999999999999999999999999999983

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-45  Score=345.86  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=210.6

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|+||.||+++++.   +|+.||+|++.............+..|+++++.++ |+||+++++++.++..+|+||||+.
T Consensus         1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence            7999999999999887   78999999997644433333345667999999996 9999999999999999999999999


Q ss_pred             CCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccc
Q 014559          235 GGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND  313 (422)
Q Consensus       235 ~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~  313 (422)
                      +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++   .++.++|+|||++...........
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~~  153 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQ  153 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCceeec
Confidence            999988775533 3589999999999999999999999999999999999994   588899999999977655444445


Q ss_pred             cccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 014559          314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFV  388 (422)
Q Consensus       314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  388 (422)
                      ..|+..|+|||++. ..++.++|||||||++|||++|+.||.....    ......+......+.   ...++.++++||
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li  230 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDIC  230 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHH
Confidence            67899999999875 4689999999999999999999999975433    223333333332221   236899999999


Q ss_pred             HHhchhccccCCCH----HHHHhccCccchhhhhh
Q 014559          389 KRLLNKDYRKRMTA----VQALSKLVVPILSFKIV  419 (422)
Q Consensus       389 ~~~L~~dP~~Rps~----~elL~~l~~~~l~~k~~  419 (422)
                      ++||+.||++|+++    .+++.|.||+.+.+...
T Consensus       231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~  265 (277)
T cd05607         231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL  265 (277)
T ss_pred             HHHhccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence            99999999999999    67889999988766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-45  Score=370.21  Aligned_cols=256  Identities=28%  Similarity=0.375  Sum_probs=217.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|.+.+.||+|+||.||+|.....  .++.||+|.+...   .......+.+|+.+++.++ |+|||++++++.+.+.+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence            3599999999999999999987651  2678999987443   2233456788999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ||||||+++|+|.+++..   ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~  217 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSK  217 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCce
Confidence            999999999999987754   234689999999999999999999999999999999999995   58899999999998


Q ss_pred             ccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ......   .....+||+.|+|||++. ..++.++|||||||++|||++|+.||......+++..+........   ...
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~  294 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP  294 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence            664332   234567999999999986 4699999999999999999999999988877777777766543311   125


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++.++.+||.+||..||++||++.++|.+.|++.+
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            88999999999999999999999999999888654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=359.97  Aligned_cols=261  Identities=34%  Similarity=0.595  Sum_probs=237.1

Q ss_pred             cccceEE--eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          145 FGAKYEL--GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       145 ~~~~y~~--~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      +..-|++  .+.||.|.||+||-|.+++   +|+.||||+|++.++..... ..+++|+.||+++. ||.||.|.-.|+.
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~-HPGiV~le~M~ET  634 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLH-HPGIVNLECMFET  634 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCchH-HHHHHHHHHHHhcC-CCCeeEEEEeecC
Confidence            3344655  3789999999999999998   99999999999988766544 78999999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          223 VNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      .+.+++|||.+.| +.++.|.. ..+++++...+.++.||+.||.|||-++|+|+||||+|||+.+.+.--.+||||||+
T Consensus       635 ~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  635 PERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             CceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence            9999999999965 77776664 568899999999999999999999999999999999999998766677899999999


Q ss_pred             ccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      |+++.+.....+.+||+.|+|||++. +.|....|+||+|||+|--+.|..||..  ++++-++|.+....++..+|.++
T Consensus       714 ARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~ei  791 (888)
T KOG4236|consen  714 ARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEI  791 (888)
T ss_pred             eeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhc
Confidence            99998888888999999999999986 5799999999999999999999999964  45677889999999999999999


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +.++.|||..+|+..-.+|.+....|.|+|++.
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            999999999999999999999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-46  Score=354.96  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=212.7

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..-+..|+++++||+||.+.||++...    +...||+|.+.... .+...+..+.+|+.+|.+|++|.+||+||||-..
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            345668999999999999999999875    34567887765433 3455678899999999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ++.+||||||-+. +|..++.++...+....++.|..|++.|+.++|+.||||.||||.|+|+.    .|.+||+|||.|
T Consensus       432 d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA  506 (677)
T KOG0596|consen  432 DGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIA  506 (677)
T ss_pred             CceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechh
Confidence            9999999998754 88888877766677679999999999999999999999999999999996    899999999999


Q ss_pred             cccCCCCC---ccccccCCcccCccccCc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHH
Q 014559          303 DFIRPDER---LNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVL  366 (422)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~  366 (422)
                      ..+..+..   ....+||+.||+||.+..            +.++++||||||||||+|+.|+.||.... ....+..|.
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~  586 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT  586 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence            87765543   345789999999998731            26789999999999999999999996533 223334444


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .....++.... .-..++.++++.||.+||++||+..|+|+|+|++.
T Consensus       587 ~P~~~Iefp~~-~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  587 DPNHEIEFPDI-PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCccccccCC-CCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            43332222111 11234999999999999999999999999999987

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-45  Score=347.59  Aligned_cols=263  Identities=25%  Similarity=0.423  Sum_probs=217.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|++..   +++.||+|.+.......  ....+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccC--chhHHHHHHHHHHhcC-CCCcceEEEEEecCCeE
Confidence            469999999999999999999876   78899999987543222  2345778999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+. ++|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccC
Confidence            99999997 489888877667799999999999999999999999999999999999994   57899999999987543


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC------------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------  371 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------  371 (422)
                      .. .......++..|+|||++.+  .++.++|||||||++|||++|+.||...+..+.+..+......            
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            22 22334567899999998753  5789999999999999999999999877665554443321110            


Q ss_pred             -------CCC-------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhh
Q 014559          372 -------FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       372 -------~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~  419 (422)
                             ++.       .....+++++++||.+||+.||.+|||+.|+|+|+||..+..++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~  297 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH  297 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence                   000       011357889999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=322.26  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=220.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +.+++..||.|+.|+|++++.+.   +|...|||.+....  +.....++...++++...+++|+||+.+|+|..+..++
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            35677889999999999999988   88999999998653  33455788889999888778999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |.||.|.. .+..++..-.+.++|..+-++...+++||.||-++ ||||||+||+|||+   |+.|++||||||.+.++.
T Consensus       168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceee
Confidence            99999853 44555555567899999999999999999999876 89999999999999   679999999999999888


Q ss_pred             CCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +....+...|-+.|||||.+.    ..|+.++||||||++++||+||..||.+ ..+.+.+-.+++..+..... -.+.|
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gFS  322 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGFS  322 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCcC
Confidence            777777889999999999985    3699999999999999999999999987 46778888888866532211 12489


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ++|++|+..||.+|+.+||...++|+|+|..
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            9999999999999999999999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-45  Score=354.55  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=202.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++|++.+.||+|+||.||+|++..  ...+++.||||++....  .......+.+|+.++..+.+|+||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            579999999999999999998532  11256789999986432  2223467889999999995599999999988764 


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------------------------------------------------
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------------------------------------------------  246 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  246 (422)
                      +.+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999886421                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCc
Q 014559          247 ----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAY  319 (422)
Q Consensus       247 ----~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~  319 (422)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++   +++.+||+|||+++.......   .....++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2477889999999999999999999999999999999994   578999999999976532221   123345678


Q ss_pred             ccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccc
Q 014559          320 YVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR  397 (422)
Q Consensus       320 y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  397 (422)
                      |+|||++. ..++.++|||||||+||||++ |..||........+...+.......  ....++.++.++|.+||..||.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCChh
Confidence            99999875 568999999999999999997 9999977554433333333222111  1136789999999999999999


Q ss_pred             cCCCHHHHHhc
Q 014559          398 KRMTAVQALSK  408 (422)
Q Consensus       398 ~Rps~~elL~~  408 (422)
                      +||++.|+++.
T Consensus       320 ~RPs~~el~~~  330 (338)
T cd05102         320 ERPTFSALVEI  330 (338)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-45  Score=359.62  Aligned_cols=251  Identities=19%  Similarity=0.305  Sum_probs=203.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++++.||+|+||.||+|++..   +++.||||....         ..+.+|++++++|+ ||||++++++|..+...
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCee
Confidence            469999999999999999999987   889999997532         34678999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       159 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccc
Confidence            99999995 5888877554 5689999999999999999999999999999999999995   57899999999997543


Q ss_pred             CC--CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHcCCC------
Q 014559          307 PD--ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-------ESGIFRAVLRSDP------  370 (422)
Q Consensus       307 ~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~------  370 (422)
                      ..  ......+||+.|+|||++. ..++.++|||||||++|||++|..||....       ....+..+.....      
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            22  2334568999999999986 469999999999999999999998875421       1112222211100      


Q ss_pred             --------------------CCC--CCCC---CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          371 --------------------NFD--DLPW---PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       371 --------------------~~~--~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                          ..+  ...|   ..++.++.+||.+||++||.+|||+.|+|+|+||..+.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                                000  0001   13567899999999999999999999999999997654

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.9e-45  Score=355.19  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=207.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||++++..   +++.||||++..... .......+.+|+.+++.++ |+||+++++++...+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   93 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQK   93 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence            44689999999999999999999876   788999999865422 2233466789999999997 999999999986543


Q ss_pred             ------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                            .+|+||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~D  166 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  166 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEec
Confidence                  57999999976 6666553   2489999999999999999999999999999999999995   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc----------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR----------  367 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~----------  367 (422)
                      ||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+..          
T Consensus       167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            999976554444555688999999999864 789999999999999999999999987654433322211          


Q ss_pred             ------------CCCCCCCCC----------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          368 ------------SDPNFDDLP----------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       368 ------------~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                  ..+......                ....+.++++||.+||+.||++|||+.|+|.|+|+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                        111111000                0124678999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=307.63  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=224.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|...++||+|.||+||+|+++.   +++.||+|.++.+..... .-....+||.+++.|+ |.|||++++....++.+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrlddddeg-vpssalreicllkelk-hknivrl~dvlhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEG-VPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhh-hcceeehhhhhccCceeE
Confidence            57778899999999999999987   899999999987654433 3356789999999998 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|+|||+. +|..++..-++.++.+.++.++.|+++||.|+|+++++||||||+|.||+   .+|.+||+|||+++.+.-
T Consensus        78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCC
Confidence            99999976 89998888899999999999999999999999999999999999999995   599999999999986653


Q ss_pred             CC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC---
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV---  380 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---  380 (422)
                      .- .....+.|.+|++|.++-+  -|+...|+||.|||+.|+.. |++.|.+..-.+++.+|...-....+..|+.+   
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            33 3455678999999999865  49999999999999999986 77889888888999998876655555555443   


Q ss_pred             ----------------------CHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          381 ----------------------SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       381 ----------------------s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                            +..-+|+++++|..+|.+|.+++++|+|++|-..
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                                  3567999999999999999999999999998754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.6e-45  Score=350.00  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.++||+|+||.||++++..   ++..+|+|++....  .....+.+.+|+++++.++ |+||++++++|.+++.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence            3579999999999999999999876   78899999986542  2223467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|+||||+.+++|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++   .++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~  153 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchh
Confidence            9999999999999998754 45689999999999999999999985 799999999999995   478899999999875


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH------------------
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV------------------  365 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i------------------  365 (422)
                      ... .......|+..|+|||++.+ .++.++|||||||++|||++|+.||...........+                  
T Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            532 22344578999999999864 6899999999999999999999999754433221111                  


Q ss_pred             --------------------------HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          366 --------------------------LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       366 --------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                                ....  .+......++.++++||.+||++||++||++.|++.|+|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                      0000  0111112367899999999999999999999999999999654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-45  Score=366.82  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=219.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++..   +++.||||++...... ......+.+|+.++..+. |+||+++++.+...+
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKD  104 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCC-CCcEEEeecceeccc
Confidence            34689999999999999999999876   7889999999765432 334567889999999997 999999988775432


Q ss_pred             --------eEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC
Q 014559          225 --------NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       225 --------~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                              .+++||||+.+|+|.+++..+   ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCC
Confidence                    378999999999999988653   34689999999999999999999999999999999999995   4889


Q ss_pred             EEEeecCcccccCCC---CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          294 MRLIDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       294 vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      +||+|||+++.....   ......+||+.|+|||++.+ .++.++|||||||+||||++|+.||......+.+..+....
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            999999999765422   22345679999999999874 69999999999999999999999998888777777776654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ....   ...+++++.++|.+||..||.+||++.++|.|+|++...
T Consensus       262 ~~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 YDPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence            3321   136899999999999999999999999999999876543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-45  Score=379.94  Aligned_cols=265  Identities=30%  Similarity=0.523  Sum_probs=218.1

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+.+..+|++++.||+|+||.||+|++..   ++..||+|++...... ......+.+|+.+++.|. |+|||+++++|.
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~   82 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELK-HKNIVRYIDRFL   82 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE
Confidence            44555689999999999999999999987   7889999998764432 223467889999999997 999999999886


Q ss_pred             e--CCeEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCcEEEeeC-
Q 014559          222 D--VNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQ-------GVVHRDLKPENFLFTSG-  288 (422)
Q Consensus       222 ~--~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~-------~iiH~Dikp~NIll~~~-  288 (422)
                      +  ...+||||||+.+++|.++|...   .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.. 
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            5  35799999999999999988652   35799999999999999999999984       49999999999999631 


Q ss_pred             -------------CCCCCEEEeecCcccccCCCCCccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCC
Q 014559          289 -------------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       289 -------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~p  352 (422)
                                   +....+||+|||++............+||+.|+|||++.   ..++.++||||||||||||++|..|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                         123458999999998765444445668999999999874   3589999999999999999999999


Q ss_pred             CCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          353 FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       353 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      |........+...+...+.++   ...++.++.+||.+||..+|.+||++.|+|.+.|+..+
T Consensus       243 F~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        243 FHKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            976655444444444333322   23678999999999999999999999999999988654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-44  Score=354.77  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=203.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +..|.+.+.||+|+||.||+|++..   .++.||||....         ..+.+|+++|++|+ |+|||++++++...+.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence            4579999999999999999999887   788999996421         23568999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .+||||++. ++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~  310 (461)
T PHA03211        235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFA  310 (461)
T ss_pred             EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceec
Confidence            999999995 689988877666799999999999999999999999999999999999995   5788999999999765


Q ss_pred             CCCCC---ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHcCCCC--
Q 014559          306 RPDER---LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART--------ESGIFRAVLRSDPN--  371 (422)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~--  371 (422)
                      .....   ....+||..|+|||++.+ .++.++|||||||+||||++|..++....        ...+.+.+......  
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            43221   234579999999999864 68999999999999999999886653321        12233322221111  


Q ss_pred             -CC------------------------CCCCC---CCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          372 -FD------------------------DLPWP---SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       372 -~~------------------------~~~~~---~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                       ++                        ...|.   .++.++.+||.+||..||.+|||+.|+|+|+||+
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence             11                        11121   3567899999999999999999999999999996

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=344.31  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=217.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .-|.++++||+|+||.||+|.++.   +|+.+|||.+..+     ..++++.+||.+|+++. .+++|++||.+..+..+
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCce
Confidence            358899999999999999999987   8999999988543     24578899999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||..|++.|.+..++..+++.+|..+++..++||+|||...-||||||..|||++   .+|..||+|||.+..+.
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVAGQLT  180 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhccccchhh
Confidence            999999999999999999999999999999999999999999999999999999999996   48999999999998664


Q ss_pred             CC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .. ...+++.||+.|||||++.. .|+.++||||||++..||..|++||.+-..-..+..|- ..+.........++.+|
T Consensus       181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCChHhhhhHH
Confidence            33 44577899999999999985 79999999999999999999999996533221111111 11111111122579999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .|||+.||-++|++|.++.++++|.|.+.
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence            99999999999999999999999998764

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=349.00  Aligned_cols=261  Identities=28%  Similarity=0.481  Sum_probs=235.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|+.-+.||+||||.||-++.+.   +|+.||+|++.+.............+|-.||.+++ .+.||.+--+|++.+.+|
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceE
Confidence            47788899999999999999887   99999999998877777667777889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||..|.||+|.-+|...+ ..|++..+..++.+|+.||++||+.+||+|||||+||||   |+.|+|+|+|+|+|..+.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecC
Confidence            9999999999988887654 469999999999999999999999999999999999999   679999999999999998


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .+......+||.+|||||++. +.|+...|+|||||+||||+.|+.||....+    +++-+.+++....+++    ..|
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~----kFS  414 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD----KFS  414 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc----ccC
Confidence            888888889999999999987 4699999999999999999999999976544    3555666666666665    799


Q ss_pred             HHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          382 PEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++++++.+.+|++||.+|.     .+.++-+|+||+.+.|+.+
T Consensus       415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence            9999999999999999997     4669999999999999876

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-46  Score=358.39  Aligned_cols=258  Identities=34%  Similarity=0.537  Sum_probs=236.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|.+.+.||+|.|+.|.+|++..   ++..||||++++....... ...+.+|+++|+.|+ |||||+++.+.+....+
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLN-HPNIVKLFSVIETEATL  130 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHH-HHHHHHHHHHHHhcC-Ccceeeeeeeeeeccee
Confidence            369999999999999999999886   8999999999987765543 355899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+.+|.+.+++.+. +++.+..++.++.|++.|++|||+++|+|||||.+||||   +.+.++||+|||++.++.
T Consensus       131 ylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence            9999999999999998665 578889999999999999999999999999999999999   458889999999999999


Q ss_pred             CCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .+....++||++.|.|||++.+  ..++++|+||+|++||-|++|.+||.+.+-.+.-..++.++..++.    -++.+.
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            8999999999999999999875  4688999999999999999999999999888888888888888777    589999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      .++|+++|..+|.+|++..++..|-|.+.....
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999999887654

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=370.47  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=209.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE-Ee---
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC-ED---  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~-~~---  222 (422)
                      -++++.+.|.+|||+.||+|++..   .|..||+|++...   ++...+.+.+||++|+.|++|+|||.++|.. ..   
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            368999999999999999999986   4489999998543   5556788999999999999999999999932 21   


Q ss_pred             C---CeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEE
Q 014559          223 V---NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       223 ~---~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      +   -+++|.||||.||.|.|++..+ ...|++.++++|+.|+++|+.+||...  |||||||-|||||.   .++..||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KL  187 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKL  187 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEe
Confidence            1   3589999999999999999864 355999999999999999999999998  99999999999995   4889999


Q ss_pred             eecCcccccCCCC-Cc---------cccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 014559          297 IDFGLSDFIRPDE-RL---------NDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF  362 (422)
Q Consensus       297 ~DfG~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~  362 (422)
                      ||||.+.-..... ..         -...-|+.|+|||++.    ..++.|+|||+|||+||-|+....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            9999986432221 11         1134689999999974    36899999999999999999999999765443   


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                       .|+++...|+..  +.++..+.+||+.||+.||.+||++.|++..++.
T Consensus       265 -aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 -AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             -eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence             456666666654  5899999999999999999999999999987543

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-44  Score=351.15  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++++.||+|+||.||+|++..   +++.||+|+....         ....|+.++++++ |+||+++++++.+.+..
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCee
Confidence            469999999999999999999876   7789999985332         2346999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++|||++. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCccccccc
Confidence            99999995 589998877777899999999999999999999999999999999999994   58889999999997654


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh----------HHHHHHHcC----CCC
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----------GIFRAVLRS----DPN  371 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------~~~~~i~~~----~~~  371 (422)
                      .........||..|+|||++. ..++.++|||||||++|||+++..++......          ..+..+...    ...
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence            444445667999999999986 47899999999999999999866555332111          111111110    001


Q ss_pred             CC--------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          372 FD--------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       372 ~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++                          ......++.++.+||.+||+.||.+|||+.|+|+|+||+.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            11                          00112467788899999999999999999999999999753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-44  Score=339.86  Aligned_cols=256  Identities=31%  Similarity=0.575  Sum_probs=223.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   +++.||+|++...........+.+.+|+++++++. |+||+++++++.+.+.+|
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLY   77 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEE
Confidence            68999999999999999999887   78899999997655444445577889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+|+||+|.|||++   .++.+||+|||++.....
T Consensus        78 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          78 LVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccCC
Confidence            999999999999987654 6799999999999999999999999999999999999994   578999999999976644


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      .  .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+......++.    .++..+++
T Consensus       154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~  227 (290)
T cd05580         154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKD  227 (290)
T ss_pred             C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHH
Confidence            3  34457899999999875 46889999999999999999999999877766667777665554443    57899999


Q ss_pred             HHHHhchhccccCC-----CHHHHHhccCccchhhh
Q 014559          387 FVKRLLNKDYRKRM-----TAVQALSKLVVPILSFK  417 (422)
Q Consensus       387 li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k  417 (422)
                      +|.+||..||.+|+     +++|++.|+||..+.|-
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            99999999999999     99999999999877653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-44  Score=352.59  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=207.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ..++|++.+.||+|+||.||+|++..   .++.||||++..... .......+.+|+.+++.++ |+||+++++++... 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   89 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK   89 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence            34689999999999999999999876   788999999865432 2233466788999999997 99999999988654 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|+||||+++ +|.+.+..   .+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~D  162 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  162 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEee
Confidence                 357999999976 67666533   489999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC---------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS---------  368 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---------  368 (422)
                      ||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+...         
T Consensus       163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987655444556689999999999864 6899999999999999999999999776544433322211         


Q ss_pred             -------------CCCCCC----------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          369 -------------DPNFDD----------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       369 -------------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                   .+.+..                ......+.++++||.+||..||++|||+.|+|+|+|+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                         111000                0011245788999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=382.47  Aligned_cols=268  Identities=28%  Similarity=0.439  Sum_probs=236.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      -.++|++++.||+|+||.|.+++.+.   +++.||+|++.+-..........|..|-.+|..-. .+-|+.++-.|.|+.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDER  148 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCcc
Confidence            34679999999999999999999988   89999999998755554555577888989998764 899999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ++|+||||+.||+|..++.+.. ++++..++.|+.+|+.||.-||+.|+|||||||+||||   |..|++||+|||.+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHh
Confidence            9999999999999999876655 89999999999999999999999999999999999999   5699999999999877


Q ss_pred             cCCCCC--ccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      +..++.  ....+|||.|.+||++.      +.|+..+|+||+||++|||+.|..||....-.+.+.+|++....+....
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~  304 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD  304 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence            664443  45678999999999983      4599999999999999999999999999999999999998754443333


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCC---HHHHHhccCccchhhhhhhc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVPILSFKIVCR  421 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~~l~~k~~~~  421 (422)
                      -..+|.++++||+++|+- |..|..   ++++-.|+||..+.|..+|.
T Consensus       305 ~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR~  351 (1317)
T KOG0612|consen  305 ETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIRE  351 (1317)
T ss_pred             ccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhhh
Confidence            346999999999999874 789998   99999999999999988764

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.8e-44  Score=352.51  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ...+|++.+.||+|+||.||+|++..   .++.||||++..... .......+.+|+.+++.++ |+||+++++++... 
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~   96 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK   96 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence            34679999999999999999999876   788999999865332 2223466788999999997 99999999987543 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|+||||+++ +|.+.+..   .+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~D  169 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  169 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEe
Confidence                 458999999975 77776643   488999999999999999999999999999999999995   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC-------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-------  370 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------  370 (422)
                      ||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..++....       
T Consensus       170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999987655444456689999999999864 689999999999999999999999987776655555443111       


Q ss_pred             ---------------CCCCC----------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          371 ---------------NFDDL----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       371 ---------------~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                     .+...                .....+.++++||.+||..||.+|||+.|+|+|+|++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                           10000                00113567999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-44  Score=346.89  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=195.2

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CCeEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VNNVYIV  229 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~lv  229 (422)
                      +++||+|+||.||+|+++.+. +++.||+|.+.....     ...+.+|+.++++++ |+||+++++++.+  ...+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCC-CCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence            468999999999999976432 668899999864322     245678999999997 9999999999865  4578999


Q ss_pred             EEccCCCChHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEeecC
Q 014559          230 MELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFG  300 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~DfG  300 (422)
                      |||+.+ +|.+.+...        ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999965 888776432        1258999999999999999999999999999999999999542 346789999999


Q ss_pred             cccccCCCC----CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHH
Q 014559          301 LSDFIRPDE----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES---------GIFRAV  365 (422)
Q Consensus       301 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------~~~~~i  365 (422)
                      +++......    ......||..|+|||++.+  .++.++|||||||++|||++|+.||......         ..+..+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            997654322    2345678999999998754  5899999999999999999999999653321         122222


Q ss_pred             HcCCCCCC----------------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          366 LRSDPNFD----------------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       366 ~~~~~~~~----------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ........                                  .......+.++.+||++||++||.+|+|++|+|+|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            11100000                                  00011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-45  Score=339.81  Aligned_cols=254  Identities=39%  Similarity=0.646  Sum_probs=210.2

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++++.||+|+||+||++++..   +++.||+|++......... .....+|+.++++++ |+||+++++++.+...+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLR-HPNIVQILDVFQDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccccc-cchhhhhhhcccccc-ccccccccccccccccccc
Confidence            7899999999999999999987   7789999999876443322 233456999999996 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc-CC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~-~~  307 (422)
                      |||++.+++|.+++. ....+++..++.++.||++||.+||++||+|+||||+||+++   .++.++|+|||.+... ..
T Consensus        76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTST
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            999999999999886 445799999999999999999999999999999999999994   6889999999999753 33


Q ss_pred             CCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          308 DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ........++..|+|||++.  ..++.++||||||+++|+|++|..||....   ....+..............+.....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE  231 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence            34455678899999999986  578999999999999999999999998763   2233333332221111111112348


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++.++|.+||+.||++||++.++++|+||
T Consensus       232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=342.41  Aligned_cols=264  Identities=30%  Similarity=0.518  Sum_probs=225.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.+..   +++.||||.+.............+.+|+++++.+. |+||+++++.+.+.+..|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   77 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLC   77 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEE
Confidence            68999999999999999999876   78899999998765544345577899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccc
Confidence            999999999999987653 35699999999999999999999999999999999999995   47899999999986543


Q ss_pred             CCC------------------------------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014559          307 PDE------------------------------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA  355 (422)
Q Consensus       307 ~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~  355 (422)
                      ...                              ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            211                              1123468889999998764 689999999999999999999999988


Q ss_pred             CChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC----HHHHHhccCccchhhhhhh
Q 014559          356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT----AVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~elL~~l~~~~l~~k~~~  420 (422)
                      ......+..+......++..  ..++.++.++|.+||..||++||+    ++|+|.|.||+...|...+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         235 SNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR  301 (316)
T ss_pred             CchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence            87777777776555444432  237899999999999999999999    9999999999988776543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-44  Score=353.68  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=210.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC---
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN---  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  224 (422)
                      +|++++.||+|+||.||+|++..   +++.||||++.... ........+.+|+.+++.++ |+||+++++++...+   
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence            37888999999999999999876   78899999986432 22233467889999999997 999999999998876   


Q ss_pred             --eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                        .+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        76 ~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a  150 (372)
T cd07853          76 FEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLA  150 (372)
T ss_pred             cceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccce
Confidence              7999999996 478776643 45799999999999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC---------
Q 014559          303 DFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---------  369 (422)
Q Consensus       303 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  369 (422)
                      +......  ......++..|+|||++.+  .++.++|||||||++|||++|+.||.+......+..+....         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            7654322  2234568899999998864  48999999999999999999999998877665555443211         


Q ss_pred             --------------CCCCC-----CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          370 --------------PNFDD-----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       370 --------------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                    ...+.     ......++++.+||.+||+.||++||++.|+|+|+||....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                          01110     01124688999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.4e-44  Score=333.60  Aligned_cols=254  Identities=28%  Similarity=0.493  Sum_probs=210.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      ...|++.+.||+|+||.||+|++..   +++.||+|++....    .....+.+|+.+++++.+|+||+++++++...  
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            4568999999999999999999876   78899999986542    12357889999999996699999999998763  


Q ss_pred             ----CeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 ----NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                          ..+|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||+++   +++.+||+|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~D  154 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVD  154 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEcc
Confidence                4689999999999999988763 35689999999999999999999999999999999999994   578899999


Q ss_pred             cCcccccCCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       299 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ||++...... .......|+..|+|||++.      ..++.++|||||||++|||++|..||...........+....  
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--  232 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--  232 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--
Confidence            9998765432 2334567899999999874      248889999999999999999999997655444443333221  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ........++.++.+||.+||..||.+||++.|++.|+||
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            1222233678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=360.62  Aligned_cols=251  Identities=26%  Similarity=0.445  Sum_probs=215.6

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEcc
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC  233 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  233 (422)
                      .||+|.||+||.|++..   +...+|||.+...   .....+-+..||.+.++|+ |.|||+++|.+.+++.+-|.||-+
T Consensus       582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeecccc---ceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence            59999999999999998   7889999998543   2233466889999999998 999999999999999999999999


Q ss_pred             CCCChHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC-CC
Q 014559          234 EGGELLDRILARGGRY--TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ER  310 (422)
Q Consensus       234 ~~g~L~~~l~~~~~~l--~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~  310 (422)
                      +||+|.+.+..+=+++  ++..+..+.+||++||.|||++.|||||||-+||||+.  ..|.+||+|||.++.+..- ..
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEEecccccchhhccCCcc
Confidence            9999999988776777  88999999999999999999999999999999999975  6899999999999876543 34


Q ss_pred             ccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HHHH-HHHcCCCCCCCCCCCCCCHHH
Q 014559          311 LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFR-AVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~-~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ..++.||+.|||||++.   +.|+.++|||||||++.||.||++||......  .+++ ...+..+.+++    .++.++
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe----elsaea  808 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE----ELSAEA  808 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH----HHHHHH
Confidence            56789999999999996   36999999999999999999999999654332  2221 12233444544    689999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      +.||.+|+..||.+||+|.++|.++|++.-..|
T Consensus       809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             HHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence            999999999999999999999999999876444

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=329.57  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=211.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc--hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .|++.+.||+|+||.||+|.+..   +++.||||.+.......  ......+.+|++++++++ |+||+++++++.+.+.
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   78 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDET   78 (263)
T ss_pred             cccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCe
Confidence            58999999999999999999876   78899999987543222  223457889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+.+... +.+++..+..++.|++.||.|||++||+|+||+|+||+++   .++.++|+|||++...
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~  154 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceec
Confidence            99999999999999887554 5689999999999999999999999999999999999995   5789999999998755


Q ss_pred             CCCCCc----cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDERL----NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......    ....|+..|+|||++.+ .++.++|||||||++|||++|+.||...........+........  ....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  232 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHV  232 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccC
Confidence            432211    33567889999999864 589999999999999999999999977655544444443322211  11368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +.++.++|++||..||.+||++.|+|+++||
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.1e-44  Score=336.60  Aligned_cols=243  Identities=17%  Similarity=0.251  Sum_probs=205.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----CCeEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VNNVYI  228 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~l  228 (422)
                      ..||+|++|.||+|..     +|+.||||.+...........+.+.+|+.+|++++ |+||+++++++.+    ...+++
T Consensus        26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l   99 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL   99 (283)
T ss_pred             eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence            5799999999999986     56789999997654444334577889999999997 9999999999877    357899


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||++   +++.+||+|||+++....
T Consensus       100 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        100 ILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSS  175 (283)
T ss_pred             EEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcc
Confidence            99999999999987654 5789999999999999999999985 999999999999994   588999999999876543


Q ss_pred             CCCccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .  .....|+..|+|||++.   +.++.++|||||||++|||++|+.||......+++..+......+...  ..++.++
T Consensus       176 ~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l  251 (283)
T PHA02988        176 P--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI  251 (283)
T ss_pred             c--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence            2  23456889999999985   468999999999999999999999999888777777776544333221  2588999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhcc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++||.+||+.||++||++.|+++.+
T Consensus       252 ~~li~~cl~~dp~~Rps~~ell~~l  276 (283)
T PHA02988        252 KCIVEACTSHDSIKRPNIKEILYNL  276 (283)
T ss_pred             HHHHHHHhcCCcccCcCHHHHHHHH
Confidence            9999999999999999999999763

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-43  Score=349.93  Aligned_cols=259  Identities=22%  Similarity=0.366  Sum_probs=208.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++++.||+|+||.||+|.... ...++.||||.+...        ....+|+++++.|+ |+||+++++++...+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            44579999999999999999997643 226788999987543        23468999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|+|||++. ++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       160 ~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCccccc
Confidence            9999999996 5888877 4456799999999999999999999999999999999999994   588999999999976


Q ss_pred             cCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCC----CCCC
Q 014559          305 IRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSD----PNFD  373 (422)
Q Consensus       305 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~----~~~~  373 (422)
                      ......   .....||..|+|||++. ..|+.++|||||||++|||++|+.||.+...   ...+..+....    ..++
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            543322   23467999999999986 4689999999999999999999999976432   12222222110    0000


Q ss_pred             C--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          374 D--------------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       374 ~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      .                          .....++.++.+||++||..||++||++.|+|.|+||....+..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence            0                          00113567899999999999999999999999999998655543

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.9e-44  Score=335.05  Aligned_cols=255  Identities=28%  Similarity=0.388  Sum_probs=207.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++...... ......+.+|+.+++++. |+||+++++++.+.+.+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC---CCcEEEEEEecccccc-CCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence            48899999999999999999876   7889999998654322 223466788999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          228 IVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +||||+. ++|.+++....  ..+++..++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++...
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~  151 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeec
Confidence            9999997 58888775432  5689999999999999999999999999999999999995   5889999999998755


Q ss_pred             CCCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC----------
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF----------  372 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  372 (422)
                      .... ......++..|+|||++.+  .++.++|||||||++|+|++|+.||...........+.......          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence            3222 2233467889999998753  47899999999999999999999998765544333322211000          


Q ss_pred             ---------------CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 ---------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                     .......+++++++||++||+.||.+||++.+++.|+||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                           001123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-46  Score=352.34  Aligned_cols=236  Identities=28%  Similarity=0.419  Sum_probs=204.6

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEE
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM  230 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  230 (422)
                      .++.||.|+.|.||+++.     .++.||||+++.          .-+.+|+-|++|+ |+||+.|.|+|.....+||||
T Consensus       128 ELeWlGSGaQGAVF~Grl-----~netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-----HNETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             hhhhhccCcccceeeeec-----cCceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEee
Confidence            456799999999999986     457899998742          2246899999997 999999999999999999999


Q ss_pred             EccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC
Q 014559          231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER  310 (422)
Q Consensus       231 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  310 (422)
                      |||..|.|...++. +..++......|.++|+.|+.|||.++|||||||.-||||+.   +..|||+|||.++.......
T Consensus       192 EfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~ST  267 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKST  267 (904)
T ss_pred             eccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhh
Confidence            99999999998754 467999999999999999999999999999999999999975   77899999999998877777


Q ss_pred             ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC-CCCHHHHHHH
Q 014559          311 LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFV  388 (422)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~~~~~li  388 (422)
                      ...++||..|||||++.+ ..+.|+|||||||||||||||..||.+.....++.-+-..   ...++.+ .+++-|+-||
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN---sL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN---SLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC---cccccCcccCchHHHHHH
Confidence            788999999999999975 6899999999999999999999999876665554433322   2222222 5788899999


Q ss_pred             HHhchhccccCCCHHHHHhcc
Q 014559          389 KRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       389 ~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.||.-.|..||+++++|.|+
T Consensus       345 Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHHH
Confidence            999999999999999999995

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-43  Score=335.49  Aligned_cols=261  Identities=29%  Similarity=0.449  Sum_probs=217.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+.|+++++||+|+||.||+|++..   +++.|++|++...   .....+.+.+|+.+++.+. |+||+++++.+..++.
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   83 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK   83 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence            3579999999999999999999876   7889999998643   2334567888999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+++++|...+.+....+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~  160 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceec
Confidence            9999999999999887766666799999999999999999999999999999999999994   5789999999998653


Q ss_pred             CCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ... .......++..|+|||++.      ..++.++|||||||++|||++|+.||........+..+....... .....
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  239 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPS  239 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCc
Confidence            322 2234456889999999873      247889999999999999999999998766555555554433211 11123


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      .++.++.++|++||..||++||++.++++|+|+..+...
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            578899999999999999999999999999999876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-44  Score=337.80  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=207.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDD-EGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeeccccc-ccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence            48899999999999999999987   7889999999754322 222356778999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|+||+.+ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        76 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          76 LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGI  151 (284)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCC
Confidence            99999974 88888776667899999999999999999999999999999999999995   578999999999876543


Q ss_pred             CC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHcCCC-------------
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP-------------  370 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~-------------  370 (422)
                      .. ......++..|+|||++.+  .++.++|||||||++|+|++|..||.. ....+.+..+.....             
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            32 2234567899999998754  478999999999999999999988643 333333333322110             


Q ss_pred             -C---CCCC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          371 -N---FDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       371 -~---~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                       .   +...        ..+.++.++++||++||..||.+|||+.++|.|+||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             0   0000        113578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-43  Score=331.30  Aligned_cols=253  Identities=18%  Similarity=0.286  Sum_probs=210.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|.++.....+..||+|.++...  .......+.+|+.+++.++ |+||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence            46999999999999999999876433367799999987542  2223467889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++|+|.+++......+++..++.++.||+.||.|||++|++||||||+|||++   .++.+||+|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCccccccc
Confidence            999999999999998877666899999999999999999999999999999999999994   58899999999876543


Q ss_pred             CCCCcc--ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLN--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ......  ...++..|+|||++. +.++.++|||||||++||+++ |..||+.....+.+..+...... +  ....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-P--APRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C--CCCCCCH
Confidence            222111  223467899999875 578999999999999999775 99999988877777766554321 1  1236889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .+.++|.+||..+|.+||++.++++.
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~~  261 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHSI  261 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-43  Score=326.07  Aligned_cols=253  Identities=26%  Similarity=0.475  Sum_probs=216.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|.+.+.||+|+||.||+|.+..   +++.|++|.+...... ......+.+|+++++.++ |+||+++++++.+.+..|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence            37888999999999999999876   7889999998764333 334567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~  152 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceecc
Confidence            999999999999988764 46799999999999999999999999999999999999995   47899999999987654


Q ss_pred             CCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....|+..|+|||++. +.++.++|+|||||++|+|++|+.||...........+.........   ..++.++
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQL  229 (256)
T ss_pred             CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence            4332 33457889999999876 46889999999999999999999999887776666666654432211   1578999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .++|.+||+.+|++||++.++++++|+
T Consensus       230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         230 AQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999999885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=333.80  Aligned_cols=259  Identities=32%  Similarity=0.473  Sum_probs=218.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||.|+||.||++.+..   ++..||+|++...   .....+.+.+|++++++++ |+||+++++++.+.+.+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKL   77 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeE
Confidence            469999999999999999999876   7789999998643   2334467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhhc
Confidence            999999999999998877667799999999999999999999999999999999999994   58899999999986543


Q ss_pred             CC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .. .......++..|++||++.      ..++.++|||||||++|||++|+.||........+..+......... ....
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  233 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSK  233 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-Cccc
Confidence            22 2234456899999999863      24788999999999999999999999877665655555544322111 1235


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ++.++.++|.+||+.||.+||++.++|+|.|+.....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            7899999999999999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.8e-44  Score=348.76  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++++.||+|+||.||+|++..  ...++..||||++......  ...+.+.+|+.+++.+.+|+|||++++++.+.+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            469999999999999999998643  1124568999999754322  234678899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC----------------------------------------------------------
Q 014559          225 NVYIVMELCEGGELLDRILARG----------------------------------------------------------  246 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  246 (422)
                      .+++|||||.+|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999875421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc---c
Q 014559          247 -----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---N  312 (422)
Q Consensus       247 -----------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~---~  312 (422)
                                 ..+++..++.++.||+.||.|||++||+||||||+|||++   +++.+||+|||+++........   .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcceeecc
Confidence                       2478889999999999999999999999999999999995   5788999999999765433221   1


Q ss_pred             ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 014559          313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR  390 (422)
Q Consensus       313 ~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  390 (422)
                      ...++..|+|||++. ..++.++|||||||++|||++ |+.||........+..+.........  ...++.++.++|.+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHH
Confidence            223456799999875 579999999999999999997 99999776554444444433222211  12468999999999


Q ss_pred             hchhccccCCCHHHHHhc
Q 014559          391 LLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       391 ~L~~dP~~Rps~~elL~~  408 (422)
                      ||+.||.+||++.++++.
T Consensus       351 cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         351 CWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-45  Score=326.54  Aligned_cols=264  Identities=29%  Similarity=0.440  Sum_probs=213.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-CC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~  224 (422)
                      ..|+++++||+|+||.||+|..++.. ...+.+|||.++-++..+... ...-+|+.+++.|+ |+||+.|..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELK-HPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence            35999999999999999999655432 123589999997654433332 45678999999998 9999999999988 78


Q ss_pred             eEEEEEEccCCCChHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEeec
Q 014559          225 NVYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDF  299 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~Df  299 (422)
                      .++|++||.+. +|++.|+..    ...++...++.|+.||+.|+.|||++-|+||||||.||||..+ .+.|.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999987 999988642    3468999999999999999999999999999999999999752 35699999999


Q ss_pred             CcccccCCC----CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------hHHHHH
Q 014559          300 GLSDFIRPD----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE---------SGIFRA  364 (422)
Q Consensus       300 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------~~~~~~  364 (422)
                      |+++.+...    .....++.|.+|+|||.+.+  .|+.++|||++|||+.||++-++.|.+..+         .+++.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999976533    23456788999999999865  699999999999999999999999866432         245666


Q ss_pred             HHcCCCCCCCCCCCC---------------------------------CCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          365 VLRSDPNFDDLPWPS---------------------------------VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       365 i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      |++.-.......|+.                                 -++...+|+.+||..||.+|.|++|+|+|++|
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            665443333333322                                 13458899999999999999999999999988


Q ss_pred             cc
Q 014559          412 PI  413 (422)
Q Consensus       412 ~~  413 (422)
                      -.
T Consensus       341 ~~  342 (438)
T KOG0666|consen  341 TE  342 (438)
T ss_pred             cc
Confidence            53

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-44  Score=347.55  Aligned_cols=257  Identities=28%  Similarity=0.504  Sum_probs=207.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +.++|++++.||+|+||.||+|++..   +++.||||++..... .......+.+|+.+++.++ |+||+++++++... 
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence            34579999999999999999999876   788999999865322 2223456778999999997 99999999988643 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|++||++ +++|.+.+.  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~D  161 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILD  161 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcC
Confidence                 4579999998 668877653  34699999999999999999999999999999999999995   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------  370 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  370 (422)
                      ||++.....  .....+|+..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+.....      
T Consensus       162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999976543  3345679999999999764  589999999999999999999999977655444443322111      


Q ss_pred             -----------------CCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          371 -----------------NFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       371 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                       ..+..    .+...++.+.+||.+||..||.+|||+.|+|.|+||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                             00000    012456788999999999999999999999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-43  Score=347.95  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=204.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++++.||+|+||.||+|++..  ...++..||||+++....  ....+.+.+|+.+++.+.+||||+++++++.+.+
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            469999999999999999997532  112567899999864432  2234678899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC----------------------------------------------------------
Q 014559          225 NVYIVMELCEGGELLDRILARG----------------------------------------------------------  246 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  246 (422)
                      ..++|||||++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886432                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC
Q 014559          247 ----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER  310 (422)
Q Consensus       247 ----------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  310 (422)
                                      ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc
Confidence                            2478888999999999999999999999999999999995   477899999999976543322


Q ss_pred             c---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          311 L---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       311 ~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .   ....++..|+|||++. ..++.++|||||||++|||++ |..||............+.......  .....+.++.
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  347 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMY  347 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHH
Confidence            1   1233456799999876 478999999999999999997 8999977654433333333222111  1124688999


Q ss_pred             HHHHHhchhccccCCCHHHHHhcc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +||.+||+.||++||++.|+++.+
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~l  371 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQLI  371 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-43  Score=329.99  Aligned_cols=254  Identities=29%  Similarity=0.449  Sum_probs=207.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||+|++.....   .....+.+|+.+++.+. |+||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREK   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Confidence            3579999999999999999999876   788999999864322   22356788999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        81 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~  156 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceee
Confidence            9999999999999988754 45789999999999999999999999999999999999994   5788999999999765


Q ss_pred             CCC-CCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC-CCC
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-WPS  379 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~  379 (422)
                      ... .......|+..|+|||.+.    ..++.++|||||||++|||++|+.||...........+.......+... ...
T Consensus       157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06646         157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK  236 (267)
T ss_pred             cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence            422 2234457889999999873    3478899999999999999999999965443332222222221111111 124


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ++.++.+||++||..||++||++.++|+++|
T Consensus       237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            7899999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=335.20  Aligned_cols=261  Identities=26%  Similarity=0.456  Sum_probs=234.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|.++..||+|+||.|.+|..+.   +.+.||||+++++..-.....+--..|-++|.....-|.+++++..|..-+.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3579999999999999999999877   7889999999987766665666666788888776668899999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+.||+|.-++.. -+++.+..+..++.+|+-||-|||++|||+||||.+||||   |.+|++||+|||+++.-
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence            9999999999999887754 4789999999999999999999999999999999999999   56999999999999743


Q ss_pred             -CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 -RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                       -.+....++|||+.|+|||++. +.|+..+|+||+||+||||+.|..||.+.++.++++.|......++.    .+|.|
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE  576 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE  576 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence             3445677899999999999875 78999999999999999999999999999999999999999988887    79999


Q ss_pred             HHHHHHHhchhccccCCCH-----HHHHhccCccchhhh
Q 014559          384 AKDFVKRLLNKDYRKRMTA-----VQALSKLVVPILSFK  417 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~-----~elL~~l~~~~l~~k  417 (422)
                      +.++++.+|.+.|.+|...     +++-.|+||..+.|-
T Consensus       577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence            9999999999999999853     688899999988874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.8e-43  Score=324.85  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=217.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.+..   +++.+|||.+....... .....+.+|++++++++ |+||+++++.+...+.++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence            48999999999999999999876   78899999997654332 23567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++  ++++.+||+|||++....
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILS  153 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecC
Confidence            9999999999999887653 4589999999999999999999999999999999999995  235568999999998766


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .........++..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+........   ...++.++.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~  230 (256)
T cd08220         154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLR  230 (256)
T ss_pred             CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHH
Confidence            5544455678999999999864 678999999999999999999999987766666655554332211   125889999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++|.+||..||.+||++.|+|+|+|+
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-43  Score=334.65  Aligned_cols=256  Identities=20%  Similarity=0.309  Sum_probs=202.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-------------ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-------------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      .+|++.++||+|+||.||+|++..+.             .++..||||++....  .......+.+|+.++.+++ |+||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni   81 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPNI   81 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCCe
Confidence            57999999999999999999864311             134579999986542  2234567889999999997 9999


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVH  275 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH  275 (422)
                      +++++++.+.+..++||||+.+++|.+++....                  ..+++..++.++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999875431                  23677889999999999999999999999


Q ss_pred             cCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh--C
Q 014559          276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--G  349 (422)
Q Consensus       276 ~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g  349 (422)
                      |||||+|||++   .++.+||+|||+++.......   .....++..|+|||++. +.++.++|||||||++|||++  +
T Consensus       162 ~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         162 RDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999995   578999999999976543321   12334578899999875 579999999999999999986  6


Q ss_pred             CCCCCCCChhHHHHHHHcC---C-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          350 SRPFWARTESGIFRAVLRS---D-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       350 ~~pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..||........+..+...   . ........+.++..+.+||.+||..||.+||++.|+.+.
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~  301 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF  301 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            6788766555544433211   1 111111123578999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.1e-43  Score=323.99  Aligned_cols=253  Identities=29%  Similarity=0.485  Sum_probs=217.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||.+++..   +++.+++|.+....... .....+.+|+.++++++ |+||+++++++.+.+.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence            48999999999999999999876   78899999986544332 33466889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+++++|.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++   +++.+||+|||++....
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcc
Confidence            999999999999988764 45689999999999999999999999999999999999995   57889999999987654


Q ss_pred             CCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ... ......++..|+|||++.+ .++.++||||||+++|||++|..||......+....+.........   ..++.++
T Consensus       153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (256)
T cd08221         153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL  229 (256)
T ss_pred             cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence            333 2345678999999998764 5889999999999999999999999887777777777654433221   3688999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .++|.+||..||.+||++.++|+++|+
T Consensus       230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         230 ISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-43  Score=339.79  Aligned_cols=259  Identities=21%  Similarity=0.272  Sum_probs=205.6

Q ss_pred             EeceeCcC--CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          151 LGKEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       151 ~~~~lG~G--~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      ++++||+|  +|++||+++++.   +|+.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+++..|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence            46789999  678999999987   8899999999764332 223456888999999996 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++   .++.++++||+.+.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccc
Confidence            99999999999988654 34589999999999999999999999999999999999995   478899999986543221


Q ss_pred             CCC--------ccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC---
Q 014559          308 DER--------LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD---  373 (422)
Q Consensus       308 ~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  373 (422)
                      ...        .....++..|+|||++.+   .++.++|||||||++|||++|+.||....................   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            110        122356778999999853   589999999999999999999999976544433333222111000   


Q ss_pred             ---------------------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          374 ---------------------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       374 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                                             ......+++++.+||++||+.||++|||+.|+|+|+||+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                   00011356789999999999999999999999999999876


Q ss_pred             hhh
Q 014559          415 SFK  417 (422)
Q Consensus       415 ~~k  417 (422)
                      ...
T Consensus       314 ~~~  316 (327)
T cd08227         314 KRR  316 (327)
T ss_pred             chh
Confidence            544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.5e-43  Score=326.97  Aligned_cols=255  Identities=27%  Similarity=0.479  Sum_probs=215.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||.|+||.||+|....   ++..+|+|++.......  ....+.+|+.+++.++ |+||+++++.+...+..+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELW   75 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEE
Confidence            68999999999999999999876   77899999986543322  4577899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||++++++|.+.+...  ...+++..+..++.|++.||.|||++||+|+||+|+||+++   +++.+||+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHh
Confidence            999999999999988654  24689999999999999999999999999999999999995   5788999999998765


Q ss_pred             CCCCCc-----cccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-CCCC-C
Q 014559          306 RPDERL-----NDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-FDDL-P  376 (422)
Q Consensus       306 ~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~-~  376 (422)
                      ......     ....|+..|++||++..  .++.++|+|||||++|+|++|+.||........+..+...... +... .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence            543222     33568999999998763  5899999999999999999999999876665555555554332 2211 1


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +..++.++.++|.+||..||++||++.+++.|+||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            24678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-43  Score=325.95  Aligned_cols=248  Identities=25%  Similarity=0.428  Sum_probs=208.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+++.+    .+..+|+|.+.....    ..+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec----cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence            35889999999999999999875    345799998764432    2367889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++   +++.+||+|||+++...
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccC
Confidence            999999999999998876656799999999999999999999999999999999999994   57889999999987653


Q ss_pred             CCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .....  ....++..|+|||++. ..++.++||||||+++|||++ |+.||......+.+..+.........   ...+.
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~  228 (256)
T cd05114         152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASM  228 (256)
T ss_pred             CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCH
Confidence            32221  1223556899999986 478999999999999999999 99999888777777777665432211   24678


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||..||++||++.++++.+
T Consensus       229 ~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-43  Score=335.05  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   ++..||+|.+....  .......+.+|++++++++ |+||+++++.+.+++.+|
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   75 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEIS   75 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEE
Confidence            58999999999999999999876   77889999986432  2223456889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+ .+++|+||||+|||++   .++.+||+|||++....
T Consensus        76 lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccc
Confidence            999999999999987654 679999999999999999999997 5999999999999995   47889999999987553


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC--------------
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--------------  371 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  371 (422)
                      .. ......|+..|+|||++.+ .++.++|+|||||++|+|++|+.||...........+......              
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            22 2345678999999998764 6889999999999999999999999655433322211111000              


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          372 --------------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       372 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                          .+..+...++.++++||.+||..||++||++.|++.|+||..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                                011111236789999999999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-43  Score=331.98  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=213.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++....... .....+.+|+.++++++ |+||+++++++.+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEG-GIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence            48999999999999999999876   68899999987654322 23467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++.....
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSE  151 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccC
Confidence            999999 8999998877667799999999999999999999999999999999999995   488899999999876654


Q ss_pred             CC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC-----------
Q 014559          308 DE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-----------  372 (422)
Q Consensus       308 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  372 (422)
                      ..  ......|+..|+|||++.+  .++.++|||||||++|||++|..+|........+..+.......           
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence            33  2344578999999998753  47899999999999999999988887766655555444311100           


Q ss_pred             --------CC-------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          373 --------DD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       373 --------~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                              ..       ...+.++.++.+||++||..||++||+++++|.|+||.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                    00       01134678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.3e-43  Score=332.43  Aligned_cols=261  Identities=28%  Similarity=0.457  Sum_probs=219.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++++..   +++.||||.+.............+.+|+++++.++ |+||+++++.+..++.++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   77 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLC   77 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEE
Confidence            58999999999999999999876   78899999987654433344567889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||+++....
T Consensus        78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          78 MVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCc
Confidence            999999999999887554 5799999999999999999999999999999999999994   588999999998863211


Q ss_pred             CC----------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          308 DE----------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       308 ~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      ..                ......++..|+|||.+. ..++.++|+|||||++|||++|..||.+....+.+..+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  233 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            00                011245788899999875 5789999999999999999999999988877777777766554


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHHhccCccchhhh
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVPILSFK  417 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~~l~~k  417 (422)
                      ..+... ..++.++.++|.+||..||++||+   +.++|+|+||....+.
T Consensus       234 ~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         234 EWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             CCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            433322 258899999999999999999998   8999999998665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-43  Score=330.57  Aligned_cols=258  Identities=31%  Similarity=0.492  Sum_probs=215.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++.+.||+|+||.||++.+..   ++..+++|.+....   ....+.+.+|+++++.+. |+||+++++++...+..+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEE
Confidence            47889999999999999999876   77889999985432   233467888999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+++|.+.+......+++..+..++.|++.||.|||+.||+||||||+|||++   .++.+||+|||++.....
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccccc
Confidence            99999999999887766566799999999999999999999999999999999999994   578899999999865432


Q ss_pred             C-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          308 D-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       308 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      . .......++..|+|||++.      ..++.++|||||||++|||++|+.||...........+........ .....+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  234 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRW  234 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCcccc
Confidence            2 2234457899999999873      2478899999999999999999999987766665555544332211 112357


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      +.++.+||.+||..||.+||++.++++|+|+.....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            899999999999999999999999999999876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-43  Score=329.01  Aligned_cols=253  Identities=27%  Similarity=0.446  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||+|+++...   ......+.+|+.+++.++ |+||+++++.+.+.+.+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Confidence            479999999999999999999876   78899999986542   223356788999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++.. .+.+++.+++.++.|++.||.|||++||+|+||||+||+++   .++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          82 WICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEcc
Confidence            999999999999997754 45799999999999999999999999999999999999994   57889999999987553


Q ss_pred             CC-CCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC-CCCC
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-WPSV  380 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~  380 (422)
                      .. .......|+..|+|||++.    +.++.++|||||||++|+|++|..||...................+... ...+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW  237 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence            22 2234457899999999863    3588999999999999999999999976554443333332222221111 1247


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      +..+.+||.+||..||++||++.+++.|+|
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-42  Score=322.99  Aligned_cols=253  Identities=23%  Similarity=0.459  Sum_probs=212.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-CCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~  226 (422)
                      .|++.+.||+|+||.||++.++.   +++.||+|.+...... ....+.+.+|++++++++ |+|++++++.+.. +..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL   75 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence            38999999999999999999876   6789999998754332 223466889999999997 9999999998864 4568


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |+||||+++++|.+++... ...+++.+++.++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~  152 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEe
Confidence            9999999999999988763 35689999999999999999999999999999999999995   5889999999998765


Q ss_pred             CCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .... ......++..|+|||++. ..++.++|||||||++|+|++|+.||...........+.......   ....++.+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPE  229 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHH
Confidence            4322 234456889999999876 468899999999999999999999998776666655555443311   11368899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +.+||.+||+.||++||++.++++|+||
T Consensus       230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         230 LGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.1e-43  Score=328.61  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=208.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|++..   +++.||+|++....  .......+.+|+++++++. |+||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEE
Confidence            57888999999999999999876   78899999986542  2223456889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|...     ..+++..+..++.|++.||.|||++||+|+||||+|||++   .++.+||+|||++.....
T Consensus        76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceeccc
Confidence            99999999887543     2578999999999999999999999999999999999995   588999999999976543


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHHHcCCCCCCCCCCCC
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-------SGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      . .....+|+..|+|||++. ..++.++|||||||++|+|++|+.||.....       ......+....  ........
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  224 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQ  224 (279)
T ss_pred             c-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCc
Confidence            2 334567999999999886 4689999999999999999999999965321       12222222222  12222335


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ++.++.++|.+||+.||++||+++|++.|+|+.....+
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence            78899999999999999999999999999999865443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.8e-43  Score=329.69  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=208.1

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--CeE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NNV  226 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  226 (422)
                      |++.+.||+|+||.||+|.+..   +++.||+|+++......  ......+|+.++.++.+|+||+++++++.+.  +.+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   75 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL   75 (282)
T ss_pred             CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence            6788999999999999999876   78899999986542221  1123457899999997799999999999988  899


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+ +|++.+......+++..++.++.|++.||.|||++|++||||||+||+++   . +.+||+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          76 ALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccc
Confidence            999999974 88888876666799999999999999999999999999999999999995   4 899999999998765


Q ss_pred             CCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-------------
Q 014559          307 PDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------------  371 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  371 (422)
                      .........++..|+|||++.  +.++.++|||||||++|||++|..||.+.+..+.+..+......             
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            554445567899999999764  35789999999999999999999999877665554444321110             


Q ss_pred             -----CCCC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 -----FDDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 -----~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                           ++..       ....++.++.+||.+||..||++||++.++|+|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                 1000       012468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-43  Score=328.66  Aligned_cols=252  Identities=30%  Similarity=0.554  Sum_probs=215.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||.|+||.||+|++..   +++.||+|++.+.........+.+.+|++++++++ |+||+++++.+.+...++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence            48999999999999999999876   78899999998765544445678999999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++   +++.++|+|||++.....
T Consensus        77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP  152 (258)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCC
Confidence            999999999999887654 6799999999999999999999999999999999999994   588999999999877655


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ........|+..|+|||++. ..++.++|+||||+++|+|++|..||.....   .............++    ..++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  228 (258)
T cd05578         153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTE  228 (258)
T ss_pred             CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHH
Confidence            54445567889999999876 4689999999999999999999999987653   233222222222222    257899


Q ss_pred             HHHHHHHhchhccccCCCH--HHHHhccCc
Q 014559          384 AKDFVKRLLNKDYRKRMTA--VQALSKLVV  411 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~--~elL~~l~~  411 (422)
                      +.++|.+||..||.+|+++  .|++.|+||
T Consensus       229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-43  Score=329.39  Aligned_cols=258  Identities=29%  Similarity=0.461  Sum_probs=211.6

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|+||.||+|.+..   +++.||+|++.............+.+|+++++.++ |+||+++++.+...+.+|+||||++
T Consensus         1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence            6999999999999876   78899999997654443334456778999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccc
Q 014559          235 GGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND  313 (422)
Q Consensus       235 ~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~  313 (422)
                      +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++   +++.+||+|||++...........
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~  153 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKG  153 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCcccc
Confidence            999998886644 3699999999999999999999999999999999999994   588999999999876654444445


Q ss_pred             cccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 014559          314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL  392 (422)
Q Consensus       314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  392 (422)
                      ..++..|++||++. +.++.++|||||||++|+|++|+.||...........+..............+++++.++|.+||
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence            56888999999875 46899999999999999999999999765442111222211111111112357899999999999


Q ss_pred             hhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          393 NKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       393 ~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ..||.+|+     ++.+++.|+||..+.|+..
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             cCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            99999999     9999999999988877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.7e-43  Score=335.70  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=193.9

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CCeEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VNNVYIV  229 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~lv  229 (422)
                      +.+||+|+||.||+|+.+.+. ++..||+|.+.....     ...+.+|+.+++.++ |+||+++++++..  +..+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence            468999999999999976432 568899998864321     245778999999997 9999999999854  5678999


Q ss_pred             EEccCCCChHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEeecC
Q 014559          230 MELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFG  300 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~DfG  300 (422)
                      |||+.+ +|.+.+...        ...+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999965 787776421        2348899999999999999999999999999999999999542 346789999999


Q ss_pred             cccccCCCC----CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHH
Q 014559          301 LSDFIRPDE----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES---------GIFRAV  365 (422)
Q Consensus       301 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------~~~~~i  365 (422)
                      +++......    ......||..|+|||++.+  .++.++|||||||++|||++|+.||....+.         ..+..+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            998654322    2234578999999998754  5899999999999999999999999654321         111111


Q ss_pred             HcCC--------------CCCCC--------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          366 LRSD--------------PNFDD--------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       366 ~~~~--------------~~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ....              ..+..                    ......+..+.+||.+||..||.+|||+.|+|+|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1100              00000                    0011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.1e-43  Score=329.87  Aligned_cols=253  Identities=29%  Similarity=0.512  Sum_probs=208.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----  222 (422)
                      ..|++.+.||+|+||.||+|++..   +++.||+|++....    .....+..|+.+++++.+|+||+++++++..    
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            468999999999999999999876   78899999986532    2335688899999999679999999999853    


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 --VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                        ...+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++   +++.++|+||
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df  165 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF  165 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence              46799999999999999987653 35688999999999999999999999999999999999995   5788999999


Q ss_pred             CcccccCCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC
Q 014559          300 GLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       300 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      |++...... .......|+..|+|||++.      ..++.++|||||||++|||++|..||...........+.....  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--  243 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--  243 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--
Confidence            998755322 2334567899999999874      3588899999999999999999999976554443333332211  


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .......++.++.+||.+||..||.+||++.|+|+|+||
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            112223588999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.4e-43  Score=323.11  Aligned_cols=251  Identities=30%  Similarity=0.512  Sum_probs=213.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   +++.||+|.++....  ....+.+.+|+.+++.++ |+||+++++.+.+.+.+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence            48899999999999999999876   788999999865432  224467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+++++|.+.+... ...+++..+..++.|++.||.|||++||+|+||||+||+++   +++.++|+|||++....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLT  151 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeec
Confidence            999999999999987653 45689999999999999999999999999999999999994   58899999999987654


Q ss_pred             CCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ... ......|+..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.........   ..++.++
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  228 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYEL  228 (255)
T ss_pred             ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHH
Confidence            332 2334678999999999864 6899999999999999999999999877766666666554432211   2578899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccC
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      .+||.+||+.||++||++.+++...+
T Consensus       229 ~~li~~~l~~~P~~Rp~~~~il~~~~  254 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSATTILSRGS  254 (255)
T ss_pred             HHHHHHHHhCCcccCCCHHHHhhccC
Confidence            99999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=323.47  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=213.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||.|+||.||+|.+..   +++.+++|++......   ..+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   75 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGD---DFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKL   75 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEE
Confidence            479999999999999999999876   6788999999754322   4577899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |++|||+.+++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++   .++.+||+|||++....
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhh
Confidence            999999999999988776657899999999999999999999999999999999999994   58889999999987654


Q ss_pred             CCC-CccccccCCcccCccccC-c---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC-CCCCC
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLH-R---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-PWPSV  380 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~  380 (422)
                      ... ......++..|+|||++. .   .++.++|+|||||++|+|++|+.||...........+.......... ....+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW  232 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence            332 334457889999999875 3   58899999999999999999999998766555444444332111111 11246


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      +.++.+||++||..||.+||++.+++.|.|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.5e-43  Score=325.89  Aligned_cols=254  Identities=27%  Similarity=0.478  Sum_probs=209.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||||.+.............+.+|+.+++.++ |+||+++++++.+.+..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL   77 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence            469999999999999999999887   78899999987644444444567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ++||||+++++|.+++..   ....+++..+..++.|++.||.|||++|++|+||||+||+++   .++.++|+|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~  154 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccce
Confidence            999999999999887753   234589999999999999999999999999999999999995   57889999999987


Q ss_pred             ccCCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ....... .....|+..|+|||++. ..++.++|+||||+++|||++|+.||.....  ......+...  ..+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEH  232 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhh
Confidence            6543322 23456889999999876 4688999999999999999999999965432  2333333221  222222235


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||..||++||++.++++.+
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~  262 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIA  262 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence            788999999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.9e-43  Score=328.24  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=208.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +++.||+|++...... ....+.+.+|+.+++.+. |+||+++++++.+...++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEE
Confidence            69999999999999999999876   7889999998654321 123356789999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||++++.|... ......+++..++.++.||+.||.|||++|++|+||||+||+++   .++.+||+|||++.....
T Consensus        77 ~v~e~~~~~~l~~~-~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          77 LVFEYCDHTVLNEL-EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EEEeccCccHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCC
Confidence            99999988666554 44455799999999999999999999999999999999999995   478899999999986654


Q ss_pred             CC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC--------------
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP--------------  370 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------  370 (422)
                      .. ......++..|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.....              
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            33 2334567889999998753  578999999999999999999999987665444433321100              


Q ss_pred             -----CCCC--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          371 -----NFDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       371 -----~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                           ..+.        .....++.++.+||.+||+.||++||++.|++.|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                 0000        0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-42  Score=329.87  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=212.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||++++..   +++.||+|.+......   ..+.+.+|+.+++.+. |+||+++++.+.+....
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEE
Confidence            579999999999999999999876   7889999998754332   2367889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++..  ..+++.++..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhcc
Confidence            999999999999998743  3689999999999999999999999999999999999994   57899999999987654


Q ss_pred             CCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....|+..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+....... ......++..+
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  246 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIF  246 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC-CCCccccCHHH
Confidence            3322 234578899999998764 68899999999999999999999998766544433333222111 11123588999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++|.+||..||++||++.+++.+.|+...
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.9e-43  Score=328.51  Aligned_cols=257  Identities=30%  Similarity=0.514  Sum_probs=207.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE--
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--  221 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--  221 (422)
                      ....+|++.+.||+|+||.||+|.+..   +++.||+|++.....    ....+.+|+.+++.+.+|+||+++++++.  
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            345689999999999999999999876   788999998754221    22567889999999966999999999884  


Q ss_pred             ---eCCeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          222 ---DVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       222 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                         ..+.+++||||+++++|.+.+..   ....+++..++.++.|++.||.|||+++|+||||||+||+++   .++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEE
Confidence               34579999999999999887653   335689999999999999999999999999999999999995   478899


Q ss_pred             EeecCcccccCCCC-CccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC
Q 014559          296 LIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS  368 (422)
Q Consensus       296 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  368 (422)
                      |+|||++....... ......|+..|+|||++.      ..++.++|||||||++|||++|+.||........+..+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  244 (286)
T cd06638         165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN  244 (286)
T ss_pred             EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence            99999987654322 233456899999999874      34789999999999999999999999766544433332222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ... .......++.++.+||.+||+.||++||++.|+|+|+|+
T Consensus       245 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            111 110112367899999999999999999999999999986

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.1e-43  Score=323.33  Aligned_cols=252  Identities=28%  Similarity=0.490  Sum_probs=212.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|.+..   +++.|++|.+.....     .+.+.+|+++++.++ |+||+++++++.+...+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED-----LQEIIKEISILKQCD-SPYIVKYYGSYFKNTDL   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcE
Confidence            469999999999999999999876   678999999865422     478899999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+++||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||+++   .++.+||+|||++....
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcc
Confidence            999999999999998876667899999999999999999999999999999999999995   57889999999988665


Q ss_pred             CCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||...........+........ .....++.++
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  229 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL-SDPEKWSPEF  229 (256)
T ss_pred             cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC-CchhhcCHHH
Confidence            433 2334568889999998764 689999999999999999999999976655444333322211111 1112477899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .++|.+||..||++||++.|+|.|+||
T Consensus       230 ~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         230 NDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8e-43  Score=333.11  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=211.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--C
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  224 (422)
                      .+|++.+.||+|+||.||+|.++.   +|+.||+|+++....... ....+.+|+.++++++ |+||+++++++.+.  +
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDG-IPISSLREITLLLNLR-HPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCC-CCCCcceEEEEecCCCC
Confidence            579999999999999999999886   788999999875432221 2234567999999997 99999999998765  5


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+.+ +|.+.+......+++..++.++.||+.||.|||++|++||||||+||+++   .++.+||+|||++..
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeee
Confidence            68999999975 88888776556799999999999999999999999999999999999994   588999999999976


Q ss_pred             cCCCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC---------
Q 014559          305 IRPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF---------  372 (422)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  372 (422)
                      ..... ......++..|+|||++.+  .++.++|||||||++|||++|+.||........+..+.......         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            64332 2233356788999998753  58999999999999999999999998887777666665422110         


Q ss_pred             ----------CCCC-------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          373 ----------DDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       373 ----------~~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                ....       ...+++++.+||++||+.||++||++.|+|.|+||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                      0000       1235788999999999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.5e-43  Score=328.82  Aligned_cols=254  Identities=19%  Similarity=0.334  Sum_probs=211.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.+.||+|+||.||+|......  .....||+|.+....  .......+.+|+.+++.++ |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            36899999999999999999876421  234689999986432  2233467889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      ..|++|||+++++|.+++....               ..+++..+..++.|++.||.|||++|++|+||||+||+++   
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---
Confidence            9999999999999999886532               4588899999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      +++.+||+|||++.......   ......++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            47889999999987653322   123345678899999875 578999999999999999998 9999988877777776


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +........   ...++.++.+|+.+||+.||.+||++.|+++++
T Consensus       239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            665443221   136899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-42  Score=329.86  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=208.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe--
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN--  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  225 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++..... .......+.+|+.+++.+.+|+||+++++++...+.  
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            68999999999999999999876   788999999865432 222335678899999999767999999999987665  


Q ss_pred             ---EEEEEEccCCCChHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          226 ---VYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       226 ---~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                         +|+||||+++ +|.+++...    ...+++..++.++.||+.||.|||++||+||||||+||+++  +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~d  154 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIAD  154 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEee
Confidence               8999999986 888887653    23589999999999999999999999999999999999995  2378899999


Q ss_pred             cCcccccCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC-
Q 014559          299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-  374 (422)
Q Consensus       299 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  374 (422)
                      ||++...... .......++..|+|||++.+  .++.++||||||+++|+|++|..||.+......+..+......... 
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9998754322 22233457889999998753  5789999999999999999999999877665554444331110000 


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          375 -----------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       375 -----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                                             ...+.++.++.+||.+||..||.+||++.|+|.|+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                   01135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-42  Score=323.88  Aligned_cols=254  Identities=29%  Similarity=0.445  Sum_probs=209.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc---chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT---TAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +|++.+.||+|+||.||+|.+.    +++.+|||.+......   .......+.+|+++++.++ |+||+++++++.+.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence            4788999999999999999763    6778999998653221   1223456889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++   .++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~  151 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARR  151 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHh
Confidence            999999999999999887553 5689999999999999999999999999999999999994   588999999999875


Q ss_pred             cCCC-------CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          305 IRPD-------ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       305 ~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      ....       .......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......+.. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  230 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL-  230 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC-
Confidence            4211       11234568999999999864 68899999999999999999999997765544444443332222222 


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ...++.++.++|++||..||.+||++.|+|.|+||
T Consensus       231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            23688999999999999999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-43  Score=324.07  Aligned_cols=254  Identities=28%  Similarity=0.456  Sum_probs=211.0

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|.+..   +++.||||++.+...........+..|..++....+|+||+++++++.+++.+|+||||
T Consensus         2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence            579999999999999876   78899999987654333323344556666555544699999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN  312 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~  312 (422)
                      +.+++|.+++.. .+.+++..+..++.|++.||.|||+++++|+||+|+||+++   .++.+||+|||++.....   ..
T Consensus        79 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~---~~  151 (260)
T cd05611          79 LNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE---NK  151 (260)
T ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc---cc
Confidence            999999987754 35689999999999999999999999999999999999995   578899999999875432   23


Q ss_pred             ccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 014559          313 DIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL  391 (422)
Q Consensus       313 ~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  391 (422)
                      ...++..|++||.+.+ .++.++||||||+++|+|++|..||........+..+......++......++.++.++|.+|
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            4568889999998764 579999999999999999999999988777777776666555444433346899999999999


Q ss_pred             chhccccCC---CHHHHHhccCccchhh
Q 014559          392 LNKDYRKRM---TAVQALSKLVVPILSF  416 (422)
Q Consensus       392 L~~dP~~Rp---s~~elL~~l~~~~l~~  416 (422)
                      |..||++||   +++|+|.|+||..+.|
T Consensus       232 l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         232 LCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            999999999   4579999999987765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-42  Score=323.68  Aligned_cols=252  Identities=28%  Similarity=0.512  Sum_probs=210.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch------hcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA------ISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      +|.+.+.||+|+||.||+|.+..   +++.||+|.+........      ...+.+.+|+.++++++ |+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence            47788999999999999999876   678999999865433221      23356889999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||+++   .++.+||+|||+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~  152 (267)
T cd06628          77 DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGI  152 (267)
T ss_pred             eCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCC
Confidence            999999999999999998887543 5789999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCCC-------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC-CCC
Q 014559          302 SDFIRPDE-------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-PNF  372 (422)
Q Consensus       302 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~  372 (422)
                      ++......       ......|+..|+|||++. ..++.++|+|||||++|+|++|+.||........+..+.... +.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI  232 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence            87654221       112346888999999876 468899999999999999999999998765544444443321 122


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +    ..++.++.++|++||+.||.+||++.|+++++||
T Consensus       233 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 P----SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             C----cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            2    2578999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.1e-43  Score=324.51  Aligned_cols=250  Identities=28%  Similarity=0.543  Sum_probs=213.6

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||.|+||.||+|++..   +++.||+|++.+.........+.+.+|+.+++.++ |+||+++++.+.+...+++||||++
T Consensus         1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence            7999999999999876   78899999998655444444577999999999996 9999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcccc
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI  314 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  314 (422)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++   .++.++|+|||++............
T Consensus        77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~  152 (262)
T cd05572          77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTF  152 (262)
T ss_pred             CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccc
Confidence            99999987554 4689999999999999999999999999999999999995   4789999999999876544434456


Q ss_pred             ccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHc--CCCCCCCCCCCCCCHHHHHHHH
Q 014559          315 VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART--ESGIFRAVLR--SDPNFDDLPWPSVSPEAKDFVK  389 (422)
Q Consensus       315 ~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~  389 (422)
                      .++..|++||++. ..++.++|+||||+++|+|++|..||....  ....+..+..  ....++.    .++.+++++|.
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~  228 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIK  228 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc----ccCHHHHHHHH
Confidence            7899999999875 468999999999999999999999998766  4555555553  2222222    45889999999


Q ss_pred             HhchhccccCCC-----HHHHHhccCccchhh
Q 014559          390 RLLNKDYRKRMT-----AVQALSKLVVPILSF  416 (422)
Q Consensus       390 ~~L~~dP~~Rps-----~~elL~~l~~~~l~~  416 (422)
                      +||+.||++|++     ++|+++|+||+.+.|
T Consensus       229 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             HHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            999999999999     999999999987654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=326.35  Aligned_cols=257  Identities=29%  Similarity=0.507  Sum_probs=216.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||.|+||.||+|++..   +++.||+|++....  .......+.+|+++++.++ |+||+++++++.+...+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   75 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLW   75 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEE
Confidence            68899999999999999999876   78899999987543  2223466889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|+||+.+++|.+++...  .+++..++.++.|++.||.|||+++++|+||+|+||+++   +++.++|+|||+++....
T Consensus        76 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeecc
Confidence            999999999999987654  799999999999999999999999999999999999995   588999999999977654


Q ss_pred             C-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 D-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      . .......++..|+|||++.+ .++.++|||||||++|+|++|..||...........+......  ......++.++.
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  228 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFK  228 (274)
T ss_pred             cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHH
Confidence            3 23345578889999998764 6899999999999999999999999776655555444443222  111123789999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ++|.+||..||++||++++++.|.|+..-..+
T Consensus       229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999999999999765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=312.18  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=206.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      ..+|++.++||+|||+-||+++.-.   ++..||+|++....   ....+...+|++..++++ ||||++++++...+  
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEK   92 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccC---cccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhc
Confidence            4589999999999999999998665   88999999997654   335688899999999997 99999999876543  


Q ss_pred             ---CeEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEE
Q 014559          224 ---NNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       224 ---~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                         ...||++.|...|+|++.+...   +..+++.++..|+.+|++||++||+..  ++||||||.|||++   +.+.++
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~v  169 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPV  169 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceE
Confidence               3599999999999999988753   346999999999999999999999998  99999999999996   478999


Q ss_pred             EeecCcccccCCCC----------CccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--
Q 014559          296 LIDFGLSDFIRPDE----------RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTES--  359 (422)
Q Consensus       296 l~DfG~a~~~~~~~----------~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--  359 (422)
                      |.|||.++...-.-          .+.....|..|+|||.++    ...+.++|||||||+||+|+.|..||......  
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            99999987543111          112235789999999985    24789999999999999999999999543221  


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       360 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+.-.+.++...++...  .+++.+.+||+.||+.||.+||++.+++.++
T Consensus       250 SlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~  297 (302)
T KOG2345|consen  250 SLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKL  297 (302)
T ss_pred             eEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence            12223344444554432  4899999999999999999999999999874

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.4e-43  Score=331.84  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=211.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +|++.+.||+|+||.||+|.+..   +++.||||.+......  .......+.+|+++++.++ |+||+++++++.+.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence            48889999999999999999876   6889999999765433  1222355778999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+ +++|.+++......+++..+..++.||++||.|||++||+|+||||+|||++   .++.+||+|||++...
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~  152 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF  152 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeec
Confidence            99999999 8899998765444799999999999999999999999999999999999995   5889999999999766


Q ss_pred             CCCC-CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC--------
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--------  374 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  374 (422)
                      .... ......++..|+|||.+.  ..++.++|||||||++|||++|..+|......+.+..+.........        
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            4432 233345788899999875  35789999999999999999998888776665555544332111000        


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          375 ----------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       375 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                      ......+.++.+||.+||.+||++||++.|+|.+.||..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                            011345788999999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-42  Score=327.94  Aligned_cols=256  Identities=28%  Similarity=0.467  Sum_probs=214.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||.|+||.||++.+..   +++.||||.+.....   ...+.+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence            469999999999999999999876   788999999865432   23467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+.+++|.+++..  ..+++.++..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhcc
Confidence            999999999999887744  3689999999999999999999999999999999999994   58899999999987654


Q ss_pred             CCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....++..|+|||.+. +.++.++|||||||++|+|++|+.||...........+........ .....++.++
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  245 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSPIF  245 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccCCHHH
Confidence            3322 23456889999999876 4689999999999999999999999987766554444433221111 1223688999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .++|++||..||.+||++.+++.|.|++...
T Consensus       246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-43  Score=329.94  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=209.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++++.||+|+||.||+|++..   +++.||+|.+....  .......+.+|+.++++++ |+||+++++.+...+.+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEE
Confidence            68999999999999999999876   78899999986431  2223467889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +||||+++++|..++...  ...+++..+..++.|++.||.|||+ .||+|+||||+||+++   .++.+||+|||++..
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~  152 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGN  152 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccc
Confidence            999999999998876543  2368999999999999999999997 5999999999999995   488999999999876


Q ss_pred             cCCCCCccccccCCcccCccccCc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ... .......++..|+|||++.+       .++.++|+|||||++|+|++|+.||...........+............
T Consensus       153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd06622         153 LVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP  231 (286)
T ss_pred             ccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence            532 22344568889999998742       3588999999999999999999999765544433322211111111112


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ..++.++.+||.+||..||++||++.+++.|+|+...
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            3589999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=322.89  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=211.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|+++....+...||||+++...  .......+.+|+.+++.++ |+||+++++++.+.+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            36899999999999999999987533345689999986542  2223467888999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++....+.+++..+..++.|++.||.|||+++|+|+||||+|||++   +++.+||+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhccc
Confidence            999999999999999877667899999999999999999999999999999999999995   58889999999998764


Q ss_pred             CCC-Cc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDE-RL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~-~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ... ..  ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+........   ...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence            211 11  1223457899999876 578999999999999999998 9999988777776666655422111   12578


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.++|.+||..||++||++.|+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l  262 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTL  262 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            9999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.8e-42  Score=325.50  Aligned_cols=257  Identities=26%  Similarity=0.457  Sum_probs=210.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ..++|++.+.||+|+||.||+|.+..   +++.||+|++.....    ..+.+.+|+.+++++.+|+||+++++++... 
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            34679999999999999999999876   788999999864321    2356788999999996699999999998754 


Q ss_pred             ----CeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          224 ----NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                          +.+|+||||+++++|.+++..   ....+++..++.++.|++.||.|||++||+|+||||+||+++   .++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEE
Confidence                368999999999999887753   345789999999999999999999999999999999999995   5788999


Q ss_pred             eecCcccccCCCC-CccccccCCcccCccccCc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          297 IDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       297 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      +|||++....... ......|+..|+|||++..      .++.++|||||||++|||++|+.||........+..+....
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            9999987654322 2234568899999998742      26899999999999999999999998766655555554433


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ..... ....++.++.+||.+||..||++||++.|+++|+||+
T Consensus       250 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 PPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            21111 1124678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.8e-43  Score=331.68  Aligned_cols=252  Identities=21%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCc--eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.+.||+|+||.||+|+++.   ++.  .+|+|.+...  ........+.+|+.++.++.+|+||+++++++.+.+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            368999999999999999999875   443  4577766432  223344678899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      .+|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++   
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---
Confidence            9999999999999999886532               2578999999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 014559          290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR  367 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  367 (422)
                      .++.+||+|||++.............++..|+|||++.+ .++.++|||||||++|||++ |..||......+....+..
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            578999999999864322111222234667999998764 68899999999999999998 9999987766666655543


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ... .  .....++.++.+||.+||..||++||++.++|..+
T Consensus       239 ~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         239 GYR-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             CCc-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            211 1  11225789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-42  Score=321.95  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||++++..    +..||||.+.....    ..+.+.+|+.+++++. |+||+++++++.+.+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence            368999999999999999998653    34699999865432    2367889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+++|.+++......+++..++.++.|++.||.|||++|++|+||||+|||++   .++.+||+|||+++...
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecC
Confidence            999999999999998876556799999999999999999999999999999999999994   57899999999987654


Q ss_pred             CCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .....  ....++..|++||++. ..++.++|||||||++|+|++ |..||...........+.........   ...+.
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  228 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE  228 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence            33221  1233567799999986 468999999999999999998 99999877777777777665433221   24688


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++++|.+||..||.+||++.+++..+
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=327.42  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=204.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|.++.   +++.||||.+.......  ....+.+|+++++.++ |+||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCeE
Confidence            469999999999999999999876   77899999987543221  2244678999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+ +|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccC
Confidence            999999975 99998876666789999999999999999999999999999999999995   58899999999986543


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHcCCCC-----------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPN-----------  371 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~-----------  371 (422)
                      .. .......++..|+|||++.+  .++.++|||||||++|+|++|+.||.... ..+.+..+......           
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            21 11223356888999998753  58899999999999999999999997654 22222222110000           


Q ss_pred             --------CCC-------CCCCCCC--HHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 --------FDD-------LPWPSVS--PEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 --------~~~-------~~~~~~s--~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                              ...       .....++  .++.++|.+||+.||++||++.|+|.++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    000       0011334  789999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-42  Score=329.10  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=213.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++.+.||+|+||.||+|.+..   +++.||+|++.............+.+|+.+++.++ |+||+++++++.+.+..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~   90 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA   90 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence            468999999999999999999876   78899999987544444444567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+. |+|.+.+......+++..+..++.|++.||.|||++||+|+||+|+||+++   +++.+||+|||++....
T Consensus        91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVS  166 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCcceecC
Confidence            99999997 478887766566799999999999999999999999999999999999994   58899999999987654


Q ss_pred             CCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..   ....++..|+|||++.    +.++.++||||||+++|||++|..||...........+......  ......++.
T Consensus       167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  241 (307)
T cd06607         167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSD  241 (307)
T ss_pred             CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCH
Confidence            32   3456888999999873    45889999999999999999999999877665554444433221  111224788


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++.++|.+||..||++||++.+++.|+|+..
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            9999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-42  Score=327.02  Aligned_cols=254  Identities=24%  Similarity=0.403  Sum_probs=212.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.+.||+|+||.||+|.+...  ..+++.||||++.....  ....+.+.+|+++++.+. |+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            4688999999999999999987643  23567899999865422  223467899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          225 NVYIVMELCEGGELLDRILARG-------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      ..++||||+++++|.+++....             ..+++..+..++.|++.||.|||++|++||||||+||+++   .+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CC
Confidence            9999999999999999886532             3478899999999999999999999999999999999995   57


Q ss_pred             CCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 014559          292 ADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVL  366 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  366 (422)
                      +.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|||++ |..||...........+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999999875432221   22334678899999876 478999999999999999998 999998877777777776


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ........   ..++.++.++|.+||..||++||++.|+++.+
T Consensus       239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence            54433222   36889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-42  Score=362.29  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=205.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.++||+|+||.||+|++..   +++.||||++...........+++.+|+++++++. ||||+++++++.+++..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l   77 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV   77 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence            479999999999999999999876   78899999997644333344567899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          227 YIVMELCEGGELLDRILAR----------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      |+||||++|++|.+++...          ...++...+..++.||+.||.|||++||+||||||+|||++   .++.+||
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEE
Confidence            9999999999999887541          12356677899999999999999999999999999999994   5889999


Q ss_pred             eecCcccccCCCC-------------------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014559          297 IDFGLSDFIRPDE-------------------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       297 ~DfG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                      +|||++.......                   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999997652110                   0123579999999998764 6899999999999999999999999775


Q ss_pred             ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .............+ .....+..+++.+.+++.+||+.||++|++..+.|.+.
T Consensus       235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~  286 (932)
T PRK13184        235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD  286 (932)
T ss_pred             chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            54433222111111 11122346889999999999999999999877766553

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.2e-42  Score=319.62  Aligned_cols=253  Identities=28%  Similarity=0.533  Sum_probs=215.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++++..   +++.||+|.+...... ......+.+|+.++++++ |+||+++++++.+.+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence            48999999999999999999876   7889999998754332 223467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+.+++|.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+|||++   .++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecC
Confidence            999999999999988654 34689999999999999999999999999999999999995   47889999999987654


Q ss_pred             CCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....|+..|+|||++. +.++.++|+|||||++++|++|+.||......+....+........   ...++.++
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (256)
T cd08218         153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL  229 (256)
T ss_pred             cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence            3322 22346888999999876 4688999999999999999999999987777777766665443211   12578999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .++|.+||+.+|.+||++.++|+|.||
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         230 RNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-42  Score=325.90  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|+++.   +|+.||||++.......  ....+..|+.++.+..+|+||+++++++..++.+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            68999999999999999999887   78999999987643222  22445567776444445999999999999999999


Q ss_pred             EEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          228 IVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +||||++ ++|.+.+..   ....+++..++.++.|++.||.|||++ +++||||||+|||++   .++.+||+|||++.
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~~  152 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGISG  152 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeeccccc
Confidence            9999997 577776654   235689999999999999999999998 999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHcC-CCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRS-DPNFDDLP  376 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~-~~~~~~~~  376 (422)
                      ............++..|+|||++.     ..++.++|+|||||++|+|++|+.||.... ..+.+..+... ...++   
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  229 (283)
T cd06617         153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---  229 (283)
T ss_pred             ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---
Confidence            664433334457889999999874     347889999999999999999999996532 22333333322 22222   


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ...++.++.++|.+||..||++||++.++++|.||.....+
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            22578999999999999999999999999999999876654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-42  Score=329.44  Aligned_cols=257  Identities=25%  Similarity=0.440  Sum_probs=212.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||++.+..   +++.||+|.+......   ..+.+.+|+.+++.++ |+||+++++++...+
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~   89 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            34679999999999999999999876   7889999998654322   2366889999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|+||||+++++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+|||++   .++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~  164 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ  164 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceE
Confidence            99999999999999998754  3689999999999999999999999999999999999994   588999999999876


Q ss_pred             cCCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...... .....++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+...... .......++.
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (297)
T cd06656         165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSA  243 (297)
T ss_pred             ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCH
Confidence            543322 23457889999999876 46899999999999999999999999765543332222221111 1111235788


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .+++||.+||..||++||++.++|.|+||...
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            99999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=339.03  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=199.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-e
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-N  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~  225 (422)
                      +.|...+.||+|+||.||+|...    ++..||||++.......   ..+|.+|+.++.+++ |+|+|+|+|||.+.+ +
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCce
Confidence            45777789999999999999986    34789999876543221   355999999999998 999999999999999 5


Q ss_pred             EEEEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          226 VYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQG---VVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~---iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      .+||+||+.+|+|.+++..... .++|....+|+.++++||+|||+..   |||||||++||||   |++...||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccC
Confidence            9999999999999999987666 8999999999999999999999864   9999999999999   5799999999999


Q ss_pred             ccccCC-CCCcccc-ccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hh---HHHHHHHcCCCCC
Q 014559          302 SDFIRP-DERLNDI-VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ES---GIFRAVLRSDPNF  372 (422)
Q Consensus       302 a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~---~~~~~i~~~~~~~  372 (422)
                      |+.... ....... .||.+|++||++. +..+.|+|||||||+|+||++|+.+.....   +.   +.....+... .+
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~  302 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KL  302 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-ch
Confidence            976554 3333333 8999999999986 689999999999999999999998876432   11   1111122111 11


Q ss_pred             CCC---C-C-CCCC-----HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          373 DDL---P-W-PSVS-----PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       373 ~~~---~-~-~~~s-----~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+.   . . ....     ..+..+..+|++.+|++||++.|+++.+
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L  349 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL  349 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence            111   1 0 1223     2256677899999999999999987665

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=323.87  Aligned_cols=254  Identities=32%  Similarity=0.540  Sum_probs=209.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  224 (422)
                      .++|++.+.||+|+||.||+|.++.   +++.|++|++.....    ..+.+.+|+.+++++.+|+||+++++++.+.. 
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            3579999999999999999999876   678999999875432    23678899999999966999999999997644 


Q ss_pred             -----eEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 -----NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 -----~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                           .+|+||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++   +++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEE
Confidence                 589999999999998877542   46799999999999999999999999999999999999995   4788999


Q ss_pred             eecCcccccCCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          297 IDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       297 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      +|||++...... .......|+..|+|||++.      ..++.++|||||||+||+|++|..||...........+....
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  234 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP  234 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence            999998755332 2234456899999999874      247889999999999999999999997655545444444432


Q ss_pred             CCCCCCCC-CCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          370 PNFDDLPW-PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       370 ~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ..  .... ..++.++++||.+||..||++|||+.|+++|+|+
T Consensus       235 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 PP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            21  1111 1378899999999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.3e-42  Score=324.19  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHh--cCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL--SGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      .||+|+||.||++++..   +++.||||++.+.............+|..+++.+  .+|+||+.+++++...+..++|||
T Consensus         1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence            48999999999999876   7889999999765443332223344555444443  249999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL  311 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~  311 (422)
                      |+.+++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++   +++.++|+|||++...... ..
T Consensus        78 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~-~~  152 (279)
T cd05633          78 LMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KP  152 (279)
T ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceecccc-Cc
Confidence            99999998877543 5699999999999999999999999999999999999994   5889999999998755432 22


Q ss_pred             cccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHH-HcCCCCCCCCCCCCCCHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAV-LRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i-~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      ....|+..|+|||++.  ..++.++|||||||++|+|++|..||......  ...... ......+    ...++.++.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  228 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL----PDSFSPELKS  228 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC----ccccCHHHHH
Confidence            3457899999999875  35899999999999999999999999754322  122211 1112222    2368899999


Q ss_pred             HHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          387 FVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       387 li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +|++||..||.+|+     ++.|+++|+||..+.+..
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            99999999999999     699999999999877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-42  Score=339.94  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=203.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++++.||+|+||.||+|.+...  ...+..||||++....  .....+.+.+|+++++++..||||+++++++.+.+
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4789999999999999999987431  1134579999986532  22334678999999999966999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC----------------------------------------------------------
Q 014559          225 NVYIVMELCEGGELLDRILARG----------------------------------------------------------  246 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  246 (422)
                      .+|||||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          247 -------------------------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       247 -------------------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                                                           ..+++..+..++.||+.||.|||+++|+||||||+|||++   
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---
Confidence                                                 2377888999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      .++.+||+|||+++.......   .....++..|+|||++. ..++.++|||||||++|||++ |..||........+..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            477899999999976543222   22345678899999875 468999999999999999997 9999976544333333


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .........  ....++.++.++|.+||..||++||++.++.+.
T Consensus       352 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         352 KIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             HHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            333222221  123688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-42  Score=328.96  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=209.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--C
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  224 (422)
                      ++|++.+.||+|+||.||+|.+..   +++.||+|.++...... .....+.+|+.++++++ |+||+++++++...  +
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKE-GFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence            368999999999999999999876   78899999997654332 22345678999999997 99999999999887  8


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+||||||+.+ +|.+.+......+++..++.++.||+.||.|||++|++|+||||+|||++   .++.+||+|||++..
T Consensus        80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~  155 (293)
T cd07843          80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLARE  155 (293)
T ss_pred             cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceee
Confidence            99999999975 88888776656799999999999999999999999999999999999995   578999999999876


Q ss_pred             cCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC---------
Q 014559          305 IRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF---------  372 (422)
Q Consensus       305 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  372 (422)
                      .... .......++..|+|||++.+  .++.++|+||||+++|+|++|..||........+..+.......         
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            5443 23344567889999998754  46899999999999999999999998766655544443211100         


Q ss_pred             ----------C-------CCCCCC--CCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 ----------D-------DLPWPS--VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ----------~-------~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                .       ....+.  +++.+.++|++||+.||++||++.|+|.|.||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                      0       000112  58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.3e-42  Score=319.01  Aligned_cols=253  Identities=33%  Similarity=0.511  Sum_probs=213.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~  225 (422)
                      +|++.+.||.|+||.||+|.+..   +++.||+|++...... ....+.+.+|+++++.++ |+||+++++++..  ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence            48899999999999999999887   7889999998754332 334467889999999997 9999999998764  456


Q ss_pred             EEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          226 VYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCH-----LQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH-----~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +|++|||+++++|.+++...   ...+++..++.++.||+.||.|||     +.+++|+||||+||+++   .++.+||+
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~  152 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLG  152 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEe
Confidence            89999999999999988653   467999999999999999999999     89999999999999995   47899999


Q ss_pred             ecCcccccCCCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          298 DFGLSDFIRPDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       298 DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      |||++........ .....++..|++||++.+ .++.++|+||||+++|+|++|..||...........+........  
T Consensus       153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  230 (265)
T cd08217         153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI--  230 (265)
T ss_pred             cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC--
Confidence            9999987654443 345678999999999864 688999999999999999999999988776666665554432211  


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                       ...++.++.++|.+||..+|++||++.++|+|+|+
T Consensus       231 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         231 -PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence             12678999999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-45  Score=318.99  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=220.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      ...|+...+||+|.||.||+|+.+.   +|+.||+|++-.+....... ....+|+++|..|+ |+|++.+++.|..   
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~T   90 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKAT   90 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence            3468888999999999999999887   78889999875432222222 34568999999998 9999999887753   


Q ss_pred             -----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          223 -----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       223 -----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                           ...+|+||++|+. +|...+.....+++..+|.+++++++.||.|+|++.|+|||+|+.|+||+   .++.+||+
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEee
Confidence                 2459999999987 88888777777899999999999999999999999999999999999995   58999999


Q ss_pred             ecCcccccCCC-----CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          298 DFGLSDFIRPD-----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       298 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |||+++.+...     .+.+..+.|++|++||.+.+  .|+.+.|||..||||.||+++.+.|.+.++...+..|.....
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999765422     23556788999999998764  699999999999999999999999999999998888877777


Q ss_pred             CCCCCCCCCCC-------------------------------HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          371 NFDDLPWPSVS-------------------------------PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       371 ~~~~~~~~~~s-------------------------------~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .+....|+++.                               +++.||+.++|..||.+|+++.++|.|.||.-
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            77666666542                               58899999999999999999999999999863

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-42  Score=327.15  Aligned_cols=254  Identities=20%  Similarity=0.334  Sum_probs=205.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|+++... ....+++|.++..  ......+.+.+|+.++.++.+|+||+++++++.+.+.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            46899999999999999999887521 2235788887532  22233467889999999995599999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          227 YIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      |+||||+++++|.+++....               ..+++..++.++.|++.||+|||++||+||||||+|||++   .+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---EN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CC
Confidence            99999999999999886532               3588999999999999999999999999999999999994   57


Q ss_pred             CCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCC
Q 014559          292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      +.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||...........+....
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            889999999986432221112222355799999875 468999999999999999997 999998877777666665432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .. .  ....++.++.+||.+||..||.+||++.++++.+
T Consensus       236 ~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  272 (297)
T cd05089         236 RM-E--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL  272 (297)
T ss_pred             CC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            11 1  1125889999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=320.13  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=206.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+++++    .+..+|+|++.....    ....+.+|+++++.++ |+||+++++++.+.+..|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec----CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceE
Confidence            5889999999999999999875    345799999864332    2356788999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||+++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccc
Confidence            99999999999999877666799999999999999999999999999999999999994   588999999999876543


Q ss_pred             CCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          308 DERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       308 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ....  ....++..|+|||++. ..++.++|||||||++|+|++ |+.||......+....+...... ..  ...++.+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~  229 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-YR--PKLAPTE  229 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-CC--CCCCCHH
Confidence            2211  1122345799999876 578999999999999999998 89999877776666666544221 11  1257899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++|.+||..+|++||++.|+++.+
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-42  Score=318.75  Aligned_cols=244  Identities=24%  Similarity=0.371  Sum_probs=200.5

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.   +++.||+|.+....  .......+.+|+++++.+. |+||+++++++.+.+.+++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec---CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999999876   78899999876432  2233467889999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcc
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN  312 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~  312 (422)
                      +.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccc
Confidence            999999998876666789999999999999999999999999999999999995   57889999999987543221111


Q ss_pred             ---ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 014559          313 ---DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF  387 (422)
Q Consensus       313 ---~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  387 (422)
                         ...++..|+|||.+. +.++.++|||||||++|||++ |..||...........+...... .  ....++.++.+|
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l  228 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-P--CPELCPDAVYRL  228 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-C--CcccCCHHHHHH
Confidence               112345699999876 468999999999999999997 89999776665555544432221 1  123578999999


Q ss_pred             HHHhchhccccCCCHHHHHhc
Q 014559          388 VKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~  408 (422)
                      |.+||..||++||++.++++.
T Consensus       229 i~~~l~~~p~~Rps~~~~~~~  249 (252)
T cd05084         229 MERCWEYDPGQRPSFSTVHQE  249 (252)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.4e-42  Score=330.94  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++.+.||+|+||.||+|++.... .....||||++...  ......+.+.+|+.+++.+. |+||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            46999999999999999999876421 12345899998643  22233467889999999997 99999999999864 5


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++|+||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEccccccccc
Confidence            7899999999999999887667799999999999999999999999999999999999995   5788999999999876


Q ss_pred             CCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......   ....++..|++||++. ..++.++|||||||++|||++ |..||.+........ +.......+..  ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQP--PIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCC--CCC
Confidence            543322   1223466899999876 578999999999999999997 999998766555443 33333222221  257


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.++|.+||..||.+||++.+++.++
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l  265 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIEF  265 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            88999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-42  Score=321.26  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=210.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-------hhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-------AISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      +|.+.+.||+|+||.||+|.+..   +++.||||.+.......       ....+.+.+|+.+++.++ |+||+++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence            58899999999999999999876   78899999986432211       112356788999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      ...+.+++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++++|+||+|+||+++   .++.++|+|||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~  153 (272)
T cd06629          78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFG  153 (272)
T ss_pred             ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecc
Confidence            9999999999999999999987654 5799999999999999999999999999999999999994   58899999999


Q ss_pred             cccccCCCC---CccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC--CCCC
Q 014559          301 LSDFIRPDE---RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNF  372 (422)
Q Consensus       301 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~  372 (422)
                      ++.......   ......|+..|+|||++..   .++.++|+||||+++|+|++|..||........+..+...  ...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            987543221   1234568899999998753   3789999999999999999999999655444433333322  2223


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +......++.++.++|.+||..||++||++.++|+|+|+
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            333334678999999999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-42  Score=322.95  Aligned_cols=253  Identities=27%  Similarity=0.490  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|++..   +++.||||.+.............+.+|+.+++.+. |+||+++++++.+.+..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   77 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL   77 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence            368899999999999999999876   78899999887654444445567889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ++||||+.+++|.+++..   ....+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~  154 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhh
Confidence            999999999999987753   235689999999999999999999999999999999999994   57899999999987


Q ss_pred             ccCCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ....... .....|+..|+|||++. ..++.++|+||||+++|+|++|..||......  .....+...  ..+...+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH  232 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence            6543322 23457889999999886 46889999999999999999999999765432  222333221  222223346


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ++.++.++|.+||..||++|||+.++++.
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~  261 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYDV  261 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence            88999999999999999999999977653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-42  Score=334.77  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++|++.+.||+|+||.||+|++..  +..+++.||+|++....  .......+.+|+.+++++.+|+||+++++++... 
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            579999999999999999997543  22356899999986432  2223456788999999995599999999988654 


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------------------------------------------------
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------------------------------------------------  246 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  246 (422)
                      ..+++||||+++++|.+.+....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57899999999999998875421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcc
Q 014559          247 ---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY  320 (422)
Q Consensus       247 ---~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y  320 (422)
                         ..+++..+..++.||+.||.|||++||+||||||+|||++   +++.+||+|||++..+.....   .....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               2578999999999999999999999999999999999995   478899999999986533221   2234566789


Q ss_pred             cCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhcccc
Q 014559          321 VAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK  398 (422)
Q Consensus       321 ~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  398 (422)
                      +|||++. ..++.++|||||||+||||++ |..||.+....+.+...+........  ...++.++.+++.+||+.+|++
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChhh
Confidence            9999875 579999999999999999997 99999765444433333332222111  1257889999999999999999


Q ss_pred             CCCHHHHHhcc
Q 014559          399 RMTAVQALSKL  409 (422)
Q Consensus       399 Rps~~elL~~l  409 (422)
                      ||++.|+++++
T Consensus       320 RPs~~ell~~l  330 (337)
T cd05054         320 RPTFSELVEIL  330 (337)
T ss_pred             CcCHHHHHHHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.5e-42  Score=318.98  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=207.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc--cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--TTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      +|++.+.||+|+||.||++++..   +++.||||++.....  ......+.+.+|+.+++++. |+||+++++++.+.  
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   78 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPME   78 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCC
Confidence            68999999999999999999876   788999999864321  12234567889999999997 99999999998764  


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++   .++.+||+|||++.
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~  154 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASK  154 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCcccc
Confidence            5688999999999999987654 5689999999999999999999999999999999999995   57899999999987


Q ss_pred             ccCCC----CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPD----ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .....    .......|+..|+|||++. ..++.++|||||||++|||++|+.||........+..+..... .+. ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~  232 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-NPV-LPP  232 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-CCC-Cch
Confidence            54321    1223456889999999875 4689999999999999999999999976654444444332221 111 123


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      .++..+.++|++||. +|++||++.|+++|+|+.
T Consensus       233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         233 HVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            578889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.9e-42  Score=325.23  Aligned_cols=261  Identities=27%  Similarity=0.418  Sum_probs=210.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|.++.   +++.||||++...... ....+.+.+|++++++++ |+||+++++++.+.+.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQED-EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhcccc-ccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence            369999999999999999999876   7889999998654322 223356788999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |+||||++ ++|.+.+.... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.  .++.+||+|||++...
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEccccccccc
Confidence            99999996 48888775543 33688999999999999999999999999999999999962  3567999999999754


Q ss_pred             CCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC-------
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-------  375 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------  375 (422)
                      ... .......++..|+|||++.+  .++.++|||||||++|+|++|+.||......+.+..+..........       
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            322 22234467889999998753  47899999999999999999999998776655555443211100000       


Q ss_pred             ------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          376 ------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       376 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                        ..+.++.++.++|.+||+.||++||++.++|+|+||..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                              1235788999999999999999999999999999998654

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-42  Score=327.54  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=208.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.+..   +++.||+|++....... ...+.+.+|+++++.++ |+||+++++++.+.+..|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEE
Confidence            68999999999999999999876   68899999986543322 23456789999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.++. .....+++..+..++.||+.||.|||+.||+|+||+|+||+++   +++.++|+|||++.....
T Consensus        77 lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          77 LVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeeccC
Confidence            999999987776644 4445699999999999999999999999999999999999994   588999999999876543


Q ss_pred             CC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-------------
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------------  371 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  371 (422)
                      .. ......++..|+|||++.+  .++.++|||||||++|||++|+.||......+.+..+......             
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            32 2334568899999998763  4788999999999999999999999766554443333321110             


Q ss_pred             ------CCC--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 ------FDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 ------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                            .+.        ..++.++..+.+||++||..||.+||++.++|+|.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                  000        0134678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.7e-42  Score=328.11  Aligned_cols=256  Identities=28%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  224 (422)
                      ++|++.+.||+|+||.||+|++..   +++.||||++....... .....+.+|+.++++++ |+||+++++++...+  
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATP   86 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence            369999999999999999999876   78899999986543222 22245668999999997 999999999987653  


Q ss_pred             ------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                            ..++||||+.+ +|.+.+......+++.+++.++.||+.||.|||++|++|+||||+||+++   .++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~d  162 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLAD  162 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECc
Confidence                  46999999965 88888776666799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCC-----ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          299 FGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       299 fG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ||++........     .....++..|+|||++.+  .++.++||||||+++|||++|..||...........+......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999976543221     233467889999998754  4788999999999999999999999776654443333221111


Q ss_pred             CCCCC----------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 FDDLP----------------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 ~~~~~----------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++...                            ....+..+.+||.+||..||.+||++.|+|+|+||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            11000                            00135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-42  Score=325.71  Aligned_cols=255  Identities=29%  Similarity=0.431  Sum_probs=208.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++.+.||.|+||.||+|++..   +++.||||++...... ......+.+|++++++++ |+||+++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccc-cccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence            38899999999999999999876   7889999998654322 223357889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.+||+|||++....
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence            9999996 5888877653 35689999999999999999999999999999999999994   58899999999987554


Q ss_pred             CCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC-----------
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-----------  372 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  372 (422)
                      ... ......++..|+|||++.+  .++.++|||||||++|||++|+.||....+......+.......           
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            322 2233457889999998754  36889999999999999999999998776655444433211110           


Q ss_pred             -------CCC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 -------DDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 -------~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                             +..       ..+.++.+++++|.+||+.||.+||+++++|.|+||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                   000       012478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.9e-42  Score=321.93  Aligned_cols=257  Identities=18%  Similarity=0.273  Sum_probs=208.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.+.||+|+||.||+|.+...  ...+..||+|.+....  .......+.+|+.+++.++ |+||+++++++.+.+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            5699999999999999999988641  1245789999875432  2223456888999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 NVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      ..++||||+.+++|.+++....      ..+++..+..++.||+.||.|||+++++||||||+|||++...+...+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999886543      2589999999999999999999999999999999999997533345799999


Q ss_pred             cCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          299 FGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       299 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      ||+++.......   ......+..|+|||++. ..++.++|||||||++|||++ |..||...........+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~  242 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP  242 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999976532221   11223356799999875 579999999999999999997 9999988777766665554322111


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                         ...++.++.++|.+||..||++||++.++|+++
T Consensus       243 ---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l  275 (277)
T cd05036         243 ---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI  275 (277)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence               136889999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-42  Score=327.07  Aligned_cols=261  Identities=24%  Similarity=0.333  Sum_probs=209.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|+..+.||+|+||.||++.+..   +++.||||.+......  .....+.+|+.++.++.+|+||+++++++...+..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            56777899999999999999886   7889999998754322  334678899999999977999999999999999999


Q ss_pred             EEEEccCCCChHHHH---HH-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          228 IVMELCEGGELLDRI---LA-RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       228 lv~e~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      +||||+.. ++.+..   .. ....+++..+..++.|++.||+|||+. +|+||||||+||+++   .++.+||+|||++
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~  155 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGIS  155 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchh
Confidence            99999864 554433   22 346799999999999999999999975 999999999999995   4788999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcCC-CCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSD-PNFDDLP  376 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~  376 (422)
                      .............|+..|+|||++.+    .++.++|||||||++|+|++|+.||..... .+.+..+.... +.+....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            76554433444578999999998863    489999999999999999999999965432 12222222222 2222222


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      +..++.++.+||.+||..||.+||++.++++|+||....++
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            23588999999999999999999999999999999776544

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.6e-42  Score=319.22  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      .|++.+.||+|+||.||+|.+..   ++..||+|++......  .......+.+|+.+++.++ |+||+++++++.+.  
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   78 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAE   78 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCC
Confidence            58899999999999999999876   7889999998654322  2223457889999999997 99999999998763  


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ..++++|||+.+++|.+.+... ..+++..++.++.|++.||.|||+++|+|+||||+||+++   .++.+||+|||++.
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~~  154 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASK  154 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCcc
Confidence            6789999999999999887553 4689999999999999999999999999999999999994   57889999999987


Q ss_pred             ccCCC----CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPD----ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .....    .......++..|+|||++.+ .++.++|||||||++|||++|+.||...........+...... +.. ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-~~  232 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-PQL-PS  232 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-CCC-ch
Confidence            54321    11233568889999998864 6899999999999999999999999766544444333322211 111 12


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      .+++.++++| +||..||++||+++|+++|+||+
T Consensus       233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            4788899999 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.6e-42  Score=321.56  Aligned_cols=255  Identities=18%  Similarity=0.318  Sum_probs=207.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .++|++.+.||+|+||.||+|.+...  ...+..||||++....  .......+.+|+.+++.++ |+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~   81 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG   81 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            45799999999999999999986531  1245789999985432  2223456889999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      +..++||||+.+++|.+++....         ..++...+..++.|++.||.|||++|++|+||||+|||++   +++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence            99999999999999999886532         2357788999999999999999999999999999999995   58899


Q ss_pred             EEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCC
Q 014559          295 RLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       295 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ||+|||++........   .....++..|+|||++. +.++.++|||||||++|||++ |..||...........+....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999875432221   11234577899999976 468999999999999999999 789998877777766666543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .....   ..++..+.++|.+||+.||++||++.|+++++
T Consensus       239 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         239 LLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             cCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            32111   25788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=343.18  Aligned_cols=254  Identities=22%  Similarity=0.401  Sum_probs=214.7

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe--
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN--  225 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  225 (422)
                      .+...+||+|+|-+||+|.|..   +|-.||--.++..++ ......+++..|+.+|+.|+ |+|||+||++|.+..+  
T Consensus        42 ~k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             eehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCce
Confidence            3556789999999999999976   788888655544333 23345688999999999997 9999999999988755  


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|+|++..|+|..++++ .++++...++.|++||++||.|||++.  |||||||.+||||+  ...|.|||+|+|||.
T Consensus       118 in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHH
Confidence            8899999999999998755 467999999999999999999999995  99999999999997  468999999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...... ....+||+.|||||++...|+..+||||||++|+||+|+..||... +...+++++..+...-....  --.+
T Consensus       195 l~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dP  271 (632)
T KOG0584|consen  195 LLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDP  271 (632)
T ss_pred             Hhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCH
Confidence            776443 3448999999999999999999999999999999999999999664 44566777776654322111  1368


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++++||.+||.. ...|+|+.|||.|.||+.
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            999999999999 899999999999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.8e-42  Score=318.91  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=207.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.++||+|+||.||+|.+.    .+..||+|.+.....    ..+.+.+|+.+++.++ |+||+++++.+.+.+..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCch----hHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCc
Confidence            47999999999999999999865    456799998764322    2467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++   .++.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~  153 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVI  153 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceec
Confidence            9999999999999988654 45689999999999999999999999999999999999995   5789999999999765


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... .+  ....++
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~  230 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MP--RMENCP  230 (261)
T ss_pred             CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCC
Confidence            43221  12234567899999876 568999999999999999998 9999988777776666655432 11  123688


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .++.++|.+||..||++||++.++++.
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~~  257 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQSV  257 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-41  Score=317.02  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=210.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   +++.|++|++...... ....+.+.+|+.+++.++ |+||+++++++.+.+.++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence            58899999999999999999876   7789999999765433 345678999999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++   +++.+||+|||++.....
T Consensus        76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             EEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCC
Confidence            999999999999987553 4589999999999999999999999999999999999995   588999999999876543


Q ss_pred             CCC-----ccccccCCcccCccccCc-c---CCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcCCCCCCCCCC
Q 014559          308 DER-----LNDIVGSAYYVAPEVLHR-S---YSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       308 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  377 (422)
                      ...     .....++..|++||++.. .   ++.++||||||+++|+|++|..||....... ....+.. ........+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  230 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDS  230 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcc
Confidence            322     123567889999999863 3   7899999999999999999999996653322 2222222 211111223


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ..++.++.+||++||..||.+||++.|++.|+|+
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            3568999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.1e-42  Score=319.33  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=208.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+.+.||+|+||.||+|.++.   .++.||+|++....    .....+.+|+++++.+. |+||+++++++...+.+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF   77 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCc
Confidence            358999999999999999999876   78899999986432    23467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++   +++.+||+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~  154 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM  154 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCcccccc
Confidence            99999999999999886543 4589999999999999999999999999999999999995   5889999999999765


Q ss_pred             CCCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ......  ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+...... .  ....++
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~  231 (263)
T cd05052         155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM-E--RPEGCP  231 (263)
T ss_pred             ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCCC
Confidence            433221  1123456799999876 578999999999999999998 99999887776666666543211 1  113688


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .++.++|.+||..||++||++.++++.
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-41  Score=322.60  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++.+.||+|+||.||+|.+..   +++.||||++......  .....+.+|+.+++.+. |+||+++++++.+.+..
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEE--GVPFTAIREASLLKGLK-HANIVLLHDIIHTKETL   78 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeE
Confidence            479999999999999999999876   7889999998654322  12245678999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+. ++|.+.+......+.+..+..++.|++.||.|||++||+|+||||+|||++   .++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccC
Confidence            99999996 688887766656788999999999999999999999999999999999995   58899999999987543


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCC-------------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSD-------------  369 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~-------------  369 (422)
                      .. .......++..|+|||++.+  .++.++|||||||++|+|++|..||...... +.+..+....             
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            22 22334567899999998854  5789999999999999999999999754432 2222211100             


Q ss_pred             -CCCCC------------CCCC--CCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          370 -PNFDD------------LPWP--SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       370 -~~~~~------------~~~~--~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                       +.+..            ..|.  ..+.++.++|.+||..||.+|||+.|+|.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             00000            0011  135789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.7e-42  Score=316.34  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=211.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +|+..+.||+|+||.||+|.+..   +++.|++|.+......  .....+.+.+|+.+++.++ |+||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence            47788999999999999999876   7789999998654321  1233467889999999996 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++   .++.+||+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~  152 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceec
Confidence            99999999999998887543 5689999999999999999999999999999999999995   5889999999998766


Q ss_pred             CCCCCccccccCCcccCccccC-cc-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ..........|+..|++||.+. .. ++.++|+|||||++|+|++|+.||...........+.... ..+. ....++.+
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~  230 (258)
T cd06632         153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPP-IPDHLSDE  230 (258)
T ss_pred             cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCC-cCCCcCHH
Confidence            5444445567899999999875 34 8999999999999999999999997765444444433311 1111 12367899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +.++|++||..||.+||++.++|.++|+
T Consensus       231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         231 AKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3e-42  Score=335.33  Aligned_cols=257  Identities=26%  Similarity=0.455  Sum_probs=206.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +..+|++.+.||+|+||.||+|++..   +++.||||++.+... .......+.+|+.++++++ |+||+++++++... 
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   88 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK   88 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence            44679999999999999999999887   788999999864322 2223456778999999997 99999999988644 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|+||||+.+ +|.+.+...   +++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~D  161 (353)
T cd07850          89 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  161 (353)
T ss_pred             CccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEcc
Confidence                 357999999965 888876433   89999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------  369 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  369 (422)
                      ||++.............++..|+|||++. ..++.++|||||||++|+|++|+.||........+..+....        
T Consensus       162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99998765444444567889999999876 478999999999999999999999997665544433332211        


Q ss_pred             --------------CCCC---------CCC--------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          370 --------------PNFD---------DLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       370 --------------~~~~---------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                    +...         ...        ....+.++++||.+||+.||++||++.|+|.|+|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                          0000         000        1134667899999999999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.1e-42  Score=320.98  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=202.1

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHh--cCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL--SGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      .||+|+||.||+|++..   +++.||+|++.+..............|..+++.+  .+|+||+++++++.+.+.+|+|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence            48999999999999876   7889999999765433222222334444433332  149999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL  311 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~  311 (422)
                      |+.|++|.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+||+++   .++.+||+|||++...... ..
T Consensus        78 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~-~~  152 (278)
T cd05606          78 LMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KP  152 (278)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCcc-CC
Confidence            9999999887754 46799999999999999999999999999999999999994   5788999999998755432 23


Q ss_pred             cccccCCcccCccccC-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          312 NDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      ....|+..|+|||++. + .++.++|||||||++|||++|+.||....   .......+......++    ..++.++.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~  228 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRS  228 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHHH
Confidence            3457999999999986 3 58999999999999999999999997652   2222222322222222    257899999


Q ss_pred             HHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          387 FVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       387 li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +|.+||..||.+|+     ++.++++|+||....+..
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            99999999999999     999999999998876654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.6e-42  Score=322.42  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=208.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||.|++|.||+|++..   +++.||||++......  ...+.+.+|+.+++.++ |+||+++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence            48899999999999999999876   7889999999764322  22356778999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          228 IVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |||||+.+ +|.+++....  ..+++..+..++.|++.||.|||++|++||||||+||+++   +++.++|+|||++...
T Consensus        75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~  150 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF  150 (284)
T ss_pred             EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhh
Confidence            99999975 8888876543  4689999999999999999999999999999999999994   5789999999998755


Q ss_pred             CCCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC----------
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF----------  372 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  372 (422)
                      .... ......++..|++||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.......          
T Consensus       151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            4322 2234567889999998754  57899999999999999999999998776655555443211000          


Q ss_pred             --------CCC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 --------DDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 --------~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                              +..       ..+.++.+++++|.+||+.||.+||++.|+++++||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                    000       012457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=339.07  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=214.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCc-cCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +-.+.++||+|+||.||+|+.+.... ....||||..+.+.........++.+|.++|++++ |+|||+|||++....-+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCcc
Confidence            44566899999999999999886432 12238999987655455667788999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+|.||+|.+++.+..+.++..+...++.+.+.||+|||++++|||||-..|+|++   .++.+||+||||++...
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCCc
Confidence            999999999999999988777899999999999999999999999999999999999996   36678999999997654


Q ss_pred             CCCCcc-ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          307 PDERLN-DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       307 ~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...... ..--...|+|||.+. +.|+.++|||||||++||+++ |..||.+.....+...|.......+..  ...+.+
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~  391 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKE  391 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHH
Confidence            221112 112457899999987 579999999999999999998 788999999988888885544332222  267888


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +..++.+|+..||++|+++.++.+.
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~~  416 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKKK  416 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHHH
Confidence            9999999999999999999998765

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-42  Score=322.34  Aligned_cols=251  Identities=28%  Similarity=0.477  Sum_probs=203.4

Q ss_pred             EEeceeCcCCCeEEEEEEec-cCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      ++.+.||.|.||.||+|... .....+..|+||.+...  ......+.+.+|++++++++ |+||++++|++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence            46789999999999999998 44446789999999542  22334678999999999995 9999999999998888999


Q ss_pred             EEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      |||||.+|+|.+++... ...+++..+..|+.||+.||.|||+++++|+||+++|||++   .++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence            99999999999999876 56799999999999999999999999999999999999996   488999999999976632


Q ss_pred             CCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          308 DER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       308 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...   .....+...|+|||++. ..++.++||||||+++|||++ |+.||...........+........   ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence            222   22345677899999986 468999999999999999999 7899988877777777754433211   126899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+.++|.+||..||++||++.++++.|
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            999999999999999999999998753

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-41  Score=322.22  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.+.||+|+||.||++.+...  ..++..||+|.+....   ......+.+|+.+++++. |+||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            4699999999999999999986432  1245679999886432   223467889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          225 NVYIVMELCEGGELLDRILARG------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      .+++||||+.+++|.+++....            ..+++..+..++.|++.||+|||++|++||||||+|||++   +++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence            9999999999999999886432            2489999999999999999999999999999999999994   588


Q ss_pred             CEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 014559          293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR  367 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  367 (422)
                      .+||+|||++........   .....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999975533221   12234577899999886 468999999999999999998 9999988777777777766


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .......   ..++.++.+||.+||+.||.+||++.+++..
T Consensus       238 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~  275 (288)
T cd05093         238 GRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSL  275 (288)
T ss_pred             CCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            5432211   2578999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-41  Score=317.25  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=209.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|.+..   +++.||+|.++..........+.+.+|+++++++. |+||+++++++.+.+..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~   77 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL   77 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence            469999999999999999999886   78899999987644444444578899999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ++||||+++++|.+++..   ....+++..+..++.|++.||.|||++||+|+||+|+||+++   .++.++|+|||++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~  154 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceee
Confidence            999999999999988754   234589999999999999999999999999999999999995   58889999999987


Q ss_pred             ccCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ...... ......++..|+|||++. ..++.++|||||||++|+|++|+.||......  .....+....  ....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADH  232 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhh
Confidence            654332 223456889999999876 46899999999999999999999999654322  2223322221  22222336


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||..+|++||++.++++.+
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~  262 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQVA  262 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            788999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-42  Score=322.17  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=211.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.++.   +++.||+|++.....  ......+.+|+++++++. |+||+++++.+...+.++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEE
Confidence            57888999999999999999986   788999999876432  234467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +|+||+.+++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++   +++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhH
Confidence            9999999999999887655789999999999999999999999 9999999999999995   58899999999987654


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHcCCCCCCCCCCCCC
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART-----ESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .... ....++..|+|||++.+ .++.++|||||||++|+|++|+.||....     .......+.....  +......+
T Consensus       153 ~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  229 (265)
T cd06605         153 NSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKF  229 (265)
T ss_pred             HHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhc
Confidence            3222 22678899999998764 68999999999999999999999996542     2233333333221  11111137


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +.++.++|.+||..||++||++.+++.|+||+.
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.9e-42  Score=320.42  Aligned_cols=258  Identities=23%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +|+..+.||+|+||.||++.+..   +++.||+|++.......   ....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence            37888999999999999999876   78899999987543211   123467899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.  .+..+||+|||++..
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~  153 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAAR  153 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccc
Confidence            99999999999999987754 457899999999999999999999999999999999999952  234699999999876


Q ss_pred             cCCCCC-----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC-CCCCCCC
Q 014559          305 IRPDER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDLPW  377 (422)
Q Consensus       305 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~  377 (422)
                      ......     .....++..|+|||++. ..++.++|||||||++|+|++|..||...........+..... .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP  233 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence            543211     12346888999999876 4689999999999999999999999965443332222221110 0111111


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ..++.++.++|.+||..||.+||++.+++.|+||.
T Consensus       234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            25789999999999999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.4e-42  Score=321.29  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=214.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|+..+.||.|+||.||+|.+..   ++..||||++.....  ......+.+|+.+++.+. |+||+++++++.+++.+|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLW   78 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence            57888999999999999999876   678999999875432  233467889999999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+++..  +.+++..+..++.|++.||.|||+++++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          79 IIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccC
Confidence            99999999999998743  4689999999999999999999999999999999999995   578899999999976543


Q ss_pred             CC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .. ......++..|+|||++. ..++.++|+|||||++|||++|..||...........+......   .....++.++.
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  230 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFK  230 (277)
T ss_pred             CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHH
Confidence            32 223346788999999875 46899999999999999999999999876655554444332221   11225788999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ++|.+||..||++||++.+++.|+|+.....|
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         231 EFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            99999999999999999999999998765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-42  Score=347.70  Aligned_cols=269  Identities=20%  Similarity=0.290  Sum_probs=199.2

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEE--------------EeecccccchhcHHHHHHHHHHHHHh
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK--------------IISKAKMTTAISIEDVRREVKILKAL  207 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l  207 (422)
                      .+.+..+|++++.||+|+||.||++..+..  .+..+++|              ++.+...........+.+|+.+|+++
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l  220 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL  220 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence            344667899999999999999999876532  22222222              11111111222345688999999999


Q ss_pred             cCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       208 ~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                      + |+|||++++++.+.+..|+|+|++. ++|.+++...    ........++.++.||+.||.|||++|||||||||+||
T Consensus       221 ~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI  298 (501)
T PHA03210        221 N-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI  298 (501)
T ss_pred             C-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            7 9999999999999999999999995 4787776542    12345677889999999999999999999999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---  357 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---  357 (422)
                      |++   .++.+||+|||+++.+.....  ....+||..|+|||++. ..++.++|||||||+||||++|..++....   
T Consensus       299 Ll~---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        299 FLN---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             EEC---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            995   588999999999986653322  23467999999999986 469999999999999999999886543321   


Q ss_pred             hhHHHHHHHcCC----CCCCC------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ESGIFRAVLRSD----PNFDD------------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ~~~~~~~i~~~~----~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+..++...    ..++.                        .....++.++.++|.+||.+||++||++.|+|.|+
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            112222222110    00110                        00123567889999999999999999999999999


Q ss_pred             Cccchhhh
Q 014559          410 VVPILSFK  417 (422)
Q Consensus       410 ~~~~l~~k  417 (422)
                      ||.....+
T Consensus       456 ~f~~~~~~  463 (501)
T PHA03210        456 LFSAEEEE  463 (501)
T ss_pred             hhhcCCch
Confidence            99765443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.2e-42  Score=319.41  Aligned_cols=248  Identities=23%  Similarity=0.431  Sum_probs=197.8

Q ss_pred             cceEEecee--CcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEV--GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~l--G~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +.|++.+.+  |+|+||.||+++++.   ++..+|+|++.......        .|+.+...+.+|+||+++++.+...+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            456666666  999999999999887   78899999986543211        13333333446999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC-CEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~  303 (422)
                      .+|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.   ++ .++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~  158 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCK  158 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccce
Confidence            999999999999999987654 47999999999999999999999999999999999999963   44 89999999987


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF-RAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....   ....++..|+|||++. ..++.++|||||||++|||++|+.||......... ....... .........++
T Consensus       159 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (267)
T PHA03390        159 IIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVS  234 (267)
T ss_pred             ecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccC
Confidence            65422   2346889999999986 46899999999999999999999999755433221 1111111 11111223689


Q ss_pred             HHHHHHHHHhchhccccCCC-HHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMT-AVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps-~~elL~~l~~~~  413 (422)
                      ..+.+||.+||+.||.+|++ .+|+|+|.||+.
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999999996 599999999963

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=318.35  Aligned_cols=253  Identities=24%  Similarity=0.390  Sum_probs=209.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|+++.....+..||+|.++...  .....+.+.+|+.++++++ |+||+++++++.+++.+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            46899999999999999999986533345589999986532  2223467889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++....+.+++.++..++.|++.||.|||++|++||||||+|||++   .++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCcccccc
Confidence            999999999999999877667789999999999999999999999999999999999994   57889999999997654


Q ss_pred             CCCCc----cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          307 PDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .....    ....++..|++||++. +.++.++|+|||||++||+++ |..||......+....+.... ..+.  ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLPA--PMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCCC--CCCC
Confidence            33211    1122356799999986 478999999999999999886 999998877666666665542 2221  2357


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +..+.++|.+||+.+|.+||++.++++.
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~  262 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSI  262 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence            8999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-42  Score=327.55  Aligned_cols=255  Identities=28%  Similarity=0.499  Sum_probs=211.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.|.....||+|+||.||++.+..   ++..||||.+....   ....+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence            446666789999999999999876   78899999986432   223466889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||+++   +++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcc
Confidence            999999999999887633  4689999999999999999999999999999999999994   57899999999987543


Q ss_pred             CC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .. .......|+..|+|||++.+ .++.++||||||+++|||++|+.||........+..+......... ....++..+
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  248 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-DSHKVSSVL  248 (292)
T ss_pred             cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-cccccCHHH
Confidence            22 22234578999999998764 6899999999999999999999999877665555554432221111 112578899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++|.+||..||.+||++.|+|+++||...
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-41  Score=320.50  Aligned_cols=261  Identities=20%  Similarity=0.333  Sum_probs=209.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++.+.||+|+||.||+|..+.  ....+..||+|.+.....  ......+.+|+.+++.+. |+||+++++++.+.+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFT-CHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence            579999999999999999997652  112456899998864322  222345788999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      ..++||||+.+|+|.+++....         ..++...+..++.||+.||.|||+++|+||||||+|||++   .++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcEE
Confidence            9999999999999999986532         2356778999999999999999999999999999999995   578999


Q ss_pred             EeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCC
Q 014559          296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       296 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |+|||+++.......   .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999875432221   12234567899999876 578999999999999999998 7889987777666666654332


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHh------ccCccchhh
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS------KLVVPILSF  416 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~------~l~~~~l~~  416 (422)
                      ....   ..++.++.++|.+||+.||++||++.++++      ++||..++|
T Consensus       240 ~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         240 LDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            1111   256789999999999999999999999987      667766543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.3e-42  Score=322.68  Aligned_cols=263  Identities=30%  Similarity=0.505  Sum_probs=216.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .|++.+.||+|+||.||+|++..+..+|+.||+|++....... ....+.+.+|+.+++.+.+|+||+.+++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3788999999999999999987554578899999987543222 223466788999999997799999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+|||++   .++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceecc
Confidence            9999999999999988654 5689999999999999999999999999999999999995   57899999999987654


Q ss_pred             CCC--CccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCCCCCCCCCC
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~  377 (422)
                      ...  ......|+..|+|||++..   .++.++||||||+++|+|++|..||.....    ..+...+......++.   
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ---  233 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc---
Confidence            332  2234568999999998753   478899999999999999999999964322    2333334333333322   


Q ss_pred             CCCCHHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                       .++..+.++|++||..||++|+     ++++++.|+||+...|..
T Consensus       234 -~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         234 -EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             -cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence             5789999999999999999997     899999999999887643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-41  Score=320.60  Aligned_cols=254  Identities=19%  Similarity=0.325  Sum_probs=207.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..|++.+.||+|+||.||+|.+.. +...+..||+|.+....  .......+.+|+.+++.++ |+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            358999999999999999998632 22256789999986432  2233467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          226 VYIVMELCEGGELLDRILARG----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      .|+||||+.+++|.+++..+.                ..+++..+..++.|++.||.|||++||+||||||+|||++   
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---
Confidence            999999999999999875321                2478889999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      .++.+||+|||+++......   ......++..|+|||++. +.++.++|||||||++|||++ |..||.+.........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            57889999999997654322   123344567899999876 568999999999999999998 9999987766666655


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +...... .  ....++.++.++|.+||+.||.+||++.++++++
T Consensus       239 ~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  280 (283)
T cd05090         239 VRKRQLL-P--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL  280 (283)
T ss_pred             HHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence            5543322 1  1236889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-42  Score=322.29  Aligned_cols=255  Identities=31%  Similarity=0.526  Sum_probs=208.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.+..   +++.||||+++.... .....+.+.+|+++++.+. |+||+++++++.+.+.++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEE
Confidence            69999999999999999999877   688999999865432 2223467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||++++. ++.+......+++..++.++.||+.||.|||++|++|+||+|+||+++   +++.+||+|||++.....
T Consensus        77 iv~e~~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          77 LVFEYVERTL-LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EEEecCCCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCC
Confidence            9999998754 444555556799999999999999999999999999999999999994   588999999999877654


Q ss_pred             CC--CccccccCCcccCccccC-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--------------
Q 014559          308 DE--RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------------  369 (422)
Q Consensus       308 ~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------  369 (422)
                      ..  ......++..|+|||++. . .++.++||||||+++|+|++|+.||......+.+..+....              
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            43  334467889999999875 4 68899999999999999999999997765544433322110              


Q ss_pred             CCC-----CCC--------CCC-CCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          370 PNF-----DDL--------PWP-SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       370 ~~~-----~~~--------~~~-~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ..+     ...        .++ .++.++++||++||..||++||++.+++++.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000     000        011 248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=321.26  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=210.2

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--CeE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NNV  226 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  226 (422)
                      |++.+.||+|+||.||+|.+..   +++.||+|++.... ........+.+|+.+++.+. |+||+++++++.+.  +..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence            6788999999999999999876   67899999998653 22223456788999999997 99999999999988  899


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++ +|.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++   +++.+||+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYT  151 (287)
T ss_pred             EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeecc
Confidence            999999975 88888766556799999999999999999999999999999999999995   58899999999998665


Q ss_pred             CCC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC-----
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW-----  377 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----  377 (422)
                      ...  ......++..|+|||.+.+  .++.++||||||+++|||++|+.||........+..+...........|     
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence            433  2334567889999997653  5789999999999999999999999887766655555432211111111     


Q ss_pred             ---------------------CC-CCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          378 ---------------------PS-VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       378 ---------------------~~-~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                           .. ++.++.++|++||..||.+||++.+++.++||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                                 11 37889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=315.78  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=206.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|.+.    .++.||||.++....    ..+.+.+|+.++++++ |+||+++++++...+.+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCe
Confidence            56999999999999999999865    346799999865432    2366889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~  153 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVI  153 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEc
Confidence            99999999999999886543 4689999999999999999999999999999999999995   5888999999999766


Q ss_pred             CCCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ......  .....+..|+|||++. ..++.++||||||+++|||++ |+.||.+......+..+...... +  ....++
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~  230 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-P--CPPGCP  230 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcCC
Confidence            532211  1122345799999876 468999999999999999999 99999887776666666543221 1  112578


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+.++|.+||..||.+||++.++++.+
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~~l  258 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQWKL  258 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            9999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=318.43  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=206.1

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe---
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN---  225 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  225 (422)
                      |++++.||+|+||.||+|....+...+..||||++..... .....+.+.+|+.+++.+. |+||+++++++.+...   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            5678899999999999999865433457899999875432 2233467889999999997 9999999998876554   


Q ss_pred             ---EEEEEEccCCCChHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          226 ---VYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       226 ---~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                         .++||||+.+++|...+...     ...+++..+..++.|++.||.|||+++|+||||||+||+++   +++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence               89999999999998887542     23589999999999999999999999999999999999994   57899999


Q ss_pred             ecCcccccCCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCC
Q 014559          298 DFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       298 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      |||+++........   ....++..|+|||++. ..++.++|||||||++|||++ |..||.+......+..+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999765433221   1223567899999876 468999999999999999999 899998877777776666543221


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .   ...++.++.++|.+||..||++||++.|+++++
T Consensus       236 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l  269 (273)
T cd05035         236 Q---PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL  269 (273)
T ss_pred             C---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            1   126889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-41  Score=317.01  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      ...||+|+||.||+|++..   ++..||+|.+....   ....+.+.+|+.+++.++ |+||+++++++.+.+..++|||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLS---TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEe
Confidence            3579999999999999876   67899999886432   223467889999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC
Q 014559          232 LCEGGELLDRILARGGRY--TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE  309 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l--~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  309 (422)
                      |+.+++|.+++......+  ++..+..++.||+.||.|||++||+||||||+||+++.  ..+.++|+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCC
Confidence            999999999887654555  88899999999999999999999999999999999952  35789999999987653322


Q ss_pred             -CccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHH--HcCCCCCCCCCCCCCCH
Q 014559          310 -RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRAV--LRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i--~~~~~~~~~~~~~~~s~  382 (422)
                       ......|+..|+|||++.+   .++.++||||||+++|+|++|+.||........ ...+  ....+.++    ..+++
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  239 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP----ESLSA  239 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC----cccCH
Confidence             2233468899999998753   378999999999999999999999965433221 1111  11112222    25789


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++++||++||+.+|.+||++.|++.|+||
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=315.62  Aligned_cols=248  Identities=24%  Similarity=0.411  Sum_probs=210.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|.+......+..|++|++.......  ..+.+.+|+++++.++ |+||+++++++.+...+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            46999999999999987632247899999997653322  4578899999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          233 CEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       233 ~~~g~L~~~l~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +++++|.+++...        ...+++..++.++.|++.||.|||++||+|+||||+||+++   .++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccc
Confidence            9999999988765        47799999999999999999999999999999999999995   579999999999986


Q ss_pred             cCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          305 IRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       305 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....   ......++..|+|||.+. ..++.++|||||||++|||++ |..||...........+...... .  ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-P--KPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCcc
Confidence            65432   233456788999999876 478999999999999999999 69999888777777776653221 1  1125


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||..||++||++.|++.++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6e-43  Score=350.07  Aligned_cols=253  Identities=22%  Similarity=0.400  Sum_probs=216.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+.+..+.||+|.||.||+|+.....  .....||||.++..  ...+...+|++|++++..|. |+|||+|+|+|.+++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence            34677889999999999999876432  24578999999754  33345689999999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------C----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          225 NVYIVMELCEGGELLDRILARG---------G----RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------~----~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      -+|+|+|||..|||.+++..+.         .    .++..+...|+.||+.|++||-++.+|||||-..|+||+   ++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---EN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cc
Confidence            9999999999999999987532         1    278899999999999999999999999999999999995   58


Q ss_pred             CCEEEeecCcccccCCCCCcc---ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 014559          292 ADMRLIDFGLSDFIRPDERLN---DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVL  366 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  366 (422)
                      ..|||+||||++.....+...   ...-..+||+||.|. ++|+.++|||||||+|||+++ |+.||.+...++.++.|.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            899999999998665433222   223467899999764 899999999999999999998 999999999999999998


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .+.. +...  .+++.++.+|+..||..+|++||++.|+-..
T Consensus       720 ~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~  758 (774)
T KOG1026|consen  720 AGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIHSR  758 (774)
T ss_pred             cCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            8776 3222  2799999999999999999999999998554

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-41  Score=324.32  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=215.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|+..+.||+|+||.||++++..   ++..||+|++.............+.+|+++++.++ |+|++++++++.+....
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTA  100 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeE
Confidence            458889999999999999999876   77899999987654444444567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+ +|.+.+......+++..+..++.|++.||.|||++||+||||+|+||+++   .++.+||+|||++....
T Consensus       101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIAS  176 (317)
T ss_pred             EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCccccC
Confidence            999999975 88887766667799999999999999999999999999999999999994   57899999999986543


Q ss_pred             CCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .   .....|+..|+|||++.    +.++.++|||||||++|||++|..||...........+.......  .....++.
T Consensus       177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  251 (317)
T cd06635         177 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSD  251 (317)
T ss_pred             C---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCccccH
Confidence            2   23456888999999863    458899999999999999999999998776666565555443221  12235788


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .++++|.+||..+|.+||++.++++++|+....
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            999999999999999999999999998875443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=324.31  Aligned_cols=267  Identities=28%  Similarity=0.451  Sum_probs=216.3

Q ss_pred             cCcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-C----Ce
Q 014559          139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-K----HL  213 (422)
Q Consensus       139 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----ni  213 (422)
                      +..++.+..+|.++..+|+|.||.|..+.+..   ++..||||+++.-..    ..+...-|+++|+++..+ |    -+
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            34467778899999999999999999999987   688999999975332    235667799999999522 2    37


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC---
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR---  289 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~---  289 (422)
                      |.+.++|+-.++.|||+|.+ |-++.+.+... ..+++..+++.+..||+++++|||+++++|.||||+|||+.+.+   
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence            88889999999999999999 56999998764 35699999999999999999999999999999999999996421   


Q ss_pred             --------------CCCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 014559          290 --------------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFW  354 (422)
Q Consensus       290 --------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~  354 (422)
                                    .+..|||+|||.|++..+.  ....+.|..|+|||++.+ .|+..+||||+||||+||++|...|.
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                          2456999999999875433  377889999999999876 89999999999999999999999998


Q ss_pred             CCChhH---HHHHHHcCCCCC-------------CCCCCCCC--------------------------CHHHHHHHHHhc
Q 014559          355 ARTESG---IFRAVLRSDPNF-------------DDLPWPSV--------------------------SPEAKDFVKRLL  392 (422)
Q Consensus       355 ~~~~~~---~~~~i~~~~~~~-------------~~~~~~~~--------------------------s~~~~~li~~~L  392 (422)
                      .....+   +.+.|+..-+.-             ..+.|++.                          ..++.|||++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            776555   444444311110             01112211                          145899999999


Q ss_pred             hhccccCCCHHHHHhccCccchh
Q 014559          393 NKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       393 ~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ..||.+|+|+.|+|.|+||+.+.
T Consensus       391 ~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  391 EFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccCccccccHHHHhcCHHhhcCC
Confidence            99999999999999999998764

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-41  Score=323.58  Aligned_cols=256  Identities=24%  Similarity=0.404  Sum_probs=207.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ++|.+++.||+|+||.||+|++....    .++..||+|++....  .......+.+|+.+++.+.+|+||+++++++.+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            57999999999999999999864311    134579999987542  222346788899999999669999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      .+.+|+||||+.+++|.+++....               ..+++.++..++.|++.||.|||++|++||||||+|||++ 
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  174 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-  174 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc-
Confidence            999999999999999999987532               2478899999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        .++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|||++ |..||......+..
T Consensus       175 --~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         175 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             --CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence              578999999999876543221   11223456899999876 468999999999999999998 88999877766666


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ..+..... ..  ....++.++.+||.+||..+|++||++.++++++.
T Consensus       253 ~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         253 KLLKEGHR-MD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             HHHHcCCC-CC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            55544332 11  11367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.6e-42  Score=322.94  Aligned_cols=254  Identities=19%  Similarity=0.307  Sum_probs=209.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.++||+|+||.||+|.+...  ...++.||||++....  .....+.+.+|+.++..+. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence            3588899999999999999987542  1246789999987542  2223466889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      ..++++||+.+++|.+++..+               ...+++..+..++.|++.||.|||++||+||||||+|||+.   
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---
Confidence            999999999999999887532               23478889999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      +++.+||+|||+++.......   .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+.+..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            478899999999876543221   22344577899999875 578999999999999999998 8889988777777777


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.........   ..++.++.+||.+||+.||.+||++.+++..+
T Consensus       239 i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l  280 (283)
T cd05091         239 IRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL  280 (283)
T ss_pred             HHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence            7765543211   26889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-41  Score=317.68  Aligned_cols=253  Identities=22%  Similarity=0.384  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++.+.||+|+||.||+|.++.....+..||||++....  .......+.+|+.+++.+. |+||+++++++.+.+.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence            35899999999999999999987633234579999986532  2334567899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++....+.+++.+++.++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCccccccc
Confidence            999999999999998877667799999999999999999999999999999999999994   57899999999987654


Q ss_pred             CCCCccc---cc---cCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          307 PDERLND---IV---GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       307 ~~~~~~~---~~---gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .......   ..   .+..|+|||++. +.++.++|||||||++|||++ |..||+..........+.... ..+.  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RLPP--PM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCCC--cc
Confidence            3222111   11   245799999886 578999999999999999886 999998877776666664332 1111  23


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .++.++.++|.+||..+|.+||++.+++..
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.6e-42  Score=318.86  Aligned_cols=252  Identities=31%  Similarity=0.511  Sum_probs=214.9

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||.|+||.||++++..   +++.|++|++...........+.+.+|++++++++ |+||+++++.+.+.+..|+||||+.
T Consensus         1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence            6899999999999876   68899999997665544455678899999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC-----
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----  309 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-----  309 (422)
                      +++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||+++   .++.++|+|||++.......     
T Consensus        77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcccccc
Confidence            99998887654 4799999999999999999999999999999999999995   58899999999987543321     


Q ss_pred             ----CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          310 ----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       310 ----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                          ......++..|++||++. ..++.++||||||+++|+|++|..||...........+......++..  ..++.++
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA  230 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence                223456788999999875 468899999999999999999999998888777777776644443331  1358999


Q ss_pred             HHHHHHhchhccccCCCH---HHHHhccCccchhh
Q 014559          385 KDFVKRLLNKDYRKRMTA---VQALSKLVVPILSF  416 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~---~elL~~l~~~~l~~  416 (422)
                      .+||++||+.+|.+||++   .++|.++||..+.|
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            999999999999999999   99999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=319.78  Aligned_cols=256  Identities=27%  Similarity=0.484  Sum_probs=212.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~  225 (422)
                      .|++.+.||+|+||.||+|.+..   +++.||+|++....  .....+.+.+|+.+++.+.  +|+||+++++++.++..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence            47888999999999999999876   78899999986532  2223467889999999996  59999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .|+||||+++++|.+++..  +.+++..++.++.|++.||.|||+.||+|+||+|+||+++   .++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~  151 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeec
Confidence            9999999999999987644  4799999999999999999999999999999999999995   4889999999998766


Q ss_pred             CCCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .... ......|+..|+|||++.+  .++.++|+|||||++|+|++|..||...........+...  ..+......++.
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  229 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSK  229 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCH
Confidence            4433 2344578999999998753  4789999999999999999999999766554443332222  122222224788


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++.++|.+||..||++||++.+++.+.|+....
T Consensus       230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999999999996544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-42  Score=324.91  Aligned_cols=257  Identities=27%  Similarity=0.463  Sum_probs=212.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++.+.||+|+||.||+|.+..   +++.||+|++.....  ....+.+.+|+.+++.+. |+||+++++++..++.+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence            357888999999999999999876   678999999865432  223467899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++..  +.+++..+..++.|++.||.|||++|++|+||+|+||+++   +++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEcccccccccc
Confidence            999999999999887643  5689999999999999999999999999999999999995   57889999999997654


Q ss_pred             CCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....|+..|+|||++.+ .++.++|||||||++|||++|+.||...........+.......   ....++.++
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPF  229 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHH
Confidence            3322 233468889999999864 68999999999999999999999997655554444333322111   112578899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      .++|.+||..+|++||++.++++|+|+.....+
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         230 KEFVEACLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence            999999999999999999999999998755443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=323.41  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc----CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK----GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ..+|.+.+.||+|+||.||+|+...    ....+..||+|++....  .......+.+|+.+++.+.+|+||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4579999999999999999997531    22245689999986432  22344678899999999955999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                      ..+.+|+||||+.+++|.+++....               ..++...+..++.||+.||.|||++||+||||||+|||++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            9999999999999999999887532               3477888999999999999999999999999999999995


Q ss_pred             eCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 014559          287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI  361 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~  361 (422)
                         .++.+||+|||+++.......   .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+.
T Consensus       172 ---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         172 ---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             ---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence               578999999999976543221   22234567899999876 468999999999999999998 8899988777777


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+........   ...++.++.+||.+||..+|++||++.|+++.+
T Consensus       249 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l  293 (304)
T cd05101         249 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL  293 (304)
T ss_pred             HHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            776654432211   136889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=322.39  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=208.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.+.||+|+||.||++......  .....||+|.+.....  ......+.+|+.+++++.+|+||+++++++...+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            47999999999999999999876421  2447899999875422  2234568899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      .+++||||+.+|+|.+++...               ...+++..+..++.|++.||.|||++||+||||||+|||++   
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---
Confidence            999999999999999988642               34689999999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      +++.+||+|||+++.......   .....++..|+|||++. ..++.++|||||||++|||++ |..||...........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            588999999999986543321   12223456799999875 578999999999999999997 9999987776666665


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +...... .  ....++.++.+||.+||..||++|||+.|+++++
T Consensus       247 ~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l  288 (293)
T cd05053         247 LKEGYRM-E--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL  288 (293)
T ss_pred             HHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            5543321 1  1125789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-41  Score=320.53  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.+.||+|+||.||+|.+..  ...++..+++|.+....   ......+.+|+.++++++ |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            468999999999999999998643  11245678999885432   223356889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      ..++||||+++++|.+++....               +.+++..++.++.||+.||.|||++||+||||||+|||++   
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence            9999999999999999886532               3488999999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      .++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|||++ |..||........+..
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            578999999999975543221   23345678899999876 568999999999999999998 9999987777666666


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +........   ...++.++.++|.+||..||++||++.++++.+
T Consensus       238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l  279 (291)
T cd05094         238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL  279 (291)
T ss_pred             HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            655433211   125788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-41  Score=316.11  Aligned_cols=254  Identities=21%  Similarity=0.356  Sum_probs=209.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|+..+.||+|+||.||+|++.........+|+|.+....  .....+.+.+|+++++.+. |+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            36888999999999999999987532234579999986542  2223467889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+++|.+++....+.+++..+..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence            999999999999998877667899999999999999999999999999999999999995   57889999999987654


Q ss_pred             CCCCc--c--ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          307 PDERL--N--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       307 ~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .....  .  ....+..|+|||++. +.++.++|||||||++|||++ |+.||......+....+...... +.  ...+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~-~~--~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-PA--PMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-CC--CCCC
Confidence            32211  1  112345799999876 578999999999999999997 99999887777777776654221 11  1257


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.++|.+||..||++||++.++++.+
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l  264 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLL  264 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            89999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=331.17  Aligned_cols=258  Identities=29%  Similarity=0.499  Sum_probs=205.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++++|++.+.||+|+||.||+|++..   +++.||||++...  ........+.+|+.+++.++ |+||+++++++... 
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence            45689999999999999999999876   7889999998642  22223456788999999997 99999999987654 


Q ss_pred             ----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                          ..+|+|+||+.+ +|.+.+.  ...+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~df  150 (336)
T cd07849          77 FESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDF  150 (336)
T ss_pred             ccccceEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcc
Confidence                358999999965 8877663  34799999999999999999999999999999999999994   5889999999


Q ss_pred             CcccccCCCCC----ccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC---
Q 014559          300 GLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP---  370 (422)
Q Consensus       300 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---  370 (422)
                      |++........    .....|+..|+|||++.  ..++.++|||||||++|+|++|+.||.+.........+.....   
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~  230 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS  230 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99876533221    23357899999999864  3689999999999999999999999976554333222211000   


Q ss_pred             --------------------CCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          371 --------------------NFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       371 --------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                          .....    ..+.++.++.+||.+||+.||.+||++.|+++|+||...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                                00000    013567889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7e-42  Score=324.84  Aligned_cols=253  Identities=30%  Similarity=0.523  Sum_probs=211.2

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |+....||+|+||.||+|.+..   +++.||||++.....   ...+.+.+|+.+++.+. |+||+++++++...+..|+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence            4556689999999999999876   788999999865332   23466889999999996 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ||||+++++|.+.+..  ..+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        96 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          96 LMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcccc
Confidence            9999999999886543  4689999999999999999999999999999999999994   5889999999998754332


Q ss_pred             C-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          309 E-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      . ......|+..|+|||++. ..++.++|||||||++|||++|+.||........+..+...... ....+..++.++.+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  249 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRD  249 (297)
T ss_pred             cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHH
Confidence            2 234467899999999986 46899999999999999999999999877666655555433222 12223467899999


Q ss_pred             HHHHhchhccccCCCHHHHHhccCccch
Q 014559          387 FVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       387 li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +|.+||+.||++||++.++++|.|+...
T Consensus       250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         250 FLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            9999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=317.34  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=208.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++.+.||+|+||.||++.++...  ..+..||+|.+....  .......+.+|+.+++.+. |+||+++++++.+.+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   82 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTGQ   82 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCCC
Confidence            57999999999999999999986422  245789999986442  2223456789999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      ..++||||+.+++|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++   .++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence            9999999999999999886432         2468889999999999999999999999999999999995   588999


Q ss_pred             EeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCC
Q 014559          296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       296 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |+|||+++.......   .....++..|+|||++. +.++.++|||||||++|||++ |..||.........+.+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            999999875543321   22345678899999875 578999999999999999998 9999988777777666653322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .  ..+ ..++.++.++|.+||+.+|++||++.++++.+
T Consensus       240 ~--~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         240 L--DLP-ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             C--CCC-CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            1  111 24789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.4e-41  Score=318.03  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=203.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++.+.||+|+||.||+|++.... .....||||++....  .......+.+|+.+++.+. |+||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-ST   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-CC
Confidence            47999999999999999999876511 112358999986432  2233467889999999997 9999999999875 45


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .+++|||+++|+|.+.+....+.+++..+..++.|++.||.|||+++|+||||||+|||++   +++.+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceeec
Confidence            7899999999999998877667799999999999999999999999999999999999995   4778999999999866


Q ss_pred             CCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......   ....++..|++||++. ..++.++|||||||++|||++ |..||...........+..... .+.  ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~  236 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQ--PPIC  236 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--CccC
Confidence            433221   1223467899999875 568999999999999999998 8999977666555554444322 111  2368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +.++.++|.+||..||++||++.+++..
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-41  Score=321.05  Aligned_cols=257  Identities=20%  Similarity=0.268  Sum_probs=206.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-------------ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-------------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      .+|++++.||+|+||.||+|.+....             ..+..||+|++.....  ....+.+.+|++++++++ |+||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCCE
Confidence            46999999999999999999875411             1235689999875432  234567889999999997 9999


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                      +++++++..++..++||||+.+++|.+++....          ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999886543          2689999999999999999999999999999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWART  357 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~  357 (422)
                      +++   .++.++|+|||+++.......   .....++..|+|||++. +.++.++|||||||++|||++  +..||....
T Consensus       162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            995   478999999999876543321   22345677899999876 478999999999999999998  778887766


Q ss_pred             hhHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ESGIFRAVLRS----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+..+...    ...........++.++.++|.+||+.||.+||++.|+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L  294 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL  294 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence            66655555432    11111111225678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=337.15  Aligned_cols=263  Identities=25%  Similarity=0.444  Sum_probs=236.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +++++.-||-||||.|-++..+.   ....+|+|++++....+....+.+..|-+||..++ .+.||++|..|.++..+|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhh
Confidence            46677789999999999998765   33358999999887777777788999999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +.||-|-||.|+..+..+ +.|++...+.++..+++|++|||++|||+|||||+|.++   +.+|.+||.|||+|+.+..
T Consensus       497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhcc
Confidence            999999999999977555 689999999999999999999999999999999999999   5699999999999999999


Q ss_pred             CCCccccccCCcccCcccc-CccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      +.++.++|||+.|.|||++ ++..+.++|.||||+++|||++|.+||.+.+....+..|+++-..+...  ..++..+.+
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~  650 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATD  650 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHH
Confidence            9999999999999999975 5789999999999999999999999999999999999999865443322  268999999


Q ss_pred             HHHHhchhccccCCC-----HHHHHhccCccchhhhhhh
Q 014559          387 FVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       387 li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~~  420 (422)
                      ||+++...+|.+|..     +.++-+|-||..+.|--.+
T Consensus       651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence            999999999999987     8899999999998886544

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.9e-41  Score=314.39  Aligned_cols=254  Identities=26%  Similarity=0.487  Sum_probs=212.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.++.   ++..||+|.+....... ...+.+.+|+.+++.++ |+||+++++.+.+.+.++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence            48899999999999999999987   78889999987643322 23467789999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.  ++..+||+|||.+....
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLN  153 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhcc
Confidence            9999999999999886543 35899999999999999999999999999999999999952  23457999999987654


Q ss_pred             CCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .... .....|+..|+|||++. ..++.++|+|||||++|||++|..||...........+.......   ..+.++.++
T Consensus       154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (257)
T cd08225         154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDL  230 (257)
T ss_pred             CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHH
Confidence            3322 23346889999999875 468999999999999999999999998766655555554433221   123578899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .++|.+||..+|++||++.|+++|+||
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         231 RSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-41  Score=321.75  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++.+.||+|+||.||++.+...  ...+..||||+++....  ....+.+.+|+.+++++.+|+||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            4799999999999999999986421  12456899999865422  2234678899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+++||||+.+++|.+++.... ..+++.++..++.|++.||.|||+++|+|+||||+|||++   .++.+||+|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcccc
Confidence            9999999999999999886543 3489999999999999999999999999999999999994   57889999999997


Q ss_pred             ccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .......   .....++..|+|||++. +.++.++|||||||++|||++ |..||........+...........  ...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  267 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPE  267 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCC
Confidence            6543321   12234567899999875 568999999999999999998 9999977665554444443322211  122


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+.++.+||.+||..+|++||++.|+++.+
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l  298 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLI  298 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            5789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.9e-42  Score=320.47  Aligned_cols=253  Identities=31%  Similarity=0.605  Sum_probs=217.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||+|.+..   +++.||+|++.+...........+.+|+.+++++.+|+||+++++++.+.+.++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            68999999999999999999887   788999999977544444445678899999999966999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+.+... +.+++..++.++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCC
Confidence            999999999999987654 4799999999999999999999999999999999999995   578999999999875543


Q ss_pred             CC---------------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 014559          308 DE---------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV  365 (422)
Q Consensus       308 ~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i  365 (422)
                      ..                     ......++..|++||++. ..++.++||||||++++++++|..||........+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            22                     122346788999999875 46889999999999999999999999887766666666


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHHhccCc
Q 014559          366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA----VQALSKLVV  411 (422)
Q Consensus       366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~elL~~l~~  411 (422)
                      ......++.    .++.++.+||++||+.||.+||++    +++|.|+||
T Consensus       235 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 LKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            654444433    678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-41  Score=317.70  Aligned_cols=261  Identities=29%  Similarity=0.424  Sum_probs=210.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--Ce
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  225 (422)
                      .|+..+.||.|++|.||++.+..   +++.||+|.+.....  ......+.+|++++++++ |+||+++++++.+.  +.
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   75 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSS   75 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCe
Confidence            58999999999999999999976   788999999875422  233467889999999997 99999999998654  47


Q ss_pred             EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      +|+||||+++++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~  152 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVS  152 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecccc
Confidence            9999999999999887643   345689999999999999999999999999999999999995   4788999999998


Q ss_pred             cccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHcCC-CCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-----ESGIFRAVLRSD-PNFDDL  375 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~-~~~~~~  375 (422)
                      ....... .....++..|++||.+. ..++.++|||||||++|+|++|..||....     ..+....+.... ..+...
T Consensus       153 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd06621         153 GELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE  231 (287)
T ss_pred             ccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC
Confidence            6543222 23456788999999876 578999999999999999999999997652     233333333312 111111


Q ss_pred             CC--CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          376 PW--PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       376 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      ..  ..+++++.+||.+||..||.+||++.|+++|.|+.....|.
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence            11  13567899999999999999999999999999997766553

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-41  Score=320.43  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=209.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||++.+..   +++.||+|++....  .....+.+.+|+++++.++ |+||+++++++.+.+.+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEE
Confidence            469999999999999999999876   78899999986532  2233567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+++||||||+||+++   +++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~  154 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccch
Confidence            999999999999887654 4579999999999999999999997 5899999999999994   5789999999998654


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHHHcCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES-----------GIFRAVLRSDPNFD  373 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~  373 (422)
                      .. .......|+..|+|||++. +.++.++|||||||++|+|++|+.||......           +.+..+.....  +
T Consensus       155 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  231 (284)
T cd06620         155 IN-SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--P  231 (284)
T ss_pred             hh-hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--C
Confidence            32 2233457899999999875 57899999999999999999999999764431           22233332221  1


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ......++.++.+||.+||..||.+||++.|+++++||.
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            111224788999999999999999999999999998874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.5e-41  Score=318.18  Aligned_cols=254  Identities=30%  Similarity=0.523  Sum_probs=212.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|...+.||+|++|.||++.+..   +++.|++|++....   ....+.+.+|+.+++.+. |+||+++++++...+..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEE
Confidence            45666799999999999999876   67899999885432   223456889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|+||+.+++|.+++..  ..+++..+..++.|++.||.|||++||+||||+|+||+++   .++.++|+|||++.....
T Consensus        93 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          93 VVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhcc
Confidence            99999999999988755  5799999999999999999999999999999999999994   588999999998865433


Q ss_pred             CC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .. ......|+..|+|||++.+ .++.++|||||||++|+|++|..||........+..+......... ....++.++.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  246 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLR  246 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHH
Confidence            22 2234568999999999764 6899999999999999999999999877666666655554322211 1124789999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccch
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +||++||..||++||++.++++|.|+...
T Consensus       247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         247 SFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             HHHHHHcccChhhCcCHHHHccCcccccC
Confidence            99999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.7e-41  Score=317.97  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.++||+|+||.||++....  ...++..+|+|.+...   .....+.+.+|+++++.+. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            468889999999999999997532  1225678999987643   2234467899999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          225 NVYIVMELCEGGELLDRILARG--------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      ..++||||+.+++|.+++....              ..+++..+..++.||+.||.|||++||+||||||+|||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence            9999999999999999886532              3488999999999999999999999999999999999995   5


Q ss_pred             CCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 014559          291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV  365 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  365 (422)
                      ++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|||++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            88999999999875533221   12234567899999876 568999999999999999998 99999877776766666


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ........   ...++.++.+||.+||+.||.+||++.|+++.+
T Consensus       238 ~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         238 TQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             HcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            55433211   126889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.7e-41  Score=314.86  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=203.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.++||+|+||.||+|.+..    ...||||++.....    ..+.+.+|+++++.++ |+||+++++.+.+ +..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~   75 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI   75 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCc
Confidence            469999999999999999998754    24699999875332    2357889999999997 9999999998754 568


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++   +++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~  152 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI  152 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeec
Confidence            9999999999999988753 34589999999999999999999999999999999999995   5788999999999765


Q ss_pred             CCCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ......  ....++..|+|||++. +.++.++|||||||++|||++ |..||...........+........   ...++
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  229 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECP  229 (262)
T ss_pred             cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccC
Confidence            433221  2234667899999875 578999999999999999999 8889987777666666554322111   13688


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+.++|.+||..||++||++.++++.
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~  256 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQAF  256 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=325.11  Aligned_cols=261  Identities=28%  Similarity=0.448  Sum_probs=204.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--Ce
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  225 (422)
                      +|++.+.||+|+||.||+|.+..+ ..++.||||++...........+.+.+|+.+++.++ |+||+++++++.+.  +.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence            488999999999999999998752 157899999997644223333466788999999997 99999999999988  88


Q ss_pred             EEEEEEccCCCChHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee-CCCCCCEEEeecC
Q 014559          226 VYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFG  300 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~-~~~~~~vkl~DfG  300 (422)
                      +++||||+++ +|.+.+...    ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999975 777766432    236899999999999999999999999999999999999953 2237889999999


Q ss_pred             cccccCCCCC----ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH---------HHHHH
Q 014559          301 LSDFIRPDER----LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESG---------IFRAV  365 (422)
Q Consensus       301 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---------~~~~i  365 (422)
                      ++........    .....++..|+|||++.+  .++.++|||||||++|+|++|+.||.......         .+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9876543222    234568899999998753  58999999999999999999999997654322         11111


Q ss_pred             HcCC--------------C-------CCCCCCC------------CCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          366 LRSD--------------P-------NFDDLPW------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       366 ~~~~--------------~-------~~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ...-              +       .......            ...+.++.++|.+||..||++|||+.|++.|+||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1100              0       0000011            1466789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-41  Score=314.35  Aligned_cols=255  Identities=30%  Similarity=0.447  Sum_probs=214.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|++|.||+|.+..   +++.|+||++......  .....+.+|+.++.+++ |+||+++++++...+.++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEIS   75 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEE
Confidence            58899999999999999999886   7889999998765332  34577899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++   .++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~~  151 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceecc
Confidence            999999999999987654 679999999999999999999999 9999999999999994   58899999999988665


Q ss_pred             CCCCc-cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDERL-NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ..... ....++..|+|||.+. ..++.++|+||||+++|+|++|..||....   .......+.....  .......++
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  229 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEFS  229 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--CCCCcccCC
Confidence            43332 2557889999999876 468899999999999999999999997763   3344444443222  112212278


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ..+.++|++||..+|++||++.|+++++|++..
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.2e-41  Score=309.07  Aligned_cols=251  Identities=33%  Similarity=0.570  Sum_probs=212.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|.+.+.||+|++|.||++.+..   +++.|++|++.....   .....+.+|+.+++.+. |+||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence            37888999999999999999876   778999999866433   24467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +++||+++++|.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++   +++.++|+|||++.....
T Consensus        74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeeccccccccc
Confidence            99999999999998876656799999999999999999999999999999999999995   478999999999987655


Q ss_pred             CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC-CCCHHHH
Q 014559          308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAK  385 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~~~~  385 (422)
                      ........++..|++||++. ..++.++||||||+++|+|++|+.||...........+....  ....... .++.++.
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  228 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFK  228 (253)
T ss_pred             cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCcccccCHHHH
Confidence            44345567899999999876 458899999999999999999999997764444443333321  1222211 2489999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccC
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ++|++||..||++||++.|+|+|+|
T Consensus       229 ~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         229 DFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.8e-41  Score=320.48  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=213.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.|...+.||+|+||.||+|++..   +++.|++|++.............+.+|+.+++.++ |+||+++++++.+....
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            447778889999999999999876   78899999997654444444567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+. ++|.+.+......+++.++..++.||+.||.|||++||+|+||+|+||++.   .++.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcccC
Confidence            99999996 588888776667799999999999999999999999999999999999994   57889999999986432


Q ss_pred             CCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                         ......|+..|+|||++.    +.++.++|||||||++|+|++|..||...........+.....  +......++.
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  247 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD  247 (313)
T ss_pred             ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence               234567899999999873    4588999999999999999999999987665555555443322  2222335788


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .+++||.+||+.+|.+||++.+++.|+|+..
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            8999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-41  Score=332.81  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|.+++.||+|+||.||+|+++.  ....++.||||++.....  ....+.+.+|+.+|.++..|+||+++++++...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            468899999999999999999753  112456899999975432  2233568899999999966999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC----------------------------------------------------------
Q 014559          225 NVYIVMELCEGGELLDRILARG----------------------------------------------------------  246 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  246 (422)
                      .++||||||.+|+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886431                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          247 ---------------------------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       247 ---------------------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                                                             ..+++..++.++.||+.||.|||+++|+||||||+|||++ 
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~-  273 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC-  273 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-
Confidence                                                   1356778899999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        +++.+||+|||+++.......   .....++..|+|||++. ..++.++|||||||++|||++ |..||......+..
T Consensus       274 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 --EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             --CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence              478899999999976432221   22345678899999876 468999999999999999998 89999765555544


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ...+.......  ....++.++.+||.+||..||.+||++.|++..
T Consensus       352 ~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44333322211  122578999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.8e-41  Score=320.51  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=211.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|.+..   +++.||||++......  .....+.+|+.++..+.+|+||+++++++.+...+
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            568999999999999999999876   6889999999754322  22355667888777776799999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |+||||+. ++|.+.+......+++..+..++.|++.||.|||+ .||+||||+|+||+++   +++.+||+|||++...
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~  165 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhc
Confidence            99999995 47777766656689999999999999999999997 5999999999999994   5889999999999766


Q ss_pred             CCCCCccccccCCcccCccccCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ..........++..|+|||++.+     .++.++||||||+++|+|++|+.||..... .+.+..+......... ....
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCC
Confidence            54444444567889999998853     378999999999999999999999965322 3444444443322111 1124


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ++.++.+||.+||..||++||++.+++.++|+....-+
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            78999999999999999999999999999998865433

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.2e-41  Score=317.39  Aligned_cols=249  Identities=19%  Similarity=0.329  Sum_probs=201.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCc----eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+|++.+.||+|+||.||+|.+..   +++    .|++|.+...  .......++..|+.+++.+. |+||+++++++..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcC---CCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC
Confidence            468999999999999999999865   333    4777776432  22223456778888999996 9999999998764


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                       ...++|+||+.+|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||++   +++.+||+|||++
T Consensus        81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~  156 (279)
T cd05111          81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVA  156 (279)
T ss_pred             -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCccc
Confidence             567899999999999999877667899999999999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +.......   .....++..|++||++. +.++.++|||||||++|||++ |..||.+.........+..... ...  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~  233 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LAQ--P  233 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--C
Confidence            86543322   23345677899999875 579999999999999999998 9999987766555444443332 211  1


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..++.++.++|.+||..||.+||++.|+++.
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=319.04  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=207.0

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||.|++|.||+|.+..   +|+.||||++...... ......+.+|+++++.++ |+||+++++++.+.+..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence            6778899999999999999876   7889999998765322 223356788999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++   .++.++|+|||++.....
T Consensus        76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCC
Confidence            999995 58888776543 3689999999999999999999999999999999999995   488999999999875532


Q ss_pred             CC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-------------
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------------  371 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  371 (422)
                      .. ......++..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+......             
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 2233456889999998753  4789999999999999999999999876655444433321110             


Q ss_pred             -----CC-------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 -----FD-------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 -----~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                           ++       ....+.++.++.++|.+||+.||.+||+++|++.+.||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                 00       01123577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-41  Score=315.51  Aligned_cols=248  Identities=21%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|+++.+. ....+++|.+...  ......+.+.+|+.++.++.+|+||+++++++...+.+|+||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-CeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            36899999999999987621 1235788887532  22233467889999999996699999999999999999999999


Q ss_pred             cCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          233 CEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       233 ~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +.+++|.+++....               ..+++..+..++.|++.||+|||++|++||||||+|||++   +++.+||+
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEEC
Confidence            99999999886532               2478999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      |||++..............+..|+|||++. ..++.++|||||||++|||++ |..||......+....+..... ..  
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~--  231 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LE--  231 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-CC--
Confidence            999985332111112223456799999875 468999999999999999997 9999987776666665544321 11  


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....++.++.++|.+||..||.+||++.+++..+
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  265 (270)
T cd05047         232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  265 (270)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            1125788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.7e-41  Score=321.69  Aligned_cols=255  Identities=23%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC----CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ++|.+++.||+|+||.||+|++...    ......||+|++....  .......+.+|+.+++.+.+|+||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            5799999999999999999986421    1235679999986432  223356788999999999669999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      .+.+|+||||+.+|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  168 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-  168 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-
Confidence            999999999999999999886532               3488899999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        .++.+||+|||+++.......   .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+.+
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         169 --EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             --CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              478899999999976543221   11223446799999876 468999999999999999999 89999887777776


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+...... .  ....++.+++++|.+||..||++||++.|+++.+
T Consensus       247 ~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l  290 (314)
T cd05099         247 KLLREGHRM-D--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL  290 (314)
T ss_pred             HHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            666554321 1  1136788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-41  Score=316.47  Aligned_cols=253  Identities=26%  Similarity=0.469  Sum_probs=211.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      -|++.+.||+|+||.||+|.+..   +++.||||++.....  ......+.+|+.++++++ |+||+++++++.+++..|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEE
Confidence            47888999999999999998876   778999999865432  223467889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+++..  ..+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          79 IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceeccc
Confidence            99999999999987743  4689999999999999999999999999999999999995   578899999999876543


Q ss_pred             CC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .. ......++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+.......   ....++.++.
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLK  230 (277)
T ss_pred             chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHH
Confidence            22 223456888999999876 468899999999999999999999998766655555544332211   1125789999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccch
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++|.+||..||.+||++.++++|+|+...
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         231 EFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-41  Score=313.30  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|+++++||+|+||.||+|.+.    +++.||+|.+.....    ..+.+.+|+.++++++ |+||+++++++. .+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~   73 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE   73 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence            3457999999999999999999865    467899999875433    2367889999999997 999999999874 45


Q ss_pred             eEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+++||||+.+++|.+++... ...+++.++..++.|++.||+|||++|++||||||+||+++   .++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~  150 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCccee
Confidence            789999999999999987653 35689999999999999999999999999999999999995   58899999999987


Q ss_pred             ccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .......  .....++..|+|||++. ..++.++||||||+++|||++ |+.||......+....+...... +  ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~  227 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-P--RPDN  227 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-C--CCCC
Confidence            6542221  12234567899999876 468999999999999999998 99999877766666655443221 1  1235


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||..||++||++++++..+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  257 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRSVL  257 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence            788999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-42  Score=333.48  Aligned_cols=266  Identities=28%  Similarity=0.468  Sum_probs=228.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .-|..++-||-|+||.|++++-..   +...||+|.+++......+.+..++.|-+||..-. .+.||+||-.|.+++.+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCce
Confidence            348889999999999999998665   78899999999988877788889999999999984 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||++||++..+|.+. +-|.|+.++.++.+|..|+++.|..|+|||||||+||||   |.+|++||.||||+.-+.
T Consensus       705 YFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccce
Confidence            9999999999999987665 579999999999999999999999999999999999999   579999999999985321


Q ss_pred             ---------CCC----------------------------------CccccccCCcccCccccC-ccCCCchhHHHHHHH
Q 014559          307 ---------PDE----------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVI  342 (422)
Q Consensus       307 ---------~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~i  342 (422)
                               .+.                                  .....+||..|+|||++. ..|+.-+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     000                                  001257999999999986 579999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHHhccCccchhhhhh
Q 014559          343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       343 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~elL~~l~~~~l~~k~~  419 (422)
                      ||||+.|+.||...+..+...++++....+....-.+++.|+.++|.++. .+++.|.   .++|+-.|+||+.+.|..+
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhh
Confidence            99999999999998888887777776655554445579999999998854 4577887   4678999999999988766


Q ss_pred             hc
Q 014559          420 CR  421 (422)
Q Consensus       420 ~~  421 (422)
                      |+
T Consensus       940 Rk  941 (1034)
T KOG0608|consen  940 RK  941 (1034)
T ss_pred             hh
Confidence            53

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5e-41  Score=312.08  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEcc
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC  233 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  233 (422)
                      +||+|+||.||+|.++... ++..||+|+++... ......+.+.+|+.+++.+. |+||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCC-CceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecC
Confidence            6999999999999764322 67889999986543 22334567889999999996 999999999886 45679999999


Q ss_pred             CCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---
Q 014559          234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---  310 (422)
Q Consensus       234 ~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---  310 (422)
                      .+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++   .++.+||+|||++........   
T Consensus        78 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          78 ELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeee
Confidence            99999988754 35799999999999999999999999999999999999995   478899999999976543322   


Q ss_pred             -ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 014559          311 -LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF  387 (422)
Q Consensus       311 -~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  387 (422)
                       .....++..|+|||++. ..++.++|||||||++|||++ |..||......+....+...... .  ....++.++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~--~~~~~~~~l~~l  230 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-E--CPQRCPPEMYDL  230 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHH
Confidence             11223457899999876 468899999999999999998 99999887777777766654321 1  112689999999


Q ss_pred             HHHhchhccccCCCHHHHHhcc
Q 014559          388 VKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~l  409 (422)
                      |.+||+.||++||++.++...+
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~~l  252 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVELRL  252 (257)
T ss_pred             HHHHhccCchhCcCHHHHHHHH
Confidence            9999999999999999987654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-41  Score=328.62  Aligned_cols=260  Identities=30%  Similarity=0.490  Sum_probs=208.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||.+..... .......+.+|+.+++.++ |+||+++++++...  
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~   78 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHR   78 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccc
Confidence            4579999999999999999999876   889999999865322 2223456778999999996 99999999988654  


Q ss_pred             ---CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          224 ---NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       224 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                         ..+|+||||+. ++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++   .++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg  153 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFG  153 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcCc
Confidence               35899999996 588887654 46799999999999999999999999999999999999995   47899999999


Q ss_pred             cccccCCC-CCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--------
Q 014559          301 LSDFIRPD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------  369 (422)
Q Consensus       301 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  369 (422)
                      ++...... .......++..|+|||++.  ..++.++|||||||++|+|++|+.||.+......+..+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         154 LARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            99765433 2234456889999999875  358999999999999999999999997654433332222100        


Q ss_pred             ---------------CCCC----CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          370 ---------------PNFD----DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       370 ---------------~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                     ....    ...++.++.++.+||++||+.||++||++.|+|+|+||..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                           0000    011246889999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.8e-41  Score=311.81  Aligned_cols=245  Identities=22%  Similarity=0.375  Sum_probs=200.0

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEcc
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC  233 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  233 (422)
                      .||+|+||.||+|.+.... .+..||+|++....  .....+.+.+|+.++++++ |+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC-CceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence            4899999999999875321 45679999986542  2334467889999999996 999999999886 45789999999


Q ss_pred             CCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc--
Q 014559          234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL--  311 (422)
Q Consensus       234 ~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~--  311 (422)
                      ++++|.+++......+++..++.++.|++.||.|||++|++||||||+|||++   .++.+||+|||++.........  
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCcccee
Confidence            99999998876667899999999999999999999999999999999999995   5788999999999755433221  


Q ss_pred             --cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 014559          312 --NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF  387 (422)
Q Consensus       312 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  387 (422)
                        ....++..|+|||++. +.++.++|||||||++|||++ |..||......+....+........   ...++.++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  230 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYAL  230 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHH
Confidence              1122356899999876 578999999999999999996 9999988777776666655432211   13578999999


Q ss_pred             HHHhchhccccCCCHHHHHhcc
Q 014559          388 VKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~l  409 (422)
                      |.+||..||++||++.++++.+
T Consensus       231 i~~c~~~~~~~Rp~~~~i~~~l  252 (257)
T cd05115         231 MKDCWIYKWEDRPNFAKVEERM  252 (257)
T ss_pred             HHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999997653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-41  Score=316.09  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=209.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||.|+||.||+|++..    +..+|+|++.....   .....+.+|+.+++.++ |+||+++++++.+.+..
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDL---LKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccch---hhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCe
Confidence            469999999999999999999863    66899999865432   23467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++   +++.+||+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~  154 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLI  154 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhc
Confidence            9999999999999988753 35689999999999999999999999999999999999995   5788999999999765


Q ss_pred             CCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          306 RPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       306 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..... .....++..|++||++. +.++.++||||||+++|+|++ |+.||......+.+..+...... +  ....++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~  231 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-P--CPAKCPQ  231 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-C--CCCCCCH
Confidence            43221 12234567899999875 578999999999999999998 89999887777777766643221 1  1236889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||..||++||++.++++.+
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L  258 (261)
T cd05148         232 EIYKIMLECWAAEPEDRPSFKALREEL  258 (261)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-41  Score=314.99  Aligned_cols=251  Identities=21%  Similarity=0.320  Sum_probs=201.5

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC------
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV------  223 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------  223 (422)
                      .+++.||+|+||.||+|++.... ....||+|.++... ......+.+.+|+.+++.++ |+||+++++++...      
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCC-CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence            46789999999999999986521 22369999886542 22334577889999999996 99999999987532      


Q ss_pred             CeEEEEEEccCCCChHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 NNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      ...++||||+.+|+|.+++...     ...+++..+..++.|++.||.|||+++|+||||||+|||++   .++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEECC
Confidence            2578999999999998877532     23488999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          299 FGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       299 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      ||+++.......   .....++..|++||++. ..++.++|||||||++|||++ |+.||...........+........
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ  235 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999986543321   12234567899999876 468999999999999999999 8999987777666666665432111


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                         ...++..+.++|.+||+.||++||++.++++.+
T Consensus       236 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  268 (272)
T cd05075         236 ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL  268 (272)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence               136889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.2e-41  Score=318.26  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=204.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +|++.+.||+|+||.||+|++..  +......+++|.+.....  ......+.+|+.+++.+. |+||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            47888999999999999998753  111346789998864322  223467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 014559          226 VYIVMELCEGGELLDRILAR-----------------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN  282 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~N  282 (422)
                      .++||||+.+++|.+++...                       ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999987542                       1247889999999999999999999999999999999


Q ss_pred             EEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014559          283 FLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART  357 (422)
Q Consensus       283 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  357 (422)
                      ||+.   +++.+||+|||+++.......   .....++..|+|||++. ..++.++||||||+++|||++ |..||.+..
T Consensus       158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9994   578999999999975533221   22334567899999865 468999999999999999998 999998777


Q ss_pred             hhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+...+..... ..  ....++.++.+||.+||+.||++||++.|+++.+
T Consensus       235 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l  283 (290)
T cd05045         235 PERLFNLLKTGYR-ME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL  283 (290)
T ss_pred             HHHHHHHHhCCCC-CC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence            7666655543321 11  1236889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-41  Score=312.49  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|.+.........||||.+......  ...+.+.+|+.++++++ |+||+++++++.+ ..+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            4689999999999998653223457999999765543  44578899999999997 9999999999998 899999999


Q ss_pred             cCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC-
Q 014559          233 CEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-  310 (422)
Q Consensus       233 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-  310 (422)
                      +++++|.+.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence            99999999987754 5689999999999999999999999999999999999995   478999999999976643221 


Q ss_pred             ---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          311 ---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                         .....++..|+|||++. ..++.++|||||||++|||++ |+.||......+....+.........  ...++.++.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence               12245678899999886 478999999999999999998 99999877777766666543222221  125789999


Q ss_pred             HHHHHhchhccccCCCHHHHHhcc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++|.+||..+|++||++.++++.+
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHHHh
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.5e-41  Score=310.41  Aligned_cols=248  Identities=25%  Similarity=0.442  Sum_probs=207.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||++.+.    .+..+|+|++.....    ....+.+|+++++.+. |+||+++++++......
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence            36899999999999999999875    356799999865432    2356889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+++|.+++....+.++++.++.++.|++.||.|||+++++|+||||+||+++   .++.+||+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecc
Confidence            999999999999998876666789999999999999999999999999999999999995   57889999999987553


Q ss_pred             CCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ....  .....++..|+|||++. +.++.++|||||||++|||++ |..||...........+......+..   ...+.
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  228 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQ  228 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCH
Confidence            2221  11223456899999876 578999999999999999998 99999877777777666544322211   24688


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.+|+.+||..+|++||++.++++.+
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.3e-41  Score=309.56  Aligned_cols=253  Identities=31%  Similarity=0.561  Sum_probs=216.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   ++..|++|++...... ......+.+|+++++.++ |+|++++++.+...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence            48899999999999999999876   7889999999764432 234567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|+||+++++|.+.+...   ...+++..+..++.+++.||.|||++|++|+||+|+||+++   +++.++|+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~  152 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceee
Confidence            999999999999988765   37799999999999999999999999999999999999995   478999999999876


Q ss_pred             cCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..... ......|+..|+|||.+. ..++.++|+||||+++++|++|+.||...................  .. ..++.
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~-~~~~~  229 (258)
T cd08215         153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--IP-SQYSS  229 (258)
T ss_pred             cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--CC-CCCCH
Confidence            54433 234457889999999875 468999999999999999999999998776666666655443221  11 26889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++.++|.+||..+|++||++.++|+++||
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-41  Score=312.81  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=203.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.++||+|+||.||+|.+.    .+..||+|.+.....    ..+.+.+|+.++++++ |+||+++++++. .+.
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~   74 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP   74 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence            357999999999999999999865    445799999875433    2356889999999997 999999999885 456


Q ss_pred             EEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++   +++.++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~  151 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARL  151 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeee
Confidence            89999999999999988653 34589999999999999999999999999999999999995   478899999999976


Q ss_pred             cCCCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .......  ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+...... +  .....
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~  228 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-P--CPQDC  228 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcC
Confidence            5433221  2233566799999875 568999999999999999999 89999887777776666543221 1  11257


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +.++.+||.+||..||++|||+.++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~  256 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQSF  256 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            8999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-41  Score=316.06  Aligned_cols=255  Identities=29%  Similarity=0.444  Sum_probs=208.1

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEeCCe-
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNN-  225 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~-  225 (422)
                      |++.+.||+|+||.||+|+++.   +++.||||++....... .....+.+|+.+++++.  +|+||+++++++.+.+. 
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence            6788999999999999999876   68899999997543322 22345667888887774  49999999999998776 


Q ss_pred             ----EEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          226 ----VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       226 ----~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                          ++++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+||+++   .++.+||+|||
T Consensus        77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg  152 (287)
T cd07838          77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFG  152 (287)
T ss_pred             CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccC
Confidence                9999999975 8888776543 3689999999999999999999999999999999999995   47899999999


Q ss_pred             cccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC--------
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--------  371 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  371 (422)
                      ++.............++..|+|||++. ..++.++|+|||||++|||++|..||......+.+..+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            997765444444556889999999876 46899999999999999999999999887776666655432110        


Q ss_pred             --------CCCC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          372 --------FDDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       372 --------~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                              +...       ..+.++.++.++|.+||+.||.+||++.|++.|.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                    0000       012356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=310.50  Aligned_cols=253  Identities=27%  Similarity=0.449  Sum_probs=207.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccc--ccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAK--MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      +|++.+.||+|+||.||+|++..   +++.||+|.+....  .........+.+|+.++++++ |+||+++++++.+.  
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~   78 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEE   78 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCC
Confidence            69999999999999999999876   78899999885432  122334567889999999997 99999999998764  


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+.+++|.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||+++   .++.++|+|||+++
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~  154 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASK  154 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcccccc
Confidence            5689999999999999887654 4589999999999999999999999999999999999994   57889999999997


Q ss_pred             ccCCC----CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPD----ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .....    .......++..|+|||++.+ .++.++|+|||||++|+|++|+.||...........+......  .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~  232 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLPD  232 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCCc
Confidence            65321    12234568899999998864 6889999999999999999999999776555544444432211  11223


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .+++++.++|.+||.. +..||++.+++.|+|.
T Consensus       233 ~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~~~~  264 (264)
T cd06653         233 GVSDACRDFLKQIFVE-EKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ccCHHHHHHHHHHhcC-cccCccHHHHhcCCCC
Confidence            6889999999999994 6999999999999884

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-41  Score=310.76  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ++||+|+||.||+|.+......+..||+|.+......  ...+.+.+|+.+++.+. |+||+++++++.. +..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEcC-CceEEEEEe
Confidence            4799999999999987653224478999998765433  23467889999999996 9999999998764 568999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc-
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~-  311 (422)
                      +.+++|.+++... ..+++..+..++.|++.||.|||.++++|+||||+|||++   .++.+||+|||+++........ 
T Consensus        77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCccc
Confidence            9999999988654 4799999999999999999999999999999999999995   5889999999998765433321 


Q ss_pred             ---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          312 ---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       312 ---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                         ....++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+.......   ....++..+++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~  229 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYS  229 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHH
Confidence               1112346799999876 468999999999999999998 999998777666666665443221   12367899999


Q ss_pred             HHHHhchhccccCCCHHHHHhcc
Q 014559          387 FVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       387 li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +|.+||..||++||++.++++.+
T Consensus       230 li~~cl~~~p~~Rp~~~~l~~~l  252 (257)
T cd05060         230 IMLSCWKYRPEDRPTFSELESTF  252 (257)
T ss_pred             HHHHHhcCChhhCcCHHHHHHHH
Confidence            99999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-44  Score=366.65  Aligned_cols=258  Identities=30%  Similarity=0.491  Sum_probs=218.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+..-+|..+..||.|.||.||.|.+..   +|+..|+|.+...... ......+.+|+.++..|+ |||+|++||+-.+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH 1305 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeec
Confidence            4455678999999999999999999887   8999999999765433 445677889999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.++|.||||++|+|.+.+ +.++-.++.....+..|++.|+.|||++|||||||||+||||+   .+|.+|++|||.|
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeecccce
Confidence            99999999999999999865 4555577778888999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCC-----CccccccCCcccCccccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHc-CCCC
Q 014559          303 DFIRPDE-----RLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLR-SDPN  371 (422)
Q Consensus       303 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~-~~~~  371 (422)
                      ..+....     ..+..+||+.|||||++.+    +...+.||||||||++||+||+.||...+. -.+...+-. ..+.
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence            8765442     2456789999999999864    467899999999999999999999966433 333333333 3455


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++    .++.+.+|||.+||..||++|+++.|+|+|-|-+.
T Consensus      1462 ~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1462 IPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             Cch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            555    59999999999999999999999999999987654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-41  Score=320.07  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|++.+.||+|+||.||+|.++.   +++.||||+++..... ......+.+|+++++.++ |+||+++++++.+..
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~   79 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEK-EGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCC-CCCeeeeeheecCcc
Confidence            34579999999999999999999986   7889999999754322 223356778999999997 999999999987654


Q ss_pred             ----------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          225 ----------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       225 ----------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                                .+++||||+++ ++.+.+......+++..++.++.|++.||.|||++||+|+||||+||+++   +++.+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~  155 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQI  155 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcE
Confidence                      79999999976 77777766556799999999999999999999999999999999999994   58899


Q ss_pred             EEeecCcccccCCCC--CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          295 RLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       295 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      ||+|||++.......  ......++..|+|||++.+  .++.++|||||||++|||++|+.||........+..+.....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999997654332  1223356788999998753  478999999999999999999999987666555544433211


Q ss_pred             CCCC--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          371 NFDD--------------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       371 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ....                          ..+..++.++.++|.+||..||.+||++.+++.++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            1000                          0123478999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-41  Score=326.60  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=200.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++|++++.||+|+||.||+|++..  ...+++.||||+++....  ......+.+|+.++.++.+|+||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            479999999999999999998642  123678999999965422  223456889999999996699999999988654 


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------------------------------------------------
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------------------------------------------------  246 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  246 (422)
                      ..+++|||||++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56899999999999999886432                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---cccc
Q 014559          247 ---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDI  314 (422)
Q Consensus       247 ---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~  314 (422)
                               ..+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++........   ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCCC
Confidence                     2367788899999999999999999999999999999994   578999999999876532221   1223


Q ss_pred             ccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 014559          315 VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL  392 (422)
Q Consensus       315 ~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  392 (422)
                      .++..|+|||++. ..++.++|||||||++|+|++ |..||......................  ..++.++.+++.+||
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl  319 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHc
Confidence            4567799999875 578999999999999999996 999997654333233322222211111  136789999999999


Q ss_pred             hhccccCCCHHHHHhcc
Q 014559          393 NKDYRKRMTAVQALSKL  409 (422)
Q Consensus       393 ~~dP~~Rps~~elL~~l  409 (422)
                      +.||++||++.|+++++
T Consensus       320 ~~~p~~Rps~~eil~~l  336 (343)
T cd05103         320 HGEPSQRPTFSELVEHL  336 (343)
T ss_pred             cCChhhCcCHHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-41  Score=323.35  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=207.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC----CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+|++++.||+|+||.||+|++...    ......||+|.+....  .....+.+.+|+.+++++.+|+||+++++++.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            4699999999999999999986431    1133479999886432  223456788999999999559999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      .+.+++||||+.+|+|.+++....               ..++...+..++.|++.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-  168 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-  168 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-
Confidence            999999999999999999886532               2477888999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        .++.+||+|||+++.......   .....++..|+|||++. ..++.++|||||||++|||++ |..||......+..
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         169 --EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             --CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence              578899999999876543221   12223456799999876 468999999999999999998 89999887777777


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+........   ...++.++.++|.+||..+|.+||++.|+++++
T Consensus       247 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         247 KLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            66655332111   125788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.4e-41  Score=327.59  Aligned_cols=258  Identities=31%  Similarity=0.486  Sum_probs=207.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++.+|++.+.||+|+||.||+|+++.   +++.||+|++.....   ...+.+.+|+++++.++ |+||+++++++... 
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~   75 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG   75 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence            45789999999999999999999887   788999999865433   33467889999999996 99999999876554 


Q ss_pred             -------------CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          224 -------------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       224 -------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                                   ..+|+||||+. ++|.+.+.  .+.+++..++.++.||+.||.|||++||+||||||+||+++.  +
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~  150 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--E  150 (342)
T ss_pred             cccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--C
Confidence                         35899999997 48887664  346999999999999999999999999999999999999962  4


Q ss_pred             CCCEEEeecCcccccCCCCC----ccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 014559          291 DADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA  364 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  364 (422)
                      ++.+||+|||++........    .....++..|+|||++.  ..++.++|||||||++|+|++|+.||...........
T Consensus       151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  230 (342)
T cd07854         151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL  230 (342)
T ss_pred             CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            56789999999876532211    12346788999999864  3588999999999999999999999987665555444


Q ss_pred             HHcCCCCC----------------------CCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          365 VLRSDPNF----------------------DDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       365 i~~~~~~~----------------------~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +....+..                      ...    ..+.++.++.+||.+||..||.+||++.|+|.|.||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            43221110                      000    013578899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-41  Score=320.98  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=213.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ....|...+.||+|+||.||+|+++.   +++.||||.+............++.+|+++++.++ |+|++++++++.+..
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   88 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH   88 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence            34568888999999999999999876   77899999987543333334467788999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..++||||+. |+|.+.+......+++..+..++.|++.||.|||+++++||||||+||+++   .++.+||+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCccccee
Confidence            9999999996 588887766666799999999999999999999999999999999999995   478999999999876


Q ss_pred             cCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ....   ....++..|+|||++.    +.++.++|||||||++|+|++|..||...........+.....  +......+
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  239 (308)
T cd06634         165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHW  239 (308)
T ss_pred             ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccc
Confidence            5432   3456888999999863    3578899999999999999999999977655544444443322  11122357


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +..+.+||++||..+|++||++.+++.++|+...
T Consensus       240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             cHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            8899999999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.9e-41  Score=349.46  Aligned_cols=149  Identities=31%  Similarity=0.541  Sum_probs=134.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|+++++||+|+||.||+|++..   +++.||||++.............+.+|+.+++.++ |+||+++++++...+.+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~   79 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNV   79 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEE
Confidence            469999999999999999999886   78899999998765555555677899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ||||||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.+|||||||||+||||+   .++.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence            999999999999998754 35689999999999999999999999999999999999995   57899999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-41  Score=326.15  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=204.3

Q ss_pred             ceeCcC--CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEE
Q 014559          153 KEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM  230 (422)
Q Consensus       153 ~~lG~G--~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  230 (422)
                      ..||+|  +||+||+|++..   +++.||||++....... ...+.+.+|+.+++.++ |+||++++++|...+.+++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEE
Confidence            456666  999999999876   88999999987543322 33477889999999997 999999999999999999999


Q ss_pred             EccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC
Q 014559          231 ELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE  309 (422)
Q Consensus       231 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  309 (422)
                      ||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+.   .++.+|++||+.+.......
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccC
Confidence            9999999998876542 4589999999999999999999999999999999999995   47889999998653322111


Q ss_pred             C--------ccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC-----
Q 014559          310 R--------LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-----  373 (422)
Q Consensus       310 ~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  373 (422)
                      .        .....++..|++||++.+   .++.++|||||||++|||++|+.||........+..+.......+     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence            1        011234667999999864   478999999999999999999999977655444433332211100     


Q ss_pred             --------------------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 --------------------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 --------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                                            ......++.++.+||++||+.||++|||+.|+|+|+||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                                  000123567899999999999999999999999999998877


Q ss_pred             hhhh
Q 014559          416 FKIV  419 (422)
Q Consensus       416 ~k~~  419 (422)
                      ..+.
T Consensus       316 ~~~~  319 (328)
T cd08226         316 EQTQ  319 (328)
T ss_pred             Hhcc
Confidence            6543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-41  Score=310.12  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=206.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|..     .++.||||.+.....    ...++.+|+.+++.+. |+||+++++++.+.+..
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCe
Confidence            4689999999999999999976     467899999865432    3467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~  152 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEA  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEccccccccc
Confidence            99999999999999886654 3689999999999999999999999999999999999995   5889999999999766


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ....  .....+..|+|||++. +.++.++||||||+++|||++ |..||...........+...... .  ....++++
T Consensus       153 ~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~  227 (256)
T cd05039         153 SQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-E--APEGCPPE  227 (256)
T ss_pred             cccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-C--CccCCCHH
Confidence            3222  2334566799999875 578899999999999999997 99999877766665555443221 1  11257899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++|.+||..+|++||++.++++.+
T Consensus       228 ~~~li~~~l~~~p~~Rp~~~~l~~~l  253 (256)
T cd05039         228 VYKVMKDCWELDPAKRPTFKQLREQL  253 (256)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=334.85  Aligned_cols=246  Identities=35%  Similarity=0.504  Sum_probs=210.6

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.+.|++...+|.|+|+.|-.+.+..   +++..++|++.+...       ...+|+.++....+|+||+++++.+.+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccc---cccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCC
Confidence            356679999999999999999998887   888999999976522       2346888888888899999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+.|+|||++.|+.+++.+...  +....++..|+.+|+.|+.|||++|||||||||+|||+.  +..+.++|+|||.++
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS  464 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence            9999999999999998887554  233378888999999999999999999999999999995  358899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  ..+.+-|..|.|||++. ..|+.++||||||++||+||+|+.||...... ++...+.....  .    ..+|
T Consensus       465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s----~~vS  536 (612)
T KOG0603|consen  465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--S----ECVS  536 (612)
T ss_pred             hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--c----cccC
Confidence            76654  45567789999999987 47999999999999999999999999887666 44444433322  2    2699


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +++++||++||+.||.+|+++.+++.|.|+
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999999999

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.7e-41  Score=319.28  Aligned_cols=257  Identities=26%  Similarity=0.451  Sum_probs=211.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||++.+..   ++..||+|.+.....   ...+.+.+|+.+++.++ |+||+++++.+...+.
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~   90 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence            3689999999999999999998776   678899999864322   23467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .|+|+||+++++|.+++..  ..+++..+..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~  165 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI  165 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecc
Confidence            9999999999999998754  3588999999999999999999999999999999999995   5788999999988755


Q ss_pred             CCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .... ......|+..|++||++. +.++.++|+|||||++|++++|+.||........+..+..... .....+..++.+
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  244 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI  244 (293)
T ss_pred             cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHH
Confidence            4332 233456889999999875 5689999999999999999999999976655443332222111 111122357889


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      +.++|++||..+|++||++.+++.|.||....
T Consensus       245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-40  Score=310.32  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=202.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.++||+|+||.||+|.+..    +..+|+|++.....    ..+.+.+|+++++.+. |+||+++++++.. +..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~   75 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPI   75 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCc
Confidence            469999999999999999998754    34699998764332    2366889999999997 9999999998854 568


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++   +++.++|+|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~  152 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEc
Confidence            99999999999999886543 3589999999999999999999999999999999999994   5888999999999765


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..... .+  ....++
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~  229 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MP--CPQGCP  229 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCcccC
Confidence            43321  12234567899999876 568999999999999999999 9999988777776666654321 11  123688


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+.++|++||.+||++||++.++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~  256 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQSF  256 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.1e-41  Score=321.07  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=205.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC---
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV---  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  223 (422)
                      ++|++.+.||+|+||.||+|.++.   +++.||||++........ ....+.+|+++++.++ |+||+++++++.+.   
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDG-FPITALREIKILKKLK-HPNVVPLIDMAVERPDK   82 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcC-CCCccchhhheeccccc
Confidence            579999999999999999999876   788999999865432221 2245678999999997 99999999987543   


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+++||||+.+ +|...+......+++..+..++.||++||.|||++||+|+||||+|||++   +++.+||+|
T Consensus        83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l~d  158 (311)
T cd07866          83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIAD  158 (311)
T ss_pred             ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECc
Confidence                 357999999965 77777766566799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCC------------ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 014559          299 FGLSDFIRPDER------------LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA  364 (422)
Q Consensus       299 fG~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  364 (422)
                      ||++........            .....++..|+|||++.+  .++.++|||||||++|||++|+.||.+.........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999875432221            123457888999998753  588999999999999999999999987776655554


Q ss_pred             HHcCCCCCCCC--------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          365 VLRSDPNFDDL--------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       365 i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +..........                          .+..+..++.+||++||..||.+|||+.|++.|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            43321111000                          012355789999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-40  Score=307.62  Aligned_cols=244  Identities=23%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||++...    .+..||+|++....  .......+.+|+++++.+. |+||+++++++.+.+..++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence            36999999999999854    56789999986532  2223356889999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc-
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~-  311 (422)
                      +++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++   .++.+||+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~  150 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSS  150 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceecccccccc
Confidence            999999998876666789999999999999999999999999999999999994   5788999999998654322211 


Q ss_pred             -cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 014559          312 -NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV  388 (422)
Q Consensus       312 -~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  388 (422)
                       ....++..|+|||++. +.++.++||||||+++|++++ |..||...........+......   .....++.++.++|
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li  227 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVM  227 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence             1123456799999876 468999999999999999998 99999877666665555443211   11235889999999


Q ss_pred             HHhchhccccCCCHHHHHhcc
Q 014559          389 KRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       389 ~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+||..+|++||++.|+++.+
T Consensus       228 ~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         228 QRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHcccCcccCCCHHHHHHHh
Confidence            999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6e-41  Score=323.88  Aligned_cols=261  Identities=25%  Similarity=0.383  Sum_probs=209.3

Q ss_pred             cccceEE-eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchh-----------cHHHHHHHHHHHHHhcCCCC
Q 014559          145 FGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----------SIEDVRREVKILKALSGHKH  212 (422)
Q Consensus       145 ~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~n  212 (422)
                      +..+|.. .+.||+|+||.||+|++..   +++.||||++.........           ....+.+|+++++.++ |+|
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~   81 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN   81 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence            3456764 5779999999999999876   7889999998654322210           0124678999999997 999


Q ss_pred             eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      |+++++++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++   .++
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~  156 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKG  156 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCC
Confidence            9999999999999999999997 588887754 45699999999999999999999999999999999999994   578


Q ss_pred             CEEEeecCcccccCC---------------CCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014559          293 DMRLIDFGLSDFIRP---------------DERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWA  355 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~  355 (422)
                      .+||+|||++.....               ........++..|+|||++.+  .++.++|||||||++|||++|..||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999875541               111223356888999998864  478999999999999999999999988


Q ss_pred             CChhHHHHHHHcCCCCCCCC------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          356 RTESGIFRAVLRSDPNFDDL------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ....+.+..+..........                        .....+.++.++|.+||+.||++||++.|+|.|+||
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            77766665554321111100                        012457889999999999999999999999999999


Q ss_pred             cch
Q 014559          412 PIL  414 (422)
Q Consensus       412 ~~l  414 (422)
                      +.-
T Consensus       317 ~~~  319 (335)
T PTZ00024        317 KSD  319 (335)
T ss_pred             CCC
Confidence            754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=310.06  Aligned_cols=262  Identities=26%  Similarity=0.496  Sum_probs=234.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+++.||+|+|..|.+++.++   +.+.||+|+++++-......+.-++.|-.+..+.++||.+|-++..|..+..+
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            469999999999999999999988   88999999999887777767777889999999999999999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc-c
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-I  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~-~  305 (422)
                      ++|.||+.||+|.-++.. ..+++++.++.+..+|+.||.|||++|||+||||.+|+|+   |..|.+||.|+|+++. +
T Consensus       327 ffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l  402 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence            999999999999877644 4579999999999999999999999999999999999999   4599999999999974 4


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCC--------CCChhHHHHHHHcCCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFW--------ARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~--------~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      .++....++|||+.|.|||++.+ .|++.+|+|+|||+|+||+.|+.||.        ..++.-+++.|++....++.  
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--  480 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--  480 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence            56677889999999999999986 69999999999999999999999993        23455677788888887776  


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCC------HHHHHhccCccchhhhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMT------AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps------~~elL~~l~~~~l~~k~~  419 (422)
                        .++-.+..+++..|.+||.+|..      ..++-.|.||..+.|...
T Consensus       481 --slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  481 --SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             --eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence              68888999999999999999974      678999999998887653

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=317.78  Aligned_cols=257  Identities=19%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-----------ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-----------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK  215 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~  215 (422)
                      .+|++.+.||+|+||.||++++....           .....||||.+....  .....+.+.+|++++++++ |+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            47999999999999999999875310           123458999986532  2234467889999999997 999999


Q ss_pred             EEeEEEeCCeEEEEEEccCCCChHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 014559          216 FCDACEDVNNVYIVMELCEGGELLDRILARG-----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFL  284 (422)
Q Consensus       216 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIl  284 (422)
                      +++++...+..++||||+.+++|.+++....           ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999875432           23688899999999999999999999999999999999


Q ss_pred             EeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCCh
Q 014559          285 FTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWARTE  358 (422)
Q Consensus       285 l~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~~  358 (422)
                      ++   +++.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|+|++  +..||.....
T Consensus       162 l~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             Ec---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            95   477899999999876533221   12234567899999875 579999999999999999988  6788877665


Q ss_pred             hHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          359 SGIFRAVLRS----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       359 ~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+..+...    .........+.++..+.+||.+||..||++||++.++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l  293 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL  293 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            5554443221    11111111235789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-40  Score=309.68  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=202.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE-eCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~  225 (422)
                      .+|++.+.||+|+||.||++..     .+..||+|.+....     ..+.+.+|+.+++++. |+||+++++++. +++.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCc
Confidence            3689999999999999999975     45679999985432     2356889999999997 999999999764 4567


Q ss_pred             EEEEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +++||||+++++|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++   +++.+||+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~  151 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE  151 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCcccee
Confidence            9999999999999998876543 489999999999999999999999999999999999995   588999999999875


Q ss_pred             cCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .....  ....++..|+|||++. ..++.++|||||||++|||++ |+.||...........+......   .....++.
T Consensus       152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  226 (256)
T cd05082         152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPP  226 (256)
T ss_pred             ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCH
Confidence            43322  2334567899999876 468999999999999999997 99999877766666666543222   11236889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||..||++||++.++++.+
T Consensus       227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l  253 (256)
T cd05082         227 VVYDVMKQCWHLDAATRPSFLQLREQL  253 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-41  Score=327.54  Aligned_cols=259  Identities=30%  Similarity=0.527  Sum_probs=207.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      +++|++.+.||+|+||.||+|.+..   +++.||+|++..... .......+.+|+.+++.++ |+||+++++++..   
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   78 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA   78 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence            4679999999999999999999887   788999999875422 2223466788999999997 9999999998763   


Q ss_pred             -CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          223 -VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       223 -~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                       ...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||+
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~  153 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGM  153 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEeccccc
Confidence             357899999996 588887644 45699999999999999999999999999999999999995   588999999999


Q ss_pred             ccccCCCCC-----ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC------
Q 014559          302 SDFIRPDER-----LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS------  368 (422)
Q Consensus       302 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------  368 (422)
                      +........     .....|+..|+|||++.+  .++.++|||||||++|||++|+.||........+..+...      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            875432221     134578999999998753  5899999999999999999999999766543333222211      


Q ss_pred             -----------------CCCCCCCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          369 -----------------DPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       369 -----------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                       ........    .+.++.++.++|++||+.||++||++.++|.|+|+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                             11111111    23578999999999999999999999999999999744

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-40  Score=306.55  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=211.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--Ce
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  225 (422)
                      +|++.+.||+|++|.||+|.+..   +++.|++|++...... ....+.+.+|+.+++++. |+||+++++.+.+.  ..
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT   75 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence            47888999999999999999876   7889999998765432 334578899999999997 99999999999998  89


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||.+...
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~  151 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEec
Confidence            999999999999999876554 899999999999999999999999999999999999995   4789999999999876


Q ss_pred             CCCCC---ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDER---LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .....   .....++..|++||.+.. .++.++||||||+++|+|++|..||..... ......+.. ...... ....+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~  229 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPE-IPEHL  229 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcC-CCccc
Confidence            65443   445678899999998864 589999999999999999999999977652 222222221 111111 11256


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +.++.+||.+||..||++||++.|++.|+||
T Consensus       230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-41  Score=314.82  Aligned_cols=245  Identities=20%  Similarity=0.277  Sum_probs=194.8

Q ss_pred             ceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      +.||+|+||.||+|.++...    .....||+|.+....   ....+.+.+|+.+++.+. |+||+++++++...+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            36999999999999876421    134458888875432   223467788999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC-----CCCEEEeecCccc
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD-----DADMRLIDFGLSD  303 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~-----~~~vkl~DfG~a~  303 (422)
                      ||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.     .+.++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999999988776667899999999999999999999999999999999999974211     1237999999986


Q ss_pred             ccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGS-RPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ....   .....++..|+|||++.+  .++.++|||||||++|||++|. .||........ ..+......++.    ..
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~  228 (258)
T cd05078         157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK  228 (258)
T ss_pred             ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence            5432   233567889999999864  5799999999999999999995 55544443333 223333333332    45


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.+||.+||+.||++||+++++++.+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            68899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.8e-41  Score=317.46  Aligned_cols=262  Identities=30%  Similarity=0.527  Sum_probs=213.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +|++.+.||+|+||.||++++..+..+++.||||++.+..... ......+.+|+.+++++.+|+||+++++.+..++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3889999999999999999876544477899999987543222 223456789999999997799999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++   .++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECccccccc
Confidence            9999999999999887553 5689999999999999999999999999999999999994   57889999999987654


Q ss_pred             CCCC--ccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHcCCCCCCCCCC
Q 014559          307 PDER--LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ....  .....|+..|++||.+.+   ..+.++||||||+++|||++|..||....    ..+....+.......+    
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  232 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP----  232 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----
Confidence            3322  223568899999998753   37889999999999999999999995432    2233333443333322    


Q ss_pred             CCCCHHHHHHHHHhchhccccCCC---HHHHHhccCccchhhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMT---AVQALSKLVVPILSFK  417 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps---~~elL~~l~~~~l~~k  417 (422)
                      ..++.++.++|.+||+.||++|||   +.++|+|+|++.+.|-
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            257899999999999999999998   5788999999988774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-40  Score=313.84  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=196.1

Q ss_pred             cce-EEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKY-ELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y-~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++| ++.+.||+|+||.||++.... ...++..||+|++.....  ......+.+|+++++.+. |+||+++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            345 899999999999998876432 122678899999865421  223467889999999996 99999999988764 


Q ss_pred             -CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       224 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                       ..+++||||+.+++|.+++..  ..+++.+++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~  154 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLA  154 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeecccc
Confidence             468999999999999998754  3599999999999999999999999999999999999995   4788999999999


Q ss_pred             cccCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HH------------HH
Q 014559          303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--GI------------FR  363 (422)
Q Consensus       303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~------------~~  363 (422)
                      ........    .....++..|+|||++. ..++.++|||||||++|||++|..||......  +.            +.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            76543322    12234566799999876 56899999999999999999999998543221  00            00


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .........+  ....++.++.++|.+||..||++||++.++++.
T Consensus       235 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~  277 (283)
T cd05080         235 ELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI  277 (283)
T ss_pred             hhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            0111111111  112578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=309.61  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=207.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||+|.+.    .++.||||.+.....    ..+.+.+|+.+++.++ |+||+++++++.+...
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   75 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEP   75 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCc
Confidence            357999999999999999999875    346799999875432    2367889999999997 9999999999999899


Q ss_pred             EEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++..
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~  152 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARL  152 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECcccccee
Confidence            999999999999999886643 4689999999999999999999999999999999999995   578999999999876


Q ss_pred             cCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....++..|+|||.+. +.++.++|||||||++|+|++ |+.||.+......+..+........   ....
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  229 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNC  229 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence            543211  11223456899999876 468999999999999999998 9999988777777777665432111   1256


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +.++.++|.+||..||++||++.++++-
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~  257 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQSF  257 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            8899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=315.61  Aligned_cols=254  Identities=33%  Similarity=0.471  Sum_probs=208.2

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||+|+||.||+|.+..   +++.|+||++......  .......+|+..++++++|+||+++++++.+++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence            6788999999999999999876   6789999998654221  1223455799999999779999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+ +++|.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccC
Confidence            99999 779998886654 5789999999999999999999999999999999999994   589999999999987665


Q ss_pred             CCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC-----------
Q 014559          308 DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-----------  374 (422)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  374 (422)
                      ........++..|+|||++.  ..++.++|+||||++++||++|+.||......+.+..+.........           
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            54555567899999999874  35799999999999999999999999776655554433321111000           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          375 ---------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       375 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                                     ...+..+.++.+||++||..||++||++.|++.++||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                           0011336889999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=312.49  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=207.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++.+.||+|+||.||+|.++... .....||+|.+.....  ......+.+|+.+++++. |+||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            57999999999999999999976521 1234689998865432  334467889999999996 9999999999987 78


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++||||+.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCcccccc
Confidence            9999999999999999877666799999999999999999999999999999999999994   5788999999999766


Q ss_pred             CCCCCccc---cccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDERLND---IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ........   ..++..|+|||.+. ..++.++|+|||||++||+++ |+.||......++...+...... +..  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQP--PIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CCC--CCC
Confidence            53322111   22356799999875 578999999999999999998 99999887776666666543321 111  247


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +.++.++|.+||..||++||++.++++.
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~  264 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELINE  264 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-40  Score=313.75  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=216.6

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .....|++.+.||+|+||.||++.+..   ++..|++|++.....    ..+.+.+|+++++.++ |+||+++++.+...
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   87 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG   87 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence            445679999999999999999999876   678999999975432    3467889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +..|+|+||+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++   .++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~  164 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAA  164 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhh
Confidence            999999999999999998877655799999999999999999999999999999999999995   47899999999986


Q ss_pred             ccCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...... ......++..|++||++. ..++.++|+|||||++|+|++|+.||...........+...... .......++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  243 (286)
T cd06614         165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS  243 (286)
T ss_pred             hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence            544322 223445788999999876 46899999999999999999999999876655544444332221 111122478


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++.+||++||+.+|.+||++.++|++.|+.-.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-40  Score=311.29  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|.+.+.||+|+||.||+|.+.........||||.+....  .....+.+.+|+.+++.+. |+||+++++++.+ +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence            46889999999999999999876532234579999886432  1234467889999999997 9999999999876 557


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++......+++..+..++.|++.||.|||++|++|+||||+|||++   .++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeecc
Confidence            899999999999999876556789999999999999999999999999999999999995   47889999999987654


Q ss_pred             CCCCc--cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .....  ....++..|+|||.+. ..++.++|||||||++|||++ |..||......+....+.......   ....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~  235 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCPP  235 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCH
Confidence            33221  1223456799999876 468999999999999999986 999998877766666655443221   1236889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||..+|.+||++.+++..+
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l  262 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQL  262 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-40  Score=309.74  Aligned_cols=248  Identities=20%  Similarity=0.310  Sum_probs=197.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE-eCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e  231 (422)
                      +.||+|+||.||+|.+.........||||.+...  ......+.+.+|+.+++.++ |+||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            4689999999999987643334568999987532  22233467888999999996 999999999776 4566899999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC--
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--  309 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~--  309 (422)
                      |+.+++|.+++......+++..+..++.|++.||.|||+++++||||||+|||++   .++.+||+|||+++......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCcce
Confidence            9999999998876666678888999999999999999999999999999999995   57889999999987543221  


Q ss_pred             ---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          310 ---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       310 ---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                         ......++..|+|||++. ..++.++|||||||++|||++| ..||...........+.........   ..++..+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHH
Confidence               112334577899999875 5789999999999999999995 6667666555555555443322111   2468899


Q ss_pred             HHHHHHhchhccccCCCHHHHHhcc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++|.+||..+|++||++.|++..+
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~l  256 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSRI  256 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHH
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-40  Score=308.02  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=207.9

Q ss_pred             EEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      ++.+.||+|+||.||++.+.... ..+..||+|++......  .....+..|+.+++.+. |+||+++++++.+.+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence            56789999999999999987521 12488999998654322  14567889999999995 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||+.+++|.+++...... +++..+..++.|++.||.|||++|++|+||||+||+++   .++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceeccc
Confidence            99999999999988664433 99999999999999999999999999999999999995   577899999999976654


Q ss_pred             CCCcc--ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          308 DERLN--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       308 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .....  ...++..|++||.+. ..++.++|||||||++|+|++ |..||...........+.........   ..++.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHH
Confidence            32222  123678899999885 468999999999999999998 88999877777777766654432221   258899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++|.+||..||++|||+.|+++.+
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            99999999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-41  Score=323.72  Aligned_cols=259  Identities=26%  Similarity=0.479  Sum_probs=210.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|.+..   +++.||||++.... ........+.+|+.+++.++ |+||+++++++...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD   86 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence            356789999999999999999999876   78899999986432 22223456889999999997 99999999998765


Q ss_pred             C------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 N------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      .      .+++||||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~  160 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKIL  160 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEe
Confidence            3      469999999 6688876643  4799999999999999999999999999999999999995   47889999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC--
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD--  373 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  373 (422)
                      |||++.....  ......++..|++||++.+  .++.++|+|||||++|+|++|+.||........+..+.......+  
T Consensus       161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         161 DFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             eccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9999976532  2234567899999998764  588999999999999999999999987665554444433211100  


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 -------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                               ...+..++.++.++|.+||+.||++||++.+++.|+||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                                     001235788999999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-40  Score=314.72  Aligned_cols=254  Identities=21%  Similarity=0.320  Sum_probs=207.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.+.||+|+||.||+|.+...  ..++..||+|++....  .......+.+|+.+++.+. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCC
Confidence            4699999999999999999987531  1256789999986532  2223466889999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          225 NVYIVMELCEGGELLDRILARG---------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                      ..++||||+.+++|.+++....                     ..+++..++.++.|++.||.|||+++++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999886432                     2477888999999999999999999999999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTE  358 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~  358 (422)
                      |++   .++.+||+|||++........   ......+..|+|||++. ..++.++|||||||++|||++ |..||.+...
T Consensus       162 l~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Eec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            994   588999999999875432221   12233466799999875 578999999999999999997 8889987777


Q ss_pred             hHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          359 SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       359 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+....+........   ...++.++.+||.+||..||.+||++.|+++.+
T Consensus       239 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l  286 (288)
T cd05050         239 EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRIL  286 (288)
T ss_pred             HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            777766665443211   125789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=337.87  Aligned_cols=256  Identities=29%  Similarity=0.489  Sum_probs=218.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      .+.|++.+.||.|.+|.||+++.++   +++..|+|+.......    .++++.|.++|+.+.+|||++.+|++|..   
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3569999999999999999999988   8889999998654332    37788999999999999999999999864   


Q ss_pred             --CCeEEEEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 --VNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                        .+++|||||||.||+..|+++. .+.++.|+.|..|++.++.||.+||.+.+||||||-.|||++.   ++.|||+||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~---e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE---NAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec---cCcEEEeee
Confidence              4689999999999999998865 3678999999999999999999999999999999999999974   899999999


Q ss_pred             CcccccCCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC
Q 014559          300 GLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       300 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      |.+..+... .+.++.+||+.|||||++.      ..|+..+|+||||++..||.-|.+|+.+.-....+..|.... ..
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PP  246 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PP  246 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cc
Confidence            998766533 4567789999999999984      247889999999999999999999997655544443333322 22


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      .-..|..++.+|.+||..||.+|-.+||+..++|+|+|..
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            2223567899999999999999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=304.58  Aligned_cols=252  Identities=33%  Similarity=0.534  Sum_probs=212.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|++|.||++.+..   +++.|++|.+...... ....+.+.+|+++++++. |+||+++++++.+.+.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence            48889999999999999999876   7789999999765432 234577899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND  151 (254)
T ss_pred             EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCC
Confidence            999999999999887654 6799999999999999999999999999999999999995   478999999999986654


Q ss_pred             CCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 DER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      ... .....++..|++||.+.+ .++.++||||||+++|+|++|..||...........+......   .....++.++.
T Consensus       152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  228 (254)
T cd06627         152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELK  228 (254)
T ss_pred             CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHH
Confidence            332 234568899999998753 5789999999999999999999999776654444443322211   11236789999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++|.+||..+|++||++.+++.+.||
T Consensus       229 ~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         229 DFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-40  Score=315.07  Aligned_cols=257  Identities=16%  Similarity=0.278  Sum_probs=201.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc-------------CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK-------------GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~-------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      .+|++.+.||+|+||.||++++..             ...+...||+|++....  .......+.+|+.+++.++ |+||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~i   81 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPNI   81 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCc
Confidence            469999999999999999986542             11134579999986542  2233467889999999997 9999


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                      +++++++.+.+..++||||+.+++|.+++....          ..+++..+..++.|++.||.|||++||+|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999886532          2367789999999999999999999999999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWART  357 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~  357 (422)
                      |++   .++.++|+|||++..+.....   .....++..|++||+.. +.++.++|||||||++|||++  |..||....
T Consensus       162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         162 LVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            995   478999999999876543221   12233467899999754 679999999999999999998  778997665


Q ss_pred             hhHHHHHHHc---CC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ESGIFRAVLR---SD-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ~~~~~~~i~~---~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+.....   .. ..........++..+.+||.+||..||++||++.++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  294 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL  294 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            5554433211   00 0000111125778999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=315.15  Aligned_cols=254  Identities=32%  Similarity=0.492  Sum_probs=210.2

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||+|++|.||+|.+..   +++.+++|.+...... ......+.+|+.++++++ |+||+++++++.+.+.+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence            5677899999999999999876   7889999998754332 123467888999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ||||+.+ +|.+.+......+++..+..++.||+.||.|||+++|+|+||||+||+++   .++.+||+|||.+......
T Consensus        76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCC
Confidence            9999975 88888877667899999999999999999999999999999999999994   5789999999998766544


Q ss_pred             C-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC-------------
Q 014559          309 E-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-------------  372 (422)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  372 (422)
                      . ......++..|+|||.+.+  .++.++|+||||+++|+|++|+.||......+.+..+.......             
T Consensus       152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence            3 2334567889999998753  68999999999999999999999997766655544443221110             


Q ss_pred             ------C-------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          373 ------D-------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       373 ------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                            +       ...++.++.++++||.+||..||.+||++.+++.|+|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                  0       00123467899999999999999999999999999996

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-40  Score=312.45  Aligned_cols=244  Identities=20%  Similarity=0.249  Sum_probs=193.7

Q ss_pred             eeCcCCCeEEEEEEeccC---------------------CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC
Q 014559          154 EVGRGHFGHTCSARGKKG---------------------ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH  212 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~---------------------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  212 (422)
                      .||+|+||.||+|.....                     ......|++|++....   ......+.+|+.+++.++ |+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            699999999999975321                     1123468999885432   223356788999999997 999


Q ss_pred             eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC----
Q 014559          213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----  288 (422)
Q Consensus       213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~----  288 (422)
                      |+++++++.+.+..++||||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++..    
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999999988876666789999999999999999999999999999999999999631    


Q ss_pred             CCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHH-HhCCCCCCCCChhHHHHHH
Q 014559          289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYIL-LCGSRPFWARTESGIFRAV  365 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~el-l~g~~pf~~~~~~~~~~~i  365 (422)
                      .....+||+|||++......   ....++..|+|||++.+  .++.++|||||||++||| ++|..||.......... .
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~  233 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F  233 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence            11234899999987543221   23457888999998753  589999999999999998 47999997765544433 2


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ......++.    ..+.++.++|.+||+.+|++||++.++|+++
T Consensus       234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            222222222    3567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=306.89  Aligned_cols=245  Identities=33%  Similarity=0.620  Sum_probs=212.3

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|+||.||++.+..   +++.||+|++.............+.+|+.+++.++ |+||+++++.+.+++.+|+||||+.
T Consensus         1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence            6999999999999876   68899999998765554445678899999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC-CCccc
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLND  313 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~~~  313 (422)
                      +++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++   .++.++|+|||++...... .....
T Consensus        77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccC
Confidence            99999987554 4689999999999999999999999999999999999995   4788999999998765443 23445


Q ss_pred             cccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 014559          314 IVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL  392 (422)
Q Consensus       314 ~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  392 (422)
                      ..++..|++||.+.+ .++.++|+||||+++|+|++|..||...........+......++.    .++.++.++|++||
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l  228 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLL  228 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHh
Confidence            678899999998764 5788999999999999999999999877766666776664444443    46899999999999


Q ss_pred             hhccccCCCH---HHHHhccCc
Q 014559          393 NKDYRKRMTA---VQALSKLVV  411 (422)
Q Consensus       393 ~~dP~~Rps~---~elL~~l~~  411 (422)
                      ..||++||++   ++++.|+||
T Consensus       229 ~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         229 QKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             cCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=305.94  Aligned_cols=244  Identities=23%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ++||+|+||.||+|.+.    .++.||+|++......  .....+.+|+++++++. |+||+++++++.+....++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEe----CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence            46999999999999875    3678999998754332  34467899999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc-
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-  311 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~-  311 (422)
                      +.+++|.+++......+++..+..++.+++.||.|||+++++||||||+|||++   .++.+||+|||++......... 
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCccee
Confidence            999999998877666789999999999999999999999999999999999994   5789999999998755422111 


Q ss_pred             --cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 014559          312 --NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF  387 (422)
Q Consensus       312 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  387 (422)
                        ....++..|+|||++. +.++.++|+|||||++|||++ |..||...........+.... ...  ....++.++.++
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l  227 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRL  227 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHH
Confidence              1123456799999876 578999999999999999998 889997776655555554322 111  112578999999


Q ss_pred             HHHhchhccccCCCHHHHHhcc
Q 014559          388 VKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~l  409 (422)
                      |.+||..+|++||++.|+|+.+
T Consensus       228 i~~~l~~~p~~Rp~~~ell~~l  249 (251)
T cd05041         228 MLQCWAYDPENRPSFSEIYNEL  249 (251)
T ss_pred             HHHHhccChhhCcCHHHHHHHh
Confidence            9999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-40  Score=309.35  Aligned_cols=245  Identities=19%  Similarity=0.239  Sum_probs=192.4

Q ss_pred             ceeCcCCCeEEEEEEeccCC---------ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          153 KEVGRGHFGHTCSARGKKGE---------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      +.||+|+||.||+|+.....         .....|++|++....   ......+.+|+.+++.++ ||||+++++++.++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            36899999999999854211         123468899875432   223356788999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC----CCCCEEEeec
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----DDADMRLIDF  299 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~----~~~~vkl~Df  299 (422)
                      ...++||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.+.    ....+|++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999998887766667799999999999999999999999999999999999996311    1123899999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      |++.....   .....++..|+|||++.  ..++.++|||||||++|||+ .|..||......+... .........   
T Consensus       157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~---  229 (262)
T cd05077         157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV---  229 (262)
T ss_pred             CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC---
Confidence            99865432   23346788899999875  46899999999999999997 5888886654433322 222221111   


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                       ...+.++.+||.+||+.||.+||++.++|+++
T Consensus       230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             13567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-41  Score=323.74  Aligned_cols=259  Identities=34%  Similarity=0.527  Sum_probs=213.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC---
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN---  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  224 (422)
                      +|++.+.||+|+||.||+|++..   +++.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+   
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence            48999999999999999999876   68899999987532 12233467889999999997 999999999998775   


Q ss_pred             --eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                        .+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++   .++.++|+|||++
T Consensus        76 ~~~~~lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~  150 (330)
T cd07834          76 FNDVYIVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLA  150 (330)
T ss_pred             ccceEEEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCce
Confidence              79999999974 78877644 44899999999999999999999999999999999999995   4789999999999


Q ss_pred             cccCCCC----CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC-
Q 014559          303 DFIRPDE----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-  375 (422)
Q Consensus       303 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  375 (422)
                      .......    ......++..|+|||++.+  .++.++|+|||||++|+|++|+.||......+.+..+.......... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence            8665443    2344568899999998763  58999999999999999999999998877766655554422211100 


Q ss_pred             --------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          376 --------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       376 --------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                                ..+.++.++.+||.+||++||.+||++.++|.|+||.....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                                      01246789999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.1e-40  Score=308.89  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=194.2

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.||+|+||.||+|.+..+ .++..+|+|.++....  ......+.+|+.++++++ |+||+++++++.+...+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence            3699999999999987542 2567899998865432  223356888999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          233 CEGGELLDRILARG----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       233 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      +++|+|.+++....    ..+++..+..++.|++.||.|||+++++||||||+||+++   .++.+||+|||++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCc
Confidence            99999999886532    2456778889999999999999999999999999999995   5788999999998654322


Q ss_pred             CC---ccccccCCcccCccccCc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc-CCCCCCCC
Q 014559          309 ER---LNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR-SDPNFDDL  375 (422)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~  375 (422)
                      ..   .....++..|+|||++.+        .++.++|||||||++|||++ |+.||.............. ....+...
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP  233 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence            21   123457788999998752        35789999999999999996 9999977655544333222 22222221


Q ss_pred             C-CCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          376 P-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       376 ~-~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      . ....++.+.++|++|+ .+|++||++.|++..
T Consensus       234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~  266 (269)
T cd05087         234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL  266 (269)
T ss_pred             ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence            1 1246788999999998 689999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-40  Score=307.53  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=204.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.++||+|+||.||++.+.    .+..+|+|.+.....    ..+.+.+|+.+++.++ |+||+++++.+.+ ..
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~   74 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EP   74 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec----CCccEEEEecCCChh----HHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CC
Confidence            457999999999999999999865    345699998864322    3467889999999997 9999999999887 78


Q ss_pred             EEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++..
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~  151 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARV  151 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceee
Confidence            89999999999999988763 35588899999999999999999999999999999999995   588999999999876


Q ss_pred             cCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....++..|+|||++. +.++.++|+|||||++|++++ |+.||...........+...... +  ....+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~  228 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-P--RPENC  228 (260)
T ss_pred             ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-C--CcccC
Confidence            543221  12234567799999886 468999999999999999998 99999887766666655543221 1  12368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.++|.+||+.||++||++.++++.+
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L  257 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQSVL  257 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            89999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.6e-40  Score=309.30  Aligned_cols=249  Identities=20%  Similarity=0.328  Sum_probs=195.4

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ++||+|+||.||+|....+ .....+|+|.+....  .......+.+|+.+++.++ |+||+++++.+.+...+|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecC-CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence            3699999999999976543 255678999875432  2223456788999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          233 CEGGELLDRILARG----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       233 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      +.+|+|.+++....    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccc
Confidence            99999999886543    2346788899999999999999999999999999999994   5889999999998653322


Q ss_pred             CC---ccccccCCcccCccccC--------ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCC-CCCCCC
Q 014559          309 ER---LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD-PNFDDL  375 (422)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~  375 (422)
                      ..   .....++..|+|||++.        ..++.++|||||||++|||++ |..||......+.+..+.... ..++..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP  233 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence            11   12334567899999863        246889999999999999999 788887766655555544332 222222


Q ss_pred             C-CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          376 P-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       376 ~-~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      . ...++.++.+++..|+ .||++||++.++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1 1257888999999998 5999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-40  Score=306.77  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=213.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +|++.+.||+|+||.||++.+..   +++.+|+|.+...... ......+.+|+.+++.++ |+||+++++++.+....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence            48899999999999999998876   7889999998764432 233466788999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++   +++.+||+|||++..
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~  152 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKV  152 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhh
Confidence            999999999999887652   35689999999999999999999999999999999999996   478899999999976


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .... ......++..|++||.+.+ .++.++|+||||+++|+|++|+.||...........+.....  +... ..++.+
T Consensus       153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~  228 (256)
T cd08530         153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--PPIP-PIYSQD  228 (256)
T ss_pred             hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCc-hhhCHH
Confidence            6544 3344568899999998764 688999999999999999999999988776666555544332  2221 267899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      ++++|.+||..+|++||++.++++|+++
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         229 LQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.4e-42  Score=350.38  Aligned_cols=256  Identities=31%  Similarity=0.513  Sum_probs=199.3

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE---
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC---  220 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~---  220 (422)
                      .+..+|+.++.||+||||.||+++++-   +|+.||||+|....  .......+.+|+.+|.+|+ |||||++|..|   
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVES  549 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-Ccceeeeehhhhcc
Confidence            455678999999999999999999986   99999999997754  4445578999999999997 99999985221   


Q ss_pred             ---------------------------------------------------------E------------------e---
Q 014559          221 ---------------------------------------------------------E------------------D---  222 (422)
Q Consensus       221 ---------------------------------------------------------~------------------~---  222 (422)
                                                                               .                  +   
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                     0                  0   


Q ss_pred             ------------------------------C--------CeEEEEEEccCCCChHHHHHHhCCCC-CHHHHHHHHHHHHH
Q 014559          223 ------------------------------V--------NNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILS  263 (422)
Q Consensus       223 ------------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~l-~~~~~~~i~~ql~~  263 (422)
                                                    +        -.+||-||||+. ++++.+..++... .....|+++++|++
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~-~ll~~iI~~N~~~~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEK-TLLRDIIRRNHFNSQRDEAWRLFREILE  708 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhh-hHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence                                          0        127999999987 5555555555433 47889999999999


Q ss_pred             HHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC-------------------CCCCccccccCCcccCcc
Q 014559          264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-------------------PDERLNDIVGSAYYVAPE  324 (422)
Q Consensus       264 aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE  324 (422)
                      ||.|+|++|||||||||.|||++   .+..|||+|||+|+...                   .....+..+||..|+|||
T Consensus       709 GLaYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            99999999999999999999994   68899999999997621                   011335578999999999


Q ss_pred             ccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccC
Q 014559          325 VLHR----SYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR  399 (422)
Q Consensus       325 ~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  399 (422)
                      ++.+    .|+.|+|+|||||||+||+.   ||...-+. .++..+..+....+...+..--++-..+|++||+.||.+|
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence            9852    59999999999999999984   47543332 3333333333322211122334567889999999999999


Q ss_pred             CCHHHHHhccCcc
Q 014559          400 MTAVQALSKLVVP  412 (422)
Q Consensus       400 ps~~elL~~l~~~  412 (422)
                      |||.|+|.+.|+.
T Consensus       863 PtA~eLL~s~llp  875 (1351)
T KOG1035|consen  863 PTATELLNSELLP  875 (1351)
T ss_pred             CCHHHHhhccCCC
Confidence            9999999999998

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-40  Score=313.52  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--C
Q 014559          148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  224 (422)
                      .|++++.||+|+||.||+|+... +..++..||+|.++...  .......+.+|+.+++.+. |+||+++++++.+.  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            47899999999999999997532 23367899999986442  2233467899999999997 99999999999875  5


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccc
Confidence            68999999999999998866555689999999999999999999999999999999999995   478899999999976


Q ss_pred             cCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------------hHHHHH
Q 014559          305 IRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---------------SGIFRA  364 (422)
Q Consensus       305 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------------~~~~~~  364 (422)
                      ......    .....++..|+|||++. ..++.++|||||||++|||+++..|+.....               ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543322    12345677899999875 4689999999999999999998776532111               111111


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +... ...+  .+..++.++.+||.+||+.||++||++.++++.+
T Consensus       239 ~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  280 (284)
T cd05079         239 LEEG-KRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF  280 (284)
T ss_pred             HHcC-ccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            1111 1111  2236889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=310.33  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=198.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CC
Q 014559          148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~  224 (422)
                      +|++.+.||+|+||.||++.... +..++..||||.+....   ....+.+.+|+++++.+. |+||+++++++..  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCC
Confidence            68999999999999999997531 22367899999986432   233467889999999997 9999999998754  34


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCccccc
Confidence            68999999999999998876656799999999999999999999999999999999999994   578899999999986


Q ss_pred             cCCCCCc----cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH---------------HHHH
Q 014559          305 IRPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG---------------IFRA  364 (422)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---------------~~~~  364 (422)
                      .......    ....++..|+|||++. ..++.++|||||||++|||++|..++......-               .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            6433221    1122345699999876 468999999999999999999877653322110               0111


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +......++  ....++.++.+||.+||..+|++|||+.|+++.+
T Consensus       238 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05081         238 LLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV  280 (284)
T ss_pred             HHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            122221111  1235789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.1e-40  Score=308.82  Aligned_cols=256  Identities=22%  Similarity=0.370  Sum_probs=209.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|++.+.||+|+||.||+|+.+...  ...+.|++|.+....  .....+.+.+|++++++++ |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            46899999999999999999976421  245689999885432  2223467899999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 NVYIVMELCEGGELLDRILARG--------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      ..|+||||+++++|.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence            9999999999999999886543        1589999999999999999999999999999999999995   4788999


Q ss_pred             eecCcccccCCCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCC
Q 014559          297 IDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       297 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      +|||++.......  ......++..|++||.+. ..++.++||||||+++|+|++ |..||........+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986443221  223345677899999875 468899999999999999998 889997766666666665444332


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ..  ...++..+.++|.+||..||.+||++.|++..+.
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            21  1358899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-40  Score=313.30  Aligned_cols=254  Identities=30%  Similarity=0.496  Sum_probs=209.8

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |....+||+|+||.||++.+..   +++.||||++....   ......+.+|+.+++.++ |+||+++++.+...+..++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   94 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV   94 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence            4445789999999999999876   78899999885432   223467889999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ||||+++++|.+++.  ...+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++......
T Consensus        95 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          95 VMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             EEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceecccc
Confidence            999999999988653  34689999999999999999999999999999999999994   5788999999998755432


Q ss_pred             C-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          309 E-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                      . ......|+..|++||++. ..++.++|+||||+++|+|++|..||...........+....+... .....++.++.+
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  248 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVSPSLKG  248 (292)
T ss_pred             cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCCHHHHH
Confidence            2 233456889999999875 4689999999999999999999999987665555544443222111 112357899999


Q ss_pred             HHHHhchhccccCCCHHHHHhccCccchh
Q 014559          387 FVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       387 li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      +|.+||..||.+||++.++|.|.||....
T Consensus       249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         249 FLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            99999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4e-40  Score=317.72  Aligned_cols=260  Identities=31%  Similarity=0.507  Sum_probs=205.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC----
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  223 (422)
                      +|++.+.||+|+||.||++++.... .+..||||++.... ........+.+|+.+++++.+|+||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4889999999999999999987621 27899999986432 22223456788999999997799999999975432    


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ..+|+++||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~  153 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLAR  153 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCce
Confidence            46889999996 588887643 45799999999999999999999999999999999999994   57899999999997


Q ss_pred             ccCCCC-----CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC------
Q 014559          304 FIRPDE-----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------  370 (422)
Q Consensus       304 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  370 (422)
                      ......     ......|+..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            654322     1234578999999998653  589999999999999999999999977654444333222110      


Q ss_pred             ---------------------CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          371 ---------------------NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       371 ---------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                           ......++.++.++.+||.+||+.||.+||++.+++.|+|+.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                                 00011234568899999999999999999999999999998543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-41  Score=324.04  Aligned_cols=259  Identities=28%  Similarity=0.519  Sum_probs=210.9

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|++..   +++.||||++..... .......+.+|+.+++.+. |+||+++++++...
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA   86 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence            356689999999999999999999987   788999999865322 2223456778999999996 99999999988765


Q ss_pred             Ce------EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 NN------VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ~~------~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +.      +++|+||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~  160 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKIL  160 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEc
Confidence            54      89999999 5699887754  4799999999999999999999999999999999999995   47899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC--
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD--  373 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  373 (422)
                      |||++......  .....++..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+........  
T Consensus       161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99999765432  344568889999998753  578999999999999999999999987766555555443221100  


Q ss_pred             ---------------------C----CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 ---------------------D----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 ---------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                           .    ..+..++.++.+||.+||..||++|||+.|+|.|+||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                                 0    00124688999999999999999999999999999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-40  Score=320.67  Aligned_cols=261  Identities=30%  Similarity=0.456  Sum_probs=208.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|.+..   +++.||||++..... .......+.+|+.+++++.+|+||+++++++...
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            355689999999999999999999876   678999998864321 2223356778999999994499999999998654


Q ss_pred             --CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          224 --NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       224 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                        ..+|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~  153 (337)
T cd07852          80 NDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGL  153 (337)
T ss_pred             CCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence              368999999974 888877543  789999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCCC------CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC--
Q 014559          302 SDFIRPDE------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--  371 (422)
Q Consensus       302 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--  371 (422)
                      +.......      ......|+..|+|||++.  ..++.++|||||||++|+|++|+.||...........+......  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            87654322      223456899999999874  35889999999999999999999999766554443333222110  


Q ss_pred             -------------------------CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          372 -------------------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       372 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                               ......+.++.++.++|.+||+.||++||++.+++++.|+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                                     0011123478999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-40  Score=308.30  Aligned_cols=253  Identities=25%  Similarity=0.450  Sum_probs=206.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +|.+.+.||+|+||.||++++..   .+..+++|+++.....  .......+.+|+.+++.++ |+||+++++++.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence            48899999999999999999876   4455666665432221  1122345678999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .++||||+.+++|.+.+..   ....+++..++.++.|++.||.|||++|++|+||||+||+++    ++.+||+|||++
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~  152 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS  152 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence            9999999999999887754   345699999999999999999999999999999999999995    456999999998


Q ss_pred             cccCCCCC-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          303 DFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       303 ~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ........ .....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+........   ...+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  229 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETY  229 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchh
Confidence            76543322 33456888999999875 4688899999999999999999999977666665555544332211   1267


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +.++.++|.+||..||++||++.|+++|+|+
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            8999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.2e-40  Score=315.84  Aligned_cols=261  Identities=31%  Similarity=0.500  Sum_probs=207.9

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      .+.++|++.+.||+|+||.||+|++..   +++.||||++.+... .....+.+.+|+.+++.++ ||||++++++|.. 
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   81 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISP   81 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC
Confidence            356789999999999999999999887   788999999865322 2223467789999999997 9999999999876 


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ...+|+||||+ +++|.+.+.  ...+++..+..++.|++.||.|||++||+||||+|+|||++   +++.+||+|||++
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~  155 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLA  155 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCccccc
Confidence            56799999999 458877654  34688999999999999999999999999999999999994   5889999999998


Q ss_pred             cccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC------------
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS------------  368 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  368 (422)
                      .....  ......++..|+|||++.+  .++.++|||||||++|+|++|+.||...........+.+.            
T Consensus       156 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         156 RIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            75432  2344567889999998753  5899999999999999999999999765543222111110            


Q ss_pred             -----------C---CCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          369 -----------D---PNFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       369 -----------~---~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                                 .   ...+ ....+.++.++.++|++||+.+|++||++.++|.+.|+.....+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                       0   0000 00113578899999999999999999999999999999765444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=311.09  Aligned_cols=254  Identities=31%  Similarity=0.492  Sum_probs=209.6

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |++.+.||+|+||.||+|....   +++.||+|++.... ......+.+.+|+.+++.++ |+||+++++++.+.+.+++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence            5677899999999999999876   78899999997653 12223466788999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ||||+.+ +|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++   +++.+||+|||++......
T Consensus        76 v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          76 VFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             EecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCC
Confidence            9999974 89998877656799999999999999999999999999999999999994   5889999999998765433


Q ss_pred             C-CccccccCCcccCccccC-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC---------------
Q 014559          309 E-RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP---------------  370 (422)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------  370 (422)
                      . ......++..|+|||++. . .++.++|||||||++|||++|+.||......+.+..+.....               
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence            2 233445678899999875 3 689999999999999999999999987766555544432110               


Q ss_pred             ---CCCC-------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          371 ---NFDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       371 ---~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                         .++.       ...+.++.++.++|++||..||++||++.+++.|+||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence               0110       1123457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-40  Score=319.96  Aligned_cols=257  Identities=29%  Similarity=0.558  Sum_probs=206.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +..+|.+.+.||+|+||.||+|++..   +++.||||++..... .......+.+|+.+++.+. |+||+++++++... 
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~   87 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV   87 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence            34579999999999999999999876   788999999865322 2223356789999999997 99999999998754 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|+|+||+.. +|.+.+   ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~d  160 (342)
T cd07879          88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILD  160 (342)
T ss_pred             cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEee
Confidence                 357999999964 666543   34689999999999999999999999999999999999995   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC-------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-------  369 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------  369 (422)
                      ||+++....  ......++..|+|||++.+  .++.++|||||||++|||++|+.||.+......+..+....       
T Consensus       161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999875432  2344567889999998754  58899999999999999999999998766544444333211       


Q ss_pred             ----------------CCCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          370 ----------------PNFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       370 ----------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                      +.....    .++.++.++.+||++||+.||.+||++.++|.|.||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                            001100    1235778899999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-43  Score=305.01  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=213.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +.+-+..||.|+||+|++..++.   .|+..|||.|+....  .....+++.|.+...+-.+.||||++||.+..++..|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            44556789999999999999987   899999999986543  3445778899998777778999999999999999999


Q ss_pred             EEEEccCCCChHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          228 IVMELCEGGELLDRIL----ARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~----~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      |.||+|+- +|..+..    .....++|..+..|...++.||.||-+. +||||||||+|||+   +..|.|||||||.+
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGIC  215 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccch
Confidence            99999964 5433222    1346799999999999999999999865 89999999999999   56999999999999


Q ss_pred             cccCCCCCccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHcCCCCCCCCCC-
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPW-  377 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~-  377 (422)
                      ..+...-..+.-+|-..|||||.+.   ..|+.++||||||++|||+.||..||..-. -.+++..+..+++....... 
T Consensus       216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence            8776555555567889999999985   259999999999999999999999996532 34566677777765433222 


Q ss_pred             -CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          378 -PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       378 -~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                       -+++..++.||.-||.+|-.+||...+++++.|...
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence             258899999999999999999999999999987654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=319.86  Aligned_cols=257  Identities=29%  Similarity=0.526  Sum_probs=205.9

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +.++|.+.+.||+|+||.||+|.+..   +++.||||++..... .....+.+.+|+.++++++ |+||+++++++... 
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~   89 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR   89 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence            45689999999999999999999876   788999999865322 2223456788999999997 99999999988643 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ...|++++++ +++|.+.+..  ..+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~d  163 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD  163 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEec
Confidence                 3478999987 6788776543  3699999999999999999999999999999999999995   578999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------  370 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  370 (422)
                      ||++....  .......++..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+.....      
T Consensus       164 fg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         164 FGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             cccccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99987543  22344578899999998754  588999999999999999999999976655444333322110      


Q ss_pred             -----------------CCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          371 -----------------NFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       371 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                       ..+..    .+...+.++.+||.+||+.||.+|+++.++|.|+||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                             01100    012467889999999999999999999999999999743

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.1e-40  Score=308.13  Aligned_cols=255  Identities=18%  Similarity=0.269  Sum_probs=206.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-C
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~  223 (422)
                      .++|++.+.||+|+||.||+|.+.... ..+..|++|.+...  ......+.+.+|+.+++.+. |+||+++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            357999999999999999999987421 13678999988643  23334577889999999996 9999999998776 4


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          224 NNVYIVMELCEGGELLDRILARG-------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      ...++++||+.+++|.+++....       ..+++..++.++.|++.||.|||+++++||||||+||+++   +++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEE
Confidence            67899999999999999886532       4589999999999999999999999999999999999995   4789999


Q ss_pred             eecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCC
Q 014559          297 IDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       297 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      +|||+++.+.....   .....++..|+|||++. ..++.++|||||||++||+++ |+.||......+....+.... .
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence            99999976543321   12234567899999876 468999999999999999998 999998766655554444332 2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +..  ...+++++.++|.+||..||++||++.++++.+
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  273 (280)
T cd05043         238 LAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCL  273 (280)
T ss_pred             CCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            221  235789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.3e-40  Score=305.76  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=208.6

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-------cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-------TTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      |++.+.||+|+||.||++.+..+  .++.+|||.+.....       ........+.+|+.++.+.-+|+||+++++++.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   79 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL   79 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence            78889999999999999998752  467899999864321       222334567789988876435999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +++..++||||+++++|.+.+..   ....+++..++.++.|++.||.|||+ .+|+|+||+|+|||++   .++.+||+
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~  156 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTIT  156 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEe
Confidence            99999999999999999887643   34579999999999999999999996 6899999999999995   58899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      |||++.............|+..|++||++. +.++.++||||||+++|+|++|+.||...........+.......  ..
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~  234 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--LP  234 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--CC
Confidence            999998765544445567899999999876 468999999999999999999999997766665555555433221  11


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...++.++.++|++||..||++||++.|+.+++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence            225789999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.8e-42  Score=292.65  Aligned_cols=255  Identities=29%  Similarity=0.593  Sum_probs=211.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      .++|++.+++|+|.|+.||.|.+..   +++.++||+++.-+      ...+.+|+.||+.|++|+||++|++...+.  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC---CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            4579999999999999999999876   77899999986433      267899999999999999999999998775  


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ....||+||+++.++....    ..++.-+|+.++.+|+.||.|||++||+|||+||.|++++  .+...++|+|+|+|.
T Consensus       108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAE  181 (338)
T ss_pred             cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHh
Confidence            4588999999987655432    3589999999999999999999999999999999999997  356789999999999


Q ss_pred             ccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHc-------------
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLR-------------  367 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~-------------  367 (422)
                      +..++...+-.+.+..|--||.+-  +.|+...|+|||||+|..|+..+.||.. ....+++-+|.+             
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            999998888889999999999874  5799999999999999999999999844 333333332211             


Q ss_pred             ----CCCCCCC-------CCCC---------CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          368 ----SDPNFDD-------LPWP---------SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       368 ----~~~~~~~-------~~~~---------~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                          .++.+..       ..|.         -+++++.|||.++|..|-++|+||.|++.|+||.-+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                1111111       1121         1469999999999999999999999999999997654

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-39  Score=304.53  Aligned_cols=249  Identities=18%  Similarity=0.274  Sum_probs=194.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ++||+|+||.||+++...+. ....+++|.+.....  ....+.+.+|+.+++.++ |+||+++++.+.+....|+||||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANAS--SKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCCC--hHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence            36999999999999765322 345567777654322  223467889999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC
Q 014559          233 CEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE  309 (422)
Q Consensus       233 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  309 (422)
                      +++|+|.+++....   ..+.+..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++.......
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcch
Confidence            99999999886532   3467778899999999999999999999999999999994   57889999999986432211


Q ss_pred             ---CccccccCCcccCccccCc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCC-CCCCCC
Q 014559          310 ---RLNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP-NFDDLP  376 (422)
Q Consensus       310 ---~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~  376 (422)
                         .....+++..|+|||++..        .++.++|||||||++|||++ |..||......+.+..+..... ......
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence               1234568899999998742        35789999999999999997 5778877666666666554332 211111


Q ss_pred             -CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 -WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 -~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                       ...+++.+.++|.+|| .+|++||++.++++.+
T Consensus       234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence             1247889999999999 6899999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.8e-40  Score=312.09  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++.+.||+|+||.||+|.+.... .....||+|.+.....  ......+.+|+.+++.+. |+||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            46889999999999999999986521 1123578888764322  222346789999999996 99999999998754 4


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++|+||+.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++   +++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEccccccccc
Confidence            6799999999999999877666789999999999999999999999999999999999994   4788999999999865


Q ss_pred             CCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .....   .....++..|++||++. ..++.++|||||||++|||++ |..||.+.........+.. ...++.  ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLPQ--PPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCC--CCCC
Confidence            43322   12234567899999876 468999999999999999997 9999977655554444333 222222  2357


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.++|.+||..||++||++.++++.+
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l  265 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAEF  265 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            88999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-40  Score=304.74  Aligned_cols=243  Identities=19%  Similarity=0.237  Sum_probs=191.2

Q ss_pred             ceeCcCCCeEEEEEEeccCC-------ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          153 KEVGRGHFGHTCSARGKKGE-------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +.||+|+||.||+|.+....       .....|++|++......    ...+.+|+.+++.++ |+||+++++++.. +.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            46999999999999987521       01135788876543221    467889999999997 9999999999988 77


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC----CCCCEEEeecCc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----DDADMRLIDFGL  301 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~----~~~~vkl~DfG~  301 (422)
                      .++||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++...    ....+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            8999999999999998876655799999999999999999999999999999999999996411    112699999999


Q ss_pred             ccccCCCCCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +.....   .....++..|+|||++.+   .++.++|||||||++|||++ |..||............. .....+.   
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~---  227 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM---  227 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence            876543   233456778999999864   58999999999999999999 578886654333322222 1111111   


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                       ....++.++|.+||..||.+||++.++++.+
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         228 -PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             1237899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=342.69  Aligned_cols=254  Identities=21%  Similarity=0.368  Sum_probs=213.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCcc--CceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELK--DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ...-++++.||+|.||.||.|....-...  ...||||.+.+.  .+.....+|.+|..+|+.+. |||||+++|++.+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence            34567889999999999999987652211  345888887643  44556688999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 NNVYIVMELCEGGELLDRILAR------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +..+|++|||+||+|+.+|.+.      ...++..++..++.||++|++||+++++|||||...|+||+   +...|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEc
Confidence            9999999999999999999876      66799999999999999999999999999999999999995   57999999


Q ss_pred             ecCcccccCCCCCcc--cc-ccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCC
Q 014559          298 DFGLSDFIRPDERLN--DI-VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       298 DfG~a~~~~~~~~~~--~~-~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      |||||+.+.......  .. .-...|||||.+. +.++.|+|||||||+|||+++ |..||.+....+++..++.+. .+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence            999999544332221  11 2345799999987 789999999999999999998 899999888888877666655 33


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +..  ..+++.+.+++..||..+|++||+...+++.
T Consensus       924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q  957 (1025)
T KOG1095|consen  924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ  957 (1025)
T ss_pred             CCC--CCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence            222  3789999999999999999999999999984

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=315.69  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=209.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+...++++||+|.||.|.++...    .+..||||.++.+...  ....+|.+||++|.+|+ |||||+|+|+|..++-
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATK--NARNDFLKEIKILSRLK-HPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccch--hHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCc
Confidence            346788999999999999999864    3578999999865433  34688999999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|+|+||+++|+|.+++.+.... +.......|+.||+.|+.||.+.++|||||.+.|+|+   |.++++||+|||+++.
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRN  686 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccc
Confidence            99999999999999999876433 3556677899999999999999999999999999999   5699999999999997


Q ss_pred             cCCCCCcc---ccccCCcccCccc-cCccCCCchhHHHHHHHHHHHH--hCCCCCCCCChhHHHHHHHcCCCCCCCC---
Q 014559          305 IRPDERLN---DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILL--CGSRPFWARTESGIFRAVLRSDPNFDDL---  375 (422)
Q Consensus       305 ~~~~~~~~---~~~gt~~y~aPE~-~~~~~~~~~DvwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  375 (422)
                      +..+....   ..+-..+|||+|. +.++++.++|+|+||+++||++  +...||...+++...+........-...   
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            65554322   2345789999996 5689999999999999999985  5789998887777666554322111111   


Q ss_pred             -CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          376 -PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       376 -~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                       ..+-++.++.++|.+||..|-.+||+.+++-.++.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence             12357889999999999999999999999866543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=302.59  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=201.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||++..     +++.||+|.+....     ..+.+.+|+.+++.++ |+||+++++++..+ ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence            4699999999999999998853     56789999986432     2357889999999997 99999999998765 47


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++   .++.+||+|||++...
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVG  150 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceec
Confidence            99999999999999887653 3589999999999999999999999999999999999995   4789999999998754


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...  ......+..|+|||++. +.++.++|+|||||++|||++ |+.||......+....+..... ..  ....++.+
T Consensus       151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~  225 (254)
T cd05083         151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-ME--PPEGCPAD  225 (254)
T ss_pred             ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-CC--CCCcCCHH
Confidence            322  22234456799999876 578999999999999999997 9999987776666555544321 11  12368899


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++|++||..+|++||++.+++..+
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=331.10  Aligned_cols=248  Identities=28%  Similarity=0.488  Sum_probs=201.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  224 (422)
                      ..|...+.||+|+||.||+++++.   +|+.||||.+....  ....++..-+|+++|++|+ |+|||++++.-++..  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLG   86 (732)
T ss_pred             cceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccC
Confidence            357888999999999999999988   99999999997644  3335577889999999998 999999999766543  


Q ss_pred             ----eEEEEEEccCCCChHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEe
Q 014559          225 ----NVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLI  297 (422)
Q Consensus       225 ----~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~  297 (422)
                          ...+|||||.||+|...+.+.  ...+++.++..++.+++.||.|||++||+||||||.||++..+. .....||+
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence                578999999999999988653  24599999999999999999999999999999999999997633 33456999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHcCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPN  371 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~  371 (422)
                      |||.|+.+.++..+.+.+||..|++||++.  +.|+..+|.|||||++|+++||..||......    ++...+...++.
T Consensus       167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            999999999999999999999999999987  57999999999999999999999999553322    233333322221


Q ss_pred             CC----------CCCCC-------CCC----HHHHHHHHHhchhccccCC
Q 014559          372 FD----------DLPWP-------SVS----PEAKDFVKRLLNKDYRKRM  400 (422)
Q Consensus       372 ~~----------~~~~~-------~~s----~~~~~li~~~L~~dP~~Rp  400 (422)
                      --          ...|.       +++    ..+-.++..+|.+++++|.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            10          00111       122    3466788889999999999

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-40  Score=306.49  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             ceeCcCCCeEEEEEEeccCC---ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGE---LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  229 (422)
                      +.||+|+||.||+|++....   ..++.||||.+.....  ......+.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36999999999999876411   1346899998864321  123467889999999997 99999999999999999999


Q ss_pred             EEccCCCChHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC--CCCCEEEeecCc
Q 014559          230 MELCEGGELLDRILAR------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGL  301 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~--~~~~vkl~DfG~  301 (422)
                      |||+++++|.+++...      ...+++..+..++.|++.||.|||+++++|+||||+||+++.++  ....+||+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999988652      23478899999999999999999999999999999999996421  123799999999


Q ss_pred             ccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          302 SDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       302 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      +........   .....++..|+|||++. +.++.++|||||||++|||++ |+.||...........+..... +.  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-LQ--K  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-cC--C
Confidence            875532221   12234567899999876 578999999999999999998 9999987766665555443221 11  1


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...++.++.++|.+||..+|.+||++.++++.+
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  267 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL  267 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            236789999999999999999999999998754

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.1e-40  Score=314.34  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=198.6

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |.+++.+|.|  |.||.++...   +++.||||++..... .......+.+|+.+++.++ |+||+++++++.+.+..++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKP---TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYV   76 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecC---CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEE
Confidence            3344445444  4555565555   788999999976432 2334578999999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++   .++.+||+|||.+.....
T Consensus        77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecc
Confidence            99999999999988754 35689999999999999999999999999999999999995   478999999998864432


Q ss_pred             CCC--------ccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-----
Q 014559          308 DER--------LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-----  371 (422)
Q Consensus       308 ~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  371 (422)
                      ...        .....++..|+|||++..   .++.++|||||||++|||++|+.||..................     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            211        123457788999999853   4889999999999999999999999765543332222111100     


Q ss_pred             --CCCC-----------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          372 --FDDL-----------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       372 --~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                        .+..                       ....++.++.+||.+||..||++||++.|+|+|+||..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence              0000                       0012346899999999999999999999999999998664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-39  Score=304.25  Aligned_cols=253  Identities=20%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC----
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN----  224 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  224 (422)
                      |++.+.||+|+||.||+|.++.+..+++.||||++..... .....+.+.+|+++++.+. |+||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            5678899999999999999775444678999999865432 2334567889999999997 999999999886532    


Q ss_pred             --eEEEEEEccCCCChHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          225 --NVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                        ..++++||+.+|+|.+++...     ...++...+..++.|++.||.|||++||+||||||+||+++   .++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence              257899999999998876532     12478899999999999999999999999999999999994   57889999


Q ss_pred             ecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCC
Q 014559          298 DFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       298 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      |||+++.......   .....++..|++||.+. +.++.++|||||||++|||++ |+.||......+....+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999876543221   12234567899999876 468899999999999999999 899998777766666665443211


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .   ....+.++.+++.+||..+|++||++.+++..+
T Consensus       236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l  269 (273)
T cd05074         236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL  269 (273)
T ss_pred             C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            1   125788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-39  Score=306.59  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC-CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--C
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--V  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~  223 (422)
                      ..|++.+.||+|+||.||+|..... ..+++.||||++......  ...+.+.+|+++++.+. |+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            3578889999999999999986531 225789999999754332  34577899999999996 9999999999987  5


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ...++||||+++++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++   .++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEccccccc
Confidence            579999999999999999877655799999999999999999999999999999999999995   47899999999998


Q ss_pred             ccCCCCCc----cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH--------------HHHH
Q 014559          304 FIRPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG--------------IFRA  364 (422)
Q Consensus       304 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--------------~~~~  364 (422)
                      ........    ....++..|++||.+. ..++.++|||||||++|||++|..||.......              .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            66532221    1224456799999875 568999999999999999999999985532211              1112


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+......+.  ...++.++.++|.+||..||++||++.|+++.+
T Consensus       238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05038         238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV  280 (284)
T ss_pred             HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            2222222221  125678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=313.15  Aligned_cols=264  Identities=30%  Similarity=0.485  Sum_probs=214.0

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc----hhcHHHHHHHHHHHHHhcCCCCeeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT----AISIEDVRREVKILKALSGHKHLVKFCD  218 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~  218 (422)
                      ..+.++|-++.+||+|||+.||+|.+..   ..+.||||+-...+.-.    .......-+|.+|.+.|. ||.||++|+
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYD  534 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYD  534 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeee
Confidence            4456789999999999999999999887   78899999976543211    112234668999999995 999999999


Q ss_pred             EEE-eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEE
Q 014559          219 ACE-DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       219 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      +|. +.+.+|-|+|||+|.+|.-++ +....+++.+++.|+.||+.||.||.+..  |||-||||.||||..+...|.+|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            996 457799999999998876655 55567999999999999999999999875  99999999999998767788999


Q ss_pred             EeecCcccccCCCCC--------ccccccCCcccCccccC-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 014559          296 LIDFGLSDFIRPDER--------LNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGI  361 (422)
Q Consensus       296 l~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~  361 (422)
                      |.|||+++.+.....        .....||-||++||.+-     ...+.|+||||+|||+|.++.|+.||..... .++
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            999999998765432        23468999999999762     2589999999999999999999999965433 223


Q ss_pred             HH--HHHcCC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          362 FR--AVLRSD-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       362 ~~--~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++  .|++.. ..|+  ..+.++.++++||++||++.-++|....++..+++|--
T Consensus       694 LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  694 LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            22  223222 2233  33579999999999999999999999999999987754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=306.44  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=207.5

Q ss_pred             CcCcccc-cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-------C
Q 014559          140 GYNKNFG-AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-------K  211 (422)
Q Consensus       140 ~~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------~  211 (422)
                      .+++.|. .+|.+.++||.|.|++||+|++..   ..+.||+|+.+..+...    +....||++|++++.+       .
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSAqhYt----EaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSAQHYT----EAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehhhHHH----HHHHHHHHHHHHHHhcCCCCCCCc
Confidence            3467777 899999999999999999999998   77899999998765544    5567899999999743       4


Q ss_pred             CeeEEEeEEEeC----CeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEE
Q 014559          212 HLVKFCDACEDV----NNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLF  285 (422)
Q Consensus       212 niv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll  285 (422)
                      +||+|+++|...    .++|||+|++ |.+|+.+|...+ ..++...++.|++||+.||.|||+. ||||.||||+|||+
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            799999999764    4899999999 779999988654 4599999999999999999999975 99999999999999


Q ss_pred             eeCC----------------------------------------------------------------------------
Q 014559          286 TSGR----------------------------------------------------------------------------  289 (422)
Q Consensus       286 ~~~~----------------------------------------------------------------------------  289 (422)
                      ...+                                                                            
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            6431                                                                            


Q ss_pred             -----------------------------------C--------------------------------------------
Q 014559          290 -----------------------------------D--------------------------------------------  290 (422)
Q Consensus       290 -----------------------------------~--------------------------------------------  290 (422)
                                                         .                                            
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                               0                                            


Q ss_pred             --------CCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 014559          291 --------DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART----  357 (422)
Q Consensus       291 --------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~----  357 (422)
                              +..|||+|||-|++..  ..++.-+.|..|+||||+.+ .|+..+||||++|+++||+||...|....    
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                    0125777777776643  23344467888999999775 79999999999999999999999994421    


Q ss_pred             --hhHHHHHHHcCCCCCCC------------------------C-CCC---------CC----CHHHHHHHHHhchhccc
Q 014559          358 --ESGIFRAVLRSDPNFDD------------------------L-PWP---------SV----SPEAKDFVKRLLNKDYR  397 (422)
Q Consensus       358 --~~~~~~~i~~~~~~~~~------------------------~-~~~---------~~----s~~~~~li~~~L~~dP~  397 (422)
                        +++.+..|++....++.                        + .|+         .+    ..+|.+||.-||+.+|+
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence              23333333322222211                        0 111         11    25799999999999999


Q ss_pred             cCCCHHHHHhccCccc
Q 014559          398 KRMTAVQALSKLVVPI  413 (422)
Q Consensus       398 ~Rps~~elL~~l~~~~  413 (422)
                      +|+||.++|+|+|++-
T Consensus       540 KR~tA~~cl~hPwLn~  555 (590)
T KOG1290|consen  540 KRPTAAQCLKHPWLNP  555 (590)
T ss_pred             ccccHHHHhcCccccC
Confidence            9999999999999983

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=321.46  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=216.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +.++.++||+|.||.|++|.++...-+.-.||||+++.+....  ...+|.+|+.+|.+|. |+|+++|||+..+ ..+.
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhh
Confidence            4567789999999999999998744455789999998765543  5688999999999997 9999999999988 6788


Q ss_pred             EEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||++++|+|++.+.+ ....|-...+..|+.||+.|+.||..+++|||||-..||||.+   ...|||+||||.+-+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceeccC
Confidence            99999999999999987 5567889999999999999999999999999999999999964   6789999999999877


Q ss_pred             CCCCccccc----cCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          307 PDERLNDIV----GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       307 ~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .++..-...    ....|+|||.|+ +.++.++|||+|||+||||++ |+.||.+.....++++|-.+. .++..  ..+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpRP--k~c  340 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPRP--KYC  340 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCCC--CCC
Confidence            665543322    345699999986 789999999999999999998 789999988888888777332 33322  268


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ++++.++++.||..+|.+||++..+.++.+
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            999999999999999999999999976544

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=302.43  Aligned_cols=254  Identities=17%  Similarity=0.227  Sum_probs=187.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcH--------HHHHHHHHHHHHhcCCCCeeE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI--------EDVRREVKILKALSGHKHLVK  215 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~niv~  215 (422)
                      ..+.+|++.+.||+|+||.||+|++..+...+..+|+|+............        .....+...+..+. |+||++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence            445689999999999999999999876322256778776543221110000        01122333444554 999999


Q ss_pred             EEeEEEeCC----eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          216 FCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       216 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      +++.+....    ..++++|++.. ++.+.+. .....++..++.++.|++.||.|||+++|+||||||+|||++   .+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~~  162 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---GN  162 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CC
Confidence            999776543    45788888743 6665543 334578899999999999999999999999999999999994   57


Q ss_pred             CCEEEeecCcccccCCCC--------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH--
Q 014559          292 ADMRLIDFGLSDFIRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG--  360 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--  360 (422)
                      +.+||+|||+++.+....        ......||+.|+|||++.+ .++.++|||||||++|||++|..||.......  
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            889999999997653221        1123469999999998764 68999999999999999999999997763322  


Q ss_pred             -------HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          361 -------IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       361 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                             .+..+......     ...+++++.++++.|+..+|++||+..++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~  292 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKI  292 (294)
T ss_pred             HHHhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence                   12222222221     23578999999999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.3e-40  Score=314.53  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=222.9

Q ss_pred             ccCcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcC-----CCC
Q 014559          138 SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-----HKH  212 (422)
Q Consensus       138 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~n  212 (422)
                      .+.+++.+..+|.+....|+|-||+|+.|.+..   .|..||||+|.....-.    ..=++|++||++|++     --|
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhH
Confidence            344567788899999999999999999999987   77899999998764432    334679999999973     458


Q ss_pred             eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      +++|+..|...+++|||+|-+.. +|.+.+.+.+  -.|....+..|+.||+.||..|-..||+|.||||+||||+  ..
T Consensus       496 clrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ES  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cC
Confidence            99999999999999999999954 9999887744  3478889999999999999999999999999999999997  45


Q ss_pred             CCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ...+||||||.|.+...++ .+-+..+..|+|||++.+ .|+...|+||+||+||||+||+..|.+.+...++...+...
T Consensus       573 k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             cceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            6789999999998766443 344556778999998776 79999999999999999999999999999999988887777


Q ss_pred             CCCCCCCC-------------------------------------------------CCCC-------HHHHHHHHHhch
Q 014559          370 PNFDDLPW-------------------------------------------------PSVS-------PEAKDFVKRLLN  393 (422)
Q Consensus       370 ~~~~~~~~-------------------------------------------------~~~s-------~~~~~li~~~L~  393 (422)
                      ..|+....                                                 +.++       ..|++||.+||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            66653210                                                 0011       468999999999


Q ss_pred             hccccCCCHHHHHhccCcc
Q 014559          394 KDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       394 ~dP~~Rps~~elL~~l~~~  412 (422)
                      .||++|.+..|+|.|+|+.
T Consensus       732 LdP~KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  732 LDPEKRITVNQALKHPFIT  750 (752)
T ss_pred             cChhhcCCHHHHhcCCccc
Confidence            9999999999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.9e-39  Score=294.24  Aligned_cols=228  Identities=23%  Similarity=0.292  Sum_probs=186.0

Q ss_pred             CCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCC
Q 014559          158 GHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE  237 (422)
Q Consensus       158 G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  237 (422)
                      |.||.||+|++..   +++.||+|.+....        ...+|...+.... |+||+++++++.+.+..|+||||+++|+
T Consensus         4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence            8999999999987   88999999996542        1233444555554 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccC
Q 014559          238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS  317 (422)
Q Consensus       238 L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  317 (422)
                      |.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++   .++.++|+|||++......  .....++
T Consensus        72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~--~~~~~~~  145 (237)
T cd05576          72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS--CDGEAVE  145 (237)
T ss_pred             HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccc--cccCCcC
Confidence            99988654 4699999999999999999999999999999999999995   5788999999987654432  2344567


Q ss_pred             CcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhcc
Q 014559          318 AYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY  396 (422)
Q Consensus       318 ~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  396 (422)
                      ..|+|||.+. +.++.++||||+||++|||++|+.+|........    ......++    ..++.+++++|.+||+.||
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~li~~~l~~dp  217 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIP----EWVSEEARSLLQQLLQFNP  217 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCc----ccCCHHHHHHHHHHccCCH
Confidence            7899999886 4689999999999999999999988754322100    00011111    2578999999999999999


Q ss_pred             ccCCCH-----HHHHhccCc
Q 014559          397 RKRMTA-----VQALSKLVV  411 (422)
Q Consensus       397 ~~Rps~-----~elL~~l~~  411 (422)
                      ++|+++     .+++.|+||
T Consensus       218 ~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         218 TERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHhcCCCccchHHHHcCCCC
Confidence            999986     999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=321.99  Aligned_cols=251  Identities=24%  Similarity=0.415  Sum_probs=220.7

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      ..|.+.||.|.||.||+++.+........||||.++..  ..+..+.+|+.|..||-++. ||||++|.|+.....-+.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEE
Confidence            56888999999999999999875556689999999865  34445678999999999996 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      |+|||++|+|..+|..+++.|+..++..+++.|+.|++||-++++|||||-..||||++   +...|++||||++++.++
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs---nLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc---ceEEEeccccceeecccC
Confidence            99999999999999999999999999999999999999999999999999999999954   888999999999987654


Q ss_pred             CC--cccccc--CCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          309 ER--LNDIVG--SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       309 ~~--~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..  .++.-|  ..+|.|||.+. ++++.++||||+||+|||.+. |..|||+....+.+..|.++-.-.+.   .+++.
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---mDCP~  861 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---MDCPA  861 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---CCCcH
Confidence            42  222223  46799999875 799999999999999998875 99999999999999998876543332   37999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .+.+|+..||++|-.+||...|++..
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=311.63  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=212.0

Q ss_pred             eEEeceeCcCCCeEEEEEEeccC-CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      ..+.+.||+|.||.||.|....- ....-.||||..+.+...  ...+.|..|..+|+.+. |||||+|+|.|.+. -.|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-cee
Confidence            34556899999999999987643 113346888888764332  33688999999999996 99999999999874 589


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      ||||++..|.|..++..+...++......++.||+.||.|||+.++|||||-..|||+.+   ...|||+|||+++.+..
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhccc
Confidence            999999999999999988889999999999999999999999999999999999999975   67799999999999887


Q ss_pred             CCCcccccc--CCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          308 DERLNDIVG--SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       308 ~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ........|  ..-|||||-++ +.++.++|||-|||.+||++. |..||.+....+.+-.+.++......   +++++.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~nCPp~  620 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PNCPPA  620 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CCCChH
Confidence            665554444  44599999887 689999999999999999975 99999998888877666665533221   379999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +..|+.+||+.||.+||...|+...+
T Consensus       621 LYslmskcWayeP~kRPrftei~~~l  646 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIKAIL  646 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHHHHH
Confidence            99999999999999999999987654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=307.49  Aligned_cols=245  Identities=22%  Similarity=0.404  Sum_probs=207.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +..+..+||-|.||.||.+.+++   -.-.||||.++.+.    ..+++|+.|..+|+.++ |||+|+|+|+|..+.-+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeec---cceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeE
Confidence            34566789999999999999998   44579999987544    35689999999999998 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||+|||..|+|++++.+.+. .++.-.+.+++.||..|++||..+++|||||-..|+|++   ++..|||+||||++++.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhc
Confidence            99999999999999987653 467778889999999999999999999999999999995   68899999999999876


Q ss_pred             CCCCcccccc---CCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDERLNDIVG---SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .+. .+...|   ..-|.|||-+. ..++.|+|||+|||+|||+.| |..||.+-....++..+.++- ....  ..+++
T Consensus       417 gDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-RM~~--PeGCP  492 (1157)
T KOG4278|consen  417 GDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-RMDG--PEGCP  492 (1157)
T ss_pred             CCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-cccC--CCCCC
Confidence            443 333344   45699999875 789999999999999999988 899998877776666554432 2222  23899


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHh
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALS  407 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~  407 (422)
                      +...+|++.||.|+|.+||+..|+-+
T Consensus       493 pkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999999999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-37  Score=318.26  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=176.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccC-CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeE-----
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA-----  219 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-----  219 (422)
                      .++|++.+.||+|+||.||+|++... ...+..||||++......     +....|  .+.... +.+++.++..     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            35799999999999999999998761 011789999987532211     111111  111111 2233222221     


Q ss_pred             -EEeCCeEEEEEEccCCCChHHHHHHhCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 014559          220 -CEDVNNVYIVMELCEGGELLDRILARGGR-------------------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLK  279 (422)
Q Consensus       220 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dik  279 (422)
                       ......++|||||+.+++|.+++......                   .....+..++.||+.||.|||+++|+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             24556899999999999999887653211                   1234567899999999999999999999999


Q ss_pred             CCcEEEeeCCCCCCEEEeecCcccccCCCC--CccccccCCcccCccccC-c----------------------cCCCch
Q 014559          280 PENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLH-R----------------------SYSLEA  334 (422)
Q Consensus       280 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~~  334 (422)
                      |+|||++  ++++.+||+|||+++.+....  .....++++.|+|||.+. .                      .++.++
T Consensus       283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999996  245789999999997654322  234568899999999652 1                      234567


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc-CCCCC-------CCCC----------CCCCCHHHHHHHHHhchhcc
Q 014559          335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLR-SDPNF-------DDLP----------WPSVSPEAKDFVKRLLNKDY  396 (422)
Q Consensus       335 DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~-------~~~~----------~~~~s~~~~~li~~~L~~dP  396 (422)
                      |||||||+||||+++..++..  ....+..++. .....       ....          ......++.+||++||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999998776532  2112222111 11000       0000          00123456699999999999


Q ss_pred             ccCCCHHHHHhccCccchhh
Q 014559          397 RKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       397 ~~Rps~~elL~~l~~~~l~~  416 (422)
                      ++|||+.|+|+|+||.....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999976443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.5e-37  Score=304.83  Aligned_cols=261  Identities=22%  Similarity=0.272  Sum_probs=188.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc-------------CCccCceEEEEEeecccccch-----------hcHHHHHHHH
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK-------------GELKDQQVAVKIISKAKMTTA-----------ISIEDVRREV  201 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~-------------~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~  201 (422)
                      .++|++.++||+|+||.||+|....             ....++.||||.+........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            4579999999999999999997521             112456899999864321110           0112234577


Q ss_pred             HHHHHhcCCCC-----eeEEEeEEEe--------CCeEEEEEEccCCCChHHHHHHhC----------------------
Q 014559          202 KILKALSGHKH-----LVKFCDACED--------VNNVYIVMELCEGGELLDRILARG----------------------  246 (422)
Q Consensus       202 ~~l~~l~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  246 (422)
                      .++.+++ |.+     +++++++|..        .+..||||||+.+++|.+++....                      
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7788886 544     3677777653        356899999999999998876421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcccc--ccCCcccCc
Q 014559          247 -GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--VGSAYYVAP  323 (422)
Q Consensus       247 -~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~--~gt~~y~aP  323 (422)
                       ..+++..++.++.|++.+|.|||+++|+||||||+|||++   .++.+||+|||++............  .+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1235677889999999999999999999999999999995   4788999999999765433332222  347899999


Q ss_pred             cccCc-c--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCh-----------hHHHHHHHcC
Q 014559          324 EVLHR-S--------------------Y--SLEADIWSIGVISYILLCGSR-PFWARTE-----------SGIFRAVLRS  368 (422)
Q Consensus       324 E~~~~-~--------------------~--~~~~DvwSlG~il~ell~g~~-pf~~~~~-----------~~~~~~i~~~  368 (422)
                      |++.. .                    |  ..+.||||+|||+|+|++|.. ||.....           ...++.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98642 1                    1  134799999999999999986 6643211           1111122222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhchhcc---ccCCCHHHHHhccCcc
Q 014559          369 DPNFDDLPWPSVSPEAKDFVKRLLNKDY---RKRMTAVQALSKLVVP  412 (422)
Q Consensus       369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~elL~~l~~~  412 (422)
                      ...+  ..+..++++.+|||.+||..+|   .+|+|+.|+|+|+||.
T Consensus       460 ~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        460 KYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            2222  2355789999999999999876   6899999999999995

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-36  Score=277.46  Aligned_cols=242  Identities=42%  Similarity=0.731  Sum_probs=203.3

Q ss_pred             CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCCh
Q 014559          159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL  238 (422)
Q Consensus       159 ~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  238 (422)
                      +||.||+|.+..   +++.||+|++........  .+.+.+|++.+++++ |+||+++++++......++||||+.+++|
T Consensus         1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999999876   678999999876543221  578899999999996 99999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCC
Q 014559          239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA  318 (422)
Q Consensus       239 ~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~  318 (422)
                      .+++.... .++...++.++.+++.+|.|||+.+++|+||+|+||+++   .++.++|+|||++.............++.
T Consensus        75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  150 (244)
T smart00220       75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTP  150 (244)
T ss_pred             HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCc
Confidence            99876543 389999999999999999999999999999999999995   46899999999998776554556667899


Q ss_pred             cccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhcc
Q 014559          319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY  396 (422)
Q Consensus       319 ~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  396 (422)
                      .|++||.+. ..++.++||||||+++++|++|..||.. .........+........ ..+..++.++.++|.+||..||
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCc
Confidence            999999876 5688899999999999999999999977 444444444443333222 1122288999999999999999


Q ss_pred             ccCCCHHHHHhccCc
Q 014559          397 RKRMTAVQALSKLVV  411 (422)
Q Consensus       397 ~~Rps~~elL~~l~~  411 (422)
                      ++||++.++++++||
T Consensus       230 ~~Rp~~~~~~~~~~~  244 (244)
T smart00220      230 EKRLTAEEALQHPFF  244 (244)
T ss_pred             hhccCHHHHhhCCCC
Confidence            999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=261.73  Aligned_cols=215  Identities=26%  Similarity=0.412  Sum_probs=181.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +....+..||+|+||.|-+.++..   +|...|+|.+...-  ..+...++.+|+++..+..++|++|.|||...+.+.+
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            345667789999999999998887   89999999997543  2344577889999988887899999999999999999


Q ss_pred             EEEEEccCCCChHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          227 YIVMELCEGGELLDR---ILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~---l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ||.||.|+. +|..+   ..++++.++|..+-+|+..++.||+|||++ .|||||+||+|||+   +.+|.|||||||.+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGIS  196 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccc
Confidence            999999964 55433   234678899999999999999999999987 89999999999999   46999999999999


Q ss_pred             cccCCCCCccccccCCcccCccccC-----ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHcCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP  370 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~  370 (422)
                      ..+...-..+.-.|-..|||||.+.     ..|+.++||||||+++.||.+++.||.. .+...++.++.+...
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~  270 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS  270 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence            8776554445467888999999874     2699999999999999999999999955 566777777776554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=313.02  Aligned_cols=254  Identities=28%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             EEeceeCcCCCeE-EEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          150 ELGKEVGRGHFGH-TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       150 ~~~~~lG~G~~g~-V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      .-.+.+|.|..|+ ||+|..     .|+.||||.+-.+..      ....+||..|+.-.+|+|||++|+.-.+...+||
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-----EGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-----CCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            3345689999984 677764     678999998754322      4578999999999899999999999999999999


Q ss_pred             EEEccCCCChHHHHHHh--CCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC--CCCCCEEEeecCccc
Q 014559          229 VMELCEGGELLDRILAR--GGRY-TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFGLSD  303 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~--~~~l-~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~--~~~~~vkl~DfG~a~  303 (422)
                      +.|.|.. +|.+++...  .... .....+.++.|++.||.+||+.+||||||||+||||...  +....++|+|||+++
T Consensus       581 alELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             EehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9999976 999988763  1111 114567889999999999999999999999999999864  234578999999999


Q ss_pred             ccCCCC----CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          304 FIRPDE----RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       304 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      .+..+.    +..+..||-+|+|||++.. .-+.++||||||||+|+.++| ..||....+  .-..|+.+......+..
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~  737 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEP  737 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeecc
Confidence            876553    2455689999999999875 456789999999999999986 899965433  23356655554433221


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                       ....++.|||.+||.+||..||+|.++|.|+||+....|+
T Consensus       738 -~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL  777 (903)
T KOG1027|consen  738 -LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL  777 (903)
T ss_pred             -CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence             1122899999999999999999999999999999877665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=279.86  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC---
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV---  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  223 (422)
                      .+|.-++.+|.|.- .|..|.+..   .++.||+|.+... +.......+..+|..++..+. |+||++++.+|.-.   
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh---ccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH
Confidence            46888889999998 788888776   8899999998765 444455677889999999997 99999999998643   


Q ss_pred             ---CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          224 ---NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       224 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                         ..+|+|||+++. +|.+.+..   .++.+.+..++.|++.|+.|||+.||+||||||+||++.   .+..+||.|||
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg  163 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFG  163 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccch
Confidence               358999999976 88887763   488999999999999999999999999999999999995   58899999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC--------
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--------  371 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  371 (422)
                      +++.....-..+.++.+..|+|||++-+ .|...+||||+||++.||++|+..|.+...-+.+.++......        
T Consensus       164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            9987665545677889999999998754 5999999999999999999999999877665555444322111        


Q ss_pred             -----------------------CCCCCCCC-------CCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          372 -----------------------FDDLPWPS-------VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       372 -----------------------~~~~~~~~-------~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                                             +++..|+.       -+..+++++.+||..||++|.+++++|+|++++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                   11111211       135689999999999999999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=281.59  Aligned_cols=257  Identities=27%  Similarity=0.433  Sum_probs=205.4

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-----Ce
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-----NN  225 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----~~  225 (422)
                      -.+.||.|+||.||.+.+..   +|+.||+|++..- +..-...+++.+|+++|..++ |.|++..++...-.     ..
T Consensus        57 PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCCcccccceeEEEeccCCC---CccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence            34679999999999999988   8999999998642 233344577899999999997 99999988865433     24


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+|+|++.. +|...|. ....++.+.++-++.||++||+|||+.+|+||||||.|.|+++   +..+||||||+++..
T Consensus       132 iYV~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS---NCvLKICDFGLARve  206 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS---NCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc---CceEEeccccccccc
Confidence            7889999964 7666553 3457999999999999999999999999999999999999964   888999999999876


Q ss_pred             CCCCC--ccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC----------
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN----------  371 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  371 (422)
                      .....  ++..+.|.+|+|||++++  .|+.++||||+|||+.||+..+..|........++.|......          
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            54443  344578999999999986  6999999999999999999999999887776666655432211          


Q ss_pred             -------------CCCCC--C-----CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          372 -------------FDDLP--W-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       372 -------------~~~~~--~-----~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                                   .+...  +     ..-..+..+++..+|..||++|.+.++.+.|+++.-..++
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r  352 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLR  352 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccccee
Confidence                         11110  0     0123578899999999999999999999999988766554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=323.69  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=183.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|...+.||+|+||.||+|+++.   ++..||||.+.....       ....|++++++++ |||||++++++.+.+..|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCE
Confidence            46677899999999999999876   788999999864321       1235688999996 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH---LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +||||+++|+|.+++.    .+++..+..++.|++.||.|||   +.+|+||||||+||+++   .++..++. ||....
T Consensus       760 lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~  831 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-eccccc
Confidence            9999999999999874    3899999999999999999999   66999999999999995   45566654 665543


Q ss_pred             cCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hHHHH---HHHcC-------CCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFR---AVLRS-------DPN  371 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~---~i~~~-------~~~  371 (422)
                      ...   .....|+..|+|||++. +.++.++|||||||++|||++|+.||.....  .....   .....       ++.
T Consensus       832 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        832 LCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             ccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence            221   12336889999999986 4699999999999999999999999853211  11111   11000       000


Q ss_pred             CCCC-C-CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          372 FDDL-P-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       372 ~~~~-~-~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .... . ......++.+++.+||+.||++||++.|+++.+
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  948 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL  948 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence            0000 0 001123577899999999999999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=299.65  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCc----cCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGEL----KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+.+.||+|.||.|++|..+.-..    ....||||.++.....  ...+.+..|+++|+.+..|+||+.++|++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3566799999999999998653221    2568999998765433  456889999999999988999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      .+++|+|||..|+|.+++....               ..++..+...++.||+.|++||++..+|||||-..|||++   
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence            9999999999999999997764               3489999999999999999999999999999999999996   


Q ss_pred             CCCCEEEeecCcccccCCCCCcc--cccc--CCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC-hhHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDERLN--DIVG--SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART-ESGIF  362 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~-~~~~~  362 (422)
                      ++..+||+|||+++.........  ...|  ...|||||.+. ..|+.++|||||||+|||+++ |..||.+.. ..+++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            47789999999998654443332  1222  34599999987 479999999999999999998 889998754 55566


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.+..+......   ..+++++.++++.||..+|++||+..++.+.+
T Consensus       533 ~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~  576 (609)
T KOG0200|consen  533 EFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFF  576 (609)
T ss_pred             HHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence            545544432111   26799999999999999999999999987653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=298.30  Aligned_cols=260  Identities=28%  Similarity=0.446  Sum_probs=218.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      +-.++|+++..+|.|+||.||+|+++.   +++..|+|+++..   ......-+..|+-+++.++ |+|||-+++.+...
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccc---cCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhh
Confidence            344679999999999999999999998   8999999999654   3334566789999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+||+||||.||+|.+. ..-.+.+++.+|..++++.+.||+|||++|-+|||||-.|||++   +.|.+|++|||.+.
T Consensus        85 dklwicMEycgggslQdi-y~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsa  160 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSA  160 (829)
T ss_pred             cCcEEEEEecCCCcccce-eeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchh
Confidence            999999999999998884 45567899999999999999999999999999999999999996   58999999999876


Q ss_pred             ccCC-CCCccccccCCcccCcccc----CccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC-C
Q 014559          304 FIRP-DERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-W  377 (422)
Q Consensus       304 ~~~~-~~~~~~~~gt~~y~aPE~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~  377 (422)
                      .+.. -.+...+.||++|||||+.    .+.|...+|||++|+...|+..-..|....-....+....+..+..+.+. .
T Consensus       161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence            5432 2445678999999999985    36799999999999999999988888655544444444444444433332 2


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ..+++-|-+|++.+|.++|++||+++.+|.|.|.-..
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            3578899999999999999999999999999876543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6.7e-36  Score=277.62  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=205.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ......|.++++||+|.|++||+|.+.......+.||+|.+.....     ..++.+|+++|..+.++.||+++.+.+..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3445579999999999999999999876434678999999865432     36689999999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ++++.+||||++..+..++..    .++..++..+++.++.||.++|.+|||||||||.|+|.+  ...+.-.|+|||+|
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLA  180 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhH
Confidence            999999999999987776542    478999999999999999999999999999999999997  46778899999998


Q ss_pred             cccC-----------------C--C---------------C-----------CccccccCCcccCccccC--ccCCCchh
Q 014559          303 DFIR-----------------P--D---------------E-----------RLNDIVGSAYYVAPEVLH--RSYSLEAD  335 (422)
Q Consensus       303 ~~~~-----------------~--~---------------~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~D  335 (422)
                      ....                 .  +               .           .....+||++|+|||++.  +..+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            5210                 0  0               0           001257999999999986  46889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChh-HHHHHH--------------HcCC------CC-----------------------
Q 014559          336 IWSIGVISYILLCGSRPFWARTES-GIFRAV--------------LRSD------PN-----------------------  371 (422)
Q Consensus       336 vwSlG~il~ell~g~~pf~~~~~~-~~~~~i--------------~~~~------~~-----------------------  371 (422)
                      |||.|||++.+++++.||....++ +.+..+              +.+.      ..                       
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            999999999999999999443221 000000              0000      00                       


Q ss_pred             ---CCCCCCCC-CCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          372 ---FDDLPWPS-VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       372 ---~~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                         .....|.. .+..+.+|+.+||+.||.+|.+|+++|.|+||....
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence               00011112 345799999999999999999999999999998654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=277.71  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=187.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-CCCCeeEEEeEEEeCC--
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFCDACEDVN--  224 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~--  224 (422)
                      ..++.+.||+|.||.||+|..     +++.||||++....      .+.+.+|-+|.+... .|+||++|+++-....  
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-----cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            467788999999999999976     56899999986543      256677777766532 3999999999876554  


Q ss_pred             --eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCcEEEeeCCCCCC
Q 014559          225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---------GVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------~iiH~Dikp~NIll~~~~~~~~  293 (422)
                        .++||+||.+.|+|.+++...  .+++....+++..+++||.|||+.         .|+|||||..||||   +.++.
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlT  354 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLT  354 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCc
Confidence              899999999999999998664  799999999999999999999963         49999999999999   45999


Q ss_pred             EEEeecCcccccCCCC---CccccccCCcccCccccCccCC-------CchhHHHHHHHHHHHHhCCCC-----------
Q 014559          294 MRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLHRSYS-------LEADIWSIGVISYILLCGSRP-----------  352 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-------~~~DvwSlG~il~ell~g~~p-----------  352 (422)
                      ..|+|||||..+.++.   .....+||.+|||||++.+...       ...||||+|.|||||++....           
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999998776443   3445789999999999976432       248999999999999985433           


Q ss_pred             -CCC-----CChhHHHHHHHc--CCCCCCCCCCC--CCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          353 -FWA-----RTESGIFRAVLR--SDPNFDDLPWP--SVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       353 -f~~-----~~~~~~~~~i~~--~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                       |..     .+.+++...+..  ..+.++.. |.  ..-..+++.|..||+.|++.|.|+.=+-+.
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~-W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR  499 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDA-WRKHAGMAVLCETIEECWDHDAEARLTAGCVEER  499 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhh-hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence             321     112233333333  22333321 22  233568999999999999999999655443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=269.00  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=189.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHH--hcCCCCeeEEEeEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA--LSGHKHLVKFCDAC  220 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~  220 (422)
                      ...+.+..+.+.||+|.||.||+|++     .|+.||||++...+.      ....+|.+|++.  |+ |+||+.|++.-
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~srdE------~SWfrEtEIYqTvmLR-HENILgFIaaD  274 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSSRDE------RSWFRETEIYQTVMLR-HENILGFIAAD  274 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-----cCCceEEEEecccch------hhhhhHHHHHHHHHhc-cchhhhhhhcc
Confidence            44567889999999999999999988     467899999864322      456677777655  55 99999999876


Q ss_pred             EeC----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEeeC
Q 014559          221 EDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSG  288 (422)
Q Consensus       221 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~Dikp~NIll~~~  288 (422)
                      ..+    .++|||++|.+.|+|.|++..  ..++.+...+++..++.||.+||..        .|.|||||..||||   
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---  349 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---  349 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---
Confidence            544    269999999999999999966  4799999999999999999999953        39999999999999   


Q ss_pred             CCCCCEEEeecCcccccCCCC-----CccccccCCcccCccccCccC------C-CchhHHHHHHHHHHHHhC-------
Q 014559          289 RDDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRSY------S-LEADIWSIGVISYILLCG-------  349 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~-~~~DvwSlG~il~ell~g-------  349 (422)
                      +.++...|+|+|||-......     ..+..+||.+|||||++....      + ..+||||||+|+||++..       
T Consensus       350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~  429 (513)
T KOG2052|consen  350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV  429 (513)
T ss_pred             ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence            469999999999997655442     245679999999999996432      2 348999999999999862       


Q ss_pred             ---CCCCCCCCh----hHHHHHHHc---CCCCCCCCCCCCCC--HHHHHHHHHhchhccccCCCHHHHH
Q 014559          350 ---SRPFWARTE----SGIFRAVLR---SDPNFDDLPWPSVS--PEAKDFVKRLLNKDYRKRMTAVQAL  406 (422)
Q Consensus       350 ---~~pf~~~~~----~~~~~~i~~---~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~elL  406 (422)
                         .+||.+...    .+..+.+.-   ..+.++ ..|...+  ..+.++++.||..||.-|.||--+-
T Consensus       430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             hhhcCCcccCCCCCCCHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence               567755322    233333322   222222 2333322  4577889999999999999987654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=284.36  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=209.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.+..++||.|+||+||++.+.- ++.-.-+||||++...  .......++..|+-+|.+|. |+|+++|++++.... +
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence            35667899999999999998864 2223458899988654  33334578899999999996 999999999998765 8


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      .||++|+++|+|+|++....+.+-.+....|..||++||.|||+++++||||-..||||.   .-..+||.|||+++...
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence            899999999999999998888899999999999999999999999999999999999995   47889999999999876


Q ss_pred             CCCCccc---cccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          307 PDERLND---IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       307 ~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....-.   ....+-|||=|.+. ..|+.++|||||||++||++| |..|+.+....++-+.+..++. +..  .+.++
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCt  926 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICT  926 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCcc
Confidence            5544222   12345689999876 689999999999999999998 9999988888777666655543 332  23789


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      -++.-++.+||..|+..||+++++...
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~~  953 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAEE  953 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHHH
Confidence            999999999999999999999998654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=272.44  Aligned_cols=201  Identities=31%  Similarity=0.550  Sum_probs=173.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHH-----HHHHHHHHHHHhc--CCCCeeEEEeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE-----DVRREVKILKALS--GHKHLVKFCDA  219 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~--~h~niv~l~~~  219 (422)
                      ..|..++.+|+|+||.|++|.++.   +...|+||.|.+++.......+     .+--||.||..|+  .|+||++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            359999999999999999999998   6789999999886543322211     2457999999996  38999999999


Q ss_pred             EEeCCeEEEEEEcc-CCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          220 CEDVNNVYIVMELC-EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       220 ~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      |++++++||+||-- +|.+|.++|.. ..+++|.++..|++|++.|+++||+.||||||||-+|+.++   .+|-+||+|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~g~~klid  713 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SNGFVKLID  713 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cCCeEEEee
Confidence            99999999999975 34588888754 46799999999999999999999999999999999999994   599999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWA  355 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~  355 (422)
                      ||.+.... ......++||..|.|||++.+ . .+..-|||+||++||-++....||..
T Consensus       714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99997654 556788999999999999986 3 57889999999999999999999853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.1e-31  Score=239.64  Aligned_cols=212  Identities=45%  Similarity=0.783  Sum_probs=183.8

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      ||+|.+|.||++....   +++.++||++.......  ..+.+.+|+++++.+. |++|+++++++......+++||++.
T Consensus         1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999999875   68899999987654321  3467899999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC-Cccc
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND  313 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~~~~  313 (422)
                      +++|.+++......++...++.++.+++.+|.+||++|++|+||++.||+++.  .++.++|+|||.+....... ....
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhc
Confidence            89999987665456899999999999999999999999999999999999952  16889999999997654332 1334


Q ss_pred             cccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 014559          314 IVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL  391 (422)
Q Consensus       314 ~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  391 (422)
                      ..+...|++||.+..  .++.+.|+|+||+++++|                                   ..+.++|.+|
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~  197 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKM  197 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHH
Confidence            567888999999864  788999999999999999                                   5689999999


Q ss_pred             chhccccCCCHHHHHhcc
Q 014559          392 LNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       392 L~~dP~~Rps~~elL~~l  409 (422)
                      |..||++||++.++++++
T Consensus       198 l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         198 LQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             hhCCcccCcCHHHHhhCC
Confidence            999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=248.15  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEe-EEEe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD-ACED  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~  222 (422)
                      .+.+.|.|.+.||+|-||.+.+++++.   +.+.+++|.+.....    ...+|.+|...--.|.-|.||+.-|+ .|..
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            355789999999999999999999988   788999999876543    34788899887777777999999876 5677


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+.+++||++.|+|..-+..  ..+.+.....++.|++.||+|+|++++||||||.+||||...| ...|||||||+.
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t  170 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLT  170 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccc
Confidence            7889999999999999876543  4588999999999999999999999999999999999997633 458999999998


Q ss_pred             cccCCCCCccccccCCcccCccccC----cc--CCCchhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHcCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLH----RS--YSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNF  372 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~  372 (422)
                      +...  ......--+..|.+||++.    +.  ..+.+|+|.||+|+|.+++|..||......    -.+.........-
T Consensus       171 ~k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  171 RKVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             cccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence            6543  2222233456799999763    22  467899999999999999999999542211    1122222222211


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccC---CCHHHHHhccCccch
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALSKLVVPIL  414 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~elL~~l~~~~l  414 (422)
                      .......+++.+..++++-|..++++|   .+++.....+|..-+
T Consensus       249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            111233588999999999999999999   777777777776544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=5.8e-31  Score=238.42  Aligned_cols=213  Identities=44%  Similarity=0.736  Sum_probs=179.7

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |.+.+.||.|++|.||++....   +++.+|+|.+......  ...+.+.+|++.+++++ |+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence            5678899999999999999876   6789999999764332  23578889999999996 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ++|++.+++|.+++......+++..+..++.+++.+|.+||+++++|+||++.||+++   .++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCc
Confidence            9999999999998765433389999999999999999999999999999999999995   4689999999999876544


Q ss_pred             C--CccccccCCcccCcccc-C-ccCCCchhHHHHHHHHHHHHhCCCCCCC--CChhHHHHHHHcCCC
Q 014559          309 E--RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLCGSRPFWA--RTESGIFRAVLRSDP  370 (422)
Q Consensus       309 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~  370 (422)
                      .  ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||..  .....+.+.+..+.+
T Consensus       152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence            3  33456788899999987 3 3578899999999999999999999976  334466666666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.7e-31  Score=283.62  Aligned_cols=198  Identities=16%  Similarity=0.193  Sum_probs=147.6

Q ss_pred             CCeeEEEeEE-------EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          211 KHLVKFCDAC-------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       211 ~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                      .||++++++|       .....++++||++ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777788877       2334678889988 5599999876556799999999999999999999999999999999999


Q ss_pred             EEee----------------CCCCCCEEEeecCcccccCCCC-----------------CccccccCCcccCccccC-cc
Q 014559          284 LFTS----------------GRDDADMRLIDFGLSDFIRPDE-----------------RLNDIVGSAYYVAPEVLH-RS  329 (422)
Q Consensus       284 ll~~----------------~~~~~~vkl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~  329 (422)
                      ||+.                .+.++.+||+|||+++......                 .....+||++|||||++. ..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9953                1235567888888876421100                 011246899999999876 47


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       330 ~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      |+.++|||||||+||||++|..||....  ..+..+....  ++.. ......+..+++.+||.+||.+||++.|+|+|+
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999998875322  1222221111  1110 012245678999999999999999999999999


Q ss_pred             Cccch
Q 014559          410 VVPIL  414 (422)
Q Consensus       410 ~~~~l  414 (422)
                      |+...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            98653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=227.33  Aligned_cols=261  Identities=22%  Similarity=0.377  Sum_probs=208.7

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+..|+++++||+|+||.++.+.+.-   +++.||||.-....     ....++.|.+..+.|.+.+.|...|-+..+.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             EecccceeccccccCcceeeecccccc---cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            456789999999999999999998765   89999999864321     2367889999999999899999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee--CCCCCCEEEeecCc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS--GRDDADMRLIDFGL  301 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~--~~~~~~vkl~DfG~  301 (422)
                      .+-.||||++ |.+|.|++.-.+.+|+..++..++.|++.-++|+|++.+|+|||||+|+||+.  ..+...|.|+|||+
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999999999 77999988878889999999999999999999999999999999999999974  23456789999999


Q ss_pred             ccccCCCCC--------ccccccCCcccCccc-cCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcCC
Q 014559          302 SDFIRPDER--------LNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSD  369 (422)
Q Consensus       302 a~~~~~~~~--------~~~~~gt~~y~aPE~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~  369 (422)
                      |+.+.+...        .....||.+||+=.. +.+..+.+.|+-|||-|++++|-|.+||.+..   ..+.+++|-..+
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            987764432        345679999999775 34578999999999999999999999997743   344455554433


Q ss_pred             CCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          370 PNFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       370 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ...+ +....+++.+|...++-.=..+-.+-|.. |-|+.+|..+|
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY-dylr~Lf~dvl  300 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY-DYLRKLFDDVL  300 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHHH
Confidence            2221 11123577888888877777777777876 44555555444

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=231.82  Aligned_cols=253  Identities=18%  Similarity=0.223  Sum_probs=202.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      .+++..-.+-+|.||.||.|.++..+  .+.+.|-+|.++.  .........+..|..++..+. |+|+..+.+++.++ 
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence            45777888999999999999776432  2345666776643  234455677889999999998 99999999988765 


Q ss_pred             CeEEEEEEccCCCChHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          224 NNVYIVMELCEGGELLDRILAR-------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      ...++++.++.-|+|..++...       ...++..++..++.|++.|++|||++||||.||-..|++|   |+...|||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEe
Confidence            5688889999889999988731       2347778889999999999999999999999999999999   56899999


Q ss_pred             eecCcccccCCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCC
Q 014559          297 IDFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      +|=.+++.+-+....   ...-....||++|.+. ..|+.++|+|||||+||||+| |+.||..-+..++...+..+.. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-  516 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-  516 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-
Confidence            999999866544321   1122356799999876 579999999999999999998 8999988777777665555432 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +..  ..++++++..++..||..+|++||+.+|+..-
T Consensus       517 laQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~c  551 (563)
T KOG1024|consen  517 LAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVIC  551 (563)
T ss_pred             ecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence            221  23799999999999999999999999998754

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-29  Score=214.79  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+.+|+++++||.|+||.+|+|....   .|+.||||+-.....     ...+..|..+.+.|++...|..+..++.+..
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence            34689999999999999999999887   899999998644321     2457789999999997889999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .-.+|||++ |.+|.+.+.-....++..++..++-|++.-++|+|.+++|||||||+|+|++-+.....+.|+|||+++.
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            999999999 7799999888888999999999999999999999999999999999999998766677899999999987


Q ss_pred             cCCCC--------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCCCCC
Q 014559          305 IRPDE--------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDPNF  372 (422)
Q Consensus       305 ~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~  372 (422)
                      +.+..        ......||.+|.+=.... -..+.+.|+-|+|.+|.++..|.+||.+...   ...++.|.+.+...
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            65332        234568999998866544 3578899999999999999999999977544   33455666555443


Q ss_pred             C-CCCCCCCCHHHHHHHHHhchhccccCCCH
Q 014559          373 D-DLPWPSVSPEAKDFVKRLLNKDYRKRMTA  402 (422)
Q Consensus       373 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~  402 (422)
                      + +..-.+++.||.-.+.-|=..--++-|..
T Consensus       244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            3 22234678899999888877766677765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1e-27  Score=229.87  Aligned_cols=255  Identities=24%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc---CCCCeeEEEeEE-EeC
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS---GHKHLVKFCDAC-EDV  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~l~~~~-~~~  223 (422)
                      +|.+.++||+|+||.||++.+....  ...+|+|+.........   ..+..|+.++..+.   +..++..+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            7999999999999999999987632  46799998765422211   25778999999987   246999999999 577


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC--CCCCEEEeecC
Q 014559          224 NNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFG  300 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~--~~~~vkl~DfG  300 (422)
                      ...||||+.+ |.+|.++..... +.++..++..++.|++.+|++||+.|++||||||+|++++...  +...+.|.|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999998 779999775554 7899999999999999999999999999999999999997532  12569999999


Q ss_pred             cccccC---CCC-------C-ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC
Q 014559          301 LSDFIR---PDE-------R-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS  368 (422)
Q Consensus       301 ~a~~~~---~~~-------~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  368 (422)
                      +++...   ...       . .....||..|.++.+.. ...+.+.|+||++.++.|++.|..||...........+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998322   111       1 12356999999999865 47899999999999999999999999765543222222222


Q ss_pred             CCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          369 DPNFDDL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       369 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ....... .....+.++.++...+-..+...+|....+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2111111 122456788888888888999999999887655

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.6e-28  Score=214.76  Aligned_cols=165  Identities=30%  Similarity=0.373  Sum_probs=129.6

Q ss_pred             CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccc
Q 014559          236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV  315 (422)
Q Consensus       236 g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~  315 (422)
                      |+|.+++..++..+++.+++.++.|++.||.|||+++      ||+|||++   .++.+|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc----CC
Confidence            6899988776677999999999999999999999998      99999994   5788898  99987654322    26


Q ss_pred             cCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcCCCCCCCC---CCCCCCH--HHHHHH
Q 014559          316 GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDL---PWPSVSP--EAKDFV  388 (422)
Q Consensus       316 gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~s~--~~~~li  388 (422)
                      |++.|+|||++. ..++.++|||||||++|||++|+.||..... ...+..+..........   ....++.  +++++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            899999999986 4789999999999999999999999976443 23333333222211110   0112333  699999


Q ss_pred             HHhchhccccCCCHHHHHhccCccchh
Q 014559          389 KRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       389 ~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .+||..||.+||++.|+++|+|+....
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHHHH
Confidence            999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2e-26  Score=219.29  Aligned_cols=253  Identities=36%  Similarity=0.601  Sum_probs=203.7

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeEEEeCCeEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACEDVNNVY  227 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~  227 (422)
                      |.+.+.||.|+||.||++.+.      ..+++|.+.............+.+|+.++..+. |+ +|+++++.+......+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEE
Confidence            778899999999999999876      579999998765544334678899999999998 66 8999999998888899


Q ss_pred             EEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC-CEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~~  304 (422)
                      ++++++.++++.+.+....  ..+....+..++.|++.++.|+|+.+++||||||+||++.   ..+ .++++|||++..
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~  151 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCccee
Confidence            9999999999986554433  2799999999999999999999999999999999999995   355 699999999875


Q ss_pred             cCCCC-------CccccccCCcccCccccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCC
Q 014559          305 IRPDE-------RLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSD  369 (422)
Q Consensus       305 ~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~  369 (422)
                      .....       ......|+..|++||.+.+    .++...|+||+|++++++++|..||.....    ......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       2466789999999998764    688899999999999999999999877653    34444444433


Q ss_pred             CC-CCCCCCCCC----CHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          370 PN-FDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       370 ~~-~~~~~~~~~----s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .. .........    ...+.+++.+++..+|..|.+..+...+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~  278 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL  278 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHh
Confidence            32 221111111    2579999999999999999999998877443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=246.13  Aligned_cols=247  Identities=24%  Similarity=0.427  Sum_probs=214.6

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      +|+|.||.|++++-..+...+..||+|+.++......... ....|..++..+++|+.+|+++-.+..++.+++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            7999999999998777777889999999987554443322 555688888888889999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcccc
Q 014559          235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI  314 (422)
Q Consensus       235 ~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  314 (422)
                      ||+|...+.+ ...+++.....+...++.+++++|+.+|+|||+|++||++   +.+|.+|+.|||+++..-..+..   
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence            9998876644 3568889999999999999999999999999999999999   56999999999999876544333   


Q ss_pred             ccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchh
Q 014559          315 VGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK  394 (422)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  394 (422)
                      |||..|||||+++ .....+|.||||++++||++|..||..    ++...|+......+.    .++.++++++.+++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            9999999999998 678889999999999999999999976    777888887777776    6889999999999999


Q ss_pred             ccccCCCH-----HHHHhccCccchhhhh
Q 014559          395 DYRKRMTA-----VQALSKLVVPILSFKI  418 (422)
Q Consensus       395 dP~~Rps~-----~elL~~l~~~~l~~k~  418 (422)
                      +|..|.-.     .|+++|.+++.+.|.-
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeeeHhh
Confidence            99999865     7999999999988873

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2e-27  Score=227.80  Aligned_cols=165  Identities=21%  Similarity=0.228  Sum_probs=127.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc--cchhcHHHHHHHHHHHHHhcCCCCeeE-EEeEEE
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--TTAISIEDVRREVKILKALSGHKHLVK-FCDACE  221 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-l~~~~~  221 (422)
                      +...|.+.+.||+|+||.||+|+++..  +++.||||++.....  ......+.+.+|+++|++|+ |+||+. ++++  
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~--   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT--   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc--
Confidence            456799999999999999999987641  466789998753211  12223467899999999997 999884 5442  


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcEEEeeCCCCCCEEEeecC
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL-KPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Di-kp~NIll~~~~~~~~vkl~DfG  300 (422)
                        +..|||||||+|++|.. + ..   ..   ...++.|++++|.|||++||+|||| ||+|||++   .++.+||+|||
T Consensus        91 --~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFG  157 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQ  157 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECc
Confidence              46899999999988862 2 11   11   1467899999999999999999999 99999994   46789999999


Q ss_pred             cccccCCCCC---------ccccccCCcccCccccC
Q 014559          301 LSDFIRPDER---------LNDIVGSAYYVAPEVLH  327 (422)
Q Consensus       301 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  327 (422)
                      +++.+.....         ..+..++..|++||++.
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9986644321         23457888999999985

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=8.1e-29  Score=252.39  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=194.5

Q ss_pred             cce-EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecc---cccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKY-ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA---KMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..| ...+.+|.|++|.|+.+....   ..+.++.|.+...   ..........+..|+.+-..|+ |+|++..+..+.+
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE  392 (601)
T ss_pred             cccCCccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence            335 456789999999888777654   3444555544311   1111111222667888888887 9999888887777


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .....-+||||++ +|...+.. .+.++..++..+++||+.||.|||..||.|||||++|+++.   .++.+||+|||.+
T Consensus       393 ~~~~~~~mE~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  393 IDGILQSMEYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAA  467 (601)
T ss_pred             cccchhhhhcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcc
Confidence            6666666999998 99887644 35799999999999999999999999999999999999996   4889999999998


Q ss_pred             cccCCCC-----CccccccCCcccCccccCc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCChhHHH--HHHHcCCCCCC
Q 014559          303 DFIRPDE-----RLNDIVGSAYYVAPEVLHR-SYS-LEADIWSIGVISYILLCGSRPFWARTESGIF--RAVLRSDPNFD  373 (422)
Q Consensus       303 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~-~~~DvwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~  373 (422)
                      ..+....     .....+|+..|+|||++.+ .|. ...||||.|++++.|++|+.||......+..  ...........
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~  547 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF  547 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence            7654222     2356789999999999875 565 5689999999999999999999665443321  11111111111


Q ss_pred             ---CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 ---DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                         ...+..++.+-+.+|.+||+.||.+|.++.+++++.|++.+.
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence               112345788899999999999999999999999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=3.5e-25  Score=226.21  Aligned_cols=222  Identities=30%  Similarity=0.522  Sum_probs=174.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|+.++.|..|+||.||+++++.   +.+.+|+|+- +...        +.+.  ++... +.|.+|            
T Consensus        83 ~df~~IklisngAygavylvrh~~---trqrfa~kiN-kq~l--------ilRn--ilt~a-~npfvv------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKIN-KQNL--------ILRN--ILTFA-GNPFVV------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccc---cccchhhccc-ccch--------hhhc--ccccc-CCccee------------
Confidence            468999999999999999999987   7788999542 2111        1111  22222 244444            


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                               |+....+ +..+.++...        +.+++|||+-||+|||+||+|.+|+.   -|.+|+.|||+++...
T Consensus       136 ---------gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~---mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ---------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ---------chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee---cccccccchhhhhhhh
Confidence                     3333333 2223444333        78999999999999999999999975   8999999999976421


Q ss_pred             CCC----------------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          307 PDE----------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       307 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ...                .-...|||+.|.|||++. +.|+..+|+|+||+|+||++.|..||.+++.++++..++...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            110                013468999999999875 689999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHHhccCccchhhh
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALSKLVVPILSFK  417 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~elL~~l~~~~l~~k  417 (422)
                      ..+++. -..++.|++++|.++|+.+|..|.   .+.++-+|.||+.|.|+
T Consensus       275 i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  275 IEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            887776 336889999999999999999997   67788899999999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=8.9e-25  Score=195.40  Aligned_cols=175  Identities=16%  Similarity=0.165  Sum_probs=133.3

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHH------HHHHHHHHHHhcCCCCeeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED------VRREVKILKALSGHKHLVKFC  217 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~l~  217 (422)
                      -+..+|++.+.||.|+||.||++..     ++..+|||++.............      +++|++.+.+|. |++|..+.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~  101 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLN  101 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcce
Confidence            3567899999999999999999755     24469999997554333333233      689999999997 99999999


Q ss_pred             eEEEeC--------CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          218 DACEDV--------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       218 ~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      +++...        +..+|||||++|.+|.+..     .+++    ..+.+++.+|..||+.|++||||||+||+++.  
T Consensus       102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~--  170 (232)
T PRK10359        102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK--  170 (232)
T ss_pred             EeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC--
Confidence            987643        3589999999998887752     2333    34669999999999999999999999999963  


Q ss_pred             CCCCEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHH
Q 014559          290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILL  347 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell  347 (422)
                       ++ ++|+|||.............          =++...|+.++|+|+||+++..+.
T Consensus       171 -~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 -NG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -CC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence             55 99999998865432221111          012346778999999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1e-24  Score=200.71  Aligned_cols=236  Identities=23%  Similarity=0.358  Sum_probs=154.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcC---------CCCeeEEE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---------HKHLVKFC  217 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~l~  217 (422)
                      ..+..++.||.|+|+.||.+.+..   +++.+|||++...........+.+++|.-....+.+         |-.++.-+
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~   88 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL   88 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred             eEEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence            457888999999999999999987   899999999977665555567778877755544332         22233323


Q ss_pred             eEEE---------eC---C-----eEEEEEEccCCCChHHHHH---HhCCC---CCHHHHHHHHHHHHHHHHHHHHCCCe
Q 014559          218 DACE---------DV---N-----NVYIVMELCEGGELLDRIL---ARGGR---YTEEDAKAIVVQILSVVAFCHLQGVV  274 (422)
Q Consensus       218 ~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~ii  274 (422)
                      +...         ..   .     +.+++|+-+. ++|.+.+.   .....   +.......+..|+++.+++||..||+
T Consensus        89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV  167 (288)
T PF14531_consen   89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV  167 (288)
T ss_dssp             EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence            3221         11   1     2477888885 48877653   22222   12222344558999999999999999


Q ss_pred             ecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc---------cCCCchhHHHHHHHHHH
Q 014559          275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR---------SYSLEADIWSIGVISYI  345 (422)
Q Consensus       275 H~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DvwSlG~il~e  345 (422)
                      |+||+++|+|++   .+|.++|+||+.........  .....+..|.+||....         .++.+.|.|+||+++|.
T Consensus       168 Hgdi~~~nfll~---~~G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLD---QDGGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE----TTS-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEc---CCCCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999995   69999999998876543222  21345577999997632         37889999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccC
Q 014559          346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR  399 (422)
Q Consensus       346 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  399 (422)
                      |+||+.||...........      .+.. . .++++.+++||+.+|++||.+|
T Consensus       243 lWC~~lPf~~~~~~~~~~~------~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW------DFSR-C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG------GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc------cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence            9999999965533222111      1111 1 1688999999999999999998

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.3e-24  Score=187.00  Aligned_cols=189  Identities=20%  Similarity=0.232  Sum_probs=141.4

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-hcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      .+...|++|+||+||++..     .+..++.+.+.....-.. .....+.+|+++|++|.+|++|++++++    +..++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l   75 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL   75 (218)
T ss_pred             ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence            3557899999999997764     456777776654332111 1123578999999999867899999986    44699


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL-KPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Di-kp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|||+.|.+|.+.+..       . ...++.|++.+|.++|++||+|||| ||+|||++   .++.++|+|||++.....
T Consensus        76 vmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         76 DRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             EEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCC
Confidence            9999999887653211       1 1357889999999999999999999 79999995   478899999999986554


Q ss_pred             CCCcc--------------ccccCCcccCccccC--ccCC-CchhHHHHHHHHHHHHhCCCCCCCCCh
Q 014559          308 DERLN--------------DIVGSAYYVAPEVLH--RSYS-LEADIWSIGVISYILLCGSRPFWARTE  358 (422)
Q Consensus       308 ~~~~~--------------~~~gt~~y~aPE~~~--~~~~-~~~DvwSlG~il~ell~g~~pf~~~~~  358 (422)
                      .....              -...++.|++|+.-.  ...+ ...++++.|+-+|.++|++.+++++.+
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            43210              123577788887532  2334 567999999999999999999987665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.6e-24  Score=188.99  Aligned_cols=142  Identities=18%  Similarity=0.186  Sum_probs=109.4

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchh-----------------------cHHHHHHHHHHHHHhc
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----------------------SIEDVRREVKILKALS  208 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~  208 (422)
                      .+.||+|+||.||+|.+.    +|+.||||+++........                       ......+|++++.+|.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   77 (190)
T cd05147           2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV   77 (190)
T ss_pred             CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            467999999999999874    6789999999765321111                       0123346999999997


Q ss_pred             CCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEEee
Q 014559          209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC-HLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       209 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~~iiH~Dikp~NIll~~  287 (422)
                       ++++.....+...  ..+|||||++|+++...+.. ...+++..+..++.|++.+|.|| |+.||+||||||+|||++ 
T Consensus        78 -~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          78 -TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             -HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence             7776443333222  23899999998776554333 45799999999999999999999 799999999999999995 


Q ss_pred             CCCCCCEEEeecCccccc
Q 014559          288 GRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~  305 (422)
                         ++.++|+|||++...
T Consensus       153 ---~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 ---DGKLYIIDVSQSVEH  167 (190)
T ss_pred             ---CCcEEEEEccccccC
Confidence               467999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8e-24  Score=195.59  Aligned_cols=190  Identities=28%  Similarity=0.428  Sum_probs=141.3

Q ss_pred             CCCCeeEEEeEEEe---------------------------CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHH
Q 014559          209 GHKHLVKFCDACED---------------------------VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI  261 (422)
Q Consensus       209 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql  261 (422)
                      .|||||++.++|.+                           ...+|+||...+. +|.+++..+  ..+......++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence            59999999887743                           2348999998876 888887554  57888999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEeeCCC-CCCEEEeecCcccccCC-------CCCccccccCCcccCccccCc---c-
Q 014559          262 LSVVAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIRP-------DERLNDIVGSAYYVAPEVLHR---S-  329 (422)
Q Consensus       262 ~~aL~~LH~~~iiH~Dikp~NIll~~~~~-~~~vkl~DfG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~-  329 (422)
                      ++|+.|||++||.|||+|.+|||+.-+|+ --.+.|+|||.+---..       ....-..-|...-||||+...   . 
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999976432 23578999997632111       111223457888999999752   2 


Q ss_pred             ---CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH
Q 014559          330 ---YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV  403 (422)
Q Consensus       330 ---~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  403 (422)
                         .-.|+|.|+.|.+.||++....||....+..+--.. .....++.. ...+++.++++|..+|..||.+|++..
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPal-p~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPAL-PSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCC-cccCChHHHHHHHHHhcCCccccCCcc
Confidence               124799999999999999999999875442221111 111112211 126889999999999999999999864

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-24  Score=220.82  Aligned_cols=245  Identities=22%  Similarity=0.295  Sum_probs=174.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +|...+.||.+.|=.|.+|++.+    | .|+||++-+..- ..-....+...|++ .... ++||++.+..+...+..-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHH
Confidence            68888999999999999999875    3 399999876431 12112233334555 3334 599999999888888888


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc--
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF--  304 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~--  304 (422)
                      |||-+|..+ +|+|.+-.+ .-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||++   =..+.|+||...+-  
T Consensus        97 ylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCcc
Confidence            999999976 999987544 34677788889999999999999999999999999999985   56789999986542  


Q ss_pred             cCCCCC------ccccccCCcccCccccCc-----------c-CCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 014559          305 IRPDER------LNDIVGSAYYVAPEVLHR-----------S-YSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV  365 (422)
Q Consensus       305 ~~~~~~------~~~~~gt~~y~aPE~~~~-----------~-~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  365 (422)
                      +..++.      +.+...-.+|.|||.+..           . .+++.||||+||+++||++ |+++|.-    .++-..
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aY  247 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAY  247 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhH
Confidence            111111      122233457999998621           1 5678999999999999987 6888821    111111


Q ss_pred             HcCCCCCCCCCCC-CCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          366 LRSDPNFDDLPWP-SVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       366 ~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+....++.... --+..++.+|..|++.||.+|.+|++.|+.
T Consensus       248 r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111000000000 012358999999999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.2e-22  Score=179.84  Aligned_cols=143  Identities=20%  Similarity=0.199  Sum_probs=111.7

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-----------------------hcHHHHHHHHHHHHHhc
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----------------------ISIEDVRREVKILKALS  208 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  208 (422)
                      .+.||+|+||.||+|++.    +|+.||||+++.......                       .....+.+|.+.+.++.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   77 (190)
T cd05145           2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY   77 (190)
T ss_pred             CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            468999999999999865    678999999986522100                       00223468999999997


Q ss_pred             CCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEee
Q 014559          209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTS  287 (422)
Q Consensus       209 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~  287 (422)
                       |++|.....+....  .+|||||++|+++...... ...++...+..++.|++.+|.+||. +||+||||||+|||++ 
T Consensus        78 -~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          78 -EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             -hCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence             88875544443332  4899999988765443333 3568899999999999999999999 9999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccC
Q 014559          288 GRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~  306 (422)
                         ++.++|+|||++....
T Consensus       153 ---~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 ---DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ---CCCEEEEEcccceecC
Confidence               6789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=9.1e-22  Score=175.41  Aligned_cols=138  Identities=20%  Similarity=0.245  Sum_probs=106.0

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc----CCCCeeEEEeEEEeCC---
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----GHKHLVKFCDACEDVN---  224 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~---  224 (422)
                      .+.||+|+||.||.  +..   ++.. +||++.....   ...+.+.+|+.+++.|.    +|+||++++++++++.   
T Consensus         7 ~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cceecCCCceEEEE--CCC---CcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            46899999999995  443   3333 6898865422   23467899999999994    3899999999999873   


Q ss_pred             eEE-EEEEc--cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEeec
Q 014559          225 NVY-IVMEL--CEGGELLDRILARGGRYTEEDAKAIVVQILSVV-AFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF  299 (422)
Q Consensus       225 ~~~-lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL-~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~Df  299 (422)
                      .++ +||||  +.+++|.+++.+  +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+||
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            434 78999  557899998854  346666  36678888887 999999999999999999997422 3458999995


Q ss_pred             Ccc
Q 014559          300 GLS  302 (422)
Q Consensus       300 G~a  302 (422)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.1e-21  Score=204.43  Aligned_cols=197  Identities=23%  Similarity=0.330  Sum_probs=156.7

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACE  221 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~  221 (422)
                      .-+..|.|.+.||+|+||.||+|...    +|+.||||+-+....-.-..      =.+++.+|+  --+.|+.++..+.
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHc
Confidence            34567999999999999999999876    48899999865432111111      122333332  1246666777777


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee----CCCCCCEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----GRDDADMRLI  297 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~----~~~~~~vkl~  297 (422)
                      -.+..+||+||.+.|+|++++. ..+.+++..+..+..|++..++.||..+|||+||||+|+||..    +.+...++|+
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            7778899999999999999876 5567999999999999999999999999999999999999964    2235569999


Q ss_pred             ecCcccc---cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCC
Q 014559          298 DFGLSDF---IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSR  351 (422)
Q Consensus       298 DfG~a~~---~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~  351 (422)
                      |||.+-.   +..+..+...++|-.+-.+|+..+ .|++.+|.|.|+.+++-||.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9998753   344556777889999999999875 79999999999999999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-21  Score=172.92  Aligned_cols=241  Identities=19%  Similarity=0.242  Sum_probs=184.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +..+..+|.+...|..|++++..     ..+++|++...+..... ..+|..|.-.|+-+. ||||+.+++.|....++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg-----ndivakil~vr~~t~ri-srdfneefp~lrifs-hpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG-----NDIVAKILNVREVTARI-SRDFNEEFPALRIFS-HPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC-----cchhhhhhhhhhcchhh-cchhhhhCcceeeec-CCchhhhhhhccCCCCce
Confidence            45667788999999999999854     45777888765544332 356788888888887 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|..||+.|+|+..++... -..+..++.+++.++++|+.|||+..  |.---|....++++. |-...+..+|--++..
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfsfq  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFSFQ  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceeeee
Confidence            9999999999999887654 33788899999999999999999874  444458888999943 2223344455443321


Q ss_pred             cCCCCCccccccCCcccCccccCcc----CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC--CCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNFDDLPWP  378 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~  378 (422)
                            .....-.+.||+||.+.+.    .-.++|+|||++++|||.|...||..-..-+.-.+|.-.  ...++    +
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip----p  412 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP----P  412 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC----C
Confidence                  1223457889999998743    245789999999999999999999776655544444322  22333    3


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHH
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQAL  406 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL  406 (422)
                      +++..+..|+.-|+..||.+||....++
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            8999999999999999999999987654

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=9.7e-21  Score=172.82  Aligned_cols=148  Identities=22%  Similarity=0.195  Sum_probs=113.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEE-eccCCccCceEEEEEeecccccch---------------------hcHHHHHHHHHH
Q 014559          146 GAKYELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTA---------------------ISIEDVRREVKI  203 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~E~~~  203 (422)
                      +.-|.+.+.||+|+||.||+|. +..   +|+.||||+++.......                     .....+.+|+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            4458899999999999999998 444   788999999976432100                     011246789999


Q ss_pred             HHHhcCCC--CeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCC
Q 014559          204 LKALSGHK--HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKP  280 (422)
Q Consensus       204 l~~l~~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-iiH~Dikp  280 (422)
                      ++++. +.  .+.+++++    ...+|||||+.|++|...... ...+....+..++.|++.+|.+||++| |+||||||
T Consensus       104 L~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp  177 (237)
T smart00090      104 LQRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE  177 (237)
T ss_pred             HHHHH-hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence            99997 42  34444443    235899999998777664422 345677778899999999999999999 99999999


Q ss_pred             CcEEEeeCCCCCCEEEeecCcccccC
Q 014559          281 ENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       281 ~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||+++    ++.++|+|||++....
T Consensus       178 ~NIli~----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE----CCCEEEEEChhhhccC
Confidence            999994    6789999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=1.3e-21  Score=187.98  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=166.8

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEe-------EE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD-------AC  220 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-------~~  220 (422)
                      .+.+.+..+..+++.+.......+....+.++-+..+.+.   ........+++-.+.... |.+..-+.+       .+
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~-~~~~s~~~d~~~s~~~~~  320 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSS-HSNRSILEDLRPSLFESS  320 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccc-cCCcccccCCCCchhhhc
Confidence            3555666777777777655544322223334444332222   122234445555555554 444333333       11


Q ss_pred             Ee-----CCeEEEEEEccCCCChHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC
Q 014559          221 ED-----VNNVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       221 ~~-----~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                      ..     ...+||.|++|+..+|.+++..+  ....+...+..++.|+..|++|   +|.+|||+||.||+..   .+..
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q  394 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQ  394 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchh
Confidence            11     23589999999999999998643  3456788899999999999999   9999999999999995   4668


Q ss_pred             EEEeecCcccccCCCC-------CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 014559          294 MRLIDFGLSDFIRPDE-------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA  364 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  364 (422)
                      +||.|||+........       ..+..+||.+||+||.+. ..|+.++||||||+||+||+. =...|.   ....+..
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d  471 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTD  471 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhh
Confidence            9999999987665544       456678999999999988 579999999999999999986 222221   1122222


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      +..  ..++..-+.++ ++-.+|+.+||.+.|.+||++.+.-.+.|.
T Consensus       472 ~r~--g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  472 IRD--GIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhc--CCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            222  22232222233 345689999999999999987777666654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.83  E-value=1.8e-19  Score=184.19  Aligned_cols=141  Identities=23%  Similarity=0.289  Sum_probs=112.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-----cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-----TTAISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      ...|...+.||+|+||.||++.+..     ..+++|+......     ......+++.+|+++++.++ |++|+..+.++
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~  405 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD  405 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE
Confidence            3445678899999999999988643     2345554322111     11123356889999999997 99999888888


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      .+....++||||++|++|.+.+.         ....++.+++.+|.|||+.||+||||||+|||+.    ++.++|+|||
T Consensus       406 ~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFG  472 (535)
T PRK09605        406 VDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFG  472 (535)
T ss_pred             EeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCc
Confidence            87778899999999999988774         3567899999999999999999999999999993    6789999999


Q ss_pred             ccccc
Q 014559          301 LSDFI  305 (422)
Q Consensus       301 ~a~~~  305 (422)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=2.3e-19  Score=161.52  Aligned_cols=137  Identities=26%  Similarity=0.324  Sum_probs=112.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-----hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      +.||+|++|.||+|+.     .+..|+||+........     ......+.+|+.++..+. |++|.....++.+.+..+
T Consensus         2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI   75 (211)
T ss_pred             cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence            5799999999999986     45679999865432211     112346788999999997 899888777777788899


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +||||++|++|.+.+...    .. ....++.+++.+|.+||+.|++|+|++|.|||++    ++.++|+|||++..
T Consensus        76 lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            999999999998877542    12 8889999999999999999999999999999995    67899999999865

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=5.5e-20  Score=179.85  Aligned_cols=200  Identities=28%  Similarity=0.355  Sum_probs=157.9

Q ss_pred             HHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCcE
Q 014559          205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV-VHRDLKPENF  283 (422)
Q Consensus       205 ~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~i-iH~Dikp~NI  283 (422)
                      +.+. |.|+.+|+|.+.+....++|.+||..|+|.|.+....-.++.-....++++|+.||.|||..-| .|+.++..|+
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4565 9999999999999999999999999999999998877778999999999999999999998865 9999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccCCC---CCccccccCCcccCccccCcc--------CCCchhHHHHHHHHHHHHhCCCC
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLHRS--------YSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DvwSlG~il~ell~g~~p  352 (422)
                      +++   ....+||.|||+.......   .......-..-|.|||.+...        .+.+.||||||++++|+++.+.|
T Consensus        81 lvd---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LVD---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             eee---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            994   5899999999998765321   111122245569999998642        46789999999999999999999


Q ss_pred             CCCCCh----hHHHHHHHc-CCCCCCCCCC-C-CCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          353 FWARTE----SGIFRAVLR-SDPNFDDLPW-P-SVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       353 f~~~~~----~~~~~~i~~-~~~~~~~~~~-~-~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      |.....    .+++..+.. ....+....+ . ...+++..++.+||..+|.+||+++++-..
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            966322    245555554 2222222111 1 455679999999999999999999988654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=8.5e-22  Score=201.06  Aligned_cols=260  Identities=26%  Similarity=0.453  Sum_probs=209.1

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|.+.+.||+|.|+.|-++....+  ....+|+|.+.... ......+.+..|..+-+.+.+|.|++++++...+....+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccchhhhhhhcCC--CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            578888899999999987776432  44567777775543 222334556678888888878999999999999999999


Q ss_pred             EEEEccCCCChHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEeeCCCCC-CEEEeecCcccc
Q 014559          228 IVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDF  304 (422)
Q Consensus       228 lv~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~~  304 (422)
                      +++||.+|+++.+.+ .......+......++.|+..++.|+| ..++.|+||||+|.+++   ..+ .+|++|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcc
Confidence            999999999998877 333336788889999999999999999 99999999999999995   466 899999999987


Q ss_pred             cCC-CC---Ccccccc-CCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHcCCCCCCCCC
Q 014559          305 IRP-DE---RLNDIVG-SAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRAVLRSDPNFDDLP  376 (422)
Q Consensus       305 ~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~  376 (422)
                      +.. ..   .....+| +..|+|||...+  ......|+||.|+++..+++|..|+........ +.........+....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            655 22   2344678 999999998765  457789999999999999999999866444332 122223333445567


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      |..++....+++.++|..+|..|.+.+++-.+.|+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999999876

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=5.6e-19  Score=157.54  Aligned_cols=134  Identities=25%  Similarity=0.285  Sum_probs=106.3

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-----chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      .||+|+||.||+++.     .+..|++|+.......     ......++.+|++++..+. |.++.....++.+.+..++
T Consensus         1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence            389999999999984     5567999986543221     1122366789999999997 7776655555566677899


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ||||++|++|.+.+.....        .++.+++.+|.+||+.|++|+|++|.||+++    ++.++|+|||++...
T Consensus        75 v~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            9999999999887643211        8899999999999999999999999999995    688999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=4e-19  Score=158.40  Aligned_cols=141  Identities=26%  Similarity=0.307  Sum_probs=108.3

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-------------------hcHHHHHHHHHHHHHhc
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-------------------ISIEDVRREVKILKALS  208 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~  208 (422)
                      .|.+.+.||+|+||.||++...    +|+.||||++........                   .......+|+.++..+.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            4888899999999999999864    678999999765321000                   01123678999999996


Q ss_pred             CCC--CeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          209 GHK--HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       209 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                       |.  .++..++    ....++||||++|++|.+...       ......++.+++.++.++|+.||+||||||+||+++
T Consensus        92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence             66  4455544    244689999999988765321       145677889999999999999999999999999994


Q ss_pred             eCCCCCCEEEeecCcccccCC
Q 014559          287 SGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~  307 (422)
                         +++.++|+|||++.....
T Consensus       160 ---~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 ---DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ---CCCcEEEEECCccccCCC
Confidence               488999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=4.3e-18  Score=150.26  Aligned_cols=141  Identities=27%  Similarity=0.272  Sum_probs=100.6

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHH---------------------HHHHHHHHHHHhcCC
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE---------------------DVRREVKILKALSGH  210 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h  210 (422)
                      ++.||+|+||.||+|.+.    +++.||||++............                     ....|...+..+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   77 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA   77 (187)
T ss_pred             CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence            467999999999999865    5778999998754322111111                     124677777777522


Q ss_pred             -CCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeC
Q 014559          211 -KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       211 -~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~  288 (422)
                       -.+.+.++.    ...++||||+.++.+........ .. ...+..++.+++.++.++|. .||+|+||||+||+++  
T Consensus        78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--  149 (187)
T cd05119          78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--  149 (187)
T ss_pred             CCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--
Confidence             234555543    24589999999854432211111 01 16788999999999999999 9999999999999995  


Q ss_pred             CCCCCEEEeecCcccccC
Q 014559          289 RDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~  306 (422)
                        ++.++|+|||.+....
T Consensus       150 --~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 --DGKVYIIDVPQAVEID  165 (187)
T ss_pred             --CCcEEEEECccccccc
Confidence              7889999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.7e-18  Score=168.17  Aligned_cols=258  Identities=23%  Similarity=0.270  Sum_probs=200.5

Q ss_pred             cccccceEEeceeCc--CCCeEEEEEEe--ccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEe
Q 014559          143 KNFGAKYELGKEVGR--GHFGHTCSARG--KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD  218 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~--G~~g~V~~a~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~  218 (422)
                      ..+...+.+.+.+|.  |.+|.||.++.  ..   ++..+|+|.-+.- ........+-.+|+...+.+..|+|.++.+.
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~---s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSE---SPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCccc---CCcccccccccCC-CCCccccccccchhhcccccCccccccccCc
Confidence            344556788889999  99999999988  54   7888999984321 1111222334578888888888999999999


Q ss_pred             EEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS----VVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       219 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~----aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      .+++.+.+|+-+|+|. .+|..+.......++...++.++.+...    ||.++|..+++|-|+||.||++..  +....
T Consensus       186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~--~~~s~  262 (524)
T KOG0601|consen  186 AWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS--DWTSC  262 (524)
T ss_pred             ccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc--cccee
Confidence            9999999999999995 6888888777777999999999999999    999999999999999999999963  22788


Q ss_pred             EEeecCcccccCCCCCc------cccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH--HHHHHH
Q 014559          295 RLIDFGLSDFIRPDERL------NDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG--IFRAVL  366 (422)
Q Consensus       295 kl~DfG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--~~~~i~  366 (422)
                      +++|||+...+......      ....|...|++||++++-++...|+|+||.++++..++...+.......  .++...
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            99999998877655422      1225788899999999999999999999999999998877664431111  111111


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                           ++.....+.+.++...+..|++.++..|+++..++.+.+..
T Consensus       343 -----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  343 -----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             -----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence                 11111124667788899999999999999999999886554

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=5.2e-17  Score=148.53  Aligned_cols=138  Identities=23%  Similarity=0.268  Sum_probs=102.8

Q ss_pred             ceeC-cCCCeEEEEEEeccCCccCceEEEEEeecccc----------cchhcHHHHHHHHHHHHHhcCCCCe--eEEEeE
Q 014559          153 KEVG-RGHFGHTCSARGKKGELKDQQVAVKIISKAKM----------TTAISIEDVRREVKILKALSGHKHL--VKFCDA  219 (422)
Q Consensus       153 ~~lG-~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~ni--v~l~~~  219 (422)
                      ..|| .||.|+||.+..     .+..++||.+.....          .......++.+|+.++..|. |++|  +..+++
T Consensus        37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~  110 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAA  110 (239)
T ss_pred             ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEee
Confidence            4577 788888888875     356799998864221          01123356789999999997 8774  677776


Q ss_pred             EEeCC----eEEEEEEccCC-CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          220 CEDVN----NVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       220 ~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      .....    ..+||||+++| .+|.+.+..  ..+++..    +.+|+.+|.+||++||+||||||+|||++   .++.+
T Consensus       111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v  181 (239)
T PRK01723        111 RVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKF  181 (239)
T ss_pred             eeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCE
Confidence            54432    23599999997 578776643  3455543    57899999999999999999999999995   36689


Q ss_pred             EEeecCccccc
Q 014559          295 RLIDFGLSDFI  305 (422)
Q Consensus       295 kl~DfG~a~~~  305 (422)
                      +|+|||.+...
T Consensus       182 ~LIDfg~~~~~  192 (239)
T PRK01723        182 WLIDFDRGELR  192 (239)
T ss_pred             EEEECCCcccC
Confidence            99999998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.2e-16  Score=135.07  Aligned_cols=133  Identities=27%  Similarity=0.318  Sum_probs=110.7

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEeEEEeCCeEEEE
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~lv  229 (422)
                      +++.||+|.++.||++...     +..++||++.....     ...+.+|+.+++.+..+ .++++++.++...+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            3568999999999999874     25799999855422     35788999999999733 6999999998888899999


Q ss_pred             EEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      |||+.++.+...        +......++.+++.+|.+||..   +++|+||+++||+++   ..+.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            999988766542        5667778899999999999985   799999999999996   368899999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=1.4e-14  Score=143.78  Aligned_cols=144  Identities=21%  Similarity=0.248  Sum_probs=97.1

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---------------------------hcH----------H
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---------------------------ISI----------E  195 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~~~----------~  195 (422)
                      +.||.|++|+||+|+.+    +|+.||||+.+......-                           ...          -
T Consensus       123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El  198 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL  198 (437)
T ss_pred             cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence            57999999999999976    678999999864311000                           000          0


Q ss_pred             HHHHHHHHHHHhc----CCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 014559          196 DVRREVKILKALS----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS-VVAFCHL  270 (422)
Q Consensus       196 ~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~-aL~~LH~  270 (422)
                      ++.+|...+.+++    ++++|.-..-+....+..+|||||++|++|.+........++   ...++.+++. .+..+|.
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence            2445666665553    234332222222223457899999999998876543222232   3445555655 4678999


Q ss_pred             CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       271 ~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      .|++|+|++|.||++.   .++.++|+|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence            9999999999999994   57899999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.60  E-value=4.3e-15  Score=149.24  Aligned_cols=149  Identities=18%  Similarity=0.288  Sum_probs=93.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---------------------------h----hcHHH
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---------------------------A----ISIED  196 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---------------------------~----~~~~~  196 (422)
                      .|+. +.||.|++|+||+|+.+.   +|+.||||+++......                           .    ...+.
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            4665 789999999999999875   58899999997542100                           0    01122


Q ss_pred             H------HHHHHHHHHhc---CCCCeeEEEeEEEe-CCeEEEEEEccCCCChHHHHH-HhCC----CCCHHHHHHHHHHH
Q 014559          197 V------RREVKILKALS---GHKHLVKFCDACED-VNNVYIVMELCEGGELLDRIL-ARGG----RYTEEDAKAIVVQI  261 (422)
Q Consensus       197 ~------~~E~~~l~~l~---~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~----~l~~~~~~~i~~ql  261 (422)
                      +      .+|+..+.+++   .+.+.+.+-.++.+ ....+|||||++|+.+.+... ...+    .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            3      33444444442   12222332222222 345679999999999876422 1212    23444445555555


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEeecCcccccCC
Q 014559          262 LSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       262 ~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~DfG~a~~~~~  307 (422)
                      +       ..|++|+|+||.||+++.+ ...+.++++|||++..+..
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4       5899999999999999641 1123899999999977643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=3e-16  Score=161.42  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.+.+.+-+-.|.++.++.+.-..   .|...++|+..+...-.....+.+..+-.++-..+ +|.++...-.+......
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             ccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCc
Confidence            357778889999999999887554   55566666665443333333344444544443333 67777766666667789


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||++|+.+++|...+... +..+.+-.+.++..+..+++|||...++|+|++|.|+|..   ..+..++.|||......
T Consensus       880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccc
Confidence            9999999999998876543 4577788888899999999999999999999999999995   58999999998432110


Q ss_pred             ---------------------CC-----------CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCC
Q 014559          307 ---------------------PD-----------ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       307 ---------------------~~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf  353 (422)
                                           ..           .......||+.|.+||.+.+ .....+|+|++|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                                 00           00123568999999998764 6888999999999999999999999


Q ss_pred             CCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH---HHHhccCccchhhhh
Q 014559          354 WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV---QALSKLVVPILSFKI  418 (422)
Q Consensus       354 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---elL~~l~~~~l~~k~  418 (422)
                      .....+.+++.|.+.+...+... ...+.++++++.++|..++.+|..+.   ++-.|.||+...|-.
T Consensus      1036 na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            99999999998888776554322 24788999999999999999999998   888899998876654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5e-15  Score=134.69  Aligned_cols=206  Identities=16%  Similarity=0.158  Sum_probs=144.9

Q ss_pred             HHHHhcCCCCeeEEEeEEEeCC-----eEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 014559          203 ILKALSGHKHLVKFCDACEDVN-----NVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQG--  272 (422)
Q Consensus       203 ~l~~l~~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~--  272 (422)
                      -|-++- |.|||+++.|+.+.+     ...++.||+..|++..++++   ....+......+|+.||+.||.|||+..  
T Consensus       120 nllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            344554 999999999987654     58899999999999888764   3456889999999999999999999985  


Q ss_pred             CeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC-----CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHH
Q 014559          273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-----ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYIL  346 (422)
Q Consensus       273 iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~el  346 (422)
                      |+|+++..+.|++.   .++-+||.---.......-     .......+-++|.+||.=. ...+-.+|||+||...+||
T Consensus       199 iihgnlTc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeec---CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            99999999999995   4777887542221111000     1112234678899999743 4567789999999999999


Q ss_pred             HhCCCCCCCC-ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc-Cccchhhhhh
Q 014559          347 LCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL-VVPILSFKIV  419 (422)
Q Consensus       347 l~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l-~~~~l~~k~~  419 (422)
                      ..+..--... .....-..+.+......       ...-+++|.+||+..|..||+++++|.|+ .|++.+.|+.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll  343 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLL  343 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHH
Confidence            8887642221 11111111211111111       11246789999999999999999999996 5566666654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=1.5e-13  Score=120.51  Aligned_cols=146  Identities=18%  Similarity=0.206  Sum_probs=104.6

Q ss_pred             eceeCcCCCeEEEEEEeccC---CccCceEEEEEeeccccc-------------------chhcHHHHH----HHHHHHH
Q 014559          152 GKEVGRGHFGHTCSARGKKG---ELKDQQVAVKIISKAKMT-------------------TAISIEDVR----REVKILK  205 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~---~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~----~E~~~l~  205 (422)
                      ...||.|.-+.||.|....+   ...+..+|||+.+.....                   .......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            35799999999999986431   113578999998642110                   011122333    8999999


Q ss_pred             HhcCC-CCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcE
Q 014559          206 ALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC-HLQGVVHRDLKPENF  283 (422)
Q Consensus       206 ~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~~iiH~Dikp~NI  283 (422)
                      ++... -++.+.+++    ..-+|||||+.++.+.....+ ...++.+++..+..+++.+|..| |+.||||+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            99743 467777765    446899999976444222222 23466677788899999999998 899999999999999


Q ss_pred             EEeeCCCCCCEEEeecCcccccC
Q 014559          284 LFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       284 ll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+.    ++.+.|+|||.+-...
T Consensus       157 L~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE----CCcEEEEECCCceeCC
Confidence            995    5779999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.53  E-value=8.1e-14  Score=120.74  Aligned_cols=129  Identities=19%  Similarity=0.223  Sum_probs=95.8

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      ++.|+.|.++.||+++.     .+..|+||+......    ....+.+|+.+++.+.+...+.+++.+..  ...++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEE-----CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence            35789999999999985     356799999754321    11345789999999974333556665543  23479999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV-----VHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~i-----iH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      |++|.++.+.         ......++.+++++|..||+.++     +|+|+++.||+++    ++.++|+|||.+..
T Consensus        72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9999876542         01123457899999999999985     9999999999995    56799999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=3.6e-13  Score=113.63  Aligned_cols=148  Identities=19%  Similarity=0.202  Sum_probs=112.0

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEee-----cccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS-----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+..|-+|+-+.|+++.+     .|+.+.||.-.     ...........+..+|+++|.++. --.|.--.-++.+...
T Consensus        11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG   84 (229)
T ss_pred             cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence            456788999999998876     56777777632     233334445567889999999987 4455555556777777


Q ss_pred             EEEEEEccCC-CChHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          226 VYIVMELCEG-GELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       226 ~~lv~e~~~~-g~L~~~l~~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      -+|+|||++| .++.+++...... ........++++|-+.+.-||.++|||+||..+||++.+++....+.|+|||++.
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            7899999987 3677777664333 3334447889999999999999999999999999999875556667999999985


Q ss_pred             c
Q 014559          304 F  304 (422)
Q Consensus       304 ~  304 (422)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=1.6e-14  Score=141.82  Aligned_cols=253  Identities=23%  Similarity=0.220  Sum_probs=184.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|..+..||.|.|+.|+...-+  ..++..|++|...+.-..... ...-..|+.+...+.-|.+++.++..|....
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3456888999999999999987733  236788999988664433322 2233467777777777999999999999988


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +.||-.|||+++++...+ .-...+++...+++..|++.++.++|++.++|+|+||+||++..  +.+..++.|||....
T Consensus       340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTR  416 (524)
T ss_pred             cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhccccccccc
Confidence            899999999998876554 22235888999999999999999999999999999999999974  127889999998764


Q ss_pred             cCCCCCccccccCCccc-CccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYV-APEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +.-.  ........++. ..|++..  .+..+.|++|||..+.+.+++...-+.....   ..|..+..  +..  ++..
T Consensus       417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~~--p~~--~~~~  487 (524)
T KOG0601|consen  417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGDT--PNL--PGLK  487 (524)
T ss_pred             ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecccc--cCC--CchH
Confidence            2111  11122334455 3666653  5788999999999999999987654332221   12222211  111  1345


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      .++..+.+.++..|+..|+.+.++..+.-|.
T Consensus       488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            7899999999999999999999998776554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=7.7e-13  Score=112.22  Aligned_cols=136  Identities=24%  Similarity=0.278  Sum_probs=98.9

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeec-----ccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISK-----AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      ..+++|+-+.+|.+.+.     |..+++|.=..     .........++..+|.+++.++. --.|..-+-++.+.+...
T Consensus         2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence            35789999999988653     33466665322     22222333456778999999987 445555555556666778


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+|||++|..|.+.+...        ...++..+-.-+.-||..||+|+||.++||++.    ++.+.++||||+.+..
T Consensus        76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s~  142 (204)
T COG3642          76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFSD  142 (204)
T ss_pred             EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccccc
Confidence            999999987777776443        255677777778889999999999999999995    5559999999997543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=3.7e-12  Score=126.61  Aligned_cols=162  Identities=20%  Similarity=0.298  Sum_probs=123.3

Q ss_pred             cCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHH
Q 014559          174 KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED  253 (422)
Q Consensus       174 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~  253 (422)
                      ++.+|.|..++....   ...+.+.+-++-|+.|+ ||||+++++.++..+.+|||+|-+.  .|..++.+    +....
T Consensus        36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~  105 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEE  105 (690)
T ss_pred             cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHH
Confidence            677888888865432   23456778889999998 9999999999999999999999985  55666644    34777


Q ss_pred             HHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC-ccccccCCcccCccccCccCC
Q 014559          254 AKAIVVQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLHRSYS  331 (422)
Q Consensus       254 ~~~i~~ql~~aL~~LH-~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~  331 (422)
                      +...+.||+.||.||| +.+++|++|.-+.|+|+   ..|..||++|.++........ .....--..|..|+.+... +
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence            8888999999999998 56899999999999995   599999999998765432221 1111222235566554321 1


Q ss_pred             CchhHHHHHHHHHHHHhC
Q 014559          332 LEADIWSIGVISYILLCG  349 (422)
Q Consensus       332 ~~~DvwSlG~il~ell~g  349 (422)
                      ...|.|-|||+++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            446999999999999999

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.33  E-value=6.5e-11  Score=114.40  Aligned_cols=212  Identities=17%  Similarity=0.240  Sum_probs=154.2

Q ss_pred             eEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----CCeEEEEEEccCC-
Q 014559          161 GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VNNVYIVMELCEG-  235 (422)
Q Consensus       161 g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~-  235 (422)
                      .+.|++....   +|..|++|++.-.+....   .....-+++++++. |.|||.|.++|..    +..+++|++|.++ 
T Consensus       290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  290 ITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            4789998876   899999999943332221   22334578899997 9999999998873    3569999999876 


Q ss_pred             CChHHHHHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          236 GELLDRILA--------------RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       236 g~L~~~l~~--------------~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      ++|.+....              .+...+++.+|.++.||..||.++|+.|+.-+-|.+.+||++.   +.+++|.-+|.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G---~~RIriS~C~i  439 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG---KMRIRISGCGI  439 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC---cceEEEecccc
Confidence            477765432              1234788999999999999999999999999999999999953   44788888887


Q ss_pred             ccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHcCCCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ...+..+..             |.+.+  -.+-|.=-||.+++.|.||..--+..+.  +..+..|.           ..
T Consensus       440 ~Dvl~~d~~-------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~  493 (655)
T KOG3741|consen  440 MDVLQEDPT-------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TT  493 (655)
T ss_pred             eeeecCCCC-------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hh
Confidence            766544330             11110  1234888999999999999654322211  11122221           25


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.+++++|.-+...++++ -++.+++.+.
T Consensus       494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  494 YSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             hhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            8899999999999999887 7888888764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=3.1e-11  Score=109.12  Aligned_cols=143  Identities=25%  Similarity=0.412  Sum_probs=103.0

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEeEEEeC---CeEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDV---NNVYI  228 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~---~~~~l  228 (422)
                      +.||.|.++.||++...    +|+.++||+.......  .....+.+|+.+++.+..+ -++.+++.+....   +..++
T Consensus         4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             eecCCCccceEEEEEec----CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence            56899999999999864    3568999997654321  1235688999999999732 3467777777654   36789


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL--------------------------------------  270 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~--------------------------------------  270 (422)
                      ||||++|.++.+.+..  ..++......++.+++++|..||+                                      
T Consensus        78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            9999998877654321  246666666677777777777763                                      


Q ss_pred             ------------------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          271 ------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       271 ------------------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                                        ..++|+|+++.||+++.+ .++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                              236999999999999531 145689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=1.8e-10  Score=100.80  Aligned_cols=130  Identities=28%  Similarity=0.307  Sum_probs=83.0

Q ss_pred             EEEEEEeccCCccCceEEEEEeeccccc-----------------------chhcHHHHHHHHHHHHHhcCC-CCeeEEE
Q 014559          162 HTCSARGKKGELKDQQVAVKIISKAKMT-----------------------TAISIEDVRREVKILKALSGH-KHLVKFC  217 (422)
Q Consensus       162 ~V~~a~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~~h-~niv~l~  217 (422)
                      .||.|...    +|..+|||+.+.....                       ........++|.+.|.++... -++.+.+
T Consensus         1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~   76 (188)
T PF01163_consen    1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY   76 (188)
T ss_dssp             EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred             CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence            48888865    5678999998742110                       001123567899999999733 2577777


Q ss_pred             eEEEeCCeEEEEEEccC--CCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          218 DACEDVNNVYIVMELCE--GGELLDRILARGGRYTEEDAKAIVVQILSVVAF-CHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~-LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      ++.    .-+|||||++  |..+.. +...  .++.+....++.+++..+.. +|..||+|+||.+.|||+.    ++.+
T Consensus        77 ~~~----~~~ivME~I~~~G~~~~~-l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~  145 (188)
T PF01163_consen   77 DYN----RNVIVMEYIGEDGVPLPR-LKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKV  145 (188)
T ss_dssp             EEE----TTEEEEE--EETTEEGGC-HHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCE
T ss_pred             EEe----CCEEEEEecCCCccchhh-HHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceE
Confidence            553    2369999998  544433 3332  22355667788888886555 6799999999999999996    4489


Q ss_pred             EEeecCcccccC
Q 014559          295 RLIDFGLSDFIR  306 (422)
Q Consensus       295 kl~DfG~a~~~~  306 (422)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=9.3e-10  Score=101.94  Aligned_cols=138  Identities=15%  Similarity=0.136  Sum_probs=95.9

Q ss_pred             eEEEEEEeccCCccCceEEEEEeecccccc--------hhcHHHHHHHHHHHHHhcCCCC--eeEEEeEEEe-----CCe
Q 014559          161 GHTCSARGKKGELKDQQVAVKIISKAKMTT--------AISIEDVRREVKILKALSGHKH--LVKFCDACED-----VNN  225 (422)
Q Consensus       161 g~V~~a~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~-----~~~  225 (422)
                      ..|+++..     .|+.|.||.........        ......+.+|...+.+|. .-+  ++..+.+++.     ...
T Consensus        36 rrvvr~~~-----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~  109 (268)
T PRK15123         36 RRTLRFEL-----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRT  109 (268)
T ss_pred             ceEEEEEE-----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccce
Confidence            34555432     56678999763322100        011124778999998885 333  3344555543     235


Q ss_pred             EEEEEEccCCC-ChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee----CCCCCCEEEeec
Q 014559          226 VYIVMELCEGG-ELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----GRDDADMRLIDF  299 (422)
Q Consensus       226 ~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~----~~~~~~vkl~Df  299 (422)
                      -+||||++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||+..    .+++..+.|+||
T Consensus       110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            78999999875 787776432 245677788899999999999999999999999999999963    123578999999


Q ss_pred             Ccccc
Q 014559          300 GLSDF  304 (422)
Q Consensus       300 G~a~~  304 (422)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98854

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=1.8e-11  Score=122.18  Aligned_cols=157  Identities=22%  Similarity=0.254  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCc-----c-----ccccCCcccCccccCc
Q 014559          260 QILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-----N-----DIVGSAYYVAPEVLHR  328 (422)
Q Consensus       260 ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~  328 (422)
                      +++.||.|+|.. ++||++|.|++|.++   ..+.+||+.|+++.........     .     -..-...|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344899999976 899999999999995   5899999999987554432111     1     1234567999999865


Q ss_pred             -cCCCchhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHcCCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 014559          329 -SYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQA  405 (422)
Q Consensus       329 -~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~el  405 (422)
                       .-+.++|+|||||++|-+. .|+.-|........+..... ....... .-.+++.|+++=|.++|..|...||++.++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-ccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence             5788999999999999998 55555544433222221111 1111111 113689999999999999999999999999


Q ss_pred             HhccCccchhhhhhh
Q 014559          406 LSKLVVPILSFKIVC  420 (422)
Q Consensus       406 L~~l~~~~l~~k~~~  420 (422)
                      +..+||..-..+.++
T Consensus       263 ~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  263 LSIPFFSDPGLKALR  277 (700)
T ss_pred             hcccccCCchhhhhh
Confidence            999999988777665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=1e-09  Score=103.85  Aligned_cols=243  Identities=17%  Similarity=0.193  Sum_probs=159.8

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeE------EEeC
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDV  223 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~------~~~~  223 (422)
                      ..++.||+|+-+.+|-.-.-.     . .+-|++.......      -.+.+..|...-+||-+-.-+.+      .-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~-----d-~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR-----D-QVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCCccccCCccceeeecchhh-----c-hhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            456789999999998654322     2 3447775532211      12233344444445544331111      1122


Q ss_pred             -CeEEEEEEccCCCChHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          224 -NNVYIVMELCEGGELLDRILA------RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       224 -~~~~lv~e~~~~g~L~~~l~~------~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                       ..+.+.|..+.|..=-..+..      ....+.+..+.+..+.|+.+...||+.|.+-+|+.++|+|++   +++.|.|
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~L  158 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVL  158 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEE
Confidence             237788888876422222211      123478889999999999999999999999999999999995   5888999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccC-c-----cCCCchhHHHHHHHHHHHHhC-CCCCCCCCh----hHHHH-H
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-R-----SYSLEADIWSIGVISYILLCG-SRPFWARTE----SGIFR-A  364 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DvwSlG~il~ell~g-~~pf~~~~~----~~~~~-~  364 (422)
                      .|-........+......+|...|.+||... +     .-+...|.|.||+++++++.| +.||.+-.-    ..-++ .
T Consensus       159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            9876554444455566678999999999754 2     246779999999999999887 999955211    11111 1


Q ss_pred             HHc------------CCCCCCCCCCCCCCHHHHHHHHHhchhc--cccCCCHHHHHh
Q 014559          365 VLR------------SDPNFDDLPWPSVSPEAKDFVKRLLNKD--YRKRMTAVQALS  407 (422)
Q Consensus       365 i~~------------~~~~~~~~~~~~~s~~~~~li~~~L~~d--P~~Rps~~elL~  407 (422)
                      |..            ..+....++|.-+++++..|+.+|+..-  +.-||+++.-+.
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a  295 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA  295 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence            111            1122234456678999999999999863  568999986654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=1.2e-09  Score=98.41  Aligned_cols=140  Identities=30%  Similarity=0.334  Sum_probs=104.6

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-------------------hhcHHHHHHHHHHHHHhcC
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-------------------AISIEDVRREVKILKALSG  209 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~~  209 (422)
                      +.++..||-|.-|.||.|.+.    .|..+|||.-+.....-                   ...+...++|.++|.+|..
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~  168 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP  168 (304)
T ss_pred             HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence            568889999999999999986    57889999876431100                   0112346789999999963


Q ss_pred             C-CCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          210 H-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       210 h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                      + -.|.+.+++    +...+|||+++|-.|...      +++.+....++..|++-+.-+-..||||+|+..-|||++  
T Consensus       169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~--  236 (304)
T COG0478         169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT--  236 (304)
T ss_pred             cCCCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe--
Confidence            3 367776664    456899999998655432      235666667777777777777799999999999999995  


Q ss_pred             CCCCCEEEeecCccccc
Q 014559          289 RDDADMRLIDFGLSDFI  305 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~  305 (422)
                       ++|.+.++||-.+...
T Consensus       237 -~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 -EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             -cCCCEEEEeCcccccC
Confidence             5889999999877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=1e-08  Score=91.72  Aligned_cols=142  Identities=18%  Similarity=0.203  Sum_probs=96.7

Q ss_pred             EEEEEeccCCccCceEEEEEeeccc----ccchhcHHHHHHHHHHHHHhcC-CCCeeEEEeEEEeC----CeEEEEEEcc
Q 014559          163 TCSARGKKGELKDQQVAVKIISKAK----MTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDV----NNVYIVMELC  233 (422)
Q Consensus       163 V~~a~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~----~~~~lv~e~~  233 (422)
                      ++.+........++.|-+|.....-    ...........+|...+..|.. .=.+.+.+.+.+..    ...+||+|++
T Consensus        20 ~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l   99 (206)
T PF06293_consen   20 GWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEAL   99 (206)
T ss_pred             EEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeC
Confidence            3444433323355666666543211    1111233567889988888862 12345566666553    2468999999


Q ss_pred             CCC-ChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          234 EGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       234 ~~g-~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++. +|.+.+.... .++......++.+++..+.-||++||+|+|+++.|||+..++....+.|+||+-++..
T Consensus       100 ~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  100 PGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            874 6777665432 3778888999999999999999999999999999999975333457999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.78  E-value=2.2e-07  Score=81.98  Aligned_cols=142  Identities=15%  Similarity=0.153  Sum_probs=99.6

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---hhcHHHHHHHHHHHHHhcCC-CCeeEEEeEEE-e----CCe
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGH-KHLVKFCDACE-D----VNN  225 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~-~----~~~  225 (422)
                      -|+||-+.|+....     .|+.+-||.-...-...   ......+.+|+..|.+|... -.+.+.. ++. .    .-.
T Consensus        26 ~~rgG~SgV~r~~~-----~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r   99 (216)
T PRK09902         26 YRRNGMSGVQCVER-----NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR   99 (216)
T ss_pred             cCCCCcceEEEEEe-----CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence            56789999988764     34468888764211111   23457789999999998721 1244444 332 1    124


Q ss_pred             EEEEEEccCC-CChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          226 VYIVMELCEG-GELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       226 ~~lv~e~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      -+||+|-+.+ .+|.+++.... .+.+......++.+++..|.-||+.|+.|+|+.+.|||+.. +.+..++++||.-++
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r  178 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccc
Confidence            7899998864 37777664432 35678888899999999999999999999999999999953 122349999998664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.75  E-value=4.1e-10  Score=111.52  Aligned_cols=247  Identities=17%  Similarity=0.214  Sum_probs=170.7

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~  226 (422)
                      -|.....+++|+++.+++.+...   +.. ...+.+...        ....-++++|.+++ ||| .+..++.+..+...
T Consensus       243 ws~~fh~fvK~altknpKkRpta---ekl-L~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTA---EKL-LQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCCh---hhh-eeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCccccc
Confidence            35666789999999999988764   222 335555322        33456889999997 999 77777777778889


Q ss_pred             EEEEEccCCC-ChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++|+++.++ +....+....-.+.+-++..+++.-+++|++||+.--+|+|    ||+..    ++..|..||+....+
T Consensus       310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQL  381 (829)
T ss_pred             chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCccc
Confidence            9999999887 22222211122355556677788888999999998778999    88885    678999999998877


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--CCCC-CCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNFD-DLPWPSVS  381 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~-~~~~~~~s  381 (422)
                      ......++..+++.++|||+.. +.+....|+|++|+--.++.-|-.|-....  .....+-...  +... +..|....
T Consensus       382 ~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~  459 (829)
T KOG0576|consen  382 TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVF  459 (829)
T ss_pred             CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCccc
Confidence            6665667788999999999875 578999999999987778877777643210  0000000000  0000 01121111


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhh
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~  419 (422)
                        -.++...|+...|..|+....++.+-+|+--..|+-
T Consensus       460 --~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~  495 (829)
T KOG0576|consen  460 --HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIH  495 (829)
T ss_pred             --ccCCcccccCCCCCCCcchhhHHHHHHhccCcccce
Confidence              125778899999999999999988877776555543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=7.1e-08  Score=96.79  Aligned_cols=147  Identities=19%  Similarity=0.258  Sum_probs=97.0

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---------------------------hhcH----H------
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---------------------------AISI----E------  195 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---------------------------~~~~----~------  195 (422)
                      +.|+.++-|+||+|+.+    +|+.||||+.+.+-...                           ....    +      
T Consensus       131 ~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         131 EPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             CchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            57899999999999987    58899999987431100                           0000    1      


Q ss_pred             HHHHHHHHHHHhc----CCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014559          196 DVRREVKILKALS----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ  271 (422)
Q Consensus       196 ~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~  271 (422)
                      ++.+|...+.+++    +.++|.--.=+++-.+.-.|+|||++|..+.+....+...++...+...+.++.  +.-+-..
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence            1345555555543    344444433344445567899999999888776543334566544444333322  2233358


Q ss_pred             CCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       272 ~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      |++|.|..|.||++.   .++.+.+.|||+...+.+.
T Consensus       285 gffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVR---SDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEe---cCCcEEEEcCcceecCCHH
Confidence            999999999999995   4799999999998776544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.73  E-value=3.5e-07  Score=81.01  Aligned_cols=141  Identities=19%  Similarity=0.226  Sum_probs=91.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcH------HHHHHHHHHHHHhc--CCCCeeEE
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI------EDVRREVKILKALS--GHKHLVKF  216 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~h~niv~l  216 (422)
                      ...+|++.+.+-......|.+..-     +|+.+++|..+..........      ....+++..+.++.  +.-.+..+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            345688888887777777766543     677899998765332221111      12334555555553  23333333


Q ss_pred             EeEEEe-----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          217 CDACED-----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       217 ~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      +-+.+-     ....+|||||++|..|.+..     .+++    .+...+..++.-||+.|++|+|..|.|+++.    +
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~  170 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----N  170 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----C
Confidence            333322     23467899999998776542     1333    2445677788999999999999999999996    5


Q ss_pred             CCEEEeecCccc
Q 014559          292 ADMRLIDFGLSD  303 (422)
Q Consensus       292 ~~vkl~DfG~a~  303 (422)
                      +.++++||+..+
T Consensus       171 ~~i~iID~~~k~  182 (229)
T PF06176_consen  171 NGIRIIDTQGKR  182 (229)
T ss_pred             CcEEEEECcccc
Confidence            569999998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.71  E-value=1.6e-07  Score=83.99  Aligned_cols=142  Identities=20%  Similarity=0.131  Sum_probs=94.9

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhc----------------HH-----HHHHHHHHHHHhcC-
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS----------------IE-----DVRREVKILKALSG-  209 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~----------------~~-----~~~~E~~~l~~l~~-  209 (422)
                      ...|..|.-+.||+|...    .+..+|||+++.........                ..     =..+|..-|+++.. 
T Consensus        53 ~g~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA  128 (268)
T COG1718          53 VGCISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA  128 (268)
T ss_pred             EeeecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc
Confidence            346778888899999864    57789999997543221110                01     13467777777752 


Q ss_pred             CCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeC
Q 014559          210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       210 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~  288 (422)
                      +=.+.+-+.+..    ..|||||+... -.-.-.-..-.+..++...+..++++.+.-|-. .++||+||..-|||+.  
T Consensus       129 GVrvP~Pi~~~~----nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--  201 (268)
T COG1718         129 GVRVPEPIAFRN----NVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--  201 (268)
T ss_pred             CCCCCCceeecC----CeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--
Confidence            234444455433    36999999442 111000112234455788888999999988776 8999999999999994  


Q ss_pred             CCCCCEEEeecCcccccC
Q 014559          289 RDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~  306 (422)
                        ++.+.|+|||.|....
T Consensus       202 --~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 --DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --CCeEEEEECccccccC
Confidence              7889999999986544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=1e-07  Score=80.65  Aligned_cols=131  Identities=24%  Similarity=0.339  Sum_probs=95.4

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      -+..+.||+|.+|.||++.+.     |..+|+|+-+.+.     ....++.|+++|..+.+-.--.++|.|..+    ++
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i   89 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FI   89 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence            356678999999999999874     4579999864432     346789999999999866666778887665    46


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC--CcEEEeeCCCCCCEEEeecCccccc
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP--ENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp--~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .|||++|-.|.+....    .+..+    +..+++.-.-|-..||-|..|.-  .||++.    ++.+.|+||..|.+.
T Consensus        90 ~me~i~G~~L~~~~~~----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k  156 (201)
T COG2112          90 RMEYIDGRPLGKLEIG----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhcCcchhhhhhc----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhc
Confidence            6999999787764321    13333    34445555557788999999874  466663    458999999998743

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.68  E-value=5.7e-07  Score=81.57  Aligned_cols=73  Identities=19%  Similarity=0.235  Sum_probs=55.0

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e  231 (422)
                      ..||+|..+.||+.       .+..+++|......     ....+.+|.++++.+....- +.+.+++..+.+..++|||
T Consensus         7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH-------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe-------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            47899999999973       23357888875322     23567899999999973332 5788888888888899999


Q ss_pred             ccCCCC
Q 014559          232 LCEGGE  237 (422)
Q Consensus       232 ~~~~g~  237 (422)
                      +++|.+
T Consensus        75 ~i~G~~   80 (226)
T TIGR02172        75 LIVGKR   80 (226)
T ss_pred             ecCCcc
Confidence            999853

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=2e-06  Score=78.06  Aligned_cols=141  Identities=18%  Similarity=0.256  Sum_probs=83.2

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeEEEe---CCeEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACED---VNNVY  227 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~---~~~~~  227 (422)
                      ++.|+.|..+.||++....     ..+++|+....     .....+.+|..+++.|..+. .+.+++.+...   ....+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-----~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-----GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-----SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred             CccCCCCCeeeEEEEEECC-----cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence            4678999999999998642     47999987543     23467889999999987442 35677765433   34589


Q ss_pred             EEEEccCCCChHH----------------HHH---Hh---CCCCCHHH---------HHHH------------HHHHHH-
Q 014559          228 IVMELCEGGELLD----------------RIL---AR---GGRYTEED---------AKAI------------VVQILS-  263 (422)
Q Consensus       228 lv~e~~~~g~L~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~ql~~-  263 (422)
                      ++|++++|..+..                .+.   ..   ...+....         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999877666                111   11   01111100         0000            111222 


Q ss_pred             HHHHHHH-------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          264 VVAFCHL-------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       264 aL~~LH~-------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+..+++       ..++|+|+.+.|||++  +.++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-EE
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceee--eccceeEEEecccceE
Confidence            2333332       3599999999999996  2466668999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.51  E-value=2.3e-06  Score=74.98  Aligned_cols=129  Identities=22%  Similarity=0.262  Sum_probs=90.9

Q ss_pred             cceEEeceeCcCCC-eEEEEEEeccCCccCceEEEEEeec---cc-------ccch--------hcHHHHHHHHHHHHHh
Q 014559          147 AKYELGKEVGRGHF-GHTCSARGKKGELKDQQVAVKIISK---AK-------MTTA--------ISIEDVRREVKILKAL  207 (422)
Q Consensus       147 ~~y~~~~~lG~G~~-g~V~~a~~~~~~~~~~~vavK~~~~---~~-------~~~~--------~~~~~~~~E~~~l~~l  207 (422)
                      ..++.++.||.|.- |.||+++.     .|+.||||++..   ..       ....        ....-|..|.+...+|
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL  111 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL  111 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence            46899999999999 99999986     567999999432   00       0000        1123477888888877


Q ss_pred             c--CCCCe--eEEEeEEEeC------------------CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 014559          208 S--GHKHL--VKFCDACEDV------------------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV  265 (422)
Q Consensus       208 ~--~h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL  265 (422)
                      +  ++.++  |+.+||..-.                  -...||.||+....          .+....    +.+|++-|
T Consensus       112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl  177 (207)
T PF13095_consen  112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDL  177 (207)
T ss_pred             HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHH
Confidence            6  24455  9999987422                  12467888876532          233333    45566677


Q ss_pred             HHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       266 ~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ..+|..||+-+|+++.|..=        -||+|||.+
T Consensus       178 ~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHHHHCCeeeccCccccccC--------CEEEecccC
Confidence            88999999999999999873        389999975

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.49  E-value=1.8e-06  Score=79.31  Aligned_cols=76  Identities=18%  Similarity=0.249  Sum_probs=55.1

Q ss_pred             eeCcCCC-eEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          154 EVGRGHF-GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       154 ~lG~G~~-g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      .|-.|.. ..||++...     +..+.||+.....      ...+.+|+++++.+.++--+.+++++....+..++|||+
T Consensus         5 ~~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   73 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-----NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA   73 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-----CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence            3445555 688988642     3468888875432      245678999999997665677888888777778999999


Q ss_pred             cCCCChHH
Q 014559          233 CEGGELLD  240 (422)
Q Consensus       233 ~~~g~L~~  240 (422)
                      ++|.++..
T Consensus        74 i~G~~l~~   81 (244)
T cd05150          74 VPGVPAAA   81 (244)
T ss_pred             eCCccHhH
Confidence            99876653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.45  E-value=2.1e-06  Score=92.58  Aligned_cols=83  Identities=24%  Similarity=0.347  Sum_probs=58.2

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCe--eEEEeEEEeC---CeE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL--VKFCDACEDV---NNV  226 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~---~~~  226 (422)
                      ++.|+.|.+..+|+.....+. ....+++|+.......  .....+.+|+++|+.|.+|.+|  .+++.++.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            467899999999998764321 1246788876443211  1235688999999999656654  7888887764   568


Q ss_pred             EEEEEccCCCC
Q 014559          227 YIVMELCEGGE  237 (422)
Q Consensus       227 ~lv~e~~~~g~  237 (422)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            99999998854

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.41  E-value=2e-06  Score=91.32  Aligned_cols=204  Identities=18%  Similarity=0.199  Sum_probs=141.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE----EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 014559          195 EDVRREVKILKALSGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL  270 (422)
Q Consensus       195 ~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~  270 (422)
                      ...+.|+..+..+. |+|++.++.|.......    .+..|+|...++...+. .-+.++....+.+..++++||.|+|+
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            44556777788887 99999999988765432    24457788777777654 44678999999999999999999999


Q ss_pred             CCCeecCCCCCcEEEeeCCCCCCEEEe--ecCcccccCCCCCccccccCCcccCccccCcc---CCCchhHHHHHHHHHH
Q 014559          271 QGVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS---YSLEADIWSIGVISYI  345 (422)
Q Consensus       271 ~~iiH~Dikp~NIll~~~~~~~~vkl~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DvwSlG~il~e  345 (422)
                      ..+.|.-+...-..-...+..+.+.+.  ||+.+.............-+..+.++|.....   .....|+|.+|..+..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            855554444332222222345566666  99888776655555555556678888876532   3445799999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       346 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +..|...-..   ......++..          ....+..+++.+|+.-|.++|+++.+++.++|...
T Consensus       385 ~~~~~~i~~~---~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  385 LSQGEDISEK---SAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhcCccccc---ccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            9887654211   1111111110          11126889999999999999999999999988764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.40  E-value=1.3e-05  Score=70.78  Aligned_cols=137  Identities=22%  Similarity=0.314  Sum_probs=95.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-------------cchhcHHHHHHHHHHHHHhc-----CCCCee
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-------------TTAISIEDVRREVKILKALS-----GHKHLV  214 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~niv  214 (422)
                      ..||+|+.=.||.--      ......||+......             .......+..+|+.....+.     .+.+|.
T Consensus         7 ~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             cccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            469999998888543      334578899876550             00112355677777776664     378999


Q ss_pred             EEEeEEEeCCeEEEEEEccCC------CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          215 KFCDACEDVNNVYIVMELCEG------GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       215 ~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                      +++|+.+++....+|+|.+..      -+|.+++..  +.++. .+.   ..+-+-..||-+++|+.+||+|.||++...
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence            999999999999999998643      266776632  34665 333   333444567889999999999999999875


Q ss_pred             CCCC-CEEEee-cCc
Q 014559          289 RDDA-DMRLID-FGL  301 (422)
Q Consensus       289 ~~~~-~vkl~D-fG~  301 (422)
                      ++.. .+.|+| ||-
T Consensus       155 ~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGE  169 (199)
T ss_pred             CCCceEEEEEeCCCC
Confidence            5444 688888 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=3.4e-06  Score=84.60  Aligned_cols=148  Identities=19%  Similarity=0.206  Sum_probs=92.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-h---------------------------cHHH------HH
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-I---------------------------SIED------VR  198 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-~---------------------------~~~~------~~  198 (422)
                      +.||.-+.|+|++|+.+    +|+.||||+-+..-...- .                           ..+.      +.
T Consensus       167 ~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~  242 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT  242 (538)
T ss_pred             chhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence            57999999999999987    588999999764211000 0                           0011      22


Q ss_pred             HHHHHHHHhc---CCCC------eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 014559          199 REVKILKALS---GHKH------LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH  269 (422)
Q Consensus       199 ~E~~~l~~l~---~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH  269 (422)
                      +|.+-.++++   .|-+      |.++|-.+  ...-.|+||||+|..+.|.-.-....++...+...+.+...-  -+=
T Consensus       243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf  318 (538)
T KOG1235|consen  243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIF  318 (538)
T ss_pred             HHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHH
Confidence            3443333322   1333      33443332  235679999999987665443333457777554444433222  233


Q ss_pred             HCCCeecCCCCCcEEEeeC-CCCCCEEEeecCcccccCCC
Q 014559          270 LQGVVHRDLKPENFLFTSG-RDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       270 ~~~iiH~Dikp~NIll~~~-~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ..|++|+|=.|.||++..+ +.++.+.+.|||+.......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            5689999999999999742 24778999999998766543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.15  E-value=1.6e-06  Score=80.25  Aligned_cols=138  Identities=20%  Similarity=0.270  Sum_probs=97.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhc-------------------HHHHHHHHHHHHHhc
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-------------------IEDVRREVKILKALS  208 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~  208 (422)
                      -+.+++.||-|.-+.||.+-+.    .|+..++|+-+.....-...                   +-...+|...|+.|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~  168 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY  168 (465)
T ss_pred             hhhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence            3678999999999999999876    57789999865432111100                   112457999999987


Q ss_pred             CCCC-eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          209 GHKH-LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       209 ~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      .|.. |.+.++    .+..++|||++.|-.|.....       ...+..+...+..-+.-|-.+|+||+|..--||++. 
T Consensus       169 e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~-  236 (465)
T KOG2268|consen  169 ERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK-  236 (465)
T ss_pred             HcCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe-
Confidence            5433 344444    355689999999877655321       122334445555566778899999999999999994 


Q ss_pred             CCCCCCEEEeecCccc
Q 014559          288 GRDDADMRLIDFGLSD  303 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~  303 (422)
                        +++.++++||-.+-
T Consensus       237 --dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 --DDDKIVVIDFPQMV  250 (465)
T ss_pred             --cCCCEEEeechHhh
Confidence              58889999998653

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.09  E-value=0.00011  Score=71.93  Aligned_cols=81  Identities=19%  Similarity=0.178  Sum_probs=56.1

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc----cchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeCCe
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM----TTAISIEDVRREVKILKALSGH--KHLVKFCDACEDVNN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~  225 (422)
                      .+.||.|.+..||++.+..   .++.|+||.-.....    ......++...|.+.|+.+..+  .++++++.+..  +.
T Consensus        31 ~~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--EL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CC
Confidence            3579999999999999763   225799998531110    1123456778888888887533  46788887743  55


Q ss_pred             EEEEEEccCCCC
Q 014559          226 VYIVMELCEGGE  237 (422)
Q Consensus       226 ~~lv~e~~~~g~  237 (422)
                      .++||||+++..
T Consensus       106 ~~lVME~L~~~~  117 (401)
T PRK09550        106 AVTVMEDLSDHK  117 (401)
T ss_pred             CEEEEecCCCcc
Confidence            789999997644

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.03  E-value=3.1e-05  Score=70.77  Aligned_cols=73  Identities=22%  Similarity=0.178  Sum_probs=46.4

Q ss_pred             ceeCcCCCe-EEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeC---CeE
Q 014559          153 KEVGRGHFG-HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDV---NNV  226 (422)
Q Consensus       153 ~~lG~G~~g-~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~---~~~  226 (422)
                      +.|+.|+.. .||+..        ..+++|+.....     ....+.+|.+++..|.++  --+.++++.....   +..
T Consensus         3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRLG--------DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEcC--------CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            467777776 488652        137778754311     235788999999998643  1345555544332   245


Q ss_pred             EEEEEccCCCCh
Q 014559          227 YIVMELCEGGEL  238 (422)
Q Consensus       227 ~lv~e~~~~g~L  238 (422)
                      |+||++++|.++
T Consensus        70 ~~l~~~i~G~~l   81 (235)
T cd05155          70 WSVYRWLEGETA   81 (235)
T ss_pred             eEEEEeecCCCC
Confidence            899999998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.00  E-value=2.7e-05  Score=68.42  Aligned_cols=100  Identities=24%  Similarity=0.318  Sum_probs=79.7

Q ss_pred             HHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 014559          198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI--LARGGRYTEEDAKAIVVQILSVVAFCHL---QG  272 (422)
Q Consensus       198 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~l~~~~~~~i~~ql~~aL~~LH~---~~  272 (422)
                      ..|.-+++.+.+.+++++++|+|-.    ++|.||...++++...  ...-...++..+.+|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            3588899999866899999999954    5789999876664210  0111246899999999999999999997   35


Q ss_pred             CeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       273 iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +.-.|++++|+-++   +++.+|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEe---CCCcEEEEechhcch
Confidence            88999999999996   478899999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.98  E-value=0.00011  Score=66.91  Aligned_cols=76  Identities=24%  Similarity=0.303  Sum_probs=49.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.|..|-...+|++....+  .++.|++|+...... .   .-...+|+.+++.+..+...++++..+..    .+||||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~~-~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKTE-L---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCcc-c---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEe
Confidence            4677788889998865321  145789997653211 1   12335799999999755556667655432    389999


Q ss_pred             cCCCCh
Q 014559          233 CEGGEL  238 (422)
Q Consensus       233 ~~~g~L  238 (422)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.86  E-value=0.00011  Score=69.47  Aligned_cols=145  Identities=18%  Similarity=0.172  Sum_probs=97.7

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-------------------hhcHHH----HHHHHHHHH
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-------------------AISIED----VRREVKILK  205 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~----~~~E~~~l~  205 (422)
                      -.+...|..|.-+.||.|...    +|..+|||+++-+-+.-                   .+.+..    .+.|++-|+
T Consensus       146 ~~inGCiSTGKEANVYHat~~----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk  221 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEE----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK  221 (520)
T ss_pred             eecccccccCccceeEeeecC----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence            355667888999999999865    67779999986432111                   011111    357888888


Q ss_pred             HhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEE
Q 014559          206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH-LQGVVHRDLKPENFL  284 (422)
Q Consensus       206 ~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~Dikp~NIl  284 (422)
                      +|+ ...|.----...  ....|||+|+.. +=+-.-.-+...++...+..+-.|++.-+.-|. ..++||.||.--|+|
T Consensus       222 Rl~-~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  222 RLN-NAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL  297 (520)
T ss_pred             HHH-hcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence            886 333221111111  124699999953 323222224456888888888888888887765 569999999999999


Q ss_pred             EeeCCCCCCEEEeecCccccc
Q 014559          285 FTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       285 l~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +.    +|.+.|+|.+.+...
T Consensus       298 yh----dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  298 YH----DGKLYIIDVSQSVEH  314 (520)
T ss_pred             EE----CCEEEEEEccccccC
Confidence            95    899999999877543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00017  Score=66.76  Aligned_cols=134  Identities=19%  Similarity=0.180  Sum_probs=76.2

Q ss_pred             eCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccC
Q 014559          155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE  234 (422)
Q Consensus       155 lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  234 (422)
                      +..|-.+.+|+...     ++..+++|+.......-  . -...+|..+++.+..+.-..+++..+.    -++||||++
T Consensus         4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~~--~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVCKAL--G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEe-----CCccEEEeeCCcccccc--c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence            45577778888762     45678888764321111  0 124779999999975433455555432    268999998


Q ss_pred             CCChHH----------HHH-------Hh---CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCeec
Q 014559          235 GGELLD----------RIL-------AR---GGRYTE-EDAKAIVVQI---------LSVVAFCHL--------QGVVHR  276 (422)
Q Consensus       235 ~g~L~~----------~l~-------~~---~~~l~~-~~~~~i~~ql---------~~aL~~LH~--------~~iiH~  276 (422)
                      |..+..          .+.       ..   ...++. ..+..+..++         ...+..+-.        ..++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            865421          111       10   111221 1222222222         111222222        248999


Q ss_pred             CCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          277 DLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       277 Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      |+.+.||+++.   ++ +.|+||..+..
T Consensus       152 Dl~~~Nil~~~---~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTP---QG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeC---CC-CEEEeccccCc
Confidence            99999999963   33 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.76  E-value=0.00039  Score=66.24  Aligned_cols=142  Identities=17%  Similarity=0.178  Sum_probs=81.9

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeE------EEe
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDA------CED  222 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~------~~~  222 (422)
                      ..++.++.|....+|++...     +..+++|+.....     ..+.+..|++++..|.++- .+.+++..      ...
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~-----~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~   94 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD-----VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL   94 (307)
T ss_pred             eeccccCCccccceEEEEeC-----CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence            34566777877899988642     2357889864321     1245667888888885221 24454442      123


Q ss_pred             CCeEEEEEEccCCCChH----H----------HHHHhCCCC--------CHHH---H--H----------HHHHHHHHHH
Q 014559          223 VNNVYIVMELCEGGELL----D----------RILARGGRY--------TEED---A--K----------AIVVQILSVV  265 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~----~----------~l~~~~~~l--------~~~~---~--~----------~i~~ql~~aL  265 (422)
                      .+..+++|||++|..+.    +          .++.....+        ....   .  .          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            46789999999885431    1          111111111        0000   0  0          0011233445


Q ss_pred             HHHHH-------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          266 AFCHL-------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       266 ~~LH~-------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +++..       .+++|+|+.+.||+++.   ++.+.|+||+.+..
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~---~~~~~vIDfd~~~~  217 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDG---DSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEEC---CceEEEeecccccC
Confidence            55542       57999999999999963   45568999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.75  E-value=0.00035  Score=66.13  Aligned_cols=139  Identities=17%  Similarity=0.178  Sum_probs=82.4

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeE------EEeCC
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDA------CEDVN  224 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~------~~~~~  224 (422)
                      .+.|..|....+|+....     +..+++|+...      ...+.+..|+.++..|..+. .+.+++..      ....+
T Consensus        19 i~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeC-----CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            456777877889988643     34689998753      12356778999998886332 24555432      23345


Q ss_pred             eEEEEEEccCCCChHH--------------HHHHhCCCCC--------HHHHH------------HHHHHHHHHHHHHHH
Q 014559          225 NVYIVMELCEGGELLD--------------RILARGGRYT--------EEDAK------------AIVVQILSVVAFCHL  270 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~--------------~l~~~~~~l~--------~~~~~------------~i~~ql~~aL~~LH~  270 (422)
                      ..++|++|++|..+..              .++.....+.        .....            .....+..++.++.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999998865421              1111000000        00000            011122334445443


Q ss_pred             -------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          271 -------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       271 -------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                             .+++|+|+.+.|||++   +++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence                   3799999999999995   345568999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.69  E-value=4.9e-06  Score=90.33  Aligned_cols=207  Identities=15%  Similarity=0.066  Sum_probs=139.0

Q ss_pred             HHHHHHHHHHhcCCCCeeEEEeEEEe--CCeEEEEEEccCCCChHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHC
Q 014559          197 VRREVKILKALSGHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGR---YTEEDAKAIVVQILSVVAFCHLQ  271 (422)
Q Consensus       197 ~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~---l~~~~~~~i~~ql~~aL~~LH~~  271 (422)
                      +..|.+.++.+. |+++...+.-...  ....|.+++||.+|.+.+.+.+....   +++.-+...-.+.+.+..-+|+.
T Consensus      1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            344555555565 9988887765543  34578999999999999988764322   33333444444447777777754


Q ss_pred             -----CCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHH
Q 014559          272 -----GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISY  344 (422)
Q Consensus       272 -----~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~  344 (422)
                           -.+|+++|+-|.+|..   +.++|++++|+.+...+. .......+++.|+.+++.+. .++.++|+|..|+.+|
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVt---ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVT---NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             ccCCccchhhhhhhhccceec---CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence                 2789999999999954   788999999999843332 33445678889999998775 6888899999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHcCCCC---CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          345 ILLCGSRPFWARTESGIFRAVLRSDPN---FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       345 ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +...|..+|..     ..+.++++...   +.... .-.+.++......+|-+.-..||.-...+....+.+
T Consensus      1432 ~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe-~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIF-----FLQPALKGIIDNHTFFSIE-KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHhcccHHHHH-----HHHHHHcCccccccccccc-ccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            99988888732     22222222211   11110 013445555666666666788998888877655544

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.66  E-value=0.00049  Score=65.33  Aligned_cols=79  Identities=13%  Similarity=0.112  Sum_probs=49.7

Q ss_pred             ceeCcCCCeEEEEEEeccC---CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKG---ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  229 (422)
                      +.|..|--..||++....+   ...++.|++|+......    ......+|.++++.+..+.-..++++++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            3455566668888865321   11357899999754321    123457899999998754445566666542    368


Q ss_pred             EEccCCCChH
Q 014559          230 MELCEGGELL  239 (422)
Q Consensus       230 ~e~~~~g~L~  239 (422)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.66  E-value=0.00016  Score=71.24  Aligned_cols=163  Identities=20%  Similarity=0.220  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEEEeEEEeC-CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014559          195 EDVRREVKILKALSGHKHLVKFCDACEDV-NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV  273 (422)
Q Consensus       195 ~~~~~E~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~i  273 (422)
                      ..+.....+++.+. |+|...++++.... ....+|||++. .+|++.+..+.  +-.....              .+++
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s~~--------------~~~~   88 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDESLL--------------AHGV   88 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhhhc--------------cccc
Confidence            44566778899997 99999999887654 45889999995 59888775543  2111111              2222


Q ss_pred             eecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCC
Q 014559          274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       274 iH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf  353 (422)
                      .|     .||          ++++| -++...      ...               ..+|+||||+|.++.|+..|...+
T Consensus        89 ~~-----~~~----------~~~td-~~~t~~------~~~---------------~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   89 LH-----LNI----------IYITD-HFLTKY------PSP---------------IGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             ce-----ehh----------hhccc-cccccC------CCC---------------CCcchhhhhHHHHHHHHHHhhHHH
Confidence            22     222          33333 111100      111               124899999999999999999888


Q ss_pred             CCCChhHHHHHHHcCCCCCCCCC--------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          354 WARTESGIFRAVLRSDPNFDDLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       354 ~~~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ......+.+..+.+-........        ...++..+.++..+|+-..|..||...++.++..|.
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence            77777666666654332211110        113567789999999999999999888888776543

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0015  Score=62.63  Aligned_cols=75  Identities=11%  Similarity=0.079  Sum_probs=45.7

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEe------EEEeCC
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCD------ACEDVN  224 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~------~~~~~~  224 (422)
                      .+.|+.|....+|+.....     ..+++|++..   .   ..+.+..|+.+++.|..+ -.+.+.+.      +....+
T Consensus        27 ~~~l~~G~~n~~y~v~t~~-----g~~vLK~~~~---~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g   95 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQ-----GEYVLTLFER---L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAG   95 (319)
T ss_pred             cchhccccccceEEEEeCC-----CcEEEEEecc---C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCC
Confidence            3456677777899887532     2589998741   1   124455677777777522 12334332      223356


Q ss_pred             eEEEEEEccCCCC
Q 014559          225 NVYIVMELCEGGE  237 (422)
Q Consensus       225 ~~~lv~e~~~~g~  237 (422)
                      ..++++||++|..
T Consensus        96 ~~~~l~~~l~G~~  108 (319)
T PRK05231         96 KPAAIVTFLEGKW  108 (319)
T ss_pred             EEEEEEEecCCCC
Confidence            7899999998864

>PLN02236 choline kinase

Probab=97.41  E-value=0.0024  Score=61.75  Aligned_cols=142  Identities=13%  Similarity=0.184  Sum_probs=82.5

Q ss_pred             ceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      +.|-.|-.-.+|++....+. ..++.|++|+.....   ....+ -.+|..+++.+.++.--.++++.+.. +   .|+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence            34544777789988643211 134689999875432   11222 26799999999865555677776643 2   5899


Q ss_pred             ccCCCChHHH----------H-------HHhC---CC-C-CHHHHHHHHHHH-----------------HHHHHHH----
Q 014559          232 LCEGGELLDR----------I-------LARG---GR-Y-TEEDAKAIVVQI-----------------LSVVAFC----  268 (422)
Q Consensus       232 ~~~~g~L~~~----------l-------~~~~---~~-l-~~~~~~~i~~ql-----------------~~aL~~L----  268 (422)
                      |+++.+|...          +       +...   .. . -.+.+..++.++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987665311          1       0100   00 1 123333333221                 1112222    


Q ss_pred             H----HCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          269 H----LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       269 H----~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .    ...++|+|+++.|||++  ++++.+.|+||..+..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence            1    22589999999999996  2346799999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.37  E-value=0.0055  Score=58.36  Aligned_cols=30  Identities=30%  Similarity=0.598  Sum_probs=25.1

Q ss_pred             CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       271 ~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++|+|+.+.||+++    ++.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~----~~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK----DNEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEe----CCcEEEEECccccc
Confidence            4789999999999995    25689999997743

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.33  E-value=0.0033  Score=60.39  Aligned_cols=78  Identities=19%  Similarity=0.184  Sum_probs=51.3

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecc----cccchhcHHHHHHHHHHHHHhcCC-C-CeeEEEeEEEeCCeEE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKA----KMTTAISIEDVRREVKILKALSGH-K-HLVKFCDACEDVNNVY  227 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~  227 (422)
                      .||-|....||++.+..   .++.|+||.-..-    ........++...|...|+..... | .+.++|.+  +.....
T Consensus         2 EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~   76 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAV   76 (370)
T ss_pred             cCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccce
Confidence            58999999999999643   2357999985421    112234556777888888876532 2 46666554  334556


Q ss_pred             EEEEccCCC
Q 014559          228 IVMELCEGG  236 (422)
Q Consensus       228 lv~e~~~~g  236 (422)
                      +|||+++..
T Consensus        77 ~vMEdL~~~   85 (370)
T TIGR01767        77 TVMEDLSHH   85 (370)
T ss_pred             ehHhhCccc
Confidence            999998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.31  E-value=0.0036  Score=60.21  Aligned_cols=142  Identities=15%  Similarity=0.163  Sum_probs=79.8

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      +.|..|=-..+|++.......++..|++|+......   .. -.-.+|..+++.+..+.--.++++++. ++   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence            344436666788886543211234789998754321   11 123579999999985544467776663 33   58999


Q ss_pred             cCCCChHH----------HHHH-----hCCC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q 014559          233 CEGGELLD----------RILA-----RGGR------Y-TEEDAKAIVVQI----------------------LSVVAFC  268 (422)
Q Consensus       233 ~~~g~L~~----------~l~~-----~~~~------l-~~~~~~~i~~ql----------------------~~aL~~L  268 (422)
                      ++|.+|..          .+..     +...      + -...+..++.++                      ..-+..+
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            97765421          1110     0101      1 122333333222                      1112222


Q ss_pred             H----HC----CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          269 H----LQ----GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       269 H----~~----~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .    ..    -++|.|+.+.|||++  ++++.++++||..|..
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag~  213 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence            1    11    279999999999996  2356899999998864

>PRK10593 hypothetical protein; Provisional

Probab=97.21  E-value=0.0034  Score=59.50  Aligned_cols=105  Identities=10%  Similarity=-0.001  Sum_probs=69.8

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeC---C
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDV---N  224 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~---~  224 (422)
                      .-.+.||.|..+.||......    + .+.+|..+. ..    ....+.+|...|+.|.++  -.+.++++++.+.   +
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~----~-~~~~k~~~~-~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g   86 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ----G-NPMPLMARS-FS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG   86 (297)
T ss_pred             heeeecCCccceeEEEEEcCC----C-CEEEEEecc-cc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence            345679999999999986532    2 467777432 10    125788999999999754  3688899887653   6


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL  270 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~  270 (422)
                      ..+||||+++|+++.+.      ..+......+..+++++|.-||+
T Consensus        87 ~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         87 PDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             CeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhC
Confidence            68999999998766431      12233344445555566665664

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.13  E-value=0.0073  Score=59.12  Aligned_cols=77  Identities=17%  Similarity=0.124  Sum_probs=52.1

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc----cchhcHHHHHHHHHHHHHhcC--CCCeeEEEeEEEeCCe
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM----TTAISIEDVRREVKILKALSG--HKHLVKFCDACEDVNN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~  225 (422)
                      .+.||-|....||+..+.     +..|+||.-.....    .......+...|.+.|+.+..  ..++.+++.++.+.  
T Consensus        37 ~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--
Confidence            567899999999998863     23588998652111    111234555667777776642  25788898888744  


Q ss_pred             EEEEEEccCC
Q 014559          226 VYIVMELCEG  235 (422)
Q Consensus       226 ~~lv~e~~~~  235 (422)
                      .++|||++++
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            5788999976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.09  E-value=0.005  Score=57.66  Aligned_cols=31  Identities=35%  Similarity=0.514  Sum_probs=24.6

Q ss_pred             CCeecCCCCCcEEEeeCCCCCC-EEEeecCccccc
Q 014559          272 GVVHRDLKPENFLFTSGRDDAD-MRLIDFGLSDFI  305 (422)
Q Consensus       272 ~iiH~Dikp~NIll~~~~~~~~-vkl~DfG~a~~~  305 (422)
                      .++|+|+.+.|||++   +++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEe---CCCCEEEEECcHhcccC
Confidence            489999999999995   2244 469999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.87  E-value=0.012  Score=55.66  Aligned_cols=130  Identities=20%  Similarity=0.306  Sum_probs=73.4

Q ss_pred             CceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEeEEEeCC--eEEEEEEccCCCChH----------HH
Q 014559          175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVN--NVYIVMELCEGGELL----------DR  241 (422)
Q Consensus       175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~--~~~lv~e~~~~g~L~----------~~  241 (422)
                      ++.++|. ... ............+|..+++.+..- --+...++.|.+..  ..|.||+|++|..+.          .+
T Consensus        48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~  125 (321)
T COG3173          48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF  125 (321)
T ss_pred             CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence            5667777 221 112222346678899999998531 22334556665554  779999999883221          11


Q ss_pred             HH--------H--h----C----C---CCCHHHHHHHHHH--------------HHHHHHHHHHC--------CCeecCC
Q 014559          242 IL--------A--R----G----G---RYTEEDAKAIVVQ--------------ILSVVAFCHLQ--------GVVHRDL  278 (422)
Q Consensus       242 l~--------~--~----~----~---~l~~~~~~~i~~q--------------l~~aL~~LH~~--------~iiH~Di  278 (422)
                      ..        .  .    +    +   .+...++..+..+              ...-..||+.+        .++|+|+
T Consensus       126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~  205 (321)
T COG3173         126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY  205 (321)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence            11        0  0    0    0   0111122222221              22234555543        3799999


Q ss_pred             CCCcEEEeeCCCCCCEEEeecCcccccCCCC
Q 014559          279 KPENFLFTSGRDDADMRLIDFGLSDFIRPDE  309 (422)
Q Consensus       279 kp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  309 (422)
                      .+.||++..   .+.+-|.||+++..-.+..
T Consensus       206 ~~gNlii~~---~~~~gVlDwe~~~lGDP~~  233 (321)
T COG3173         206 RPGNLIIDP---GRPTGVLDWELATLGDPLE  233 (321)
T ss_pred             ccCCEEEeC---CCeeEEEeccccccCCcHH
Confidence            999999964   4458999999997655443

>KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton]

Probab=96.85  E-value=0.0055  Score=62.60  Aligned_cols=8  Identities=13%  Similarity=0.401  Sum_probs=3.7

Q ss_pred             ceEEEEEe
Q 014559          176 QQVAVKII  183 (422)
Q Consensus       176 ~~vavK~~  183 (422)
                      +.+++|++
T Consensus       689 k~kel~il  696 (1102)
T KOG1924|consen  689 KVKELRIL  696 (1102)
T ss_pred             hhhhheec
Confidence            34455554

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.70  E-value=0.029  Score=53.83  Aligned_cols=71  Identities=11%  Similarity=0.045  Sum_probs=43.5

Q ss_pred             CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEE---e--EEEeCCeEEEEEEc
Q 014559          159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFC---D--ACEDVNNVYIVMEL  232 (422)
Q Consensus       159 ~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~---~--~~~~~~~~~lv~e~  232 (422)
                      .-..||++...    ++..+++|+.+...    .....+..|++++..|..+. .++...   |  ....++..+.|+++
T Consensus        37 ~eN~vy~v~~~----~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~  108 (325)
T PRK11768         37 YENRVYQFGDE----DGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPR  108 (325)
T ss_pred             ccceEEEEecC----CCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEee
Confidence            34578888753    45679999875332    23466778888888886321 122211   1  22335678889999


Q ss_pred             cCCCC
Q 014559          233 CEGGE  237 (422)
Q Consensus       233 ~~~g~  237 (422)
                      ++|..
T Consensus       109 ~~G~~  113 (325)
T PRK11768        109 RGGRA  113 (325)
T ss_pred             eCCCC
Confidence            98753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.64  E-value=0.021  Score=55.62  Aligned_cols=79  Identities=20%  Similarity=0.140  Sum_probs=53.7

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecc---cccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeCCeE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA---KMTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDVNNV  226 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~  226 (422)
                      .+.||-|.-..||++.+..   .++.|+||.-..-   ........++...|.+.|+.+...  .+++++|.+-.  ...
T Consensus        34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~  108 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMN  108 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHh
Confidence            5689999999999998743   2457999875321   112244567788888988887532  35677766533  445


Q ss_pred             EEEEEccCC
Q 014559          227 YIVMELCEG  235 (422)
Q Consensus       227 ~lv~e~~~~  235 (422)
                      .+|||+++.
T Consensus       109 ~~vMEdL~~  117 (409)
T PRK12396        109 CCVMEDLSD  117 (409)
T ss_pred             hHHHHhCcc
Confidence            689999854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.57  E-value=0.024  Score=53.25  Aligned_cols=76  Identities=20%  Similarity=0.190  Sum_probs=48.8

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEeCCeEE
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~  227 (422)
                      +-.+.|+.|....+|+...     +++.+.||+-...      ....+..|..-|+.|.  .--.+.+.+++....+.-|
T Consensus        20 ~~~~~v~GG~i~~a~~~~~-----~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDT-----DGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             -EEEEE--SSSSEEEEEET-----TS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeEecCCCChhheEEEEC-----CCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            3456788888999998872     5678999986522      2256788999998884  2456889999988877789


Q ss_pred             EEEEccCCC
Q 014559          228 IVMELCEGG  236 (422)
Q Consensus       228 lv~e~~~~g  236 (422)
                      |||||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999775

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.51  E-value=0.024  Score=55.56  Aligned_cols=78  Identities=21%  Similarity=0.240  Sum_probs=47.2

Q ss_pred             ceeCcCCCeEEEEEEeccCC---ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGE---LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  229 (422)
                      +.|..|--..+|++....+.   ...+.|.+++...   ..... -.-.+|+.+++.|..+..-.++++.+..    ++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            45544777889988754321   0112244444311   11111 1235689999999866677778887753    599


Q ss_pred             EEccCCCCh
Q 014559          230 MELCEGGEL  238 (422)
Q Consensus       230 ~e~~~~g~L  238 (422)
                      .||++|.+|
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999998665

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.37  E-value=0.077  Score=50.53  Aligned_cols=30  Identities=27%  Similarity=0.495  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       272 ~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +++|+|+.+.|||++   .++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD---ETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEc---CCCCEEEEEhhhccc
Confidence            699999999999994   467899999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.33  E-value=0.018  Score=51.55  Aligned_cols=120  Identities=23%  Similarity=0.225  Sum_probs=60.7

Q ss_pred             CceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHH-------H---H--
Q 014559          175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-------R---I--  242 (422)
Q Consensus       175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-------~---l--  242 (422)
                      ++.|+||+.....    ...-.-.+|..+++.+..+..-.++++.+.+.    +|+||++|.+|..       .   +  
T Consensus         2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~   73 (211)
T PF01633_consen    2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAK   73 (211)
T ss_dssp             TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHH
Confidence            3568888876541    12234567999999998666667777766442    6779987655311       1   0  


Q ss_pred             -----HH--h--C-CCC-CHHHHHHH----------------------HHHHHHHHHHHHH--------CCCeecCCCCC
Q 014559          243 -----LA--R--G-GRY-TEEDAKAI----------------------VVQILSVVAFCHL--------QGVVHRDLKPE  281 (422)
Q Consensus       243 -----~~--~--~-~~l-~~~~~~~i----------------------~~ql~~aL~~LH~--------~~iiH~Dikp~  281 (422)
                           +.  .  . ... -...+..+                      +..+..-+..+.+        ..++|+||.+.
T Consensus        74 ~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~  153 (211)
T PF01633_consen   74 LLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPG  153 (211)
T ss_dssp             HHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGG
T ss_pred             HHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccc
Confidence                 00  1  0 000 11222222                      1112222222221        24899999999


Q ss_pred             cEEEeeCCCCCCEEEeecCcccc
Q 014559          282 NFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       282 NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      |||+.  +.++.++|+||..|..
T Consensus       154 Nil~~--~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  154 NILIN--NKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEET--SSSSCEEE--GTT-EE
T ss_pred             cEEec--cCCCeEEEecHHHHhh
Confidence            99992  3488999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.30  E-value=0.055  Score=51.02  Aligned_cols=79  Identities=19%  Similarity=0.159  Sum_probs=47.2

Q ss_pred             CcCCCeEEEEEEecc-----CCccCceEEEEEeecccccch--hcHHHHHHHHHHHHHhcC------------CCCeeEE
Q 014559          156 GRGHFGHTCSARGKK-----GELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSG------------HKHLVKF  216 (422)
Q Consensus       156 G~G~~g~V~~a~~~~-----~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~------------h~niv~l  216 (422)
                      |.|-.|.+|++....     +......++||..........  .....+.+|+.+.+.+-.            ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            567778888777643     122346788898762221111  123557888888776530            1235666


Q ss_pred             EeEEEeCCeEEEEEEccC
Q 014559          217 CDACEDVNNVYIVMELCE  234 (422)
Q Consensus       217 ~~~~~~~~~~~lv~e~~~  234 (422)
                      +....+.+..+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            666655557889998763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.25  E-value=0.027  Score=53.75  Aligned_cols=117  Identities=16%  Similarity=0.248  Sum_probs=74.1

Q ss_pred             CCCeeEEEeEE-EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEee
Q 014559          210 HKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTS  287 (422)
Q Consensus       210 h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~  287 (422)
                      -++..+.+-+- .+....|++|++- |+.+.- +    .....+++..++.+.+..+.-+..+ .+-|||+.-+||||+ 
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-  356 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-  356 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence            34444444333 2334678888875 545432 2    1246778888888888877777665 688999999999993 


Q ss_pred             CCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIG  340 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG  340 (422)
                         +|+|.|+||-+++.-..+..    +-....--|-.+.|.-+..-|||-+-
T Consensus       357 ---~GnvtLIDfklsRl~~~q~~----isy~rldhp~lF~G~dd~QFeIYrlM  402 (488)
T COG5072         357 ---EGNVTLIDFKLSRLSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRLM  402 (488)
T ss_pred             ---cCceEEEEeeeeecccCCce----eeccccCchhhhcCccceeeeHHHHH
Confidence               89999999999984333222    11122333444555445555666543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.92  E-value=0.046  Score=48.66  Aligned_cols=101  Identities=11%  Similarity=0.152  Sum_probs=67.0

Q ss_pred             eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHH
Q 014559          177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA  256 (422)
Q Consensus       177 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~  256 (422)
                      ...+|++......-  ....+.++.+++.++.   .|+++..-  +.-.+.+|+|+|-....          ..    ..
T Consensus        87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~----~N  145 (308)
T PF07387_consen   87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKI----------NF----SN  145 (308)
T ss_pred             hhhhhhccCCCccc--chhhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCccc----------ch----hH
Confidence            35667665433321  2245678899998875   68888732  34467899999953211          01    11


Q ss_pred             HHHHHHHHHHHHHHC--CCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          257 IVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       257 i~~ql~~aL~~LH~~--~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      ++..=+.+|.-+|+.  +.+|+|..|+||+-   |..|.+||.|=+.
T Consensus       146 ~i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~  189 (308)
T PF07387_consen  146 FITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhh
Confidence            222225677888943  69999999999999   5699999999764

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=95.61  E-value=0.19  Score=50.29  Aligned_cols=80  Identities=14%  Similarity=0.055  Sum_probs=48.0

Q ss_pred             EeceeCcCCCeEEEEEEeccCC-----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          151 LGKEVGRGHFGHTCSARGKKGE-----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      -++.|..|---.+|++....+.     ..++.|.+++.....   .... .-.+|..+++.+..+.--.++++.+. +  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence            3455655666688888754321     125689999875421   1111 23568888888874444446666653 2  


Q ss_pred             EEEEEEccCCCCh
Q 014559          226 VYIVMELCEGGEL  238 (422)
Q Consensus       226 ~~lv~e~~~~g~L  238 (422)
                       +.|.||++|.+|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             467899987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.55  E-value=0.14  Score=49.00  Aligned_cols=132  Identities=20%  Similarity=0.266  Sum_probs=75.4

Q ss_pred             CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-----eeEEEeEE--EeCC--eEEEE
Q 014559          159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-----LVKFCDAC--EDVN--NVYIV  229 (422)
Q Consensus       159 ~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-----iv~l~~~~--~~~~--~~~lv  229 (422)
                      .-..||+.....    | .++||+.... .    ....+.-|+..|..|..+.-     +..+-|-.  .-.+  ..+-|
T Consensus        37 ~eN~~f~~~~~~----g-~~iLki~~~~-~----~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          37 EENSNFRVQTED----G-RYILKIYRPG-W----TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             ccCceEEEEecC----C-CeEEEEecCC-C----CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            445788887643    3 3499998654 2    23667788888888874321     22222211  1123  78889


Q ss_pred             EEccCCCChHH---------------HHHH--hCC---------CCCHH----H---------HHHHHHHHHHHHHHHHH
Q 014559          230 MELCEGGELLD---------------RILA--RGG---------RYTEE----D---------AKAIVVQILSVVAFCHL  270 (422)
Q Consensus       230 ~e~~~~g~L~~---------------~l~~--~~~---------~l~~~----~---------~~~i~~ql~~aL~~LH~  270 (422)
                      ++|++|..+..               .++.  ++-         ...+.    .         -.....++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99998876651               1111  000         11111    0         01122334444444443


Q ss_pred             --------CC--CeecCCCCCcEEEeeCCCCC-CEEEeecCccc
Q 014559          271 --------QG--VVHRDLKPENFLFTSGRDDA-DMRLIDFGLSD  303 (422)
Q Consensus       271 --------~~--iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~  303 (422)
                              .+  +||+|+.+.||+++.   +. .+.++||+-++
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~---~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDD---DTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcC---CCCeeeEEEccccc
Confidence                    23  999999999999952   33 48899999875

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	422
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-50
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-49
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-49
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-49
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-49
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-49
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-49
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-49
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-48
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-48
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-48
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-48
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-47
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-47
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-46
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-46
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-45
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-45
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-45
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-44
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-43
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-42
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-41
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-41
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-41
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-40
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-40
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-40
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-40
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-40
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-40
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-39
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-39
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-39
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-39
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-39
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-39
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-39
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-39
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-39
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-39
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-39
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-39
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-39
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-39
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-39
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-39
3soa_A	444	Full-Length Human Camkii Length = 444		1e-38
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-38
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-38
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-38
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-38
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-38
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-37
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-37
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-37
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-36
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-36
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-36
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-35
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-35
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-35
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-35
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-34
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-34
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-34
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-34
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-34
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-34
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-34
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-34
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-34
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-34
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-34
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-34
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-34
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-34
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-33
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-33
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-33
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-33
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-33
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-33
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-33
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-33
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-33
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-32
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-32
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-32
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-31
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-31
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-31
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-31
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-31
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-31
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-31
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-31
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-31
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-31
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-31
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-31
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-31
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-31
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-31
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-31
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-30
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-30
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-30
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-30
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-30
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-30
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-30
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-29
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-29
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-29
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-29
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-29
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-29
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-29
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-29
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-29
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-29
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-29
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-29
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-29
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-29
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-29
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-29
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-29
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-29
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-28
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-28
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-28
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-28
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-28
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-28
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-28
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-28
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-28
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-28
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-28
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-28
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-28
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-28
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-28
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-28
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-28
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-28
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-28
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-28
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-28
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-28
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-28
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-28
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-28
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-28
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-28
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-28
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-28
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-28
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-28
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-28
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-28
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-28
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-27
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-27
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-26
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-26
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-26
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-26
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-26
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-25
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-25
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-25
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-25
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-25
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-25
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-25
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-25
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-25
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-25
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-25
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-25
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-24
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-24
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-24
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-24
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-24
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-24
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-24
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-24
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-24
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-24
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-24
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-24
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-24
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-24
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-24
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-24
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-24
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-24
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-24
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-24
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-24
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-24
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-24
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-24
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-24
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-24
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-24
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-24
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-24
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-24
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-24
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-24
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-24
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-24
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-24
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-24
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-24
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-24
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-23
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-23
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-23
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-23
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-23
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-23
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-23
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-23
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-23
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-23
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-23
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-23
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-23
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-22
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-22
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-22
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-22
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-22
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-22
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-22
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-21
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-21
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-21
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-21
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-21
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-21
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-21
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-21
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-21
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-21
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-21
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-21
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-21
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-21
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-21
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-21
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-21
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-21
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-21
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-21
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-21
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-21
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-21
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-21
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-21
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-21
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-21
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-21
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-21
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-21
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-21
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-21
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-21
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-21
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-21
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-21
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-21
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-21
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-21
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-21
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-21
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-21
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-21
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-21
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-21
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-21
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-20
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-20
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-20
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-20
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-20
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-20
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-20
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-20
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-19
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-19
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-19
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-19
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-19
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-19
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-19
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-19
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-19
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-19
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-19
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-19
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-19
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-19
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-19
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-19
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-19
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-19
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-19
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-19
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-19
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-19
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-19
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-19
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-19
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-19
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-19
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-19
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-18
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-18
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-18
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-18
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-18
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-18
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-18
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-18
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-18
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-18
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-18
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-18
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-18
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-18
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-18
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-18
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-18
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-17
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-17
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-17
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-17
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-17
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-17
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-17
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-17
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-17
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-17
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-17
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-17
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-17
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-17
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-17
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-17
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-17
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-17
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-17
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-17
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-17
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-17
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-17
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-17
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-15
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-14
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-12
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-11
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-10
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-10
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-10
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-09
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-08
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		7e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-07

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  194 bits (493), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 106/258 (41%), Positives = 156/258 (60%), Gaps = 6/258 (2%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+  K++G G +G     R K   +   + A+KII K  ++T+ S   +  EV +LK L 
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHV---ERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD 94
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H +++K  D  ED  N Y+VME  +GGEL D I+ R  ++ E DA  I+ Q+LS V + 
Sbjct: 95  -HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL 152
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
           H   +VHRDLKPEN L  S   DA ++++DFGLS      +++ + +G+AYY+APEVL +
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
            Y  + D+WSIGVI +ILL G  PF  +T+  I R V +    FD   W +VS  AKD +
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272
Query: 389 KRLLNKDYRKRMTAVQAL 406
           K++L  D ++R++A QAL
Sbjct: 273 KQMLQFDSQRRISAQQAL 290

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 155/266 (58%), Gaps = 6/266 (2%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           +   F  +Y +   +G+G FG     + +   +  Q+ AVK+I+KA          + RE
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNK-DTSTILRE 71
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V++LK L  H +++K  +  ED ++ YIV EL  GGEL D I+ R  R++E DA  I+ Q
Sbjct: 72  VELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           + S + + H   +VHRDLKPEN L  S   D D+++IDFGLS   + + ++ D +G+AYY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 321 VAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           +APEVL  +Y  + D+WS GVI YILL G+ PF+ + E  I + V      FD   W ++
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQAL 406
           S +AKD ++++L      R+TA Q L
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 155/266 (58%), Gaps = 6/266 (2%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           +   F  +Y +   +G+G FG     + +   +  Q+ AVK+I+KA          + RE
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNK-DTSTILRE 71
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V++LK L  H +++K  +  ED ++ YIV EL  GGEL D I+ R  R++E DA  I+ Q
Sbjct: 72  VELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           + S + + H   +VHRDLKPEN L  S   D D+++IDFGLS   + + ++ D +G+AYY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 321 VAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           +APEVL  +Y  + D+WS GVI YILL G+ PF+ + E  I + V      FD   W ++
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQAL 406
           S +AKD ++++L      R+TA Q L
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  193 bits (491), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 155/266 (58%), Gaps = 6/266 (2%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           +   F  +Y +   +G+G FG     + +   +  Q+ AVK+I+KA          + RE
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNK-DTSTILRE 71
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V++LK L  H +++K  +  ED ++ YIV EL  GGEL D I+ R  R++E DA  I+ Q
Sbjct: 72  VELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQ 129
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           + S + + H   +VHRDLKPEN L  S   D D+++IDFGLS   + + ++ D +G+AYY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 321 VAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           +APEVL  +Y  + D+WS GVI YILL G+ PF+ + E  I + V      FD   W ++
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQAL 406
           S +AKD ++++L      R+TA Q L
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 154/262 (58%), Gaps = 5/262 (1%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+  + +G+G FG     + K   +  Q+ AVK+ISK ++      E + REV++L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLL 103
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H +++K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+LS 
Sbjct: 104 KQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSG 161
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      +++ D +G+AYY+APE
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           VLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS  A
Sbjct: 222 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 281
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD ++++L      R++A  AL
Sbjct: 282 KDLIRKMLTYVPSMRISARDAL 303

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 154/262 (58%), Gaps = 5/262 (1%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+  + +G+G FG     + K   +  Q+ AVK+ISK ++      E + REV++L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLL 104
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H +++K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+LS 
Sbjct: 105 KQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSG 162
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      +++ D +G+AYY+APE
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           VLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS  A
Sbjct: 223 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 282
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD ++++L      R++A  AL
Sbjct: 283 KDLIRKMLTYVPSMRISARDAL 304

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 154/262 (58%), Gaps = 5/262 (1%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+  + +G+G FG     + K   +  Q+ AVK+ISK ++      E + REV++L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLL 86
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H +++K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+LS 
Sbjct: 87  KQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSG 144
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      +++ D +G+AYY+APE
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           VLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS  A
Sbjct: 205 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 264
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD ++++L      R++A  AL
Sbjct: 265 KDLIRKMLTYVPSMRISARDAL 286

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 154/262 (58%), Gaps = 5/262 (1%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+  + +G+G FG     + K   +  Q+ AVK+ISK ++      E + REV++L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H +++K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+LS 
Sbjct: 81  KQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSG 138
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      +++ D +G+AYY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           VLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS  A
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD ++++L      R++A  AL
Sbjct: 259 KDLIRKMLTYVPSMRISARDAL 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 105/267 (39%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           Y +    +Y+  K++G G +G     + K   L   + A+KII K+ +TT  +   +  E
Sbjct: 15  YFQGLSDRYQRVKKLGSGAYGEVLLCKDK---LTGAERAIKIIKKSSVTTTSNSGALLDE 71
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V +LK L  H +++K  +  ED  N Y+VME+  GGEL D I+ R  +++E DA  I+ Q
Sbjct: 72  VAVLKQLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQ 129
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           +LS   + H   +VHRDLKPEN L  S   DA ++++DFGLS       ++ + +G+AYY
Sbjct: 130 VLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYY 189
Query: 321 VAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           +APEVL + Y  + D+WS GVI YILLCG  PF  +T+  I + V +   +FD   W  V
Sbjct: 190 IAPEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 249
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALS 407
           S EAK  VK +L  +  KR++A +AL+
Sbjct: 250 SDEAKQLVKLMLTYEPSKRISAEEALN 276

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  189 bits (479), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 102/261 (39%), Positives = 153/261 (58%), Gaps = 14/261 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILK 205
           Y L   +GRG +G    A          Q   +I   AK      +EDV R   E++I+K
Sbjct: 11  YTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           +L  H ++++  +  ED  ++Y+VMELC GGEL +R++ +   + E DA  I+  +LS V
Sbjct: 62  SLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAV 119
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
           A+CH   V HRDLKPENFLF +   D+ ++LIDFGL+   +P + +   VG+ YYV+P+V
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           L   Y  E D WS GV+ Y+LLCG  PF A T+  +   +      F +  W +VSP+A+
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
             ++RLL K  ++R+T++QAL
Sbjct: 240 SLIRRLLTKSPKQRITSLQAL 260

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 102/261 (39%), Positives = 153/261 (58%), Gaps = 14/261 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILK 205
           Y L   +GRG +G    A          Q   +I   AK      +EDV R   E++I+K
Sbjct: 28  YTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 78
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           +L  H ++++  +  ED  ++Y+VMELC GGEL +R++ +   + E DA  I+  +LS V
Sbjct: 79  SLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAV 136
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
           A+CH   V HRDLKPENFLF +   D+ ++LIDFGL+   +P + +   VG+ YYV+P+V
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 196
Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           L   Y  E D WS GV+ Y+LLCG  PF A T+  +   +      F +  W +VSP+A+
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAE 256
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
             ++RLL K  ++R+T++QAL
Sbjct: 257 SLIRRLLTKSPKQRITSLQAL 277

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 155/272 (56%), Gaps = 15/272 (5%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--------- 196
           G  Y   +++G G +G     + K G     + A+K+I K++       +D         
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGH---SEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 197 -VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
            +  E+ +LK+L  H +++K  D  ED    Y+V E  EGGEL ++I+ R  ++ E DA 
Sbjct: 92  EIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAA 149
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            I+ QILS + + H   +VHRD+KPEN L  +     +++++DFGLS F   D +L D +
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 316 GSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           G+AYY+APEVL + Y+ + D+WS GVI YILLCG  PF  + +  I + V +    FD  
Sbjct: 210 GTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            W ++S EAK+ +K +L  DY KR TA +AL+
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 151/262 (57%), Gaps = 5/262 (1%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+  + +G+G FG     + K   +  Q+ AVK+ISK ++      E + REV++L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H ++ K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+LS 
Sbjct: 81  KQLD-HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSG 138
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      ++  D +G+AYY+APE
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           VLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS  A
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD +++ L      R++A  AL
Sbjct: 259 KDLIRKXLTYVPSXRISARDAL 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 155/260 (59%), Gaps = 5/260 (1%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K++G G +G     + K   L   + A+KII K+ +TT  +   +  EV +LK L
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDK---LTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H +++K  +  ED  N Y+VME+  GGEL D I+ R  +++E DA  I+ Q+LS   +
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQVLSGTTY 119
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
            H   +VHRDLKPEN L  S   DA ++++DFGLS       ++ + +G+AYY+APEVL 
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + Y  + D+WS GVI YILLCG  PF  +T+  I + V +   +FD   W  VS EAK  
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           VK +L  +  KR++A +AL+
Sbjct: 240 VKLMLTYEPSKRISAEEALN 259

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 151/259 (58%), Gaps = 10/259 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E  + +G G F     A  K  G+L     AVK I K  +    S   +  E+ +L+ +
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKL----FAVKCIPKKALKGKES--SIENEIAVLRKI 77
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H+++V   D  E  N++Y+VM+L  GGEL DRI+ +G  YTE+DA  ++ Q+L  V +
Sbjct: 78  K-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF-YTEKDASTLIRQVLDAVYY 135
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
            H  G+VHRDLKPEN L+ S  +++ + + DFGLS      + ++   G+  YVAPEVL 
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            + YS   D WSIGVI+YILLCG  PF+   +S +F  +L+++  FD   W  +S  AKD
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKD 255
Query: 387 FVKRLLNKDYRKRMTAVQA 405
           F++ L+ KD  KR T  QA
Sbjct: 256 FIRNLMEKDPNKRYTCEQA 274

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 148/260 (56%), Gaps = 8/260 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+    +G G F     A  K+ +   + VA+K I+K  +        +  E+ +L  + 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKKALEGKEG--SMENEIAVLHKIK 74
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V   D  E   ++Y++M+L  GGEL DRI+ +G  YTE DA  ++ Q+L  V + 
Sbjct: 75  -HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL 132
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H  G+VHRDLKPEN L+ S  +D+ + + DFGLS    P   L+   G+  YVAPEVL  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + YS   D WSIGVI+YILLCG  PF+   ++ +F  +L+++  FD   W  +S  AKDF
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++ L+ KD  KR T  QAL 
Sbjct: 253 IRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 148/260 (56%), Gaps = 8/260 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+    +G G F     A  K+ +   + VA+K I+K  +        +  E+ +L  + 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKEALEGKEG--SMENEIAVLHKIK 74
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V   D  E   ++Y++M+L  GGEL DRI+ +G  YTE DA  ++ Q+L  V + 
Sbjct: 75  -HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL 132
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H  G+VHRDLKPEN L+ S  +D+ + + DFGLS    P   L+   G+  YVAPEVL  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + YS   D WSIGVI+YILLCG  PF+   ++ +F  +L+++  FD   W  +S  AKDF
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++ L+ KD  KR T  QAL 
Sbjct: 253 IRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 148/260 (56%), Gaps = 8/260 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+    +G G F     A  K+ +   + VA+K I+K  +        +  E+ +L  + 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKEALEGKEG--SMENEIAVLHKIK 74
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V   D  E   ++Y++M+L  GGEL DRI+ +G  YTE DA  ++ Q+L  V + 
Sbjct: 75  -HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL 132
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H  G+VHRDLKPEN L+ S  +D+ + + DFGLS    P   L+   G+  YVAPEVL  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + YS   D WSIGVI+YILLCG  PF+   ++ +F  +L+++  FD   W  +S  AKDF
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++ L+ KD  KR T  QAL 
Sbjct: 253 IRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 148/260 (56%), Gaps = 8/260 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+    +G G F     A  K+ +   + VA+K I+K  +        +  E+ +L  + 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKEALEGKEG--SMENEIAVLHKIK 74
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++V   D  E   ++Y++M+L  GGEL DRI+ +G  YTE DA  ++ Q+L  V + 
Sbjct: 75  -HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL 132
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H  G+VHRDLKPEN L+ S  +D+ + + DFGLS    P   L+   G+  YVAPEVL  
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + YS   D WSIGVI+YILLCG  PF+   ++ +F  +L+++  FD   W  +S  AKDF
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++ L+ KD  KR T  QAL 
Sbjct: 253 IRHLMEKDPEKRFTCEQALQ 272

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 100/239 (41%), Positives = 142/239 (59%), Gaps = 7/239 (2%)
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           K  L  +  A+K I K+      S+E+   E+ +LK +  H+++V   D  E   + Y+V
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIK-HENIVTLEDIYESTTHYYLV 84
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           M+L  GGEL DRIL RG  YTE+DA  ++ Q+LS V + H  G+VHRDLKPEN L+ +  
Sbjct: 85  MQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE 143
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLC 348
           +++ + + DFGLS  +  +  ++   G+  YVAPEVL  + YS   D WSIGVI+YILLC
Sbjct: 144 ENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           G  PF+  TES +F  +      F+   W  +S  AKDF+  LL KD  +R T  +ALS
Sbjct: 203 GYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/262 (38%), Positives = 151/262 (57%), Gaps = 16/262 (6%)
Query: 149 YELGKEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +E+  E+GRG     + C  +G +     +  A+K++ K      +  + VR E+ +L  
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKT-----VDKKIVRTEIGVLLR 104
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           LS H +++K  +  E    + +V+EL  GGEL DRI+ +G  Y+E DA   V QIL  VA
Sbjct: 105 LS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVA 162
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           + H  G+VHRDLKPEN L+ +   DA +++ DFGLS  +     +  + G+  Y APE+L
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
              +Y  E D+WS+G+I+YILLCG  PF+  R +  +FR +L  +  F    W  VS  A
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KD V++L+  D +KR+T  QAL
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQAL 304

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/257 (35%), Positives = 151/257 (58%), Gaps = 10/257 (3%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G FG       +   L+     +K I+K +  + + +E +  E+++LK+L  H +
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLER---VIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPN 81
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCH 269
           ++K  +  ED +N+YIVME CEGGELL+RI+   ARG   +E     ++ Q+++ +A+ H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS 329
            Q VVH+DLKPEN LF      + +++IDFGL++  + DE   +  G+A Y+APEV  R 
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
            + + DIWS GV+ Y LL G  PF   +   + +     +PN+     P ++P+A D +K
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLLK 260
Query: 390 RLLNKDYRKRMTAVQAL 406
           ++L KD  +R +A Q L
Sbjct: 261 QMLTKDPERRPSAAQVL 277

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 157/312 (50%), Gaps = 24/312 (7%)
Query: 110 AKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRG--HFGHTCSAR 167
           AK+L   +PK +     +   PE  L   +   K F  KY+    +GRG       C  R
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 168 GKKGELKDQQVAVKIIS-KAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACED 222
               E      AVKI+   A+  +   +E+VR    RE  IL+ ++GH H++   D+ E 
Sbjct: 117 ATGHEF-----AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171
Query: 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
            + +++V +L   GEL D +  +    +E++ ++I+  +L  V+F H   +VHRDLKPEN
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEAD 335
            L     D+  +RL DFG S  + P E+L ++ G+  Y+APE+L       H  Y  E D
Sbjct: 231 ILLD---DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 336 IWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKD 395
           +W+ GVI + LL GS PFW R +  + R ++     F    W   S   KD + RLL  D
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVD 347
Query: 396 YRKRMTAVQALS 407
              R+TA QAL 
Sbjct: 348 PEARLTAEQALQ 359

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 152/265 (57%), Gaps = 14/265 (5%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKI 203
           YE+G+E+G G F     C  +G       ++ A K I K +++++   +S E++ REV I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L+ +  H +++   D  E+  +V +++EL  GGEL D  LA     TE++A   + QIL 
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTEDEATQFLKQILD 119
Query: 264 VVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
            V + H + + H DLKPEN  L      +  ++LIDFG++  I       +I G+  +VA
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PE++ +    LEAD+WSIGVI+YILL G+ PF   T+      +   + +FD+  + + S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
             AKDF++RLL KD ++RMT  Q+L
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSL 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 148/263 (56%), Gaps = 7/263 (2%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F   Y++ +E+G+G F        K   L   + A KII+  K++ A   + + RE +I 
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLS-ARDFQKLEREARIC 82
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+ ++ +  Y+V +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 83  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES 140
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +A+CH  G+VHR+LKPEN L  S    A ++L DFGL+  +   E  +   G+  Y++PE
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           VL +  YS   DIW+ GVI YILL G  PFW   +  ++  +     ++    W +V+PE
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AK  +  +L  + +KR+TA QAL
Sbjct: 261 AKSLIDSMLTVNPKKRITADQAL 283

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 148/263 (56%), Gaps = 7/263 (2%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F   Y++ +E+G+G F        K   L   + A KII+  K++ A   + + RE +I 
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLS-ARDFQKLEREARIC 59
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+ ++ +  Y+V +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 60  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES 117
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +A+CH  G+VHR+LKPEN L  S    A ++L DFGL+  +   E  +   G+  Y++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           VL +  YS   DIW+ GVI YILL G  PFW   +  ++  +     ++    W +V+PE
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AK  +  +L  + +KR+TA QAL
Sbjct: 238 AKSLIDSMLTVNPKKRITADQAL 260

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 151/265 (56%), Gaps = 14/265 (5%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKI 203
           YE+G+E+G G F     C  +G       ++ A K I K +++++   +S E++ REV I
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L+ +  H +++   D  E+  +V +++EL  GGEL D  LA     TE++A   + QIL 
Sbjct: 69  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTEDEATQFLKQILD 126
Query: 264 VVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
            V + H + + H DLKPEN  L      +  ++LIDFG++  I       +I G+  +VA
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PE++ +    LEAD+WSIGVI+YILL G+ PF   T+      +   + +FD+  + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 246
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
             AKDF++RLL KD ++RM   Q+L
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSL 271

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 148/263 (56%), Gaps = 7/263 (2%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F   Y++ +E+G+G F        K   L   + A KII+  K++ A   + + RE +I 
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLS-ARDFQKLEREARIC 59
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+ ++ +  Y+V +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 60  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES 117
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +A+CH  G+VHR+LKPEN L  S    A ++L DFGL+  +   E  +   G+  Y++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           VL +  YS   DIW+ GVI YILL G  PFW   +  ++  +     ++    W +V+PE
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AK  +  +L  + +KR+TA QAL
Sbjct: 238 AKSLIDSMLTVNPKKRITADQAL 260

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 148/263 (56%), Gaps = 7/263 (2%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F   Y++ +E+G+G F        K   L   + A KII+  K++ A   + + RE +I 
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLS-ARDFQKLEREARIC 58
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+ ++ +  Y+V +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 59  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES 116
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +A+CH  G+VHR+LKPEN L  S    A ++L DFGL+  +   E  +   G+  Y++PE
Sbjct: 117 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           VL +  YS   DIW+ GVI YILL G  PFW   +  ++  +     ++    W +V+PE
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 236
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AK  +  +L  + +KR+TA QAL
Sbjct: 237 AKSLIDSMLTVNPKKRITADQAL 259

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 150/267 (56%), Gaps = 8/267 (2%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           N  F + Y+L +E+G+G F      R     L  Q+ A KII+  K++ A   + + RE 
Sbjct: 17  NLYFQSMYQLFEELGKGAFS---VVRRCVKVLAGQEYAAKIINTKKLS-ARDHQKLEREA 72
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           +I + L  H ++V+  D+  +  + Y++ +L  GGEL + I+AR   Y+E DA   + QI
Sbjct: 73  RICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQI 130
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYY 320
           L  V  CH  GVVHRDLKPEN L  S    A ++L DFGL+  +  +++      G+  Y
Sbjct: 131 LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 190
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           ++PEVL +  Y    D+W+ GVI YILL G  PFW   +  +++ +     +F    W +
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 250
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           V+PEAKD + ++L  +  KR+TA +AL
Sbjct: 251 VTPEAKDLINKMLTINPSKRITAAEAL 277

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 150/265 (56%), Gaps = 14/265 (5%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKI 203
           YE+G+E+G G F     C  +G       ++ A K I K ++ ++   +S E++ REV I
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L+ +  H +++   D  E+  +V +++EL  GGEL D  LA     TE++A   + QIL 
Sbjct: 83  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTEDEATQFLKQILD 140
Query: 264 VVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
            V + H + + H DLKPEN  L      +  ++LIDFG++  I       +I G+  +VA
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PE++ +    LEAD+WSIGVI+YILL G+ PF   T+      +   + +FD+  + + S
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
             AKDF++RLL KD ++RM   Q+L
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSL 285

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 147/270 (54%), Gaps = 10/270 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRR 199
           +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ R
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           EV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   + 
Sbjct: 64  EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFLK 121
Query: 260 QILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
           QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+ 
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 319 YYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
            +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  +
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 62  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 119
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 62  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 119
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+L +E+G+G F      R        Q+ A KII+  K++ A   + + RE +I + L
Sbjct: 5   EYQLFEELGKGAFS---VVRRCMKIPTGQEYAAKIINTKKLS-ARDHQKLEREARICRLL 60
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+  D+  +    Y+V +L  GGEL + I+AR   Y+E DA   + QIL  V  
Sbjct: 61  K-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIQQILESVNH 118
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVL 326
           CHL G+VHRDLKPEN L  S    A ++L DFGL+  ++ D++      G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            +  Y    D+W+ GVI YILL G  PFW   +  +++ +     +F    W +V+PEAK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
           D + ++L  +  KR+TA +AL
Sbjct: 239 DLINKMLTINPAKRITASEAL 259

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 147/270 (54%), Gaps = 10/270 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           + + S  AKDF++RLL KD +KRMT   +L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 147/270 (54%), Gaps = 10/270 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           + + S  AKDF++RLL KD +KRMT   +L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGKFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+L +E+G+G F      R        Q+ A KII+  K++ A   + + RE +I + L
Sbjct: 5   EYQLFEELGKGAFS---VVRRCMKIPTGQEYAAKIINTKKLS-ARDHQKLEREARICRLL 60
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+  D+  +    Y+V +L  GGEL + I+AR   Y+E DA   + QIL  V  
Sbjct: 61  K-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIQQILESVNH 118
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVL 326
           CHL G+VHRDLKPEN L  S    A ++L DFGL+  ++ D++      G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            +  Y    D+W+ GVI YILL G  PFW   +  +++ +     +F    W +V+PEAK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
           D + ++L  +  KR+TA +AL
Sbjct: 239 DLINKMLTINPAKRITASEAL 259

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGVFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V +++EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 146/271 (53%), Gaps = 10/271 (3%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVR 198
            +N    Y+ G+E+G G F      R K   L   Q A K I K +  ++   +S ED+ 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV ILK +  H +++   +  E+  +V ++ EL  GGEL D  LA     TEE+A   +
Sbjct: 63  REVSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFD-FLAEKESLTEEEATEFL 120
Query: 259 VQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
            QIL+ V + H   + H DLKPEN  L         +++IDFGL+  I       +I G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 148/264 (56%), Gaps = 8/264 (3%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F  +Y+L +E+G+G F      R     L  Q+ A  II+  K++ A   + + RE +I 
Sbjct: 9   FTEEYQLFEELGKGAFS---VVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARIC 64
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+  +  + Y++ +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 65  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEA 122
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAP 323
           V  CH  GVVHR+LKPEN L  S    A ++L DFGL+  +  +++      G+  Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           EVL +  Y    D+W+ GVI YILL G  PFW   +  +++ +     +F    W +V+P
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 383 EAKDFVKRLLNKDYRKRMTAVQAL 406
           EAKD + ++L  +  KR+TA +AL
Sbjct: 243 EAKDLINKMLTINPSKRITAAEAL 266

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +S E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +S E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +S E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +S E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +S E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 146/263 (55%), Gaps = 10/263 (3%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILK 205
           Y++G+E+G G F      R K   L   + A K I K +   +   +  E++ REV IL+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            +  H +++   D  E+  +V +++EL  GGEL D  LA+    +EE+A + + QIL  V
Sbjct: 71  QVL-HPNIITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGV 128
Query: 266 AFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
            + H + + H DLKPEN  L         ++LIDFGL+  I       +I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ +    LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+  +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+++LL K+ RKR+T  +AL
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEAL 271

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 147/261 (56%), Gaps = 8/261 (3%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+L +++G+G F      R         + A KII+  K++ A   + + RE +I + L
Sbjct: 5   EYQLYEDIGKGAFS---VVRRCVKLCTGHEYAAKIINTKKLS-ARDHQKLEREARICRLL 60
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+  D+  +    Y+V +L  GGEL + I+AR   Y+E DA   + QIL  V  
Sbjct: 61  K-HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLH 118
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVL 326
           CH  GVVHRDLKPEN L  S    A ++L DFGL+  ++ D++      G+  Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            + +Y    DIW+ GVI YILL G  PFW   +  +++ +     +F    W +V+PEAK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
           + + ++L  +  KR+TA +AL
Sbjct: 239 NLINQMLTINPAKRITAHEAL 259

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 147/268 (54%), Gaps = 22/268 (8%)
Query: 145 FGAKYELG---KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           F   Y+L    K +G G F        KK    +Q  AVKIISK +M       + ++E+
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKS---NQAFAVKIISK-RMEA-----NTQKEI 56
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
             LK   GH ++VK  +   D  + ++VMEL  GGEL +RI  +   ++E +A  I+ ++
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKL 115
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYY 320
           +S V+  H  GVVHRDLKPEN LFT   D+ ++++IDFG +    PD + L     + +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES-------GIFRAVLRSDPNF 372
            APE+L+++ Y    D+WS+GVI Y +L G  PF +   S        I + + + D +F
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRM 400
           +   W +VS EAKD ++ LL  D  KR+
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRL 263

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 146/264 (55%), Gaps = 8/264 (3%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           F   Y+L +E+G+G F      R    +   Q+ A KII+  K++ A   + + RE +I 
Sbjct: 29  FTDDYQLFEELGKGAFS---VVRRCVKKTPTQEYAAKIINTKKLS-ARDHQKLEREARIC 84
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           + L  H ++V+  D+  +    Y+V +L  GGEL + I+AR   Y+E DA   + QIL  
Sbjct: 85  RLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIHQILES 142
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAP 323
           V   H   +VHRDLKPEN L  S    A ++L DFGL+  ++ +++      G+  Y++P
Sbjct: 143 VNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSP 202
Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           EVL +  Y    DIW+ GVI YILL G  PFW   +  +++ +     +F    W +V+P
Sbjct: 203 EVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTP 262
Query: 383 EAKDFVKRLLNKDYRKRMTAVQAL 406
           EAK+ + ++L  +  KR+TA QAL
Sbjct: 263 EAKNLINQMLTINPAKRITADQAL 286

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 135/261 (51%), Gaps = 13/261 (4%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           Y++ +E+G G FG  H  + R           A K +     +     E VR+E++ +  
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNF-----AAKFVMTPHESDK---ETVRKEIQTMSV 210
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           L  H  LV   DA ED N + ++ E   GGEL +++     + +E++A   + Q+   + 
Sbjct: 211 LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
             H    VH DLKPEN +FT+ R + +++LIDFGL+  + P + +    G+A + APEV 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             +      D+WS+GV+SYILL G  PF    +    R V   D N DD  +  +S + K
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 386 DFVKRLLNKDYRKRMTAVQAL 406
           DF+++LL  D   RMT  QAL
Sbjct: 389 DFIRKLLLADPNTRMTIHQAL 409

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 137/262 (52%), Gaps = 15/262 (5%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILK 205
           Y++ +E+G G FG  H  + R           A K +    MT   S  E VR+E++ + 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNF-----AAKFV----MTPHESDKETVRKEIQTMS 103
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            L  H  LV   DA ED N + ++ E   GGEL +++     + +E++A   + Q+   +
Sbjct: 104 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 162
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
              H    VH DLKPEN +FT+ R + +++LIDFGL+  + P + +    G+A + APEV
Sbjct: 163 CHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
              +      D+WS+GV+SYILL G  PF    +    R V   D N DD  +  +S + 
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 281
Query: 385 KDFVKRLLNKDYRKRMTAVQAL 406
           KDF+++LL  D   RMT  QAL
Sbjct: 282 KDFIRKLLLADPNTRMTIHQAL 303

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/245 (35%), Positives = 133/245 (54%), Gaps = 17/245 (6%)
Query: 176 QQVAVKII--SKAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           ++ AVKII  +     +A  ++++R    +EV IL+ +SGH ++++  D  E     ++V
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
            +L + GEL D  L      +E++ + I+  +L V+   H   +VHRDLKPEN L     
Sbjct: 103 FDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--- 158
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVI 342
           DD +++L DFG S  + P E+L ++ G+  Y+APE++       H  Y  E D+WS GVI
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
            Y LL GS PFW R +  + R ++  +  F    W   S   KD V R L    +KR TA
Sbjct: 219 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278
Query: 403 VQALS 407
            +AL+
Sbjct: 279 EEALA 283

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/245 (35%), Positives = 133/245 (54%), Gaps = 17/245 (6%)
Query: 176 QQVAVKII--SKAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           ++ AVKII  +     +A  ++++R    +EV IL+ +SGH ++++  D  E     ++V
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
            +L + GEL D  L      +E++ + I+  +L V+   H   +VHRDLKPEN L     
Sbjct: 90  FDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--- 145
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVI 342
           DD +++L DFG S  + P E+L ++ G+  Y+APE++       H  Y  E D+WS GVI
Sbjct: 146 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 205
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
            Y LL GS PFW R +  + R ++  +  F    W   S   KD V R L    +KR TA
Sbjct: 206 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 265
Query: 403 VQALS 407
            +AL+
Sbjct: 266 EEALA 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/257 (35%), Positives = 141/257 (54%), Gaps = 17/257 (6%)
Query: 155 VGRGHFG--HTC--SARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G G FG  H C  +A G K       +A KII    M      E+V+ E+ ++  L  H
Sbjct: 97  LGGGRFGQVHKCEETATGLK-------LAAKIIKTRGMKDK---EEVKNEISVMNQLD-H 145
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +L++  DA E  N++ +VME  +GGEL DRI+      TE D    + QI   +   H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSY 330
             ++H DLKPEN L  + RD   +++IDFGL+   +P E+L    G+  ++APEV++  +
Sbjct: 206 MYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 331 -SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
            S   D+WS+GVI+Y+LL G  PF    ++     +L    + +D  +  +S EAK+F+ 
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324
Query: 390 RLLNKDYRKRMTAVQAL 406
           +LL K+   R++A +AL
Sbjct: 325 KLLIKEKSWRISASEAL 341

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/245 (35%), Positives = 132/245 (53%), Gaps = 17/245 (6%)
Query: 176 QQVAVKII--SKAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           ++ AVKII  +     +A  ++++R    +EV IL+ +SGH ++++  D  E     ++V
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
            +L + GEL D  L      +E++ + I+  +L V+   H   +VHRDLKPEN L     
Sbjct: 103 FDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--- 158
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVI 342
           DD +++L DFG S  + P E+L  + G+  Y+APE++       H  Y  E D+WS GVI
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
            Y LL GS PFW R +  + R ++  +  F    W   S   KD V R L    +KR TA
Sbjct: 219 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278
Query: 403 VQALS 407
            +AL+
Sbjct: 279 EEALA 283

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/260 (35%), Positives = 148/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++ ++ S++ + REV+I+K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/260 (35%), Positives = 148/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++ ++ S++ + REV+I+K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 149/260 (57%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAV+II K ++ ++ S++ + REV+I+K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L++  GS  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/260 (37%), Positives = 140/260 (53%), Gaps = 24/260 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y LG  +G G FG     +  K EL   +VAVKI+++ K+ +   +  +RRE++ LK L 
Sbjct: 18  YILGDTLGVGTFG---KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LF 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K        +++++VME   GGEL D I  + GR  E++++ +  QILS V +C
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           H   VVHRDLKPEN L      DA M  ++ DFGLS+ +   E L    GS  Y APEV+
Sbjct: 133 HRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187
Query: 327 H-RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVS 381
             R Y+  E DIWS GVI Y LLCG+ PF       +F+ +   +   P +       ++
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------LN 240
Query: 382 PEAKDFVKRLLNKDYRKRMT 401
           P     +K +L  D  KR T
Sbjct: 241 PSVISLLKHMLQVDPMKRAT 260

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 142/276 (51%), Gaps = 16/276 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----- 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K     + E     
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPAL 66
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R  E   K
Sbjct: 67  NVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCK 123
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 124 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 183
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 243
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 244 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 142/276 (51%), Gaps = 16/276 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----- 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K     + E     
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R  E   K
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCK 117
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 142/276 (51%), Gaps = 16/276 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----- 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K     + E     
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R  E   K
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCK 117
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 142/276 (51%), Gaps = 16/276 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----- 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K     + E     
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPAL 59
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R  E   K
Sbjct: 60  NVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCK 116
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 117 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 176
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 236
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 237 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 272

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 142/276 (51%), Gaps = 16/276 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----- 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K     + E     
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R  E   K
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCK 117
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 17/263 (6%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKIL 204
           Y++ +E+G G FG  H C           ++   ++     + T   ++   V+ E+ I+
Sbjct: 53  YDILEELGSGAFGVVHRCV----------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 102
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             L  H  L+   DA ED   + +++E   GGEL DRI A   + +E +    + Q    
Sbjct: 103 NQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           +   H   +VH D+KPEN +  + +  + +++IDFGL+  + PDE +     +A + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++ R       D+W+IGV+ Y+LL G  PF    +    + V R D  FD+  + SVSPE
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKDF+K LL K+ RKR+T   AL
Sbjct: 281 AKDFIKNLLQKEPRKRLTVHDAL 303

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 145/274 (52%), Gaps = 20/274 (7%)
Query: 145 FGAKYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRRE 200
           F   YEL + +G+G F     C  R        QQ AVKI+  AK T++  +S ED++RE
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAI 257
             I   L  H H+V+  +       +Y+V E  +G +L   I+ R   G  Y+E  A   
Sbjct: 77  ASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDI 314
           + QIL  + +CH   ++HRD+KPEN L  S  + A ++L DFG++  I+  E        
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGR 193
Query: 315 VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           VG+ +++APEV+ R  Y    D+W  GVI +ILL G  PF+  T+  +F  +++     +
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMN 252
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              W  +S  AKD V+R+L  D  +R+T  +AL+
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 148/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAV+II K ++ ++ S++ + REV+I+K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 148/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++ ++ S++ + REV+I+K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   G+  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 16/283 (5%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           ++D    Y K    +Y + K +G G  G    A  +K     ++VA++IISK K     +
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSA 178
Query: 194 IE-----DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
            E     +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R
Sbjct: 179 READPALNVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKR 235
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             E   K    Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +   
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFR 363
             +  + G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +  
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            +     NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 16/283 (5%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           ++D    Y K    +Y + K +G G  G    A  +K     ++VA++IISK K     +
Sbjct: 136 TVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSA 192
Query: 194 IE-----DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
            E     +V  E++ILK L+ H  ++K  +   D  + YIV+EL EGGEL D+++    R
Sbjct: 193 READPALNVETEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKR 249
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             E   K    Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +   
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFR 363
             +  + G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +  
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 369
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            +     NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 370 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 412

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 100/278 (35%), Positives = 142/278 (51%), Gaps = 35/278 (12%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
            F   YE+ +++G G +   C     K    + + AVKII K+K        D   E++I
Sbjct: 19  QFTDGYEVKEDIGVGSYS-VCKRCIHKA--TNMEFAVKIIDKSK-------RDPTEEIEI 68
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L     H +++   D  +D   VY+V EL +GGELLD+IL R   ++E +A A++  I  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITK 127
Query: 264 VVAFCHLQGVVHRDLKPENFLFT--SGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYY 320
            V + H QGVVHRDLKP N L+   SG  ++ +R+ DFG +  +R +   L     +A +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF-----------WARTESGIFRAVLRS 368
           VAPEVL R  Y    DIWS+GV+ Y +L G  PF            AR  SG F      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF------ 240
Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             +     W SVS  AKD V ++L+ D  +R+TA   L
Sbjct: 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/221 (38%), Positives = 127/221 (57%), Gaps = 11/221 (4%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++    S++ + REV+I+K L+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHV---LTGREVAVKIIDKTQLNPT-SLQKLFREVRIMKILN 72
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 73  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYC 130
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L      D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 131 HQKYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQG 187
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR 367
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 92/260 (35%), Positives = 147/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++ ++ S++ + REV+I+K L+
Sbjct: 9   YRLLKTIGKGNFAKVKLARHI---LTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLN 64
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+VME   GGE+ D ++A G    E++A+A   QI+S V +C
Sbjct: 65  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWM-KEKEARAKFRQIVSAVQYC 122
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 123 HQKFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 235
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +K+ L  +  KR T  Q +
Sbjct: 236 LLKKFLILNPSKRGTLEQIM 255

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/221 (40%), Positives = 124/221 (56%), Gaps = 14/221 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y LG  +G G FG     +  + +L   +VAVKI+++ K+ +   +  ++RE++ LK L 
Sbjct: 13  YVLGDTLGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LF 68
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K         + ++VME   GGEL D I  + GR  E +A+ +  QILS V +C
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           H   VVHRDLKPEN L      DA M  ++ DFGLS+ +   E L D  GS  Y APEV+
Sbjct: 128 HRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVI 182
Query: 327 H-RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365
             R Y+  E DIWS GVI Y LLCG+ PF       +F+ +
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 146/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VA+KII K ++    S++ + REV+I+K L+
Sbjct: 14  YRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILN 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y++ME   GGE+ D ++A G R  E++A++   QI+S V +C
Sbjct: 70  -HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   GS  Y APE+   
Sbjct: 128 HQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQG 184
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 240
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +KR L  +  KR T  Q +
Sbjct: 241 LLKRFLVLNPIKRGTLEQIM 260

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/231 (37%), Positives = 123/231 (53%), Gaps = 17/231 (7%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGR-YTEE 252
           R+EV      SG  H+V   D  E++++    + I+ME  EGGEL  RI  RG + +TE 
Sbjct: 69  RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I + + F H   + HRD+KPEN L+TS   DA ++L DFG +     +  L 
Sbjct: 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQ 187
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++ T      G+ R +  
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS------KLVVP 412
               F +  W  VS +AK  ++ LL  D  +R+T  Q ++       +VVP
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 86/231 (37%), Positives = 123/231 (53%), Gaps = 17/231 (7%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGR-YTEE 252
           R+EV      SG  H+V   D  E++++    + I+ME  EGGEL  RI  RG + +TE 
Sbjct: 50  RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 109
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I + + F H   + HRD+KPEN L+TS   DA ++L DFG +     +  L 
Sbjct: 110 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQ 168
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++ T      G+ R +  
Sbjct: 169 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 228
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS------KLVVP 412
               F +  W  VS +AK  ++ LL  D  +R+T  Q ++       +VVP
Sbjct: 229 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 279

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 100/278 (35%), Positives = 140/278 (50%), Gaps = 35/278 (12%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
            F   YE+ +++G G +   C     K    + + AVKII K+K        D   E++I
Sbjct: 19  QFTDGYEVKEDIGVGSYS-VCKRCIHKA--TNXEFAVKIIDKSK-------RDPTEEIEI 68
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L     H +++   D  +D   VY+V EL +GGELLD+IL R   ++E +A A++  I  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL-RQKFFSEREASAVLFTITK 127
Query: 264 VVAFCHLQGVVHRDLKPENFLFT--SGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYY 320
            V + H QGVVHRDLKP N L+   SG  ++ +R+ DFG +  +R +   L     +A +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLXTPCYTANF 186
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF-----------WARTESGIFRAVLRS 368
           VAPEVL R  Y    DIWS+GV+ Y  L G  PF            AR  SG F      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF------ 240
Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             +     W SVS  AKD V + L+ D  +R+TA   L
Sbjct: 241 --SLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVL 276

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/260 (34%), Positives = 146/260 (56%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VA+KII K ++    S++ + REV+I+K L+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILN 72
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y++ME   GGE+ D ++A G R  E++A++   QI+S V +C
Sbjct: 73  -HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC 130
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   G+  Y APE+   
Sbjct: 131 HQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+  +S + ++
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YMSTDCEN 243
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            +KR L  +  KR T  Q +
Sbjct: 244 LLKRFLVLNPIKRGTLEQIM 263

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/221 (39%), Positives = 123/221 (55%), Gaps = 14/221 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y LG  +G G FG     +  + +L   +VAVKI+++ K+ +   +  ++RE++ LK L 
Sbjct: 13  YVLGDTLGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LF 68
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K         + ++VME   GGEL D I  + GR  E +A+ +  QILS V +C
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           H   VVHRDLKPEN L      DA M  ++ DFGLS+ +   E L    GS  Y APEV+
Sbjct: 128 HRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 327 H-RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365
             R Y+  E DIWS GVI Y LLCG+ PF       +F+ +
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 144/258 (55%), Gaps = 15/258 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L K +G+G+F     AR     L  ++VAVKII K ++ ++ S++ + REV+I K L+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHI---LTGKEVAVKIIDKTQLNSS-SLQKLFREVRIXKVLN 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  +  E    +Y+V E   GGE+ D ++A G R  E++A+A   QI+S V +C
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG-RXKEKEARAKFRQIVSAVQYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +VHRDLK EN L  +   D ++++ DFG S+      +L+   G+  Y APE+   
Sbjct: 130 HQKFIVHRDLKAENLLLDA---DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR       +P+   S + ++
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPF-YXSTDCEN 242
Query: 387 FVKRLLNKDYRKRMTAVQ 404
            +K+ L  +  KR T  Q
Sbjct: 243 LLKKFLILNPSKRGTLEQ 260

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 14/267 (5%)
Query: 143 KNFGAKYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           K    KY + +++GRG FG  H C     K     + V VK   +  +   ISI ++ R 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR- 59
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
                    H++++   ++ E +  + ++ E   G ++ +RI        E +  + V Q
Sbjct: 60  ---------HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           +   + F H   + H D++PEN ++ + R  + +++I+FG +  ++P +    +  +  Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 321 VAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
            APEV  H   S   D+WS+G + Y+LL G  PF A T   I   ++ ++  FD+  +  
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           +S EA DFV RLL K+ + RMTA +AL
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEAL 256

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 116/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 56  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
           +   + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 235
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 236 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 275

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 142/274 (51%), Gaps = 20/274 (7%)
Query: 145 FGAKYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRRE 200
           F   YEL + +G+G F     C  R        QQ AVKI+  AK T++  +S ED++RE
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKRE 78
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAI 257
             I   L  H H+V+  +       +Y+V E  +G +L   I+ R   G  Y+E  A   
Sbjct: 79  ASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 137
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDI 314
           + QIL  + +CH   ++HRD+KP   L  S  + A ++L  FG++  I+  E        
Sbjct: 138 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGR 195
Query: 315 VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           VG+ +++APEV+ R  Y    D+W  GVI +ILL G  PF+  T+  +F  +++     +
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMN 254
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              W  +S  AKD V+R+L  D  +R+T  +AL+
Sbjct: 255 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 288

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 72  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 131
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 132 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 191
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 192 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 251
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 252 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 291

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 64  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 123
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 124 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 183
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 184 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 243
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 244 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 283

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 63  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 122
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 123 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 182
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 183 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 242
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 243 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 282

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 108 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 167
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 168 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 227
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 287
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 288 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 327

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 62  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 121
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 122 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 181
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 182 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 241
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 242 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 141/272 (51%), Gaps = 16/272 (5%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVK 202
           F   YEL + +G+G F      R        QQ AVKI+  AK T++  +S ED++RE  
Sbjct: 22  FEDVYELCEVIGKGPFS---VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVV 259
           I   L  H H+V+  +       +Y+V E  +G +L   I+ R   G  Y+E  A   + 
Sbjct: 79  ICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVG 316
           QIL  + +CH   ++HRD+KP   L  S  + A ++L  FG++  I+  E        VG
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 195
Query: 317 SAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           + +++APEV+ R  Y    D+W  GVI +ILL G  PF+  T+  +F  +++     +  
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPR 254
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            W  +S  AKD V+R+L  D  +R+T  +AL+
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 56  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 235
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 236 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 275

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 237
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 238 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 277

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 57  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 116
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 117 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 176
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 236
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 237 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 276

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 136/271 (50%), Gaps = 17/271 (6%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           N  F   Y + + +G G +        K   +   + AVK+I K+K        D   E+
Sbjct: 22  NLVFSDGYVVKETIGVGSYSECKRCVHKATNM---EYAVKVIDKSK-------RDPSEEI 71
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           +IL     H +++   D  +D  +VY+V EL  GGELLD+IL R   ++E +A  ++  I
Sbjct: 72  EILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL-RQKFFSEREASFVLHTI 130
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-MRLIDFGLSDFIRPDE-RLNDIVGSAY 319
              V + H QGVVHRDLKP N L+     + + +R+ DFG +  +R +   L     +A 
Sbjct: 131 GKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 320 YVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDL 375
           +VAPEVL R  Y    DIWS+G++ Y +L G  PF    + T   I   +          
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGG 250
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            W +VS  AKD V ++L+ D  +R+TA Q L
Sbjct: 251 NWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +  
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 237
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 238 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 277

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 85/238 (35%), Positives = 126/238 (52%), Gaps = 14/238 (5%)
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
           + + AVK+I K+K        D   E++IL     H +++   D  +D  +VY+V EL  
Sbjct: 52  NMEYAVKVIDKSK-------RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMR 104
Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD- 293
           GGELLD+IL R   ++E +A  ++  I   V + H QGVVHRDLKP N L+     + + 
Sbjct: 105 GGELLDKIL-RQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC 163
Query: 294 MRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSR 351
           +R+ DFG +  +R +   L     +A +VAPEVL R  Y    DIWS+G++ Y +L G  
Sbjct: 164 LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223
Query: 352 PFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           PF    + T   I   +           W +VS  AKD V ++L+ D  +R+TA Q L
Sbjct: 224 PFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 142/263 (53%), Gaps = 19/263 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++G  +G+G F     A      L   +VA+K+I K  M  A  ++ V+ EVKI   L 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGL---EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  +++  +  ED N VY+V+E+C  GE+   +  R   ++E +A+  + QI++ + + 
Sbjct: 70  -HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVLH 327
           H  G++HRDL   N L T    + ++++ DFGL+  ++ P E+   + G+  Y++PE+  
Sbjct: 129 HSHGILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 328 RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSVSPE 383
           RS + LE+D+WS+G + Y LL G  PF   T       V+ +D   P+F       +S E
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF-------LSIE 238
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
           AKD + +LL ++   R++    L
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVL 261

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 140/258 (54%), Gaps = 14/258 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YEL K++G G+FG    AR  + +  ++ VAVK I + +   A    +V+RE+   ++L
Sbjct: 20  RYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIERGEKIAA----NVKREIINHRSL 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ IVME   GGEL +RI    GR++E++A+    Q++S V++
Sbjct: 73  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-L 326
           CH   V HRDLK EN L   G     +++ DFG S       +    VG+  Y+APEV L
Sbjct: 131 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 327 HRSYSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLP-WPSVSPE 383
            + Y  + AD+WS GV  Y++L G+ PF    E   FR  +    N    +P +  +SPE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 384 AKDFVKRLLNKDYRKRMT 401
            +  + R+   D  KR++
Sbjct: 250 CRHLISRIFVADPAKRIS 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 137/252 (54%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 93  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 150
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R +D+ G+  Y+ PE++  
Sbjct: 151 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEG 206
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 262
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 263 ISRLLKHNPSQR 274

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 140/259 (54%), Gaps = 14/259 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++G+ +G+G FG+   AR ++ +     +A+K++ K ++  A     +RREV+I   L 
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFI---LALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  R+ E+     + ++ + +++C
Sbjct: 71  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSRFDEQRTATYITELANALSYC 128
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S   + ++++ DFG S    P  R + + G+  Y+ PE++  
Sbjct: 129 HSKRVIHRDIKPENLLLGS---NGELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEG 184
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    +R + R +  F D     V+  A+D 
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF----VTEGARDL 240
Query: 388 VKRLLNKDYRKRMTAVQAL 406
           + RLL  +  +R+T  + L
Sbjct: 241 ISRLLKHNASQRLTLAEVL 259

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 140/258 (54%), Gaps = 14/258 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YEL K++G G+FG    AR  + +  ++ VAVK I + +       E+V+RE+   ++L
Sbjct: 19  RYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSL 71
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ IVME   GGEL +RI    GR++E++A+    Q++S V++
Sbjct: 72  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 129
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-L 326
           CH   V HRDLK EN L   G     +++ DFG S       +    VG+  Y+APEV L
Sbjct: 130 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 327 HRSYSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLP-WPSVSPE 383
            + Y  + AD+WS GV  Y++L G+ PF    E   FR  +    N    +P +  +SPE
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 248
Query: 384 AKDFVKRLLNKDYRKRMT 401
            +  + R+   D  KR++
Sbjct: 249 CRHLISRIFVADPAKRIS 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 139/259 (53%), Gaps = 14/259 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++G+ +G+G FG+   AR ++ +     +A+K++ K ++  A     +RREV+I   L 
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFI---LALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  R+ E+     + ++ + +++C
Sbjct: 71  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSRFDEQRTATYITELANALSYC 128
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S   + ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 129 HSKRVIHRDIKPENLLLGS---NGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 184
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    +R + R +  F D     V+  A+D 
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF----VTEGARDL 240
Query: 388 VKRLLNKDYRKRMTAVQAL 406
           + RLL  +  +R+T  + L
Sbjct: 241 ISRLLKHNASQRLTLAEVL 259

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 140/258 (54%), Gaps = 14/258 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YEL K++G G+FG    AR  + +  ++ VAVK I + +       E+V+RE+   ++L
Sbjct: 20  RYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSL 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ IVME   GGEL +RI    GR++E++A+    Q++S V++
Sbjct: 73  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-L 326
           CH   V HRDLK EN L   G     +++  FG S       +  D VG+  Y+APEV L
Sbjct: 131 CHAMQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 327 HRSYSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLP-WPSVSPE 383
            + Y  + AD+WS GV  Y++L G+ PF    E   FR  +    N    +P +  +SPE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 384 AKDFVKRLLNKDYRKRMT 401
            +  + R+   D  KR++
Sbjct: 250 CRHLISRIFVADPAKRIS 267

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 137/252 (54%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R +D+ G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/323 (28%), Positives = 157/323 (48%), Gaps = 60/323 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVK 202
           KY L   +G+G +G    A      +++Q  A++ I     +K +      +E ++ EV+
Sbjct: 27  KYHLKGAIGQGSYGVVRVA------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA------------------ 244
           ++K L  H ++ +  +  ED   + +VMELC GG LLD++                    
Sbjct: 81  LMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 245 ---------------RGGRYT------EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283
                           G R +      E+    I+ QI S + + H QG+ HRD+KPENF
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 284 LFTSGRDDADMRLIDFGLS-DFIRPDER----LNDIVGSAYYVAPEVLH---RSYSLEAD 335
           LF++ +   +++L+DFGLS +F + +      +    G+ Y+VAPEVL+    SY  + D
Sbjct: 200 LFSTNKS-FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 336 IWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKD 395
            WS GV+ ++LL G+ PF    ++     VL     F++  +  +SP A+D +  LLN++
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318
Query: 396 YRKRMTAVQALSKLVVPILSFKI 418
             +R  A++AL    +   S KI
Sbjct: 319 VDERFDAMRALQHPWISQFSDKI 341

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 68  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R  D+ G+  Y+ PE++  
Sbjct: 126 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEG 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 237
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 72  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R  D+ G+  Y+ PE++  
Sbjct: 130 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEG 185
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 241
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R  D+ G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R  D+ G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 139/293 (47%), Gaps = 37/293 (12%)
Query: 145 FGAKYELGKEV-GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           F   Y+L  E+ G G +      +G       ++ AVKII K       S   V REV+ 
Sbjct: 10  FEDMYKLTSELLGEGAYA---KVQGAVSLQNGKEYAVKIIEK---QAGHSRSRVFREVET 63
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           L    G+K++++  +  ED    Y+V E  +GG +L  I  +   + E +A  +V  + +
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVRDVAA 122
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-------- 315
            + F H +G+ HRDLKPEN L  S    + +++ DF L   ++ +     I         
Sbjct: 123 ALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 316 GSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPF---------WARTE-- 358
           GSA Y+APEV+         Y    D+WS+GV+ YI+L G  PF         W R E  
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVC 242
Query: 359 ----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               + +F ++      F D  W  +S EAKD + +LL +D ++R++A Q L 
Sbjct: 243 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQ 295

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 137/258 (53%), Gaps = 21/258 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y + + +G G FG    A   K +   Q+VA+K IS+  +  +     V RE+  LK L 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K  D      ++ +V+E   GGEL D I+ +  R TE++ +    QI+  + +C
Sbjct: 68  -HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H   +VHRDLKPEN L     D+ ++++ DFGLS+ +     L    GS  Y APEV++ 
Sbjct: 125 HRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING 181
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVSPE 383
           + Y+  E D+WS G++ Y++L G  PF       +F+ V   +   P+F       +SP 
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPG 234
Query: 384 AKDFVKRLLNKDYRKRMT 401
           A+  ++R++  D  +R+T
Sbjct: 235 AQSLIRRMIVADPMQRIT 252

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    GE+    L +  ++ E+     + ++ + +++C
Sbjct: 72  -HPNILRLYGYFHDATRVYLILEYAPRGEVYKE-LQKLSKFDEQRTATYITELANALSYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 130 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 185
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 241
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 93  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 150
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 151 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 206
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 262
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 263 ISRLLKHNPSQR 274

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IV E  +GGEL  RI  RG + +TE 
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTER 161
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I   I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L 
Sbjct: 162 EASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLR 367
               + YYVAPEVL    Y    D WS+GVI YILLCG  PF++        G    +  
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRX 281
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
               F +  W  VS E K  ++ LL  +  +R T  +
Sbjct: 282 GQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITE 318

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 14/258 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YEL K++G G+FG    AR  + +  ++ VAVK I + +       E+V+RE+   ++L
Sbjct: 20  RYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSL 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ IVME   GGEL +RI    GR++E++A+    Q++S V++
Sbjct: 73  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-L 326
           CH   V HRDLK EN L   G     +++  FG S       +    VG+  Y+APEV L
Sbjct: 131 CHAMQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 327 HRSYSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLP-WPSVSPE 383
            + Y  + AD+WS GV  Y++L G+ PF    E   FR  +    N    +P +  +SPE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 384 AKDFVKRLLNKDYRKRMT 401
            +  + R+   D  KR++
Sbjct: 250 CRHLISRIFVADPAKRIS 267

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    GE+    L +  ++ E+     + ++ + +++C
Sbjct: 72  -HPNILRLYGYFHDATRVYLILEYAPRGEVYKE-LQKLSKFDEQRTATYITELANALSYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 130 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRXXLXGTLDYLPPEMIEG 185
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 241
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R  ++ G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 84  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 141
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 142 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 197
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 253
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 254 ISRLLKHNPSQR 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 136/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 68  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R + + G+  Y+ PE++  
Sbjct: 126 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEG 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 237
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F  T  AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 32  FKFGKILGEGSFSTTVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 88  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 146 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 258
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 259 ARDLVEKLLVLDATKRL 275

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 72  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 130 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 185
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 241
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 14/258 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YEL K++G G+FG    AR  + +  ++ VAVK I + +       E+V+RE+   ++L
Sbjct: 20  RYELVKDIGAGNFG---VARLMRDKQANELVAVKYIERGEKID----ENVKREIINHRSL 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ IVME   GGEL +RI    GR++E++A+    Q++S V++
Sbjct: 73  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-L 326
            H   V HRDLK EN L   G     +++ DFG S       +    VG+  Y+APEV L
Sbjct: 131 AHAMQVAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 327 HRSYSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLP-WPSVSPE 383
            + Y  + AD+WS GV  Y++L G+ PF    E   FR  +    N    +P +  +SPE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 384 AKDFVKRLLNKDYRKRMT 401
            +  + R+   D  KR++
Sbjct: 250 CRHLISRIFVADPAKRIS 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 68  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 126 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEG 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 237
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 71  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 128
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 129 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 184
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 240
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 241 ISRLLKHNPSQR 252

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 72  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEXIEG 185
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 241
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 69  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 127 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEG 182
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 238
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 239 ISRLLKHNPSQR 250

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 66  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 123
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 124 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 235
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 236 ISRLLKHNPSQR 247

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTXLCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 35  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 91  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 149 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 261
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 262 ARDLVEKLLVLDATKRL 278

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 35  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 91  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 149 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 261
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 262 ARDLVEKLLVLDATKRL 278

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 132/249 (53%), Gaps = 21/249 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +G G FG    A         Q+VA+KII+K  +  +     + RE+  L+ L 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K  D  +  + + +V+E   G EL D I+ R  + +E++A+    QI+S V +C
Sbjct: 73  -HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC 129
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H   +VHRDLKPEN L     +  ++++ DFGLS+ +     L    GS  Y APEV+  
Sbjct: 130 HRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 186
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVSPE 383
           + Y+  E D+WS GVI Y++LC   PF   +   +F+ +   + + P F       +SP 
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPG 239
Query: 384 AKDFVKRLL 392
           A   +KR+L
Sbjct: 240 AAGLIKRML 248

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 132/249 (53%), Gaps = 21/249 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +G G FG    A         Q+VA+KII+K  +  +     + RE+  L+ L 
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K  D  +  + + +V+E   G EL D I+ R  + +E++A+    QI+S V +C
Sbjct: 72  -HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC 128
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H   +VHRDLKPEN L     +  ++++ DFGLS+ +     L    GS  Y APEV+  
Sbjct: 129 HRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 185
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVSPE 383
           + Y+  E D+WS GVI Y++LC   PF   +   +F+ +   + + P F       +SP 
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPG 238
Query: 384 AKDFVKRLL 392
           A   +KR+L
Sbjct: 239 AAGLIKRML 247

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 69  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ +FG S    P  R   + G+  Y+ PE++  
Sbjct: 127 HSKRVIHRDIKPENLLLGSA---GELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 182
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 238
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 239 ISRLLKHNPSQR 250

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 12  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 67
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 68  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 126 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 238
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 239 ARDLVEKLLVLDATKRL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 70  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ +FG S    P  R   + G+  Y+ PE++  
Sbjct: 128 HSKRVIHRDIKPENLLLGSA---GELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 183
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 239
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 132/249 (53%), Gaps = 21/249 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +G G FG    A         Q+VA+KII+K  +  +     + RE+  L+ L 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K  D  +  + + +V+E   G EL D I+ R  + +E++A+    QI+S V +C
Sbjct: 67  -HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC 123
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H   +VHRDLKPEN L     +  ++++ DFGLS+ +     L    GS  Y APEV+  
Sbjct: 124 HRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 180
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVSPE 383
           + Y+  E D+WS GVI Y++LC   PF   +   +F+ +   + + P F       +SP 
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPG 233
Query: 384 AKDFVKRLL 392
           A   +KR+L
Sbjct: 234 AAGLIKRML 242

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 132/249 (53%), Gaps = 21/249 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +G G FG    A         Q+VA+KII+K  +  +     + RE+  L+ L 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H++K  D  +  + + +V+E   G EL D I+ R  + +E++A+    QI+S V +C
Sbjct: 63  -HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC 119
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H   +VHRDLKPEN L     +  ++++ DFGLS+ +     L    GS  Y APEV+  
Sbjct: 120 HRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 176
Query: 328 RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAV---LRSDPNFDDLPWPSVSPE 383
           + Y+  E D+WS GVI Y++LC   PF   +   +F+ +   + + P F       +SP 
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPG 229
Query: 384 AKDFVKRLL 392
           A   +KR+L
Sbjct: 230 AAGLIKRML 238

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 145/299 (48%), Gaps = 37/299 (12%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDV 197
           G   +F  ++E   ++     G    AR +     +  Q+ AVKII K           V
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRV 57
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            REV++L    GH+++++  +  E+ +  Y+V E   GG +L  I  R   + E +A  +
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVV 116
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
           V  + S + F H +G+ HRDLKPEN L       + +++ DFGL   I+ +   + I   
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 315 -----VGSAYYVAPEVLHRSYSLEA-------DIWSIGVISYILLCGSRPF--------- 353
                 GSA Y+APEV+  ++S EA       D+WS+GVI YILL G  PF         
Sbjct: 177 ELLTPCGSAEYMAPEVV-EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 354 WARTESG------IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           W R E+       +F ++      F D  W  +S  AKD + +LL +D ++R++A Q L
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 32  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 88  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 146 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 258
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 259 ARDLVEKLLVLDATKRL 275

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 11  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 67  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 125 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 237
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 238 ARDLVEKLLVLDATKRL 254

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 134/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF  +++ + +F +       P+
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K+ +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 64  -HPNILRLYGYFHDATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 122 HSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEG 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDL 233
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 234 ISRLLKHNPSQR 245

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 37  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 92
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 93  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 151 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F      +  P+
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----AAFFPK 263
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 264 ARDLVEKLLVLDATKRL 280

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 32  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 88  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 146 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 258
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 259 ARDLVEKLLVLDATKRL 275

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 32  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 88  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 146 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 258
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 259 ARDLVEKLLVLDATKRL 275

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 10  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 66  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 124 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 236
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 237 ARDLVEKLLVLDATKRL 253

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 9   FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 64
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 65  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 123 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 235
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 236 ARDLVEKLLVLDATKRL 252

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 39  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 94
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 95  D-HPFFVKLYFCFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 153 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 265
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 266 ARDLVEKLLVLDATKRL 282

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR K  +     +A+K++ KA++  A     +RREV+I   L 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++C
Sbjct: 67  -HPNILRLYGYFHDSTRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYC 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 125 HSKKVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEG 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF----VTEGARDL 236
Query: 388 VKRLLNKDYRKR 399
           + RLL  +  +R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 134/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF  +++ + +F +       P+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 31  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 87  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 145 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 257
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 258 ARDLVEKLLVLDATKRL 274

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 34  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + G LL + + + G + E   +    +I+S + +
Sbjct: 90  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGCLL-KYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 148 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S S  +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 260
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 261 ARDLVEKLLVLDATKRL 277

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 16  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 71
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 72  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 130 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 242
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 243 ARDLVEKLLVLDATKRL 259

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++ GK +G G F     AR    EL   ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 31  FKFGKILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL + + + G + E   +    +I+S + +
Sbjct: 87  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 145 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F +       P+
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 257
Query: 384 AKDFVKRLLNKDYRKRM 400
           A+D V++LL  D  KR+
Sbjct: 258 ARDLVEKLLVLDATKRL 274

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 7/272 (2%)
Query: 139 FGYNKNFGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDV 197
           F   +NF   Y L  KE+GRG F      R    +   Q+ A K + K +       E +
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFA---VVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-I 75
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKA 256
             E+ +L+       ++   +  E+ + + +++E   GGE+    L       +E D   
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           ++ QIL  V + H   +VH DLKP+N L +S     D++++DFG+S  I     L +I+G
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 317 SAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           +  Y+APE+L+    +   D+W+IG+I+Y+LL  + PF        +  + + + ++ + 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            + SVS  A DF++ LL K+  KR TA   LS
Sbjct: 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 144/299 (48%), Gaps = 37/299 (12%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDV 197
           G   +F  ++E   ++     G    AR +     +  Q+ AVKII K           V
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRV 57
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            REV++L    GH+++++  +  E+ +  Y+V E   GG +L  I  R   + E +A  +
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVV 116
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
           V  + S + F H +G+ HRDLKPEN L       + +++ DF L   I+ +   + I   
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 315 -----VGSAYYVAPEVLHRSYSLEA-------DIWSIGVISYILLCGSRPF--------- 353
                 GSA Y+APEV+  ++S EA       D+WS+GVI YILL G  PF         
Sbjct: 177 ELLTPCGSAEYMAPEVV-EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 354 WARTESG------IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           W R E+       +F ++      F D  W  +S  AKD + +LL +D ++R++A Q L
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 140/263 (53%), Gaps = 24/263 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K++G G+FG    AR  + +L  + VAVK I +     AI  E+V+RE+   ++L
Sbjct: 21  RYDFVKDIGSGNFG---VARLMRDKLTKELVAVKYIERG---AAID-ENVQREIINHRSL 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ I+ME   GGEL +RI    GR++E++A+    Q+LS V++
Sbjct: 74  R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
           CH   + HRDLK EN L   G     +++ DFG S       +    VG+  Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 328 RS-YSLE-ADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-------SDPNFDDLPWP 378
           R  Y  + AD+WS GV  Y++L G+ PF    E   +R  ++       S P  DD+   
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDI--- 245
Query: 379 SVSPEAKDFVKRLLNKDYRKRMT 401
            +SPE    + R+   D   R++
Sbjct: 246 RISPECCHLISRIFVADPATRIS 268

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 139/263 (52%), Gaps = 20/263 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKAL 207
           +EL K +G G +G     R   G    +  A+K++ KA +   A + E  R E ++L+ +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
                LV    A +    ++++++   GGEL   +  R  R+TE + +  V +I+  +  
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEH 174
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPD-ERLNDIVGSAYYVAPEV 325
            H  G+++RD+K EN L  S   +  + L DFGLS +F+  + ER  D  G+  Y+AP++
Sbjct: 175 LHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 326 LH---RSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNFDDLPWP 378
           +      +    D WS+GV+ Y LL G+ PF       +++ I R +L+S+P     P+P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 286
Query: 379 S-VSPEAKDFVKRLLNKDYRKRM 400
             +S  AKD ++RLL KD +KR+
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRL 309

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEE 252
           RREV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           +A  I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG            
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------- 166
Query: 313 DIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLRS 368
                    A E     Y    D+WS+GVI YILLCG  PF++        G+   +   
Sbjct: 167 ---------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217
Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G+ K   +++EL K +G+G FG     +   G    Q  A+K++ KA +     +   + 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           E  IL  ++ H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + 
Sbjct: 76  ERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLA 133
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           ++   +   H  G+++RDLKPEN L     ++  ++L DFGLS + I  +++     G+ 
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDD 374
            Y+APEV++ R ++  AD WS GV+ + +L G+ PF  +        +L++    P F  
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-- 248
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
                +SPEA+  ++ L  ++   R+ A
Sbjct: 249 -----LSPEAQSLLRMLFKRNPANRLGA 271

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G+ K   +++EL K +G+G FG     +   G    Q  A+K++ KA +     +   + 
Sbjct: 18  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 76
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           E  IL  ++ H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + 
Sbjct: 77  ERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLA 134
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           ++   +   H  G+++RDLKPEN L     ++  ++L DFGLS + I  +++     G+ 
Sbjct: 135 ELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDD 374
            Y+APEV++ R ++  AD WS GV+ + +L G+ PF  +        +L++    P F  
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-- 249
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
                +SPEA+  ++ L  ++   R+ A
Sbjct: 250 -----LSPEAQSLLRMLFKRNPANRLGA 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G+ K   +++EL K +G+G FG     +   G    Q  A+K++ KA +     +   + 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           E  IL  ++ H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + 
Sbjct: 76  ERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLA 133
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           ++   +   H  G+++RDLKPEN L     ++  ++L DFGLS + I  +++     G+ 
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDD 374
            Y+APEV++ R ++  AD WS GV+ + +L G+ PF  +        +L++    P F  
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-- 248
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
                +SPEA+  ++ L  ++   R+ A
Sbjct: 249 -----LSPEAQSLLRMLFKRNPANRLGA 271

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQV----AVKIISKAKMTTAISIEDVRREVKI 203
           +Y  G+ +G+G F        K  E+ D       A K++ K+ +      E +  E+ I
Sbjct: 43  RYMRGRFLGKGGFA-------KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K+L  + H+V F    ED + VY+V+E+C    LL+ +  R    TE +A+  + Q + 
Sbjct: 96  HKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQ 153
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVA 322
            V + H   V+HRDLK  N       DD D+++ DFGL+  I  D ER  D+ G+  Y+A
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 210
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL  + +S E DIWS+G I Y LL G  PF     S +    +R   N   +P   ++
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYSVPR-HIN 266
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           P A   ++R+L+ D   R +  + L+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLT 292

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQV----AVKIISKAKMTTAISIEDVRREVKI 203
           +Y  G+ +G+G F        K  E+ D       A K++ K+ +      E +  E+ I
Sbjct: 27  RYMRGRFLGKGGFA-------KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K+L  + H+V F    ED + VY+V+E+C    LL+ +  R    TE +A+  + Q + 
Sbjct: 80  HKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQ 137
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVA 322
            V + H   V+HRDLK  N       DD D+++ DFGL+  I  D ER  D+ G+  Y+A
Sbjct: 138 GVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 194
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL  + +S E DIWS+G I Y LL G  PF     S +    +R   N   +P   ++
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYSVPR-HIN 250
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           P A   ++R+L+ D   R +  + L+
Sbjct: 251 PVASALIRRMLHADPTLRPSVAELLT 276

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKE---TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKE---TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 120 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 178 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 232
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 287
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 288 DLLRNLLQVDLTKRF 302

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKE---TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 136/258 (52%), Gaps = 14/258 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+G+ +G+G FG+   AR KK       VA+K++ K+++        +RRE++I +A  
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFI---VALKVLFKSQIEKEGVEHQLRREIEI-QAHL 80
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++  +   D   +Y+++E    GEL    L +   + E+    I+ ++   + +C
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKE-LQKSCTFDEQRTATIMEELADALMYC 139
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN          ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 140 HGKKVIHRDIKPEN---LLLGLKGELKIADFGWSVHA-PSLRRKTMCGTLDYLPPEMIEG 195
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           R ++ + D+W IGV+ Y LL G+ PF + + +  +R +++ D  F      SV   A+D 
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP----ASVPTGAQDL 251
Query: 388 VKRLLNKDYRKRMTAVQA 405
           + +LL  +  +R+   Q 
Sbjct: 252 ISKLLRHNPSERLPLAQV 269

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 92  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 150 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 204
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 259
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 260 DLLRNLLQVDLTKRF 274

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEIXI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEIXI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 125/250 (50%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 34  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 89
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 148
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L     +   +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 149 LIYRDLKPENLLID---EQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 204 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 258
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 259 LLQVDLTKRF 268

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEIXI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 48  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 103
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 162
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 163 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 272
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 273 LLQVDLTKRF 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 133/266 (50%), Gaps = 22/266 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQV----AVKIISKAKMTTAISIEDVRREVKI 203
           +Y  G+ +G+G F        K  E+ D       A K++ K+ +      E +  E+ I
Sbjct: 43  RYMRGRFLGKGGFA-------KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K+L  + H+V F    ED + VY+V+E+C    LL+ +  R    TE +A+  + Q + 
Sbjct: 96  HKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQ 153
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVA 322
            V + H   V+HRDLK  N       DD D+++ DFGL+  I  D ER   + G+  Y+A
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIA 210
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL  + +S E DIWS+G I Y LL G  PF     S +    +R   N   +P   ++
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYSVPR-HIN 266
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           P A   ++R+L+ D   R +  + L+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLT 292

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 68  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 123
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEYLHSLD 182
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 183 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 292
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 293 LLQVDLTKRF 302

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 92  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 150 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 204
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 259
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 260 DLLRNLLQVDLTKRF 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 133/266 (50%), Gaps = 22/266 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQV----AVKIISKAKMTTAISIEDVRREVKI 203
           +Y  G+ +G+G F        K  E+ D       A K++ K+ +      E +  E+ I
Sbjct: 43  RYMRGRFLGKGGFA-------KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K+L  + H+V F    ED + VY+V+E+C    LL+ +  R    TE +A+  + Q + 
Sbjct: 96  HKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQ 153
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVA 322
            V + H   V+HRDLK  N       DD D+++ DFGL+  I  D ER   + G+  Y+A
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIA 210
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL  + +S E DIWS+G I Y LL G  PF     S +    +R   N   +P   ++
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYSVPR-HIN 266
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           P A   ++R+L+ D   R +  + L+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLT 292

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 142/273 (52%), Gaps = 22/273 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++G+ +G+G FG+   AR K+ +     +A+K++ K+++        +RRE++I   L 
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++  +   D   +Y+++E    GEL  + L + GR+ E+ +   + ++   + +C
Sbjct: 74  -HPNILRMYNYFHDRKRIYLMLEFAPRGELY-KELQKHGRFDEQRSATFMEELADALHYC 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L        ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 132 HERKVIHRDIKPENLLMGY---KGELKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEG 187
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           +++  + D+W  GV+ Y  L G  PF + + +   R ++  D  F     P +S  +KD 
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL 243
Query: 388 VKRLLNKDYRKRMTA--------VQALSKLVVP 412
           + +LL     +R+          V+A S+ V+P
Sbjct: 244 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 276

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 139/263 (52%), Gaps = 18/263 (6%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           VAPE+L R   ++   D+WS G++   +L G  P+   ++S    +  +    + + PW 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWK 232
Query: 379 SVSPEAKDFVKRLLNKDYRKRMT 401
            +       + ++L ++   R+T
Sbjct: 233 KIDSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 139/263 (52%), Gaps = 18/263 (6%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           VAPE+L R   ++   D+WS G++   +L G  P+   ++S    +  +    + + PW 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWK 232
Query: 379 SVSPEAKDFVKRLLNKDYRKRMT 401
            +       + ++L ++   R+T
Sbjct: 233 KIDSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 139/263 (52%), Gaps = 18/263 (6%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           VAPE+L R   ++   D+WS G++   +L G  P+   ++S    +  +    + + PW 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWK 232
Query: 379 SVSPEAKDFVKRLLNKDYRKRMT 401
            +       + ++L ++   R+T
Sbjct: 233 KIDSAPLALLHKILVENPSARIT 255

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+  E+G G FG    A+ K+  +     A K+I      +   +ED   E+ IL A  
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTK---SEEELEDYMVEIDIL-ASC 91
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  DA    NN++I++E C GG +   +L      TE   + +  Q L  + + 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H   ++HRDLK  N LFT    D D++L DFG+S    R  +R +  +G+ Y++APEV+ 
Sbjct: 152 HDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 327 -----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-V 380
                 R Y  +AD+WS+G+    +     P        +   + +S+P    L  PS  
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--PTLAQPSRW 266
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
           S   KDF+K+ L K+   R T  Q L    V + S K
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFGL+   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGLAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFAEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 42  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 97
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    + H   
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEYLHSLD 156
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 157 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 212 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 266
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 267 LLQVDLTKRF 276

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 56
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 57  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 114
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFGL+   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLMIDQ---QGYIQVTDFGLAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+  E+G G FG    A+ K+  +     A K+I      +   +ED   E+ IL A  
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSV---LAAAKVID---TKSEEELEDYMVEIDIL-ASC 91
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  DA    NN++I++E C GG +   +L      TE   + +  Q L  + + 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H   ++HRDLK  N LFT    D D++L DFG+S    R  +R +  +G+ Y++APEV+ 
Sbjct: 152 HDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 327 -----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-V 380
                 R Y  +AD+WS+G+    +     P        +   + +S+P    L  PS  
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--PTLAQPSRW 266
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
           S   KDF+K+ L K+   R T  Q L    V + S K
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+  E+G G FG    A+ K+  +     A K+I      +   +ED   E+ IL A  
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSV---LAAAKVID---TKSEEELEDYMVEIDIL-ASC 91
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  DA    NN++I++E C GG +   +L      TE   + +  Q L  + + 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H   ++HRDLK  N LFT    D D++L DFG+S    R  +R +  +G+ Y++APEV+ 
Sbjct: 152 HDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 327 -----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-V 380
                 R Y  +AD+WS+G+    +     P        +   + +S+P    L  PS  
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--PTLAQPSRW 266
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
           S   KDF+K+ L K+   R T  Q L    V + S K
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +  E   + VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +  E   + VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 120/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWTLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 84
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 85  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 143 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWTLCGTPEYLAPEIIL 197
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 252
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 253 DLLRNLLQVDLTKRF 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +  E   + VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +  E   + VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G +G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 58
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
             A+  H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 59  -NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKAL 207
           +EL + +G+G +G     R   G    +  A+K++ KA +   A      + E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  +V    A +    +Y+++E   GGEL  + L R G + E+ A   + +I   +  
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGH 136
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL 326
            H +G+++RDLKPEN +         ++L DFGL  + I      +   G+  Y+APE+L
Sbjct: 137 LHQKGIIYRDLKPENIMLNH---QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            RS ++   D WS+G + Y +L G+ PF           +L+   N   LP P ++ EA+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN---LP-PYLTQEAR 249
Query: 386 DFVKRLLNKDYRKRMTA 402
           D +K+LL ++   R+ A
Sbjct: 250 DLLKKLLKRNAASRLGA 266

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 122/258 (47%), Gaps = 13/258 (5%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           + +   K +G+G FG    AR K  E+     AVK++ K  +      + +  E  +L  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVF---YAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
              H  LV    + +  + +Y V++   GGEL    L R   + E  A+    +I S + 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALG 153
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
           + H   +V+RDLKPEN L  S      + L DFGL  + I  +   +   G+  Y+APEV
Sbjct: 154 YLHSLNIVYRDLKPENILLDS---QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 326 LHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           LH+  Y    D W +G + Y +L G  PF++R  + ++  +L           P+++  A
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSA 266
Query: 385 KDFVKRLLNKDYRKRMTA 402
           +  ++ LL KD  KR+ A
Sbjct: 267 RHLLEGLLQKDRTKRLGA 284

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKAL 207
           +EL + +G+G +G     R   G    +  A+K++ KA +   A      + E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  +V    A +    +Y+++E   GGEL  + L R G + E+ A   + +I   +  
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGH 136
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL 326
            H +G+++RDLKPEN +         ++L DFGL  + I      +   G+  Y+APE+L
Sbjct: 137 LHQKGIIYRDLKPENIMLNH---QGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL 193
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            RS ++   D WS+G + Y +L G+ PF           +L+   N   LP P ++ EA+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN---LP-PYLTQEAR 249
Query: 386 DFVKRLLNKDYRKRMTA 402
           D +K+LL ++   R+ A
Sbjct: 250 DLLKKLLKRNAASRLGA 266

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 68  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 123
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 182
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R       + G+  Y+APE +L + Y+
Sbjct: 183 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGATWTLCGTPEYLAPEIILSKGYN 237
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 292
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 293 LLQVDLTKRF 302

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE ++ + Y+
Sbjct: 162 LIYRDLKPENLIIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLMIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+AP  +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GG++    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 123/248 (49%), Gaps = 17/248 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRK 398
           LL  D  K
Sbjct: 272 LLQVDLTK 279

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GG++    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 157 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 266
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 133/255 (52%), Gaps = 15/255 (5%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G G  G  C AR K      +QVAVK++   K       E +  EV I++    H ++
Sbjct: 52  KIGEGSTGIVCLAREKHS---GRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HFNV 104
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           V+   +      ++++ME  +GG L D  +    R  EE    +   +L  +A+ H QGV
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YS 331
           +HRD+K ++ L T    D  ++L DFG    I  D  +   +VG+ Y++APEV+ RS Y+
Sbjct: 163 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
            E DIWS+G++   ++ G  P+++ +     +  LR  P         VSP  +DF++R+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 392 LNKDYRKRMTAVQAL 406
           L +D ++R TA + L
Sbjct: 279 LVRDPQERATAQELL 293

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 119/215 (55%), Gaps = 17/215 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI-EDVRREVKI 203
           F   ++L + +G G  G    A  +   + ++ VAVKI+    M  A+   E++++E+ I
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNR---VTEEAVAVKIVD---MKRAVDCPENIKKEICI 57
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            K L+ H+++VKF     + N  Y+ +E C GGEL DRI    G   E DA+    Q+++
Sbjct: 58  NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMA 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320
            V + H  G+ HRD+KPEN L    RD  ++++ DFGL+   R + R   LN + G+  Y
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDE-RD--NLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 321 VAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           VAPE+L R   ++   D+WS G++   +L G  P+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    L K   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    L K   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 50  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 108
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 109 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 164
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 165 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 223
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 224 --SCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 46  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 104
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 105 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 160
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 161 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 219
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 220 --SCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 46  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 104
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 105 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 160
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 161 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 219
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 220 --SCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A++    
Sbjct: 47  KTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPF 102
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    + H   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
           +++RDLKPEN L         +++ DFG +   R   R   + G+   +APE +L + Y+
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWXLCGTPEALAPEIILSKGYN 216
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKR 390
              D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + KD ++ 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRN 271
Query: 391 LLNKDYRKRM 400
           LL  D  KR 
Sbjct: 272 LLQVDLTKRF 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 128/257 (49%), Gaps = 15/257 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ + +G G FG     R +      +  A+K++ K  +     +E    E +++ ++ 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIV 63
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  +++     +D   ++++M+  EGGEL   +L +  R+    AK    ++   + + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + +++RDLKPEN L      +  +++ DFG + ++ PD     + G+  Y+APEV+  
Sbjct: 123 HSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYV-PDVTYX-LCGTPDYIAPEVVST 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + Y+   D WS G++ Y +L G  PF+       +  +L ++  F     P  + + KD 
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDL 233
Query: 388 VKRLLNKDYRKRMTAVQ 404
           + RL+ +D  +R+  +Q
Sbjct: 234 LSRLITRDLSQRLGNLQ 250

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G G FG     +  +        A+KI+ K K+     IE    E +IL+A+
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHME---TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    L K   + +D +N+Y+VME   GGE+    L R GR+ E  A+    QI+    +
Sbjct: 100 N-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSH-LRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN +         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLMIDQ---QGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  + +G G FG     + K+        A+KI+ K K+     IE    E +I +A+
Sbjct: 43  QFERIRTLGTGSFGRVMLVKHKE---TGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+V+E   GGE+    L R GR++E  A+    QI+    +
Sbjct: 100 N-FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VL 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+  Y+APE +L
Sbjct: 158 LHSLDLIYRDLKPENLLIDQ---QGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIIL 212
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F     PS  S + K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLK 267
Query: 386 DFVKRLLNKDYRKRM 400
           D ++ LL  D  KR 
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ + +G+G FG+   AR K+ +     +A+K++ K+++        +RRE++I   L 
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++++  +   D   +Y+++E    GEL    L + GR+ E+ +   + ++   + +C
Sbjct: 73  -HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHYC 130
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH- 327
           H + V+HRD+KPEN L        ++++ DFG S    P  R   + G+  Y+ PE++  
Sbjct: 131 HERKVIHRDIKPENLLMGY---KGELKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEG 186
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           +++  + D+W  GV+ Y  L G  PF + + +   R ++  D  F     P +S  +KD 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL 242
Query: 388 VKRLLNKDYRKRMTA--------VQALSKLVVP 412
           + +LL     +R+          V+A S+ V+P
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 70  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 128
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 129 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 184
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 243
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 244 --SCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLN 291

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/337 (27%), Positives = 161/337 (47%), Gaps = 53/337 (15%)
Query: 107 ASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSA 166
            SL K+ G      +   +ER T   Q L+K+         +Y+    VG G +G  CS+
Sbjct: 14  TSLYKKAGSAAAPFTMSHKERPTFYRQELNKTIW---EVPERYQTLSPVGSGAYGSVCSS 70
Query: 167 RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------AC 220
              K  LK   +AVK +S+    + I  +   RE+++LK +  H++++   D      + 
Sbjct: 71  YDVKSGLK---IAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPATSL 125
Query: 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP 280
           E+ N+VY+V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP
Sbjct: 126 EEFNDVYLVTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 182
Query: 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWS 338
            N    +  +D +++++DFGL+     D+ +   V + +Y APE++     Y++  DIWS
Sbjct: 183 SNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWS 237
Query: 339 IGVISYILLCGSRPF-----------------------WARTESGIFRAVLRSDP----- 370
           +G I   LL G   F                        +R  S   R  + S P     
Sbjct: 238 VGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKR 297
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           NF D+ +   +P A D ++++L  D  KR+TA +AL+
Sbjct: 298 NFADV-FIGANPLAVDLLEKMLVLDTDKRITASEALA 333

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 68  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 126
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 127 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 182
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 183 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 241
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 242 --SCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 289

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A KI+ K+ +      E +  E+ I ++L+ H+H+V F    ED + V++V+ELC    L
Sbjct: 44  AGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 102
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           L+ +  R    TE +A+  + QI+    + H   V+HRDLK  N       +D ++++ D
Sbjct: 103 LE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGD 158
Query: 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+  +  D ER   + G+  Y+APEVL +  +S E D+WSIG I Y LL G  PF   
Sbjct: 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET- 217
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S +    LR   N   +P   ++P A   ++++L  D   R T  + L+
Sbjct: 218 --SCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 265

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 17/260 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            +E  + +G+G FG    AR K+ G+L     AVK++ K  +     +E    E +IL  
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDL----YAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
              H  L +     +  + ++ VME   GG+L+  I  +  R+ E  A+    +I+S + 
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALM 138
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
           F H +G+++RDLK +N L      +   +L DFG+  + I          G+  Y+APE+
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 326 LHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPE 383
           L    Y    D W++GV+ Y +LCG  PF A  E  +F A+L      D++ +P+ +  +
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLHED 250
Query: 384 AKDFVKRLLNKDYRKRMTAV 403
           A   +K  + K+   R+ ++
Sbjct: 251 ATGILKSFMTKNPTMRLGSL 270

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 10  FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 65
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 124
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 125 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 237
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 238 LLAGLLKKDPKQRL 251

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 234
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 235 LLAGLLKKDPKQRL 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKS 234
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 235 LLAGLLKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 234
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 235 LLAGLLKKDPKQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 234
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 235 LLAGLLKKDPKQRL 248

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 12  FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 127 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 239
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 240 LLAGLLKKDPKQRL 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  +
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-T 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L     A +  + +  VME   GGEL    L+R   +TEE A+    +I+S + + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H + VV+RD+K EN +      D  +++ DFGL  + I     +    G+  Y+APEVL 
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
              Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS 234
Query: 387 FVKRLLNKDYRKRM 400
            +  LL KD ++R+
Sbjct: 235 LLAGLLKKDPKQRL 248

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 13/254 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +EL K +G+G FG    A  KK    +Q  A+K + K  +     +E    E ++L    
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L       +   N++ VME   GG+L+  I +   ++    A     +I+  + F 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFL 135
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H +G+V+RDLK +N L      D  +++ DFG+  + +  D + N+  G+  Y+APE+L 
Sbjct: 136 HSKGIVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            + Y+   D WS GV+ Y +L G  PF  + E  +F ++   +P +    W  +  EAKD
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RW--LEKEAKD 248
Query: 387 FVKRLLNKDYRKRM 400
            + +L  ++  KR+
Sbjct: 249 LLVKLFVREPEKRL 262

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 131/259 (50%), Gaps = 18/259 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           + +EL K +G+G FG     R           A+K++ KA +     +   + E  IL  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILAD 86
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           ++ H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + ++   + 
Sbjct: 87  VN-HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALGLD 144
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
             H  G+++RDLKPEN L     ++  ++L DFGLS + I  +++     G+  Y+APEV
Sbjct: 145 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 326 LHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSVS 381
           ++R  +S  AD WS GV+ + +L GS PF  +        +L++    P F       +S
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF-------LS 254
Query: 382 PEAKDFVKRLLNKDYRKRM 400
            EA+  ++ L  ++   R+
Sbjct: 255 TEAQSLLRALFKRNPANRL 273

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 156/329 (47%), Gaps = 53/329 (16%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G  P+ S + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR 68
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYI 228
              VAVK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+
Sbjct: 69  ---VAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 123
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    + 
Sbjct: 124 VTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AV 177
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL 346
            +D +++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   L
Sbjct: 178 NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 347 LCGSRPFWARTESGIFRAVLR----------------------------SDPNFDDLPWP 378
           L G   F         + +LR                               NF ++ + 
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FI 294
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +P A D ++++L  D  KR+TA QAL+
Sbjct: 295 GANPLAVDLLEKMLVLDSDKRITAAQALA 323

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 156/329 (47%), Gaps = 53/329 (16%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G  P+ S + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR 69
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYI 228
              VAVK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+
Sbjct: 70  ---VAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 124
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    + 
Sbjct: 125 VTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AV 178
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL 346
            +D +++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   L
Sbjct: 179 NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 347 LCGSRPFWARTESGIFRAVLR----------------------------SDPNFDDLPWP 378
           L G   F         + +LR                               NF ++ + 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FI 295
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +P A D ++++L  D  KR+TA QAL+
Sbjct: 296 GANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 209
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 268 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 382
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 383 RLLVRDPAQRATAAELL 399

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 57/299 (19%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y+L +++GRG +     A        +++V VKI+   K         ++RE+KIL+ L 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKNK------IKREIKILENLR 89
Query: 209 GHKHLVKFCDACED--VNNVYIVMELCEGGEL--LDRILARGGRYTEEDAKAIVVQILSV 264
           G  +++   D  +D       +V E     +   L + L      T+ D +  + +IL  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL------TDYDIRFYMYEILKA 143
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +  N  V S Y+  PE
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 201
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES------------------GIFRA 364
           +L  ++ Y    D+WS+G +   ++    PF+   ++                   I + 
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 365 VLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +  DP F+D+        W           VSPEA DF+ +LL  D++ R+TA +A+ 
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 320

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 49/288 (17%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VG G +G  CSA  K+     ++VA+K +S+    + I  +   RE+ +LK +  H++++
Sbjct: 32  VGSGAYGSVCSAIDKRS---GEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQ-HENVI 86
Query: 215 KFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              D      +  +  + Y+VM   +    L +I+  G +++EE  + +V Q+L  + + 
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIM--GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-- 326
           H  GVVHRDLKP N    +  +D +++++DFGL+     D  +   V + +Y APEV+  
Sbjct: 143 HSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILS 197
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----------------SD 369
              Y+   DIWS+G I   +L G   F  +        +L+                 + 
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 370 PNFDDLP----------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                LP          +P  SP+A D ++++L  D  KR+TA QAL+
Sbjct: 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 81  KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 132
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 191 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 305
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 306 RLLVRDPAQRATAAELL 322

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K     D+  A+KI++K +M         R E  +L    
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVL-VNG 131
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
             K +     A +D NN+Y+VM+   GG+LL  +     R  EE A+  + +++  +   
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEVL 326
           H    VHRD+KP+N L      +  +RL DFG    +  D  +     VG+  Y++PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 327 HR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS- 379
                    Y  E D WS+GV  Y +L G  PF+A +    +  ++     F    +P+ 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPTQ 305
Query: 380 ---VSPEAKDFVKRLL-NKDYRKRMTAVQALSK 408
              VS  AKD ++RL+ ++++R     ++   K
Sbjct: 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 49/288 (17%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VG G +G  CSA  K+     ++VA+K +S+    + I  +   RE+ +LK +  H++++
Sbjct: 50  VGSGAYGSVCSAIDKRS---GEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQ-HENVI 104
Query: 215 KFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              D      +  +  + Y+VM   +    L +I+  G  ++EE  + +V Q+L  + + 
Sbjct: 105 GLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIM--GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-- 326
           H  GVVHRDLKP N    +  +D +++++DFGL+     D  +   V + +Y APEV+  
Sbjct: 161 HSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILS 215
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----------------SD 369
              Y+   DIWS+G I   +L G   F  +        +L+                 + 
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275
Query: 370 PNFDDLP----------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                LP          +P  SP+A D ++++L  D  KR+TA QAL+
Sbjct: 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 155/329 (47%), Gaps = 53/329 (16%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G  P+ S + +ER T   Q L+K+         +Y+    VG G +G  C+A   K    
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---T 66
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYI 228
             +VAVK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+
Sbjct: 67  GHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 124
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    + 
Sbjct: 125 VTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AV 178
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL 346
            +D +++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   L
Sbjct: 179 NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 347 LCGSRPFWARTESGIFRAVLR----------------------------SDPNFDDLPWP 378
           L G   F         + +LR                               NF ++ + 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FI 295
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +P A D ++++L  D  KR+TA QAL+
Sbjct: 296 GANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 155/329 (47%), Gaps = 53/329 (16%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G  P+ S + +ER T   Q L+K+         +Y+    VG G +G  C+A   K    
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---T 65
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYI 228
             +VAVK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+
Sbjct: 66  GHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 123
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    + 
Sbjct: 124 VTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AV 177
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL 346
            +D +++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   L
Sbjct: 178 NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 347 LCGSRPFWARTESGIFRAVLR----------------------------SDPNFDDLPWP 378
           L G   F         + +LR                               NF ++ + 
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FI 294
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +P A D ++++L  D  KR+TA QAL+
Sbjct: 295 GANPLAVDLLEKMLVLDSDKRITAAQALA 323

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 38  KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 89
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 148 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 262
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 263 RLLVRDPAQRATAAELL 279

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 155/329 (47%), Gaps = 53/329 (16%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G  P+ S + +ER T   Q L+K+         +Y+    VG G +G  C+A   K    
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---T 66
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYI 228
             +VAVK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+
Sbjct: 67  GHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 124
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
           V  L  G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    + 
Sbjct: 125 VTHLM-GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AV 178
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL 346
            +D +++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   L
Sbjct: 179 NEDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 347 LCGSRPFWARTESGIFRAVLR----------------------------SDPNFDDLPWP 378
           L G   F         + +LR                               NF ++ + 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FI 295
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +P A D ++++L  D  KR+TA QAL+
Sbjct: 296 GANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 133/260 (51%), Gaps = 15/260 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ + +G+G FG  C    +K + K +  A+K ++K K      + +V +E++I++ L 
Sbjct: 17  FEILRAIGKGSFGKVCIV--QKNDTK-KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV    + +D  ++++V++L  GG+L    L +   + EE  K  + +++  + + 
Sbjct: 74  -HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYL 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
             Q ++HRD+KP+N L     +   + + DF ++  +  + ++  + G+  Y+APE+   
Sbjct: 132 QNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 329 ----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV-SPE 383
                YS   D WS+GV +Y LL G RP+  R+ +     V   +     + +PS  S E
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQE 246
Query: 384 AKDFVKRLLNKDYRKRMTAV 403
               +K+LL  +  +R + +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQL 266

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 36  KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 87
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 146 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 260
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 261 RLLVRDPAQRATAAELL 277

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/322 (26%), Positives = 153/322 (47%), Gaps = 53/322 (16%)
Query: 122 TIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK 181
           ++ +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK
Sbjct: 12  SMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVK 65
Query: 182 IISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEG 235
            +SK    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G
Sbjct: 66  KLSKP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++
Sbjct: 123 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELK 177
Query: 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F
Sbjct: 178 ILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 354 WARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAK 385
                    + +LR                               NF ++ +   +P A 
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAV 294
Query: 386 DFVKRLLNKDYRKRMTAVQALS 407
           D ++++L  D  KR+TA QAL+
Sbjct: 295 DLLEKMLVLDSDKRITAAQALA 316

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 78
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 137 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 251
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 252 RLLVRDPAQRATAAELL 268

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 13/252 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L K +G+G FG    A  KK    +Q  A+K + K  +     +E    E ++L     H
Sbjct: 21  LHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
             L       +   N++ VME   GG+L+  I +   ++    A     +I+  + F H 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-R 328
           +G+V+RDLK +N L      D  +++ DFG+  + +  D + N   G+  Y+APE+L  +
Sbjct: 137 KGIVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
            Y+   D WS GV+ Y +L G  PF  + E  +F ++   +P +    W  +  EAKD +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLL 249
Query: 389 KRLLNKDYRKRM 400
            +L  ++  KR+
Sbjct: 250 VKLFVREPEKRL 261

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           ++G G  G  C A  +  G+L    VAVK   K  +      E +  EV I++    H++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 82
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+  ++    + +++VME  EGG L D  +    R  EE   A+ + +L  ++  H QG
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
           V+HRD+K ++ L T    D  ++L DFG    +  +  R   +VG+ Y++APE++ R  Y
Sbjct: 141 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVK 389
             E DIWS+G++   ++ G  P++        + +  +  P   +L    VSP  K F+ 
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL--HKVSPSLKGFLD 255
Query: 390 RLLNKDYRKRMTAVQAL 406
           RLL +D  +R TA + L
Sbjct: 256 RLLVRDPAQRATAAELL 272

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN- 204
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + +
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDY 263
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
            H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEV
Sbjct: 264 LHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++ PEA
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEA 376
Query: 385 KDFVKRLLNKDYRKRM 400
           K  +  LL KD ++R+
Sbjct: 377 KSLLSGLLKKDPKQRL 392

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN- 207
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + +
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDY 266
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
            H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEV
Sbjct: 267 LHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 323
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++ PEA
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEA 379
Query: 385 KDFVKRLLNKDYRKRM 400
           K  +  LL KD ++R+
Sbjct: 380 KSLLSGLLKKDPKQRL 395

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 28/265 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAV-KIISKAKMTTAISIEDVRREVKILKAL 207
           YE+   +G G +G     R K     D ++ V K +    MT A   + +  EV +L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGR----YTEEDAKAIVVQI 261
             H ++V++ D   D  N  +YIVME CEGG+L   ++ +G +      EE    ++ Q+
Sbjct: 63  K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQL 120
Query: 262 LSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIV 315
              +  CH +      V+HRDLKP N +F  G+   +++L DFGL+  +  DE    + V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPAN-VFLDGK--QNVKLGDFGLARILNHDEDFAKEFV 177
Query: 316 GSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           G+ YY++PE ++R SY+ ++DIWS+G + Y L     PF A ++  +   +   +  F  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKFRR 235
Query: 375 LPWPSVSPEAKDFVKRLLN-KDYRK 398
           +P+   S E  + + R+LN KDY +
Sbjct: 236 IPY-RYSDELNEIITRMLNLKDYHR 259

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN- 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + +
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDY 124
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
            H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEV
Sbjct: 125 LHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++ PEA
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEA 237
Query: 385 KDFVKRLLNKDYRKRM 400
           K  +  LL KD ++R+
Sbjct: 238 KSLLSGLLKKDPKQRL 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN- 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + +
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDY 125
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
            H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEV
Sbjct: 126 LHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++ PEA
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEA 238
Query: 385 KDFVKRLLNKDYRKRM 400
           K  +  LL KD ++R+
Sbjct: 239 KSLLSGLLKKDPKQRL 254

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 155/321 (48%), Gaps = 51/321 (15%)
Query: 122 TIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK 181
           ++ +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK
Sbjct: 2   SMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVK 55
Query: 182 IISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEG 235
            +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G
Sbjct: 56  KLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D++++
Sbjct: 113 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELK 167
Query: 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F
Sbjct: 168 ILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 354 WARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKD 386
                    + +LR                S  N+      +P       +   +P A D
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 285
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 286 LLEKMLVLDSDKRITAAQALA 306

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN- 64
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +I+S + +
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDY 123
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEV 325
            H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+  Y+APEV
Sbjct: 124 LHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 180
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++ PEA
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEA 236
Query: 385 KDFVKRLLNKDYRKRM 400
           K  +  LL KD ++R+
Sbjct: 237 KSLLSGLLKKDPKQRL 252

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 153/322 (47%), Gaps = 53/322 (16%)
Query: 122 TIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK 181
           ++ +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK
Sbjct: 12  SMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVK 65
Query: 182 IISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEG 235
            +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G
Sbjct: 66  KLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++
Sbjct: 123 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELK 177
Query: 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F
Sbjct: 178 ILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 354 WARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAK 385
                    + +LR                               NF ++ +   +P A 
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAV 294
Query: 386 DFVKRLLNKDYRKRMTAVQALS 407
           D ++++L  D  KR+TA QAL+
Sbjct: 295 DLLEKMLVLDSDKRITAAQALA 316

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 153/322 (47%), Gaps = 53/322 (16%)
Query: 122 TIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK 181
           ++ +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK
Sbjct: 12  SMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVK 65
Query: 182 IISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEG 235
            +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G
Sbjct: 66  KLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++
Sbjct: 123 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELK 177
Query: 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F
Sbjct: 178 ILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 354 WARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAK 385
                    + +LR                               NF ++ +   +P A 
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAV 294
Query: 386 DFVKRLLNKDYRKRMTAVQALS 407
           D ++++L  D  KR+TA QAL+
Sbjct: 295 DLLEKMLVLDSDKRITAAQALA 316

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A+K++ K  +     I+ V+ E  + +  S
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV      +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + + 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 122
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H +G+++RDLK +N L  S   +  ++L D+G+  + +RP +  +   G+  Y+APE+L 
Sbjct: 123 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPW 377
              Y    D W++GV+ + ++ G  PF            TE  +F+ +L        +P 
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP- 235
Query: 378 PSVSPEAKDFVKRLLNKDYRKRM 400
            S+S +A   +K  LNKD ++R+
Sbjct: 236 RSLSVKAASVLKSFLNKDPKERL 258

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 153/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++  +  Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A+K++ K  +     I+ V+ E  + +  S
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV      +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + + 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H +G+++RDLK +N L  S   +  ++L D+G+  + +RP +  +   G+  Y+APE+L 
Sbjct: 127 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPW 377
              Y    D W++GV+ + ++ G  PF            TE  +F+ +L        +P 
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP- 239
Query: 378 PSVSPEAKDFVKRLLNKDYRKRM 400
            S+S +A   +K  LNKD ++R+
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL 262

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 154/323 (47%), Gaps = 51/323 (15%)
Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVA 179
           +S   +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VA
Sbjct: 21  QSNASQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VA 74
Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELC 233
           VK +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L 
Sbjct: 75  VKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM 132
Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
            G +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +
Sbjct: 133 -GADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCE 186
Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSR 351
           ++++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G  
Sbjct: 187 LKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244
Query: 352 PFWARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEA 384
            F         + +LR                S  N+      +P       +   +P A
Sbjct: 245 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 304
Query: 385 KDFVKRLLNKDYRKRMTAVQALS 407
            D ++++L  D  KR+TA QAL+
Sbjct: 305 VDLLEKMLVLDSDKRITAAQALA 327

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 153/320 (47%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 284
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 285 LEKMLVLDSDKRITAAQALA 304

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 154/320 (48%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 7   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 60
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 61  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 117
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D+++++
Sbjct: 118 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 172
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 173 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 290
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 291 LEKMLVLDSDKRITAAQALA 310

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A+K++ K  +     I+ V+ E  + +  S
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV      +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + + 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 137
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H +G+++RDLK +N L  S   +  ++L D+G+  + +RP +  +   G+  Y+APE+L 
Sbjct: 138 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPW 377
              Y    D W++GV+ + ++ G  PF            TE  +F+ +L        +P 
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP- 250
Query: 378 PSVSPEAKDFVKRLLNKDYRKRM 400
            S+S +A   +K  LNKD ++R+
Sbjct: 251 RSMSVKAASVLKSFLNKDPKERL 273

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 3   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 56
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 57  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 113
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D++++++D
Sbjct: 114 NN--IVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKILD 168
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL      D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 169 FGLCR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 227 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 285
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 286 EKMLVLDSDKRITAAQALA 304

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 154/321 (47%), Gaps = 51/321 (15%)
Query: 122 TIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK 181
           ++ +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK
Sbjct: 2   SMSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVK 55
Query: 182 IISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEG 235
            +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G
Sbjct: 56  KLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++
Sbjct: 113 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELK 167
Query: 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F
Sbjct: 168 ILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 354 WARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKD 386
                    + +LR                S  N+      +P       +   +P A D
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 285
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 286 LLEKMLVLDSDKRITAAQALA 306

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 136/268 (50%), Gaps = 22/268 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G FG     +  +     +Q  +K I+ ++M++    E+ RREV +L  +
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLANM 80
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA-IVVQILSVVA 266
             H ++V++ ++ E+  ++YIVM+ CEGG+L  RI A+ G   +ED      VQI   + 
Sbjct: 81  K-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAPEV 325
             H + ++HRD+K +N   T    D  ++L DFG++  +     L    +G+ YY++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV---- 380
             ++ Y+ ++DIW++G + Y L      F A +   +   ++          +P V    
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------FPPVSLHY 249
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALSK 408
           S + +  V +L  ++ R R +    L K
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 20/256 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG F      + K+     Q  A+KI++K  M     +   R E  +L    
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-G 118
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
             + + +   A +D N +Y+VME   GG+LL  +   G R   E A+  + +I+  +   
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--VGSAYYVAPEVL 326
           H  G VHRD+KP+N L         +RL DFG    +R D  +  +  VG+  Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 327 HRSYSL--------EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW- 377
                         E D W++GV +Y +  G  PF+A + +  +  ++    +   LP  
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL-SLPLV 294
Query: 378 -PSVSPEAKDFVKRLL 392
              V  EA+DF++RLL
Sbjct: 295 DEGVPEEARDFIQRLL 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 24  MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 77
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 78  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 134
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 135 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 189
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 190 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 247
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 248 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 306
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 307 LLEKMLVLDSDKRITAAQALA 327

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A++++ K  +     I+ V+ E  + +  S
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV      +  + ++ V+E   GG+L+   + R  +  EE A+    +I   + + 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 169
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH 327
           H +G+++RDLK +N L  S   +  ++L D+G+  + +RP +  +   G+  Y+APE+L 
Sbjct: 170 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPW 377
              Y    D W++GV+ + ++ G  PF            TE  +F+ +L        +P 
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP- 282
Query: 378 PSVSPEAKDFVKRLLNKDYRKRM 400
            S+S +A   +K  LNKD ++R+
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERL 305

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 153/320 (47%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 12  MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 65
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 66  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 122
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 123 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 177
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 178 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 235
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 236 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 295
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 296 LEKMLVLDSDKRITAAQALA 315

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 7   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 60
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 61  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 117
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 118 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 173 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 289
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 290 LLEKMLVLDSDKRITAAQALA 310

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 140/290 (48%), Gaps = 42/290 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G +G    A+   GE      A+K I   K    I    +R E+ ILK L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGE----TFALKKIRLEKEDEGIPSTTIR-EISILKEL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
             H ++VK  D       + +V E  +    +LLD  +  GG      AK+ ++Q+L+ +
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGG-LESVTAKSFLLQLLNGI 113
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPE 324
           A+CH + V+HRDLKP+N L      + ++++ DFGL+  F  P  +    V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFR--------------A 364
           VL   + YS   DIWS+G I   ++ G+  F   +E+     IFR               
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 365 VLRSDPNF---DDLPWPS----VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + DPNF   + LPW S    +     D + ++L  D  +R+TA QAL 
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 152/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 8   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 61
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 62  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 118
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 119 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILD 173
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 174 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 232 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 291
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 292 KMLVLDSDKRITAAQALA 309

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 12  MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 65
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 66  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 122
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 123 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 177
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 178 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 235
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 236 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 294
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 295 LLEKMLVLDSDKRITAAQALA 315

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 6   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 59
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 60  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 116
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 117 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 171
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 229
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 230 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 288
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 289 LLEKMLVLDSDKRITAAQALA 309

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 3   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 56
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 57  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 113
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 114 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 169 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 226
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 227 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 285
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 286 LLEKMLVLDSDKRITAAQALA 306

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 140/290 (48%), Gaps = 42/290 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G +G    A+   GE      A+K I   K    I    +R E+ ILK L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGE----TFALKKIRLEKEDEGIPSTTIR-EISILKEL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
             H ++VK  D       + +V E  +    +LLD  +  GG      AK+ ++Q+L+ +
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGG-LESVTAKSFLLQLLNGI 113
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPE 324
           A+CH + V+HRDLKP+N L      + ++++ DFGL+  F  P  +    V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFR--------------A 364
           VL   + YS   DIWS+G I   ++ G+  F   +E+     IFR               
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 365 VLRSDPNF---DDLPWPS----VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + DPNF   + LPW S    +     D + ++L  D  +R+TA QAL 
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 10  QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 63
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 64  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 120
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 121 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 175
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 176 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 292
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 293 EKMLVLDSDKRITAAQALA 311

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 152/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 5   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 58
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 59  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 115
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 116 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 170
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 171 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 229 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 288
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 289 KMLVLDSDKRITAAQALA 306

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 152/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 9   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 62
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 63  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 119
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 120 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 174
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 175 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 233 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 292
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 293 KMLVLDSDKRITAAQALA 310

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 3   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 56
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 57  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 113
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 114 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 168
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 169 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 227 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 285
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 286 EKMLVLDSDKRITAAQALA 304

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 8   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 61
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 62  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 118
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 119 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 173
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 174 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 232 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 290
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 291 EKMLVLDSDKRITAAQALA 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 2   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 55
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 56  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 112
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 113 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 167
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 168 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 226 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 284
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 285 EKMLVLDSDKRITAAQALA 303

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 140/290 (48%), Gaps = 42/290 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G +G    A+   GE      A+K I   K    I    +R E+ ILK L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGE----TFALKKIRLEKEDEGIPSTTIR-EISILKEL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
             H ++VK  D       + +V E  +    +LLD  +  GG      AK+ ++Q+L+ +
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGG-LESVTAKSFLLQLLNGI 113
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPE 324
           A+CH + V+HRDLKP+N L      + ++++ DFGL+  F  P  +    + + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFR--------------A 364
           VL   + YS   DIWS+G I   ++ G+  F   +E+     IFR               
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 365 VLRSDPNF---DDLPWPS----VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + + DPNF   + LPW S    +     D + ++L  D  +R+TA QAL 
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 151/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    +G G +G  C+A   K  L+   VAVK +S
Sbjct: 8   QERPTFYRQELNKTIW---EVPERYQNLSPIGSGAYGSVCAAFDTKTGLR---VAVKKLS 61
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 62  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 118
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 119 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILD 173
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 174 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 232 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLL 290
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 291 EKMLVLDSDKRITAAQALA 309

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 131/269 (48%), Gaps = 24/269 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E+  E+G G FG    A+ K+ G L     A K+I   +  +   +ED   E++IL A 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGAL----AAAKVI---ETKSEEELEDYIVEIEIL-AT 64
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK   A      ++I++E C GG +   +L      TE   + +  Q+L  + F
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 124
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
            H + ++HRDLK  N L T    + D+RL DFG+S   ++  ++ +  +G+ Y++APEV+
Sbjct: 125 LHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--WP 378
                    Y  +ADIWS+G+    +     P        +   + +SDP     P  W 
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW- 240
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S E +DF+K  L+K+   R +A Q L 
Sbjct: 241 --SVEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 150/318 (47%), Gaps = 53/318 (16%)
Query: 126 ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
           ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S+
Sbjct: 1   ERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSR 54
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELL 239
               + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L 
Sbjct: 55  P-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN 111
Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
           +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DF
Sbjct: 112 N--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDF 166
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWART 357
           GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F    
Sbjct: 167 GLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224
Query: 358 ESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVK 389
                + +LR                               NF ++ +   +P A D ++
Sbjct: 225 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLE 283
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 284 KMLVLDSDKRITAAQALA 301

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 150/318 (47%), Gaps = 53/318 (16%)
Query: 126 ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
           ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S+
Sbjct: 1   ERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSR 54
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELL 239
               + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L 
Sbjct: 55  P-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN 111
Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
           +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DF
Sbjct: 112 N--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDF 166
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWART 357
           GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F    
Sbjct: 167 GLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224
Query: 358 ESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVK 389
                + +LR                               NF ++ +   +P A D ++
Sbjct: 225 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLE 283
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 284 KMLVLDSDKRITAAQALA 301

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 131/269 (48%), Gaps = 24/269 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +E+  E+G G FG    A+ K+ G L     A K+I   +  +   +ED   E++IL A 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGAL----AAAKVI---ETKSEEELEDYIVEIEIL-AT 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK   A      ++I++E C GG +   +L      TE   + +  Q+L  + F
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
            H + ++HRDLK  N L T    + D+RL DFG+S   ++  ++ +  +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--WP 378
                    Y  +ADIWS+G+    +     P        +   + +SDP     P  W 
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW- 248
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             S E +DF+K  L+K+   R +A Q L 
Sbjct: 249 --SVEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 140/293 (47%), Gaps = 31/293 (10%)
Query: 131 PEQSLDK-SFGYNKNFGAKYELGKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKM 188
           P +SLD+      ++    +EL + VG G +G     R  K G+L     A+K++     
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQL----AAIKVMD---- 58
Query: 189 TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN------NVYIVMELCEGGELLDRI 242
            T    E++++E+ +LK  S H+++  +  A    N       +++VME C  G + D I
Sbjct: 59  VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 243 L-ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301
              +G    EE    I  +IL  ++  H   V+HRD+K +N L T   ++A+++L+DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGV 175
Query: 302 S-DFIRPDERLNDIVGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFW 354
           S    R   R N  +G+ Y++APEV+        +Y  ++D+WS+G+ +  +  G+ P  
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
Query: 355 -ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                  +F       P      W   S + + F++  L K++ +R    Q +
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLM 285

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VG G +G  CSA   +     Q+VAVK +S+    + I      RE+++LK L  H++++
Sbjct: 36  VGSGAYGSVCSAYDARLR---QKVAVKKLSRP-FQSLIHARRTYRELRLLKHLK-HENVI 90
Query: 215 KFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              D      + ED + VY+V  L  G +L +  + +    ++E  + +V Q+L  + + 
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM-GADLNN--IVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-- 326
           H  G++HRDLKP N    +  +D+++R++DFGL+   + DE +   V + +Y APE++  
Sbjct: 148 HSAGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLN 202
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPF-----------------------WARTESGIFR 363
              Y+   DIWS+G I   LL G   F                        A+  S   R
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 364 AVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
             ++S P        S+    +P A D + R+L  D  +R++A +AL+
Sbjct: 263 TYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALA 310

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 24/259 (9%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED---VR 198
            + F A+Y LG  +G+G FG   +       L   QVA+K+I + ++     + D     
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL---QVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 199 REVKIL---KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
            EV +L    A  GH  +++  D  E      +V+E     + L   +   G   E  ++
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+++ +  CH +GVVHRD+K EN L    R  A  +LIDFG    +  DE   D  
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLH-DEPYTDFD 199
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           G+  Y  PE +  H+ ++L A +WS+G++ Y ++CG  PF    E      +L ++ +F 
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP 253
Query: 374 DLPWPSVSPEAKDFVKRLL 392
                 VSP+    ++R L
Sbjct: 254 A----HVSPDCCALIRRCL 268

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 19/280 (6%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           +P E   +P  +LD+    + NF         +G+G FG    A  K  E   +  A+KI
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMV------LGKGSFGKVMLADRKGTE---ELYAIKI 51
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI 242
           + K  +     +E    E ++L  L     L +     + V+ +Y VME   GG+L+  I
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI 111
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL- 301
             + G++ E  A     +I   + F H +G+++RDLK +N +  S   +  +++ DFG+ 
Sbjct: 112 -QQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDS---EGHIKIADFGMC 167
Query: 302 SDFIRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
            + +       +  G+  Y+APE++ ++ Y    D W+ GV+ Y +L G  PF    E  
Sbjct: 168 KEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM 400
           +F++++  + ++      S+S EA    K L+ K   KR+
Sbjct: 228 LFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPAKRL 263

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 153/320 (47%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +D+GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 284
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 285 LEKMLVLDSDKRITAAQALA 304

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 28/265 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAV-KIISKAKMTTAISIEDVRREVKILKAL 207
           YE+   +G G +G     R K     D ++ V K +    MT A   + +  EV +L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGR----YTEEDAKAIVVQI 261
             H ++V++ D   D  N  +YIVME CEGG+L   ++ +G +      EE    ++ Q+
Sbjct: 63  K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQL 120
Query: 262 LSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIV 315
              +  CH +      V+HRDLKP N +F  G+ +  ++L DFGL+  +  D       V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKTFV 177
Query: 316 GSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           G+ YY++PE ++R SY+ ++DIWS+G + Y L     PF A ++  +   +   +  F  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKFRR 235
Query: 375 LPWPSVSPEAKDFVKRLLN-KDYRK 398
           +P+   S E  + + R+LN KDY +
Sbjct: 236 IPY-RYSDELNEIITRMLNLKDYHR 259

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 28/265 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAV-KIISKAKMTTAISIEDVRREVKILKAL 207
           YE+   +G G +G     R K     D ++ V K +    MT A   + +  EV +L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGR----YTEEDAKAIVVQI 261
             H ++V++ D   D  N  +YIVME CEGG+L   ++ +G +      EE    ++ Q+
Sbjct: 63  K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQL 120
Query: 262 LSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIV 315
              +  CH +      V+HRDLKP N +F  G+ +  ++L DFGL+  +  D       V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKAFV 177
Query: 316 GSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           G+ YY++PE ++R SY+ ++DIWS+G + Y L     PF A ++  +   +   +  F  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKFRR 235
Query: 375 LPWPSVSPEAKDFVKRLLN-KDYRK 398
           +P+   S E  + + R+LN KDY +
Sbjct: 236 IPY-RYSDELNEIITRMLNLKDYHR 259

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 150/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK +S
Sbjct: 9   QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLS 62
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 63  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 119
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 120 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 174
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 175 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 233 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLL 291
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 292 EKMLVLDSDKRITAAQALA 310

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DFGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 150/319 (47%), Gaps = 53/319 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK +S
Sbjct: 13  QERPTFYRQELNKTIW---EVPERYQNLAPVGSGAYGSVCAAFDTK---TGHRVAVKKLS 66
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 67  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 123
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 124 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 178
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 179 FGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236
Query: 357 TESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFV 388
                 + +LR                               NF ++ +   +P A D +
Sbjct: 237 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLL 295
Query: 389 KRLLNKDYRKRMTAVQALS 407
           +++L  D  KR+TA QAL+
Sbjct: 296 EKMLVLDSDKRITAAQALA 314

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VG G +G  CSA   +     Q+VAVK +S+    + I      RE+++LK L  H++++
Sbjct: 36  VGSGAYGSVCSAYDARLR---QKVAVKKLSRP-FQSLIHARRTYRELRLLKHLK-HENVI 90
Query: 215 KFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              D      + ED + VY+V  L  G +L +  + +    ++E  + +V Q+L  + + 
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM-GADLNN--IVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-- 326
           H  G++HRDLKP N    +  +D+++R++DFGL+   + DE +   V + +Y APE++  
Sbjct: 148 HSAGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLN 202
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPF-----------------------WARTESGIFR 363
              Y+   DIWS+G I   LL G   F                        A+  S   R
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 364 AVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
             ++S P        S+    +P A D + R+L  D  +R++A +AL+
Sbjct: 263 TYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALA 310

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 18/277 (6%)
Query: 130 EPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT 189
           +P+++L    GYN    A + + K++GRG F     A      L    VA+K +    + 
Sbjct: 17  QPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRA---ACLLDGVPVALKKVQIFDLM 71
Query: 190 TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI--LARGG 247
            A +  D  +E+ +LK L+ H +++K+  +  + N + IV+EL + G+L   I    +  
Sbjct: 72  DAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 248 RYT-EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
           R   E       VQ+ S +   H + V+HRD+KP N   T+      ++L D GL  F  
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 187
Query: 307 PDER-LNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES--GIF 362
                 + +VG+ YY++PE +H + Y+ ++DIWS+G + Y +     PF+    +   + 
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247
Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           + + + D  +  LP    S E +  V   +N D  KR
Sbjct: 248 KKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 149/317 (47%), Gaps = 53/317 (16%)
Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
           R T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S+ 
Sbjct: 1   RPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRP 54
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLD 240
              + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L +
Sbjct: 55  -FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 111
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DFG
Sbjct: 112 --IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFG 166
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
           L+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F     
Sbjct: 167 LAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 359 SGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVKR 390
               + +LR                               NF ++ +   +P A D +++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEK 283
Query: 391 LLNKDYRKRMTAVQALS 407
           +L  D  KR+TA QAL+
Sbjct: 284 MLVLDSDKRITAAQALA 300

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 149/317 (47%), Gaps = 53/317 (16%)
Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
           R T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S+ 
Sbjct: 3   RPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRP 56
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLD 240
              + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L +
Sbjct: 57  -FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 113
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DFG
Sbjct: 114 --IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFG 168
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
           L+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F     
Sbjct: 169 LAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 226
Query: 359 SGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVKR 390
               + +LR                               NF ++ +   +P A D +++
Sbjct: 227 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEK 285
Query: 391 LLNKDYRKRMTAVQALS 407
           +L  D  KR+TA QAL+
Sbjct: 286 MLVLDSDKRITAAQALA 302

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 151/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 10  QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 63
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 64  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 120
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 121 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 175
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+      + +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 176 FGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 294 KMLVLDSDKRITAAQALA 311

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 151/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 10  QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 63
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 64  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 120
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 121 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 175
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+      + +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 176 FGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 294 KMLVLDSDKRITAAQALA 311

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 139/290 (47%), Gaps = 48/290 (16%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           + VG G +G  CSA   +     Q+VAVK +S+    + I      RE+++LK L  H++
Sbjct: 26  RPVGSGAYGSVCSAYDARLR---QKVAVKKLSRP-FQSLIHARRTYRELRLLKHLK-HEN 80
Query: 213 LVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           ++   D      + ED + VY+V  L  G +L +  + +    ++E  + +V Q+L  + 
Sbjct: 81  VIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNN--IVKCQALSDEHVQFLVYQLLRGLK 137
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           + H  G++HRDLKP N    +  +D ++R++DFGL+   + DE +   V + +Y APE++
Sbjct: 138 YIHSAGIIHRDLKPSN---VAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIM 192
Query: 327 --HRSYSLEADIWSIGVISYILLCGSRPF-----------------------WARTESGI 361
                Y+   DIWS+G I   LL G   F                        A+  S  
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 252
Query: 362 FRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
            R  ++S P        S+    +P A D + R+L  D  +R++A +AL+
Sbjct: 253 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALA 302

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           + FGL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 126/256 (49%), Gaps = 17/256 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G G  G  C A  K      +QVAVK   K  +      E +  EV I++    H ++
Sbjct: 52  KIGEGSTGIVCIATEKH---TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HDNV 104
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           V    +    + +++VME  EGG L D  +    R  EE    + + +L  +++ H QGV
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLHNQGV 162
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SYS 331
           +HRD+K ++ L TS   D  ++L DFG    +  +  +   +VG+ Y++APEV+ R  Y 
Sbjct: 163 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVKR 390
            E DIWS+G++   ++ G  P++        R +  S  P   DL    VS   + F+  
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDL--HKVSSVLRGFLDL 277
Query: 391 LLNKDYRKRMTAVQAL 406
           +L ++  +R TA + L
Sbjct: 278 MLVREPSQRATAQELL 293

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 151/318 (47%), Gaps = 51/318 (16%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK +S
Sbjct: 10  QERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLS 63
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGEL 238
           +    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L
Sbjct: 64  RP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 120
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
            +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++D
Sbjct: 121 NN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILD 175
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           FGL+      + +   V + +Y APE++     Y+   DIWS+G I   LL G   F   
Sbjct: 176 FGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 357 TESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDFVK 389
                 + +LR                S  N+      +P       +   +P A D ++
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 390 RLLNKDYRKRMTAVQALS 407
           ++L  D  KR+TA QAL+
Sbjct: 294 KMLVLDSDKRITAAQALA 311

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 24/263 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K  E   +  A+KI++K +M         R E  +L  ++
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTE---RIYAMKILNKWEMLKRAETACFREERDVL--VN 130
Query: 209 GH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           G  + +     A +D N++Y+VM+   GG+LL  +     +  E+ A+  + +++  +  
Sbjct: 131 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
            H    VHRD+KP+N L      +  +RL DFG    +  D  +     VG+  Y++PE+
Sbjct: 191 IHQLHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           L         Y  E D WS+GV  Y +L G  PF+A +    +  ++  +  F    +PS
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 304
Query: 380 ----VSPEAKDFVKRLLNKDYRK 398
               VS EAKD ++RL+    R+
Sbjct: 305 HVTDVSEEAKDLIQRLICSRERR 327

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 24/257 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K  E   +  A+KI++K +M         R E  +L  ++
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTE---RIYAMKILNKWEMLKRAETACFREERDVL--VN 146
Query: 209 GH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           G  + +     A +D N++Y+VM+   GG+LL  +     +  E+ A+  + +++  +  
Sbjct: 147 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
            H    VHRD+KP+N L      +  +RL DFG    +  D  +     VG+  Y++PE+
Sbjct: 207 IHQLHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           L         Y  E D WS+GV  Y +L G  PF+A +    +  ++  +  F    +PS
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 320
Query: 380 ----VSPEAKDFVKRLL 392
               VS EAKD ++RL+
Sbjct: 321 HVTDVSEEAKDLIQRLI 337

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +D GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 133/285 (46%), Gaps = 41/285 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-------------- 193
           +Y L  E+G+G +G    A     E  +   A+K++SK K+                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYN---ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 194 ---------IEDVRREVKILKALSGHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRI 242
                    IE V +E+ ILK L  H ++VK  +  +D N  ++Y+V EL   G +++  
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
             +    +E+ A+     ++  + + H Q ++HRD+KP N L     +D  +++ DFG+S
Sbjct: 130 TLK--PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVS 184
Query: 303 -DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEA----DIWSIGVISYILLCGSRPFWART 357
            +F   D  L++ VG+  ++APE L  +  + +    D+W++GV  Y  + G  PF    
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
              +   +      F D   P ++ + KD + R+L+K+   R+  
Sbjct: 245 IMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVV 287

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 141/296 (47%), Gaps = 50/296 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+    VG G +G  C+A   K      +VAVK +S+    + I  +   RE+++LK +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM 74
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
             H++++   D      + E+ N+VY+V  L  G +L +  + +  + T++  + ++ QI
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN--IVKCAKLTDDHVQFLIYQI 130
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  + + H   ++HRDLKP N    +  +D +++++DFGL+     D+ +   V + +Y 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYR 185
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR------------ 367
           APE++     Y+   DIWS+G I   LL G   F         + +LR            
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 368 ----------------SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                              NF ++ +   +P A D ++++L  D  KR+TA QAL+
Sbjct: 246 ISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 152/320 (47%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +D GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 284
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 285 LEKMLVLDSDKRITAAQALA 304

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 53/321 (16%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K  L+   VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +D GL+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKD 386
                   + +LR                               NF ++ +   +P A D
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVD 283
Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            ++++L  D  KR+TA QAL+
Sbjct: 284 LLEKMLVLDSDKRITAAQALA 304

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 148/317 (46%), Gaps = 53/317 (16%)
Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
           R T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK +S+ 
Sbjct: 1   RPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRP 54
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLD 240
              + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L +
Sbjct: 55  -FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 111
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DFG
Sbjct: 112 --IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFG 166
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
           L+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F     
Sbjct: 167 LAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 359 SGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVKR 390
               + +LR                               NF ++ +   +P A D +++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEK 283
Query: 391 LLNKDYRKRMTAVQALS 407
           +L  D  KR+TA QAL+
Sbjct: 284 MLVLDSDKRITAAQALA 300

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 148/317 (46%), Gaps = 53/317 (16%)
Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
           R T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK +S+ 
Sbjct: 1   RPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRP 54
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLD 240
              + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G +L +
Sbjct: 55  -FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 111
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D +++++DFG
Sbjct: 112 --IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFG 166
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
           L+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F     
Sbjct: 167 LAR--HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 359 SGIFRAVLR----------------------------SDPNFDDLPWPSVSPEAKDFVKR 390
               + +LR                               NF ++ +   +P A D +++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEK 283
Query: 391 LLNKDYRKRMTAVQALS 407
           +L  D  KR+TA QAL+
Sbjct: 284 MLVLDSDKRITAAQALA 300

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 151/320 (47%), Gaps = 51/320 (15%)
Query: 123 IPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
           + +ER T   Q L+K+         +Y+    VG G +G  C+A   K      +VAVK 
Sbjct: 1   MSQERPTFYRQELNKTIW---EVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKK 54
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGG 236
           +S+    + I  +   RE+++LK +  H++++   D      + E+ N+VY+V  L  G 
Sbjct: 55  LSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 111
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L +  + +  + T++  + ++ QIL  + + H   ++HRDLKP N    +  +D ++++
Sbjct: 112 DLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +DF L+     D+ +   V + +Y APE++     Y+   DIWS+G I   LL G   F 
Sbjct: 167 LDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 355 ARTESGIFRAVLR----------------SDPNF----DDLP-------WPSVSPEAKDF 387
                   + +LR                S  N+      +P       +   +P A D 
Sbjct: 225 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 284
Query: 388 VKRLLNKDYRKRMTAVQALS 407
           ++++L  D  KR+TA QAL+
Sbjct: 285 LEKMLVLDSDKRITAAQALA 304

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-----VR 198
            +  KY     +G G FG   +A  K+   K+++V VK I K K+     IED     V 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
            E+ IL  +  H +++K  D  E+     +VME    G  L   + R  R  E  A  I 
Sbjct: 78  LEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q++S V +  L+ ++HRD+K EN +     +D  ++LIDFG + ++   +      G+ 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 319 YYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
            Y APEVL    +R   LE  +WS+GV  Y L+    PF    E+
Sbjct: 194 EYCAPEVLMGNPYRGPELE--MWSLGVTLYTLVFEENPFCELEET 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 65
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 124
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 181
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 64
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA-LQEELARSFFWQV 123
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 180
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 80
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 139
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 196
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 80
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 139
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 196
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 79
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 138
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 195
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 79
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 138
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 195
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 99
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 158
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 215
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 138/302 (45%), Gaps = 50/302 (16%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 76
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L A   H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 77  LLAFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 132
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +    +D+++ DFGL+    PD      L + 
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---SDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVI--------------------SYILLCGSRP 352
           V + +Y APE++  S  Y+   DIWS+G I                    ++IL     P
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249
Query: 353 FWARTESGI---FRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                  GI    R  L S P+ + +PW    P+   +A D + ++L  +  KR+   QA
Sbjct: 250 SQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 406 LS 407
           L+
Sbjct: 310 LA 311

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 80
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 139
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 196
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 119
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 176
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 107
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 108 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 166
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 223
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 93
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 152
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 209
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 92
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 151
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 208
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 92
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 151
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 208
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 93
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 152
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 209
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 92
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 151
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 208
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 12/213 (5%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 93
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           LK +S G   +++  D  E  ++  +++E  E  + L   +   G   EE A++   Q+L
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
             V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYSP 210
Query: 323 PEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 92
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 151
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 208
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 93
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 152
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 209
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 135/311 (43%), Gaps = 62/311 (19%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           N  + ++L   +G G +G  CSA  K  GE+    VA+K I        +      RE+K
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEI----VAIKKIEP--FDKPLFALRTLREIK 61
Query: 203 ILKALSGHKHLVKFC----DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           ILK       +  F     D+ E+ N VYI+ EL +    L R+++     +++  +  +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVIS-TQMLSDDHIQYFI 118
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-------- 310
            Q L  V   H   V+HRDLKP N L  S   + D+++ DFGL+  I  DE         
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARII--DESAADNSEPT 173
Query: 311 -----LNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWAR------- 356
                + + V + +Y APEV+  S  YS   D+WS G I   L      F  R       
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 357 -----------------TESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKD 395
                             ES   R  ++S P +   P    +P V+P+  D ++R+L  D
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 396 YRKRMTAVQAL 406
             KR+TA +AL
Sbjct: 294 PAKRITAKEAL 304

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 112
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 113 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 171
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 228
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 229 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 64
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 123
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 180
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 65
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 124
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 181
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 107
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 108 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 166
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 223
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 135/311 (43%), Gaps = 62/311 (19%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           N  + ++L   +G G +G  CSA  K  GE+    VA+K I        +      RE+K
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEI----VAIKKIEP--FDKPLFALRTLREIK 61
Query: 203 ILKALSGHKHLVKFC----DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           ILK       +  F     D+ E+ N VYI+ EL +    L R+++     +++  +  +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVIS-TQMLSDDHIQYFI 118
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-------- 310
            Q L  V   H   V+HRDLKP N L  S   + D+++ DFGL+  I  DE         
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARII--DESAADNSEPT 173
Query: 311 -----LNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWAR------- 356
                + + V + +Y APEV+  S  YS   D+WS G I   L      F  R       
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 357 -----------------TESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKD 395
                             ES   R  ++S P +   P    +P V+P+  D ++R+L  D
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 396 YRKRMTAVQAL 406
             KR+TA +AL
Sbjct: 294 PAKRITAKEAL 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 87
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 88  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 146
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 147 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 203
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 204 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 65
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 124
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 181
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 134/311 (43%), Gaps = 62/311 (19%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           N  + ++L   +G G +G  CSA  K  GE+    VA+K I        +      RE+K
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEI----VAIKKIEP--FDKPLFALRTLREIK 61
Query: 203 ILKALSGHKHLVKFC----DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           ILK       +  F     D+ E+ N VYI+ EL +    L R+++     +++  +  +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVIS-TQMLSDDHIQYFI 118
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----- 313
            Q L  V   H   V+HRDLKP N L  S   + D+++ DFGL+  I  DE   D     
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARII--DESAADNSEPT 173
Query: 314 --------IVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWAR------- 356
                    V + +Y APEV+  S  YS   D+WS G I   L      F  R       
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 357 -----------------TESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKD 395
                             ES   R  ++S P +   P    +P V+P+  D ++R+L  D
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 396 YRKRMTAVQAL 406
             KR+TA +AL
Sbjct: 294 PAKRITAKEAL 304

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
            F   ++  +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISL 62
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQI 261
           LK L+ H ++VK  D     N +Y+V E       + +D     G        K+ + Q+
Sbjct: 63  LKELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQL 119
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
           L  +AFCH   V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
            APE+L   + YS   DIWS+G I   ++     F   +E      + R+    D++ WP
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 379 SVS--PEAKDFVKRLLNKDYRK 398
            V+  P+ K    +   +D+ K
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSK 258

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 119
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 176
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 119
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 176
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKI 203
           ++Y++G  +G G FG   S       L    VA+K + K +++    + +  R   EV +
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVL 63
Query: 204 LKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQI 261
           LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++   Q+
Sbjct: 64  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 122
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  V  CH  GV+HRD+K EN L    R   +++LIDFG    ++ D    D  G+  Y 
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 179
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
            PE +  HR +   A +WS+G++ Y ++CG  PF
Sbjct: 180 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 76
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L A   H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 77  LLAFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 132
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 248
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 249 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 308
Query: 405 ALS 407
           AL+
Sbjct: 309 ALA 311

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
            F   ++  +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISL 62
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQI 261
           LK L+ H ++VK  D     N +Y+V E       + +D     G        K+ + Q+
Sbjct: 63  LKELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQL 119
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
           L  +AFCH   V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 321 VAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
            APE+L   + YS   DIWS+G I   ++     F   +E      + R+    D++ WP
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 379 SVS--PEAKDFVKRLLNKDYRK 398
            V+  P+ K    +   +D+ K
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSK 258

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 143/311 (45%), Gaps = 52/311 (16%)
Query: 137 KSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED 196
           +SF    + G +YE+ + +G G +G   SAR +   L  QQVA+K I  A      + + 
Sbjct: 45  RSFDVTFDVGDEYEIIETIGNGAYGVVSSARRR---LTGQQVAIKKIPNA-FDVVTNAKR 100
Query: 197 VRREVKILKALSGHKHLVKFCDACE------DVNNVYIVMELCEGGELLDRILARGGRYT 250
             RE+KILK    H +++   D         +  +VY+V++L E    L +I+      T
Sbjct: 101 TLRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLT 157
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPD 308
            E  +  + Q+L  + + H   V+HRDLKP N L     ++ ++++ DFG++  +   P 
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMARGLCTSPA 214
Query: 309 ER---LNDIVGSAYYVAPEV---LHRSYSLEADIWSIGVI-------------------- 342
           E    + + V + +Y APE+   LH  Y+   D+WS+G I                    
Sbjct: 215 EHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 273
Query: 343 SYILLCGSRPFWARTE---SGIFRAVLRSDPNFDDLPWPSVSP----EAKDFVKRLLNKD 395
             I++    P  A  +   +   RA ++S P    +PW +V P    +A   + R+L  +
Sbjct: 274 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE 333
Query: 396 YRKRMTAVQAL 406
              R++A  AL
Sbjct: 334 PSARISAAAAL 344

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+ K +GRG FG     R K      +  A+K++SK +M           E  I+ A +
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 126
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ A+    +++  +   
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
           H  G +HRD+KP+N L         ++L DFG    +  +   R +  VG+  Y++PEVL
Sbjct: 185 HSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 327 HRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378
                   Y  E D WS+GV  Y +L G  PF+A +  G +  ++      + L +P   
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDN 298
Query: 379 SVSPEAKDFVKRLL 392
            +S EAK+ +   L
Sbjct: 299 DISKEAKNLICAFL 312

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+ K +GRG FG     R K      +  A+K++SK +M           E  I+ A +
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 131
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ A+    +++  +   
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
           H  G +HRD+KP+N L         ++L DFG    +  +   R +  VG+  Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 327 HRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378
                   Y  E D WS+GV  Y +L G  PF+A +  G +  ++      + L +P   
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDN 303
Query: 379 SVSPEAKDFVKRLL 392
            +S EAK+ +   L
Sbjct: 304 DISKEAKNLICAFL 317

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+ K +GRG FG     R K      +  A+K++SK +M           E  I+ A +
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 131
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ A+    +++  +   
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
           H  G +HRD+KP+N L         ++L DFG    +  +   R +  VG+  Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 327 HRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378
                   Y  E D WS+GV  Y +L G  PF+A +  G +  ++      + L +P   
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDN 303
Query: 379 SVSPEAKDFVKRLL 392
            +S EAK+ +   L
Sbjct: 304 DISKEAKNLICAFL 317

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 11  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 65
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 123
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKPEN L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 241 PSFPKWARQDFSK 253

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 17/281 (6%)
Query: 124 PEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII 183
           PEE+        D +   ++     +     +G+G FG    +  +KG   D+  AVKI+
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSE-RKG--TDELYAVKIL 374
Query: 184 SKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRI 242
            K  +     +E    E ++L AL G    +    +C + ++ +Y VME   GG+L+  I
Sbjct: 375 KKDVVIQDDDVECTMVEKRVL-ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL- 301
             + GR+ E  A     +I   + F   +G+++RDLK +N +  S   +  +++ DFG+ 
Sbjct: 434 -QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EGHIKIADFGMC 489
Query: 302 SDFIRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
            + I          G+  Y+APE++ ++ Y    D W+ GV+ Y +L G  PF    E  
Sbjct: 490 KENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 361 IFRAVLRSDPNFDDLPWP-SVSPEAKDFVKRLLNKDYRKRM 400
           +F++++       ++ +P S+S EA    K L+ K   KR+
Sbjct: 550 LFQSIMEH-----NVAYPKSMSKEAVAICKGLMTKHPGKRL 585

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 143/311 (45%), Gaps = 52/311 (16%)
Query: 137 KSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED 196
           +SF    + G +YE+ + +G G +G   SAR +   L  QQVA+K I  A      + + 
Sbjct: 44  RSFDVTFDVGDEYEIIETIGNGAYGVVSSARRR---LTGQQVAIKKIPNA-FDVVTNAKR 99
Query: 197 VRREVKILKALSGHKHLVKFCDACE------DVNNVYIVMELCEGGELLDRILARGGRYT 250
             RE+KILK    H +++   D         +  +VY+V++L E    L +I+      T
Sbjct: 100 TLRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLT 156
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPD 308
            E  +  + Q+L  + + H   V+HRDLKP N L     ++ ++++ DFG++  +   P 
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMARGLCTSPA 213
Query: 309 ER---LNDIVGSAYYVAPEV---LHRSYSLEADIWSIGVI-------------------- 342
           E    + + V + +Y APE+   LH  Y+   D+WS+G I                    
Sbjct: 214 EHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272
Query: 343 SYILLCGSRPFWARTE---SGIFRAVLRSDPNFDDLPWPSVSP----EAKDFVKRLLNKD 395
             I++    P  A  +   +   RA ++S P    +PW +V P    +A   + R+L  +
Sbjct: 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE 332
Query: 396 YRKRMTAVQAL 406
              R++A  AL
Sbjct: 333 PSARISAAAAL 343

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELC--EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E    +  + +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKPEN L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 10  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 64
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKPEN L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 240 PSFPKWARQDFSK 252

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 10  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 64
Query: 213 LVKFCDACEDVNNVYIVMELC--EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E    +  + +D     G        K+ + Q+L  +AFCH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKPEN L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 240 PSFPKWARQDFSK 252

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKPEN L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVL--H 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YEL + +G G    T   +      K ++VA+K I+  K  T  S++++ +E++ +    
Sbjct: 12  YELQEVIGSGA---TAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCH 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD---RILARG----GRYTEEDAKAIVVQI 261
            H ++V +  +    + +++VM+L  GG +LD    I+A+G    G   E     I+ ++
Sbjct: 67  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF------IRPDERLNDIV 315
           L  + + H  G +HRD+K  N L     +D  +++ DFG+S F      I  ++     V
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 316 GSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           G+  ++APEV+   R Y  +ADIWS G+ +  L  G+ P+       +    L++DP   
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--- 239
Query: 374 DLPWPSVSPEAKDFVKRL-----------LNKDYRKRMTAVQAL 406
             P      + K+ +K+            L KD  KR TA + L
Sbjct: 240 --PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YEL + +G G    T   +      K ++VA+K I+  K  T  S++++ +E++ +    
Sbjct: 17  YELQEVIGSGA---TAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCH 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD---RILARG----GRYTEEDAKAIVVQI 261
            H ++V +  +    + +++VM+L  GG +LD    I+A+G    G   E     I+ ++
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF------IRPDERLNDIV 315
           L  + + H  G +HRD+K  N L     +D  +++ DFG+S F      I  ++     V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 316 GSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
           G+  ++APEV+   R Y  +ADIWS G+ +  L  G+ P+       +    L++DP   
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--- 244
Query: 374 DLPWPSVSPEAKDFVKRL-----------LNKDYRKRMTAVQAL 406
             P      + K+ +K+            L KD  KR TA + L
Sbjct: 245 --PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 125/263 (47%), Gaps = 19/263 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ +++G G +G    A  K+     Q VA+K     ++     ++++ +E+ I++   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKE---TGQIVAIK-----QVPVESDLQEIIKEISIMQQCD 82
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
              H+VK+  +     +++IVME C  G + D I  R    TE++   I+   L  + + 
Sbjct: 83  S-PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH 327
           H    +HRD+K  N L  +   +   +L DFG++        + N ++G+ +++APEV+ 
Sbjct: 142 HFMRKIHRDIKAGNILLNT---EGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 328 R-SYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSV-SPEA 384
              Y+  ADIWS+G+ +  +  G  P+        IF       P F     P + S   
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK---PELWSDNF 255
Query: 385 KDFVKRLLNKDYRKRMTAVQALS 407
            DFVK+ L K   +R TA Q L 
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQ 278

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 10  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 64
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 240 PSFPKWARQDFSK 252

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 126/266 (47%), Gaps = 21/266 (7%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G+ +NF    +  +++G G +G    AR K   L  + VA+K I     T  +    +R 
Sbjct: 1   GHMENF----QKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR- 52
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           E+ +LK L+ H ++VK  D     N +Y+V E       + +D     G        K+ 
Sbjct: 53  EISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSY 109
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
           + Q+L  +AFCH   V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V 
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 317 SAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           + +Y APE+L   + YS   DIWS+G I   ++     F   +E      + R+    D+
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 375 LPWPSVS--PEAKDFVKRLLNKDYRK 398
           + WP V+  P+ K    +   +D+ K
Sbjct: 227 VVWPGVTSMPDYKPSFPKWARQDFSK 252

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 13  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 67
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 125
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 126 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 182
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 243 PSFPKWARQDFSK 255

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 125/250 (50%), Gaps = 17/250 (6%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG    +  +KG   D+  AVKI+ K  +     +E    E ++L AL G    +
Sbjct: 28  LGKGSFGKVMLSE-RKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVL-ALPGKPPFL 83
Query: 215 KFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
               +C + ++ +Y VME   GG+L+  I  + GR+ E  A     +I   + F   +G+
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSYS 331
           ++RDLK +N +  S   +  +++ DFG+  + I          G+  Y+APE++ ++ Y 
Sbjct: 143 IYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVKR 390
              D W+ GV+ Y +L G  PF    E  +F++++       ++ +P S+S EA    K 
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----NVAYPKSMSKEAVAICKG 254
Query: 391 LLNKDYRKRM 400
           L+ K   KR+
Sbjct: 255 LMTKHPGKRL 264

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 13  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 67
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 125
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 126 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 243 PSFPKWARQDFSK 255

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 94
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 150
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 266
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 267 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 326
Query: 405 ALS 407
           AL+
Sbjct: 327 ALA 329

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 11  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 65
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 123
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 241 PSFPKWARQDFSK 253

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 76
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 77  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 132
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 248
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 249 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 308
Query: 405 ALS 407
           AL+
Sbjct: 309 ALA 311

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELC--EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E    +  + +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 11  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 65
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 123
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 241 PSFPKWARQDFSK 253

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 74
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 246
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 247 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 306
Query: 405 ALS 407
           AL+
Sbjct: 307 ALA 309

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 79
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 135
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 251
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 252 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 311
Query: 405 ALS 407
           AL+
Sbjct: 312 ALA 314

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 26  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 80
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 81  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 136
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 252
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 253 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 312
Query: 405 ALS 407
           AL+
Sbjct: 313 ALA 315

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 17  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 71
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 72  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 127
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 243
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 244 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 303
Query: 405 ALS 407
           AL+
Sbjct: 304 ALA 306

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 72
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 128
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 244
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 245 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 304
Query: 405 ALS 407
           AL+
Sbjct: 305 ALA 307

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 72
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 128
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 244
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 245 PEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 304
Query: 405 ALS 407
           AL+
Sbjct: 305 ALA 307

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 11  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 65
Query: 213 LVKFCDACEDVNNVYIVMELC--EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E    +  + +D     G        K+ + Q+L  +AFCH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 123
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 241 PSFPKWARQDFSK 253

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 28  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 82
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 83  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 138
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 254
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 255 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 314
Query: 405 ALS 407
           AL+
Sbjct: 315 ALA 317

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 74
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 246
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 247 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 306
Query: 405 ALS 407
           AL+
Sbjct: 307 ALA 309

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYX--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 74
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 246
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 247 PSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 306
Query: 405 ALS 407
           AL+
Sbjct: 307 ALA 309

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 10  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 64
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 240 PSFPKWARQDFSK 252

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 74
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 246
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 247 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 306
Query: 405 ALS 407
           AL+
Sbjct: 307 ALA 309

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 74
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 246
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 247 PSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 306
Query: 405 ALS 407
           AL+
Sbjct: 307 ALA 309

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E         +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KCQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYC--QRTLREIKI 79
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 135
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 251
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 252 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 311
Query: 405 ALS 407
           AL+
Sbjct: 312 ALA 314

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y++ K +GRG FG     R K  +   +  A+K++SK +M           E  I+ A +
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 132
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               +V+   A +D   +Y+VME   GG+L++  L       E+ AK    +++  +   
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAI 190
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAPE 324
           H  G++HRD+KP+N L         ++L DFG    ++ DE      +  VG+  Y++PE
Sbjct: 191 HSMGLIHRDVKPDNMLLDKH---GHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPE 245
Query: 325 VLHRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL 366
           VL        Y  E D WS+GV  + +L G  PF+A +  G +  ++
Sbjct: 246 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 12  EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E  +    + +D     G        K+ + Q+L  +AFCH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 242 PSFPKWARQDFSK 254

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           Y +    KY+  ++VG G +G    A+  +G +    VA+K I        I    +R E
Sbjct: 15  YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRIRLDAEDEGIPSTAIR-E 69
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVV 259
           + +LK L  H ++V   D       + +V E  E    L ++L        +   K  + 
Sbjct: 70  ISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLY 126
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSA 318
           Q+L  VA CH   ++HRDLKP+N L  S   D  ++L DFGL+  F  P       V + 
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 319 YYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPN- 371
           +Y AP+VL   + YS   DIWSIG I   ++ G   F   T+      IF  +   +P  
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 372 -----------------FDDLPWPSVSP----EAKDFVKRLLNKDYRKRMTAVQALS 407
                            F+  PW S+ P    E  D +  +L  D  KR++A  A++
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           Y +    KY+  ++VG G +G    A+  +G +    VA+K I        I    +R E
Sbjct: 15  YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRIRLDAEDEGIPSTAIR-E 69
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVV 259
           + +LK L  H ++V   D       + +V E  E    L ++L        +   K  + 
Sbjct: 70  ISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLY 126
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSA 318
           Q+L  VA CH   ++HRDLKP+N L  S   D  ++L DFGL+  F  P       V + 
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 319 YYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPN- 371
           +Y AP+VL   + YS   DIWSIG I   ++ G   F   T+      IF  +   +P  
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 372 -----------------FDDLPWPSVSP----EAKDFVKRLLNKDYRKRMTAVQALS 407
                            F+  PW S+ P    E  D +  +L  D  KR++A  A++
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA++ IS  +  T    +   RE+KI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIRKISPFEHQTYC--QRTLREIKI 78
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +    + +     +
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 250
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 405 ALS 407
           AL+
Sbjct: 311 ALA 313

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  ++FCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLSFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA     +++   VA+K IS  +  T    +   RE+KI
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYC--QRTLREIKI 94
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VY+V  L  G +L    L +    + +     +
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYK--LLKTQHLSNDHICYFL 150
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 266
Query: 363 --------------RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L S P+ + +PW    P+   +A D + ++L  +  KR+   Q
Sbjct: 267 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 326
Query: 405 ALS 407
           AL+
Sbjct: 327 ALA 329

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 144/306 (47%), Gaps = 57/306 (18%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII--SKAKMTTAISIEDVRREVK 202
           + + +E    +G+G FG    AR     L  +  A+K I  ++ K++T +S      EV 
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHTEEKLSTILS------EVM 54
Query: 203 ILKALSGHKHLVKFCDACEDVNN-------------VYIVMELCEGGELLDRILARGGRY 249
           +L +L+ H+++V++  A  +  N             ++I ME CE G L D I +     
Sbjct: 55  LLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
             ++   +  QIL  +++ H QG++HRDLKP N      R   ++++ DFGL+       
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSL 170
Query: 303 DFIRPD--------ERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP 352
           D ++ D        + L   +G+A YVA EVL  +  Y+ + D++S+G+I + ++    P
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227
Query: 353 FWARTESGIFRAVLRS-----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           F    E       LRS      P+FDD    +     K  ++ L++ D  KR  A   L+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDD----NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
Query: 408 KLVVPI 413
              +P+
Sbjct: 284 SGWLPV 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+K I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E         +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+  I     T  +    +R E+ +LK L+ H +
Sbjct: 9   EKIGEGTYGVVYKARNK---LTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN-HPN 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 239 PSFPKWARQDFSK 251

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G G +G    AR K   L  + VA+  I     T  +    +R E+ +LK L+ H +
Sbjct: 8   EKIGEGTYGVVYKARNK---LTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN-HPN 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK  D     N +Y+V E       + +D     G        K+ + Q+L  +AFCH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-- 327
             V+HRDLKP+N L  +   +  ++L DFGL+  F  P       V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS--PEAK 385
           + YS   DIWS+G I   ++     F   +E      + R+    D++ WP V+  P+ K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 386 DFVKRLLNKDYRK 398
               +   +D+ K
Sbjct: 238 PSFPKWARQDFSK 250

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N L     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 144 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGK 201
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 262 KVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 321
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 322 YDHQERLTALEAMT 335

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 134 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 191
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 192 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 251
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 252 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 311
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 312 YDHQSRLTAREAME 325

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 125 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 182
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 303 YDHQERLTALEAMT 316

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 124 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 181
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 302 YDHQERLTALEAMT 315

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 124 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 181
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 302 YDHQERLTALEAMT 315

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 134/269 (49%), Gaps = 17/269 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + +++VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           +DF+ R L+ D  KR +A + L    + I
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + ++L  + +CH QG++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 123 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 180
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG------- 360
             N  V S Y+  PE+L   + Y    D+WS+G +   ++    PF+   ++        
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 361 -----------IFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      + +  +  DP  + L       PW           VSPEA DF+ +LL 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 394 KDYRKRMTAVQALS 407
            D+++R+TA++A++
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 185
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 306 YDHQSRLTAREAME 319

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 185
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 306 YDHQSRLTAREAME 319

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 48/243 (19%)
Query: 204 LKALSGHKHLVKFCDACED--VNNVYIVMELCEGGEL--LDRILARGGRYTEEDAKAIVV 259
           L+ L G  +++K  D  +D       +V E     +   L +IL      T+ D +  + 
Sbjct: 86  LENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQIL------TDFDIRFYMY 139
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           ++L  + +CH +G++HRD+KP N +    +    +RLID+GL++F  P +  N  V S Y
Sbjct: 140 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQ--KKLRLIDWGLAEFYHPAQEYNVRVASRY 197
Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-----------------G 360
           +  PE+L  ++ Y    D+WS+G +   ++    PF+   ++                 G
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 257
Query: 361 IFRAV-LRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLNKDYRKRMTAV 403
             +   +  DP+F+D+        W +         VSPEA D + +LL  D+++R+TA 
Sbjct: 258 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 317
Query: 404 QAL 406
           +A+
Sbjct: 318 EAM 320

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 186
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 307 YDHQSRLTAREAME 320

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 48/244 (19%)
Query: 204 LKALSGHKHLVKFCDACED--VNNVYIVMELCEGGEL--LDRILARGGRYTEEDAKAIVV 259
           L+ L G  +++K  D  +D       +V E     +   L +IL      T+ D +  + 
Sbjct: 91  LENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQIL------TDFDIRFYMY 144
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           ++L  + +CH +G++HRD+KP N +    +    +RLID+GL++F  P +  N  V S Y
Sbjct: 145 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQ--KKLRLIDWGLAEFYHPAQEYNVRVASRY 202
Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-----------------G 360
           +  PE+L  ++ Y    D+WS+G +   ++    PF+   ++                 G
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 262
Query: 361 IFRAV-LRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLNKDYRKRMTAV 403
             +   +  DP+F+D+        W +         VSPEA D + +LL  D+++R+TA 
Sbjct: 263 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 322
Query: 404 QALS 407
           +A+ 
Sbjct: 323 EAME 326

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T+ D +  + +IL  + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ 184
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-------- 359
             N  V S Y+  PE+L  ++ Y    D+WS+G +   ++    PF+   ++        
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 360 ----------GIFRAVLRSDPNFDDL-------PWPS---------VSPEAKDFVKRLLN 393
                      I +  +  DP F+D+        W           VSPEA DF+ +LL 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 394 KDYRKRMTAVQALS 407
            D++ R+TA +A+ 
Sbjct: 305 YDHQSRLTAREAME 318

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 97/183 (53%), Gaps = 11/183 (6%)
Query: 178 VAVKIISKAKMTTAISIEDVRR---EVKILKALS-GHKHLVKFCDACEDVNNVYIVMELC 233
           VA+K + K +++    + +  R   EV +LK +S G   +++  D  E  ++  +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 234 EG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
           E   +L D I  RG    EE A++   Q+L  V  CH  GV+HRD+K EN L    R   
Sbjct: 139 EPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--G 195
Query: 293 DMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGS 350
           +++LIDFG    ++ D    D  G+  Y  PE +  HR +   A +WS+G++ Y ++CG 
Sbjct: 196 ELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 351 RPF 353
            PF
Sbjct: 255 IPF 257

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE   ++G G +G     R +      Q VA+K   +++    I  +   RE+++LK L
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL 59
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGEL--LDRILARGGRYTEEDAKAIVVQILSVV 265
             H +LV   +       +++V E C+   L  LDR   RG    E   K+I  Q L  V
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRG--VPEHLVKSITWQTLQAV 115
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPE 324
            FCH    +HRD+KPEN L T     + ++L DFG +  +  P +  +D V + +Y +PE
Sbjct: 116 NFCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFW 354
           +L     Y    D+W+IG +   LL G  P W
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV-PLW 203

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 133/269 (49%), Gaps = 17/269 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           +DF+ R L+ D  KR +A + L    + I
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 127/258 (49%), Gaps = 24/258 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG        + +   Q VA+KII   +    I    +++E+ +L       ++ 
Sbjct: 31  IGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-SYVT 84
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           K+  +    + ++I+ME   GG  LD  L R G + E     ++ +IL  + + H +  +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 142
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
           HRD+K  N L +   +  D++L DFG++  +   + + N  VG+ +++APEV+ +S Y  
Sbjct: 143 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFV 388
           +ADIWS+G+ +  L  G  P        +   + +++P       P++    +   K+F+
Sbjct: 200 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLVGDFTKSFKEFI 252
Query: 389 KRLLNKDYRKRMTAVQAL 406
              LNKD   R TA + L
Sbjct: 253 DACLNKDPSFRPTAKELL 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 143/306 (46%), Gaps = 57/306 (18%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII--SKAKMTTAISIEDVRREVK 202
           + + +E    +G+G FG    AR     L  +  A+K I  ++ K++T +S      EV 
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHTEEKLSTILS------EVM 54
Query: 203 ILKALSGHKHLVKFCDACEDVNN-------------VYIVMELCEGGELLDRILARGGRY 249
           +L +L+ H+++V++  A  +  N             ++I ME CE   L D I +     
Sbjct: 55  LLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ 113
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
             ++   +  QIL  +++ H QG++HRDLKP N      R   ++++ DFGL+       
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSL 170
Query: 303 DFIRPD--------ERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP 352
           D ++ D        + L   +G+A YVA EVL  +  Y+ + D++S+G+I + ++    P
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227
Query: 353 FWARTESGIFRAVLRS-----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           F    E       LRS      P+FDD    +     K  ++ L++ D  KR  A   L+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDD----NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
Query: 408 KLVVPI 413
              +P+
Sbjct: 284 SGWLPV 289

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 132/269 (49%), Gaps = 17/269 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           +DF+ R L  D  KR +A + L    + I
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 145/319 (45%), Gaps = 58/319 (18%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G++Y   K +G G  G   SA        D++VA+K   K  +T   S++   RE+KI
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDC---DKRVAIK---KIVLTDPQSVKHALREIKI 61
Query: 204 LKALSGHKHLVKFCD--------------ACEDVNNVYIVMELCEGGELLDRILARGGRY 249
           ++ L  H ++VK  +              +  ++N+VYIV E  E    L  +L +G   
Sbjct: 62  IRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP-L 117
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
            EE A+  + Q+L  + + H   V+HRDLKP N    +  +D  +++ DFGL+  + P  
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHY 175
Query: 310 ----RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
                L++ + + +Y +P +L    +Y+   D+W+ G I   +L G   F    E    +
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 364 AVLRSDPNFDD---------LP-----------------WPSVSPEAKDFVKRLLNKDYR 397
            +L S P   +         +P                  P +S EA DF++++L     
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295
Query: 398 KRMTAVQALSKLVVPILSF 416
            R+TA +ALS   + I SF
Sbjct: 296 DRLTAEEALSHPYMSIYSF 314

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 128/258 (49%), Gaps = 17/258 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 133 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 247
Query: 385 KDFVKRLLNKDYRKRMTA 402
           +DF+ R L  D  KR +A
Sbjct: 248 RDFLNRCLEMDVEKRGSA 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 112/235 (47%), Gaps = 46/235 (19%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG FG    A+ K   + D   A+K I        ++ E V REVK L  L  H  +V
Sbjct: 13  LGRGGFGVVFEAKNK---VDDCNYAIKRIRLP--NRELAREKVMREVKALAKLE-HPGIV 66
Query: 215 KFCDACEDVNN------------VYIVMELCEGGELLDRILARGGRYTEEDAKA-----I 257
           ++ +A  + N             +YI M+LC    L D +    GR T E+ +      I
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHI 123
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
            +QI   V F H +G++HRDLKP N  FT   DD  +++ DFGL   +  DE    +   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDV-VKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 315 ----------VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE 358
                     VG+  Y++PE +H  SYS + DI+S+G+I + LL    PF  + E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 132/274 (48%), Gaps = 32/274 (11%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G+G FG     +G     K + VA+KII   +    I    +++E+ +L       ++ 
Sbjct: 27  IGKGSFGEVY--KGIDNHTK-EVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-PYIT 80
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
           ++  +      ++I+ME   GG  LD  L + G   E     I+ +IL  + + H +  +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERKI 138
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
           HRD+K  N L +   +  D++L DFG++  +   + + N  VG+ +++APEV+ +S Y  
Sbjct: 139 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFV 388
           +ADIWS+G+ +  L  G  P        +   + ++ P       P++    S   K+FV
Sbjct: 196 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQHSKPFKEFV 248
Query: 389 KRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY 422
           +  LNKD R R TA +        +L  K + RY
Sbjct: 249 EACLNKDPRFRPTAKE--------LLKHKFITRY 274

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA---KMTTAISIEDVRREVKIL 204
           KYE    VG G +G     R K      + VA+K   ++   KM   I++    RE+K+L
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM----REIKLL 78
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           K L  H++LV   + C+     Y+V E  +   L D  L   G    +  +  + QI++ 
Sbjct: 79  KQLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIING 136
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
           + FCH   ++HRD+KPEN L +       ++L DFG +     P E  +D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 324 EVL--HRSYSLEADIWSIGVISYILLCGSRPF 353
           E+L     Y    D+W+IG +   +  G   F
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 128/258 (49%), Gaps = 17/258 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++   +  +      E +  E+ +++  
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HR++K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 133 LHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
            R +Y  + DIWS+G+++  ++ G  P+    E+ +    L +     +L  P  +S   
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 247
Query: 385 KDFVKRLLNKDYRKRMTA 402
           +DF+ R L  D  KR +A
Sbjct: 248 RDFLNRCLEMDVEKRGSA 265

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS- 208
           E+ + VGRG FG  C A+ +      + VA+K I       A  +E        L+ LS 
Sbjct: 12  EVEEVVGRGAFGVVCKAKWRA-----KDVAIKQIESESERKAFIVE--------LRQLSR 58
Query: 209 -GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR----YTEEDAKAIVVQILS 263
             H ++VK   AC  +N V +VME  EGG L +  +  G      YT   A +  +Q   
Sbjct: 59  VNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 264 VVAFCHL---QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
            VA+ H    + ++HRDLKP N L  +G     +++ DFG +  I+    + +  GSA +
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAW 170
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           +APEV   S YS + D++S G+I + ++   +PF
Sbjct: 171 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE  +++G G +G    A+ ++     + VA+K +        +      RE+ +LK L
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVP-SSALREICLLKEL 58
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             HK++V+  D       + +V E C+  +L     +  G    E  K+ + Q+L  + F
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVL 326
           CH + V+HRDLKP+N L      + +++L DFGL+  F  P    +  V + +Y  P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINR---NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 327 H--RSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAV----------LRSD 369
              + YS   D+WS G I   L   +RP +   +       IFR +          +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 370 PNFDDLPW-----------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           P++   P            P ++   +D ++ LL  +  +R++A +AL 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y   + +G G +G   SA      ++  +VA+K IS  +  T    +   RE++I
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYD---HVRKTRVAIKKISPFEHQTYC--QRTLREIQI 94
Query: 204 LKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VYIV +L E    L ++L +  + + +     +
Sbjct: 95  LLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLL-KSQQLSNDHICYFL 150
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    P+      L + 
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTT---CDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
           V + +Y APE++  S  Y+   DIWS+G I   +L  +RP +             GI   
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGILGS 266
Query: 363 --------------RAVLRSDPNFDDLPWPSVSP----EAKDFVKRLLNKDYRKRMTAVQ 404
                         R  L+S P+   + W  + P    +A D + R+L  +  KR+T  +
Sbjct: 267 PSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEE 326
Query: 405 ALS 407
           AL+
Sbjct: 327 ALA 329

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS- 208
           E+ + VGRG FG  C A+ +      + VA+K I       A  +E        L+ LS 
Sbjct: 11  EVEEVVGRGAFGVVCKAKWRA-----KDVAIKQIESESERKAFIVE--------LRQLSR 57
Query: 209 -GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR----YTEEDAKAIVVQILS 263
             H ++VK   AC  +N V +VME  EGG L +  +  G      YT   A +  +Q   
Sbjct: 58  VNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 264 VVAFCHL---QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
            VA+ H    + ++HRDLKP N L  +G     +++ DFG +  I+    + +  GSA +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAW 169
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           +APEV   S YS + D++S G+I + ++   +PF
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 38/233 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           KYEL K++G+G +G    +  ++ GE+    VAVK I  A    +   +   RE+ IL  
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEV----VAVKKIFDA-FQNSTDAQRTFREIMILTE 64
Query: 207 LSGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
           LSGH+++V   +     N+  VY+V +  E        + R         + +V Q++ V
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQYVVYQLIKV 121
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---------------------- 302
           + + H  G++HRD+KP N L  +   +  +++ DFGLS                      
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 303 DFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPF 353
           +F      L D V + +Y APE+L  S  Y+   D+WS+G I   +LCG   F
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           ++YE   E+G G +G    AR          VA+K +        + I  VR EV +L+ 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVPNGEEGLPISTVR-EVALLRR 59
Query: 207 LSGHKH--LVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           L   +H  +V+  D C          V +V E  +      LD+    G     E  K +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q L  + F H   +VHRDLKPEN L TSG     ++L DFGL+        L+ +V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALDPVVVT 174
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVI 342
            +Y APEVL +S Y+   D+WS+G I
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCI 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           ++YE   E+G G +G    AR           +V++ +       + I  VR EV +L+ 
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRR 67
Query: 207 LSGHKH--LVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           L   +H  +V+  D C          V +V E  +      LD+    G     E  K +
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 125
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q L  + F H   +VHRDLKPEN L TSG     ++L DFGL+        L  +V +
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALTPVVVT 182
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVI 342
            +Y APEVL +S Y+   D+WS+G I
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCI 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 117/246 (47%), Gaps = 30/246 (12%)
Query: 149 YELGKEVGRGHFGHTCS-ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKIL 204
           +E+ + +G G FG+         GE    QVA+K     +    +S ++  R   E++I+
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGE----QVAIK-----QCRQELSPKNRERWCLEIQIM 67
Query: 205 KALSGHKHLVKFCDACEDVNNV------YIVMELCEGGEL---LDRILARGGRYTEEDAK 255
           K L+ H ++V   +  + +  +       + ME CEGG+L   L++     G   E   +
Sbjct: 68  KKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIR 125
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            ++  I S + + H   ++HRDLKPEN +   G      ++ID G +  +   E   + V
Sbjct: 126 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 185
Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--- 371
           G+  Y+APE+L  + Y++  D WS G +++  + G RPF    +   +   +R   N   
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 245
Query: 372 --FDDL 375
             +DDL
Sbjct: 246 VVYDDL 251

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 117/246 (47%), Gaps = 30/246 (12%)
Query: 149 YELGKEVGRGHFGHTCS-ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKIL 204
           +E+ + +G G FG+         GE    QVA+K     +    +S ++  R   E++I+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGE----QVAIK-----QCRQELSPKNRERWCLEIQIM 66
Query: 205 KALSGHKHLVKFCDACEDVNNV------YIVMELCEGGEL---LDRILARGGRYTEEDAK 255
           K L+ H ++V   +  + +  +       + ME CEGG+L   L++     G   E   +
Sbjct: 67  KKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIR 124
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            ++  I S + + H   ++HRDLKPEN +   G      ++ID G +  +   E   + V
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--- 371
           G+  Y+APE+L  + Y++  D WS G +++  + G RPF    +   +   +R   N   
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 372 --FDDL 375
             +DDL
Sbjct: 245 VVYDDL 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 9/234 (3%)
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
           +VA+K I         +++   REV     LS H+++V   D  E+ +  Y+VME  EG 
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGP 96
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
            L + I + G   + + A     QIL  +   H   +VHRD+KP+N L  S +    +++
Sbjct: 97  TLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK---TLKI 152
Query: 297 IDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLHRSYSLE-ADIWSIGVISYILLCGSRPF 353
            DFG++  +      + N ++G+  Y +PE      + E  DI+SIG++ Y +L G  PF
Sbjct: 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 354 WARTESGI-FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              T   I  + +  S PN        +     + + R   KD   R   +Q +
Sbjct: 213 NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKA 206
           +YELG+ +G G       AR    +L+D + VAVK++              RRE +   A
Sbjct: 13  RYELGEILGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 207 LSGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           L+ H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++    
Sbjct: 69  LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADAC 126
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSA 318
             + F H  G++HRD+KP N L ++      ++++DFG++  I        +   ++G+A
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 319 YYVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
            Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP      
Sbjct: 184 QYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 377 WPSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
              +S +    V + L K+   R  TA +  + LV
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 141/297 (47%), Gaps = 50/297 (16%)
Query: 147 AKYELGKEVGRGHFGHTCSA-RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           A Y   + VG G +G  CSA  G+ G     +VA+K + +    + +  +   RE+++LK
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRP-FQSELFAKRAYRELRLLK 79
Query: 206 ALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
            +  H++++   D        +D  + Y+VM     G  L +++ +  +  E+  + +V 
Sbjct: 80  HMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM-KHEKLGEDRIQFLVY 135
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+L  + + H  G++HRDLKP N    +  +D +++++DFGL+   + D  +   V + +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QADSEMXGXVVTRW 190
Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSR-----------------------PFW 354
           Y APEV+     Y+   DIWS+G I   ++ G                          F 
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 355 ARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
            R +S   +  ++  P  +   + S+    SP A + ++++L  D  +R+TA +AL+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   DA ++++DFGL+        +   V + YY 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+GVI
Sbjct: 193 APEVILGMGYKENVDIWSVGVI 214

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKA 206
           +YELG+ +G G       AR    +L+D + VAVK++              RRE +   A
Sbjct: 13  RYELGEILGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 207 LSGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           L+ H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++    
Sbjct: 69  LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADAC 126
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSA 318
             + F H  G++HRD+KP N + ++      ++++DFG++  I        +   ++G+A
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 YYVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
            Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP      
Sbjct: 184 QYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSAR 242
Query: 377 WPSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
              +S +    V + L K+   R  TA +  + LV
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           ++YE   E+G G +G    AR          VA+K +        + I  VR EV +L+ 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVPNGEEGLPISTVR-EVALLRR 59
Query: 207 LSGHKH--LVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           L   +H  +V+  D C          V +V E  +      LD+    G     E  K +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q L  + F H   +VHRDLKPEN L TSG     ++L DFGL+        L  +V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALAPVVVT 174
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVI 342
            +Y APEVL +S Y+   D+WS+G I
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCI 200

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 45/235 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+   +G G +GH C A  K   L+ + VA+K I +      I  + + RE+ IL  L
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDK---LEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL 109
Query: 208 SGHKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           + H H+VK  D       E  + +Y+V+E+ +      ++       TE   K ++  +L
Sbjct: 110 N-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLL 166
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DF---------IRPDE- 309
             V + H  G++HRDLKP N L      D  +++ DFGL+   D+         I P E 
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQ---DCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 310 ---------------RLNDIVGSAYYVAPEV--LHRSYSLEADIWSIGVISYILL 347
                          +L   V + +Y APE+  L  +Y+   D+WSIG I   LL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 38/289 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE  +++G G +G    A+ ++     + VA+K +        +      RE+ +LK L
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVP-SSALREICLLKEL 58
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             HK++V+  D       + +V E C+  +L     +  G    E  K+ + Q+L  + F
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPEVL 326
           CH + V+HRDLKP+N L      + +++L +FGL+  F  P    +  V + +Y  P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 327 H--RSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAV----------LRSD 369
              + YS   D+WS G I   L    RP +   +       IFR +          +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 370 PNFDDLPW-----------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           P++   P            P ++   +D ++ LL  +  +R++A +AL 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           ++YE   E+G G +G    AR          VA+K +        + I  VR EV +L+ 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVPNGEEGLPISTVR-EVALLRR 59
Query: 207 LSGHKH--LVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           L   +H  +V+  D C          V +V E  +      LD+    G     E  K +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q L  + F H   +VHRDLKPEN L TSG     ++L DFGL+        L  +V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALFPVVVT 174
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVI 342
            +Y APEVL +S Y+   D+WS+G I
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCI 200

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKA 206
           +YELG+ +G G       AR    +L+D + VAVK++              RRE +   A
Sbjct: 13  RYELGEILGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 207 LSGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           L+ H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++    
Sbjct: 69  LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADAC 126
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSA 318
             + F H  G++HRD+KP N + ++      ++++DFG++  I        +   ++G+A
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 YYVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
            Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP      
Sbjct: 184 QYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 377 WPSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
              +S +    V + L K+   R  TA +  + LV
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D       +Y+VME C G   L+  L +       + K+    +L  
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-C-GNIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 254
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 255 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQV----AVKIISKAKMTTAISIE-DVRREV 201
            KY +G  +G G +G       K  E+ D +     AVKI+ K K+    + E +V++E+
Sbjct: 5   GKYLMGDLLGEGSYG-------KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI 57
Query: 202 KILKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAI 257
           ++L+ L  HK++++  D    E+   +Y+VME C  G  E+LD +  +  R+    A   
Sbjct: 58  QLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPVCQAHGY 114
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP---DERLNDI 314
             Q++  + + H QG+VH+D+KP N L T+G     +++   G+++ + P   D+     
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTS 171
Query: 315 VGSAYYVAPEV---LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371
            GS  +  PE+   L      + DIWS GV  Y +  G  PF       +F  + +    
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
                     P   D +K +L  +  KR +  Q
Sbjct: 232 IPG----DCGPPLSDLLKGMLEYEPAKRFSIRQ 260

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 110 KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 282
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 283 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 65
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 66  KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 123
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 124 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 238
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 239 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 282

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR  K     + VA+K +        + +  +R EV +L+ L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 68
Query: 208 SGHKH--LVKFCDAC-----EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
              +H  +V+  D C     +    + +V E  +      LD++   G     E  K ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 126
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q+L  + F H   VVHRDLKP+N L TS      ++L DFGL+        L  +V + 
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y APEV L  SY+   D+WS+G I
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCI 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 57/306 (18%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII--SKAKMTTAISIEDVRREVK 202
           + + +E    +G+G FG    AR     L  +  A+K I  ++ K++T +S      EV 
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHTEEKLSTILS------EVX 54
Query: 203 ILKALSGHKHLVKFCDACEDVNN-------------VYIVMELCEGGELLDRILARGGRY 249
           +L +L+ H+++V++  A  +  N             ++I  E CE   L D I +     
Sbjct: 55  LLASLN-HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ 113
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
             ++   +  QIL  +++ H QG++HR+LKP N      R   ++++ DFGL+       
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESR---NVKIGDFGLAKNVHRSL 170
Query: 303 DFIRPD--------ERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP 352
           D ++ D        + L   +G+A YVA EVL  +  Y+ + D +S+G+I +  +    P
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---P 227
Query: 353 FWARTESGIFRAVLRS-----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           F    E       LRS      P+FDD    +     K  ++ L++ D  KR  A   L+
Sbjct: 228 FSTGXERVNILKKLRSVSIEFPPDFDD----NKXKVEKKIIRLLIDHDPNKRPGARTLLN 283
Query: 408 KLVVPI 413
              +P+
Sbjct: 284 SGWLPV 289

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G FG        + +   + VA+KII   +    I    +++E+ +L       +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-PY 81
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K+  +      ++I+ME   GG  LD  L   G   E     I+ +IL  + + H + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
            +HRD+K  N L +   +  +++L DFG++  +   + + N  VG+ +++APEV+ +S Y
Sbjct: 140 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
             +ADIWS+G+ +  L  G  P        +   + +++P       P++    S   K+
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 249
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           FV+  LNK+   R TA + L
Sbjct: 250 FVEACLNKEPSFRPTAKELL 269

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 63  KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 235
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 236 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 61
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 62  KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 119
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 120 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 234
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 235 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 278

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR  K     + VA+K +        + +  +R EV +L+ L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 68
Query: 208 SGHKH--LVKFCDAC-----EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
              +H  +V+  D C     +    + +V E  +      LD++   G     E  K ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 126
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q+L  + F H   VVHRDLKP+N L TS      ++L DFGL+        L  +V + 
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y APEV L  SY+   D+WS+G I
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCI 208

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D       +Y+VME C G   L+  L +       + K+    +L  
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-C-GNIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 254
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 255 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G FG        + +   + VA+KII   +    I    +++E+ +L       +
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-PY 86
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K+  +      ++I+ME   GG  LD  L   G   E     I+ +IL  + + H + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
            +HRD+K  N L +   +  +++L DFG++  +   + + N  VG+ +++APEV+ +S Y
Sbjct: 145 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
             +ADIWS+G+ +  L  G  P        +   + +++P       P++    S   K+
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 254
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           FV+  LNK+   R TA + L
Sbjct: 255 FVEACLNKEPSFRPTAKELL 274

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 110 KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 282
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 283 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   DA ++++DFGL+        +   V + YY 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G FG        + +   + VA+KII   +    I    +++E+ +L       +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-PY 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K+  +      ++I+ME   GG  LD  L   G   E     I+ +IL  + + H + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
            +HRD+K  N L +   +  +++L DFG++  +   + + N  VG+ +++APEV+ +S Y
Sbjct: 125 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
             +ADIWS+G+ +  L  G  P        +   + +++P       P++    S   K+
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 234
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           FV+  LNK+   R TA + L
Sbjct: 235 FVEACLNKEPSFRPTAKELL 254

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 206 ALSGHK-HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D   ++ + YI M +  G   L+  L +       + K+    +L  
Sbjct: 110 KLQQHSDKIIRLYDY--EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 322 APEVLHRSYS------------LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
            PE +    S             ++D+WS+G I Y +  G  PF  +  + I +     D
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIID 282
Query: 370 PN----FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI 413
           PN    F D+P      + +D +K  L +D ++R++  + L+   V I
Sbjct: 283 PNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   DA ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   DA ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR  K     + VA+K +        + +  +R EV +L+ L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 68
Query: 208 SGHKH--LVKFCDAC-----EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
              +H  +V+  D C     +    + +V E  +      LD++   G     E  K ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 126
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            Q+L  + F H   VVHRDLKP+N L TS      ++L DFGL+        L  +V + 
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y APEV L  SY+   D+WS+G I
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCI 208

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G FG        + +   + VA+KII   +    I    +++E+ +L       +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIED--IQQEITVLSQCDS-PY 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + K+  +      ++I+ME   GG  LD  L   G   E     I+ +IL  + + H + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
            +HRD+K  N L +   +  +++L DFG++  +   + + N  VG+ +++APEV+ +S Y
Sbjct: 125 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
             +ADIWS+G+ +  L  G  P        +   + +++P       P++    S   K+
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 234
Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           FV+  LNK+   R TA + L
Sbjct: 235 FVEACLNKEPSFRPTAKELL 254

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 11/249 (4%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G FG  C+ + +  G++   +   K   K +   A+++     E +IL+ ++  + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----EKQILEKVNS-RFV 246
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQG 272
           V    A E  + + +V+ L  GG+L   I   G   + E  A     +I   +   H + 
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYS 331
           +V+RDLKPEN L     D   +R+ D GL+  +   + +   VG+  Y+APEV+ +  Y+
Sbjct: 307 IVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
              D W++G + Y ++ G  PF  R +      V R      +      SP+A+    +L
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 392 LNKDYRKRM 400
           L KD  +R+
Sbjct: 424 LCKDPAERL 432

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 54  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 111
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  DE  N+ V
Sbjct: 112 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DEMANEFV 167
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV--LRSDPNF 372
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P   R    IF  +  + ++P  
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPP- 223
Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             LP    S E +DFV + L K+  +R    Q +
Sbjct: 224 PKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLM 257

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 11/249 (4%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G FG  C+ + +  G++   +   K   K +   A+++     E +IL+ ++  + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----EKQILEKVNS-RFV 246
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQG 272
           V    A E  + + +V+ L  GG+L   I   G   + E  A     +I   +   H + 
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYS 331
           +V+RDLKPEN L     D   +R+ D GL+  +   + +   VG+  Y+APEV+ +  Y+
Sbjct: 307 IVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
              D W++G + Y ++ G  PF  R +      V R      +      SP+A+    +L
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 392 LNKDYRKRM 400
           L KD  +R+
Sbjct: 424 LCKDPAERL 432

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G   +A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   DA ++++DFGL+        +   V + YY 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           APEV L   Y    DIWS+GVI   ++ G   F
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YELG+ +G G       AR  +     + VAVK++              RRE +   AL
Sbjct: 13  RYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 208 SGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           + H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++     
Sbjct: 70  N-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSAY 319
            + F H  G++HRD+KP N + ++      ++++DFG++  I        +   ++G+A 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 320 YVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
           Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP       
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 378 PSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
             +S +    V + L K+   R  TA +  + LV
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 74  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM--ELDHERMSYLLYQM 128
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 186 APEVILGMGYKENVDIWSVGCI 207

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 139/319 (43%), Gaps = 61/319 (19%)
Query: 133 QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI 192
           Q  D +F   K    +Y+  K +G G  G  C+A      +    VAVK +S+       
Sbjct: 12  QVADSTFTVLK----RYQQLKPIGSGAQGIVCAAFDTVLGIN---VAVKKLSRP-FQNQT 63
Query: 193 SIEDVRREVKILKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARG 246
             +   RE+ +LK ++ HK+++   +        E+  +VY+VMEL +    L +++   
Sbjct: 64  HAKRAYRELVLLKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM- 119
Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
                E    ++ Q+L  +   H  G++HRDLKP N +  S   D  ++++DFGL+    
Sbjct: 120 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAS 175
Query: 307 PDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR- 356
            +  +   V + YY APEV L   Y    DIWS+G I   L+ GS  F        W + 
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235
Query: 357 -----TESGIFRAVLRS-----------------DPNFDDLPWPSVS-------PEAKDF 387
                T S  F A L+                  +  F D  +PS S        +A+D 
Sbjct: 236 IEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDL 295
Query: 388 VKRLLNKDYRKRMTAVQAL 406
           + ++L  D  KR++  +AL
Sbjct: 296 LSKMLVIDPDKRISVDEAL 314

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G   +    R KK G+L     A+K+ +       + ++   RE ++LK L+ HK++
Sbjct: 17  LGQGATANVFRGRHKKTGDL----FAIKVFNNISFLRPVDVQ--MREFEVLKKLN-HKNI 69
Query: 214 VKFCDACEDVNNVY--IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK     E+    +  ++ME C  G L   +      Y   +++ ++V    V    HL+
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 272 --GVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
             G+VHR++KP N +   G D   + +L DFG +  +  DE+   + G+  Y+ P++  R
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 329 S---------YSLEADIWSIGVISYILLCGSRPF 353
           +         Y    D+WSIGV  Y    GS PF
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YELG+ +G G       AR  +     + VAVK++              RRE +   AL
Sbjct: 30  RYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 86
Query: 208 SGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           + H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++     
Sbjct: 87  N-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 144
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSAY 319
            + F H  G++HRD+KP N + ++      ++++DFG++  I        +   ++G+A 
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 320 YVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
           Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP       
Sbjct: 202 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 260
Query: 378 PSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
             +S +    V + L K+   R  TA +  + LV
Sbjct: 261 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 294

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 118
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 119 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 173
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 231 APEVILGMGYKENVDIWSVGCI 252

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 11/190 (5%)
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLD-RILARGGRYTEED-A 254
           RE+ ++K L  H+++V+  D     N + +V E  +    + +D R +    R  E +  
Sbjct: 52  REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLND 313
           K    Q+L  +AFCH   ++HRDLKP+N L         ++L DFGL+  F  P    + 
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINK---RGQLKLGDFGLARAFGIPVNTFSS 167
Query: 314 IVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371
            V + +Y AP+VL   R+YS   DIWS G I   ++ G   F    +    + +      
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 372 FDDLPWPSVS 381
            ++  WPSV+
Sbjct: 228 PNESLWPSVT 237

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G   +    R KK G+L     A+K+ +       + ++   RE ++LK L+ HK++
Sbjct: 17  LGQGATANVFRGRHKKTGDL----FAIKVFNNISFLRPVDVQ--MREFEVLKKLN-HKNI 69
Query: 214 VKFCDACEDVNNVY--IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK     E+    +  ++ME C  G L   +      Y   +++ ++V    V    HL+
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 272 --GVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
             G+VHR++KP N +   G D   + +L DFG +  +  DE+   + G+  Y+ P++  R
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189
Query: 329 S---------YSLEADIWSIGVISYILLCGSRPF 353
           +         Y    D+WSIGV  Y    GS PF
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 150 ELGKEVGRGHFGH--TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           E GK +G G FG     +A G        QVAVK++ +   ++    E +  E+K++  L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQL 105
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE---------------- 251
             H+++V    AC     +Y++ E C  G+LL+ + ++  +++E                
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 252 ------EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
                 ED      Q+   + F   +  VHRDL   N L T G+    +++ DFGL+  I
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICDFGLARDI 222
Query: 306 RPDERLNDIV-GSAY----YVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPF 353
             D   N +V G+A     ++APE L    Y++++D+WS G++ + I   G  P+
Sbjct: 223 MSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 118
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 119 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 173
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 231 APEVILGMGYKENVDIWSVGCI 252

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           L KE+G G FG       K G+ K Q  VAVK+I +  M+     ++  +E + +  LS 
Sbjct: 12  LLKELGSGQFGVV-----KLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLS- 61
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H  LVKF   C     +YIV E    G LL+ + + G          +   +   +AF  
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVL 326
               +HRDL   N L      D  +++ DFG++ ++  D+ ++  VG+ +   + APEV 
Sbjct: 122 SHQFIHRDLAARNCLVDR---DLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVF 177
Query: 327 HR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           H   YS ++D+W+ G++ + +   G  P+   T S +   V
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 81
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 82  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 136
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 194 APEVILGMGYKENVDIWSVGCI 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 85
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 86  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 140
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 141 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 197
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           APEV L   Y    D+WS+G I   ++C    F  R
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 81
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 82  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 136
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 194 APEVILGMGYKENVDIWSVGCI 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 79
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 80  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 134
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 191
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 192 APEVILGMGYKENVDIWSVGCI 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 74
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 75  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 129
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 186
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 187 APEVILGMGYKENVDIWSVGCI 208

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 74  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 128
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 186 APEVILGMGYKENVDIWSVGCI 207

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 74
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 75  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 129
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 186
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 187 APEVILGMGYKENVDIWSVGCI 208

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           APEV L   Y    DIWS+G I   ++C    F  R
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGR 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIR 306
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+ D   
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 307 PDERLNDIVGS--AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            D   N   G     ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 81
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 82  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 136
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 194 APEVILGMGYKENVDIWSVGCI 215

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 74
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 75  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 129
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 186
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           APEV L   Y    D+WS+G I   ++C    F  R
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +KYE   ++G+G FG    AR +K     Q+VA+K +          I  +R E+KIL+ 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 207 LSGHKHLVKFCDACEDV--------NNVYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
           L  H+++V   + C            ++Y+V + CE     LL  +L +   +T  + K 
Sbjct: 74  LK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKR 129
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------RPDER 310
           ++  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+         +P+  
Sbjct: 130 VMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVI 342
            N +V + +Y  PE+L   R Y    D+W  G I
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCI 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 43/227 (18%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+   +GRG +G+   A  K     ++ VA+K +++      I  + + RE+ IL  L 
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNA---NKNVAIKKVNRM-FEDLIDCKRILREITILNRLK 85
Query: 209 GHKHLVKFCDAC--EDV---NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
              ++++  D    ED+   + +YIV+E+ +    L ++       TE+  K I+  +L 
Sbjct: 86  S-DYIIRLHDLIIPEDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDI------ 314
              F H  G++HRDLKP N L      D  +++ DFGL+  I  D+ +   ND+      
Sbjct: 143 GEKFIHESGIIHRDLKPANCLLNQ---DCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 315 -----------------VGSAYYVAPE--VLHRSYSLEADIWSIGVI 342
                            V + +Y APE  +L  +Y+   DIWS G I
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 82
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 83  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 137
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 138 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRYYR 194
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 195 APEVILGMGYKENVDIWSVGCI 216

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + D+ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  MR+ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 134/304 (44%), Gaps = 57/304 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      +    VAVK +S+         +   RE+ +LK +
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGIN---VAVKKLSRP-FQNQTHAKRAYRELVLLKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+     +  +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR------TESGIFRAVL 366
           APEV L   Y+   DIWS+G I   L+ G   F        W +      T S  F A L
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 252
Query: 367 -----------------RSDPNFDDLPWPSVS-------PEAKDFVKRLLNKDYRKRMTA 402
                            + +  F D  +PS S        +A+D + ++L  D  KR++ 
Sbjct: 253 QPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 312
Query: 403 VQAL 406
            +AL
Sbjct: 313 DEAL 316

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 21/256 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG    AR  +     + VA+K +S +   +    +D+ +EV+ L+ L  H +
Sbjct: 60  REIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 115
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
            +++       +  ++VME C G    D +        E +  A+    L  +A+ H   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
           ++HRD+K  N L +   +   ++L DFG +  + P    N  VG+ Y++APEV+      
Sbjct: 175 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEG 228
Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            Y  + D+WS+G I+ I L   +P  F     S ++       P      W   S   ++
Sbjct: 229 QYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRN 284
Query: 387 FVKRLLNKDYRKRMTA 402
           FV   L K  + R T+
Sbjct: 285 FVDSCLQKIPQDRPTS 300

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--IEDVRRE 200
           K+   +YE    +G G F     AR K     +Q VA+K I     + A         RE
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVV 259
           +K+L+ LS H +++   DA    +N+ +V +  E    L+ I+       T    KA ++
Sbjct: 63  IKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYML 119
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
             L  + + H   ++HRDLKP N L     ++  ++L DFGL+  F  P+      V + 
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYXHQVVTR 176
Query: 319 YYVAPEVLH--RSYSLEADIWSIGVISYILL 347
           +Y APE+L   R Y +  D+W++G I   LL
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 193 SIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE 252
           +IE+VR+E K+   L  H +++     C    N+ +VME   GG L +R+L+ G R   +
Sbjct: 49  TIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLS-GKRIPPD 105
Query: 253 DAKAIVVQILSVVAFCHLQGVV---HRDLKPENFLFTSGRDDADM-----RLIDFGLSDF 304
                 VQI   + + H + +V   HRDLK  N L     ++ D+     ++ DFGL+  
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 305 IRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
                +++   G+  ++APEV+  S +S  +D+WS GV+ + LL G  PF  R   G+  
Sbjct: 166 WHRTTKMS-AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAV 222
Query: 364 AVLRSDPNFDDLPWPSVSPEA-KDFVKRLLNKDYRKRMTAVQALSKL 409
           A   +  N   LP PS  PE     ++   N D   R +    L +L
Sbjct: 223 AYGVA-MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 22/256 (8%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +GRG FG   + + K  G+L     A K ++K ++      +    E KIL  +   + +
Sbjct: 193 LGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFI 247
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
           V    A E   ++ +VM +  GG++   I         + E  A     QI+S +   H 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPE-VLHR 328
           + +++RDLKPEN L     DD ++R+ D GL+  ++  + +     G+  ++APE +L  
Sbjct: 308 RNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEA 384
            Y    D +++GV  Y ++    PF AR E      + + VL     + D      SP +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPAS 420
Query: 385 KDFVKRLLNKDYRKRM 400
           KDF + LL KD  KR+
Sbjct: 421 KDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 22/256 (8%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +GRG FG   + + K  G+L     A K ++K ++      +    E KIL  +   + +
Sbjct: 193 LGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFI 247
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
           V    A E   ++ +VM +  GG++   I         + E  A     QI+S +   H 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPE-VLHR 328
           + +++RDLKPEN L     DD ++R+ D GL+  ++  + +     G+  ++APE +L  
Sbjct: 308 RNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEA 384
            Y    D +++GV  Y ++    PF AR E      + + VL     + D      SP +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPAS 420
Query: 385 KDFVKRLLNKDYRKRM 400
           KDF + LL KD  KR+
Sbjct: 421 KDFCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 22/256 (8%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +GRG FG   + + K  G+L     A K ++K ++      +    E KIL  +   + +
Sbjct: 193 LGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFI 247
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
           V    A E   ++ +VM +  GG++   I         + E  A     QI+S +   H 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPE-VLHR 328
           + +++RDLKPEN L     DD ++R+ D GL+  ++  + +     G+  ++APE +L  
Sbjct: 308 RNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEA 384
            Y    D +++GV  Y ++    PF AR E      + + VL     + D      SP +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPAS 420
Query: 385 KDFVKRLLNKDYRKRM 400
           KDF + LL KD  KR+
Sbjct: 421 KDFCEALLQKDPEKRL 436

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVI 342
           APEV L   Y    DIWS+G I
Sbjct: 193 APEVILGMGYKENVDIWSVGCI 214

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A      + ++ VA+K +S+         +   RE+ ++K +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +      + E+  +VYIVMEL +    L +++        E    ++ Q+
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
           APEV L   Y    D+WS+G I   ++C    F  R
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 228

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 22/256 (8%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +GRG FG   + + K  G+L     A K ++K ++      +    E KIL  +   + +
Sbjct: 193 LGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFI 247
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
           V    A E   ++ +VM +  GG++   I         + E  A     QI+S +   H 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPE-VLHR 328
           + +++RDLKPEN L     DD ++R+ D GL+  ++  + +     G+  ++APE +L  
Sbjct: 308 RNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEA 384
            Y    D +++GV  Y ++    PF AR E      + + VL     + D      SP +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPAS 420
Query: 385 KDFVKRLLNKDYRKRM 400
           KDF + LL KD  KR+
Sbjct: 421 KDFCEALLQKDPEKRL 436

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 118/262 (45%), Gaps = 14/262 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y    ++G G +G    A      + ++ VA+K I        +    +R EV +LK L
Sbjct: 35  RYRRITKLGEGTYGEVYKA---IDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKEL 90
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H+++++        + ++++ E  E    L + + +    +    K+ + Q+++ V F
Sbjct: 91  Q-HRNIIELKSVIHHNHRLHLIFEYAEND--LKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 268 CHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAPE 324
           CH +  +HRDLKP+N L   +   +   +++ DFGL+  F  P  +    + + +Y  PE
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS- 381
           +L   R YS   DIWSI  I   +L  +  F   +E      +       DD  WP V+ 
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267
Query: 382 -PEAKDFVKRLLNKDYRKRMTA 402
            P+ K    +   K  ++ + A
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGA 289

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +KYE   ++G+G FG    AR +K     Q+VA+K +          I  +R E+KIL+ 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR-EIKILQL 72
Query: 207 LSGHKHLVKFCDACEDV--------NNVYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
           L  H+++V   + C            ++Y+V + CE     LL  +L +   +T  + K 
Sbjct: 73  LK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKR 128
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------RPDER 310
           ++  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+         +P+  
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVI 342
            N +V + +Y  PE+L   R Y    D+W  G I
Sbjct: 186 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCI 218

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +KYE   ++G+G FG    AR +K     Q+VA+K +          I  +R E+KIL+ 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 207 LSGHKHLVKFCDACEDV--------NNVYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
           L  H+++V   + C            ++Y+V + CE     LL  +L +   +T  + K 
Sbjct: 74  LK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKR 129
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------RPDER 310
           ++  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+         +P+  
Sbjct: 130 VMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVI 342
            N +V + +Y  PE+L   R Y    D+W  G I
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCI 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YELG+ +G G       AR  +     + VAVK++              RRE +   AL
Sbjct: 13  RYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 208 SGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           + H  +V      E         YIVME  +G  L D I+   G  T + A  ++     
Sbjct: 70  N-HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----ERLNDIVGSAY 319
            + F H  G++HRD+KP N + ++      ++++DFG++  I        +   ++G+A 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 320 YVAPEVLHRSYSLEA--DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
           Y++PE   R  S++A  D++S+G + Y +L G  PF   +   +    +R DP       
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 378 PSVSPEAKDFVKRLLNKDYRKR-MTAVQALSKLV 410
             +S +    V + L K+   R  TA +  + LV
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 170 KGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225
           K +L D  VA+K I     +    TAI      REV +LK L  H ++V   D      +
Sbjct: 22  KSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLKDLK-HANIVTLHDIIHTEKS 74
Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
           + +V E  +  +L   +   G      + K  + Q+L  +A+CH Q V+HRDLKP+N L 
Sbjct: 75  LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI 133
Query: 286 TSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVI 342
               +  +++L DFGL+     P +  ++ V + +Y  P++L  S  YS + D+W +G I
Sbjct: 134 N---ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190
Query: 343 SYILLCGSRPFWARTE-----SGIFRAV----------LRSDPNFDDLPWPSVSPEA--- 384
            Y +  G RP +  +        IFR +          + S+  F    +P    EA   
Sbjct: 191 FYEMATG-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS 249
Query: 385 ---------KDFVKRLLNKDYRKRMTAVQAL 406
                     D + +LL  + R R++A  A+
Sbjct: 250 HAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 70  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 127
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 128 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFV 183
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAV--LRSDPN 371
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P  + + S  IF  +  + ++P 
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP 243
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              LP    S E +DFV + L K+  +R    Q +
Sbjct: 244 -PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIR 306
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+ D   
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 307 PDERLNDIVGS--AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            D       G     ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +KYE   ++G+G FG    AR +K     Q+VA+K +          I  +R E+KIL+ 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 207 LSGHKHLVKFCDACEDVNN--------VYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
           L  H+++V   + C    +        +Y+V + CE     LL  +L +   +T  + K 
Sbjct: 74  LK-HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKR 129
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------RPDER 310
           ++  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+         +P+  
Sbjct: 130 VMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVI 342
            N +V + +Y  PE+L   R Y    D+W  G I
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCI 219

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 120/243 (49%), Gaps = 42/243 (17%)
Query: 200 EVKILKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK--- 255
           E+K+L     H +++++ C    D   +YI +ELC    L D  L      ++E+ K   
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCNLN-LQD--LVESKNVSDENLKLQK 113
Query: 256 -----AIVVQILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDAD-------MRLI--DFG 300
                +++ QI S VA  H   ++HRDLKP+N L  TS R  AD       +R++  DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 301 LSDFIRPDE-----RLNDIVGSAYYVAPEVLHRSYSLEA--------DIWSIG-VISYIL 346
           L   +   +      LN+  G++ + APE+L  S +L+         DI+S+G V  YIL
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 347 LCGSRPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV 403
             G  PF   ++R ES I R +   D     L   S+  EA D + ++++ D  KR TA+
Sbjct: 234 SKGKHPFGDKYSR-ESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
Query: 404 QAL 406
           + L
Sbjct: 292 KVL 294

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 30  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEETSS-VGSKFPVRWSPPEVLMY 195
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 21/256 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG    AR  +     + VA+K +S +   +    +D+ +EV+ L+ L  H +
Sbjct: 21  REIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 76
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
            +++       +  ++VME C G    D +        E +  A+    L  +A+ H   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
           ++HRD+K  N L +   +   ++L DFG +  + P    N  VG+ Y++APEV+      
Sbjct: 136 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEG 189
Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            Y  + D+WS+G I+ I L   +P  F     S ++       P      W   S   ++
Sbjct: 190 QYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRN 245
Query: 387 FVKRLLNKDYRKRMTA 402
           FV   L K  + R T+
Sbjct: 246 FVDSCLQKIPQDRPTS 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 138
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 255
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 120/243 (49%), Gaps = 42/243 (17%)
Query: 200 EVKILKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK--- 255
           E+K+L     H +++++ C    D   +YI +ELC    L D  L      ++E+ K   
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCNLN-LQD--LVESKNVSDENLKLQK 113
Query: 256 -----AIVVQILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDAD-------MRLI--DFG 300
                +++ QI S VA  H   ++HRDLKP+N L  TS R  AD       +R++  DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 301 LSDFIRPDE-----RLNDIVGSAYYVAPEVLHRSYSLEA--------DIWSIG-VISYIL 346
           L   +   +      LN+  G++ + APE+L  S +L+         DI+S+G V  YIL
Sbjct: 174 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 347 LCGSRPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV 403
             G  PF   ++R ES I R +   D     L   S+  EA D + ++++ D  KR TA+
Sbjct: 234 SKGKHPFGDKYSR-ESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
Query: 404 QAL 406
           + L
Sbjct: 292 KVL 294

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEEDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG----------GRYTEE 252
           ++K +  HK+++    AC     +Y+++E    G L + + AR            R  EE
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 253 -----DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIR 306
                D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+ D   
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 307 PDERLNDIVGS--AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            D       G     ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 81
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 82  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 198
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 79
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 80  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINN 196
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 84
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++E    G L + + AR   G  Y          
Sbjct: 85  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 145 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 201
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 30  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMY 195
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           LG+++GRG+FG   S R     L+     V + S  +           +E +ILK  S H
Sbjct: 118 LGEQIGRGNFGEVFSGR-----LRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-H 171
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++V+    C     +YIVMEL +GG+ L  +   G R   +    +V    + + +   
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA--------YYVA 322
           +  +HRDL   N L T   +   +++ DFG+S      E  + +  ++         + A
Sbjct: 232 KCCIHRDLAARNCLVT---EKNVLKISDFGMS-----REEADGVYAASGGLRQVPVKWTA 283
Query: 323 PEVLHRS-YSLEADIWSIGVISY-ILLCGSRPF 353
           PE L+   YS E+D+WS G++ +     G+ P+
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           LG+++GRG+FG   S R     L+     V + S  +           +E +ILK  S H
Sbjct: 118 LGEQIGRGNFGEVFSGR-----LRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-H 171
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++V+    C     +YIVMEL +GG+ L  +   G R   +    +V    + + +   
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA--------YYVA 322
           +  +HRDL   N L T   +   +++ DFG+S      E  + +  ++         + A
Sbjct: 232 KCCIHRDLAARNCLVT---EKNVLKISDFGMS-----REEADGVXAASGGLRQVPVKWTA 283
Query: 323 PEVLHRS-YSLEADIWSIGVISY-ILLCGSRPF 353
           PE L+   YS E+D+WS G++ +     G+ P+
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           +++G GHFG     R   +G+   +QVAVK +     +    I D+++E++IL+ L  H+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HE 83
Query: 212 HLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           ++VK+   C +   N + ++ME    G L + +     +   +      VQI   + +  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAYYVAPEV 325
            +  VHRDL   N L  S   +  +++ DFGL+  I  D+      +D     ++ APE 
Sbjct: 144 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 326 LHRS-YSLEADIWSIGVISYILL 347
           L +S + + +D+WS GV  + LL
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 118/239 (49%), Gaps = 38/239 (15%)
Query: 200 EVKILKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK--- 255
           E+K+L     H +++++ C    D   +YI +ELC    L  + L      ++E+ K   
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCN---LNLQDLVESKNVSDENLKLQK 131
Query: 256 -----AIVVQILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDAD-------MRLI--DFG 300
                +++ QI S VA  H   ++HRDLKP+N L  TS R  AD       +R++  DFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 301 LSDFIRPDE-----RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIG-VISYILLCGS 350
           L   +   +      LN+  G++ + APE+L     R  +   DI+S+G V  YIL  G 
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 351 RPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            PF   ++R ES I R +   D     L   S+  EA D + ++++ D  KR TA++ L
Sbjct: 252 HPFGDKYSR-ESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 118/239 (49%), Gaps = 38/239 (15%)
Query: 200 EVKILKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK--- 255
           E+K+L     H +++++ C    D   +YI +ELC    L  + L      ++E+ K   
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCN---LNLQDLVESKNVSDENLKLQK 131
Query: 256 -----AIVVQILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDAD-------MRLI--DFG 300
                +++ QI S VA  H   ++HRDLKP+N L  TS R  AD       +R++  DFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 301 LSDFIRPDE-----RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIG-VISYILLCGS 350
           L   +   +      LN+  G++ + APE+L     R  +   DI+S+G V  YIL  G 
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 351 RPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            PF   ++R ES I R +   D     L   S+  EA D + ++++ D  KR TA++ L
Sbjct: 252 HPFGDKYSR-ESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           +++G GHFG     R   +G+   +QVAVK +     +    I D+++E++IL+ L  H+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HE 71
Query: 212 HLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           ++VK+   C +   N + ++ME    G L + +     +   +      VQI   + +  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAYYVAPEV 325
            +  VHRDL   N L  S   +  +++ DFGL+  I  D+      +D     ++ APE 
Sbjct: 132 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 326 LHRS-YSLEADIWSIGVISYILL 347
           L +S + + +D+WS GV  + LL
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELL 211

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 151 LGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           LGK +G G FG    A      K    +  +VAVK++      T   + D+  E++++K 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 130
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------TE 251
           +  HK+++    AC     +Y+++E    G L + + AR   G  Y            + 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
           +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   +  
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 247
Query: 312 NDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                      ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 19  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 75
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D + A   R           QI   + +   
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 136 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y +   +GRG +G+   A  K  E   + VA+K +++      I  + + RE+ IL  L 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTE---KNVAIKKVNRM-FEDLIDCKRILREITILNRLK 83
Query: 209 GHKHLVKFCDAC--EDV---NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
              ++++  D    +D+   + +YIV+E+ +    L ++       TEE  K I+  +L 
Sbjct: 84  S-DYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--------- 314
              F H  G++HRDLKP N L      D  +++ DFGL+  I  ++  N +         
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 315 --------------VGSAYYVAPE--VLHRSYSLEADIWSIGVISYILL 347
                         V + +Y APE  +L  +Y+   DIWS G I   LL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 21  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 70
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 131 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMY 186
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 14  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 63
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 124 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMY 179
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 15  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 64
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMY 180
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 51  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 164
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFW-------ARTESGIFRAV-- 365
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P         +R    IF  +  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDY 224
Query: 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           + ++P    LP    S E +DFV + L K+  +R    Q +
Sbjct: 225 IVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 21  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 77
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 78  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 138 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 194
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 25  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 81
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 82  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 142 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 198
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 32  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 88
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 205
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 24  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 80
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 81  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 141 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 197
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 32  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 88
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 205
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 10  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 59
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +  VGS +   +  PEVL  
Sbjct: 120 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMY 175
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPFWARTES 359
           S +S ++DIW+ GV+ + I   G  P+   T S
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 32  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 88
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
            +  HK+++    AC     +Y+++E    G L + + AR   G  Y            +
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   + 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 205
Query: 311 LNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                       ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD---QQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   GK +G G FG    A    G +K      VAVK++  +   T    E +  E+K+L
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 103
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIV----- 258
             L  H ++V    AC       ++ E C  G+LL+ +   R      + + AI+     
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 259 -----------VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
                       Q+   +AF   +  +HRDL   N L T GR     ++ DFGL+  I+ 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARHIKN 220
Query: 308 DERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISYILL-CGSRPFWARTESG 360
           D   N +V G+A     ++APE + +  Y+ E+D+WS G+  + L   GS P+       
Sbjct: 221 DS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            F  +++    F  L       E  D +K   + D  KR T  Q
Sbjct: 279 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 151 LGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           LGK +G G FG    A      K    +  +VAVK++      T   + D+  E++++K 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 74
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------TE 251
           +  HK+++    AC     +Y+++E    G L + + AR   G  Y            + 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
           +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+  I   +  
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 191
Query: 312 NDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                      ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 41/297 (13%)
Query: 126 ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIIS 184
           E G      L+  + Y++N G +  LGK    G +G   + R    +L +Q ++A+K I 
Sbjct: 6   EEGDCESDLLEYDYEYDEN-GDRVVLGK----GTYGIVYAGR----DLSNQVRIAIKEIP 56
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA 244
           +     +   + +  E+ + K L  HK++V++  +  +   + I ME   GG L   + +
Sbjct: 57  ERDSRYS---QPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112
Query: 245 RGG--RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
           + G  +  E+       QIL  + + H   +VHRD+K +N L  +      +++ DFG S
Sbjct: 113 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTS 170
Query: 303 DFIRPDERLNDI-------VGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRP 352
                 +RL  I        G+  Y+APE++    R Y   ADIWS+G     +  G  P
Sbjct: 171 ------KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
Query: 353 FW--ARTESGIFR-AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           F+     ++ +F+  + +  P   +    S+S EAK F+ +    D  KR  A   L
Sbjct: 225 FYELGEPQAAMFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLL 277

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 36/268 (13%)
Query: 155 VGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           +G+G +G   + R    +L +Q ++A+K I +     +   + +  E+ + K L  HK++
Sbjct: 16  LGKGTYGIVYAGR----DLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLK-HKNI 67
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHLQ 271
           V++  +  +   + I ME   GG L   + ++ G  +  E+       QIL  + + H  
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI-------VGSAYYVAPE 324
            +VHRD+K +N L  +      +++ DFG S      +RL  I        G+  Y+APE
Sbjct: 128 QIVHRDIKGDNVLINTY--SGVLKISDFGTS------KRLAGINPCTETFTGTLQYMAPE 179
Query: 325 VLH---RSYSLEADIWSIGVISYILLCGSRPFW--ARTESGIFR-AVLRSDPNFDDLPWP 378
           ++    R Y   ADIWS+G     +  G  PF+     ++ +F+  + +  P   +    
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE---- 235
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           S+S EAK F+ +    D  KR  A   L
Sbjct: 236 SMSAEAKAFILKCFEPDPDKRACANDLL 263

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED-AKAIVVQILSV-- 264
             H+++V    AC     V ++ E C  G+LL+  L R  R  E D A AI    LS   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 265 -----------VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
                      +AF   +  +HRD+   N L T+G      ++ DFGL+  I  D   N 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDS--NY 220
Query: 314 IV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           IV G+A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +     A+S ED   E +++  LS H  
Sbjct: 13  QEIGSGQFGLVHLGYW----LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPK 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 124 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGI 361
            YS ++D+WS GV+ + +   G  P+  R+ S +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---HK 211
           +G G FG  CS R K    +D  VA+K + K   T     E  RR+     ++ G   H 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTL-KVGYT-----EKQRRDFLCEASIMGQFDHP 104
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++V           V IV+E  E G L   +    G++T      ++  I + + +    
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGS---AYYVAPEVL- 326
           G VHRDL   N L  S   +   ++ DFGLS  I  D E +    G      + APE + 
Sbjct: 165 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++     G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 127/298 (42%), Gaps = 60/298 (20%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVR---REVKIL 204
           Y   K +G G FG    A+    GEL    VA+K +          ++D R   RE++I+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKV----------LQDKRFKNRELQIM 146
Query: 205 KALSGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKA 256
           + L  H ++V+    F  + E  + VY+ + L    E + R+     R  +       K 
Sbjct: 147 RKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 205
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
            + Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + 
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 317 SAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI------------- 361
           S YY APE++     Y+   D+WS G +   LL G   F    +SG+             
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTP 321
Query: 362 FRAVLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            R  +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 322 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 379

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGAVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILK 205
           LGK +G G FG    A    G  KD+     +VAVK++      T   + D+  E++++K
Sbjct: 32  LGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMK 88
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---------------GGRYT 250
            +  HK+++    AC     +Y+++E    G L + + AR                 + +
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDE 309
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+ D    D 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDX 205
Query: 310 RLNDIVGS--AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
                 G     ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 108
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 109 D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 283
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A +
Sbjct: 284 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 340

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 39  RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 96
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 97  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 152
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 153 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 16  RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 74  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 129
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 130 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 128/300 (42%), Gaps = 60/300 (20%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVR---REVKIL 204
           Y   K +G G FG    A+    GEL    VA+K +          ++D R   RE++I+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKV----------LQDKRFKNRELQIM 103
Query: 205 KALSGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKA 256
           + L  H ++V+    F  + E  + VY+ + L    E + R+     R  +       K 
Sbjct: 104 RKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 162
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
            + Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + 
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 317 SAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI------------- 361
           S YY APE++     Y+   D+WS G +   LL G   F    +SG+             
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTP 278
Query: 362 FRAVLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            R  +R  +PN+ +         PW     P   PEA     RLL      R+T ++A +
Sbjct: 279 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 338

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 30/283 (10%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---HK 211
           +G G FG  C  R K    K+  VA+K + K   T     E  RRE     ++ G   H 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYT-----ERQRREFLSEASIMGQFEHP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++++      +   V I+ E  E G L   +    G++T      ++  I S + +    
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA--------YYVAP 323
             VHRDL   N L  S   +   ++ DFGLS F+  +E  +D   ++         + AP
Sbjct: 138 SYVHRDLAARNILVNS---NLVCKVSDFGLSRFL--EENSSDPTETSSLGGKIPIRWTAP 192
Query: 324 EVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           E +  R ++  +D WS G++ + ++  G RP+W  +   +  A+   + ++   P P   
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI---EQDYRLPPPPDCP 249
Query: 382 PEAKDFVKRLLNKDYRKR---MTAVQALSKLVVPILSFKIVCR 421
                 +     KD   R      V AL K++    S KIV R
Sbjct: 250 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVAR 292

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 103
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 163
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 164 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVK 202
           K  LGK +G G FG    A    G  KD+      VAVK++      T   + D+  E++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAV-GIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
           ++K +  HK+++    AC     +Y+++     G L + + AR   G  Y          
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             T +D  +   Q+   + +   Q  +HRDL   N L T   ++  M++ DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 308 DERLNDIVGS---AYYVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
            +             ++APE L  R Y+ ++D+WS GV+ + I   G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 128/300 (42%), Gaps = 60/300 (20%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVR---REVKIL 204
           Y   K +G G FG    A+    GEL    VA+K +          ++D R   RE++I+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKV----------LQDKRFKNRELQIM 101
Query: 205 KALSGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKA 256
           + L  H ++V+    F  + E  + VY+ + L    E + R+     R  +       K 
Sbjct: 102 RKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
            + Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 317 SAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI------------- 361
           S YY APE++     Y+   D+WS G +   LL G   F    +SG+             
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTP 276
Query: 362 FRAVLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            R  +R  +PN+ +         PW     P   PEA     RLL      R+T ++A +
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 13/245 (5%)
Query: 128 GTEPEQSLDKSFGYNKNFGA-KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
           G  P  S      + K   A    + K VG G FG  CS R K    K+  VA+K +   
Sbjct: 13  GLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 72
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG 246
              T     D   E  I+     H ++++          V IV E  E G L   +    
Sbjct: 73  --YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 129
Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
            ++T      ++  I S + +    G VHRDL   N L  S   +   ++ DFGLS  + 
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLE 186
Query: 307 PD-ERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESG 360
            D E      G      + +PE + +R ++  +D+WS G++ + ++  G RP+W  +   
Sbjct: 187 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 246
Query: 361 IFRAV 365
           + +AV
Sbjct: 247 VIKAV 251

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQGKAFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 81/304 (26%)
Query: 148 KYELGKEVGRGHFGHTCSA----RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           KY LGK +G G FG  C       GK+  LK      K++   +           RE+ I
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK------KVLQDPRYKN--------RELDI 53
Query: 204 LKALSGHKHLVKFCDAC------------------------EDVNN-------------- 225
           +K L  H +++K  D                            VNN              
Sbjct: 54  MKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVV-QILSVVAFCHLQGVVHRDLKPE 281
           + ++ME     + L ++L    R GR    +  +I + Q+   V F H  G+ HRD+KP+
Sbjct: 113 LNVIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSI 339
           N L  S   D  ++L DFG +  + P E     + S +Y APE++     Y+   D+WSI
Sbjct: 171 NLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 340 GVISYILLCGSRPFWARTE-SGIFRAV-----------LRSDPNFDDLPWPSVSPEAKDF 387
           G +   L+ G   F   T    + R +           +R +P++ ++ +P++  +AKD+
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL--KAKDW 286
Query: 388 VKRL 391
            K L
Sbjct: 287 RKIL 290

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 98
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 99  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 273
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A +
Sbjct: 274 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 330

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQGKAFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 25/263 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +     A+S ED   E +++  LS H  
Sbjct: 16  QEIGSGQFGLVHLGYW----LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPK 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 127 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
            YS ++D+WS GV+ + +   G  P+  R+ S +   +      +     P +   A   
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRL---ASTH 235
Query: 388 VKRLLNKDYRKRMTAVQALSKLV 410
           V +++N  +R+R     A S+L+
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLL 258

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 27/299 (9%)
Query: 138 SFGYNKNFGAKY-ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED 196
           S  + K     Y ++ + +G G FG  C  R K    K+  VA+K + K   T     E 
Sbjct: 4   SMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYT-----ER 57
Query: 197 VRREVKILKALSG---HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
            RRE     ++ G   H ++++      +   V I+ E  E G L   +    G++T   
Sbjct: 58  QRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ 117
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR---PDER 310
              ++  I S + +      VHRDL   N L  S   +   ++ DFGLS F+     D  
Sbjct: 118 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDPT 174
Query: 311 LNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
               +G      + APE +  R ++  +D WS G++ + ++  G RP+W  +   +  A+
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234
Query: 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALSKLVVPILSFKIVCR 421
              + ++   P P         +     KD   R      V AL K++    S KIV R
Sbjct: 235 ---EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVAR 290

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 104
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 105 D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 221
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 279
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 14  RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 71
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 72  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 127
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 128 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K       T      D  RE  + +AL
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-------TCKNCTSDSVREKFLQEAL 63
Query: 208 S----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQI 261
           +     H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQL 120
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AY 319
            + +A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           ++APE ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD---QQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   GK +G G FG    A    G +K      VAVK++  +   T    E +  E+K+L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIV----- 258
             L  H ++V    AC       ++ E C  G+LL+ +   R      + + AI+     
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 259 -----------VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
                       Q+   +AF   +  +HRDL   N L T GR     ++ DFGL+  I+ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 197
Query: 308 DERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISYILL-CGSRPFWARTESG 360
           D   N +V G+A     ++APE + +  Y+ E+D+WS G+  + L   GS P+       
Sbjct: 198 DS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            F  +++    F  L       E  D +K   + D  KR T  Q
Sbjct: 256 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 13  RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 70
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 71  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 126
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 127 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 76
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 137 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           RE+++L   +   ++V F  A      + I ME  +GG L D++L    R  EE    + 
Sbjct: 63  RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 120
Query: 259 VQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + +L  +A+   +  ++HRD+KP N L  S     +++L DFG+S  +  D   N  VG+
Sbjct: 121 IAVLRGLAYLREKHQIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFVGT 176
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
             Y+APE L  + YS+++DIWS+G+    L  G  P 
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 16  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 72
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 133 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 75
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 76  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 192
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 250
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 251 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 305

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 76
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGLS  +  D E      G      + +PE +
Sbjct: 137 MGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +     A+S ED   E +++  LS H  
Sbjct: 13  QEIGSGQFGLVHLGYW----LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPK 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 124 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGI 361
            YS ++D+WS GV+ + +   G  P+  R+ S +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 11  RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 69  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 125 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-------- 259
             H+++V    AC     V ++ E C  G+LL+  L R  R  E D    +         
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165
Query: 260 ------QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
                 Q+   +AF   +  +HRD+   N L T+G      ++ DFGL+  I  D   N 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDS--NY 220
Query: 314 IV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           IV G+A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 47  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 103
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 164 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 221 TESKFSVASDVWSFGVVLYELF 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD---QQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   GK +G G FG    A    G +K      VAVK++  +   T    E +  E+K+L
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 103
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIV----- 258
             L  H ++V    AC       ++ E C  G+LL+ +   R      + + AI+     
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 259 -----------VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
                       Q+   +AF   +  +HRDL   N L T GR     ++ DFGL+  I+ 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 220
Query: 308 DERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISYILL-CGSRPFWARTESG 360
           D   N +V G+A     ++APE + +  Y+ E+D+WS G+  + L   GS P+       
Sbjct: 221 DS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            F  +++    F  L       E  D +K   + D  KR T  Q
Sbjct: 279 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 23  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 79
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 140 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 197 TESKFSVASDVWSFGVVLYELF 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 34  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 90
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 151 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 208 TESKFSVASDVWSFGVVLYELF 229

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG     +G     ++  +AV I +    T+    E   +E   ++  
Sbjct: 8   RIELGRCIGEGQFGDV--HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQILSVV 265
             H H+VK      + N V+I+MELC  GEL   +  R  +Y+ + A  I+   Q+ + +
Sbjct: 66  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTAL 121
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAP 323
           A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     ++AP
Sbjct: 122 AYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 324 EVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           E ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 83
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 84  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 258
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 259 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 313

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 16  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 72
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 133 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD---QQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   GK +G G FG    A    G +K      VAVK++  +   T    E +  E+K+L
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 96
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIV----- 258
             L  H ++V    AC       ++ E C  G+LL+ +   R      + + AI+     
Sbjct: 97  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 156
Query: 259 -----------VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
                       Q+   +AF   +  +HRDL   N L T GR     ++ DFGL+  I+ 
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 213
Query: 308 DERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISYILL-CGSRPFWARTESG 360
           D   N +V G+A     ++APE + +  Y+ E+D+WS G+  + L   GS P+       
Sbjct: 214 DS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 271
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            F  +++    F  L       E  D +K   + D  KR T  Q
Sbjct: 272 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 313

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD---QQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   GK +G G FG    A    G +K      VAVK++  +   T    E +  E+K+L
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 98
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIV----- 258
             L  H ++V    AC       ++ E C  G+LL+ +   R      + + AI+     
Sbjct: 99  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 259 -----------VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
                       Q+   +AF   +  +HRDL   N L T GR     ++ DFGL+  I+ 
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 215
Query: 308 DERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISYILL-CGSRPFWARTESG 360
           D   N +V G+A     ++APE + +  Y+ E+D+WS G+  + L   GS P+       
Sbjct: 216 DS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 273
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            F  +++    F  L       E  D +K   + D  KR T  Q
Sbjct: 274 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 315

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +     A+S ED   E +++  LS H  
Sbjct: 11  QEIGSGQFGLVHLGYW----LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPK 61
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 122 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGI 361
            YS ++D+WS GV+ + +   G  P+  R+ S +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 34  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 90
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 151 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 208 TESKFSVASDVWSFGVVLYELF 229

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 23/257 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG FG           ++D+Q   +   K      + +E  R E  +  A      +V
Sbjct: 82  LGRGSFGEV-------HRMEDKQTGFQCAVKK-----VRLEVFRAEELMACAGLTSPRIV 129
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               A  +   V I MEL EGG L  +++   G   E+ A   + Q L  + + H + ++
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRIL 188
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPE-VLH 327
           H D+K +N L +S  D +   L DFG +  ++PD    D++      G+  ++APE VL 
Sbjct: 189 HGDVKADNVLLSS--DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           RS   + D+WS   +   +L G  P+       +   +    P   ++P PS +P     
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQA 305
Query: 388 VKRLLNKDYRKRMTAVQ 404
           ++  L K+   R++A +
Sbjct: 306 IQEGLRKEPIHRVSAAE 322

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 78
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 79  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 195
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 253
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 254 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 308

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 16  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 72
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 133 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 20  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 76
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 137 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 194 TESKFSVASDVWSFGVVLYELF 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 19  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 75
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 136 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 82
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 83  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 257
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 312

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 21  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 77
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 138 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 195 TESKFSVASDVWSFGVVLYELF 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 14  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 70
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 131 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 188 TESKFSVASDVWSFGVVLYELF 209

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 25/263 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +     A+S ED   E +++  LS H  
Sbjct: 14  QEIGSGQFGLVHLGYW----LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPK 64
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 125 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
            YS ++D+WS GV+ + +   G  P+  R+ S +   +      +     P +   A   
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRL---ASTH 233
Query: 388 VKRLLNKDYRKRMTAVQALSKLV 410
           V +++N  +R+R     A S+L+
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLL 256

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 89
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 90  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 206
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 264
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 265 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 319

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 82
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 83  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 257
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 312

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 74
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 75  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 191
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 249
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 250 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 304

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 22  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 78
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 139 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 196 TESKFSVASDVWSFGVVLYELF 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 113 IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 170
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 171 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 226
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 15  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 71
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 132 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 189 TESKFSVASDVWSFGVVLYELF 210

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 224 NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFC-HLQGVVHRDLKPE 281
            +V+I MEL   G   +++  R  G   E     + V I+  + +     GV+HRD+KP 
Sbjct: 97  TDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL------HRSYSLEAD 335
           N L     +   ++L DFG+S  +  D+  +   G A Y+APE +         Y + AD
Sbjct: 155 NILLD---ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 336 IWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVKRLLN 393
           +WS+G+    L  G  P+   +T+  +   VL+ +P    LP     S + + FVK  L 
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--LPGHMGFSGDFQSFVKDCLT 269
Query: 394 KDYRKR 399
           KD+RKR
Sbjct: 270 KDHRKR 275

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGL+  +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 155 VGRGHFGHTCSAR-GKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHK 211
           +GRG FG     R    G++     A+K + K   KM    ++    R +  L +     
Sbjct: 196 IGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 251
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    A    + +  +++L  GG+L    L++ G ++E D +    +I+  +   H +
Sbjct: 252 FIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 310
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-- 328
            VV+RDLKP N L     +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  
Sbjct: 311 FVVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV 365
Query: 329 SYSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           +Y   AD +S+G + + LL G  PF     + +  I R  L       D    S SPE +
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELR 421
Query: 386 DFVKRLLNKDYRKRM 400
             ++ LL +D  +R+
Sbjct: 422 SLLEGLLQRDVNRRL 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 155 VGRGHFGHTCSAR-GKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHK 211
           +GRG FG     R    G++     A+K + K   KM    ++    R +  L +     
Sbjct: 197 IGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    A    + +  +++L  GG+L    L++ G ++E D +    +I+  +   H +
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-- 328
            VV+RDLKP N L     +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  
Sbjct: 312 FVVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV 366
Query: 329 SYSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           +Y   AD +S+G + + LL G  PF     + +  I R  L       D    S SPE +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELR 422
Query: 386 DFVKRLLNKDYRKRM 400
             ++ LL +D  +R+
Sbjct: 423 SLLEGLLQRDVNRRL 437

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 155 VGRGHFGHTCSAR-GKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHK 211
           +GRG FG     R    G++     A+K + K   KM    ++    R +  L +     
Sbjct: 197 IGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    A    + +  +++L  GG+L    L++ G ++E D +    +I+  +   H +
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-- 328
            VV+RDLKP N L     +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  
Sbjct: 312 FVVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV 366
Query: 329 SYSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           +Y   AD +S+G + + LL G  PF     + +  I R  L       D    S SPE +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELR 422
Query: 386 DFVKRLLNKDYRKRM 400
             ++ LL +D  +R+
Sbjct: 423 SLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 155 VGRGHFGHTCSAR-GKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHK 211
           +GRG FG     R    G++     A+K + K   KM    ++    R +  L +     
Sbjct: 197 IGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            +V    A    + +  +++L  GG+L    L++ G ++E D +    +I+  +   H +
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-- 328
            VV+RDLKP N L     +   +R+ D GL+ DF +  ++ +  VG+  Y+APEVL +  
Sbjct: 312 FVVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV 366
Query: 329 SYSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
           +Y   AD +S+G + + LL G  PF     + +  I R  L       D    S SPE +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELR 422
Query: 386 DFVKRLLNKDYRKRM 400
             ++ LL +D  +R+
Sbjct: 423 SLLEGLLQRDVNRRL 437

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           KE+G G FG       K G+ + Q  VA+K+I +  M+    IE    E K++  LS H+
Sbjct: 15  KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HE 64
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
            LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + +   +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHR 328
             +HRDL   N L     D   +++ DFGLS ++  DE  +   GS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSS-RGSKFPVRWSPPEVLMY 180
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
           S +S ++DIW+ GV+ + I   G  P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 71
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 72  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 246
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 247 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 301

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K       T      D  RE  + +AL
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-------TCKNCTSDSVREKFLQEAL 63
Query: 208 S----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQI 261
           +     H H+VK      + N V+I+MELC  GEL   +  R  +++ + A  I+   Q+
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQL 120
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AY 319
            + +A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           ++APE ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +E+G G FG           L   +VA+K I +  M+     +D   E +++  LS H  
Sbjct: 33  QEIGSGQFGLVHLGYW----LNKDKVAIKTIKEGSMSE----DDFIEEAEVMMKLS-HPK 83
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+     
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLHRS 329
           V+HRDL   N L     ++  +++ DFG++ F+  D++     G+ +   + +PEV   S
Sbjct: 144 VIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 330 -YSLEADIWSIGVISYILLC-GSRPFWARTESGI 361
            YS ++D+WS GV+ + +   G  P+  R+ S +
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 233

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +      T     D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL 326
            G VHRDL   N L  S   +   ++ DFGL   +  D E      G      + +PE +
Sbjct: 166 MGYVHRDLAARNILINS---NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 19  RQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 75
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L + +     R           QI   + +   
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVL 326
           +  +HRDL   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 136 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 35/304 (11%)
Query: 118 PKESTIPEERGTEPEQSLDK----SFGYNKNFGAK---YELGKEVGRGHFGHTCSARGKK 170
           PKE+    +  + P + LD     S G N+NF  K    E   E+GRG +G     R   
Sbjct: 16  PKEAFEQPQTSSTPPRDLDSKACISIG-NQNFEVKADDLEPIMELGRGAYGVVEKMRHVP 74
Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHKHLVKFCDACEDVNNVY 227
                Q +AVK     ++   ++ ++ +R   ++ I          V F  A     +V+
Sbjct: 75  S---GQIMAVK-----RIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 126
Query: 228 IVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFL 284
           I MEL +    +   +++ +G    E+    I V I+  +   H +  V+HRD+KP N L
Sbjct: 127 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 186
Query: 285 FTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSI 339
             +      +++ DFG+S ++          G   Y+APE ++     + YS+++DIWS+
Sbjct: 187 INAL---GQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 243
Query: 340 GVISYILLCGSRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
           G+    L     P+  W      + + V    P    LP    S E  DF  + L K+ +
Sbjct: 244 GITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---LPADKFSAEFVDFTSQCLKKNSK 300
Query: 398 KRMT 401
           +R T
Sbjct: 301 ERPT 304

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L    E + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 78  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 135
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 191
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 27/245 (11%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K       T      D  RE  + +AL
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-------TCKNCTSDSVREKFLQEAL 443
Query: 208 S----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQI 261
           +     H H+VK      + N V+I+MELC  GEL   +  R  +++ + A  I+   Q+
Sbjct: 444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQL 500
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AY 319
            + +A+   +  VHRD+   N L +S  +D  ++L DFGLS ++          G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSS--NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
           ++APE ++ R ++  +D+W  GV  + IL+ G +PF     + +   +     N + LP 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPM 613
Query: 378 PSVSP 382
           P   P
Sbjct: 614 PPNCP 618

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 54/295 (18%)
Query: 149 YELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           Y   K +G G FG    A+    GEL    VA+K + + K           RE++I++ L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQGKAFK-------NRELQIMRKL 70
Query: 208 SGHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE----DAKAIVV 259
             H ++V+    F  + E  + VY+ + L      + R+     R  +       K  + 
Sbjct: 71  D-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +A+ H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI-------------FRA 364
           Y APE++     Y+   D+WS G +   LL G   F    +SG+              R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 365 VLRS-DPNFDDL--------PW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            +R  +PN+ +         PW     P   PEA     RLL      R+T ++A
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 129/299 (43%), Gaps = 61/299 (20%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y   K +G G FG    A+     ++  +VA+K + + K           RE++I++ + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAK----LVESDEVAIKKVLQDKRFK-------NRELQIMRIVK 90
Query: 209 GHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI------- 257
            H ++V     F    +  + V++ + L    E +   + R  R+  +  + +       
Sbjct: 91  -HPNVVDLKAFFYSNGDKKDEVFLNLVL----EYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 258 -VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
            + Q+L  +A+ H  G+ HRD+KP+N L         ++LIDFG +  +   E     + 
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 317 SAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV--------- 365
           S YY APE++    +Y+   DIWS G +   L+ G   F    ESGI + V         
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG--ESGIDQLVEIIKVLGTP 261
Query: 366 -----LRSDPNFDDLPWPSV-------------SPEAKDFVKRLLNKDYRKRMTAVQAL 406
                   +PN+ +  +P +              P+A D + RLL      R+TA++AL
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 20/236 (8%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
           E+    P    D S+ Y +   ++  L   +G G FG     +          VAVKI+ 
Sbjct: 15  EKNKIRPRGQRDSSY-YWEIEASEVMLSTRIGSGSFGTVYKGKWHG------DVAVKIL- 66
Query: 185 KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA 244
           K    T    +  R EV +L+  + H +++ F       +N+ IV + CEG  L   +  
Sbjct: 67  KVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV 124
Query: 245 RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
           +  ++       I  Q    + + H + ++HRD+K  N     G     +++ DFGL+  
Sbjct: 125 QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATV 181
Query: 305 ---IRPDERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPF 353
                  +++    GS  ++APEV+    +  +S ++D++S G++ Y L+ G  P+
Sbjct: 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 24/227 (10%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G N   G  Y++G+ +G G FG           L +QQVA+K   + + + A  + D  R
Sbjct: 3   GQNNVVGVHYKVGRRIGEGSFGVIFEG---TNLLNNQQVAIKF--EPRRSDAPQLRDEYR 57
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
             K+L   +G  ++  F    E ++NV ++  L  G  L D +   G +++ +       
Sbjct: 58  TYKLLAGCTGIPNVYYF--GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAK 113
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGR---DDADM-RLIDFGLSDFIR--------P 307
           Q+L+ V   H + +V+RD+KP+NFL   GR    +A+M  ++DFG+  F R        P
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 308 DERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
                ++ G+A Y++    L R  S   D+ ++G +    L GS P+
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           +++G+G+FG     R     L+D    V  + K + +T   + D  RE++ILK+L  H +
Sbjct: 17  QQLGKGNFGSVEMCR--YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDN 73
Query: 213 LVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           +VK+   C      N+ ++ME    G L D +     R           QI   + +   
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV----GSAYYVAPEVL 326
           +  +HR+L   N L     ++  +++ DFGL+  +  D+    +        ++ APE L
Sbjct: 134 KRYIHRNLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             S +S+ +D+WS GV+ Y L 
Sbjct: 191 TESKFSVASDVWSFGVVLYELF 212

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 51  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 164
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVV------- 259
             H+++V    AC     V ++ E C  G+LL+ +  +      +ED + + +       
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 260 -QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GS 317
            Q+   +AF   +  +HRD+   N L T+G      ++ DFGL+  I  D   N IV G+
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDS--NYIVKGN 213
Query: 318 AY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 111/227 (48%), Gaps = 24/227 (10%)
Query: 140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           G N   G  Y++G+ +G G FG           L +QQVA+K   + + + A  + D  R
Sbjct: 2   GQNNVVGVHYKVGRRIGEGSFGVIFEG---TNLLNNQQVAIKF--EPRRSDAPQLRDEYR 56
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
             K+L   +G  ++  F    E ++NV +V++L  G  L D +   G +++ +       
Sbjct: 57  TYKLLAGCTGIPNVYYF--GQEGLHNV-LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK 112
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGR---DDADM-RLIDFGLSDFIR--------P 307
           Q+L+ V   H + +V+RD+KP+NFL   GR    +A+M  ++DFG+  F R        P
Sbjct: 113 QMLARVQSIHEKSLVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 170
Query: 308 DERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
                ++ G+A Y++    L R  S   D+ ++G +    L GS P+
Sbjct: 171 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 51  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 164
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 79
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   + A   ++  +    I  Q    + + H 
Sbjct: 80  VNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVV------- 259
             H+++V    AC     V ++ E C  G+LL+ +  +      +ED + + +       
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 260 -QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GS 317
            Q+   +AF   +  +HRD+   N L T+G      ++ DFGL+  I  D   N IV G+
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDS--NYIVKGN 221
Query: 318 AY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 16/220 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G FG  CS   K    ++  VA+K +      T     D   E  I+     H +++
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVI 97
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                      V I+ E  E G L   +    G++T      ++  I + + +      V
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-------YVAPEVL- 326
           HRDL   N L  S   +   ++ DFGLS F+  D+  +    SA        + APE + 
Sbjct: 158 HRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           +R ++  +D+WS G++ + ++  G RP+W  T   +  A+
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 23/257 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG FG           ++D+Q   +   K      + +E  R E  +  A      +V
Sbjct: 101 LGRGSFGEV-------HRMEDKQTGFQCAVKK-----VRLEVFRAEELMACAGLTSPRIV 148
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               A  +   V I MEL EGG L  +++   G   E+ A   + Q L  + + H + ++
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRIL 207
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPE-VLH 327
           H D+K +N L +S  D +   L DFG +  ++PD     ++      G+  ++APE VL 
Sbjct: 208 HGDVKADNVLLSS--DGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           RS   + D+WS   +   +L G  P+       +   +    P   ++P PS +P     
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQA 324
Query: 388 VKRLLNKDYRKRMTAVQ 404
           ++  L K+   R++A +
Sbjct: 325 IQEGLRKEPIHRVSAAE 341

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 12/217 (5%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G FG  CS R K    ++  VA+K +      T     D   E  I+     H +++
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNII 86
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                      V IV E  E G L   +    G++T      ++  I + + +    G V
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL-HRS 329
           HRDL   N L  S   +   ++ DFGLS  +  D E      G      + APE +  R 
Sbjct: 147 HRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 330 YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           ++  +D+WS G++ + ++  G RP+W  T   + +AV
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 70/138 (50%), Gaps = 19/138 (13%)
Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKA--IVVQILSVVAFCHLQGVVHRDLKPENF 283
           +YI M+LC    L D +  R      E      I +QI   V F H +G++HRDLKP N 
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDI-------------VGSAYYVAPEVLH-RS 329
            FT   DD  +++ DFGL   +  DE    +             VG+  Y++PE +H  +
Sbjct: 196 FFTM--DDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 330 YSLEADIWSIGVISYILL 347
           YS + DI+S+G+I + LL
Sbjct: 253 YSHKVDIFSLGLILFELL 270

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 16  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 67
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   + A   ++  +    I  Q    + + H 
Sbjct: 68  VNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 127 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 51  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 164
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           + RE+++L   +   ++V F  A      + I ME  +GG L D++L + GR  E+    
Sbjct: 51  IIRELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 257 IVVQILSVVAFC-HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
           + + ++  + +      ++HRD+KP N L  S     +++L DFG+S  +  D   N  V
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLI-DSMANSFV 164
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
           G+  Y++PE L  + YS+++DIWS+G+    +  G  P 
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 79
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   + A   ++  +    I  Q    + + H 
Sbjct: 80  VNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K       T      D  RE  + +AL
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-------TCKNCTSDSVREKFLQEAL 63
Query: 208 S----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQI 261
           +     H H+VK      + N V+I+MELC  GEL   +  R  +++ + A  I+   Q+
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQL 120
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AY 319
            + +A+   +  VHRD+   N L ++   D  ++L DFGLS ++          G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSA--TDC-VKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPF 353
           ++APE ++ R ++  +D+W  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 12/222 (5%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ++ K +G G FG  CS R K    ++  VA+K + KA  T      D   E  I+     
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDK-QRRDFLSEASIMGQFD- 88
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +++           V I+ E  E G L   +    GR+T      ++  I S + +  
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS 148
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEV 325
               VHRDL   N L  S   +   ++ DFG+S  +  D E      G      + APE 
Sbjct: 149 DMSAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
             A+YE+   +G G FG        K     + VAVKI+           E  R E+++L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNVDRYC----EAARSEIQVL 65
Query: 205 KALSGHK-----HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIV 258
           + L+          V+  +  E   ++ IV EL  G    D I   G   +  +  + + 
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSG-----------RDD-----ADMRLIDFGLS 302
            QI   V F H   + H DLKPEN LF              RD+      D++++DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 303 DFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVI 342
            +   DE  + +V + +Y APEV L   +S   D+WSIG I
Sbjct: 185 TY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 91/185 (49%), Gaps = 10/185 (5%)
Query: 173 LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232
           ++++ VA+K+ S+   +  +     +RE +    L    H+V   D  E    +Y+   L
Sbjct: 57  VRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDXRL 115
Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
             G +L    L R G      A AIV QI S +   H  G  HRD+KPEN L ++   D 
Sbjct: 116 INGVDLA-AXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA---DD 171
Query: 293 DMRLIDFGLSDFIRPDERLNDI---VGSAYYVAPEVLHRSY-SLEADIWSIGVISYILLC 348
              L+DFG++     DE+L  +   VG+ YY APE    S+ +  ADI+++  + Y  L 
Sbjct: 172 FAYLVDFGIASATT-DEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLT 230
Query: 349 GSRPF 353
           GS P+
Sbjct: 231 GSPPY 235

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 12/222 (5%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ++ K +G G FG  CS R K    ++  VA+K + KA  T      D   E  I+     
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDK-QRRDFLSEASIMGQFD- 73
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +++           V I+ E  E G L   +    GR+T      ++  I S + +  
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS 133
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEV 325
               VHRDL   N L  S   +   ++ DFG+S  +  D E      G      + APE 
Sbjct: 134 DMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 12/222 (5%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ++ K +G G FG  CS R K    ++  VA+K + KA  T      D   E  I+     
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDK-QRRDFLSEASIMGQFD- 67
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +++           V I+ E  E G L   +    GR+T      ++  I S + +  
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS 127
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEV 325
               VHRDL   N L  S   +   ++ DFG+S  +  D E      G      + APE 
Sbjct: 128 DMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K       T      D  RE  + +AL
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-------TCKNCTSDSVREKFLQEAL 443
Query: 208 S----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--VQI 261
           +     H H+VK      + N V+I+MELC  GEL   +  R  +++ + A  I+   Q+
Sbjct: 444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQL 500
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AY 319
            + +A+   +  VHRD+   N L ++   D  ++L DFGLS ++          G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSAT--DC-VKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
           ++APE ++ R ++  +D+W  GV  + IL+ G +PF     + +   +     N + LP 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPM 613
Query: 378 PSVSP 382
           P   P
Sbjct: 614 PPNCP 618

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 214 VKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           V F  A     +V+I MEL +    +   +++ +G    E+    I V I+  +   H +
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 272 -GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--- 327
             V+HRD+KP N L  +      +++ DFG+S ++  D   +   G   Y+APE ++   
Sbjct: 129 LSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 328 --RSYSLEADIWSIGVISYILLCGSRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
             + YS+++DIWS+G+    L     P+  W      + + V    P    LP    S E
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---LPADKFSAE 242
Query: 384 AKDFVKRLLNKDYRKRMT 401
             DF  + L K+ ++R T
Sbjct: 243 FVDFTSQCLKKNSKERPT 260

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG    A   K      +VAVK +    M    S+E    E  ++K L  
Sbjct: 18  KLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ- 68
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LVK   A      +YI+ E    G LLD + +  G +           QI   +AF 
Sbjct: 69  HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L ++       ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 128 EQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEA 183
Query: 326 LHR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
           ++  S+++++D+WS G++   I+  G  P+   +   + RA+ R
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 227

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------TEE 252
             H+++V    AC     V ++ E C  G+LL+ +  +   G  Y            +  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           D      Q+   +AF   +  +HRD+   N L T+G      ++ DFGL+  I  D   N
Sbjct: 167 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDS--N 221
Query: 313 DIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
            IV G+A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG               +VAVK +    M    S++    E  ++K L  
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTM----SVQAFLEEANLMKTLQ- 65
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LV+          +YI+ E    G LLD + +  GG+           QI   +A+ 
Sbjct: 66  HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   +    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 126 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 326 LHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           ++   +++++++WS G++ Y I+  G  P+  RT + +  A+
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 24/240 (10%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG    A   K      +VAVK +    M    S+E    E  ++K L  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ- 241
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LVK   A      +YI+ E    G LLD + +  G +           QI   +AF 
Sbjct: 242 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L ++       ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 301 EQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEA 356
Query: 326 LHR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           ++  S+++++D+WS G++   I+  G  P+   +   + RA+ R       +P P   PE
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----YRMPRPENCPE 412

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K +G G FG               +VAVK +    M    S++    E  ++K L  
Sbjct: 16  KLVKRLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTM----SVQAFLEEANLMKTLQ- 66
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LV+          +YI+ E    G LLD + +  GG+           QI   +A+ 
Sbjct: 67  HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   +    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 127 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEA 182
Query: 326 LHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           ++   +++++D+WS G++ Y I+  G  P+  RT + +  A+
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 55/273 (20%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           SLDK      +   K++LG     G FG       KK  L    VAVK + +  M     
Sbjct: 2   SLDKWEMERTDITMKHKLGG----GQFGEVYEGVWKKYSLT---VAVKTLKEDTM----E 50
Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
           +E+  +E  ++K +  H +LV+    C      YI+ E    G LLD +         ++
Sbjct: 51  VEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQE 105
Query: 254 AKAIVV-----QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             A+V+     QI S + +   +  +HRDL   N L     ++  +++ DFGLS  +  D
Sbjct: 106 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD 162
Query: 309 ERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
                  G+ +   + APE L +  +S+++D+W+ GV+           W     G+   
Sbjct: 163 TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL----------LWEIATYGM--- 208
Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
                      P+P + P     V  LL KDYR
Sbjct: 209 ----------SPYPGIDPSQ---VYELLEKDYR 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 47/246 (19%)
Query: 151 LGKEVGRGHFGHTCSARGKK-GELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L +E+G G FG    A        KD+  VAVK +   K  T  + +D +RE ++L  L 
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 75
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---------------GRYTEED 253
            H+H+VKF   C D + + +V E  + G+L   + A G               G      
Sbjct: 76  -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
              I  QI S + +   Q  VHRDL   N L  +   +  +++ DFG+S          D
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 182
Query: 314 IVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTES 359
           +  + YY            + PE +++R ++ E+D+WS GVI + I   G +P++  + +
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 360 GIFRAV 365
            +   +
Sbjct: 243 EVIECI 248

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
             A+YE+   +G G FG        K     + VAVKI+           E  R E+++L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNVDRYC----EAARSEIQVL 65
Query: 205 KALSGHK-----HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIV 258
           + L+          V+  +  E   ++ IV EL  G    D I   G   +  +  + + 
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSG-----------RDD-----ADMRLIDFGLS 302
            QI   V F H   + H DLKPEN LF              RD+      D++++DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 303 DFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVI 342
            +   DE  + +V   +Y APEV L   +S   D+WSIG I
Sbjct: 185 TY--DDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCI 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 38/235 (16%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 91
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-----------LARG---------- 246
             H+++V    AC     V ++ E C  G+LL+ +           LA G          
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 247 GRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
           GR  E  D      Q+   +AF   +  +HRD+   N L T+G      ++ DFGL+  I
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDI 208
Query: 306 RPDERLNDIV-GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
             D   N IV G+A     ++APE +    Y++++D+WS G++ + I   G  P+
Sbjct: 209 MNDS--NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 116/273 (42%), Gaps = 55/273 (20%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           SLDK      +   K++LG     G +G       KK  L    VAVK + +  M     
Sbjct: 2   SLDKWEMERTDITMKHKLGG----GQYGEVYEGVWKKYSLT---VAVKTLKEDTM----E 50
Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
           +E+  +E  ++K +  H +LV+    C      YI++E    G LLD  L    R   ++
Sbjct: 51  VEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNR---QE 105
Query: 254 AKAIVV-----QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             A+V+     QI S + +   +  +HRDL   N L     ++  +++ DFGLS  +  D
Sbjct: 106 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD 162
Query: 309 ERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
                  G+ +   + APE L +  +S+++D+W+ GV+           W     G+   
Sbjct: 163 TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL----------LWEIATYGM--- 208
Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
                      P+P + P     V  LL KDYR
Sbjct: 209 ----------SPYPGIDPSQ---VYELLEKDYR 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 63
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 64  VNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 17/271 (6%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            ++  + K +G G  G  C  R +    +D  VA+K +      T     D   E  I+ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMG 105
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
               H ++++            IV E  E G L   +    G++T      ++  + + +
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--PDERLNDIVGSA--YYV 321
            +    G VHRDL   N L  S   +   ++ DFGLS  +   PD       G     + 
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 322 APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           APE +  R++S  +D+WS GV+ + +L  G RP+W  T     R V+ S      LP P 
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEEGYRLPAPM 277
Query: 380 VSPEA-KDFVKRLLNKDYRKRMTAVQALSKL 409
             P A    +    +KD  +R    Q +S L
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 17/271 (6%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            ++  + K +G G  G  C  R +    +D  VA+K +      T     D   E  I+ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMG 105
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
               H ++++            IV E  E G L   +    G++T      ++  + + +
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--PDERLNDIVGSA--YYV 321
            +    G VHRDL   N L  S   +   ++ DFGLS  +   PD       G     + 
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 322 APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           APE +  R++S  +D+WS GV+ + +L  G RP+W  T     R V+ S      LP P 
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEEGYRLPAPM 277
Query: 380 VSPEA-KDFVKRLLNKDYRKRMTAVQALSKL 409
             P A    +    +KD  +R    Q +S L
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 55/273 (20%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           SLDK      +   K++LG     G +G       KK  L    VAVK + +  M     
Sbjct: 2   SLDKWEMERTDITMKHKLGG----GQYGEVYEGVWKKYSLT---VAVKTLKEDTM----E 50
Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
           +E+  +E  ++K +  H +LV+    C      YI+ E    G LLD  L    R   ++
Sbjct: 51  VEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR---QE 105
Query: 254 AKAIVV-----QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             A+V+     QI S + +   +  +HRDL   N L     ++  +++ DFGLS  +  D
Sbjct: 106 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD 162
Query: 309 ERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
                  G+ +   + APE L +  +S+++D+W+ GV+           W     G+   
Sbjct: 163 -TFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL----------LWEIATYGM--- 208
Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
                      P+P + P     V  LL KDYR
Sbjct: 209 ----------SPYPGIDPSQ---VYELLEKDYR 228

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKII----SKAKMTTAISIEDVRREVKIL 204
           E  K++G+G FG     R     +KD+ V A+K +    S+ +       ++ +REV I+
Sbjct: 22  EYEKQIGKGGFGLVHKGR----LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             L+ H ++VK        N   +VME    G+L  R+L +           +++ I   
Sbjct: 78  SNLN-HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 265 VAFCHLQG--VVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYY 320
           + +   Q   +VHRDL+  N    S  ++A +  ++ DFGLS   +    ++ ++G+  +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQW 192
Query: 321 VAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
           +APE +     SY+ +AD +S  +I Y +L G  PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + E+G+ +G+G FG     R   GE     VA+++I   +      ++  +REV   +  
Sbjct: 34  QLEIGELIGKGRFGQVYHGRWH-GE-----VAIRLIDIER-DNEDQLKAFKREVMAYRQ- 85
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H+++V F  AC    ++ I+  LC+G  L   +            + I  +I+  + +
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------RPDERLNDIVGSAYYV 321
            H +G++H+DLK +N  + +G+    + + DFGL          R +++L    G   ++
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 322 APEVLHR----------SYSLEADIWSIGVISYILLCGSRPF 353
           APE++ +           +S  +D++++G I Y L     PF
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 16/220 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +G G FG  CS   K    ++  VA+K +      T     D   E  I+     H +++
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVI 71
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                      V I+ E  E G L   +    G++T      ++  I + + +      V
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-------YVAPEVL- 326
           HR L   N L  S   +   ++ DFGLS F+  D+  +    SA        + APE + 
Sbjct: 132 HRALAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           +R ++  +D+WS G++ + ++  G RP+W  T   +  A+
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +  LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY-----------TEED 253
            +  H ++V    AC      + +++E C+ G L   + ++   +           T E 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---R 310
                 Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D    R
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVR 202
Query: 311 LNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
             D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 152 GKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           G+ +G+G FG       ++ GE+   +  ++   + + T         +EVK+++ L  H
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL-------KEVKVMRCLE-H 66
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++KF         +  + E  +GG L   I +   +Y      +    I S +A+ H 
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--------------RPDERLN-DIV 315
             ++HRDL   N L    R++ ++ + DFGL+  +              +PD +    +V
Sbjct: 127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 316 GSAYYVAPEVLH-RSYSLEADIWSIGVI 342
           G+ Y++APE+++ RSY  + D++S G++
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIV 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 17  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 69  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 128 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 63
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 64  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+ K +G+G FG    A   K     Q VA+K++   K     + E++R    IL+ L
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVH---QHVALKMVRNEKRFHRQAAEEIR----ILEHL 150
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQ 260
                    +++   +     N++ +  EL      EL+ +   +G  ++    +     
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVRKFAHS 208
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           IL  +   H   ++H DLKPEN L    GR  + +++IDFG S +    +R+   + S +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGR--SGIKVIDFGSSCY--EHQRVYTXIQSRF 264
Query: 320 YVAPEV-LHRSYSLEADIWSIGVISYILLCG 349
           Y APEV L   Y +  D+WS+G I   LL G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+ K +G+G FG    A   K     Q VA+K++   K     + E++R    IL+ L
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVH---QHVALKMVRNEKRFHRQAAEEIR----ILEHL 150
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQ 260
                    +++   +     N++ +  EL      EL+ +   +G  ++    +     
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVRKFAHS 208
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           IL  +   H   ++H DLKPEN L    GR  + +++IDFG S +    +R+   + S +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGR--SGIKVIDFGSSCY--EHQRVYXXIQSRF 264
Query: 320 YVAPEV-LHRSYSLEADIWSIGVISYILLCG 349
           Y APEV L   Y +  D+WS+G I   LL G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 30/231 (12%)
Query: 133 QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI 192
           QS+DK      +   K++LG     G +G       KK  L    VAVK + +  M    
Sbjct: 22  QSMDKWEMERTDITMKHKLGG----GQYGEVYVGVWKKYSLT---VAVKTLKEDTM---- 70
Query: 193 SIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE 252
            +E+  +E  ++K +  H +LV+    C      YIV E    G LLD +         E
Sbjct: 71  EVEEFLKEAAVMKEIK-HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL----RECNRE 125
Query: 253 DAKAIVV-----QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
           +  A+V+     QI S + +   +  +HRDL   N L     ++  +++ DFGLS  +  
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTG 182
Query: 308 DERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D       G+ +   + APE L + ++S+++D+W+ GV+ + I   G  P+
Sbjct: 183 DTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 17  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 69  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 128 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILI 87
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY-------------TE 251
            +  H ++V    AC      + +++E C+ G L   + ++   +             T 
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-- 309
           E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D   
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDX 204
Query: 310 -RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
            R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 14  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 65
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 66  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 125 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +  LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY-----------TEED 253
            +  H ++V    AC      + +++E C+ G L   + ++   +           T E 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---R 310
                 Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D    R
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVR 202
Query: 311 LNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
             D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 146 GAKYELGKEVGRGHFGHT-CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           G KY LG+++G G FG     A    GE    +VA+K+         + IE      K  
Sbjct: 8   GNKYRLGRKIGSGSFGDIYLGANIASGE----EVAIKLECVKTKHPQLHIES-----KFY 58
Query: 205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           K + G   +  +K+C A  D N   +VMEL  G  L D       +++ +    +  Q++
Sbjct: 59  KMMQGGVGIPSIKWCGAEGDYN--VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMI 115
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--------PDERLNDI 314
           S + + H +  +HRD+KP+NFL   G+    + +IDFGL+   R        P     ++
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 315 VGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
            G+A Y +    L    S   D+ S+G +      GS P+
Sbjct: 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 39  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 90
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 91  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 150 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 40  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 91
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 92  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---IRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 151 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+ K +G+G FG    A   K     Q VA+K++   K     + E++R    IL+ L
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVH---QHVALKMVRNEKRFHRQAAEEIR----ILEHL 150
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQ 260
                    +++   +     N++ +  EL      EL+ +   +G  ++    +     
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVRKFAHS 208
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           IL  +   H   ++H DLKPEN L    GR  + +++IDFG S +    +R+   + S +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGR--SGIKVIDFGSSCY--EHQRVYTXIQSRF 264
Query: 320 YVAPEV-LHRSYSLEADIWSIGVISYILLCG 349
           Y APEV L   Y +  D+WS+G I   LL G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 63
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 64  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 44/243 (18%)
Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L +E+G G FG    A       E     VAVK +  A        +D  RE ++L  L 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG------------GRYTEEDAKA 256
            H+H+VKF   C + + + +V E  + G+L   + A G               T+     
Sbjct: 74  -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           I  QI + + +   Q  VHRDL   N L     ++  +++ DFG+S          D+  
Sbjct: 133 IAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYS 180
Query: 317 SAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
           + YY            + PE +++R ++ E+D+WS+GV+ + I   G +P++  + + + 
Sbjct: 181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240
Query: 363 RAV 365
             +
Sbjct: 241 ECI 243

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 73
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI++E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 187
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 69
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI++E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 127
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 128 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH-AGAKFPIKWTAPE 183
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K++G G FG    A   K      +VAVK +    M    S+E    E  ++K L  
Sbjct: 185 KLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ- 235
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
           H  LVK   A      +YI+ E    G LLD + +  G +           QI   +AF 
Sbjct: 236 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 294
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L ++       ++ DFGL+            VG+ +   + APE 
Sbjct: 295 EQRNYIHRDLRAANILVSAS---LVCKIADFGLAR-----------VGAKFPIKWTAPEA 340
Query: 326 LHR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
           ++  S+++++D+WS G++   I+  G  P+   +   + RA+ R
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 384

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 32  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 83
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 84  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 143 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 34/184 (18%)
Query: 255 KAIVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
           K  + Q++  +   HL    V HRD+KP N L      D  ++L DFG +  + P E   
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSEPNV 189
Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIF-------- 362
             + S YY APE++  ++ Y+   DIWS+G I   ++ G   F     +G          
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 363 ---RAVLRS-DPNFDD--------LPWPSV--------SPEAKDFVKRLLNKDYRKRMTA 402
              R VLR  +P+  D        +PW +V        + EA D +  LL     +RM  
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 403 VQAL 406
            +AL
Sbjct: 310 YEAL 313

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +G+ +G G FG     +          VAVK+++     T   ++  + EV +L+  + H
Sbjct: 40  VGQRIGSGSFGTVYKGKWHG------DVAVKMLN-VTAPTPQQLQAFKNEVGVLRK-TRH 91
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            +++ F         + IV + CEG  L   +     ++       I  Q    + + H 
Sbjct: 92  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAYYVAPEVLH 327
           + ++HRDLK  N       +D  +++ DFGL+          +   + GS  ++APEV+ 
Sbjct: 151 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 328 RS----YSLEADIWSIGVISYILLCGSRPF 353
                 YS ++D+++ G++ Y L+ G  P+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 73
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH-AGAKFPIKWTAPE 187
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 69
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 127
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 128 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPE 183
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 72
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 131 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 186
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 73
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 187
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKII----SKAKMTTAISIEDVRREVKIL 204
           E  K++G+G FG     R     +KD+ V A+K +    S+ +       ++ +REV I+
Sbjct: 22  EYEKQIGKGGFGLVHKGR----LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             L+ H ++VK        N   +VME    G+L  R+L +           +++ I   
Sbjct: 78  SNLN-HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 265 VAFCHLQG--VVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYY 320
           + +   Q   +VHRDL+  N    S  ++A +  ++ DFG S   +    ++ ++G+  +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQW 192
Query: 321 VAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
           +APE +     SY+ +AD +S  +I Y +L G  PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 122
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 239
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 73
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 187
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 76
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDP 193
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI++E    G LLD  L    R   ++  A+V+     QI S +
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 180
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDP 202
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIVME    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +  LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 29  RLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 86
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------T 250
            +  H ++V    AC      + +++E C+ G L   + ++   +              T
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE- 309
            E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D  
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 203
Query: 310 --RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
             R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 128
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPE 184
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI++E    G LLD  L    R   ++  A+V+     QI S +
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 180
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 126
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 182
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 214 VKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           V F  A     +V+I  EL +    +   +++ +G    E+    I V I+  +   H +
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 272 -GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--- 327
             V+HRD+KP N L  +      ++  DFG+S ++  D   +   G   Y APE ++   
Sbjct: 156 LSVIHRDVKPSNVLINAL---GQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 328 --RSYSLEADIWSIGVISYILLCGSRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
             + YS+++DIWS+G+    L     P+  W      + + V    P    LP    S E
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---LPADKFSAE 269
Query: 384 AKDFVKRLLNKDYRKRMT 401
             DF  + L K+ ++R T
Sbjct: 270 FVDFTSQCLKKNSKERPT 287

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 30  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 81
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 82  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 139
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 140 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 195
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 126
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 182
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 128
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPE 184
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKII----SKAKMTTAISIEDVRREVKIL 204
           E  K++G+G FG     R     +KD+ V A+K +    S+ +       ++ +REV I+
Sbjct: 22  EYEKQIGKGGFGLVHKGR----LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             L+ H ++VK        N   +VME    G+L  R+L +           +++ I   
Sbjct: 78  SNLN-HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 265 VAFCHLQG--VVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYY 320
           + +   Q   +VHRDL+  N    S  ++A +  ++ DF LS   +    ++ ++G+  +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQW 192
Query: 321 VAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
           +APE +     SY+ +AD +S  +I Y +L G  PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAF 267
            +LV+    C      YI+ E    G LLD +  R     E +A  ++    QI S + +
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEY 128
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE 324
              +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPE 184
Query: 325 VL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 73
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI+ E    G LLD  L    R   ++  A+V+     QI S +
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR---QEVSAVVLLYMATQISSAM 129
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 130 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 185
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 76
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + ++ E C+ G L   + ++   +               
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDP 193
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS-KAKMTTAISIEDVRREVKIL 204
           G K+ LG+++G G FG        +    +++VA+K+ + K K    +       E KI 
Sbjct: 6   GNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLLY------ESKIY 56
Query: 205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           + L G   +  V++     D N   +VM+L  G  L D       + + +    +  Q++
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYN--VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--------PDERLNDI 314
           + V F H +  +HRD+KP+NFL   GR    + +IDFGL+   R        P     ++
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 315 VGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
            G+A Y +    L    S   D+ S+G +    L GS P W   ++G
Sbjct: 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAG 219

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 153 KEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G GHFG     C      G    + VAVK +         S    ++E+ IL+ L  
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKADAGPQHRS--GWKQEIDILRTLY- 91
Query: 210 HKHLVKFCDACEDVN--NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVV 265
           H+H++K+   CED    ++ +VME    G L D +     R++   A+ ++   QI   +
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGM 147
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAYYV 321
           A+ H Q  +HRDL   N L     +D  +++ DFGL+  +           D     ++ 
Sbjct: 148 AYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY 204
Query: 322 APEVLHR-SYSLEADIWSIGVISYILL 347
           APE L    +   +D+WS GV  Y LL
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 87
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + +++E C+ G L   + ++   +               
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 204
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 30/238 (12%)
Query: 131 PEQSLDKSFGYNKNFGAKYELGK-------EVGRGHFGHTCSARGKKGELKDQQVAVKII 183
           P+++    +G + N+  K+E+ +       ++G G +G       KK  L    VAVK +
Sbjct: 237 PKRNKPTVYGVSPNYD-KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTL 292
Query: 184 SKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL 243
            +  M     +E+  +E  ++K +  H +LV+    C      YI+ E    G LLD + 
Sbjct: 293 KEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL- 346
Query: 244 ARGGRYTEEDAKAIV---VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
            R     E +A  ++    QI S + +   +  +HR+L   N L     ++  +++ DFG
Sbjct: 347 -RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFG 402
Query: 301 LSDFIRPDERLNDIVGSAY---YVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           LS  +  D       G+ +   + APE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 403 LSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 23/262 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VGRG FG           +KD+Q   +   K      + +E  R E  +  A      +V
Sbjct: 66  VGRGSFGEV-------HRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLSSPRIV 113
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               A  +   V I MEL EGG L  +++ + G   E+ A   + Q L  + + H + ++
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPE-VLH 327
           H D+K +N L +S  D +   L DFG +  ++PD     ++      G+  ++APE V+ 
Sbjct: 173 HGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           +    + DIWS   +   +L G  P W +   G     + S+P       PS +P     
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289
Query: 388 VKRLLNKDYRKRMTAVQALSKL 409
           ++  L K+   R +A++   K+
Sbjct: 290 IQEGLRKEPVHRASAMELRRKV 311

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI+ E    G LLD  L    R   ++  A+V+     QI S +
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 180
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 114/242 (47%), Gaps = 16/242 (6%)
Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
           P ++++ E   ++PE+  DK     ++     ++  E+G G+FG   S R     ++ +Q
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI--ELGCGNFG---SVRQGVYRMRKKQ 363
Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
           + V I    + T     E++ RE +I+  L  + ++V+    C+    + +VME+  GG 
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVMEMAGGGP 421
Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
           L   ++ +       +   ++ Q+   + +   +  VHR+L   N L  + R  A  ++ 
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN-RHYA--KIS 478
Query: 298 DFGLSDFIRPDERLNDIVGSA----YYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSR 351
           DFGLS  +  D+       +      + APE ++ R +S  +D+WS GV  +  L  G +
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 352 PF 353
           P+
Sbjct: 539 PY 540

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV+E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI+ E    G LLD  L    R   ++  A+V+     QI S +
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HRDL   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 180
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  H
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 275
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-----QILSVV 265
            +LV+    C      YI+ E    G LLD +         ++  A+V+     QI S +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAM 331
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
            +   +  +HR+L   N L     ++  +++ DFGLS  +  D       G+ +   + A
Sbjct: 332 EYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 387
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
           PE L +  +S+++D+W+ GV+ + I   G  P+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 21/232 (9%)
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
           +VA+K +    M    S E   +E +++K L  H+ LV+      +   +YIV E    G
Sbjct: 293 RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG 346
Query: 237 ELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
            LLD +    G+Y        +  QI S +A+      VHRDL+  N L     ++   +
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCK 403
Query: 296 LIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHRSYSLEADIWSIGVISYILLCGSR 351
           + DFGL+  I  D       G+ +   + APE  L+  +++++D+WS G++   L    R
Sbjct: 404 VADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 352 -PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KDFVKRLLNKDYRKRMT 401
            P+       + R VL        +P P   PE+  D + +   K+  +R T
Sbjct: 463 VPY----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 510

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 76
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + ++ E C+ G L   + ++   +               
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 193
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV+E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 153 KEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G GHFG     C      G    + VAVK + +       S    +RE++IL+ L  
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKEGCGPQLRS--GWQREIEILRTLY- 69
Query: 210 HKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVV 265
           H+H+VK+   CED    +V +VME    G L D +     R+    A+ ++   QI   +
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGM 125
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDIVGSA 318
           A+ H Q  +HR L   N L     +D  +++ DFGL+       ++ R  E   D     
Sbjct: 126 AYLHAQHYIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVRE---DGDSPV 179
Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILL 347
           ++ APE L    +   +D+WS GV  Y LL
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A   G       + VAVK++ +    T      +  E+KIL 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 76
Query: 206 ALSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC      + ++ E C+ G L   + ++   +               
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 193
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
              R  D      ++APE +  R Y++++D+WS GV+ + I   G+ P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 40/235 (17%)
Query: 151 LGKEVGRGHFGHTCSARG--KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           LGK +G G FG    A     KG      VAVK++ +    +   + D+  E  +LK ++
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN 84
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-----------------YTE 251
            H H++K   AC     + +++E  + G L  R   R  R                    
Sbjct: 85  -HPHVIKLYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 252 EDAKAIVVQILSVVAFCHLQG--------VVHRDLKPENFLFTSGRDDADMRLIDFGLS- 302
            D +A+ +  L   A+   QG        +VHRDL   N L   GR    M++ DFGLS 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR---KMKISDFGLSR 198
Query: 303 DFIRPD---ERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D    D   +R    +   +     +    Y+ ++D+WS GV+ + I+  G  P+
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 153 KEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G GHFG     C      G    + VAVK + +       S    +RE++IL+ L  
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKEGCGPQLRS--GWQREIEILRTLY- 68
Query: 210 HKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVV 265
           H+H+VK+   CED    +V +VME    G L D +     R+    A+ ++   QI   +
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGM 124
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDIVGSA 318
           A+ H Q  +HR L   N L     +D  +++ DFGL+       ++ R  E   D     
Sbjct: 125 AYLHAQHYIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVRE---DGDSPV 178
Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILL 347
           ++ APE L    +   +D+WS GV  Y LL
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 40/235 (17%)
Query: 151 LGKEVGRGHFGHTCSARG--KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           LGK +G G FG    A     KG      VAVK++ +    +   + D+  E  +LK ++
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN 84
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-----------------YTE 251
            H H++K   AC     + +++E  + G L  R   R  R                    
Sbjct: 85  -HPHVIKLYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 252 EDAKAIVVQILSVVAFCHLQG--------VVHRDLKPENFLFTSGRDDADMRLIDFGLS- 302
            D +A+ +  L   A+   QG        +VHRDL   N L   GR    M++ DFGLS 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGR---KMKISDFGLSR 198
Query: 303 DFIRPD---ERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D    D   +R    +   +     +    Y+ ++D+WS GV+ + I+  G  P+
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 23/262 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           VGRG FG           +KD+Q   +   K      + +E  R E  +  A      +V
Sbjct: 82  VGRGSFGEV-------HRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLSSPRIV 129
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               A  +   V I MEL EGG L  +++ + G   E+ A   + Q L  + + H + ++
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 188
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPE-VLH 327
           H D+K +N L +S  D +   L DFG +  ++PD     ++      G+  ++APE V+ 
Sbjct: 189 HGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           +    + DIWS   +   +L G  P W +   G     + S+P       PS +P     
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 305
Query: 388 VKRLLNKDYRKRMTAVQALSKL 409
           ++  L K+   R +A++   K+
Sbjct: 306 IQEGLRKEPVHRASAMELRRKV 327

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 151 LGKEVGRGHFGHTCSARG--KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           LGK +G G FG    A     KG      VAVK++ +    +   + D+  E  +LK ++
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN 84
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-----------------YTE 251
            H H++K   AC     + +++E  + G L  R   R  R                    
Sbjct: 85  -HPHVIKLYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 252 EDAKAIVVQILSVVAFCHLQG--------VVHRDLKPENFLFTSGRDDADMRLIDFGLS- 302
            D +A+ +  L   A+   QG        +VHRDL   N L   GR    M++ DFGLS 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR---KMKISDFGLSR 198
Query: 303 DFIRPDERLNDIVGS---AYYVAPEVLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
           D    D  +    G     +     +    Y+ ++D+WS GV+ + I+  G  P+
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 26  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 76
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 77  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 136 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 191
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 146 GAKYELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           G +Y LG+++G G FG     T  A G       ++VA+K+         + IE      
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAG-------EEVAIKLECVKTKHPQLHIES----- 55
Query: 202 KILKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           KI K + G   +  +++C A  D N   +VMEL  G  L D       +++ +    +  
Sbjct: 56  KIYKMMQGGVGIPTIRWCGAEGDYN--VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD 112
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--------PDERL 311
           Q++S + + H +  +HRD+KP+NFL   G+    + +IDFGL+   R        P    
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 312 NDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
            ++ G+A Y +    L    S   D+ S+G +      GS P+
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 24  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 74
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 75  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 134 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 189
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 233

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 22  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 72
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 73  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 132 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 187
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 146 GAKYELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           G +Y LG+++G G FG     T  A G       ++VA+K+         + IE      
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAG-------EEVAIKLECVKTKHPQLHIES----- 53
Query: 202 KILKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           KI K + G   +  +++C A  D N   +VMEL  G  L D       +++ +    +  
Sbjct: 54  KIYKMMQGGVGIPTIRWCGAEGDYN--VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD 110
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR--------PDERL 311
           Q++S + + H +  +HRD+KP+NFL   G+    + +IDFGL+   R        P    
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 312 NDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
            ++ G+A Y +    L    S   D+ S+G +      GS P+
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 14  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 64
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 65  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 124 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 179
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 235
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 236 LMCQCWRKDPEERPT 250

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 31/244 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L + +G G FG      G     K +++ V + +  K  T  + E    E  I+K L  H
Sbjct: 28  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-H 84
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--------QIL 262
            H+VK     E+    +I+MEL   GEL        G Y E +  ++ V        QI 
Sbjct: 85  PHIVKLIGIIEE-EPTWIIMELYPYGEL--------GHYLERNKNSLKVLTLVLYSLQIC 135
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYY 320
             +A+      VHRD+   N L  S      ++L DFGLS +I  ++     V      +
Sbjct: 136 KAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 321 VAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           ++PE ++ R ++  +D+W   V  + IL  G +PF+      +   + +     D LP P
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG----DRLPKP 248
Query: 379 SVSP 382
            + P
Sbjct: 249 DLCP 252

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L K +G G FG             + +VA+K +    M    S E    E +I+K L  
Sbjct: 12  QLIKRLGNGQFGEVWMGTWNG----NTKVAIKTLKPGTM----SPESFLEEAQIMKKLK- 62
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFC 268
           H  LV+      +   +YIV E    G LLD +    GR  +  +   +  Q+ + +A+ 
Sbjct: 63  HDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE- 324
                +HRDL+  N L  +G      ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 122 ERMNYIHRDLRSANILVGNG---LICKIADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 177
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSR 351
            L+  +++++D+WS G++   L+   R
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 23/262 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
           +GRG FG           +KD+Q   +   K      + +E  R E  +  A      +V
Sbjct: 80  LGRGSFGEV-------HRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLSSPRIV 127
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
               A  +   V I MEL EGG L  +++ + G   E+ A   + Q L  + + H + ++
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 186
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPE-VLH 327
           H D+K +N L +S  D +   L DFG +  ++PD     ++      G+  ++APE V+ 
Sbjct: 187 HGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           +    + DIWS   +   +L G  P W +   G     + S+P       PS +P     
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 303
Query: 388 VKRLLNKDYRKRMTAVQALSKL 409
           ++  L K+   R +A++   K+
Sbjct: 304 IQEGLRKEPVHRASAMELRRKV 325

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 25  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 75
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 76  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 135 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 190
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 234

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 16  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 66
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 67  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 126 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 181
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 237
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 238 LMCQCWRKDPEERPT 252

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE G +VGRG +GH   A+ K G+        +I       +A     + RE+K    +
Sbjct: 23  EYE-GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVI 81
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-------KAIVVQ 260
           S  K  +   D       V+++ +  E          R  +  ++         K+++ Q
Sbjct: 82  SLQKVFLSHAD-----RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDF----IRPDERLNDIV 315
           IL  + + H   V+HRDLKP N L    G +   +++ D G +      ++P   L+ +V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
            + +Y APE+L   R Y+   DIW+IG I   LL     F  R E
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 56/239 (23%)
Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L  E+G G FG    A       E     VAVK + +A  +     +D +RE ++L  L 
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQ 101
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI----------- 257
            H+H+V+F   C +   + +V E    G+L +R L   G     DAK +           
Sbjct: 102 -HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHG----PDAKLLAGGEDVAPGPL 155
Query: 258 -VVQILSVVA-----FCHLQGV--VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
            + Q+L+V +       +L G+  VHRDL   N L   G     +++ DFG+S       
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG---LVVKIGDFGMS------- 205
Query: 310 RLNDIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
              DI  + YY            + PE +L+R ++ E+D+WS GV+ + I   G +P++
Sbjct: 206 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 31/244 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L + +G G FG      G     K +++ V + +  K  T  + E    E  I+K L  H
Sbjct: 16  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-H 72
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--------QIL 262
            H+VK     E+    +I+MEL   GEL        G Y E +  ++ V        QI 
Sbjct: 73  PHIVKLIGIIEE-EPTWIIMELYPYGEL--------GHYLERNKNSLKVLTLVLYSLQIC 123
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYY 320
             +A+      VHRD+   N L  S      ++L DFGLS +I  ++     V      +
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 321 VAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           ++PE ++ R ++  +D+W   V  + IL  G +PF+      +   + +     D LP P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG----DRLPKP 236
Query: 379 SVSP 382
            + P
Sbjct: 237 DLCP 240

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 192 KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGNM----SPEAFLQEAQVMKKLR-HEKL 242
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 243 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL   I  D       G+ +   + APE  L+ 
Sbjct: 302 YVHRDLRAANILVG---ENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPEAALYG 357
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 413
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 414 LMCQCWRKDPEERPT 428

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 31/244 (12%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L + +G G FG      G     K +++ V + +  K  T  + E    E  I+K L  H
Sbjct: 12  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-H 68
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--------QIL 262
            H+VK     E+    +I+MEL   GEL        G Y E +  ++ V        QI 
Sbjct: 69  PHIVKLIGIIEE-EPTWIIMELYPYGEL--------GHYLERNKNSLKVLTLVLYSLQIC 119
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYY 320
             +A+      VHRD+   N L  S      ++L DFGLS +I  ++     V      +
Sbjct: 120 KAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKW 176
Query: 321 VAPEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           ++PE ++ R ++  +D+W   V  + IL  G +PF+      +   + +     D LP P
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG----DRLPKP 232
Query: 379 SVSP 382
            + P
Sbjct: 233 DLCP 236

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 22  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 72
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 73  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 132 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 187
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + +++G G FG        + E     VAVKI+ +     A  + +  REV I+K L  H
Sbjct: 41  IKEKIGAGSFGTV-----HRAEWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLR-H 93
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK---AIVVQILSVVAF 267
            ++V F  A     N+ IV E    G L  R+L + G   + D +   ++   +   + +
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 268 CHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAP 323
            H +   +VHRDLK  N L         +++ DFGLS  ++    L      G+  ++AP
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAP 208
Query: 324 EVLHRSYSLE-ADIWSIGVISYILLCGSRPF 353
           EVL    S E +D++S GVI + L    +P+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 13/220 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG       K    K +  VA+K + KA  T    + D   E  I+   S H 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRV-DFLGEAGIMGQFS-HH 106
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++++          + I+ E  E G L   +  + G ++      ++  I + + +    
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVL- 326
             VHRDL   N L  S   +   ++ DFGLS  +  D               + APE + 
Sbjct: 167 NYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 56/239 (23%)
Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L  E+G G FG    A       E     VAVK + +A  +     +D +RE ++L  L 
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQ 78
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI----------- 257
            H+H+V+F   C +   + +V E    G+L +R L   G     DAK +           
Sbjct: 79  -HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHG----PDAKLLAGGEDVAPGPL 132
Query: 258 -VVQILSVVA-----FCHLQGV--VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
            + Q+L+V +       +L G+  VHRDL   N L   G     +++ DFG+S       
Sbjct: 133 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG---LVVKIGDFGMS------- 182
Query: 310 RLNDIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
              DI  + YY            + PE +L+R ++ E+D+WS GV+ + I   G +P++
Sbjct: 183 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 56/239 (23%)
Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           L  E+G G FG    A       E     VAVK + +A  +     +D +RE ++L  L 
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQ 72
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI----------- 257
            H+H+V+F   C +   + +V E    G+L +R L   G     DAK +           
Sbjct: 73  -HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHG----PDAKLLAGGEDVAPGPL 126
Query: 258 -VVQILSVVA-----FCHLQGV--VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
            + Q+L+V +       +L G+  VHRDL   N L   G     +++ DFG+S       
Sbjct: 127 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG---LVVKIGDFGMS------- 176
Query: 310 RLNDIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
              DI  + YY            + PE +L+R ++ E+D+WS GV+ + I   G +P++
Sbjct: 177 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 66
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 67  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 126 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 181
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 21  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 71
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 72  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 130
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 131 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 186
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 92/221 (41%), Gaps = 24/221 (10%)
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           EV   + +  H   V+   A E+   +Y+  ELC G  L     A G    E      + 
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLR 164
Query: 260 QILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             L  +A  H QG+VH D+KP N FL   GR     +L DFGL   +          G  
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGR----CKLGDFGLLVELGTAGAGEVQEGDP 220
Query: 319 YYVAPEVLHRSYSLEADIWSIGVISYILLCGSR-----PFWARTESGIFRAVLRSDPNFD 373
            Y+APE+L  SY   AD++S+G+    + C          W +   G         P F 
Sbjct: 221 RYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL------PPEFT 274
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL 414
                 +S E +  +  +L  D + R TA +AL  L +P+L
Sbjct: 275 A----GLSSELRSVLVMMLEPDPKLRATA-EAL--LALPVL 308

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 18  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 68
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 69  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 128 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 183
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K +  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKIR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL   N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLAAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 18  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 68
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 69  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 128 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 183
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 184 RFTIKSDVWSFGIL 197

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 191 KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 241
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 357 RFTIKSDVWSFGIL 370

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 66
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 67  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 126 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 22  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 72
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 73  VQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 132 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEAALYG 187
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 188 RFTIKSDVWSFGIL 201

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 25/255 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 25  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 75
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 76  VQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 329 SYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA-KD 386
            +++++D+WS G++   L    R P+       + R VL        +P P   PE+  D
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 387 FVKRLLNKDYRKRMT 401
            + +   KD  +R T
Sbjct: 247 LMCQCWRKDPEERPT 261

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 17  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 67
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 68  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 127 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 182
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 191 KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 241
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 357 RFTIKSDVWSFGIL 370

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 66
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 67  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 126 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEA 181
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 131 PEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT 190
           PEQ  D +    K+ G       E+GRG +G       K      Q +AVK I       
Sbjct: 13  PEQHWDFTAEDLKDLG-------EIGRGAYGSVNKMVHKPS---GQIMAVKRIR------ 56
Query: 191 AISIEDVRREVKILKAL------SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA 244
             S  D + + ++L  L      S   ++V+F  A     + +I MEL      +     
Sbjct: 57  --STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL------MSTSFD 108
Query: 245 RGGRYTEEDAKAIV-------VQILSVVAFCHLQ---GVVHRDLKPENFLFTSGRDDADM 294
           +  +Y       ++       + + +V A  HL+    ++HRD+KP N L        ++
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNI 165
Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-----YSLEADIWSIGVISYILLCG 349
           +L DFG+S  +          G   Y+APE +  S     Y + +D+WS+G+  Y L  G
Sbjct: 166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 350 SRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
             P+  W      + + V    P   +      SP   +FV   L KD  KR
Sbjct: 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+   +G+G FG    A  +   ++ + VA+KII   K      +   + EV++L+ +
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNKKAF----LNQAQIEVRLLELM 88
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGG--RYTEEDAKAIV 258
           + H      ++V         N++ +V E+      +LL     RG     T + A+ + 
Sbjct: 89  NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             +L  +A   L  ++H DLKPEN L  + +  A ++++DFG S   +  +R+   + S 
Sbjct: 149 TALL-FLATPEL-SIIHCDLKPENILLCNPKRSA-IKIVDFGSS--CQLGQRIYQXIQSR 203
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y +PEV L   Y L  D+WS+G I
Sbjct: 204 FYRSPEVLLGMPYDLAIDMWSLGCI 228

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 22  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 72
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 73  VQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 132 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 187
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 188 RFTIKSDVWSFGIL 201

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 42/252 (16%)
Query: 187 KMTTAISIEDVRREVKILKALSGHKHLVKFCDACE----DVNNVYIVMELCEGGELL--- 239
           K++     +D + E++I+  +       ++C  CE    + + VYI+ E  E   +L   
Sbjct: 80  KISIKSKYDDFKNELQIITDIKN-----EYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 240 DRILARGGRYT----EEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLF-TSGRDDAD 293
           +        YT     +  K I+  +L+  ++ H +  + HRD+KP N L   +GR    
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---- 190
Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSL---EADIWSIGVISYILLCGS 350
           ++L DFG S+++  D+++    G+  ++ PE      S    + DIWS+G+  Y++    
Sbjct: 191 VKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 351 RPFWARTESGIFRAVLRS-------DPNFDDLPWPS---------VSPEAKDFVKRLLNK 394
            PF  +         +R+       D N    P  +         +S E  DF+K  L K
Sbjct: 250 VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 395 DYRKRMTAVQAL 406
           +  +R+T+  AL
Sbjct: 310 NPAERITSEDAL 321

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 11  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 61
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 62  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 121 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 176
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPF 353
           + + ++++++D+WS G+ ++ I+  G  P+
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           E+G G+FG   S R     ++ +Q+ V I    + T     E++ RE +I+  L  + ++
Sbjct: 17  ELGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
           V+    C+    + +VME+  GG L   ++ +       +   ++ Q+   + +   +  
Sbjct: 73  VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH-R 328
           VHRDL   N L  + R  A  ++ DFGLS  +  D+       +      + APE ++ R
Sbjct: 132 VHRDLAARNVLLVN-RHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 329 SYSLEADIWSIGVISYILLC-GSRPF 353
            +S  +D+WS GV  +  L  G +P+
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+   +G+G FG    A  +   ++ + VA+KII   K      +   + EV++L+ +
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNKKAF----LNQAQIEVRLLELM 107
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGG--RYTEEDAKAIV 258
           + H      ++V         N++ +V E+      +LL     RG     T + A+ + 
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             +L  +A   L  ++H DLKPEN L  + +  A ++++DFG S   +  +R+   + S 
Sbjct: 168 TALL-FLATPEL-SIIHCDLKPENILLCNPKRSA-IKIVDFGSS--CQLGQRIYQXIQSR 222
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y +PEV L   Y L  D+WS+G I
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCI 247

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 113/249 (45%), Gaps = 21/249 (8%)
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           +G   ++ VAVK I    +    S  D  REV++L+    H +++++    +D    YI 
Sbjct: 43  RGMFDNRDVAVKRI----LPECFSFAD--REVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           +ELC    L + +  +   +   +   ++ Q  S +A  H   +VHRDLKP N L +   
Sbjct: 97  IELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 290 DDADMRLI--DFGLSDFI----RPDERLNDIVGSAYYVAPEVLHRSY----SLEADIWSI 339
               ++ +  DFGL   +        R + + G+  ++APE+L        +   DI+S 
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 340 G-VISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-PWPSVSPEAKDFVKRLLNKDYR 397
           G V  Y++  GS PF    +      +L    + D L P       A++ +++++  D +
Sbjct: 216 GCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQ 273
Query: 398 KRMTAVQAL 406
           KR +A   L
Sbjct: 274 KRPSAKHVL 282

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 154 EVGRGHF-GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           EV  G++ GHT             +VAVK + +  M    S +    E  ++K L  H+ 
Sbjct: 28  EVWMGYYNGHT-------------KVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 69
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQ 271
           LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF   +
Sbjct: 70  LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVL-H 327
             +HRDL+  N L +   D    ++ DFGL+  I  D       G+ +   + APE + +
Sbjct: 129 NYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAINY 184
Query: 328 RSYSLEADIWSIGV-ISYILLCGSRPF 353
            ++++++D+WS G+ ++ I+  G  P+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 33/184 (17%)
Query: 199 REVKILKALSGHKHLVKFCDAC----EDVNN----VYIVMELCEGG--ELLDRILARGGR 248
           +EV  +K LSGH ++V+FC A     E+ +       ++ ELC+G   E L ++ +RG  
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 249 YTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
             +   K I  Q    V   H Q   ++HRDLK EN L +   +   ++L DFG +  I 
Sbjct: 134 SCDTVLK-IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTIS 189
Query: 307 --PD-----------ERLNDIVGSAYYVAPEV--LHRSYSL--EADIWSIGVISYILLCG 349
             PD           E       +  Y  PE+  L+ ++ +  + DIW++G I Y+L   
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 350 SRPF 353
             PF
Sbjct: 250 QHPF 253

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE+   +G+G FG    A  +   ++ + VA+KII   K      +   + EV++L+ +
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNKKAF----LNQAQIEVRLLELM 107
Query: 208 SGHK-----HLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGG--RYTEEDAKAIV 258
           + H      ++V         N++ +V E+      +LL     RG     T + A+ + 
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             +L  +A   L  ++H DLKPEN L  + +  A ++++DFG S   +  +R+   + S 
Sbjct: 168 TALL-FLATPEL-SIIHCDLKPENILLCNPKRXA-IKIVDFGSS--CQLGQRIYQXIQSR 222
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
           +Y +PEV L   Y L  D+WS+G I
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCI 247

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 191 KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 241
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   +YIV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 242 VQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 357 RFTIKSDVWSFGIL 370

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +K FG  ++  + +G G FG    A+ +            +I + K       E   REV
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN----EKAEREV 55
Query: 202 KILKALSGHKHLVKFCDACED-----------------VNNVYIVMELCEGGELLDRILA 244
           K L  L  H ++V + + C D                    ++I ME C+ G L   I  
Sbjct: 56  KALAKLD-HVNIVHY-NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 245 RGGRYTEED-AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
           R G   ++  A  +  QI   V + H + +++RDLKP N       D   +++ DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 304 FIRPDERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISYILL 347
            ++ D +     G+  Y++PE +  + Y  E D++++G+I   LL
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 148 KYELGKEVGRGHFGHTCS----ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           +YE+   +G G FG        ARGK       QVA+KII           E  R E+ +
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGK------SQVALKIIRNVGKYR----EAARLEINV 69
Query: 204 LKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDR----ILARGGR--YTEEDAKA 256
           LK +       KF C    D  N +  M  C   ELL +     L       Y     + 
Sbjct: 70  LKKIKEKDKENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRH 127
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLIDFG 300
           +  Q+   + F H   + H DLKPEN LF +                   +  +R+ DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISY 344
            + F    E    IV + +Y  PEV L   ++   D+WSIG I +
Sbjct: 188 SATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           A+Y L +++G GHF     A   K  + +  VA+KI+   K+ T    E    E+K+L+ 
Sbjct: 19  ARYILVRKLGWGHFSTVWLA---KDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQR 71
Query: 207 LS----------GHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEED- 253
           ++          G  H++K  D       N V++VM     GE    +LA   +Y     
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE---NLLALIKKYEHRGI 128
Query: 254 ----AKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFT---SGRDDADMRLIDFGLSDFI 305
                K I  Q+L  + + H + G++H D+KPEN L     S  +   +++ D G + + 
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 306 RPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
             DE   + + +  Y +PEVL  + +   ADIWS   + + L+ G   F
Sbjct: 189 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +YE+   +G G FG    C    + G     +VA+KII   +       E  R E+ +L+
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGG----ARVALKIIKNVEKYK----EAARLEINVLE 85
Query: 206 ALS----GHKHL-VKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVV 259
            ++     +K+L V+  D  +   ++ I  EL  G    D +       Y     + +  
Sbjct: 86  KINEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSG-----------RDD-----ADMRLIDFGLSD 303
           Q+   V F H   + H DLKPEN LF +            RD+       +R++DFG + 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 304 FIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           F    E  + IV + +Y APEV L   +S   D+WSIG I +    G   F
Sbjct: 205 F--DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLF 253

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           A+Y L +++G GHF     A   K  + +  VA+KI+   K+ T    E    E+K+L+ 
Sbjct: 19  ARYILVRKLGWGHFSTVWLA---KDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQR 71
Query: 207 LS----------GHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEED- 253
           ++          G  H++K  D       N V++VM     GE    +LA   +Y     
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE---NLLALIKKYEHRGI 128
Query: 254 ----AKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFT---SGRDDADMRLIDFGLSDFI 305
                K I  Q+L  + + H + G++H D+KPEN L     S  +   +++ D G + + 
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 306 RPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPF 353
             DE   + + +  Y +PEVL  + +   ADIWS   + + L+ G   F
Sbjct: 189 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G G FG         G  K   VAVK + +  M    S +    E  ++K L  
Sbjct: 12  KLVERLGAGQFGEVWMGY-YNGHTK---VAVKSLKQGSM----SPDAFLAEANLMKQLQ- 62
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFC 268
           H+ LV+   A      +YI+ E  E G L+D +    G + T      +  QI   +AF 
Sbjct: 63  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
             +  +HR+L+  N L +   D    ++ DFGL+  I  D       G+ +   + APE 
Sbjct: 122 EERNYIHRNLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 177
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
           + + ++++++D+WS G+ ++ I+  G  P+   T   + + + R
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 148 KYELGKEVGRGHFGHTCS----ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           +YE+   +G G FG        ARGK       QVA+KII           E  R E+ +
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKS------QVALKIIRNVGKYR----EAARLEINV 101
Query: 204 LKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDR----ILARGGR--YTEEDAKA 256
           LK +       KF C    D  N +  M  C   ELL +     L       Y     + 
Sbjct: 102 LKKIKEKDKENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRH 159
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLIDFG 300
           +  Q+   + F H   + H DLKPEN LF +                   +  +R+ DFG
Sbjct: 160 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 219
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISY 344
            + F    E    IV + +Y  PEV L   ++   D+WSIG I +
Sbjct: 220 SATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 262

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 153 KEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G GHFG     C      G    + VAVK +         S    ++E+ IL+ L  
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKADCGPQHRS--GWKQEIDILRTLY- 74
Query: 210 HKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVV 265
           H+H++K+   CED    ++ +VME    G L D +     R++   A+ ++   QI   +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGM 130
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDIVGSA 318
           A+ H Q  +HR+L   N L     +D  +++ DFGL+       ++ R  E   D     
Sbjct: 131 AYLHAQHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVRE---DGDSPV 184
Query: 319 YYVAPEVLHR-SYSLEADIWSIGVISYILL 347
           ++ APE L    +   +D+WS GV  Y LL
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 148 KYELGKEVGRGHFGHTCS----ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           +YE+   +G G FG        ARGK       QVA+KII           E  R E+ +
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGK------SQVALKIIRNVGKYR----EAARLEINV 78
Query: 204 LKALSGHKHLVKF-CDACEDVNNVYIVMELCEGGELLDR----ILARGGR--YTEEDAKA 256
           LK +       KF C    D  N +  M  C   ELL +     L       Y     + 
Sbjct: 79  LKKIKEKDKENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRH 136
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLIDFG 300
           +  Q+   + F H   + H DLKPEN LF +                   +  +R+ DFG
Sbjct: 137 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 196
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISY 344
            + F    E    IV + +Y  PEV L   ++   D+WSIG I +
Sbjct: 197 SATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 239

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGH 210
           G ++G G FG        KG + +  VAVK + +   +TT    +   +E+K++ A   H
Sbjct: 36  GNKMGEGGFGVV-----YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM-AKCQH 89
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAFC 268
           ++LV+      D +++ +V      G LLDR+    G    +      I     + + F 
Sbjct: 90  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 269 HLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERL------NDIVGSAYYV 321
           H    +HRD+K  N L     D+A   ++ DFGL+   R  E+       + IVG+  Y+
Sbjct: 150 HENHHIHRDIKSANILL----DEAFTAKISDFGLA---RASEKFAQTVMXSRIVGTTAYM 202
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCG 349
           APE L    + ++DI+S GV+   ++ G
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 226 VYIVMELCEGGELLDRILARGGRYTEED-AKAIVVQILSVVAFCHLQGVVHRDLKPENFL 284
           ++I ME C+ G L   I  R G   ++  A  +  QI   V + H + ++HRDLKP N  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 285 FTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVIS 343
                D   +++ DFGL   ++ D +     G+  Y++PE +  + Y  E D++++G+I 
Sbjct: 169 LV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 225
Query: 344 YILL 347
             LL
Sbjct: 226 AELL 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGH 210
           G ++G G FG        KG + +  VAVK + +   +TT    +   +E+K++ A   H
Sbjct: 36  GNKMGEGGFGVV-----YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM-AKCQH 89
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAFC 268
           ++LV+      D +++ +V      G LLDR+    G    +      I     + + F 
Sbjct: 90  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 269 HLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERLND------IVGSAYYV 321
           H    +HRD+K  N L     D+A   ++ DFGL+   R  E+         IVG+  Y+
Sbjct: 150 HENHHIHRDIKSANILL----DEAFTAKISDFGLA---RASEKFAQTVMXXRIVGTTAYM 202
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCG 349
           APE L    + ++DI+S GV+   ++ G
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 153 KEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +++G GHFG     C      G    + VAVK +         S    ++E+ IL+ L  
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKADCGPQHRS--GWKQEIDILRTLY- 74
Query: 210 HKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVV 265
           H+H++K+   CED    ++ +VME    G L D +     R++   A+ ++   QI   +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGM 130
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDIVGSA 318
           A+ H Q  +HR+L   N L     +D  +++ DFGL+       ++ R  E   D     
Sbjct: 131 AYLHSQHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVRE---DGDSPV 184
Query: 319 YYVAPEVLHR-SYSLEADIWSIGVISYILL 347
           ++ APE L    +   +D+WS GV  Y LL
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGH 210
           G ++G G FG        KG + +  VAVK + +   +TT    +   +E+K++ A   H
Sbjct: 30  GNKMGEGGFGVV-----YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM-AKCQH 83
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAFC 268
           ++LV+      D +++ +V      G LLDR+    G    +      I     + + F 
Sbjct: 84  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 269 HLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERLND------IVGSAYYV 321
           H    +HRD+K  N L     D+A   ++ DFGL+   R  E+         IVG+  Y+
Sbjct: 144 HENHHIHRDIKSANILL----DEAFTAKISDFGLA---RASEKFAQXVMXXRIVGTTAYM 196
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCG 349
           APE L    + ++DI+S GV+   ++ G
Sbjct: 197 APEALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286
           YIVME   GG+ L R  ++G +    +A A +++IL  +++ H  G+V+ DLKPEN + T
Sbjct: 160 YIVMEYV-GGQSLKR--SKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216
Query: 287 SGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYIL 346
               +  ++LID G    I        + G+  + APE++    ++  DI+++G      
Sbjct: 217 ----EEQLKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVRTGPTVATDIYTVG------ 263
Query: 347 LCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
               R   A T     R     D   +D P           ++R ++ D R+R T  + +
Sbjct: 264 ----RTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319
Query: 407 SKLVVPIL 414
           S  +  +L
Sbjct: 320 SAQLTGVL 327

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 78
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 79  HVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 138 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+KI+++   TT         +  ++ A   H 
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE---TTGPKANVEFMDEALIMASMDHP 100
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           HLV+    C     + +V +L   G LL+ +         +      VQI   + +   +
Sbjct: 101 HLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLH- 327
            +VHRDL   N L  S      +++ DFGL+  +  DE+  +  G      ++A E +H 
Sbjct: 160 RLVHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R ++ ++D+WS GV  + L+  G +P+
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 81
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 82  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 141 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G+FG     R     L D   A+  + + + +      D +RE++ILKAL     +
Sbjct: 17  QLGKGNFGSVELCR--YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFI 73
Query: 214 VKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK+          ++ +VME    G L D +     R           QI   + +   +
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVLH 327
             VHRDL   N L  S   +A +++ DFGL+  +  D+    +        ++ APE L 
Sbjct: 134 RCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 328 RS-YSLEADIWSIGVISYILL 347
            + +S ++D+WS GV+ Y L 
Sbjct: 191 DNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G+FG     R     L D   A+  + + + +      D +RE++ILKAL     +
Sbjct: 18  QLGKGNFGSVELCR--YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFI 74
Query: 214 VKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK+          ++ +VME    G L D +     R           QI   + +   +
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVLH 327
             VHRDL   N L  S   +A +++ DFGL+  +  D+    +        ++ APE L 
Sbjct: 135 RCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 328 RS-YSLEADIWSIGVISYILL 347
            + +S ++D+WS GV+ Y L 
Sbjct: 192 DNIFSRQSDVWSFGVVLYELF 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G FG               +VA+K +    M    S E   +E +++K L  H+ L
Sbjct: 15  KLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKL 65
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQG 272
           V+      +   + IV E    G LLD +    G+Y        +  QI S +A+     
Sbjct: 66  VQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHR 328
            VHRDL+  N L     ++   ++ DFGL+  I  D       G+ +   + APE  L+ 
Sbjct: 125 YVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYG 180
Query: 329 SYSLEADIWSIGVI 342
            +++++D+WS G++
Sbjct: 181 RFTIKSDVWSFGIL 194

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G+FG     R     L D   A+  + + + +      D +RE++ILKAL     +
Sbjct: 30  QLGKGNFGSVELCR--YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFI 86
Query: 214 VKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK+          ++ +VME    G L D +     R           QI   + +   +
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPEVLH 327
             VHRDL   N L  S   +A +++ DFGL+  +  D+    +        ++ APE L 
Sbjct: 147 RCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 328 RS-YSLEADIWSIGVISYILL 347
            + +S ++D+WS GV+ Y L 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELF 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 80
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 81  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGH 210
           G + G G FG        KG + +  VAVK + +   +TT    +   +E+K+  A   H
Sbjct: 27  GNKXGEGGFGVV-----YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKV-XAKCQH 80
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAFC 268
           ++LV+      D +++ +V      G LLDR+    G    +      I     + + F 
Sbjct: 81  ENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFL 140
Query: 269 HLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERL------NDIVGSAYYV 321
           H    +HRD+K  N L     D+A   ++ DFGL+   R  E+       + IVG+  Y 
Sbjct: 141 HENHHIHRDIKSANILL----DEAFTAKISDFGLA---RASEKFAQXVXXSRIVGTTAYX 193
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCG 349
           APE L    + ++DI+S GV+   ++ G
Sbjct: 194 APEALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+KI+++   TT         +  ++ A   H 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE---TTGPKANVEFMDEALIMASMDHP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           HLV+    C     + +V +L   G LL+ +         +      VQI   + +   +
Sbjct: 78  HLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLH- 327
            +VHRDL   N L  S      +++ DFGL+  +  DE+  +  G      ++A E +H 
Sbjct: 137 RLVHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R ++ ++D+WS GV  + L+  G +P+
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 78  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 78
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 79  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 138 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHK 211
           +G G+FG    AR KK  L+    A+K     +M    S +D R    E+++L  L  H 
Sbjct: 33  IGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV----------QI 261
           +++    ACE    +Y+ +E    G LLD    R  R  E D    +           Q+
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 262 LSVVA-------FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313
           L   A       +   +  +HRDL   N L     ++   ++ DFGLS   R  E  +  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKK 198
Query: 314 IVGS--AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            +G     ++A E L+ S Y+  +D+WS GV+ + I+  G  P+   T + ++  +
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHK 211
           +G G+FG    AR KK  L+    A+K     +M    S +D R    E+++L  L  H 
Sbjct: 23  IGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 76
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV----------QI 261
           +++    ACE    +Y+ +E    G LLD    R  R  E D    +           Q+
Sbjct: 77  NIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 262 LSVVA-------FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313
           L   A       +   +  +HRDL   N L     ++   ++ DFGLS   R  E  +  
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKK 188
Query: 314 IVGS--AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
            +G     ++A E L+ S Y+  +D+WS GV+ + I+  G  P+   T + ++
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 241

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+V+    C   +++ +V +    G LLD +    G    +      VQI   + +  
Sbjct: 92  HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVL 326
             G+VHR+L   N L  S    + +++ DFG++D + PD++    ++      ++A E +
Sbjct: 151 EHGMVHRNLAARNVLLKS---PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 327 H-RSYSLEADIWSIGVISYILLC-GSRPF 353
           H   Y+ ++D+WS GV  + L+  G+ P+
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+V+    C   +++ +V +    G LLD +    G    +      VQI   + +  
Sbjct: 74  HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVL 326
             G+VHR+L   N L  S    + +++ DFG++D + PD++    ++      ++A E +
Sbjct: 133 EHGMVHRNLAARNVLLKS---PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 327 H-RSYSLEADIWSIGVISYILLC-GSRPF 353
           H   Y+ ++D+WS GV  + L+  G+ P+
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
           ++G+G+FG     R     L D   A+  + + + +      D +RE++ILKAL     +
Sbjct: 14  QLGKGNFGSVELCR--YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFI 70
Query: 214 VKFCDACEDVN--NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           VK+           + +VME    G L D +     R           QI   + +   +
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-----GSAYYVAPEVL 326
             VHRDL   N L  S   +A +++ DFGL+  + P ++   +V        ++ APE L
Sbjct: 131 RCVHRDLAARNILVES---EAHVKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPESL 186
Query: 327 HRS-YSLEADIWSIGVISYILL 347
             + +S ++D+WS GV+ Y L 
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELF 208

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 21/263 (7%)
Query: 128 GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAK 187
           G  P QSL    G          L +++G G FG            K   VAVK +    
Sbjct: 4   GEGPLQSLTCLIGEKD-----LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV 58
Query: 188 MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG 247
           ++   +++D  REV  + +L  H++L++          + +V EL   G LLDR+    G
Sbjct: 59  LSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQG 116
Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
            +         VQ+   + +   +  +HRDL   N L  + RD   +++ DFGL   + P
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRAL-P 172
Query: 308 DERLNDIVGSAY-----YVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESG 360
               + ++         + APE L  R++S  +D W  GV  + +   G  P+     S 
Sbjct: 173 QNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
Query: 361 IFRAVLRSDPNFDDLPWPSVSPE 383
           I   +   D   + LP P   P+
Sbjct: 233 ILHKI---DKEGERLPRPEDCPQ 252

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 23/264 (8%)
Query: 128 GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAK 187
           G  P QSL    G          L +++G G FG            K   VAVK +    
Sbjct: 4   GEGPLQSLTCLIGEKD-----LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV 58
Query: 188 MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG 247
           ++   +++D  REV  + +L  H++L++          + +V EL   G LLDR+    G
Sbjct: 59  LSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQG 116
Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
            +         VQ+   + +   +  +HRDL   N L  + RD   +++ DFGL   +  
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRALPQ 173
Query: 308 DERLNDIVGSAY------YVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTES 359
           ++  +  V   +      + APE L  R++S  +D W  GV  + +   G  P+     S
Sbjct: 174 ND--DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPE 383
            I   +   D   + LP P   P+
Sbjct: 232 QILHKI---DKEGERLPRPEDCPQ 252

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           ++L++          + +V EL   G LLDR+    G +         VQ+   + +   
Sbjct: 75  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YVAPE 324
           +  +HRDL   N L  + RD   +++ DFGL   +  ++  +  V   +      + APE
Sbjct: 134 KRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPE 188
Query: 325 VLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            L  R++S  +D W  GV  + +   G  P+     S I   +   D   + LP P   P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPRPEDCP 245
Query: 383 E 383
           +
Sbjct: 246 Q 246

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 104/239 (43%), Gaps = 33/239 (13%)
Query: 138 SFGYNKNFGAKYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIE 195
           + G    +  ++   +++G G FG    C  R     L     A+K  SK  +  ++  +
Sbjct: 2   AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKR-SKKPLAGSVDEQ 55
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRY 249
           +  REV     L  H H+V++  A  + +++ I  E C GG L D      RI++    +
Sbjct: 56  NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS---YF 112
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT-----------SGRDDADMRLID 298
            E + K +++Q+   + + H   +VH D+KP N   +              DD     + 
Sbjct: 113 KEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 299 FGLSDFIRPDERLNDIV--GSAYYVAPEVLHRSYSL--EADIWSIGVISYILLCGSRPF 353
           F + D        +  V  G + ++A EVL  +Y+   +ADI+++  ++ +   G+ P 
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPL 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 16/240 (6%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           ++L++          + +V EL   G LLDR+    G +         VQ+   + +   
Sbjct: 71  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-----YVAPEV 325
           +  +HRDL   N L  + RD   +++ DFGL   + P    + ++         + APE 
Sbjct: 130 KRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPES 185
Query: 326 LH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           L  R++S  +D W  GV  + +   G  P+     S I   +   D   + LP P   P+
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPRPEDCPQ 242

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 47/231 (20%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
            +    + ++ K++G+G +G         G+ + ++VAVK+    +  +        RE 
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVW-----MGKWRGEKVAVKVFFTTEEASWF------RET 80
Query: 202 KILKA-LSGHKHLVKFCDA----CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
           +I +  L  H++++ F  A          +Y++ +  E G L D +     + T  DAK+
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKS 135
Query: 257 IV-VQILSVVAFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGL---- 301
           ++ +   SV   CHL            + HRDLK +N L    + +    + D GL    
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKF 192
Query: 302 -SDFIRPDERLNDIVGSAYYVAPEVLHRSYS-------LEADIWSIGVISY 344
            SD    D   N  VG+  Y+ PEVL  S +       + AD++S G+I +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G  + +GK++G G+FG     R  K    ++ VA+K+         + +E      + 
Sbjct: 1   SMGPNFRVGKKIGCGNFG---ELRLGKNLYTNEYVAIKLEPIKSRAPQLHLE-----YRF 52
Query: 204 LKALSGHKHLVKFCDACEDVNNVY----------IVMELCEGGELLDRILARGGRYTEED 253
            K LS          A E V  VY          +V+EL  G  L D        +T + 
Sbjct: 53  YKQLS----------ATEGVPQVYYFGPXGKYNAMVLELL-GPSLEDLFDLCDRTFTLKT 101
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLF---TSGRDDADMRLIDFGLS-DFIRPDE 309
              I +Q+++ + + H + +++RD+KPENFL     + R  A + +IDFGL+ ++I P+ 
Sbjct: 102 VLMIAIQLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHA-IHIIDFGLAKEYIDPET 160
Query: 310 RLN-------DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           + +        + G+A Y++    L +  S   D+ ++G +    L GS P+
Sbjct: 161 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 212

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           +GE     VA+K + +A  T+  + +++  E  ++ ++  + H+ +    C   + V ++
Sbjct: 46  EGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICL-TSTVQLI 101
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           M+L   G LLD +         +      VQI   + +   + +VHRDL   N L  + +
Sbjct: 102 MQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 161
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLHRSYSLEADIWSIGVISYI 345
               +++ DFGL+  +  +E+     G      +     +LHR Y+ ++D+WS GV  + 
Sbjct: 162 H---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 218
Query: 346 LLC-GSRPF 353
           L+  GS+P+
Sbjct: 219 LMTFGSKPY 227

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHK 211
           +G G+FG    AR KK  L+    A+K     +M    S +D R    E+++L  L  H 
Sbjct: 30  IGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 83
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV----------QI 261
           +++    ACE    +Y+ +E    G LLD    R  R  E D    +           Q+
Sbjct: 84  NIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 262 LSVVA-------FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313
           L   A       +   +  +HR+L   N L     ++   ++ DFGLS   R  E  +  
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLS---RGQEVYVKK 195
Query: 314 IVGS--AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
            +G     ++A E L+ S Y+  +D+WS GV+ + I+  G  P+   T + ++
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 248

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           ++L++          + +V EL   G LLDR+    G +         VQ+   + +   
Sbjct: 75  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YVAPE 324
           +  +HRDL   N L  + RD   +++ DFGL   +  ++  +  V   +      + APE
Sbjct: 134 KRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPE 188
Query: 325 VLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            L  R++S  +D W  GV  + +   G  P+     S I   +   D   + LP P   P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPRPEDCP 245
Query: 383 E 383
           +
Sbjct: 246 Q 246

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  + +GK++G G+FG     R  K    ++ VA+K+         + +E   R  K L 
Sbjct: 8   GPNFRVGKKIGCGNFG---ELRLGKNLYTNEYVAIKLEPMKSRAPQLHLE--YRFYKQLG 62
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           +  G   +  F   C   N   +V+EL  G  L D        ++ +    I +Q++S +
Sbjct: 63  SGDGIPQVYYF-GPCGKYNA--MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 266 AFCHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLS-DFIRPDERLN-------DIV 315
            + H + +++RD+KPENFL      +    + +IDFGL+ ++I P+ + +        + 
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLT 178
Query: 316 GSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           G+A Y++    L +  S   D+ ++G +    L GS P+
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           ++L++          + +V EL   G LLDR+    G +         VQ+   + +   
Sbjct: 71  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YVAPE 324
           +  +HRDL   N L  + RD   +++ DFGL   +  ++  +  V   +      + APE
Sbjct: 130 KRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPE 184
Query: 325 VLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            L  R++S  +D W  GV  + +   G  P+     S I   +   D   + LP P   P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPRPEDCP 241
Query: 383 E 383
           +
Sbjct: 242 Q 242

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 80  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 102
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 103 HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 162 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
           ++L++          + +V EL   G LLDR+    G +         VQ+   + +   
Sbjct: 71  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YVAPE 324
           +  +HRDL   N L  + RD   +++ DFGL   +  ++  +  V   +      + APE
Sbjct: 130 KRFIHRDLAARNLLLAT-RD--LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPE 184
Query: 325 VLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            L  R++S  +D W  GV  + +   G  P+     S I   +   D   + LP P   P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPRPEDCP 241
Query: 383 E 383
           +
Sbjct: 242 Q 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG          GE     VA+K++ +   T+  + +++  E  ++  + G  
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGV-GSP 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           ++ +    C   + V +V +L   G LLD +    GR   +D     +QI   +++    
Sbjct: 80  YVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS----AYYVAPEVLH 327
            +VHRDL   N L  S      +++ DFGL+  +  DE      G      +     +L 
Sbjct: 139 RLVHRDLAARNVLVKSPN---HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R ++ ++D+WS GV  + L+  G++P+
Sbjct: 196 RRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 80
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 80
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 80
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 87
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 88  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 147 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 83
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 84  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 143 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFG +  +  +E+     G      +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 79
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFG +  +  +E+     G      +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 84
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 85  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 144 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++  ++G G F     A  +     ++++A+K +        I+ E     ++ L    
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAE-----LQCLTVAG 77
Query: 209 GHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           G  ++  VK+C    D  +V I M   E    LD +       + ++ +  ++ +   + 
Sbjct: 78  GQDNVMGVKYCFRKND--HVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALK 131
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-----------FIRPD------- 308
             H  G+VHRD+KP NFL+   R      L+DFGL+            F++ +       
Sbjct: 132 RIHQFGIVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 309 -----------ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFW 354
                      +++    G+  + APEVL +  + +   D+WS GVI   LL G  PF+
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 375 KELGSGNFG--TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 431
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 432 IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 490 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 376 KELGSGNFG--TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 432
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 433 IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 491 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 81
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++M+L   G LLD +         +      VQI   + +   +
Sbjct: 82  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFG +  +  +E+     G      +     +LH
Sbjct: 141 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 74
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 75  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 134 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 191 RIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 77
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
           K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++  + 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 71
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
           H+ +    C   + V ++ +L   G LLD +         +      VQI   + +   +
Sbjct: 72  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLH 327
            +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LH
Sbjct: 131 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
           R Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 46  LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 94
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 150
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 205
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 33  LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 81
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 137
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 192
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 149 YELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +EL K +G G FG    C  R     L     A+K  SK  +  ++  ++  REV     
Sbjct: 10  HELEK-IGSGEFGSVFKCVKR-----LDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAV 62
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRYTEEDAKAIVVQ 260
           L  H H+V++  A  + +++ I  E C GG L D      RI++    + E + K +++Q
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS---YFKEAELKDLLLQ 119
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFT-----------SGRDDADMRLIDFGLSDFIRPDE 309
           +   + + H   +VH D+KP N   +              DD     + F + D      
Sbjct: 120 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 179
Query: 310 RLNDIV--GSAYYVAPEVLHRSYSL--EADIWSIGVISYILLCGSRPF 353
             +  V  G + ++A EVL  +Y+   +ADI+++  ++ +   G+ P 
Sbjct: 180 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVXAAGAEPL 226

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 13  LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 61
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 117
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 172
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 149 YELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +EL K +G G FG    C  R     L     A+K  SK  +  ++  ++  REV     
Sbjct: 12  HELEK-IGSGEFGSVFKCVKR-----LDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAV 64
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRYTEEDAKAIVVQ 260
           L  H H+V++  A  + +++ I  E C GG L D      RI++    + E + K +++Q
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS---YFKEAELKDLLLQ 121
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFT-----------SGRDDADMRLIDFGLSDFIRPDE 309
           +   + + H   +VH D+KP N   +              DD     + F + D      
Sbjct: 122 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 181
Query: 310 RLNDIV--GSAYYVAPEVLHRSYSL--EADIWSIGVISYILLCGSRPF 353
             +  V  G + ++A EVL  +Y+   +ADI+++  ++ +   G+ P 
Sbjct: 182 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPL 228

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I       A        E  ++  L  
Sbjct: 196 KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAF-----LAEASVMTQLR- 244
Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      D      + +   + +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
                 VHRDL   N L +   +D   ++ DFGL+      +    +     + APE L 
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 359
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            + +S ++D+WS G++ + I   G  P+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I       A        E  ++  L  
Sbjct: 24  KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAF-----LAEASVMTQLR- 72
Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      D      + +   + +
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
                 VHRDL   N L +   +D   ++ DFGL+      +    +     + APE L 
Sbjct: 133 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 187
Query: 327 HRSYSLEADIWSIGVISY-ILLCGSRPF 353
            + +S ++D+WS G++ + I   G  P+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           K +G G FG T        E +  ++ V I+   + T+  + +++  E  ++ ++  + H
Sbjct: 55  KVLGSGAFG-TVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD-NPH 112
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           + +    C   + V ++ +L   G LLD +         +      VQI   + +   + 
Sbjct: 113 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 171
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLHR 328
           +VHRDL   N L  + +    +++ DFGL+  +  +E+     G      +     +LHR
Sbjct: 172 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 329 SYSLEADIWSIGVISYILLC-GSRPF 353
            Y+ ++D+WS GV  + L+  GS+P+
Sbjct: 229 IYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 149 YELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
           +EL K +G G FG    C  R     L     A+K  SK  +  ++  ++  REV     
Sbjct: 12  HELEK-IGSGEFGSVFKCVKR-----LDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAV 64
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRYTEEDAKAIVVQ 260
           L  H H+V++  A  + +++ I  E C GG L D      RI++    + E + K +++Q
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS---YFKEAELKDLLLQ 121
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFT-----------SGRDDADMRLIDFGLSDFIRPDE 309
           +   + + H   +VH D+KP N   +              DD     + F + D      
Sbjct: 122 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 181
Query: 310 RLNDIV--GSAYYVAPEVLHRSYSL--EADIWSIGVISYILLCGSRPF 353
             +  V  G + ++A EVL  +Y+   +ADI+++  ++ +   G+ P 
Sbjct: 182 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPL 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I       A        E  ++  L  
Sbjct: 15  KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAF-----LAEASVMTQLR- 63
Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      D      + +   + +
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
                 VHRDL   N L +   +D   ++ DFGL+      +    +     + APE L 
Sbjct: 124 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 178
Query: 328 R-SYSLEADIWSIGVISY 344
             ++S ++D+WS G++ +
Sbjct: 179 EAAFSTKSDVWSFGILLW 196

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 10  LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 58
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 59  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 114
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 169
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 8   LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 56
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 57  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 112
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 167
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA-LSG 209
           L + +G+G FG        +G+ + ++VAVKI S  +  +        RE +I +  +  
Sbjct: 7   LQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWF------REAEIYQTVMLR 55
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N     +++V +  E G L D +     RYT      I + + +  
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTAS 111
Query: 266 AFCHLQ----------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
              HL            + HRDLK +N L    + +    + D GL+  +R D   + I 
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLA--VRHDSATDTID 166
Query: 315 ------VGSAYYVAPEVLHRSYSLE-------ADIWSIGVISY 344
                 VG+  Y+APEVL  S +++       ADI+++G++ +
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 31  KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 87
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 88  IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 146 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I       A        E  ++  L  
Sbjct: 9   KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAF-----LAEASVMTQLR- 57
Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      D      + +   + +
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
                 VHRDL   N L +   +D   ++ DFGL+      +    +     + APE L 
Sbjct: 118 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172
Query: 327 HRSYSLEADIWSIGVISY 344
            + +S ++D+WS G++ +
Sbjct: 173 EKKFSTKSDVWSFGILLW 190

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  + +GK++G G+FG     R  K    ++ VA+K+         + +E   R  K L 
Sbjct: 8   GPNFRVGKKIGCGNFG---ELRLGKNLYTNEYVAIKLEPMKSRAPQLHLE--YRFYKQLG 62
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           +  G   +  F   C   N   +V+EL  G  L D        ++ +    I +Q++S +
Sbjct: 63  SGDGIPQVYYF-GPCGKYNA--MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 266 AFCHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLS-DFIRPDERLN-------DIV 315
            + H + +++RD+KPENFL      +    + +IDF L+ ++I P+ + +        + 
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 316 GSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           G+A Y++    L +  S   D+ ++G +    L GS P+
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 33  KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 89
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 90  IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 148 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 33  KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 89
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 90  IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 148 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 17  KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 73
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 74  IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----VAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE          +     APE + +
Sbjct: 132 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
             +S ++D+WS GV+ +     G +P+
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG     +G     K  +     I K +       +++  E  +++ L  + +
Sbjct: 17  KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 73
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 74  IVRMIGICE-AESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YVAPEVL 326
            VHRDL   N L  +       ++ DFGLS  +R DE  N      +      + APE +
Sbjct: 132 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADE--NXYKAQTHGKWPVKWYAPECI 186
Query: 327 -HRSYSLEADIWSIGVISYILLC-GSRPF 353
            +  +S ++D+WS GV+ +     G +P+
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  + +GK++G G+FG     R  K    ++ VA+K+         + +E   R  K L 
Sbjct: 29  GPNFRVGKKIGCGNFG---ELRLGKNLYTNEYVAIKLEPMKSRAPQLHLE--YRFYKQLG 83
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           +  G   +  F   C   N   +V+EL  G  L D        ++ +    I +Q++S +
Sbjct: 84  SGDGIPQVYYF-GPCGKYNA--MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 139
Query: 266 AFCHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLS-DFIRPDERLN-------DIV 315
            + H + +++RD+KPENFL      +    + +IDF L+ ++I P+ + +        + 
Sbjct: 140 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 199
Query: 316 GSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF 353
           G+A Y++    L +  S   D+ ++G +    L GS P+
Sbjct: 200 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           +GE     VA+K + +A  T+  + +++  E  ++ ++  + H+ +    C   + V ++
Sbjct: 46  EGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICL-TSTVQLI 101
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
            +L   G LLD +         +      VQI   + +   + +VHRDL   N L  + +
Sbjct: 102 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 161
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPEVLHRSYSLEADIWSIGVISYI 345
               +++ DFGL+  +  +E+     G      +     +LHR Y+ ++D+WS GV  + 
Sbjct: 162 H---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 218
Query: 346 LLC-GSRPF 353
           L+  GS+P+
Sbjct: 219 LMTFGSKPY 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	422
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-154
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-152
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-151
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-150
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-149
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-148
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-146
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-144
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-144
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-140
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-136
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-136
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-135
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-135
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-135
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-133
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-131
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-130
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-129
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-129
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-129
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-128
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-127
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-126
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-126
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-125
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-123
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-123
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-121
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-121
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-121
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-118
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-118
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-104
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-101
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-85
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-83
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-82
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-82
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-80
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-79
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-79
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-79
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-75
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-74
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-74
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-72
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-72
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-72
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-72
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-71
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-70
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-70
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-70
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-70
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-69
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-69
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-69
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-69
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-68
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-68
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-68
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-67
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-67
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-66
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-65
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-64
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-62
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-61
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-59
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-57
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-55
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-54
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-49
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-48
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-48
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-46
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-45
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-45
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-45
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-45
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-45
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-44
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-44
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-44
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-44
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-05
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-44
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-42
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-42
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-42
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-42
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-42
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-42
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-41
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-41
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-41
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-41
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-40
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-40
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-39
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-39
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-38
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-37
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-37
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-37
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-36
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-36
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-36
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-36
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-36
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-35
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-35
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-34
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-34
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-33
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-32
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-32
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-31
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-30
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-22
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-09
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	1e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  439 bits (1130), Expect = e-154
 Identities = 107/363 (29%), Positives = 162/363 (44%), Gaps = 22/363 (6%)

Query: 57  HPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG 116
           H S   + +      +         P      RR F R             + AK+L   
Sbjct: 7   HSSGVDNKFNKERRRARREI--RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64

Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
           +PK +     +   PE  L   +   K F  KY+    +GRG          +       
Sbjct: 65  QPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGH 120

Query: 177 QVAVKIISKAKMTTAIS-----IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
           + AVKI+       +        E  RRE  IL+ ++GH H++   D+ E  + +++V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
           L   GEL D +  +    +E++ ++I+  +L  V+F H   +VHRDLKPEN L     D+
Sbjct: 181 LMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236

Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVISY 344
             +RL DFG S  + P E+L ++ G+  Y+APE+L       H  Y  E D+W+ GVI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296

Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            LL GS PFW R +  + R ++     F    W   S   KD + RLL  D   R+TA Q
Sbjct: 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356

Query: 405 ALS 407
           AL 
Sbjct: 357 ALQ 359

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  439 bits (1131), Expect = e-152
 Identities = 103/274 (37%), Positives = 157/274 (57%), Gaps = 6/274 (2%)

Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
           S  ++  +   F  +Y +   +G+G FG     + +      Q+ AVK+I+KA       
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-D 64

Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
              + REV++LK L  H +++K  +  ED ++ YIV EL  GGEL D I+ R  R++E D
Sbjct: 65  TSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD 122

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
           A  I+ Q+ S + + H   +VHRDLKPEN L  S   D D+++IDFGLS   + + ++ D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 314 IVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
            +G+AYY+APEVL  +Y  + D+WS GVI YILL G+ PF+ + E  I + V      FD
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              W ++S +AKD ++++L      R+TA Q L 
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  428 bits (1103), Expect = e-151
 Identities = 103/277 (37%), Positives = 157/277 (56%), Gaps = 6/277 (2%)

Query: 131 PEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT 190
              S  ++  +   F  +Y +   +G+G FG     + +      Q+ AVK+I+KA    
Sbjct: 6   HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN 62

Query: 191 AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYT 250
                 + REV++LK L  H +++K  +  ED ++ YIV EL  GGEL D I+ R  R++
Sbjct: 63  K-DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFS 119

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
           E DA  I+ Q+ S + + H   +VHRDLKPEN L  S   D D+++IDFGLS   + + +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179

Query: 311 LNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370
           + D +G+AYY+APEVL  +Y  + D+WS GVI YILL G+ PF+ + E  I + V     
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            FD   W ++S +AKD ++++L      R+TA Q L 
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  425 bits (1095), Expect = e-150
 Identities = 90/280 (32%), Positives = 153/280 (54%), Gaps = 10/280 (3%)

Query: 131 PEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT 190
              S  ++  +       +   +++G G FG       +       +  +K I+K +   
Sbjct: 6   HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-- 60

Query: 191 AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GG 247
            + +E +  E+++LK+L  H +++K  +  ED +N+YIVME CEGGELL+RI++    G 
Sbjct: 61  QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119

Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
             +E     ++ Q+++ +A+ H Q VVH+DLKPEN LF      + +++IDFGL++  + 
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 308 DERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR 367
           DE   +  G+A Y+APEV  R  + + DIWS GV+ Y LL G  PF   +   + +    
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239

Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +PN+     P ++P+A D +K++L KD  +R +A Q L 
Sbjct: 240 KEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLH 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  422 bits (1088), Expect = e-149
 Identities = 100/264 (37%), Positives = 156/264 (59%), Gaps = 8/264 (3%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           +    Y L   +GRG +G    A  K       + A K I K  +     ++  ++E++I
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFKQEIEI 59

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           +K+L  H ++++  +  ED  ++Y+VMELC GGEL +R++ +   + E DA  I+  +LS
Sbjct: 60  MKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLS 117

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
            VA+CH   V HRDLKPENFLF +   D+ ++LIDFGL+   +P + +   VG+ YYV+P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

Query: 324 EVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +VL   Y  E D WS GV+ Y+LLCG  PF A T+S +   +      F +  W +VSP+
Sbjct: 178 QVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237

Query: 384 AKDFVKRLLNKDYRKRMTAVQALS 407
           A+  ++RLL K  ++R+T++QAL 
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALE 261

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  429 bits (1106), Expect = e-148
 Identities = 105/301 (34%), Positives = 163/301 (54%), Gaps = 18/301 (5%)

Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
             +E+   +     P   + K  G     G  Y   +++G G +G     + K G     
Sbjct: 9   SGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG---HS 62

Query: 177 QVAVKIISKAKMTTAISI----------EDVRREVKILKALSGHKHLVKFCDACEDVNNV 226
           + A+K+I K++                 E++  E+ +LK+L  H +++K  D  ED    
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYF 121

Query: 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286
           Y+V E  EGGEL ++I+ R  ++ E DA  I+ QILS + + H   +VHRD+KPEN L  
Sbjct: 122 YLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180

Query: 287 SGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYIL 346
           +     +++++DFGLS F   D +L D +G+AYY+APEVL + Y+ + D+WS GVI YIL
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYIL 240

Query: 347 LCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           LCG  PF  + +  I + V +    FD   W ++S EAK+ +K +L  DY KR TA +AL
Sbjct: 241 LCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

Query: 407 S 407
           +
Sbjct: 301 N 301

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  424 bits (1093), Expect = e-146
 Identities = 104/266 (39%), Positives = 153/266 (57%), Gaps = 5/266 (1%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
              F  +Y+  + +G+G FG     + K      Q+ AVK+ISK ++      E + REV
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           ++LK L  H +++K  +  ED    Y+V E+  GGEL D I++R  R++E DA  I+ Q+
Sbjct: 78  QLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           LS + + H   +VHRDLKPEN L  S   DA++R+IDFGLS      +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 322 APEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           APEVLH +Y  + D+WS GVI YILL G  PF    E  I + V +    F+   W  VS
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
             AKD ++++L      R++A  AL 
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALD 281

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  419 bits (1080), Expect = e-144
 Identities = 106/266 (39%), Positives = 156/266 (58%), Gaps = 6/266 (2%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
             +    Y+  K++G G +G     R K       + A+KII K  ++T+ S   +  EV
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            +LK L  H +++K  D  ED  N Y+VME  +GGEL D I+ R  ++ E DA  I+ Q+
Sbjct: 88  AVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQV 145

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           LS V + H   +VHRDLKPEN L  S   DA ++++DFGLS      +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 322 APEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           APEVL + Y  + D+WSIGVI +ILL G  PF  +T+  I R V +    FD   W +VS
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
             AKD +K++L  D ++R++A QAL 
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALE 291

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  411 bits (1059), Expect = e-144
 Identities = 72/266 (27%), Positives = 129/266 (48%), Gaps = 10/266 (3%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           K    KY + +++GRG FG              +    K +             V++E+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGT----DQVLVKKEIS 53

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           IL     H++++   ++ E +  + ++ E   G ++ +RI        E +  + V Q+ 
Sbjct: 54  ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
             + F H   + H D++PEN ++ + R  + +++I+FG +  ++P +    +  +  Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEV  H   S   D+WS+G + Y+LL G  PF A T   I   ++ ++  FD+  +  +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
            EA DFV RLL K+ + RMTA +AL 
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  400 bits (1029), Expect = e-140
 Identities = 94/266 (35%), Positives = 147/266 (55%), Gaps = 7/266 (2%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
             F   Y++ +E+G+G F        K       + A KII+  K++ A   + + RE +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLS-ARDFQKLEREAR 57

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           I + L  H ++V+  D+ ++ +  Y+V +L  GGEL + I+AR   Y+E DA   + QIL
Sbjct: 58  ICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQIL 115

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
             +A+CH  G+VHR+LKPEN L  S    A ++L DFGL+  +   E  +   G+  Y++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175

Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL +  YS   DIW+ GVI YILL G  PFW   +  ++  +     ++    W +V+
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
           PEAK  +  +L  + +KR+TA QAL 
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALK 261

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  397 bits (1023), Expect = e-136
 Identities = 91/267 (34%), Positives = 143/267 (53%), Gaps = 8/267 (2%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
             F  +Y+L +E+G+G F               Q+ A  II+  K++     + + RE +
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREAR 62

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           I + L  H ++V+  D+  +  + Y++ +L  GGEL + I+AR   Y+E DA   + QIL
Sbjct: 63  ICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQIL 120

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYV 321
             V  CH  GVVHR+LKPEN L  S    A ++L DFGL+  +    +      G+  Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           +PEVL +  Y    D+W+ GVI YILL G  PFW   +  +++ +     +F    W +V
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240

Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALS 407
           +PEAKD + ++L  +  KR+TA +AL 
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALK 267

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  393 bits (1012), Expect = e-136
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 12/273 (4%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRR 199
           +  F   YEL + +G+G F        ++     QQ AVKI+  AK T+   +S ED++R
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKR 75

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---GRYTEEDAKA 256
           E  I   L  H H+V+  +       +Y+V E  +G +L   I+ R      Y+E  A  
Sbjct: 76  EASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
            + QIL  + +CH   ++HRD+KP   L  S  + A ++L  FG++             V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           G+ +++APEV+ R  Y    D+W  GVI +ILL G  PF+  T+  +F  +++     + 
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNP 253

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             W  +S  AKD V+R+L  D  +R+T  +AL+
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  388 bits (1000), Expect = e-135
 Identities = 91/278 (32%), Positives = 138/278 (49%), Gaps = 20/278 (7%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI------ED 196
             F   YE  + +GRG          K      ++ AVKII      +  +       E 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
             +EV IL+ +SGH ++++  D  E     ++V +L + GEL D +  +    +E++ + 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRK 128

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           I+  +L V+   H   +VHRDLKPEN L     DD +++L DFG S  + P E+L ++ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185

Query: 317 SAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
           +  Y+APE++       H  Y  E D+WS GVI Y LL GS PFW R +  + R ++  +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             F    W   S   KD V R L    +KR TA +AL+
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  391 bits (1006), Expect = e-135
 Identities = 96/291 (32%), Positives = 156/291 (53%), Gaps = 9/291 (3%)

Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
           P  +++    G +  +  +     +  F   Y++ +E+G+G F        K       +
Sbjct: 2   PHMASMTG--GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTG---LE 56

Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
            A KII+  K++ A   + + RE +I + L  H ++V+  D+ ++ +  Y+V +L  GGE
Sbjct: 57  FAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114

Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
           L + I+AR   Y+E DA   + QIL  +A+CH  G+VHR+LKPEN L  S    A ++L 
Sbjct: 115 LFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
           DFGL+  +   E  +   G+  Y++PEVL +  YS   DIW+ GVI YILL G  PFW  
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233

Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +  ++  +     ++    W +V+PEAK  +  +L  + +KR+TA QAL 
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  389 bits (1002), Expect = e-135
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 9/270 (3%)

Query: 142 NKNFGAKYEL-GKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRR 199
            +NF   Y L  KE+GRG F        K  G    Q+ A K + K +        ++  
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTG----QEYAAKFLKKRRRG-QDCRAEILH 77

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIV 258
           E+ +L+       ++   +  E+ + + +++E   GGE+    L       +E D   ++
Sbjct: 78  EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            QIL  V + H   +VH DLKP+N L +S     D++++DFG+S  I     L +I+G+ 
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
            Y+APE+L+    +   D+W+IG+I+Y+LL  + PF        +  + + + ++ +  +
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257

Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            SVS  A DF++ LL K+  KR TA   LS
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  383 bits (987), Expect = e-133
 Identities = 93/269 (34%), Positives = 150/269 (55%), Gaps = 10/269 (3%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRRE 200
                YE+G+E+G G F      R K      ++ A K I K ++++    +S E++ RE
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIERE 58

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V IL+ +  H +++   D  E+  +V +++EL  GGEL D +  +    TE++A   + Q
Sbjct: 59  VNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQ 116

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           IL  V + H + + H DLKPEN +       +  ++LIDFG++  I       +I G+  
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176

Query: 320 YVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           +VAPE+++     LEAD+WSIGVI+YILL G+ PF   T+      +   + +FD+  + 
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           + S  AKDF++RLL KD ++RMT  Q+L 
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  388 bits (998), Expect = e-131
 Identities = 92/329 (27%), Positives = 148/329 (44%), Gaps = 14/329 (4%)

Query: 82  PARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGY 141
           P   + P      P       +        ++  GK   S+  +    +  +        
Sbjct: 93  PCEPTAPVL---IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 142 NK--NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
            K  +    Y++ +E+G G FG       +         A K +     +     E VR+
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRK 203

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           E++ +  L  H  LV   DA ED N + ++ E   GGEL +++     + +E++A   + 
Sbjct: 204 EIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
           Q+   +   H    VH DLKPEN +FT+ +   +++LIDFGL+  + P + +    G+A 
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321

Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           + APEV   +      D+WS+GV+SYILL G  PF    +    R V   D N DD  + 
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +S + KDF+++LL  D   RMT  QAL 
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALE 410

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  377 bits (969), Expect = e-130
 Identities = 105/313 (33%), Positives = 157/313 (50%), Gaps = 15/313 (4%)

Query: 97  PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
              S       +L  +        S  P      P+  +D S          +E+  E+G
Sbjct: 6   HHSSGVDLGTENLYFQ-SMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVESELG 62

Query: 157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF 216
           RG        + K      +  A+K++ K         + VR E+ +L  LS H +++K 
Sbjct: 63  RGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKL 113

Query: 217 CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHR 276
            +  E    + +V+EL  GGEL DRI+ +G  Y+E DA   V QIL  VA+ H  G+VHR
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHR 172

Query: 277 DLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEAD 335
           DLKPEN L+ +   DA +++ DFGLS  +     +  + G+  Y APE+L   +Y  E D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232

Query: 336 IWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK 394
           +WS+G+I+YILLCG  PF+    +  +FR +L  +  F    W  VS  AKD V++L+  
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292

Query: 395 DYRKRMTAVQALS 407
           D +KR+T  QAL 
Sbjct: 293 DPKKRLTTFQALQ 305

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  377 bits (970), Expect = e-129
 Identities = 96/338 (28%), Positives = 147/338 (43%), Gaps = 30/338 (8%)

Query: 81  SPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFG 140
           S ++  +P   F  P PPP P                P +   P  +             
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPH--------PPAQPPPPPPQQFPQFHVKSGLQI 54

Query: 141 YNKNFGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
                   Y++  + +G G  G       K+     ++ A+K++              RR
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARR 103

Query: 200 EVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
           EV++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG + +TE +A
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
             I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG +        L   
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223

Query: 315 VGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSD 369
             + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++        G+   +    
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283

Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             F +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  374 bits (963), Expect = e-129
 Identities = 98/272 (36%), Positives = 146/272 (53%), Gaps = 12/272 (4%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
            +N    Y+ G+E+G G F      R K  G     Q A K I K +  +    +S ED+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            REV ILK +  H +++   +  E+  +V +++EL  GGEL D +  +    TEE+A   
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEF 119

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           + QIL+ V + H   + H DLKPEN +          +++IDFGL+  I       +I G
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179

Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           +  +VAPE+++     LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            + + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  375 bits (966), Expect = e-129
 Identities = 88/298 (29%), Positives = 141/298 (47%), Gaps = 15/298 (5%)

Query: 117 KPKESTIPEERGTEPEQSLDKSFGY------NKNFGAKYELGKEVGRGHFGHTCSARGKK 170
           + K          +  + + K +          +    Y++ +E+G G FG       K 
Sbjct: 15  RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74

Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
                +    K I+       +    V+ E+ I+  L  H  L+   DA ED   + +++
Sbjct: 75  TG---RVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLIL 127

Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
           E   GGEL DRI A   + +E +    + Q    +   H   +VH D+KPEN +  + + 
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KK 186

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCG 349
            + +++IDFGL+  + PDE +     +A + APE++ R       D+W+IGV+ Y+LL G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

Query: 350 SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             PF    +    + V R D  FD+  + SVSPEAKDF+K LL K+ RKR+T   AL 
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  372 bits (957), Expect = e-128
 Identities = 90/332 (27%), Positives = 149/332 (44%), Gaps = 54/332 (16%)

Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
               +   ++L    G       KY L   +G+G +G    A   +        A+KI++
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR---AIRAIKIMN 60

Query: 185 KAKM--TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI 242
           K K+       +E ++ EV+++K L  H ++ +  +  ED   + +VMELC GG LLD++
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 243 LARGGR---------------------------------------YTEEDAKAIVVQILS 263
                                                          E+    I+ QI S
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-----DERLNDIVGSA 318
            + + H QG+ HRD+KPENFLF++     +++L+DFGLS             +    G+ 
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238

Query: 319 YYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           Y+VAPEVL+    SY  + D WS GV+ ++LL G+ PF    ++     VL     F++ 
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +  +SP A+D +  LLN++  +R  A++AL 
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  369 bits (951), Expect = e-127
 Identities = 100/265 (37%), Positives = 145/265 (54%), Gaps = 10/265 (3%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           N    +   + +G G F      + +      +  A+K I K+          +  E+ +
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLT---GKLFALKCIKKSPA---FRDSSLENEIAV 59

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           LK +  H+++V   D  E   + Y+VM+L  GGEL DRIL RG  YTE+DA  ++ Q+LS
Sbjct: 60  LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLS 117

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
            V + H  G+VHRDLKPEN L+ +  +++ + + DFGLS   +    ++   G+  YVAP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAP 176

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           EVL +  YS   D WSIGVI+YILLCG  PF+  TES +F  +      F+   W  +S 
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALS 407
            AKDF+  LL KD  +R T  +ALS
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALS 261

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  369 bits (949), Expect = e-126
 Identities = 96/345 (27%), Positives = 159/345 (46%), Gaps = 13/345 (3%)

Query: 67  HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEE 126
           H  S   L        +  ++  +  R             A L +R+     + S +  +
Sbjct: 7   HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWS-NADLTERMPVKSKRTSALAVD 65

Query: 127 RGTEPEQSLDKSFGYNK-NFGAKYELGK--EVGRGHFGHTCSARGKKGELKDQQVAVKII 183
               P     +     +    + Y + K   +G G FG               ++A KII
Sbjct: 66  IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKII 122

Query: 184 SKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL 243
               M      E+V+ E+ ++  L  H +L++  DA E  N++ +VME  +GGEL DRI+
Sbjct: 123 KTRGMK---DKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 244 ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
                 TE D    + QI   +   H   ++H DLKPEN L  + RD   +++IDFGL+ 
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLAR 237

Query: 304 FIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIF 362
             +P E+L    G+  ++APEV++    S   D+WS+GVI+Y+LL G  PF    ++   
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             +L    + +D  +  +S EAK+F+ +LL K+   R++A +AL 
Sbjct: 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  366 bits (941), Expect = e-126
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 22/277 (7%)

Query: 142 NKNFGAKYELG---KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
           +  F   Y+L    K +G G F        KK    +Q  AVKIISK          + +
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKRME------ANTQ 53

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           +E+  LK   GH ++VK  +   D  + ++VMEL  GGEL +RI  +   ++E +A  I+
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIM 112

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGS 317
            +++S V+  H  GVVHRDLKPEN LFT   D+ ++++IDFG +    PD + L     +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172

Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES-------GIFRAVLRSD 369
            +Y APE+L+++ Y    D+WS+GVI Y +L G  PF +   S        I + + + D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232

Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            +F+   W +VS EAKD ++ LL  D  KR+      
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  363 bits (933), Expect = e-125
 Identities = 93/272 (34%), Positives = 146/272 (53%), Gaps = 12/272 (4%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
            +     Y++G+E+G G F      R K  G     + A K I K +       +S E++
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVSREEI 62

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            REV IL+ +  H +++   D  E+  +V +++EL  GGEL D +  +    +EE+A + 
Sbjct: 63  EREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSF 120

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD-ADMRLIDFGLSDFIRPDERLNDIVG 316
           + QIL  V + H + + H DLKPEN +          ++LIDFGL+  I       +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           +  +VAPE+++     LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +   S  AKDF+++LL K+ RKR+T  +AL 
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  361 bits (929), Expect = e-123
 Identities = 92/272 (33%), Positives = 145/272 (53%), Gaps = 12/272 (4%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
            +     Y++G+E+G G F      R K  G     + A K I K +       +  E++
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVCREEI 62

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
            REV IL+ +  H +++   D  E+  +V +++EL  GGEL D +  +    +EE+A + 
Sbjct: 63  EREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSF 120

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           + QIL  V + H + + H DLKPEN +          ++LIDFGL+  I       +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           +  +VAPE+++     LEAD+WSIGVI+YILL G+ PF   T+      +     +FD+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +   S  AKDF+++LL K+ RKR+T  +AL 
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  358 bits (922), Expect = e-123
 Identities = 88/296 (29%), Positives = 138/296 (46%), Gaps = 37/296 (12%)

Query: 141 YNKNFGAKYELGKEV-GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
           ++  F   Y+L ++V G G      +          Q+ AVKII K           V R
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGH---IRSRVFR 59

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           EV++L    GH+++++  +  E+ +  Y+V E   GG +L  I  R   + E +A  +V 
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQ 118

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----- 314
            + S + F H +G+ HRDLKPEN L       + +++ DF L   I+ +   + I     
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 315 ---VGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWAR--------- 356
               GSA Y+APEV+         Y    D+WS+GVI YILL G  PF  R         
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

Query: 357 ------TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                  ++ +F ++      F D  W  +S  AKD + +LL +D ++R++A Q L
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  353 bits (909), Expect = e-121
 Identities = 97/276 (35%), Positives = 141/276 (51%), Gaps = 16/276 (5%)

Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIE 195
           Y K    +Y + K +G G  G    A  +K     ++VA+KIISK K        A    
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPAL 60

Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +V  E++ILK L+ H  ++K  +  +   + YIV+EL EGGEL D+++    R  E   K
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
               Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +     +  + 
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177

Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
           G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +   +     
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237

Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  354 bits (910), Expect = e-121
 Identities = 93/271 (34%), Positives = 137/271 (50%), Gaps = 17/271 (6%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +  F   YE+ +++G G +        K     + + AVKII K+K        D   E+
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK-------RDPTEEI 66

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           +IL     H +++   D  +D   VY+V EL +GGELLD+IL +   ++E +A A++  I
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTI 125

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPDER-LNDIVGSAY 319
              V + H QGVVHRDLKP N L+     + +  R+ DFG +  +R +   L     +A 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 320 YVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR---TESGIFRAVLRSDPNFDDL 375
           +VAPEVL R  Y    DIWS+GV+ Y +L G  PF      T   I   +     +    
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            W SVS  AKD V ++L+ D  +R+TA   L
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  353 bits (909), Expect = e-121
 Identities = 93/277 (33%), Positives = 137/277 (49%), Gaps = 23/277 (8%)

Query: 142 NKNFGAKYELGKEV-GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
                  Y+L K+V G G  G       ++     Q+ A+K++  +           R+E
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDSP--------KARQE 71

Query: 201 VKILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARG-GRYTEEDAK 255
           V      SG  H+V   D  E++++    + I+ME  EGGEL  RI  RG   +TE +A 
Sbjct: 72  VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            I+  I + + F H   + HRD+KPEN L+TS   DA ++L DFG +     +  L    
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPC 190

Query: 316 GSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDP 370
            + YYVAPEVL    Y    D+WS+GVI YILLCG  PF++ T      G+ R +     
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250

Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            F +  W  VS +AK  ++ LL  D  +R+T  Q ++
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  346 bits (890), Expect = e-118
 Identities = 79/275 (28%), Positives = 120/275 (43%), Gaps = 40/275 (14%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           N          + +G G  G       K+     ++ A+K++              RREV
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARREV 61

Query: 202 KILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARG-GRYTEEDAKA 256
           ++    S   H+V+  D  E++      + IVME  +GGEL  RI  RG   +TE +A  
Sbjct: 62  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
           I+  I   + + H   + HRD+KPEN L+TS R +A ++L DFG                
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 317 SAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNF 372
                A E     Y    D+WS+GVI YILLCG  PF++        G+   +      F
Sbjct: 167 -----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            +  W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  349 bits (898), Expect = e-118
 Identities = 97/283 (34%), Positives = 144/283 (50%), Gaps = 16/283 (5%)

Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--- 190
           ++D    Y K    +Y + K +G G  G    A  +K     ++VA++IISK K      
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSA 178

Query: 191 --AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
             A    +V  E++ILK L+ H  ++K  +  +   + YIV+EL EGGEL D+++    R
Sbjct: 179 READPALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-R 235

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             E   K    Q+L  V + H  G++HRDLKPEN L +S  +D  +++ DFG S  +   
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFR 363
             +  + G+  Y+APEVL       Y+   D WS+GVI +I L G  PF   RT+  +  
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355

Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            +     NF    W  VS +A D VK+LL  D + R T  +AL
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  314 bits (806), Expect = e-104
 Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 44/299 (14%)

Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           + ++        K +G G  G        +G  + + VAVK +           +    E
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG------GRYTEEDA 254
           +K+L     H +++++  +      +YI +ELC    L D + ++           E + 
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----------GRDDADMRLIDFGLSDF 304
            +++ QI S VA  H   ++HRDLKP+N L ++          G ++  + + DFGL   
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 305 IRPDE-----RLNDIVGSAYYVAPEVL--------HRSYSLEADIWSIGVISYILLC-GS 350
           +   +      LN+  G++ + APE+L         R  +   DI+S+G + Y +L  G 
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 351 RPFWAR--TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            PF  +   ES I R +   D     L   S+  EA D + ++++ D  KR TA++ L 
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  308 bits (790), Expect = e-101
 Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 25/272 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +     +G G  G        +G   ++ VAVK I               REV++L+  
Sbjct: 25  SFCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPECF------SFADREVQLLRES 74

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H +++++    +D    YI +ELC    L + +  +   +   +   ++ Q  S +A 
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDE----RLNDIVGSAYYV 321
            H   +VHRDLKP N L +       ++  + DFGL   +        R + + G+  ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 322 APEVL----HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDL- 375
           APE+L      + +   DI+S G + Y ++  GS PF    +      +L    + D L 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           P       A++ +++++  D +KR +A   L 
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  260 bits (666), Expect = 8e-85
 Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 43/296 (14%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +  + + +E    +G+G FG    AR        +  A+K I   +      +  +  EV
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEV 53

Query: 202 KILKALSGHKHLVKFCDACEDVNN-------------VYIVMELCEGGELLDRILARGGR 248
            +L +L+ H+++V++  A  +  N             ++I ME CE G L D I +    
Sbjct: 54  MLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
              ++   +  QIL  +++ H QG++HRDLKP N          ++++ DFGL+      
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE---SRNVKIGDFGLAKNVHRS 169

Query: 303 ---------DFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSR 351
                    +     + L   +G+A YVA EVL  +  Y+ + D++S+G+I + ++    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                    I + +      F      +     K  ++ L++ D  KR  A   L+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  258 bits (660), Expect = 1e-83
 Identities = 65/310 (20%), Positives = 114/310 (36%), Gaps = 46/310 (14%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + L   +G+G   +    R KK        A+K+ +         ++   RE ++LK L+
Sbjct: 11  WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN 65

Query: 209 GHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSV 264
            HK++VK     E+    +  ++ME C  G L   +          E +   ++  ++  
Sbjct: 66  -HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
           +      G+VHR++KP N +   G D  +  +L DFG +  +  DE+   + G+  Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 324 EVL---------HRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDP 370
           ++           + Y    D+WSIGV  Y    GS PF      R    +   ++   P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 371 N-----------------FDDLPWPSVSPEAKD----FVKRLLNKDYRKRMTAVQALSKL 409
           +                  D     S+S   +      +  +L  D  K     Q     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF-AE 303

Query: 410 VVPILSFKIV 419
              IL     
Sbjct: 304 TSDILHRGNS 313

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  254 bits (650), Expect = 3e-82
 Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 30/300 (10%)

Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
                    + +  F      G  Y + K++G G          +K     Q  A+K ++
Sbjct: 6   HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVN 61

Query: 185 KAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRIL 243
             +     +++  R E+  L  L  H   +++  D       +Y+VME C   +L    L
Sbjct: 62  LEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS-WL 118

Query: 244 ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
            +       + K+    +L  V   H  G+VH DLKP NFL   G     ++LIDFG+++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIAN 174

Query: 304 FIRPDER---LNDIVGSAYYVAPEVLHRS------------YSLEADIWSIGVISYILLC 348
            ++PD      +  VG+  Y+ PE +                S ++D+WS+G I Y +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 349 GSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           G  PF           A++  +   +         + +D +K  L +D ++R++  + L+
Sbjct: 235 GKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  256 bits (656), Expect = 5e-82
 Identities = 65/310 (20%), Positives = 116/310 (37%), Gaps = 46/310 (14%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + L   +G+G   +    R KK        A+K+ +         ++   RE ++LK L+
Sbjct: 11  WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN 65

Query: 209 GHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSV 264
            HK++VK     E+    +  ++ME C  G L   +          E +   ++  ++  
Sbjct: 66  -HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
           +      G+VHR++KP N +   G D  +  +L DFG +  +  DE+   + G+  Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 324 EVL---------HRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDP 370
           ++           + Y    D+WSIGV  Y    GS PF      R    +   ++   P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 371 N-----------------FDDLPWPSVSPEAKD----FVKRLLNKDYRKRMTAVQALSKL 409
           +                  D     S+S   +      +  +L  D  K     Q     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF-AE 303

Query: 410 VVPILSFKIV 419
              IL   ++
Sbjct: 304 TSDILHRMVI 313

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  253 bits (649), Expect = 1e-81
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 30/279 (10%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y + K++G G          +K ++     A+K ++  +     +++  R E+  L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 62

Query: 206 ALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            L  H   +++  D       +Y+VME C   +L    L +       + K+    +L  
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS-WLKKKKSIDPWERKSYWKNMLEA 120

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYV 321
           V   H  G+VH DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 322 APEVLHRS------------YSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRS 368
            PE +                S ++D+WS+G I Y +  G  PF           A++  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           +   +         + +D +K  L +D ++R++  + L+
Sbjct: 237 NHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  252 bits (644), Expect = 2e-80
 Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 34/327 (10%)

Query: 97  PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
           P  S  K   A+  +R     P   T  +++ +    S ++        G  Y + K++G
Sbjct: 12  PRGSGMKETAAAKFERQHMDSPDLGTDDDDKAS---SSANECISVK---GRIYSILKQIG 65

Query: 157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVK 215
            G          +K ++     A+K ++  +     +++  R E+  L  L  H   +++
Sbjct: 66  SGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 216 FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVH 275
             D       +Y+VME C   +L   +  +       + K+    +L  V   H  G+VH
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLHRS--- 329
            DLKP NFL   G     ++LIDFG+++ ++PD      +  VG+  Y+ PE +      
Sbjct: 179 SDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 330 ---------YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
                     S ++D+WS+G I Y +  G  PF       I +     DPN +       
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIP 293

Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALS 407
             + +D +K  L +D ++R++  + L+
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLA 320

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  246 bits (631), Expect = 1e-79
 Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 20/266 (7%)

Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
            +     +Y  G+ +G+G F               +  A KI+ K+ +      E +  E
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           + I ++L+ H+H+V F    ED + V++V+ELC    LL+    R    TE +A+  + Q
Sbjct: 66  ISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQ 123

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFI-RPDERLNDIVGS 317
           I+    + H   V+HRDLK  N        + D+ +   DFGL+  +    ER   + G+
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFL-----NEDLEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
             Y+APEVL  + +S E D+WSIG I Y LL G  PF        +  + ++     +  
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----EYS 233

Query: 377 WPS-VSPEAKDFVKRLLNKDYRKRMT 401
            P  ++P A   ++++L  D   R T
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPT 259

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  245 bits (628), Expect = 3e-79
 Identities = 77/256 (30%), Positives = 136/256 (53%), Gaps = 13/256 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +++G  +G+G F     A          +VA+K+I K  M  A  ++ V+ EVKI   L
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  +++  +  ED N VY+V+E+C  GE+   +  R   ++E +A+  + QI++ + +
Sbjct: 69  K-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEVL 326
            H  G++HRDL   N L T    + ++++ DFGL+  +  P E+   + G+  Y++PE+ 
Sbjct: 128 LHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
              ++ LE+D+WS+G + Y LL G  PF   T       V+ +D      P   +S EAK
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAK 240

Query: 386 DFVKRLLNKDYRKRMT 401
           D + +LL ++   R++
Sbjct: 241 DLIHQLLRRNPADRLS 256

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  246 bits (630), Expect = 7e-79
 Identities = 82/308 (26%), Positives = 133/308 (43%), Gaps = 29/308 (9%)

Query: 99  PSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRG 158
           P+PA   KA +              P      P          +     +Y  G+ +G+G
Sbjct: 2   PAPADPGKAGV---------PGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKG 52

Query: 159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD 218
            F               +  A KI+ K+ +      E +  E+ I ++L+ H+H+V F  
Sbjct: 53  GFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHG 108

Query: 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL 278
             ED + V++V+ELC    LL+    R    TE +A+  + QI+    + H   V+HRDL
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167

Query: 279 KPENFLFTSGRDDADMRL--IDFGLSDFI-RPDERLNDIVGSAYYVAPEVL-HRSYSLEA 334
           K  N        + D+ +   DFGL+  +    ER   + G+  Y+APEVL  + +S E 
Sbjct: 168 KLGNLFL-----NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222

Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKRLLN 393
           D+WSIG I Y LL G  PF        +  + ++     +   P  ++P A   ++++L 
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----EYSIPKHINPVAASLIQKMLQ 277

Query: 394 KDYRKRMT 401
            D   R T
Sbjct: 278 TDPTARPT 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  246 bits (630), Expect = 3e-75
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 35/286 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E+ + +G G FG+      +      +QVA+K   +       + E    E++I+K L
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELSPK--NRERWCLEIQIMKKL 69

Query: 208 SGHKHLVKFCDACEDVNNV------YIVMELCEGGELLDRILARG--GRYTEEDAKAIVV 259
           + H ++V   +  + +  +       + ME CEGG+L   +          E   + ++ 
Sbjct: 70  N-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
            I S + + H   ++HRDLKPEN +   G      ++ID G +  +   E   + VG+  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----- 373
           Y+APE+L  + Y++  D WS G +++  + G RPF    +   +   +R   N       
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 374 ----------DLPWPS-----VSPEAKDFVKRLLNKDYRKRMTAVQ 404
                      LP P+     ++ + + +++ +L    R+R T  Q
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  233 bits (597), Expect = 1e-74
 Identities = 75/260 (28%), Positives = 136/260 (52%), Gaps = 14/260 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E+G+ +G+G FG+   AR K+       +A+K++ KA++  A     +RREV+I   L
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++++      D   VY+++E    G +    L +  ++ E+     + ++ + +++
Sbjct: 67  R-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALSY 124

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH + V+HRD+KPEN L  S     ++++ DFG S    P  R  D+ G+  Y+ PE++ 
Sbjct: 125 CHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIE 180

Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F   P   V+  A+D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARD 236

Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            + RLL  +  +R    + L
Sbjct: 237 LISRLLKHNPSQRPMLREVL 256

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  234 bits (598), Expect = 3e-74
 Identities = 88/256 (34%), Positives = 143/256 (55%), Gaps = 15/256 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y L K +G+G+F     AR     L  ++VA+KII K ++    S++ + REV+I+K L
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKIL 71

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H ++VK  +  E    +Y++ME   GGE+ D ++A G R  E++A++   QI+S V +
Sbjct: 72  N-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQY 129

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
           CH + +VHRDLK EN L  +   D ++++ DFG S+      +L+   G+  Y APE+  
Sbjct: 130 CHQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186

Query: 328 -RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            + Y   E D+WS+GVI Y L+ GS PF  +    +   VLR    +    +  +S + +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTDCE 242

Query: 386 DFVKRLLNKDYRKRMT 401
           + +KR L  +  KR T
Sbjct: 243 NLLKRFLVLNPIKRGT 258

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  228 bits (584), Expect = 1e-72
 Identities = 68/258 (26%), Positives = 133/258 (51%), Gaps = 14/258 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +++G+ +G+G FG+   AR K+       +A+K++ K+++        +RRE++I   L
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++++  +   D   +Y+++E    GEL    L + GR+ E+ +   + ++   + +
Sbjct: 72  R-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHY 129

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH + V+HRD+KPEN L        ++++ DFG S    P  R   + G+  Y+ PE++ 
Sbjct: 130 CHERKVIHRDIKPENLLMGY---KGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIE 185

Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            +++  + D+W  GV+ Y  L G  PF + + +   R ++  D  F   P P +S  +KD
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKD 241

Query: 387 FVKRLLNKDYRKRMTAVQ 404
            + +LL     +R+    
Sbjct: 242 LISKLLRYHPPQRLPLKG 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  227 bits (580), Expect = 4e-72
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 22/262 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++L + +G G +G    A  +   + ++ VAVKI+   +       E++++E+ I K L
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H+++VKF     + N  Y+ +E C GGEL DRI        E DA+    Q+++ V +
Sbjct: 63  N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRP---DERLNDIVGSAYYVA 322
            H  G+ HRD+KPEN L      D    L   DFGL+   R    +  LN + G+  YVA
Sbjct: 121 LHGIGITHRDIKPENLLL-----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 323 PEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPS 379
           PE+L  R +     D+WS G++   +L G  P+   ++S   +             PW  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233

Query: 380 VSPEAKDFVKRLLNKDYRKRMT 401
           +       + ++L ++   R+T
Sbjct: 234 IDSAPLALLHKILVENPSARIT 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  229 bits (586), Expect = 6e-72
 Identities = 54/354 (15%), Positives = 100/354 (28%), Gaps = 63/354 (17%)

Query: 92  FRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYEL 151
           + R      PA  ++A  A           T+         +                +L
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAET--TVDSLLSQGERK---------------LKL 66

Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL---- 207
            + +  G        R  +     +  A+K+ +     +   +E +         L    
Sbjct: 67  VEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 208 -------------------SGHKHLVKFCDACED--VNNVYIVMELCEG-----GELLDR 241
                                     +     +D  V N  ++M             LD 
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 242 ILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301
           +    G         +  Q++ + A    +G+VH    P+N        D  + L D   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVSA 240

Query: 302 SDFIRPDERLNDIVGSAYYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPFWARTE 358
               +   R         Y   E L+ S   ++   + W +G+  Y + C   PF   T 
Sbjct: 241 L--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 359 S--GIFRAVLRSDPNFDDLP---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              G ++      P  D L       +    K  + R LN D R+R+  ++A+ 
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  226 bits (578), Expect = 7e-72
 Identities = 90/256 (35%), Positives = 129/256 (50%), Gaps = 14/256 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y LG  +G G FG       +   L   +VAVKI+++ K+ +   +  ++RE++ LK  
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQ---LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H H++K         + ++VME   GGEL D I   G R  E +A+ +  QILS V +
Sbjct: 69  R-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDY 126

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH   VVHRDLKPEN L  +     + ++ DFGLS+ +   E L    GS  Y APEV+ 
Sbjct: 127 CHRHMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183

Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            R Y+  E DIWS GVI Y LLCG+ PF       +F+ +      F    +  ++    
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRSVA 239

Query: 386 DFVKRLLNKDYRKRMT 401
             +  +L  D  KR T
Sbjct: 240 TLLMHMLQVDPLKRAT 255

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  226 bits (578), Expect = 3e-71
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 22/262 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++L + +G G +G    A  +   + ++ VAVKI+   +       E++++E+ I K L
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H+++VKF     + N  Y+ +E C GGEL DRI        E DA+    Q+++ V +
Sbjct: 63  N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRP---DERLNDIVGSAYYVA 322
            H  G+ HRD+KPEN L      D    L   DFGL+   R    +  LN + G+  YVA
Sbjct: 121 LHGIGITHRDIKPENLLL-----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 323 PEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPS 379
           PE+L  R +     D+WS G++   +L G  P+   ++S   +             PW  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233

Query: 380 VSPEAKDFVKRLLNKDYRKRMT 401
           +       + ++L ++   R+T
Sbjct: 234 IDSAPLALLHKILVENPSARIT 255

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  223 bits (570), Expect = 2e-70
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 41/284 (14%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-------------- 193
           +Y L  E+G+G +G    A  +     +   A+K++SK K+                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNEND---NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 194 ---------IEDVRREVKILKALSGHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRI 242
                    IE V +E+ ILK L  H ++VK  +  +D N  ++Y+V EL   G +++  
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129

Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
                  +E+ A+     ++  + + H Q ++HRD+KP N L      D  +++ DFG+S
Sbjct: 130 --TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE---DGHIKIADFGVS 184

Query: 303 -DFIRPDERLNDIVGSAYYVAPEVL---HRSYS-LEADIWSIGVISYILLCGSRPFWART 357
            +F   D  L++ VG+  ++APE L    + +S    D+W++GV  Y  + G  PF    
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT 401
              +   +      F D   P ++ + KD + R+L+K+   R+ 
Sbjct: 245 IMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIV 286

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  225 bits (575), Expect = 2e-70
 Identities = 84/260 (32%), Positives = 132/260 (50%), Gaps = 18/260 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K++G G+FG     R K   L  + VAVK I +         E+V+RE+   ++L
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDK---LTKELVAVKYIERGAAID----ENVQREIINHRSL 73

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+F +      ++ I+ME   GGEL +RI   G R++E++A+    Q+LS V++
Sbjct: 74  R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSY 131

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH   + HRDLK EN L   G     +++ DFG S       +    VG+  Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFR----AVLRSDPNFDDLPWPSVS 381
            + Y    AD+WS GV  Y++L G+ PF    E   +R     +L    +  D     +S
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--IS 248

Query: 382 PEAKDFVKRLLNKDYRKRMT 401
           PE    + R+   D   R++
Sbjct: 249 PECCHLISRIFVADPATRIS 268

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (569), Expect = 8e-70
 Identities = 80/256 (31%), Positives = 131/256 (51%), Gaps = 15/256 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y + + +G G FG    A         Q+VA+K IS+  +  +     V RE+  LK L
Sbjct: 10  PYIIRETLGEGSFGKVKLATHY---KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H H++K  D      ++ +V+E   GGEL D I+ +  R TE++ +    QI+  + +
Sbjct: 67  R-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEY 123

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH   +VHRDLKPEN L      + ++++ DFGLS+ +     L    GS  Y APEV+ 
Sbjct: 124 CHRHKIVHRDLKPENLLLDD---NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
            + Y+  E D+WS G++ Y++L G  PF       +F+ V      +    +  +SP A+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQ 236

Query: 386 DFVKRLLNKDYRKRMT 401
             ++R++  D  +R+T
Sbjct: 237 SLIRRMIVADPMQRIT 252

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  222 bits (567), Expect = 9e-70
 Identities = 68/299 (22%), Positives = 105/299 (35%), Gaps = 18/299 (6%)

Query: 113 LGGGKPKESTIPEERGTEPEQSLDKSFGYNKN---FGAKYELGKEVGRGHFGHTCSARGK 169
                  +      RG   E      +  ++    F   ++    +G G +G     R K
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
           +     +  AVK                  EV   + +  H   V+   A E+   +Y+ 
Sbjct: 80  ED---GRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135

Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
            ELC G  L     A G    E      +   L  +A  H QG+VH D+KP N       
Sbjct: 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP-- 192

Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCG 349
                +L DFGL   +          G   Y+APE+L  SY   AD++S+G+    + C 
Sbjct: 193 -RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACN 251

Query: 350 -SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              P        + +  L   P F       +S E +  +  +L  D + R TA   L+
Sbjct: 252 MELPHGGEGWQQLRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  220 bits (563), Expect = 1e-69
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            YE+   +G G +G     R K      + +  K +    MT A   + +  EV +L+ L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62

Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQIL 262
             H ++V++ D   D  N  +YIVME CEGG+L   I           EE    ++ Q+ 
Sbjct: 63  K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 263 SVVAFCH-----LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVG 316
             +  CH        V+HRDLKP N          +++L DFGL+  +  D       VG
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 317 SAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           + YY++PE +   SY+ ++DIWS+G + Y L     PF A ++  +   +          
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---- 234

Query: 376 PWPSV-SPEAKDFVKRLLNKDYRKRMTAVQALS 407
             P   S E  + + R+LN     R +  + L 
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  221 bits (566), Expect = 2e-69
 Identities = 80/262 (30%), Positives = 115/262 (43%), Gaps = 26/262 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-----VRREVK 202
           KY     +G G FG   +A  K    K+++V VK I K K+     IED     V  E+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMEL-CEGGELLDRILARGGRYTEEDAKAIVVQI 261
           IL  +  H +++K  D  E+     +VME    G +L   I     R  E  A  I  Q+
Sbjct: 82  ILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQL 139

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           +S V +  L+ ++HRD+K EN +      D  ++LIDFG + ++   +      G+  Y 
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAE---DFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196

Query: 322 APEVLH-RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           APEVL    Y   E ++WS+GV  Y L+    PF    E     A +   P         
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--TVEAAIH-PPYL------- 246

Query: 380 VSPEAKDFVKRLLNKDYRKRMT 401
           VS E    V  LL     +R T
Sbjct: 247 VSKELMSLVSGLLQPVPERRTT 268

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  226 bits (577), Expect = 2e-69
 Identities = 95/261 (36%), Positives = 136/261 (52%), Gaps = 24/261 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y LG  +G G FG     + +   L   +VAVKI+++ K+ +   +  +RRE++ LK  
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHE---LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H H++K        +++++VME   GGEL D I   G R  E++++ +  QILS V +
Sbjct: 74  R-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDY 131

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
           CH   VVHRDLKPEN L      DA M  ++ DFGLS+ +   E L    GS  Y APEV
Sbjct: 132 CHRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

Query: 326 L-HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSV 380
           +  R Y+  E DIWS GVI Y LLCG+ PF       +F+ +       P +       +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------L 239

Query: 381 SPEAKDFVKRLLNKDYRKRMT 401
           +P     +K +L  D  KR T
Sbjct: 240 NPSVISLLKHMLQVDPMKRAT 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  218 bits (557), Expect = 3e-68
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 31/293 (10%)

Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
            +    P    T P    D+     + F A+Y LG  +G+G FG   +           Q
Sbjct: 7   LQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFGTVFAGHRL---TDRLQ 58

Query: 178 VAVKIISKAKMTTAISIED---VRREVKILKALS---GHKHLVKFCDACEDVNNVYIVME 231
           VA+K+I + ++     + D      EV +L  +    GH  +++  D  E      +V+E
Sbjct: 59  VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118

Query: 232 L-CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
                 +L D I  +G    E  ++    Q+++ +  CH +GVVHRD+K EN L      
Sbjct: 119 RPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--R 175

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYS-LEADIWSIGVISYILLC 348
               +LIDFG    +  DE   D  G+  Y  PE +    Y  L A +WS+G++ Y ++C
Sbjct: 176 RGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT 401
           G  PF    +  I  A L         P   VSP+    ++R L      R +
Sbjct: 235 GDIPF--ERDQEILEAELH-------FP-AHVSPDCCALIRRCLAPKPSSRPS 277

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  218 bits (558), Expect = 5e-68
 Identities = 62/333 (18%), Positives = 123/333 (36%), Gaps = 55/333 (16%)

Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
           P  S             L+K       +   Y + + + +G F      +    E  ++ 
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFN-----KIILCEKDNKF 56

Query: 178 VAVKIISKA--------------KMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223
            A+K   K+              K++     +D + E++I+  +  +++ +       + 
Sbjct: 57  YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNY 115

Query: 224 NNVYIVMELCEGGELLDRILARG-------GRYTEEDAKAIVVQILSVVAFCHLQ-GVVH 275
           + VYI+ E  E   +L                   +  K I+  +L+  ++ H +  + H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175

Query: 276 RDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS---Y 330
           RD+KP N L      D + R+   DFG S+    D+++    G+  ++ PE         
Sbjct: 176 RDVKPSNILM-----DKNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPEFFSNESSYN 229

Query: 331 SLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNF---------------DD 374
             + DIWS+G+  Y++     PF    +   +F  +   +  +                 
Sbjct: 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                +S E  DF+K  L K+  +R+T+  AL 
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  218 bits (558), Expect = 5e-68
 Identities = 70/264 (26%), Positives = 132/264 (50%), Gaps = 16/264 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G FG     +  +     +Q  +K I+ ++M++    E+ RREV +L  +
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLANM 80

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVA 266
             H ++V++ ++ E+  ++YIVM+ CEGG+L  RI A+ G    E+      VQI   + 
Sbjct: 81  K-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEV 325
             H + ++HRD+K +N   T    D  ++L DFG++  +    E     +G+ YY++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPE 383
             ++ Y+ ++DIW++G + Y L      F A +   +   ++         P     S +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYD 252

Query: 384 AKDFVKRLLNKDYRKRMTAVQALS 407
            +  V +L  ++ R R +    L 
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILE 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  216 bits (552), Expect = 2e-67
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 24/267 (8%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED---VR 198
            +   ++Y++G  +G G FG   S         +  VA+K + K +++    + +   V 
Sbjct: 38  KEPLESQYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVP 94

Query: 199 REVKILKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKA 256
            EV +LK +S G   +++  D  E  ++  +++E  E   +L D I  RG    EE A++
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARS 153

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
              Q+L  V  CH  GV+HRD+K EN L     +  +++LIDFG    +  D    D  G
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALL-KDTVYTDFDG 210

Query: 317 SAYYVAPEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           +  Y  PE + +  Y    A +WS+G++ Y ++CG  PF    +  I R  +        
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVF------- 261

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMT 401
                VS E +  ++  L      R T
Sbjct: 262 FR-QRVSSECQHLIRWCLALRPSDRPT 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  214 bits (546), Expect = 4e-67
 Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 40/284 (14%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
           +K FG  ++  + +G G FG    A+ +      +   +K +           E   REV
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREV 55

Query: 202 KILKALSGHKHLVKFCDACEDV----------------NNVYIVMELCEGGELLDRILAR 245
           K L  L  H ++V +    +                    ++I ME C+ G L   I  R
Sbjct: 56  KALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 246 GGRY-TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
            G    +  A  +  QI   V + H + +++RDLKP N       D   +++ DFGL   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTS 171

Query: 305 IRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
           ++ D +     G+  Y++PE +  + Y  E D++++G+I   LL      +  ++     
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----- 226

Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               +D     +       + K  +++LL+K    R    + L 
Sbjct: 227 --FFTDLRDGIIS-DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  213 bits (544), Expect = 2e-66
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 24/265 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKA 206
           KY +G  +G G +G               + AVKI+ K K+    + E  V++E+++L+ 
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 207 LSGHKHLVKFCD--ACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQIL 262
           L  HK++++  D    E+   +Y+VME C  G  E+LD +     R+    A     Q++
Sbjct: 63  LR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLI 119

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAY 319
             + + H QG+VH+D+KP N L T+      +++   G++        D+      GS  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 320 YVAPEVL--HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
           +  PE+     ++S  + DIWS GV  Y +  G  PF       +F  + +        P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI---P 233

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMT 401
                P   D +K +L  +  KR +
Sbjct: 234 -GDCGPPLSDLLKGMLEYEPAKRFS 257

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  213 bits (543), Expect = 1e-65
 Identities = 45/303 (14%), Positives = 94/303 (31%), Gaps = 60/303 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
               G  +G+        A  ++     +   V +    +   + +I+ ++ EV  L+ L
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130

Query: 208 SGHKHL--------------------------VKFCDACEDVNNVYIVMELCEG-----G 236
            G K+                           V+  +    V + + +    +      G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190

Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           E+L    +            + +Q++ ++A  H  G+VH  L+P + +         + L
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFL 247

Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS------------YSLEADIWSIGVISY 344
             F        D        S  +  PE+  R              +   D W++G++ Y
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
            + C   P       G    + RS  N        +    +  ++  L      R+  +Q
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQ 356

Query: 405 ALS 407
           A+ 
Sbjct: 357 AME 359

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  206 bits (526), Expect = 9e-64
 Identities = 76/311 (24%), Positives = 137/311 (44%), Gaps = 20/311 (6%)

Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
           + +    P     +P+++L    GYN    A + + K++GRG F     A          
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRAACLLD---GV 58

Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
            VA+K +    +  A +  D  +E+ +LK L+ H +++K+  +  + N + IV+EL + G
Sbjct: 59  PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117

Query: 237 ELLDRI---LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
           +L   I     +     E       VQ+ S +   H + V+HRD+KP N   T+      
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGV 174

Query: 294 MRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR 351
           ++L D GL  F        + +VG+ YY++PE +    Y+ ++DIWS+G + Y +     
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234

Query: 352 PFWARTES--GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS-- 407
           PF+    +   + + + + D  +  LP    S E +  V   +N D  KR          
Sbjct: 235 PFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292

Query: 408 KLVVPILSFKI 418
           K +    +  +
Sbjct: 293 KRMHACTASSL 303

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  204 bits (520), Expect = 1e-62
 Identities = 56/287 (19%), Positives = 103/287 (35%), Gaps = 36/287 (12%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
              Y   +++G G F +     G          A+K I   +       E+ +RE  + +
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHR 81

Query: 206 ALSGHKHLVKFCDACED----VNNVYIVMELCEGGELLDRI---LARGGRYTEEDAKAIV 258
               H ++++    C       +  ++++   + G L + I     +G   TE+    ++
Sbjct: 82  LF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD---------- 308
           + I   +   H +G  HRDLKP N L     D+    L+D G  +               
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESG--IF 362
           +       +  Y APE+     H       D+WS+G + Y ++ G  P+    + G  + 
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
            AV            P  S      +  ++  D  +R      LS+L
Sbjct: 258 LAVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  198 bits (505), Expect = 8e-61
 Identities = 83/287 (28%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E  + +GRG FG    A+ K     D   A+K I       A   E V REVK L  L
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKALAKL 60

Query: 208 SGHKHLVKFCDACEDVNN------------VYIVMELCEGGELLDRILARGGRYTEEDAK 255
             H  +V++ +A  + N             +YI M+LC    L D +  R      E + 
Sbjct: 61  E-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 256 A--IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS----------- 302
              I +QI   V F H +G++HRDLKP N  FT    D  +++ DFGL            
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 303 --DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES 359
               +    R    VG+  Y++PE +H  SYS + DI+S+G+I + LL    PF  + E 
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233

Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                 +R +  F  L      P     V+ +L+    +R  A+  +
Sbjct: 234 VRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINII 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  195 bits (498), Expect = 4e-59
 Identities = 47/285 (16%), Positives = 98/285 (34%), Gaps = 30/285 (10%)

Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
              +   +G G F   +  +          Q+  +K+   A            + ++ LK
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLK 122

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI----LARGGRYTEEDAKAIVVQI 261
                   +KF  A    N   +V EL   G LL+ I            +    +  +++
Sbjct: 123 PSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--------RLIDFGLSDFIR---PDER 310
           L ++   H   ++H D+KP+NF+  +G  + D          LID G S  ++       
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 311 LNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
                 ++ +   E+L ++ ++ + D + +    Y +L G+               L   
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL 414
               D+ W        +F   +LN      + ++  L + +  + 
Sbjct: 302 LPHLDM-W-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  191 bits (486), Expect = 1e-57
 Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 45/293 (15%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
             +  + + +  G F     A+        ++ A+K +   +         + +EV  +K
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMK 80

Query: 206 ALSGHKHLVKFCDACEDVNN--------VYIVMELCEGGELLDRILAR--GGRYTEEDAK 255
            LSGH ++V+FC A                ++ ELC+G  L++ +      G  + +   
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVL 139

Query: 256 AIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----- 308
            I  Q    V   H Q   ++HRDLK EN L +   +   ++L DFG +  I        
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSW 196

Query: 309 --------ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
                   E       +  Y  PE++    +     + DIW++G I Y+L     PF   
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--- 253

Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
            E G    ++     +   P  +        ++ +L  +  +R++  + + +L
Sbjct: 254 -EDGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  183 bits (466), Expect = 5e-55
 Identities = 53/285 (18%), Positives = 114/285 (40%), Gaps = 36/285 (12%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
            +  ++   +++G G FG       +  G +     A+K   K    +    ++  REV 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCI----YAIKRSKKPLAGSV-DEQNALREVY 62

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVV 259
               L  H H+V++  A  + +++ I  E C GG L D I         + E + K +++
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFT----------------SGRDDADMRLIDFGLSD 303
           Q+   + + H   +VH D+KP N   +                   +    ++ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV- 181

Query: 304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI 361
                       G + ++A EVL    ++  +ADI+++  ++ +   G+ P     +   
Sbjct: 182 --TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ-- 236

Query: 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           +  + +       +P   +S E  + +K +++ D  +R +A+  +
Sbjct: 237 WHEIRQG--RLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALV 278

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  182 bits (463), Expect = 2e-54
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 21/290 (7%)

Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAK-YELGKEVGRGHFGHTCSARGKKGELKDQQV 178
           + T  E R         +     +    + ++ GK +G G F     AR        ++ 
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58

Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
           A+KI+ K  +     +  V RE  ++  L  H   VK     +D   +Y  +   + GEL
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117

Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--RL 296
           L   + + G + E   +    +I+S + + H +G++HRDLKPEN L      + DM  ++
Sbjct: 118 LKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-----NEDMHIQI 171

Query: 297 IDFGLS---DFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP 352
            DFG +          R N  VG+A YV+PE+L        +D+W++G I Y L+ G  P
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

Query: 353 FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
           F A  E  IF+ +++ + +F   P     P+A+D V++LL  D  KR+  
Sbjct: 232 FRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGC 277

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  179 bits (456), Expect = 2e-52
 Identities = 53/375 (14%), Positives = 115/375 (30%), Gaps = 69/375 (18%)

Query: 81  SPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQS-----L 135
           S  R +     + + F    P   +   L  R+     + ++   +   +   S      
Sbjct: 8   SSGRENL----YFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNT 63

Query: 136 DKSFGYNKNFGAKYEL---GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI 192
            + F      G +      G  +G+        A  ++     +   V +    +   + 
Sbjct: 64  GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSN 120

Query: 193 SIEDVRREVKILKALSGHKHL--------------------------VKFCDACEDVNNV 226
           +I+ ++ EV  L+ L G K+                           V+  +    V + 
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180

Query: 227 YIVMELCEG-----GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
           + +    +      GE+L    +            + +Q++ ++A  H  G+VH  L+P 
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240

Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY----YVAPEVLHRS------YS 331
           + +         + L  F     +R        +G  +      A  +L          +
Sbjct: 241 DIVLD---QRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
              D W++G+  Y + C   P       G    + RS  N        +    +  ++  
Sbjct: 296 FAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGF 347

Query: 392 LNKDYRKRMTAVQAL 406
           L      R+  +QA+
Sbjct: 348 LRYPKEDRLLPLQAM 362

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  171 bits (436), Expect = 4e-50
 Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 31/323 (9%)

Query: 97  PPPSPAKHIKASLAK--RLGGGKPKEST--IPEERGTEPEQSLDKSFGYNKNFGAKYELG 152
              S   H  ASLAK    G  K +       +  G    + L       +         
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63

Query: 153 KEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVR-REVKILKALSGH 210
             VGRG FG     + K+ G       AVK +          +E  R  E+     LS  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQ----CAVKKVR---------LEVFRVEELVACAGLS-S 109

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
             +V    A  +   V I MEL EGG L   ++ + G   E+ A   + Q L  + + H 
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE------RLNDIVGSAYYVAPE 324
           + ++H D+K +N L +S  D +   L DFG +  ++PD         + I G+  ++APE
Sbjct: 169 RRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           V+       + DIWS   +   +L G  P+       +   +    P   ++P PS +P 
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPL 285

Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
               ++  L K+   R +A++  
Sbjct: 286 TAQAIQEGLRKEPVHRASAMELR 308

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  170 bits (433), Expect = 4e-49
 Identities = 65/261 (24%), Positives = 128/261 (49%), Gaps = 25/261 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALS 208
           E+ + +G+G FG  C  +        +++ A+K ++K K      + +V +E++I++ L 
Sbjct: 18  EILRAIGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV    + +D  ++++V++L  GG+L    L +   + EE  K  + +++  + + 
Sbjct: 74  -HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYL 131

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
             Q ++HRD+KP+N L      D    + + DF ++  +  + ++  + G+  Y+APE+ 
Sbjct: 132 QNQRIIHRDMKPDNILL-----DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186

Query: 327 HRS----YSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNFDDLPWPS 379
                  YS   D WS+GV +Y LL G RP+  R+ +    I      +   +   P  +
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SA 242

Query: 380 VSPEAKDFVKRLLNKDYRKRM 400
            S E    +K+LL  +  +R 
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRF 263

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  165 bits (419), Expect = 4e-48
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 33/298 (11%)

Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVA 179
           S    E G      L+  + Y++N          +G+G +G   + R           +A
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDEN-----GDRVVLGKGTYGIVYAGRDLSNQVR----IA 51

Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
           +K I +         + +  E+ + K L  HK++V++  +  +   + I ME   GG L 
Sbjct: 52  IKEIPERDSR---YSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107

Query: 240 DRILARGGR--YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
             + ++ G     E+       QIL  + + H   +VHRD+K +N L  +      +++ 
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKIS 165

Query: 298 DFGLSDFI-RPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIG--VISYILLCGSR 351
           DFG S  +   +       G+  Y+APE++    R Y   ADIWS+G  +I   +  G  
Sbjct: 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE--MATGKP 223

Query: 352 PFWARTE--SGIFR-AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
           PF+   E  + +F+  + +  P   +    S+S EAK F+ +    D  KR  A   L
Sbjct: 224 PFYELGEPQAAMFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLL 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  166 bits (422), Expect = 7e-48
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 22/291 (7%)

Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAK---YELGKEVGRGHFGHTCSARGKKG 171
             K  E    +E   + ++   K +       A+   ++  K +G G FG     + K+ 
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE- 64

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
                  A+KI+ K K+     IE    E +IL+A++    LVK   + +D +N+Y+VME
Sbjct: 65  --SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVME 121

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
              GGE+    L R GR++E  A+    QI+    + H   +++RDLKPEN L      D
Sbjct: 122 YVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-----D 175

Query: 292 AD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLC 348
               +++ DFG +   R   R   + G+   +APE++    Y+   D W++GV+ Y +  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           G  PF+A     I+  ++     F   P    S + KD ++ LL  D  KR
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKR 280

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  160 bits (406), Expect = 6e-46
 Identities = 62/255 (24%), Positives = 122/255 (47%), Gaps = 19/255 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ + +G G FG     R +      +  A+K++ K  +     +E    E  +L  ++
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  +++     +D   ++++M+  EGGEL    L +  R+    AK    ++   + + 
Sbjct: 65  -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           H + +++RDLKPEN L      D +  +++ DFG +      +    + G+  Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILL-----DKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVV 175

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
               Y+   D WS G++ Y +L G  PF+       +  +L ++  F   P P  + + K
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVK 231

Query: 386 DFVKRLLNKDYRKRM 400
           D + RL+ +D  +R+
Sbjct: 232 DLLSRLITRDLSQRL 246

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  161 bits (409), Expect = 2e-45
 Identities = 80/268 (29%), Positives = 126/268 (47%), Gaps = 29/268 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG F      + K+     Q  A+KI++K  M     +   R E  +L    
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNG 118

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
             + + +   A +D N +Y+VME   GG+LL  +   G R   E A+  + +I+  +   
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
           H  G VHRD+KP+N L      D    +RL DFG    +R D   R    VG+  Y++PE
Sbjct: 179 HRLGYVHRDIKPDNILL-----DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

Query: 325 VLHR--------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
           +L          SY  E D W++GV +Y +  G  PF+A + +  +  ++      + L 
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---EHLS 290

Query: 377 WPS----VSPEAKDFVKRLLNKDYRKRM 400
            P     V  EA+DF++RLL      R+
Sbjct: 291 LPLVDEGVPEEARDFIQRLLCPP-ETRL 317

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  158 bits (401), Expect = 4e-45
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 55/299 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y+L +++GRG +     A        +++V VKI+   K           RE+KIL+ L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------REIKILENL 87

Query: 208 SGHKHLVKFCDACEDVNN---VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            G  +++   D  +D  +     +   +        ++       T+ D +  + +IL  
Sbjct: 88  RGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLY---QTLTDYDIRFYMYEILKA 142

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           + +CH  G++HRD+KP N +     +   +RLID+GL++F  P +  N  V S Y+  PE
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200

Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPF-------------------------WART 357
           +L  ++ Y    D+WS+G +   ++    PF                           + 
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260

Query: 358 ESGIFRAVLRSDPNFDDLPW---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              +               W           VSPEA DF+ +LL  D++ R+TA +A+ 
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  158 bits (401), Expect = 7e-45
 Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 18/276 (6%)

Query: 131 PEQSLDKSFGYNKNFGAKY-----ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
           P++S  +  G   N   +      E  + +G+G FG    AR K+        AVK++ K
Sbjct: 2   PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKK 58

Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
             +     +E    E +IL     H  L +     +  + ++ VME   GG+L+  I  +
Sbjct: 59  DVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QK 117

Query: 246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DF 304
             R+ E  A+    +I+S + F H +G+++RDLK +N L      +   +L DFG+  + 
Sbjct: 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCKEG 174

Query: 305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
           I          G+  Y+APE+L    Y    D W++GV+ Y +LCG  PF A  E  +F 
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           A+L  +  +   P   +  +A   +K  + K+   R
Sbjct: 235 AILNDEVVY---P-TWLHEDATGILKSFMTKNPTMR 266

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  160 bits (406), Expect = 7e-45
 Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 20/258 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+ K +GRG FG     + K     D+  A+KI++K +M         R E  +L    
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
             K +     A +D NN+Y+VM+   GG+LL  +     R  EE A+  + +++  +   
Sbjct: 133 -SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
           H    VHRD+KP+N L      D +  +RL DFG    +  D   + +  VG+  Y++PE
Sbjct: 192 HQLHYVHRDIKPDNILM-----DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 325 VL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           +L         Y  E D WS+GV  Y +L G  PF+A +    +  ++     F      
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 379 S-VSPEAKDFVKRLLNKD 395
           + VS  AKD ++RL+   
Sbjct: 307 TDVSENAKDLIRRLICSR 324

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  159 bits (405), Expect = 7e-45
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 23/262 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
           YE+ K +GRG FG     R K      ++V A+K++SK +M           E  I+ A 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKS----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AF 125

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    +V+   A +D   +Y+VME   GG+L+   L       E+ A+    +++  +  
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV--NLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAP 323
            H  G +HRD+KP+N L      D    ++L DFG    +  +   R +  VG+  Y++P
Sbjct: 184 IHSMGFIHRDVKPDNMLL-----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

Query: 324 EVL-----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
           EVL        Y  E D WS+GV  Y +L G  PF+A +  G +  ++    +       
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298

Query: 379 SVSPEAKDFVKRLLNKDYRKRM 400
            +S EAK+ +   L  D   R+
Sbjct: 299 DISKEAKNLICAFL-TDREVRL 319

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  156 bits (397), Expect = 2e-44
 Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 21/257 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +     +G+G FG    +  K     D+  AVKI+ K  +     +E    E ++L    
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
               L     C    D   +Y VME   GG+L+  I  + GR+ E  A     +I   + 
Sbjct: 79  KPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLF 135

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
           F   +G+++RDLK +N +      D++  +++ DFG+  + I          G+  Y+AP
Sbjct: 136 FLQSKGIIYRDLKLDNVML-----DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           E++    Y    D W+ GV+ Y +L G  PF    E  +F++++  +  +   P  S+S 
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSK 246

Query: 383 EAKDFVKRLLNKDYRKR 399
           EA    K L+ K   KR
Sbjct: 247 EAVAICKGLMTKHPGKR 263

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  162 bits (412), Expect = 3e-44
 Identities = 83/404 (20%), Positives = 153/404 (37%), Gaps = 16/404 (3%)

Query: 1   MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
           +   Y K     +  + +   T T+  S N                  + +         
Sbjct: 192 LSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLT 251

Query: 61  WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK- 119
             + +   +S        +          +     F  P P +  + +   R    + K 
Sbjct: 252 SRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKI 311

Query: 120 --ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
              +  PEE+        D +   ++     +     +G+G FG    +  K     D+ 
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDEL 368

Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
            AVKI+ K  +     +E    E ++L        L +     + ++ +Y VME   GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428

Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
           L+  I  + GR+ E  A     +I   + F   +G+++RDLK +N +  S   +  +++ 
Sbjct: 429 LMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EGHIKIA 484

Query: 298 DFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA 355
           DFG+  + I          G+  Y+APE++    Y    D W+ GV+ Y +L G  PF  
Sbjct: 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

Query: 356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
             E  +F++++  +  +   P  S+S EA    K L+ K   KR
Sbjct: 545 EDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKR 584

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  155 bits (395), Expect = 3e-44
 Identities = 72/255 (28%), Positives = 124/255 (48%), Gaps = 16/255 (6%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-SIEDVRREVKILKALS 208
           EL + +G+G +G     R   G    +  A+K++ KA +          + E  IL+ + 
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  +V    A +    +Y+++E   GGEL  + L R G + E+ A   + +I   +   
Sbjct: 80  -HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHL 137

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
           H +G+++RDLKPEN +      +    ++L DFGL  + I      +   G+  Y+APE+
Sbjct: 138 HQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 326 LHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L RS ++   D WS+G + Y +L G+ PF           +L+   N    P P ++ EA
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEA 248

Query: 385 KDFVKRLLNKDYRKR 399
           +D +K+LL ++   R
Sbjct: 249 RDLLKKLLKRNAASR 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  156 bits (396), Expect = 3e-44
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 17/255 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + L K +G+G FG    A  KK    +Q  A+K + K  +     +E    E ++L    
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L       +   N++ VME   GG+L+  I     ++    A     +I+  + F 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 134

Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
           H +G+V+RDLK +N L      D D  +++ DFG+  + +  D + N   G+  Y+APE+
Sbjct: 135 HSKGIVYRDLKLDNILL-----DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
           L    Y+   D WS GV+ Y +L G  PF  + E  +F ++   +P +   P   +  EA
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEA 245

Query: 385 KDFVKRLLNKDYRKR 399
           KD + +L  ++  KR
Sbjct: 246 KDLLVKLFVREPEKR 260

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  155 bits (394), Expect = 4e-44
 Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 20/256 (7%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDV--RREVKILKAL 207
           EL K +G+G FG     +   G    Q  A+K++ KA +      + V  + E  IL  +
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVEV 83

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H  +VK   A +    +Y++++   GG+L  R L++   +TEED K  + ++   +  
Sbjct: 84  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDH 141

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPE 324
            H  G+++RDLKPEN L      D +  ++L DFGLS + I  +++     G+  Y+APE
Sbjct: 142 LHSLGIIYRDLKPENILL-----DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           V++R  ++  AD WS GV+ + +L G+ PF  +        +L++       P   +SPE
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPE 252

Query: 384 AKDFVKRLLNKDYRKR 399
           A+  ++ L  ++   R
Sbjct: 253 AQSLLRMLFKRNPANR 268

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  155 bits (394), Expect = 4e-44
 Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 25/247 (10%)

Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
           +       +   +++   ++    +++ +   S  K+ V           +YI M+LC  
Sbjct: 87  EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRK 145

Query: 236 GELLDRILARGGRYTEEDAKA--IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
             L D +  R      E      I +QI   V F H +G++HRDLKP N  FT    D  
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDV 202

Query: 294 MRLIDFGLS-------------DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSI 339
           +++ DFGL                +         VG+  Y++PE +H  +YS + DI+S+
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262

Query: 340 GVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           G+I + LL     F  + E       +R +  F  L      P+    V+ +L+    +R
Sbjct: 263 GLILFELLY---SFSTQMERVRIITDVR-NLKFPLLF-TQKYPQEHMMVQDMLSPSPTER 317

Query: 400 MTAVQAL 406
             A   +
Sbjct: 318 PEATDII 324

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 6/89 (6%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
           +   +E  + +GRG FG    A+ K   + D   A+K I         + E V REVK L
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNREL--AREKVMREVKAL 58

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELC 233
             L  H  +V++ +A  +        E+ 
Sbjct: 59  AKLE-HPGIVRYFNAWLETPPEKWQEEMD 86

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (391), Expect = 4e-44
 Identities = 60/288 (20%), Positives = 115/288 (39%), Gaps = 18/288 (6%)

Query: 126 ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
            +  +  + L+       N G   +   E+GRG F         +      +VA   +  
Sbjct: 5   NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQD 61

Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDR 241
            K+T +   +  + E ++LK L  H ++V+F D+ E        + +V EL   G L   
Sbjct: 62  RKLTKS-ERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT- 118

Query: 242 ILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDF 299
            L R      +  ++   QIL  + F H +   ++HRDLK +N   T       +++ D 
Sbjct: 119 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDL 176

Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
           GL+   R       ++G+  ++APE+    Y    D+++ G+    +     P+     +
Sbjct: 177 GLATLKRASFA-KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235

Query: 360 G-IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             I+R V                PE K+ ++  + ++  +R +    L
Sbjct: 236 AQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  152 bits (387), Expect = 1e-42
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 22/294 (7%)

Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKY-----ELGKEVGRGHFGHTCSARGK 169
           G    +          P  +  +      +             K +G+G FG    AR K
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60

Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
               ++   AVK++ K  +      + +  E  +L     H  LV    + +  + +Y V
Sbjct: 61  A---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117

Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
           ++   GGEL    L R   + E  A+    +I S + + H   +V+RDLKPEN L     
Sbjct: 118 LDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---- 172

Query: 290 DDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYI 345
            D+   + L DFGL  + I  +   +   G+  Y+APEVLH+  Y    D W +G + Y 
Sbjct: 173 -DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231

Query: 346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           +L G  PF++R  + ++  +L           P+++  A+  ++ LL KD  KR
Sbjct: 232 MLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKR 281

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  157 bits (399), Expect = 2e-42
 Identities = 78/339 (23%), Positives = 131/339 (38%), Gaps = 34/339 (10%)

Query: 83  ARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG---KPKESTIPEERGTEPEQSLDKS- 138
                            S  +H++  L K+       +P    I +    +  Q   +S 
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169

Query: 139 ----FGYNKNFGAKYELGKE-------VGRGHFGHTCSARGKKGELKDQQVAVKIISKAK 187
               F   KN      L          +GRG FG     R        +  A+K + K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR 226

Query: 188 MTTAISIEDVRREVKILKALSGHKH--LVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
           +           E  +L  +S      +V    A    + +  +++L  GG+L    L++
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQ 285

Query: 246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
            G ++E D +    +I+  +   H + VV+RDLKP N L     +   +R+ D GL+   
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF 342

Query: 306 RPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESG--- 360
              ++ +  VG+  Y+APEVL +  +Y   AD +S+G + + LL G  PF          
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           I R  L            S SPE +  ++ LL +D  +R
Sbjct: 402 IDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRR 436

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  155 bits (394), Expect = 2e-42
 Identities = 80/337 (23%), Positives = 135/337 (40%), Gaps = 33/337 (9%)

Query: 83  ARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYN 142
           A    P+      F         +A     L   +P    +    G  P Q    S  + 
Sbjct: 112 AAYLEPQAQLFCSFLDAETVARARAGAGDGLF--QPLLRAVLAHLGQAPFQEFLDSLYFL 169

Query: 143 KNFGAKY-----------ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA 191
           +    K+              + +GRG FG   + + K      +  A K ++K ++   
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKR 226

Query: 192 ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL---LDRILARGGR 248
              +    E KIL  +   + +V    A E   ++ +VM +  GG++   +  +      
Sbjct: 227 KGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRP 307
           + E  A     QI+S +   H + +++RDLKPEN L     DD ++R+ D GL+ +    
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAG 342

Query: 308 DERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG----IF 362
             +     G+  ++APE+L    Y    D +++GV  Y ++    PF AR E      + 
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           + VL     + D      SP +KDF + LL KD  KR
Sbjct: 403 QRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKR 435

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  150 bits (382), Expect = 3e-42
 Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 22/257 (8%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+   
Sbjct: 7   FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H  L   K+     D   +  VME   GGEL    L+R   +TEE A+    +I+S + 
Sbjct: 64  -HPFLTALKYAFQTHD--RLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALE 119

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
           + H + VV+RD+K EN +      D D  +++ DFGL  + I     +    G+  Y+AP
Sbjct: 120 YLHSRDVVYRDIKLENLML-----DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           EVL    Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F   P  ++SP
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSP 230

Query: 383 EAKDFVKRLLNKDYRKR 399
           EAK  +  LL KD ++R
Sbjct: 231 EAKSLLAGLLKKDPKQR 247

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  150 bits (382), Expect = 4e-42
 Identities = 72/266 (27%), Positives = 129/266 (48%), Gaps = 30/266 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A+K++ K  +     I+ V+ E  + +  S
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H  LV    C   E    ++ V+E   GG+L+   + R  +  EE A+    +I   + 
Sbjct: 68  NHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALN 124

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
           + H +G+++RDLK +N L      D++  ++L D+G+  + +RP +  +   G+  Y+AP
Sbjct: 125 YLHERGIIYRDLKLDNVLL-----DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFW---------ARTESGIFRAVLRSDPNFD 373
           E+L    Y    D W++GV+ + ++ G  PF            TE  +F+ +L       
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 238

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKR 399
             P  S+S +A   +K  LNKD ++R
Sbjct: 239 --P-RSLSVKAASVLKSFLNKDPKER 261

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  150 bits (382), Expect = 5e-42
 Identities = 83/295 (28%), Positives = 143/295 (48%), Gaps = 23/295 (7%)

Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAK-YELGKEVGRGHFGHTCSARGKKGELKDQ 176
                  +    + E       G+ +  G + +EL K +G G +G     R   G    +
Sbjct: 24  DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83

Query: 177 QVAVKIISKAK-MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
             A+K++ KA  +  A + E  R E ++L+ +     LV    A +    ++++++   G
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143

Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-- 293
           GEL    L++  R+TE + +  V +I+  +   H  G+++RD+K EN L      D++  
Sbjct: 144 GELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL-----DSNGH 197

Query: 294 MRLIDFGLS--DFIRPDERLNDIVGSAYYVAPEVLHRS---YSLEADIWSIGVISYILLC 348
           + L DFGLS        ER  D  G+  Y+AP+++      +    D WS+GV+ Y LL 
Sbjct: 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

Query: 349 GSRPFWA----RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
           G+ PF       +++ I R +L+S+P +   P   +S  AKD ++RLL KD +KR
Sbjct: 258 GASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALAKDLIQRLLMKDPKKR 308

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  149 bits (378), Expect = 7e-42
 Identities = 79/263 (30%), Positives = 129/263 (49%), Gaps = 19/263 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
             +   ++G G  G  C AR K      +QVAVK++    +      E +  EV I++  
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY 99

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++V+   +      ++++ME  +GG L D  +    R  EE    +   +L  +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
            H QGV+HRD+K ++ L T    D  ++L DFG    I  D  +   +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
            RS Y+ E DIWS+G I  I +    P +        + R      P   +     VSP 
Sbjct: 214 SRSLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN--SHKVSPV 270

Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
            +DF++R+L +D ++R TA + L
Sbjct: 271 LRDFLERMLVRDPQERATAQELL 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  149 bits (378), Expect = 8e-42
 Identities = 78/302 (25%), Positives = 139/302 (46%), Gaps = 39/302 (12%)

Query: 127 RGTEPEQSLDK-SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
               P +SLD+      ++    +EL + VG G +G     R  K     Q  A+K++  
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD- 58

Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELL 239
               T    E++++E+ +LK  S H+++  +  A          + +++VME C  G + 
Sbjct: 59  ---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 240 DRI-LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
           D I   +G    EE    I  +IL  ++  H   V+HRD+K +N L T   ++A+++L+D
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVD 172

Query: 299 FGLS-DFIRPDERLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYIL----- 346
           FG+S    R   R N  +G+ Y++APEV+        +Y  ++D+WS+G+ +  +     
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

Query: 347 -LCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
            LC   P  A     +F       P      W   S + + F++  L K++ +R    Q 
Sbjct: 233 PLCDMHPMRA-----LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQL 284

Query: 406 LS 407
           + 
Sbjct: 285 MK 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  148 bits (375), Expect = 9e-42
 Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 19/263 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++ +    +      E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQM---NLQQQPKKELIINEILVMREN 74

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             + ++V + D+    + +++VME   GG L D  +       E    A+  + L  + F
Sbjct: 75  K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
            R  Y  + DIWS+G I  I +    P +        ++       P   +     +S  
Sbjct: 189 TRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAI 245

Query: 384 AKDFVKRLLNKDYRKRMTAVQAL 406
            +DF+ R L  D  KR +A + L
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELL 268

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  147 bits (373), Expect = 2e-41
 Identities = 81/271 (29%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E+  E+G G FG    A+ K+        A K+I      +   +ED   E++IL   
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK   A      ++I++E C GG +   +L      TE   + +  Q+L  + F
Sbjct: 74  D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
            H + ++HRDLK  N L T    + D+RL DFG+S       ++ +  +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 327 HR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPW 377
                    Y  +ADIWS+G+    +     P     E    R +L   +SDP    L  
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPP--TLLT 244

Query: 378 PS-VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           PS  S E +DF+K  L+K+   R +A Q L 
Sbjct: 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  149 bits (379), Expect = 3e-41
 Identities = 71/266 (26%), Positives = 129/266 (48%), Gaps = 30/266 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           ++L + +GRG +      R KK    D+  A++++ K  +     I+ V+ E  + +  S
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H  LV    C   E    ++ V+E   GG+L+   + R  +  EE A+    +I   + 
Sbjct: 111 NHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALN 167

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
           + H +G+++RDLK +N L      D++  ++L D+G+  + +RP +  +   G+  Y+AP
Sbjct: 168 YLHERGIIYRDLKLDNVLL-----DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFW---------ARTESGIFRAVLRSDPNFD 373
           E+L    Y    D W++GV+ + ++ G  PF            TE  +F+ +L       
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 281

Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKR 399
             P  S+S +A   +K  LNKD ++R
Sbjct: 282 --P-RSLSVKAASVLKSFLNKDPKER 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  148 bits (375), Expect = 4e-41
 Identities = 66/319 (20%), Positives = 127/319 (39%), Gaps = 24/319 (7%)

Query: 96  FPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEV 155
           +       +   +       G           G+  +  + + F +  +    +   +E+
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELF-FKDDPEKLFSDLREI 62

Query: 156 GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK 215
           G G FG    AR  +     + VA+K +S +   +    +D+ +EV+ L+ L  H + ++
Sbjct: 63  GHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118

Query: 216 FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVH 275
           +       +  ++VME C G    D +        E +  A+    L  +A+ H   ++H
Sbjct: 119 YRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177

Query: 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS----YS 331
           RD+K  N L +   +   ++L DFG +  +      N  VG+ Y++APEV+       Y 
Sbjct: 178 RDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYD 231

Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPWPSVSPEAKDFV 388
            + D+WS+G+    L     P +         A+    +++     L     S   ++FV
Sbjct: 232 GKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESP--ALQSGHWSEYFRNFV 286

Query: 389 KRLLNKDYRKRMTAVQALS 407
              L K  + R T+   L 
Sbjct: 287 DSCLQKIPQDRPTSEVLLK 305

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  150 bits (381), Expect = 4e-41
 Identities = 82/322 (25%), Positives = 142/322 (44%), Gaps = 24/322 (7%)

Query: 90  RFFRRPFPPPSPA---------KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFG 140
               R F   +P          + +   L K+        S  P +     E  +  +  
Sbjct: 82  TVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKP 141

Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
            ++    ++E  K +G+G FG     + K      +  A+KI+ K  +     +     E
Sbjct: 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTE 198

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
            ++L   S H  L     + +  + +  VME   GGEL    L+R   ++E+ A+    +
Sbjct: 199 NRVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAE 256

Query: 261 ILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
           I+S + + H +  VV+RDLK EN +      D  +++ DFGL  + I+    +    G+ 
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
            Y+APEVL  + Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F   P 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P- 369

Query: 378 PSVSPEAKDFVKRLLNKDYRKR 399
            ++ PEAK  +  LL KD ++R
Sbjct: 370 RTLGPEAKSLLSGLLKKDPKQR 391

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  146 bits (372), Expect = 4e-41
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 55/297 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMT-----TAISIEDVRREV 201
           KYE   ++G G +G     R +  G++    VA+K   +++        A+      RE+
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQI----VAIKKFLESEDDPVIKKIAL------REI 53

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           ++LK L  H +LV   +       +++V E C+   +L  +        E   K+I  Q 
Sbjct: 54  RMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT 111

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
           L  V FCH    +HRD+KPEN L T     + ++L DFG +     P +  +D V + +Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168

Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW-ARTE----SGIFRAVL-----RS 368
            +PE+L     Y    D+W+IG +   LL G  P W  +++      I +  L     R 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRK-TLGDLIPRH 226

Query: 369 DPNFDDLPW-------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              F    +                   P++S  A   +K  L+ D  +R+T  Q L
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  152 bits (386), Expect = 4e-41
 Identities = 75/324 (23%), Positives = 131/324 (40%), Gaps = 30/324 (9%)

Query: 95  PFPPPSPAKHIKASLAKRLGGGKPKEST--IPEERGTEPEQSLDKSFGYNKNFGAKY--- 149
           P  P     +    L +       +E T    E     P      S  +N+    K+   
Sbjct: 119 PEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLER 178

Query: 150 --------ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
                      + +G+G FG  C+ + +      +  A K + K ++           E 
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEK 235

Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQ 260
           +IL+ ++  + +V    A E  + + +V+ L  GG+L   I   G   + E  A     +
Sbjct: 236 QILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           I   +   H + +V+RDLKPEN L     D   +R+ D GL+  +   + +   VG+  Y
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351

Query: 321 VAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDL 375
           +APEV+    Y+   D W++G + Y ++ G  PF  R +      + R V      + + 
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE- 410

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKR 399
                SP+A+    +LL KD  +R
Sbjct: 411 ---RFSPQARSLCSQLLCKDPAER 431

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  145 bits (368), Expect = 1e-40
 Identities = 71/283 (25%), Positives = 132/283 (46%), Gaps = 22/283 (7%)

Query: 129 TEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM 188
           +  +  L        +    +   +++G+G FG        +     + VA+KII   + 
Sbjct: 4   SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA 60

Query: 189 TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
                IED+++E+ +L       ++ K+  +      ++I+ME   GG  LD  L   G 
Sbjct: 61  ED--EIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP 115

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
             E     I+ +IL  + + H +  +HRD+K  N L +   +  +++L DFG++  +   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172

Query: 309 -ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL 366
             + N  VG+ +++APEV+ +S Y  +ADIWS+G+ +  L  G  P     E    + + 
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLF 229

Query: 367 ---RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              +++P   +  +   S   K+FV+  LNK+   R TA + L
Sbjct: 230 LIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELL 269

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  144 bits (366), Expect = 2e-40
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 32/280 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YEL + +G G      +A       K ++VA+K I+  K  T  S++++ +E++ +    
Sbjct: 17  YELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCH 71

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD-------RILARGGRYTEEDAKAIVVQI 261
            H ++V +  +    + +++VM+L  GG +LD       +   + G   E     I+ ++
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDI 314
           L  + + H  G +HRD+K  N L     +D  +++ DFG+S       D  R   R    
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR-KTF 186

Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-- 370
           VG+  ++APEV+ +   Y  +ADIWS G+ +  L  G+ P+       +    L++DP  
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246

Query: 371 ----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                 D           +  +   L KD  KR TA + L
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  145 bits (367), Expect = 3e-40
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 19/264 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +++ +++G G +G    A  K+     Q VA+K +          ++++ +E+ I++  
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
               H+VK+  +     +++IVME C  G + D I  R    TE++   I+   L  + +
Sbjct: 82  D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
            H    +HRD+K  N L      +   +L DFG++  +     + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
               Y+  ADIWS+G I+ I +   +P +A       IF       P F        S  
Sbjct: 198 QEIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK--PELWSDN 254

Query: 384 AKDFVKRLLNKDYRKRMTAVQALS 407
             DFVK+ L K   +R TA Q L 
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQ 278

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  144 bits (366), Expect = 1e-39
 Identities = 61/308 (19%), Positives = 112/308 (36%), Gaps = 54/308 (17%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----SIEDVR 198
              + Y + + +  G +G  C+    +G      VA+K +                   +
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74

Query: 199 ---REVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRIL-ARGGRY 249
              RE+++L     H +++   D         ++ +Y+V EL      L +++  +    
Sbjct: 75  RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           + +  +  +  IL  +   H  GVVHRDL P N L      + D+ + DF L+     D 
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTADA 188

Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG------------------ 349
                V   +Y APE++   + ++   D+WS G +   +                     
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248

Query: 350 -----SRPFWARTESGIFRAVLR-SDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKR 399
                         S   R  LR S  N     W    P+  P A D + ++L  + ++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 400 MTAVQALS 407
           ++  QAL 
Sbjct: 309 ISTEQALR 316

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  143 bits (363), Expect = 2e-39
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 61/300 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMT--------TAISIEDVR 198
           KYE    VG G +G     R K  G +    VA+K   K   +         A+      
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRI----VAIK---KFLESDDDKMVKKIAM------ 72

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           RE+K+LK L  H++LV   + C+     Y+V E  +   +LD +         +  +  +
Sbjct: 73  REIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL 130

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGS 317
            QI++ + FCH   ++HRD+KPEN L +       ++L DFG +     P E  +D V +
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGFARTLAAPGEVYDDEVAT 187

Query: 318 AYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW-ARTE----SGIFRAVL---- 366
            +Y APE+L     Y    D+W+IG +   +  G  P +   ++      I    L    
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMM-CLGNLI 245

Query: 367 -RSDPNFDDLPW-------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            R    F+  P                    P +S    D  K+ L+ D  KR    + L
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  142 bits (361), Expect = 6e-39
 Identities = 76/300 (25%), Positives = 135/300 (45%), Gaps = 54/300 (18%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
             +Y+    VG G +G  C+A   K      +VAVK +S+    +  A       RE+++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YRELRL 81

Query: 204 LKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           LK +  H++++   D      + E+ N+VY+V  L      L+ I+ +  + T++  + +
Sbjct: 82  LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQFL 137

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVG 316
           + QIL  + + H   ++HRDLKP N        D +++++DFGL+   R   + +   V 
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGLA---RHTADEMTGYVA 191

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG-----------------------SR 351
           + +Y APE++     Y+   DIWS+G I   LL G                         
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               +  S   R  ++S      + +       +P A D ++++L  D  KR+TA QAL+
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (352), Expect = 1e-38
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 19/214 (8%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALS 208
            L + +G G FG        +      +VAVK          + +IE+VR+E K+   L 
Sbjct: 10  TLEEIIGIGGFGKVY-----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H +++     C    N+ +VME   GG L   +   G R   +      VQI   + + 
Sbjct: 65  -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYL 121

Query: 269 HLQG---VVHRDLKPENFLFTSGRDDADMR-----LIDFGLSDFIRPDERLNDIVGSAYY 320
           H +    ++HRDLK  N L     ++ D+      + DFGL+       +++   G+  +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAW 180

Query: 321 VAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
           +APEV+    +S  +D+WS GV+ + LL G  PF
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  138 bits (350), Expect = 5e-38
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           E+ + VGRG FG  C     K + + + VA+K I           +    E++ L  ++ 
Sbjct: 11  EVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSRVN- 59

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF-- 267
           H ++VK   AC  +N V +VME  EGG L   +L          A    +      +   
Sbjct: 60  HPNIVKLYGAC--LNPVCLVMEYAEGGSL-YNVLHGAEPLPYYTAA-HAMSWCLQCSQGV 115

Query: 268 -----CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
                   + ++HRDLKP N L  +      +++ DFG +  I     + +  GSA ++A
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGTACDI--QTHMTNNKGSAAWMA 171

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
           PEV    +YS + D++S G+I + ++   +PF
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (349), Expect = 9e-38
 Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 34/268 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           E+G+ +G+G FG      G+  GE     VA+++I   +      ++  +REV   +   
Sbjct: 36  EIGELIGKGRFGQVY--HGRWHGE-----VAIRLIDIERDNED-QLKAFKREVMAYRQTR 87

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H+++V F  AC    ++ I+  LC+G  L   +            + I  +I+  + + 
Sbjct: 88  -HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSAYYVA 322
           H +G++H+DLK +N  +    D+  + + DFGL          R +++L    G   ++A
Sbjct: 147 HAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 323 PEVL----------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-PN 371
           PE++             +S  +D++++G I Y L     PF  +    I   +     P 
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP- 261

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
             +L    +  E  D +      +  +R
Sbjct: 262 --NLSQIGMGKEISDILLFCWAFEQEER 287

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  138 bits (351), Expect = 1e-37
 Identities = 80/300 (26%), Positives = 134/300 (44%), Gaps = 55/300 (18%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
              Y     VG G +G  CSA  K+     ++VA+K +S+       A       RE+ +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRA---YRELLL 76

Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           LK +  H++++   D         +  + Y+VM   +    L +I+    +++EE  + +
Sbjct: 77  LKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYL 131

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVG 316
           V Q+L  + + H  GVVHRDLKP N        D +++++DFGL+   R  D  +   V 
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFGLA---RHADAEMTGYVV 185

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG-----------------------SR 351
           + +Y APEV+     Y+   DIWS+G I   +L G                         
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245

Query: 352 PFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            F  +      ++ ++S P      +    P  SP+A D ++++L  D  KR+TA QAL+
Sbjct: 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  137 bits (347), Expect = 1e-37
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 27/272 (9%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
            E   E+GRG +G     R        Q +AVK I     T      + +  ++ I    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDISMRT 62

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
                 V F  A     +V+I MEL +    +   +++ +G    E+    I V I+  +
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 266 AFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
              H +  V+HRD+KP N L  +      +++ DFG+S ++  D   +   G   Y+APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA---LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

Query: 325 VLH-----RSYSLEADIWSIGVISYI-LLCGSRPFWARTESGIFR---AVLRSDPNFDDL 375
            ++     + YS+++DIWS+G I+ I L     P+   +    F+    V+        L
Sbjct: 180 RINPELNQKGYSVKSDIWSLG-ITMIELAILRFPY--DSWGTPFQQLKQVVEEPSP--QL 234

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           P    S E  DF  + L K+ ++R T  + + 
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  139 bits (352), Expect = 1e-37
 Identities = 75/325 (23%), Positives = 140/325 (43%), Gaps = 58/325 (17%)

Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
           S  P   G   ++    ++       A Y   + VG G +G  CSA   +      +VA+
Sbjct: 3   SPPPARSGFYRQEVTKTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAI 55

Query: 181 KIISKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMEL 232
           K + +       A       RE+++LK +  H++++   D        +D  + Y+VM  
Sbjct: 56  KKLYRPFQSELFAKRA---YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPF 111

Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
                 L +++ +  +  E+  + +V Q+L  + + H  G++HRDLKP N        D 
Sbjct: 112 MGTD--LGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DC 165

Query: 293 DMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG 349
           +++++DFGL+   R  D  +   V + +Y APEV+     Y+   DIWS+G I   ++ G
Sbjct: 166 ELKILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

Query: 350 -----------------------SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSP 382
                                     F  R +S   +  ++  P  +   +     + SP
Sbjct: 223 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALS 407
            A + ++++L  D  +R+TA +AL+
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALA 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  136 bits (346), Expect = 2e-37
 Identities = 84/299 (28%), Positives = 137/299 (45%), Gaps = 60/299 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
           KY   +++G G +G    A+   GE      A+K   K ++        +T I      R
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET----FALK---KIRLEKEDEGIPSTTI------R 49

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
           E+ ILK L  H ++VK  D       + +V E  +    +LLD      G      AK+ 
Sbjct: 50  EISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSF 105

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
           ++Q+L+ +A+CH + V+HRDLKP+N L      + ++++ DFGL+  F  P  +    + 
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL---- 366
           + +Y AP+VL   + YS   DIWS+G I   ++ G+  F   +E      IFR +L    
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR-ILGTPN 221

Query: 367 -RSDPNFDDLPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            ++ PN  +LP                    +     D + ++L  D  +R+TA QAL 
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  137 bits (347), Expect = 2e-37
 Identities = 78/309 (25%), Positives = 128/309 (41%), Gaps = 60/309 (19%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G++Y   K +G G  G   SA        D++VA+K I      +        RE+KI++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVKHA---LREIKIIR 63

Query: 206 ALSGHKHLVKFCD--------------ACEDVNNVYIVMELCEGGELLDRILARGGRYTE 251
            L  H ++VK  +              +  ++N+VYIV E  E    L  +L   G   E
Sbjct: 64  RLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQGPLLE 119

Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
           E A+  + Q+L  + + H   V+HRDLKP N    +  +D  +++ DFGL+  + P    
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSH 177

Query: 312 NDI----VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG---------------- 349
                  + + +Y +P +L    +Y+   D+W+ G I   +L G                
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 350 -------SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRK 398
                           S      +R+D      P     P +S EA DF++++L      
Sbjct: 238 LESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 399 RMTAVQALS 407
           R+TA +ALS
Sbjct: 297 RLTAEEALS 305

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  137 bits (346), Expect = 3e-37
 Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 31/275 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
            +   E+GRG +G       K      Q +AVK I   + T      + +  ++ ++   
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRS 77

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL-----ARGGRYTEEDAKAIVVQIL 262
           S   ++V+F  A     + +I MEL       D+              EE    I +  +
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 263 SVVAFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
             +        ++HRD+KP N L        +++L DFG+S   +    +  D  G   Y
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDR---SGNIKLCDFGISGQLVDSIAKTRD-AGCRPY 191

Query: 321 VAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSD-PN 371
           +APE +      + Y + +D+WS+G+  Y L  G  P+     + +F     V++ D P 
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQ 249

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
             +      SP   +FV   L KD  KR    + L
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  136 bits (345), Expect = 3e-37
 Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 28/271 (10%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
            E   E+G G  G     R +K       +AVK +   + +      + +  ++ ++   
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQM---RRSGNKEENKRILMDLDVVLKS 80

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
               ++V+         +V+I MEL              G   E     + V I+  + +
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
              + GV+HRD+KP N L         ++L DFG+S  +  D+  +   G A Y+APE +
Sbjct: 140 LKEKHGVIHRDVKPSNILLDE---RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196

Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---AVLRSDPNF--DDL 375
                    Y + AD+WS+G+    L  G  P+  +     F     VL+ +P      +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHM 254

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
            +   S + + FVK  L KD+RKR    + L
Sbjct: 255 GF---SGDFQSFVKDCLTKDHRKRPKYNKLL 282

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  135 bits (341), Expect = 8e-37
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELK--DQQVAVKII----SKAKMTTAISIEDVRREVKI 203
           E  K++G+G FG        KG L      VA+K +    S+ +       ++ +REV I
Sbjct: 22  EYEKQIGKGGFGLVH-----KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
           +  L+ H ++VK        N   +VME    G+L  R+L +           +++ I  
Sbjct: 77  MSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 264 VVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDERLNDIVGSAY 319
            + +   Q   +VHRDL+  N    S  ++A +     DFGLS        ++ ++G+  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQ 191

Query: 320 YVAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
           ++APE +     SY+ +AD +S  +I Y +L G  PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  134 bits (341), Expect = 1e-36
 Identities = 84/300 (28%), Positives = 128/300 (42%), Gaps = 61/300 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
           KY+  ++VG G +G    A+  +G +    VA+K   + ++        +TAI      R
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRI----VALK---RIRLDAEDEGIPSTAI------R 68

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
           E+ +LK L  H ++V   D       + +V E  E    ++LD          +   K  
Sbjct: 69  EISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIY 124

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
           + Q+L  VA CH   ++HRDLKP+N L      D  ++L DFGL+  F  P       V 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHEVV 181

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL---- 366
           + +Y AP+VL   + YS   DIWSIG I   ++ G   F   T+      IF  +L    
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS-ILGTPN 240

Query: 367 -RSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            R  P   +LP                   P    E  D +  +L  D  KR++A  A++
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  134 bits (339), Expect = 2e-36
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            + +++G G FG        + E     VAVKI+ +        + +  REV I+K L  
Sbjct: 40  NIKEKIGAGSFGTVH-----RAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR- 92

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAF 267
           H ++V F  A     N+ IV E    G L   +   G R    E    ++   +   + +
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 268 CHLQG--VVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDER-LNDIVGSAYYVA 322
            H +   +VHR+LK  N L      D    +   DFGLS              G+  ++A
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV-----DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
           PEVL     + ++D++S GVI + L    +P+
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (337), Expect = 3e-36
 Identities = 61/263 (23%), Positives = 109/263 (41%), Gaps = 29/263 (11%)

Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            +G+ +G G FG     +GK  G+     VAVK+++    T    ++  + EV +L+   
Sbjct: 27  TVGQRIGSGSFGTVY--KGKWHGD-----VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTR 78

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H +++ F         + IV + CEG  L   + A   ++  +    I  Q    + + 
Sbjct: 79  -HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRP---DERLNDIVGSAYYVAP 323
           H + ++HRDLK  N          D  +   DFGL+          +   + GS  ++AP
Sbjct: 137 HAKSIIHRDLKSNNIFL-----HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 324 EVL----HRSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSD--PNFDDLP 376
           EV+       YS ++D+++ G++ Y L+ G  P+        I   V R    P+   + 
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

Query: 377 WPSVSPEAKDFVKRLLNKDYRKR 399
             +     K  +   L K   +R
Sbjct: 252 -SNCPKRMKRLMAECLKKKRDER 273

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  133 bits (336), Expect = 4e-36
 Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 62/301 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
           KYE  +++G G +G    A+ ++  E+    VA+K   + ++        ++A+      
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEI----VALK---RVRLDDDDEGVPSSAL------ 49

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
           RE+ +LK L  HK++V+  D       + +V E C+    +  D      G    E  K+
Sbjct: 50  REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKS 105

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
            + Q+L  + FCH + V+HRDLKP+N L      + +++L +FGL+  F  P    +  V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTE----SGIFRAVL-- 366
            + +Y  P+VL   + YS   D+WS G I   L    RP F           IFR +L  
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGT 221

Query: 367 ---RSDPNFDDLPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                 P+   LP                  P ++   +D ++ LL  +  +R++A +AL
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

Query: 407 S 407
            
Sbjct: 282 Q 282

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  133 bits (338), Expect = 5e-36
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
           +Y    ++G G +G    A      E     VA+K   + ++         TAI      
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNET----VAIK---RIRLEHEEEGVPGTAI------ 81

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           REV +LK L  H+++++        + ++++ E  E    L + + +    +    K+ +
Sbjct: 82  REVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEND--LKKYMDKNPDVSMRVIKSFL 138

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLS-DFIRPDERLNDIV 315
            Q+++ V FCH +  +HRDLKP+N L +         L   DFGL+  F  P  +    +
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198

Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV---- 365
            + +Y  PE+L   R YS   DIWSI  I   +L  +  F   +E      IF  +    
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258

Query: 366 LRSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
             + P    LP                     +  E  D +  +L  D  KR++A  AL 
Sbjct: 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  134 bits (339), Expect = 8e-36
 Identities = 79/306 (25%), Positives = 128/306 (41%), Gaps = 62/306 (20%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK------AKMTTAISIEDVRR 199
           G +Y     +G G +G  CSA          +VA+K IS        + T         R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQRTL--------R 74

Query: 200 EVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA 254
           E+KIL     H++++   D       E + +VYIV +L E    L ++L +    + +  
Sbjct: 75  EIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHI 130

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
              + QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGF 187

Query: 315 ----VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG------------------- 349
               V + +Y APE++   + Y+   DIWS+G I   +L                     
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247

Query: 350 ----SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMT 401
               S+       +   R  L S P+ + +PW    P+   +A D + ++L  +  KR+ 
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307

Query: 402 AVQALS 407
             QAL+
Sbjct: 308 VEQALA 313

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  131 bits (333), Expect = 2e-35
 Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 59/299 (19%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-------TTAISIEDVRR 199
            Y    ++G G +      + K    L    VA+K   + ++        TAI      R
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNL----VALK---EIRLEHEEGAPCTAI------R 49

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
           EV +LK L  H ++V   D      ++ +V E  +    + LD     G      + K  
Sbjct: 50  EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD---CGNIINMHNVKLF 105

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
           + Q+L  +A+CH Q V+HRDLKP+N L     +  +++L DFGL+     P +  ++ V 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV----L 366
           + +Y  P++L     YS + D+W +G I Y +  G   F   T       IFR +     
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222

Query: 367 RSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            + P                         P +  +  D + +LL  + R R++A  A+ 
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  133 bits (336), Expect = 5e-35
 Identities = 80/350 (22%), Positives = 132/350 (37%), Gaps = 68/350 (19%)

Query: 97  PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
           P   P+      +++   G K         +G +  Q +             Y   K +G
Sbjct: 16  PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV------------SYTDTKVIG 63

Query: 157 RGHFGHTCSARGKK-GELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
            G FG    A+    GEL    VA+K ++   +           RE++I++ L  H ++V
Sbjct: 64  NGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKN--------RELQIMRKLD-HCNIV 110

Query: 215 K----FCDACEDVNNVYI--VMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           +    F  + E  + VY+  V++        +                K  + Q+   +A
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
           + H  G+ HRD+KP+N L     D A ++L DFG +  +   E     + S YY APE++
Sbjct: 171 YIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESG------IFR--------------- 363
             +  Y+   D+WS G +   LL G +P +   +SG      I +               
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLG-QPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNP 286

Query: 364 -AVLRSDPNFDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                  P     PW     P   PEA     RLL      R+T ++A +
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  131 bits (331), Expect = 8e-35
 Identities = 85/313 (27%), Positives = 130/313 (41%), Gaps = 64/313 (20%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR---RE 200
           N  + ++L   +G G +G  CSA  K      + VA+K     K+             RE
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIK-----KIEPFDKPLFALRTLRE 59

Query: 201 VKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
           +KILK    H++++   +     + E+ N VYI+ EL +    L R++      +++  +
Sbjct: 60  IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
             + Q L  V   H   V+HRDLKP N L  S   + D+++ DFGL+  I      N   
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEP 172

Query: 316 GSA-----------YYVAPEVL--HRSYSLEADIWSIGVI--------------SY---- 344
                         +Y APEV+     YS   D+WS G I               Y    
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232

Query: 345 --IL-LCG---SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNK 394
             I  + G   S       ES   R  ++S P +   P     P V+P+  D ++R+L  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 395 DYRKRMTAVQALS 407
           D  KR+TA +AL 
Sbjct: 293 DPAKRITAKEALE 305

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  131 bits (331), Expect = 1e-34
 Identities = 74/323 (22%), Positives = 125/323 (38%), Gaps = 57/323 (17%)

Query: 124 PEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK-I 182
           P +   +  + L       +     Y   K +G G FG    A+     ++  +VA+K +
Sbjct: 17  PLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKV 72

Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMELCEG- 235
           +   +           RE++I++ +  H ++V            +D   + +V+E     
Sbjct: 73  LQDKRFKN--------RELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123

Query: 236 -GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
                               K  + Q+L  +A+ H  G+ HRD+KP+N L         +
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVL 181

Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP 352
           +LIDFG +  +   E     + S YY APE++  +  Y+   DIWS G +   L+ G +P
Sbjct: 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP 240

Query: 353 FWARTESG------IFRAVL-----------------RSDPNFDDLPW-----PSVSPEA 384
            +   ESG      I + VL                    P     P+     P   P+A
Sbjct: 241 LF-PGESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA 298

Query: 385 KDFVKRLLNKDYRKRMTAVQALS 407
            D + RLL      R+TA++AL 
Sbjct: 299 IDLISRLLEYTPSARLTAIEALC 321

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  130 bits (330), Expect = 2e-34
 Identities = 72/310 (23%), Positives = 128/310 (41%), Gaps = 63/310 (20%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
             +Y+  K +G G  G  C+A        ++ VA+K +S+     T A       RE+ +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRA---YRELVL 77

Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           +K +  HK+++   +        E+  +VYIVMEL +    L +++        E    +
Sbjct: 78  MKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYL 132

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q+L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVT 189

Query: 318 AYYVAPEV-LHRSYSLEADIWSIGVISYILLCG-----------------------SRPF 353
            YY APEV L   Y    DIWS+G I   ++ G                          F
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249

Query: 354 WARTESGIFRAVLRSDPNFDDLPW----------------PSVSPEAKDFVKRLLNKDYR 397
             + +  + R  + + P +    +                   + +A+D + ++L  D  
Sbjct: 250 MKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308

Query: 398 KRMTAVQALS 407
           KR++  +AL 
Sbjct: 309 KRISVDEALQ 318

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  128 bits (324), Expect = 4e-34
 Identities = 45/222 (20%), Positives = 92/222 (41%), Gaps = 30/222 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
             G+ +G+G FG        K   ++    + +    +     +     +EVK+++ L  
Sbjct: 13  IHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLE- 65

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H +++KF         +  + E  +GG L   I +   +Y      +    I S +A+ H
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRPDERLND-------------- 313
              ++HRDL   N L        +  ++  DFGL+  +  ++   +              
Sbjct: 126 SMNIIHRDLNSHNCLV-----RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 314 -IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
            +VG+ Y++APE++  RSY  + D++S G++   ++      
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  130 bits (329), Expect = 7e-34
 Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 63/310 (20%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
             +Y+  K +G G  G  C+A        D+ VA+K +S+     T A       RE+ +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRA---YRELVL 114

Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           +K +  HK+++   +        E+  +VY+VMEL +    L +++        E    +
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 169

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + Q+L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVT 226

Query: 318 AYYVAPEV-LHRSYSLEADIWSIGVISYILLCG-----------------------SRPF 353
            YY APEV L   Y    DIWS+G I   ++                            F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286

Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSV----------------SPEAKDFVKRLLNKDYR 397
             + +  + R  + + P +  L +P +                + +A+D + ++L  D  
Sbjct: 287 MKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345

Query: 398 KRMTAVQALS 407
           KR++   AL 
Sbjct: 346 KRISVDDALQ 355

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (335), Expect = 7e-34
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 30/272 (11%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YE+   +  G  G    A  +   +  + V +K +  +    A ++     E + L  + 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSGDAEAQAM--AMAERQFLAEVV 137

Query: 209 GHKHLVKFCDACEDVNN-----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            H  +V+  +  E  +       YIVME   G  L       G +    +A A +++IL 
Sbjct: 138 -HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILP 193

Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
            +++ H  G+V+ DLKPEN + T  +    ++LID G             + G+  + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYGTPGFQAP 246

Query: 324 EVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           E++    ++  DI+++G     L            +G +   L  D      P       
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTR-----NGRYVDGLPEDD-----PVLKTYDS 296

Query: 384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPILS 415
               ++R ++ D R+R T  + +S  +  +L 
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  126 bits (319), Expect = 8e-34
 Identities = 36/213 (16%), Positives = 72/213 (33%), Gaps = 23/213 (10%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
               ++   H G        KG  +   + VK++     +T     D   E   L+  S 
Sbjct: 13  NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS- 65

Query: 210 HKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVA 266
           H +++    AC+     +  ++      G L + +         +  A    + +   +A
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 267 FCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
           F H     +    L   + +     +D   R+    +        +    + +  +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFS----FQSPGRMYAPAWVAPE 178

Query: 325 VL-HRSYSLE---ADIWSIGVISYILLCGSRPF 353
            L  +        AD+WS  V+ + L+    PF
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  127 bits (321), Expect = 9e-34
 Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 64/306 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-------TTAISIEDVRR 199
           +++  +++G G +        K  G      VA+K   + K+       +TAI      R
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVY----VALK---EVKLDSEEGTPSTAI------R 52

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLD--RILARGGRYTEEDAK 255
           E+ ++K L  H+++V+  D     N + +V E  +    + +D   +            K
Sbjct: 53  EISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDI 314
               Q+L  +AFCH   ++HRDLKP+N L         ++L DFGL+  F  P    +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTFSSE 168

Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL-- 366
           V + +Y AP+VL   R+YS   DIWS G I   ++ G   F    +      IF  ++  
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD-IMGT 227

Query: 367 ---RSDPNFDDLPW----------------------PSVSPEAKDFVKRLLNKDYRKRMT 401
                 P+   LP                         +     DF+  LL  +   R++
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 402 AVQALS 407
           A QAL 
Sbjct: 288 AKQALH 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  128 bits (322), Expect = 1e-33
 Identities = 73/340 (21%), Positives = 131/340 (38%), Gaps = 63/340 (18%)

Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
           G K +E  + E++    E  L +     +     +E   E+G G+ G       K     
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPS--- 57

Query: 175 DQQVAVKIISKAKMTTAIS-IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233
              +A K+I    +    +    + RE+++L   +   ++V F  A      + I ME  
Sbjct: 58  GLVMARKLI---HLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHM 113

Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDA 292
           +GG  LD++L + GR  E+    + + ++  + +   +  ++HRD+KP N L  S     
Sbjct: 114 DGG-SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RG 169

Query: 293 DMRLIDFG----LSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
           +++L DFG    L D +      N  VG+  Y++PE L  + YS+++DIWS+G+    + 
Sbjct: 170 EIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224

Query: 348 CGSRPF--------------------WARTESGIFRAVLRSDPNFDDLPWPSV------- 380
            G  P                                   +    D  P  ++       
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284

Query: 381 -------------SPEAKDFVKRLLNKDYRKRMTAVQALS 407
                        S E +DFV + L K+  +R    Q + 
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  127 bits (320), Expect = 4e-33
 Identities = 61/316 (19%), Positives = 113/316 (35%), Gaps = 64/316 (20%)

Query: 148 KYELGKEVGRGH--FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            YEL   +G+G         AR K      + V V+ I+    +    +  ++ E+ + K
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNE-MVTFLQGELHVSK 81

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-QILSV 264
             + H ++V +       N +++V      G   D I         E A A ++  +L  
Sbjct: 82  LFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD--------ERLNDIVG 316
           + + H  G VHR +K  + L +    D  + L     +  +           +     V 
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 317 SAYYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPF-------------------- 353
              +++PEVL ++   Y  ++DI+S+G+ +  L  G  PF                    
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 354 ----------------WARTESGIFRAVLRSDPNFDDLPWPSV------SPEAKDFVKRL 391
                            +   SG+  ++  S P   +   PS       SP    FV++ 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 392 LNKDYRKRMTAVQALS 407
           L ++   R +A   L+
Sbjct: 318 LQRNPDARPSASTLLN 333

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  126 bits (319), Expect = 6e-33
 Identities = 76/333 (22%), Positives = 131/333 (39%), Gaps = 83/333 (24%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
             KYEL K++G+G +G    +  ++     + VAVK I  A    T A       RE+ I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQRT---FREIMI 61

Query: 204 LKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           L  LSGH+++V   +    ++  +VY+V +  E    L  ++ R         + +V Q+
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQYVVYQL 118

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA--- 318
           + V+ + H  G++HRD+KP N L  +   +  +++ DFGLS       R+ + +  +   
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 319 -------------------YYVAPEVL--HRSYSLEADIWSIGVI--------------S 343
                              +Y APE+L     Y+   D+WS+G I              S
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235

Query: 344 Y------IL-LCG--SRPFWARTESGIFRAVLRSDPNF--------------------DD 374
                  I+ +    S       +S   + ++ S                          
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            P    + EA D + +LL  +  KR++A  AL 
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALK 328

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  125 bits (317), Expect = 7e-33
 Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 63/301 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-----------TTAISIE 195
           +YE    +G G F     AR K   ++    VA+K   K K+            TA+   
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQI----VAIK---KIKLGHRSEAKDGINRTAL--- 60

Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEED 253
              RE+K+L+ LS H +++   DA    +N+ +V +  E     ++          T   
Sbjct: 61  ---REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSH 113

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLN 312
            KA ++  L  + + H   ++HRDLKP N L     ++  ++L DFGL+  F  P+    
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYT 170

Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWA-RTE----SGIFRAV 365
             V + +Y APE+L   R Y +  D+W++G I   LL    PF    ++    + IF  +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETL 229

Query: 366 ----LRSDPNFDDLPW----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                   P+   LP                  +   +  D ++ L   +   R+TA QA
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289

Query: 406 L 406
           L
Sbjct: 290 L 290

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  127 bits (321), Expect = 1e-32
 Identities = 79/393 (20%), Positives = 138/393 (35%), Gaps = 107/393 (27%)

Query: 110 AKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGK 169
            +    G  +E    ++  +    +       +     +YE+   +G G +GH C A  K
Sbjct: 16  TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75

Query: 170 KGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCD-----ACED 222
               + + VA+K I +    +     I    RE+ IL  L+ H H+VK  D       E 
Sbjct: 76  L---EKRVVAIKKILRVFEDLIDCKRI---LREIAILNRLN-HDHVVKVLDIVIPKDVEK 128

Query: 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
            + +Y+V+E+ +      ++       TE   K ++  +L  V + H  G++HRDLKP N
Sbjct: 129 FDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186

Query: 283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA------------------------ 318
            L      D  +++ DFGL+  +   E  N  +  +                        
Sbjct: 187 CLVNQ---DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243

Query: 319 ----YYVAPEVL--HRSYSLEADIWSIGVI-------------------------SYILL 347
               +Y APE++    +Y+   D+WSIG I                         S   L
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPL 303

Query: 348 CGSRPFWARTESG----------IF-------------------RAVLRSDPNFDDLPW- 377
              +      +            IF                   +  +R  P  +     
Sbjct: 304 SPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363

Query: 378 ---PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
              P+ S +A   +KR+L  +  KR+T  + L+
Sbjct: 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA 396

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  124 bits (314), Expect = 1e-32
 Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 57/301 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
           +YE   E+G G +G    AR  K     + VA+K   + ++         + I      R
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLK--NGGRFVALK---RVRVQTGEEGMPLSTI------R 60

Query: 200 EVKILKALSG--HKHLVKFCDAC-----EDVNNVYIVMELCEG--GELLDRILARGGRYT 250
           EV +L+ L    H ++V+  D C     +    + +V E  +      LD++        
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVP 118

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            E  K ++ Q+L  + F H   VVHRDLKP+N L T       ++L DFGL+        
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175

Query: 311 LNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV 365
           L  +V + +Y APEVL   SY+   D+WS+G I   +      F   ++      I   +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

Query: 366 ----LRSDPNFDDLPW---------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                   P    LP                  +    KD + + L  +  KR++A  AL
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

Query: 407 S 407
           S
Sbjct: 296 S 296

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  126 bits (318), Expect = 2e-32
 Identities = 71/371 (19%), Positives = 127/371 (34%), Gaps = 99/371 (26%)

Query: 124 PEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII 183
                +   ++L      N +    Y +   +GRG +G+   A  K     ++ VA+K +
Sbjct: 3   HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKV 59

Query: 184 SKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGG 236
           ++    +     I    RE+ IL  L    ++++  D          + +YIV+E+ +  
Sbjct: 60  NRMFEDLIDCKRI---LREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115

Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
             L ++       TEE  K I+  +L    F H  G++HRDLKP N L      D  +++
Sbjct: 116 --LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKV 170

Query: 297 IDFGLSDFIRPDERLNDIVGSA-----------------------YYVAPEVL--HRSYS 331
            DFGL+  I  ++  N +                           +Y APE++    +Y+
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230

Query: 332 LEADIWSIGVI----------SYILLCGSRPFW--------------------------- 354
              DIWS G I                   P +                           
Sbjct: 231 KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLN 290

Query: 355 --------------ARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDY 396
                                    ++  P+   +      PS+S +  + ++ +L  + 
Sbjct: 291 IIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP 350

Query: 397 RKRMTAVQALS 407
            KR+T  QAL 
Sbjct: 351 NKRITIDQALD 361

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  123 bits (312), Expect = 2e-32
 Identities = 76/305 (24%), Positives = 117/305 (38%), Gaps = 63/305 (20%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-----------TTAISIE 195
           +YE   E+G G +G    AR    G      VA+K     ++            + +   
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHF----VALK---SVRVPNGGGGGGGLPISTV--- 59

Query: 196 DVRREVKILKALSG--HKHLVKFCDAC-----EDVNNVYIVMELCEG--GELLDRILARG 246
              REV +L+ L    H ++V+  D C     +    V +V E  +      LD+     
Sbjct: 60  ---REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PP 114

Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
                E  K ++ Q L  + F H   +VHRDLKPEN L T       ++L DFGL+    
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYS 171

Query: 307 PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGI 361
               L  +V + +Y APEVL   +Y+   D+WS+G I   +      F   +E      I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 362 FRAV----LRSDPNFDDLPW---------------PSVSPEAKDFVKRLLNKDYRKRMTA 402
           F  +        P    LP                P +       +  +L  +  KR++A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291

Query: 403 VQALS 407
            +AL 
Sbjct: 292 FRALQ 296

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  125 bits (317), Expect = 2e-32
 Identities = 72/329 (21%), Positives = 123/329 (37%), Gaps = 77/329 (23%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
           + +   +YE+ K +G+G FG    A   K     Q VA+K++ ++ +     + E     
Sbjct: 92  HDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQAAEE----- 143

Query: 201 VKILKALSGH-----KHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEED 253
           ++IL+ L         +++   +     N++ +  EL      EL+ +   +G  ++   
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPL 201

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
            +     IL  +   H   ++H DLKPEN L    +  + +++IDFG S +    +R+  
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSCYE--HQRVYT 258

Query: 314 IVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTE-------------- 358
            + S +Y APEV L   Y +  D+WS+G I   LL G        E              
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318

Query: 359 -SGIFRAVLRSDPNFDDLPWPS------------VSPEAK-------------------- 385
              +  A  R+        +P             V    +                    
Sbjct: 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378

Query: 386 --------DFVKRLLNKDYRKRMTAVQAL 406
                   DF+K+ L  D   RMT  QAL
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (307), Expect = 7e-32
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 14/260 (5%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
              +Y++  ++G G       A      L + +VA+K I         +++   REV   
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTI--L-NIKVAIKAIFIPPREKEETLKRFEREVHNS 65

Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
             LS H+++V   D  E+ +  Y+VME  EG  L +  +   G  + + A     QIL  
Sbjct: 66  SQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDG 123

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
           +   H   +VHRD+KP+N L      +  +++ DFG++  +  +  L   N ++G+  Y 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYF 179

Query: 322 APE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-PNFDDLPWPS 379
           +PE     +     DI+SIG++ Y +L G  PF   T   I    ++   PN        
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 380 VSPEAKDFVKRLLNKDYRKR 399
           +     + + R   KD   R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 3e-31
 Identities = 81/297 (27%), Positives = 128/297 (43%), Gaps = 37/297 (12%)

Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
               S+    RG+  + + +   G    FG  Y L + VGRG  G    A      ++++
Sbjct: 7   HHHHSSGLVPRGSHMDGTAESREG--TQFG-PYRLRRLVGRGGMGDVYEAED---TVRER 60

Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
            VA+K++S+   +  +    ++RE +    L    H+V   D  E    +Y+ M L  G 
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDMRLINGV 119

Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
           +L   +L R G      A AIV QI S +   H  G  HRD+KPEN L +    D    L
Sbjct: 120 DL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYL 175

Query: 297 IDFGLSDFIRPDERL---NDIVGSAYYVAPE------VLHRSYSLEADIWSIGVISYILL 347
           +DFG++     DE+L    + VG+ YY+APE        +R+     DI+++  + Y  L
Sbjct: 176 VDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRA-----DIYALTCVLYECL 229

Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-----VSPEAKDFVKRLLNKDYRKR 399
            GS P+     S +  A +         P PS     +       + R + K+   R
Sbjct: 230 TGSPPYQGDQLS-VMGAHINQAI-----PRPSTVRPGIPVAFDAVIARGMAKNPEDR 280

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  120 bits (304), Expect = 6e-31
 Identities = 69/319 (21%), Positives = 117/319 (36%), Gaps = 65/319 (20%)

Query: 137 KSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED 196
            +   ++    ++++ +  G+G FG     + K        VA+K + +           
Sbjct: 13  AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR------ 63

Query: 197 VRREVKILKALSGHKH--LVKFCD-----ACEDVNNVY--IVMELCEGGELLDRILARGG 247
             RE++I++ L+   H  +V+           D  ++Y  +VME     + L R      
Sbjct: 64  -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYY 120

Query: 248 RY----TEEDAKAIVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGL 301
           R          K  + Q++  +   HL    V HRD+KP N L      D  ++L DFG 
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGS 178

Query: 302 SDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG---------- 349
           +  + P E     + S YY APE++  ++ Y+   DIWS+G I   ++ G          
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 350 -------------SRPFWARTESGIFRAVLRSDPNFDDLPW--------PSVSPEAKDFV 388
                        SR    +              N   +PW           + EA D +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295

Query: 389 KRLLNKDYRKRMTAVQALS 407
             LL     +RM   +AL 
Sbjct: 296 SALLQYLPEERMKPYEALC 314

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  120 bits (304), Expect = 7e-31
 Identities = 73/324 (22%), Positives = 120/324 (37%), Gaps = 76/324 (23%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRREVKILKA 206
           +Y L +++G GHF     A+       +  VA+KI+      T A        E+K+L+ 
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEA-----AEDEIKLLQR 71

Query: 207 LS----------GHKHLVKFCDA----CEDVNNVYIVMELCEGGELLDRILARGGR-YTE 251
           ++          G  H++K  D       +  +V +V E+  G  LL  I     R    
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130

Query: 252 EDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADM---RLIDFGLSDFIRP 307
              K I  Q+L  + + H + G++H D+KPEN L        ++   ++ D G + +   
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-- 188

Query: 308 DERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR--- 363
           DE   + + +  Y +PEV L   +   ADIWS   + + L+ G   F         +   
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248

Query: 364 ------AVL------------RSDPNFDDL----------PWP----------SVSPEAK 385
                  +L             +   F+             WP              EAK
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308

Query: 386 ---DFVKRLLNKDYRKRMTAVQAL 406
              DF+  +L  D RKR  A   +
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLV 332

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  118 bits (298), Expect = 3e-30
 Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 74/329 (22%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
                A+YE+   +G G FG        K     + VAVKI+ +  +   A   E     
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE----- 61

Query: 201 VKILKAL-----SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
           +++L+ L     +     V+  +  E   ++ IV EL  G    D I   G   +  +  
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLID 298
           + +  QI   V F H   + H DLKPEN LF                     + D++++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWART 357
           FG + +   DE  + +V + +Y APEV L   +S   D+WSIG I      G   F    
Sbjct: 181 FGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 358 ES----------GIF-RAVLRSDP---NFDD--LPWPSVSPEAK---------------- 385
                       G   + +++       F    L W   S   +                
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298

Query: 386 --------DFVKRLLNKDYRKRMTAVQAL 406
                   D ++++L  D  KR+T  +AL
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREAL 327

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  117 bits (295), Expect = 5e-30
 Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 17/260 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           YELG+ +G G       AR  +     + VAVK++              RRE +   AL+
Sbjct: 14  YELGEILGFGGMSEVHLARDLR--D-HRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 209 GHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++      
Sbjct: 71  -HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQA 128

Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL----SDFIRPDERLNDIVGSAYY 320
           + F H  G++HRD+KP N + +       ++++DFG+    +D      +   ++G+A Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 321 VAPE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
           ++PE     S    +D++S+G + Y +L G  PF   +   +    +R DP         
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245

Query: 380 VSPEAKDFVKRLLNKDYRKR 399
           +S +    V + L K+   R
Sbjct: 246 LSADLDAVVLKALAKNPENR 265

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  116 bits (293), Expect = 2e-29
 Identities = 64/336 (19%), Positives = 111/336 (33%), Gaps = 82/336 (24%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
                  + + +++G G FG     +        +  AVK++ +  K T +  IE     
Sbjct: 30  GMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRSAKIE----- 81

Query: 201 VKILKALSGH----KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAK 255
             ILK +        ++VK+       +++ ++ E   G  L + I       +  ED K
Sbjct: 82  ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK 140

Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----------------------RDDAD 293
              ++IL  + +     + H DLKPEN L                               
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRP 352
           ++LIDFG + F    +    I+ +  Y APEV L+  + + +D+WS G +   L  GS  
Sbjct: 201 IKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 353 FWARTES----------GIF------RAVLRSDPNFDD-----LPWPSVS---------- 381
           F                          A   +   + +     L WP  +          
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318

Query: 382 -----------PEAKDFVKRLLNKDYRKRMTAVQAL 406
                          DF+  +L  D   R +  + L
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  115 bits (291), Expect = 3e-29
 Identities = 70/329 (21%), Positives = 110/329 (33%), Gaps = 74/329 (22%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
                 +YE+   +G G FG               QVA+KII +  K   A      R E
Sbjct: 14  GDWLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYREA-----ARLE 66

Query: 201 VKILKAL-----SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
           + +LK +           V   D      ++ I  EL  G    + +     + Y     
Sbjct: 67  INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV 125

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLID 298
           + +  Q+   + F H   + H DLKPEN LF +                   +  +R+ D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWART 357
           FG + F    E    IV + +Y  PEV L   ++   D+WSIG I +    G   F    
Sbjct: 186 FGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

Query: 358 E---------------SGIFRAVLRSDPNFDD-LPWPSVSPEAK---------------- 385
                           S +     +    +   L W   S + +                
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303

Query: 386 --------DFVKRLLNKDYRKRMTAVQAL 406
                   D ++R+L  D  +R+T  +AL
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEAL 332

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (287), Expect = 3e-29
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 25/232 (10%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            L +++G G FG            K   VAVK +    ++   +++D  REV  + +L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H++L++          + +V EL   G LLDR+    G +         VQ+   + +  
Sbjct: 80  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
            +  +HRDL   N L  +      +++ DFGL   +  ++         Y +        
Sbjct: 139 SKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQND-------DHYVMQEHRKVPF 188

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRS 368
              APE L  R++S  +D W  GV  + +   G  P+     S I   + + 
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  114 bits (287), Expect = 1e-28
 Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 82/317 (25%)

Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
           KYE   ++G+G FG    AR +K G+     VA+K   K  M         TA+      
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQK----VALK---KVLMENEKEGFPITAL------ 64

Query: 199 REVKILKALSGHKHLVKFCDAC--------EDVNNVYIVMELCEG--GELLDRILARGGR 248
           RE+KIL+ L  H+++V   + C            ++Y+V + CE     LL        +
Sbjct: 65  REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVK 120

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
           +T  + K ++  +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 177

Query: 309 ERLNDIVGSAY--------YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWART 357
           +       + Y        Y  PE+L   R Y    D+W  G I   +     P     T
Sbjct: 178 KNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT 233

Query: 358 ESG----IFRAV----LRSDPNFDDLPW--------------------PSVSPEAKDFVK 389
           E      I +          PN D+                           P A D + 
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293

Query: 390 RLLNKDYRKRMTAVQAL 406
           +LL  D  +R+ +  AL
Sbjct: 294 KLLVLDPAQRIDSDDAL 310

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (287), Expect = 2e-28
 Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 24/228 (10%)

Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
            + +  +YE+   +G+G FG    A  +    + + VA+KII +K            + E
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLNQA-----QIE 100

Query: 201 VKILKALSGH-----KHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEED 253
           V++L+ ++ H      ++V         N++ +V E+      +LL     RG   +   
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNL 158

Query: 254 AKAIVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
            +    Q+ + + F       ++H DLKPEN L  +    + ++++DFG S  +   +R+
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQL--GQRI 215

Query: 312 NDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
              + S +Y +PEV L   Y L  D+WS+G I   +  G   F    E
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (279), Expect = 5e-28
 Identities = 45/234 (19%), Positives = 80/234 (34%), Gaps = 31/234 (13%)

Query: 150 ELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
              + +G+G F           G  G+L + +V +K++ KA    +   E       ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            LS HKHLV     C   +   +V E  + G L   +              +  Q+ + +
Sbjct: 68  KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLI-----DFGLSDFIRPDERLNDIVGSAYY 320
            F     ++H ++  +N L     D            D G+S  + P +           
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------IL 177

Query: 321 ------VAPEVLH--RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                 V PE +   ++ +L  D WS G   + I   G +P  A       +  
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (281), Expect = 6e-28
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 29/230 (12%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +  K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            + H+ +    C   + V ++ +L   G LLD +         +      VQI   + + 
Sbjct: 76  -NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             + +VHRDL   N L  + +    +++ DFGL+  +  +E          Y        
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
               A E + HR Y+ ++D+WS GV  + ++  GS+P+     S I   +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  112 bits (282), Expect = 8e-28
 Identities = 66/332 (19%), Positives = 113/332 (34%), Gaps = 90/332 (27%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY LGK +G G FG  C     +     ++ A+K + +             RE+ I+K L
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK-------NRELDIMKVL 57

Query: 208 SGHKHLVKFCD--------------------------------------ACEDVNNVYIV 229
             H +++K  D                                             + ++
Sbjct: 58  D-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 230 MELCEGGELLDRILARGGRY----TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
           ME     + L ++L    R             + Q+   V F H  G+ HRD+KP+N L 
Sbjct: 117 MEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 286 TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVIS 343
            S   D  ++L DFG +  + P E     + S +Y APE++     Y+   D+WSIG + 
Sbjct: 175 NS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 344 YILLCG-----------------------SRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
             L+ G                       ++    R             P      W  +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKI 289

Query: 381 -----SPEAKDFVKRLLNKDYRKRMTAVQALS 407
                   A D ++++L  +   R+   +A++
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  111 bits (280), Expect = 2e-27
 Identities = 73/322 (22%), Positives = 124/322 (38%), Gaps = 71/322 (22%)

Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILK 205
            +E  G +VGRG +GH   A+ K G+  D+  A+K I    +  +A       RE+ +L+
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIALLR 73

Query: 206 ALSGHKHLVKFCDACEDVNN--VYIVMELCEG--GELLDRILARGGRY-----TEEDAKA 256
            L  H +++          +  V+++ +  E     ++    A               K+
Sbjct: 74  ELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGL----SDFIRPDERL 311
           ++ QIL  + + H   V+HRDLKP N L      +   +++ D G     +  ++P   L
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 312 NDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRS 368
           + +V + +Y APE+L   R Y+   DIW+IG I   LL    P F  R E          
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHH 251

Query: 369 D-----------------PNFDDLPW--------------------------PSVSPEAK 385
           D                  +   +P                                +A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 386 DFVKRLLNKDYRKRMTAVQALS 407
             +++LL  D  KR+T+ QA+ 
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQ 333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  110 bits (278), Expect = 3e-27
 Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 32/232 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            LG+++GRG+FG   S R +     +  VAVK   +             +E +ILK  S 
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLPPDLK--AKFLQEARILKQYS- 170

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H ++V+    C     +YIVMEL +GG+ L  +   G R   +    +V    + + +  
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
            +  +HRDL   N L T   +   +++ DFG+S                Y          
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVP 278

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
               APE L +  YS E+D+WS G++ +     G+ P+   +       V +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  108 bits (271), Expect = 6e-27
 Identities = 37/270 (13%), Positives = 65/270 (24%), Gaps = 44/270 (16%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           Y L    G         A        D+QVA+  +    +     +++       L  + 
Sbjct: 33  YRLLIFHGGVPPLQFWQALD---TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
               + +  D         +V E   GG L +         +   A   +  + +     
Sbjct: 90  -KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAA 145

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
           H  GV      P     +    D D+ L                        +       
Sbjct: 146 HRAGVALSIDHPSRVRVS---IDGDVVLAYPA-------------------TMPDA---- 179

Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-----VSPE 383
             + + DI  IG   Y LL    P              R          P+     +  +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQ 235

Query: 384 AKDFVKRLLNKD--YRKRMTAVQALSKLVV 411
                 R +  D   R   T +  + +   
Sbjct: 236 ISAVAARSVQGDGGIRSASTLLNLMQQATA 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  106 bits (268), Expect = 1e-26
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 36/231 (15%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           L KE+G G FG         G+ K Q  VAVK+I +  M    S ++  +E + +  LS 
Sbjct: 12  LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS- 61

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H  LVKF   C     +YIV E    G LL+ + + G          +   +   +AF  
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
               +HRDL   N L      D  +++ DFG++ ++  D+         Y          
Sbjct: 122 SHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
              APEV  +  YS ++D+W+ G++ + +   G  P+   T S +   V +
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  108 bits (271), Expect = 1e-26
 Identities = 56/251 (22%), Positives = 104/251 (41%), Gaps = 40/251 (15%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            L + +G+G FG        +G+ + ++VAVKI S  +  +         E+     L  
Sbjct: 45  VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94

Query: 210 HKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A    N      ++V +  E G L D +       T E    + +   S +
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 152

Query: 266 AFCHLQ--------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
           A  H++         + HRDLK +N L    + +    + D GL+          DI   
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 315 --VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRA 364
             VG+  Y+APEVL       H      ADI+++G++ + +           +  + +  
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 365 VLRSDPNFDDL 375
           ++ SDP+ +++
Sbjct: 270 LVPSDPSVEEM 280

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (267), Expect = 2e-26
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 36/230 (15%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
              +E+G G FG         G   ++ +VA+K I +  M    S ED   E +++  LS
Sbjct: 11  TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS 61

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+ 
Sbjct: 62  -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
               V+HRDL   N L    +    +++ DFG++ F+  D+         Y         
Sbjct: 121 EEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQ---------YTSSTGTKFP 168

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
               +PEV     YS ++D+WS GV+ + +   G  P+  R+ S +   +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  106 bits (267), Expect = 4e-26
 Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 32/243 (13%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +   ++G+G+FG     R    G+     VAVK +   + +      D +RE++ILKAL 
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH 82

Query: 209 GHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
               +VK+          ++ +VME    G L D +     R           QI   + 
Sbjct: 83  -SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
           +   +  VHRDL   N L  S   +A +++ DFGL+  +  D+         YYV     
Sbjct: 142 YLGSRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDK--------DYYVVREPG 190

Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNF 372
                  APE L    +S ++D+WS GV+ Y +     +      E        R  P  
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 373 DDL 375
             L
Sbjct: 251 SRL 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 5e-26
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 36/232 (15%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
              KE+G G FG         G+ + Q  VA+K+I +  M    S ++   E K++  LS
Sbjct: 27  TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS 77

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H+ LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + + 
Sbjct: 78  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  +HRDL   N L     D   +++ DFGLS ++  DE         Y         
Sbjct: 137 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDE---------YTSSVGSKFP 184

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                PEVL +  +S ++DIW+ GV+ + I   G  P+   T S     + +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (264), Expect = 9e-26
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 29/230 (12%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +  K +G G FG         +GE     VA+K + +A  T+  + +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            + H+ +    C   + V ++ +L   G LLD +         +      VQI   + + 
Sbjct: 76  -NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             + +VHRDL   N L  + +    +++ DFGL+  +  +E          Y        
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
               A E + HR Y+ ++D+WS GV  + ++  GS+P+     S I   +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  104 bits (262), Expect = 1e-25
 Identities = 55/254 (21%), Positives = 101/254 (39%), Gaps = 46/254 (18%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK-ALS 208
            L + VG+G +G        +G  + + VAVKI S          +   RE ++    + 
Sbjct: 11  TLLECVGKGRYGEVW-----RGSWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59

Query: 209 GHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
            H++++ F  +     +    ++++    E G L D +  +           IV+ I S 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117

Query: 265 VAFCHLQ--------GVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERLNDI 314
           +A  H++         + HRDLK +N L        + +  + D GL+          D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNIL-----VKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 315 -----VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI- 361
                VG+  Y+APEVL               DIW+ G++ + +           +    
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

Query: 362 FRAVLRSDPNFDDL 375
           F  V+ +DP+F+D+
Sbjct: 233 FYDVVPNDPSFEDM 246

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  104 bits (261), Expect = 1e-25
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 29/229 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ELG+ +G G FG          E     VA+K        +    E   +E   ++    
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 74

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+VK      + N V+I+MELC  GEL   +  R              Q+ + +A+  
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
            +  VHRD+   N L +S   +  ++L DFGLS ++             YY         
Sbjct: 134 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDST---------YYKASKGKLPI 181

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
              APE +  R ++  +D+W  GV  + IL+ G +PF     + +   +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  104 bits (262), Expect = 2e-25
 Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 26/229 (11%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            + K +G G  G  C  R +    +D  VA+K +            D   E  I+     
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFD- 108

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H ++++            IV E  E G L   +    G++T      ++  + + + +  
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
             G VHRDL   N L  S       ++ DFGLS  +  D         A Y         
Sbjct: 169 DLGYVHRDLAARNVLVDSNL---VCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
              APE +  R++S  +D+WS GV+ + +L  G RP+W  T   +  +V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (259), Expect = 3e-25
 Identities = 59/231 (25%), Positives = 88/231 (38%), Gaps = 29/231 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            L + +G G FG          + +   VAVK   K    T  + E    E  I+K L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+VK     E+    +I+MEL   GEL   +                +QI   +A+  
Sbjct: 72  HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
               VHRD+   N L  S      ++L DFGLS   R       I    YY         
Sbjct: 131 SINCVHRDIAVRNILVASPE---CVKLGDFGLS---R------YIEDEDYYKASVTRLPI 178

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
              +PE +  R ++  +D+W   V  + IL  G +PF+      +   + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  107 bits (268), Expect = 3e-25
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 29/229 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ELG+ +G G FG          E     VA+K        +    E   +E   ++    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 449

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H H+VK      + N V+I+MELC  GEL   +  R              Q+ + +A+  
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
            +  VHRD+   N L +S   +  ++L DFGLS ++             YY         
Sbjct: 509 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDST---------YYKASKGKLPI 556

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
              APE +  R ++  +D+W  GV  + IL+ G +PF     + +   +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  105 bits (265), Expect = 3e-25
 Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 44/277 (15%)

Query: 103 KHIKASLAKRLGGGKPKESTIPEERG-TEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFG 161
                 L  RL   K  E T+  +        +L+           + +L + +G+G FG
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMK---------ELKLLQTIGKGEFG 207

Query: 162 HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC- 220
                    G+ +  +VAVK I K   T     +    E  ++  L  H +LV+      
Sbjct: 208 DVM-----LGDYRGNKVAVKCI-KNDATA----QAFLAEASVMTQLR-HSNLVQLLGVIV 256

Query: 221 EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFCHLQGVVHRDLK 279
           E+   +YIV E    G L+D + +RG      +      + +   + +      VHRDL 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316

Query: 280 PENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------APEVL-HRSYS 331
             N L +   +D   ++ DFGL+   +      +   +           APE L  + +S
Sbjct: 317 ARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 332 LEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
            ++D+WS G++ + I   G  P+       +   V +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  104 bits (262), Expect = 4e-25
 Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 34/232 (14%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
           + K VG G FG  CS R K    K+  VA+K +            D   E  I+     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFD-H 105

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
            ++++          V IV E  E G L   +     ++T      ++  I S + +   
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165

Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLI----DFGLSDFIRPDERLNDIVGSAYYV----- 321
            G VHRDL   N L  S        L+    DFGL   +  D         A Y      
Sbjct: 166 MGYVHRDLAARNILINSN-------LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 322 ------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                 +PE + +R ++  +D+WS G++ + ++  G RP+W  +   + +AV
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 4e-25
 Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 54/270 (20%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +  +++G+G+FG    C     +     + VAVK +  +       + D  RE++ILK+L
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEH---LRDFEREIEILKSL 99

Query: 208 SGHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
             H ++VK+   C      N+ ++ME    G L D +     R           QI   +
Sbjct: 100 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---- 321
            +   +  +HRDL   N L  +   +  +++ DFGL+  +  D+         YY     
Sbjct: 159 EYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDK--------EYYKVKEP 207

Query: 322 --------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESGIFRAVLR 367
                   APE L    +S+ +D+WS GV      +YI    S P       G       
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG------- 260

Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
                 +     +       +  LL  + R
Sbjct: 261 ------NDKQGQMIVFH---LIELLKNNGR 281

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  102 bits (257), Expect = 6e-25
 Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 34/232 (14%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            +  ++G G +G       KK  L    VAVK + +  M     +E+  +E  ++K +  
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK- 67

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFC 268
           H +LV+    C      YI+ E    G LLD +     +  +      +  QI S + + 
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  +HRDL   N L     ++  +++ DFGLS  +  D          Y         
Sbjct: 128 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDT---------YTAHAGAKFP 175

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
               APE L +  +S+++D+W+ GV+ + I   G  P+     S ++  + +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (258), Expect = 7e-25
 Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 29/232 (12%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
              K +G G FG         +GE     V +K+I     +   S + V   +  + +L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLD 73

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H H+V+    C   +++ +V +    G LLD +    G    +      VQI   + + 
Sbjct: 74  -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
              G+VHR+L   N L  S      +++ DFG++D + PD+           +       
Sbjct: 132 EEHGMVHRNLAARNVLLKSPS---QVQVADFGVADLLPPDD--------KQLLYSEAKTP 180

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
               A E +    Y+ ++D+WS GV  + ++  G+ P+     + +   + +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (262), Expect = 1e-24
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 16/223 (7%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            +  ++G G +G       KK  L    VAVK + +  M      E+  +E  ++K +  
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEIK- 274

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFC 268
           H +LV+    C      YI+ E    G LLD +     +  +      +  QI S + + 
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY--VAPEVL 326
             +  +HR+L   N L     ++  +++ DFGLS  +  D               APE L
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
            +  +S+++D+W+ GV+ + I   G  P+     S ++  + +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (255), Expect = 1e-24
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 38/233 (16%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +  +++G+G+FG    C     +     + VAVK +   + +T   + D  RE++ILK+L
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKL---QHSTEEHLRDFEREIEILKSL 68

Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
             H ++VK+   C       + ++ME    G L D +     R           QI   +
Sbjct: 69  Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---- 321
            +   +  +HRDL   N L  +   +  +++ DFGL+  +  D+         ++     
Sbjct: 128 EYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDK--------EFFKVKEP 176

Query: 322 --------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESG 360
                   APE L    +S+ +D+WS GV      +YI    S P       G
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  102 bits (256), Expect = 1e-24
 Identities = 53/253 (20%), Positives = 103/253 (40%), Gaps = 44/253 (17%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           ++ K++G+G +G         G+ + ++VAVK+      TT  +      E+     +  
Sbjct: 40  QMVKQIGKGRYGEVW-----MGKWRGEKVAVKVFF----TTEEASWFRETEIYQTVLMR- 89

Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
           H++++ F  A          +Y++ +  E G L D +  +      +    +    +S +
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147

Query: 266 AFCHLQ--------GVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERLNDI- 314
              H +         + HRDLK +N L        +    + D GL+     D    DI 
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILV-----KKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 315 ----VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-F 362
               VG+  Y+ PEVL       H    + AD++S G+I + +           E  + +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 363 RAVLRSDPNFDDL 375
             ++ SDP+++D+
Sbjct: 263 HDLVPSDPSYEDM 275

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (254), Expect = 2e-24
 Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 32/233 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
              + +GRGHFG          + K    AVK ++  ++T    +     E  I+K  S 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 84

Query: 210 HKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
           H +++     C        +V+   + G+L + I       T +D     +Q+   + + 
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  VHRDL   N +         +++ DFGL+   R      D+    YY        
Sbjct: 145 ASKKFVHRDLAARNCMLDEKF---TVKVADFGLA---R------DMYDKEYYSVHNKTGA 192

Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                  A E L  + ++ ++D+WS GV+ + ++  G+ P+       I   +
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 5e-24
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 31/227 (13%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +  +++G GHFG     R   +G+   +QVAVK + K +      I D+++E++IL+ L 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN-HIADLKKEIEILRNLY 81

Query: 209 GHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H+++VK+   C  +  N + ++ME    G L + +     +   +      VQI   + 
Sbjct: 82  -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
           +   +  VHRDL   N L      +  +++ DFGL+  I  D+         YY      
Sbjct: 141 YLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189

Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTES 359
                  APE L    + + +D+WS GV  + +L             
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  100 bits (251), Expect = 5e-24
 Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 44/255 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
             +L +   RG FG        K +L ++ VAVKI                 EV  L  +
Sbjct: 25  PLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLPGM 75

Query: 208 SGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
             H+++++F  A +   +V    +++    E G L D +  +    +  +   I   +  
Sbjct: 76  K-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMAR 132

Query: 264 VVAFCHLQ----------GVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERL 311
            +A+ H             + HRD+K +N L        ++   + DFGL+      +  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVL-----LKNNLTACIADFGLALKFEAGKSA 187

Query: 312 NDI---VGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI- 361
            D    VG+  Y+APEVL       R   L  D++++G++ + L           +  + 
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 362 -FRAVLRSDPNFDDL 375
            F   +   P+ +D+
Sbjct: 248 PFEEEIGQHPSLEDM 262

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 99.2 bits (248), Expect = 7e-24
 Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
           +L + +G+G FG         G+ +  +VAVK I           +    E  ++  L  
Sbjct: 24  KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 72

Query: 210 HKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
           H +LV+      E+   +YIV E    G L+D + +RG      +      + +   + +
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
                 VHRDL   N L +   +D   ++ DFGL+   +      +   +          
Sbjct: 133 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 180

Query: 322 -APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
            APE L  + +S ++D+WS G++ + I   G  P+       +   V +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 38/233 (16%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +L + +G G FG         G      +VAVK + +  M    S +    E  ++K L 
Sbjct: 16  KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
            H+ LV+          +YI+ E  E G L+D +    G   T      +  QI   +AF
Sbjct: 67  -HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
              +  +HRDL+  N L +   D    ++ DFGL+  I  +E         Y        
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNE---------YTAREGAKF 172

Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                APE + + ++++++D+WS G++   I+  G  P+   T   + + + R
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 27/229 (11%)

Query: 151 LGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
             K +G G FG       K     K+  VA+K +            D   E  I+   S 
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFS- 104

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           H ++++          + I+ E  E G L   +  + G ++      ++  I + + +  
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
               VHRDL   N L  S       ++ DFGLS  +  D         A Y         
Sbjct: 165 NMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLEDDP-------EATYTTSGGKIPI 214

Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
              APE + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 49/235 (20%), Positives = 95/235 (40%), Gaps = 32/235 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
              + +G+GHFG               Q A+K +S+   T    +E   RE  +++ L+ 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80

Query: 210 HKHLVKFCDACEDVNNV-YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
           H +++           + ++++     G+LL  I +     T +D  +  +Q+   + + 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             Q  VHRDL   N +         +++ DFGL+   R      DI+   YY        
Sbjct: 141 AEQKFVHRDLAARNCMLDESF---TVKVADFGLA---R------DILDREYYSVQQHRHA 188

Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                  A E L    ++ ++D+WS GV+ + +L  G+ P+       +   + +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  101 bits (253), Expect = 1e-23
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 38/233 (16%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            L  ++G+G FG         G      +VA+K +    M+     E   +E +++K L 
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 237

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
            H+ LV+      +   +YIV E    G LLD +    G+Y        +  QI S +A+
Sbjct: 238 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
                 VHRDL+  N L     ++   ++ DFGL+  I  +E         Y        
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 343

Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                APE   +  +++++D+WS G++   +   G  P+       +   V R
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  100 bits (252), Expect = 2e-23
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 38/233 (16%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +L K++G G FG                +VAVK +    M+     E    E  ++K L 
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQ 241

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
            H  LVK          +YI+ E    G LLD + +  G             QI   +AF
Sbjct: 242 -HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
              +  +HRDL+  N L +        ++ DFGL+  I  +E         Y        
Sbjct: 300 IEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE---------YTAREGAKF 347

Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                APE +   S+++++D+WS G++   I+  G  P+   +   + RA+ R
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 71/401 (17%), Positives = 128/401 (31%), Gaps = 124/401 (30%)

Query: 118 PKESTIPEERGTEPEQSLD-KSFGY-----NKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
            +E  I      E E   D    GY        F  +Y + +++G GHF     +   + 
Sbjct: 2   EQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ- 60

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-------GHKHLVKFCDACEDVN 224
               + VA+K++  A+  T    E    E+++LK++          + +V+  D    ++
Sbjct: 61  --GKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSDPNDPNREMVVQLLD-DFKIS 113

Query: 225 NVY-----IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHR 276
            V      +V E+   G  L + + +           K I+ Q+L  + + H +  ++H 
Sbjct: 114 GVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171

Query: 277 DLKPENFLFTSGR----------------------------------------------D 290
           D+KPEN L +                                                 +
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCG 349
              +++ D G +      +   + + +  Y + EV +   Y+  ADIWS   +++ L  G
Sbjct: 232 KLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289

Query: 350 SRPFWARTESGIFR---------AVL------------RSDPNFDD----------LPWP 378
              F   +     R          +L             S   F             PW 
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349

Query: 379 SVS----------PEAK---DFVKRLLNKDYRKRMTAVQAL 406
                         EA    DF+  +L     KR TA + L
Sbjct: 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 32/227 (14%)

Query: 154 EVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           E+G G+FG     +G  +   K   VA+K++ +   T     E++ RE +I+  L  + +
Sbjct: 17  ELGCGNFGSVR--QGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPY 71

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    C+    + +VME+  GG L   ++ +       +   ++ Q+   + +   + 
Sbjct: 72  IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----------- 321
            VHRDL   N L  +       ++ DFGLS  +  D+        +YY            
Sbjct: 131 FVHRDLAARNVLLVNRH---YAKISDFGLSKALGADD--------SYYTARSAGKWPLKW 179

Query: 322 -APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
            APE +  R +S  +D+WS GV  +  L  G +P+       +   +
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 97.8 bits (244), Expect = 5e-23
 Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 39/243 (16%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            LG+ +G+G FG    A+ K+ +    +VAVK++ KA +  +  IE+  RE   +K    
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83

Query: 210 HKHLVKFCDAC------EDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIV 258
           H H+ K             +    +++   + G+L       RI         +     +
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
           V I   + +   +  +HRDL   N +         + + DFGLS   R       I    
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDM---TVCVADFGLS---R------KIYSGD 191

Query: 319 YYV------------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRA 364
           YY             A E L    Y++ +D+W+ GV  + I+  G  P+     + I+  
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

Query: 365 VLR 367
           ++ 
Sbjct: 252 LIG 254

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 34/238 (14%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            L + +G G FG  +     G   +    QVAVK + +          D   E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY------TEEDAKAIVVQI 261
           + H+++V+           +I+MEL  GG+L   +     R          D   +   I
Sbjct: 91  N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
                +      +HRD+   N L T        ++ DFG++   R      DI  ++YY 
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYR 200

Query: 322 ------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                        PE      ++ + D WS GV+ + I   G  P+ +++   +   V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 42/220 (19%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + GK +G G FG     +A G   E    +VAVK++       A   E +  E+KI+  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-------------RILARGGRYTEEDA 254
             H+++V    AC     V ++ E C  G+LL+                      +  D 
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
                Q+   +AF   +  +HRD+   N L T   +    ++ DFGL+   R      DI
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---R------DI 214

Query: 315 VGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
           +  + Y+            APE +    Y++++D+WS G+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 32/230 (13%)

Query: 151 LGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
             KE+G G+FG     +G  + +   + VAVKI+ K +       +++  E  +++ L  
Sbjct: 21  EDKELGSGNFGTVK--KGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD- 76

Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
           + ++V+    CE   +  +VME+ E G L    L +     +++   +V Q+   + +  
Sbjct: 77  NPYIVRMIGICEA-ESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
               VHRDL   N L  +       ++ DFGLS  +R DE         YY         
Sbjct: 135 ESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADE--------NYYKAQTHGKWP 183

Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
               APE + +  +S ++D+WS GV+ +     G +P+     S +   +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 32/233 (13%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
              + +GRGHFG          + K    AVK ++  ++T    +     E  I+K  S 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 148

Query: 210 HKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
           H +++     C        +V+   + G+L + I       T +D     +Q+   + F 
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
             +  VHRDL   N +         +++ DFGL+   R      D+    +         
Sbjct: 209 ASKKFVHRDLAARNCMLDEKF---TVKVADFGLA---R------DMYDKEFDSVHNKTGA 256

Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                  A E L  + ++ ++D+WS GV+ + ++  G+ P+       I   +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 38/242 (15%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
            LGK +G G FG       K+ +    +VAVK + K   ++   IE+   E   +K  S 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFS- 94

Query: 210 HKHLVKFCDAC-----EDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVV 259
           H ++++    C     + +    +++   + G+L       R+         +     +V
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
            I   + +   +  +HRDL   N +         + + DFGLS   +       I    Y
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDM---TVCVADFGLS---K------KIYSGDY 202

Query: 320 YV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           Y             A E L  R Y+ ++D+W+ GV  + I   G  P+       ++  +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

Query: 366 LR 367
           L 
Sbjct: 263 LH 264

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 46/224 (20%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
             GK +G G FG     +A G         VAVK++  +        E +  E+K+L  L
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----------------RILARGGRYT 250
             H ++V    AC       ++ E C  G+LL+                  +        
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            ED  +   Q+   +AF   +  +HRDL   N L T        ++ DFGL+   R    
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R---- 193

Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
             DI   + YV            APE + +  Y+ E+D+WS G+
Sbjct: 194 --DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 56/264 (21%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK-ALS 208
           +L + +GRG +G        KG L ++ VAVK+ S A      + ++   E  I +  L 
Sbjct: 16  KLLELIGRGRYGAVY-----KGSLDERPVAVKVFSFA------NRQNFINEKNIYRVPLM 64

Query: 209 GHKHLVKFCDACEDVN-----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
            H ++ +F    E V         +VME    G L   +           +  +   +  
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTR 122

Query: 264 VVAFCHLQ---------GVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRPDERL- 311
            +A+ H +          + HRDL   N L        D   +  DFGLS  +  +  + 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLV-----KNDGTCVISDFGLSMRLTGNRLVR 177

Query: 312 --------NDIVGSAYYVAPEVL--------HRSYSLEADIWSIGVISYILL---CGSRP 352
                      VG+  Y+APEVL          S   + D++++G+I + +        P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 353 FWARTESGI-FRAVLRSDPNFDDL 375
             +  E  + F+  + + P F+D+
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDM 261

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 49/238 (20%), Positives = 87/238 (36%), Gaps = 34/238 (14%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            L + +G G FG  +     G   +    QVAVK + +    +     D   E  I+   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF 131

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRYTEEDAKAIVVQI 261
           + H+++V+           +I++EL  GG+L           ++       D   +   I
Sbjct: 132 N-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
                +      +HRD+   N L T        ++ DFG++   R      DI  + YY 
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYR 241

Query: 322 ------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
                        PE      ++ + D WS GV+ + I   G  P+ +++   +   V
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.5 bits (245), Expect = 3e-22
 Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 47/331 (14%)

Query: 53  GRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKR 112
             +   S   +         P        P R             P       K      
Sbjct: 251 KEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPR---- 306

Query: 113 LGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGE 172
                P ++++ E   ++PE+  DK     ++     +   E+G G+FG       +  +
Sbjct: 307 ---PMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD--IELGCGNFGSVRQGVYRMRK 361

Query: 173 LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232
            K   VA+K++ +   T     E++ RE +I+  L  + ++V+    C+    + +VME+
Sbjct: 362 -KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEM 416

Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
             GG L   ++ +       +   ++ Q+   + +   +  VHR+L   N L  +     
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN----- 471

Query: 293 DMRLI----DFGLSDFIRPDERLNDIVGSAYYV------------APEVL-HRSYSLEAD 335
             R      DFGLS  +  D+        +YY             APE +  R +S  +D
Sbjct: 472 --RHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSD 521

Query: 336 IWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
           +WS GV  +  L  G +P+       +   +
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 47/244 (19%)

Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
               +G G+FG    AR KK  L+    A+K + K +  +     D   E+++L  L  H
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRM-K-EYASKDDHRDFAGELEVLCKLGHH 85

Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQILSVV 265
            +++    ACE    +Y+ +E    G LLD     R+L     +   ++ A  +    ++
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 266 AFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
            F         +L  +  +HRDL   N L     ++   ++ DFGLS       R  +  
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQE-- 193

Query: 316 GSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGI 361
               YV            A E L +  Y+  +D+WS GV+ + I+  G  P+   T + +
Sbjct: 194 ---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250

Query: 362 FRAV 365
           +  +
Sbjct: 251 YEKL 254

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 33/243 (13%)

Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +  +++G GHFG           +   + VAVK + KA           ++E+ IL+ L 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQ-HRSGWKQEIDILRTLY 91

Query: 209 GHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
            H+H++K+   CED    ++ +VME    G L D +                 QI   +A
Sbjct: 92  -HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMA 148

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
           + H Q  +HRDL   N L  + R    +++ DFGL+  +             YY      
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHE--------YYRVREDG 197

Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNF 372
                  APE L    +   +D+WS GV  Y +L          T+      + +     
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257

Query: 373 DDL 375
             L
Sbjct: 258 LRL 260

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 49/239 (20%), Positives = 87/239 (36%), Gaps = 46/239 (19%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
              +E+G   FG  +     G     + Q VA+K +           E+ R E  +   L
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRARL 69

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--RILARGGRYTEEDAKAIVVQILSVV 265
             H ++V           + ++   C  G+L +   + +        D    V   L   
Sbjct: 70  Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 266 AFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
            F HL               VVH+DL   N L        ++++ D GL    R      
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL---NVKISDLGLF---R------ 176

Query: 313 DIVGSAYYV------------APE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
           ++  + YY             APE +++  +S+++DIWS GV+ + +   G +P+   +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.9 bits (241), Expect = 6e-22
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 38/233 (16%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            L  ++G+G FG         G      +VA+K +    M+     E   +E +++K L 
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 320

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
            H+ LV+      +   +YIV E    G LLD +    G+Y        +  QI S +A+
Sbjct: 321 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
                 VHRDL+  N L     ++   ++ DFGL+  I  +E         Y        
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 426

Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
                APE   +  +++++D+WS G++   +   G  P+       +   V R
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 49/243 (20%), Positives = 96/243 (39%), Gaps = 40/243 (16%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            + +E+G+G FG  +   A+G   +  + +VA+K +++A         +   E  ++K  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEF 85

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA---------IV 258
               H+V+            ++MEL   G+L   + +           A         + 
Sbjct: 86  -NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
            +I   +A+ +    VHRDL   N +         +++ DFG++   R      DI  + 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---R------DIYETD 192

Query: 319 YYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRA 364
           YY             +PE L    ++  +D+WS GV+ + I     +P+   +   + R 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252

Query: 365 VLR 367
           V+ 
Sbjct: 253 VME 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
            G +Y LG+++G G FG              ++VA+K+   K K         +  E KI
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTKHPQ------LHIESKI 57

Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            K + G   +  +++C A  D N   +VMEL  G  L D       +++ +    +  Q+
Sbjct: 58  YKMMQGGVGIPTIRWCGAEGDYN--VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM 114

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---------IRPDERLN 312
           +S + + H +  +HRD+KP+NFL   G+    + +IDFGL+           I   E   
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN-K 173

Query: 313 DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSRPFW 354
           ++ G+A Y +    L    S   D+ S+G   Y+L     GS P W
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLG---YVLMYFNLGSLP-W 215

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 45/223 (20%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +LGK +GRG FG      A G       + VAVK++ +    T      +  E+KIL  +
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 87

Query: 208 SGHKHLVKFCDACEDVNN-VYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQI 261
             H ++V    AC      + +++E C+ G L       R      +   ED     + +
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 262 LSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
             ++ +          L  +  +HRDL   N L +   +   +++ DFGL+   R     
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R----- 196

Query: 312 NDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
            DI     YV            APE +  R Y++++D+WS GV
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 47/239 (19%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            L +E+G G FG                  VAVK +    +      +D +RE ++L  L
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNL 74

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--RILARGGRYTEEDAKAIVVQILSVV 265
             H+H+VKF   C D + + +V E  + G+L    R          +         L + 
Sbjct: 75  Q-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 266 AFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
              H+             Q  VHRDL   N L  +      +++ DFG+S   R      
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---R------ 181

Query: 313 DIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
           D+  + YY              PE + +R ++ E+D+WS GVI + I   G +P++  +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 46/238 (19%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            L  E+G G FG            E     VAVK + +A  +     +D +RE ++L  L
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA---RQDFQREAELLTML 100

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--------------RILARGGRYTEED 253
             H+H+V+F   C +   + +V E    G+L                      G      
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
             A+  Q+ + + +      VHRDL   N L   G     +++ DFG+S   R      D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---R------D 207

Query: 314 IVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
           I  + YY              PE + +R ++ E+D+WS GV+ + I   G +P++  +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
            G  + +GK++G G+FG     +       ++ VA+K+   K++         +  E + 
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRAPQ------LHLEYRF 57

Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            K L     +  V +   C   N   +V+EL  G  L D        ++ +    I +Q+
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYN--AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLS----DF-----IRPDER 310
           +S + + H + +++RD+KPENFL     +       +IDF L+    D      I   E 
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 311 LNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSRPFW 354
            + + G+A Y++    L +  S   D+ ++G   ++    L GS P W
Sbjct: 175 KS-LTGTARYMSINTHLGKEQSRRDDLEALG---HMFMYFLRGSLP-W 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 51/229 (22%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           E GK +G G FG     +A G        QVAVK++ +     +   E +  E+K++  L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMMTQL 105

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--------------RILARGGRYTEED 253
             H+++V    AC     +Y++ E C  G+LL+                  +     EED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 254 AKAIVVQILSVVAFC------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
              +  + L   A+        L  +  VHRDL   N L T       +++ DFGL+   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA--- 219

Query: 306 RPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
           R      DI+  + YV            APE L    Y++++D+WS G+
Sbjct: 220 R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 47/251 (18%)

Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            LGK +G G FG           K    +  +VAVK++        +   D+  E++++K
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMK 129

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD---------------RILARGGRYT 250
            +  HK+++    AC     +Y+++E    G L +                      + +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
            +D  +   Q+   + +   +  +HRDL   N L T   +D  M++ DFGL+   R    
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R---- 239

Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWAR 356
             DI    YY             APE L  R Y+ ++D+WS GV+ + I   G  P+   
Sbjct: 240 --DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297

Query: 357 TESGIFRAVLR 367
               +F+ +  
Sbjct: 298 PVEELFKLLKE 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 46/224 (20%)

Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            LGK +G G FG           K    +   VAVK++      T   + D+  E++++K
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMK 95

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQ 260
            +  HK+++    AC     +Y+++E    G L +     R       Y         + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 261 ILSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
              +V+          +L  Q  +HRDL   N L T   ++  M++ DFGL+   R    
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R---- 205

Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
             DI    YY             APE L  R Y+ ++D+WS GV
Sbjct: 206 --DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS-KAKMTTAISIEDVRREVKIL 204
           G K+ LG+++G G FG        +    +++VA+K+ + K K         +  E KI 
Sbjct: 6   GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ------LLYESKIY 56

Query: 205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           + L G   +  V++     D N   +VM+L  G  L D       + + +    +  Q++
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYN--VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---------IRPDERLND 313
           + V F H +  +HRD+KP+NFL   GR    + +IDFGL+           I   E   +
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN-KN 172

Query: 314 IVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFW 354
           + G+A Y +    L    S   D+ S+G +    L GS P W
Sbjct: 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 54/255 (21%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            LGK +G G FG     +A   KG      VAVK++ +    +   + D+  E  +LK +
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLKQV 83

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD----------RILARGGRYTEEDAKAI 257
             H H++K   AC     + +++E  + G L              L  GG          
Sbjct: 84  -NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 258 VVQILSV---VAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
             + L++   ++F         +L    +VHRDL   N L     +   M++ DFGLS  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLS-- 197

Query: 305 IRPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGS 350
            R      D+     YV            A E L    Y+ ++D+WS GV+ + I+  G 
Sbjct: 198 -R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250

Query: 351 RPFWARTESGIFRAV 365
            P+       +F  +
Sbjct: 251 NPYPGIPPERLFNLL 265

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 29/225 (12%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
            G  Y++G+ +G G FG             +QQVA+K    ++          +R E + 
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQ------LRDEYRT 58

Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
            K L+G   +  V +       N   +V++L  G  L D +   G +++ +       Q+
Sbjct: 59  YKLLAGCTGIPNVYYFGQEGLHN--VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 262 LSVVAFCHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLS----DF-----IRPDER 310
           L+ V   H + +V+RD+KP+NFL    + ++   + ++DFG+     D      I   E+
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 311 LNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFW 354
            N + G+A Y++    L R  S   D+ ++G +    L GS P W
Sbjct: 176 KN-LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 46/224 (20%)

Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
            LGK +G G FG           K    +   VAVK++      T   + D+  E++++K
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMK 141

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQ 260
            +  HK+++    AC     +Y+++E    G L +     R       Y         + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 261 ILSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
              +V+          +L  Q  +HRDL   N L T   ++  M++ DFGL+   R    
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R---- 251

Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
             DI    YY             APE L  R Y+ ++D+WS GV
Sbjct: 252 --DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 54/247 (21%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           E  +++G G FG      A G         VAVK++ +    +A    D +RE  ++   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEF 107

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD----------RILARGGRYTEEDAKAI 257
             + ++VK    C     + ++ E    G+L +            L+     T     + 
Sbjct: 108 D-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 258 VVQILSVVAFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
               LS      +             +  VHRDL   N L         +++ DFGLS  
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIADFGLS-- 221

Query: 305 IRPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGS 350
            R      +I  + YY              PE + +  Y+ E+D+W+ GV+ + I   G 
Sbjct: 222 -R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 351 RPFWART 357
           +P++   
Sbjct: 275 QPYYGMA 281

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 48/242 (19%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
            G ++ LGK++G G FG    A       KD +  VK+  +           +  E+K  
Sbjct: 35  EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFY 87

Query: 205 KALSGHKHLVKFCD------------------ACEDVNNVYIVMELCEGGELLDRILARG 246
           + ++    + K+ +                    +  +  ++VME    G  L +I  + 
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145

Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFI 305
           G + +     + +++L V+ + H    VH D+K  N L   G  + D   L D+GLS   
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL--GYKNPDQVYLADYGLSYRY 203

Query: 306 RPDERLNDI--------VGSAYYVAPEVLHRSY--SLEADIWSIGVISYIL---LCGSRP 352
            P+               G+  +      H+    S  +D+  +G   Y +   LCG  P
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG---YCMLRWLCGKLP 259

Query: 353 FW 354
            W
Sbjct: 260 -W 260

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 43/243 (17%), Positives = 83/243 (34%), Gaps = 47/243 (19%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVK 202
             A +++G  +G+G FG    A     E    D    VK+              +  E+K
Sbjct: 33  AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS-------DNGPLFTELK 85

Query: 203 ILKALSGHKHL----------------VKFCDACEDVNNVY--IVMELCEGGELLDRILA 244
             +  +  + +                       +     Y  ++M+   G +L     A
Sbjct: 86  FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA 144

Query: 245 RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSD 303
              R++ +    + ++IL ++ + H    VH D+K  N L      + D   L+D+GL+ 
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL--NYKNPDQVYLVDYGLAY 202

Query: 304 FIRPDERLNDI--------VGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSR 351
              P+               G+  + + +     + S   D+  +G   Y +   L G  
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG---YCMIQWLTGHL 259

Query: 352 PFW 354
           P W
Sbjct: 260 P-W 261

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 43/238 (18%), Positives = 75/238 (31%), Gaps = 39/238 (16%)

Query: 146 GAKYELGKEVGRGHFG-----HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR- 199
           G +++L     R + G        S        + Q+ ++K+ +K            R  
Sbjct: 41  GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100

Query: 200 ---EVKILKALSGHKHL----VKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YT 250
              +V   K L     L           +D    ++V+     G  L   L    +   +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLS 157

Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPD- 308
           E     +  ++L  + F H    VH ++  EN       +D     L  +G +    P  
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV--DPEDQSQVTLAGYGFAFRYCPSG 215

Query: 309 ------ERLND-IVGSAYYVAPEVLHRSY--SLEADIWSIGVISYIL---LCGSRPFW 354
                 E       G   +     LH+    S  +D+ S+G   Y +   L G  P W
Sbjct: 216 KHVAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLG---YCMLKWLYGFLP-W 268

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 70/352 (19%), Positives = 113/352 (32%), Gaps = 111/352 (31%)

Query: 125 EERGTEPEQSLDKSFGYN------KNFGAKYELGKE--VGRGHFGHTCSARGKKGELKDQ 176
           E +  E   +   SF +        NF  +        +G G FG        KG + + 
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFG-----VVYKGYVNNT 55

Query: 177 QVAVKIISKAKMTTAISIEDV------RREVKILKALSGHKHLVK---FCDACEDVNN-- 225
            VAVK     K+   + I          +E+K++     H++LV+   F    +  +   
Sbjct: 56  TVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFS--SDGDDLCL 107

Query: 226 VYIVMELCEGGELLDRILARGG--------RYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
           VY        G LLDR+    G        R        I     + + F H    +HRD
Sbjct: 108 VY---VYMPNGSLLDRLSCLDGTPPLSWHMRC------KIAQGAANGINFLHENHHIHRD 158

Query: 278 LKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERLND----------IVGSAYYVAPEV 325
           +K  N L      D      + DFGL+       R ++          IVG+  Y+APE 
Sbjct: 159 IKSANILL-----DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPEA 206

Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPF-----------WAR---TESGIFRAVLRSDPN 371
           L    + ++DI+S GV+   ++ G                      E       +  D  
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DKK 264

Query: 372 FDDLPWPS-----------VSPEAKDFVKRLLNKDYRKRMTAV-QALSKLVV 411
            +D    S           +  +             R  +  V Q L ++  
Sbjct: 265 MNDADSTSVEAMYSVASQCLHEKKNK----------RPDIKKVQQLLQEMTA 306

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 4e-14
 Identities = 46/343 (13%), Positives = 98/343 (28%), Gaps = 69/343 (20%)

Query: 132 EQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKA 186
            Q     F +      K +  +++G G FG        +       VA+KII        
Sbjct: 6   SQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVF-----QTIADHTPVAIKIIAIEGPDLV 59

Query: 187 KMTTAISIEDVRREVKILKALSG--------HKHLVKFCDAC------------------ 220
             +   + E++  E+ I K LS          +  +                        
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 221 ------------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
                          + ++IV+E   GG  L+++  +    +   AK+I+ Q+ + +A  
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVA 177

Query: 269 HLQ-GVVHRDLKPENFLFTSG-----RDDADMRLIDFGLSDFI--------RPDERLNDI 314
                  HRDL   N L             + +                     ER   +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237

Query: 315 VGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           V     +  ++       + DI+ +  +          +   +       +         
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL--MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK 417
                 +P  K   +++  +++ + M    + + L+     FK
Sbjct: 296 FKTKCNTPAMKQIKRKI--QEFHRTMLNFSSATDLLCQHSLFK 336

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 20/186 (10%)

Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +LGK +GRG FG      A G       + VAVK++ +    T      +  E+KIL  +
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82

Query: 208 SGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
             H ++V    AC      + +++E C+ G L   +     R    +      +      
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKTKGARFRQ 137

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----------LNDIVG 316
                G +  DLK      TS +  A    ++      +  +E           L  ++ 
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197

Query: 317 SAYYVA 322
            ++ VA
Sbjct: 198 YSFQVA 203

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 26/117 (22%)

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +       +++ DFGL+   R   
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLA---R--- 241

Query: 310 RLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRP 352
              DI     YV            APE +  R Y++++D+WS GV+ + I   G+ P
Sbjct: 242 ---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.1 bits (144), Expect = 6e-10
 Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 67/265 (25%)

Query: 123 IPEERGTEPEQSLDKSFGYN------KNFGAKYELGKEVGRGHFGHTCSARGKKGELKD- 175
           +P E   E      K F          NF  K  LG    RG FG        KG L D 
Sbjct: 4   VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILG----RGGFGKV-----YKGRLADG 54

Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN---VYIVME- 231
             VAVK + K + T    ++  + EV+++     H++L++    C        VY  M  
Sbjct: 55  TLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMAN 111

Query: 232 ---------LCEGGELLD-----RIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
                      E    LD     RI    ARG  Y  +               C  + ++
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH--------------CDPK-II 156

Query: 275 HRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLN---DIVGSAYYVAPEVLHRS 329
           HRD+K  N L      D +    + DFGL+  +   +  +    + G+  ++APE L   
Sbjct: 157 HRDVKAANILL-----DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTG 210

Query: 330 YSLE-ADIWSIGVISYILLCGSRPF 353
            S E  D++  GV+   L+ G R F
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAF 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 57/268 (21%), Positives = 100/268 (37%), Gaps = 73/268 (27%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKD-QQVAVKIISKAKMTTAISIEDVR--- 198
            NF  K+ +G     G FG     +  KG L+D  +VA+K  +        S + +    
Sbjct: 39  NNFDHKFLIGH----GVFG-----KVYKGVLRDGAKVALKRRTPE------SSQGIEEFE 83

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED----- 253
            E++ L     H HLV     C++ N + ++ +  E G L   +                
Sbjct: 84  TEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 254 ------AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLS-DF 304
                 A+ +         + H + ++HRD+K  N L      D +   ++ DFG+S   
Sbjct: 143 EICIGAARGL--------HYLHTRAIIHRDVKSINILL-----DENFVPKITDFGISKKG 189

Query: 305 IRPDE-----RLNDIVGSAYYVAPEVLHRSYSLE-ADIWSIGVISYILLCGSRPF----- 353
              D+         + G+  Y+ PE   +    E +D++S GV+ + +LC          
Sbjct: 190 TELDQTHLSTV---VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 354 --------WART--ESGIFRAVLRSDPN 371
                   WA     +G    ++  DPN
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIV--DPN 272

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 25/103 (24%), Positives = 39/103 (37%), Gaps = 17/103 (16%)

Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           R E + L+ L G                  ++MEL +  EL             E+   +
Sbjct: 152 RNEFRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYR--------VRVENPDEV 198

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
           +  IL  VA  + +G+VH DL   N L +       + +IDF 
Sbjct: 199 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFP 237

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 30/178 (16%), Positives = 51/178 (28%), Gaps = 32/178 (17%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-------------------ISKA 186
           G    +G  +  G   +   A G     K   +AVKI                       
Sbjct: 46  GYITAMGGVISTGKEANVFYADGVFDG-KPVAMAVKIYRIETSEFDKMDEYLYGDERFDM 104

Query: 187 KMTTAISIED--VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL-LDRIL 243
           +  +          +E + L+     +  V             ++ME     EL    ++
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERA--KEAGVS-VPQPYTYMKNVLLMEFIGEDELPAPTLV 161

Query: 244 ARGGRYTEEDAKAIVVQILS-VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
             G    E D + I   ++  V        +VH DL   N ++        +  ID G
Sbjct: 162 ELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 14/88 (15%)

Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
           D++N  I+M    G    D I         ED   I  +I  +V   H   V+H DL   
Sbjct: 410 DLDNKRIMMSYINGKLAKDVI---------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTS 460

Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           NF+F     D D+ +IDFGL      DE
Sbjct: 461 NFIF-----DKDLYIIDFGLGKISNLDE 483

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	422
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.77
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.38
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.06
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.84
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.59
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.33
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.67
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.27
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.76
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.39
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.21

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.7e-66  Score=484.87  Aligned_cols=262  Identities=30%  Similarity=0.564  Sum_probs=238.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||+||+|+++.   +++.||||++.+.........+.+.+|+++|++|+ |||||+++++|.+++.+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence            369999999999999999999987   89999999998766555566788999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.+.
T Consensus       108 yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecC
Confidence            9999999999999998654 5799999999999999999999999999999999999994   58999999999998765


Q ss_pred             CC---CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PD---ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..   ....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|......++.    .+++
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~  259 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP  259 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence            33   2356789999999999987 47999999999999999999999999999999999999998877765    6899


Q ss_pred             HHHHHHHHhchhccccCCCHHH------HHhccCccchhhhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQ------ALSKLVVPILSFKIVC  420 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~e------lL~~l~~~~l~~k~~~  420 (422)
                      ++++||++||.+||++|+|++|      +++|+||+.+.|..+.
T Consensus       260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            9999999999999999999987      6899999998877654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-64  Score=467.94  Aligned_cols=254  Identities=32%  Similarity=0.575  Sum_probs=212.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++.+.........+.+.+|+++|++|+ |||||++++++.+.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            369999999999999999999887   88999999998776665556678999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||| +|+|.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+...
T Consensus        89 ~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC----
T ss_pred             EEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecC
Confidence            9999999 67999988654 6799999999999999999999999999999999999994   58899999999998877


Q ss_pred             CCCCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ......+.+||+.|||||++.+ . ++.++|||||||++|||++|+.||.+.+...++..+......++.    .+++++
T Consensus       164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~  239 (275)
T 3hyh_A          164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGA  239 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHH
T ss_pred             CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence            6666777899999999999875 4 468999999999999999999999998888899999888776654    689999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||++||++||++|||+.|+|+|+||+.
T Consensus       240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-63  Score=477.55  Aligned_cols=254  Identities=29%  Similarity=0.503  Sum_probs=226.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|+++++||+|+||.||+|+++.   +|+.||||++.......   .+.+.+|+++|+.|+ |||||+++++|.+.+.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            469999999999999999999987   89999999997654332   356889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++..  +.+++.+++.|+.||+.||+|||++|||||||||+||||+   .++.+||+|||+|+.+.
T Consensus       147 ~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecC
Confidence            999999999999998754  4699999999999999999999999999999999999994   58999999999998765


Q ss_pred             CC-CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .. ....+.+||+.|||||++. ..|+.++||||||||||||++|+.||.+....+.+..|...... ....+..+++++
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~  300 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSL  300 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHHH
T ss_pred             CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHHH
Confidence            43 4456789999999999987 47999999999999999999999999998888888888765432 222345799999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||.+||++||++|||+.|+|+|+||..
T Consensus       301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          301 KGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            99999999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-64  Score=481.00  Aligned_cols=256  Identities=27%  Similarity=0.488  Sum_probs=222.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++.+.... ....+.+.+|+++|++|+ |||||+++++|.+++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMS-SKEREESRREVAVLANMK-HPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence            479999999999999999999987   8899999999876543 334678999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |||||||+||+|.+++..+. ..+++.+++.|+.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+..
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceee
Confidence            99999999999999987654 4589999999999999999999999999999999999994   5889999999999876


Q ss_pred             CCCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .... ...+.+||+.|||||++.+ .|+.++||||||||||||++|+.||.+.+..+++..+.......   .+..++++
T Consensus       176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~  252 (350)
T 4b9d_A          176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYD  252 (350)
T ss_dssp             CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHH
T ss_pred             cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHH
Confidence            5432 2355789999999999875 69999999999999999999999999999999999988876432   23479999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++||.+||++||++|||+.|+|+|+||..
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.6e-63  Score=484.35  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=226.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ...|+++++||+|+||.||+|+++.   +|+.||||++......   ..+.+.+|+.+|+.|+ |||||+++++|.+.+.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence            3569999999999999999999987   8999999999765433   2356889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||+||+|.+++..  +.+++.+++.|+.||+.||+|||++|||||||||+||||+   .++.+||+|||+|+.+
T Consensus       223 ~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceEC
Confidence            9999999999999998754  4699999999999999999999999999999999999994   5899999999999876


Q ss_pred             CCC-CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ... ....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+....+.+..|...... ....+..++++
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~  376 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPS  376 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSCHH
T ss_pred             CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCCHH
Confidence            543 4456789999999999987 47999999999999999999999999999888888888765432 22234579999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++||.+||++||++|+|+.|+|+|+||..
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            999999999999999999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-63  Score=470.06  Aligned_cols=263  Identities=27%  Similarity=0.500  Sum_probs=227.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|++..+..+++.||||++.+...... ....+.+|+++|++|+ |||||++++++.+.+.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            479999999999999999999876555789999999987554332 2346788999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+...
T Consensus       102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC--
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceecc
Confidence            9999999999999988654 5799999999999999999999999999999999999994   58899999999998654


Q ss_pred             C-CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      . .....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|.+....++.    .+++++
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~  253 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEA  253 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHH
Confidence            3 34456789999999999986 57999999999999999999999999999999999999988776654    699999


Q ss_pred             HHHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      ++||++||++||++|+|     ++|+++|+||+.+.|..+
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l  293 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL  293 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence            99999999999999998     589999999998877644

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.1e-62  Score=455.03  Aligned_cols=254  Identities=22%  Similarity=0.356  Sum_probs=216.5

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----CC
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VN  224 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~  224 (422)
                      |++.++||+|+||.||+|+++.   ++..||||++...... ....+.+.+|+++|++|+ |||||+++++|.+    .+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence            5788899999999999999987   8899999999765433 334578999999999997 9999999999976    35


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++|  ||||||||+||||+  +.++.+||+|||+|
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla  179 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence            689999999999999988654 57999999999999999999999998  99999999999995  24689999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcCCCCCCCCCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +... .....+.+||+.|||||++.+.|+.++|||||||+||||++|+.||.+..... ++..+......  ......++
T Consensus       180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~  256 (290)
T 3fpq_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAI  256 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCC
T ss_pred             EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCC
Confidence            7543 44556789999999999998899999999999999999999999997755444 44444433221  11223578


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++++||.+||.+||++|||+.|+|+|+||+.
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-61  Score=457.01  Aligned_cols=244  Identities=27%  Similarity=0.352  Sum_probs=212.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ..|++.++||+|+||.||+|+++.   +|+.||||+++.....        .+|+.+|+.|+ |||||+++++|.+.+.+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            468999999999999999999987   8899999999765332        36999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC-CEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~-~vkl~DfG~a~~~  305 (422)
                      |||||||+||+|.+++... +.+++.+++.|+.||+.||.|||++|||||||||+||||+   .++ .+||+|||+|+.+
T Consensus       126 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEc
Confidence            9999999999999988655 5799999999999999999999999999999999999995   355 6999999999876


Q ss_pred             CCCCC------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDER------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .....      ....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.....++..|......+.. .++
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~  280 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE-IPP  280 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG-SCT
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh-cCc
Confidence            54322      234689999999999874 6999999999999999999999999988888888888876654332 235


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS  407 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~  407 (422)
                      .+++++++||.+||++||.+|||+.|+++
T Consensus       281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~  309 (336)
T 4g3f_A          281 SCAPLTAQAIQEGLRKEPVHRASAMELRR  309 (336)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            79999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-59  Score=455.31  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=221.3

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      .++++|++++.||+|+||+||+|+++.   +|+.||||++++... .....+.+.+|+++|+.|+ |||||++++++.. 
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  125 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPT  125 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecc
Confidence            345789999999999999999999987   899999999976432 2334567889999999997 9999999998764 


Q ss_pred             -----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          223 -----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       223 -----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                           .+.+|||||||+ |+|.+++.. .+.+++.+++.|+.||+.||.|||++|||||||||+|||++   .++.+||+
T Consensus       126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~  200 (398)
T 4b99_A          126 VPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIG  200 (398)
T ss_dssp             SCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEEC
T ss_pred             cccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEe
Confidence                 367999999996 588887754 56799999999999999999999999999999999999994   58999999


Q ss_pred             ecCcccccCCC-----CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          298 DFGLSDFIRPD-----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       298 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |||+|+.+...     ....+.+||+.|||||++.+  .|+.++||||||||+|||++|+.||.+.+..+++..|.....
T Consensus       201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g  280 (398)
T 4b99_A          201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG  280 (398)
T ss_dssp             CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999865432     23456799999999998764  579999999999999999999999999999888888765433


Q ss_pred             CCCCC---------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          371 NFDDL---------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       371 ~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .+...                           .++.++++++|||++||.+||++|+|+.|+|+|+||...
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            22211                           124578999999999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=437.36  Aligned_cols=251  Identities=23%  Similarity=0.400  Sum_probs=207.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++++++++||+|+||+||+|+++.      .||||+++.... .....+.+.+|+.+|++|+ |||||++++++.+ +.+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS------EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeE
Confidence            468899999999999999998643      499999875432 3345678999999999997 9999999998864 568


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++......+++.++..|+.||+.||.|||+++||||||||+||||+   +++.+||+|||+|+...
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC--
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecc
Confidence            999999999999999987778899999999999999999999999999999999999995   58899999999998654


Q ss_pred             CC---CCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC--CCC
Q 014559          307 PD---ERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--LPW  377 (422)
Q Consensus       307 ~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~  377 (422)
                      ..   ......+||+.|||||++.    +.|+.++|||||||+||||+||+.||.+......+..+.......+.  ..+
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            32   2345678999999999984    35899999999999999999999999886665555555443322221  234


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+++++.+||.+||+.||++|||+.|+++++
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            57899999999999999999999999988764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.4e-59  Score=475.95  Aligned_cols=262  Identities=32%  Similarity=0.561  Sum_probs=240.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|++++.||+|+||.||+|+++.   +|+.||||++.....   ...+.+.+|+++|+.|+ |||||+++++|.+.+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN  227 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccch---hhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence            44689999999999999999999987   899999999976432   23467889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||+||+|.+++..+.+.+++.+++.|+.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence            999999999999999998777778999999999999999999999999999999999999964 3458999999999998


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      +.........+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+....+++..|......++...+..++++
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            887777778899999999999874 6999999999999999999999999999999999999998888877777899999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++||++||++||.+|+++.|+|+|+||...
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-58  Score=446.80  Aligned_cols=261  Identities=24%  Similarity=0.411  Sum_probs=213.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|+++++||+|+||+||+|+++....+++.||||++....     ...++.+|+++|+.+.+|||||+++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            45678999999999999999999987543467899999986532     2356789999999997799999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +++|||||||+||+|.+++    +.+++.+++.++.||+.||+|||++|||||||||+|||++.  +.+.+||+|||+|+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~  166 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ  166 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred             CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence            9999999999999999977    35999999999999999999999999999999999999963  34789999999997


Q ss_pred             ccCCCC-----------------------------CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCC
Q 014559          304 FIRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       304 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~p  352 (422)
                      ......                             ...+.+||+.|+|||++.+  .|+.++||||+|||+|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            543221                             2234689999999999864  589999999999999999999999


Q ss_pred             CCCCC-hhHHHHHHHcC--------------------------------------CCC------------CCCCCCCCCC
Q 014559          353 FWART-ESGIFRAVLRS--------------------------------------DPN------------FDDLPWPSVS  381 (422)
Q Consensus       353 f~~~~-~~~~~~~i~~~--------------------------------------~~~------------~~~~~~~~~s  381 (422)
                      |.... +.+.+..|...                                      ...            .....|..++
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            96543 33444333210                                      000            0112356789


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++++|||++||.+||++|+|++|+|+|+||+.+.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-58  Score=435.35  Aligned_cols=251  Identities=23%  Similarity=0.381  Sum_probs=213.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.++||+|+||.||+|++..  ...++..||||+++..   .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            479999999999999999998753  1225789999999653   2334578999999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          225 NVYIVMELCEGGELLDRILAR------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      .+|||||||++|+|.+++...            ...+++.++..|+.||+.||.|||+++||||||||+||||+   .++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CCC
Confidence            999999999999999998753            24699999999999999999999999999999999999995   588


Q ss_pred             CEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 014559          293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR  367 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  367 (422)
                      .+||+|||+|+.......   ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....+++..+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986544332   23356999999999986 579999999999999999998 8999999888888888887


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHh
Q 014559          368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS  407 (422)
Q Consensus       368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~  407 (422)
                      +.....   ...+++++.+||.+||+.||++|||+.|++.
T Consensus       246 ~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~  282 (299)
T 4asz_A          246 GRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHT  282 (299)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            653211   1368999999999999999999999999965

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-59  Score=437.95  Aligned_cols=255  Identities=33%  Similarity=0.499  Sum_probs=199.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  224 (422)
                      .+|++++.||+|+||.||+|+++.   +|+.||||++....  .....+.+.+|+++|++|+ |||||+++++|.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence            469999999999999999999987   88999999997543  3334577899999999997 999999999997654  


Q ss_pred             ----------eEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          225 ----------NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       225 ----------~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                                .+|||||||++|+|.+++..+.  ....+..++.|+.||+.||+|||++|||||||||+||||+   .++
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~  155 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDD  155 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCC
Confidence                      3799999999999999886543  2345677899999999999999999999999999999995   588


Q ss_pred             CEEEeecCcccccCCCCC-------------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 014559          293 DMRLIDFGLSDFIRPDER-------------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE  358 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~  358 (422)
                      .+||+|||+|+.......             ..+.+||+.|||||++.+ .|+.++|||||||+||||++   ||....+
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            999999999987654321             234689999999999875 79999999999999999996   7864322


Q ss_pred             h-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          359 S-GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       359 ~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      . ..+..+....  ++. .+...++++.+||++||++||++|||+.|+|+|+||+.+.+
T Consensus       233 ~~~~~~~~~~~~--~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          233 RVRTLTDVRNLK--FPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHHHTTC--CCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHHHhcCC--CCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            2 2222333222  221 12245678899999999999999999999999999998766

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9e-58  Score=432.49  Aligned_cols=255  Identities=20%  Similarity=0.300  Sum_probs=216.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..++++.++||+|+||.||+|+...  ...+++.||||+++...  .....+.+.+|+.++++|+ |||||+++|+|.+.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence            3468999999999999999998642  12267899999996542  2334578999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                      +.++||||||++|+|.+++..+.               ..+++.++..|+.||+.||.|||+++||||||||+||||+  
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~--  179 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--  179 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC--
Confidence            99999999999999999986532               3589999999999999999999999999999999999994  


Q ss_pred             CCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 014559          289 RDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFR  363 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~  363 (422)
                       +++.+||+|||+++......   .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+....+++.
T Consensus       180 -~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 -DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             -GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             -CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             58899999999998654332   234568999999999876 689999999999999999998 899999998888888


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+..+....   ....++.++.+||.+||+.||++|||+.|+++++
T Consensus       259 ~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L  301 (308)
T 4gt4_A          259 MIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL  301 (308)
T ss_dssp             HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            887654321   1237899999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.1e-58  Score=437.15  Aligned_cols=252  Identities=23%  Similarity=0.395  Sum_probs=210.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+|.+.++||+|+||.||+|+++.  ...+++.||||+++..   .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            468999999999999999998753  2236789999999653   3334578999999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          225 NVYIVMELCEGGELLDRILAR--------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      .+|||||||++|+|.+++...              .+.+++.++..|+.||+.||.|||+++||||||||+||||+   .
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence            999999999999999988653              24699999999999999999999999999999999999995   5


Q ss_pred             CCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 014559          291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV  365 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  365 (422)
                      ++.+||+|||+++.......   ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....+.+..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            88999999999986643322   24467999999999986 479999999999999999999 89999998888888888


Q ss_pred             HcCCC-CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          366 LRSDP-NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       366 ~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+.. ..+    ..+++++.+||.+||+.||++|||+.|+++++
T Consensus       274 ~~g~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L  314 (329)
T 4aoj_A          274 TQGRELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL  314 (329)
T ss_dssp             HHTCCCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred             HcCCCCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            77542 222    36899999999999999999999999998864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.8e-57  Score=462.85  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=225.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHH---HHHHHhcCCCCeeEEEeEEEeC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV---KILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++.+...........+.+|.   .+++.++ |||||+++++|.+.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTP  264 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECS
T ss_pred             HHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEEC
Confidence            579999999999999999999987   8999999999876554444445555554   4445554 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||   +.+|.+||+|||+|+
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLAC  340 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceee
Confidence            9999999999999999988665 579999999999999999999999999999999999999   468999999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .+.. ....+.+||+.|||||++. + .|+.++||||||||||||++|+.||.+..   ...+...+......++.    
T Consensus       341 ~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~----  415 (689)
T 3v5w_A          341 DFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----  415 (689)
T ss_dssp             ECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT----
T ss_pred             ecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc----
Confidence            7653 3456789999999999985 3 69999999999999999999999997642   34556667776666554    


Q ss_pred             CCCHHHHHHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      .+++++++||.+||++||.+|++     +.|+++|+||+.+.|..+
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence            79999999999999999999998     899999999999998765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-56  Score=430.61  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=212.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .++|++++.||+|+||.||+|++...  ...++.||||++.....  ....+.+.+|+++|.++..|||||+++++|.+.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            35799999999999999999997642  23457899999975432  234567899999999997569999999999764


Q ss_pred             -CeEEEEEEccCCCChHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          224 -NNVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       224 -~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                       +.+|||||||++|+|.+++...               ...+++.++..|+.||+.||.|||+++||||||||+|||++ 
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-  219 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  219 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-
Confidence             5699999999999999998753               23489999999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        +++.+||+|||+|+.......   ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+......+
T Consensus       220 --~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             --CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              588999999999987654332   34567999999999986 579999999999999999998 99999886644444


Q ss_pred             -HHHHcCC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 -RAVLRSD-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 -~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                       ..+..+. ...+    ..+++++.+||.+||+.||++|||+.|+++++
T Consensus       298 ~~~i~~g~~~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          298 CRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence             4444332 2222    26899999999999999999999999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-53  Score=413.20  Aligned_cols=262  Identities=27%  Similarity=0.486  Sum_probs=230.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.+
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            479999999999999999999987   78999999998765545556677889999999986699999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecc
Confidence            9999999999999988654 5799999999999999999999999999999999999994   58999999999998543


Q ss_pred             -CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 -PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                       ........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||......+++..+......++.    .++.++
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  251 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDA  251 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence             2334556789999999999864 6999999999999999999999999999999999999988877665    589999


Q ss_pred             HHHHHHhchhccccCCCH------HHHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRMTA------VQALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~------~elL~~l~~~~l~~k~~  419 (422)
                      .+||++||++||.+|+++      .|+++|+||+.+.|..+
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l  292 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL  292 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence            999999999999999999      99999999999887654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-53  Score=411.29  Aligned_cols=269  Identities=34%  Similarity=0.589  Sum_probs=236.8

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---hcHHHHHHHHHHHHHhcCCCCeeEEEeE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDA  219 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~  219 (422)
                      ..+.++|++++.||+|+||.||+|+++.   +|+.||||++.+......   ...+.+.+|+.+++.++ ||||++++++
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~   83 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDV   83 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEE
Confidence            3466789999999999999999999987   889999999987543221   23578899999999997 9999999999


Q ss_pred             EEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEee
Q 014559          220 CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLID  298 (422)
Q Consensus       220 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~D  298 (422)
                      +.+.+.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999999998744 46799999999999999999999999999999999999996311 012799999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+......++...|
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            999988776666677889999999999874 7999999999999999999999999999999999999888777665556


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ..++.++++||++||..||.+||++.|+|+|+||..+.+
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            689999999999999999999999999999999986543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.6e-53  Score=404.73  Aligned_cols=261  Identities=28%  Similarity=0.515  Sum_probs=233.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEE
Confidence            479999999999999999999886   78999999998765444445678899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        81 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence            9999999999999887654 5799999999999999999999999999999999999994   58899999999998643


Q ss_pred             -CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                       ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.......+...+......++.    .+++++
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  232 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEA  232 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence             334456778999999999986 46899999999999999999999999998888888888887766654    689999


Q ss_pred             HHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++||.+||..||.+|+     ++.|+++|+||..+.|..+
T Consensus       233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            9999999999999999     9999999999998877643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-52  Score=402.83  Aligned_cols=256  Identities=34%  Similarity=0.589  Sum_probs=230.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||+|++..   +|+.||||++..... .....+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCE
Confidence            3579999999999999999999876   889999999976543 3334577889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGG
T ss_pred             EEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceec
Confidence            99999999999999988665 5699999999999999999999999999999999999994   5889999999999877


Q ss_pred             CCCCCccccccCCcccCccccCc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      .........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.........+......++.    .++.+
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~  240 (328)
T 3fe3_A          165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTD  240 (328)
T ss_dssp             SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred             CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            76666777899999999999864 44 57999999999999999999999999988888888888776654    58999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +.+||++||..||.+|||+.|+|+|+|++..
T Consensus       241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-53  Score=408.33  Aligned_cols=263  Identities=27%  Similarity=0.513  Sum_probs=235.6

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++++.||+|+||.||+|++..   +++.||+|++....    ...+.+.+|+.+++.++ ||||+++++++.+.
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   73 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence            355789999999999999999999887   78899999986432    23466889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||++.
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCe
Confidence            9999999999999999988666667999999999999999999999999999999999999964 236899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ............||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......+....|..++.
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T 1tki_A          153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence            8776666667789999999999875 579999999999999999999999999999999999998887776656678999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++.+||.+||..||.+|||+.|+|+|+||....
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999999987543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-53  Score=404.81  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=192.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  224 (422)
                      ..+|.+.++||+|+||.||+|++     +|+.||||++.....    .....++|+..+.+|+ |||||++++++.+.+ 
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNG   71 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence            35689999999999999999986     567899999865322    1123445666677886 999999999998764 


Q ss_pred             ---eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEeeCCCCCC
Q 014559          225 ---NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       225 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~Dikp~NIll~~~~~~~~  293 (422)
                         .+|||||||++|+|.+++...  .++++.+.+++.|++.||.|||++        +||||||||+||||   +.++.
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~  146 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  146 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence               689999999999999988654  699999999999999999999987        99999999999999   46899


Q ss_pred             EEEeecCcccccCCCCC-----ccccccCCcccCccccCc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 014559          294 MRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWART----  357 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlG~il~ell~g~~pf~~~~----  357 (422)
                      +||+|||+++.......     ....+||+.|||||++.+       .|+.++|||||||+||||+||..||....    
T Consensus       147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            99999999987654332     234689999999999864       36789999999999999999977653211    


Q ss_pred             -----------hhHHHHHHHcCCC--CCCCCC-CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 -----------ESGIFRAVLRSDP--NFDDLP-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 -----------~~~~~~~i~~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                                 ...+...+.....  .++... ....++.+.+||.+||+.||++|||+.|+++.+
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  292 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                       1223333332221  121110 012335789999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.7e-53  Score=410.09  Aligned_cols=265  Identities=35%  Similarity=0.647  Sum_probs=237.4

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+.++|++.+.||+|+||.||+|.++.   +++.||||++...... ....+.+.+|+.+++.|+ ||||+++++++.+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~   99 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQE   99 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence            3456789999999999999999999887   7899999999765432 334567899999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+..|+|||||.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999999999988754 357999999999999999999999999999999999999975444567999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+......++...|..++
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred             eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            87776666667889999999999875 79999999999999999999999999988888888998888777777777899


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++++||.+||..||.+||++.|+|+|+|+..
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-52  Score=410.94  Aligned_cols=262  Identities=25%  Similarity=0.505  Sum_probs=227.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|..++.++.+||||++++++|.+.+.+
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            579999999999999999999987   78999999998765555445567889999999886699999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc-c
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-I  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~-~  305 (422)
                      |||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++. .
T Consensus       129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred             EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecc
Confidence            9999999999999887654 5799999999999999999999999999999999999994   589999999999986 3


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHcCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~  375 (422)
                      .........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||...         ....+...+......++. 
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-  283 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-  283 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT-
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC-
Confidence            34455677899999999999874 7999999999999999999999999532         234466677777766664 


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCH------HHHHhccCccchhhhhh
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTA------VQALSKLVVPILSFKIV  419 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~------~elL~~l~~~~l~~k~~  419 (422)
                         .++.++++||++||++||.+|+++      .|+++|+||..+.|..+
T Consensus       284 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l  330 (396)
T 4dc2_A          284 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  330 (396)
T ss_dssp             ---TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred             ---cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence               689999999999999999999985      89999999999888654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=416.60  Aligned_cols=265  Identities=35%  Similarity=0.633  Sum_probs=236.3

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++++.||+|+||.||+|.++.   +|+.||+|++...... ....+.+.+|+.+++.|+ ||||+++++++.+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLS-ARDHQKLEREARICRLLK-HPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence            456789999999999999999999887   8899999999765433 234567899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||.||+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++.
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999999999988664 569999999999999999999999999999999999999764467899999999997


Q ss_pred             ccCCCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+......++...|..++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence            665433 3456789999999999875 69999999999999999999999999999999999999988888888888999


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++++||.+||..||.+||++.|+|+|+|+...
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999999654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-52  Score=413.56  Aligned_cols=257  Identities=33%  Similarity=0.574  Sum_probs=213.3

Q ss_pred             ccceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--
Q 014559          146 GAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       146 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  222 (422)
                      .++|.+. +.||+|+||.||+|+++.   +++.||||++...        ..+.+|+.++.++.+|+||+++++++..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3467776 789999999999999887   8899999998532        4567899998776669999999999876  


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          223 --VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                        .+.+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567999999999999999987643 46999999999999999999999999999999999999975334789999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHcCCCCCCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDD  374 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~  374 (422)
                      |+++...........+||+.|+|||++. ..|+.++|||||||++|||++|+.||......    .....+......++.
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            9998776555566788999999999986 47999999999999999999999999765432    255666667767776


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ..|..++.++++||++||..||.+|||+.|+|+|+||..
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            667789999999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-52  Score=403.33  Aligned_cols=262  Identities=27%  Similarity=0.464  Sum_probs=233.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.+
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            479999999999999999999987   78999999998765444445677889999999885599999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcc
Confidence            9999999999999988654 5799999999999999999999999999999999999994   58899999999997643


Q ss_pred             C-CCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 P-DERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      . .......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.....++..+......++.    .++.++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  245 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA  245 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHH
Confidence            2 334566789999999999864 6899999999999999999999999999888999999887776654    589999


Q ss_pred             HHHHHHhchhccccCCCHH-HHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRMTAV-QALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~-elL~~l~~~~l~~k~~  419 (422)
                      ++||.+||..||.+|+++. ++++|+||..+.|..+
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l  281 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  281 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence            9999999999999999998 9999999998887654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-52  Score=403.13  Aligned_cols=262  Identities=24%  Similarity=0.451  Sum_probs=234.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|..++..+.+|+||+++++++.+.+.+
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            579999999999999999999886   78999999998765444455678889999999886699999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcccccc
Confidence            9999999999999988654 5699999999999999999999999999999999999994   58899999999998643


Q ss_pred             -CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                       ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+++..+......++.    .++.++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  248 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEA  248 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHH
Confidence             334456678999999999986 47999999999999999999999999999999999999988776664    689999


Q ss_pred             HHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          385 KDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++||++||..||.+|+     +++|+++|+||..+.|..+
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l  288 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  288 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence            9999999999999999     4799999999998887654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-51  Score=399.05  Aligned_cols=262  Identities=25%  Similarity=0.491  Sum_probs=229.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.+++++.+||||+++++++.+.+.+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            479999999999999999999987   78999999998776655556677899999999985599999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEecccccccc
Confidence            9999999999999988654 5799999999999999999999999999999999999994   58899999999998633


Q ss_pred             -CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCC---------CChhHHHHHHHcCCCCCCCC
Q 014559          307 -PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA---------RTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~  375 (422)
                       ........+||+.|+|||++.+ .++.++|||||||++|||++|+.||..         .....+...+......++. 
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-  240 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-  240 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-
Confidence             3344566789999999999864 789999999999999999999999965         2334556667776665554 


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCH------HHHHhccCccchhhhhh
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTA------VQALSKLVVPILSFKIV  419 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~------~elL~~l~~~~l~~k~~  419 (422)
                         .++.++++||++||..||.+|+++      .|+++|+||..+.|..+
T Consensus       241 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~  287 (345)
T 3a8x_A          241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  287 (345)
T ss_dssp             ---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred             ---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence               689999999999999999999995      89999999998887644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-52  Score=395.85  Aligned_cols=259  Identities=22%  Similarity=0.517  Sum_probs=232.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEE
Confidence            479999999999999999999887   78999999998765444455678889999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        82 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             EEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred             EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecC
Confidence            999999999999998765 45799999999999999999999999999999999999994   58899999999998654


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .  .....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++.    .++.+++
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  231 (318)
T 1fot_A          158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVK  231 (318)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHH
Confidence            3  345678999999999986 46899999999999999999999999998888888899887766654    6899999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      +||++||..||.+|+     +++|+++|+||..+.|..+
T Consensus       232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~  270 (318)
T 1fot_A          232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  270 (318)
T ss_dssp             HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence            999999999999999     9999999999998877654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-52  Score=404.41  Aligned_cols=267  Identities=32%  Similarity=0.570  Sum_probs=228.6

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc--hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+.++|++.+.||+|+||.||+|+++.   +++.||||++.......  ....+.+.+|+.+++.++ ||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~   96 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS   96 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            355689999999999999999999887   78999999997643322  123577899999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          222 DVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      +.+.+|||||||++++|.+.+...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999999998877653   34589999999999999999999999999999999999997544456699999


Q ss_pred             cCcccccCCCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          299 FGLSDFIRPDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       299 fG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      ||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. ....+..+......+....
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~  255 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ  255 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc
Confidence            999987654433 445689999999999864 6899999999999999999999999774 4556677777665555444


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      |..++.++++||++||..||++||++.|+|+|+||+...
T Consensus       256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            567999999999999999999999999999999997654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-52  Score=406.36  Aligned_cols=262  Identities=33%  Similarity=0.553  Sum_probs=233.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +.++|++++.||+|+||.||+|+++.   +++.||+|++....   ......+.+|+.+++.|+ |+||+++++++.+.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY  121 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred             cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence            44689999999999999999999887   78899999996542   223457889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++||||||.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence            999999999999999988766667999999999999999999999999999999999999963 2457899999999988


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ..........+||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+..+......+....+..++++
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            766655566789999999999864 6899999999999999999999999998888888888887777766667789999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++||.+||..||.+||++.|+|+|+||...
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            9999999999999999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.9e-52  Score=396.27  Aligned_cols=267  Identities=36%  Similarity=0.602  Sum_probs=233.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---hhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      .+.++|++.+.||+|+||.||+|+++.   +++.||||++.......   ....+.+.+|+.+++.++ ||||+++++++
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   83 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY   83 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            456789999999999999999999887   78999999997654322   124578999999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEeec
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF  299 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~Df  299 (422)
                      .+.+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999999998744 46799999999999999999999999999999999999996311 1227999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      |++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+.
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (326)
T 2y0a_A          163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  242 (326)
T ss_dssp             TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence            9998876666666778999999999987 479999999999999999999999999988888888888776666544456


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .++.++.+||++||..||.+|||+.|+|+|+||....
T Consensus       243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            7899999999999999999999999999999997543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-52  Score=414.67  Aligned_cols=268  Identities=28%  Similarity=0.447  Sum_probs=232.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|++++.||+|+||.||+|+++.   +++.||||++.+...........+.+|+.++..++ |+||++++++|.+.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDN  147 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCC
Confidence            34689999999999999999999987   78899999997654433333445889999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||.||+|.+++....+.+++..++.++.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhh
Confidence            9999999999999999987766789999999999999999999999999999999999999   4689999999999976


Q ss_pred             cCCCCC--ccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--CCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNFDD  374 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~  374 (422)
                      ......  ....+||+.|+|||++.      +.|+.++|||||||++|||++|+.||.+....+.+..+....  ..++.
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  304 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT  304 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred             cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence            654433  23468999999999974      358999999999999999999999999988888888887643  22322


Q ss_pred             CCCCCCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhhhhhh
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~k~~~  420 (422)
                       .+..+++++++||++||+.+|++  |++++|+++|+||..+.|..++
T Consensus       305 -~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          305 -QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             -SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             -ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence             12468999999999999999988  9999999999999988877654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.3e-52  Score=411.74  Aligned_cols=264  Identities=27%  Similarity=0.434  Sum_probs=229.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.+++.++ |||||+++++|.+.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR  142 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence            34579999999999999999999987   78999999997654333333456789999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||+||+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEe
Confidence            99999999999999998754  369999999999999999999999999999999999999   4689999999999987


Q ss_pred             cCCCC--CccccccCCcccCccccCc-c----CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          305 IRPDE--RLNDIVGSAYYVAPEVLHR-S----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       305 ~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      .....  ...+.+||+.|+|||++.+ .    |+.++|||||||+||||++|+.||.+......+..+......+....+
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  297 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD  297 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence            65443  2346789999999999753 2    789999999999999999999999999988888888875433333334


Q ss_pred             CCCCHHHHHHHHHhchhcccc--CCCHHHHHhccCccchhhh
Q 014559          378 PSVSPEAKDFVKRLLNKDYRK--RMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~--Rps~~elL~~l~~~~l~~k  417 (422)
                      ..++.++++||++||..+|.+  |++++|+++|+||+.+.|.
T Consensus       298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            479999999999999999998  9999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=401.25  Aligned_cols=262  Identities=24%  Similarity=0.510  Sum_probs=230.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++++.||+|+||.||+|++..   +++.||||++.+...........+.+|+.+++.++ |||||+++++|.+.+.
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED   89 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence            3579999999999999999999887   78999999998765555556678999999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAML  165 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeec
Confidence            9999999999999987754 46799999999999999999999999999999999999994   5889999999999887


Q ss_pred             CCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCC---ChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWAR---TESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .........+||+.|+|||++.    ..|+.++|||||||++|||++|+.||...   .....+..+......++.    
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----  241 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----  241 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----
Confidence            7666777889999999999985    24899999999999999999999999743   334455555555555543    


Q ss_pred             CCCHHHHHHHHHhchhccccCCC-HHHHHhccCccchhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMT-AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps-~~elL~~l~~~~l~~k~~  419 (422)
                      .++.++.+||.+||..||.+|++ +.+++.|+||..+.|..+
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV  283 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence            68999999999999999999998 999999999999887654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-51  Score=398.52  Aligned_cols=259  Identities=28%  Similarity=0.508  Sum_probs=233.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEE
Confidence            579999999999999999999887   78999999998765544456678899999999996 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ||||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred             EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceecc
Confidence            9999999999999988665 5699999999999999999999999999999999999994   58899999999998664


Q ss_pred             CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .  .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.......++..+......++.    .++.++.
T Consensus       193 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  266 (350)
T 1rdq_E          193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK  266 (350)
T ss_dssp             S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHH
T ss_pred             C--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHH
Confidence            3  345678999999999976 47899999999999999999999999998888899999888766654    6899999


Q ss_pred             HHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      +||.+||+.||.+|++     +.|+++|+||..+.|..+
T Consensus       267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence            9999999999999998     999999999998877543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-52  Score=420.99  Aligned_cols=268  Identities=39%  Similarity=0.675  Sum_probs=243.1

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+..+|++.+.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.++++++ ||||+++++++.+
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~   97 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED   97 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            3466789999999999999999999887   88999999998766555556788999999999996 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+|+|||||.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999999999999999987654 57999999999999999999999999999999999999965456789999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+.+..+......+....|..+++
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            88776666667789999999999988999999999999999999999999999999999999998887777666778999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++++||++||..||.+|||+.|+|+|+|+....
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999997543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-51  Score=417.37  Aligned_cols=265  Identities=38%  Similarity=0.701  Sum_probs=236.9

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++++.||+|+||.||+|+++.   +++.||||++.+.... ......+.+|+.++++++ ||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence            456789999999999999999999886   7899999999764432 224577899999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|+|||||.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999999999988665 579999999999999999999999999999999999999765557789999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|+.||.+....+++..+......+....|..++++
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            77766666778899999999999988999999999999999999999999999999999999988877776667789999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++||++||..||.+|||+.|+|+|+|++..
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-51  Score=417.69  Aligned_cols=267  Identities=40%  Similarity=0.677  Sum_probs=235.8

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++++.||+|+||.||+|+++.   ++..||||++.+...... ....+.+|+.+++.++ ||||+++++++.+.
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  108 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK  108 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence            455689999999999999999999987   788999999986543222 2467889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999999999988665 569999999999999999999999999999999999999754456779999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            87766666778899999999999888999999999999999999999999999999999999988888777778899999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      +++||++||..||.+|||+.|+|+|+|++....
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            999999999999999999999999999976543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-51  Score=385.31  Aligned_cols=263  Identities=34%  Similarity=0.643  Sum_probs=224.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|+++.   +++.||+|++.....  ....+.+.+|++++++++ ||||+++++++.+.
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   92 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY   92 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             ChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence            456789999999999999999999887   788999999976542  234578899999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          224 NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      +.+++||||+++++|.+.+..   ....+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            999999999999999998864   34679999999999999999999999999999999999999654456889999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ++.............||..|+|||++.+.++.++|||||||++|||++|+.||.+.........+......+... ...+
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  251 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL  251 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred             cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence            998776665566778999999999998889999999999999999999999999888877777776655544332 2358


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++++.+||.+||..||++||++.|+|+|+||+.
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999999973

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-51  Score=391.93  Aligned_cols=266  Identities=27%  Similarity=0.391  Sum_probs=220.1

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+.+.++|++++.||+|+||.||+|++.    +++.||||++..... .......+.+|++++++++ ||||+++++++.
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   89 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIH   89 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEc
Confidence            3456678999999999999999999985    578999999975432 2223467889999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.+.++|||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~  165 (311)
T 3niz_A           90 SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGL  165 (311)
T ss_dssp             CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcC
Confidence            99999999999975 88888877767799999999999999999999999999999999999994   578999999999


Q ss_pred             ccccCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC--
Q 014559          302 SDFIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--  376 (422)
Q Consensus       302 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--  376 (422)
                      ++..... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+...........  
T Consensus       166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            9876433 33455678999999998753  589999999999999999999999988777766666544211111100  


Q ss_pred             ------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          377 ------------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       377 ------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                                              .+.+++++.+||++||++||.+|||+.|+|+|+||+.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence                                    13478899999999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.1e-51  Score=382.50  Aligned_cols=266  Identities=35%  Similarity=0.649  Sum_probs=237.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|.++.   +++.||+|++..... .....+.+.+|+.++++++ |+||+++++++.+.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence            466789999999999999999999887   788999999976543 3334577889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +..++||||+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++..+.+||+|||++.
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999999999999999887665 569999999999999999999999999999999999999754445669999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ............||..|+|||++.+ .++.++|||||||++|+|++|+.||...........+......++...+..+++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  236 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence            7766666667789999999999864 689999999999999999999999999988888888888887777766778999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++.+||.+||..||++||++.|+|+|+||....
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999999999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-51  Score=384.86  Aligned_cols=265  Identities=38%  Similarity=0.699  Sum_probs=237.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|++..   ++..||+|++......   ..+.+.+|+++++.++ |+||+++++++.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   78 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLD-HPNIIRLYETFEDN   78 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            456789999999999999999999887   7889999999764332   3577899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999999999999999987654 569999999999999999999999999999999999999654568899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ............||+.|+|||++.+.++.++|||||||++|+|++|+.||......+....+......++...+..++++
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence            87766666777899999999999888999999999999999999999999998888888888888777766555679999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      +.+||.+||+.||.+||++.|+|+|+||+....
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            999999999999999999999999999976543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-52  Score=408.64  Aligned_cols=267  Identities=29%  Similarity=0.436  Sum_probs=229.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+.++..++ |+||+++++++.+.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDEN  134 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCC
Confidence            34679999999999999999999986   88999999997654433334456889999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||+||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhhee
Confidence            9999999999999999998766689999999999999999999999999999999999999   4589999999999987


Q ss_pred             cCCCCC--ccccccCCcccCccccC--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC--CCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNF  372 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~  372 (422)
                      ......  ....+||+.|+|||++.        +.|+.++|||||||++|||++|+.||......+.+..+....  ..+
T Consensus       212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  291 (412)
T 2vd5_A          212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL  291 (412)
T ss_dssp             CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence            654433  23468999999999975        358999999999999999999999999988888888887533  222


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccC---CCHHHHHhccCccchhhhhhh
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~elL~~l~~~~l~~k~~~  420 (422)
                      +. ....++.++++||++||+ +|.+|   ++++|+++|+||..+.|..++
T Consensus       292 p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          292 PL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             Cc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            21 123689999999999999 99998   599999999999988876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-51  Score=386.52  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=221.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++..   +++.||||++......   ..+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence            45689999999999999999999876   7899999999754432   3467889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|+|||||++++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCcee
Confidence            999999999999999988654  699999999999999999999999999999999999994   588999999999976


Q ss_pred             cCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+........ .....++.
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSA  244 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCH
T ss_pred             cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCH
Confidence            65433 345568999999999876 5789999999999999999999999988777666665554332211 11236899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++.+||.+||+.||.+||++.|+|+|+||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.3e-52  Score=400.68  Aligned_cols=257  Identities=32%  Similarity=0.566  Sum_probs=221.9

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..-.+|++.+.||+|+||.||+|++..   +++.||||++.............+.+|+.+++.++ ||||+++++++.+.
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP   81 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence            344579999999999999999999877   88999999997654444444567899999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccce
Confidence            9999999999 67999988665 5699999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||...........+......++    ..++
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  232 (336)
T 3h4j_B          157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLS  232 (336)
T ss_dssp             TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSC
T ss_pred             eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCC
Confidence            8776666777899999999999875 33 7899999999999999999999987655444333333332222    2589


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++.+||++||..||.+|||+.|+++|+||+.
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            99999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-51  Score=400.10  Aligned_cols=261  Identities=27%  Similarity=0.517  Sum_probs=221.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHH-HHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI-LKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.+...........+.+|..+ ++.++ ||||+++++++.+.+.
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADK  113 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCE
Confidence            479999999999999999999887   788999999987665544455667778776 45565 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGG
T ss_pred             EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCcccccc
Confidence            99999999999999987654 5799999999999999999999999999999999999994   5889999999999863


Q ss_pred             -CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 -RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 -~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                       .........+||+.|+|||++.+ .|+.++|||||||++|||++|..||......+++..+......++.    .++.+
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~  265 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNS  265 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHH
T ss_pred             ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHH
Confidence             33445567889999999999864 6999999999999999999999999998888999999887665553    68999


Q ss_pred             HHHHHHHhchhccccCCCH----HHHHhccCccchhhhhh
Q 014559          384 AKDFVKRLLNKDYRKRMTA----VQALSKLVVPILSFKIV  419 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~----~elL~~l~~~~l~~k~~  419 (422)
                      +++||++||+.||.+|+++    .++++|+||..+.|.-+
T Consensus       266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL  305 (373)
T ss_dssp             HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence            9999999999999999986    69999999998887654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-51  Score=416.82  Aligned_cols=267  Identities=37%  Similarity=0.680  Sum_probs=234.5

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch----------hcHHHHHHHHHHHHHhcCCCC
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA----------ISIEDVRREVKILKALSGHKH  212 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~n  212 (422)
                      ..+..+|+++++||+|+||.||+|+++.   +++.||||++........          ...+.+.+|+.++++|+ |||
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  107 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN  107 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence            3466789999999999999999999987   788999999976543321          33567899999999997 999


Q ss_pred             eeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      |+++++++.+.+.+|||||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+....
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999999999988665 5699999999999999999999999999999999999997533334


Q ss_pred             CEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC
Q 014559          293 DMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      .+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            79999999998877666667788999999999999889999999999999999999999999999999999999888776


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ....|..+++++++||++||..||.+|||+.|+|+|+|++..
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            665667899999999999999999999999999999998643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=401.13  Aligned_cols=261  Identities=33%  Similarity=0.560  Sum_probs=227.8

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      |...+.||+|+||.||+|++..   +|+.||||++.....   ...+.+.+|++++++|+ |+||+++++++.+.+.++|
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEEEECC-----CEEEEEETT---TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccccc---ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence            3446789999999999999877   789999999976432   23467899999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      ||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+++.....
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence            99999999999988776667999999999999999999999999999999999999964 34678999999999887766


Q ss_pred             CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 014559          309 ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF  387 (422)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  387 (422)
                      ......+||+.|+|||++. +.++.++|||||||++|||++|+.||.+....+.+..+......+....+..+++++++|
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            6666778999999999986 468999999999999999999999999998888888888877766665567899999999


Q ss_pred             HHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          388 VKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      |.+||..||.+||++.|+|+|+||....+.
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDHKLH  352 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence            999999999999999999999999877543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=395.25  Aligned_cols=262  Identities=38%  Similarity=0.654  Sum_probs=211.9

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|++..   +++.||||++....     ..+.+.+|+.++++++ |+||+++++++.+.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  120 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP  120 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence            455689999999999999999999886   78899999997542     2356789999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             CeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999999998754 4569999999999999999999999999999999999999754458899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ...........+||+.|+|||++.+ .++.++|||||||++|||++|..||....... .+..+......+....+..++
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence            7665555566789999999999875 69999999999999999999999997765544 666777766666555567899


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .++.+||++||..||++||++.|+|+|+||....
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999999999999997543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-50  Score=382.30  Aligned_cols=259  Identities=26%  Similarity=0.442  Sum_probs=217.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||||++..... .......+.+|+.++++++ |+||+++++++.+.+.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence            479999999999999999999987   789999999976543 3334567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +|||||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecC
Confidence            999999975 78888877778899999999999999999999999999999999999994   58899999999998664


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHcCCCCCCCC-------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPF-WARTESGIFRAVLRSDPNFDDL-------  375 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~-------  375 (422)
                      .. .......||..|+|||++.+  .++.++|||||||++|+|++|..|| ........+..+..........       
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            33 33455688999999999864  3899999999999999999988885 4455555555554321111111       


Q ss_pred             ------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          376 ------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       376 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                        ..+.++.++++||++||+.||++|||++|+|+|+||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                              123578999999999999999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-50  Score=388.36  Aligned_cols=264  Identities=25%  Similarity=0.465  Sum_probs=220.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+|++.+.||+|+||.||+|++..+..+++.||||++.+.... .......+.+|+.+++.++ |+||+++++++.+.+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            35799999999999999999998654448899999999765332 2223456788999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+||||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC--
T ss_pred             EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCcccc
Confidence            999999999999999988654 5699999999999999999999999999999999999994   588999999999975


Q ss_pred             cCC-CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRP-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ... .......+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++.    .++.
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~  246 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQ  246 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence            432 23345678999999999976 46899999999999999999999999998888888888887766554    6899


Q ss_pred             HHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      ++++||.+||..||.+||     ++.|+++|+||..+.|..
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~  287 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE  287 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence            999999999999999999     899999999999877654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-51  Score=394.63  Aligned_cols=259  Identities=36%  Similarity=0.580  Sum_probs=225.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|+++.   +++.||||++.+....       ..+|++++.++.+||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            456789999999999999999999987   7899999999765422       356888998886699999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEeecCcc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDFGLS  302 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~DfG~a  302 (422)
                      +.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999999998754 45799999999999999999999999999999999999995321 1245999999999


Q ss_pred             cccCCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCC---CChhHHHHHHHcCCCCCCCCCC
Q 014559          303 DFIRPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA---RTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       303 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +..... ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||..   ....+++..+......+....|
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            866443 33456789999999999875 589999999999999999999999976   3556777888888777776677


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ..+++++++||++||..||++||++.|+|+|+||..
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            889999999999999999999999999999999843

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.5e-51  Score=391.86  Aligned_cols=274  Identities=29%  Similarity=0.497  Sum_probs=235.0

Q ss_pred             CcCcccccceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEe
Q 014559          140 GYNKNFGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD  218 (422)
Q Consensus       140 ~~~~~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~  218 (422)
                      ...+.+..+|.+. +.||+|+||.||+|++..   +++.||||++...... ......+.+|+.+++.+.+|+||+++++
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3456677889998 899999999999999887   7899999999765432 2345778999999999987899999999


Q ss_pred             EEEeCCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          219 ACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       219 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      ++.+.+.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999999999877543 3579999999999999999999999999999999999999643346899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      |||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+......+....
T Consensus       177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  256 (327)
T 3lm5_A          177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET  256 (327)
T ss_dssp             CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence            999998776665566678999999999986 5789999999999999999999999999888888888888777777766


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      +..++.++.+||.+||..||.+||++.|+|+|+||+...+.
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            77899999999999999999999999999999999877654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-51  Score=408.51  Aligned_cols=262  Identities=27%  Similarity=0.500  Sum_probs=222.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||+|++..   +++.||||++.............+.+|+.+++.++ |+||+++++++.+.+.
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDR  222 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCE
Confidence            3579999999999999999999887   88999999998754444445567788999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|||||||++|+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+||||+   .++.+||+|||+++.
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCCT
T ss_pred             EEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCcee
Confidence            99999999999999887654 579999999999999999999998 9999999999999994   588999999999976


Q ss_pred             cC-CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IR-PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .. ........+||+.|+|||++. ..|+.++|||||||+||||++|+.||...........+......++.    .+++
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~  374 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGP  374 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence            43 333456678999999999986 57999999999999999999999999998888888888887776654    6899


Q ss_pred             HHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++.+||.+||..||.+||     ++.|+|+|+||..+.|..+
T Consensus       375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~  416 (446)
T 4ejn_A          375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV  416 (446)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence            999999999999999999     9999999999999877654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-50  Score=385.44  Aligned_cols=269  Identities=33%  Similarity=0.541  Sum_probs=219.5

Q ss_pred             cCcccccceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeE
Q 014559          141 YNKNFGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA  219 (422)
Q Consensus       141 ~~~~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  219 (422)
                      +...+.+.|++. +.||+|+||.||+|++..   +++.||||++....   ....+.+.+|+.++.++.+|+||++++++
T Consensus         6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~   79 (316)
T 2ac3_A            6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEF   79 (316)
T ss_dssp             SCCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            345677889995 789999999999999876   78899999997543   23457789999999996569999999999


Q ss_pred             EEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          220 CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       220 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                      +.+.+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           80 FEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            99999999999999999999988665 56999999999999999999999999999999999999964333345999999


Q ss_pred             CcccccCCCC--------CccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------
Q 014559          300 GLSDFIRPDE--------RLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTE-------  358 (422)
Q Consensus       300 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------  358 (422)
                      |++.......        .....+||..|+|||++.      ..++.++|||||||++|||++|+.||.....       
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            9987553221        123456999999999975      3589999999999999999999999976542       


Q ss_pred             --------hHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          359 --------SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       359 --------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                              ......+......++...+..++.++++||++||..||.+||++.|+|+|+||+....
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence                    3456666666665554444578999999999999999999999999999999986543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.4e-50  Score=379.31  Aligned_cols=272  Identities=33%  Similarity=0.564  Sum_probs=234.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc------chhcHHHHHHHHHHHHHhcCCCCeeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT------TAISIEDVRREVKILKALSGHKHLVKFC  217 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~l~  217 (422)
                      .+..+|++.+.||+|+||.||+|+++.   +++.||||++......      .....+.+.+|+.+++++.+|+||++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            355689999999999999999999987   7899999999754311      1223466889999999997799999999


Q ss_pred             eEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +++.+.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~  166 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLT  166 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEe
Confidence            9999999999999999999999988654 5799999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |||++.............|+..|+|||++.       ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            999998776666666778999999999873       3588999999999999999999999998888888888888777


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhhhcC
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVCRY  422 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~~~~  422 (422)
                      .+....+..++.++.+||.+||..||.+||++.|+|+|+||+......+++|
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  298 (298)
T 1phk_A          247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF  298 (298)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-------
T ss_pred             ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhccC
Confidence            6665556679999999999999999999999999999999998888777664

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-50  Score=412.05  Aligned_cols=264  Identities=26%  Similarity=0.468  Sum_probs=231.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|+++.   +|+.||||++.+...........+.+|+.+|+.++ |+|||++++++.+.+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD  257 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence            34579999999999999999999887   88999999998765544455677899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+||||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~  334 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAV  334 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecccce
Confidence            9999999999999999886543 3499999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHcCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ...........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....    ...+...+......++.    
T Consensus       335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~----  410 (576)
T 2acx_A          335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE----  410 (576)
T ss_dssp             ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT----
T ss_pred             ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc----
Confidence            8766666667799999999999874 69999999999999999999999997753    34555666655554443    


Q ss_pred             CCCHHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      .++.++++||++||+.||.+|+     ++.|+++|+||+.+.|..+
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l  456 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL  456 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence            6899999999999999999999     8999999999999888654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=381.70  Aligned_cols=265  Identities=26%  Similarity=0.375  Sum_probs=217.2

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc--hhcHHHHHHHHHHHHHhc--CCCCeeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALS--GHKHLVKFCD  218 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~niv~l~~  218 (422)
                      +.+..+|++++.||+|+||.||+|++..   +++.||||++.......  ......+.+|+.+++.++  +|+||+++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            3456789999999999999999999876   78999999997543211  112245677888877775  4999999999


Q ss_pred             EEEeCC-----eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          219 ACEDVN-----NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       219 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      ++.+..     .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGG  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTS
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCC
Confidence            998765     5899999997 59999886643 3399999999999999999999999999999999999994   588


Q ss_pred             CEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          293 DMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      .+||+|||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus       158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999999998776666667788999999999875 57999999999999999999999999998888877777653222


Q ss_pred             CCCCC-----------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          372 FDDLP-----------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       372 ~~~~~-----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .+...                       .+.+++++.+||.+||+.||++|||+.|+|+|+||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            22111                       13578999999999999999999999999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=384.12  Aligned_cols=259  Identities=24%  Similarity=0.292  Sum_probs=213.5

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+.+..+|++.++||+|+||+||+|++..   +++.||||++...... ........+|+..+..+.+|+||+++++++.
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            34556789999999999999999999987   7899999998654322 2233455667777777756999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.+.+||||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEcccee
Confidence            999999999999 6699999888877899999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +.............||+.|+|||++.+.++.++|||||||++|||++|..+|....   ....+.....  +......++
T Consensus       204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~  278 (311)
T 3p1a_A          204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLS  278 (311)
T ss_dssp             CEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSC
T ss_pred             eeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCC
Confidence            98776555556678999999999998899999999999999999999987775432   2233332221  111123689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++.+||.+||+.||++||++.|+|+|+||+.
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-50  Score=422.09  Aligned_cols=263  Identities=24%  Similarity=0.444  Sum_probs=236.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|..++..+.+|+||+++++++.+.+.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            3579999999999999999999987   7899999999875544444557788999999988779999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +||||||++||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+   .++.+||+|||+++..
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEEC
T ss_pred             EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeecc
Confidence            99999999999999988665 5799999999999999999999999999999999999994   5889999999999854


Q ss_pred             C-CCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 R-PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      . ........+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+....+++..|......++.    .++.+
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~  568 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE  568 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHH
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHH
Confidence            3 334456789999999999986 57999999999999999999999999999999999999998877765    69999


Q ss_pred             HHHHHHHhchhccccCCCH-----HHHHhccCccchhhhhh
Q 014559          384 AKDFVKRLLNKDYRKRMTA-----VQALSKLVVPILSFKIV  419 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~-----~elL~~l~~~~l~~k~~  419 (422)
                      +++||++||.+||.+|+++     +|+++|+||+.+.|..+
T Consensus       569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred             HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence            9999999999999999997     99999999999888654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.1e-50  Score=384.94  Aligned_cols=265  Identities=35%  Similarity=0.607  Sum_probs=232.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---hcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      .+.++|++.+.||+|+||.||+|++..   +++.||||++........   ...+.+.+|+.+++.+. |+||+++++++
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   84 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY   84 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence            455789999999999999999999886   788999999976543221   23578999999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC----CEEE
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA----DMRL  296 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~----~vkl  296 (422)
                      .+.+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++    .+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~---~~~~~~~~kl  160 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD---KNIPIPHIKL  160 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC---TTSSSCCEEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec---CCCCcCCEEE
Confidence            999999999999999999998754 467999999999999999999999999999999999999963   44    7999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      +|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  240 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE  240 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             ccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence            9999998776665566778999999999986 478999999999999999999999999988888888888766555443


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      .+..++.++.+||.+||..||.+||++.|+|+|+||....+
T Consensus       241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            34578999999999999999999999999999999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.1e-51  Score=391.17  Aligned_cols=260  Identities=37%  Similarity=0.610  Sum_probs=205.1

Q ss_pred             cccceEEe---ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          145 FGAKYELG---KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       145 ~~~~y~~~---~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      |..+|++.   +.||+|+||.||+|+++.   +++.||||++...      ....+.+|+.+++.+.+||||+++++++.
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~   76 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFH   76 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            34567775   789999999999999987   7899999998643      23567899999999988999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.+..||||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           77 DQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             cCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            999999999999999999988654 6799999999999999999999999999999999999997533344899999999


Q ss_pred             ccccCCC-CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHHHcCCCCC
Q 014559          302 SDFIRPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-------SGIFRAVLRSDPNF  372 (422)
Q Consensus       302 a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~  372 (422)
                      ++..... ......+||..|+|||++. ..++.++|||||||++|+|++|+.||.....       .+.+..+......+
T Consensus       156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~  235 (325)
T 3kn6_A          156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF  235 (325)
T ss_dssp             CEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred             ceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence            9865433 2345667899999999986 4699999999999999999999999976433       45667777766666


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ....|..+++++++||++||..||.+||++.|+|+|+||+..
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            655556799999999999999999999999999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-50  Score=384.59  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=206.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++.....  ....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENKL   78 (317)
T ss_dssp             --------------CEEEEEECSS---SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeE
Confidence            479999999999999999999876   789999999976432  223367889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          227 YIVMELCEGGELLDRILARG-----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      ||||||++ ++|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcc
Confidence            99999998 49998886542     4589999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC---
Q 014559          302 SDFIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL---  375 (422)
Q Consensus       302 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  375 (422)
                      +...... ......+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+..+..........   
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            9866432 33455689999999999864  58999999999999999999999999888877777665421111000   


Q ss_pred             ---------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          376 ---------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       376 ---------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                                                 ....++.++.+||.+||+.||++|||+.|+|+|+||......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                       012578899999999999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-50  Score=379.40  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=213.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|++.    +++.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence            46999999999999999999983    6789999999764422 223367889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG  151 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred             EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccC
Confidence            999999975 99998877667899999999999999999999999999999999999994   58899999999997654


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----------  373 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------  373 (422)
                      .. .......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+..+........          
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            32 23345678999999999864  589999999999999999999999988877776666643211000          


Q ss_pred             -----------CC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          374 -----------DL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       374 -----------~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                 ..    ....++.++.+||++||..||++|||+.|+|+|+||+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                       00    11357899999999999999999999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-50  Score=405.30  Aligned_cols=257  Identities=34%  Similarity=0.563  Sum_probs=229.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|.+++.||+|+||.||+|++..   +|+.||||++...........+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPS   89 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            34579999999999999999999886   88999999998765444445678999999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhh
Confidence            99999999999999998753 46799999999999999999999999999999999999994   588999999999988


Q ss_pred             cCCCCCccccccCCcccCccccCcc--CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..........+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+......+..+.......+.    .+++
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  241 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNP  241 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCH
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCH
Confidence            7766666778999999999998753  478999999999999999999999988888888888877655443    5899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++.+||++||..||.+|||+.|+++|+||..
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            9999999999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-50  Score=389.71  Aligned_cols=255  Identities=32%  Similarity=0.534  Sum_probs=204.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++++.||+|+||.||+|+++.   +++.||||++......    .+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAI----DENVQREIINHRSLR-HPNIVRFKEVILTPTH   90 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTS----CHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCccc----cHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence            3579999999999999999999987   7899999999764332    266889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++..
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccc
Confidence            99999999999999988654 46999999999999999999999999999999999999953 22345999999999865


Q ss_pred             CCCCCccccccCCcccCccccC-ccCCCc-hhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH-RSYSLE-ADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~-~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .........+||+.|+|||++. ..++.+ +|||||||++|+|++|+.||.....    ...+..+......++.  ...
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  246 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIR  246 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCC
Confidence            5455556678999999999875 455544 8999999999999999999976443    3444555555444433  236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +++++++||++||..||.+|||+.|+|+|+||.
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence            899999999999999999999999999999983

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.2e-50  Score=390.94  Aligned_cols=262  Identities=34%  Similarity=0.625  Sum_probs=230.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-----chhcHHHHHHHHHHHHHhcCCCCeeEEEe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFCD  218 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~  218 (422)
                      .+..+|++.+.||+|+||.||+|+++.   +|+.||||++......     .....+.+.+|+.+++++.+|+||+++++
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            455689999999999999999999876   7889999999764321     11224567899999999955999999999


Q ss_pred             EEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       219 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      ++...+..||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEe
Confidence            999999999999999999999988654 5699999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ||++............+||+.|+|||++.       ..++.++|||||||++|+|++|+.||........+..+......
T Consensus       244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99998877666667788999999999874       24889999999999999999999999988888888888877766


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +....|..++.++.+||++||..||.+||++.|+|+|+||+
T Consensus       324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            55444567899999999999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-50  Score=379.76  Aligned_cols=255  Identities=27%  Similarity=0.529  Sum_probs=214.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-----------------------hcHHHHHHHHHH
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----------------------ISIEDVRREVKI  203 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~  203 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||||++........                       ...+.+.+|+++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            579999999999999999999877   788999999976543211                       123568899999


Q ss_pred             HHHhcCCCCeeEEEeEEEe--CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 014559          204 LKALSGHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE  281 (422)
Q Consensus       204 l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~  281 (422)
                      +++++ |+||+++++++.+  .+.+|+||||+++++|.+.+  ....+++..++.++.||+.||.|||++||+||||||+
T Consensus        90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            99997 9999999999987  57899999999999988753  3457999999999999999999999999999999999


Q ss_pred             cEEEeeCCCCCCEEEeecCcccccCCCC-CccccccCCcccCccccCcc----CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014559          282 NFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       282 NIll~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                      |||++   .++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|+.||...
T Consensus       167 Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          167 NLLVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GEEEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HEEEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99994   58899999999998765432 23456899999999998643    478899999999999999999999888


Q ss_pred             ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ........+......++.  ...+++++.+||.+||+.||++||++.|+|+|+||.
T Consensus       244 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             cHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            777777777665554443  247899999999999999999999999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-50  Score=405.09  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=230.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||+|+++.   +|+.||||++.+.........+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD  259 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence            4679999999999999999999876   78999999998765554455678899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          226 VYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      +||||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla  336 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeeccee
Confidence            99999999999999988653   34699999999999999999999999999999999999994   5899999999999


Q ss_pred             cccCCCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHcCCCCCCCCC
Q 014559          303 DFIRPDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       303 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~  376 (422)
                      +....... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....    ...+...+......++.  
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--  414 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--  414 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--
T ss_pred             eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--
Confidence            87654433 345689999999999875 69999999999999999999999997753    35666777776665553  


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                        .++.++++||++||..||.+||+     +.++++|+||..+.|..+
T Consensus       415 --~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l  460 (543)
T 3c4z_A          415 --KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL  460 (543)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred             --ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence              68999999999999999999995     589999999999888654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-51  Score=393.24  Aligned_cols=272  Identities=33%  Similarity=0.582  Sum_probs=229.2

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--chhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      ..+..+|++.+.||+|+||.||+|++..   +++.||||++......  .....+.+.+|+.++++++ ||||+++++++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   97 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY   97 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence            3456789999999999999999999877   7889999999765332  2334578899999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHh---------------------------------------CCCCCHHHHHHHHHHH
Q 014559          221 EDVNNVYIVMELCEGGELLDRILAR---------------------------------------GGRYTEEDAKAIVVQI  261 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~ql  261 (422)
                      .+.+.++||||||++|+|.+++...                                       ...+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            9999999999999999999877310                                       1124678899999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC-----CccccccCCcccCccccC---ccCCCc
Q 014559          262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLH---RSYSLE  333 (422)
Q Consensus       262 ~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~  333 (422)
                      +.||.|||++||+||||||+|||++. +..+.+||+|||++.......     ......||+.|+|||++.   ..++.+
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999999999963 223489999999997653221     234567999999999875   468999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          334 ADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       334 ~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +|||||||++|||++|+.||.+....+....+......+....+..+++++.+||.+||+.||.+||++.|+|+|+||+.
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            99999999999999999999998888888888887777666555678999999999999999999999999999999998


Q ss_pred             hhhhhh
Q 014559          414 LSFKIV  419 (422)
Q Consensus       414 l~~k~~  419 (422)
                      +.+++.
T Consensus       337 ~~~~~~  342 (345)
T 3hko_A          337 FSDKIY  342 (345)
T ss_dssp             TSSCSS
T ss_pred             ChHhhE
Confidence            877654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-49  Score=385.50  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=223.0

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .....|++++.||+|+||.||+|++..   +++.||||++...........+.+.+|++++++++ ||||+++++++.+.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  126 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE  126 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC
Confidence            344579999999999999999999876   78899999997654444445577899999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +..+|||||+. |+|.+.+......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSAS  202 (348)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCB
T ss_pred             CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCce
Confidence            99999999997 588888877777899999999999999999999999999999999999995   47899999999997


Q ss_pred             ccCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ....   ....+||+.|+|||++.    +.++.++|||||||++|||++|+.||........+..+.......  .....
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  277 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGH  277 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCC
Confidence            6543   24567999999999873    468999999999999999999999998887777666666544322  22236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++.++.+||.+||+.||++||++.++|+|+|+..
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            8999999999999999999999999999999853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-50  Score=392.62  Aligned_cols=261  Identities=30%  Similarity=0.484  Sum_probs=209.0

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++++.||+|+||.||+|++..   +++.||||++.... ........+.+|+.+++.+.+|+||+++++++...
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            455689999999999999999999987   88999999986532 33344567889999999997799999999999865


Q ss_pred             C--eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          224 N--NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       224 ~--~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +  .+|||||||+ ++|.+.+..  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~  155 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGL  155 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             CCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCcc
Confidence            4  7999999997 588887755  4799999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCC----------------------CCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014559          302 SDFIRP----------------------DERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWART  357 (422)
Q Consensus       302 a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~  357 (422)
                      ++....                      .......+||++|+|||++.+  .|+.++|||||||++|||++|+.||.+..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            976532                      112344689999999998854  68999999999999999999999999988


Q ss_pred             hhHHHHHHHcCCCCCC--------------------------C-----------------CCCCCCCHHHHHHHHHhchh
Q 014559          358 ESGIFRAVLRSDPNFD--------------------------D-----------------LPWPSVSPEAKDFVKRLLNK  394 (422)
Q Consensus       358 ~~~~~~~i~~~~~~~~--------------------------~-----------------~~~~~~s~~~~~li~~~L~~  394 (422)
                      ....+..+........                          .                 ..+..+++++.+||++||..
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            8777776653211100                          0                 01126789999999999999


Q ss_pred             ccccCCCHHHHHhccCccch
Q 014559          395 DYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       395 dP~~Rps~~elL~~l~~~~l  414 (422)
                      ||.+|||+.|+|+|+||...
T Consensus       316 dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          316 NPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             SGGGSCCHHHHTTSTTTTTT
T ss_pred             CcccCCCHHHHhCCHHHHHh
Confidence            99999999999999998654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.5e-50  Score=376.04  Aligned_cols=267  Identities=39%  Similarity=0.698  Sum_probs=235.4

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+..+|++++.||+|+||.||+|++..   +++.||||++...... ....+.+.+|++++++++ |+||+++++++.+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   92 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILED   92 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeC
Confidence            3456789999999999999999999876   7889999999765432 234578899999999996 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             CCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999999999987655 46999999999999999999999999999999999999975444568999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .............|+..|+|||++.+.++.++||||||+++|+|++|+.||...........+......+....+..++.
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            87765555566679999999999988899999999999999999999999999888888888887776655545567999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ++.+||++||..||.+||++.|+|+|+||+...
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999987653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.4e-50  Score=374.95  Aligned_cols=271  Identities=35%  Similarity=0.630  Sum_probs=228.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---hcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      +.++|++.+.||+|+||.||+|++..   +++.||||++........   ...+.+.+|+.++++++ |+||+++++++.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   78 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE   78 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence            34679999999999999999999886   788999999976543221   23578999999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEeecC
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDFG  300 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~DfG  300 (422)
                      +.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999999988654 5699999999999999999999999999999999999996411 12379999999


Q ss_pred             cccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ++.............|+..|+|||++. ..++.++||||||+++|+|++|..||........+..+......+....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            998776555556678999999999986 5789999999999999999999999998888888887777665554333457


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIVC  420 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~~  420 (422)
                      ++.++.+||++||..||.+||++.|+|+|+||+.+..+.++
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence            89999999999999999999999999999999988776543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-50  Score=399.50  Aligned_cols=270  Identities=35%  Similarity=0.556  Sum_probs=218.2

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-----hhcHHHHHHHHHHHHHhcCCCCeeEEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFC  217 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~  217 (422)
                      ..+.++|++.+.||+|+||.||+|++..   +++.||||++.+.....     ......+.+|+.+|++++ ||||++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  206 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK  206 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            4456789999999999999999999987   78999999998654321     112235789999999996 99999999


Q ss_pred             eEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +++. .+.+||||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+
T Consensus       207 ~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          207 NFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             EEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             EEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence            9975 4568999999999999887643 4679999999999999999999999999999999999999764456679999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNF  372 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  372 (422)
                      |||+++...........+||+.|+|||++.    ..|+.++|||||||++|+|++|+.||...... .....+......+
T Consensus       285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            999998876666666788999999999974    46888999999999999999999999765433 4445555555444


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      ....|..+++++.+||++||..||.+||++.|+|+|+||+...++.
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  410 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHH
Confidence            4334557899999999999999999999999999999999877664

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-49  Score=373.04  Aligned_cols=258  Identities=28%  Similarity=0.539  Sum_probs=224.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||+|++..   +++.||||++.............+.+|+.+++.++ |+||+++++++.+.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATR   83 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCE
Confidence            3579999999999999999999887   78899999997765554455678899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHA  159 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccC
Confidence            99999999999999988654 5699999999999999999999999999999999999994   5889999999998654


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .. .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+......++.    .++.++
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  234 (279)
T 3fdn_A          160 PS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA  234 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHH
T ss_pred             Cc-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHH
Confidence            32 33455689999999999864 6899999999999999999999999988888888888777666554    589999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      .+||.+||..||.+||++.|+|+|+||.....
T Consensus       235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          235 RDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999999999976543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=386.44  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=214.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|++..   +++.||||++.......  ....+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccccc--cchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence            469999999999999999999886   78899999996543211  1123457999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +|||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCccccccc
Confidence            99999997 499998888777899999999999999999999999999999999999994   57899999999997654


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC-------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-------  376 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  376 (422)
                      .. ......+||..|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+...........       
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            32 23345678999999998754  589999999999999999999999999888777776655322222111       


Q ss_pred             -------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          377 -------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       377 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                                         .+.++.++.+||.+||+.||.+|||+.|+|+|+||..+..+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                               125789999999999999999999999999999999887654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-49  Score=376.91  Aligned_cols=261  Identities=38%  Similarity=0.654  Sum_probs=228.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++.+.||+|+||.||+|++..   +++.||||++......   ..+.+.+|+.+++.++ |+||+++++++.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   78 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAF---RDSSLENEIAVLKKIK-HENIVTLEDIYEST   78 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             chhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccccc---chHHHHHHHHHHHhCC-CCCeeehhhhcccC
Confidence            455689999999999999999999886   7889999999754322   2356889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|+||||+++++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999999999988655 469999999999999999999999999999999999999654568899999999997


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .... .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+......+....+..++.
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          158 MEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             CCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             ecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence            5443 23445679999999999864 689999999999999999999999999888888888888776666656678999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++.+||.+||..||.+||++.|+|+|+||..
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.9e-50  Score=403.75  Aligned_cols=257  Identities=27%  Similarity=0.457  Sum_probs=209.2

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +..+|++++.||+|+||.||+|++..   +++.||||++.... ........+.+|+.+++.++ |+||+++++++... 
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK  134 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence            45689999999999999999999887   78999999997642 33344577889999999997 99999999999654 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+||||||+++ +|.+.+.   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~D  207 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  207 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEE
Confidence                 468999999976 5666553   3599999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------  371 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------  371 (422)
                      ||+++...........+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+....+.+..+......      
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             CCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             EEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999987766656677899999999999764 7999999999999999999999999988877777666542111      


Q ss_pred             ----------------CCCCCCC----C------------CCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          372 ----------------FDDLPWP----S------------VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       372 ----------------~~~~~~~----~------------~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                      +....++    .            .++++++||++||..||++|||++|+|+|+||+.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                            1111000    0            1567999999999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-50  Score=384.58  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=212.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|++++.||+|+||.||+|++..   +++.||||++..... .....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETT
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence            34579999999999999999999887   789999999976432 2223456779999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC--CCCCCEEEeecCcc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFGLS  302 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~--~~~~~vkl~DfG~a  302 (422)
                      .+||||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+  +..+.+||+|||++
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999999975 999887554 569999999999999999999999999999999999999642  23456999999999


Q ss_pred             cccCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC-
Q 014559          303 DFIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-  378 (422)
Q Consensus       303 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-  378 (422)
                      +..... ......+||..|+|||++.+  .++.++|||||||++|||++|+.||......+.+..+...........|+ 
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            866433 33455678999999999864  48999999999999999999999999888877777765432222111111 


Q ss_pred             -------------------------CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          379 -------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       379 -------------------------~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                               .+++++.+||.+||+.||.+|||+.|+|+|+||+...|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                     16789999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.2e-50  Score=384.47  Aligned_cols=258  Identities=29%  Similarity=0.518  Sum_probs=214.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +.++|++++.||+|+||.||+|++..   +++.||||++.......  ..+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN-HENVVKFYGHRREGN   78 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            45689999999999999999999887   78899999996543222  2356889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..|||||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV  154 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             eEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccce
Confidence            9999999999999998764 345699999999999999999999999999999999999994   578999999999976


Q ss_pred             cCCC---CCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHcCCCCCCCCCCC
Q 014559          305 IRPD---ERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGI-FRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       305 ~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  378 (422)
                      ....   ......+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||........ +..........  ..+.
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  232 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWK  232 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGG
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--Cccc
Confidence            5322   22345689999999999864 3 47899999999999999999999987655433 33333322222  2345


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++.++.+||.+||..||.+||++.|+|+|+||+..
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            789999999999999999999999999999999754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-49  Score=390.56  Aligned_cols=264  Identities=21%  Similarity=0.291  Sum_probs=216.0

Q ss_pred             ccceEEeceeCcC--CCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++++.||+|  +||.||+|+++.   +++.||||++...... ....+.+.+|+.+++.++ |+|||++++++.+.
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence            4579999999999  999999999987   7899999999765432 345577889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          224 NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      +.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~  175 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSN  175 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccc
Confidence            9999999999999999988764 35699999999999999999999999999999999999994   5889999999987


Q ss_pred             cccCCC--------CCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          303 DFIRPD--------ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       303 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ......        ......+||..|+|||++.+   .++.++|||||||++|||++|+.||.+......+..+......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            543211        11233478999999999864   5899999999999999999999999876665554443322111


Q ss_pred             C------------------------------------------CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          372 F------------------------------------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       372 ~------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .                                          ....+..+++++.+||++||+.||.+|||+.|+|+|+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            0                                          0011235789999999999999999999999999999


Q ss_pred             Cccchhhh
Q 014559          410 VVPILSFK  417 (422)
Q Consensus       410 ~~~~l~~k  417 (422)
                      ||+.+..+
T Consensus       336 ~f~~~~~~  343 (389)
T 3gni_B          336 FFKQIKRR  343 (389)
T ss_dssp             GGGGC---
T ss_pred             HHHHHhhc
Confidence            99877653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-49  Score=382.95  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=219.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      ..+|++++.||+|+||.||+|++..   +++.||||++....... .....+.+|+.+++.++ |+||+++++++.+   
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccc-cchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence            3589999999999999999999987   78999999986654322 23356789999999997 9999999999987   


Q ss_pred             -----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          223 -----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       223 -----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                           .+.+||||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEc
Confidence                 4579999999975 88888877767899999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCC-----CCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          298 DFGLSDFIRP-----DERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       298 DfG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |||+++....     .......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999976542     223345678999999998753  589999999999999999999999999888887777765444


Q ss_pred             CCCCCCCCCC----------------------------CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          371 NFDDLPWPSV----------------------------SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       371 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .++...|+.+                            ++++.+||.+||..||.+|||+.|+|+|+||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            4433333322                            678999999999999999999999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=373.11  Aligned_cols=259  Identities=30%  Similarity=0.543  Sum_probs=199.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEE
T ss_pred             ccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeE
Confidence            469999999999999999999876   78899999997654444445678899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeecc
Confidence            999999999999998877667899999999999999999999999999999999999994   58899999999997654


Q ss_pred             CC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      .. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.......+    ..++.++
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  239 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEA  239 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHH
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHH
Confidence            32 23345679999999998864 689999999999999999999999987666555554443333322    2589999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      .+||.+||..||++||++.++|+|+||.....
T Consensus       240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            99999999999999999999999999986543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-49  Score=386.50  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=220.7

Q ss_pred             ccCcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc----CCCCe
Q 014559          138 SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----GHKHL  213 (422)
Q Consensus       138 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~ni  213 (422)
                      .+.....+..+|+++++||+|+||.||+|++..   +++.||||++....    .....+.+|+.+++.+.    +|+||
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            444556778899999999999999999999976   78899999986432    23356788999999996    49999


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC----
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----  288 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~----  288 (422)
                      +++++++...+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..    
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999999 889999887654 459999999999999999999999999999999999999521    


Q ss_pred             ------------------CCCCCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhC
Q 014559          289 ------------------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG  349 (422)
Q Consensus       289 ------------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g  349 (422)
                                        ..++.+||+|||++.....  .....+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence                              1267899999999976442  334568999999999976 4799999999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHcCCCCCCCC---------------------CCC---------------------CCCHHHHHH
Q 014559          350 SRPFWARTESGIFRAVLRSDPNFDDL---------------------PWP---------------------SVSPEAKDF  387 (422)
Q Consensus       350 ~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~~l  387 (422)
                      +.||......+.+..+......++..                     .|+                     ..++++.+|
T Consensus       256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  335 (360)
T 3llt_A          256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF  335 (360)
T ss_dssp             SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred             CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence            99998887777666655433222210                     011                     123778899


Q ss_pred             HHHhchhccccCCCHHHHHhccCcc
Q 014559          388 VKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       388 i~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      |++||+.||.+|||+.|+|+|+||+
T Consensus       336 i~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          336 LYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-50  Score=384.95  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=220.6

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+.++|++.+.||+|+||.||+|++..   +++.||||++.............+.+|+.++++++ ||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   83 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA   83 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEE
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeec
Confidence            4566789999999999999999999877   78999999998765555555678899999999997 9999999999876


Q ss_pred             CC----eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 VN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      ..    ..||||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEee
Confidence            54    359999999999999988654 5799999999999999999999999999999999999995   478999999


Q ss_pred             cCcccccCCCC----CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          299 FGLSDFIRPDE----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       299 fG~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      ||++.......    .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.........+.......+
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  239 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence            99997654332    223457999999999886 4689999999999999999999999998888777777776665544


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ...+..++.++.+||.+||+.||.+||++.++|.+.|+...
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            33345799999999999999999999999999999988754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-49  Score=371.25  Aligned_cols=259  Identities=25%  Similarity=0.529  Sum_probs=228.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+++++.++ |+||+++++++.+.+.+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEE
Confidence            579999999999999999999876   78899999997655444445578899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECS
T ss_pred             EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccCc
Confidence            9999999999999988665 4699999999999999999999999999999999999994   58899999999987554


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      . .......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+......++.    .++.+++
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  240 (284)
T 2vgo_A          166 S-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSK  240 (284)
T ss_dssp             S-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred             c-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----cCCHHHH
Confidence            3 23455689999999999864 6899999999999999999999999988888888888776665543    6899999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      +||.+||..||.+||++.|+|+|+||+....+.
T Consensus       241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            999999999999999999999999998765544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.5e-49  Score=374.06  Aligned_cols=265  Identities=25%  Similarity=0.406  Sum_probs=218.5

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ++.+..+|++++.||+|+||.||+|++..   +++.||||++...........+.+.+|+.++++++ ||||+++++++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~   81 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE   81 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee
Confidence            45567789999999999999999999876   78899999997765555556678999999999997 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.+.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~  157 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGI  157 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCC
Confidence            999999999999999999988655 5799999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-CCCCCC
Q 014559          302 SDFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-FDDLPW  377 (422)
Q Consensus       302 a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~  377 (422)
                      +.......  .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+................ ......
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR  237 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred             ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence            98664332  234467999999999876 46899999999999999999999999888776665555544322 212223


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ..+++.+.++|.+||+.||.+||+..+.+.+.|...+
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            4789999999999999999999965566665555444

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.1e-49  Score=379.51  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=227.8

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ....+|++++.||+|+||.||++++..   +++.||+|++...........+.+.+|+.+++.++ |+||+++++++.+.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  113 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN  113 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence            345689999999999999999999887   78899999998765555556678999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|+||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCce
Confidence            9999999999999999977654 5799999999999999999999999999999999999994   57899999999998


Q ss_pred             ccCCC-CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ..... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++.    .++
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~  265 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HIN  265 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred             ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCC
Confidence            66432 3345567999999999976 46899999999999999999999999988888877777776655543    689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .++.+||++||+.||++||++.|+|+|+||..
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999854

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8e-50  Score=382.16  Aligned_cols=269  Identities=35%  Similarity=0.558  Sum_probs=219.9

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-----chhcHHHHHHHHHHHHHhcCCCCeeEEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFC  217 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~  217 (422)
                      ..+.++|++.+.||+|+||.||+|++..   +++.||||++......     .......+.+|+.+++.++ |+||++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~   81 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK   81 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEe
Confidence            3456789999999999999999999887   7889999999764321     1122345789999999996 99999999


Q ss_pred             eEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +++...+ +|+||||+++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence            9987665 8999999999999987743 4679999999999999999999999999999999999999753345569999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNF  372 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  372 (422)
                      |||++.............||..|+|||++.    ..++.++|||||||++|+|++|..||...... .....+......+
T Consensus       160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (322)
T 2ycf_A          160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  239 (322)
T ss_dssp             CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred             cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence            999998765544445567999999999862    46899999999999999999999999765443 3444455544443


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ....+..++.++.+||.+||..||.+||++.|+|+|+||....++
T Consensus       240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~  284 (322)
T 2ycf_A          240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK  284 (322)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence            322345789999999999999999999999999999999877654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-49  Score=396.81  Aligned_cols=263  Identities=29%  Similarity=0.466  Sum_probs=198.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +.++|++++.||+|+||.||+|+++.   +++.||||++.... ......+.+.+|+.+|+.|+ |+|||++++++... 
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD  125 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC-----CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence            45689999999999999999999887   78999999996532 33344577899999999997 99999999999543 


Q ss_pred             ----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                          +.+||||||+. ++|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+||
T Consensus       126 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DF  200 (458)
T 3rp9_A          126 VEKFDELYVVLEIAD-SDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDF  200 (458)
T ss_dssp             TTTCCCEEEEECCCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCC
T ss_pred             cccCceEEEEEeccc-cchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeeccc
Confidence                57999999985 58888764 446799999999999999999999999999999999999994   5889999999


Q ss_pred             CcccccCCCC----------------------------CccccccCCcccCcccc-C-ccCCCchhHHHHHHHHHHHHh-
Q 014559          300 GLSDFIRPDE----------------------------RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLC-  348 (422)
Q Consensus       300 G~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~-  348 (422)
                      |+++......                            .....+||++|+|||++ . ..|+.++||||||||||||++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            9998654221                            23456789999999975 3 469999999999999999999 


Q ss_pred             ----------CCCCCCCCCh--------------------hHHHHHHHcC-----------------------CCCC---
Q 014559          349 ----------GSRPFWARTE--------------------SGIFRAVLRS-----------------------DPNF---  372 (422)
Q Consensus       349 ----------g~~pf~~~~~--------------------~~~~~~i~~~-----------------------~~~~---  372 (422)
                                |+.+|.+...                    .+.+..+...                       .+..   
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      6677755331                    1222222210                       0000   


Q ss_pred             -CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          373 -DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       373 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                       ....++.++.++.+||++||.+||.+|+|++|+|+|+||..+.+.
T Consensus       361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence             011235679999999999999999999999999999999877543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-49  Score=367.36  Aligned_cols=258  Identities=34%  Similarity=0.552  Sum_probs=217.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++++.||+|+||.||+|++..   +++.||||++...........+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPT   84 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence            44689999999999999999999876   78899999997655444445678899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGC
T ss_pred             eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccccc
Confidence            999999999999999988655 4699999999999999999999999999999999999994   578999999999987


Q ss_pred             cCCCCCccccccCCcccCccccCcc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHRS-Y-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...........|++.|+|||++.+. + +.++||||||+++|+|++|+.||...........+......++.    .++.
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~  236 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNR  236 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----hcCH
Confidence            7655555667899999999998753 3 68999999999999999999999888877777777776554443    5889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++.++|.+||+.||.+||++.|+++|+||+..
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-48  Score=369.09  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=227.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ....+|++.+.||+|+||.||+|++..   +++.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   87 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN   87 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence            345689999999999999999999887   78899999998765555556678899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCce
Confidence            9999999999999999877554 5799999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ..... .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||......+....+......++.    .++
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  239 (294)
T 2rku_A          164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HIN  239 (294)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSC
T ss_pred             ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccC
Confidence            65432 33445679999999999864 6899999999999999999999999988888877777776655443    689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .++.++|.+||+.||++||++.|+|+|+||..
T Consensus       240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          240 PVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence            99999999999999999999999999999853

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-49  Score=382.42  Aligned_cols=265  Identities=31%  Similarity=0.522  Sum_probs=222.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++++.||+|+||.||+|++..+..+++.||||++...... .....+.+.+|+.+++.+.+|+||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999998655458899999999764321 122335567899999999669999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++|||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCeec
Confidence            99999999999999988665 4699999999999999999999999999999999999994   5889999999999765


Q ss_pred             CCCC--CccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHcCCCCCCCCC
Q 014559          306 RPDE--RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~  376 (422)
                      ....  .....+||+.|+|||++.+   .++.++|||||||+||||++|+.||....    ...+...+......++.  
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  287 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--  287 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--
Confidence            4322  2344689999999999863   47899999999999999999999996533    34455555555554443  


Q ss_pred             CCCCCHHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                        .++..+.+||.+||..||.+||     ++.|+++|+||..+.|..+
T Consensus       288 --~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l  333 (355)
T 1vzo_A          288 --EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL  333 (355)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             --ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence              6899999999999999999999     9999999999998776543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-48  Score=372.90  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=219.2

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|+..+.||+|+||.||+|++..   +|+.||||++.....   ...+.+.+|+.+++.++ |+||+++++++...+..+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  118 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW  118 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence            48888899999999999999876   788999999975432   23567889999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +||||+++++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       119 lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          119 VLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             EEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeeccc
Confidence            9999999999998764  34799999999999999999999999999999999999994   588999999999986654


Q ss_pred             CC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .. .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+........ .....+++++.
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~  272 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLR  272 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHH
T ss_pred             CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHH
Confidence            32 345568999999999986 4689999999999999999999999988877777776665443221 11235889999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCccch
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +||.+||+.||++||++.|+|+|+||...
T Consensus       273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          273 DFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            99999999999999999999999999643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=373.83  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=213.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|++..   +++.||||++.... ......+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeE
Confidence            579999999999999999999986   78999999986643 22334567889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++ .....+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           78 HLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEEEECCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEEeCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhcc
Confidence            9999999987777654 4456799999999999999999999999999999999999994   58899999999998765


Q ss_pred             CC-CCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC-------------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-------------  370 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  370 (422)
                      .. ......+||..|+|||++.  ..++.++|||||||++|+|++|+.||.+....+....+.....             
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            33 3345568999999999875  4689999999999999999999999988877666555433111             


Q ss_pred             ------CCCCC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          371 ------NFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       371 ------~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                            ..+..        .++.++.++.+||++||+.||.+|||+.|+|+|+||+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                  01100        12468899999999999999999999999999999997654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-49  Score=382.34  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=214.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch--hcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++++.||+|+||.||+|++..   +|+.||||++........  .....+.+|+.+++.++ |+||+++++++.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHK   84 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeC
Confidence            4579999999999999999999876   788999999975432211  11246789999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++ +|.+.+......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccce
Confidence            999999999986 88888766666799999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC----
Q 014559          304 FIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP----  376 (422)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  376 (422)
                      ..... ......+||+.|+|||++.+  .++.++|||||||++|||++|..||.+....+.+..+...........    
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            76433 33455789999999999853  489999999999999999999999998888877777765322111111    


Q ss_pred             --------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          377 --------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       377 --------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                          +..++.++++||++||..||.+|||+.|+|+|+||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                                13567899999999999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-48  Score=383.96  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=211.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcC-CCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~  224 (422)
                      +.+|++++.||+|+||.||+|.+.    +++.||||++..... .....+.+.+|+.+|+.|.. |+||+++++++...+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            457999999999999999999875    477899999976543 33455788999999999973 699999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++.
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence            9999999 5577999987654 5799999999999999999999999999999999999994    57899999999987


Q ss_pred             cCCCC---CccccccCCcccCccccCc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcC
Q 014559          305 IRPDE---RLNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRS  368 (422)
Q Consensus       305 ~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~  368 (422)
                      .....   .....+||+.|+|||++.+            .++.++|||||||+||||++|+.||..... ...+..+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            65432   2345689999999999753            589999999999999999999999977543 3455555554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ...+...  ...+.++.+||.+||..||.+||++.|+|+|+|++..
T Consensus       284 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          284 NHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             TSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            4333221  2457899999999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=374.75  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=217.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++......+..||||++....  .....+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            3468999999999999999999987644355679999997542  2334577899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+||||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCcccc
Confidence            99999999999999999877767899999999999999999999999999999999999994   588999999999987


Q ss_pred             cCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          305 IRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       305 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ......    .....+|..|+|||++. ..++.++|||||||++|||++ |..||...........+........   ..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CC
Confidence            654322    22234677899999986 578999999999999999999 9999999888888877776532221   23


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.++.+||.+||..||.+||++.|+++.+
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L  308 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVL  308 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            6899999999999999999999999999764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-48  Score=386.70  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=213.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ...+|++.+.||+|+||.||+|++..   +++.||||++.....       ...+|+++|+.|+ |+|||+++++|... 
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccC
Confidence            34579999999999999999999986   789999999865432       2247999999997 99999999998542 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          224 -----NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                           ..+++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++||+||||||+||||+.  +.+.+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEE
Confidence                 247899999976 66665543   4567999999999999999999999999999999999999962  346789


Q ss_pred             EeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC-----
Q 014559          296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-----  368 (422)
Q Consensus       296 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----  368 (422)
                      |+|||+++...........+||..|+|||++.+  .|+.++|||||||+||||++|+.||.+....+.+..++..     
T Consensus       198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             eccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999987766666667789999999998753  6999999999999999999999999988777666655431     


Q ss_pred             -------CCCCCCC--------C-----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          369 -------DPNFDDL--------P-----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       369 -------~~~~~~~--------~-----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                             .+.+...        .     ...++.++++||++||..||.+|+++.|+|+|+||+.+..
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                   1111111        1     1256899999999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=376.37  Aligned_cols=261  Identities=22%  Similarity=0.373  Sum_probs=215.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++.+.||+|+||.||+|++..   +++.||||++......  ...+.+.+|++++++++ |+||+++++++.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   79 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEET   79 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecC
Confidence            345689999999999999999999987   7889999999754332  23567889999999997 99999999999876


Q ss_pred             C--eEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEee
Q 014559          224 N--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLID  298 (422)
Q Consensus       224 ~--~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~D  298 (422)
                      +  .+||||||+++++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            5  7899999999999999887543  239999999999999999999999999999999999998432 3456799999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHH
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH---------RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAV  365 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i  365 (422)
                      ||+++............||..|+|||++.         ..++.++|||||||++|||++|+.||....    ..+.+..+
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            99998877666667778999999999874         568999999999999999999999996432    23455555


Q ss_pred             HcCCCCC-------------------CC--CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          366 LRSDPNF-------------------DD--LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       366 ~~~~~~~-------------------~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ....+..                   +.  .....++..+.+||++||+.||++||++.|+|+|+-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            5444311                   00  001124567999999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-49  Score=381.65  Aligned_cols=258  Identities=26%  Similarity=0.470  Sum_probs=212.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +..+|++++.||+|+||.||+|++..   +|+.||||++.... ......+.+.+|+++++.++ |+||+++++++... 
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            45689999999999999999999877   88999999986532 23334567889999999997 99999999999875 


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           ..+|+||||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~D  171 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD  171 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEEe
Confidence                 3469999999 7799887755  4799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC----
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF----  372 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  372 (422)
                      ||+++....  .....+||..|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+..+.......    
T Consensus       172 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          172 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999987542  3456789999999998754  69999999999999999999999999888777766665421111    


Q ss_pred             -------------------CC----CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          373 -------------------DD----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       373 -------------------~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                         ..    ..+..+++++.+||.+||..||.+|+|+.|+|+|+||..+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                               11    11246789999999999999999999999999999998654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-48  Score=377.79  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=216.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc----CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK----GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .++|++++.||+|+||.||+|++..    ...++..||||++....  .....+.+.+|+.+++.+.+||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3579999999999999999998752    11256789999997542  33345778999999999945999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                      +.+.+|+||||+++|+|.+++....               ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            9999999999999999999987643               3589999999999999999999999999999999999994


Q ss_pred             eCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 014559          287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI  361 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~  361 (422)
                         .++.+||+|||+++.......   .....+++.|+|||++. ..++.++|||||||++|||++ |+.||.+....+.
T Consensus       238 ---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          238 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence               588999999999986543322   23346788999999875 579999999999999999999 9999998888777


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+........   ...++.++.+||.+||..||.+||++.|+++++
T Consensus       315 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          315 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             HHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            777665542211   136899999999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-48  Score=363.29  Aligned_cols=260  Identities=21%  Similarity=0.329  Sum_probs=217.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      ..+..|++.+.||+|+||.||+|.+..   ++..||+|++...... ....+.+.+|+.+++.++ |+||+++++++.. 
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST   97 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccc
Confidence            345579999999999999999999887   7889999999765433 334577899999999997 9999999999876 


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                         ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++|  |+||||||+|||++  +.++.+||+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~  174 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIG  174 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEEC
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEe
Confidence               35699999999999999988654 56999999999999999999999999  99999999999995  257899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      |||++..... .......||+.|+|||++.+.++.++|||||||++|+|++|+.||.................... ...
T Consensus       175 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  252 (290)
T 1t4h_A          175 DLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFD  252 (290)
T ss_dssp             CTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGG
T ss_pred             eCCCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc-ccC
Confidence            9999975443 33455679999999999988899999999999999999999999987555444333333222111 112


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ...++++.+||.+||+.||.+||++.|+|+|+||+.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            257789999999999999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-48  Score=381.76  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=215.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  222 (422)
                      ...+|++++.||+|+||.||+|++..   +|+.||||++......       ..+|+.+++.++ |+||+++++++..  
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~   73 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG   73 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence            34579999999999999999999887   8899999998654322       247999999997 9999999999854  


Q ss_pred             ------------------------------------CCeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHH
Q 014559          223 ------------------------------------VNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILS  263 (422)
Q Consensus       223 ------------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~  263 (422)
                                                          ...+++||||+++ +|.+.+..   ....+++..++.++.||+.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             ------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence                                                3348999999985 87776653   4567999999999999999


Q ss_pred             HHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHH
Q 014559          264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGV  341 (422)
Q Consensus       264 aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~  341 (422)
                      ||.|||++||+||||||+|||++.  .++.+||+|||+++............||..|+|||++.+  .++.++|||||||
T Consensus       153 aL~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          153 AVGFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            999999999999999999999962  478899999999988776666677789999999998764  5899999999999


Q ss_pred             HHHHHHhCCCCCCCCChhHHHHHHHcCCC-----------------CCCCC--------CCCCCCHHHHHHHHHhchhcc
Q 014559          342 ISYILLCGSRPFWARTESGIFRAVLRSDP-----------------NFDDL--------PWPSVSPEAKDFVKRLLNKDY  396 (422)
Q Consensus       342 il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------~~~~~--------~~~~~s~~~~~li~~~L~~dP  396 (422)
                      ++|||++|+.||.+....+.+..+.....                 .++..        ....++.++.+||.+||..||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999999998888777766653111                 11111        012478999999999999999


Q ss_pred             ccCCCHHHHHhccCccchhh
Q 014559          397 RKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       397 ~~Rps~~elL~~l~~~~l~~  416 (422)
                      .+|||+.|+|+|+||+.+..
T Consensus       311 ~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GGSCCHHHHHTSGGGHHHHH
T ss_pred             hhCCCHHHHhcCHHHHHHHh
Confidence            99999999999999987754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.6e-49  Score=376.97  Aligned_cols=256  Identities=30%  Similarity=0.457  Sum_probs=206.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +..+|++++.||+|+||.||+|+++.   +++.||||++....  .....+.+.+|+.++++|+ ||||++++++|.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence            45689999999999999999999986   78899999997543  2334577899999999997 999999999986643


Q ss_pred             ---------------------------------------------------------eEEEEEEccCCCChHHHHHHhC-
Q 014559          225 ---------------------------------------------------------NVYIVMELCEGGELLDRILARG-  246 (422)
Q Consensus       225 ---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~-  246 (422)
                                                                               .+++|||||++++|.+++.... 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     3899999999999999886543 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCC-------------Ccc
Q 014559          247 -GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-------------RLN  312 (422)
Q Consensus       247 -~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-------------~~~  312 (422)
                       ....+..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++......             ...
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence             2356677999999999999999999999999999999994   58899999999998765432             224


Q ss_pred             ccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 014559          313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL  391 (422)
Q Consensus       313 ~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  391 (422)
                      ..+||+.|+|||++. ..++.++|||||||++|||++|..|+..  .......+.....  + ..+...++++.+||.+|
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~  309 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKF--P-LLFTQKYPQEHMMVQDM  309 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC--C-HHHHHHCHHHHHHHHHH
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCC--C-cccccCChhHHHHHHHH
Confidence            457999999999986 4789999999999999999998776521  1222222322211  1 11124678899999999


Q ss_pred             chhccccCCCHHHHHhccCccch
Q 014559          392 LNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       392 L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      |..||++||++.|+|+|+||+.+
T Consensus       310 l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          310 LSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ccCCCCcCCCHHHHhhchhhhcC
Confidence            99999999999999999999853

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-48  Score=386.46  Aligned_cols=264  Identities=28%  Similarity=0.454  Sum_probs=209.0

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++++.||+|+||.||+|+++.   +++.||||++.... ......+++.+|+.+|+.++ |+||+++++++...
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence            345789999999999999999999987   78999999997532 33344578899999999997 99999999999876


Q ss_pred             -----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                           +.+||||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEcc
Confidence                 57999999996 599887744 46799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCC-----------------------CccccccCCcccCcccc-C-ccCCCchhHHHHHHHHHHHHhCCCC-
Q 014559          299 FGLSDFIRPDE-----------------------RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLCGSRP-  352 (422)
Q Consensus       299 fG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~g~~p-  352 (422)
                      ||+++......                       .....+||.+|+|||++ . ..|+.++|||||||++|||++|..| 
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            99998764332                       23567899999999985 3 4699999999999999999985433 


Q ss_pred             ----------CCCCC-----------------hhHHHHHHHc-----------------------CCCCCCCC----CCC
Q 014559          353 ----------FWART-----------------ESGIFRAVLR-----------------------SDPNFDDL----PWP  378 (422)
Q Consensus       353 ----------f~~~~-----------------~~~~~~~i~~-----------------------~~~~~~~~----~~~  378 (422)
                                |.+..                 ..+.+..+..                       ........    .++
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                      33322                 1122222211                       11111100    124


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      .+++++.+||++||..||.+|||++|+|+|+||..+.+.
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            689999999999999999999999999999999887554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.8e-49  Score=378.40  Aligned_cols=254  Identities=30%  Similarity=0.462  Sum_probs=214.9

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch-----hcHHHHHHHHHHHHHhcCCCCeeEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----ISIEDVRREVKILKALSGHKHLVKF  216 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l  216 (422)
                      ...+..+|++.+.||+|+||.||+|+++.   +++.||||++........     .....+.+|+.++++++ |+||+++
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~   94 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKV   94 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCE
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeE
Confidence            34566789999999999999999999887   789999999987543221     12345678999999996 9999999


Q ss_pred             EeEEEeCCeEEEEEEccCCC-ChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          217 CDACEDVNNVYIVMELCEGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       217 ~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      ++++.+.+.+++||||+.+| +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~k  170 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIK  170 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEE
Confidence            99999999999999999776 8888764 445799999999999999999999999999999999999994   588999


Q ss_pred             EeecCcccccCCCCCccccccCCcccCccccCc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC
Q 014559          296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD  373 (422)
Q Consensus       296 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  373 (422)
                      |+|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.....      ........ 
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~-  243 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHP-  243 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCC-
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCC-
Confidence            999999988776666667789999999999864 44 8899999999999999999999965322      11111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                         ...+++++.+||.+||..||++||++.|+|+|+||..
T Consensus       244 ---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          244 ---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             ---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ---CcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence               1258999999999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=379.58  Aligned_cols=265  Identities=17%  Similarity=0.245  Sum_probs=221.2

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      +....+|++++.||+|+||.||+|++..  +..+++.||||++...  ........+.+|+.++++++ |+||+++++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  143 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS  143 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            3445689999999999999999999543  2236789999998643  22334467889999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      .+.+..|||||||++|+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.+..+..+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999987653      459999999999999999999999999999999999999653345579


Q ss_pred             EEeecCcccccCCC---CCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCC
Q 014559          295 RLIDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       295 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ||+|||+++.....   .......||+.|+|||++. +.++.++|||||||++|||++ |..||........+..+....
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999754221   2234456899999999875 579999999999999999998 999999988888888777655


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .....   ..++.++.+||.+||+.||.+||++.++++++++..
T Consensus       304 ~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          304 RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            32221   368999999999999999999999999999986543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-48  Score=367.91  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++     +++.||||++..... .....+.+.+|++++++++ |+||+++++++.+.+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence            346899999999999999999976     467899999976543 2334567889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          225 NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      .+++||||+++|+|.+++....  ..+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCC
Confidence            9999999999999999886543  13999999999999999999999999  99999999999994   58899999999


Q ss_pred             cccccCCCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          301 LSDFIRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       301 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      +++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+.........  ..
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~  262 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PR  262 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CT
T ss_pred             CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--Cc
Confidence            997544332 2345679999999999864 6899999999999999999999999988887777666543333221  13


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .+++++.+||.+||..||.+||++.|+++.
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~  292 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDL  292 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            689999999999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-48  Score=372.61  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=208.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEeEEEeC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDV  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~  223 (422)
                      .+.+|++++.||+|+||.||+|.+.    +++.||||++..... .....+.+.+|+.+++.+..| +||+++++++.+.
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            4568999999999999999999874    578899999976543 333457789999999999722 9999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||+ .+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~  155 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN  155 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred             CEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence            999999995 47799998865 45799999999999999999999999999999999999995    6789999999998


Q ss_pred             ccCCCCC---ccccccCCcccCccccC------------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHc
Q 014559          304 FIRPDER---LNDIVGSAYYVAPEVLH------------RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLR  367 (422)
Q Consensus       304 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~  367 (422)
                      .......   ....+||+.|+|||++.            ..++.++|||||||++|||++|+.||...... ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            7654332   34568999999999874            45889999999999999999999999765433 33444443


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      .......  ....+.++.+||.+||..||.+|||+.|+|+|+||..
T Consensus       236 ~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          236 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CCcccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            3322211  1246789999999999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.1e-48  Score=369.61  Aligned_cols=256  Identities=28%  Similarity=0.523  Sum_probs=212.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  222 (422)
                      ..++|++++.||+|+||.||+|++..   +++.||||++...      ..+.+.+|+.+++++++|+||+++++++.+  
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            34689999999999999999999877   7889999998643      236788999999999779999999999998  


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ....++||||+.+++|.+++.    .+++..++.++.||+.||.|||++||+||||||+|||++.  +...+||+|||++
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLA  178 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTC
T ss_pred             CCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCc
Confidence            678999999999999888652    4899999999999999999999999999999999999963  3448999999999


Q ss_pred             cccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHH-------------H
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAV-------------L  366 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i-------------~  366 (422)
                      +............|+..|+|||++.  ..++.++|||||||++|+|++|+.||..... .+.+..+             .
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            8777666667778999999999875  4689999999999999999999999954332 2222211             1


Q ss_pred             cCCCCCC--------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          367 RSDPNFD--------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       367 ~~~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      .......                    ......+++++.+||++||..||.+|||+.|+|+|+||+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            1111110                    001123789999999999999999999999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-47  Score=360.32  Aligned_cols=261  Identities=20%  Similarity=0.308  Sum_probs=213.2

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ...+..+|++.+.||+|+||.||+|++..   +++.||||++....... .....+.+|+.++..+.+||||+++++++.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            44566789999999999999999999887   78899999997643322 234678899999999955999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC---------
Q 014559          222 DVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR---------  289 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~---------  289 (422)
                      +.+.+++||||+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.+.         
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence            999999999999999999988653   25699999999999999999999999999999999999996422         


Q ss_pred             -------CCCCEEEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 014559          290 -------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESG  360 (422)
Q Consensus       290 -------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~  360 (422)
                             ....+||+|||++......   ....||..|+|||++.+  .++.++|||||||++|+|++|..++...   .
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~  235 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---D  235 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---H
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---h
Confidence                   4557999999999876533   23469999999999865  4567999999999999999999877543   2


Q ss_pred             HHHHHHcCCC-CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          361 IFRAVLRSDP-NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       361 ~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ....+..... .++    ..+++++.+||.+||..||.+||++.|+|+|+||.....
T Consensus       236 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          236 QWHEIRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             HHHHHHTTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             HHHHHHcCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence            3334443332 222    368999999999999999999999999999999986544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-48  Score=359.74  Aligned_cols=248  Identities=24%  Similarity=0.416  Sum_probs=216.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++.    +++.||||++.....    ..+.+.+|++++++++ |+||+++++++.+.+.+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred             hhceeeheecCCCccEEEEEEec----CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCce
Confidence            57999999999999999999986    456799999975433    2367899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccc
Confidence            999999999999999877777899999999999999999999999999999999999995   47899999999998654


Q ss_pred             CCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...  ......++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+.........   ..++.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  234 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST  234 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred             ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCH
Confidence            332  223445778899999986 579999999999999999999 99999988888888777765433222   25799


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||+.||.+||++.|+++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~l  261 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQL  261 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            999999999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-48  Score=379.91  Aligned_cols=257  Identities=26%  Similarity=0.446  Sum_probs=204.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +..+|++++.||+|+||.||+|++..   +++.||||++.... ......+.+.+|+.+++.++ |+||+++++++...+
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK   97 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence            44689999999999999999999877   78899999997543 23334567889999999997 999999999998765


Q ss_pred             ------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                            .+|+||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred             ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEE
Confidence                  79999999975 7888764   3599999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC-----
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-----  372 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  372 (422)
                      ||+++...........+||..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.......     
T Consensus       171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987665545566789999999999864 69999999999999999999999999888877777766532211     


Q ss_pred             -----------------CCCC---------CC-------CCCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          373 -----------------DDLP---------WP-------SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       373 -----------------~~~~---------~~-------~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                                       ....         ++       ..+.++++||++||..||.+|||+.|+|+|+||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                             0000         00       01567999999999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=386.21  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=198.2

Q ss_pred             ccccceEE-eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          144 NFGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       144 ~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+.+.|++ +++||+|+||.||+|+++.+. +++.||||++.....     ...+.+|+.+|+.|+ |+||+++++++.+
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~   89 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLS   89 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence            45567887 558999999999999976322 678999999965432     246789999999997 9999999999965


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCC
Q 014559          223 --VNNVYIVMELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDD  291 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~  291 (422)
                        ...+||||||+.+ +|.+.+...        ...+++..++.++.||+.||.|||++||+||||||+||||... +.+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence              6789999999975 888877532        1249999999999999999999999999999999999999543 357


Q ss_pred             CCEEEeecCcccccCCC----CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------
Q 014559          292 ADMRLIDFGLSDFIRPD----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE-------  358 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------  358 (422)
                      +.+||+|||+++.....    ......+||+.|+|||++.+  .++.++|||||||+||||++|+.||.+...       
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            89999999999876432    23345689999999998864  589999999999999999999999976544       


Q ss_pred             --hHHHHHHHcCCCCCCCCCCC----------------------------------CCCHHHHHHHHHhchhccccCCCH
Q 014559          359 --SGIFRAVLRSDPNFDDLPWP----------------------------------SVSPEAKDFVKRLLNKDYRKRMTA  402 (422)
Q Consensus       359 --~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dP~~Rps~  402 (422)
                        .+.+..+...........|.                                  ..+.++.+||++||..||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              24444444322222222221                                  127789999999999999999999


Q ss_pred             HHHHhccCccch
Q 014559          403 VQALSKLVVPIL  414 (422)
Q Consensus       403 ~elL~~l~~~~l  414 (422)
                      .|+|+|+||...
T Consensus       329 ~e~L~hp~f~~~  340 (405)
T 3rgf_A          329 EQAMQDPYFLED  340 (405)
T ss_dssp             HHHHTSGGGTSS
T ss_pred             HHHhcChhhccC
Confidence            999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-48  Score=381.01  Aligned_cols=260  Identities=26%  Similarity=0.392  Sum_probs=213.8

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+....+|++++.||+|+||.||+|++..   ++ .||+|++......       ..+|+++++.++ |+||+++++++.
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~---~~-~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~  102 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE---SD-EVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFY  102 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETT---TE-EEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECC---CC-eEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEE
Confidence            44556789999999999999999999875   33 4888888654322       236999999997 999999999996


Q ss_pred             eCC------eEEEEEEccCCCChHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCC
Q 014559          222 DVN------NVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       222 ~~~------~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~  292 (422)
                      ..+      .+++||||+.+ ++.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++  ..++
T Consensus       103 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~  179 (394)
T 4e7w_A          103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSG  179 (394)
T ss_dssp             EESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTT
T ss_pred             ecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCC
Confidence            544      38999999976 5554443   2356799999999999999999999999999999999999995  2578


Q ss_pred             CEEEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC-
Q 014559          293 DMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-  369 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-  369 (422)
                      .+||+|||+++...........+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+....+.+..+.... 
T Consensus       180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  259 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG  259 (394)
T ss_dssp             EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999999988766666677889999999998754  58999999999999999999999999888777666655421 


Q ss_pred             ----------------CCCCCC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          370 ----------------PNFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       370 ----------------~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                      ..++..        ....+++++.+||.+||..||.+||++.|+|+|+||+.+.+
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                            111110        12348899999999999999999999999999999987654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-48  Score=385.63  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=215.5

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-----CCCCeeEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-----GHKHLVKF  216 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l  216 (422)
                      .+.+..+|++++.||+|+||.||+|++..   +++.||||++....    .....+.+|+.+++.++     +|+||+++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            34566789999999999999999999887   78999999996532    23356788999999885     37799999


Q ss_pred             EeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC--
Q 014559          217 CDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD--  293 (422)
Q Consensus       217 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~--  293 (422)
                      ++++...+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.  
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~---~~~~~  240 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ---QGRSG  240 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESS---TTSCC
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcc---CCCcc
Confidence            999999999999999996 59999887654 45999999999999999999999999999999999999953   554  


Q ss_pred             EEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC
Q 014559          294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      +||+|||+++...  ......+||+.|+|||++. ..++.++|||||||+||||++|..||.+....+.+..+.......
T Consensus       241 vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          241 IKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             EEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eEEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999997643  3345568999999999876 479999999999999999999999999888877766655321100


Q ss_pred             CC--------------------------------------------------C-----CCCCCCHHHHHHHHHhchhccc
Q 014559          373 DD--------------------------------------------------L-----PWPSVSPEAKDFVKRLLNKDYR  397 (422)
Q Consensus       373 ~~--------------------------------------------------~-----~~~~~s~~~~~li~~~L~~dP~  397 (422)
                      +.                                                  .     .....++++.+||++||++||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            00                                                  0     0012478899999999999999


Q ss_pred             cCCCHHHHHhccCccchh
Q 014559          398 KRMTAVQALSKLVVPILS  415 (422)
Q Consensus       398 ~Rps~~elL~~l~~~~l~  415 (422)
                      +|||+.|+|+|+||+...
T Consensus       399 ~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             TSCCHHHHHTSTTTC---
T ss_pred             hCCCHHHHhCChhhccCC
Confidence            999999999999998643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-47  Score=356.78  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=216.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++.    ++..||||++.....    ..+.+.+|+.++++++ |+||+++++++.+.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY   76 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            3468999999999999999999876    456799999975433    2367899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEE
T ss_pred             ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCcccee
Confidence            99999999999999999987766799999999999999999999999999999999999994   588999999999986


Q ss_pred             cCCCCC--ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....++..|+|||++.+ .++.++||||||+++|+|++ |+.||...........+.........   ..+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  230 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA  230 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence            654332  223456778999999864 78999999999999999999 99999888888777777665543322   257


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++++.++|.+||+.||.+||++.|+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            89999999999999999999999999885

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.7e-49  Score=384.35  Aligned_cols=264  Identities=17%  Similarity=0.192  Sum_probs=202.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-CCCCeeEEE-------e
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFC-------D  218 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~-------~  218 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+.+++.|+ +||||++++       +
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            459999999999999999999887   78899999998866545556677888977666664 499988855       5


Q ss_pred             EEEeC-----------------CeEEEEEEccCCCChHHHHHHhCCCCCHHHH------HHHHHHHHHHHHHHHHCCCee
Q 014559          219 ACEDV-----------------NNVYIVMELCEGGELLDRILARGGRYTEEDA------KAIVVQILSVVAFCHLQGVVH  275 (422)
Q Consensus       219 ~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~ql~~aL~~LH~~~iiH  275 (422)
                      ++...                 ..+|||||||+ |+|.+++......+.+..+      ..++.||+.||.|||++||+|
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            55443                 34899999998 7999999875545555555      677799999999999999999


Q ss_pred             cCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCC
Q 014559          276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       276 ~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~p  352 (422)
                      |||||+|||++   .++.+||+|||+++....  ......+|+.|+|||++.+   .++.++|||||||+||||++|+.|
T Consensus       218 rDikp~NIll~---~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIM---PDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEEC---TTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEEC---CCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999994   588999999999986542  2224567799999999863   699999999999999999999999


Q ss_pred             CCCCChhHH--HHH---HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhh
Q 014559          353 FWARTESGI--FRA---VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       353 f~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~  419 (422)
                      |........  +..   .......+....+..+++++.+||.+||+.||++||++.|+|+|+||+.+.+...
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence            977643211  000   1111112222223478999999999999999999999999999999998877653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6e-48  Score=365.33  Aligned_cols=262  Identities=29%  Similarity=0.460  Sum_probs=219.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ....+|++++.||+|+||.||+|++..   +++.||+|++....   ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHD   88 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred             CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence            456789999999999999999999886   78899999986542   234578899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSA  165 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCc
Confidence            999999999999999998877777899999999999999999999999999999999999994   57899999999875


Q ss_pred             ccCC-CCCccccccCCcccCcccc------CccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          304 FIRP-DERLNDIVGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       304 ~~~~-~~~~~~~~gt~~y~aPE~~------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      .... ........|+..|+|||++      ...++.++|||||||++|+|++|..||...........+........ ..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  244 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT  244 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence            3221 1223345799999999987      24689999999999999999999999988877777766666543321 11


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ...++.++.+||.+||..||.+||++.|+++|+||..+..
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            2358899999999999999999999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-48  Score=371.22  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=213.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|++..   +++.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEE
Confidence            579999999999999999999886   78999999986543 23334466789999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.++ ......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       100 ~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          100 YLVFEFVDHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEECCSEEHHHHH-HHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC----
T ss_pred             EEEEecCCcchHHHH-HhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeec
Confidence            999999998776664 44456799999999999999999999999999999999999994   57899999999997654


Q ss_pred             CC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC-------------
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-------------  370 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  370 (422)
                      .. .......|+..|+|||++.+  .++.++|||||||++|+|++|+.||........+..+.....             
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            33 33455679999999999864  689999999999999999999999988877666555542111             


Q ss_pred             ------CCCCC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          371 ------NFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       371 ------~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                            ..+..        .++.+++++.+||.+||..||.+||++.|+|+|+||+...+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  315 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF  315 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence                  01110        12367899999999999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=365.20  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=214.3

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      ....+|++++.||+|+||.||+|++..   +++.||||++.....    ..+.+.+|+.+++++.+|+||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            345689999999999999999999876   788999999975432    236788999999999569999999999987 


Q ss_pred             -----CCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          223 -----VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       223 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                           .+.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEE
Confidence                 46899999999999999988764 35799999999999999999999999999999999999994   5889999


Q ss_pred             eecCcccccCCC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          297 IDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       297 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      +|||++...... .......|+..|+|||++.      ..++.++|||||||++|+|++|..||........+..+....
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  250 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  250 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence            999999765432 2234567999999999874      358999999999999999999999998877766666555443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ..  ......++.++.+||.+||..||.+||++.|+|+|+||....
T Consensus       251 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          251 AP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            22  222346899999999999999999999999999999987643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.7e-48  Score=374.08  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=211.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..++|++++.||+|+||.||+|++..  ...+++.||||++....  .....+.+.+|+++++++.+||||+++++++.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            34689999999999999999998543  22377899999997542  223346789999999999669999999999988


Q ss_pred             CC-eEEEEEEccCCCChHHHHHHhCC------------------------------------------------------
Q 014559          223 VN-NVYIVMELCEGGELLDRILARGG------------------------------------------------------  247 (422)
Q Consensus       223 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  247 (422)
                      .+ .+++|||||++|+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            65 49999999999999998875432                                                      


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC---ccc
Q 014559          248 -----------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LND  313 (422)
Q Consensus       248 -----------~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~  313 (422)
                                 .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........   ...
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhccc
Confidence                       189999999999999999999999999999999999995   578999999999986543322   334


Q ss_pred             cccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 014559          314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL  391 (422)
Q Consensus       314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  391 (422)
                      ..||..|+|||++. ..++.++|||||||++|||++ |..||.+......+............  ...+++++.++|.+|
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHH
Confidence            56889999999875 578999999999999999998 99999887655444444433322221  135899999999999


Q ss_pred             chhccccCCCHHHHHhcc
Q 014559          392 LNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       392 L~~dP~~Rps~~elL~~l  409 (422)
                      |..||.+||++.|+++++
T Consensus       333 l~~dP~~Rps~~ell~~L  350 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHL  350 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHH
Confidence            999999999999999885

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=373.15  Aligned_cols=256  Identities=24%  Similarity=0.405  Sum_probs=217.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc----CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK----GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .++|++++.||+|+||.||+|++..    ....+..||||++...  ........+.+|+++++++.+|+||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            4589999999999999999999753    1124568999999754  233345778999999999955999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                      +.+.++|||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence            9999999999999999999987653               3599999999999999999999999999999999999994


Q ss_pred             eCCCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 014559          287 SGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI  361 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~  361 (422)
                         .++.+||+|||+++......   ......+|..|+|||++. ..++.++|||||||++|+|++ |..||......+.
T Consensus       226 ---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          226 ---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence               57899999999998665432   233456788999999876 468999999999999999999 9999998888887


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+........   ...+++++.+||.+||..||++||++.|+++++
T Consensus       303 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          303 FKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            777766543221   136899999999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.9e-48  Score=361.89  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=199.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||+|++..   +++.||||++...... ....+.+.++..+++.+. |+||+++++++.+.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCC
Confidence            4679999999999999999999877   7899999999754322 222233444444566665 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      .++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~  156 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGI  156 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC--
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCC
Confidence            9999999975 88776654   456799999999999999999999998 999999999999994   578999999999


Q ss_pred             ccccCCCCCccccccCCcccCcccc----C-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHcCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVL----H-RSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~  375 (422)
                      +.............||+.|+|||++    . ..++.++|||||||++|+|++|+.||... .....+.........  ..
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~  234 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QL  234 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CC
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Cc
Confidence            9877655555566899999999996    2 35899999999999999999999999763 333334444433322  12


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ....++.++.+||.+||+.||++|||+.|+|+|+||.....
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            22468999999999999999999999999999999986543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-47  Score=359.18  Aligned_cols=256  Identities=24%  Similarity=0.366  Sum_probs=206.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++......+..||||++...  ......+.+.+|+.++++++ ||||+++++++. .+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cC
Confidence            446899999999999999999998764445678999998653  22334577899999999997 999999999984 56


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC---CCCEEECccccccc
Confidence            789999999999999998877667999999999999999999999999999999999999964   78899999999987


Q ss_pred             cCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....+++.|+|||++. ..++.++|||||||++|||++ |..||......+....+.......   ....+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~  242 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC  242 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCC
Confidence            654332  22345678899999986 578999999999999999996 999999888888877777654321   12378


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ++++.++|.+||..||.+||++.|+++++-
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999999999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.3e-48  Score=377.05  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=217.2

Q ss_pred             CcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-----ee
Q 014559          140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-----LV  214 (422)
Q Consensus       140 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-----iv  214 (422)
                      ...+.+..+|++.+.||+|+||.||+|++..   +++.||||++....    .....+.+|+.+++.+..|++     |+
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            3345677899999999999999999999886   78899999996432    234667889999999875664     99


Q ss_pred             EEEeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEEeeCCCC
Q 014559          215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCH--LQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       215 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH--~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      ++++++...+.+||||||+.+ +|.+++.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++. +.+
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~  197 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKR  197 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTS
T ss_pred             EeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCC
Confidence            999999999999999999965 9999887654 56999999999999999999999  579999999999999964 346


Q ss_pred             CCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      +.+||+|||+++....  .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus       198 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             CCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            7899999999987643  3456789999999999864 799999999999999999999999998888777766654211


Q ss_pred             CCC------------------CCCC--------------C---C-------------------------CCHHHHHHHHH
Q 014559          371 NFD------------------DLPW--------------P---S-------------------------VSPEAKDFVKR  390 (422)
Q Consensus       371 ~~~------------------~~~~--------------~---~-------------------------~s~~~~~li~~  390 (422)
                      ..+                  ...|              +   .                         .++++++||++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            110                  0000              0   0                         01378999999


Q ss_pred             hchhccccCCCHHHHHhccCccch
Q 014559          391 LLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       391 ~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ||++||++|||+.|+|+|+||+..
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             hcCCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.8e-48  Score=372.20  Aligned_cols=258  Identities=36%  Similarity=0.589  Sum_probs=188.0

Q ss_pred             cccceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          145 FGAKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       145 ~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      +.++|++.+ .||+|+||.||+|+++.   +++.||||++...        ....+|+..+.++.+|+||+++++++.. 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            456799965 69999999999999987   7899999998643        2233444443333359999999999986 


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                         ...++||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence               456899999999999999887653 4699999999999999999999999999999999999997644567799999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH----HHHHHcCCCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGI----FRAVLRSDPNFD  373 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~  373 (422)
                      ||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||........    ...+......++
T Consensus       175 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          175 FGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            999976543 3345567899999999985 4689999999999999999999999976654433    233333444445


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ...+..++.++.+||.+||..||.+||++.|+|+|+||+..
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            55566899999999999999999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-49  Score=386.66  Aligned_cols=254  Identities=16%  Similarity=0.226  Sum_probs=204.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEE------
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFC------  217 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~------  217 (422)
                      ..+|++.+.||+|+||.||+|++..   +|+.||||++...........+.+.+|+.+++.++  +|||||+++      
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            4689999999999999999999876   78899999998655555556688999995555443  499999998      


Q ss_pred             -eEEEeCCe-----------------EEEEEEccCCCChHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCC
Q 014559          218 -DACEDVNN-----------------VYIVMELCEGGELLDRILARGGRYT-------EEDAKAIVVQILSVVAFCHLQG  272 (422)
Q Consensus       218 -~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~l~-------~~~~~~i~~ql~~aL~~LH~~~  272 (422)
                       +++.+.+.                 .||||||+ +|+|.+++.... .++       +..++.|+.||+.||.|||++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence             77665542                 89999999 579999887542 244       4888899999999999999999


Q ss_pred             CeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc------------cCCCchhHHHHH
Q 014559          273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR------------SYSLEADIWSIG  340 (422)
Q Consensus       273 iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG  340 (422)
                      |+||||||+|||++   .++.+||+|||+++...  ......+| ..|+|||++.+            .++.++||||||
T Consensus       227 ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEEC---TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEc---CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999995   57899999999998643  34456678 99999999863            599999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          341 VISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       341 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      |+||||++|+.||...........+..        .+..+++++.+||.+||+.||.+||++.|+|+|+||+.+....
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            999999999999976554333332222        1246899999999999999999999999999999998776543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.3e-47  Score=359.29  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=221.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ....|++++.||+|+||.||+|++..   +++.||||++......  ...+.+.+|+.+++.+. |+||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT   93 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            34579999999999999999999876   7889999999765432  34578999999999996 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+++||||+++++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        94 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeeccccee
Confidence            9999999999999998774  35799999999999999999999999999999999999994   578999999999976


Q ss_pred             cCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          305 IRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ..... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+........   ...++.
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  245 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSK  245 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCH
T ss_pred             cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCH
Confidence            55432 334567999999999986 4689999999999999999999999988777776666655443221   236899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ++.+||.+||..||.+||++.|+|+|+||...
T Consensus       246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999999999998543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-47  Score=358.68  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=217.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++......  ...+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCE
Confidence            4579999999999999999999886   7889999999754332  23477899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .|+||||+++++|.+++. ....+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCcccc
Confidence            999999999999998764 345699999999999999999999999999999999999994   5789999999999765


Q ss_pred             CCC---CCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcCCCCCCCCCCCC
Q 014559          306 RPD---ERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  379 (422)
                      ...   .......|+..|+|||++.+ . ++.++|||||||++|+|++|+.||....... .+..+.......  ..+..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  233 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKK  233 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGG
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--Cchhh
Confidence            322   22345679999999999864 3 4788999999999999999999998765432 333333332222  22346


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ++.++.+||.+||..||.+||++.|+++|+||+....+
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             cCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            89999999999999999999999999999999876544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-47  Score=365.98  Aligned_cols=265  Identities=28%  Similarity=0.386  Sum_probs=218.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEE-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACE-  221 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~-  221 (422)
                      +..+|++.+.||+|+||.||+|++...  +++.||||++........ ....+.+|+.+++.+.  +|+||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            446899999999999999999998531  678999999976443221 1234667888888773  4999999999987 


Q ss_pred             ----eCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          222 ----DVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       222 ----~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                          ....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl  161 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKL  161 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEE
Confidence                4567999999997 59999887643 4599999999999999999999999999999999999994   5889999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC--
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD--  373 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  373 (422)
                      +|||++.............|+..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+........  
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999998766555556678999999999876 4789999999999999999999999998888777766653211000  


Q ss_pred             ---------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          374 ---------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       374 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                           ...+..++.++++||.+||..||.+||++.|+|+|+||..+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                 0112468899999999999999999999999999999987653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8e-48  Score=374.69  Aligned_cols=258  Identities=28%  Similarity=0.489  Sum_probs=215.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++.+|++++.||+|+||.||+|++..   +++.||||++....  .....+.+.+|++++++++ |+||+++++++... 
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   98 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence            45689999999999999999999887   78899999997432  2334467889999999997 99999999999765 


Q ss_pred             ----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                          ..+|+||||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Df  172 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDF  172 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeC
Confidence                469999999974 89888754  3699999999999999999999999999999999999994   5889999999


Q ss_pred             CcccccCCCCC----ccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC-
Q 014559          300 GLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-  372 (422)
Q Consensus       300 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-  372 (422)
                      |++........    ....+||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+....+.+..+....... 
T Consensus       173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  252 (364)
T 3qyz_A          173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  252 (364)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred             cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99986543322    34468999999999864  358999999999999999999999998887777766664311111 


Q ss_pred             ----------------------CCCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          373 ----------------------DDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       373 ----------------------~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                            ....    .+.++.++.+||.+||..||.+|||+.|+|+|+||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                                  0011    24678999999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=362.07  Aligned_cols=258  Identities=26%  Similarity=0.443  Sum_probs=215.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ....+|++.+.||+|+||.||+|++..   +|+.||||++....     ..+.+.+|+.+++.+. |+||+++++++.+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   96 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKN   96 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeC
Confidence            445679999999999999999999876   78899999997542     2367889999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~  173 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAG  173 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccch
Confidence            999999999999999999876777899999999999999999999999999999999999994   57899999999997


Q ss_pred             ccCCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ..... .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+........ .....++
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  252 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWS  252 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSC
T ss_pred             hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCC
Confidence            65433 23345679999999999864 689999999999999999999999988776665555544332211 1122578


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++.+||.+||..||.+||++.++|+|+||...
T Consensus       253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-48  Score=377.77  Aligned_cols=258  Identities=29%  Similarity=0.523  Sum_probs=200.0

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++++.||+|+||.||+|++..   +|+.||||++.... ........+.+|+.+++.++ |+||+++++++...
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  100 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA  100 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            455789999999999999999999887   88999999986532 23334567889999999997 99999999999754


Q ss_pred             ------CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 ------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                            ..+|+|||++ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEe
Confidence                  5689999999 6799887754  5799999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC----
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN----  371 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----  371 (422)
                      |||+++....  .....+||..|+|||++.+  .++.++|||||||++|||++|+.||.+......+..+......    
T Consensus       175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999976542  2455689999999998764  6899999999999999999999999988877776666542111    


Q ss_pred             -------------------CCCCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          372 -------------------FDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       372 -------------------~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                         .+...    ++.+++++.+||++||..||.+|||+.|+|+|+||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                               11111    23578999999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-47  Score=366.56  Aligned_cols=268  Identities=28%  Similarity=0.427  Sum_probs=217.6

Q ss_pred             cCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC------Cee
Q 014559          141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK------HLV  214 (422)
Q Consensus       141 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv  214 (422)
                      .++.+..+|++.+.||+|+||.||+|.+..  .+++.||||++....    ...+.+.+|+.+++.++ |+      +|+
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-~~~~~~~~~i~   80 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN-TTDPNSTFRCV   80 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHH-HHCTTCTTCBC
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecCC----chhHHHHHHHHHHHHhh-hcCCCCceeeE
Confidence            355677899999999999999999998843  167899999986432    23467889999999987 55      499


Q ss_pred             EEEeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC---
Q 014559          215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD---  290 (422)
Q Consensus       215 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~---  290 (422)
                      ++++++.+.+.++|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.   
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence            9999999999999999999 789999887654 36899999999999999999999999999999999999964211   


Q ss_pred             -------------CCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014559          291 -------------DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       291 -------------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                                   ++.+||+|||++.....  .....+||..|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                         56799999999976432  3355689999999999864 7999999999999999999999999887


Q ss_pred             ChhHHHHHHHcCCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhchhcc
Q 014559          357 TESGIFRAVLRSDPNFDD----------------LPW------------------------PSVSPEAKDFVKRLLNKDY  396 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dP  396 (422)
                      ...+....+......++.                ..|                        ...++++.+||.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            776655444322111110                001                        1234678999999999999


Q ss_pred             ccCCCHHHHHhccCccchhhhh
Q 014559          397 RKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       397 ~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      .+|||+.|+|+|+||+.+..++
T Consensus       318 ~~Rpt~~ell~hp~f~~~~~~~  339 (339)
T 1z57_A          318 AKRITLREALKHPFFDLLKKSI  339 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGGGC--
T ss_pred             ccccCHHHHhcCHHHHHHhccC
Confidence            9999999999999999877653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-47  Score=358.03  Aligned_cols=250  Identities=23%  Similarity=0.384  Sum_probs=213.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||++.+.    ++..||||++......    .+.+.+|++++++++ |+||+++++++.+.+.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCCC
Confidence            357999999999999999999876    4567999999754332    367889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEccccccccc
Confidence            9999999999999999877566799999999999999999999999999999999999994   5889999999999865


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+.........   ..++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  247 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS  247 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCC
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCC
Confidence            43321  23345678899999986 578999999999999999998 99999988888887777765433222   3578


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      +++.+||.+||+.||.+||++.|+++++.
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            99999999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=364.67  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|++..   +++.||+|++...   .....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred             hHeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCee
Confidence            579999999999999999999987   7889999998542   3344578899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceecc
Confidence            999999999999999987777899999999999999999999999999999999999994   58899999999997654


Q ss_pred             CCCCc---------------cccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-----HHHHH
Q 014559          307 PDERL---------------NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG-----IFRAV  365 (422)
Q Consensus       307 ~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-----~~~~i  365 (422)
                      .....               ...+||+.|+|||++.+ .++.++|||||||++|||++|..||.......     .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            33221               15679999999999874 68999999999999999999999986532211     11111


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ....  .    ...+++++.++|.+||+.||++||++.++++.
T Consensus       240 ~~~~--~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~  276 (310)
T 3s95_A          240 LDRY--C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW  276 (310)
T ss_dssp             HHHT--C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccc--C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111  1    13678899999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.8e-48  Score=370.09  Aligned_cols=251  Identities=19%  Similarity=0.276  Sum_probs=207.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++.+|++.+.||+|+||.||+|++..   +++.||||++......     +.+.+|+.+++.|.+|+||+++++++.+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            45689999999999999999999876   7899999998754321     357899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC-----EEEeec
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-----MRLIDF  299 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~-----vkl~Df  299 (422)
                      ..+|||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.     +||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~---~~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR---PGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC---GGGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc---CCCCCCceEEEEEc
Confidence            999999999 88999998776678999999999999999999999999999999999999963   444     999999


Q ss_pred             CcccccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHc
Q 014559          300 GLSDFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLR  367 (422)
Q Consensus       300 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~  367 (422)
                      |+++.......        ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...   .+.+..+..
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            99986543322        245689999999999864 689999999999999999999999987433   333444433


Q ss_pred             CCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          368 SDPNFDDL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       368 ~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .....+.. ....++ ++.++|.+||..||.+||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~  275 (330)
T 2izr_A          235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL  275 (330)
T ss_dssp             HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence            22211110 011344 99999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.5e-47  Score=357.55  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=209.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhc----HHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS----IEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      ...+|++.+.||+|+||.||+|++..   +++.||||++..........    .+.+.+|+.++++++ |+||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   92 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM   92 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             hhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheee
Confidence            34679999999999999999999987   78899999987644332211    267889999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCC--CCCCEEE
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGR--DDADMRL  296 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~--~~~~vkl  296 (422)
                      .+..  ++||||+++++|.+.+......+++..++.++.|++.||.|||++|  |+||||||+|||++.++  ....+||
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7766  6999999999999998877778999999999999999999999999  99999999999996411  1123999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH--HHHHHcCCCC
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGI--FRAVLRSDPN  371 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~  371 (422)
                      +|||+++...  .......||..|+|||++.   ..++.++|||||||++|||++|+.||........  ...+......
T Consensus       171 ~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          171 ADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             CCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             CCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            9999997543  2345578999999999983   3578999999999999999999999977554433  3333333222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .  .....+++++.+||.+||+.||.+||++.|+++.+
T Consensus       249 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  284 (287)
T 4f0f_A          249 P--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL  284 (287)
T ss_dssp             C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C--CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            1  12237899999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-47  Score=372.41  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=217.5

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+....+|++.+.||+|+||.||+|++..   +++.||+|++....  .....+.+.+|+.+++.++ |+||+++++++.
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  101 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY  101 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE
Confidence            34556789999999999999999999886   78999999997642  3334577899999999996 999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      +.+.+||||||+++++|.+++... +.+++..+..++.|++.||.|||++ ||+||||||+|||++   .++.+||+|||
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg  177 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFG  177 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECC
Confidence            999999999999999999988654 4699999999999999999999996 999999999999994   58899999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH----------------
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFR----------------  363 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~----------------  363 (422)
                      ++..... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||..........                
T Consensus       178 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          178 VSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             CCHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             CCccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            9875432 22345689999999999864 68999999999999999999999997765543322                


Q ss_pred             --------------------------HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          364 --------------------------AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       364 --------------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                                .+.....  +......++.++.+||++||..||.+|||+.|+|+|+||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                                      1121111  11222357899999999999999999999999999999986554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-48  Score=364.37  Aligned_cols=263  Identities=27%  Similarity=0.464  Sum_probs=198.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++......  ...+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSC
T ss_pred             hhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCC
Confidence            3579999999999999999999876   7889999998654322  23467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          226 VYIVMELCEGGELLDRILA-------RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      .++||||+++++|.+++..       ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEEe
Confidence            9999999999999998864       245699999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCC------CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC
Q 014559          299 FGLSDFIRPDE------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       299 fG~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      ||++.......      ......||+.|+|||++.  ..++.++|||||||++|+|++|+.||.................
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99987654322      123457999999999986  3689999999999999999999999988777666655554433


Q ss_pred             CCCC------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          371 NFDD------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       371 ~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ....      .....++.++.+||.+||+.||.+||++.|+++|+||.....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            2211      1224688999999999999999999999999999999877654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.9e-47  Score=360.17  Aligned_cols=259  Identities=27%  Similarity=0.462  Sum_probs=211.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  222 (422)
                      +..+|++++.||+|+||.||+|++..   +++.||||++...    ....+.+.+|+.+++.++ |+||+++++++.+  
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence            45689999999999999999999876   7889999999643    233467889999999997 9999999998865  


Q ss_pred             -----------CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          223 -----------VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       223 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                                 .+.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .+
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~  152 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ES  152 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CC
Confidence                       3578999999999999999987766789999999999999999999999999999999999994   58


Q ss_pred             CCEEEeecCcccccCCC---------------CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 014559          292 ADMRLIDFGLSDFIRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFW  354 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~  354 (422)
                      +.+||+|||++......               .......|+..|+|||++.+  .++.++|||||||++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            89999999999765422               12344578999999999863  68999999999999999998   554


Q ss_pred             CC-ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          355 AR-TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       355 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      .. ........+......++......++..+.+||++||..||.+||++.|+|+|+||......
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            32 2334555555555555544445678899999999999999999999999999999765444

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.7e-47  Score=369.45  Aligned_cols=262  Identities=23%  Similarity=0.385  Sum_probs=209.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc--------chhcHHHHHHHHHHHHHhcCCCCeeE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--------TAISIEDVRREVKILKALSGHKHLVK  215 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~  215 (422)
                      .+..+|++++.||+|+||.||+|++.    +++.||||++......        .....+.+.+|++++++++ |+||++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~   93 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG   93 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence            34568999999999999999999875    5788999999653322        1223477899999999997 999999


Q ss_pred             EEeEEEe-----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          216 FCDACED-----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       216 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      +++++..     ...+|+||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~  169 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---D  169 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---T
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---C
Confidence            9999854     346899999997 599998877767899999999999999999999999999999999999994   5


Q ss_pred             CCCEEEeecCcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcC
Q 014559          291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS  368 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  368 (422)
                      ++.+||+|||++.............||..|+|||++.  ..++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  249 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV  249 (362)
T ss_dssp             TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            8899999999998666555566678999999999876  46899999999999999999999999988877766665431


Q ss_pred             CCC------------------------CCCCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          369 DPN------------------------FDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       369 ~~~------------------------~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ...                        .+...    .+.+++++.+||.+||..||.+|||+.|+|+|+||+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            111                        11111    23568899999999999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=362.68  Aligned_cols=258  Identities=24%  Similarity=0.443  Sum_probs=217.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE--
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACE--  221 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--  221 (422)
                      +..+|++++.||+|+||.||+|++..   +++.||||++....... ....+.+.+|+.+++.++ |+||+++++++.  
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE   78 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence            34579999999999999999999876   78899999997654322 234577899999999997 999999999984  


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          222 DVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      +.+.+|+||||++++ |.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg  154 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALG  154 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccc
Confidence            456899999999875 77766553 45799999999999999999999999999999999999994   58899999999


Q ss_pred             cccccCCC---CCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          301 LSDFIRPD---ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       301 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      ++......   .......|+..|+|||++.+   .++.++|||||||++|+|++|+.||...........+......++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  234 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG  234 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC
Confidence            99765432   22345679999999999864   2478999999999999999999999988888888888776655443


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                          .++.++.+||.+||..||.+||++.|+++|+||...
T Consensus       235 ----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          235 ----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                689999999999999999999999999999998653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-47  Score=359.11  Aligned_cols=252  Identities=18%  Similarity=0.262  Sum_probs=208.7

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA  219 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  219 (422)
                      ...++|++.+.||+|+||.||+|++....    ..+..||+|++....   ....+.+.+|+.++++++ |+||++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   80 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGV   80 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence            34568999999999999999999987621    112579999986533   234577899999999997 9999999999


Q ss_pred             EEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC------
Q 014559          220 CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD------  293 (422)
Q Consensus       220 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~------  293 (422)
                      +.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.      
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~~~~~~  157 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR---EEDRKTGNP  157 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE---CCBGGGTBC
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec---CCccccccc
Confidence            99999999999999999999998776666999999999999999999999999999999999999975   443      


Q ss_pred             --EEEeecCcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          294 --MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       294 --vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                        +||+|||++......   ....|+..|+|||++.  ..++.++|||||||++|||++|..|+................
T Consensus       158 ~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~  234 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR  234 (289)
T ss_dssp             CEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             ceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence              999999998754322   3456889999999886  468999999999999999999665555544444444444444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..++.    .++.++.+||.+||+.||.+||++.|+++++
T Consensus       235 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          235 HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            44333    4678899999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-47  Score=356.07  Aligned_cols=257  Identities=29%  Similarity=0.468  Sum_probs=217.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~  224 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||+|++...... ....+.+.+|+.++++++ |+||+++++++.+  .+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGT
T ss_pred             hheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCc
Confidence            579999999999999999999886   7899999999765432 334577899999999997 9999999998854  57


Q ss_pred             eEEEEEEccCCCChHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~-----iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      .+|+||||+++++|.+++...   ...+++..++.++.||+.||.|||++|     |+||||||+|||++   .++.+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl  157 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKL  157 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEE
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEE
Confidence            899999999999999988653   345999999999999999999999999     99999999999994   5889999


Q ss_pred             eecCcccccCCCCC-ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          297 IDFGLSDFIRPDER-LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       297 ~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      +|||++........ .....|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+........ 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-  236 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-  236 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred             ecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC-
Confidence            99999976543322 234578999999998764 689999999999999999999999998887777777776554211 


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                        ...++.++.++|.+||..||.+||++.|+|+++|+..-
T Consensus       237 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          237 --PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence              12689999999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-47  Score=366.38  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=216.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++++.||+|+||.||+|++....  .+++.||||++....  .....+.+.+|+.+++.++ |+||+++++++.+.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  122 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG  122 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccC
Confidence            457999999999999999999986421  256899999997542  2334577899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 014559          224 NNVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP  280 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp  280 (422)
                      +.+|+||||+++++|.+++....                       ..+++.+++.++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            99999999999999999987642                       5699999999999999999999999999999999


Q ss_pred             CcEEEeeCCCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 014559          281 ENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWA  355 (422)
Q Consensus       281 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~  355 (422)
                      +|||++   .++.+||+|||++.......   ......+|+.|+|||++. ..++.++|||||||++|||++ |..||.+
T Consensus       203 ~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          203 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999995   57899999999997654322   223456889999999876 579999999999999999999 9999998


Q ss_pred             CChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+....+........   ...++.++.+||++||+.||.+||++.++++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L  330 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  330 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence            888888777776553221   136899999999999999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-47  Score=371.17  Aligned_cols=268  Identities=21%  Similarity=0.385  Sum_probs=225.7

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhc--------------HHHHHHHHHHHHHh
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--------------IEDVRREVKILKAL  207 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l  207 (422)
                      .+.+..+|++++.||+|+||.||+|++     +++.||||++..........              .+.+.+|+.+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            345567899999999999999999987     56899999997654332211              27789999999999


Q ss_pred             cCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHH------HHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCC
Q 014559          208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDR------ILAR-GGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLK  279 (422)
Q Consensus       208 ~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dik  279 (422)
                      + |+||+++++++.+.+.+++||||+++++|.++      +... ...+++..++.++.||+.||.|||+ +||+|||||
T Consensus       101 ~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          101 K-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             C-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             C-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            7 99999999999999999999999999999887      4332 4679999999999999999999999 999999999


Q ss_pred             CCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc--cCCC-chhHHHHHHHHHHHHhCCCCCCCC
Q 014559          280 PENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSL-EADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       280 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                      |+|||++   .++.+||+|||++...... ......|+..|+|||++.+  .++. ++|||||||++|||++|+.||...
T Consensus       180 p~Nil~~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          180 PSNILMD---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             GGGEEEC---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEEc---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999994   5889999999999865433 4455689999999999874  3555 999999999999999999999887


Q ss_pred             Ch-hHHHHHHHcCCCCCCCCC---------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhhh
Q 014559          357 TE-SGIFRAVLRSDPNFDDLP---------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       357 ~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~~  419 (422)
                      .. .+....+......++...               ...++.++.+||.+||+.||.+||++.|+|+|+||....+..+
T Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~  334 (348)
T 2pml_X          256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL  334 (348)
T ss_dssp             SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHH
T ss_pred             CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHH
Confidence            66 677777766655444211               1468999999999999999999999999999999998776544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.2e-47  Score=367.43  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN-  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  225 (422)
                      ++|++.+.||+|+||.||+|++..   +++.||||++.......    ....+|++.+..++ |+||+++++++...+. 
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             TTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhccccc
Confidence            479999999999999999999886   78899999986543222    34567888888886 9999999999976443 


Q ss_pred             ------EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          226 ------VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCH--LQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       226 ------~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH--~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                            +++||||+.+ +|.+.+..   ....+++..++.++.|++.||.|||  ++||+||||||+|||++  ..++.+
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcE
Confidence                  8999999986 66555443   4567999999999999999999999  99999999999999996  237899


Q ss_pred             EEeecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC
Q 014559          295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF  372 (422)
Q Consensus       295 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  372 (422)
                      ||+|||+++............||..|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+.......
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            9999999988776666667789999999998753  48999999999999999999999999888877776665421110


Q ss_pred             C--------------------CC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          373 D--------------------DL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       373 ~--------------------~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      .                    ..        ....++.++.+||.+||+.||.+|||+.|+|+|+||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            0                    00        01125689999999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-47  Score=375.20  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=213.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|+++.   +++.||||++....  .....+.+.+|++++++++ ||||+++++++.+.+.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence            3579999999999999999999886   78899999986432  2223456789999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +||||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceec
Confidence            9999999999999999987766799999999999999999999999999999999999994   5889999999999764


Q ss_pred             CCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......   ....++..|+|||++. +.++.++|||||||++|||++ |..||...........+...... +.  ...+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~  340 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-PC--PELC  340 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-CC--CTTC
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCC
Confidence            432211   1223567899999986 578999999999999999998 99999888777766666554321 11  1258


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++++.+||.+||+.||++|||+.++++.+
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L  369 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQEL  369 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            89999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=364.09  Aligned_cols=262  Identities=32%  Similarity=0.502  Sum_probs=212.0

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE-
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-  221 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-  221 (422)
                      ..++.+|++++.||+|+||.||+|++..   +++.||||++...   .....+.+.+|+.++++++ |+||+++++++. 
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   79 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGP   79 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECT
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccc
Confidence            3466789999999999999999999886   7899999998653   2334577889999999997 999999999873 


Q ss_pred             -------------eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          222 -------------DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       222 -------------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                                   +.+.+|+||||++ |+|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-  155 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-  155 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-
Confidence                         3468999999997 59988773  357999999999999999999999999999999999999962 


Q ss_pred             CCCCCEEEeecCcccccCCC----CCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 014559          289 RDDADMRLIDFGLSDFIRPD----ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF  362 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~  362 (422)
                       +++.+||+|||+++.....    .......++..|+|||++.  ..++.++|||||||++|||++|+.||.+......+
T Consensus       156 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          156 -EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             -TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             -CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             4678999999999865432    2234456799999999874  46899999999999999999999999988877776


Q ss_pred             HHHHcCCCCCC----------------------CC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          363 RAVLRSDPNFD----------------------DL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       363 ~~i~~~~~~~~----------------------~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ..+....+...                      ..    .++.++.++++||++||+.||.+||++.|+|+|+||....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            66654332211                      00    12368999999999999999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-47  Score=377.05  Aligned_cols=263  Identities=22%  Similarity=0.382  Sum_probs=209.4

Q ss_pred             CcCcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-------CCCC
Q 014559          140 GYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-------GHKH  212 (422)
Q Consensus       140 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~n  212 (422)
                      ...+.+..+|++.+.||+|+||.||+|++..   +++.||||++...    ....+.+.+|+.+++.++       +|+|
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~  102 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREM  102 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence            3456677899999999999999999999887   7889999999643    223467889999999996       2788


Q ss_pred             eeEEEeEEE----eCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEe
Q 014559          213 LVKFCDACE----DVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFT  286 (422)
Q Consensus       213 iv~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~  286 (422)
                      |+++++++.    +...+||||||+ +++|++.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus       103 iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~  181 (397)
T 1wak_A          103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             BCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred             eeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence            999999998    456899999999 567777776653 5699999999999999999999998 999999999999996


Q ss_pred             eCC----------------------------------------------CCCCEEEeecCcccccCCCCCccccccCCcc
Q 014559          287 SGR----------------------------------------------DDADMRLIDFGLSDFIRPDERLNDIVGSAYY  320 (422)
Q Consensus       287 ~~~----------------------------------------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y  320 (422)
                      .++                                              ....+||+|||++.....  .....+||..|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y  259 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQY  259 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGG
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcc
Confidence            311                                              113799999999986543  34556899999


Q ss_pred             cCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHcCCCCCC--------------------
Q 014559          321 VAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE------SGIFRAVLRSDPNFD--------------------  373 (422)
Q Consensus       321 ~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~--------------------  373 (422)
                      +|||++. ..++.++|||||||+||||++|+.||.....      ...+..+.......+                    
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            9999876 4699999999999999999999999976442      222222222111000                    


Q ss_pred             ----CC-C-------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          374 ----DL-P-------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       374 ----~~-~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                          .. .             ....+.++.+||.+||+.||++|||+.|+|+|+||+
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                00 0             012346789999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.8e-47  Score=359.02  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=214.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++.+.||+|+||.||+|++..  ...+++.||||++.....  ....+.+.+|+.+++++.+||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            4589999999999999999998642  223678999999975432  234577899999999995599999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          224 NNVYIVMELCEGGELLDRILARGG-----------------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                      +..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            999999999999999999876543                 489999999999999999999999999999999999995


Q ss_pred             eCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 014559          287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI  361 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~  361 (422)
                         .++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|+|++ |+.||........
T Consensus       180 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          180 ---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             ---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence               478999999999986654432   23345788999999875 578999999999999999999 9999988766555


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+........  ....++.++.++|.+||..||.+||++.|+++++
T Consensus       257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  302 (313)
T 1t46_A          257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (313)
T ss_dssp             HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            554444332221  1236899999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-46  Score=351.15  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=201.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+|++.+.||+|+||.||+|++     +++.||||++....... ....+.+.+|+++++.++ |+||+++++++.+.+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP   79 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence            35799999999999999999986     45789999987643322 234577899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEEeeCC-----CCCCEEE
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG---VVHRDLKPENFLFTSGR-----DDADMRL  296 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---iiH~Dikp~NIll~~~~-----~~~~vkl  296 (422)
                      ..++||||+++++|.+++.  ...+++..++.++.|++.||.|||++|   |+||||||+|||++...     .++.+||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999999999988763  457999999999999999999999999   99999999999996311     2678999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      +|||++....... .....|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+......... 
T Consensus       158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  235 (271)
T 3dtc_A          158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI-  235 (271)
T ss_dssp             CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC-
T ss_pred             ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC-
Confidence            9999997654332 33567999999999886 46899999999999999999999999988877776666655443322 


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                       ...+++++.++|.+||+.||.+||++.|+++++
T Consensus       236 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L  268 (271)
T 3dtc_A          236 -PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL  268 (271)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence             236899999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-47  Score=358.83  Aligned_cols=258  Identities=20%  Similarity=0.300  Sum_probs=211.9

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..++.+|++.+.||+|+||.||+|++..   +++.||||++.....     .+.+.+|+.+++.+.+|+||+++++++.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   77 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQE   77 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence            3456789999999999999999999876   789999999865432     24578899999999769999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC--CCCCCEEEeecC
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFG  300 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~--~~~~~vkl~DfG  300 (422)
                      ....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+  +....+||+|||
T Consensus        78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999999999 889999988776779999999999999999999999999999999999999642  122349999999


Q ss_pred             cccccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHcC
Q 014559          301 LSDFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRS  368 (422)
Q Consensus       301 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~  368 (422)
                      +++.......        .....||..|+|||++.+ .++.++|||||||++|||++|+.||....   ....+..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            9986654322        345679999999999864 68999999999999999999999997743   33333333322


Q ss_pred             CCCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          369 DPNFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       369 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+ ......+++++.+||.+||+.||.+||++.++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l  278 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  278 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence            11111 111236889999999999999999999999998763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-47  Score=372.08  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=205.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|+++....++..||||++....  .....+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            357999999999999999999987433367889999997542  2334577899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++|||||+++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCcccccc
Confidence            9999999999999999877767899999999999999999999999999999999999994   5889999999999866


Q ss_pred             CCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....    .....++..|+|||++. +.++.++|||||||++|||++ |+.||...........+........   ...
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            43321    12234577899999986 579999999999999999998 9999998888777777665432111   236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.+||.+||+.||.+||++.|+++.+
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L  304 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL  304 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence            889999999999999999999999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.5e-47  Score=365.97  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=217.2

Q ss_pred             cCcccccceEEeceeCcCCCeEEEEEEeccCCccC-ceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC------e
Q 014559          141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKD-QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH------L  213 (422)
Q Consensus       141 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------i  213 (422)
                      .++.+..+|++.+.||+|+||.||+|++..   ++ +.||||++....    ...+.+.+|+.+++.++ |++      +
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-~~~~~~~~~~   84 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNVG----KYREAARLEINVLKKIK-EKDKENKFLC   84 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHH-HHCTTSCSCB
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecC---CCceEEEEEEEcccc----cchhHHHHHHHHHHHHh-hcCCCCceeE
Confidence            455677899999999999999999999875   44 789999996432    23467888999999997 655      9


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC----
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----  288 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~----  288 (422)
                      +.+++++...+.+||||||+ +++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+...    
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred             EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence            99999999999999999999 568888776654 569999999999999999999999999999999999999432    


Q ss_pred             ------------CCCCCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014559          289 ------------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA  355 (422)
Q Consensus       289 ------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~  355 (422)
                                  +.++.+||+|||++....  ......+||..|+|||++. ..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                        247889999999997643  2335568999999999986 4799999999999999999999999988


Q ss_pred             CChhHHHHHHHcCCCCCCC----------------CCCC------------------------CCCHHHHHHHHHhchhc
Q 014559          356 RTESGIFRAVLRSDPNFDD----------------LPWP------------------------SVSPEAKDFVKRLLNKD  395 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~d  395 (422)
                      ......+..+......++.                ..|.                        ..+.++.+||++||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            7776655544332211110                0011                        12457899999999999


Q ss_pred             cccCCCHHHHHhccCccchhhh
Q 014559          396 YRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       396 P~~Rps~~elL~~l~~~~l~~k  417 (422)
                      |.+|||+.|+|+|+||..+...
T Consensus       322 P~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGCCHH
T ss_pred             hhhCcCHHHHhcChhhcCCChh
Confidence            9999999999999999987654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-47  Score=362.33  Aligned_cols=251  Identities=20%  Similarity=0.312  Sum_probs=206.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCc----eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ..+|++.+.||+|+||.||+|++..   +++    .||+|.+....  .....+.+.+|+.++++++ |+||+++++++.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   87 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICL   87 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcC---CCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe
Confidence            3579999999999999999999865   444    45778775432  2334578899999999997 999999999998


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.. .++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~  163 (327)
T 3poz_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGL  163 (327)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCTTH
T ss_pred             cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC---CCCEEEccCcc
Confidence            765 78999999999999999887788999999999999999999999999999999999999964   78899999999


Q ss_pred             ccccCCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          302 SDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       302 a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      ++........   ....+|..|+|||++. ..++.++|||||||++|||++ |+.||.+.........+........   
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---  240 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---  240 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---
T ss_pred             eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---
Confidence            9876543322   2345688999999876 579999999999999999999 9999988877777666655432211   


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...++.++.++|.+||+.||.+||++.|+++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l  273 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            136889999999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-46  Score=355.93  Aligned_cols=255  Identities=27%  Similarity=0.478  Sum_probs=202.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNE  106 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCc
Confidence            3579999999999999999999876   78899999998655455556678899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      +++||||+++++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC---
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEeccce
Confidence            9999999999999988764   346699999999999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCC-CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHcCCCCCCCCCCC
Q 014559          303 DFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ....... ......|+..|+|||++. ..++.++|||||||++|+|++|..||.+...  ......+....  ++.....
T Consensus       184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  261 (310)
T 2wqm_A          184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSD  261 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTT
T ss_pred             eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCccc
Confidence            7654332 234457899999999876 4689999999999999999999999976432  23344444332  2223334


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.++.+||.+||..||.+||++.++++.+
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l  292 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVA  292 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            7899999999999999999999999999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-46  Score=357.54  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+.++++++ |+||+++++++.+.+.+
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeE
Confidence            479999999999999999999876   78899999997665545555678999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-----
T ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCcccc
Confidence            9999999999999988654 5699999999999999999999999999999999999994   57899999999987654


Q ss_pred             CCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ...  ......|+..|+|||++. ..++.++||||||+++|+|++|+.||.......... ...............++.+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCCCCccccCCCCCHH
Confidence            332  233567999999999986 468999999999999999999999998766554433 3333333222334578999


Q ss_pred             HHHHHHHhchhccccCC-CHHHHHhcc
Q 014559          384 AKDFVKRLLNKDYRKRM-TAVQALSKL  409 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rp-s~~elL~~l  409 (422)
                      +.++|.+||..||++|| +++++++.+
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~~l  291 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSAAA  291 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence            99999999999999999 888887653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.1e-47  Score=357.46  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ...+|++++.||+|+||.||+|+... ...+++.||||++...   .....+.+.+|++++++++ |+||+++++++...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            45689999999999999999998421 1227889999998643   2334567899999999997 99999999998654


Q ss_pred             --CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          224 --NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       224 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                        ..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~---~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC---CCeEEEccCcc
Confidence              5689999999999999998776667999999999999999999999999999999999999964   78899999999


Q ss_pred             ccccCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh----------------H
Q 014559          302 SDFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----------------G  360 (422)
Q Consensus       302 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------------~  360 (422)
                      +........    .....++..|+|||++. ..++.++|||||||++|||++|..||......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987644322    23345778899999886 57999999999999999999999998543211                1


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       361 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+.. ....+  ....+++++.+||.+||..||++|||+.|+++.+
T Consensus       241 ~~~~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L  286 (295)
T 3ugc_A          241 LIELLKN-NGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  286 (295)
T ss_dssp             HHHHHHT-TCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhc-cCcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            1222222 21211  1236899999999999999999999999998764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-46  Score=363.61  Aligned_cols=261  Identities=29%  Similarity=0.460  Sum_probs=214.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+..+|++.+.||+|+||.||+|++..   +|+.||||++...  ........+.+|+.+++.++ |+||+++++++..
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   80 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRP   80 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc
Confidence            3456789999999999999999999876   7889999999643  22334467889999999997 9999999998876


Q ss_pred             C-----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          223 V-----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       223 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      .     ...|+||||+. ++|.+.+..  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~  154 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVC  154 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEEC
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEE
Confidence            4     67999999997 588887755  4699999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCCCC-----------CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 014559          298 DFGLSDFIRPDE-----------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA  364 (422)
Q Consensus       298 DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  364 (422)
                      |||++.......           .....+||..|+|||++.  ..++.++|||||||++|+|++|+.||.+......+..
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999997654321           123357899999999864  4689999999999999999999999988776665554


Q ss_pred             HHcCCC------------------------CCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          365 VLRSDP------------------------NFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       365 i~~~~~------------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      +.....                        .....    .++.+++++.+||.+||..||.+||++.|+|+|+||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            432111                        00000    1246889999999999999999999999999999997653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-46  Score=360.14  Aligned_cols=263  Identities=22%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++++.||+|+||.||+|++.........||||++...... ....+.+.+|+.++++++ |+||+++++++.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence            345799999999999999999998763222248999999764332 234578899999999996 999999999998876


Q ss_pred             eE------EEEEEccCCCChHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC
Q 014559          225 NV------YIVMELCEGGELLDRILARG-----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       225 ~~------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                      ..      ++||||+.+|+|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCC
Confidence            55      99999999999999886532     2599999999999999999999999999999999999994   5789


Q ss_pred             EEEeecCcccccCCCCCc---cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcC
Q 014559          294 MRLIDFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRS  368 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  368 (422)
                      +||+|||+++........   ....++..|+|||++. ..++.++|||||||++|||++ |..||.+.........+...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999999866443322   2345678899999986 468999999999999999999 99999988888888777765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-------HHHHHhccCccchh
Q 014559          369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT-------AVQALSKLVVPILS  415 (422)
Q Consensus       369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~elL~~l~~~~l~  415 (422)
                      .....   ...+++++.+||.+||+.||.+||+       +++++.++|+....
T Consensus       256 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          256 NRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            53222   2368999999999999999999999       67777778876544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-47  Score=364.52  Aligned_cols=258  Identities=26%  Similarity=0.391  Sum_probs=212.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++.+.||+|+||.||+|++...  ..++..||||++....  .....+.+.+|+.+++++.+||||+++++++.+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            46899999999999999999997431  1256789999997532  2223467899999999994599999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 014559          224 NNVYIVMELCEGGELLDRILARGG----------------------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE  281 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~  281 (422)
                      +.++|||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            999999999999999999876532                      3789999999999999999999999999999999


Q ss_pred             cEEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 014559          282 NFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWAR  356 (422)
Q Consensus       282 NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~  356 (422)
                      |||++   .++.+||+|||++........   .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.
T Consensus       202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99995   478999999999976543322   23346788999999875 579999999999999999998 99999887


Q ss_pred             ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      .....+..+.........  ...+++++.+||.+||..||.+||++.|+++++.
T Consensus       279 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            665555555544333222  2368999999999999999999999999998864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.9e-47  Score=370.78  Aligned_cols=257  Identities=30%  Similarity=0.535  Sum_probs=212.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|.+.+.||+|+||.||+|++..   +|+.||||++.... ........+.+|+.+++.++ |+||+++++++...
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  113 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA  113 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence            355789999999999999999999887   78999999997543 23334577889999999997 99999999999887


Q ss_pred             CeE------EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 NNV------YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ~~~------~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +..      |+||||+. ++|.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEE
Confidence            654      99999997 5887765   34599999999999999999999999999999999999994   58899999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCC---
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF---  372 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---  372 (422)
                      |||+++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.......   
T Consensus       187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            9999976542  3455688999999998764  68999999999999999999999998887777666654321110   


Q ss_pred             --------------------CCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          373 --------------------DDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       373 --------------------~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                          ...    .++.+++++.+||++||+.||.+|||+.|+|+|+||..+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                                000    123578999999999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.8e-46  Score=350.49  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=212.6

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++.....++..||||++....  .....+.+.+|+.+++.++ ||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CC
Confidence            357999999999999999999977544456679999987542  2334577899999999997 9999999999875 45


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---PECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE---TTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC---CCcEEeCccCCCccc
Confidence            68999999999999999877778999999999999999999999999999999999999964   789999999999866


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+........   ...++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  240 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLCP  240 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTCC
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCCC
Confidence            44322  23345788999999986 578999999999999999998 9999988777777766665433221   12689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++.++|.+||..||.+||++.|+++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~L  268 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCSL  268 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            9999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-46  Score=357.69  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=215.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++.+.||+|+||.||+|++..  +..+++.||||++....  .....+.+.+|+++++.++ ||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC
Confidence            4579999999999999999998743  12356899999997542  3334577899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 014559          224 NNVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP  280 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp  280 (422)
                      +.+++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            99999999999999999987643                       2389999999999999999999999999999999


Q ss_pred             CcEEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 014559          281 ENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWA  355 (422)
Q Consensus       281 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~  355 (422)
                      +|||++   .++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|||++ |..||.+
T Consensus       179 ~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          179 RNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             heEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999995   478899999999986643322   23345788899999876 468999999999999999999 9999988


Q ss_pred             CChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .........+.......   ....+++++.++|.+||..||.+||++.|+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l  306 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL  306 (314)
T ss_dssp             CCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            88877777666544221   1236899999999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=348.41  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=214.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++.    +++.||||++.....    ..+.+.+|+++++.++ |+||+++++++.+.+.+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSC
T ss_pred             hheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCe
Confidence            57999999999999999999986    456899999976433    2367899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccc
Confidence            999999999999999887767899999999999999999999999999999999999994   47899999999997654


Q ss_pred             CCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...  ......++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........   ...++.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~  232 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST  232 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCH
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcH
Confidence            321  123346788899999986 578999999999999999999 8999998888887777776543222   125789


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++|.+||..||.+||++.++++++
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRPAFSRLLRQL  259 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-46  Score=361.32  Aligned_cols=266  Identities=17%  Similarity=0.239  Sum_probs=216.9

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      +....+|++++.||+|+||.||+|++..  ...+++.||||++...  ........+.+|+.++++++ |+||+++++++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  102 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS  102 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence            4456789999999999999999998542  1237789999999643  22334567889999999996 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCE
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM  294 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~v  294 (422)
                      .+.+..||||||+++++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999987653      358999999999999999999999999999999999999753446679


Q ss_pred             EEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCC
Q 014559          295 RLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       295 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ||+|||++.......   ......|+..|+|||++. ..++.++|||||||++|+|++ |..||...........+....
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            999999987543222   223456789999999875 578999999999999999998 999998888777777776654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      ....   ...++.++.+||.+||..||.+||++.+++++++...-
T Consensus       263 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          263 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            3222   23689999999999999999999999999999876543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-46  Score=354.88  Aligned_cols=257  Identities=22%  Similarity=0.338  Sum_probs=207.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++......+..||||++...........+.+.+|++++++++ |+||+++++++.+.. 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            357999999999999999999875432234579999997655444455678999999999997 999999999998765 


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC---CCCEEEccccccccc
Confidence            89999999999999999877677999999999999999999999999999999999999964   788999999999876


Q ss_pred             CCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....    .....++..|+|||++. ..++.++|||||||++|+|++ |+.||........+..+.......+.  ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  249 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED  249 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence            54332    22346788899999986 468999999999999999999 99999988888888877765544332  236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||..||.+||++.++++.+
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  279 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFL  279 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            899999999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=353.52  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=206.8

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEE
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  229 (422)
                      .....||+|+||.||+|++..   +++.||||++....   ....+.+.+|+.+++.++ |+||+++++++.+.+.+++|
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEE
Confidence            334489999999999999876   78899999987542   223467899999999997 99999999999999999999


Q ss_pred             EEccCCCChHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          230 MELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      |||+++++|.+++....+  .+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCC
Confidence            999999999998876533  467999999999999999999999999999999999996  2378999999999976543


Q ss_pred             CC-CccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-HHH--HHcCCCCCCCCCCCCC
Q 014559          308 DE-RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRA--VLRSDPNFDDLPWPSV  380 (422)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~--i~~~~~~~~~~~~~~~  380 (422)
                      .. ......|+..|+|||++.+   .++.++|||||||++|+|++|+.||........ ...  .......++    ..+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~  251 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP----ESM  251 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC----TTS
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc----ccC
Confidence            32 2345679999999999853   389999999999999999999999976433222 111  122222222    368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      +.++.+||.+||..||++||++.|+|+|+||.....+
T Consensus       252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            9999999999999999999999999999999876654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-46  Score=354.12  Aligned_cols=255  Identities=22%  Similarity=0.423  Sum_probs=200.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      +....+|++.+.||+|+||.||+|++..      .||||++..... .....+.+.+|+.++++++ |+||+++++++ .
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~   90 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-T   90 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-C
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-c
Confidence            4456789999999999999999998643      499999975432 3344577899999999997 99999999965 5


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceec
Confidence            5678999999999999998876667899999999999999999999999999999999999996   4789999999999


Q ss_pred             cccCC---CCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc-CCCCCC-
Q 014559          303 DFIRP---DERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-SDPNFD-  373 (422)
Q Consensus       303 ~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~-  373 (422)
                      .....   ........||..|+|||++.    ..++.++|||||||++|+|++|+.||........+..... ...... 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            75542   22234567999999999874    3588899999999999999999999988665554444433 222211 


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ......+++++.+||.+||..||.+||++.|+++.+
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  283 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI  283 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            112346899999999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-46  Score=350.59  Aligned_cols=257  Identities=21%  Similarity=0.364  Sum_probs=214.8

Q ss_pred             cceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|.+.+ .||+|+||.||+|.+.... ++..||||++....  .....+.+.+|+++++.++ |+||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCC
Confidence            4677776 9999999999999865322 57789999997642  3334577899999999996 99999999999 5567


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN---RHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC---CCCEEECcccceeee
Confidence            99999999999999988766677999999999999999999999999999999999999964   789999999999876


Q ss_pred             CCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....    .....+|..|+|||++. ..++.++|||||||++|||++ |+.||...........+........   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCC
Confidence            43322    22345688999999986 578999999999999999998 9999988888777777766542211   137


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++++.++|.+||..||.+||++.+++++++--..
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999999998754433

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-46  Score=360.37  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=210.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCce--EEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQ--VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++.+.||+|+||.||+|++..   ++..  ||||.+....  .....+.+.+|+++++++.+||||+++++++.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            3579999999999999999999876   5554  4999886432  2234467889999999995599999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                      +.+|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc--
Confidence            99999999999999999886543               4699999999999999999999999999999999999995  


Q ss_pred             CCCCCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 014559          289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVL  366 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  366 (422)
                       .++.+||+|||+++............++..|+|||++. ..++.++|||||||++|||++ |+.||...........+.
T Consensus       177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence             47899999999997544333334456788999999986 468999999999999999998 999998888877777666


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ......   ....++.++.+||.+||..||.+||++.|+++++
T Consensus       256 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          256 QGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             GTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            543211   1236899999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.2e-46  Score=358.24  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=214.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccC----CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .++|++++.||+|+||.||+|++...    ..++..||||++....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            45899999999999999999997531    1257789999997542  33345778999999999955999999999999


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                      +.+.+|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            9999999999999999999887543               2489999999999999999999999999999999999994


Q ss_pred             eCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 014559          287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI  361 (422)
Q Consensus       287 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~  361 (422)
                         .++.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.
T Consensus       192 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          192 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence               588999999999986654332   23345788899999875 568999999999999999999 9999988888777


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+........   ...++.++.++|.+||..||.+||++.|+++++
T Consensus       269 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  313 (334)
T 2pvf_A          269 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  313 (334)
T ss_dssp             HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            777666542211   236899999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.9e-46  Score=351.34  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=215.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++..   ++..||||++....    ...+.+.+|+.++++++ |+||+++++++.+.+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP   82 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            45689999999999999999999987   78899999986532    23477889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccce
Confidence            9999999999999999887643 4599999999999999999999999999999999999995   47899999999998


Q ss_pred             ccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .......  .....++..|+|||++. ..++.++||||||+++|+|++ |..||...........+.......   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  236 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEG  236 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---CCCC
Confidence            6654332  23345788899999886 578999999999999999999 999998887777766665543221   1236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++++.+||.+||..||.+||++.|+++.+
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l  266 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQAF  266 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-46  Score=353.02  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=207.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACED  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~  222 (422)
                      .++.+|++.+.||+|+||.||+|++..   +++.||||++......     +.+.+|+.+++.++ |++ +..+..++.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE   76 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhh-cCCCCCccccccCC
Confidence            356789999999999999999999876   7899999998654322     45789999999998 655 4455555567


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            78899999999 88999998766778999999999999999999999999999999999999964445789999999999


Q ss_pred             cccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCCC
Q 014559          303 DFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDP  370 (422)
Q Consensus       303 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  370 (422)
                      ........        .....||..|+|||++.+ .++.++|||||||++|||++|+.||.....   ...+..+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            86654322        245679999999999864 689999999999999999999999976332   223333332221


Q ss_pred             CCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          371 NFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       371 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+ ......+++++.+||.+||+.||.+||++.++++.+
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  275 (296)
T 3uzp_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  275 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred             CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence            111 001136889999999999999999999999998763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.1e-47  Score=363.95  Aligned_cols=250  Identities=21%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCce----EEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQ----VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+|++.+.||+|+||.||+|++..   +++.    ||+|.+.....  ......+.+|+.++++++ |+||+++++++. 
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-   85 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-   85 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECC---TTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred             hHceeeeeeeecCCceEEEEEEcC---CCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-
Confidence            579999999999999999999876   4444    77777653321  122245678999999997 999999999986 


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+..++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a  162 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA  162 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCcc
Confidence            4668999999999999999876666899999999999999999999999999999999999994   5889999999999


Q ss_pred             cccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +.......   .....|+..|+|||++. +.++.++|||||||++|+|++ |+.||.+.........+.........   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  239 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---  239 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---
Confidence            87654332   24456788999999986 579999999999999999999 99999888777777766654432221   


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..++.++.++|.+||..||.+||++.|+++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l  271 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANEF  271 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            25788899999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-46  Score=355.17  Aligned_cols=260  Identities=21%  Similarity=0.283  Sum_probs=208.0

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ......+|++.+.||+|+||.||+|++.....++..||||++..... .....+.+.+|+.++++++ |+||+++++++.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~  106 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCI  106 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEe
Confidence            33445689999999999999999998876544677899999875432 2334567899999999997 999999999998


Q ss_pred             eCC-----eEEEEEEccCCCChHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          222 DVN-----NVYIVMELCEGGELLDRILA-----RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       222 ~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      +.+     ..++||||+++++|.+++..     ....+++..++.++.||+.||.|||++||+||||||+|||++   .+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CC
Confidence            765     35999999999999998854     235699999999999999999999999999999999999994   57


Q ss_pred             CCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 014559          292 ADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVL  366 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  366 (422)
                      +.+||+|||++........   .....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+.
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            8999999999976543321   23345788999999976 468999999999999999999 999998888888777776


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .......   ...+++++.+||.+||..||.+||++.++++++
T Consensus       264 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  303 (313)
T 3brb_A          264 HGHRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL  303 (313)
T ss_dssp             TTCCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            6543211   236899999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=356.07  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++++.||+|+||.||+|+++.   +++.||||++....... ...+.+.++..+++.+. |+||+++++++.+.+.+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccch-HHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcE
Confidence            579999999999999999999987   78899999997653222 22233444445666665 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||+ ++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC---
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhc
Confidence            9999999 5455555555567899999999999999999999995 999999999999994   5889999999999876


Q ss_pred             CCCCCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ..........|+..|+|||++.      ..++.++|||||||++|+|++|+.||... .....+..+......... ...
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccC
Confidence            6555555668999999999973      35899999999999999999999999773 444555566554433211 223


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .++.++.+||.+||..||.+||++.|+|+|+||+..
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            689999999999999999999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-46  Score=356.42  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=210.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .++|++.+.||+|+||.||+|++..  ...+++.||||++....  .....+.+.+|+.+++++.+|+||+++++++.+.
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            4689999999999999999998643  22367899999997543  2234467899999999996699999999999876


Q ss_pred             C-eEEEEEEccCCCChHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          224 N-NVYIVMELCEGGELLDRILARGGR---------------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       224 ~-~~~lv~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      + .+++||||+++++|.+++......               +++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-  182 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  182 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-
Confidence            4 599999999999999988764332               89999999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        .++.+||+|||+++.......   .....||..|+|||++. ..++.++|||||||++|+|++ |..||........+
T Consensus       183 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             --CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence              478999999999986543322   23456788999999875 578999999999999999998 99999876644433


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ............  ...+++++.++|.+||..||.+||++.|+++++
T Consensus       261 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          261 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            333332222111  125899999999999999999999999999885

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=374.41  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++.+.||+|+||.||+|++..   +++.||||++......  ...+.+.+|++++++++ |+||+++++++.+.
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   79 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEET   79 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCCCeEEEeeccC
Confidence            355689999999999999999999987   7899999999754332  23567889999999997 99999999999876


Q ss_pred             C--eEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC-CCCCCEEEee
Q 014559          224 N--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLID  298 (422)
Q Consensus       224 ~--~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~-~~~~~vkl~D  298 (422)
                      +  ..+||||||++|+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            5  7899999999999999886532  239999999999999999999999999999999999998432 3456799999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC---------ccCCCchhHHHHHHHHHHHHhCCCCCCC----CChhHHHHHH
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH---------RSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAV  365 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlG~il~ell~g~~pf~~----~~~~~~~~~i  365 (422)
                      ||+++...........+||..|+|||++.         ..++.++|||||||++|||++|+.||..    ....+.+..+
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            99998877666666778999999999874         3578899999999999999999999964    2334555566


Q ss_pred             HcCCCCCC-------------------CC--CCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          366 LRSDPNFD-------------------DL--PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       366 ~~~~~~~~-------------------~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+...                   ..  ....++..+.++|++||++||++|+++.|+++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l  304 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence            55543210                   00  0012456789999999999999999999998775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-46  Score=358.83  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=213.9

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---hcHHHHHHHHHHHHHhc-CCCCeeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALS-GHKHLVKFCD  218 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~l~~  218 (422)
                      +.+..+|++++.||+|+||.||+|++..   +++.||||++........   ...+.+.+|+.+++++. +|+||+++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            3456689999999999999999999877   789999999976543321   11244678999999997 3699999999


Q ss_pred             EEEeCCeEEEEEEccCC-CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          219 ACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       219 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      ++.+.+.+++|||++.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .+++.+||+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~  192 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLI  192 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEe
Confidence            99999999999999986 7999987654 5799999999999999999999999999999999999996  247889999


Q ss_pred             ecCcccccCCCCCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       298 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      |||++..... .......||..|+|||++.+ . ++.++|||||||++|||++|+.||....      .+......+.  
T Consensus       193 Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--  263 (320)
T 3a99_A          193 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--  263 (320)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--
T ss_pred             eCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--
Confidence            9999987653 33455679999999998753 3 4788999999999999999999996431      2233333222  


Q ss_pred             CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       376 ~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                        ..+++++.+||.+||..||++||++.|+++|+||+....
T Consensus       264 --~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             --ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence              368999999999999999999999999999999986543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.4e-46  Score=350.28  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=206.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ...|++++.||+|+||.||+|+... +..+++.||||++....  .....+.+.+|+.+++.++ |+||+++++++.+. 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            4569999999999999999998421 22378999999997543  2334578899999999997 99999999999877 


Q ss_pred             -CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       224 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                       ..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC---CCCEEECccccc
Confidence             6799999999999999999777778999999999999999999999999999999999999964   789999999999


Q ss_pred             cccCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--------------ChhHHHH
Q 014559          303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR--------------TESGIFR  363 (422)
Q Consensus       303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~--------------~~~~~~~  363 (422)
                      ........    .....||..|+|||++. ..++.++|||||||++|+|++|..|+...              .....+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654432    23456888899999876 46889999999999999999999876321              1111222


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..........  ....+++++.+||.+||+.||.+||++.|+++.+
T Consensus       254 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  297 (302)
T 4e5w_A          254 NTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF  297 (302)
T ss_dssp             HHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            2222222221  2237899999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-46  Score=356.64  Aligned_cols=256  Identities=18%  Similarity=0.309  Sum_probs=215.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ...+|++.+.||+|+||.||+|+++.  ...+++.||||++....  .......+.+|+.+++.++ |+||+++++++.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEcc
Confidence            45689999999999999999998762  11257889999987542  2234467889999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC
Q 014559          223 VNNVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                      .+..++||||+++++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCCe
Confidence            999999999999999999886532         4579999999999999999999999999999999999994   5789


Q ss_pred             EEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcC
Q 014559          294 MRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRS  368 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  368 (422)
                      +||+|||++........   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||...........+...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            99999999976543321   23345788999999986 578999999999999999999 89999888887777777665


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .....   ...++.++.+||.+||..||.+||++.|+++++
T Consensus       257 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          257 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            43221   136899999999999999999999999999885

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-46  Score=356.35  Aligned_cols=255  Identities=20%  Similarity=0.335  Sum_probs=209.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+|++.+.||+|+||.||+|++.... ..+..||||++....  .......+.+|+.+++.++ |+||+++++++.+.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence            457999999999999999999976421 134579999997542  2334467889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++|||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcchh
Confidence            99999999999999999887777899999999999999999999999999999999999994   588999999999986


Q ss_pred             cCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          305 IRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       305 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      ......    .....++..|+|||++. ..++.++|||||||++|||++ |+.||......+....+........   ..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~~  273 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PM  273 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---cc
Confidence            643321    12234678899999876 578999999999999999999 9999988888777777765432211   23


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.++.++|.+||+.||.+||++.++++.+
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  304 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSIL  304 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            6899999999999999999999999998864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=360.77  Aligned_cols=257  Identities=30%  Similarity=0.535  Sum_probs=210.7

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +..+|.+.+.||+|+||.||+|+++.   +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++...+
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS   96 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence            45689999999999999999999887   78999999997543 23334567889999999997 999999999998765


Q ss_pred             e------EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 N------VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ~------~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      .      +|+||||+. ++|.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEee
Confidence            4      599999997 5887765   23599999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------  370 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  370 (422)
                      ||++.....  ......||..|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.....      
T Consensus       170 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          170 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             cccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999976542  2345678999999998764  689999999999999999999999988877666655543110      


Q ss_pred             -----------------CC----CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          371 -----------------NF----DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       371 -----------------~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                       ..    ....+..++.++.+||.+||+.||++||++.|+|+|+||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                             00    0112346899999999999999999999999999999997543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-46  Score=366.58  Aligned_cols=262  Identities=17%  Similarity=0.228  Sum_probs=200.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchh--------cHHHHHHHHHHHHHhcCCCCe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAI--------SIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      ....+|++++.||+|+||.||+|++..+.  ..++.||||++.........        ....+..|+..++.++ |+||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence            34568999999999999999999987532  13688999998654311100        0012234445555665 9999


Q ss_pred             eEEEeEEEeC----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          214 VKFCDACEDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       214 v~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      +++++++...    ..+||||||| +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            9999998875    4589999999 89999998877678999999999999999999999999999999999999963 2


Q ss_pred             CCCCEEEeecCcccccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 014559          290 DDADMRLIDFGLSDFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG  360 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~  360 (422)
                      .++.+||+|||+++.+.....        ....+||+.|+|||++.+ .++.++|||||||+||||++|+.||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            478999999999976543321        134569999999999875 69999999999999999999999998643322


Q ss_pred             HHHHHHcC--CCCCC-----CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          361 IFRAVLRS--DPNFD-----DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       361 ~~~~i~~~--~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ........  ...+.     .+....++.++.+||.+||..||.+||++.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            21111110  00000     00113688999999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-45  Score=352.19  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=208.8

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcC-CCCeeEEEeEEEe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACED  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~  222 (422)
                      ..+.+|++++.||+|+||.||+|++.    +++.||||++..... .....+.+.+|+.+++++.. |+||+++++++.+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            34567999999999999999999875    577899999976443 33345788999999999973 5999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+.+++|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++
T Consensus       100 ~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~  173 (313)
T 3cek_A          100 DQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIA  173 (313)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSS
T ss_pred             CCEEEEEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccc
Confidence            9999999995 577999987654 5799999999999999999999999999999999999995    588999999999


Q ss_pred             cccCCCCC---ccccccCCcccCccccCc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHH
Q 014559          303 DFIRPDER---LNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVL  366 (422)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~  366 (422)
                      ........   .....|+..|+|||++.+            .++.++|||||||++|+|++|+.||..... ...+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            86643322   234579999999999753            588899999999999999999999976543 33344444


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ........  ....+.++.+||.+||..||.+||++.|+|+|+||....
T Consensus       254 ~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          254 DPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             hcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            43322211  125688999999999999999999999999999987543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-46  Score=360.29  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=198.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  224 (422)
                      .+|++++.||+|+||.||+|++.     ++.||||++.....    ......+|+.++++++ ||||+++++++.+..  
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSV   93 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             hhchhhheecccCceEEEEEEEC-----CCEEEEEEeecCch----HHHHHHHHHHHHhcCC-CCCchhhcceeccCCCC
Confidence            47999999999999999999863     57899999965422    2345667999999997 999999999998754  


Q ss_pred             --eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCcEEEeeCCCCC
Q 014559          225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ----------GVVHRDLKPENFLFTSGRDDA  292 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------~iiH~Dikp~NIll~~~~~~~  292 (422)
                        .+++|||||++|+|.+++...  .+++..++.++.||+.||.|||++          ||+||||||+|||++   .++
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~  168 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNL  168 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTC
T ss_pred             CceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCC
Confidence              489999999999999988653  599999999999999999999999          999999999999994   588


Q ss_pred             CEEEeecCcccccCCCCC---ccccccCCcccCccccCc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-----
Q 014559          293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTE-----  358 (422)
Q Consensus       293 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~-----  358 (422)
                      .+||+|||+++.......   ....+||..|+|||++.+      .++.++|||||||++|||++|+.||.+...     
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999976654332   334679999999999864      466789999999999999999999965422     


Q ss_pred             -----------hHHHHHHHcCCCCCCCCC--C--CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          359 -----------SGIFRAVLRSDPNFDDLP--W--PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       359 -----------~~~~~~i~~~~~~~~~~~--~--~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                                 ......+...... +...  +  ...+.++.+||.+||+.||++|||+.|+++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  313 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI  313 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCC-CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                       1222222222211 1110  0  11245699999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=356.74  Aligned_cols=251  Identities=21%  Similarity=0.326  Sum_probs=205.2

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCce----EEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQ----VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ..+|++++.||+|+||.||+|++..   +++.    ||+|.+...  ......+.+.+|+.+++.++ ||||+++++++.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   87 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICL   87 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC---TTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcC---CCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEe
Confidence            3579999999999999999999876   4544    466666432  22334578899999999997 999999999998


Q ss_pred             eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       222 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      +.. .++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kL~DfG~  163 (327)
T 3lzb_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGL  163 (327)
T ss_dssp             SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCTTC
T ss_pred             cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC---CCCEEEccCcc
Confidence            765 88999999999999999887788999999999999999999999999999999999999964   78899999999


Q ss_pred             ccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          302 SDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       302 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      ++.......   .....+|..|+|||++. ..++.++|||||||++|||++ |..||...........+........   
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---  240 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---  240 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            987643332   22345678899999876 578999999999999999999 9999988888777766665442221   


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...++.++.+||++||..||.+||++.|+++.+
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  273 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            236899999999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-46  Score=351.26  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=209.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE-eCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~  224 (422)
                      ..+|++.+.||+|+||.||+|++..+..+...||+|.+...  ......+.+.+|+.++++++ |+||+++++++. .++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence            35799999999999999999997654335567899998653  23334577899999999997 999999999865 456


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccccccc
Confidence            88999999999999999877677799999999999999999999999999999999999994   588999999999976


Q ss_pred             cCCCCC-----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          305 IRPDER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       305 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ......     .....+|..|+|||++. ..++.++|||||||++|+|++ |..||...........+.........   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence            543321     23356788999999886 578999999999999999999 66677776666666666665543322   


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..++.++.++|.+||..||.+||++.|+++.+
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  286 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  286 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            35889999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.1e-46  Score=376.87  Aligned_cols=251  Identities=20%  Similarity=0.355  Sum_probs=214.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|+++.   ++..||||++.....    ..+.+.+|+.+|++|+ |+||+++++++.+.+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  289 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP  289 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence            34579999999999999999999986   688999999975432    3577899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~  366 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSR  366 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEE
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccce
Confidence            9999999999999999987643 4699999999999999999999999999999999999994   57899999999998


Q ss_pred             ccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .......  .....++..|+|||++. +.++.++|||||||+||||++ |..||.+.....+...+..... ..  ....
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~  443 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-ME--RPEG  443 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CC--CCTT
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence            7643322  22345678899999986 578999999999999999999 9999988877777666654322 11  1236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++++.+||.+||+.||.+||++.++++.+
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L  473 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQAF  473 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            899999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-45  Score=369.64  Aligned_cols=245  Identities=23%  Similarity=0.369  Sum_probs=208.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  224 (422)
                      ..+|++.+.||+|+||.||+|.+.     ++.||||+++...     ..+.+.+|+.+|++++ |+||+++++++.+.+ 
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence            457999999999999999999863     5689999997543     2367899999999997 999999999987765 


Q ss_pred             eEEEEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+|||||||++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK  337 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCE
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCcc
Confidence            79999999999999999987654 379999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. +.++.++|||||||+||||++ |+.||......+....+..+... .  ....++
T Consensus       338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~--~p~~~~  412 (450)
T 1k9a_A          338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-D--APDGCP  412 (450)
T ss_dssp             ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-C--CCTTCC
T ss_pred             ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcCC
Confidence            54322  22346788999999985 579999999999999999998 99999888777777777654321 1  123689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++.+||.+||..||.+||++.++++.+
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L  440 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQL  440 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999999999999999999999998753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.8e-46  Score=356.87  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=212.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ..+|++.+.||+|+||.||+|++....  .....||||++....  .....+.+.+|+.+++.+.+||||+++++++.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            467999999999999999999986521  133589999997543  2234577899999999994499999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHh-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCC
Q 014559          224 NNVYIVMELCEGGELLDRILAR-------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~  290 (422)
                      +.+++||||+++|+|.+++...             ...+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence            9999999999999999988653             34689999999999999999999999999999999999996   4


Q ss_pred             CCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 014559          291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV  365 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  365 (422)
                      ++.+||+|||++........   .....|+..|+|||++. ..++.++|||||||++|||++ |..||.+......+..+
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            78899999999976543322   23345788999999875 578999999999999999998 99999887665555555


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      .........  ...++.++.++|.+||+.||.+||++.|+++++-
T Consensus       280 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          280 VKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             HHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence            544332221  2357899999999999999999999999998653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-46  Score=348.87  Aligned_cols=248  Identities=26%  Similarity=0.453  Sum_probs=210.8

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+.++.+|++++.||+|+||.||+|++..   +++.||||++....       +.+.+|+++++.++ |+||+++++++.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~   74 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWD   74 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEe
Confidence            34567789999999999999999999876   78899999996542       34678999999997 999999999886


Q ss_pred             e----------------CCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 014559          222 D----------------VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFL  284 (422)
Q Consensus       222 ~----------------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIl  284 (422)
                      .                ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil  154 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF  154 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence            5                45589999999999999998764 357999999999999999999999999999999999999


Q ss_pred             EeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 014559          285 FTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR  363 (422)
Q Consensus       285 l~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~  363 (422)
                      ++.   ++.+||+|||++.............|+..|+|||++. ..++.++|||||||++|+|++|..||..  ......
T Consensus       155 ~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~  229 (284)
T 2a19_B          155 LVD---TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFT  229 (284)
T ss_dssp             EEE---TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHH
T ss_pred             EcC---CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHH
Confidence            964   7889999999998776665556678999999999876 4689999999999999999999998843  222333


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                      .+....  +.    ..++.++.+||.+||..||.+||++.|++++++.
T Consensus       230 ~~~~~~--~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          230 DLRDGI--IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHHTTC--CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Hhhccc--cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            333221  22    2588999999999999999999999999999754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.9e-46  Score=350.36  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=201.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEe
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACED  222 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~  222 (422)
                      .++++|++.+.||+|+||.||+|++..   +++.||||++......     ..+.+|+.+++.+. |++ |..+..++.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE   76 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---C-----CCHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccc-----hHHHHHHHHHHHhc-CCCCCCeeeeecCC
Confidence            355789999999999999999999876   7889999987654322     34788999999998 555 4455555577


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            88899999999 88999998776778999999999999999999999999999999999999954345889999999999


Q ss_pred             cccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHcCCC
Q 014559          303 DFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDP  370 (422)
Q Consensus       303 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~  370 (422)
                      ........        .....||..|+|||++.+ .++.++|||||||++|+|++|+.||......   ..+..+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            86654322        235679999999999864 7899999999999999999999999764322   22222222211


Q ss_pred             CCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          371 NFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       371 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+ ......+++++.+||.+||+.||++||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  274 (296)
T 4hgt_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence            111 11113578999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=348.52  Aligned_cols=255  Identities=19%  Similarity=0.257  Sum_probs=210.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ...|++.+.||+|+||.||+|++.....++..||+|++...  ......+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   96 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG   96 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence            34688899999999999999997664435568999998643  23334577899999999997 9999999999987665


Q ss_pred             E-EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 V-YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~-~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      . ++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARD  173 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCccc
Confidence            5 999999999999999877677899999999999999999999999999999999999994   588999999999976


Q ss_pred             cCCCC-----CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          305 IRPDE-----RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       305 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      .....     ......++..|+|||++.+ .++.++|||||||++|+|++|..| |...........+........   .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~  250 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---P  250 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---C
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---C
Confidence            54322     2334568899999999864 689999999999999999995555 555555555555555442221   1


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+++++.+||.+||..||.+|||+.++++.+
T Consensus       251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  282 (298)
T 3pls_A          251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV  282 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            36899999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.7e-46  Score=357.36  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=191.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHH-HHHHhcCCCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+|++++.||+|+||.||+|+++.   +++.||||++.....  ......+.+|+. +++.+ +|+||+++++++.+.+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecccC--chHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence            3579999999999999999999876   788999999975422  223345666666 55555 4999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          225 NVYIVMELCEGGELLDRILA----RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                      ..++||||+.+ +|.+.+..    ....+++..++.++.|++.||.|||++ ||+||||||+|||++   .++.+||+||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Df  170 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDF  170 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCC
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccC
Confidence            99999999975 77776653    256799999999999999999999999 999999999999995   4889999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccC-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCC-CCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSD-PNF  372 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~-~~~  372 (422)
                      |+++............||..|+|||++.     ..++.++|||||||++|+|++|+.||...... ..+..+.... ..+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            9998766554445568999999999983     35899999999999999999999999764321 2222222221 122


Q ss_pred             CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       373 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      ....+..++.++.+||.+||..||.+||++.|+|+|+||.....+
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence            222334689999999999999999999999999999999876554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.2e-46  Score=371.80  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=211.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++.    .+..||||+++....    ..+.+.+|+.+|++|+ |+||+++++++. .+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SS
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CC
Confidence            4467999999999999999999986    456799999975432    3578999999999997 999999999986 56


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+|||||||.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLAR  332 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGG
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCce
Confidence            7899999999999999987432 3689999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .......  .....++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+....+...... +.  ...
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~--~~~  409 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-PR--PEN  409 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-CC--CTT
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--CCC
Confidence            7643221  22345678899999986 579999999999999999999 99999988888877777654322 11  236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++++.+||.+||..||++||++.++++.+
T Consensus       410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L  439 (454)
T 1qcf_A          410 CPEELYNIMMRCWKNRPEERPTFEYIQSVL  439 (454)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            899999999999999999999999997653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=365.09  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=203.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-CCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~  225 (422)
                      ..|++.+.||+|+||.||+|++......+..||||.+...  ......+.+.+|+.++++++ ||||+++++++.+ ++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence            4689999999999999999998653334567999998643  23334578899999999997 9999999998754 568


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      .++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeeccccccc
Confidence            8999999999999999877667799999999999999999999999999999999999994   5889999999999765


Q ss_pred             CCCCC-----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          306 RPDER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       306 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      .....     .....++..|+|||++. ..++.++|||||||++|||++ |..||......+....+.........   .
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---T
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence            43221     23345778899999986 578999999999999999999 77888777666666666655432221   3


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.++.++|.+||..||++||++.|+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L  350 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  350 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            6899999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.6e-46  Score=354.94  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=206.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE--eC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--DV  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~  223 (422)
                      .+|++++.||+|+||.||+|+... +..+++.||||++...   .....+.+.+|++++++++ |+||+++++++.  +.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence            579999999999999999998421 1237889999998654   2334467899999999996 999999999987  45


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES---EAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC---CCCEEEcccccce
Confidence            6799999999999999998876667999999999999999999999999999999999999964   7889999999998


Q ss_pred             ccCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh---------------HHHH
Q 014559          304 FIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES---------------GIFR  363 (422)
Q Consensus       304 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------------~~~~  363 (422)
                      .......    .....|+..|+|||++. ..++.++|||||||++|+|++|..||......               ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            7654332    23346888899999886 46899999999999999999999998543321               1222


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+.. .....  ....+++++.+||.+||..||.+||++.|+++++
T Consensus       256 ~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  298 (327)
T 3lxl_A          256 LLEE-GQRLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQL  298 (327)
T ss_dssp             HHHT-TCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             Hhhc-ccCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            2222 22111  1236899999999999999999999999997663

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=371.47  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||+||... ..   +++.||||++......      .+.+|+.+|+.+.+|||||++++++.+.+.+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~-~~---~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRG-MF---DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEE-ES---SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEecCCeeecCcCEEEEEEE-Ee---CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            469999999999999976433 22   6789999998654322      2468999999995699999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC--CCCCEEEeecCcccc
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGLSDF  304 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~--~~~~vkl~DfG~a~~  304 (422)
                      |||||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++.++  ....+||+|||+++.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999996 599999877666677777889999999999999999999999999999996422  234688999999987


Q ss_pred             cCCCC----CccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCC
Q 014559          305 IRPDE----RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDL  375 (422)
Q Consensus       305 ~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  375 (422)
                      .....    .....+||+.|+|||++.    ..++.++|||||||++|||++ |..||........ ..+.. .......
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~-~~~~~~~  250 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLG-ACSLDCL  250 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTT-CCCCTTS
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhc-cCCcccc
Confidence            65332    234567999999999985    357889999999999999999 8999965544333 22222 2221111


Q ss_pred             -CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          376 -PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       376 -~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                       .....+..+++||.+||+.||.+||++.|+|+|+||..+.+++
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~~  294 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQL  294 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHHH
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHHH
Confidence             1123456789999999999999999999999999998877643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.3e-46  Score=344.68  Aligned_cols=247  Identities=18%  Similarity=0.248  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--C
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  224 (422)
                      .+|++.+.||+|+||.||+|++.     ++.||||++..... .....+.+.+|+.++++++ |+||+++++++.+.  +
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSS
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCC
Confidence            57999999999999999999873     57899999976532 2334567899999999997 99999999999887  7


Q ss_pred             eEEEEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          225 NVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      .+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~  159 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADV  159 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGS
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEeccc
Confidence            89999999999999998876443 5899999999999999999999999  99999999999994   578899999988


Q ss_pred             ccccCCCCCccccccCCcccCccccCc-c---CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          302 SDFIRPDERLNDIVGSAYYVAPEVLHR-S---YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       302 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +....    .....||+.|+|||++.+ .   ++.++|||||||++|||++|+.||...........+.........  .
T Consensus       160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~  233 (271)
T 3kmu_A          160 KFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--P  233 (271)
T ss_dssp             CCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--C
T ss_pred             eeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--C
Confidence            75432    234578999999999864 2   344899999999999999999999988887776666655433221  2


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..++.++.++|.+||+.||++||++.|+++.+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L  265 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL  265 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            36899999999999999999999999999763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.5e-47  Score=360.67  Aligned_cols=255  Identities=20%  Similarity=0.317  Sum_probs=205.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++.    +++.||||++....   ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTT
T ss_pred             HHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence            4457999999999999999999964    57889999986542   234577899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCc
Q 014559          225 NVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL  301 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~  301 (422)
                      .+++||||+++|+|.+++....   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeeccc
Confidence            9999999999999998875432   3589999999999999999999999999999999999994   588999999999


Q ss_pred             ccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH-----HHcCCCCC
Q 014559          302 SDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA-----VLRSDPNF  372 (422)
Q Consensus       302 a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~~  372 (422)
                      ++......   ......||..|+|||++. +.++.++|||||||++|||++|+.||...........     .......+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            97643222   233456899999999875 5799999999999999999999999976443221110     00111111


Q ss_pred             C--------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          373 D--------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       373 ~--------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      .        ....+.++.++.++|.+||+.||++||++.|+++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1        1111134567999999999999999999999998863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.5e-45  Score=344.82  Aligned_cols=252  Identities=22%  Similarity=0.338  Sum_probs=208.3

Q ss_pred             cceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+|++.+ .||+|+||.||+|.+.... .++.||||++..... .....+.+.+|+.+++.++ |+||+++++++ +.+.
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred             hhhhhccCccccccCeeeEeeeecCCC-ceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence            4799988 9999999999999654322 678999999976432 2233577899999999997 99999999999 5677


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC---CCcEEEccCCcceee
Confidence            8999999999999998865 456999999999999999999999999999999999999964   789999999999876


Q ss_pred             CCCCCc----cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ......    ....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+........   ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  244 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAG  244 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence            543321    2234678899999986 468899999999999999999 9999998888777776665442211   136


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.++|.+||+.||.+||++.++++.+
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  274 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVELRL  274 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999998753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.7e-46  Score=349.87  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=198.3

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHH--hcCCCCeeEEEeEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA--LSGHKHLVKFCDAC  220 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~  220 (422)
                      +.+..+|++.+.||+|+||.||+|++     +++.||||++....      ...+.+|.+++..  ++ |+||+++++++
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~-h~niv~~~~~~   71 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSRD------EKSWFRETELYNTVMLR-HENILGFIASD   71 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCC-CTTBCCEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEecccc------chhhHHHHHHHHHhhcc-CcCeeeEEEee
Confidence            45667899999999999999999976     56789999986432      2456667777777  65 99999999987


Q ss_pred             EeC----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEEeeC
Q 014559          221 EDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH--------LQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       221 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~iiH~Dikp~NIll~~~  288 (422)
                      .+.    ..+|+||||+++|+|.+++.  ...+++..++.++.||+.||.|||        ++||+||||||+|||++  
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~--  147 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK--  147 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC--
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc--
Confidence            653    46899999999999999883  457999999999999999999999        99999999999999994  


Q ss_pred             CCCCCEEEeecCcccccCCCCC-----ccccccCCcccCccccCc-------cCCCchhHHHHHHHHHHHHhC-------
Q 014559          289 RDDADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR-------SYSLEADIWSIGVISYILLCG-------  349 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlG~il~ell~g-------  349 (422)
                       .++.+||+|||+++.......     ....+||+.|+|||++.+       .++.++|||||||++|||++|       
T Consensus       148 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          148 -KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             -TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             -CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence             588999999999976543322     233579999999999864       345789999999999999999       


Q ss_pred             ---CCCCCCCC----hhHHHHHHHcCCCCCCCCCC----CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          350 ---SRPFWART----ESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       350 ---~~pf~~~~----~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                         ..||....    ....+..........+..+.    ..++.++.+||.+||+.||.+|||+.|+++.+
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence               88885532    22333333332222222111    12457899999999999999999999999764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.3e-46  Score=372.93  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=210.7

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .++++|+++++||+|+||.||+|++..   +++.||||++......     ..+.+|+++++.|..|++|+.+..++.+.
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            456789999999999999999999876   7889999998654322     34788999999998667888888888889


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +..+|||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.++.+||+|||+++
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999999999 889999988767789999999999999999999999999999999999999644468899999999998


Q ss_pred             ccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCCCC
Q 014559          304 FIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDPN  371 (422)
Q Consensus       304 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~  371 (422)
                      .......        ....+||..|+|||++.+ .++.++||||||||||||++|+.||.+...   ...+..+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            7654332        225689999999999864 799999999999999999999999977443   2233333222111


Q ss_pred             CC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          372 FD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       372 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      .. ......++.++.+||.+||..||++||++.++++.
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~  272 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL  272 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            00 00112678999999999999999999999988764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=362.62  Aligned_cols=263  Identities=20%  Similarity=0.240  Sum_probs=200.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch--------hcHHHHHHHHHHHHHhcCCCCeeE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--------ISIEDVRREVKILKALSGHKHLVK  215 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~  215 (422)
                      ....+|++++.||+|+||.||+|++.....++..||||++........        .....+.+|+.+++.+. |+||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence            345689999999999999999999976545778999999876432111        11134667888888886 999999


Q ss_pred             EEeEEEe----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          216 FCDACED----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       216 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                      +++++.+    ...+||||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +..
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~  189 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY-KNP  189 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES-SST
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc-CCC
Confidence            9999988    67899999999 88999987554 37999999999999999999999999999999999999974 223


Q ss_pred             CCEEEeecCcccccCCCCC--------ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hH
Q 014559          292 ADMRLIDFGLSDFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE--SG  360 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~  360 (422)
                      +.+||+|||+++.......        .....||..|+|||++.+ .++.++|||||||++|||++|+.||.....  ..
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            4999999999976543221        244579999999999865 689999999999999999999999965322  22


Q ss_pred             HHHHHHcCCCCCCC-----CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          361 IFRAVLRSDPNFDD-----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       361 ~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ...........++.     .....++.++.+||.+||..||++||++.++++.+-
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            21111111111111     011268899999999999999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-45  Score=344.10  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++++.||+|+||.||+|++.    .+..||||++.....    ..+.+.+|+++++.++ |+||+++++++.+ +.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CC
Confidence            457999999999999999999875    456799999865432    3467899999999997 9999999999874 56


Q ss_pred             EEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCccccc
Confidence            899999999999999875432 3699999999999999999999999999999999999994   588999999999987


Q ss_pred             cCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+.......   ....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  235 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNC  235 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Ccccc
Confidence            654322  23345778899999986 568999999999999999999 999998888877777776543221   12368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.++.++|.+||..||++||++.++++.+
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l  264 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVL  264 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            99999999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=354.51  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=203.2

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---hcHHHHHHHHHHHHHhc---CCCCeeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALS---GHKHLVKFC  217 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~l~  217 (422)
                      .+..+|++.+.||+|+||.||+|++..   +++.||||++........   .....+.+|+.+++++.   +|+||++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            345679999999999999999999876   788999999976543221   12234567999999993   399999999


Q ss_pred             eEEEeCCeEEEEEEc-cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          218 DACEDVNNVYIVMEL-CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       218 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      +++.+.+..++|||+ +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEE
Confidence            999999999999999 7889999988664 4699999999999999999999999999999999999996  25788999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      +|||++..... .......|+..|+|||++.+ . ++.++|||||||++|+|++|+.||....      .+......++ 
T Consensus       182 ~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~-  253 (312)
T 2iwi_A          182 IDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP-  253 (312)
T ss_dssp             CCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC-
T ss_pred             EEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc-
Confidence            99999987653 33456679999999998753 3 3568999999999999999999996431      2333333333 


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                         ..++.++.+||.+||..||++||++.|+|+|+||+.....
T Consensus       254 ---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          254 ---AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence               2689999999999999999999999999999999876543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.3e-45  Score=350.77  Aligned_cols=256  Identities=24%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             ccccce-EEeceeCcCCCeEEEEEEec-cCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          144 NFGAKY-ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       144 ~~~~~y-~~~~~lG~G~~g~V~~a~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      .+..+| ++++.||+|+||.||++... ....+++.||||++....  .....+.+.+|++++++++ |+||+++++++.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  103 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE  103 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe
Confidence            345556 99999999999999988643 223378899999997542  2334577899999999997 999999999999


Q ss_pred             eC--CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          222 DV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       222 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                      +.  ..+++||||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~Df  178 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDF  178 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCG
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECCc
Confidence            84  6799999999999999987543  599999999999999999999999999999999999994   5889999999


Q ss_pred             CcccccCCCCC----ccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh--------------H
Q 014559          300 GLSDFIRPDER----LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTES--------------G  360 (422)
Q Consensus       300 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--------------~  360 (422)
                      |++........    .....++..|+|||++.+ .++.++|||||||++|+|++|+.||......              .
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            99987654432    234568888999999864 6889999999999999999999999653221              0


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       361 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .+...........  ....++.++.+||++||+.||.+||++.|+++.+
T Consensus       259 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  305 (318)
T 3lxp_A          259 RLTELLERGERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL  305 (318)
T ss_dssp             HHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhcccCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            1112222222211  1236899999999999999999999999999753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=354.09  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=187.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE----
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE----  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----  221 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++...   .....+.+.+|+.+++++.+|+||+++++++.    
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            4579999999999999999999877   7889999998543   22344678899999999977999999999994    


Q ss_pred             ----eCCeEEEEEEccCCCChHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCC
Q 014559          222 ----DVNNVYIVMELCEGGELLDRILA--RGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       222 ----~~~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~  293 (422)
                          ....+++||||+. |+|.+++..  ..+.+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~  176 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGT  176 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSC
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCC
Confidence                3346899999996 699988865  3467999999999999999999999999  99999999999994   5789


Q ss_pred             EEEeecCcccccCCCCCc-------------cccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014559          294 MRLIDFGLSDFIRPDERL-------------NDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWAR  356 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~  356 (422)
                      +||+|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|++|+.||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999999999876533221             1456899999999972    35889999999999999999999999765


Q ss_pred             ChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ........    ....+  ....++.++.+||++||+.||.+||++.|+++++.
T Consensus       257 ~~~~~~~~----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          257 AKLRIVNG----KYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hHHHhhcC----cccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            44333222    21111  12357788999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=353.26  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=202.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe---
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  222 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++...   .....+.+.+|+.+++.++ |+||+++++++..   
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence            4579999999999999999999876   7899999998653   2334577899999999996 9999999999873   


Q ss_pred             -CCeEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 -VNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 -~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                       ....|+||||+.+++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~d  177 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMD  177 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEe
Confidence             3479999999999999998876   356799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCC----------ccccccCCcccCccccCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhHHH
Q 014559          299 FGLSDFIRPDER----------LNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWART--ESGIF  362 (422)
Q Consensus       299 fG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~  362 (422)
                      ||++........          .....||..|+|||++.+    .++.++|||||||++|+|++|+.||....  .....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            999875432111          123457999999999863    37899999999999999999999995311  11122


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+.. ...++.  ...++.++.+||.+||..||.+||++.++++++
T Consensus       258 ~~~~~-~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          258 LAVQN-QLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHHC-C--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhhc-cCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            22222 222222  246899999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.3e-45  Score=365.49  Aligned_cols=260  Identities=26%  Similarity=0.386  Sum_probs=200.0

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ..+...|.+.+.||+|+||+||.+.. .   +|+.||||++....      .+.+.+|+.+++++.+|||||++++++.+
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~~-~---~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQGS-F---QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEEE-S---SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEEE-E---CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            34556788889999999999986543 2   68899999986532      25678899999987559999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC--------
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGR------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--------  288 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~------l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~--------  288 (422)
                      .+.+|||||||. |+|.+++......      .++..++.++.||+.||.|||++||+||||||+|||++..        
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence            999999999996 5999988653211      1333467899999999999999999999999999999742        


Q ss_pred             --CCCCCEEEeecCcccccCCCCC-----ccccccCCcccCccccC--------ccCCCchhHHHHHHHHHHHHh-CCCC
Q 014559          289 --RDDADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLC-GSRP  352 (422)
Q Consensus       289 --~~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~-g~~p  352 (422)
                        +.++.+||+|||+++.......     ....+||+.|+|||++.        ..++.++|||||||++|||++ |+.|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence              2356899999999987654322     23467999999999874        358999999999999999999 9999


Q ss_pred             CCCCChhHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          353 FWARTESGIFRAVLRSDPNFDDLP---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       353 f~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      |.......  ..+...........   ...++.++.+||.+||+.||.+||++.|+|+|+||....
T Consensus       240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~  303 (434)
T 2rio_A          240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS  303 (434)
T ss_dssp             TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred             CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence            97654433  33444433333221   123568899999999999999999999999999997544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.5e-46  Score=362.97  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc----------CCCCeeE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----------GHKHLVK  215 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~  215 (422)
                      ..+|++.+.||+|+||.||+|++..   +++.||||++....    ...+.+.+|+.+++++.          +|+||++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            3579999999999999999999876   78899999986432    23466888999999886          2789999


Q ss_pred             EEeEEEeCC----eEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEeeC-
Q 014559          216 FCDACEDVN----NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSG-  288 (422)
Q Consensus       216 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~Dikp~NIll~~~-  288 (422)
                      +++++...+    .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.. 
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999998754    799999999 78999988764 35699999999999999999999998 99999999999999642 


Q ss_pred             --CCCCCEEEeecCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------hh
Q 014559          289 --RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART------ES  359 (422)
Q Consensus       289 --~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~------~~  359 (422)
                        +..+.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||....      ..
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              2344799999999976543  3445689999999999864 68999999999999999999999997643      22


Q ss_pred             HHHHHHHcCCCCCCC------------------------C--------------CCCCCCHHHHHHHHHhchhccccCCC
Q 014559          360 GIFRAVLRSDPNFDD------------------------L--------------PWPSVSPEAKDFVKRLLNKDYRKRMT  401 (422)
Q Consensus       360 ~~~~~i~~~~~~~~~------------------------~--------------~~~~~s~~~~~li~~~L~~dP~~Rps  401 (422)
                      ..+..+.......+.                        .              ....++.++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            222222221111000                        0              00134578999999999999999999


Q ss_pred             HHHHHhccCccch
Q 014559          402 AVQALSKLVVPIL  414 (422)
Q Consensus       402 ~~elL~~l~~~~l  414 (422)
                      +.|+|+|+||...
T Consensus       328 ~~ell~hp~f~~~  340 (373)
T 1q8y_A          328 AGGLVNHPWLKDT  340 (373)
T ss_dssp             HHHHHTCGGGTTC
T ss_pred             HHHHhhChhhhcc
Confidence            9999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-45  Score=367.29  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=205.9

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++.+.||+|+||.||+|++..    +..||||++.....    ..+.+.+|+.+|++|+ |+||+++++++.+ +
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E  251 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence            34679999999999999999999863    45799999975432    3467899999999997 9999999999876 6


Q ss_pred             eEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+||||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLAR  328 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccce
Confidence            789999999999999998653 35699999999999999999999999999999999999995   57899999999998


Q ss_pred             ccCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .......  .....++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+....+.......   ....
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~  405 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPE  405 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Confidence            6643321  22345678899999876 579999999999999999999 999999888888777776543211   1136


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +++++.+||.+||..||++|||+.++++.
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~  434 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQAF  434 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            89999999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=374.20  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=210.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.++||+|+||.||+|++..    +..||||++.....    ..+.+.+|+++|++|+ |+||+++++++.+ +.
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             hhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-cc
Confidence            4579999999999999999999863    45799999975432    3467899999999997 9999999999876 67


Q ss_pred             EEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|||||||++|+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++.
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEccccccee
Confidence            89999999999999998653 35699999999999999999999999999999999999994   578999999999986


Q ss_pred             cCCCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      .....  ......++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+++..+...... +  ....+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~~~  489 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPPEC  489 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-C--CCTTC
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCC
Confidence            64322  122345678899999876 579999999999999999999 99999988888887777654321 1  11368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +.++.+||.+||..||++||++.++++.
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=374.77  Aligned_cols=252  Identities=21%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             cceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++.+.+ .||+|+||.||+|.++... ++..||||+++...  .....+.+.+|+++|++++ |+|||++++++.+ +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence            3455655 8999999999999876422 56789999997642  2334578999999999996 9999999999976 56


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++||||||.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN---RHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC---CCcEEEeeccCcccc
Confidence            99999999999999988766677999999999999999999999999999999999999964   789999999999876


Q ss_pred             CCCCCc----cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ......    ....++..|+|||++. +.++.++|||||||+||||++ |+.||.+....++...+..+.....   ...
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCc
Confidence            433221    1234568899999986 579999999999999999998 9999999888888877776543211   136


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++++.+||.+||..||.+||++.++++.+
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L  593 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQRM  593 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            899999999999999999999999997653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-45  Score=353.33  Aligned_cols=262  Identities=19%  Similarity=0.257  Sum_probs=205.7

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ....+|++.+.||+|+||.||+|++.    +++.||||++.......  ....+.+|+.+++.++ |+||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   99 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTP   99 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCS
T ss_pred             HHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCch--HHHHHHHHHHHHHhcc-CCCccceEEEEecC
Confidence            34568999999999999999999854    57889999997643322  1236889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEEeeCCCCCCEEEe
Q 014559          224 NNVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQ---GVVHRDLKPENFLFTSGRDDADMRLI  297 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~iiH~Dikp~NIll~~~~~~~~vkl~  297 (422)
                      +..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||++   ||+||||||+|||++   .++.+||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~  176 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVG  176 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEEC
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEec
Confidence            99999999999999999887542   3499999999999999999999999   999999999999994   57899999


Q ss_pred             ecCcccccCCCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCC-----CChhHHHHHHHcC-
Q 014559          298 DFGLSDFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA-----RTESGIFRAVLRS-  368 (422)
Q Consensus       298 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~-----~~~~~~~~~i~~~-  368 (422)
                      |||++.......  ......||..|+|||++. +.++.++|||||||++|+|++|+.||..     .........+... 
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999998664332  234456999999999885 5789999999999999999999999942     1111111111110 


Q ss_pred             -CCCCCCCC--------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          369 -DPNFDDLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       369 -~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                       ........        ....+.++.++|.+||+.||.+|||+.|+++++....+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence             00111100        011236799999999999999999999999998655444

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.7e-45  Score=342.29  Aligned_cols=245  Identities=22%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-C
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-N  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-~  224 (422)
                      ..+|++.+.||+|+||.||+|++     +++.||||++....     ..+.+.+|+.++++++ |+||+++++++.+. +
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred             hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence            35799999999999999999976     46789999986432     3467899999999997 99999999997654 5


Q ss_pred             eEEEEEEccCCCChHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      .+++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK  165 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC--
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccc
Confidence            79999999999999998876432 389999999999999999999999999999999999994   58899999999987


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+......   .....++
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  240 (278)
T 1byg_A          166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP  240 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred             ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCcccCC
Confidence            55432  23346788999999986 578999999999999999998 99999888777777666554321   1123689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++.++|.+||..||.+||++.|+++.+
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L  268 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLREQL  268 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence            9999999999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=357.35  Aligned_cols=256  Identities=18%  Similarity=0.239  Sum_probs=202.5

Q ss_pred             cccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcC--CCCeeEEEeEE
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG--HKHLVKFCDAC  220 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~  220 (422)
                      ...+|++.+.||+|+||.||+|.+..  ...+++.||||++....      ...+.+|+++++.++.  |+||+++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            34679999999999999999995322  12278899999986532      3567788888888853  89999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee--------C
Q 014559          221 EDVNNVYIVMELCEGGELLDRILA----RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS--------G  288 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~--------~  288 (422)
                      ...+..|||||||++|+|.+++..    ....+++..++.++.||+.||.|||++||+||||||+|||++.        +
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999999875    3467999999999999999999999999999999999999953        1


Q ss_pred             CCCCCEEEeecCcccccC---CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 014559          289 RDDADMRLIDFGLSDFIR---PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA  364 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  364 (422)
                      +.++.+||+|||+++...   ........+||..|+|||++.+ .|+.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence            227899999999996543   3334556789999999999875 689999999999999999999999965432110   


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                        .....+...   ..++.+.++|.+||..+|.+|++..+.|.+.+.+++
T Consensus       294 --~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          294 --KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             --EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             --eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence              011111111   346789999999999999999876666665544443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=355.96  Aligned_cols=251  Identities=16%  Similarity=0.206  Sum_probs=202.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCc-----cCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeE-----
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGEL-----KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK-----  215 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~-----  215 (422)
                      +.+|++.+.||+|+||.||+|++.....     .++.||||++...        +.+.+|++++++++ |+||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            4689999999999999999999875211     3789999998653        35778999999997 999887     


Q ss_pred             ----------EEeEEEe-CCeEEEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 014559          216 ----------FCDACED-VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF  283 (422)
Q Consensus       216 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NI  283 (422)
                                +++++.. ++.+||||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777776 68899999999 89999998764 36799999999999999999999999999999999999


Q ss_pred             EEeeCCCCC--CEEEeecCcccccCCCC--------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCC
Q 014559          284 LFTSGRDDA--DMRLIDFGLSDFIRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       284 ll~~~~~~~--~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~p  352 (422)
                      |++   .++  .+||+|||+++......        ......||+.|+|||++.+ .++.++|||||||+||||++|+.|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            996   355  89999999997654322        1234579999999999875 789999999999999999999999


Q ss_pred             CCCCC--hhHHHHHH---HcCCCCCC--CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          353 FWART--ESGIFRAV---LRSDPNFD--DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       353 f~~~~--~~~~~~~i---~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      |....  ...+....   ......+.  ...+..++.++.+||.+||..||.+||++.++++.+
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  331 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL  331 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence            97753  22222222   22222221  112346799999999999999999999999998764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-44  Score=342.70  Aligned_cols=240  Identities=32%  Similarity=0.553  Sum_probs=193.0

Q ss_pred             cccceEEe-ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          145 FGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       145 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      +..+|.+. +.||+|+||.||+|++..   +++.||||++...        ..+.+|+.++.++.+|+||+++++++.+ 
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            44568777 789999999999999887   7899999998532        4567899998666569999999999987 


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                         .+.++|||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999987654 4699999999999999999999999999999999999997533478899999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc----CCCCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR----SDPNFDD  374 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~  374 (422)
                      ||++.....                    ..++.++|||||||++|||++|+.||...........+..    ....++.
T Consensus       164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            999865431                    3467899999999999999999999976544332211111    1111111


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ..+..+++++.+||.+||+.||.+||++.|+|+|+||....
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            11246899999999999999999999999999999987543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=343.55  Aligned_cols=242  Identities=29%  Similarity=0.461  Sum_probs=193.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|++     .++.||||++...     ...+.+.+|++++++++ ||||+++++++.+  ..
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PV   74 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--Cc
Confidence            5799999999999999999986     3567999998532     23467899999999997 9999999998874  47


Q ss_pred             EEEEEccCCCChHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCcEEEeeCCCCCC-EEEeecC
Q 014559          227 YIVMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHL---QGVVHRDLKPENFLFTSGRDDAD-MRLIDFG  300 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~ql~~aL~~LH~---~~iiH~Dikp~NIll~~~~~~~~-vkl~DfG  300 (422)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||.|||+   +||+||||||+|||++.   ++. +||+|||
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~~kl~Dfg  151 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA---GGTVLKICDFG  151 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET---TTTEEEECCCC
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC---CCCEEEEcccc
Confidence            999999999999998865432  47899999999999999999999   89999999999999963   554 8999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHcCCCCCCCCCC
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  377 (422)
                      ++......  .....||..|+|||++.+ .++.++|||||||++|||++|+.||......  .....+......   ...
T Consensus       152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  226 (307)
T 2eva_A          152 TACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLI  226 (307)
T ss_dssp             C--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC---CCB
T ss_pred             cccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC---Ccc
Confidence            99755422  334569999999999864 7899999999999999999999999764332  233333332211   112


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..++.++.++|.+||..||.+||++.|+++.+
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  258 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM  258 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            36899999999999999999999999999863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-44  Score=374.05  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=204.8

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      .++||+|+||.||+|.+.... .++.||||+++... ......+.+.+|+++|++|+ |+|||++++++.+ +.++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCC-cceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEE
Confidence            358999999999999664322 56899999997643 23334578999999999997 9999999999965 56899999


Q ss_pred             ccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC-
Q 014559          232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-  310 (422)
Q Consensus       232 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-  310 (422)
                      ||++|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.   ++.+||+|||+++....... 
T Consensus       450 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~---~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC---CCCEEEEEcCCccccccCccc
Confidence            9999999998854 467999999999999999999999999999999999999964   78999999999987654332 


Q ss_pred             ---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          311 ---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                         .....++..|+|||++. ..++.++|||||||+||||++ |+.||.+....+....+........   ...+++++.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  602 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMY  602 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence               22335678899999986 479999999999999999998 9999999888888777776543211   136899999


Q ss_pred             HHHHHhchhccccCCCHHHHHhcc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +||.+||..||++||++.++++.+
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~~L  626 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVELRL  626 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHH
Confidence            999999999999999999998763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.8e-45  Score=346.34  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      |..++.||+|+||.||+|++     +++.||||++..... ......+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  106 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC  106 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred             cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence            55568999999999999985     467899999875432 22334577899999999997 999999999999999999


Q ss_pred             EEEEccCCCChHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARAS  183 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeeccccccc
Confidence            999999999999988643  35699999999999999999999999999999999999994   5889999999999765


Q ss_pred             CCCCC---ccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHcCCCCCC-----
Q 014559          306 RPDER---LNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFD-----  373 (422)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~-----  373 (422)
                      .....   .....||..|+|||++.+.++.++|||||||++|+|++|..||.......    +...+......+.     
T Consensus       184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (307)
T 2nru_A          184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK  263 (307)
T ss_dssp             CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred             ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence            43222   23457999999999998889999999999999999999999997654322    2222222111110     


Q ss_pred             --CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          374 --DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       374 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                        ......++.++.++|.+||..||.+||++.++++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L  301 (307)
T 2nru_A          264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL  301 (307)
T ss_dssp             SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence              000113457799999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=345.11  Aligned_cols=255  Identities=22%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc-CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..+|++++.||+|+||.||+|+... ...+++.||||++...   .....+.+.+|+.++++++ |+||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence            4579999999999999999998421 1227889999998653   2334567899999999997 999999999987654


Q ss_pred             --eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       225 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                        .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~---~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC---CCcEEEecCcch
Confidence              789999999999999999877677999999999999999999999999999999999999964   789999999999


Q ss_pred             cccCCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh------------H---HH
Q 014559          303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES------------G---IF  362 (422)
Q Consensus       303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~------------~---~~  362 (422)
                      ........    .....++..|+|||++. ..++.++|||||||++|||++|..||......            .   .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654432    22345778899999886 46899999999999999999999998532110            0   11


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...+......+  ....++.++.+||.+||..||.+||++.|+++.+
T Consensus       273 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L  317 (326)
T 2w1i_A          273 IELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  317 (326)
T ss_dssp             HHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            11222222221  1236899999999999999999999999999763

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-44  Score=344.60  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=194.7

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc-CCCCeeEEEeEEE
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFCDACE  221 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~  221 (422)
                      ..+.++|++.+.||+|+||.||+|++     +++.||||++....      .....+|.+++..+. +|+||+++++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            34567899999999999999999986     46789999985432      234455556555441 4999999999999


Q ss_pred             eC----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEeeCC
Q 014559          222 DV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       222 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~Dikp~NIll~~~~  289 (422)
                      +.    ..+|+||||+++|+|.+++...  .+++..++.++.|++.||.|||++        ||+||||||+|||++   
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---  176 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---  176 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---
Confidence            87    7899999999999999988554  699999999999999999999999        999999999999994   


Q ss_pred             CCCCEEEeecCcccccCCCCC-----ccccccCCcccCccccCc-cCCC------chhHHHHHHHHHHHHhC--------
Q 014559          290 DDADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR-SYSL------EADIWSIGVISYILLCG--------  349 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~------~~DvwSlG~il~ell~g--------  349 (422)
                      .++.+||+|||++........     ....+||..|+|||++.+ .++.      ++|||||||++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            588999999999976543322     134579999999999864 3444      38999999999999999        


Q ss_pred             --CCCCCCCC----hhHHHHHHHcCCCCCCCCC----CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          350 --SRPFWART----ESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       350 --~~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                        ..||....    ...............+..+    ...+++++.+||.+||+.||.+||++.|+++++
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence              77775432    1222233332221111111    113567799999999999999999999999885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=349.68  Aligned_cols=250  Identities=22%  Similarity=0.394  Sum_probs=207.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|++.+.||+|+||.||+|++..      .||||++...... ....+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPH  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCc
Confidence            3579999999999999999998753      4999998764322 222345778999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccc
Confidence            9999999999999998866656799999999999999999999999999999999999994    678999999998654


Q ss_pred             CC------CCCccccccCCcccCccccCc----------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC
Q 014559          306 RP------DERLNDIVGSAYYVAPEVLHR----------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD  369 (422)
Q Consensus       306 ~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  369 (422)
                      ..      ........|+..|+|||++.+          .++.++|||||||++|||++|+.||...........+....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  259 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM  259 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence            31      122334568999999998753          47889999999999999999999999888877777766544


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ...  .....++.++.++|.+||..||.+||++.++++.+
T Consensus       260 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l  297 (319)
T 2y4i_B          260 KPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML  297 (319)
T ss_dssp             CCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred             CCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            322  22236889999999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7e-44  Score=371.31  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=214.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+|++++.||+|+||.||+|++......+..||||++...  ......+.+.+|+.++++++ ||||+++++++. .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cC
Confidence            346799999999999999999998764445678999998643  23334577899999999997 999999999985 46


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~---~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC---CCCEEEEecCCCee
Confidence            689999999999999998877667999999999999999999999999999999999999964   78999999999987


Q ss_pred             cCCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ......  .....+++.|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+........   ...+
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~  617 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNC  617 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CTTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence            654332  22345678999999986 579999999999999999997 9999998888888777776543211   1368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++++.+||.+||..||.+||++.|+++.+
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L  646 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKAQL  646 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            99999999999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-45  Score=377.98  Aligned_cols=266  Identities=24%  Similarity=0.399  Sum_probs=211.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----  222 (422)
                      .+|++.+.||+|+||.||+|++..   +|+.||||++...  ......+.+.+|++++++++ ||||+++++++..    
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccc
Confidence            579999999999999999999876   7889999998653  23334577899999999997 9999999998765    


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 --VNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                        .+..|+|||||++|+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              677899999999999999886543  2699999999999999999999999999999999999997533344599999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH---------HH---
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---------AV---  365 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---------~i---  365 (422)
                      ||++.............||..|+|||++. ..++.++|||||||++|+|++|..||........+.         .+   
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            99998877666666778999999999986 579999999999999999999999997643322110         00   


Q ss_pred             --HcCCCCCCC------CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          366 --LRSDPNFDD------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       366 --~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                        ..+...+..      .....++.++.+||.+||.+||.+||++.|+|+|+||..+..-+
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence              001111110      01123568899999999999999999999999999998876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=344.13  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=187.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHH--HHHhcCCCCeeEEEeEEEe--
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI--LKALSGHKHLVKFCDACED--  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~h~niv~l~~~~~~--  222 (422)
                      ++|++++.||+|+||.||+|++     +++.||||++.....      ..+..|.++  +..++ |+||+++++.+..  
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFANR------QNFINEKNIYRVPLME-HDNIARFIVGDERVT   80 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC
T ss_pred             HHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccch------hhHHHHHHHHHHHhcc-Ccchhhheecccccc
Confidence            4799999999999999999965     567899999864321      333444444  44565 9999999986653  


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCcEEEeeCCC
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---------GVVHRDLKPENFLFTSGRD  290 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------~iiH~Dikp~NIll~~~~~  290 (422)
                         ...++||||||++|+|.+++...  .+++..++.++.||+.||.|||++         ||+||||||+|||++   .
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~  155 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---N  155 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---T
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---C
Confidence               23689999999999999988554  468999999999999999999999         999999999999994   5


Q ss_pred             CCCEEEeecCcccccCCCC---------CccccccCCcccCccccCc--------cCCCchhHHHHHHHHHHHHhCCCCC
Q 014559          291 DADMRLIDFGLSDFIRPDE---------RLNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       291 ~~~vkl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~g~~pf  353 (422)
                      ++.+||+|||+++......         .....+||..|+|||++.+        .++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            7899999999997654321         2234579999999999864        4667899999999999999998776


Q ss_pred             CCCCh-----------------hHHHHHHHcCC---CCCCCC--CCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          354 WARTE-----------------SGIFRAVLRSD---PNFDDL--PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       354 ~~~~~-----------------~~~~~~i~~~~---~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .....                 ...........   +.++..  ....+++++.+||.+||..||++|||+.|+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            43211                 11111222211   111111  0112456899999999999999999999997753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.2e-43  Score=341.70  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=200.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHH--hcCCCCeeEEEeEEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA--LSGHKHLVKFCDACE  221 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~  221 (422)
                      .+..+|++.+.||+|+||.||+|++     +++.||||++...      ....+.+|+++++.  ++ |+||+++++++.
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~  106 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADN  106 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEE
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEeeec
Confidence            4556899999999999999999986     4678999998543      23567789999988  55 999999999998


Q ss_pred             eCC----eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEEeeCC
Q 014559          222 DVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH--------LQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       222 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~iiH~Dikp~NIll~~~~  289 (422)
                      +.+    .+++||||+++|+|.+++...  .+++..++.++.|++.||.|||        ++||+||||||+|||++   
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---  181 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---  181 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---
Confidence            876    899999999999999988653  6999999999999999999999        89999999999999994   


Q ss_pred             CCCCEEEeecCcccccCCCC-----CccccccCCcccCccccCcc-------CCCchhHHHHHHHHHHHHhC--------
Q 014559          290 DDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSLEADIWSIGVISYILLCG--------  349 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlG~il~ell~g--------  349 (422)
                      .++.+||+|||++.......     ......||..|+|||++.+.       ++.++|||||||++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            57899999999997665443     23456799999999998653       33689999999999999999        


Q ss_pred             --CCCCCCCC-----hhHHHHHHHcCCCCCCCC-C--CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          350 --SRPFWART-----ESGIFRAVLRSDPNFDDL-P--WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       350 --~~pf~~~~-----~~~~~~~i~~~~~~~~~~-~--~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                        ..||....     .......+.......... .  ...+++.+.+||.+||+.||.+||++.|+++++
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence              78986642     223333333322111110 0  012346799999999999999999999999885

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.4e-45  Score=358.83  Aligned_cols=253  Identities=17%  Similarity=0.219  Sum_probs=198.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCee-----------
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLV-----------  214 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv-----------  214 (422)
                      ..|++.+.||+|+||.||+|++..   +|+.||||++...........+.+.+|+.+++.+. | .|+.           
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCC
T ss_pred             eeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccc
Confidence            458899999999999999999887   78899999997554444445678999999999986 5 3211           


Q ss_pred             ----------EEEeEEEe-----CCeEEEEEEccCCCChHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014559          215 ----------KFCDACED-----VNNVYIVMELCEGGELLDRILA------RGGRYTEEDAKAIVVQILSVVAFCHLQGV  273 (422)
Q Consensus       215 ----------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~------~~~~l~~~~~~~i~~ql~~aL~~LH~~~i  273 (422)
                                .++.++..     ...++++|+++ +++|.+++..      ....+++..+..++.||+.||.|||++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  232 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  232 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                      11111222     23478888887 5699887742      23457888999999999999999999999


Q ss_pred             eecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCcccc----------Cc-cCCCchhHHHHHHH
Q 014559          274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----------HR-SYSLEADIWSIGVI  342 (422)
Q Consensus       274 iH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DvwSlG~i  342 (422)
                      +||||||+||||+   .++.+||+|||+++.....  ....+| +.|+|||++          .+ .++.++|||||||+
T Consensus       233 iHrDiKp~NILl~---~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEEC---TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEe---cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999994   5788999999998765432  455678 999999988          32 47889999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhhh
Q 014559          343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFKI  418 (422)
Q Consensus       343 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k~  418 (422)
                      +|||++|+.||...........+...        +..+++++.+||.+||+.||++||++.|+|+|+||+.+...+
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~  374 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  374 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence            99999999999776554443333221        236889999999999999999999999999999998876654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.5e-44  Score=335.14  Aligned_cols=230  Identities=16%  Similarity=0.096  Sum_probs=189.1

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+..+|++.+.||+|+||.||+|++..   +++.||||++...........+.+.+|+.++.+++ |+||+++++++.+.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR  103 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC
Confidence            345689999999999999999999876   78999999998765554555678899999999996 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+||||||++|++|.+++..   .....++..++.||+.||.|||++||+||||||+|||++   .++.+||+++|.  
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~~--  175 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPAT--  175 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCCC--
T ss_pred             CcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEeccc--
Confidence            999999999999999998732   256778899999999999999999999999999999996   478899985543  


Q ss_pred             ccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH---HHHcCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---AVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~  380 (422)
                                       ++      .++.++|||||||++|||++|+.||.+......+.   ................+
T Consensus       176 -----------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T 3uqc_A          176 -----------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI  232 (286)
T ss_dssp             -----------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred             -----------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence                             22      36889999999999999999999998765433111   11111111111122468


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++++.+||.+||+.||++| |+.|+++.+
T Consensus       233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L  260 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIR-SASTLLNLM  260 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred             CHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence            9999999999999999999 999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-44  Score=346.28  Aligned_cols=250  Identities=19%  Similarity=0.239  Sum_probs=196.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-----chhcHHHHHHHHHHHHHhc--------CCCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALS--------GHKHL  213 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~ni  213 (422)
                      .+|++++.||+|+||.||+|++     +|+.||||++......     .....+.+.+|+.+++.|+        +|+||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             ccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            5799999999999999999987     4689999999865432     2334577899999999996        58888


Q ss_pred             eEEEeEEE------------------------------eCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHH
Q 014559          214 VKFCDACE------------------------------DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS  263 (422)
Q Consensus       214 v~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~  263 (422)
                      |++.+.+.                              +.+.+|||||||++|++++.+..  ..+++..++.++.||+.
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHH
Confidence            88887653                              26789999999999987776633  56899999999999999


Q ss_pred             HHHHHH-HCCCeecCCCCCcEEEeeCC-----------------CCCCEEEeecCcccccCCCCCccccccCCcccCccc
Q 014559          264 VVAFCH-LQGVVHRDLKPENFLFTSGR-----------------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV  325 (422)
Q Consensus       264 aL~~LH-~~~iiH~Dikp~NIll~~~~-----------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~  325 (422)
                      ||.||| ++||+||||||+|||++.++                 ....+||+|||+++.....    ..+||+.|+|||+
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~  248 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence            999999 99999999999999997521                 0128999999999876532    4589999999999


Q ss_pred             cCccCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHHHHcCCC---CCCCCCCCCCCHHHHHHHHHhchhccccCC
Q 014559          326 LHRSYSLEADIWSIGVI-SYILLCGSRPFWARTE-SGIFRAVLRSDP---NFDDLPWPSVSPEAKDFVKRLLNKDYRKRM  400 (422)
Q Consensus       326 ~~~~~~~~~DvwSlG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  400 (422)
                      +.+..+.++||||||++ .++++.|..||..... ......+.....   ......+..+++++++||++||++|     
T Consensus       249 ~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----  323 (336)
T 2vuw_A          249 FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----  323 (336)
T ss_dssp             GCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred             hcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence            98766899999998777 7788999999843211 122233332111   1111112357889999999999987     


Q ss_pred             CHHHHH-hccCcc
Q 014559          401 TAVQAL-SKLVVP  412 (422)
Q Consensus       401 s~~elL-~~l~~~  412 (422)
                      |+.|+| +|+||+
T Consensus       324 sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHCGGGC
T ss_pred             CHHHHHhcCCCcC
Confidence            999999 999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-43  Score=371.20  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=203.9

Q ss_pred             CcccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014559          142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE  221 (422)
Q Consensus       142 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  221 (422)
                      ++.+..+|++.+.||+|+||.||+|++..  .+++.||||++....  .....+.+.+|+.++++++ ||||+++++++.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~  149 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVE  149 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEe
Confidence            45566789999999999999999999864  157889999986432  2334567889999999997 999999999998


Q ss_pred             eCCe-----EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEE
Q 014559          222 DVNN-----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       222 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      +.+.     .||||||++|++|.+.+..   .+++.+++.++.||+.||.|||++|||||||||+|||++    .+.+||
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~~~~kl  222 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKL  222 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSCEEE
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----CCcEEE
Confidence            8765     7999999999999886533   699999999999999999999999999999999999995    348999


Q ss_pred             eecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC
Q 014559          297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP  376 (422)
Q Consensus       297 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  376 (422)
                      +|||+++.....   ...+||+.|+|||++.+.++.++|||||||+||+|++|..||.+......          .....
T Consensus       223 ~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~  289 (681)
T 2pzi_A          223 IDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDP  289 (681)
T ss_dssp             CCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCH
T ss_pred             EecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc----------ccccc
Confidence            999999876433   45679999999999987779999999999999999999998864221100          00111


Q ss_pred             CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                      ...+++.+.+||.+||+.||.+||++.+.+.+.|+..+.
T Consensus       290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            112467899999999999999999999999888877654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.4e-37  Score=313.03  Aligned_cols=189  Identities=21%  Similarity=0.162  Sum_probs=135.3

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccc-------cchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-------TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .++.|++|.+..++...   .|+.||||++.+...       ......+++.+|+++|+++..|+||+++++++++++.+
T Consensus       241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            46778888777776665   789999999976432       12334567999999999997799999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+|++|.+.+.. .+.+++.   +|+.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+...
T Consensus       318 yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESCC
T ss_pred             EEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeCC
Confidence            999999999999998854 4667765   4789999999999999999999999999994   58899999999998665


Q ss_pred             CC-CCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCC
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRP  352 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~p  352 (422)
                      .. ....+.+||+.|+|||++.+.+..++|+||+|+++++|.++..+
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             CCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            43 34556789999999999999889999999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.4e-30  Score=261.39  Aligned_cols=184  Identities=22%  Similarity=0.231  Sum_probs=144.0

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-----hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ...+.||+|+||.||+|..     .++.+++|+........     ....+++.+|++++++++ |+||+++..++.+.+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD  412 (540)
T ss_dssp             ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred             CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence            4467899999999999943     56789999875533221     122456899999999997 999996666666777


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..|||||||++++|.+++..         +..++.|++.||.|||++||+||||||+|||++    . .+||+|||+++.
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~-~~kL~DFGla~~  478 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K-DLYIIDFGLGKI  478 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S-SEEECCCTTCEE
T ss_pred             ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C-eEEEEECccCEE
Confidence            88999999999999987743         668999999999999999999999999999994    3 999999999987


Q ss_pred             cCCCCC--------ccccccCCcccCccccC---ccCCCchhHHHHHHHHHHHHhCCCCC
Q 014559          305 IRPDER--------LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       305 ~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf  353 (422)
                      ......        ....+||+.|+|||++.   ..|+..+|+|+..+-.++.+.++.+|
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            754322        13568999999999986   35888899999999998888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.4e-26  Score=216.56  Aligned_cols=148  Identities=24%  Similarity=0.275  Sum_probs=115.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch---------------hcHHHHHHHHHHHHHhcCCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---------------ISIEDVRREVKILKALSGHK  211 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~  211 (422)
                      ..|.+++.||+|+||.||+|++ .   +|+.||||+++.......               .....+.+|+.++++++ | 
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~-  163 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G-  163 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-
T ss_pred             eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-
Confidence            3466779999999999999998 4   788999999965322111               13466889999999997 4 


Q ss_pred             CeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCC
Q 014559          212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD  291 (422)
Q Consensus       212 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~  291 (422)
                        +++++++.. +..|+||||++|++|.+ +       .......++.|++.||.|||++||+||||||+|||++    +
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~  228 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E  228 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----C
Confidence              555554443 45699999999999987 3       1134557999999999999999999999999999994    7


Q ss_pred             CCEEEeecCcccccCCCCCccccccCCcccCccccC
Q 014559          292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH  327 (422)
Q Consensus       292 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  327 (422)
                      +.+||+|||+++.            +..++|||++.
T Consensus       229 ~~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE------------CCCCCHHHHHH
Confidence            8899999999963            33478888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=6.2e-23  Score=189.44  Aligned_cols=141  Identities=18%  Similarity=0.182  Sum_probs=107.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCce--EEEEEeecccccc---------------------hhcHHHHHHHHHHH
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQ--VAVKIISKAKMTT---------------------AISIEDVRREVKIL  204 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l  204 (422)
                      .|++.+.||+|+||.||+|.+..   +|+.  ||||+++......                     ......+.+|+.+|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  124 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL  124 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence            48899999999999999999854   6778  9999975432110                     01123678999999


Q ss_pred             HHhcCCCCe--eEEEeEEEeCCeEEEEEEccCC-C----ChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeec
Q 014559          205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEG-G----ELLDRILARGGRYTEEDAKAIVVQILSVVAFCH-LQGVVHR  276 (422)
Q Consensus       205 ~~l~~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~  276 (422)
                      ++|. |++|  +.+++.    +..+|||||+.+ |    +|.+....    .++..+..++.||+.||.||| ++||+||
T Consensus       125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9997 7753  444442    346899999942 3    55554321    345678899999999999999 9999999


Q ss_pred             CCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          277 DLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       277 Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ||||+|||++    . .++|+|||+|...
T Consensus       196 Dlkp~NILl~----~-~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYI----D-KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEES----S-SEEECCCTTCEET
T ss_pred             CCCHHHEEEc----C-cEEEEECcccccC
Confidence            9999999994    3 8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=5.5e-20  Score=176.98  Aligned_cols=141  Identities=18%  Similarity=0.241  Sum_probs=100.0

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc-----------hhcH--------HHHHHHHHHHHHhc
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----------AISI--------EDVRREVKILKALS  208 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~--------~~~~~E~~~l~~l~  208 (422)
                      -|++++.||+|+||.||+|.+.    +|+.||||+++......           ....        -...+|...|.+|.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            4999999999999999999975    67899999986432110           0000        11245777788875


Q ss_pred             CCCCee--EEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe
Q 014559          209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT  286 (422)
Q Consensus       209 ~h~niv--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~  286 (422)
                       +.++.  ..++.  .  ..+|||||++|++|.+..       .......++.||+.+|.|||++|||||||||.|||++
T Consensus       172 -~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          172 -EEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             -HTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             -hcCCCCCeeeec--c--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence             44432  22222  2  237999999998875431       2234567889999999999999999999999999997


Q ss_pred             eCCCC-------CCEEEeecCcccc
Q 014559          287 SGRDD-------ADMRLIDFGLSDF  304 (422)
Q Consensus       287 ~~~~~-------~~vkl~DfG~a~~  304 (422)
                      .+.+.       ..+.|+||+.+..
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCcccccccccceEEEEeCCccc
Confidence            52110       1389999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=7.6e-14  Score=128.48  Aligned_cols=140  Identities=19%  Similarity=0.185  Sum_probs=110.6

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|++...+|.|+++.||++..     .+..++||+.......   ....+.+|+.+++.|.++..+.++++++.+.+..|
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            488888899899999999974     3568999998643211   12458899999999976778899999999999999


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-------------------------------------  270 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-------------------------------------  270 (422)
                      +||||++|.+|.+.+      .+......++.++..+|..||+                                     
T Consensus        87 lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           87 LLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999998877642      1223345788899999999998                                     


Q ss_pred             ----------------------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          271 ----------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       271 ----------------------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                                            ..++|+|+++.|||++   ++..+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                                  4589999999999995   244457999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=2.4e-12  Score=117.85  Aligned_cols=135  Identities=14%  Similarity=0.137  Sum_probs=96.5

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC-eeEEEeEEEeCCeE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVNNV  226 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~  226 (422)
                      .|.+....+.|..+.||++...    +|..++||+.....      ...+.+|+.+++.|..+.- +.++++++.+.+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            3555444445666999999653    46679999975431      1457889999999975522 66789988888889


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG----------------------------------  272 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~----------------------------------  272 (422)
                      ++||||++|.+|.  . .   ..+   ...++.+++..|..||+..                                  
T Consensus        91 ~~v~e~i~G~~l~--~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEEECCSSEETT--T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEEEecCCcccC--c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            9999999998773  1 1   122   2245666677777777543                                  


Q ss_pred             ------------------------CeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          273 ------------------------VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       273 ------------------------iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                                              ++|+|+++.|||++   +++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                    99999999999995   244566999998854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=1.8e-11  Score=117.96  Aligned_cols=143  Identities=23%  Similarity=0.368  Sum_probs=104.9

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEee--cccccchhcHHHHHHHHHHHHHhcC-CCCeeEEEeEEEeC---Ce
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS--KAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDV---NN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~---~~  225 (422)
                      ++.|+.|.++.||++...     +..+++|+..  .....  .....+.+|+.+++.|.. +..+++++.++.+.   +.
T Consensus        43 ~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             EEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            467899999999998753     3578899875  32211  123567899999999974 34588899988776   45


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-----------------------------------  270 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-----------------------------------  270 (422)
                      .|+||||++|..+.+.   ....++..+...++.+++..|..||+                                   
T Consensus       116 ~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             CEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             eEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            8999999998776442   12347888889999999999999997                                   


Q ss_pred             -----------------------CCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          271 -----------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       271 -----------------------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                                             ..++|+|+++.|||++. +....+.|+||+.+...
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~-~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHP-TEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECS-SSSCEEEECCCTTCEEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeC-CCCcEEEEECccccccC
Confidence                                   35899999999999953 11123689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.20  E-value=1.8e-11  Score=115.10  Aligned_cols=184  Identities=16%  Similarity=0.234  Sum_probs=122.6

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCC--eeEEEeEEEeCC---eEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH--LVKFCDACEDVN---NVY  227 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~---~~~  227 (422)
                      +.++.|.+..||++.        ..++||+....     .....+.+|+.+|+.|..+..  +.+++......+   ..|
T Consensus        26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN--------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CEEEECSSEEEEEST--------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             EecCCCCcceEEEEC--------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            458899999999763        24899986432     234678999999999853433  445555543333   358


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-------------------------------------  270 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-------------------------------------  270 (422)
                      +|||+++|.+|.+....   .++.++...++.+++..|..||+                                     
T Consensus        93 ~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999999888654332   47888888888888888888886                                     


Q ss_pred             ---------------------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccC--
Q 014559          271 ---------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--  327 (422)
Q Consensus       271 ---------------------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--  327 (422)
                                           ..++|+|+++.||+++. +....+.|+||+.+.................-..++.+.  
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~-~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDT-EKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEET-TTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeC-CCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence                                 13699999999999963 114457899999986543321111111100002233211  


Q ss_pred             -ccC------------CCchhHHHHHHHHHHHHhCCCCC
Q 014559          328 -RSY------------SLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       328 -~~~------------~~~~DvwSlG~il~ell~g~~pf  353 (422)
                       ..|            ....+.|++|.++|++.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             112            12258999999999999998877

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.81  E-value=8.7e-08  Score=89.95  Aligned_cols=138  Identities=15%  Similarity=0.282  Sum_probs=92.3

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC--CeeEEEeEEE-eCCeEEEE
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK--HLVKFCDACE-DVNNVYIV  229 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~l~~~~~-~~~~~~lv  229 (422)
                      +.++.|....||+.        +..++||+-..     ......+.+|..+|+.|..+-  .+.+.+.++. ..+..++|
T Consensus        25 ~~l~~G~~n~v~~v--------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           25 ESLGEGFRNYAILV--------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEECSSEEEEEE--------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eecCCCcceeEEEE--------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            45788888899987        23588888522     123467899999999997432  3567777764 45668899


Q ss_pred             EEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 014559          230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------------------------------------  271 (422)
Q Consensus       230 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------------------------------------  271 (422)
                      ||+++|..+.+....   .++..+...++.++...|..||+.                                      
T Consensus        92 ~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           92 YRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999999877653211   234444455555555555555432                                      


Q ss_pred             ----------------------CCeecCCCCCcEEEeeCCCCCCE-EEeecCcccccC
Q 014559          272 ----------------------GVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIR  306 (422)
Q Consensus       272 ----------------------~iiH~Dikp~NIll~~~~~~~~v-kl~DfG~a~~~~  306 (422)
                                            .++|+|+++.|||++.++.++.+ .|+||+.+....
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                  35999999999999531123554 899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.77  E-value=7e-08  Score=88.64  Aligned_cols=133  Identities=17%  Similarity=0.203  Sum_probs=94.0

Q ss_pred             eCcCCCe-EEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEcc
Q 014559          155 VGRGHFG-HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC  233 (422)
Q Consensus       155 lG~G~~g-~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  233 (422)
                      +..|..| .||+.....   .+..++||+-...      ....+.+|..+|+.|..+--+.+++.++.+.+..|+|||++
T Consensus        32 ~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP---NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEECCT---TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEecC---CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4445444 689887664   5567999986533      23668899999999976555788999999999999999999


Q ss_pred             CCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 014559          234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ------------------------------------------  271 (422)
Q Consensus       234 ~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~------------------------------------------  271 (422)
                      +|.++.+.....     ......+..++...|.-||..                                          
T Consensus       103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            998776644221     122234445555555555521                                          


Q ss_pred             ----------------CCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          272 ----------------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       272 ----------------~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                                      .++|+|+.+.|||++   +++.+-|+||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                            168999999999995   345566999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.60  E-value=2.1e-07  Score=90.55  Aligned_cols=81  Identities=17%  Similarity=0.187  Sum_probs=51.9

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc----cchhcHHHHHHHHHHHHHhcCC-C-CeeEEEeEEEeCCe
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM----TTAISIEDVRREVKILKALSGH-K-HLVKFCDACEDVNN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~  225 (422)
                      .+.||.|.++.||++....   .++.|+||.......    ......+++..|.++++.+..+ + .+.+++.+  +.+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred             EEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence            4579999999999997654   456899998653211    0011235677899999988643 3 34566654  3445


Q ss_pred             EEEEEEccCCCC
Q 014559          226 VYIVMELCEGGE  237 (422)
Q Consensus       226 ~~lv~e~~~~g~  237 (422)
                      .++|||++++..
T Consensus       110 ~~lvmE~l~g~~  121 (397)
T 2olc_A          110 AVTVMEDLSHLK  121 (397)
T ss_dssp             TEEEECCCTTSE
T ss_pred             cEEEEEeCCCcc
Confidence            689999997743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=1.2e-07  Score=90.74  Aligned_cols=89  Identities=10%  Similarity=0.139  Sum_probs=58.0

Q ss_pred             EEecee-CcCCCeEEEEEEec---cCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeC
Q 014559          150 ELGKEV-GRGHFGHTCSARGK---KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDV  223 (422)
Q Consensus       150 ~~~~~l-G~G~~g~V~~a~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~  223 (422)
                      ...+.| +.|....+|++...   .+...+..+++|+..............+.+|+.+++.|..+  -.+.+++.++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88888899988653   10001567899986543200000114577899999998754  3577888887665


Q ss_pred             ---CeEEEEEEccCCCCh
Q 014559          224 ---NNVYIVMELCEGGEL  238 (422)
Q Consensus       224 ---~~~~lv~e~~~~g~L  238 (422)
                         +..|+||||++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               457899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.38  E-value=2.7e-06  Score=80.58  Aligned_cols=137  Identities=12%  Similarity=0.146  Sum_probs=79.2

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC-CCeeEEEe------EEEeCCe
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCD------ACEDVNN  225 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~------~~~~~~~  225 (422)
                      +.|+.|..+.||++...    + ..+++|+....       ...+..|+.+++.|..+ -.+.+++.      +....+.
T Consensus        38 ~~l~gG~~n~~~~v~~~----~-~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~  105 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD----S-GAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF  105 (346)
T ss_dssp             EECC----CEEEEEEET----T-EEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred             eeccccccCcEEEEEeC----C-CCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence            45666778899998753    2 34899988642       13445667777766521 13344443      2235678


Q ss_pred             EEEEEEccCCCChH--------------HHHHHhCCCC-------------CHHH-------------------------
Q 014559          226 VYIVMELCEGGELL--------------DRILARGGRY-------------TEED-------------------------  253 (422)
Q Consensus       226 ~~lv~e~~~~g~L~--------------~~l~~~~~~l-------------~~~~-------------------------  253 (422)
                      .++||||++|..+.              ..++.....+             .+..                         
T Consensus       106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  185 (346)
T 2q83_A          106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS  185 (346)
T ss_dssp             EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred             EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence            89999999986431              1122111101             1110                         


Q ss_pred             ------HHHHHHHHHHHHHHHHH-------------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          254 ------AKAIVVQILSVVAFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       254 ------~~~i~~ql~~aL~~LH~-------------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                            +..+..++..++.+|++             ..++|+|+++.|||++   .++.+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG---ENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEEC---GGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEe---CCCcEEEEehhhccc
Confidence                  11122234445666652             5799999999999994   356899999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.06  E-value=5.9e-05  Score=65.77  Aligned_cols=137  Identities=17%  Similarity=0.069  Sum_probs=93.1

Q ss_pred             CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCCcccc
Q 014559          236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI  314 (422)
Q Consensus       236 g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  314 (422)
                      -+|.+.+...+.+++++++|.++.|.+.+|.-+-. ..-..+=+.+..|++.   .+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence            38899999999999999999999999999876522 2212333456889885   478887664 1110           


Q ss_pred             ccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchh
Q 014559          315 VGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK  394 (422)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  394 (422)
                      .....+.+||......+.+.=|||||+++|..+--..+=                     ..-..+|+.+.+||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHhc
Confidence            122346788887656678889999999999888433321                     11126899999999999765


Q ss_pred             -------------------------ccccCCCHHHHHhc
Q 014559          395 -------------------------DYRKRMTAVQALSK  408 (422)
Q Consensus       395 -------------------------dP~~Rps~~elL~~  408 (422)
                                               .+..|.+.+++|+.
T Consensus       157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             CC--------------------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCcCCHHHHHHH
Confidence                                     24689999999864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.06  E-value=2.5e-05  Score=76.52  Aligned_cols=77  Identities=13%  Similarity=0.011  Sum_probs=46.0

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccc--cc----hhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--TT----AISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~--~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .+.||.|..+.||++..     .+..++||.......  ..    ......++.|+..+..-.....+.+++.+.  .+.
T Consensus        39 i~~l~~G~~n~vyrv~~-----~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~  111 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-----SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTM  111 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-----SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTT
T ss_pred             EEEccCCCcEEEEEEEc-----CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCc
Confidence            46789999999999953     456799994321110  00    012233444444333222235677777765  466


Q ss_pred             EEEEEEcc-CC
Q 014559          226 VYIVMELC-EG  235 (422)
Q Consensus       226 ~~lv~e~~-~~  235 (422)
                      .++||||+ ++
T Consensus       112 ~~lv~e~l~~g  122 (420)
T 2pyw_A          112 ALIGMRYLEPP  122 (420)
T ss_dssp             TEEEECCCCTT
T ss_pred             cEEEEeecCCc
Confidence            78999999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=4.4e-05  Score=71.47  Aligned_cols=76  Identities=14%  Similarity=0.133  Sum_probs=60.6

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeCCeEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDVNNVYIV  229 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~lv  229 (422)
                      .+.|+.|....+|+...     .+..++||+....      ....+.+|...|+.|..+  -.+++++.++...+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-----EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEES-----SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEE-----CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            46789999999999874     3457889987532      246788999999998643  5688899998888899999


Q ss_pred             EEccCCCCh
Q 014559          230 MELCEGGEL  238 (422)
Q Consensus       230 ~e~~~~g~L  238 (422)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.84  E-value=3.1e-05  Score=72.07  Aligned_cols=72  Identities=10%  Similarity=-0.033  Sum_probs=46.2

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      ++.|+.|....+|++         ..+++|+....... .   ....+|+.+++.+..+.-..+++.++.  +.-++|+|
T Consensus        23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~~~-~---~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA---------GDLCLRIPGKGTEE-Y---INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE---------TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEE
T ss_pred             eeEcCCcccccccee---------eeEEEECCCCCccc-e---eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEe
Confidence            567888999999988         23899987543111 0   123568888888874443356665543  33468999


Q ss_pred             cc-CCCCh
Q 014559          232 LC-EGGEL  238 (422)
Q Consensus       232 ~~-~~g~L  238 (422)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.79  E-value=0.00018  Score=66.42  Aligned_cols=81  Identities=16%  Similarity=0.024  Sum_probs=56.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC--CeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK--HLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~  223 (422)
                      +.+..-++.+|.|..+.||+++..    +|+.|.||+.......   ....+.+|...|+.|...-  -+.+++.+.  .
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~   84 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELA----DGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D   84 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEET----TSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T
T ss_pred             CCCeEEEEecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C
Confidence            345566788999999999999865    6788999986543221   2245789999999996432  345555543  2


Q ss_pred             CeEEEEEEccCCCC
Q 014559          224 NNVYIVMELCEGGE  237 (422)
Q Consensus       224 ~~~~lv~e~~~~g~  237 (422)
                        -++||||++++.
T Consensus        85 --~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 --RTLAMEWVDERP   96 (288)
T ss_dssp             --TEEEEECCCCCC
T ss_pred             --ceEEEEeecccC
Confidence              378999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.70  E-value=0.00016  Score=68.02  Aligned_cols=75  Identities=8%  Similarity=0.097  Sum_probs=49.2

Q ss_pred             eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeE-----EEeCCeEE
Q 014559          154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDA-----CEDVNNVY  227 (422)
Q Consensus       154 ~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~-----~~~~~~~~  227 (422)
                      .|+ |....||++...    +|+.+++|+......    ..+.+..|..+++.|..+. .+++++..     ....+..+
T Consensus        33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~  103 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  103 (328)
T ss_dssp             EEC-CSSSEEEEECCT----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             eec-CcccceEEEEcC----CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence            466 777899988653    355799999853221    2356778999998886332 24444442     23356778


Q ss_pred             EEEEccCCCC
Q 014559          228 IVMELCEGGE  237 (422)
Q Consensus       228 lv~e~~~~g~  237 (422)
                      +|||+++|..
T Consensus       104 ~l~~~i~G~~  113 (328)
T 1zyl_A          104 AVFPSVGGRQ  113 (328)
T ss_dssp             EEEECCCCEE
T ss_pred             EEEEecCCCC
Confidence            9999998744

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.65  E-value=6.2e-05  Score=70.60  Aligned_cols=141  Identities=17%  Similarity=0.153  Sum_probs=79.6

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeE------EEeC
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDA------CEDV  223 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~------~~~~  223 (422)
                      -.+.|+.|....+|++....     ..+++|+.....     ..+.+..|+.+++.|..+. .+.+++..      ....
T Consensus        26 ~~~~i~~G~~n~~~~v~~~~-----g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTTK-----DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             EEEEECC---EEEEEEEESS-----CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             EeeccCCCcccceEEEEeCC-----ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            45678888889999987532     258899886421     1245677888888886431 13344321      2334


Q ss_pred             CeEEEEEEccCCCChH--------------HHHHHhCCCC--------CHHHHHHH---------------HHHHHHHHH
Q 014559          224 NNVYIVMELCEGGELL--------------DRILARGGRY--------TEEDAKAI---------------VVQILSVVA  266 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~--------------~~l~~~~~~l--------~~~~~~~i---------------~~ql~~aL~  266 (422)
                      +..++||+|++|..+.              ..++.....+        ........               ...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            6789999999885431              1122111111        11100000               011344455


Q ss_pred             HHHH-------CCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          267 FCHL-------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       267 ~LH~-------~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +|.+       .+++|+|+.+.|||++   ++..+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence            5553       3699999999999995   234457999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.61  E-value=0.00016  Score=68.26  Aligned_cols=142  Identities=15%  Similarity=0.102  Sum_probs=72.8

Q ss_pred             ceeCcCCCeE-EEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeEEEeCCeEEEEE
Q 014559          153 KEVGRGHFGH-TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACEDVNNVYIVM  230 (422)
Q Consensus       153 ~~lG~G~~g~-V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~  230 (422)
                      +.|+.|.... +|+....    ++..+++|.......      +.+..|+.+++.|..+. .+.+++.+..+.+  ++||
T Consensus        24 ~~l~gg~s~~~~~r~~~~----~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~   91 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP----TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLI   91 (333)
T ss_dssp             CC--------CCEEEECT----TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEE
T ss_pred             eECCCCCCCceEEEEEcC----CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEE
Confidence            3465554443 5566431    245677776533210      23456888888886442 3566776644444  7899


Q ss_pred             EccCCCChHHHHHHh-------------------C------CCCCHHHHH-------H-HH------------HHHHHHH
Q 014559          231 ELCEGGELLDRILAR-------------------G------GRYTEEDAK-------A-IV------------VQILSVV  265 (422)
Q Consensus       231 e~~~~g~L~~~l~~~-------------------~------~~l~~~~~~-------~-i~------------~ql~~aL  265 (422)
                      |++.+..+.+.+...                   .      ..++.....       . +.            ..+...+
T Consensus        92 e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~  171 (333)
T 3csv_A           92 EDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRF  171 (333)
T ss_dssp             CCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHH
T ss_pred             eeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            999765554332110                   0      112222111       0 00            1112222


Q ss_pred             HHHH------HCCCeecCCCCCcEEEeeCCC-CCCEEEeecCcccccC
Q 014559          266 AFCH------LQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIR  306 (422)
Q Consensus       266 ~~LH------~~~iiH~Dikp~NIll~~~~~-~~~vkl~DfG~a~~~~  306 (422)
                      ..|.      ...++|+|+.+.|||+..+.. .+.+.|+||+.+....
T Consensus       172 ~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          172 AQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             HHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            3331      246999999999999953100 1578999999886543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.59  E-value=0.00027  Score=67.88  Aligned_cols=144  Identities=13%  Similarity=0.097  Sum_probs=84.9

Q ss_pred             ceeCcCCCeEEEEEEeccC----CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          153 KEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      +.|..|-...+|++....+    ...++.|+||+....    ......+.+|..+++.|..+.-..++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            4566677778898876421    113468999986321    11245667999999999866556777776653    29


Q ss_pred             EEEccCCCChH----------HHH-------HHhC----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 014559          229 VMELCEGGELL----------DRI-------LARG----GRYT--EEDAKAIVVQILS-------------------VVA  266 (422)
Q Consensus       229 v~e~~~~g~L~----------~~l-------~~~~----~~l~--~~~~~~i~~ql~~-------------------aL~  266 (422)
                      ||||++|.+|.          ..+       +...    ....  ..++.+++.++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            99999875442          111       1111    1122  3566666655422                   233


Q ss_pred             HHH----H----CCCeecCCCCCcEEEeeC-CCCCCEEEeecCcccc
Q 014559          267 FCH----L----QGVVHRDLKPENFLFTSG-RDDADMRLIDFGLSDF  304 (422)
Q Consensus       267 ~LH----~----~~iiH~Dikp~NIll~~~-~~~~~vkl~DfG~a~~  304 (422)
                      .|.    .    ..++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            333    2    248999999999999742 1236899999998854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.42  E-value=0.00033  Score=68.60  Aligned_cols=77  Identities=12%  Similarity=-0.005  Sum_probs=51.6

Q ss_pred             eceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      ++.|+.|....||++....+.    ..+..|+||+....  .   ..+.+.+|..+++.|..+.-..++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            457888888999999754211    02467999987431  1   114455799999999755445777776542    3


Q ss_pred             EEEEccCCCC
Q 014559          228 IVMELCEGGE  237 (422)
Q Consensus       228 lv~e~~~~g~  237 (422)
                      +||||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.33  E-value=0.00035  Score=66.88  Aligned_cols=78  Identities=15%  Similarity=0.075  Sum_probs=46.0

Q ss_pred             eceeCcCCCeEEEEEEeccCC-----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          152 GKEVGRGHFGHTCSARGKKGE-----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+.|+.|....+|++....+.     ..+..|++|+......    .......|..+++.|..+.-+.++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            356777888899998754210     0125789998754211    1112367899999887444355777654  22  


Q ss_pred             EEEEEccCCCC
Q 014559          227 YIVMELCEGGE  237 (422)
Q Consensus       227 ~lv~e~~~~g~  237 (422)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0037  Score=61.58  Aligned_cols=76  Identities=16%  Similarity=0.091  Sum_probs=48.9

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  231 (422)
                      ++.|+.|-...+|++....   .+..|++|+..... ...   -...+|..+++.|..+.-..++++.+.  +  .+|||
T Consensus       113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~-~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT-DEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---TTEEEEEEEECC-C-CSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh-hhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence            4578878888999997642   24678999874321 111   112589999999985544567887763  2  25999


Q ss_pred             ccCCCCh
Q 014559          232 LCEGGEL  238 (422)
Q Consensus       232 ~~~~g~L  238 (422)
                      |++|.+|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.0027  Score=60.03  Aligned_cols=69  Identities=10%  Similarity=0.043  Sum_probs=44.5

Q ss_pred             CcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeE------EEeCCeEE
Q 014559          156 GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH--KHLVKFCDA------CEDVNNVY  227 (422)
Q Consensus       156 G~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~------~~~~~~~~  227 (422)
                      |.|....||++...    +| .+++|+......         .+|+.+++.|..+  +++++.+..      ....+..+
T Consensus        32 G~g~~N~vy~v~~~----~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~   97 (339)
T 3i1a_A           32 GADTNAFAYQADSE----SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKI   97 (339)
T ss_dssp             TSCSSCEEEEEECS----SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEE
T ss_pred             cCccccceEEEEeC----CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEE
Confidence            33446789998753    34 799998765331         3577777777532  334555432      23457889


Q ss_pred             EEEEccCCCCh
Q 014559          228 IVMELCEGGEL  238 (422)
Q Consensus       228 lv~e~~~~g~L  238 (422)
                      +||+|++|..+
T Consensus        98 ~l~~~i~G~~~  108 (339)
T 3i1a_A           98 IAYPFIHAPNG  108 (339)
T ss_dssp             EEEECCCCCBT
T ss_pred             EEEeccCCCcC
Confidence            99999998655

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.60  E-value=0.012  Score=57.36  Aligned_cols=79  Identities=14%  Similarity=0.137  Sum_probs=50.3

Q ss_pred             eceeCcCCCeEEEEEEeccCCcc----CceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGELK----DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      ++.|..|-...+|++....+..+    +..|+||+..... ..   .-...+|..+++.|..+.-..++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK---FYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C---CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            45666677778999886532111    5789999864321 11   1123579999999875555667776442  2  6


Q ss_pred             EEEEccCCCCh
Q 014559          228 IVMELCEGGEL  238 (422)
Q Consensus       228 lv~e~~~~g~L  238 (422)
                      +||||++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.27  E-value=0.063  Score=51.75  Aligned_cols=32  Identities=31%  Similarity=0.596  Sum_probs=26.1

Q ss_pred             CeecCCCCCcEEEeeC---CCCCCEEEeecCcccc
Q 014559          273 VVHRDLKPENFLFTSG---RDDADMRLIDFGLSDF  304 (422)
Q Consensus       273 iiH~Dikp~NIll~~~---~~~~~vkl~DfG~a~~  304 (422)
                      ++|+|+.+.|||+..+   +++..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999531   3467899999998854

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.76  E-value=0.11  Score=51.20  Aligned_cols=64  Identities=11%  Similarity=0.083  Sum_probs=18.1

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEE------EEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAV------KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      +.+.||   ||.||++....   +...|||      |....... .......+.+|..+++.+. |+|+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~---~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK---KHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQ-IPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC------------CCBGGGC-------------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccc---cCCchhhhhccCccccccccc-ccccccccccccccccccc-ccccCCCcceEEe
Confidence            445676   99999998865   3457888      65543222 2223345778888998886 9999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.39  E-value=8.9  Score=33.15  Aligned_cols=120  Identities=18%  Similarity=0.220  Sum_probs=80.9

Q ss_pred             HHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHCCCeecCC
Q 014559          200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA-FCHLQGVVHRDL  278 (422)
Q Consensus       200 E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~-~LH~~~iiH~Di  278 (422)
                      |+.+|..  .||++  -...-.+++.+.|.++.-+++.-+..+    ..++....++++.+|+.... ++  ..-+|--|
T Consensus        41 e~~lL~~--~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l  110 (219)
T 4ano_A           41 ELEVLKE--VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIV  110 (219)
T ss_dssp             GGGGGGG--SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCC
T ss_pred             HHHHHhc--cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEE
Confidence            4555544  38888  445557788888888876554333434    24789999999888887665 43  44678889


Q ss_pred             CCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHH-HHHHHHHHHHhCCCCC
Q 014559          279 KPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIW-SIGVISYILLCGSRPF  353 (422)
Q Consensus       279 kp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dvw-SlG~il~ell~g~~pf  353 (422)
                      .|+||++   +.++.++|.-.|+-..+.+..                +.     ..|.| .+=|++..++.++..|
T Consensus       111 ~P~NL~f---~~~~~p~i~hRGi~~~lpP~e----------------~~-----ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          111 CPENLMF---NRALEPFFLHVGVKESLPPDE----------------WD-----DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CGGGEEE---CTTCCEEESCCEETTTBSSCS----------------CC-----HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eCceEEE---eCCCcEEEEEcCCcccCCCCC----------------CC-----HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999   468999999888654432221                11     11333 4667888888888777

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.21  E-value=2.1  Score=36.95  Aligned_cols=122  Identities=12%  Similarity=0.139  Sum_probs=82.7

Q ss_pred             HHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEccCCC-ChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 014559          199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRD  277 (422)
Q Consensus       199 ~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~D  277 (422)
                      .|+.+|..  .||+++.. ..-.+.+.+.|.++.-+.+ ++.. +    ..++....++++.+|+....+++  .-+|--
T Consensus        35 ~el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~  104 (215)
T 4ann_A           35 HLMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFV  104 (215)
T ss_dssp             GGGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEECC
T ss_pred             HHHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceEEE
Confidence            46666654  38999876 5666777888877765433 3222 2    24788999999999988875443  357888


Q ss_pred             CCCCcEEEeeCCCCCCEEEeecCcccccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCC
Q 014559          278 LKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPF  353 (422)
Q Consensus       278 ikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf  353 (422)
                      |.|+||++   +.++.++|.-.|+-..+.+..                    ++...=+-.+=|++..++.++..|
T Consensus       105 L~P~NL~f---~~~~~p~i~~RGik~~l~P~~--------------------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          105 LAPDELFF---TRDGLPIAKTRGLQNVVDPLP--------------------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CSGGGEEE---CTTSCEEESCCEETTTBSCCC--------------------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EecceEEE---cCCCCEEEEEccCccCCCCCC--------------------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999   468889999887654433221                    111112334678888889988887

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	422
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-81
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-80
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-79
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-78
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-76
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-75
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-73
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-72
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-72
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-71
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-69
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-68
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-65
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-65
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-61
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-59
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-58
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-57
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-55
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-55
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-55
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-53
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-52
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22
d1j7la_	263	d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos	4e-06

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  251 bits (642), Expect = 5e-81
 Identities = 86/261 (32%), Positives = 133/261 (50%), Gaps = 9/261 (3%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y++ +E+G G FG       K      +    K I+       +    V+ E+ I+  L
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQL 83

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  L+   DA ED   + +++E   GGEL DRI A   + +E +    + Q    +  
Sbjct: 84  H-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
            H   +VH D+KPEN +  + +  + +++IDFGL+  + PDE +     +A + APE++ 
Sbjct: 143 MHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201

Query: 328 RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           R       D+W+IGV+ Y+LL G  PF    +    + V R D  FD+  + SVSPEAKD
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261

Query: 387 FVKRLLNKDYRKRMTAVQALS 407
           F+K LL K+ RKR+T   AL 
Sbjct: 262 FIKNLLQKEPRKRLTVHDALE 282

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  248 bits (634), Expect = 6e-80
 Identities = 86/261 (32%), Positives = 133/261 (50%), Gaps = 9/261 (3%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y++ +E+G G FG       +         A K +     +     E VR+E++ +  L
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQTMSVL 80

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  LV   DA ED N + ++ E   GGEL +++     + +E++A   + Q+   +  
Sbjct: 81  R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
            H    VH DLKPEN +FT+ R + +++LIDFGL+  + P + +    G+A + APEV  
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            +      D+WS+GV+SYILL G  PF    +    R V   D N DD  +  +S + KD
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258

Query: 387 FVKRLLNKDYRKRMTAVQALS 407
           F+++LL  D   RMT  QAL 
Sbjct: 259 FIRKLLLADPNTRMTIHQALE 279

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  244 bits (625), Expect = 2e-79
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 20/276 (7%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS------IEDVR 198
           F   YE  + +GRG          K      ++ AVKII      +  +       E   
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           +EV IL+ +SGH ++++  D  E     ++V +L + GEL D +       +E++ + I+
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             +L V+   H   +VHRDLKPEN L     DD +++L DFG S  + P E+L ++ G+ 
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 319 YYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371
            Y+APE++       H  Y  E D+WS GVI Y LL GS PFW R +  + R ++  +  
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           F    W   S   KD V R L    +KR TA +AL+
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  241 bits (617), Expect = 7e-78
 Identities = 101/266 (37%), Positives = 149/266 (56%), Gaps = 8/266 (3%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           ++    Y+    +G G F     A  K+     + VA+K I+K  +        +  E+ 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEIA 59

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           +L  +  H ++V   D  E   ++Y++M+L  GGEL DRI+ +G  YTE DA  ++ Q+L
Sbjct: 60  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVL 117

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
             V + H  G+VHRDLKPEN L+ S  +D+ + + DFGLS    P   L+   G+  YVA
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEVL  + YS   D WSIGVI+YILLCG  PF+   ++ +F  +L+++  FD   W  +S
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
             AKDF++ L+ KD  KR T  QAL 
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 2e-76
 Identities = 75/261 (28%), Positives = 136/261 (52%), Gaps = 14/261 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E+G+ +G+G FG+   AR K+       +A+K++ KA++  A     +RREV+I   L
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++++      D   VY+++E    G +  R L +  ++ E+     + ++ + +++
Sbjct: 64  R-HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSY 121

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
           CH + V+HRD+KPEN L  S     ++++ DFG S    P  R   + G+  Y+ PE++ 
Sbjct: 122 CHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIE 177

Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            R +  + D+WS+GV+ Y  L G  PF A T    ++ + R +  F D     V+  A+D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 233

Query: 387 FVKRLLNKDYRKRMTAVQALS 407
            + RLL  +  +R    + L 
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 6e-76
 Identities = 80/266 (30%), Positives = 125/266 (46%), Gaps = 18/266 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +E+  E+G G FG    A+ K+        A K+I          +ED   E+ IL +  
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD 67

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H ++VK  DA    NN++I++E C GG +   +L      TE   + +  Q L  + + 
Sbjct: 68  -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH 327
           H   ++HRDLK  N LFT    D D++L DFG+S    R  +R +  +G+ Y++APEV+ 
Sbjct: 127 HDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183

Query: 328 ------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
                 R Y  +AD+WS+G+    +     P        +   + +S+P     P    S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALS 407
              KDF+K+ L K+   R T  Q L 
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 1e-75
 Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 10/265 (3%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
           K    KY + +++GRG FG              +    K +             V++E+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGT----DQVLVKKEIS 53

Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
           IL     H++++   ++ E +  + ++ E   G ++ +RI        E +  + V Q+ 
Sbjct: 54  ILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
             + F H   + H D++PEN ++ + R  + +++I+FG +  ++P +    +  +  Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171

Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           PEV  H   S   D+WS+G + Y+LL G  PF A T   I   ++ ++  FD+  +  +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
            EA DFV RLL K+ + RMTA +AL
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEAL 256

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 2e-73
 Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 16/264 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++ GK +G G F     AR        ++ A+KI+ K  +     +  V RE  ++  L
Sbjct: 9   DFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H   VK     +D   +Y  +   + GELL  I  + G + E   +    +I+S + +
Sbjct: 66  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 123

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H +G++HRDLKPEN L     +D  +++ DFG +  + P+    R N  VG+A YV+PE
Sbjct: 124 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           +L  +S    +D+W++G I Y L+ G  PF A  E  IF+ +++ + +F         P+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPK 236

Query: 384 AKDFVKRLLNKDYRKRMTAVQALS 407
           A+D V++LL  D  KR+   +   
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEG 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-72
 Identities = 98/270 (36%), Positives = 146/270 (54%), Gaps = 10/270 (3%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRR 199
           +N    Y+ G+E+G G F      R K       Q A K I K +  ++   +S ED+ R
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           EV ILK +  H +++   +  E+  +V +++EL  GGEL D + A     TEE+A   + 
Sbjct: 63  EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK 120

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
           QIL+ V + H   + H DLKPEN +          +++IDFGL+  I       +I G+ 
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180

Query: 319 YYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
            +VAPE++ +    LEAD+WSIGVI+YILL G+ PF   T+      V   +  F+D  +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            + S  AKDF++RLL KD +KRMT   +L 
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  226 bits (578), Expect = 4e-72
 Identities = 63/271 (23%), Positives = 117/271 (43%), Gaps = 17/271 (6%)

Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
           +  +    +   +E+G G FG    AR  +     + VA+K +S +   +    +D+ +E
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
           V+ L+ L  H + +++       +  ++VME C G    D +        E +  A+   
Sbjct: 66  VRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHG 123

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
            L  +A+ H   ++HRD+K  N L +   +   ++L DFG +  + P    N  VG+ Y+
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYW 177

Query: 321 VAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
           +APEV+       Y  + D+WS+G+    L     P +          + +++     L 
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQ 235

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
               S   ++FV   L K  + R T+   L 
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 5e-71
 Identities = 86/271 (31%), Positives = 130/271 (47%), Gaps = 22/271 (8%)

Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
            Y+   + +G G  G       K+     ++ A+K++              RREV++   
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREVELHWR 60

Query: 207 LSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQI 261
            S   H+V+  D  E++      + IVME  +GGEL  RI  RG   +TE +A  I+  I
Sbjct: 61  ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
              + + H   + HRD+KPEN L+TS R +A ++L DFG +        L     + YYV
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180

Query: 322 APEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLP 376
           APEVL    Y    D+WS+GVI YILLCG  PF++        G+   +      F +  
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           W  VS E K  ++ LL  +  +RMT  + ++
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 6e-71
 Identities = 74/265 (27%), Positives = 132/265 (49%), Gaps = 16/265 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++L + +G G +G    A  +     ++ VAVKI+   +       E++++E+ I K L
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICINKML 60

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H+++VKF     + N  Y+ +E C GGEL DRI        E DA+    Q+++ V +
Sbjct: 61  N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPE 324
            H  G+ HRD+KPEN L        ++++ DFGL+   R + R   LN + G+  YVAPE
Sbjct: 119 LHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 325 VLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
           +L R   ++   D+WS G++   +L G  P+   ++S    +  +    + + PW  +  
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDS 234

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALS 407
                + ++L ++   R+T      
Sbjct: 235 APLALLHKILVENPSARITIPDIKK 259

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 5e-69
 Identities = 59/271 (21%), Positives = 110/271 (40%), Gaps = 21/271 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +  +G+ +G G FG        KG+     VAVK+++    T    ++  + EV +L+  
Sbjct: 9   QITVGQRIGSGSFGTVY-----KGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 61

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H +++ F         + IV + CEG  L   +     ++       I  Q    + +
Sbjct: 62  R-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
            H + ++HRDLK  N        D  +++ DFGL+          +   + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLHE---DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 325 VL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--WP 378
           V+       YS ++D+++ G++ Y L+ G  P+           ++       DL     
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
           +     K  +   L K   +R    Q L+ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  217 bits (553), Expect = 8e-69
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 11/270 (4%)

Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
            +   +YELG+ +G G       AR  +     + VAVK++              RRE +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 203 ILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
              AL+ H  +V   D  E         YIVME  +G  L D I+   G  T + A  ++
Sbjct: 60  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG-LSDFIRPDERLNDIVGS 317
                 + F H  G++HRD+KP N + ++      M       ++D      +   ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
           A Y++PE     S    +D++S+G + Y +L G  PF   +   +    +R DP      
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
              +S +    V + L K+   R      +
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEM 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 2e-68
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 13/260 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + L K +G+G FG    A  KK    +Q  A+K + K  +     +E    E ++L    
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  L       +   N++ VME   GG+L+  I     ++    A     +I+  + F 
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 119

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
           H +G+V+RDLK +N L      D  +++ DFG+  + +  D + N   G+  Y+APE+L 
Sbjct: 120 HSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176

Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            + Y+   D WS GV+ Y +L G  PF  + E  +F ++   +P +       +  EAKD
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKD 232

Query: 387 FVKRLLNKDYRKRMTAVQAL 406
            + +L  ++  KR+     +
Sbjct: 233 LLVKLFVREPEKRLGVRGDI 252

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-68
 Identities = 64/262 (24%), Positives = 126/262 (48%), Gaps = 15/262 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G+G  G   +A         Q+VA++ ++  +       E +  E+ +++  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMREN 74

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             + ++V + D+    + +++VME   GG L D +        E    A+  + L  + F
Sbjct: 75  K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 131

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
            H   V+HRD+K +N L      D  ++L DFG    I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             ++Y  + DIWS+G+++  ++ G  P+           +  +    +      +S   +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR 247

Query: 386 DFVKRLLNKDYRKRMTAVQALS 407
           DF+ R L+ D  KR +A + L 
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQ 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-67
 Identities = 59/271 (21%), Positives = 112/271 (41%), Gaps = 18/271 (6%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           N G   +   E+GRG F         +      +VA   +   K+T +   +  + E ++
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEM 61

Query: 204 LKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
           LK L  H ++V+F D+ E        + +V EL   G  L   L R      +  ++   
Sbjct: 62  LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCR 119

Query: 260 QILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           QIL  + F H +   ++HRDLK +N   T       +++ D GL+   R       ++G+
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRAS-FAKAVIGT 176

Query: 318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLP 376
             ++APE+    Y    D+++ G+    +     P+   +  + I+R V           
Sbjct: 177 PEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASF 234

Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                PE K+ ++  + ++  +R +    L+
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 6e-66
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 23/271 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            YE+   +G G +G     R K      + +  K +    MT A   + +  EV +L+ L
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 60

Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQIL 262
             H ++V++ D   D  N  +YIVME CEGG+L   I           EE    ++ Q+ 
Sbjct: 61  K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 263 SVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVG 316
             +  CH +      V+HRDLKP N          +++L DFGL+  +  D       VG
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
           + YY++PE ++R SY+ ++DIWS+G + Y L     PF A ++  +   +          
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 233

Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                S E  + + R+LN     R +  + L
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-65
 Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 53/302 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            +E   E+G G+ G       K        +A K+I             + RE+++L   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHEC 61

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +   ++V F  A      + I ME  +GG L D++L + GR  E+    + + ++  + +
Sbjct: 62  N-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 268 CH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
                 ++HRD+KP N L  S     +++L DFG+S  +  D   N  VG+  Y++PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERL 175

Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDPNF---------- 372
               YS+++DIWS+G+    +  G  P           +F   +  D             
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 373 ---------------------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                                        LP    S E +DFV + L K+  +R    Q 
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 406 LS 407
           + 
Sbjct: 296 MV 297

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-65
 Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED---VRREV 201
             ++Y++G  +G G FG   S         +  VA+K + K +++    + +   V  EV
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58

Query: 202 KILKALS-GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
            +LK +S G   +++  D  E  ++  +++E  E  + L   +   G   EE A++   Q
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           +L  V  CH  GV+HRD+K EN L     +  +++LIDFG    +  D    D  G+  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-KDTVYTDFDGTRVY 175

Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
             PE +  HR +   A +WS+G++ Y ++CG  PF    E      ++R    F      
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----Q 225

Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
            VS E +  ++  L      R T  +  +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  204 bits (519), Expect = 1e-62
 Identities = 64/260 (24%), Positives = 115/260 (44%), Gaps = 13/260 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           + + + +GRG FG     R        +  A+K + K ++           E  +L  +S
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 209 --GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
                 +V    A    + +  +++L  GG+L    L++ G ++E D +    +I+  + 
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
             H + VV+RDLKP N L     +   +R+ D GL+      ++ +  VG+  Y+APEVL
Sbjct: 122 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVL 177

Query: 327 HR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
            +  +Y   AD +S+G + + LL G  PF           + R           S SPE 
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPEL 236

Query: 385 KDFVKRLLNKDYRKRMTAVQ 404
           +  ++ LL +D  +R+  + 
Sbjct: 237 RSLLEGLLQRDVNRRLGCLG 256

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-61
 Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 13/267 (4%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
             L +++G G FG            K   VAVK +    ++   +++D  REV  + +L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H++L++          + +V EL   G LLDR+    G +         VQ+   + + 
Sbjct: 70  -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAPE 324
             +  +HRDL   N L         +++ DFGL   +  ++              + APE
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 325 VL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            L  R++S  +D W  GV  + +   G  P+     S I   + +               
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALSKL 409
           +  + + +        R T V     L
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  197 bits (501), Expect = 1e-60
 Identities = 61/258 (23%), Positives = 126/258 (48%), Gaps = 15/258 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
           +++ + +G G FG     R +      +  A+K++ K  +     +E    E  +L  ++
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  +++     +D   ++++M+  EGGEL   +L +  R+    AK    ++   + + 
Sbjct: 63  -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
           H + +++RDLKPEN L      +  +++ DFG + ++   +    + G+  Y+APEV+  
Sbjct: 121 HSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 175

Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
           + Y+   D WS G++ Y +L G  PF+       +  +L ++  F     P  + + KD 
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDL 231

Query: 388 VKRLLNKDYRKRMTAVQA 405
           + RL+ +D  +R+  +Q 
Sbjct: 232 LSRLITRDLSQRLGNLQN 249

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 5e-60
 Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 36/291 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
             E GK +G G FG   +A            QVAVK++ +   ++    E +  E+K++ 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMT 95

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY---------------- 249
            L  H+++V    AC     +Y++ E C  G+LL+ + ++  ++                
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 250 ------TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
                 T ED      Q+   + F   +  VHRDL   N L T       +++ DFGL+ 
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212

Query: 304 FIRPDERL---NDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTE 358
            I  D       +      ++APE L    Y++++D+WS G++ + I   G  P+     
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 359 SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
              F  ++++    D       + E    ++     D RKR +     S L
Sbjct: 273 DANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 1e-59
 Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 19/266 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
               KE+G G FG     + +        VA+K+I +  M    S ++   E K++  LS
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSM----SEDEFIEEAKVMMNLS 57

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H+ LV+    C     ++I+ E    G LL+ +     R+  +    +   +   + + 
Sbjct: 58  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
             +  +HRDL   N L     D   +++ DFGLS ++  DE            +  PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
            +  +S ++DIW+ GV+ + I   G  P+   T S     + +    +        S + 
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV 230

Query: 385 KDFVKRLLNKDYRKRMTAVQALSKLV 410
              +    ++   +R T    LS ++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNIL 256

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-59
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 10/264 (3%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKA 206
            +EL K +G G +G     R   G    +  A+K++ KA +   A + E  R E ++L+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           +     LV    A +    ++++++   GGEL    L++  R+TE + +  V +I+  + 
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP--DERLNDIVGSAYYVAPE 324
             H  G+++RD+K EN L      +  + L DFGLS        ER  D  G+  Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 325 VL---HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           ++      +    D WS+GV+ Y LL G+ PF    E      + R     +      +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQA 405
             AKD ++RLL KD +KR+     
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPR 284

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-59
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 14/260 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++  K +G+G FG     R K      +  A+KI+ K  +     +     E ++L+  
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H  L     A +  + +  VME   GGEL   + +R   +TEE A+    +I+S + +
Sbjct: 63  R-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL 326
            H + VV+RD+K EN +      D  +++ DFGL          +    G+  Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
             + Y    D W +GV+ Y ++CG  PF+ +    +F  +L  +  F      ++SPEAK
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAK 233

Query: 386 DFVKRLLNKDYRKRMTAVQA 405
             +  LL KD ++R+    +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPS 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-59
 Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 23/266 (8%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + +L + +G+G FG         G+ +  +VAVK I           +    E  ++  L
Sbjct: 8   ELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 57

Query: 208 SGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVV 265
             H +LV+      E+   +YIV E    G L+D + +RG      +      + +   +
Sbjct: 58  R-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
            +      VHRDL   N L +   +D   ++ DFGL+         +       + APE 
Sbjct: 117 EYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEA 171

Query: 326 L-HRSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
           L  + +S ++D+WS G++ + +   G  P+       +   V +    +         P 
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPA 228

Query: 384 AKDFVKRLLNKDYRKRMTAVQALSKL 409
             + +K   + D   R + +Q   +L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  193 bits (490), Expect = 9e-59
 Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 53/298 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            Y+L +++GRG +     A        +++V VKI+   K       + ++RE+KIL+ L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILENL 86

Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            G  +++   D  +D       +V E     +            T+ D +  + +IL  +
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKAL 142

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
            +CH  G++HRD+KP N +     +   +RLID+GL++F  P +  N  V S Y+  PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWA------------------RTESGIFRAV 365
           L  ++ Y    D+WS+G +   ++    PF+                        I +  
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 366 LRSDPNFDDL----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
           +  DP F+D+                    VSPEA DF+ +LL  D++ R+TA +A+ 
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 38/288 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KY   +++G G +G    A+   G    +  A+K I   K    I      RE+ ILK L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKEL 57

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H ++VK  D       + +V E  +  +L   +    G      AK+ ++Q+L+ +A+
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL 326
           CH + V+HRDLKP+N L      + ++++ DFGL+     P  +    + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP------ 378
             S  YS   DIWS+G I   ++ G+  F   +E+     + R     +   WP      
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 379 -------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                               +     D + ++L  D  +R+TA QAL 
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-58
 Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 37/291 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +YE   E+G G +G    AR  K     + VA+K +        +      REV +L+ L
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHL 64

Query: 208 SG--HKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
               H ++V+  D C     +    + +V E  +                 E  K ++ Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
           +L  + F H   VVHRDLKP+N L TS      ++L DFGL+        L  +V + +Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWY 181

Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP- 378
            APEVL +S Y+   D+WS+G I   +      F   ++      +L       +  WP 
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 379 ----------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                                  +    KD + + L  +  KR++A  ALS
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 57/265 (21%), Positives = 106/265 (40%), Gaps = 19/265 (7%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
               +E+G G FG               +VA+K I +  M    S ED   E +++  LS
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAM----SEEDFIEEAEVMMKLS 58

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H  LV+    C +   + +V E  E G L D +  + G +  E    + + +   +A+ 
Sbjct: 59  -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEVL 326
               V+HRDL   N L     ++  +++ DFG++ F+  D+  +         + +PEV 
Sbjct: 118 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
               YS ++D+WS GV+ + +    +  +  R+ S +   +      +        S   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV 231

Query: 385 KDFVKRLLNKDYRKRMTAVQALSKL 409
              +     +    R    + L +L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQL 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-57
 Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 50/302 (16%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           + G +Y     +G G +G  CSA          +VA+K IS  +  T    +   RE+KI
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTYC--QRTLREIKI 59

Query: 204 LKALSGHKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           L     H++++   D       E + +VY+V  L  G +L   +  +    + +     +
Sbjct: 60  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFL 115

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDI 314
            QIL  + + H   V+HRDLKP N L  +     D+++ DFGL+    PD      L + 
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR----- 367
           V + +Y APE++  S  Y+   DIWS+G I   +L     F  +        +L      
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 368 ------------------SDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
                             S P+ + +PW    P+   +A D + ++L  +  KR+   QA
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

Query: 406 LS 407
           L+
Sbjct: 293 LA 294

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 7e-57
 Identities = 55/263 (20%), Positives = 107/263 (40%), Gaps = 17/263 (6%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
            E+G G+FG       +  + K   VA+K++ +   T     E++ RE +I+  L  + +
Sbjct: 15  IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPY 70

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    C+    + +VME+  GG L   ++ +       +   ++ Q+   + +   + 
Sbjct: 71  IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYYVAPEVL-H 327
            VHRDL   N L     +    ++ DFGLS  +  D+              + APE +  
Sbjct: 130 FVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 328 RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
           R +S  +D+WS GV  +  L  G +P+       +   + +      + P P   PE   
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECP-PECPPELYA 243

Query: 387 FVKRLLNKDYRKRMTAVQALSKL 409
            +       +  R   +    ++
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRM 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 16/267 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           + ELG+ +G G FG          E     VA+K        +    E   +E   ++  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 65

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             H H+VK      + N V+I+MELC  GEL   +  R              Q+ + +A+
Sbjct: 66  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEV 325
              +  VHRD+   N L +S      ++L DFGLS ++      + +       ++APE 
Sbjct: 124 LESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSP 382
           +  R ++  +D+W  GV  + IL+ G +PF     + +   +   +     LP P    P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LPMPPNCPP 236

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALSKL 409
                + +    D  +R    +  ++L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (472), Expect = 2e-56
 Identities = 53/277 (19%), Positives = 99/277 (35%), Gaps = 22/277 (7%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G +Y LG+++G G FG              ++VA+K+              +  E KI K
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            + G   +        + +   +VMEL     L D       +++ +    +  Q++S +
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--------RLNDIVGS 317
            + H +  +HRD+KP+NFL   G+    + +IDFGL+   R              ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
           A Y +         S   D+ S+G +      GS P+     +   +   R        P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236

Query: 377 ----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
                     E   ++    +  +  +          
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 68/324 (20%), Positives = 120/324 (37%), Gaps = 58/324 (17%)

Query: 119 KESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQV 178
           K +T+    G  P++  + S          Y   K +G G FG    A+        + V
Sbjct: 2   KVTTVVATPGQGPDRPQEVS----------YTDTKVIGNGSFGVVYQAKLCD---SGELV 48

Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC------EDVNNVYIVMEL 232
           A+K + + K           RE++I++ L  H ++V+           +D   + +V++ 
Sbjct: 49  AIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100

Query: 233 CEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
                  +                K  + Q+   +A+ H  G+ HRD+KP+N L     D
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--D 158

Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLC 348
            A ++L DFG +  +   E     + S YY APE++  +  Y+   D+WS G +   LL 
Sbjct: 159 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218

Query: 349 GSRPFWARTESGIFRAVLR-------------------------SDPNFDDLPWPSVSPE 383
           G   F   +       +++                             +  +  P   PE
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278

Query: 384 AKDFVKRLLNKDYRKRMTAVQALS 407
           A     RLL      R+T ++A +
Sbjct: 279 AIALCSRLLEYTPTARLTPLEACA 302

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 31/286 (10%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
           +   GK +G G FG    A        D    VAVK++  +   T    E +  E+K+L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLS 81

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-----------------GR 248
            L  H ++V    AC       ++ E C  G+LL+ +  +                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
              ED  +   Q+   +AF   +  +HRDL   N L          ++ DFGL+  I+ D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKND 198

Query: 309 ERL---NDIVGSAYYVAPEVLHRSY-SLEADIWSIGVISYILLCGSRP-FWARTESGIFR 363
                  +      ++APE +     + E+D+WS G+  + L       +        F 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
            +++    F  L       E  D +K   + D  KR T  Q +  +
Sbjct: 259 KMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 17/269 (6%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            ++ + +G G FG  CS   K    ++  VA+K +      T     D   E  I+    
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD 85

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
            H +++           V I+ E  E G L   +    G++T      ++  I + + + 
Sbjct: 86  -HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND------IVGSAYYVA 322
                VHRDL   N L  S   +   ++ DFGLS F+  D                 + A
Sbjct: 145 ADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
           PE + +R ++  +D+WS G++ + ++  G RP+W  T   +  A+ +   ++   P    
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDC 258

Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
                  +     KD   R    Q ++ L
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 59/267 (22%), Positives = 108/267 (40%), Gaps = 21/267 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
             +L + +G G FG               +VAVK + +  M    S +    E  ++K L
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSM----SPDAFLAEANLMKQL 65

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVA 266
             H+ LV+          +YI+ E  E G L+D +    G + T      +  QI   +A
Sbjct: 66  Q-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
           F   +  +HRDL+  N L     D    ++ DFGL+  I  +E            + APE
Sbjct: 124 FIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 325 VL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
            + + ++++++D+WS G++   ++  G  P+   T   + + + R    +  +   +   
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPE 237

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALSKL 409
           E    ++    +    R T     S L
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-55
 Identities = 59/264 (22%), Positives = 113/264 (42%), Gaps = 19/264 (7%)

Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
           KE+G G+FG       +  ++  + VAVKI+       A+  +++  E  +++ L  + +
Sbjct: 13  KELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPY 69

Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
           +V+    CE   +  +VME+ E G L ++ L +     +++   +V Q+   + +     
Sbjct: 70  IVRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYYVAPEVL-H 327
            VHRDL   N L  +       ++ DFGLS  +R DE              + APE + +
Sbjct: 128 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 328 RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
             +S ++D+WS GV+ +     G +P+     S +   + + +     +  P+    E  
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGCPAGCPREMY 240

Query: 386 DFVKRLLNKDYRKRMTAVQALSKL 409
           D +      D   R        +L
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRL 264

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 4e-55
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 52/303 (17%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE   ++G+G FG    AR +K     Q+VA+K +          I    RE+KIL+ L
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQLL 66

Query: 208 SGHKHLVKFCDACEDV--------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
             H+++V   + C            ++Y+V + CE   L   +     ++T  + K ++ 
Sbjct: 67  K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQ 124

Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDI 314
            +L+ + + H   ++HRD+K  N L T    D  ++L DFGL+      +     R  + 
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
           V + +Y  PE+L   R Y    D+W  G I   +   S      TE      + +   + 
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 373 DDLPWPSV----------------------------SPEAKDFVKRLLNKDYRKRMTAVQ 404
               WP+V                             P A D + +LL  D  +R+ +  
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 405 ALS 407
           AL+
Sbjct: 302 ALN 304

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 5e-55
 Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 37/286 (12%)

Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--IEDVRREVKILKAL 207
           E    +G G F     AR K     +Q VA+K I     + A         RE+K+L+ L
Sbjct: 1   EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H +++   DA    +N+ +V +  E    +  I       T    KA ++  L  + +
Sbjct: 58  S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
            H   ++HRDLKP N L     ++  ++L DFGL+  F  P+      V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172

Query: 327 --HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP------ 378
              R Y +  D+W++G I   LL         ++      +  +     +  WP      
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 379 ------------------SVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
                             +   +  D ++ L   +   R+TA QAL
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 8e-55
 Identities = 75/259 (28%), Positives = 126/259 (48%), Gaps = 15/259 (5%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +++  K +G G FG     + K+        A+KI+ K K+     IE    E +IL+A+
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           +    LVK   + +D +N+Y+VME   GGE+    L R GR++E  A+    QI+    +
Sbjct: 99  N-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
            H   +++RDLKPEN L         +++ DFG +   R   R   + G+   +APE++ 
Sbjct: 157 LHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIIL 211

Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
            + Y+   D W++GV+ Y +  G  PF+A     I+  ++     F        S + KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKD 267

Query: 387 FVKRLLNKDYRKRMTAVQA 405
            ++ LL  D  KR   ++ 
Sbjct: 268 LLRNLLQVDLTKRFGNLKN 286

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-54
 Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 26/278 (9%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
            +    +G G+FG    AR KK  L+    A+K + +          D   E+++L  L 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 68

Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---------------GGRYTEED 253
            H +++    ACE    +Y+ +E    G LLD +                      + + 
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
                  +   + +   +  +HRDL   N L     ++   ++ DFGLS       +   
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185

Query: 314 IVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPN 371
                 ++A E L+ S Y+  +D+WS GV+ + ++  G  P+   T + ++  + +    
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---G 242

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
           +      +   E  D +++   +   +R +  Q L  L
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 21/267 (7%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
              L  ++G+G FG               +VA+K +    M    S E   +E +++K L
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKKL 69

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYT-EEDAKAIVVQILSVVA 266
             H+ LV+      +   +YIV E    G LLD +    G+Y        +  QI S +A
Sbjct: 70  R-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
           +      VHRDL+  N L     ++   ++ DFGL+  I  +E            + APE
Sbjct: 128 YVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184

Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSVSP 382
              +  +++++D+WS G++   L    R  +       +   V R    +     P    
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPE 241

Query: 383 EAKDFVKRLLNKDYRKRMTAVQALSKL 409
              D + +   K+  +R T     + L
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 4e-54
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 28/284 (9%)

Query: 148 KYELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
           +  LGK +G G FG    A      K    +  +VAVK++      T   + D+  E+++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEM 71

Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---------------GR 248
           +K +  HK+++    AC     +Y+++E    G L + + AR                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
            + +D  +   Q+   + +   +  +HRDL   N L T                  I   
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 309 ERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVL 366
           ++  +      ++APE L  R Y+ ++D+WS GV+ + I   G  P+       +F+ + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 367 RSDPNFDDLPWPS-VSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
                   +  PS  + E    ++   +    +R T  Q +  L
Sbjct: 252 EGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 24/269 (8%)

Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           G  Y++G+ +G G FG             +QQVA+K   +           +R E +  K
Sbjct: 4   GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
            L+G   +       ++  +  +V++L  G  L D +   G +++ +       Q+L+ V
Sbjct: 56  LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--------RLNDIV 315
              H + +V+RD+KP+NFL           + ++DFG+  F R              ++ 
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
           G+A Y++      R  S   D+ ++G +    L GS P+     +   +   R       
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234

Query: 375 LP----WPSVSPEAKDFVKRLLNKDYRKR 399
            P          E   ++    N  +   
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-53
 Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 36/288 (12%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
            ++  +++G G +G    AR K      + VA+K I     T  +      RE+ +LK L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           + H ++VK  D     N +Y+V E            +          K+ + Q+L  +AF
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEVL 326
           CH   V+HRDLKP+N L      +  ++L DFGL+     P       V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS----- 379
                YS   DIWS+G I   ++     F   +E      + R+    D++ WP      
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 380 --------------------VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                               +  + +  + ++L+ D  KR++A  AL+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 3e-53
 Identities = 51/266 (19%), Positives = 105/266 (39%), Gaps = 14/266 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           ++  K +G G FG          GE     VA+K + +A    A   +++  E  ++ ++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASV 68

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             + H+ +    C   + V ++ +L   G LLD +         +      VQI   + +
Sbjct: 69  D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPE 324
              + +VHRDL   N L  +      +++ DFGL+  +  +E+            ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
            + HR Y+ ++D+WS GV  + L+      +    +    ++L           P  + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ--PPICTID 241

Query: 384 AKDFVKRLLNKDYRKRMTAVQALSKL 409
               + +    D   R    + + + 
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEF 267

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-52
 Identities = 67/299 (22%), Positives = 126/299 (42%), Gaps = 48/299 (16%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
              A Y   + VG G +G  CSA   +      +VA+K + +   +     +   RE+++
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELF-AKRAYRELRL 70

Query: 204 LKALSGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           LK +  H++++   D        +D  + Y+VM            L +  +  E+  + +
Sbjct: 71  LKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFL 126

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           V Q+L  + + H  G++HRDLKP N       +D +++++DFGL+     D  +   V +
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVT 181

Query: 318 AYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
            +Y APEV+     Y+   DIWS+G I   ++ G   F         + +++        
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 376 PW---------------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                                         + SP A + ++++L  D  +R+TA +AL+
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 51/266 (19%), Positives = 101/266 (37%), Gaps = 17/266 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
              +  ++G G +G       KK       VAVK + +  M     +E+  +E  ++K +
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 70

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVA 266
             H +LV+    C      YI+ E    G LLD +        +      +  QI S + 
Sbjct: 71  K-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
           +   +  +HRDL   N L     ++  +++ DFGLS  +  D             + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
            L +  +S+++D+W+ GV+ + +       +   +      +L  D   +         +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPEK 244

Query: 384 AKDFVKRLLNKDYRKRMTAVQALSKL 409
             + ++     +   R +  +     
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAF 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 72/289 (24%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           KYE  +++G G +G    A+ ++     + VA+K +        +      RE+ +LK L
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKEL 58

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
             HK++V+  D       + +V E C+           G     E  K+ + Q+L  + F
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGF 116

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
           CH + V+HRDLKP+N L      + +++L +FGL+  F  P    +  V + +Y  P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 327 HRS--YSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPS---- 379
             +  YS   D+WS G I   L    RP F         + + R      +  WPS    
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 380 ---------------------VSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                                ++   +D ++ LL  +  +R++A +AL 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 53/292 (18%), Positives = 107/292 (36%), Gaps = 39/292 (13%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
             E  +++G G FG    AR       +    VAVK++ +          D +RE  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY---------------- 249
               + ++VK    C     + ++ E    G+L + + +                     
Sbjct: 72  EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 250 -------TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
                  +  +   I  Q+ + +A+   +  VHRDL   N L     ++  +++ DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 187

Query: 303 DFIRPDERL---NDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWART 357
             I   +      +      ++ PE + +  Y+ E+D+W+ GV+ + +      P++   
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
              +   V   D N    P  +   E  + ++   +K    R +       L
Sbjct: 248 HEEVIYYVR--DGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 2e-50
 Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 57/305 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y+  K +G G  G  C+A        D+ VA+K +S+         +   RE+ ++K +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCV 73

Query: 208 SGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
           + HK+++   +        E+  +VY+VMEL +                 E    ++ Q+
Sbjct: 74  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQM 128

Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
           L  +   H  G++HRDLKP N +  S   D  ++++DFGL+        +   V + YY 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185

Query: 322 APE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR------------- 367
           APE +L   Y    DIWS+G I   ++     F  R     +  V+              
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 368 ---------SDPNFDDLPWPS----------------VSPEAKDFVKRLLNKDYRKRMTA 402
                    + P +  L +P                  + +A+D + ++L  D  KR++ 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 403 VQALS 407
             AL 
Sbjct: 306 DDALQ 310

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 7e-50
 Identities = 49/270 (18%), Positives = 101/270 (37%), Gaps = 17/270 (6%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
                + +GRGHFG          + K    AVK +++      +       E  I+K  
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV--SQFLTEGIIMKDF 85

Query: 208 SGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
           S H +++     C     +  +V+   + G+L + I       T +D     +Q+   + 
Sbjct: 86  S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144

Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYV 321
           F   +  VHRDL   N +     +   +++ DFGL+  +   E               ++
Sbjct: 145 FLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 322 APEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPS 379
           A E L  + ++ ++D+WS GV+ + L+    P +       I   +L+            
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 258

Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
                 + + +  +     R +  + +S++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-47
 Identities = 53/268 (19%), Positives = 102/268 (38%), Gaps = 16/268 (5%)

Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
               K +G G FG       K     K+  VA+K +      T     D   E  I+   
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF 66

Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
           S H ++++          + I+ E  E G L   +  + G ++      ++  I + + +
Sbjct: 67  S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAP 323
                 VHRDL   N L      +   ++ DFGLS  +  D       +       + AP
Sbjct: 126 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 324 EVL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
           E + +R ++  +D+WS G++ + ++  G RP+W  +   + +A+   +  F         
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMDCP 239

Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALSKL 409
                 + +   ++  +R      +S L
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSIL 267

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-47
 Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 48/299 (16%)

Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
               +Y+    VG G +G  C+A   K      +VAVK +S+   +  I  +   RE+++
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRL 70

Query: 204 LKALSGHKHLVKFCDACE------DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
           LK +  H++++   D         + N+VY+V  L          + +  + T++  + +
Sbjct: 71  LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFL 126

Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
           + QIL  + + H   ++HRDLKP N       +D +++++DFGL+     D+ +   V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVAT 181

Query: 318 AYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
            +Y APE++     Y+   DIWS+G I   LL G   F         + +LR        
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241

Query: 376 PW---------------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALS 407
                                           +P A D ++++L  D  KR+TA QAL+
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 59/304 (19%), Positives = 113/304 (37%), Gaps = 57/304 (18%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
              L + +G+G FG        +G+ + ++VAVKI S  +  +         E+     L
Sbjct: 4   TIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVML 54

Query: 208 SGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
             H++++ F  A    N     +++V +  E G L D +       T E    + +   S
Sbjct: 55  R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111

Query: 264 VVAFCHLQ--------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----R 310
            +A  H++         + HRDLK +N L      +    + D GL+             
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 311 LNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-F 362
            N  VG+  Y+APEVL       H      ADI+++G++ + +           +  + +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 363 RAVLRSDPNFDDL-----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
             ++ SDP+ +++                             ++     +   R+TA++ 
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 406 LSKL 409
              L
Sbjct: 289 KKTL 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-46
 Identities = 49/278 (17%), Positives = 115/278 (41%), Gaps = 25/278 (8%)

Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
           K  + +E+G+G FG  +   A+G   +  + +VA+K +++A         +   E  ++K
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMK 78

Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR---------YTEEDAKA 256
             +   H+V+            ++MEL   G+L   + +              +      
Sbjct: 79  EFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---ND 313
           +  +I   +A+ +    VHRDL   N +     +D  +++ DFG++  I   +       
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 314 IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPN 371
            +    +++PE L    ++  +D+WS GV+ + +   +  P+   +   + R V+  +  
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--EGG 252

Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
             D P  +      + ++     + + R + ++ +S +
Sbjct: 253 LLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 30/285 (10%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
           + +LGK +GRG FG    A     +     + VAVK++ +    +      +  E+KIL 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 71

Query: 206 ALSGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY--------------- 249
            +  H ++V    AC +    + +++E C+ G L   + ++   +               
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
           T E       Q+   + F   +  +HRDL   N L +   +   +++ DFGL+  I  D 
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 188

Query: 310 ---RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRA 364
              R  D      ++APE +  R Y++++D+WS GV+ + +      P+        F  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL 409
            L+         +   +PE    +    + +  +R T  + +  L
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 68/320 (21%), Positives = 114/320 (35%), Gaps = 68/320 (21%)

Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
           +Y L +++G GHF     A+       +  VA+KI+   K+ T    E    E+K+L+ +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQRV 66

Query: 208 S----------GHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
           +          G  H++K    F     +  +V +V E+     L               
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 254 AKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERL 311
            K I  Q+L  + + H + G++H D+KPEN L       +  +++    L +    DE  
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 312 NDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIF-------- 362
            + + +  Y +PEVL    +   ADIWS   + + L+ G   F                 
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 363 -------------------------RAVLRSDPNFDDLPWPSV-----------SPEAKD 386
                                    R +LR+       P   V           + E  D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 387 FVKRLLNKDYRKRMTAVQAL 406
           F+  +L  D RKR  A   +
Sbjct: 307 FLSPMLQLDPRKRADAGGLV 326

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.2 bits (228), Expect = 2e-22
 Identities = 45/208 (21%), Positives = 72/208 (34%), Gaps = 29/208 (13%)

Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVR-REVK 202
             +GK +G G      +   +K      +  VK       S  K+       D+    + 
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57

Query: 203 ILKALSGHKHLVKFCDACE----DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
           I  A +  + L K                ++MEL +             R   E+   ++
Sbjct: 58  IRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVL 109

Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
             IL  VA  + +G+VH DL   N L      +  + +IDF  S  +  +E   +I+   
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVG-EEGWREILERD 164

Query: 319 YYVAPEVLHRSYSLEADIWSIGVISYIL 346
                    R+Y  E DI S   I  IL
Sbjct: 165 VRNIITYFSRTYRTEKDINS--AIDRIL 190

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

 Score = 45.8 bits (107), Expect = 4e-06
 Identities = 22/176 (12%), Positives = 50/176 (28%), Gaps = 4/176 (2%)

Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
             +++ + +K+       T     DV RE  ++  L G   + K            ++M 
Sbjct: 34  VGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90

Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
             +G    +            +  A  +++   +           D +     +    D 
Sbjct: 91  EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150

Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYIL 346
           AD+   ++      +    L D + +       V  H            G +S  +
Sbjct: 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	422
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.74
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.32
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.16
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.54
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.46
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.38

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-62  Score=450.98  Aligned_cols=253  Identities=28%  Similarity=0.555  Sum_probs=230.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|++++++++ |||||++++++.+.+.+
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV   81 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEE
Confidence            479999999999999999999987   78999999998766555556788999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        82 ~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCC
T ss_pred             EEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecC
Confidence            9999999999999988654 5699999999999999999999999999999999999994   57899999999997665


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      . ......+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+....+.+..+.+....++.    .++++++
T Consensus       158 ~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  232 (263)
T d2j4za1         158 S-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR  232 (263)
T ss_dssp             C-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred             C-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence            3 34456789999999999875 6899999999999999999999999999888999999888776654    6899999


Q ss_pred             HHHHHhchhccccCCCHHHHHhccCcc
Q 014559          386 DFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       386 ~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +||.+||+.||++|||++|+|+|+||.
T Consensus       233 ~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         233 DLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            999999999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-62  Score=460.23  Aligned_cols=264  Identities=38%  Similarity=0.688  Sum_probs=219.5

Q ss_pred             cccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       143 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      +++.+.|++++.||+|+||.||+|+++.   +++.||||++.+.....  ....+.+|+.+|++|+ |||||++++++.+
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~   78 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYES   78 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            3456779999999999999999999987   78999999998654432  2356889999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      ++.+|||||||+||+|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||+...++++.+||+|||++
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence            9999999999999999998854 467999999999999999999999999999999999999976566889999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +.........+.+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+.........+......++...+..++
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  237 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS  237 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence            88776666777899999999999874 69999999999999999999999999999999999999988877766677899


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +++++||.+||.+||++|||+.|+|+|+||..
T Consensus       238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999999963

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-62  Score=453.92  Aligned_cols=262  Identities=30%  Similarity=0.564  Sum_probs=232.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +++.||||++.+.........+.+.+|+++|++|+ |||||++++++.+++.+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence            469999999999999999999987   78999999998766555556688999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++... +.+++..++.++.|++.||.|||++|||||||||+|||++   +++.+||+|||+|+.+.
T Consensus        84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecc
Confidence            9999999999999987654 5799999999999999999999999999999999999994   58899999999998765


Q ss_pred             CCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...   .....+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+...++..+......++.    .+++
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  235 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFP  235 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCH
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCH
Confidence            332   345578999999999986 47999999999999999999999999999999999999988776654    6899


Q ss_pred             HHHHHHHHhchhccccCCCHHH------HHhccCccchhhhhhh
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQ------ALSKLVVPILSFKIVC  420 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~e------lL~~l~~~~l~~k~~~  420 (422)
                      ++++||++||+.||++|||++|      +++|+||+.+.|..+.
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            9999999999999999999987      5889999988776554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-61  Score=462.71  Aligned_cols=262  Identities=32%  Similarity=0.561  Sum_probs=237.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .-++|++++.||+|+||.||+|+++.   +|+.||||++.....   ...+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccch---hhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            34579999999999999999999987   889999999965432   23477899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      .+|||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||++. +.++.+||+|||+++.
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence            999999999999999988766678999999999999999999999999999999999999964 3467899999999998


Q ss_pred             cCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ..........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+......++...+..++++
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            877777777899999999999864 6899999999999999999999999999999999999988877776666789999


Q ss_pred             HHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          384 AKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      +++||.+||..||++|||+.|+|+|+||...
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-61  Score=462.36  Aligned_cols=260  Identities=33%  Similarity=0.558  Sum_probs=237.5

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++++.||+|+||.||+|+++.   +|+.||||++.....   ...+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            3579999999999999999999987   889999999976432   23467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||+||+|.+.+......+++.+++.|+.||+.||.|||++|||||||||+||||+. ..++.+||+|||+|+..
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence            99999999999999987776678999999999999999999999999999999999999963 34689999999999988


Q ss_pred             CCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      ..........||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+......+..+......++...+..+++++
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            77777777899999999999875 69999999999999999999999999999999999999988888777778899999


Q ss_pred             HHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          385 KDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++||.+||++||.+|||+.|+|+|+||+.
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-60  Score=446.72  Aligned_cols=254  Identities=26%  Similarity=0.474  Sum_probs=222.9

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ..+|+++++||+|+||.||+|+++.   +|+.||||++......   ..+.+.+|+.+|++++ |||||++++++.+.+.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence            3579999999999999999999887   8899999999765432   3477899999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||+||+|.+++.+  +.+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheee
Confidence            9999999999999987654  3699999999999999999999999999999999999995   5789999999999876


Q ss_pred             CCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCC-CCCCCCCCCCCH
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDLPWPSVSP  382 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~  382 (422)
                      ... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+..+..... .+.  .+..+++
T Consensus       167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~  244 (293)
T d1yhwa1         167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ--NPEKLSA  244 (293)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS--SGGGSCH
T ss_pred             ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC--CcccCCH
Confidence            543 34566789999999999875 689999999999999999999999998887777666665432 222  2246899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++++||.+||+.||++|||+.|+|+|+||+.
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-61  Score=446.87  Aligned_cols=257  Identities=28%  Similarity=0.507  Sum_probs=216.3

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      -++|++++.||+|+||.||+|+++.   +|+.||||++.......  ..+.+.+|+++|++|+ |||||++++++.+.+.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN-HENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCC-CCCEeeEeeeeccCce
Confidence            3579999999999999999999987   78999999997653322  3356889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||++|+|.+++. ..+.+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheee
Confidence            999999999999999874 446799999999999999999999999999999999999994   5789999999999876


Q ss_pred             CCCC---CccccccCCcccCccccCc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          306 RPDE---RLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       306 ~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ....   .....+||+.|+|||++.+ . ++.++|||||||+||||++|+.||................... ...+..+
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  232 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKI  232 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-STTGGGS
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCccccC
Confidence            4332   3456789999999999864 4 4688999999999999999999997765544433333333222 2234578


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      ++++++||.+||+.||++|||++|+|+|+||+-
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            999999999999999999999999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-60  Score=446.14  Aligned_cols=268  Identities=36%  Similarity=0.599  Sum_probs=236.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---hhcHHHHHHHHHHHHHhcCCCCeeEEEeEE
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGHKHLVKFCDAC  220 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  220 (422)
                      ++.++|++++.||+|+||.||+|+++.   +|+.||||++.+.....   ....+.+.+|+.+|++|+ |||||+++++|
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~   82 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY   82 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            456789999999999999999999987   88999999997654332   224678999999999997 99999999999


Q ss_pred             EeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC-CCCCEEEeec
Q 014559          221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF  299 (422)
Q Consensus       221 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~-~~~~vkl~Df  299 (422)
                      .+.+.+|||||||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+||
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999999988665 5799999999999999999999999999999999999996421 1236999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      |++.............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+......++...+.
T Consensus       162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (293)
T d1jksa_         162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  241 (293)
T ss_dssp             TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence            99998877777777899999999999874 69999999999999999999999999999999999998887776655556


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      .++.++++||++||+.||++|||++|+|+|+||+...+
T Consensus       242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            79999999999999999999999999999999986544

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-61  Score=447.50  Aligned_cols=260  Identities=31%  Similarity=0.482  Sum_probs=227.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      +.|++++.||+|+||.||+|+++.   +++.||||++.....   ...+.+.+|+++|++|+ |||||++++++.+.+.+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKSE---EELEDYMVEIDILASCD-HPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeE
Confidence            469999999999999999999987   889999999976432   23467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||++|+|.+++.+..+.+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+...
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECH
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccC
Confidence            999999999999998877777899999999999999999999999999999999999995   58899999999997653


Q ss_pred             CC-CCccccccCCcccCccccC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          307 PD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .. ......+||+.|+|||++.      ..|+.++|||||||+||||++|+.||.+....+.+..+......... ....
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~  240 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSR  240 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGG
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-cccc
Confidence            22 2334678999999999873      35899999999999999999999999998888888888876643221 1246


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCccchhhh
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSFK  417 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~k  417 (422)
                      +++++++||++||+.||++|||+.|+|+|+||.....+
T Consensus       241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~  278 (288)
T d2jfla1         241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK  278 (288)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            89999999999999999999999999999999764443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-60  Score=450.56  Aligned_cols=260  Identities=28%  Similarity=0.512  Sum_probs=235.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++++.........+.+.+|+.+|++++ |||||+++++|.+.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccc
Confidence            469999999999999999999987   88999999998766555556788999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+...
T Consensus        81 ~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred             ccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccc
Confidence            9999999999999987654 579999999999999999999999999999999999999   458999999999998654


Q ss_pred             C-CCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHH
Q 014559          307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA  384 (422)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  384 (422)
                      . .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+......++.    .+++++
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  232 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEA  232 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHH
Confidence            3 44556789999999999987 47999999999999999999999999999999999999988877664    799999


Q ss_pred             HHHHHHhchhccccCCC-----HHHHHhccCccchhhhh
Q 014559          385 KDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKI  418 (422)
Q Consensus       385 ~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~  418 (422)
                      ++||++||++||.+|++     +.|+++|+||..+.|.-
T Consensus       233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~  271 (337)
T d1o6la_         233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence            99999999999999994     99999999998776543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-59  Score=437.06  Aligned_cols=261  Identities=34%  Similarity=0.586  Sum_probs=235.0

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc------hhcHHHHHHHHHHHHHhcCCCCeeEEEe
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT------AISIEDVRREVKILKALSGHKHLVKFCD  218 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~l~~  218 (422)
                      |.++|++.+.||+|+||+||+|+++.   +++.||||++.+.....      ....+.+.+|+.++++|+.|||||++++
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~   77 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   77 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence            45789999999999999999999887   78999999998754322      1233568899999999977999999999


Q ss_pred             EEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       219 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                      ++.+++.+|||||||++|+|.+++..+ +.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~D  153 (277)
T d1phka_          78 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTD  153 (277)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred             ecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEcc
Confidence            999999999999999999999998665 5799999999999999999999999999999999999994   689999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ||+++...........+||..|+|||++.       ..++.++||||+||+||||++|+.||.+.........+......
T Consensus       154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~  233 (277)
T d1phka_         154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  233 (277)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999887766677789999999999874       24788999999999999999999999999999999999988777


Q ss_pred             CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       372 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ++...+.++|+++++||.+||+.||++||+++|+|+|+||+
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence            66666678999999999999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=435.30  Aligned_cols=253  Identities=22%  Similarity=0.356  Sum_probs=215.8

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----CC
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VN  224 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~  224 (422)
                      |++.++||+|+||+||+|+++.   +++.||+|++...... ....+.+.+|+++|++|+ |||||+++++|.+    ..
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence            5788899999999999999987   7889999999765433 334577899999999997 9999999999876    35


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      .+|||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+|||++  ++++.+||+|||++
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence            689999999999999988654 57999999999999999999999998  99999999999995  34788999999999


Q ss_pred             cccCCCCCccccccCCcccCccccCccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHcCCCCCCCCCCCCCC
Q 014559          303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      +... .......+||+.|+|||++.+.|+.++|||||||++|||++|+.||.+.... .+.+.+.......  .....++
T Consensus       163 ~~~~-~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~  239 (270)
T d1t4ha_         163 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAI  239 (270)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCC
T ss_pred             eecc-CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccCC
Confidence            7644 3345567899999999999989999999999999999999999999765544 4444444432211  1223588


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +++++||.+||..||++|||+.|+|+|+||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-60  Score=445.88  Aligned_cols=256  Identities=24%  Similarity=0.375  Sum_probs=224.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      +....|++++.||+|+||.||+|+++.   +++.||||++...........+.+.+|+++|++|+ |||||++++++.+.
T Consensus        12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~   87 (309)
T d1u5ra_          12 DPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLRE   87 (309)
T ss_dssp             CHHHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEET
T ss_pred             CcHHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEEC
Confidence            344569999999999999999999987   78999999998766555556678999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||.+|+|..++ ...+.+++.+++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+++
T Consensus        88 ~~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          88 HTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSAS  163 (309)
T ss_dssp             TEEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCB
T ss_pred             CEEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeeccccc
Confidence            9999999999998776544 4556799999999999999999999999999999999999995   48899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      ....   ....+||+.|+|||++.    +.|+.++|||||||++|||++|+.||.+......+..+........  ....
T Consensus       164 ~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~  238 (309)
T d1u5ra_         164 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGH  238 (309)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTT
T ss_pred             ccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCC
Confidence            6543   34568999999999974    3589999999999999999999999998888887777776554332  2346


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      +++++++||.+||+.||.+|||+.|+|+|+|+.
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence            899999999999999999999999999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=451.89  Aligned_cols=260  Identities=27%  Similarity=0.525  Sum_probs=235.4

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++++.||+|+||+||+|+++.   +++.||||+++....    ....+.+|+++|+.++ |||||+++++|.+.
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~   73 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGT----DQVLVKKEISILNIAR-HRNILHLHESFESM   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence            345689999999999999999999987   789999999976432    2356889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||+||+|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++. ++...+||+|||+++
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhh
Confidence            9999999999999999988766668999999999999999999999999999999999999964 345689999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+....+.+..|......++...+..+++
T Consensus       153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence            877666667778999999999876 4689999999999999999999999999999999999999888777666678999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ++++||++||..||++|||+.|+|+|+||.
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            999999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-60  Score=437.07  Aligned_cols=254  Identities=29%  Similarity=0.480  Sum_probs=211.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe--CC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~  224 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++...... ....+.+.+|+++|++++ |||||++++++.+  ++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCC
Confidence            479999999999999999999987   8899999999876543 334577899999999997 9999999999965  45


Q ss_pred             eEEEEEEccCCCChHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEEeeCCCCCCEEE
Q 014559          225 NVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRL  296 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~-----iiH~Dikp~NIll~~~~~~~~vkl  296 (422)
                      .+|||||||++|+|.+++.+   ....+++..++.++.||+.||.|||++|     ||||||||+|||++   .++.+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl  155 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKL  155 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEE
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEE
Confidence            69999999999999998864   3567999999999999999999999976     99999999999994   5889999


Q ss_pred             eecCcccccCCCC-CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          297 IDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       297 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      +|||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....++...+........ 
T Consensus       156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~-  234 (269)
T d2java1         156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-  234 (269)
T ss_dssp             CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-
T ss_pred             eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            9999998765443 3456789999999999864 799999999999999999999999999888888888877654321 


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCc
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVV  411 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~  411 (422)
                        ...+++++++||++||+.||++|||+.|+|+|+|+
T Consensus       235 --~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 --PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence              23689999999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-59  Score=442.37  Aligned_cols=259  Identities=22%  Similarity=0.517  Sum_probs=233.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||+||+|+++.   +|+.||||++.+.........+.+.+|+.+|++++ |||||++++++.+.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   79 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI   79 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence            469999999999999999999987   88999999998765555556788999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |+|||||+||+|.+.+. ....+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+...
T Consensus        80 ~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          80 FMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             EEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred             eeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEec
Confidence            99999999999888665 446789999999999999999999999999999999999994   58899999999998764


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .  ...+.+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+....+.+..+......++.    .++++++
T Consensus       156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  229 (316)
T d1fota_         156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVK  229 (316)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHH
Confidence            3  3456789999999999875 6999999999999999999999999999999999999988776654    6899999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKIV  419 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~~  419 (422)
                      ++|.+||.+||.+|+     +++|+|+|+||+.+.|..+
T Consensus       230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             HHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence            999999999999996     9999999999998876643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-58  Score=444.96  Aligned_cols=258  Identities=28%  Similarity=0.502  Sum_probs=233.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++.+.........+.+.+|+++|+.++ |||||++++++.+.+.+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence            479999999999999999999987   88999999998765555556678999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+.+|+|.+.+... +.+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+...
T Consensus       117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred             ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeecc
Confidence            9999999999999988665 5799999999999999999999999999999999999994   58899999999998765


Q ss_pred             CCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 014559          307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK  385 (422)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  385 (422)
                      .  .....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+.....++..+......++.    .+++++.
T Consensus       193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  266 (350)
T d1rdqe_         193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK  266 (350)
T ss_dssp             S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHH
T ss_pred             c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHH
Confidence            3  3456789999999999875 6999999999999999999999999999888999999888776654    7999999


Q ss_pred             HHHHHhchhccccCC-----CHHHHHhccCccchhhhh
Q 014559          386 DFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFKI  418 (422)
Q Consensus       386 ~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k~  418 (422)
                      +||++||.+||.+|+     +++|+|+|+||+...|..
T Consensus       267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~  304 (350)
T d1rdqe_         267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHH
Confidence            999999999999995     999999999998877653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=443.71  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=214.6

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ..++|+++++||+|+||+||+|+++.   +|+.||||+++...  .....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            34689999999999999999999987   88999999997642  2334577899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||+|+
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~  153 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred             EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCcc
Confidence            999999999999999988654 579999999999999999999997 5999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH-------------------
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFR-------------------  363 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~-------------------  363 (422)
                      .... ....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+........                   
T Consensus       154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6543 33456799999999999864 79999999999999999999999997654432111                   


Q ss_pred             -----------------------HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          364 -----------------------AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       364 -----------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                             .+....  .+......++.++++||.+||..||++|||++|+|+|+||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                                   011100  11111224689999999999999999999999999999997544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-58  Score=436.55  Aligned_cols=259  Identities=27%  Similarity=0.476  Sum_probs=229.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHH-HhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK-ALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~niv~l~~~~~~~~~  225 (422)
                      ++|++++.||+|+||+||+|+++.   +++.||||++++.........+.+.+|+.++. .++ |||||++++++.+++.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~   77 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKEN   77 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCc
Confidence            469999999999999999999987   88999999998765444455677778888776 465 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||++|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        78 ~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCC
T ss_pred             eeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhc
Confidence            99999999999999987654 5799999999999999999999999999999999999994   5899999999999865


Q ss_pred             CCC-CCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHH
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE  383 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  383 (422)
                      ... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+...++..+....+.++.    .++++
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~  229 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE  229 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred             ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHH
Confidence            533 33455789999999999874 7999999999999999999999999999999999999888776654    68999


Q ss_pred             HHHHHHHhchhccccCCCHH-HHHhccCccchhhh
Q 014559          384 AKDFVKRLLNKDYRKRMTAV-QALSKLVVPILSFK  417 (422)
Q Consensus       384 ~~~li~~~L~~dP~~Rps~~-elL~~l~~~~l~~k  417 (422)
                      +++||++||++||.+||++. |+++|+||+.+.|.
T Consensus       230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence            99999999999999999996 89999999887654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-59  Score=442.98  Aligned_cols=257  Identities=33%  Similarity=0.568  Sum_probs=218.1

Q ss_pred             cccceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-
Q 014559          145 FGAKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-  222 (422)
Q Consensus       145 ~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  222 (422)
                      +-++|++.+ .||+|+||.||+|+++.   +++.||||+++..        ..+.+|+.++.++.+|||||+++++|.+ 
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            345799875 59999999999999987   8899999998643        4577899998776569999999999976 


Q ss_pred             ---CCeEEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                         +..+|||||||+||+|.+++..+. ..+++.+++.|+.||+.||+|||++||+||||||+|||++..++.+.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               467999999999999999987653 4699999999999999999999999999999999999997655577899999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH----HcCCCCCC
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV----LRSDPNFD  373 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~~~  373 (422)
                      ||+++...........+||+.|+|||++.+ .|+.++|||||||+||+|++|+.||.+.........+    ......++
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            999998877777778899999999999875 6999999999999999999999999876655444333    23333444


Q ss_pred             CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       374 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                      ...+..+++++++||++||++||++|||+.|+|+|+||.
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            444456899999999999999999999999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-57  Score=438.05  Aligned_cols=263  Identities=24%  Similarity=0.386  Sum_probs=218.5

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHH---HHHHHHhcCCCCeeEEEeEEEeC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE---VKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||++.+...........+.+|   +.+++.+. |||||+++++|.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTP   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECS
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEEC
Confidence            469999999999999999999987   889999999986554444444445555   55555554 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      +.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~  155 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLAC  155 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCE
T ss_pred             CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceee
Confidence            9999999999999999988654 5799999999999999999999999999999999999994   58899999999998


Q ss_pred             ccCCCCCccccccCCcccCccccC-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ..... .....+||+.|+|||++. + .|+.++|||||||+||||++|+.||.+............. .......+..++
T Consensus       156 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s  233 (364)
T d1omwa3         156 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFS  233 (364)
T ss_dssp             ECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-SSCCCCCCSSSC
T ss_pred             ecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCCCC
Confidence            76543 445678999999999985 3 5899999999999999999999999876544333222211 111112223799


Q ss_pred             HHHHHHHHHhchhccccCCC-----HHHHHhccCccchhhhhh
Q 014559          382 PEAKDFVKRLLNKDYRKRMT-----AVQALSKLVVPILSFKIV  419 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps-----~~elL~~l~~~~l~~k~~  419 (422)
                      +++++||.+||.+||.+|++     ++|+++|+||+.+.|..+
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~  276 (364)
T d1omwa3         234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  276 (364)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence            99999999999999999999     899999999998876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-56  Score=417.95  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=217.5

Q ss_pred             ccccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       144 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .+.++|++.+.||+|+||.||+|++..   +|+.||||++++.........+.+.+|+++++.++ |||||++++++.+.
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~   79 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE   79 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence            345789999999999999999999987   88999999998766655556678999999999997 99999999999875


Q ss_pred             C----eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          224 N----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       224 ~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                      +    .+|||||||+|++|.+.+... +.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.++|+||
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~  155 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDF  155 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCC
T ss_pred             cCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehh
Confidence            4    489999999999999877554 5799999999999999999999999999999999999996   4889999999


Q ss_pred             CcccccCCCC----CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC
Q 014559          300 GLSDFIRPDE----RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD  374 (422)
Q Consensus       300 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  374 (422)
                      |++.......    .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  235 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence            9987543322    3445689999999999875 6999999999999999999999999998888888888888777666


Q ss_pred             CCCCCCCHHHHHHHHHhchhccccCC-CHHHHHhc
Q 014559          375 LPWPSVSPEAKDFVKRLLNKDYRKRM-TAVQALSK  408 (422)
Q Consensus       375 ~~~~~~s~~~~~li~~~L~~dP~~Rp-s~~elL~~  408 (422)
                      ..+..+++++.+||.+||++||.+|| +++++++.
T Consensus       236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~  270 (277)
T d1o6ya_         236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD  270 (277)
T ss_dssp             GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence            66678999999999999999999999 66666543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=421.26  Aligned_cols=261  Identities=28%  Similarity=0.424  Sum_probs=217.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.   +|+.||||+++..... ....+.+.+|+++|++++ |||||++++++.+.+.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence            479999999999999999999987   8899999999765432 233467889999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |||||||.+ .+.+.+.. ....+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+..
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHH
T ss_pred             eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceec
Confidence            999999976 55555544 456799999999999999999999999999999999999994   5889999999999876


Q ss_pred             CCC-CCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC------
Q 014559          306 RPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP------  376 (422)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  376 (422)
                      ... .......||+.|+|||++..  .++.++|||||||++|+|++|+.||.+....+.+..+........+..      
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            543 34556689999999998653  468999999999999999999999998887777666654222111111      


Q ss_pred             -------------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          377 -------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       377 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                         ...++.++++||++||..||++|||+.|+|+|+||+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                               2356889999999999999999999999999999987654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-57  Score=418.01  Aligned_cols=252  Identities=28%  Similarity=0.467  Sum_probs=212.8

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchh---cHHHHHHHHHHHHHhc-CCCCeeEEEeEEE
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI---SIEDVRREVKILKALS-GHKHLVKFCDACE  221 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~l~~~~~  221 (422)
                      .++|++++.||+|+||.||+|+++.   +|+.||||++.+.......   ...++.+|+.+|++++ +|||||++++++.
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            4689999999999999999999987   7899999999865433221   1234668999999996 4899999999999


Q ss_pred             eCCeEEEEEEccCC-CChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          222 DVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       222 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                      +.+.+|+||||+.+ +++.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.  +++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG  156 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFG  156 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCT
T ss_pred             eCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccc
Confidence            99999999999986 466666544 457999999999999999999999999999999999999963  45789999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCC
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP  378 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  378 (422)
                      +++... .....+.+||+.|+|||++.+  .++.++|||||||++|||++|+.||...      ..+......++.    
T Consensus       157 ~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~----  225 (273)
T d1xwsa_         157 SGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----  225 (273)
T ss_dssp             TCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSS----
T ss_pred             cceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCC----
Confidence            997654 344566789999999999863  3577899999999999999999999652      234444444443    


Q ss_pred             CCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          379 SVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       379 ~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                      .+|+++++||++||..||++|||++|+|+|+||+.+
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            699999999999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-57  Score=424.34  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=211.3

Q ss_pred             EeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccch--hcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEE
Q 014559          151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI  228 (422)
Q Consensus       151 ~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  228 (422)
                      .+++||+|+||+||+|+++.   +|+.||||+++.......  ...+.+.+|+.+|++++ |||||++++++.+++.+||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEE
T ss_pred             cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceee
Confidence            46789999999999999987   889999999976443221  12346889999999997 9999999999999999999


Q ss_pred             EEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCC
Q 014559          229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD  308 (422)
Q Consensus       229 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~  308 (422)
                      |||||.++++. .+......+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        78 vmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          78 VFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             EEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSC
T ss_pred             hhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCC
Confidence            99999886544 4445567799999999999999999999999999999999999994   5899999999999866543


Q ss_pred             -CCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCC---------
Q 014559          309 -ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP---------  376 (422)
Q Consensus       309 -~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  376 (422)
                       ......+||+.|+|||++.  ..|+.++|||||||++|||++|..||.+....+.+..+.+.........         
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             3345678999999999875  3589999999999999999999999999888888877764321111100         


Q ss_pred             ---------------CCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          377 ---------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       377 ---------------~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                     ...+++++++||++||+.||++|||+.|+|+|+||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                           13568999999999999999999999999999999753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=417.33  Aligned_cols=251  Identities=22%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+.+.      .||||+++..... ....+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~------~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS------EEEEEECCCSSCC-TTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC------EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEE
Confidence            479999999999999999997542      4999999765433 335678999999999997 9999999998754 568


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||||++|+|.+++......+++..+..++.||+.||+|||++|||||||||+||||+   .++.+||+|||+|+...
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC--
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeecc
Confidence            999999999999999877777899999999999999999999999999999999999995   58899999999998764


Q ss_pred             CCC---CccccccCCcccCccccC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCC--CCC
Q 014559          307 PDE---RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--LPW  377 (422)
Q Consensus       307 ~~~---~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~  377 (422)
                      ...   ......||+.|+|||++.    +.|+.++|||||||+||||++|+.||.+......+..+.......+.  ...
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            322   335568999999999985    24899999999999999999999999887665555444443322221  123


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+++++.+||.+||..||++|||+.|+++++
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            47899999999999999999999999999885

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=412.35  Aligned_cols=247  Identities=23%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++    +++.||||++.....    ..+++.+|++++++++ |||||++++++.+.+.+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence            46999999999999999999976    456799999975432    3367899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      +||||||++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++...
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC------
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheecc
Confidence            999999999999999887777899999999999999999999999999999999999994   58899999999998765


Q ss_pred             CCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ....  .....||..|+|||++. +.|+.++|||||||++|||++ |..||.......++..+........   ...+++
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~  229 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST  229 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred             CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence            4332  23467899999999987 579999999999999999999 5666777777777777776543222   136789


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ++.+||.+||+.||++|||++|+|++
T Consensus       230 ~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         230 HVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-56  Score=419.58  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      .++|++.+.||+|+||.||+|+++........||||++....  .....+.+.+|+++|++|+ |||||++++++.+.+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence            357999999999999999999987632233468999886432  2334567999999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||++|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCcccceEc
Confidence            9999999999999998877677899999999999999999999999999999999999994   5889999999999876


Q ss_pred             CCCCCc------cccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          306 RPDERL------NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       306 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      ......      ....||+.|+|||++. +.|+.++|||||||+||||++ |+.||.+....+++..+.......   ..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---PP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            543322      2245789999999976 579999999999999999998 899999988888888777653221   12


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+++++.+||.+||+.||++|||+.|+++.+
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L  287 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL  287 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            37899999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-56  Score=416.48  Aligned_cols=249  Identities=20%  Similarity=0.343  Sum_probs=210.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++.+.||+|+||.||+|+++.   +++.||||+++.+..    ..+++.+|+++|++|+ |||||+++++|.+.+.+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCee
Confidence            479999999999999999999987   788999999875432    3467999999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |||||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+   .++.+||+|||+++..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeec
Confidence            9999999999999988764 45789999999999999999999999999999999999995   5889999999999876


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      .....  .....|++.|+|||++. +.|+.++|||||||++|||++|..||........+..++......+.  ...+++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~--~~~~~~  243 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--PEGCPE  243 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC--CTTCCH
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC--CccchH
Confidence            54432  23346889999999876 67999999999999999999977776554444433334333322221  237899


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ++.+||.+||+.||++|||+.|+++.
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~~  269 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQA  269 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=406.79  Aligned_cols=248  Identities=24%  Similarity=0.382  Sum_probs=218.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|+++++||+|+||.||+|+++    +++.||||++++...    ..+.+.+|+.++++++ |||||++++++.+++.+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~   74 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI   74 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence            36889999999999999999975    567899999986543    2367899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++||||+++|+|.+++......+++..+++++.|++.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCS
T ss_pred             EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheecc
Confidence            999999999999998887777899999999999999999999999999999999999994   58899999999998665


Q ss_pred             CCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ....  .....||..|+|||++. +.|+.++|||||||++|||+| |+.||.+....++...+........   ...+++
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~  228 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASE  228 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccH
Confidence            4433  23357899999999986 579999999999999999998 8999999998888888877543222   236889


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.+||.+||+.||++|||+.|+|+++
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~L  255 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSNI  255 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence            999999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=419.18  Aligned_cols=264  Identities=27%  Similarity=0.370  Sum_probs=218.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc--CCCCeeEEEeEEEe-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACED-  222 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~-  222 (422)
                      .++|+++++||+|+||+||+|++...  +++.||||+++....... ....+.+|+.+|+.|+  +||||++++++|.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            35899999999999999999998651  467899999976443222 2234667888887773  49999999999863 


Q ss_pred             ----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 ----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                          ...++++||||.++.+..........+++..++.++.|++.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecc
Confidence                3478999999998766555445567799999999999999999999999999999999999994   588999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----  373 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  373 (422)
                      ||+++...........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+........    
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            99998776666667789999999999876 5799999999999999999999999999888887777654211100    


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          374 -------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       374 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                         ......+++++++||++||++||++|||+.|+|+|+||+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                               001235789999999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=421.51  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC--ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++++.||+|+||.||+|+++...  .....||||.+.....  ......+.+|+.+|.++.+|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            57999999999999999999987522  1234799999865432  2234678899999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 014559          225 NVYIVMELCEGGELLDRILARG----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN  282 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~N  282 (422)
                      .+|||||||++|+|.+++..+.                      ..+++..++.|+.||+.||.|||++|||||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999999999999986543                      348899999999999999999999999999999999


Q ss_pred             EEEeeCCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014559          283 FLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART  357 (422)
Q Consensus       283 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  357 (422)
                      ||++   .++.+||+|||+|+.......   ..+..||+.|+|||++. +.|+.++|||||||+||||++ |+.||.+..
T Consensus       195 ill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9995   588999999999986654332   23456899999999876 679999999999999999997 899998877


Q ss_pred             hhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ....+..++.....++.  ...+++++++||.+||+.||++|||++|++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  321 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  321 (325)
T ss_dssp             CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            66666666665443332  236899999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=408.37  Aligned_cols=251  Identities=21%  Similarity=0.377  Sum_probs=211.5

Q ss_pred             cceEEec-eeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ++|.+.+ +||+|+||.||+|.++... ++..||||+++...  .....+++.+|+++|++|+ |||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence            4678887 4999999999999875422 45689999997542  3334578999999999997 9999999999875 46


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +|||||||++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~---~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN---RHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc---CCceeeccchhhhcc
Confidence            89999999999999987666678999999999999999999999999999999999999964   889999999999876


Q ss_pred             CCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....    .....||+.|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..+....   ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence            54332    23456899999999986 579999999999999999998 999999888888877777654321   1237


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      +++++.+||.+||+.||++||++.++++.
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~  265 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQR  265 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999998543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=406.23  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             ceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEEEEEEc
Q 014559          153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL  232 (422)
Q Consensus       153 ~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  232 (422)
                      ++||+|+||.||+|.++... .++.||||+++.... .....+.+.+|+++|++|+ |||||+++++|.+ +..+|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence            47999999999999875432 567899999975432 3334577999999999997 9999999999965 457899999


Q ss_pred             cCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCCCCC--
Q 014559          233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER--  310 (422)
Q Consensus       233 ~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~--  310 (422)
                      |++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++.......  
T Consensus        89 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~---~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          89 AELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             CTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc---cCcccccchhhhhhcccccccc
Confidence            999999997754 467999999999999999999999999999999999999964   88999999999987654332  


Q ss_pred             --ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 014559          311 --LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD  386 (422)
Q Consensus       311 --~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  386 (422)
                        .....||+.|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..+.....   ...+++++.+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~  241 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYD  241 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHH
Confidence              23357899999999886 578999999999999999997 8999998888888777776542211   1368999999


Q ss_pred             HHHHhchhccccCCCHHHHH---hccCccchhh
Q 014559          387 FVKRLLNKDYRKRMTAVQAL---SKLVVPILSF  416 (422)
Q Consensus       387 li~~~L~~dP~~Rps~~elL---~~l~~~~l~~  416 (422)
                      ||.+||+.||++|||+.+++   ++.|++.+.+
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e  274 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  274 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence            99999999999999999984   5666655543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=404.27  Aligned_cols=253  Identities=24%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|++......+..||||.++..  ......+.+.+|+.+|++++ |||||++++++. ++.+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCeE
Confidence            5799999999999999999998764445667899988543  23344577999999999997 999999999996 4678


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      |||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~---~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECC--------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC---CCcEEEccchhheecc
Confidence            9999999999999988877788999999999999999999999999999999999999964   7899999999998765


Q ss_pred             CCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCCCH
Q 014559          307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP  382 (422)
Q Consensus       307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  382 (422)
                      ...  ......||+.|+|||++. +.|+.++|||||||++|||++ |..||......+++..+......   ..++++++
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  236 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPP  236 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            332  234456899999999986 579999999999999999998 89999998888888888775432   12347999


Q ss_pred             HHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          383 EAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       383 ~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.+||.+||+.||++|||+.|+++++
T Consensus       237 ~~~~li~~cl~~dp~~Rps~~ei~~~L  263 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRPRFTELKAQL  263 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            999999999999999999999999884

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-55  Score=403.92  Aligned_cols=245  Identities=23%  Similarity=0.379  Sum_probs=206.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++    +++.||||+++....    ..+.+.+|++++++++ |||||++++++.+ +.+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCe
Confidence            57999999999999999999975    456899999975432    3467999999999997 9999999998755 567


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      |||||||++|+|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+||||+   +++.+||+|||+|+..
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEc
Confidence            9999999999999876543 23599999999999999999999999999999999999994   6899999999999876


Q ss_pred             CCCC--CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS-RPFWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      ....  ......||+.|+|||++. +.|+.++|||||||+||||+||. .||......+.+..+........   ...++
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~  236 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP  236 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccCh
Confidence            5443  234467899999999986 57999999999999999999954 55566666667777665432221   13689


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHh
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALS  407 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~  407 (422)
                      +++.+||.+||+.||++|||+.|+++
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~  262 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRS  262 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-54  Score=406.15  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=213.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|+++++||+|+||+||+|+++    +|+.||||++...... ....+.+.+|+.+|++++ |||||++++++.+.+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence            47999999999999999999985    6789999999765432 334578899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++|||++.+ .++..+....+.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++....
T Consensus        76 ~i~~e~~~~-~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG  151 (286)
T ss_dssp             EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred             eEEEEeehh-hhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEecccccceecc
Confidence            999999976 55555666678899999999999999999999999999999999999994   58999999999998765


Q ss_pred             CCC-CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCCCC--------
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL--------  375 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------  375 (422)
                      ... ......|++.|+|||++.  ..++.++|||||||++|||++|+.||.+....+.+..+..........        
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence            332 345567999999999875  357999999999999999999999999888777766664321111100        


Q ss_pred             -----------------CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCcc
Q 014559          376 -----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVP  412 (422)
Q Consensus       376 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~  412 (422)
                                       ....++++++|||++||.+||++|||+.|+|+|+||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                             1235789999999999999999999999999999996

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=402.66  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=208.6

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      .+|++.+.||+|+||.||+|+..........||||++.+.........+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence            46999999999999999999876533344579999998766555556678999999999997 9999999999976 467


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++|||||++|++.+.+..+.+.+++..+..++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence            8999999999999988887778999999999999999999999999999999999999965   7889999999998765


Q ss_pred             CCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCCCCC
Q 014559          307 PDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       307 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ....    .....|+..|+|||++. ..++.++|||||||++|||++ |+.||.+....+.+..+......++.  ...+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence            4432    23346788999999986 468999999999999999998 89999999999998888876654433  2478


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHh
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALS  407 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~  407 (422)
                      ++++++||.+||..||++|||+.|+++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=414.15  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=213.4

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC----
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----  223 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  223 (422)
                      +|+.+++||+|+||+||+|+++.   +|+.||||++......       ..+|+++|++|+ |+|||+++++|...    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccC
Confidence            69999999999999999999987   8899999999765322       247999999997 99999999998643    


Q ss_pred             --CeEEEEEEccCCCChHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          224 --NNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       224 --~~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                        .++|||||||+++ +.+.+.   .....+++.+++.++.||+.||+|||++||+||||||+|||++.  +...+||+|
T Consensus        90 ~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~D  166 (350)
T d1q5ka_          90 DEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD  166 (350)
T ss_dssp             SCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECC
T ss_pred             CceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEec
Confidence              3589999999765 444333   34567999999999999999999999999999999999999952  345899999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC-------
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-------  369 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------  369 (422)
                      ||+++.........+.+||..|+|||++.  ..|+.++|||||||++|||++|+.||......+.+..+.+..       
T Consensus       167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            99998887777777789999999999865  368999999999999999999999998888777766664311       


Q ss_pred             ----------CCCC--------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          370 ----------PNFD--------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       370 ----------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                                ..++        ......+++++.+||.+||.+||++|||+.|+|+|+||+.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                      0111        1113457899999999999999999999999999999987643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-54  Score=410.79  Aligned_cols=256  Identities=28%  Similarity=0.519  Sum_probs=213.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC--
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  223 (422)
                      .++|+++++||+|+||+||+|+++.   +|+.||||+++...      .+++.+|+++|+.+++||||++++++|...  
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            3579999999999999999999987   88999999986532      367889999999997799999999999854  


Q ss_pred             CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccc
Q 014559          224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD  303 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~  303 (422)
                      ..+++|||||.+++|...    ...+++..++.++.||+.||.|||++||+||||||+|||++.  +++.+||+|||+|+
T Consensus       105 ~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~  178 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAE  178 (328)
T ss_dssp             CSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCE
T ss_pred             CceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccce
Confidence            569999999999998664    346999999999999999999999999999999999999963  34569999999999


Q ss_pred             ccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHc-------------
Q 014559          304 FIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLR-------------  367 (422)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~-------------  367 (422)
                      ...........+||..|+|||++.+  .++.++|||||||++|||++|+.||...... .....+..             
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            8877777778899999999998753  5899999999999999999999999765432 22221111             


Q ss_pred             CCCC--------------------CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchhh
Q 014559          368 SDPN--------------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILSF  416 (422)
Q Consensus       368 ~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~~  416 (422)
                      ....                    +....+..++++++|||++||.+||++|+|++|+|+|+||+.+.|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0000                    001112247899999999999999999999999999999987653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=398.93  Aligned_cols=254  Identities=19%  Similarity=0.312  Sum_probs=204.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC-ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      +.|++.+.||+|+||.||+|.++... .....||||++....  .......+.+|++++++|+ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            46999999999999999999987522 123579999986543  2234467889999999997 9999999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++|||||.++++.+.+......+++.++..++.||+.||.|||+++|+||||||+||||+   .++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccchhhcc
Confidence            9999999999999998887778899999999999999999999999999999999999994   5899999999999876


Q ss_pred             CCCCC----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHcCCCCCCCCCCCC
Q 014559          306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPS  379 (422)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~  379 (422)
                      .....    .....||+.|+|||++. +.++.++|||||||+||||++|..| |......+++..+...... +.  ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~--~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-PT--PMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CC--CTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-CC--chh
Confidence            44322    23356899999999886 5799999999999999999996555 5555666666666554321 11  236


Q ss_pred             CCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          380 VSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       380 ~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++.++.+||.+||..||++||++.|+++.+
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L  267 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVSIL  267 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence            899999999999999999999999998753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=404.01  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=210.7

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----  222 (422)
                      ++|+++++||+|+||+||+|+++.   +|+.||||++....... .....+.+|+++|+.++ |+||+++++++..    
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~   84 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKASP   84 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred             CCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeccccc
Confidence            589999999999999999999987   88999999997654432 34467889999999997 9999999998865    


Q ss_pred             ----CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          223 ----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       223 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                          .+.+|+|||||.++ +...+......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        85 ~~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~d  160 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLAD  160 (318)
T ss_dssp             ------CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred             ccccCceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeee
Confidence                34689999999765 4444555567899999999999999999999999999999999999995   588999999


Q ss_pred             cCcccccCCCC-----CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC
Q 014559          299 FGLSDFIRPDE-----RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN  371 (422)
Q Consensus       299 fG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  371 (422)
                      ||+++......     .....+||+.|+|||++.  ..|+.++|||||||++|||++|+.||.+.........+......
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99997654322     234467999999999875  36899999999999999999999999988887776666553333


Q ss_pred             CCCCCCCC----------------------------CCHHHHHHHHHhchhccccCCCHHHHHhccCccc
Q 014559          372 FDDLPWPS----------------------------VSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPI  413 (422)
Q Consensus       372 ~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~  413 (422)
                      +....+..                            .+++++|||.+||.+||++|+|++|+|+|+||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            22221111                            2678899999999999999999999999999973

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-54  Score=407.65  Aligned_cols=263  Identities=30%  Similarity=0.509  Sum_probs=220.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeeccccc-chhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  225 (422)
                      ++|++++.||+|+||.||+|++..+..+|+.||||++.+.... .....+.+.+|+++|++++.|+||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5799999999999999999998765558899999999765432 222345678999999999845899999999999999


Q ss_pred             EEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      +++||||+.+|+|.+++... +.+.+..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhhh
Confidence            99999999999999987655 4688999999999999999999999999999999999994   5889999999999865


Q ss_pred             CCC--CCccccccCCcccCccccCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH----cCCCCCCCCC
Q 014559          306 RPD--ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL----RSDPNFDDLP  376 (422)
Q Consensus       306 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~  376 (422)
                      ...  .......|++.|++||.+.+   .++.++|||||||+||||++|+.||.+.........+.    .....++   
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---  256 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---  256 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---
Confidence            433  23455789999999998753   47889999999999999999999997765544433333    3333333   


Q ss_pred             CCCCCHHHHHHHHHhchhccccCC-----CHHHHHhccCccchhhh
Q 014559          377 WPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALSKLVVPILSFK  417 (422)
Q Consensus       377 ~~~~s~~~~~li~~~L~~dP~~Rp-----s~~elL~~l~~~~l~~k  417 (422)
                       ..+++++++||++||++||++|+     +++|+|+|+||+.+.|.
T Consensus       257 -~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         257 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             -ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence             36999999999999999999999     58999999999876654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=401.74  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=208.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCc----eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      .+|++++.||+|+||.||+|++..   +|+    .||||.+...  ......+.+.+|++++++|+ |||||+++++|.+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~---~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcC---CCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence            369999999999999999999875   443    6888887643  22334578999999999997 9999999999987


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcc
Q 014559          223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS  302 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a  302 (422)
                      + ..+++||++.+|+|.+.+......+++..++.++.||+.||.|||++|||||||||+||||+.   ++.+||+|||++
T Consensus        83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~---~~~~kl~DFGla  158 (317)
T d1xkka_          83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA  158 (317)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCCSHH
T ss_pred             C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC---CCCeEeeccccc
Confidence            5 567888999999999998888888999999999999999999999999999999999999964   789999999999


Q ss_pred             cccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCCCCCCCCC
Q 014559          303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW  377 (422)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  377 (422)
                      +.......   .....||+.|+|||++. +.|+.++|||||||+||||+| |..||.+....++...+..+.....   .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p  235 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---P  235 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---C
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            87654332   23356899999999876 579999999999999999998 8999988887777777766542211   1


Q ss_pred             CCCCHHHHHHHHHhchhccccCCCHHHHHhccC
Q 014559          378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLV  410 (422)
Q Consensus       378 ~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~  410 (422)
                      ..+++++.+||.+||..||.+|||+.|+++++.
T Consensus       236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            368999999999999999999999999998853

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=406.94  Aligned_cols=258  Identities=26%  Similarity=0.476  Sum_probs=210.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      +..+|+++++||+|+||+||+|+++.   +|+.||||++++.. ......+.+.+|+++|+.++ |||||+++++|...+
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   90 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence            56789999999999999999999987   88999999997643 23344577899999999997 999999999998654


Q ss_pred             ------eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEee
Q 014559          225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID  298 (422)
Q Consensus       225 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~D  298 (422)
                            .+||||||| +.+|...+..  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~D  164 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD  164 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred             cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccc
Confidence                  579999999 5566665433  4799999999999999999999999999999999999994   689999999


Q ss_pred             cCcccccCCCCCccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC-----
Q 014559          299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-----  371 (422)
Q Consensus       299 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  371 (422)
                      ||+++...  ......+||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+......+..+......     
T Consensus       165 fg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         165 FGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            99998654  3345678999999999875  35799999999999999999999999887776665544332111     


Q ss_pred             ------------------CCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccchh
Q 014559          372 ------------------FDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPILS  415 (422)
Q Consensus       372 ------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l~  415 (422)
                                        ....    ....+++++++||++||..||++|||+.|+|+|+||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                              1111    1236789999999999999999999999999999998654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=395.26  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|++++.||+|+||.||+|+++.    ++.||||++.....    ..+.+.+|+.++++++ |+|||++++++.+ +.+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~   86 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI   86 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCe
Confidence            479999999999999999999864    45799999975432    2367999999999997 9999999999854 568


Q ss_pred             EEEEEccCCCChHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCccccc
Q 014559          227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI  305 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~  305 (422)
                      ++|||||++|+|.+.+... ...+++.++..++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++..
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI  163 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhc
Confidence            9999999999998877643 35699999999999999999999999999999999999994   5789999999999876


Q ss_pred             CCCCC--ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHcCCCCCCCCCCCCCC
Q 014559          306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPSVS  381 (422)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s  381 (422)
                      .....  .....||+.|+|||++. +.++.++|||||||+||||++|..| |......+++..+...... +  ....++
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-~--~~~~~~  240 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPPECP  240 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-C--CCTTSC
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-C--CCcccC
Confidence            43332  33467899999999886 5799999999999999999996555 5555666677666654321 1  223789


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHh--ccCcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALS--KLVVP  412 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~--~l~~~  412 (422)
                      +++++||.+||+.||++||++.++++  +.|+.
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            99999999999999999999999987  44554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=398.51  Aligned_cols=256  Identities=24%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccC--CccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      ++|+++++||+|+||.||+|++...  ..+++.||||++....  .....+.+.+|+.++.++.+|+|||.+++++.+. 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            5799999999999999999997642  2356789999987543  2233467788999998887799999999998765 


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeC
Q 014559          224 NNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG  288 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~  288 (422)
                      +.+++|||||++|+|.+++....               ..+++.++..++.||+.||.|||++|||||||||+||||+  
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~--  168 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--  168 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--
Confidence            56899999999999999986532               3489999999999999999999999999999999999995  


Q ss_pred             CCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHH
Q 014559          289 RDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFR  363 (422)
Q Consensus       289 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~  363 (422)
                       .++.+||+|||+|+......   .....+||+.|+|||++. +.++.++|||||||++|||++| ..||.+......+.
T Consensus       169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             58899999999998654332   234567999999999886 5799999999999999999987 46787665555444


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      .++.....+..  ...+++++++||.+||+.||++|||+.|+++|+
T Consensus       248 ~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L  291 (299)
T d1ywna1         248 RRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  291 (299)
T ss_dssp             HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            44433322221  136899999999999999999999999999984

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=401.03  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=210.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCc--eEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++.+.||+|+||.||+|+++.   ++.  .||||.+...  ......+.+.+|+++|+++.+|||||++++++.+.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            579999999999999999999876   444  5777776533  222344678999999999955999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC
Q 014559          225 NVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR  289 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~  289 (422)
                      .++||||||++|+|.+++...               ...+++..+..++.||+.||.|||+++|+||||||+|||++   
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~---  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---
Confidence            999999999999999988643               35799999999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHc
Q 014559          290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS-RPFWARTESGIFRAVLR  367 (422)
Q Consensus       290 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~  367 (422)
                      .++.+||+|||+++............||..|+|||.+. +.|+.++|||||||++|||++|. .||.+....+++..+..
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            57899999999998766555555667999999999986 57999999999999999999975 57887888888777766


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +.. ++  .+..+++++++||.+||+.||++|||+.|+++++
T Consensus       242 ~~~-~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L  280 (309)
T d1fvra_         242 GYR-LE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  280 (309)
T ss_dssp             TCC-CC--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCC-CC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            432 11  1237899999999999999999999999999873

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-53  Score=404.38  Aligned_cols=258  Identities=27%  Similarity=0.467  Sum_probs=209.1

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++.+|+++++||+|+||+||+|+++.   +|+.||||++.+..  .....+.+.+|+.+|+.|+ ||||+++++++....
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   79 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecc
Confidence            45689999999999999999999887   88999999997543  3334567889999999997 999999999997653


Q ss_pred             -----eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          225 -----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       225 -----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                           .+||+| ++.+|+|.+++...  .+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+||
T Consensus        80 ~~~~~~~~l~~-~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~Df  153 (345)
T d1pmea_          80 IEQMKDVYLVT-HLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDF  153 (345)
T ss_dssp             TTTCCCEEEEE-ECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccccceEEEEE-eecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEccc
Confidence                 355555 45588999988653  699999999999999999999999999999999999994   5889999999


Q ss_pred             CcccccCCCC----CccccccCCcccCccccC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCC--
Q 014559          300 GLSDFIRPDE----RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--  371 (422)
Q Consensus       300 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--  371 (422)
                      |+++......    .....+||+.|+|||++.  ..++.++||||+||++|||++|+.||.+....+...........  
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence            9997654332    235567999999999975  35899999999999999999999999887765554444321110  


Q ss_pred             ---------------------CCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          372 ---------------------FDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       372 ---------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                           ....    .++.++.++++||.+||+.||.+|||+.|+|+|+||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                                 0011    134688999999999999999999999999999998744

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=394.58  Aligned_cols=255  Identities=24%  Similarity=0.419  Sum_probs=211.0

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  222 (422)
                      ++|++++.||+|+||.||+|+.....    .++..||||+++...  .......+.+|+.++.++.+|||||+++++|.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            57999999999999999999875421    234589999997643  233457788999999999669999999999999


Q ss_pred             CCeEEEEEEccCCCChHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      ++.+++|||||++|+|.+++..+.               ..+++.+++.++.||+.||+|||+++||||||||+|||+  
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--  168 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--  168 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence            999999999999999999986542               458999999999999999999999999999999999999  


Q ss_pred             CCCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                       +.++.+||+|||+++......   ......|++.|+|||++. +.|+.++|||||||++|||++ |..||.+.....++
T Consensus       169 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         169 -TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             -CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             -cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence             458899999999998664332   234467899999999876 689999999999999999998 78999888887777


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ..+..+.. ++.  ...+++++.+||.+||+.||.+|||+.|+|+.+
T Consensus       248 ~~i~~~~~-~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         248 KLLKEGHR-MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             HHHHTTCC-CCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCCC-CCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence            76665432 221  236899999999999999999999999999865

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-52  Score=394.59  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=214.4

Q ss_pred             ccceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV  223 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  223 (422)
                      .++|++++.||+|+||.||+|+.+.  +..+++.||||++....  .....+++.+|+++|++++ |+||+++++++.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            3579999999999999999999753  12356789999987543  2334577999999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCChHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 014559          224 NNVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP  280 (422)
Q Consensus       224 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp  280 (422)
                      +.+++||||+.+|+|.+++....                       ..+++..+..|+.||+.||.|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999886432                       2488999999999999999999999999999999


Q ss_pred             CcEEEeeCCCCCCEEEeecCcccccCCCC---CccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCC-CCCCC
Q 014559          281 ENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS-RPFWA  355 (422)
Q Consensus       281 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~-~pf~~  355 (422)
                      +||||+   .++.+||+|||+++......   ...+..|++.|+|||++. ..|+.++|||||||++|||++|. .||.+
T Consensus       169 ~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999995   58899999999998654332   234567899999999886 57999999999999999999985 67888


Q ss_pred             CChhHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ....+++..+.......   ....+++++.+||.+||+.||++|||+.|+++.
T Consensus       246 ~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~  295 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  295 (301)
T ss_dssp             SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            88888888887665321   123789999999999999999999999999764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=389.36  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=215.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeE
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV  226 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  226 (422)
                      ++|+++++||+|+||+||+|+++.   +++.||||+++.... .......+.+|+.+|+.++ |+||+++++++.+...+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence            479999999999999999999987   889999999976543 3345678899999999997 99999999999999999


Q ss_pred             EEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccC
Q 014559          227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR  306 (422)
Q Consensus       227 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~  306 (422)
                      ++|||++.+++|... ....+.+++..++.++.|++.||+|||++||+||||||+|||++   .++.+||+|||.++...
T Consensus        77 ~iv~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          77 TLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEECCSEEHHHHH-HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             eEEeeeccccccccc-cccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhccc
Confidence            999999988776554 45667899999999999999999999999999999999999995   57899999999998765


Q ss_pred             CCC-CccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHcCCCCCC---------
Q 014559          307 PDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFD---------  373 (422)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~---------  373 (422)
                      ... ......++..|+|||++.+  .++.++|||||||++|||++|+.||.. ....+.+..+........         
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            443 3344567889999998763  479999999999999999999998644 444555554432111110         


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          374 ----------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       374 ----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                      ......+++++++||++||+.||++|||++|+|+|+||+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                            01123578999999999999999999999999999999753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-53  Score=387.67  Aligned_cols=243  Identities=22%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-CCe
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNN  225 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~  225 (422)
                      ++|++++.||+|+||.||+|++     +|+.||||+++.+.     ..+.+.+|++++++++ |||||++++++.+ .+.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--C
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-----CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCc
Confidence            4699999999999999999987     35679999996542     3367899999999997 9999999999865 467


Q ss_pred             EEEEEEccCCCChHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       226 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      +||||||+++|+|.+++..+. ..+++..+..++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~  152 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC---
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeeccccccee
Confidence            899999999999999986543 3589999999999999999999999999999999999994   589999999999986


Q ss_pred             cCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcCCC-CCCCCCCCCCC
Q 014559          305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP-NFDDLPWPSVS  381 (422)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s  381 (422)
                      ...  ......++..|+|||++. +.++.++|||||||++|||++ |+.||.......+...+.++.. .++    ..++
T Consensus       153 ~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~  226 (262)
T d1byga_         153 ASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP----DGCP  226 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC----TTCC
T ss_pred             cCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC----ccCC
Confidence            543  234457899999999885 679999999999999999998 7888988888888887765432 222    2688


Q ss_pred             HHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          382 PEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       382 ~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      +++.+||.+||+.||.+|||+.|+++++
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L  254 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQL  254 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            9999999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=390.03  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=213.3

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++++.||+|+||.||+|+++.  +..+++.||||+++....  ......+.+|+.+++.+.+|||||++++++.+.+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            579999999999999999998753  224678999999976432  3345678899999999966999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEee
Q 014559          225 NVYIVMELCEGGELLDRILARG-----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS  287 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~  287 (422)
                      .++||||||++|+|.+++....                 ..+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-  179 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-  179 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence            9999999999999999886532                 2589999999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 014559          288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF  362 (422)
Q Consensus       288 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~  362 (422)
                        .++.+||+|||+++.......   ....+||+.|+|||++. +.++.++|||||||++|||++ |.++|......+.+
T Consensus       180 --~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         180 --HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             --TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             --ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              488999999999987654332   23467899999999886 578999999999999999998 56666666665666


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ..+.........  ...+++++.+||.+||+.||++|||+.|+|+.
T Consensus       258 ~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~  301 (311)
T d1t46a_         258 YKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (311)
T ss_dssp             HHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555544333222  13689999999999999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=398.77  Aligned_cols=256  Identities=27%  Similarity=0.463  Sum_probs=201.1

Q ss_pred             cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe----
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----  222 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----  222 (422)
                      .+|+++++||+|+||+||+|+++.   +|+.||||++.+... ......++.+|+.++++++ |||||+++++|..    
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence            579999999999999999999987   889999999976543 3334567899999999997 9999999999964    


Q ss_pred             --CCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecC
Q 014559          223 --VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG  300 (422)
Q Consensus       223 --~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG  300 (422)
                        ...+|+|||||.+ ++++.+   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        92 ~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df~  164 (355)
T d2b1pa1          92 EEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  164 (355)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCC
T ss_pred             ccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeechh
Confidence              3689999999976 555544   34699999999999999999999999999999999999995   58899999999


Q ss_pred             cccccCCCCCccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCC----------
Q 014559          301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD----------  369 (422)
Q Consensus       301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  369 (422)
                      +++...........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.........+....          
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             C---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            9988777667777889999999999864 79999999999999999999999998877666655543211          


Q ss_pred             ------------CCCCCCCC----------------CCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          370 ------------PNFDDLPW----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       370 ------------~~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                  .......+                ...++++++||++||.+||++||||+|+|+|+||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                        11111100                0135789999999999999999999999999999853

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=386.86  Aligned_cols=252  Identities=20%  Similarity=0.292  Sum_probs=205.1

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEe-CCeEE
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNNVY  227 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~  227 (422)
                      +++.++||+|+||+||+|++..+..+...||||+++..  ......+++.+|+++|++|+ |||||++++++.+ ++.++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence            34467899999999999998764334457999998643  34445678999999999997 9999999999876 46899


Q ss_pred             EEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccccCC
Q 014559          228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP  307 (422)
Q Consensus       228 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~~~~  307 (422)
                      +|||||++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+   ++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccc
Confidence            9999999999999887777778999999999999999999999999999999999999   4688999999999987654


Q ss_pred             CCC-----ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHcCCCCCCCCCCCCC
Q 014559          308 DER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSV  380 (422)
Q Consensus       308 ~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  380 (422)
                      ...     .....||..|+|||++. +.++.++|||||||++|||++|..||.... .......+..+.... .  ...+
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~--p~~~  259 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-Q--PEYC  259 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-C--CTTC
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-C--cccC
Confidence            322     22356899999999876 679999999999999999999888876543 334445555443221 1  1368


Q ss_pred             CHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          381 SPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       381 s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                      ++++.+||.+||..||++||++.|+++++
T Consensus       260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L  288 (311)
T d1r0pa_         260 PDPLYEVMLKCWHPKAEMRPSFSELVSRI  288 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            89999999999999999999999999883

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=399.07  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=211.3

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeC-
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-  223 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  223 (422)
                      +.++|+++++||+|+||+||+|+++.   +|+.||||++.+... .....+.+.+|+++|++|+ |+|||++++++... 
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR   90 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence            34689999999999999999999987   889999999976533 3334467889999999997 99999999998643 


Q ss_pred             ----CeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeec
Q 014559          224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF  299 (422)
Q Consensus       224 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~Df  299 (422)
                          ...++||+++.+|+|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---cccccccccc
Confidence                34456667777999998773  35799999999999999999999999999999999999994   5899999999


Q ss_pred             CcccccCCCCCccccccCCcccCccccCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcCCCCCC----
Q 014559          300 GLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----  373 (422)
Q Consensus       300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  373 (422)
                      |++....  .......|+..|+|||++.+  .++.++|||||||++|+|++|+.||.+.........+........    
T Consensus       166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            9997543  34456789999999998653  478999999999999999999999988887776666654322211    


Q ss_pred             -------------------CC----CCCCCCHHHHHHHHHhchhccccCCCHHHHHhccCccch
Q 014559          374 -------------------DL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKLVVPIL  414 (422)
Q Consensus       374 -------------------~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l~~~~l  414 (422)
                                         ..    .+..+++++++||++||+.||.+|+|+.|+|+|+||.-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                               11    124688999999999999999999999999999999753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-51  Score=384.33  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=202.8

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      .+++|++++.||+|+||.||+|++..   +|+.||||++......     +.+.+|+++++.+++|++|+.+.+++.+.+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            45689999999999999999999877   7889999998764322     347889999999984556777777788889


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..++||||+ +++|.+.+......+++..+..++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.
T Consensus        77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            999999999 5578887777778899999999999999999999999999999999999997655677899999999987


Q ss_pred             cCCCC--------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH---cCCCCC
Q 014559          305 IRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNF  372 (422)
Q Consensus       305 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~  372 (422)
                      .....        .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+.   ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            65332        2345689999999999875 69999999999999999999999997755443322221   111001


Q ss_pred             -CCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 014559          373 -DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA  405 (422)
Q Consensus       373 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  405 (422)
                       ......++++++.+||.+||..||++||++.++
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence             111123689999999999999999999998755

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=382.96  Aligned_cols=253  Identities=18%  Similarity=0.305  Sum_probs=214.4

Q ss_pred             cceEEeceeCcCCCeEEEEEEecc--CCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       147 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++|++++.||+|+||.||+|.++.  ...+++.||||+++...  .......+.+|++++++++ |||||++++++...+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCC
Confidence            589999999999999999998753  11246789999997542  3334567899999999997 999999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCCEE
Q 014559          225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR  295 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~vk  295 (422)
                      .+++|||||.+|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||+   +.++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEE
Confidence            9999999999999999876421         347899999999999999999999999999999999999   4688999


Q ss_pred             EeecCcccccCCCCC---ccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHcCCC
Q 014559          296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDP  370 (422)
Q Consensus       296 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~  370 (422)
                      |+|||+++.......   .....||+.|+|||.+. +.++.++|||||||++|||++| ..||.+....+.+..+.+...
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999986643322   23457899999999986 5789999999999999999998 578888888888888776543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHHhc
Q 014559          371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALSK  408 (422)
Q Consensus       371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~  408 (422)
                      ...   ...+++++.+||.+||+.||++|||+.|++++
T Consensus       254 ~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         254 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            211   13689999999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-49  Score=371.83  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=207.4

Q ss_pred             cccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC
Q 014559          145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN  224 (422)
Q Consensus       145 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  224 (422)
                      ++.+|++++.||+|+||.||+|++..   +|+.||||++......     ..+.+|+++++.|.+|+||+.+++++.+..
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            46789999999999999999999887   7899999998654321     346789999999986799999999999999


Q ss_pred             eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCC--CCCCEEEeecCcc
Q 014559          225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGLS  302 (422)
Q Consensus       225 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~--~~~~vkl~DfG~a  302 (422)
                      ..++||||| +++|.+.+......++...+..++.|++.||+|||++|||||||||+|||++...  ..+.+||+|||+|
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            999999999 6799998877777899999999999999999999999999999999999996421  3578999999999


Q ss_pred             cccCCCC--------CccccccCCcccCccccCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHcCCC
Q 014559          303 DFIRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDP  370 (422)
Q Consensus       303 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  370 (422)
                      +......        .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...   ...+..+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            8754321        2345689999999999875 699999999999999999999999976433   223333322211


Q ss_pred             CC-CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHH
Q 014559          371 NF-DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL  406 (422)
Q Consensus       371 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~elL  406 (422)
                      .. .......+++++.++|..|+..+|++||+.+.+.
T Consensus       234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            11 1111236889999999999999999999976654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=373.95  Aligned_cols=249  Identities=23%  Similarity=0.290  Sum_probs=191.0

Q ss_pred             ccceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCC-
Q 014559          146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-  224 (422)
Q Consensus       146 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  224 (422)
                      ..+|.+.+.||+|+||.||+|+.     +|+.||||+++....    .....++|+..+..++ |||||++++++.+.+ 
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNG   71 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence            35789999999999999999985     567999999864422    1122344555666776 999999999998754 


Q ss_pred             ---eEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCcEEEeeCCCCCC
Q 014559          225 ---NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL--------QGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       225 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~--------~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                         .+|||||||++|+|.+++.+.  .+++..+..++.|++.||.|||+        +|||||||||+||||   +.++.
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~  146 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  146 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred             cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCC
Confidence               689999999999999998654  69999999999999999999996        599999999999999   46899


Q ss_pred             EEEeecCcccccCCCC-----CccccccCCcccCccccCcc-------CCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 014559          294 MRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSLEADIWSIGVISYILLCGSRPFWART----  357 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlG~il~ell~g~~pf~~~~----  357 (422)
                      +||+|||+++......     .....+||+.|+|||++.+.       ++.++|||||||+||||++|..||....    
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999999998764433     23456899999999998642       5778999999999999999988763321    


Q ss_pred             ----------hhHHHHHHHcC-CC--CCCCCC-CCCCCHHHHHHHHHhchhccccCCCHHHHHhcc
Q 014559          358 ----------ESGIFRAVLRS-DP--NFDDLP-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALSKL  409 (422)
Q Consensus       358 ----------~~~~~~~i~~~-~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~elL~~l  409 (422)
                                ........... ..  .++... ......++.+||.+||..||++|||+.|+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L  292 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                      11222222222 21  111100 011235699999999999999999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-46  Score=358.18  Aligned_cols=264  Identities=26%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             Ccccc-cceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhc----------CC
Q 014559          142 NKNFG-AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----------GH  210 (422)
Q Consensus       142 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h  210 (422)
                      ++.|. .+|+++++||+|+||+||+|+++.   +|+.||||++++...    ..+.+.+|+++++.+.          +|
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~   79 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGA   79 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence            34444 469999999999999999999987   889999999975432    2356788999998885          25


Q ss_pred             CCeeEEEeEEEe--CCeEEEEEEccCCCChHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEE
Q 014559          211 KHLVKFCDACED--VNNVYIVMELCEGGELLDRI--LARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLF  285 (422)
Q Consensus       211 ~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l--~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~Dikp~NIll  285 (422)
                      +||+++++++..  ....+++|+++..+......  ......+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus        80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll  159 (362)
T d1q8ya_          80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM  159 (362)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred             CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence            789999998865  35677777776554433322  2345679999999999999999999998 899999999999999


Q ss_pred             eeCCCC---CCEEEeecCcccccCCCCCccccccCCcccCccccC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--
Q 014559          286 TSGRDD---ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--  359 (422)
Q Consensus       286 ~~~~~~---~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--  359 (422)
                      +.++..   ..+||+|||.+....  ......+||+.|+|||++. ..|+.++|||||||++++|++|+.||......  
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             eccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            752211   248999999997653  3345678999999999875 57999999999999999999999999654321  


Q ss_pred             ----HHHHHHHcC--C----------------------CCCCCC--------------CCCCCCHHHHHHHHHhchhccc
Q 014559          360 ----GIFRAVLRS--D----------------------PNFDDL--------------PWPSVSPEAKDFVKRLLNKDYR  397 (422)
Q Consensus       360 ----~~~~~i~~~--~----------------------~~~~~~--------------~~~~~s~~~~~li~~~L~~dP~  397 (422)
                          ..+......  .                      ..+...              .+...+++++|||.+||.+||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence                111111100  0                      000000              0112457899999999999999


Q ss_pred             cCCCHHHHHhccCccch
Q 014559          398 KRMTAVQALSKLVVPIL  414 (422)
Q Consensus       398 ~Rps~~elL~~l~~~~l  414 (422)
                      +|||++|+|+|+||+..
T Consensus       318 ~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TCBCHHHHHTCGGGTTC
T ss_pred             HCcCHHHHhcCcccCCC
Confidence            99999999999999743

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=5.4e-28  Score=211.09  Aligned_cols=167  Identities=25%  Similarity=0.265  Sum_probs=123.3

Q ss_pred             eEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccc---------------hhcHHHHHHHHHHHHHhcCCCCe
Q 014559          149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---------------AISIEDVRREVKILKALSGHKHL  213 (422)
Q Consensus       149 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~~h~ni  213 (422)
                      +.++++||+|+||.||+|++.    +|+.||||+++......               ........+|...+.++. |.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v   76 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV   76 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred             chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence            467899999999999999875    57899999876422110               011233567889999997 9999


Q ss_pred             eEEEeEEEeCCeEEEEEEccCCCChHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEeeCCCCCC
Q 014559          214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD  293 (422)
Q Consensus       214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~Dikp~NIll~~~~~~~~  293 (422)
                      +..+++..    .++||||+++..+.        .++...+..++.|++.+|.|||++||+||||||+|||++    +..
T Consensus        77 ~~~~~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~  140 (191)
T d1zara2          77 PKVYAWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEG  140 (191)
T ss_dssp             CCEEEEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTE
T ss_pred             ceEEEecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCC
Confidence            99887632    27999999886543        255566778999999999999999999999999999996    445


Q ss_pred             EEEeecCcccccCCCCCccccccCCcccC------ccccCccCCCchhHHHHHHHH
Q 014559          294 MRLIDFGLSDFIRPDERLNDIVGSAYYVA------PEVLHRSYSLEADIWSIGVIS  343 (422)
Q Consensus       294 vkl~DfG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DvwSlG~il  343 (422)
                      ++|+|||+|.........       .|..      -|.+.+.|+.++|+||+.--+
T Consensus       141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            999999999765432211       1111      123346789999999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.74  E-value=4.6e-08  Score=87.23  Aligned_cols=85  Identities=16%  Similarity=0.139  Sum_probs=61.9

Q ss_pred             ceEEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       148 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      .|+..+..+-++.+.||+...     ++..++||+.......   ....+.+|..++..|.++--+.+++.++.+++..+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            566666655455578998863     4556888987543322   22457889999998876655788899999999999


Q ss_pred             EEEEccCCCChHH
Q 014559          228 IVMELCEGGELLD  240 (422)
Q Consensus       228 lv~e~~~~g~L~~  240 (422)
                      +||++++|.++.+
T Consensus        87 lv~~~l~G~~~~~   99 (263)
T d1j7la_          87 LLMSEADGVLCSE   99 (263)
T ss_dssp             EEEECCSSEEHHH
T ss_pred             EEEEecccccccc
Confidence            9999998877644

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.32  E-value=8.9e-07  Score=83.68  Aligned_cols=82  Identities=17%  Similarity=0.198  Sum_probs=52.6

Q ss_pred             eceeCcCCCeEEEEEEeccCCccCceEEEEEeeccc----ccchhcHHHHHHHHHHHHHhcCC--CCeeEEEeEEEeCCe
Q 014559          152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAK----MTTAISIEDVRREVKILKALSGH--KHLVKFCDACEDVNN  225 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~  225 (422)
                      .+.||.|....||++.+..   .++.|+||.-....    .......++...|.+.|+.+..+  ..+.+++.+  +...
T Consensus        31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred             EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence            4578999999999998765   56789999753211    11112335567799989887644  346677655  3445


Q ss_pred             EEEEEEccCCCCh
Q 014559          226 VYIVMELCEGGEL  238 (422)
Q Consensus       226 ~~lv~e~~~~g~L  238 (422)
                      .++|||++.+..+
T Consensus       106 ~~lvmE~L~~~~~  118 (392)
T d2pula1         106 AVTVMEDLSHLKI  118 (392)
T ss_dssp             TEEEECCCTTSEE
T ss_pred             CEEEEeccCCccc
Confidence            5789999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.16  E-value=3.1e-06  Score=74.54  Aligned_cols=75  Identities=12%  Similarity=0.132  Sum_probs=53.2

Q ss_pred             eeCcCCC-eEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCC-CeeEEEeEEEeCCeEEEEEE
Q 014559          154 EVGRGHF-GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACEDVNNVYIVME  231 (422)
Q Consensus       154 ~lG~G~~-g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e  231 (422)
                      .+..|.. +.||+....    .+..+++|.......      ..+..|...++.|..+. .+.+++.+..+.+..++||+
T Consensus        17 ~~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~   86 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   86 (255)
T ss_dssp             ECSCTTSSCEEEEEECT----TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             EcCCcccCCeEEEEEeC----CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence            3444543 678988764    455688898654321      34678899998887432 26778888888889999999


Q ss_pred             ccCCCCh
Q 014559          232 LCEGGEL  238 (422)
Q Consensus       232 ~~~~g~L  238 (422)
                      +++|.++
T Consensus        87 ~i~G~~~   93 (255)
T d1nd4a_          87 EVPGQDL   93 (255)
T ss_dssp             CCSSEET
T ss_pred             eeecccc
Confidence            9987654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.54  E-value=0.00013  Score=68.37  Aligned_cols=78  Identities=13%  Similarity=0.012  Sum_probs=53.5

Q ss_pred             eceeCcCCCeEEEEEEeccCC----ccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCeeEEEeEEEeCCeEE
Q 014559          152 GKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY  227 (422)
Q Consensus       152 ~~~lG~G~~g~V~~a~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  227 (422)
                      ++.|+.|---.+|++....+.    ...+.|.+++....  .   ......+|..+++.+..+.-..++++++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            357877777899999865432    13456778776421  1   223456899999999866656688888754    5


Q ss_pred             EEEEccCCCCh
Q 014559          228 IVMELCEGGEL  238 (422)
Q Consensus       228 lv~e~~~~g~L  238 (422)
                      +||||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.46  E-value=0.0003  Score=63.96  Aligned_cols=67  Identities=9%  Similarity=0.115  Sum_probs=45.4

Q ss_pred             eEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCCCCee--EEE-----eEEEeCCeEEEEEEcc
Q 014559          161 GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV--KFC-----DACEDVNNVYIVMELC  233 (422)
Q Consensus       161 g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv--~l~-----~~~~~~~~~~lv~e~~  233 (422)
                      -.||+++..    +|+.|++|+.+...    ...+.+..|...+..|.++ .|.  ..+     ..+...+..+.+++++
T Consensus        36 N~vy~v~~~----dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          36 NRVYQFQDE----DRRRFVVKFYRPER----WTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             SEEEEECCT----TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             ceeEEEEcC----CCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence            589999865    67789999986432    2346788899999888732 221  111     1334567789999999


Q ss_pred             CCC
Q 014559          234 EGG  236 (422)
Q Consensus       234 ~~g  236 (422)
                      .|.
T Consensus       107 ~G~  109 (325)
T d1zyla1         107 GGR  109 (325)
T ss_dssp             CCE
T ss_pred             CCc
Confidence            763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.38  E-value=0.0033  Score=56.27  Aligned_cols=142  Identities=16%  Similarity=0.118  Sum_probs=72.3

Q ss_pred             EEeceeCcCCCeEEEEEEeccCCccCceEEEEEeecccccchhcHHHHHHHHHHHHHhcCC----CCeeEEE---eEEEe
Q 014559          150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH----KHLVKFC---DACED  222 (422)
Q Consensus       150 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----~niv~l~---~~~~~  222 (422)
                      .-.+.|..|---+.|+.....     ..+++|++....     ..+.+..|++++..|..+    |..+...   .+...
T Consensus        21 ~~~~~i~~G~~N~ny~v~t~~-----g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          21 TSYKGIAEGVENSNFLLHTTK-----DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             EEEEEECC---EEEEEEEESS-----CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eEeecCCCCcccCeEEEEECC-----CcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            334456667667889887542     358999985431     124566788888887632    1111110   11223


Q ss_pred             CCeEEEEEEccCCCChH--------------HHHHHhCC--------CCCHH------------------HHHHHHHHHH
Q 014559          223 VNNVYIVMELCEGGELL--------------DRILARGG--------RYTEE------------------DAKAIVVQIL  262 (422)
Q Consensus       223 ~~~~~lv~e~~~~g~L~--------------~~l~~~~~--------~l~~~------------------~~~~i~~ql~  262 (422)
                      .+....++.++.+....              ..+.....        .....                  .....+..+.
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence            45566777776653221              01110000        00111                  1122222222


Q ss_pred             HHHHHHH----HCCCeecCCCCCcEEEeeCCCCCCEEEeecCcccc
Q 014559          263 SVVAFCH----LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF  304 (422)
Q Consensus       263 ~aL~~LH----~~~iiH~Dikp~NIll~~~~~~~~vkl~DfG~a~~  304 (422)
                      ..+.-.+    ..|+||+|+.++||+++   .+...-|+||+.+..
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             HhhhccCccccccccccCCcchhhhhcc---cccceeEeccccccc
Confidence            3232222    24799999999999995   344557999998853